Citrus Sinensis ID: 035917
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 611 | 2.2.26 [Sep-21-2011] | |||||||
| O04567 | 601 | Probable inactive recepto | no | no | 0.914 | 0.930 | 0.629 | 0.0 | |
| C0LGI5 | 591 | Probable LRR receptor-lik | no | no | 0.914 | 0.945 | 0.585 | 0.0 | |
| Q9ASS4 | 620 | Probably inactive leucine | no | no | 0.888 | 0.875 | 0.448 | 1e-140 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.785 | 0.402 | 0.366 | 4e-80 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.767 | 0.388 | 0.383 | 2e-79 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.767 | 0.388 | 0.383 | 2e-79 | |
| Q9ZWC8 | 1166 | Serine/threonine-protein | no | no | 0.767 | 0.402 | 0.361 | 3e-78 | |
| O22476 | 1196 | Protein BRASSINOSTEROID I | no | no | 0.785 | 0.401 | 0.368 | 8e-78 | |
| Q9LJF3 | 1164 | Receptor-like protein kin | no | no | 0.779 | 0.408 | 0.352 | 8e-77 | |
| Q9ZPS9 | 1143 | Serine/threonine-protein | no | no | 0.795 | 0.425 | 0.328 | 4e-71 |
| >sp|O04567|Y1719_ARATH Probable inactive receptor kinase At1g27190 OS=Arabidopsis thaliana GN=At1g27190 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 743 bits (1919), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/578 (62%), Positives = 456/578 (78%), Gaps = 19/578 (3%)
Query: 48 AEDDVKCLEGVKSSLNDPQRKLSSWSFGNSTIGFICQFVGVSCWNDKENRILNLELREMK 107
AEDDV CL+G+K+SL DP +LSSWSF NS+ IC+ GVSCWN+KENRI++L+L+ M+
Sbjct: 24 AEDDVLCLQGLKNSLIDPSSRLSSWSFPNSSASSICKLTGVSCWNEKENRIISLQLQSMQ 83
Query: 108 LSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGN 167
L+G+IPE LK C+S+Q LDLS NDLSG+IP+QIC+WLPYLV LDLS N L G IP +
Sbjct: 84 LAGEIPESLKLCRSLQSLDLSGNDLSGSIPSQICSWLPYLVTLDLSGNKLGGSIPTQIVE 143
Query: 168 CTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKADFDGNSDL 227
C +LN LILS+NKLSG IP QLS L RL++ S+A NDL+GTIPS F DF GN+ L
Sbjct: 144 CKFLNALILSDNKLSGSIPSQLSRLDRLRRLSLAGNDLSGTIPSELARFGGDDFSGNNGL 203
Query: 228 CGGPLGSKCGGLSKKNLAIIIAAGIFGAAASMLLAFGLWWWYHLRWVRRRKRGYGIGRDD 287
CG PL S+CG L+ +NL+III AG+ GA S+ + ++WW+ +R R+K+GYG G+
Sbjct: 204 CGKPL-SRCGALNGRNLSIIIVAGVLGAVGSLCVGLVIFWWFFIREGSRKKKGYGAGKSK 262
Query: 288 DDSRWLERLRSHKLAQVSLFQKPLVKVKLADLMAASNSFCSENVIISTRTGTTYKAMLPD 347
DDS W+ LRSHKL QV+LFQKP+VK+KL DLMAA+N+F S N+ +S+RTG +YKA LPD
Sbjct: 263 DDSDWIGLLRSHKLVQVTLFQKPIVKIKLGDLMAATNNFSSGNIDVSSRTGVSYKADLPD 322
Query: 348 GSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLY 407
GS LAVKRL+ C GEK+FR+EMN+LG+LRHPNL PLLGYCVVE+E+LL+YK+M +GTL+
Sbjct: 323 GSALAVKRLSACGFGEKQFRSEMNKLGELRHPNLVPLLGYCVVEDERLLVYKHMVNGTLF 382
Query: 408 SLLQGNA---TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARI 464
S L LDWPTR IG+GAA+GLAWLHHGCQPP+LHQ I SNVIL+D+DFDARI
Sbjct: 383 SQLHNGGLCDAVLDWPTRRAIGVGAAKGLAWLHHGCQPPYLHQFISSNVILLDDDFDARI 442
Query: 465 MDFGLAKLMTSSD--ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELA--- 519
D+GLAKL+ S D +SSF NGDLGE GY+APEYSSTMVASLKGDVYG G+VLLEL
Sbjct: 443 TDYGLAKLVGSRDSNDSSFNNGDLGELGYVAPEYSSTMVASLKGDVYGFGIVLLELVTGQ 502
Query: 520 ----------GFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSR 569
GFKG+LVDWV+Q +GRSK+AID+++C KG+DEEILQFLK+AC+CVVSR
Sbjct: 503 KPLSVINGVEGFKGSLVDWVSQYLGTGRSKDAIDRSICDKGHDEEILQFLKIACSCVVSR 562
Query: 570 PKDRWSMYQVYQSLNSIAAQHGFSERYDEFPLIFHRQD 607
PK+R +M QVY+SL ++A +HG SE YDEFPL+F++Q+
Sbjct: 563 PKERPTMIQVYESLKNMADKHGVSEHYDEFPLVFNKQE 600
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGI5|Y1699_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g69990 OS=Arabidopsis thaliana GN=At1g69990 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 696 bits (1797), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/584 (58%), Positives = 449/584 (76%), Gaps = 25/584 (4%)
Query: 42 LASETVAEDDVKCLEGVKSSLNDPQRKLSSWSFGNSTIGFICQFVGVSCWNDKENRILNL 101
L S + AEDDV CL+G KSSL DP +L++WSF NS+ IC+ GVSCWN KENRIL+L
Sbjct: 12 LMSSSHAEDDVLCLKGFKSSLKDPSNQLNTWSFPNSSSS-ICKLTGVSCWNAKENRILSL 70
Query: 102 ELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPI 161
+L+ M+LSG+IPE LK C+S+Q LDLS ND SG IP+QIC+WLPYLV LDLS N LSG I
Sbjct: 71 QLQSMQLSGQIPESLKLCRSLQSLDLSFNDFSGLIPSQICSWLPYLVTLDLSGNKLSGSI 130
Query: 162 PADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKADF 221
P+ + +C +LN+L L+ NKL+G IP +L+ L RL++ S+A+NDL+G+IPS + + F
Sbjct: 131 PSQIVDCKFLNSLALNQNKLTGSIPSELTRLNRLQRLSLADNDLSGSIPSELSHYGEDGF 190
Query: 222 DGNSDLCGGPLGSKCGGLSKKNLAIIIAAGIFGAAASMLLAFGLWWWYHLRWVRRRKR-G 280
GN LCG PL S CG + KNL II+ AG+ GA S+ + FG++WW+ +R R+ G
Sbjct: 191 RGNGGLCGKPL-SNCGSFNGKNLTIIVTAGVIGAVGSLCVGFGMFWWFFIRDRRKMNNYG 249
Query: 281 YGIGRDDDDSRWLERLRSHKLAQVSLFQKPLVKVKLADLMAASNSFCSENVIISTRTGTT 340
YG G+ DDS W+ LRSHKL QV+LFQKP+VK+KL DL+ A+N F S N+++S+R+G +
Sbjct: 250 YGAGKCKDDSDWIGLLRSHKLVQVTLFQKPIVKIKLVDLIEATNGFDSGNIVVSSRSGVS 309
Query: 341 YKAMLPDGSVLAVKRLNT-CKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399
YKA LPDGS L VKRL++ C+L EK+FR+E+N+LGQ+RHPNL PLLG+CVVE+E LL+YK
Sbjct: 310 YKADLPDGSTLEVKRLSSCCELSEKQFRSEINKLGQIRHPNLVPLLGFCVVEDEILLVYK 369
Query: 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDED 459
+M++GTLYS LQ ++DWPTR R+ +GAARGLAWLHHGCQP ++HQ I SNVIL+DED
Sbjct: 370 HMANGTLYSQLQ--QWDIDWPTRVRVAVGAARGLAWLHHGCQPLYMHQYISSNVILLDED 427
Query: 460 FDARIMDFGLAKLMTSSD--ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLE 517
FDAR++D+GL KL++S D +SSF N G+FGY+APEYSSTMVASL GDVYG G+VLLE
Sbjct: 428 FDARVIDYGLGKLVSSQDSKDSSFSN---GKFGYVAPEYSSTMVASLSGDVYGFGIVLLE 484
Query: 518 LA-------------GFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACN 564
+ GFK +LV+WV++ S+GRSK+AID+ + GKGYD+EI+Q L++AC+
Sbjct: 485 IVTGQKPVLINNGEEGFKESLVEWVSKHLSNGRSKDAIDRRIFGKGYDDEIMQVLRIACS 544
Query: 565 CVVSRPKDRWSMYQVYQSLNSIAAQHG-FSERYDEFPLIFHRQD 607
CVVSRPK+R M QVY+SL ++ QHG FSE DEFPLIF++Q+
Sbjct: 545 CVVSRPKERPLMIQVYESLKNLGDQHGFFSEYSDEFPLIFNKQE 588
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ASS4|Y5838_ARATH Probably inactive leucine-rich repeat receptor-like protein kinase At5g48380 OS=Arabidopsis thaliana GN=At5g48380 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 499 bits (1284), Expect = e-140, Method: Compositional matrix adjust.
Identities = 259/578 (44%), Positives = 361/578 (62%), Gaps = 35/578 (6%)
Query: 49 EDDVKCLEGVKSSLNDPQRKLSSWSFGNSTIGFICQFVGVSCWNDKENRILNLELREMKL 108
+ ++ CL KS + DP R LS+W FGN T G+IC+F GV+CW+D ENR+L+++L L
Sbjct: 29 QANIDCLRTFKSQVEDPNRYLSTWVFGNETAGYICKFSGVTCWHDDENRVLSIKLSGYGL 88
Query: 109 SGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNC 168
G P +K C + LDLS N+ SG +PA I +P + +LDLS N SG IP + N
Sbjct: 89 RGVFPPAVKLCADLTGLDLSRNNFSGPLPANISTLIPLVTILDLSYNSFSGEIPMLISNI 148
Query: 169 TYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG--FDKADFDGNSD 226
T+LNTL+L +N+ +G +P QL+ LGRLK FSV++N L G IP+ + F + F N D
Sbjct: 149 TFLNTLMLQHNQFTGTLPPQLAQLGRLKTFSVSDNRLVGPIPNFNQTLQFKQELFANNLD 208
Query: 227 LCGGPLGS-KCGGLSKKNLAIIIAAGIFGAAASMLLAFGLWWWYHLRWVRRRKRGYGIGR 285
LCG PL K S+ + II A G AAA ++ +++ L VR+++
Sbjct: 209 LCGKPLDDCKSASSSRGKVVIIAAVGGLTAAALVVGVVLFFYFRKLGAVRKKQ------D 262
Query: 286 DDDDSRWLERLRSHKLAQVSLFQKPLVKVKLADLMAASNSFCSENVIISTRTGTTYKAML 345
D + +RW + L+ K +V +F+K + K+KL+DLM A+ F +N+I + RTGT YK L
Sbjct: 263 DPEGNRWAKSLKGQKGVKVFMFKKSVSKMKLSDLMKATEEFKKDNIIATGRTGTMYKGRL 322
Query: 346 PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGT 405
DGS+L +KRL + EK+F EM LG +++ NL PLLGYCV +E+LL+Y+YM++G
Sbjct: 323 EDGSLLMIKRLQDSQRSEKEFDAEMKTLGSVKNRNLVPLLGYCVANKERLLMYEYMANGY 382
Query: 406 LYSLLQGNATE----LDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFD 461
LY L E LDWP+R +I +G A+GLAWLHH C P +H+NI S IL+ +F+
Sbjct: 383 LYDQLHPADEESFKPLDWPSRLKIAIGTAKGLAWLHHSCNPRIIHRNISSKCILLTAEFE 442
Query: 462 ARIMDFGLAKLMTSSDE--SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELA 519
+I DFGLA+LM D S+FVNG+ G+FGY+APEYS TMVA+ KGDVY GVVLLEL
Sbjct: 443 PKISDFGLARLMNPIDTHLSTFVNGEFGDFGYVAPEYSRTMVATPKGDVYSFGVVLLELV 502
Query: 520 -------------------GFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLK 560
FKGNLV+W+ +LSS + +EAID++L G G D+EI + LK
Sbjct: 503 TGQKATSVTKVSEEKAEEENFKGNLVEWITKLSSESKLQEAIDRSLLGNGVDDEIFKVLK 562
Query: 561 VACNCVVSR-PKDRWSMYQVYQSLNSIAAQHGFSERYD 597
VACNCV+ K R +M++VYQ L +I + F+ D
Sbjct: 563 VACNCVLPEIAKQRPTMFEVYQLLRAIGESYNFTADDD 600
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 299 bits (766), Expect = 4e-80, Method: Compositional matrix adjust.
Identities = 192/524 (36%), Positives = 283/524 (54%), Gaps = 44/524 (8%)
Query: 98 ILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDL 157
++ L L + KL G +P L K + +DLS N+LSG + +++ + LV L + N
Sbjct: 678 LVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELST-MEKLVGLYIEQNKF 736
Query: 158 SGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFD 217
+G IP++LGN T L L +S N LSG IP ++ L L+ ++A N+L G +PS D
Sbjct: 737 TGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQD 796
Query: 218 --KADFDGNSDLCGGPLGSKCGGLSKKNLAIIIAAGIFGAAASMLLAFGLWWWYHLRWVR 275
KA GN +LCG +GS C + + A GI G ++L F + + + +R
Sbjct: 797 PSKALLSGNKELCGRVVGSDC---KIEGTKLRSAWGIAG----LMLGFTIIVFVFVFSLR 849
Query: 276 RRKRGYGIGRDDDDSRWLE-----------------RLRSHKLAQVSLFQKPLVKVKLAD 318
R + + DD R E R R +++F++PL+KV+L D
Sbjct: 850 RWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGD 909
Query: 319 LMAASNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKL-GEKKFRNEMNRLGQLR 377
++ A++ F +N+I GT YKA LP +AVK+L+ K G ++F EM LG+++
Sbjct: 910 IVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKVK 969
Query: 378 HPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQ---GNATELDWPTRFRIGLGAARGLA 434
HPNL LLGYC EEKLL+Y+YM +G+L L+ G LDW R +I +GAARGLA
Sbjct: 970 HPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLA 1029
Query: 435 WLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAP 494
+LHHG P +H++I ++ IL+D DF+ ++ DFGLA+L+ S+ ES G FGYI P
Sbjct: 1030 FLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLI-SACESHVSTVIAGTFGYIPP 1088
Query: 495 EYSSTMVASLKGDVYGIGVVLLELAGFK------------GNLVDWVNQLSSSGRSKEAI 542
EY + A+ KGDVY GV+LLEL K GNLV W Q + G++ + I
Sbjct: 1089 EYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAVDVI 1148
Query: 543 DKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586
D L L+ L++A C+ P R +M V ++L I
Sbjct: 1149 DPLLVSVALKNSQLRLLQIAMLCLAETPAKRPNMLDVLKALKEI 1192
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 297 bits (761), Expect = 2e-79, Method: Compositional matrix adjust.
Identities = 195/509 (38%), Positives = 277/509 (54%), Gaps = 40/509 (7%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNK 180
SM LDLS N L G+IP ++ + YL +L+L +NDLSG IP LG + L LS N+
Sbjct: 664 SMIFLDLSYNKLEGSIPKEL-GAMYYLSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNR 722
Query: 181 LSGPIPYQLSNLGRLKKFSVANNDLTGTIPSS--FKGFDKADFDGNSDLCGGPLGSKCGG 238
+G IP L++L L + ++NN+L+G IP S F F F NS LCG PL C
Sbjct: 723 FNGTIPNSLTSLTLLGEIDLSNNNLSGMIPESAPFDTFPDYRFANNS-LCGYPLPLPCSS 781
Query: 239 ----------LSKKNLAIIIAAGIFGAAASMLLAFGLWWWYHLRWVRRRKR-----GYGI 283
S + A + + G S+ FGL RRRK+ Y
Sbjct: 782 GPKSDANQHQKSHRRQASLAGSVAMGLLFSLFCIFGLIIVAIETKKRRRKKEAALEAYMD 841
Query: 284 GRDDD---DSRW-LERLRSHKLAQVSLFQKPLVKVKLADLMAASNSFCSENVIISTRTGT 339
G +S W R ++ F+KPL K+ ADL+ A+N F +++++ S G
Sbjct: 842 GHSHSATANSAWKFTSAREALSINLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGD 901
Query: 340 TYKAMLPDGSVLAVKRL-NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398
YKA L DGSV+A+K+L + G+++F EM +G+++H NL PLLGYC V EE+LL+Y
Sbjct: 902 VYKAQLKDGSVVAIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 961
Query: 399 KYMSSGTLYSLLQG---NATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVIL 455
+YM G+L +L +L+WP R +I +GAARGLA+LHH C P +H+++ S+ +L
Sbjct: 962 EYMKYGSLEDVLHDRKKTGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVL 1021
Query: 456 VDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVL 515
+DE+ +AR+ DFG+A+LM++ D V+ G GY+ PEY + S KGDVY GVVL
Sbjct: 1022 LDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVL 1081
Query: 516 LELAGFK----------GNLVDWVNQLSSSGRSKEAIDKALCGK--GYDEEILQFLKVAC 563
LEL K NLV WV +L + G+ + D+ L + + E+LQ LKVAC
Sbjct: 1082 LELLTGKQPTDSADFGDNNLVGWV-KLHAKGKITDVFDRELLKEDASIEIELLQHLKVAC 1140
Query: 564 NCVVSRPKDRWSMYQVYQSLNSIAAQHGF 592
C+ R R +M QV I A G
Sbjct: 1141 ACLDDRHWKRPTMIQVMAMFKEIQAGSGM 1169
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 297 bits (761), Expect = 2e-79, Method: Compositional matrix adjust.
Identities = 195/509 (38%), Positives = 277/509 (54%), Gaps = 40/509 (7%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNK 180
SM LDLS N L G+IP ++ + YL +L+L +NDLSG IP LG + L LS N+
Sbjct: 664 SMIFLDLSYNKLEGSIPKEL-GAMYYLSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNR 722
Query: 181 LSGPIPYQLSNLGRLKKFSVANNDLTGTIPSS--FKGFDKADFDGNSDLCGGPLGSKCGG 238
+G IP L++L L + ++NN+L+G IP S F F F NS LCG PL C
Sbjct: 723 FNGTIPNSLTSLTLLGEIDLSNNNLSGMIPESAPFDTFPDYRFANNS-LCGYPLPIPCSS 781
Query: 239 ----------LSKKNLAIIIAAGIFGAAASMLLAFGLWWWYHLRWVRRRKR-----GYGI 283
S + A + + G S+ FGL RRRK+ Y
Sbjct: 782 GPKSDANQHQKSHRRQASLAGSVAMGLLFSLFCIFGLIIVAIETKKRRRKKEAALEAYMD 841
Query: 284 GRDDD---DSRW-LERLRSHKLAQVSLFQKPLVKVKLADLMAASNSFCSENVIISTRTGT 339
G +S W R ++ F+KPL K+ ADL+ A+N F +++++ S G
Sbjct: 842 GHSHSATANSAWKFTSAREALSINLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGD 901
Query: 340 TYKAMLPDGSVLAVKRL-NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398
YKA L DGSV+A+K+L + G+++F EM +G+++H NL PLLGYC V EE+LL+Y
Sbjct: 902 VYKAQLKDGSVVAIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 961
Query: 399 KYMSSGTLYSLLQGN---ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVIL 455
+YM G+L +L +L+WP R +I +GAARGLA+LHH C P +H+++ S+ +L
Sbjct: 962 EYMKYGSLEDVLHDRKKIGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVL 1021
Query: 456 VDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVL 515
+DE+ +AR+ DFG+A+LM++ D V+ G GY+ PEY + S KGDVY GVVL
Sbjct: 1022 LDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVL 1081
Query: 516 LELAGFK----------GNLVDWVNQLSSSGRSKEAIDKALCGK--GYDEEILQFLKVAC 563
LEL K NLV WV +L + G+ + D+ L + + E+LQ LKVAC
Sbjct: 1082 LELLTGKQPTDSADFGDNNLVGWV-KLHAKGKITDVFDRELLKEDASIEIELLQHLKVAC 1140
Query: 564 NCVVSRPKDRWSMYQVYQSLNSIAAQHGF 592
C+ R R +M QV I A G
Sbjct: 1141 ACLDDRHWKRPTMIQVMAMFKEIQAGSGM 1169
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 293 bits (750), Expect = 3e-78, Method: Compositional matrix adjust.
Identities = 190/525 (36%), Positives = 279/525 (53%), Gaps = 56/525 (10%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNK 180
SM D+S N +SG IP N + YL +L+L +N ++G IP G + L LS+N
Sbjct: 640 SMIYFDISYNAVSGFIPPGYGN-MGYLQVLNLGHNRITGTIPDSFGGLKAIGVLDLSHNN 698
Query: 181 LSGPIPYQLSNLGRLKKFSVANNDLTGTIP--SSFKGFDKADFDGNSDLCGGPLGSKCGG 238
L G +P L +L L V+NN+LTG IP F + + NS LCG PL CG
Sbjct: 699 LQGYLPGSLGSLSFLSDLDVSNNNLTGPIPFGGQLTTFPVSRYANNSGLCGVPL-RPCGS 757
Query: 239 L-----------SKKNLAIIIAAGIFGAAASMLLAFGLWWWYHLRWVRRRKRGYGIGRDD 287
K+ +A + AGI A + M + Y +R V+++++
Sbjct: 758 APRRPITSRIHAKKQTVATAVIAGI--AFSFMCFVMLVMALYRVRKVQKKEQ-------- 807
Query: 288 DDSRWLERLR-----SHKLA--------QVSLFQKPLVKVKLADLMAASNSFCSENVIIS 334
+++E L S KL+ V+ F+KPL K+ A L+ A+N F +E ++ S
Sbjct: 808 KREKYIESLPTSGSCSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSAETMVGS 867
Query: 335 TRTGTTYKAMLPDGSVLAVKRL-NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEE 393
G YKA L DGSV+A+K+L G+++F EM +G+++H NL PLLGYC V EE
Sbjct: 868 GGFGEVYKAQLRDGSVVAIKKLIRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEE 927
Query: 394 KLLIYKYMSSGTLYSLLQGNATE-----LDWPTRFRIGLGAARGLAWLHHGCQPPFLHQN 448
+LL+Y+YM G+L ++L +++ L+W R +I +GAARGLA+LHH C P +H++
Sbjct: 928 RLLVYEYMKWGSLETVLHEKSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRD 987
Query: 449 ICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDV 508
+ S+ +L+DEDF+AR+ DFG+A+L+++ D V+ G GY+ PEY + + KGDV
Sbjct: 988 MKSSNVLLDEDFEARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDV 1047
Query: 509 YGIGVVLLELA-----------GFKGNLVDWVNQLSSSGRSKEAIDKALCG-KGYDEEIL 556
Y GV+LLEL G NLV W QL R E +D L K D E+
Sbjct: 1048 YSYGVILLELLSGKKPIDPGEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELF 1107
Query: 557 QFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFSERYDEFPL 601
+LK+A C+ RP R +M Q+ + A E DEF L
Sbjct: 1108 HYLKIASQCLDDRPFKRPTMIQLMAMFKEMKADTEEDESLDEFSL 1152
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 291 bits (746), Expect = 8e-78, Method: Compositional matrix adjust.
Identities = 196/532 (36%), Positives = 287/532 (53%), Gaps = 52/532 (9%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNK 180
SM LD+S N LSG IP +I + +PYL +L+L +ND+SG IP ++G+ LN L LS+NK
Sbjct: 655 SMMFLDMSYNMLSGYIPKEIGS-MPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 713
Query: 181 LSGPIPYQLSNLGRLKKFSVANNDLTGTIPS--SFKGFDKADFDGNSDLCGGPL------ 232
L G IP +S L L + ++NN+L+G IP F+ F A F N LCG PL
Sbjct: 714 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPS 773
Query: 233 -------GSKCGGLSKKNLAIIIAAGIFGAAASMLLAFGLWW---------WYHLRWVRR 276
+ G +LA +A G+ S + FGL +
Sbjct: 774 NADGYAHHQRSHGRRPASLAGSVAMGLL---FSFVCIFGLILVGREMRKRRRKKEAELEM 830
Query: 277 RKRGYGIG--RDDDDSRW-LERLRSHKLAQVSLFQKPLVKVKLADLMAASNSFCSENVII 333
G+G R +++ W L ++ ++ F+KPL K+ ADL+ A+N F ++++I
Sbjct: 831 YAEGHGNSGDRTANNTNWKLTGVKEALSINLAAFEKPLRKLTFADLLQATNGFHNDSLIG 890
Query: 334 STRTGTTYKAMLPDGSVLAVKRL-NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE 392
S G YKA+L DGS +A+K+L + G+++F EM +G+++H NL PLLGYC V +
Sbjct: 891 SGGFGDVYKAILKDGSAVAIKKLIHVSGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGD 950
Query: 393 EKLLIYKYMSSGTLYSLLQG---NATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNI 449
E+LL+Y++M G+L +L +L+W TR +I +G+ARGLA+LHH C P +H+++
Sbjct: 951 ERLLVYEFMKYGSLEDVLHDPKKAGVKLNWSTRRKIAIGSARGLAFLHHNCSPHIIHRDM 1010
Query: 450 CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVY 509
S+ +L+DE+ +AR+ DFG+A+LM++ D V+ G GY+ PEY + S KGDVY
Sbjct: 1011 KSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVY 1070
Query: 510 GIGVVLLELAGFK----------GNLVDWVNQLSSSGRSKEAIDKALCGK--GYDEEILQ 557
GVVLLEL K NLV WV Q + R + D L + + E+LQ
Sbjct: 1071 SYGVVLLELLTGKRPTDSPDFGDNNLVGWVKQ-HAKLRISDVFDPELMKEDPALEIELLQ 1129
Query: 558 FLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFSERYDEFPLIFHRQDGG 609
LKVA C+ R R +M QV I A G D I +DGG
Sbjct: 1130 HLKVAVACLDDRAWRRPTMVQVMAMFKEIQAGSGI----DSQSTIRSIEDGG 1177
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 288 bits (737), Expect = 8e-77, Method: Compositional matrix adjust.
Identities = 188/533 (35%), Positives = 279/533 (52%), Gaps = 57/533 (10%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNK 180
SM LDLS N +SG+IP + YL +L+L +N L+G IP G + L LS+N
Sbjct: 640 SMIYLDLSYNAVSGSIPLGY-GAMGYLQVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHND 698
Query: 181 LSGPIPYQLSNLGRLKKFSVANNDLTGTIP--SSFKGFDKADFDGNSDLCGGPLGSKCGG 238
L G +P L L L V+NN+LTG IP F + NS LCG PL G
Sbjct: 699 LQGFLPGSLGGLSFLSDLDVSNNNLTGPIPFGGQLTTFPLTRYANNSGLCGVPLPPCSSG 758
Query: 239 L---------SKKNLAIIIAAGIFGAAASMLLAFGLWWWYHLRWVRRRKRGYGIGRDDDD 289
K+++A ++AGI + M + + Y R V+++++
Sbjct: 759 SRPTRSHAHPKKQSIATGMSAGI--VFSFMCIVMLIMALYRARKVQKKEK--------QR 808
Query: 290 SRWLERLRSHKLA-------------QVSLFQKPLVKVKLADLMAASNSFCSENVIISTR 336
+++E L + + V+ F+KPL K+ A L+ A+N F ++++I S
Sbjct: 809 EKYIESLPTSGSSSWKLSSVHEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGG 868
Query: 337 TGTTYKAMLPDGSVLAVKRL-NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395
G YKA L DGSV+A+K+L G+++F EM +G+++H NL PLLGYC + EE+L
Sbjct: 869 FGDVYKAKLADGSVVAIKKLIQVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERL 928
Query: 396 LIYKYMSSGTLYSLLQGNATE----LDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICS 451
L+Y+YM G+L ++L + LDW R +I +GAARGLA+LHH C P +H+++ S
Sbjct: 929 LVYEYMKYGSLETVLHEKTKKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKS 988
Query: 452 NVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGI 511
+ +L+D+DF AR+ DFG+A+L+++ D V+ G GY+ PEY + + KGDVY
Sbjct: 989 SNVLLDQDFVARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSY 1048
Query: 512 GVVLLELA-----------GFKGNLVDWVNQLSSSGRSKEAIDKALC-GKGYDEEILQFL 559
GV+LLEL G NLV W QL R E +D L K D E+L +L
Sbjct: 1049 GVILLELLSGKKPIDPEEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELLHYL 1108
Query: 560 KVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFSERYDEF-----PLIFHRQD 607
K+A C+ RP R +M QV + ++ DEF PL+ +D
Sbjct: 1109 KIASQCLDDRPFKRPTMIQVMTMFKELVQVDTENDSLDEFLLKETPLVEESRD 1161
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZPS9|BRL2_ARATH Serine/threonine-protein kinase BRI1-like 2 OS=Arabidopsis thaliana GN=BRL2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 269 bits (688), Expect = 4e-71, Method: Compositional matrix adjust.
Identities = 178/542 (32%), Positives = 277/542 (51%), Gaps = 56/542 (10%)
Query: 109 SGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNC 168
SG I ++++ LDLS N L G IP +I + L +L+LS+N LSG IP +G
Sbjct: 600 SGPILSLFTRYQTIEYLDLSYNQLRGKIPDEIGEMIA-LQVLELSHNQLSGEIPFTIGQL 658
Query: 169 TYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPS--SFKGFDKADFDGNSD 226
L S+N+L G IP SNL L + ++NN+LTG IP + N
Sbjct: 659 KNLGVFDASDNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPATQYANNPG 718
Query: 227 LCGGPL------------GSKCGGLSKKNL-------AIIIAAGIFGAAASMLLAFGLWW 267
LCG PL G++ G +K +I++ I A+ +L+ + +
Sbjct: 719 LCGVPLPECKNGNNQLPAGTEEGKRAKHGTRAASWANSIVLGVLISAASVCILIVWAIAV 778
Query: 268 WYHLRWVRRRKRGYGIGRDDDDSRW-LERLRSHKLAQVSLFQKPLVKVKLADLMAASNSF 326
R K + + + + W +E+ + V+ FQ+ L K+K + L+ A+N F
Sbjct: 779 RARRRDADDAKMLHSLQAVNSATTWKIEKEKEPLSINVATFQRQLRKLKFSQLIEATNGF 838
Query: 327 CSENVIISTRTGTTYKAMLPDGSVLAVKRLN--TCKLGEKKFRNEMNRLGQLRHPNLAPL 384
+ ++I G +KA L DGS +A+K+L +C+ G+++F EM LG+++H NL PL
Sbjct: 839 SAASMIGHGGFGEVFKATLKDGSSVAIKKLIRLSCQ-GDREFMAEMETLGKIKHRNLVPL 897
Query: 385 LGYCVVEEEKLLIYKYMSSGTLYSLLQGNATE-----LDWPTRFRIGLGAARGLAWLHHG 439
LGYC + EE+LL+Y++M G+L +L G T L W R +I GAA+GL +LHH
Sbjct: 898 LGYCKIGEERLLVYEFMQYGSLEEVLHGPRTGEKRRILGWEERKKIAKGAAKGLCFLHHN 957
Query: 440 CQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSST 499
C P +H+++ S+ +L+D+D +AR+ DFG+A+L+++ D V+ G GY+ PEY +
Sbjct: 958 CIPHIIHRDMKSSNVLLDQDMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQS 1017
Query: 500 MVASLKGDVYGIGVVLLELAGFK----------GNLVDWVNQLSSSGRSKEAIDKALCGK 549
+ KGDVY IGVV+LE+ K NLV W + G+ E ID+ L +
Sbjct: 1018 FRCTAKGDVYSIGVVMLEILSGKRPTDKEEFGDTNLVGWSKMKAREGKHMEVIDEDLLKE 1077
Query: 550 GYDE---------------EILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFSE 594
G E E+L++L++A CV P R +M QV SL + S
Sbjct: 1078 GSSESLNEKEGFEGGVIVKEMLRYLEIALRCVDDFPSKRPNMLQVVASLRELRGSENNSH 1137
Query: 595 RY 596
+
Sbjct: 1138 SH 1139
|
Receptor with a serine/threonine-protein kinase activity, which may transduce extracellular spatial and temporal signals into downstream cell differentiation responses in provascular and procambial cells. In contrast to BRI1, BRL1 and BRL3, it does not bind brassinolide. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 611 | ||||||
| 255552774 | 602 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.932 | 0.946 | 0.761 | 0.0 | |
| 224140895 | 602 | predicted protein [Populus trichocarpa] | 0.916 | 0.930 | 0.742 | 0.0 | |
| 359488761 | 613 | PREDICTED: probable inactive receptor ki | 0.926 | 0.923 | 0.742 | 0.0 | |
| 224055521 | 595 | predicted protein [Populus trichocarpa] | 0.929 | 0.954 | 0.730 | 0.0 | |
| 449461899 | 604 | PREDICTED: probable inactive receptor ki | 0.914 | 0.925 | 0.714 | 0.0 | |
| 357496269 | 602 | LRR receptor-like serine/threonine-prote | 0.923 | 0.936 | 0.684 | 0.0 | |
| 297815142 | 579 | hypothetical protein ARALYDRAFT_484619 [ | 0.909 | 0.960 | 0.686 | 0.0 | |
| 15233004 | 605 | leucine-rich repeat protein kinase-like | 0.936 | 0.945 | 0.670 | 0.0 | |
| 224134625 | 606 | predicted protein [Populus trichocarpa] | 0.913 | 0.920 | 0.646 | 0.0 | |
| 224077382 | 609 | predicted protein [Populus trichocarpa] | 0.937 | 0.940 | 0.641 | 0.0 |
| >gi|255552774|ref|XP_002517430.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223543441|gb|EEF44972.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 934 bits (2413), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 446/586 (76%), Positives = 509/586 (86%), Gaps = 16/586 (2%)
Query: 37 ITFSSLASETVAEDDVKCLEGVKSSLNDPQRKLSSWSFGNSTIGFICQFVGVSCWNDKEN 96
++ + ++S + EDD KCLEGV++SL+DPQ KLSSW+F NS+ GF+C FVGVSCWND+EN
Sbjct: 16 VSATLISSSVIGEDDAKCLEGVRNSLSDPQGKLSSWNFANSSSGFLCNFVGVSCWNDQEN 75
Query: 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNND 156
RI+NLELR+M+LSG++PE LK+CKS+Q LDLS+N LSG IP+QIC WLPYLV LDLSNND
Sbjct: 76 RIINLELRDMQLSGQVPESLKYCKSLQNLDLSSNALSGTIPSQICTWLPYLVTLDLSNND 135
Query: 157 LSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF 216
LSG IP DL NCTYLN LILSNN+LSGPIPY+ S+L RLK+FSVANNDLTGTIPS F F
Sbjct: 136 LSGSIPHDLVNCTYLNNLILSNNRLSGPIPYEFSSLSRLKRFSVANNDLTGTIPSFFSNF 195
Query: 217 DKADFDGNSDLCGGPLGSKCGGLSKKNLAIIIAAGIFGAAASMLLAFGLWWWYHLRWVRR 276
D ADFDGN+ LCG PLGS CGGLSKKNLAIIIAAG+FGAAAS+LL FG+WWWYHLR+ RR
Sbjct: 196 DPADFDGNNGLCGKPLGSNCGGLSKKNLAIIIAAGVFGAAASLLLGFGVWWWYHLRYSRR 255
Query: 277 RKRGYGIGRDDDDSRWLERLRSHKLAQVSLFQKPLVKVKLADLMAASNSFCSENVIISTR 336
RKRG+GIGR DD S W +LRSHKL QVSLFQKPLVKV+LADL+AA+N+F EN+IIS+R
Sbjct: 256 RKRGHGIGRGDDTS-WAAKLRSHKLVQVSLFQKPLVKVRLADLIAATNNFNPENIIISSR 314
Query: 337 TGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396
TG TYKA+LPDGS LA+KRLNTCKLGEK FR+EMNRLGQLRHPNL PLLG+CVVE+EKLL
Sbjct: 315 TGITYKALLPDGSALAIKRLNTCKLGEKHFRSEMNRLGQLRHPNLTPLLGFCVVEDEKLL 374
Query: 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV 456
+YK+MS+GTLY+LL GN T LDWPTRFRIG+GAARGLAWLHHGCQPPFLHQNICSNVILV
Sbjct: 375 VYKHMSNGTLYALLHGNGTLLDWPTRFRIGVGAARGLAWLHHGCQPPFLHQNICSNVILV 434
Query: 457 DEDFDARIMDFGLAKLMTSSD--ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVV 514
DEDFDARIMDFGLA+LMTSSD ESS+VNGDLGE GY+APEYSSTMVASLKGDVYG GVV
Sbjct: 435 DEDFDARIMDFGLARLMTSSDSNESSYVNGDLGELGYVAPEYSSTMVASLKGDVYGFGVV 494
Query: 515 LLELAG-------------FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKV 561
LLEL FKGNLVDWVNQLSSSGR K+AIDK+LCGKG+DEEILQFLK+
Sbjct: 495 LLELVTGQKPLDIATPEEEFKGNLVDWVNQLSSSGRLKDAIDKSLCGKGHDEEILQFLKI 554
Query: 562 ACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFSERYDEFPLIFHRQD 607
NCV++RPKDRWSM +VYQSL + GFSE+ +EFPLIF +QD
Sbjct: 555 GLNCVIARPKDRWSMLRVYQSLKVTGSDLGFSEQDEEFPLIFGKQD 600
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224140895|ref|XP_002323813.1| predicted protein [Populus trichocarpa] gi|222866815|gb|EEF03946.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 897 bits (2319), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 429/578 (74%), Positives = 499/578 (86%), Gaps = 18/578 (3%)
Query: 46 TVAEDDVKCLEGVKSSLNDPQRKLSSWSFGNSTIGFICQFVGVSCWNDKENRILNLELRE 105
+ EDDV+CL+GVK+SL++P+ KL++W+F NS++GFIC FVGVSCWND+ENRI+NL+LR+
Sbjct: 25 VLGEDDVRCLQGVKNSLDNPEGKLTTWNFANSSVGFICNFVGVSCWNDRENRIINLQLRD 84
Query: 106 MKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADL 165
MKLSG++PE L++C+S+Q LDLS+N LSG IPAQIC W+PYLV LDLSNNDLSGPIP DL
Sbjct: 85 MKLSGQVPESLRYCQSLQNLDLSSNSLSGTIPAQICTWVPYLVTLDLSNNDLSGPIPPDL 144
Query: 166 GNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKADFDGNS 225
NCTYLN LILSNN+LSG IP++LS LGRLK+FSV NNDL GT+PS F D A FDGN
Sbjct: 145 ANCTYLNKLILSNNRLSGSIPFELSGLGRLKQFSVENNDLAGTVPSFFTNLDSASFDGNK 204
Query: 226 DLCGGPLGSKCGGLSKKNLAIIIAAGIFGAAASMLLAFGLWWWYHLRWV-RRRKRGYGIG 284
LCG PL SKCGGL +KNLAIIIAAG+FGAA+S+LL FG+WWWYHLR+ R+RK GYG G
Sbjct: 205 GLCGKPL-SKCGGLREKNLAIIIAAGVFGAASSLLLGFGVWWWYHLRYSERKRKGGYGFG 263
Query: 285 RDDDDSRWLERLRSHKLAQVSLFQKPLVKVKLADLMAASNSFCSENVIISTRTGTTYKAM 344
R DD S W +RLRSHKL QVSLFQKPLVKVKLADL+AA+N+F +N+IISTRTGTTYKA+
Sbjct: 264 RGDDTS-WAQRLRSHKLVQVSLFQKPLVKVKLADLIAATNNFSPDNIIISTRTGTTYKAV 322
Query: 345 LPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSG 404
LPDGS LA+KRL TCKLGEK+FR+EMNRLGQ+RHPNLAPLLG+CVVEEEKLL+YK+MS G
Sbjct: 323 LPDGSALALKRLTTCKLGEKQFRSEMNRLGQIRHPNLAPLLGFCVVEEEKLLVYKHMSYG 382
Query: 405 TLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARI 464
TLYSLL G+ LDW TRFRIGLGAARGLAWLHHGCQ PFL+QN+CSNVILVDEDFDARI
Sbjct: 383 TLYSLLHGSGNALDWSTRFRIGLGAARGLAWLHHGCQRPFLYQNMCSNVILVDEDFDARI 442
Query: 465 MDFGLAKLMTS-SDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELA---- 519
MDFGLAK+ S S+ESS+VNGDLGEFGY+APEYSSTMVASLKGDVYG GVVLLEL
Sbjct: 443 MDFGLAKMTCSDSNESSYVNGDLGEFGYVAPEYSSTMVASLKGDVYGFGVVLLELVTGQK 502
Query: 520 ---------GFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRP 570
GFKG+LVDWVN LSSSGRSK+A+DKA+CGKG+DE I QFLK+ACNCV++RP
Sbjct: 503 PLDISNAEEGFKGSLVDWVNHLSSSGRSKDAVDKAICGKGHDEGIYQFLKIACNCVIARP 562
Query: 571 KDRWSMYQVYQSLNSIAAQHG-FSERYDEFPLIFHRQD 607
KDRWSMY+ YQSL +IA++H SE DEFPLIF +QD
Sbjct: 563 KDRWSMYKTYQSLKTIASEHHVLSELDDEFPLIFGKQD 600
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359488761|ref|XP_003633815.1| PREDICTED: probable inactive receptor kinase At1g27190-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 897 bits (2319), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 432/582 (74%), Positives = 495/582 (85%), Gaps = 16/582 (2%)
Query: 41 SLASETVAEDDVKCLEGVKSSLNDPQRKLSSWSFGNSTIGFICQFVGVSCWNDKENRILN 100
+L S VAEDDVKCL GVK SL+DPQ KLSSWSF N ++G +C+FVGV+CWND+ENRI
Sbjct: 28 ALFSAAVAEDDVKCLRGVKESLSDPQGKLSSWSFSNISVGSLCKFVGVACWNDRENRIFG 87
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
LEL +MKLSG+IP+PL++C+SMQ LDLS N L GNIP+QIC WLPYLV LDLSNNDLSG
Sbjct: 88 LELPDMKLSGEIPKPLEYCQSMQTLDLSGNRLYGNIPSQICTWLPYLVTLDLSNNDLSGT 147
Query: 161 IPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKAD 220
IP DL NC++LN+L+L++N+LSG IP QLS+LGRLKKFSVANN LTGTIPS+F FDKA
Sbjct: 148 IPPDLANCSFLNSLLLADNQLSGIIPSQLSSLGRLKKFSVANNRLTGTIPSAFGKFDKAG 207
Query: 221 FDGNSDLCGGPLGSKCGGLSKKNLAIIIAAGIFGAAASMLLAFGLWWWYHLRWVRRRKRG 280
FDGNS LCG PLGSKCGGL+KK+LAIIIAAG+FGAAAS+LL FGLWWW+ R +RKR
Sbjct: 208 FDGNSGLCGRPLGSKCGGLNKKSLAIIIAAGVFGAAASLLLGFGLWWWFFARLRGQRKRR 267
Query: 281 YGIGRDDDDSRWLERLRSHKLAQVSLFQKPLVKVKLADLMAASNSFCSENVIISTRTGTT 340
YGIGRDD S W ERLR+HKL QV+LFQKP+VKVKLADLMAA+N+F EN+I STRTGT+
Sbjct: 268 YGIGRDDHSS-WTERLRAHKLVQVTLFQKPIVKVKLADLMAATNNFHPENIINSTRTGTS 326
Query: 341 YKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400
YKA+LPDGS LA+KRLNTC LGEK+FR+EMNRLGQ RHPNLAPLLG+C VEEEKLL+YKY
Sbjct: 327 YKAILPDGSALAIKRLNTCNLGEKQFRSEMNRLGQFRHPNLAPLLGFCAVEEEKLLVYKY 386
Query: 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF 460
MS+GTLYSLL GN T +DW TRFRIGLGAARGLAWLHHGCQPP LH+NI SNVIL+D+DF
Sbjct: 387 MSNGTLYSLLHGNGTPMDWATRFRIGLGAARGLAWLHHGCQPPLLHENISSNVILIDDDF 446
Query: 461 DARIMDFGLAKLMTSSDE--SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
DARI+DFGLA+LM +SD SSFVNG LGEFGY+APEYSSTMVASLKGDVYG GVVLLEL
Sbjct: 447 DARIVDFGLARLMATSDSNGSSFVNGGLGEFGYVAPEYSSTMVASLKGDVYGFGVVLLEL 506
Query: 519 A-------------GFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNC 565
GFKGNLV+WVNQL SGR+K+ ID+ALCGKG+DEEILQFLK+ACNC
Sbjct: 507 VTGQKPLEVTNAEEGFKGNLVEWVNQLCGSGRNKDVIDEALCGKGHDEEILQFLKIACNC 566
Query: 566 VVSRPKDRWSMYQVYQSLNSIAAQHGFSERYDEFPLIFHRQD 607
+ RPKDR SMYQ ++SL S+ HGFSE YDEFPLIF +QD
Sbjct: 567 LGPRPKDRLSMYQAFESLKSMGDHHGFSEHYDEFPLIFGKQD 608
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224055521|ref|XP_002298520.1| predicted protein [Populus trichocarpa] gi|222845778|gb|EEE83325.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 897 bits (2319), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 429/587 (73%), Positives = 495/587 (84%), Gaps = 19/587 (3%)
Query: 37 ITFSSLASETVAEDDVKCLEGVKSSLNDPQRKLSSWSFGNSTIGFICQFVGVSCWNDKEN 96
+ F++L + AEDD +CL+GV++SL DP+ +L++W+FGN+++GFIC FVGVSCWND+EN
Sbjct: 8 VIFAALGATVFAEDDARCLQGVQNSLGDPEGRLATWNFGNTSVGFICNFVGVSCWNDREN 67
Query: 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNND 156
RI+NLELR+MKLSG++PE L++CKS+Q LDLS+N LSG IPAQIC WLPYLV LDLSNND
Sbjct: 68 RIINLELRDMKLSGQVPESLQYCKSLQNLDLSSNSLSGTIPAQICTWLPYLVTLDLSNND 127
Query: 157 LSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF 216
SGPIP DL NC YLN LILSNN+LSG IP S LGRLKKFSVANNDLTG +PSSF +
Sbjct: 128 FSGPIPPDLANCIYLNNLILSNNRLSGSIPLGFSALGRLKKFSVANNDLTGPVPSSFNNY 187
Query: 217 DKADFDGNSDLCGGPLGSKCGGLSKKNLAIIIAAGIFGAAASMLLAFGLWWWYHLRWVRR 276
D ADFDGN LCG PL SKCGGLSKKNLAIIIAAG+FGAA+S+LL FG+WWWY + R
Sbjct: 188 DSADFDGNKGLCGRPL-SKCGGLSKKNLAIIIAAGVFGAASSLLLGFGVWWWYQSKHSGR 246
Query: 277 RKRGYGIGRDDDDSRWLERLRSHKLAQVSLFQKPLVKVKLADLMAASNSFCSENVIISTR 336
RK GY GR DD + W +RLRSHKL QVSLFQKPLVKVKL DLMAA+N+F E++IISTR
Sbjct: 247 RKGGYDFGRGDD-TNWAQRLRSHKLVQVSLFQKPLVKVKLGDLMAATNNFSPESIIISTR 305
Query: 337 TGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396
+GTTYKA+LPDGS LA+KRL+TCKLGEK+F+ EMNRLGQ+RHPNLAPLLG+CV EEKLL
Sbjct: 306 SGTTYKAVLPDGSALAIKRLSTCKLGEKQFQLEMNRLGQVRHPNLAPLLGFCVAGEEKLL 365
Query: 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV 456
+YK+MS+GTLYSLL G LDWPTRFRIG GAARGLAWLHHG QPPFLHQNICSN ILV
Sbjct: 366 VYKHMSNGTLYSLLHGTGNALDWPTRFRIGFGAARGLAWLHHGYQPPFLHQNICSNAILV 425
Query: 457 DEDFDARIMDFGLAKLMTSSD--ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVV 514
DEDFDARIMDFGLA++MTSSD ESS+VNGDLGE GY+APEYSSTMVASLKGDVYG GVV
Sbjct: 426 DEDFDARIMDFGLARMMTSSDSNESSYVNGDLGEIGYVAPEYSSTMVASLKGDVYGFGVV 485
Query: 515 LLELA-------------GFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKV 561
LLEL GFKGNLVDWVN LSSSGRSK+A++KA+CGKG+DEEI QFLK+
Sbjct: 486 LLELVTGQKPLDISTAEEGFKGNLVDWVNNLSSSGRSKDAVEKAICGKGHDEEISQFLKI 545
Query: 562 ACNCVVSRPKDRWSMYQVYQSLNSIAAQHG--FSERYDEFPLIFHRQ 606
AC CV++RPKDRWSMY+ YQSL IA +HG SE+ DEFPLIF +Q
Sbjct: 546 ACKCVIARPKDRWSMYEAYQSLKIIANEHGLTLSEQDDEFPLIFGKQ 592
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449461899|ref|XP_004148679.1| PREDICTED: probable inactive receptor kinase At1g27190-like [Cucumis sativus] gi|449522849|ref|XP_004168438.1| PREDICTED: probable inactive receptor kinase At1g27190-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 854 bits (2206), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/577 (71%), Positives = 479/577 (83%), Gaps = 18/577 (3%)
Query: 46 TVAEDDVKCLEGVKSSLNDPQRKLSSWSFGNSTIGFIC-QFVGVSCWNDKENRILNLELR 104
V EDD++CL GVK++L DP +LSSW F N+++G +C +FVG+SCWND+ENRIL+LEL+
Sbjct: 27 VVPEDDIRCLRGVKNALVDPIGRLSSWDFKNTSVGHLCDKFVGLSCWNDRENRILSLELK 86
Query: 105 EMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPAD 164
+MKLSG I E L++C S+Q+LDLS N SG IP IC WLPYLV +DLSNN +G IPAD
Sbjct: 87 DMKLSGSISEDLQYCVSLQKLDLSGNSFSGEIPPHICEWLPYLVSMDLSNNQFTGSIPAD 146
Query: 165 LGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKADFDGN 224
L C+YLN+LILS+N+LSG IP +L++LGRL KFSVANN LTGTIPS F F K DFDGN
Sbjct: 147 LARCSYLNSLILSDNELSGTIPVELTSLGRLNKFSVANNQLTGTIPSFFDKFGKEDFDGN 206
Query: 225 SDLCGGPLGSKCGGLSKKNLAIIIAAGIFGAAASMLLAFGLWWWYHLRWVRRRKRGYGIG 284
SDLCGGP+GS CGGLSKKNLAIIIAAG+FGAAAS+LL FGLWWWYH R +R+RGYG G
Sbjct: 207 SDLCGGPVGSSCGGLSKKNLAIIIAAGVFGAAASLLLGFGLWWWYHSRMNMKRRRGYGDG 266
Query: 285 RDDDDSRWLERLRSHKLAQVSLFQKPLVKVKLADLMAASNSFCSENVIISTRTGTTYKAM 344
D W +RLR++KL QVSLFQKPLVKV+LADLMAA+N+F SEN+I+S+RTGTTY+A+
Sbjct: 267 ISGD---WADRLRAYKLVQVSLFQKPLVKVRLADLMAATNNFNSENIIVSSRTGTTYRAV 323
Query: 345 LPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSG 404
LPDGSVLA+KRLNTCKLGEK FR EMNRLG +RHPNL PLLG+CVVEEEKLL+YKYMS+G
Sbjct: 324 LPDGSVLAIKRLNTCKLGEKLFRMEMNRLGSIRHPNLTPLLGFCVVEEEKLLVYKYMSNG 383
Query: 405 TLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARI 464
TL SLL GN LDW TRFRIGLGAARGLAWLHHGCQPPF+HQNICS+VILVDED+DARI
Sbjct: 384 TLSSLLHGNDEILDWATRFRIGLGAARGLAWLHHGCQPPFMHQNICSSVILVDEDYDARI 443
Query: 465 MDFGLAKLMTS-SDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL----- 518
MDFGLA+LM S S +SSFVNGDLGE GY+APEY STMVASLKGDVYG GVVLLEL
Sbjct: 444 MDFGLARLMASDSQDSSFVNGDLGELGYVAPEYPSTMVASLKGDVYGFGVVLLELITGQK 503
Query: 519 --------AGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRP 570
G+KGNLVDWVNQLS+SGR K+ ID+ LCGKG DEEILQFLK+ NC+VSRP
Sbjct: 504 PLEVTKAEEGYKGNLVDWVNQLSTSGRIKDVIDRDLCGKGNDEEILQFLKITMNCIVSRP 563
Query: 571 KDRWSMYQVYQSLNSIAAQHGFSERYDEFPLIFHRQD 607
KDRWSMYQVYQS+ ++A + F E DEFPL+ + D
Sbjct: 564 KDRWSMYQVYQSMRTMAKDYSFPEPDDEFPLLLGKGD 600
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357496269|ref|XP_003618423.1| LRR receptor-like serine/threonine-protein kinase FEI [Medicago truncatula] gi|355493438|gb|AES74641.1| LRR receptor-like serine/threonine-protein kinase FEI [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 827 bits (2135), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 400/584 (68%), Positives = 470/584 (80%), Gaps = 20/584 (3%)
Query: 41 SLASETVAEDDVKCLEGVKSSLNDPQRKLSSWSFGNSTIGFICQFVGVSCWNDKENRILN 100
+L+S V ED+V+CL+G++ +L + +S+W F N T+GFIC FVGV+CWN +ENR+L
Sbjct: 18 TLSSSQVEEDNVRCLQGIQQNLGNSDSPISNWKFNNRTVGFICDFVGVTCWNVRENRVLG 77
Query: 101 LELREMKLSGKIPEPLKFC-KSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG 159
LEL+ MKLSGKIPE LK+C +S+QRLDL +N LS IP QIC W+P+LV +DLS N+L+G
Sbjct: 78 LELKGMKLSGKIPESLKYCGQSLQRLDLGSNSLSSVIPTQICEWMPFLVTMDLSGNNLNG 137
Query: 160 PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKA 219
IP + NC+YLN L+L NN L+G IPY++++L RL KFSVANN+L+G IPS F GFDK
Sbjct: 138 EIPHTIVNCSYLNELMLDNNHLTGSIPYEITSLTRLHKFSVANNELSGDIPSFFNGFDKD 197
Query: 220 DFDGNSDLCGGPLGSKCGGLSKKNLAIIIAAGIFGAAASMLLAFGLWWWYHLRW---VRR 276
FDGNS LCGGPLGSKCGG+SKKNLAIIIAAG+FGAA S+L AFGLWWWYHLR RR
Sbjct: 198 GFDGNSGLCGGPLGSKCGGMSKKNLAIIIAAGVFGAAGSLLAAFGLWWWYHLRLGGERRR 257
Query: 277 RKRGYGIGRDDDDSRWLERLRSHKLAQVSLFQKPLVKVKLADLMAASNSFCSENVIISTR 336
K GY +G DD W RLR HKLAQV+LFQKP+VKVKL DLMAA+N+F +ENV+I+TR
Sbjct: 258 SKEGYVVGGVDD---WAVRLRGHKLAQVNLFQKPIVKVKLGDLMAATNNFSNENVLITTR 314
Query: 337 TGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396
TG TY+A LPDGS LAVKRL++CK+GEK+FR EMNRLGQ+RHPNLAPLLGYCVVEEEKLL
Sbjct: 315 TGATYRADLPDGSTLAVKRLSSCKIGEKQFRMEMNRLGQVRHPNLAPLLGYCVVEEEKLL 374
Query: 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV 456
+YK+MS+GTLYSLL N+ LDW RFRIGLGAARGLAWLHHGC PP + QNICSNVILV
Sbjct: 375 VYKHMSNGTLYSLLHKNSGVLDWLMRFRIGLGAARGLAWLHHGCHPPIIQQNICSNVILV 434
Query: 457 DEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLL 516
DE+FDARIMDFGLA+LMTS SFVNGDLGE GYIAPEYSSTMVASLKGDVYG GV+LL
Sbjct: 435 DEEFDARIMDFGLARLMTSDANGSFVNGDLGELGYIAPEYSSTMVASLKGDVYGFGVLLL 494
Query: 517 ELAG-------------FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVAC 563
EL FKGNLVDWVN SSSGR K+ ID+++ GKG DEEILQFLK+A
Sbjct: 495 ELVTGCKPLEVNNIDEEFKGNLVDWVNMHSSSGRLKDCIDRSISGKGNDEEILQFLKIAS 554
Query: 564 NCVVSRPKDRWSMYQVYQSLNSIAAQHGFSERYDEFPLIFHRQD 607
NCV++R KDRWSMYQVY SL I+ H FSE DEFPLIF + +
Sbjct: 555 NCVIARAKDRWSMYQVYNSLKGISKDHSFSEHDDEFPLIFGKPE 598
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297815142|ref|XP_002875454.1| hypothetical protein ARALYDRAFT_484619 [Arabidopsis lyrata subsp. lyrata] gi|297321292|gb|EFH51713.1| hypothetical protein ARALYDRAFT_484619 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 823 bits (2126), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/574 (68%), Positives = 475/574 (82%), Gaps = 18/574 (3%)
Query: 49 EDDVKCLEGVKSSLNDPQRKLSSWSFGNSTIGFICQFVGVSCWNDKENRILNLELREMKL 108
EDD++CL G+K+SL DPQ L SW+F N+T+GF+C FVGVSCWN++ENR++NLELR+M L
Sbjct: 5 EDDIRCLRGLKTSLTDPQNALKSWNFDNTTLGFLCNFVGVSCWNNQENRVINLELRDMGL 64
Query: 109 SGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNC 168
SGKIP+ L++C S+Q+LDLS+N LSGNIP ++CNWLP+LV LDLSNN+L+G IP DL C
Sbjct: 65 SGKIPDSLQYCASLQKLDLSSNRLSGNIPKELCNWLPFLVSLDLSNNELNGEIPPDLAKC 124
Query: 169 TYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG--FDKADFDGNSD 226
+++N+L+LS+N+LSG IP Q S LGRL +FSVANNDL+G IP F + DF GN
Sbjct: 125 SFVNSLVLSDNRLSGQIPVQFSALGRLGRFSVANNDLSGRIPVFFSSPSYSSDDFKGNKG 184
Query: 227 LCGGPLGSKCGGLSKKNLAIIIAAGIFGAAASMLLAFGLWWWYHLRWVRRRKRGYGIGRD 286
LCG PL S CGGLSKKNLAIIIAAG+FGAAASMLLAFG+WW+YHL+W RRR+ G +
Sbjct: 185 LCGRPLSSSCGGLSKKNLAIIIAAGVFGAAASMLLAFGIWWYYHLKWTRRRRSGL---TE 241
Query: 287 DDDSRWLERLRSHKLAQVSLFQKPLVKVKLADLMAASNSFCSENVIISTRTGTTYKAMLP 346
S +RLRSHKL QVSLFQKPLVKVKL DLMAA+N+F S N+I+STRTGTTYKA+LP
Sbjct: 242 VGVSGLAKRLRSHKLTQVSLFQKPLVKVKLGDLMAATNNFSSGNIIVSTRTGTTYKALLP 301
Query: 347 DGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTL 406
DGS LAVK L+ CKLGE++FR EMN+L +LRHPNLAPLLGYCVVEE+KLL+YKYMS+GTL
Sbjct: 302 DGSALAVKHLSACKLGEREFRYEMNQLWELRHPNLAPLLGYCVVEEDKLLVYKYMSNGTL 361
Query: 407 YSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMD 466
+SLL N ELDW TRFRIGLGAARGLAWLHHGC+PP LHQNICS+VIL+DEDFDARI+D
Sbjct: 362 HSLLDSNGVELDWSTRFRIGLGAARGLAWLHHGCRPPILHQNICSSVILIDEDFDARIID 421
Query: 467 FGLAKLMTSSD--ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELA----- 519
GLA+LM SD ESSF+ GDLGEFGY+APEYS+TM+ASLKGDVYG+GVVLLELA
Sbjct: 422 SGLARLMVPSDNNESSFMTGDLGEFGYVAPEYSTTMLASLKGDVYGLGVVLLELATGLKA 481
Query: 520 ----GFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWS 575
GFKG+LVDWV QL SSGR E D+ + GKG++EEIL+F+++ACNCV SRPK+RWS
Sbjct: 482 LGREGFKGSLVDWVKQLESSGRIAETFDENIRGKGHEEEILKFVEIACNCVSSRPKERWS 541
Query: 576 MYQVYQSLNSIAAQHG--FSERYDEFPLIFHRQD 607
M+Q YQSL +IA + G FSE+ D+FPLIF Q+
Sbjct: 542 MFQAYQSLKAIAEKQGYSFSEQDDDFPLIFDTQE 575
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15233004|ref|NP_189486.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] gi|9294580|dbj|BAB02861.1| receptor-like protein kinase-like protein [Arabidopsis thaliana] gi|26449808|dbj|BAC42027.1| putative receptor kinase [Arabidopsis thaliana] gi|224589583|gb|ACN59325.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332643925|gb|AEE77446.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 817 bits (2110), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/592 (67%), Positives = 478/592 (80%), Gaps = 20/592 (3%)
Query: 37 ITFSSLASETVA--EDDVKCLEGVKSSLNDPQRKLSSWSFGNSTIGFICQFVGVSCWNDK 94
I F S +A EDD++CL G+K+SL DPQ L SW+F N+T+GF+C FVGVSCWN++
Sbjct: 17 IIFLCFCSSVMAADEDDIRCLRGLKASLTDPQNALKSWNFDNTTLGFLCNFVGVSCWNNQ 76
Query: 95 ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSN 154
ENR++NLELR+M LSGKIP+ L++C S+Q+LDLS+N LSGNIP ++CNWLP+LV LDLSN
Sbjct: 77 ENRVINLELRDMGLSGKIPDSLQYCASLQKLDLSSNRLSGNIPTELCNWLPFLVSLDLSN 136
Query: 155 NDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFK 214
N+L+G IP DL C+++N+L+LS+N+LSG IP Q S LGRL +FSVANNDL+G IP F
Sbjct: 137 NELNGEIPPDLAKCSFVNSLVLSDNRLSGQIPVQFSALGRLGRFSVANNDLSGRIPVFFS 196
Query: 215 G--FDKADFDGNSDLCGGPLGSKCGGLSKKNLAIIIAAGIFGAAASMLLAFGLWWWYHLR 272
+ DF GN LCG PL S CGGLSKKNL IIIAAG+FGAAASMLLAFG+WW+YHL+
Sbjct: 197 SPSYSSDDFSGNKGLCGRPLSSSCGGLSKKNLGIIIAAGVFGAAASMLLAFGIWWYYHLK 256
Query: 273 WVRRRKRGYGIGRDDDDSRWLERLRSHKLAQVSLFQKPLVKVKLADLMAASNSFCSENVI 332
W RRR+ G + S +RLRSHKL QVSLFQKPLVKVKL DLMAA+N+F SEN+I
Sbjct: 257 WTRRRRSGL---TEVGVSGLAQRLRSHKLTQVSLFQKPLVKVKLGDLMAATNNFNSENII 313
Query: 333 ISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE 392
+STRTGTTYKA+LPDGS LAVK L+TCKLGE++FR EMN+L +LRH NLAPLLG+CVVEE
Sbjct: 314 VSTRTGTTYKALLPDGSALAVKHLSTCKLGEREFRYEMNQLWELRHSNLAPLLGFCVVEE 373
Query: 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSN 452
EK L+YKYMS+GTL+SLL N ELDW TRFRIGLGAARGLAWLHHGC+PP LHQNICS+
Sbjct: 374 EKFLVYKYMSNGTLHSLLDSNRGELDWSTRFRIGLGAARGLAWLHHGCRPPILHQNICSS 433
Query: 453 VILVDEDFDARIMDFGLAKLMTSSD--ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYG 510
VIL+DEDFDARI+D GLA+LM SD ESSF+ GDLGEFGY+APEYS+TM+ASLKGDVYG
Sbjct: 434 VILIDEDFDARIIDSGLARLMVPSDNNESSFMTGDLGEFGYVAPEYSTTMLASLKGDVYG 493
Query: 511 IGVVLLELA---------GFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKV 561
+GVVLLELA GFKG+LVDWV QL SSGR E D+ + GKG+DEEI +F+++
Sbjct: 494 LGVVLLELATGLKAVGGEGFKGSLVDWVKQLESSGRIAETFDENIRGKGHDEEISKFVEI 553
Query: 562 ACNCVVSRPKDRWSMYQVYQSLNSIAAQHG--FSERYDEFPLIFHRQDGGSV 611
A NCV SRPK+RWSM+Q YQSL +IA + G FSE+ D+FPLIF Q+ V
Sbjct: 554 ALNCVSSRPKERWSMFQAYQSLKAIAEKQGYSFSEQDDDFPLIFDTQENEKV 605
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224134625|ref|XP_002327450.1| predicted protein [Populus trichocarpa] gi|222836004|gb|EEE74425.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 771 bits (1991), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/580 (64%), Positives = 458/580 (78%), Gaps = 22/580 (3%)
Query: 49 EDDVKCLEGVKSSLNDPQRKLSSWSFGNSTIGFICQFVGVSCWNDKENRILNLELREMKL 108
EDD+ CLEGVK S DP +L+SW+F N+++ F+C+ GVSCWN+KENRI++L+L +L
Sbjct: 23 EDDITCLEGVKKSFTDPLGRLTSWTFNNNSVAFVCKLNGVSCWNEKENRIISLQLSSFQL 82
Query: 109 SGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNC 168
SGK+PE LK+C S+ LDLS+NDLSG IP +ICNWLPY+V LDLS N SGPIP ++ NC
Sbjct: 83 SGKLPESLKYCHSLTTLDLSSNDLSGPIPPEICNWLPYIVSLDLSGNKFSGPIPPEIVNC 142
Query: 169 TYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKADFDGNSDLC 228
+LN LILS N+L+G IP+ L L RLK FSVA+N+L+G+IP F K FDGN LC
Sbjct: 143 KFLNNLILSGNQLTGSIPFGLGRLDRLKTFSVASNELSGSIPDELWAFSKDSFDGNDGLC 202
Query: 229 GGPLGSKCGGLSKKNLAIIIAAGIFGAAASMLLAFGLWWWYHLRWVRRRKRGYGIGRDDD 288
G PLG KCGGLS K+L III AG+ GA S++L F +WWW +R ++++ G G D
Sbjct: 203 GKPLG-KCGGLSSKSLGIIIVAGVVGAGGSLILGFVIWWWLFVRGGKKKRGSGGGGGKGD 261
Query: 289 DSRWLERLRSHKLAQVSLFQKPLVKVKLADLMAASNSFCSENVIISTRTGTTYKAMLPDG 348
D W+E LRSHKL QV+LFQKP+VK+KLAD++AA+NSF EN++ISTRTG +YKA LPDG
Sbjct: 262 DPSWIELLRSHKLVQVTLFQKPIVKIKLADILAATNSFDFENIVISTRTGDSYKADLPDG 321
Query: 349 SVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYS 408
S LA+KRLN CKLGEK+FR EMNRLG+LRHPNL PLLGYC VE EKLL+YK+M +GTLYS
Sbjct: 322 SSLAIKRLNACKLGEKQFRGEMNRLGELRHPNLVPLLGYCAVEVEKLLVYKHMPNGTLYS 381
Query: 409 LLQGN------ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDA 462
L G+ ++ LDWPTR R+G+GA RGLAWLHHGC PP++HQ I SNVIL+D+DFDA
Sbjct: 382 QLHGSGFGISQSSVLDWPTRVRVGVGATRGLAWLHHGCDPPYIHQYISSNVILLDDDFDA 441
Query: 463 RIMDFGLAKLMTSSD--ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELA- 519
RI DFGLA+L++S D +SS+VNGDLGEFGYIAPEYSSTMVASLKGDVYG GVVLLEL
Sbjct: 442 RITDFGLARLISSPDSNDSSYVNGDLGEFGYIAPEYSSTMVASLKGDVYGFGVVLLELVT 501
Query: 520 ------------GFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVV 567
GFKGNLVDWVNQL S+GRSK+AIDKAL GKG+D+EI+QFL+VA +CVV
Sbjct: 502 GQKALDVNNEEEGFKGNLVDWVNQLVSTGRSKDAIDKALTGKGHDDEIMQFLRVAWSCVV 561
Query: 568 SRPKDRWSMYQVYQSLNSIAAQHGFSERYDEFPLIFHRQD 607
SRPKDR SMYQVY+SL +A +HGFS++YDEFPLIF + D
Sbjct: 562 SRPKDRPSMYQVYESLKGLAEKHGFSDQYDEFPLIFGKPD 601
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224077382|ref|XP_002305238.1| predicted protein [Populus trichocarpa] gi|222848202|gb|EEE85749.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 768 bits (1982), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/597 (64%), Positives = 460/597 (77%), Gaps = 24/597 (4%)
Query: 34 STQITFSSLASETVAEDDVKCLEGVKSSLNDPQRKLSSWSFGNSTIGFICQFVGVSCWND 93
S + FS A EDDV CLEGVK+S DP +L+SW F N+++ +IC+ GVSCWN+
Sbjct: 9 SFSLLFSLFAFSFAIEDDVTCLEGVKNSFTDPLGRLTSWDFNNNSVAYICKLNGVSCWNE 68
Query: 94 KENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLS 153
KENRI++L+L +LSGK+PE LK+C S+ LDLS NDLSG IP +ICNWLPY+V LDLS
Sbjct: 69 KENRIISLQLPLFQLSGKLPESLKYCHSLTTLDLSNNDLSGPIPPEICNWLPYVVTLDLS 128
Query: 154 NNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213
N SGPIP ++ NC +LN+LILS NKL+G IPY L RLK+FSVA+NDLTG+IP
Sbjct: 129 GNKFSGPIPPEIVNCKFLNSLILSGNKLTGSIPYGFGRLDRLKRFSVASNDLTGSIPEEL 188
Query: 214 KGFDKADFDGNSDLCGGPLGSKCGGLSKKNLAIIIAAGIFGAAASMLLAFGLWWWYH--L 271
F K FDGN LCG PLG KCGGLS K+L III AG+ GA S++L F +WWW
Sbjct: 189 GVFPKDAFDGNEGLCGKPLG-KCGGLSSKSLGIIIVAGVIGAGGSLILGFVIWWWLFVKG 247
Query: 272 RWVRRRKRGYGIGRDDDDSRWLERLRSHKLAQVSLFQKPLVKVKLADLMAASNSFCSENV 331
+ G G DDS W+ LRSHKL QV+LFQKP+VK+KLAD++AA+NSF ENV
Sbjct: 248 KSGGGSGGVGGSGGKGDDSSWIGLLRSHKLVQVTLFQKPIVKIKLADILAATNSFDFENV 307
Query: 332 IISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE 391
+ISTRTG +Y+A LPDGS LA+KRLNTCKLGEK+FR EMNRLGQLRHPNL PLLG+CVVE
Sbjct: 308 VISTRTGVSYQADLPDGSSLAIKRLNTCKLGEKQFRGEMNRLGQLRHPNLVPLLGFCVVE 367
Query: 392 EEKLLIYKYMSSGTLYSLLQGNA------TELDWPTRFRIGLGAARGLAWLHHGCQPPFL 445
EKLL+YK+M +GTLYS L G+ + LDWPTR R+G+GAARGLAWLHHGC PP++
Sbjct: 368 VEKLLVYKHMPNGTLYSQLHGSGFGIGQTSVLDWPTRVRVGVGAARGLAWLHHGCHPPYI 427
Query: 446 HQNICSNVILVDEDFDARIMDFGLAKLMTSSD--ESSFVNGDLGEFGYIAPEYSSTMVAS 503
HQ I SNVIL+D+DFDARI DFGLA+L++S D +SSFV+GDLGEFGY+APEYSSTMVAS
Sbjct: 428 HQYISSNVILLDDDFDARITDFGLARLISSPDSNDSSFVHGDLGEFGYVAPEYSSTMVAS 487
Query: 504 LKGDVYGIGVVLLELA-------------GFKGNLVDWVNQLSSSGRSKEAIDKALCGKG 550
LKGDVYG GVVLLEL GFKGNLVDWVNQL+S GRS +AIDKAL GKG
Sbjct: 488 LKGDVYGFGVVLLELVSGQKPLDVSNAEEGFKGNLVDWVNQLASIGRSTDAIDKALVGKG 547
Query: 551 YDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFSERYDEFPLIFHRQD 607
+D+EI+QFLKVA +CVVSRPKDR +MYQ+Y+SL +A +HGFS++YDEFPLIF +QD
Sbjct: 548 HDDEIMQFLKVAWSCVVSRPKDRPTMYQIYESLKGMAEKHGFSDKYDEFPLIFGKQD 604
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 611 | ||||||
| TAIR|locus:2088937 | 605 | AT3G28450 [Arabidopsis thalian | 0.936 | 0.945 | 0.640 | 6.9e-205 | |
| TAIR|locus:2020558 | 591 | AT1G69990 [Arabidopsis thalian | 0.914 | 0.945 | 0.561 | 1.6e-175 | |
| TAIR|locus:2205834 | 601 | AT1G27190 [Arabidopsis thalian | 0.782 | 0.795 | 0.613 | 1.4e-160 | |
| TAIR|locus:2165981 | 620 | BIR1 "AT5G48380" [Arabidopsis | 0.793 | 0.782 | 0.429 | 2e-104 | |
| TAIR|locus:2005498 | 1196 | BRI1 "BRASSINOSTEROID INSENSIT | 0.523 | 0.267 | 0.383 | 1.5e-75 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.797 | 0.408 | 0.367 | 1e-73 | |
| TAIR|locus:2020457 | 1166 | BRL1 "BRI1 like" [Arabidopsis | 0.487 | 0.255 | 0.408 | 7.6e-72 | |
| TAIR|locus:2092810 | 1164 | BRL3 "BRI1-like 3" [Arabidopsi | 0.510 | 0.268 | 0.396 | 5.3e-71 | |
| TAIR|locus:2051628 | 1008 | PSKR1 "phytosulfokin receptor | 0.749 | 0.454 | 0.369 | 2.8e-66 | |
| UNIPROTKB|Q942F3 | 1121 | P0480C01.18-1 "cDNA clone:J033 | 0.489 | 0.266 | 0.391 | 3.4e-66 |
| TAIR|locus:2088937 AT3G28450 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1982 (702.8 bits), Expect = 6.9e-205, P = 6.9e-205
Identities = 379/592 (64%), Positives = 457/592 (77%)
Query: 37 ITFSSLASETVA--EDDVKCLEGVKSSLNDPQRKLSSWSFGNSTIGFICQFVGVSCWNDK 94
I F S +A EDD++CL G+K+SL DPQ L SW+F N+T+GF+C FVGVSCWN++
Sbjct: 17 IIFLCFCSSVMAADEDDIRCLRGLKASLTDPQNALKSWNFDNTTLGFLCNFVGVSCWNNQ 76
Query: 95 ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVXXXXXX 154
ENR++NLELR+M LSGKIP+ L++C S+Q+LDLS+N LSGNIP ++CNWLP+LV
Sbjct: 77 ENRVINLELRDMGLSGKIPDSLQYCASLQKLDLSSNRLSGNIPTELCNWLPFLVSLDLSN 136
Query: 155 XXXXGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFK 214
G IP DL C+++N+L+LS+N+LSG IP Q S LGRL +FSVANNDL+G IP F
Sbjct: 137 NELNGEIPPDLAKCSFVNSLVLSDNRLSGQIPVQFSALGRLGRFSVANNDLSGRIPVFFS 196
Query: 215 G--FDKADFDGNSDLCGGPLGSKCGGLSKKNLXXXXXXXXXXXXXSMLLAFGLWWWYHLR 272
+ DF GN LCG PL S CGGLSKKNL SMLLAFG+WW+YHL+
Sbjct: 197 SPSYSSDDFSGNKGLCGRPLSSSCGGLSKKNLGIIIAAGVFGAAASMLLAFGIWWYYHLK 256
Query: 273 WVRRRKRGYGIGRDDDDSRWLERLRSHKLAQVSLFQKPLVKVKLADLMAASNSFCSENVI 332
W RRR+ G + S +RLRSHKL QVSLFQKPLVKVKL DLMAA+N+F SEN+I
Sbjct: 257 WTRRRRSGL---TEVGVSGLAQRLRSHKLTQVSLFQKPLVKVKLGDLMAATNNFNSENII 313
Query: 333 ISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE 392
+STRTGTTYKA+LPDGS LAVK L+TCKLGE++FR EMN+L +LRH NLAPLLG+CVVEE
Sbjct: 314 VSTRTGTTYKALLPDGSALAVKHLSTCKLGEREFRYEMNQLWELRHSNLAPLLGFCVVEE 373
Query: 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSN 452
EK L+YKYMS+GTL+SLL N ELDW TRFRIGLGAARGLAWLHHGC+PP LHQNICS+
Sbjct: 374 EKFLVYKYMSNGTLHSLLDSNRGELDWSTRFRIGLGAARGLAWLHHGCRPPILHQNICSS 433
Query: 453 VILVDEDFDARIMDFGLAKLMTSSD--ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYG 510
VIL+DEDFDARI+D GLA+LM SD ESSF+ GDLGEFGY+APEYS+TM+ASLKGDVYG
Sbjct: 434 VILIDEDFDARIIDSGLARLMVPSDNNESSFMTGDLGEFGYVAPEYSTTMLASLKGDVYG 493
Query: 511 IGVVLLELA---------GFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKV 561
+GVVLLELA GFKG+LVDWV QL SSGR E D+ + GKG+DEEI +F+++
Sbjct: 494 LGVVLLELATGLKAVGGEGFKGSLVDWVKQLESSGRIAETFDENIRGKGHDEEISKFVEI 553
Query: 562 ACNCVVSRPKDRWSMYQVYQSLNSIAAQHG--FSERYDEFPLIFHRQDGGSV 611
A NCV SRPK+RWSM+Q YQSL +IA + G FSE+ D+FPLIF Q+ V
Sbjct: 554 ALNCVSSRPKERWSMFQAYQSLKAIAEKQGYSFSEQDDDFPLIFDTQENEKV 605
|
|
| TAIR|locus:2020558 AT1G69990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1705 (605.2 bits), Expect = 1.6e-175, P = 1.6e-175
Identities = 328/584 (56%), Positives = 433/584 (74%)
Query: 42 LASETVAEDDVKCLEGVKSSLNDPQRKLSSWSFGNSTIGFICQFVGVSCWNDKENRILNL 101
L S + AEDDV CL+G KSSL DP +L++WSF NS+ IC+ GVSCWN KENRIL+L
Sbjct: 12 LMSSSHAEDDVLCLKGFKSSLKDPSNQLNTWSFPNSSSS-ICKLTGVSCWNAKENRILSL 70
Query: 102 ELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVXXXXXXXXXXGPI 161
+L+ M+LSG+IPE LK C+S+Q LDLS ND SG IP+QIC+WLPYLV G I
Sbjct: 71 QLQSMQLSGQIPESLKLCRSLQSLDLSFNDFSGLIPSQICSWLPYLVTLDLSGNKLSGSI 130
Query: 162 PADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKADF 221
P+ + +C +LN+L L+ NKL+G IP +L+ L RL++ S+A+NDL+G+IPS + + F
Sbjct: 131 PSQIVDCKFLNSLALNQNKLTGSIPSELTRLNRLQRLSLADNDLSGSIPSELSHYGEDGF 190
Query: 222 DGNSDLCGGPLGSKCGGLSKKNLXXXXXXXXXXXXXSMLLAFGLWWWYHLRWVRRRKR-G 280
GN LCG PL S CG + KNL S+ + FG++WW+ +R R+ G
Sbjct: 191 RGNGGLCGKPL-SNCGSFNGKNLTIIVTAGVIGAVGSLCVGFGMFWWFFIRDRRKMNNYG 249
Query: 281 YGIGRDDDDSRWLERLRSHKLAQVSLFQKPLVKVKLADLMAASNSFCSENVIISTRTGTT 340
YG G+ DDS W+ LRSHKL QV+LFQKP+VK+KL DL+ A+N F S N+++S+R+G +
Sbjct: 250 YGAGKCKDDSDWIGLLRSHKLVQVTLFQKPIVKIKLVDLIEATNGFDSGNIVVSSRSGVS 309
Query: 341 YKAMLPDGSVLAVKRLNTC-KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399
YKA LPDGS L VKRL++C +L EK+FR+E+N+LGQ+RHPNL PLLG+CVVE+E LL+YK
Sbjct: 310 YKADLPDGSTLEVKRLSSCCELSEKQFRSEINKLGQIRHPNLVPLLGFCVVEDEILLVYK 369
Query: 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDED 459
+M++GTLYS LQ ++DWPTR R+ +GAARGLAWLHHGCQP ++HQ I SNVIL+DED
Sbjct: 370 HMANGTLYSQLQ--QWDIDWPTRVRVAVGAARGLAWLHHGCQPLYMHQYISSNVILLDED 427
Query: 460 FDARIMDFGLAKLMTSSD--ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLE 517
FDAR++D+GL KL++S D +SSF NG +FGY+APEYSSTMVASL GDVYG G+VLLE
Sbjct: 428 FDARVIDYGLGKLVSSQDSKDSSFSNG---KFGYVAPEYSSTMVASLSGDVYGFGIVLLE 484
Query: 518 LA-------------GFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACN 564
+ GFK +LV+WV++ S+GRSK+AID+ + GKGYD+EI+Q L++AC+
Sbjct: 485 IVTGQKPVLINNGEEGFKESLVEWVSKHLSNGRSKDAIDRRIFGKGYDDEIMQVLRIACS 544
Query: 565 CVVSRPKDRWSMYQVYQSLNSIAAQHGFSERY-DEFPLIFHRQD 607
CVVSRPK+R M QVY+SL ++ QHGF Y DEFPLIF++Q+
Sbjct: 545 CVVSRPKERPLMIQVYESLKNLGDQHGFFSEYSDEFPLIFNKQE 588
|
|
| TAIR|locus:2205834 AT1G27190 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1564 (555.6 bits), Expect = 1.4e-160, P = 1.4e-160
Identities = 297/484 (61%), Positives = 369/484 (76%)
Query: 40 SSLASETVAEDDVKCLEGVKSSLNDPQRKLSSWSFGNSTIGFICQFVGVSCWNDKENRIL 99
S L S + AEDDV CL+G+K+SL DP +LSSWSF NS+ IC+ GVSCWN+KENRI+
Sbjct: 16 SFLCSSSSAEDDVLCLQGLKNSLIDPSSRLSSWSFPNSSASSICKLTGVSCWNEKENRII 75
Query: 100 NLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVXXXXXXXXXXG 159
+L+L+ M+L+G+IPE LK C+S+Q LDLS NDLSG+IP+QIC+WLPYLV G
Sbjct: 76 SLQLQSMQLAGEIPESLKLCRSLQSLDLSGNDLSGSIPSQICSWLPYLVTLDLSGNKLGG 135
Query: 160 PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKA 219
IP + C +LN LILS+NKLSG IP QLS L RL++ S+A NDL+GTIPS F
Sbjct: 136 SIPTQIVECKFLNALILSDNKLSGSIPSQLSRLDRLRRLSLAGNDLSGTIPSELARFGGD 195
Query: 220 DFDGNSDLCGGPLGSKCGGLSKKNLXXXXXXXXXXXXXSMLLAFGLWWWYHLRWVRRRKR 279
DF GN+ LCG PL S+CG L+ +NL S+ + ++WW+ +R R+K+
Sbjct: 196 DFSGNNGLCGKPL-SRCGALNGRNLSIIIVAGVLGAVGSLCVGLVIFWWFFIREGSRKKK 254
Query: 280 GYGIGRDDDDSRWLERLRSHKLAQVSLFQKPLVKVKLADLMAASNSFCSENVIISTRTGT 339
GYG G+ DDS W+ LRSHKL QV+LFQKP+VK+KL DLMAA+N+F S N+ +S+RTG
Sbjct: 255 GYGAGKSKDDSDWIGLLRSHKLVQVTLFQKPIVKIKLGDLMAATNNFSSGNIDVSSRTGV 314
Query: 340 TYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399
+YKA LPDGS LAVKRL+ C GEK+FR+EMN+LG+LRHPNL PLLGYCVVE+E+LL+YK
Sbjct: 315 SYKADLPDGSALAVKRLSACGFGEKQFRSEMNKLGELRHPNLVPLLGYCVVEDERLLVYK 374
Query: 400 YMSSGTLYSLLQ-GNATE--LDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV 456
+M +GTL+S L G + LDWPTR IG+GAA+GLAWLHHGCQPP+LHQ I SNVIL+
Sbjct: 375 HMVNGTLFSQLHNGGLCDAVLDWPTRRAIGVGAAKGLAWLHHGCQPPYLHQFISSNVILL 434
Query: 457 DEDFDARIMDFGLAKLMTSSD--ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVV 514
D+DFDARI D+GLAKL+ S D +SSF NGDLGE GY+APEYSSTMVASLKGDVYG G+V
Sbjct: 435 DDDFDARITDYGLAKLVGSRDSNDSSFNNGDLGELGYVAPEYSSTMVASLKGDVYGFGIV 494
Query: 515 LLEL 518
LLEL
Sbjct: 495 LLEL 498
|
|
| TAIR|locus:2165981 BIR1 "AT5G48380" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1034 (369.0 bits), Expect = 2.0e-104, P = 2.0e-104
Identities = 215/501 (42%), Positives = 302/501 (60%)
Query: 42 LASETVAED--DVKCLEGVKSSLNDPQRKLSSWSFGNSTIGFICQFVGVSCWNDKENRIL 99
L S V D ++ CL KS + DP R LS+W FGN T G+IC+F GV+CW+D ENR+L
Sbjct: 20 LLSSLVDADQANIDCLRTFKSQVEDPNRYLSTWVFGNETAGYICKFSGVTCWHDDENRVL 79
Query: 100 NLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVXXXXXXXXXXG 159
+++L L G P +K C + LDLS N+ SG +PA I +P + G
Sbjct: 80 SIKLSGYGLRGVFPPAVKLCADLTGLDLSRNNFSGPLPANISTLIPLVTILDLSYNSFSG 139
Query: 160 PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG--FD 217
IP + N T+LNTL+L +N+ +G +P QL+ LGRLK FSV++N L G IP+ + F
Sbjct: 140 EIPMLISNITFLNTLMLQHNQFTGTLPPQLAQLGRLKTFSVSDNRLVGPIPNFNQTLQFK 199
Query: 218 KADFDGNSDLCGGPLGSKCGGLSKKNLXXXXXXXXXXXXXSMLLAFGLWWWYHLRWVRRR 277
+ F N DLCG PL S + ++++ L++++ R+
Sbjct: 200 QELFANNLDLCGKPLDDCKSASSSRGKVVIIAAVGGLTAAALVVGVVLFFYFRKLGAVRK 259
Query: 278 KRGYGIGRDDDDSRWLERLRSHKLAQVSLFQKPLVKVKLADLMAASNSFCSENVIISTRT 337
K+ D + +RW + L+ K +V +F+K + K+KL+DLM A+ F +N+I + RT
Sbjct: 260 KQD-----DPEGNRWAKSLKGQKGVKVFMFKKSVSKMKLSDLMKATEEFKKDNIIATGRT 314
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397
GT YK L DGS+L +KRL + EK+F EM LG +++ NL PLLGYCV +E+LL+
Sbjct: 315 GTMYKGRLEDGSLLMIKRLQDSQRSEKEFDAEMKTLGSVKNRNLVPLLGYCVANKERLLM 374
Query: 398 YKYMSSGTLYSLLQGNATE----LDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNV 453
Y+YM++G LY L E LDWP+R +I +G A+GLAWLHH C P +H+NI S
Sbjct: 375 YEYMANGYLYDQLHPADEESFKPLDWPSRLKIAIGTAKGLAWLHHSCNPRIIHRNISSKC 434
Query: 454 ILVDEDFDARIMDFGLAKLMTSSDE--SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGI 511
IL+ +F+ +I DFGLA+LM D S+FVNG+ G+FGY+APEYS TMVA+ KGDVY
Sbjct: 435 ILLTAEFEPKISDFGLARLMNPIDTHLSTFVNGEFGDFGYVAPEYSRTMVATPKGDVYSF 494
Query: 512 GVVLLELA-GFKGNLVDWVNQ 531
GVVLLEL G K V V++
Sbjct: 495 GVVLLELVTGQKATSVTKVSE 515
|
|
| TAIR|locus:2005498 BRI1 "BRASSINOSTEROID INSENSITIVE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 548 (198.0 bits), Expect = 1.5e-75, Sum P(3) = 1.5e-75
Identities = 131/342 (38%), Positives = 196/342 (57%)
Query: 285 RDDDDSRW-LERLRSHKLAQVSLFQKPLVKVKLADLMAASNSFCSENVIISTRTGTTYKA 343
R +++ W L ++ ++ F+KPL K+ ADL+ A+N F ++++I S G YKA
Sbjct: 841 RTANNTNWKLTGVKEALSINLAAFEKPLRKLTFADLLQATNGFHNDSLIGSGGFGDVYKA 900
Query: 344 MLPDGSVLAVKRL-NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402
+L DGS +A+K+L + G+++F EM +G+++H NL PLLGYC V +E+LL+Y++M
Sbjct: 901 ILKDGSAVAIKKLIHVSGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGDERLLVYEFMK 960
Query: 403 SGTLYSLLQGN---ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDED 459
G+L +L +L+W TR +I +G+ARGLA+LHH C P +H+++ S+ +L+DE+
Sbjct: 961 YGSLEDVLHDPKKAGVKLNWSTRRKIAIGSARGLAFLHHNCSPHIIHRDMKSSNVLLDEN 1020
Query: 460 FDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELA 519
+AR+ DFG+A+LM++ D V+ G GY+ PEY + S KGDVY GVVLLEL
Sbjct: 1021 LEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELL 1080
Query: 520 GFK----------GNLVDWVNQLSSSGRSKEAIDKALCGK--GYDEEILQFLKVACNCVV 567
K NLV WV Q + R + D L + + E+LQ LKVA C+
Sbjct: 1081 TGKRPTDSPDFGDNNLVGWVKQHAKL-RISDVFDPELMKEDPALEIELLQHLKVAVACLD 1139
Query: 568 SRPKDRWSMYQVYQSLNSIAAQHGFSERYDEFPLIFHRQDGG 609
R R +M QV I A G D I +DGG
Sbjct: 1140 DRAWRRPTMVQVMAMFKEIQAGSGI----DSQSTIRSIEDGG 1177
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 751 (269.4 bits), Expect = 1.0e-73, P = 1.0e-73
Identities = 190/517 (36%), Positives = 280/517 (54%)
Query: 98 ILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVXXXXXXXXX 157
++ L L + KL G +P L K + +DLS N+LSG + +++ + LV
Sbjct: 678 LVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELST-MEKLVGLYIEQNKF 736
Query: 158 XGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFD 217
G IP++LGN T L L +S N LSG IP ++ L L+ ++A N+L G +PS D
Sbjct: 737 TGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQD 796
Query: 218 --KADFDGNSDLCGGPLGSKCG--GLSKKNLXXXXXXXXXXXXXSMLLAFGLWWWYHLRW 273
KA GN +LCG +GS C G ++ + F L W +
Sbjct: 797 PSKALLSGNKELCGRVVGSDCKIEGTKLRSAWGIAGLMLGFTIIVFVFVFSLRRWAMTKR 856
Query: 274 VRRRKRGYGI------GRDDDDSRWLERLRSHK-LA-QVSLFQKPLVKVKLADLMAASNS 325
V++R + G D + +L RS + L+ +++F++PL+KV+L D++ A++
Sbjct: 857 VKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDIVEATDH 916
Query: 326 FCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKL-GEKKFRNEMNRLGQLRHPNLAPL 384
F +N+I GT YKA LP +AVK+L+ K G ++F EM LG+++HPNL L
Sbjct: 917 FSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSL 976
Query: 385 LGYCVVEEEKLLIYKYMSSGTLYSLLQ---GNATELDWPTRFRIGLGAARGLAWLHHGCQ 441
LGYC EEKLL+Y+YM +G+L L+ G LDW R +I +GAARGLA+LHHG
Sbjct: 977 LGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFI 1036
Query: 442 PPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMV 501
P +H++I ++ IL+D DF+ ++ DFGLA+L+ S+ ES G FGYI PEY +
Sbjct: 1037 PHIIHRDIKASNILLDGDFEPKVADFGLARLI-SACESHVSTVIAGTFGYIPPEYGQSAR 1095
Query: 502 ASLKGDVYGIGVVLLELA------G--FK----GNLVDWVNQLSSSGRSKEAIDKALCGK 549
A+ KGDVY GV+LLEL G FK GNLV W Q + G++ + ID L
Sbjct: 1096 ATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAVDVIDPLLVSV 1155
Query: 550 GYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586
L+ L++A C+ P R +M V ++L I
Sbjct: 1156 ALKNSQLRLLQIAMLCLAETPAKRPNMLDVLKALKEI 1192
|
|
| TAIR|locus:2020457 BRL1 "BRI1 like" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 579 (208.9 bits), Expect = 7.6e-72, Sum P(2) = 7.6e-72
Identities = 129/316 (40%), Positives = 188/316 (59%)
Query: 304 VSLFQKPLVKVKLADLMAASNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRL-NTCKLG 362
V+ F+KPL K+ A L+ A+N F +E ++ S G YKA L DGSV+A+K+L G
Sbjct: 837 VATFEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKKLIRITGQG 896
Query: 363 EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATE-----L 417
+++F EM +G+++H NL PLLGYC V EE+LL+Y+YM G+L ++L +++ L
Sbjct: 897 DREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHEKSSKKGGIYL 956
Query: 418 DWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477
+W R +I +GAARGLA+LHH C P +H+++ S+ +L+DEDF+AR+ DFG+A+L+++ D
Sbjct: 957 NWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDFGMARLVSALD 1016
Query: 478 ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL-AGFK----------GNLV 526
V+ G GY+ PEY + + KGDVY GV+LLEL +G K NLV
Sbjct: 1017 THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPGEFGEDNNLV 1076
Query: 527 DWVNQLSSSGRSKEAIDKALC-GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNS 585
W QL R E +D L K D E+ +LK+A C+ RP R +M Q+
Sbjct: 1077 GWAKQLYREKRGAEILDPELVTDKSGDVELFHYLKIASQCLDDRPFKRPTMIQLMAMFKE 1136
Query: 586 IAAQHGFSERYDEFPL 601
+ A E DEF L
Sbjct: 1137 MKADTEEDESLDEFSL 1152
|
|
| TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 576 (207.8 bits), Expect = 5.3e-71, Sum P(2) = 5.3e-71
Identities = 131/330 (39%), Positives = 191/330 (57%)
Query: 290 SRW-LERLRSHKLAQVSLFQKPLVKVKLADLMAASNSFCSENVIISTRTGTTYKAMLPDG 348
S W L + V+ F+KPL K+ A L+ A+N F ++++I S G YKA L DG
Sbjct: 821 SSWKLSSVHEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADG 880
Query: 349 SVLAVKRL-NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLY 407
SV+A+K+L G+++F EM +G+++H NL PLLGYC + EE+LL+Y+YM G+L
Sbjct: 881 SVVAIKKLIQVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLE 940
Query: 408 SLLQGNATE----LDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDAR 463
++L + LDW R +I +GAARGLA+LHH C P +H+++ S+ +L+D+DF AR
Sbjct: 941 TVLHEKTKKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVAR 1000
Query: 464 IMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL-AGFK 522
+ DFG+A+L+++ D V+ G GY+ PEY + + KGDVY GV+LLEL +G K
Sbjct: 1001 VSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKK 1060
Query: 523 ----------GNLVDWVNQLSSSGRSKEAIDKALC-GKGYDEEILQFLKVACNCVVSRPK 571
NLV W QL R E +D L K D E+L +LK+A C+ RP
Sbjct: 1061 PIDPEEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELLHYLKIASQCLDDRPF 1120
Query: 572 DRWSMYQVYQSLNSIAAQHGFSERYDEFPL 601
R +M QV + ++ DEF L
Sbjct: 1121 KRPTMIQVMTMFKELVQVDTENDSLDEFLL 1150
|
|
| TAIR|locus:2051628 PSKR1 "phytosulfokin receptor 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 678 (243.7 bits), Expect = 2.8e-66, P = 2.8e-66
Identities = 179/485 (36%), Positives = 255/485 (52%)
Query: 125 LDLSANDLSGNIPAQICNWLPYLVXXXXXXXXXXGPIPADLGNCTYLNTLILSNNKLSGP 184
++L N+LSG I + N L L G IP+ L T L L LSNN+LSG
Sbjct: 528 IELGHNNLSGPIWEEFGN-LKKLHVFDLKWNALSGSIPSSLSGMTSLEALDLSNNRLSGS 586
Query: 185 IPYQLSNLGRLKKFSVANNDLTGTIPSS--FKGFDKADFDGNSDLCGGPLGSKCGGLSKK 242
IP L L L KFSVA N+L+G IPS F+ F + F+ N LCG G
Sbjct: 587 IPVSLQQLSFLSKFSVAYNNLSGVIPSGGQFQTFPNSSFESNH-LCGEHRFPCSEGTESA 645
Query: 243 NLXXXXXXXXXXXXXSMLLAFG---LWWWYHLRWVRRRKRGYGIGRDDDDSRWLERLRSH 299
+ ++ +AFG L L +R R+R + + ++S + R
Sbjct: 646 LIKRSRRSRGGDIGMAIGIAFGSVFLLTLLSLIVLRARRRSGEVDPEIEESESMNRKELG 705
Query: 300 KLAQ--VSLFQKPLVKVKLADLMAASNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLN 357
++ V LFQ ++ DL+ ++NSF N+I G YKA LPDG +A+K+L+
Sbjct: 706 EIGSKLVVLFQSNDKELSYDDLLDSTNSFDQANIIGCGGFGMVYKATLPDGKKVAIKKLS 765
Query: 358 -TCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTL-YSLLQGN-- 413
C E++F E+ L + +HPNL L G+C + ++LLIY YM +G+L Y L + N
Sbjct: 766 GDCGQIEREFEAEVETLSRAQHPNLVLLRGFCFYKNDRLLIYSYMENGSLDYWLHERNDG 825
Query: 414 ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLM 473
L W TR RI GAA+GL +LH GC P LH++I S+ IL+DE+F++ + DFGLA+LM
Sbjct: 826 PALLKWKTRLRIAQGAAKGLLYLHEGCDPHILHRDIKSSNILLDENFNSHLADFGLARLM 885
Query: 474 TSSDESSFVNGDL-GEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFK---------G 523
S + V+ DL G GYI PEY VA+ KGDVY GVVLLEL K G
Sbjct: 886 --SPYETHVSTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTDKRPVDMCKPKG 943
Query: 524 --NLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQ 581
+L+ WV ++ R+ E D + K D+E+ + L++AC C+ PK R + Q+
Sbjct: 944 CRDLISWVVKMKHESRASEVFDPLIYSKENDKEMFRVLEIACLCLSENPKQRPTTQQLVS 1003
Query: 582 SLNSI 586
L+ +
Sbjct: 1004 WLDDV 1008
|
|
| UNIPROTKB|Q942F3 P0480C01.18-1 "cDNA clone:J033069J12, full insert sequence" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 536 (193.7 bits), Expect = 3.4e-66, Sum P(3) = 3.4e-66
Identities = 125/319 (39%), Positives = 180/319 (56%)
Query: 289 DSRWLERLRSHKLAQVSL--FQKPLVKVKLADLMAASNSFCSENVIISTRTGTTYKAMLP 346
+S W + L L ++L F+KPL + LADL+ A+N F I S G YKA L
Sbjct: 768 NSDWRQNLSGTNLLSINLAAFEKPLQNLTLADLVEATNGFHIACQIGSGGFGDVYKAQLK 827
Query: 347 DGSVLAVKRL-NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGT 405
DG V+A+K+L + G+++F EM +G+++H NL PLLGYC EE+LL+Y YM G+
Sbjct: 828 DGKVVAIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKAGEERLLVYDYMKFGS 887
Query: 406 LYSLLQGN---ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDA 462
L +L +L+W R +I +GAARGLA+LHH C P +H+++ S+ +L+DE +A
Sbjct: 888 LEDVLHDRKKIGKKLNWEARRKIAVGAARGLAFLHHNCIPHIIHRDMKSSNVLIDEQLEA 947
Query: 463 RIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELA--- 519
R+ DFG+A+LM+ D V+ G GY+ PEY + + KGDVY GVVLLEL
Sbjct: 948 RVSDFGMARLMSVVDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVVLLELLTGK 1007
Query: 520 --------GFKGNLVDWVNQLSSSGRSKEAIDKALCGK--GYDEEILQFLKVACNCVVSR 569
G NLV WV Q + + + D L + + E+L+ LK+AC C+ R
Sbjct: 1008 PPTDSADFGEDNNLVGWVKQHTKL-KITDVFDPELLKEDPSVELELLEHLKIACACLDDR 1066
Query: 570 PKDRWSMYQVYQSLNSIAA 588
P R +M +V I A
Sbjct: 1067 PSRRPTMLKVMAMFKEIQA 1085
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.XVII.773.1 | hypothetical protein (588 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 611 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-31 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-24 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-23 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-22 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-21 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-21 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-20 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-16 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-16 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-14 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-14 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-13 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-12 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-12 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-12 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-12 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-11 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-11 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-11 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-10 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-09 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-09 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-09 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-08 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-08 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-08 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-08 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-08 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-08 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-08 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-07 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-07 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-07 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-07 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-07 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-07 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-07 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-06 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-06 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-06 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-06 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-06 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-06 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-06 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-06 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-06 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-05 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-05 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-05 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-05 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-05 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-05 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-05 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-05 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-05 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-05 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-05 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-05 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-05 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-05 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-04 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-04 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-04 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-04 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-04 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 5e-04 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-04 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-04 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-04 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 9e-04 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 0.001 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 0.001 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 0.002 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 0.002 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 0.002 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 0.002 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 0.002 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.002 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 0.003 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 0.003 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 0.003 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 2e-45
Identities = 145/511 (28%), Positives = 233/511 (45%), Gaps = 56/511 (10%)
Query: 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNN 155
R+ NL+L + SG +P L + +L LS N LSG IP ++ + LV LDLS+N
Sbjct: 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSS-CKKLVSLDLSHN 533
Query: 156 DLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSS--F 213
LSG IPA L+ L LS N+LSG IP L N+ L + ++++N L G++PS+ F
Sbjct: 534 QLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAF 593
Query: 214 KGFDKADFDGNSDLCGGPLGS---KCGGLSKKNLAIIIAAGIFGAAASMLL-AFGLWWWY 269
+ + GN DLCGG S C + K GA + L AFG +
Sbjct: 594 LAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVF-- 651
Query: 270 HLRWVRRRKRGYGIGR-DDDDSRWLERLRSHKLAQVSLFQKPLVK-VKLADLMAASNSFC 327
R + + R +++D W ++ F + K + + D++++
Sbjct: 652 -----IRGRNNLELKRVENEDGTW----------ELQFFDSKVSKSITINDILSSLK--- 693
Query: 328 SENVIISTRTGTTYKAMLPDGSV-LAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLG 386
ENVI + G +YK + VK +N +M G+L+HPN+ L+G
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADM---GKLQHPNIVKLIG 750
Query: 387 YCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLH 446
C E+ LI++Y+ L +L+ L W R +I +G A+ L +LH C P +
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVV 806
Query: 447 QNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKG 506
N+ I++D + + L L+ +D F++ Y+APE T + K
Sbjct: 807 GNLSPEKIIIDGKDEPHLR-LSLPGLLC-TDTKCFISS-----AYVAPETRETKDITEKS 859
Query: 507 DVYGIGVVLLEL----------AGFKGNLVDWVNQLSSSGRSKEAIDKALCGKG--YDEE 554
D+YG G++L+EL G G++V+W S ID ++ G E
Sbjct: 860 DIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNE 919
Query: 555 ILQFLKVACNCVVSRPKDRWSMYQVYQSLNS 585
I++ + +A +C + P R V ++L S
Sbjct: 920 IVEVMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-31
Identities = 58/191 (30%), Positives = 90/191 (47%), Gaps = 12/191 (6%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKK--FRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394
GT Y A G +A+K + E+ L +L HPN+ L G E
Sbjct: 7 GTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHL 66
Query: 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLH-HGCQPPFLHQNI-CSN 452
L+ +Y G+L LL+ N +L RI L GL +LH +G +H+++ N
Sbjct: 67 YLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG----IIHRDLKPEN 122
Query: 453 VILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPE-YSSTMVASLKGDVYGI 511
++L ++ ++ DFGL+KL+TS S + +G Y+APE S K D++ +
Sbjct: 123 ILLDSDNGKVKLADFGLSKLLTSD--KSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSL 180
Query: 512 GVVLLELAGFK 522
GV+L EL K
Sbjct: 181 GVILYELPELK 191
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 7e-24
Identities = 65/187 (34%), Positives = 98/187 (52%), Gaps = 8/187 (4%)
Query: 35 TQITFSSLASETVAEDDVKCLEGVKSSLNDPQRKLSSWSFGNSTIGFICQFVGVSCWNDK 94
+ F L + ++++ L KSS+NDP + LS+W NS+ C + G++C N
Sbjct: 14 FMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNW---NSSADV-CLWQGITCNN-- 67
Query: 95 ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSN 154
+R+++++L +SGKI + +Q ++LS N LSG IP I L L+LSN
Sbjct: 68 SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSN 127
Query: 155 NDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFK 214
N+ +G IP G+ L TL LSNN LSG IP + + LK + N L G IP+S
Sbjct: 128 NNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLT 185
Query: 215 GFDKADF 221
+F
Sbjct: 186 NLTSLEF 192
|
Length = 968 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 9e-23
Identities = 55/183 (30%), Positives = 83/183 (45%), Gaps = 9/183 (4%)
Query: 340 TYKAMLPDGSVL-AVKRLNTCKLGE--KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396
K V AVK L + ++F E + +L HPN+ LLG C EE +
Sbjct: 19 KLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYI 78
Query: 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNI-CSNVIL 455
+ +YM G L S L+ N +L L ARG+ +L F+H+++ N L
Sbjct: 79 VMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK---NFIHRDLAARN-CL 134
Query: 456 VDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVL 515
V E+ +I DFGL++ + D G L ++APE + K DV+ GV+L
Sbjct: 135 VGENLVVKISDFGLSRDLYDDDYYRKRGGKL-PIRWMAPESLKEGKFTSKSDVWSFGVLL 193
Query: 516 LEL 518
E+
Sbjct: 194 WEI 196
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (241), Expect = 2e-22
Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 5/169 (2%)
Query: 352 AVKRLN--TCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSL 409
AVK L + ++F E + + +L HPN+ LLG C E ++ +YM G L
Sbjct: 32 AVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDF 91
Query: 410 LQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGL 469
L+ + +L ++ L A+G+ +L F+H+++ + LV E+ +I DFGL
Sbjct: 92 LRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGL 148
Query: 470 AKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
++ + D G ++APE + K DV+ GV+L E+
Sbjct: 149 SRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEI 197
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 1e-21
Identities = 55/197 (27%), Positives = 85/197 (43%), Gaps = 21/197 (10%)
Query: 338 GTTYKAML---PDGSVL-AVKRLNTCKLGE--KKFRNEMNRLGQLRHPNLAPLLGYCVVE 391
G YK L + AVK L E K F E + +L HPN+ LLG C E
Sbjct: 9 GEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEE 68
Query: 392 EEKLLIYKYMSSGTLYSLLQ--------GNATELDWPTRFRIGLGAARGLAWLHHGCQPP 443
E L+ +YM G L L+ + L + A+G+ +L
Sbjct: 69 EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKK 125
Query: 444 FLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEF--GYIAPEYSSTMV 501
F+H+++ + LV ED +I DFGL++ + D + G+ ++APE +
Sbjct: 126 FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY--YRKKTGGKLPIRWMAPESLKDGI 183
Query: 502 ASLKGDVYGIGVVLLEL 518
+ K DV+ GV+L E+
Sbjct: 184 FTSKSDVWSFGVLLWEI 200
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 56/184 (30%), Positives = 84/184 (45%), Gaps = 10/184 (5%)
Query: 340 TYKAMLPDGSVL-AVKRLNTCKLGE--KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396
T K V AVK L + ++F E + +L HPN+ LLG C EE ++
Sbjct: 19 TLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78
Query: 397 IYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNI-CSNVI 454
+ +YM G L L+ N EL L ARG+ +L F+H+++ N
Sbjct: 79 VMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARN-C 134
Query: 455 LVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVV 514
LV E+ +I DFGL++ + D G L ++APE + K DV+ GV+
Sbjct: 135 LVGENLVVKISDFGLSRDLYDDDYYKVKGGKL-PIRWMAPESLKEGKFTSKSDVWSFGVL 193
Query: 515 LLEL 518
L E+
Sbjct: 194 LWEI 197
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 71/264 (26%), Positives = 109/264 (41%), Gaps = 38/264 (14%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKKF---RNEMNRLGQLRHPNLAPLLGYCVVEEE 393
GT YKA G ++AVK L KK R E+ L +L HPN+ L+ ++
Sbjct: 13 GTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDH 72
Query: 394 KLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLH-HGCQPPFLHQNICSN 452
L+ +Y G L+ L L +I L RGL +LH +G +H+++
Sbjct: 73 LYLVMEYCEGGDLFDYLS-RGGPLSEDEAKKIALQILRGLEYLHSNG----IIHRDLKPE 127
Query: 453 VILVDEDFDARIMDFGLAKLMTSSDES--SFVNGDLGEFGYIAPE-YSSTMVASLKGDVY 509
IL+DE+ +I DFGLAK + S S +FV G Y+APE K DV+
Sbjct: 128 NILLDENGVVKIADFGLAKKLLKSSSSLTTFV----GTPWYMAPEVLLGGNGYGPKVDVW 183
Query: 510 GIGVVLLELAG----FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQ-------F 558
+GV+L EL F G + + I + L + + +
Sbjct: 184 SLGVILYELLTGKPPFSG---------ENILDQLQLIRRILGPP-LEFDEPKWSSGSEEA 233
Query: 559 LKVACNCVVSRPKDRWSMYQVYQS 582
+ C+ P R + ++ Q
Sbjct: 234 KDLIKKCLNKDPSKRPTAEEILQH 257
|
Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 6e-20
Identities = 59/256 (23%), Positives = 114/256 (44%), Gaps = 41/256 (16%)
Query: 337 TGTTYKAM-LPDGSVLAVKRLNTCKLGEKKF-RNEMNRLGQLRHPNLAPLLGYCVVEEEK 394
G YKA G +A+K + +K+ NE+ L + +HPN+ G +++++
Sbjct: 13 FGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG-SYLKKDE 71
Query: 395 L-LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLH-HGCQPPFLHQNICSN 452
L ++ ++ S G+L LL+ L + +GL +LH +G +H++I +
Sbjct: 72 LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG----IIHRDIKAA 127
Query: 453 VILVDEDFDARIMDFGLAKLMTSS-DESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGI 511
IL+ D + +++DFGL+ ++ + ++ V G ++APE + K D++ +
Sbjct: 128 NILLTSDGEVKLIDFGLSAQLSDTKARNTMV----GTPYWMAPEVINGKPYDYKADIWSL 183
Query: 512 GVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL------------CGKGYDEEILQFL 559
G+ +ELA +G S+ KAL + + +E FL
Sbjct: 184 GITAIELA--EGK----------PPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFL 231
Query: 560 KVACNCVVSRPKDRWS 575
K C+ P+ R +
Sbjct: 232 K---KCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 10/177 (5%)
Query: 348 GSVLAVKRLNTCKLGEKK--FRNEMNRLGQLRHPNLAPLLGYCVVEEEK--LLIYKYMSS 403
G +AVK LN + + F E+ L L H N+ G C + LI +Y+ S
Sbjct: 33 GEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPS 92
Query: 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDAR 463
G+L LQ + +++ +G+ +L ++H+++ + ILV+ + +
Sbjct: 93 GSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVK 149
Query: 464 IMDFGLAKLMTSSDESSFVN--GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
I DFGLAK++ + +V G+ F Y APE T S DV+ GV L EL
Sbjct: 150 ISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRTSKFSSASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-17
Identities = 45/116 (38%), Positives = 69/116 (59%), Gaps = 1/116 (0%)
Query: 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNND 156
++++L+L + LSG+IPE + ++++ L L +N+ +G IP + + LP L +L L +N
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTS-LPRLQVLQLWSNK 343
Query: 157 LSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSS 212
SG IP +LG L L LS N L+G IP L + G L K + +N L G IP S
Sbjct: 344 FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKS 399
|
Length = 968 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-17
Identities = 71/235 (30%), Positives = 100/235 (42%), Gaps = 32/235 (13%)
Query: 50 DDVKCLEGVKSSLNDPQRKLSSWSFGNSTIGFICQFVGVSCWNDKENR---ILNLELREM 106
++V L+ +KSSL P R W+ G+ + + G C D I L L
Sbjct: 372 EEVSALQTLKSSLGLPLR--FGWN-GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQ 428
Query: 107 KLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLG 166
L G IP + + +Q ++LS N + GNIP + + + L +LDLS N +G IP LG
Sbjct: 429 GLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGS-ITSLEVLDLSYNSFNGSIPESLG 487
Query: 167 NCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKADFDGNSD 226
T L L L+ N LSG +P L GRL L +F N+
Sbjct: 488 QLTSLRILNLNGNSLSGRVPAALG--GRL---------LHRAS---------FNFTDNAG 527
Query: 227 LCGGPLGSKCGGLSKKNLAIIIAAGIFGAAASMLL--AFGLWWWYHLRWVRRRKR 279
LCG P CG I IA FG + + L + WW + + R +R
Sbjct: 528 LCGIPGLRACGPHLSVGAKIGIA---FGVSVAFLFLVICAMCWWKRRQNILRAQR 579
|
Length = 623 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-16
Identities = 47/113 (41%), Positives = 61/113 (53%), Gaps = 1/113 (0%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
L+L LSG+IP + S++ LDL N L G IP + N L L L L++N L G
Sbjct: 145 LDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTN-LTSLEFLTLASNQLVGQ 203
Query: 161 IPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213
IP +LG L + L N LSG IPY++ L L + N+LTG IPSS
Sbjct: 204 IPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSL 256
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 2e-16
Identities = 55/196 (28%), Positives = 92/196 (46%), Gaps = 32/196 (16%)
Query: 338 GTTYKAM-LPDGSVLAVKRLN--TCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394
G Y A G ++A+K + K ++ E+ L +L+HPN+ L E++
Sbjct: 13 GKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKL 72
Query: 395 LLIYKYMSSGTLYSLLQ--GNATELDWPTRFRIGLGAARGLAWLH-HGCQPPFLHQNI-C 450
L+ +Y G L+ LL+ G +E + RF L +LH G +H+++
Sbjct: 73 YLVMEYCEGGDLFDLLKKRGRLSEDE--ARF-YLRQILSALEYLHSKG----IVHRDLKP 125
Query: 451 SNVILVDEDFDARIMDFGLAKLMTSSDE-SSFVNGDLGEFGYIAPE------YSSTMVAS 503
N IL+DED ++ DFGLA+ + ++ ++FV G Y+APE Y
Sbjct: 126 EN-ILLDEDGHVKLADFGLARQLDPGEKLTTFV----GTPEYMAPEVLLGKGYGK----- 175
Query: 504 LKGDVYGIGVVLLELA 519
D++ +GV+L EL
Sbjct: 176 -AVDIWSLGVILYELL 190
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-16
Identities = 49/110 (44%), Positives = 66/110 (60%), Gaps = 1/110 (0%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
L L +L G+IP L KS++ + L N+LSG IP +I L L LDL N+L+GP
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGG-LTSLNHLDLVYNNLTGP 251
Query: 161 IPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIP 210
IP+ LGN L L L NKLSGPIP + +L +L +++N L+G IP
Sbjct: 252 IPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 8e-16
Identities = 70/258 (27%), Positives = 114/258 (44%), Gaps = 41/258 (15%)
Query: 338 GTTYKAMLPD-GSVLAVKRLNTCKLGEKK---FRNEMNRLGQLRHPNLAPLLGYCVVEEE 393
G+ Y A+ D G ++AVK + E++ E+ L L+HPN+ G EE+
Sbjct: 14 GSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEK 73
Query: 394 K-LLIY-KYMSSGTLYSLLQGNATELDWPTRFRIGLGAA------RGLAWLH-HGCQPPF 444
L I+ +Y+S G+L SLL+ + + GLA+LH +G
Sbjct: 74 NTLNIFLEYVSGGSLSSLLKKFG-------KLPEPVIRKYTRQILEGLAYLHSNG----I 122
Query: 445 LHQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVAS 503
+H++I +N ILVD D ++ DFG AK + + G ++APE
Sbjct: 123 VHRDIKGAN-ILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181
Query: 504 LKGDVYGIGVVLLELA------GFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQ 557
D++ +G ++E+A GN + + ++ SSG E I + L EE
Sbjct: 182 RAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPE-IPEHL-----SEEAKD 235
Query: 558 FLKVACNCVVSRPKDRWS 575
FL+ C+ PK R +
Sbjct: 236 FLR---KCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 61/258 (23%), Positives = 114/258 (44%), Gaps = 25/258 (9%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLG-----EKKFRNEMNRLGQLRHPNLAPLLGYCVVEE 392
G YK +L + +AVK TC+ ++KF E L Q HPN+ L+G CV ++
Sbjct: 9 GDVYKGVLKGNTEVAVK---TCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ 65
Query: 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSN 452
++ + + G+L + L+ L ++ L AA G+ +L +H+++ +
Sbjct: 66 PIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAAR 122
Query: 453 VILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEF--GYIAPEYSSTMVASLKGDVYG 510
LV E+ +I DFG+++ V+ L + + APE + + + DV+
Sbjct: 123 NCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWS 180
Query: 511 IGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL---CGKGYDEEILQFLKVACNCVV 567
G++L E F + S+ +++E I+ + EEI + + C
Sbjct: 181 YGILLWET--FSLGDTPYPGM--SNQQTRERIESGYRMPAPQLCPEEIYRLML---QCWA 233
Query: 568 SRPKDRWSMYQVYQSLNS 585
P++R S ++Y L
Sbjct: 234 YDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 49/175 (28%), Positives = 87/175 (49%), Gaps = 5/175 (2%)
Query: 348 GSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLY 407
+AVK L + ++F E + +++HPNL LLG C E +I ++M+ G L
Sbjct: 31 SLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 90
Query: 408 SLLQ-GNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMD 466
L+ N E++ + + + +L + F+H+++ + LV E+ ++ D
Sbjct: 91 DYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVAD 147
Query: 467 FGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGF 521
FGL++LMT D + G + APE + S+K DV+ GV+L E+A +
Sbjct: 148 FGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 201
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 6e-14
Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 5/171 (2%)
Query: 352 AVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQ 411
AVK L + K F E + +LRHP L L C +EE ++ + M G+L LQ
Sbjct: 34 AVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQ 93
Query: 412 GNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLA 470
G A L P + A G+A+L ++H+++ + +LV E+ ++ DFGLA
Sbjct: 94 GGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLA 150
Query: 471 KLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGF 521
+++ + + APE + S+K DV+ G++L E+ +
Sbjct: 151 RVIKEDIYEAREGAKF-PIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTY 200
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 7e-14
Identities = 48/121 (39%), Positives = 63/121 (52%), Gaps = 4/121 (3%)
Query: 108 LSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGN 167
L GKIP L S++ L L++N L G IP ++ + L + L N+LSG IP ++G
Sbjct: 176 LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQ-MKSLKWIYLGYNNLSGEIPYEIGG 234
Query: 168 CTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDK---ADFDGN 224
T LN L L N L+GPIP L NL L+ + N L+G IP S K D N
Sbjct: 235 LTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDN 294
Query: 225 S 225
S
Sbjct: 295 S 295
|
Length = 968 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 7e-14
Identities = 62/203 (30%), Positives = 93/203 (45%), Gaps = 21/203 (10%)
Query: 330 NVIISTRTGTTYKAM-LPDGSVLAVKRLNTCKLGEKKFR---NEMNRLGQLRHPNLAPLL 385
N I G Y A+ L G ++AVK + K + +EM L L+HPNL
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 386 GYCVVEEEKLLIY-KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLH-HGCQPP 443
G V EK+ I+ +Y S GTL LL+ + R L GLA+LH HG
Sbjct: 66 G-VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIR-VYTLQLLEGLAYLHSHG---- 119
Query: 444 FLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES--SFVNGDLGEFGYIAPEYSSTMV 501
+H++I I +D + ++ DFG A + ++ + V G Y+APE +
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG-- 177
Query: 502 ASLKG-----DVYGIGVVLLELA 519
KG D++ +G V+LE+A
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMA 200
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 9e-14
Identities = 43/116 (37%), Positives = 61/116 (52%), Gaps = 2/116 (1%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
L++ L G+I S+Q L L+ N G +P + L LDLS N SG
Sbjct: 433 LDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS--KRLENLDLSRNQFSGA 490
Query: 161 IPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF 216
+P LG+ + L L LS NKLSG IP +LS+ +L +++N L+G IP+SF
Sbjct: 491 VPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEM 546
|
Length = 968 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-14
Identities = 55/194 (28%), Positives = 95/194 (48%), Gaps = 17/194 (8%)
Query: 327 CSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLG 386
C V + T GTT +A+K L + + F E + +LRH L PL
Sbjct: 18 CFGEVWMGTWNGTTK---------VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL-- 66
Query: 387 YCVVEEEKL-LIYKYMSSGTLYSLL-QGNATELDWPTRFRIGLGAARGLAWLHHGCQPPF 444
Y VV EE + ++ ++M G+L L +G+ L P + A G+A++ + +
Sbjct: 67 YAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNY 123
Query: 445 LHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASL 504
+H+++ + ILV ++ +I DFGLA+L+ +E + G + APE + ++
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 505 KGDVYGIGVVLLEL 518
K DV+ G++L EL
Sbjct: 183 KSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 1e-13
Identities = 56/195 (28%), Positives = 94/195 (48%), Gaps = 17/195 (8%)
Query: 327 CSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLG 386
C V + T GTT +A+K L + + F E + +LRH L L
Sbjct: 18 CFGEVWMGTWNGTTR---------VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL-- 66
Query: 387 YCVVEEEKL-LIYKYMSSGTLYSLLQGN-ATELDWPTRFRIGLGAARGLAWLHHGCQPPF 444
Y VV EE + ++ +YMS G+L L+G L P + A G+A++ + +
Sbjct: 67 YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 123
Query: 445 LHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASL 504
+H+++ + ILV E+ ++ DFGLA+L+ +E + G + APE + ++
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 505 KGDVYGIGVVLLELA 519
K DV+ G++L EL
Sbjct: 183 KSDVWSFGILLTELT 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-13
Identities = 42/113 (37%), Positives = 57/113 (50%), Gaps = 1/113 (0%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
L L +GKIP L +Q L L +N SG IP + L +LDLS N+L+G
Sbjct: 313 LHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKH-NNLTVLDLSTNNLTGE 371
Query: 161 IPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213
IP L + L LIL +N L G IP L L++ + +N +G +PS F
Sbjct: 372 IPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEF 424
|
Length = 968 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 51/197 (25%), Positives = 92/197 (46%), Gaps = 21/197 (10%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKK---FRNEMNRLGQLRHPNLAPLLGYC--VVE 391
GT K DG +L K ++ + EK+ +E+N L +L+HPN+ + Y +++
Sbjct: 14 GTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI---VRYYDRIID 70
Query: 392 EEKLLIYKYM---SSGTLYSLLQGNATE----LDWPTRFRIGLGAARGLAWLHHGCQPP- 443
+Y M G L L+Q + ++ +RI L H+ P
Sbjct: 71 RSNQTLYIVMEYCEGGDLAQLIQ-KCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN 129
Query: 444 -FLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVA 502
LH+++ I +D + + ++ DFGLAK++ +SSF +G Y++PE + M
Sbjct: 130 TVLHRDLKPANIFLDANNNVKLGDFGLAKILG--HDSSFAKTYVGTPYYMSPEQLNHMSY 187
Query: 503 SLKGDVYGIGVVLLELA 519
K D++ +G ++ EL
Sbjct: 188 DEKSDIWSLGCLIYELC 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 71.7 bits (174), Expect = 2e-13
Identities = 61/267 (22%), Positives = 100/267 (37%), Gaps = 27/267 (10%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEKK----FRNEMNRLGQLRHP-NLAPLLGYCVVEE 392
G Y A D ++A+K L + K F E+ L L HP N+ L + E
Sbjct: 14 GEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG 71
Query: 393 EKLLIYKYMSSGTLYSLLQ--GNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNI- 449
L+ +Y+ G+L LL+ G L I L +LH +H++I
Sbjct: 72 SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIK 128
Query: 450 CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEF----GYIAPEYSSTMV---A 502
N++L + +++DFGLAKL+ +S + GY+APE + A
Sbjct: 129 PENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYA 188
Query: 503 SLKGDVYGIGVVLLELA----GFKG-NLVDWVNQLSSSGRSK--EAIDKALCGKGYDEEI 555
S D++ +G+ L EL F+G +Q ++ L +
Sbjct: 189 SSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELIS 248
Query: 556 LQFLKVACNCVVSRPKDRWSMYQVYQS 582
+ + PK+R S
Sbjct: 249 KAASDLLKKLLAKDPKNRLSSSSDLSH 275
|
Length = 384 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 5e-13
Identities = 45/111 (40%), Positives = 62/111 (55%), Gaps = 1/111 (0%)
Query: 100 NLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG 159
+L+L L+G IP L K++Q L L N LSG IP I + L L+ LDLS+N LSG
Sbjct: 240 HLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS-LQKLISLDLSDNSLSG 298
Query: 160 PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIP 210
IP + L L L +N +G IP L++L RL+ + +N +G IP
Sbjct: 299 EIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIP 349
|
Length = 968 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 9e-13
Identities = 45/170 (26%), Positives = 79/170 (46%), Gaps = 22/170 (12%)
Query: 366 FRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLL--------------- 410
FR E + L+HPN+ LLG C E+ ++++Y++ G L+ L
Sbjct: 55 FRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGD 114
Query: 411 QGNATELDWPTRFRIGLGAARGLAWL--HHGCQPPFLHQNICSNVILVDEDFDARIMDFG 468
+ + LD I + A G+ +L HH F+H+++ + LV E +I DFG
Sbjct: 115 ETVKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFG 169
Query: 469 LAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
L++ + S+D + L ++ PE + + D++ GVVL E+
Sbjct: 170 LSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-12
Identities = 43/115 (37%), Positives = 63/115 (54%), Gaps = 1/115 (0%)
Query: 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNND 156
R+ L+L K SG+IP+ L ++ LDLS N+L+G IP +C+ L L L +N
Sbjct: 333 RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS-SGNLFKLILFSNS 391
Query: 157 LSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPS 211
L G IP LG C L + L +N SG +P + + L + ++NN+L G I S
Sbjct: 392 LEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINS 446
|
Length = 968 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 53/183 (28%), Positives = 89/183 (48%), Gaps = 8/183 (4%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL-L 396
G + + +AVK L + + F E + +LRH L L Y VV EE + +
Sbjct: 20 GEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQL--YAVVSEEPIYI 77
Query: 397 IYKYMSSGTLYSLLQ-GNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVIL 455
+ +YMS G+L L+ G L P + A G+A++ + ++H+++ S IL
Sbjct: 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANIL 134
Query: 456 VDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVL 515
V + +I DFGLA+L+ +E + G + APE + ++K DV+ G++L
Sbjct: 135 VGDGLVCKIADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 193
Query: 516 LEL 518
EL
Sbjct: 194 TEL 196
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 53/191 (27%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 338 GTTYKAMLPDGSVLAVKRL---NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394
G ++ + + +A+K L + K + F+ E+ L +LRH +L L C V E
Sbjct: 20 GEVWEGLWKNRVRVAIKILKSDDLLKQQD--FQKEVQALKRLRHKHLISLFAVCSVGEPV 77
Query: 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGA--ARGLAWLHHGCQPPFLHQNICSN 452
+I + M G+L + L + P I + A G+A+L + +H+++ +
Sbjct: 78 YIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAAR 133
Query: 453 VILVDEDFDARIMDFGLAKLM-----TSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGD 507
ILV ED ++ DFGLA+L+ SSD+ + APE +S S K D
Sbjct: 134 NILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK-------WTAPEAASHGTFSTKSD 186
Query: 508 VYGIGVVLLEL 518
V+ G++L E+
Sbjct: 187 VWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 49/173 (28%), Positives = 87/173 (50%), Gaps = 8/173 (4%)
Query: 351 LAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY-KYMSSGTLYSL 409
+A+K L + + F E N + QL+HP L L Y VV +E + I +YM +G+L
Sbjct: 33 VAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRL--YAVVTQEPIYIITEYMENGSLVDF 90
Query: 410 LQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFG 468
L+ +L + A G+A++ + ++H+++ + ILV E +I DFG
Sbjct: 91 LKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFG 147
Query: 469 LAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGF 521
LA+L+ +E + G + APE + ++K DV+ G++L E+ +
Sbjct: 148 LARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTY 199
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 53/197 (26%), Positives = 93/197 (47%), Gaps = 24/197 (12%)
Query: 338 GTTYKAMLP-DGSVLAVKRLNTCKLGEKKFR---NEMNRLGQLRHPNLAPLLGY--CVVE 391
G +K + D V A+K+++ K+ ++ +E L +L + + Y ++
Sbjct: 14 GVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI---IRYYESFLD 70
Query: 392 EEKL-LIYKYMSSGTLYSLLQGN-----ATELDWPTRFRIGLGAARGLAWLHHGCQPPFL 445
+ KL ++ +Y +G L+ LL+ + W R + GLA LH L
Sbjct: 71 KGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAHLH---SKKIL 123
Query: 446 HQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLK 505
H++I S + +D + +I D G+AKL+ SD ++F N +G Y++PE + K
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLSPELCEDKPYNEK 181
Query: 506 GDVYGIGVVLLELAGFK 522
DV+ +GVVL E K
Sbjct: 182 SDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 65/249 (26%), Positives = 107/249 (42%), Gaps = 31/249 (12%)
Query: 348 GSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLY 407
G +AVK L + F E + + LRHPNL LLG + ++ +YM+ G+L
Sbjct: 29 GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLV 88
Query: 408 SLL--QGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIM 465
L +G A + + L G+ +L + F+H+++ + +LV ED A++
Sbjct: 89 DYLRSRGRAV-ITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVS 144
Query: 466 DFGLAKLMTSSDESSFVNGDLGEF--GYIAPEYSSTMVASLKGDVYGIGVVLLELAGF-- 521
DFGLAK + D G+ + APE S K DV+ G++L E+ F
Sbjct: 145 DFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197
Query: 522 ----KGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMY 577
+ L D V + R + +G E+ + +K +C P R +
Sbjct: 198 VPYPRIPLKDVVPHVEKGYRME-------APEGCPPEVYKVMK---DCWELDPAKRPTFK 247
Query: 578 QVYQSLNSI 586
Q+ + L I
Sbjct: 248 QLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 45/180 (25%), Positives = 78/180 (43%), Gaps = 24/180 (13%)
Query: 363 EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQ----------- 411
+ F+ E + + HPN+ LLG C V + L+++YM+ G L L+
Sbjct: 52 QADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLS 111
Query: 412 ----------GNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFD 461
N L + I A G+A+L + F+H+++ + LV E+
Sbjct: 112 HSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMV 168
Query: 462 ARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGF 521
+I DFGL++ + S+D D ++ PE + + DV+ GVVL E+ +
Sbjct: 169 VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 228
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 47/160 (29%), Positives = 77/160 (48%), Gaps = 10/160 (6%)
Query: 364 KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY-KYMSSGTLYSLLQGNA-TELDWPT 421
+ F E + + QLRH NL LLG V E+ L I +YM+ G+L L+ + L
Sbjct: 44 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 103
Query: 422 RFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481
+ L + +L F+H+++ + +LV ED A++ DFGL K +S+ ++
Sbjct: 104 LLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK 160
Query: 482 VNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGF 521
+ + APE S K DV+ G++L E+ F
Sbjct: 161 L-----PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF 195
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 6e-12
Identities = 46/192 (23%), Positives = 83/192 (43%), Gaps = 14/192 (7%)
Query: 332 IISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE 391
I S + G + + +A+K + + E+ F E + +L HP L L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 392 EEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICS 451
L++++M G L L+ + T + L G+A+L +H+++ +
Sbjct: 72 SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAA 128
Query: 452 NVILVDEDFDARIMDFGLAKLM-----TSSDESSFVNGDLGEFGYIAPEYSSTMVASLKG 506
LV E+ ++ DFG+ + + TSS + F + +PE S S K
Sbjct: 129 RNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF------PVKWSSPEVFSFSKYSSKS 182
Query: 507 DVYGIGVVLLEL 518
DV+ GV++ E+
Sbjct: 183 DVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 9e-12
Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 330 NVIISTRTGTTYKAM-LPDGSVLAVKRLN--TCKLGEKKFRNEMNRLGQLRHPNLAPLLG 386
VI T Y A+ LP+ +A+KR++ C+ + R E+ + Q HPN+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 387 YCVVEEEKLLIYKYMSSGTLYSLLQGNATE--LDWPTRFRIGLGAARGLAWLHHGCQPPF 444
VV +E L+ Y+S G+L +++ + LD + +GL +LH Q
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123
Query: 445 LHQNICSNVILVDEDFDARIMDFGL-AKLMTSSDESSFVNGDL-GEFGYIAPE------- 495
+H++I + IL+ ED +I DFG+ A L D + V G ++APE
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183
Query: 496 YSSTMVASLKGDVYGIGVVLLELA 519
Y K D++ G+ +ELA
Sbjct: 184 YDF------KADIWSFGITAIELA 201
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 49/175 (28%), Positives = 80/175 (45%), Gaps = 11/175 (6%)
Query: 348 GSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLY 407
G +AVK + C + + F E + +L H NL LLG ++ ++ + MS G L
Sbjct: 29 GQKVAVKNIK-CDVTAQAFLEETAVMTKLHHKNLVRLLG-VILHNGLYIVMELMSKGNLV 86
Query: 408 SLLQGNATEL-DWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMD 466
+ L+ L + L A G+ +L +H+++ + ILV ED A++ D
Sbjct: 87 NFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSD 143
Query: 467 FGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGF 521
FGLA++ S V+ + APE S K DV+ GV+L E+ +
Sbjct: 144 FGLARV-----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSY 193
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 61/197 (30%), Positives = 100/197 (50%), Gaps = 29/197 (14%)
Query: 338 GTTYKAM-LPDGSVLAVKRLN------TCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVV 390
G+ Y+ + L DG AVK ++ T + K+ E+ L +L+HPN+ LG
Sbjct: 14 GSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLG-TER 72
Query: 391 EEEKLLIY-KYMSSGTLYSLLQ--GNATE--LDWPTRFRIGLGAARGLAWLHHGCQPPFL 445
EE+ L I+ + + G+L LL+ G+ E + TR +I L GL +LH +
Sbjct: 73 EEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILL----GLEYLH---DRNTV 124
Query: 446 HQNI-CSNVILVDEDFDARIMDFGLAK-LMTSSDESSFVNGDLGEFGYIAPEY-SSTMVA 502
H++I +N ILVD + ++ DFG+AK ++ S SF G ++APE +
Sbjct: 125 HRDIKGAN-ILVDTNGVVKLADFGMAKQVVEFSFAKSFK----GSPYWMAPEVIAQQGGY 179
Query: 503 SLKGDVYGIGVVLLELA 519
L D++ +G +LE+A
Sbjct: 180 GLAADIWSLGCTVLEMA 196
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 51/168 (30%), Positives = 84/168 (50%), Gaps = 5/168 (2%)
Query: 352 AVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQ 411
AVK L + + F E + +LRH L L C EE ++ +YMS G+L L+
Sbjct: 34 AVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLK 93
Query: 412 -GNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLA 470
G +L P + A G+A+L ++H+++ + ILV E+ +I DFGLA
Sbjct: 94 SGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLA 150
Query: 471 KLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
+L+ DE + G + APE ++ ++K DV+ G++L E+
Sbjct: 151 RLI-EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 48/193 (24%), Positives = 87/193 (45%), Gaps = 15/193 (7%)
Query: 338 GTTYKAM-LPDGS----VLAVKRL--NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVV 390
GT YK + +P+G +A+K L T K+ +E + + HP++ LLG C+
Sbjct: 21 GTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICL- 79
Query: 391 EEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWL--HHGCQPPFLHQN 448
+ LI + M G L ++ + + + A+G+++L +H++
Sbjct: 80 SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR-----LVHRD 134
Query: 449 ICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDV 508
+ + +LV +I DFGLAKL+ ++ G ++A E + + K DV
Sbjct: 135 LAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDV 194
Query: 509 YGIGVVLLELAGF 521
+ GV + EL F
Sbjct: 195 WSYGVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 45/185 (24%), Positives = 87/185 (47%), Gaps = 5/185 (2%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397
G + + + +AVK L + + F E N + L+H L L EE +I
Sbjct: 20 GEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79
Query: 398 YKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV 456
+YM+ G+L L+ + ++ P A G+A++ + ++H+++ + +LV
Sbjct: 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLV 136
Query: 457 DEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLL 516
E +I DFGLA+++ +E + G + APE + ++K DV+ G++L
Sbjct: 137 SESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLY 195
Query: 517 ELAGF 521
E+ +
Sbjct: 196 EIVTY 200
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 52/188 (27%), Positives = 88/188 (46%), Gaps = 18/188 (9%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLG-----EKKFRNEMNRLGQLRHPNLAPLLGYCVVEE 392
G +K L D + +AVK TCK + KF +E L Q HPN+ L+G C +
Sbjct: 9 GEVFKGTLKDKTPVAVK---TCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ 65
Query: 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLH-HGCQPPFLHQNICS 451
++ + + G S L+ EL + L AA G+A+L C +H+++ +
Sbjct: 66 PIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC----IHRDLAA 121
Query: 452 NVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGE--FGYIAPEYSSTMVASLKGDVY 509
LV E+ +I DFG+++ D+ + + L + + APE + S + DV+
Sbjct: 122 RNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVW 178
Query: 510 GIGVVLLE 517
G++L E
Sbjct: 179 SYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 51/211 (24%), Positives = 93/211 (44%), Gaps = 12/211 (5%)
Query: 329 ENVIISTRTGTTYKAML--PDGSVL--AVKRLNTCKLGEKK--FRNEMNRLGQLRHPNLA 382
E VI G + L P + A+K L +++ F E + +GQ HPN+
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 383 PLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQP 442
L G ++I +YM +G+L L+ N + + G A G+ +L
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN-- 126
Query: 443 PFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVA 502
++H+++ + ILV+ + ++ DFGL++ + S+ + G + APE +
Sbjct: 127 -YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185
Query: 503 SLKGDVYGIGVVLLELAGFKGN--LVDWVNQ 531
+ DV+ G+V+ E+ + G D NQ
Sbjct: 186 TSASDVWSFGIVMWEVMSY-GERPYWDMSNQ 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 51/176 (28%), Positives = 80/176 (45%), Gaps = 9/176 (5%)
Query: 348 GSVLAVKRLNTCKLGE-KKFRNEMNRLGQLRHPNLAPLLGYCVV--EEEKLLIYKYMSSG 404
G V+AVK+L + F E+ L L+H N+ G C L+ +Y+ G
Sbjct: 33 GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92
Query: 405 TLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARI 464
+L LQ + LD +G+ +L ++H+++ + ILV+ + +I
Sbjct: 93 SLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKI 149
Query: 465 MDFGLAKLMTSSDESSFVN--GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
DFGL K++ E V G+ F Y APE + S+ DV+ GVVL EL
Sbjct: 150 GDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 44/172 (25%), Positives = 76/172 (44%), Gaps = 14/172 (8%)
Query: 352 AVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQ 411
A+K + + E F E + +L HPNL L G C + ++ +YM++G L + L+
Sbjct: 32 AIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLR 91
Query: 412 GNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAK 471
+L + + +L F+H+++ + LV ED ++ DFGLA+
Sbjct: 92 ERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLAR 148
Query: 472 LM-----TSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
+ TSS + F + PE S K DV+ GV++ E+
Sbjct: 149 YVLDDQYTSSQGTKF------PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 5e-10
Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 16/185 (8%)
Query: 347 DGSVLAVKRL-NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGT 405
D ++AVK L + K F E L L+H ++ G CV + +++++YM G
Sbjct: 34 DKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGD 93
Query: 406 LYSLL-----------QGN-ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNV 453
L L +GN EL I A G+ +L F+H+++ +
Sbjct: 94 LNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRN 150
Query: 454 ILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGV 513
LV E+ +I DFG+++ + S+D + ++ PE + + DV+ +GV
Sbjct: 151 CLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGV 210
Query: 514 VLLEL 518
VL E+
Sbjct: 211 VLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 56/229 (24%), Positives = 97/229 (42%), Gaps = 23/229 (10%)
Query: 365 KFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFR 424
KF E L Q HPN+ L+G C ++ ++ + + G + L+ L +
Sbjct: 39 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQ 98
Query: 425 IGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNG 484
+ AA G+ +L +H+++ + LV E +I DFG+ S +E V
Sbjct: 99 MVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGM-----SREEEDGVYA 150
Query: 485 DLGEFGYI-----APEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSK 539
G I APE + S + DV+ G++L E F V + N S+ +++
Sbjct: 151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWE--AFSLGAVPYANL--SNQQTR 206
Query: 540 EAIDKA---LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNS 585
EAI++ C + + + + ++ C P R S V+Q L S
Sbjct: 207 EAIEQGVRLPCPELCPDAVYRLME---RCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 47/202 (23%), Positives = 88/202 (43%), Gaps = 21/202 (10%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEK--KFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395
G Y + ++A+K L ++ +F+ E + + +L HPN+ LLG E+
Sbjct: 24 GHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83
Query: 396 LIYKYMSSGTLYSLLQGNA----------------TELDWPTRFRIGLGAARGLAWLHHG 439
++++Y++ G L+ L + + LD I + A G+ +L
Sbjct: 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL--- 140
Query: 440 CQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSST 499
F+H+++ + IL+ E +I D GL++ + S+D L ++ PE
Sbjct: 141 SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY 200
Query: 500 MVASLKGDVYGIGVVLLELAGF 521
S D++ GVVL E+ F
Sbjct: 201 GKFSSDSDIWSFGVVLWEIFSF 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 47/185 (25%), Positives = 89/185 (48%), Gaps = 9/185 (4%)
Query: 338 GTTYKAM-LPDGSVLAVK--RLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394
G K + P G ++AVK RL + +K+ E++ L + P + G +
Sbjct: 15 GVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDI 74
Query: 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVI 454
+ +YM G+L +L+ + +I + +GL +LH + +H+++ + I
Sbjct: 75 SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNI 132
Query: 455 LVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVV 514
LV+ ++ DFG++ + +S +FV G Y+APE S+K D++ +G+
Sbjct: 133 LVNSRGQIKLCDFGVSGQLVNSLAKTFV----GTSSYMAPERIQGNDYSVKSDIWSLGLS 188
Query: 515 LLELA 519
L+ELA
Sbjct: 189 LIELA 193
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 49/202 (24%), Positives = 86/202 (42%), Gaps = 22/202 (10%)
Query: 345 LPDGSVLAVKRL--NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402
+ +AVK L N + +E N L Q+ HP++ L G C + LLI +Y
Sbjct: 27 RAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAK 86
Query: 403 SGTLYSLLQ---------------GNATELDWPTRFRIGLGAARGLAW-----LHHGCQP 442
G+L S L+ N++ LD P + +G AW + + +
Sbjct: 87 YGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM 146
Query: 443 PFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVA 502
+H+++ + +LV E +I DFGL++ + D + ++A E +
Sbjct: 147 KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY 206
Query: 503 SLKGDVYGIGVVLLELAGFKGN 524
+ + DV+ GV+L E+ GN
Sbjct: 207 TTQSDVWSFGVLLWEIVTLGGN 228
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 47/182 (25%), Positives = 87/182 (47%), Gaps = 13/182 (7%)
Query: 347 DGSVLAVKRLNTCKLGEKKFR---NEMNRLGQLRHPNLAPLLGYCVVEEEKLLI-YKYMS 402
D S++ K +N +L EK+ R NE+ L L+HPN+ + +++ LLI +Y +
Sbjct: 24 DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH-FMDDNTLLIEMEYAN 82
Query: 403 SGTLYS-LLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNI-CSNVILVDEDF 460
GTLY +++ + ++++H + LH++I N+ L
Sbjct: 83 GGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGL 139
Query: 461 DARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG 520
++ DFG++K++ E S +G Y++PE + + K D++ +G VL EL
Sbjct: 140 -IKLGDFGISKIL--GSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT 196
Query: 521 FK 522
K
Sbjct: 197 LK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 60/270 (22%), Positives = 108/270 (40%), Gaps = 55/270 (20%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKKFRNEMNR---LGQLRHPNL-----APLLG-- 386
G+ YK L D A+K ++ + +K+ + +N L + HPN+ A L G
Sbjct: 14 GSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNK 73
Query: 387 YCVVEEEKLLIYKYMSSGTLYSLLQGNA-------TELDWPTRFRIGLGAARGLAWLHHG 439
C+V E Y G L + + W RI + RGL LH
Sbjct: 74 LCIVME-------YAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLLRGLQALH-- 120
Query: 440 CQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSST 499
+ LH+++ S IL+ + +I D G++K++ + +G Y+APE
Sbjct: 121 -EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYMAPEVWKG 175
Query: 500 MVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYD------- 552
S K D++ +G +L E+A F RS + + + Y
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPPF---------EARSMQDLRYKVQRGKYPPIPPIYS 226
Query: 553 EEILQFLKVACNCVVSRPKDRWSMYQVYQS 582
+++ F++ + + +PK R + ++ S
Sbjct: 227 QDLQNFIR---SMLQVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 50/207 (24%), Positives = 103/207 (49%), Gaps = 14/207 (6%)
Query: 324 NSFCSENVIISTRTGTTYKAML--PDGSVLAVKRLNTCKLG--EKK---FRNEMNRLGQL 376
+ + VI + G ++ +L P +AV + T K G EK+ F +E + +GQ
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVA-IKTLKPGYTEKQRQDFLSEASIMGQF 63
Query: 377 RHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLA-W 435
H N+ L G + ++I +YM +G L L+ + E + +++ +G RG+A
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEF---SSYQL-VGMLRGIAAG 119
Query: 436 LHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF-VNGDLGEFGYIAP 494
+ + ++H+++ + ILV+ + + ++ DFGL++++ E ++ +G + AP
Sbjct: 120 MKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 495 EYSSTMVASLKGDVYGIGVVLLELAGF 521
E + + DV+ G+V+ E+ F
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSF 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 55/195 (28%), Positives = 89/195 (45%), Gaps = 19/195 (9%)
Query: 340 TYKAMLPDGS---VLAVKRLNTCKLGE--KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394
T +L GS +AVK L + K+F E + + HPN+ LLG C++ E +
Sbjct: 15 TATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQ 74
Query: 395 LLIYKYMSSGTLYSLLQGNATELDWPTRF------RIGLGAARGLAWLHHGCQPPFLHQN 448
+I + M G L S L+ E P I L A+G +L Q F+H++
Sbjct: 75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRD 131
Query: 449 I-CSNVILVDEDFDAR----IMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVAS 503
+ N ++ ++ +DA I DFGLA+ + SD L ++APE +
Sbjct: 132 LAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFT 191
Query: 504 LKGDVYGIGVVLLEL 518
+ DV+ GV++ E+
Sbjct: 192 TQSDVWSFGVLMWEI 206
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 47/178 (26%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 357 NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL----LIYKYMSSGTLYSLLQG 412
K+ NE+ L ++ N+ + G+ + + L LI +Y + G L +L
Sbjct: 56 KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD- 114
Query: 413 NATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKL 472
+L + T+ + + +GL L+ P ++N+ S LV E++ +I+ GL K+
Sbjct: 115 KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKI 172
Query: 473 MTSSDESSFVNGDLGEFGY-----IAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNL 525
+ SS VN + F Y I EY ++K D+Y +GVVL E+ F G +
Sbjct: 173 L-SSPPFKNVN-FMVYFSYKMLNDIFSEY------TIKDDIYSLGVVLWEI--FTGKI 220
|
Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 41/168 (24%), Positives = 77/168 (45%), Gaps = 4/168 (2%)
Query: 351 LAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLL 410
+A+K + + E +F E + +L H L L G C + ++ +YMS+G L + L
Sbjct: 31 VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL 90
Query: 411 QGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLA 470
+ + + G+A+L F+H+++ + LVD+ ++ DFGL+
Sbjct: 91 REHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLS 147
Query: 471 KLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
+ + + +S V G + PE S K DV+ GV++ E+
Sbjct: 148 RYVLDDEYTSSV-GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 59/257 (22%), Positives = 120/257 (46%), Gaps = 31/257 (12%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL-L 396
G + A + +AVK + + + F E N + L+H L L + VV +E + +
Sbjct: 20 GEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL--HAVVTKEPIYI 77
Query: 397 IYKYMSSGTLYSLL---QGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNV 453
I ++M+ G+L L +G+ L P A G+A++ Q ++H+++ +
Sbjct: 78 ITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIE---QRNYIHRDLRAAN 132
Query: 454 ILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEF--GYIAPEYSSTMVASLKGDVYGI 511
ILV +I DFGLA+++ +++ + + +F + APE + ++K DV+
Sbjct: 133 ILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 189
Query: 512 GVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGY-----DEEILQFLKVACNCV 566
G++L+E+ + ++ G S + +AL +GY + + + C
Sbjct: 190 GILLMEIVTY--------GRIPYPGMSNPEVIRAL-ERGYRMPRPENCPEELYNIMMRCW 240
Query: 567 VSRPKDRWSMYQVYQSL 583
+RP++R ++ QS+
Sbjct: 241 KNRPEER-PTFEYIQSV 256
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 41/115 (35%), Positives = 60/115 (52%), Gaps = 8/115 (6%)
Query: 99 LNLELREMKLSG----KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSN 154
L L+E+ LS +P PL+ +++ LDLS NDLS ++P + N L L LDLS
Sbjct: 138 LKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSN-LSNLNNLDLSG 195
Query: 155 NDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTI 209
N +S +P ++ + L L LSNN + + LSNL L ++NN L
Sbjct: 196 NKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLP 248
|
Length = 394 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 67/287 (23%), Positives = 117/287 (40%), Gaps = 47/287 (16%)
Query: 329 ENVIISTRTGTTYKAMLP-DGSVL--AVKRLN--TCKLGEKKFRNEMNRLGQL-RHPNLA 382
E+VI G +AM+ DG + A+K L + + F E+ L +L HPN+
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 383 PLLGYCVVEEEKLLIYKYMSSGTLYSLLQ---------------GNATELDWPTRFRIGL 427
LLG C + +Y G L L+ G A+ L +
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 428 GAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLG 487
A G+ +L + F+H+++ + +LV E+ ++I DFGL S E +V +G
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGL-----SRGEEVYVKKTMG 178
Query: 488 EFG--YIAPEYSSTMVASLKGDVYGIGVVLLELAGFKG------NLVDWVNQLSSSGRSK 539
++A E + V + K DV+ GV+L E+ G + +L R +
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRME 238
Query: 540 EAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586
+ + D+E+ + ++ C RP +R Q+ L+ +
Sbjct: 239 KP-------RNCDDEVYELMR---QCWRDRPYERPPFAQISVQLSRM 275
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 32/212 (15%)
Query: 345 LPDGSVL--AVKRL--NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400
+ G + AVK L G+K+F E + + QL HP + L+G C E +L+ +
Sbjct: 18 MKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC-KGEPLMLVMEL 76
Query: 401 MSSGTLYSLLQGN-----ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICS-NVI 454
G L L+ + + + A G+A+L F+H+++ + NV+
Sbjct: 77 APLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYL-ESKH--FVHRDLAARNVL 127
Query: 455 LVDEDFDARIMDFGLAKLM-TSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGV 513
LV+ A+I DFG+++ + SD + APE + S K DV+ GV
Sbjct: 128 LVNRHQ-AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGV 186
Query: 514 VLLEL--------AGFKGNLVDWVNQLSSSGR 537
L E KG V + L S R
Sbjct: 187 TLWEAFSYGAKPYGEMKGAEV--IAMLESGER 216
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 6e-09
Identities = 50/190 (26%), Positives = 92/190 (48%), Gaps = 29/190 (15%)
Query: 347 DGSVLAVKRLNTCKLGEKK---FRNEMNRLGQLRHPNLAPLLGY--CVVEEEKLLI-YKY 400
D ++ +K++ ++ + + +NE L L HPN+ + Y +E++ L+I +Y
Sbjct: 24 DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI---IEYYENFLEDKALMIVMEY 80
Query: 401 MSSGTLYSLLQ--GNA-----TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNV 453
GTL +Q N+ T L + + + L HH LH+++ +
Sbjct: 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL---------HHVHTKLILHRDLKTQN 131
Query: 454 ILVDE-DFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIG 512
IL+D+ +I DFG++K+++S ++ V +G YI+PE + K D++ +G
Sbjct: 132 ILLDKHKMVVKIGDFGISKILSSKSKAYTV---VGTPCYISPELCEGKPYNQKSDIWALG 188
Query: 513 VVLLELAGFK 522
VL ELA K
Sbjct: 189 CVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 6e-09
Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 25/202 (12%)
Query: 338 GTTYKAML--PDGSVL--AVK--RLNTCKLGE-KKFRNEMNRLGQLRHPNLAPLLGYCVV 390
G+ + L DGS L AVK +L+ E ++F +E + HPN+ L+G C
Sbjct: 13 GSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFE 72
Query: 391 EEEK------LLIYKYMSSGTL-----YSLLQGNATELDWPTRFRIGLGAARGLAWLHHG 439
++I +M G L YS L G +L T + + A G+ +L
Sbjct: 73 ASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL--- 129
Query: 440 CQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEF--GYIAPEYS 497
F+H+++ + ++ ED + DFGL+K + S D + G + + +IA E
Sbjct: 130 SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD--YYRQGRIAKMPVKWIAIESL 187
Query: 498 STMVASLKGDVYGIGVVLLELA 519
+ V + K DV+ GV + E+A
Sbjct: 188 ADRVYTSKSDVWAFGVTMWEIA 209
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 6e-09
Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 331 VIISTRTGTTYKAM-LPDGSVL----AVKRLN--TCKLGEKKFRNEMNRLGQLRHPNLAP 383
V+ S GT YK + +P+G + A+K LN T +F +E + + HP+L
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 384 LLGYCVVEEEKLLIYKYMSSGTLYSLLQ------GNATELDWPTRFRIGLGAARGLAWLH 437
LLG C+ +L + + M G L + G+ L+W + A+G+ +L
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126
Query: 438 HGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYS 497
+ +H+++ + +LV +I DFGLA+L+ ++ +G ++A E
Sbjct: 127 ---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 498 STMVASLKGDVYGIGVVLLELAGFKGNLVDWV 529
+ + DV+ GV + EL F G D +
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 65/261 (24%), Positives = 109/261 (41%), Gaps = 44/261 (16%)
Query: 352 AVKRLN--TCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYS 408
A+KR+ K + F E+ L +L HPN+ LLG C L +Y G L
Sbjct: 38 AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 97
Query: 409 LLQGN---------------ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNV 453
L+ + A+ L ARG+ +L Q F+H+++ +
Sbjct: 98 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARN 154
Query: 454 ILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFG--YIAPEYSSTMVASLKGDVYGI 511
ILV E++ A+I DFGL S + +V +G ++A E + V + DV+
Sbjct: 155 ILVGENYVAKIADFGL-----SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 209
Query: 512 GVVLLELAGFKG------NLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNC 565
GV+L E+ G + +L R ++ ++ C D+E+ ++ C
Sbjct: 210 GVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN---C----DDEVYDLMR---QC 259
Query: 566 VVSRPKDRWSMYQVYQSLNSI 586
+P +R S Q+ SLN +
Sbjct: 260 WREKPYERPSFAQILVSLNRM 280
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 9e-09
Identities = 56/240 (23%), Positives = 96/240 (40%), Gaps = 42/240 (17%)
Query: 364 KKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQ----------- 411
+ F E+ L +L HPN+ LLG C L +Y G L L+
Sbjct: 40 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 99
Query: 412 ----GNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDF 467
A+ L ARG+ +L Q F+H+++ + ILV E++ A+I DF
Sbjct: 100 AIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADF 156
Query: 468 GLAKLMTSSDESSFVNGDLGEFG--YIAPEYSSTMVASLKGDVYGIGVVLLELAGFKG-- 523
GL++ + +V +G ++A E + V + DV+ GV+L E+ G
Sbjct: 157 GLSR-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
Query: 524 ----NLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQV 579
+ +L R ++ D+E+ ++ C +P +R S Q+
Sbjct: 212 YCGMTCAELYEKLPQGYRLEKP-------LNCDDEVYDLMR---QCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 40/175 (22%), Positives = 77/175 (44%), Gaps = 22/175 (12%)
Query: 364 KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLL------------- 410
++F++E +L+HPN+ LLG E+ +I+ Y S L+ L
Sbjct: 53 EEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTD 112
Query: 411 --QGNATELDWPTRFRIGLGAARGLAWL--HHGCQPPFLHQNICSNVILVDEDFDARIMD 466
+ + L+ I A G+ +L HH H+++ + +LV + + +I D
Sbjct: 113 DDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVV-----HKDLATRNVLVFDKLNVKISD 167
Query: 467 FGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGF 521
GL + + ++D + L +++PE S+ D++ GVVL E+ +
Sbjct: 168 LGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSY 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 2e-08
Identities = 53/215 (24%), Positives = 89/215 (41%), Gaps = 56/215 (26%)
Query: 337 TGTTYKAM-LPDGSVLAVKRLNTCKLGEK---KFRNEMNRLGQLRHPNLAPLLGY--CVV 390
G Y DG + +K ++ + EK NE+ L +L HPN ++ Y
Sbjct: 13 FGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN---IIKYYESFE 69
Query: 391 EEEKLLI-YKYMSSGTLYSLLQGNATE---------LDWPTRFRIGLGAARGLAWLH--H 438
E+ KL I +Y G L ++ E LDW ++ L L +LH
Sbjct: 70 EKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV--QLCL----ALKYLHSRK 123
Query: 439 GCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE--SSFVNGDLGEFG---YIA 493
LH++I I + + ++ DFG++K+++S+ + + V G Y++
Sbjct: 124 -----ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-------GTPYYLS 171
Query: 494 PE------YSSTMVASLKGDVYGIGVVLLELAGFK 522
PE Y+ K D++ +G VL EL K
Sbjct: 172 PELCQNKPYNY------KSDIWSLGCVLYELCTLK 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (134), Expect = 2e-08
Identities = 59/203 (29%), Positives = 84/203 (41%), Gaps = 55/203 (27%)
Query: 348 GSVLAVKRLNT-----CKLGEKKF----------RNEMNRLGQLRHPNLAPLLGYCVVEE 392
G VL V++ +T K+ +KK E N L ++ HP + L Y E
Sbjct: 7 GKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH-YAFQTE 65
Query: 393 EKL-LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAAR--------GLAWLH-HGCQP 442
EKL L+ +Y G L+S L R AR L +LH G
Sbjct: 66 EKLYLVLEYAPGGELFSHLS---------KEGRFSEERARFYAAEIVLALEYLHSLG--- 113
Query: 443 PFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVA 502
+++++ IL+D D ++ DFGLAK + S E S N G Y+APE
Sbjct: 114 -IIYRDLKPENILLDADGHIKLTDFGLAKEL--SSEGSRTNTFCGTPEYLAPEV------ 164
Query: 503 SLKGDVYG-------IGVVLLEL 518
L G YG +GV+L E+
Sbjct: 165 -LLGKGYGKAVDWWSLGVLLYEM 186
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 49/186 (26%), Positives = 86/186 (46%), Gaps = 17/186 (9%)
Query: 338 GTTYKAM-LPDGSVLAVKRLN---TCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEE 393
GT YKA L +LAVK + T +L +K+ +E+ L + P + G VE
Sbjct: 15 GTVYKAYHLLTRRILAVKVIPLDITVEL-QKQIMSELEILYKCDSPYIIGFYGAFFVENR 73
Query: 394 KLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNV 453
+ ++M G+L + E RI + +GL +L LH+++ +
Sbjct: 74 ISICTEFMDGGSLD--VYRKIPE---HVLGRIAVAVVKGLTYL---WSLKILHRDVKPSN 125
Query: 454 ILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGV 513
+LV+ ++ DFG++ + +S ++V G Y+APE S + DV+ +G+
Sbjct: 126 MLVNTRGQVKLCDFGVSTQLVNSIAKTYV----GTNAYMAPERISGEQYGIHSDVWSLGI 181
Query: 514 VLLELA 519
+ELA
Sbjct: 182 SFMELA 187
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 62/256 (24%), Positives = 113/256 (44%), Gaps = 39/256 (15%)
Query: 338 GTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNR-LGQLR---HPNLAPLLGYCVVEE 392
G YK P G + A+K+++ G+++FR ++ R L LR P + G E
Sbjct: 15 GVVYKVRHKPTGKIYALKKIHV--DGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG 72
Query: 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRF--RIGLGAARGLAWLHHGCQPPFLHQNIC 450
E ++ +YM G+L LL+ P I +GL +LH + +H++I
Sbjct: 73 EISIVLEYMDGGSLADLLKKVGK---IPEPVLAYIARQILKGLDYLHT--KRHIIHRDIK 127
Query: 451 SNVILVDEDFDARIMDFGLAKLMTSSDE--SSFVNGDLGEFGYIAPEYSSTMVASLKGDV 508
+ +L++ + +I DFG++K++ ++ + ++FV G Y++PE S D+
Sbjct: 128 PSNLLINSKGEVKIADFGISKVLENTLDQCNTFV----GTVTYMSPERIQGESYSYAADI 183
Query: 509 YGIGVVLLELA-G----FKGNLVDWVNQLSSSGRSKEAIDK----ALCGKGYDEEILQFL 559
+ +G+ LLE A G + + +AI +L + + E F+
Sbjct: 184 WSLGLTLLECALGKFPFLPPGQPSFFELM-------QAICDGPPPSLPAEEFSPEFRDFI 236
Query: 560 KVACNCVVSRPKDRWS 575
C+ PK R S
Sbjct: 237 SA---CLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 43/188 (22%), Positives = 80/188 (42%), Gaps = 19/188 (10%)
Query: 347 DGSVLAVKRLNTCKLGEKK-FRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGT 405
D ++AVK L L +K F+ E L L+H ++ G C + +++++YM G
Sbjct: 34 DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGD 93
Query: 406 LYSLLQGNAT---------------ELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNIC 450
L L+ + EL I A G+ +L F+H+++
Sbjct: 94 LNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLA 150
Query: 451 SNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYG 510
+ LV + +I DFG+++ + S+D + ++ PE + + DV+
Sbjct: 151 TRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 210
Query: 511 IGVVLLEL 518
GV+L E+
Sbjct: 211 FGVILWEI 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 45/192 (23%), Positives = 87/192 (45%), Gaps = 13/192 (6%)
Query: 338 GTTYKAM-LPDGSVL----AVKRLNTCKLGEKKFR---NEMNRLGQLRHPNLAPLLGYCV 389
GT +K + +P+G + A+K + + G + F+ + M +G L H + LLG C
Sbjct: 21 GTVHKGIWIPEGDSIKIPVAIKTIQD-RSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP 79
Query: 390 VEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNI 449
+L + + G+L ++ + LD + A+G+ +L +H+N+
Sbjct: 80 GASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNL 135
Query: 450 CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVY 509
+ IL+ D +I DFG+A L+ D+ F + ++A E + + DV+
Sbjct: 136 AARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVW 195
Query: 510 GIGVVLLELAGF 521
GV + E+ +
Sbjct: 196 SYGVTVWEMMSY 207
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 59/192 (30%), Positives = 96/192 (50%), Gaps = 18/192 (9%)
Query: 350 VLAVKRLN-TCKLGEKKFRN---EMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGT 405
V+AVK+++ + K +K+++ E+ L QL+HPN G + E L+ +Y G+
Sbjct: 48 VVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY-CLGS 106
Query: 406 LYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIM 465
LL+ + L I GA +GLA+LH +H++I + IL+ E ++
Sbjct: 107 ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLA 163
Query: 466 DFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASL---KGDVYGIGVVLLELAGFK 522
DFG A SS +SFV G ++APE M K DV+ +G+ +ELA K
Sbjct: 164 DFGSASK--SSPANSFV----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 217
Query: 523 GNLVDWVNQLSS 534
L + +N +S+
Sbjct: 218 PPLFN-MNAMSA 228
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 18/194 (9%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGE---KKFRNEMNRLGQLRHPNLAPLLGYCVVEEE 393
G YK + L G +A+K+++ K+ E K E++ L L+HPN+ +G +
Sbjct: 14 GVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDS 73
Query: 394 KLLIYKYMSSGTLYSLLQ--GNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNI-C 450
+I +Y +G+L +++ G E L +GLA+LH + +H++I
Sbjct: 74 LYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL---QGLAYLH---EQGVIHRDIKA 127
Query: 451 SNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYG 510
+N IL +D ++ DFG+A + + +G ++APE AS D++
Sbjct: 128 AN-ILTTKDGVVKLADFGVATKLNDVSKDD--ASVVGTPYWMAPEVIEMSGASTASDIWS 184
Query: 511 IGVVLLELAGFKGN 524
+G ++EL GN
Sbjct: 185 LGCTVIEL--LTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 41/156 (26%), Positives = 65/156 (41%), Gaps = 18/156 (11%)
Query: 376 LRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGN----ATELDWPTRFRIGLGAAR 431
L HPN+ LG C+ LL+ ++ G L + L+ N A R+ A
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111
Query: 432 GLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFG- 490
GL WLH Q F+H ++ + D +I D+GLA + E ++ D
Sbjct: 112 GLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAVPL 166
Query: 491 -YIAPEYSSTMVASL-------KGDVYGIGVVLLEL 518
++APE L K +++ +GV + EL
Sbjct: 167 RWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 53/175 (30%), Positives = 83/175 (47%), Gaps = 14/175 (8%)
Query: 352 AVKRLN-TCKLGE-KKFRNEMNRLGQLRHPNLAPLLGYCVVEE-EKLLIYKYMSSGTLYS 408
AVK LN L E ++F E + HPN+ LLG C+ E L++ YM G L +
Sbjct: 27 AVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRN 86
Query: 409 LL---QGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIM 465
+ N T D GL A+G+ +L F+H+++ + ++DE F ++
Sbjct: 87 FIRSETHNPTVKDL---IGFGLQVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVA 140
Query: 466 DFGLAKLMTSSDESSFVNGDLGEF--GYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
DFGLA+ + + S N + ++A E T + K DV+ GV+L EL
Sbjct: 141 DFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 195
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 5e-08
Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 16/180 (8%)
Query: 348 GSVLAVKRLNTCKLGEK--KFRNEMNRLGQLRHPNLAPLLGYCVVEEEK--LLIYKYMSS 403
G +AVK L G + E+ L L H N+ G C + LI +++ S
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDAR 463
G+L L N +++ + + + +G+ +L G + ++H+++ + +LV+ + +
Sbjct: 93 GSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL--GSRQ-YVHRDLAARNVLVESEHQVK 149
Query: 464 IMDFGLAKLMTSSDESSFVNGDLGE--FGYIAPE---YSSTMVASLKGDVYGIGVVLLEL 518
I DFGL K + + E V DL F Y APE S +AS DV+ GV L EL
Sbjct: 150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQSKFYIAS---DVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 63/256 (24%), Positives = 113/256 (44%), Gaps = 33/256 (12%)
Query: 346 PDGSVLAVKRLNTC-KLGEK-KFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403
P+ V A+K +N + E+ +F NE + + + ++ LLG + L++ + M+
Sbjct: 35 PETRV-AIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAK 93
Query: 404 GTLYSLLQG------NATELDWPTRFRIGLGA---ARGLAWLHHGCQPPFLHQNICSNVI 454
G L S L+ N L PT + A A G+A+L F+H+++ +
Sbjct: 94 GDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNC 150
Query: 455 LVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVV 514
+V ED +I DFG+ + + +D L ++APE V + K DV+ GVV
Sbjct: 151 MVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVV 210
Query: 515 LLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGY-------DEEILQFLKVACNCVV 567
L E+A + G S E + K + G+ +++L+ +++ C
Sbjct: 211 LWEMATLA--------EQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRM---CWQ 259
Query: 568 SRPKDRWSMYQVYQSL 583
PK R + ++ SL
Sbjct: 260 YNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 6e-08
Identities = 53/177 (29%), Positives = 80/177 (45%), Gaps = 12/177 (6%)
Query: 348 GSVLAVKRLNT--CKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK--LLIYKYMSS 403
G ++AVK L + ++ E+N L L H N+ G C + K LI +Y+
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPL 92
Query: 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDAR 463
G+L L + L F + G+A+LH ++H+++ + +L+D D +
Sbjct: 93 GSLRDYLPKHKLNLAQLLLFAQQI--CEGMAYLH---SQHYIHRDLAARNVLLDNDRLVK 147
Query: 464 IMDFGLAKLMTSSDESSFV--NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
I DFGLAK + E V +GD F Y A E S DV+ GV L EL
Sbjct: 148 IGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLKENKFSYASDVWSFGVTLYEL 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 6e-08
Identities = 38/161 (23%), Positives = 75/161 (46%), Gaps = 6/161 (3%)
Query: 364 KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRF 423
+ F +E + +GQ HPN+ L G ++I ++M +G L S L+ N +
Sbjct: 50 RDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLV 109
Query: 424 RIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483
+ G A G+ +L + ++H+++ + ILV+ + ++ DFGL++ +
Sbjct: 110 GMLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT 166
Query: 484 GDLG---EFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGF 521
LG + APE + + DV+ G+V+ E+ +
Sbjct: 167 SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSY 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 49/191 (25%), Positives = 91/191 (47%), Gaps = 23/191 (12%)
Query: 347 DGSVL--AVK--RLNTCKLGE-KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK------L 395
D S+L AVK ++ C E + F +E + + HPN+ L+G C+ E +
Sbjct: 23 DDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82
Query: 396 LIYKYMSSGTLYSLL---QGNATELDWPTRFRIGLGA--ARGLAWLHHGCQPPFLHQNIC 450
+I +M G L+S L + PT+ + A G+ +L F+H+++
Sbjct: 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLA 139
Query: 451 SNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEF--GYIAPEYSSTMVASLKGDV 508
+ +++E+ + + DFGL+K + + D + G + + +IA E + V + K DV
Sbjct: 140 ARNCMLNENMNVCVADFGLSKKIYNGD--YYRQGRIAKMPVKWIAIESLADRVYTTKSDV 197
Query: 509 YGIGVVLLELA 519
+ GV + E+A
Sbjct: 198 WSFGVTMWEIA 208
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 7e-08
Identities = 41/172 (23%), Positives = 86/172 (50%), Gaps = 9/172 (5%)
Query: 356 LNTCKLG--EKKFRN---EMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLL 410
+ T K G EK+ R+ E + +GQ HPN+ L G + +++ +YM +G+L + L
Sbjct: 37 IKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL 96
Query: 411 QGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLA 470
+ + + + G A G+ +L ++H+++ + ILV+ + ++ DFGL+
Sbjct: 97 RKHDGQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLS 153
Query: 471 KLMTSSDESSFVN-GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGF 521
+++ E+++ G + APE + + DV+ G+V+ E+ +
Sbjct: 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSY 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 8e-08
Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 19/198 (9%)
Query: 338 GTTYKAM-LPDGSVLAVKR--LNTCKLGEKK---------FRNEMNRLGQLRHPNLAPLL 385
G Y A+ + G ++AVK+ L G R+E+ L L H N+ L
Sbjct: 15 GRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYL 74
Query: 386 GYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFL 445
G+ EE + +Y+ G++ S L+ + RF GLA+LH L
Sbjct: 75 GFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRF-FTEQVLEGLAYLH---SKGIL 130
Query: 446 HQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPE--YSSTMVAS 503
H+++ ++ +LVD D +I DFG++K ++ G ++APE +S + S
Sbjct: 131 HRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYS 190
Query: 504 LKGDVYGIGVVLLE-LAG 520
K D++ +G V+LE AG
Sbjct: 191 AKVDIWSLGCVVLEMFAG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 46/180 (25%), Positives = 85/180 (47%), Gaps = 14/180 (7%)
Query: 351 LAVKRLN-TCKLGEK-KFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYS 408
+A+K +N + E+ +F NE + + + ++ LLG + L+I + M+ G L S
Sbjct: 39 VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 98
Query: 409 LL-------QGNATELDWPTRFRIGLGA--ARGLAWLHHGCQPPFLHQNICSNVILVDED 459
L + N + + I + A G+A+L+ F+H+++ + +V ED
Sbjct: 99 YLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 155
Query: 460 FDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELA 519
F +I DFG+ + + +D L +++PE V + DV+ GVVL E+A
Sbjct: 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 35/199 (17%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEK----KFRN--EMNRLGQLRHPNLAPLLGYCVV 390
G YKA G ++A+K++ KL + E+ L +L HPN+ LL V
Sbjct: 13 GVVYKARDKLTGEIVAIKKI---KLRFESEGIPKTALREIKLLKELNHPNIIKLLD--VF 67
Query: 391 EEEK--LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLH-HGCQPPFLHQ 447
+ L++++M + LY L++ L +GLA+ H HG LH+
Sbjct: 68 RHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI----LHR 122
Query: 448 NICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPE-------YSSTM 500
++ +L++ + ++ DFGLA+ S + Y APE YS+ +
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLLGDKGYSTPV 180
Query: 501 VASLKGDVYGIGVVLLELA 519
D++ +G + EL
Sbjct: 181 ------DIWSVGCIFAELL 193
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 41/157 (26%), Positives = 79/157 (50%), Gaps = 11/157 (7%)
Query: 367 RNEMNRLGQLRH----PNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTR 422
RN++ R Q+ H P + G + E + ++M G+L +L+ A +
Sbjct: 47 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-EAKRIPEEIL 105
Query: 423 FRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482
++ + RGLA+L Q +H+++ + ILV+ + ++ DFG++ + S +SFV
Sbjct: 106 GKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 163
Query: 483 NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELA 519
G Y++PE S++ D++ +G+ L+ELA
Sbjct: 164 ----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELA 196
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 48/187 (25%), Positives = 91/187 (48%), Gaps = 12/187 (6%)
Query: 337 TGTTYKAM-LPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395
+G YKA G +A+K++ K ++ NE+ + +HPN+ +V +E
Sbjct: 32 SGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91
Query: 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLH-HGCQPPFLHQNICSNVI 454
++ +YM G+L ++ N ++ P + +GL +LH +H++I S+ I
Sbjct: 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNV----IHRDIKSDNI 147
Query: 455 LVDEDFDARIMDFGLAKLMTS--SDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIG 512
L+ +D ++ DFG A +T S +S V G ++APE K D++ +G
Sbjct: 148 LLSKDGSVKLADFGFAAQLTKEKSKRNSVV----GTPYWMAPEVIKRKDYGPKVDIWSLG 203
Query: 513 VVLLELA 519
++ +E+A
Sbjct: 204 IMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 326 FCSENVIISTRTGTTYKAM-LPDGS----VLAVKRLN--TCKLGEKKFRNEMNRLGQLRH 378
F V+ S GT YK + +P+G +A+K L T K+ +E + + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 379 PNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATE------LDWPTRFRIGLGAARG 432
P++ LLG C+ +L I + M G L ++ + L+W + A+G
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 121
Query: 433 LAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYI 492
+ +L + +H+++ + +LV +I DFGLAKL+ + ++ G ++
Sbjct: 122 MNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 493 APEYSSTMVASLKGDVYGIGVVLLELAGF 521
A E + + + DV+ GV + EL F
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 62/231 (26%), Positives = 110/231 (47%), Gaps = 21/231 (9%)
Query: 350 VLAVKRLN-TCKLGEKKFRN---EMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGT 405
V+A+K+++ + K +K+++ E+ L +LRHPN G + E L+ +Y G+
Sbjct: 42 VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY-CLGS 100
Query: 406 LYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIM 465
LL+ + L + GA +GLA+LH +H+++ + IL+ E ++
Sbjct: 101 ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLG 157
Query: 466 DFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASL---KGDVYGIGVVLLELAGFK 522
DFG A +M ++ FV G ++APE M K DV+ +G+ +ELA K
Sbjct: 158 DFGSASIMAPAN--XFV----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211
Query: 523 GNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDR 573
L + +N +S+ + AL + E F+ +C+ P+DR
Sbjct: 212 PPLFN-MNAMSALYHIAQNESPALQSGHWSEYFRNFVD---SCLQKIPQDR 258
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 39/168 (23%), Positives = 78/168 (46%), Gaps = 4/168 (2%)
Query: 351 LAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLL 410
+A+K +N + E+ F E + +L HP L L G C ++ ++ ++M +G L + L
Sbjct: 31 VAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYL 90
Query: 411 QGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLA 470
+ +L + G+ +L + F+H+++ + LV ++ DFG+
Sbjct: 91 RQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMT 147
Query: 471 KLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
+ + DE + +G + PE + S K DV+ GV++ E+
Sbjct: 148 RYVL-DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 53/258 (20%), Positives = 106/258 (41%), Gaps = 29/258 (11%)
Query: 339 TTYKAM-LPDGSVLAVKRLNTCKLGEKKFRN----EMNRLGQLRHPNLAPLLGYCVVEEE 393
YKA+ L DG V+A+K++ ++ + K R E++ L QL HPN+ L + E
Sbjct: 17 VVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNE 76
Query: 394 KLLIYKYMSSGTLYSLL---QGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNIC 450
++ + +G L ++ + + T ++ + L +H +H++I
Sbjct: 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIK 133
Query: 451 SNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYG 510
+ + ++ D GL + +S +++ + +G Y++PE + K D++
Sbjct: 134 PANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWS 191
Query: 511 IGVVLLELAGF-------KGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVAC 563
+G +L E+A K NL ++ L Y EE+ +
Sbjct: 192 LGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY------PPLPADHYSEELRDLVSR-- 243
Query: 564 NCVVSRPKDRWSMYQVYQ 581
C+ P+ R + V Q
Sbjct: 244 -CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 46/194 (23%), Positives = 82/194 (42%), Gaps = 26/194 (13%)
Query: 347 DGSVLAVKRLN--TCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSG 404
D ++AVK L K F E L +H N+ G C + +++++YM G
Sbjct: 34 DKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHG 93
Query: 405 TLYSLLQGNA-------------TELDWPTRFRIGLGAARGLAWL--HHGCQPPFLHQNI 449
L L+ + EL +I + A G+ +L H F+H+++
Sbjct: 94 DLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH-----FVHRDL 148
Query: 450 CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVA--SLKGD 507
+ LV D +I DFG+++ + ++D + ++ PE S M + + D
Sbjct: 149 ATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPE--SIMYRKFTTESD 206
Query: 508 VYGIGVVLLELAGF 521
V+ GVVL E+ +
Sbjct: 207 VWSFGVVLWEIFTY 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 43/185 (23%), Positives = 81/185 (43%), Gaps = 14/185 (7%)
Query: 348 GSVLAVKRLNTCKLGE-------KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400
G+++AVK++ + + R E+ + +L HP++ +LG + L ++
Sbjct: 25 GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84
Query: 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDED- 459
M+ G++ LL RGL++LH + +H+++ +L+D
Sbjct: 85 MAGGSVSHLLS-KYGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTG 140
Query: 460 FDARIMDFGLAKLMTS--SDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLE 517
RI DFG A + + + F LG ++APE DV+ +G V++E
Sbjct: 141 QRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIE 200
Query: 518 LAGFK 522
+A K
Sbjct: 201 MATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 33/220 (15%)
Query: 344 MLP--DGSVLAVKRLNTCKLGEKK-FRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400
+LP D ++AVK L ++ F+ E L L+H ++ G C L++++Y
Sbjct: 29 LLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEY 88
Query: 401 MSSGTLYSLLQGNATE--------------LDWPTRFRIGLGAARG---LAWLHHGCQPP 443
M G L L+ + + L I A G LA LH
Sbjct: 89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH------ 142
Query: 444 FLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVAS 503
F+H+++ + LV + +I DFG+++ + S+D + ++ PE +
Sbjct: 143 FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT 202
Query: 504 LKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID 543
+ D++ GVVL E+ F W QLS++ EAI+
Sbjct: 203 TESDIWSFGVVLWEI--FTYGKQPWY-QLSNT----EAIE 235
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 46/169 (27%), Positives = 84/169 (49%), Gaps = 15/169 (8%)
Query: 363 EKKFRNEMNRLGQLRH----PNLAPLLGYCVVEEEKLLIYKYMSS-GTLYSLLQGNATEL 417
EK R+EM R ++ H P + ++G C E E L++ M+S G L L G E+
Sbjct: 35 EKSVRDEMMREAEIMHQLDNPYIVRMIGVC--EAEALMLVMEMASGGPLNKFLSGKKDEI 92
Query: 418 DWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICS-NVILVDEDFDARIMDFGLAKLMTSS 476
+ + G+ +L F+H+++ + NV+LV++ + A+I DFGL+K + +
Sbjct: 93 TVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHY-AKISDFGLSKAL-GA 147
Query: 477 DESSFVNGDLGEF--GYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKG 523
D+S + G++ + APE + S + DV+ G+ + E +
Sbjct: 148 DDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQ 196
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 5e-07
Identities = 44/184 (23%), Positives = 95/184 (51%), Gaps = 9/184 (4%)
Query: 337 TGTTYKAM-LPDGSVLAVKRLNTCKLGEKKFR-NEMNRLGQLRHPNLAPLLGYCVVEEEK 394
+GT + A+ + G +A+K++N K +K+ NE+ + +L++PN+ L +V +E
Sbjct: 32 SGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDEL 91
Query: 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVI 454
++ +Y++ G+L ++ T +D + + L +LH +H++I S+ +
Sbjct: 92 FVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNV 146
Query: 455 LVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVV 514
L+ D ++ DFG +T E S + +G ++APE + K D++ +G++
Sbjct: 147 LLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 204
Query: 515 LLEL 518
+E+
Sbjct: 205 AIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 7e-07
Identities = 44/184 (23%), Positives = 94/184 (51%), Gaps = 9/184 (4%)
Query: 337 TGTTYKAM-LPDGSVLAVKRLNTCKLGEKKFR-NEMNRLGQLRHPNLAPLLGYCVVEEEK 394
+GT Y AM + G +A++++N + +K+ NE+ + + ++PN+ L +V +E
Sbjct: 33 SGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92
Query: 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVI 454
++ +Y++ G+L ++ T +D + + L +LH +H++I S+ I
Sbjct: 93 WVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNI 147
Query: 455 LVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVV 514
L+ D ++ DFG +T E S + +G ++APE + K D++ +G++
Sbjct: 148 LLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 205
Query: 515 LLEL 518
+E+
Sbjct: 206 AIEM 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 7e-07
Identities = 54/232 (23%), Positives = 93/232 (40%), Gaps = 70/232 (30%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKKF-----RNEMNRLGQLRHPNLAPLLGYCVVE 391
G YKA G ++A+K++ + ++ F R E+ L +LRHPN+ L +V
Sbjct: 13 GQVYKARNKKTGELVALKKIRM-ENEKEGFPITAIR-EIKLLQKLRHPNIVRL--KEIVT 68
Query: 392 EEKL----LIYKYMS---SGTLYSLLQGNATELDWPTRFRIGLGAAR--------GLAWL 436
+ ++++YM +G L S + + GL +L
Sbjct: 69 SKGKGSIYMVFEYMDHDLTGLLDS------------PEVKFTESQIKCYMKQLLEGLQYL 116
Query: 437 HHGCQPPFLHQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGD---------- 485
H LH++I SN IL++ D ++ DFGLA+ T + + + N
Sbjct: 117 HSN---GILHRDIKGSN-ILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172
Query: 486 -LGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL----AGFKGNLVDWVNQL 532
LG Y + D++ +G +L EL F+G+ + QL
Sbjct: 173 LLGATRY-----------GPEVDMWSVGCILAELFLGKPIFQGS--TELEQL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 9e-07
Identities = 44/184 (23%), Positives = 94/184 (51%), Gaps = 9/184 (4%)
Query: 337 TGTTYKAM-LPDGSVLAVKRLNTCKLGEKKFR-NEMNRLGQLRHPNLAPLLGYCVVEEEK 394
+GT Y A+ + G +A+K++N + +K+ NE+ + + ++PN+ L +V +E
Sbjct: 32 SGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91
Query: 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVI 454
++ +Y++ G+L ++ T +D + + L +LH +H++I S+ I
Sbjct: 92 WVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNI 146
Query: 455 LVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVV 514
L+ D ++ DFG +T E S + +G ++APE + K D++ +G++
Sbjct: 147 LLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 204
Query: 515 LLEL 518
+E+
Sbjct: 205 AIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 46/195 (23%), Positives = 92/195 (47%), Gaps = 19/195 (9%)
Query: 338 GTTYKAMLPDGSVLAVKRL----NTCKLGEKKFRN---EMNRLGQLRHPNLAPLLGYCVV 390
GT Y + G ++AVK++ + EK++ E++ L L+H N+ LG C+
Sbjct: 14 GTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD 73
Query: 391 EEEKLLIYKYMSSGTLYSLLQ--GNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQN 448
+ + +++ G++ S+L G E P + G+A+LH+ C +H++
Sbjct: 74 DNTISIFMEFVPGGSISSILNRFGPLPE---PVFCKYTKQILDGVAYLHNNC---VVHRD 127
Query: 449 ICSNVILVDEDFDARIMDFGLAKLMT----SSDESSFVNGDLGEFGYIAPEYSSTMVASL 504
I N +++ + +++DFG A+ + S+ + G ++APE +
Sbjct: 128 IKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGR 187
Query: 505 KGDVYGIGVVLLELA 519
K D++ IG + E+A
Sbjct: 188 KSDIWSIGCTVFEMA 202
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 9e-07
Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 31/202 (15%)
Query: 338 GTTYKAML----PDGSVLAVKRLNTCKLGEKK---FRNEMNRLGQLRHPNLAPLLGYCVV 390
G+ KA+L DG +K +N K+ K+ R E+ L ++HPN+ + Y
Sbjct: 11 GSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI---VQYQES 67
Query: 391 EEEKLLIY---KYMSSGTLYSLLQGNA-------TELDWPTRFRIGLGAARGLAWLHHGC 440
EE +Y Y G LY + LDW + + L H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL---------KHVH 118
Query: 441 QPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTM 500
LH++I S I + +D ++ DFG+A+++ S+ E +G Y++PE
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENR 176
Query: 501 VASLKGDVYGIGVVLLELAGFK 522
+ K D++ +G VL E+ K
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 43/179 (24%), Positives = 77/179 (43%), Gaps = 13/179 (7%)
Query: 348 GSVLAVKRLNTCKLGE------KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY-KY 400
G LAVK++ E+ L L+H + G C+ ++E L I+ +Y
Sbjct: 27 GRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYG-CLRDDETLSIFMEY 85
Query: 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF 460
M G++ L+ + TR + G+ +LH +H++I IL D
Sbjct: 86 MPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAG 141
Query: 461 DARIMDFGLAK-LMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
+ ++ DFG +K L T + + G +++PE S K DV+ +G ++E+
Sbjct: 142 NVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEM 200
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 35/141 (24%), Positives = 65/141 (46%), Gaps = 16/141 (11%)
Query: 350 VLAVKRL--NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLY 407
++AVK L + K F E+ + +L++PN+ LLG CV ++ +I +YM +G L
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 408 SLLQ-----------GNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV 456
L N + + + A G+ +L F+H+++ + LV
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162
Query: 457 DEDFDARIMDFGLAKLMTSSD 477
+ +I DFG+++ + S D
Sbjct: 163 GNHYTIKIADFGMSRNLYSGD 183
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 60/216 (27%), Positives = 88/216 (40%), Gaps = 33/216 (15%)
Query: 350 VLAVKRLNTCKLGEKK----FRNEMNRLGQLRHPNLAPLLGYCVVEEEKL-LIYKYMSSG 404
+ A+K +N K EK NE L +L HP L L Y +EE + L+ + G
Sbjct: 27 MFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW-YSFQDEENMYLVVDLLLGG 85
Query: 405 TL-YSLLQGNA-TELDWPTRFRIGLGAARGLAWLH-HGCQPPFLHQNICSNVILVDEDFD 461
L Y L Q +E +F I L +LH G +H++I + IL+DE
Sbjct: 86 DLRYHLSQKVKFSEEQ--VKFWI-CEIVLALEYLHSKG----IIHRDIKPDNILLDEQGH 138
Query: 462 ARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELA-- 519
I DF +A +T + G GY+APE S+ D + +GV E
Sbjct: 139 VHITDFNIATKVTP---DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRG 195
Query: 520 --GFKGNLVDWVNQ----------LSSSGRSKEAID 543
++G+ +Q L + S EAID
Sbjct: 196 KRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAID 231
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 46/191 (24%), Positives = 84/191 (43%), Gaps = 11/191 (5%)
Query: 338 GTTYKAM-LPDGS------VLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVV 390
GT YK + +PDG + V R NT K+ +E + + P + LLG C+
Sbjct: 21 GTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT 80
Query: 391 EEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNIC 450
+L + + M G L ++ N + + A+G+++L + +H+++
Sbjct: 81 STVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLA 136
Query: 451 SNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYG 510
+ +LV +I DFGLA+L+ + +G ++A E + + DV+
Sbjct: 137 ARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWS 196
Query: 511 IGVVLLELAGF 521
GV + EL F
Sbjct: 197 YGVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 60/231 (25%), Positives = 110/231 (47%), Gaps = 21/231 (9%)
Query: 350 VLAVKRLN-TCKLGEKKFRN---EMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGT 405
V+A+K+++ + K +K+++ E+ L +++HPN G + E L+ +Y G+
Sbjct: 52 VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY-CLGS 110
Query: 406 LYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIM 465
LL+ + L I GA +GLA+LH +H++I + IL+ E ++
Sbjct: 111 ASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLA 167
Query: 466 DFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASL---KGDVYGIGVVLLELAGFK 522
DFG A + + ++ SFV G ++APE M K DV+ +G+ +ELA K
Sbjct: 168 DFGSASIASPAN--SFV----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 221
Query: 523 GNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDR 573
L + +N +S+ + L + + F+ +C+ P+DR
Sbjct: 222 PPLFN-MNAMSALYHIAQNESPTLQSNEWSDYFRNFVD---SCLQKIPQDR 268
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 51/193 (26%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 346 PDGSVLAVKRLNTCKLGE---KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402
P G+++ V+ + E K +NE+ RHPN+ +I +M+
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 403 SGTLYSLLQGNATELDWPTRFR-IGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFD 461
G+ SLL+ E I GA RGL +LH Q ++H+NI ++ IL+ D
Sbjct: 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGD-- 137
Query: 462 ARIMDFGLAKLMTSSDESSFV-NGDLGEFGYIAPEYSSTMVA--------------SLKG 506
GL L S S V NG + Y P++S++++ ++K
Sbjct: 138 ------GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKS 191
Query: 507 DVYGIGVVLLELA 519
D+Y +G+ ELA
Sbjct: 192 DIYSVGITACELA 204
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 43/144 (29%), Positives = 70/144 (48%), Gaps = 16/144 (11%)
Query: 347 DGSVL-AVKRL--NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403
D VL AVK L + + F E+ L +L PN+A LLG C V+ +I +YM +
Sbjct: 44 DAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMEN 103
Query: 404 GTLYSLLQ----------GNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNV 453
G L LQ N+ L + T + A G+ +L F+H+++ +
Sbjct: 104 GDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN 160
Query: 454 ILVDEDFDARIMDFGLAKLMTSSD 477
LV +++ +I DFG+++ + SSD
Sbjct: 161 CLVGKNYTIKIADFGMSRNLYSSD 184
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 44/183 (24%), Positives = 78/183 (42%), Gaps = 11/183 (6%)
Query: 340 TYKAMLPDGSVLAVKRLNTCKLGEK--KFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397
Y + + +AVK C KF E + Q HP++ L+G E ++
Sbjct: 26 VYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVI-TENPVWIV 84
Query: 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD 457
+ G L S LQ N LD + + LA+L F+H++I + +LV
Sbjct: 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVS 141
Query: 458 EDFDARIMDFGLAKLMTSSDESSFVNGDLGEF--GYIAPEYSSTMVASLKGDVYGIGVVL 515
++ DFGL++ + ++ S+ G+ ++APE + + DV+ GV +
Sbjct: 142 SPDCVKLGDFGLSRYL---EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 198
Query: 516 LEL 518
E+
Sbjct: 199 WEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 50/195 (25%), Positives = 88/195 (45%), Gaps = 22/195 (11%)
Query: 348 GSVLAVKRL----NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403
G +A+K++ +T L ++ +R E+ L LRH N+ L + E + +
Sbjct: 35 GQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSDIFISPLEDIYFVTELLG 93
Query: 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDAR 463
L+ LL E + F + RGL ++H +H+++ + IL++E+ D +
Sbjct: 94 TDLHRLLTSRPLEKQFIQYFLYQI--LRGLKYVHSA---GVVHRDLKPSNILINENCDLK 148
Query: 464 IMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVA-SLKGDVYGIGVVLLELAG-- 520
I DFGLA++ + + G + Y APE T ++ D++ G + E+
Sbjct: 149 ICDFGLARI-----QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
Query: 521 --FKGNLVDWVNQLS 533
F G D VNQ S
Sbjct: 204 PLFPGK--DHVNQFS 216
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 13/153 (8%)
Query: 376 LRHPNLAPLLGYCVVEEEK-LLIYKYMSSGTLYSLLQ-------GNATELDWPTRFRIGL 427
L H N+ P+L C+ + E ++Y YM+ G L LQ N L + +
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124
Query: 428 GAARGLAWLH-HGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDL 486
A G+++LH G +H++I + ++DE+ +I D L++ + D + +
Sbjct: 125 QIACGMSYLHKRG----VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN 180
Query: 487 GEFGYIAPEYSSTMVASLKGDVYGIGVVLLELA 519
++A E S DV+ GV+L EL
Sbjct: 181 RPVKWMALESLVNKEYSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 63/243 (25%), Positives = 116/243 (47%), Gaps = 25/243 (10%)
Query: 348 GSVLAVKRLN-TCKLGEKKFRN---EMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM-- 401
V+A+K+++ + K +K+++ E+ L QLRHPN G + E L+ +Y
Sbjct: 40 NEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG 99
Query: 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFD 461
S+ + + + E++ I GA +GLA+LH + +H++I + IL+ E
Sbjct: 100 SASDILEVHKKPLQEVEIAA---ICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGT 153
Query: 462 ARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASL---KGDVYGIGVVLLEL 518
++ DFG A L++ ++ SFV G ++APE M K DV+ +G+ +EL
Sbjct: 154 VKLADFGSASLVSPAN--SFV----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
Query: 519 AGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQ 578
A K L + +N +S+ + L + + F+ C+ P+DR S +
Sbjct: 208 AERKPPLFN-MNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDS---CLQKIPQDRPSSEE 263
Query: 579 VYQ 581
+ +
Sbjct: 264 LLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 37/148 (25%), Positives = 68/148 (45%), Gaps = 23/148 (15%)
Query: 350 VLAVK--RLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLY 407
++AVK R + K F E+ L +L+ PN+ LLG CV E+ +I +YM +G L
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 408 SLLQGNATE------------------LDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNI 449
L + + + + + + L A G+ +L F+H+++
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDL 164
Query: 450 CSNVILVDEDFDARIMDFGLAKLMTSSD 477
+ LV E+ +I DFG+++ + + D
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGD 192
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 46/186 (24%), Positives = 94/186 (50%), Gaps = 13/186 (6%)
Query: 337 TGTTYKAM-LPDGSVLAVKRLNTCKLGEKKFR-NEMNRLGQLRHPNLAPLLGYCVVEEEK 394
+GT Y A+ + G +A+K++N + +K+ NE+ + + +HPN+ L +V +E
Sbjct: 32 SGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDEL 91
Query: 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVI 454
++ +Y++ G+L ++ T +D + + L +LH +H++I S+ I
Sbjct: 92 WVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNI 146
Query: 455 LVDEDFDARIMDFGLAKLMT--SSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIG 512
L+ D ++ DFG +T S S+ V G ++APE + K D++ +G
Sbjct: 147 LLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEVVTRKAYGPKVDIWSLG 202
Query: 513 VVLLEL 518
++ +E+
Sbjct: 203 IMAIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 51/229 (22%), Positives = 108/229 (47%), Gaps = 27/229 (11%)
Query: 309 KPLVKVKLADLMAASNSFCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCKLGEKKFR 367
+ L + L+ L + F V+ + G YK + G + A+K ++ + E++ +
Sbjct: 1 RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIK 60
Query: 368 NEMNRLGQL-RHPNLAPLLGYCVV------EEEKLLIYKYMSSGTLYSLLQ---GNATEL 417
E+N L + H N+A G + +++ L+ ++ +G++ L++ GNA +
Sbjct: 61 LEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE 120
Query: 418 DWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLM--TS 475
DW I RGLA LH +H++I +L+ E+ + +++DFG++ + T
Sbjct: 121 DWIAY--ICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 175
Query: 476 SDESSFVNGDLGEFGYIAPEY-----SSTMVASLKGDVYGIGVVLLELA 519
++F+ G ++APE + + D++ +G+ +E+A
Sbjct: 176 GRRNTFI----GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMA 220
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 5e-06
Identities = 45/200 (22%), Positives = 97/200 (48%), Gaps = 27/200 (13%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCV------ 389
G YK + G + A+K ++ E++ + E+N L + H N+A G +
Sbjct: 20 GQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79
Query: 390 VEEEKLLIYKYMSSGTLYSLLQ---GNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLH 446
++++ L+ ++ +G++ L++ GN + +W I RGL+ LH Q +H
Sbjct: 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLH---QHKVIH 134
Query: 447 QNICSNVILVDEDFDARIMDFGLAKLM--TSSDESSFVNGDLGEFGYIAPEY-----SST 499
++I +L+ E+ + +++DFG++ + T ++F+ G ++APE +
Sbjct: 135 RDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI----GTPYWMAPEVIACDENPD 190
Query: 500 MVASLKGDVYGIGVVLLELA 519
K D++ +G+ +E+A
Sbjct: 191 ATYDFKSDLWSLGITAIEMA 210
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 43/179 (24%), Positives = 77/179 (43%), Gaps = 14/179 (7%)
Query: 350 VLAVKRLNTCKLGE--KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLY 407
++ VK L K +FR E++ +L H N+ LLG C E +I +Y G L
Sbjct: 37 LVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLK 96
Query: 408 SLLQGNATE--------LDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDED 459
L+ ++ L + + A G+ L + F+H+++ + LV
Sbjct: 97 QFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQ 153
Query: 460 FDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
+ ++ L+K + +S+ N L ++APE S K DV+ GV++ E+
Sbjct: 154 REVKVSLLSLSKDVYNSEYYKLRNA-LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 50/180 (27%), Positives = 79/180 (43%), Gaps = 12/180 (6%)
Query: 346 PDGSVL--AVKRLNTCKLGE--KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL-LIYKY 400
G V+ AVK L + KL + F E + L H NL L Y VV L ++ +
Sbjct: 19 SGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL--YGVVLTHPLMMVTEL 76
Query: 401 MSSGTLYSLLQGNAT-ELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDED 459
G+L L+ +A T + A G+ +L F+H+++ + IL+ D
Sbjct: 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASD 133
Query: 460 FDARIMDFGLAKLMTSSDESSFVNGDLG-EFGYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
+I DFGL + + +++ + L F + APE T S DV+ GV L E+
Sbjct: 134 DKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 10/158 (6%)
Query: 370 MNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLG 428
M+ LG H N+ LLG C + L+I +Y G L + L+ + L
Sbjct: 92 MSHLGN--HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQ 149
Query: 429 AARGLAWL-HHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAK-LMTSSDESSFVNGDL 486
A+G+A+L C +H+++ + +L+ +I DFGLA+ +M S+ N L
Sbjct: 150 VAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205
Query: 487 GEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGN 524
++APE V + + DV+ G++L E+ N
Sbjct: 206 -PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSN 242
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 24/199 (12%)
Query: 338 GTTYK-AMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYC-----VV 390
G YK DGS+ AVK L+ +++ E N L L HPN+ G +V
Sbjct: 36 GKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95
Query: 391 EEEKLLIYKYMSSGTLYSLLQG---NATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQ 447
+ L+ + + G++ L++G LD I GA GL LH+ +H+
Sbjct: 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHR 152
Query: 448 NICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPE-------YSSTM 500
++ N IL+ + +++DFG++ +TS+ N +G ++APE Y +
Sbjct: 153 DVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQYDYSY 210
Query: 501 VASLKGDVYGIGVVLLELA 519
A + DV+ +G+ +EL
Sbjct: 211 DA--RCDVWSLGITAIELG 227
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 47/197 (23%), Positives = 89/197 (45%), Gaps = 21/197 (10%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKK----------FRNEMNRLGQLRHPNLAPLLG 386
G+ Y M G ++AVK++ + E+ L +L+H N+ LG
Sbjct: 14 GSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLG 73
Query: 387 YCVVEEEKLLIY-KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFL 445
++ + L I+ +Y+ G++ +LL N + +GL +LH +
Sbjct: 74 -SSLDADHLNIFLEYVPGGSVAALLN-NYGAFEETLVRNFVRQILKGLNYLH---NRGII 128
Query: 446 HQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGD----LGEFGYIAPEYSSTMV 501
H++I ILVD +I DFG++K + ++ S+ NG G ++APE
Sbjct: 129 HRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS 188
Query: 502 ASLKGDVYGIGVVLLEL 518
+ K D++ +G +++E+
Sbjct: 189 YTRKADIWSLGCLVVEM 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 41/156 (26%), Positives = 74/156 (47%), Gaps = 13/156 (8%)
Query: 367 RNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQ-GNATELDWPTRFRI 425
+ E+ L Q P + G + + +I +Y+ G+ LL+ G E T R
Sbjct: 50 QQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILRE 109
Query: 426 GLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD--ESSFVN 483
L +GL +LH + +H++I + +L+ E D ++ DFG+A +T + ++FV
Sbjct: 110 IL---KGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV- 162
Query: 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELA 519
G ++APE K D++ +G+ +ELA
Sbjct: 163 ---GTPFWMAPEVIKQSAYDFKADIWSLGITAIELA 195
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 40/176 (22%), Positives = 86/176 (48%), Gaps = 16/176 (9%)
Query: 348 GSVLAVKRLNTCKLGEKKFR-NEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTL 406
G +AVK+++ K ++ NE+ + +HPN+ + +V +E ++ +++ G L
Sbjct: 44 GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103
Query: 407 YSLLQGNATELDWPTRFRIGLGAARGLAWLH-HGCQPPFLHQNICSNVILVDEDFDARIM 465
++ T ++ + L + L++LH G +H++I S+ IL+ D ++
Sbjct: 104 TDIV--THTRMNEEQIATVCLAVLKALSFLHAQG----VIHRDIKSDSILLTSDGRVKLS 157
Query: 466 DFGLAKLMTSSD---ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
DFG S + S V G ++APE S + + D++ +G++++E+
Sbjct: 158 DFGFCA-QVSKEVPRRKSLV----GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 51/197 (25%), Positives = 78/197 (39%), Gaps = 40/197 (20%)
Query: 348 GSVLAVKRLNTCKLGE----KKFRN-------------EMNRLGQLRHPNLAPLLGYCVV 390
G VL + T GE KKF+ E+ L QLRH N+ L
Sbjct: 15 GVVLKCRNKAT---GEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR 71
Query: 391 EEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLH-HGCQPPFLHQNI 449
+ L+++Y+ TL LL+ + L + +A+ H H +H++I
Sbjct: 72 KGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNI----IHRDI 126
Query: 450 CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEF----GYIAPEY--SSTMVAS 503
ILV E ++ DFG A+ + + S L ++ Y APE T
Sbjct: 127 KPENILVSESGVLKLCDFGFARALRARPAS-----PLTDYVATRWYRAPELLVGDTNYG- 180
Query: 504 LKG-DVYGIGVVLLELA 519
K DV+ IG ++ EL
Sbjct: 181 -KPVDVWAIGCIMAELL 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 65/277 (23%), Positives = 113/277 (40%), Gaps = 45/277 (16%)
Query: 338 GTTYKAMLP--DGSV--LAVKRLNT---CKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVV 390
G+ +A L DGS +AVK L ++F E + + HPN+ L+G +
Sbjct: 13 GSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLR 72
Query: 391 EEEK------LLIYKYMSSGTLYSLL-----QGNATELDWPTRFRIGLGAARGLAWLHHG 439
K ++I +M G L++ L L T R + A G+ +L
Sbjct: 73 SRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS-- 130
Query: 440 CQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEF--GYIAPEYS 497
F+H+++ + +++E+ + DFGL+K + S D + G + ++A E
Sbjct: 131 -SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD--YYRQGCASKLPVKWLALESL 187
Query: 498 STMVASLKGDVYGIGVVLLEL--------AGFKGNLVDWVNQLSSSGRSKEAIDKALCGK 549
+ V + DV+ GV + E+ AG + + + N L R K+ D C
Sbjct: 188 ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI--YNYLIKGNRLKQPPD---C-- 240
Query: 550 GYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586
E++ + + C C PK R S + L I
Sbjct: 241 --LEDVYELM---CQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 36/200 (18%)
Query: 338 GTTYKA-MLPDGSVLAVKRLNTCKLGEKK----FRNEMNRLGQLRHPNLAPLLG-YCVVE 391
G YKA + G ++A+K + KL + E++ L + RHPN+ G Y +
Sbjct: 17 GDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY--LR 71
Query: 392 EEKLLI-YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNI- 449
+KL I +Y G+L + Q L + +GLA+LH + +H++I
Sbjct: 72 RDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGK---IHRDIK 128
Query: 450 CSNVILVDEDFDARIMDFGLAKLMTS--SDESSFVNGDLGEFGYIAPEYSSTMVAS---- 503
+N IL+ ED D ++ DFG++ +T+ + SF+ G ++APE VA+
Sbjct: 129 GAN-ILLTEDGDVKLADFGVSAQLTATIAKRKSFI----GTPYWMAPE-----VAAVERK 178
Query: 504 ----LKGDVYGIGVVLLELA 519
K D++ +G+ +ELA
Sbjct: 179 GGYDGKCDIWALGITAIELA 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 40/154 (25%), Positives = 73/154 (47%), Gaps = 9/154 (5%)
Query: 367 RNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQ-GNATELDWPTRFRI 425
+ E+ L Q P + G + + + +I +Y+ G+ LL+ G E T R
Sbjct: 50 QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILRE 109
Query: 426 GLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGD 485
L +GL +LH + +H++I + +L+ E + ++ DFG+A +T D N
Sbjct: 110 IL---KGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTF 161
Query: 486 LGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELA 519
+G ++APE K D++ +G+ +ELA
Sbjct: 162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 57/267 (21%), Positives = 115/267 (43%), Gaps = 21/267 (7%)
Query: 325 SFCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCKLGEKKFR----NEMNRLGQLRHP 379
+F E I + Y+A L DG +A+K++ L + K R E++ L QL HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 380 NLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDW-PTR----FRIGLGAARGLA 434
N+ + + E ++ + +G L +++ + P + + + L +A
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA---- 118
Query: 435 WLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAP 494
L H +H++I + + ++ D GL + +S +++ + +G Y++P
Sbjct: 119 -LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSP 175
Query: 495 EYSSTMVASLKGDVYGIGVVLLELAGFKGNLV-DWVNQLSSSGRSKEAIDKALCGKGYDE 553
E + K D++ +G +L E+A + D +N S + ++ L Y E
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 235
Query: 554 EILQFLKVACNCVVSRPKDRWSMYQVY 580
E+ Q + + C+ P+ R + VY
Sbjct: 236 ELRQLVNM---CINPDPEKRPDITYVY 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 47/185 (25%), Positives = 85/185 (45%), Gaps = 15/185 (8%)
Query: 346 PDGSVLAVKRLN-TCKLGEK-KFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403
+ V AVK +N + L E+ +F NE + + ++ LLG + L++ + M+
Sbjct: 35 AETRV-AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAH 93
Query: 404 GTLYSLLQGNATELDWPT-------RFRIGLGA--ARGLAWLHHGCQPPFLHQNICSNVI 454
G L S L+ E + + I + A A G+A+L+ F+H+++ +
Sbjct: 94 GDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNC 150
Query: 455 LVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVV 514
+V DF +I DFG+ + + +D L ++APE V + D++ GVV
Sbjct: 151 MVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVV 210
Query: 515 LLELA 519
L E+
Sbjct: 211 LWEIT 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 49/194 (25%), Positives = 83/194 (42%), Gaps = 23/194 (11%)
Query: 349 SVLAVKRL--NTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIYKYMSSGT 405
S +AVK L + + +EM + + +H N+ LLG C E ++ +Y + G
Sbjct: 43 STVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGN 102
Query: 406 LYSLLQGN-------ATELDWPTRFRIGLGA--------ARGLAWLHHGCQPPFLHQNIC 450
L L+ + + P + ARG+ +L +H+++
Sbjct: 103 LRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLA 159
Query: 451 SNVILVDEDFDARIMDFGLAKLMTSSD-ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVY 509
+ +LV ED +I DFGLA+ + D NG L ++APE V + + DV+
Sbjct: 160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL-PVKWMAPEALFDRVYTHQSDVW 218
Query: 510 GIGVVLLELAGFKG 523
GV+L E+ G
Sbjct: 219 SFGVLLWEIFTLGG 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 48/192 (25%), Positives = 91/192 (47%), Gaps = 18/192 (9%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEK--KFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395
G YKA + VLA ++ K E+ + E++ L HPN+ LL E
Sbjct: 19 GKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 78
Query: 396 LIYKYMSSGTLYSLLQGNATELDWP-TRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVI 454
++ ++ + G + +++ EL+ P T +I + + L L++ + +H+++ + I
Sbjct: 79 ILIEFCAGGAVDAVM----LELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNI 134
Query: 455 LVDEDFDARIMDFGLAKLMTSSDE--SSFVNGDLGEFGYIAPEY-----SSTMVASLKGD 507
L D D ++ DFG++ T + + SF+ G ++APE S K D
Sbjct: 135 LFTLDGDIKLADFGVSAKNTRTIQRRDSFI----GTPYWMAPEVVMCETSKDRPYDYKAD 190
Query: 508 VYGIGVVLLELA 519
V+ +G+ L+E+A
Sbjct: 191 VWSLGITLIEMA 202
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 33/140 (23%), Positives = 66/140 (47%), Gaps = 15/140 (10%)
Query: 350 VLAVK--RLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLY 407
++AVK R + K F E+ + +L+ PN+ LL C+ + +I +YM +G L
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 408 SLL----------QGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD 457
L + + + + T + A G+ +L F+H+++ + LV
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVG 164
Query: 458 EDFDARIMDFGLAKLMTSSD 477
+++ +I DFG+++ + S D
Sbjct: 165 KNYTIKIADFGMSRNLYSGD 184
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 27/97 (27%), Positives = 49/97 (50%), Gaps = 7/97 (7%)
Query: 424 RIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483
+I +GL++LH +H++I + IL+ ++ DFG++ + +S +F
Sbjct: 109 KIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT- 164
Query: 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG 520
G Y+APE S+ DV+ +G+ LLE+A
Sbjct: 165 ---GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQ 198
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 39/209 (18%)
Query: 341 YKAMLPDGSVLAVKRL----NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396
M +AVK L N L ++ R E N + QL +P + ++G C E E +
Sbjct: 15 MYKMKKSEKTVAVKILKNDNNDPALKDELLR-EANVMQQLDNPYIVRMIGIC--EAESWM 71
Query: 397 IYKYMSS-GTLYSLLQGN-------ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQN 448
+ ++ G L LQ N TEL + G+ +L + F+H++
Sbjct: 72 LVMELAELGPLNKFLQKNKHVTEKNITELVHQV--------SMGMKYLE---ETNFVHRD 120
Query: 449 ICS-NVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEF--GYIAPEYSSTMVASLK 505
+ + NV+LV + + A+I DFGL+K + +DE+ + G++ + APE + S K
Sbjct: 121 LAARNVLLVTQHY-AKISDFGLSKALG-ADENYYKAKTHGKWPVKWYAPECMNYYKFSSK 178
Query: 506 GDVYGIGVVLLE--------LAGFKGNLV 526
DV+ GV++ E G KGN V
Sbjct: 179 SDVWSFGVLMWEAFSYGQKPYKGMKGNEV 207
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 37/157 (23%), Positives = 78/157 (49%), Gaps = 11/157 (7%)
Query: 367 RNEMNRLGQLRH----PNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTR 422
RN++ R Q+ H P + G + E + ++M G+L +L+ A +
Sbjct: 47 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQIL 105
Query: 423 FRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482
++ + +GL +L + +H+++ + ILV+ + ++ DFG++ + S +SFV
Sbjct: 106 GKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 163
Query: 483 NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELA 519
G Y++PE S++ D++ +G+ L+E+A
Sbjct: 164 ----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 196
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 69/275 (25%), Positives = 102/275 (37%), Gaps = 79/275 (28%)
Query: 347 DGSVLAVKRLNTCKLGEKK----FRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL--IYKY 400
G V A+K L + ++ R E + L P + L Y ++E+ L + +Y
Sbjct: 25 TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL--YYSFQDEEHLYLVMEY 82
Query: 401 MSSGTLYSLL--QGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE 458
M G L +LL + E + RF I A + L + F+H++I + IL+D
Sbjct: 83 MPGGDLMNLLIRKDVFPE-ET-ARFYI----AELVLALDSVHKLGFIHRDIKPDNILIDA 136
Query: 459 DFDARIMDFGLAKLMTSSDESSFVNGDL---------------------------GEFGY 491
D ++ DFGL K M + + + D G Y
Sbjct: 137 DGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDY 196
Query: 492 IAPEYSSTMVASLKGDVYG-------IGVVLLE-LAGF-----------KGNLVDWVNQL 532
IAPE L+G YG +GV+L E L GF +++W L
Sbjct: 197 IAPEV-------LRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESL 249
Query: 533 ---SSSGRSKEAID---KALCGK----GYDEEILQ 557
S EAID + LC G EEI
Sbjct: 250 RFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKS 284
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 42/164 (25%), Positives = 70/164 (42%), Gaps = 20/164 (12%)
Query: 377 RHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGN---------------ATELDWPT 421
+H N+ LLG C + +I +Y S G L L+ +L +
Sbjct: 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 422 RFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD-ESS 480
ARG+ +L +H+++ + +LV ED +I DFGLA+ + D
Sbjct: 142 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198
Query: 481 FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGN 524
NG L ++APE + + + DV+ GV+L E+ G+
Sbjct: 199 TTNGRL-PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 241
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 42/165 (25%), Positives = 71/165 (43%), Gaps = 22/165 (13%)
Query: 377 RHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQG---------------NATELDWPT 421
+H N+ LLG C E +I +Y + G L L+ +L +
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 422 RFRIGLGAARGLAWLH-HGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD-ES 479
ARG+ +L C +H+++ + +LV ED +I DFGLA+ + D
Sbjct: 136 LVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191
Query: 480 SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGN 524
NG L ++APE V + + DV+ G+++ E+ G+
Sbjct: 192 KTSNGRL-PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGS 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 51/252 (20%), Positives = 112/252 (44%), Gaps = 21/252 (8%)
Query: 341 YKAM-LPDGSVLAVKRLNTCKLGEKKFRN----EMNRLGQLRHPNLAPLLGYCVVEEEKL 395
Y+A L D +A+K++ ++ + K R E++ L QL HPN+ L + + E
Sbjct: 19 YRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELN 78
Query: 396 LIYKYMSSGTLYSLLQGNATELDW-PTR----FRIGLGAARGLAWLHHGCQPPFLHQNIC 450
++ + +G L +++ + P R + + L +A + H +H++I
Sbjct: 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA-----VEHMHSRRVMHRDIK 133
Query: 451 SNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYG 510
+ + ++ D GL + +S +++ + +G Y++PE + K D++
Sbjct: 134 PANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWS 191
Query: 511 IGVVLLELAGFKGNLV-DWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSR 569
+G +L E+A + D +N S + ++ L + Y E++ + + + C+
Sbjct: 192 LGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSM---CIYPD 248
Query: 570 PKDRWSMYQVYQ 581
P R + V+Q
Sbjct: 249 PDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 44/165 (26%), Positives = 73/165 (44%), Gaps = 22/165 (13%)
Query: 377 RHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGN-----------ATELDWPTRFR- 424
+H N+ LLG C + +I +Y S G L L+ A D F+
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 425 ---IGLGAARGLAWL-HHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD-ES 479
ARG+ +L C +H+++ + +LV E+ +I DFGLA+ + + D
Sbjct: 139 LVSCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYK 194
Query: 480 SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGN 524
NG L ++APE V + + DV+ GV++ E+ G+
Sbjct: 195 KTTNGRL-PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 9e-05
Identities = 31/110 (28%), Positives = 59/110 (53%), Gaps = 12/110 (10%)
Query: 431 RGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS--DESSFVNGDLGE 488
RGL ++H +H+++ + +LV+ED + RI DFG+A+ ++SS + F+ +
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 489 FGYIAPEYSSTMVA-SLKGDVYGIGVVLLELAG----FKGNLVDWVNQLS 533
Y APE ++ + D++ +G + E+ G F G ++V+QL
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK--NYVHQLK 222
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 9e-05
Identities = 38/172 (22%), Positives = 83/172 (48%), Gaps = 8/172 (4%)
Query: 348 GSVLAVKRLNTCKLGEKKFR-NEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTL 406
G +AVK+++ K ++ NE+ + H N+ + +V +E ++ +++ G L
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106
Query: 407 YSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMD 466
++ T ++ + L R L++LH +H++I S+ IL+ D ++ D
Sbjct: 107 TDIV--THTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSD 161
Query: 467 FGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
FG + S E +G ++APE S + + D++ +G++++E+
Sbjct: 162 FGFCAQV--SKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 9e-05
Identities = 43/176 (24%), Positives = 84/176 (47%), Gaps = 15/176 (8%)
Query: 349 SVLAVKRLNTCKLGEK--KFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTL 406
V+A+K ++ + ++ + E+ L Q P + G + + +I +Y+ G+
Sbjct: 30 QVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSA 89
Query: 407 YSLLQ-GNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIM 465
LL+ G E T + L +GL +LH + +H++I + +L+ E D ++
Sbjct: 90 LDLLRAGPFDEFQIATMLKEIL---KGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLA 143
Query: 466 DFGLAKLMTSSD--ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELA 519
DFG+A +T + ++FV G ++APE K D++ +G+ +ELA
Sbjct: 144 DFGVAGQLTDTQIKRNTFV----GTPFWMAPEVIQQSAYDSKADIWSLGITAIELA 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 33/158 (20%), Positives = 63/158 (39%), Gaps = 13/158 (8%)
Query: 373 LGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARG 432
L + HP++ + V ++ + SS LY+ L + L I G
Sbjct: 111 LQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEG 169
Query: 433 LAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYI 492
L +LH +H+++ + I +++ I D G A+ + LG G +
Sbjct: 170 LRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA------FLGLAGTV 220
Query: 493 ---APEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVD 527
APE + + K D++ G+VL E+ + + +
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFE 258
|
Length = 357 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 41/158 (25%), Positives = 69/158 (43%), Gaps = 20/158 (12%)
Query: 377 RHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGN---------------ATELDWPT 421
+H N+ LLG C + ++ +Y S G L L+ +L +
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 422 RFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD-ESS 480
ARG+ +L +H+++ + +LV ED +I DFGLA+ + + D
Sbjct: 136 LVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192
Query: 481 FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
NG L ++APE V + + DV+ GV+L E+
Sbjct: 193 TTNGRL-PVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 43/193 (22%), Positives = 92/193 (47%), Gaps = 21/193 (10%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396
G+ YKA+ G V+A+K + + ++ E++ L Q P + G + +
Sbjct: 17 GSVYKAIHKETGQVVAIKVVPV-EEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI 75
Query: 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV 456
+ +Y +G++ +++ L I +GL +LH +H++I + IL+
Sbjct: 76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILL 132
Query: 457 DEDFDARIMDFGLA-KLMTSSDESSFVNGDLGEFGYIAPE------YSSTMVASLKGDVY 509
+E+ A++ DFG++ +L + + + V +G ++APE Y++ K D++
Sbjct: 133 NEEGQAKLADFGVSGQLTDTMAKRNTV---IGTPFWMAPEVIQEIGYNN------KADIW 183
Query: 510 GIGVVLLELAGFK 522
+G+ +E+A K
Sbjct: 184 SLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 58/262 (22%), Positives = 106/262 (40%), Gaps = 32/262 (12%)
Query: 338 GTTYKAMLPDG--SVLAVKRLN--------TCKLGEKKFRNEMNRLG----QLRHPNLAP 383
G YK + ++LA+K +N + +K + ++ + QLRHPN+
Sbjct: 14 GCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNI-- 71
Query: 384 LLGY--CVVEEEKLLIYKYM----SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLH 437
+ Y +E ++L I + G ++ L+ + I + L +LH
Sbjct: 72 -VRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH 130
Query: 438 HGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYS 497
+ +H+++ N I++ ED I DFGLAK S + +G Y PE
Sbjct: 131 K--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYSCPEIV 185
Query: 498 STMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQ 557
K DV+ G +L ++ + N LS + + EA+ + L Y E++
Sbjct: 186 KNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPEGMYSEDVTD 244
Query: 558 FLKVACNCVVSRPKDRWSMYQV 579
+ +C+ + R + QV
Sbjct: 245 VIT---SCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 43/192 (22%), Positives = 85/192 (44%), Gaps = 18/192 (9%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEK--KFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395
G YKA + + A ++ + E+ F E++ L + +HPN+ L E +
Sbjct: 19 GKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW 78
Query: 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVIL 455
++ ++ G L S++ L P + L +LH +H+++ + IL
Sbjct: 79 ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNIL 135
Query: 456 VDEDFDARIMDFGLAKLMTSSDE--SSFVNGDLGEFGYIAPE------YSSTMVASLKGD 507
+ D D ++ DFG++ S+ + +F+ G ++APE + K D
Sbjct: 136 LTLDGDVKLADFGVSAKNKSTLQKRDTFI----GTPYWMAPEVVACETFKDNPYDY-KAD 190
Query: 508 VYGIGVVLLELA 519
++ +G+ L+ELA
Sbjct: 191 IWSLGITLIELA 202
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 35/113 (30%), Positives = 60/113 (53%), Gaps = 27/113 (23%)
Query: 431 RGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFG 490
RGL ++H +H+++ + + V+ED + RI+DFGLA+ + DE + G +
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDE---MTGYVATRW 180
Query: 491 YIAPE-------YSSTMVASLKGDVYGIGVVLLEL----AGFKGNLVDWVNQL 532
Y APE Y+ T+ D++ +G ++ EL A F GN D+++QL
Sbjct: 181 YRAPEIMLNWMHYNQTV------DIWSVGCIMAELLKGKALFPGN--DYIDQL 225
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 42/187 (22%), Positives = 74/187 (39%), Gaps = 22/187 (11%)
Query: 347 DGSVLAVKRLNTCKLGEKK---FRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403
D +K ++ K+ K+ + E+ L +++HPN+ ++ +Y
Sbjct: 24 DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDG 83
Query: 404 GTLYSLLQ-------GNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICS-NVIL 455
G L + L W + +GL H LH++I S N+ L
Sbjct: 84 GDLMKRINRQRGVLFSEDQILSWFVQISLGL---------KHIHDRKILHRDIKSQNIFL 134
Query: 456 VDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVL 515
A++ DFG+A+ + S E +G Y++PE + K D++ +G VL
Sbjct: 135 SKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVL 192
Query: 516 LELAGFK 522
EL K
Sbjct: 193 YELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 27/95 (28%), Positives = 45/95 (47%), Gaps = 3/95 (3%)
Query: 424 RIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483
R AA L L + +++++ IL+D+ RI D GLA E +
Sbjct: 103 RALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA---VKIPEGESIR 159
Query: 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
G +G GY+APE + +L D +G+G ++ E+
Sbjct: 160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 47/183 (25%), Positives = 82/183 (44%), Gaps = 18/183 (9%)
Query: 348 GSVLAVKRLNTCKLGEKK----FRNEMNRLGQLRHPNLAPLLGYCVVEEEKL-LIYKYMS 402
G + A+K + L ++ F E + L P + P L Y +++ L L+ +Y
Sbjct: 26 GDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWI-PQLQYAFQDKDNLYLVMEYQP 84
Query: 403 SGTLYSLLQGNATELDWP-TRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFD 461
G L SLL + D +F + A + +H Q ++H++I +L+D
Sbjct: 85 GGDLLSLLNRYEDQFDEDMAQFYL----AELVLAIHSVHQMGYVHRDIKPENVLIDRTGH 140
Query: 462 ARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKG------DVYGIGVVL 515
++ DFG A +T +++ +G YIAPE +TM KG D + +GV+
Sbjct: 141 IKLADFGSAARLT-ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIA 199
Query: 516 LEL 518
E+
Sbjct: 200 YEM 202
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 38/163 (23%), Positives = 70/163 (42%), Gaps = 18/163 (11%)
Query: 367 RNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNA-------TELDW 419
R E L +++HPN+ + ++ +Y G L ++ T L W
Sbjct: 46 RKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW 105
Query: 420 PTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479
+ +G+ H + LH++I S I + ++ ++ DFG A+L+TS
Sbjct: 106 FVQMCLGV---------QHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--G 154
Query: 480 SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFK 522
++ +G Y+ PE M + K D++ +G +L EL K
Sbjct: 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 35/152 (23%), Positives = 67/152 (44%), Gaps = 17/152 (11%)
Query: 375 QLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLA 434
Q+ H ++ L G CV + E +++ +++ G L + + L P +F++ A L+
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALS 119
Query: 435 WLHHGCQPPFLHQNICS-NVILVDEDFDA------RIMDFGLAKLMTSSDESSFVNGDLG 487
+L +H N+C+ N++L E D ++ D G+ + S E +
Sbjct: 120 YLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQEC------VE 170
Query: 488 EFGYIAPE-YSSTMVASLKGDVYGIGVVLLEL 518
+IAPE + S+ D + G L E+
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 34/110 (30%), Positives = 58/110 (52%), Gaps = 16/110 (14%)
Query: 431 RGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFG 490
RGL ++H LH+++ + +L++ + D +I DFGLA+ T+S++ F+ +
Sbjct: 119 RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRW 173
Query: 491 YIAPEY---SSTMVASLKGDVYGIGVVLLELAG----FKGNLVDWVNQLS 533
Y APE S ++ DV+ +G + EL G F G D+V+QL
Sbjct: 174 YRAPELLLNCSEYTTAI--DVWSVGCIFAELLGRKPLFPGK--DYVHQLK 219
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 47/177 (26%), Positives = 75/177 (42%), Gaps = 18/177 (10%)
Query: 355 RLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQG-N 413
R++ + KF E L+H NL LG C LL+ ++ G L L+
Sbjct: 31 RVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCR 90
Query: 414 ATEL---DWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLA 470
EL D T R+ A GL LH + F+H ++ L+ D +I D+GL+
Sbjct: 91 KAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLS 147
Query: 471 KLMTSSDESSFVNGD--LGEFGYIAPE-----YSSTMVA--SLKGDVYGIGVVLLEL 518
E +V D +IAPE + + +V + + +V+ +GV + EL
Sbjct: 148 HN--KYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 37.7 bits (88), Expect = 5e-04
Identities = 19/45 (42%), Positives = 22/45 (48%), Gaps = 4/45 (8%)
Query: 48 AEDDVKCLEGVKSSLN-DPQRKLSSWSFGNSTIGFICQFVGVSCW 91
DD L KSSLN DP LSSW N + C + GV+C
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSW---NPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 37/172 (21%), Positives = 84/172 (48%), Gaps = 8/172 (4%)
Query: 348 GSVLAVKRLNTCKLGEKKFR-NEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTL 406
G ++AVK+++ K ++ NE+ + +H N+ + +V +E ++ +++ G L
Sbjct: 45 GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104
Query: 407 YSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMD 466
++ T ++ + L + L+ LH +H++I S+ IL+ D ++ D
Sbjct: 105 TDIV--THTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSD 159
Query: 467 FGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
FG + S E +G ++APE S + + D++ +G++++E+
Sbjct: 160 FGFCAQV--SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 6e-04
Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 66/215 (30%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKKFRNE-MNR--------LGQLRHPNLAPLLGY 387
YKA G ++A+K++ KLGE+K + +N L +L+HPN+ LL
Sbjct: 14 AVVYKARDKETGRIVAIKKI---KLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDV 70
Query: 388 CVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAA----------RGLAWLH 437
+ L++++M + L +++ I L A RGL +LH
Sbjct: 71 FGHKSNINLVFEFMET-DLEKVIKDK----------SIVLTPADIKSYMLMTLRGLEYLH 119
Query: 438 HGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFG------- 490
LH+++ N +L+ D ++ DFGLA+ S + +
Sbjct: 120 SNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR---------KMTHQVVTRW 167
Query: 491 YIAPE-------YSSTMVASLKGDVYGIGVVLLEL 518
Y APE Y + D++ +G + EL
Sbjct: 168 YRAPELLFGARHYGVGV------DMWSVGCIFAEL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 6e-04
Identities = 49/201 (24%), Positives = 94/201 (46%), Gaps = 23/201 (11%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGE--KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395
G YKA LA ++ + G+ + E+ + + +H N+ G + E+
Sbjct: 23 GDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW 82
Query: 396 LIYKYMSSGTLYSL--LQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNV 453
+ +Y G+L + + G +EL R L +GLA+LH + +H++I
Sbjct: 83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL---QGLAYLHSKGK---MHRDIKGAN 136
Query: 454 ILVDEDFDARIMDFGLAKLMTSS--DESSFVNGDLGEFGYIAPEYSSTMVASLKG----- 506
IL+ ++ D ++ DFG+A +T++ SF+ G ++APE ++ V G
Sbjct: 137 ILLTDNGDVKLADFGVAAKITATIAKRKSFI----GTPYWMAPEVAA--VEKNGGYNQLC 190
Query: 507 DVYGIGVVLLELAGFKGNLVD 527
D++ +G+ +ELA + + D
Sbjct: 191 DIWAVGITAIELAELQPPMFD 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 40/165 (24%), Positives = 74/165 (44%), Gaps = 12/165 (7%)
Query: 363 EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTR 422
E F E + + H N+ L+G + ++ + M+ G L S L+ N + P+
Sbjct: 53 ESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSS 112
Query: 423 FRIG--LGAARGLAWLHHGCQ----PPFLHQNICS-NVILVDEDFD--ARIMDFGLAKLM 473
+ L AR +A GC+ F+H++I + N +L + A+I DFG+A+ +
Sbjct: 113 LTMKDLLFCARDVA---KGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI 169
Query: 474 TSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
+ + ++ PE + + K DV+ GV+L E+
Sbjct: 170 YRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 41/195 (21%), Positives = 81/195 (41%), Gaps = 34/195 (17%)
Query: 346 PDGSVLAVKRLNTCKLGEKKFR---NEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402
P +++AVK++N ++ + E+ QL+HPN+ P + +V+ E ++ M+
Sbjct: 23 PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82
Query: 403 SGTLYSLLQGNATELDWPTRFRIGL----------GAARGLAWLHH-GCQPPFLHQNICS 451
G+ LL+ T F GL L ++H G +H+++ +
Sbjct: 83 YGSCEDLLK---------THFPEGLPELAIAFILKDVLNALDYIHSKGF----IHRSVKA 129
Query: 452 NVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFG-----YIAPE--YSSTMVASL 504
+ IL+ D + + M + V D + +++PE + +
Sbjct: 130 SHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNE 189
Query: 505 KGDVYGIGVVLLELA 519
K D+Y +G+ ELA
Sbjct: 190 KSDIYSVGITACELA 204
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 9e-04
Identities = 24/61 (39%), Positives = 32/61 (52%), Gaps = 1/61 (1%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNK 180
+++ LDLS N L+ IP LP L +LDLS N+L+ P L +L LS N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 181 L 181
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 9e-04
Identities = 35/120 (29%), Positives = 58/120 (48%), Gaps = 33/120 (27%)
Query: 431 RGLAWLHH-GCQPPFLHQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGE 488
RGL +LH +H+++ SN ILV+ + D +I DFGLA+ + ++ G L E
Sbjct: 114 RGLKYLHSANV----IHRDLKPSN-ILVNSNCDLKICDFGLARGVDPDEDEK---GFLTE 165
Query: 489 F----GYIAPE-------YSSTMVASLKGDVYGIGVVLLELAG----FKGNLVDWVNQLS 533
+ Y APE Y+ + D++ +G + EL F G D+++QL+
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAI------DIWSVGCIFAELLTRKPLFPGR--DYIDQLN 217
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.001
Identities = 22/60 (36%), Positives = 28/60 (46%), Gaps = 2/60 (3%)
Query: 147 LVLLDLSNNDLSGPIPAD-LGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDL 205
L LDLSNN L+ IP L L LS N L+ P S L L+ ++ N+L
Sbjct: 2 LKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 38/165 (23%), Positives = 62/165 (37%), Gaps = 17/165 (10%)
Query: 364 KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL-IYKYMSSGTLYSLLQGN-----ATEL 417
+FR E +L HPN+ LL L +++Y+ TL +L +
Sbjct: 23 ARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETG 82
Query: 418 DWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477
+ L A +H +P QNI V A+++DFG+ L+
Sbjct: 83 RLMLQVLDALACAHNQGIVHRDLKP----QNIM--VSQTGVRPHAKVLDFGIGTLLPGVR 136
Query: 478 ES-----SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLE 517
++ + LG Y APE + D+Y G++ LE
Sbjct: 137 DADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 46/190 (24%), Positives = 83/190 (43%), Gaps = 28/190 (14%)
Query: 347 DGSVLAVKRLNTCKLGEKKFR---NEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM-- 401
DG +K+LN ++ + E L QL+HPN+ E E L+Y M
Sbjct: 24 DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESW--EGEDGLLYIVMGF 81
Query: 402 -SSGTLYSLLQGNATEL-------DWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNV 453
G LY L+ +L +W + A L +LH + LH+++ +
Sbjct: 82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQI------AMALQYLH---EKHILHRDLKTQN 132
Query: 454 ILVDEDFDARIMDFGLAKLMTSS-DESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIG 512
+ + ++ D G+A+++ + D +S + +G Y++PE S + K DV+ +G
Sbjct: 133 VFLTRTNIIKVGDLGIARVLENQCDMASTL---IGTPYYMSPELFSNKPYNYKSDVWALG 189
Query: 513 VVLLELAGFK 522
+ E+A K
Sbjct: 190 CCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 38/157 (24%), Positives = 69/157 (43%), Gaps = 6/157 (3%)
Query: 366 FRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRI 425
F E LGQ H N+ L G +++ +YMS+G L S L+ + +L +
Sbjct: 53 FLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGM 112
Query: 426 GLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN-G 484
G A G+ +L + ++H+ + ++ +LV+ D +I F +L E+ +
Sbjct: 113 LPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMS 167
Query: 485 DLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGF 521
+ APE S DV+ G+V+ E+ +
Sbjct: 168 GKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSY 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 44/191 (23%), Positives = 84/191 (43%), Gaps = 16/191 (8%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEK--KFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395
G YKA + LA ++ K E+ + E+ L HP + LLG + +
Sbjct: 26 GKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW 85
Query: 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVIL 455
++ ++ G + +++ L P I L +LH +H+++ + +L
Sbjct: 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVL 142
Query: 456 VDEDFDARIMDFGLA--KLMTSSDESSFVNGDLGEFGYIAPE--YSSTMVAS---LKGDV 508
+ D D ++ DFG++ + T SF+ G ++APE TM + K D+
Sbjct: 143 LTLDGDIKLADFGVSAKNVKTLQRRDSFI----GTPYWMAPEVVMCETMKDTPYDYKADI 198
Query: 509 YGIGVVLLELA 519
+ +G+ L+E+A
Sbjct: 199 WSLGITLIEMA 209
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 54/197 (27%), Positives = 91/197 (46%), Gaps = 22/197 (11%)
Query: 338 GTTYKAM-LPDGSVLAVKRLN--TCKLGEKKFRNEMNRLGQLRH---PNLAPLLGYCVVE 391
G Y+ +P G V+A+K +N T + E+ L QLR PN+ G +
Sbjct: 15 GAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG 74
Query: 392 EEKLLIYKYMSSGTLYSLLQ-GNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNIC 450
+I +Y G++ +L++ G E R L A L ++H +H++I
Sbjct: 75 PRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVA---LKYIHKV---GVIHRDIK 128
Query: 451 SNVILVDEDFDARIMDFGLAKLM--TSSDESSFVNGDLGEFGYIAPEYSSTMVA-SLKGD 507
+ ILV + ++ DFG+A L+ SS S+FV G ++APE + K D
Sbjct: 129 AANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV----GTPYWMAPEVITEGKYYDTKAD 184
Query: 508 VYGIGVVLLELAGFKGN 524
++ +G+ + E+A GN
Sbjct: 185 IWSLGITIYEMA--TGN 199
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 51/187 (27%), Positives = 81/187 (43%), Gaps = 22/187 (11%)
Query: 342 KAMLPD-GSVLAVKRLNTCKLGEK-KFRNEMNR--LGQLRHPNLAPLLGYCVVEEEKL-L 396
K PD G + A+K L L + + R +M R L ++ HP + L Y E KL L
Sbjct: 17 KITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL-HYAFQTEGKLYL 75
Query: 397 IYKYMSSGTLYSLLQGNA--TELD---WPTRFRIGLGAARGLAWLHHGCQPPFLHQNICS 451
I ++ G L++ L TE D + + L L ++ +P +NI
Sbjct: 76 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKP----ENI-- 129
Query: 452 NVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGI 511
L+DE+ ++ DFGL+K S D G Y+APE + + D +
Sbjct: 130 ---LLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSF 184
Query: 512 GVVLLEL 518
GV++ E+
Sbjct: 185 GVLMFEM 191
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 39/152 (25%), Positives = 67/152 (44%), Gaps = 10/152 (6%)
Query: 369 EMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLG 428
E L RHP L L ++ + +Y++ G L+ L + TRF G
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAE 103
Query: 429 AARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAK--LMTSSDESSFVNGDL 486
L +LH G +++++ +++D+D +I DFGL K + ++ +F
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC---- 156
Query: 487 GEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
G Y+APE D +G+GVV+ E+
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 188
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 30/114 (26%), Positives = 51/114 (44%), Gaps = 16/114 (14%)
Query: 360 KLGEKKFRNEMNR-------LGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQ- 411
K+ +K RN + QL H +L G CV +E +++ +Y+ G+L + L+
Sbjct: 33 KVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKK 92
Query: 412 -GNATELDWPTRFRIGLGAARGLAW-LHHGCQPPFLHQNICSNVILVDEDFDAR 463
N + W L A+ LAW LH H N+C+ +L+ + D +
Sbjct: 93 NKNLINISWK------LEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRK 140
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.003
Identities = 40/138 (28%), Positives = 68/138 (49%), Gaps = 36/138 (26%)
Query: 431 RGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFG 490
RGL ++H +H+++ + I V+ED + +I+DFGLA+ T + + +V
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLAR-HTDDEMTGYV----ATRW 180
Query: 491 YIAPE-------YSSTMVASLKGDVYGIGVVLLEL----AGFKGNLVDWVNQLSSSGRSK 539
Y APE Y+ T+ D++ +G ++ EL F G+ D ++QL K
Sbjct: 181 YRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGKTLFPGS--DHIDQL------K 226
Query: 540 EAIDKALCGKGYDEEILQ 557
++ L G DEE+LQ
Sbjct: 227 RIMN--LVGTP-DEELLQ 241
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.003
Identities = 30/120 (25%), Positives = 63/120 (52%), Gaps = 7/120 (5%)
Query: 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDED 459
+M G+L +L+ A + +I + RGL +L + +H+++ + ILV+
Sbjct: 80 HMDGGSLDQVLK-KAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSR 136
Query: 460 FDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELA 519
+ ++ DFG++ + S +SFV G Y++PE +++ D++ +G+ L+E+A
Sbjct: 137 GEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMA 192
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 27/99 (27%), Positives = 51/99 (51%), Gaps = 12/99 (12%)
Query: 424 RIGLGAARGLAWL---HHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480
+I + GL +L H +H++I + ILV+ ++ DFG++ + +S +
Sbjct: 107 KIAVAVVEGLTYLYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT 161
Query: 481 FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELA 519
FV G Y++PE ++K DV+ +G+ ++ELA
Sbjct: 162 FV----GTSTYMSPERIQGGKYTVKSDVWSLGISIIELA 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 44/177 (24%), Positives = 74/177 (41%), Gaps = 13/177 (7%)
Query: 348 GSVLAVKRLNTCKL----GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL-LIYKYMS 402
G + A K+L+ +L GE+ NE L ++ + L Y ++ L L+ M+
Sbjct: 18 GKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-AYAFETKDDLCLVMTLMN 76
Query: 403 SGTL-YSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFD 461
G L Y + R AA+ + L H Q +++++ +L+D+ +
Sbjct: 77 GGDLKYHIYNVGEPGFPEA---RAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN 133
Query: 462 ARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
RI D GLA + + G G GY+APE V D + +G L E+
Sbjct: 134 VRISDLGLAVELK---GGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEM 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 611 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.68 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.68 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.55 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.34 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.33 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.31 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.16 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.11 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.09 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.07 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.98 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.98 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.94 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.93 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.9 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.86 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.85 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.84 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.82 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.8 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.79 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.78 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.78 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.78 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.74 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.71 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.65 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.63 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.61 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.6 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.54 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.52 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.49 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.49 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.48 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.48 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.48 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.46 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.4 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.39 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.31 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.29 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.27 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.27 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.26 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.22 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.21 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.18 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.17 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.13 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.13 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.1 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.09 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.09 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.05 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.03 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.03 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.99 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 97.94 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.92 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.89 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-60 Score=568.03 Aligned_cols=461 Identities=30% Similarity=0.518 Sum_probs=351.9
Q ss_pred CcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccc
Q 035917 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
..+..|+|++|+++|.+|..+.++++|+.|+|++|++.|.+|..+.. +++|+.|+|++|.++|.+|..++++++|+.|+
T Consensus 475 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 553 (968)
T PLN00113 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSS-CKKLVSLDLSHNQLSGQIPASFSEMPVLSQLD 553 (968)
T ss_pred ccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcC-ccCCCEEECCCCcccccCChhHhCcccCCEEE
Confidence 35788999999999999999999999999999999999999999988 99999999999999999999999999999999
Q ss_pred ccccccCCCCChhhhcCCCcccccccccccCCCCCcc--CCCCCcccCCCCCCCCCCCCC---CCcCCCCCc-chhhhhh
Q 035917 176 LSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSS--FKGFDKADFDGNSDLCGGPLG---SKCGGLSKK-NLAIIIA 249 (611)
Q Consensus 176 L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~--~~~~~~~~~~~n~~lc~~~~~---~~c~~~~~~-~~~~ii~ 249 (611)
|++|+++|.+|..+.++++|+.|++++|+++|.+|.. +..+....+.||+.+|+++.. ++|...... ....+++
T Consensus 554 Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~ 633 (968)
T PLN00113 554 LSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYIT 633 (968)
T ss_pred CCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehh
Confidence 9999999999999999999999999999999999964 456667788999999986532 356432111 1122222
Q ss_pred hhHHHHHHHHHHHHHHHHHhhhhhccccccCcccccCCCChhhHHhhhcccccchhccc-cCcccccHHHHHHhhhcCCC
Q 035917 250 AGIFGAAASMLLAFGLWWWYHLRWVRRRKRGYGIGRDDDDSRWLERLRSHKLAQVSLFQ-KPLVKVKLADLMAASNSFCS 328 (611)
Q Consensus 250 ~~v~~~~~~~l~~~~l~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~t~~f~~ 328 (611)
+++ ++++++++++++++ +.+++++.+.+.. ..+...|. ...+. .....++++++. ..|..
T Consensus 634 ~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~----~~~~~~~~----------~~~~~~~~~~~~~~~~~~---~~~~~ 694 (968)
T PLN00113 634 CTL-GAFLVLALVAFGFV-FIRGRNNLELKRV----ENEDGTWE----------LQFFDSKVSKSITINDIL---SSLKE 694 (968)
T ss_pred HHH-HHHHHHHHHHHHHH-HHHhhhccccccc----cccccccc----------ccccccccchhhhHHHHH---hhCCc
Confidence 222 22222222222222 2222111111100 00011111 01111 111224445543 45778
Q ss_pred CCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCChH
Q 035917 329 ENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLY 407 (611)
Q Consensus 329 ~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL~ 407 (611)
.++||+|+||.||+|+. .++..||||+++..... ...|++++++++|||||+++|+|.+++..++||||+++|+|.
T Consensus 695 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~ 771 (968)
T PLN00113 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLS 771 (968)
T ss_pred ccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHH
Confidence 89999999999999996 57999999998653322 235688999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccCCCc
Q 035917 408 SLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLG 487 (611)
Q Consensus 408 ~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 487 (611)
++++ .++|..+.+|+.|+++||+|||+.++++|+|||+||+||+++.++.+++. ||.+...... ....|
T Consensus 772 ~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~ 840 (968)
T PLN00113 772 EVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFI 840 (968)
T ss_pred HHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------CCccc
Confidence 9996 38999999999999999999998778899999999999999999988876 6665543211 12258
Q ss_pred ccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCH----------HHHHHHHhhcCChhhhhchhhcC--CCCHHHH
Q 035917 488 EFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNL----------VDWVNQLSSSGRSKEAIDKALCG--KGYDEEI 555 (611)
Q Consensus 488 t~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~----------~~~~~~~~~~~~~~~~~~~~l~~--~~~~~~~ 555 (611)
|+.|+|||++.+..++.|+|||||||++|||++|+.|+ .+|.............+|+.+.. ....+++
T Consensus 841 t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (968)
T PLN00113 841 SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEI 920 (968)
T ss_pred cccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHH
Confidence 89999999999999999999999999999999998875 23444333333344445555433 2345677
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
.++.+++.+||+.||++||+|.||+++|+++.+..
T Consensus 921 ~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 921 VEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred HHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 78889999999999999999999999999987754
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-57 Score=476.62 Aligned_cols=278 Identities=46% Similarity=0.776 Sum_probs=248.4
Q ss_pred CcccccHHHHHHhhhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchh-HHHHHHHHHHHhccCCCCccceeeEE
Q 035917 310 PLVKVKLADLMAASNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLG-EKKFRNEMNRLGQLRHPNLAPLLGYC 388 (611)
Q Consensus 310 ~~~~~~~~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~-~~~~~~Ev~~l~~l~H~nIv~l~g~~ 388 (611)
....|++.++..||++|+..++||+|+||.||+|.+++|+.||||++...... .++|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45579999999999999999999999999999999999999999998765544 66799999999999999999999999
Q ss_pred EeCC-eeEEEEeccCCCChHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEee
Q 035917 389 VVEE-EKLLIYKYMSSGTLYSLLQGNAT-ELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMD 466 (611)
Q Consensus 389 ~~~~-~~~lv~ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~D 466 (611)
.+.+ +.+||||||++|+|.++|+.... +++|..|++||.++|+||+|||+.|.++|+||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 59999999999999999998765 899999999999999999999999889999999999999999999999999
Q ss_pred cccccccCCCCCCccccCC-CcccccccccccCCCCCCcccchHHHHHHHHHHhCCCC-----------CHHHHHHHHhh
Q 035917 467 FGLAKLMTSSDESSFVNGD-LGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKG-----------NLVDWVNQLSS 534 (611)
Q Consensus 467 FGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~-----------~~~~~~~~~~~ 534 (611)
||+|+...... ...... .||.+|+|||++..+..++|+|||||||+|+||++|+. .+.+|......
T Consensus 221 FGLa~~~~~~~--~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 221 FGLAKLGPEGD--TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred ccCcccCCccc--cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 99997664311 111112 69999999999999999999999999999999998874 26789888888
Q ss_pred cCChhhhhchhhc-CCCCH-HHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 535 SGRSKEAIDKALC-GKGYD-EEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 535 ~~~~~~~~~~~l~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
.....+++|+.+. ..+.. +++.++..+|.+|++.+|++||+|.||+++|+.+...
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 8899999999987 44444 6899999999999999999999999999999766544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-48 Score=401.60 Aligned_cols=255 Identities=29% Similarity=0.409 Sum_probs=205.9
Q ss_pred CCCeeeecCCceEEEEEeCCCCEEEEEeccccchh---HHHHHHHHHHHhccCCCCccceeeEEEeCC-eeEEEEeccCC
Q 035917 328 SENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLG---EKKFRNEMNRLGQLRHPNLAPLLGYCVVEE-EKLLIYKYMSS 403 (611)
Q Consensus 328 ~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~---~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~-~~~lv~ey~~~ 403 (611)
..+.||+|+||+||+|.+.....||||++.....+ .++|.+|+.+|.+++|||||+++|+|.++. ..++|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 34569999999999999965555999999764433 458999999999999999999999999887 78999999999
Q ss_pred CChHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-eeecCCCCCeEEeCCCC-CeEEeecccccccCCCCCCc
Q 035917 404 GTLYSLLQGN-ATELDWPTRFRIGLGAARGLAWLHHGCQPP-FLHQNICSNVILVDEDF-DARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 404 gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHrDlkp~NILld~~~-~~kl~DFGla~~~~~~~~~~ 480 (611)
|+|.+++++. ...+++..+++++.|||+||.||| +.+ ||||||||+|||++.++ ++||+|||+++...... .
T Consensus 125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~ 199 (362)
T KOG0192|consen 125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T 199 (362)
T ss_pred CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence 9999999873 568999999999999999999999 566 99999999999999997 99999999998765321 2
Q ss_pred cccCCCcccccccccccC--CCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHH
Q 035917 481 FVNGDLGEFGYIAPEYSS--TMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQF 558 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~--~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 558 (611)
..+...||+.|||||++. ...|+.|+|||||||++|||++++.||.+...... ...++....+..........+
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~----~~~v~~~~~Rp~~p~~~~~~l 275 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV----ASAVVVGGLRPPIPKECPPHL 275 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH----HHHHHhcCCCCCCCccCCHHH
Confidence 223356999999999999 56899999999999999999999998854322111 111111112222222233445
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 559 LKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 559 ~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
..++.+||+.||+.||++.+|+..|+.+.....
T Consensus 276 ~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 276 SSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred HHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 555559999999999999999999999887654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=378.80 Aligned_cols=249 Identities=26% Similarity=0.362 Sum_probs=209.2
Q ss_pred ccHHHHHHhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccc--cchhHHHHHHHHHHHhccCCCCccceeeEEEe
Q 035917 314 VKLADLMAASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNT--CKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVV 390 (611)
Q Consensus 314 ~~~~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~--~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~ 390 (611)
++..|++. .+.||+|..|+|||+++ ++++.+|+|.+.. +....+++.+|++++++.+||+||.++|.|..
T Consensus 76 i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 55666655 36899999999999996 4689999999943 34456889999999999999999999999999
Q ss_pred CC-eeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccc
Q 035917 391 EE-EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGL 469 (611)
Q Consensus 391 ~~-~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGl 469 (611)
++ ...++||||.+|||.+++... +.+++...-+|+.+|++||.|||+ +++||||||||+|||++..|++||||||.
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccc
Confidence 98 599999999999999999865 458999999999999999999995 48999999999999999999999999999
Q ss_pred ccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCCh----hhhhc--
Q 035917 470 AKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRS----KEAID-- 543 (611)
Q Consensus 470 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~----~~~~~-- 543 (611)
++.+... ...+.+||..|||||.+.+..|+.++||||||+.++|++.|+.|+..- ....... ..+++
T Consensus 226 S~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~---~~~~~~~~~Ll~~Iv~~p 298 (364)
T KOG0581|consen 226 SGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP---NPPYLDIFELLCAIVDEP 298 (364)
T ss_pred cHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc---CCCCCCHHHHHHHHhcCC
Confidence 9987543 345678999999999999999999999999999999999999886431 0000111 12222
Q ss_pred -hhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 544 -KALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 544 -~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
|.+....+++++..|+. .|++.||.+||+++|+++|
T Consensus 299 pP~lP~~~fS~ef~~FV~---~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 299 PPRLPEGEFSPEFRSFVS---CCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCCcccCCHHHHHHHH---HHhcCCcccCCCHHHHhcC
Confidence 22323347788888888 9999999999999999988
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=383.22 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=206.9
Q ss_pred CeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCChHHh
Q 035917 330 NVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSL 409 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL~~~ 409 (611)
+.||+|.||.||.|.+.....||+|.++......++|.+|+++|++|+|+|||+++|+|..++..+||||||+.|+|.++
T Consensus 212 ~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~y 291 (468)
T KOG0197|consen 212 RELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDY 291 (468)
T ss_pred HHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHH
Confidence 57999999999999998888999999988777889999999999999999999999999998899999999999999999
Q ss_pred hhc-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccCCCcc
Q 035917 410 LQG-NATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGE 488 (611)
Q Consensus 410 l~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 488 (611)
|.. .+..+...+.+.++.|||+||+||+ ++++|||||.++|||++++..+||+||||||...++. .....+..-+
T Consensus 292 Lr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~~~~~~kfP 367 (468)
T KOG0197|consen 292 LRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YTASEGGKFP 367 (468)
T ss_pred hhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCc-eeecCCCCCC
Confidence 986 3357899999999999999999999 8999999999999999999999999999999554333 3333333456
Q ss_pred cccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHHhhccc
Q 035917 489 FGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVV 567 (611)
Q Consensus 489 ~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~ 567 (611)
..|.|||.+...+++.|||||||||+||||+| |+.|+..+... .+.+.++...+-..++.+...+.+|+..||+
T Consensus 368 IkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~-----ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~ 442 (468)
T KOG0197|consen 368 IKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE-----EVLELLERGYRLPRPEGCPDEVYELMKSCWH 442 (468)
T ss_pred ceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH-----HHHHHHhccCcCCCCCCCCHHHHHHHHHHhh
Confidence 78999999999999999999999999999997 45554332211 1122222222222233334445556669999
Q ss_pred CCCCCCCCHHHHHHHHHHchhh
Q 035917 568 SRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 568 ~dP~~RPs~~evl~~L~~i~~~ 589 (611)
.+|++|||++.+...|+++...
T Consensus 443 ~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 443 EDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCcccCCCHHHHHHHHHHhhhc
Confidence 9999999999999999887654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=380.62 Aligned_cols=247 Identities=20% Similarity=0.272 Sum_probs=210.2
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccc----cchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNT----CKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~----~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
..|..+++||+|+|+.+|+++. ..|+.||+|++.+ .....++..+||++.+.|+|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688899999999999999996 8899999999976 3345678999999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
|+|++|+|.++++ .++++++.+++.+..||+.||.||| +.+|+|||||..|+++++++++||+|||||..+..+..
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 9999999999998 4467999999999999999999999 88999999999999999999999999999998864421
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHH-HHHHhhcCChhhhhchhhcCCCCHHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDW-VNQLSSSGRSKEAIDKALCGKGYDEEILQ 557 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 557 (611)
...+.+|||.|+|||++.....+..+||||+|||+|-|+.|++||..- +......-. .-+. ..+...+.++.+
T Consensus 174 --rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik---~~~Y-~~P~~ls~~A~d 247 (592)
T KOG0575|consen 174 --RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK---LNEY-SMPSHLSAEAKD 247 (592)
T ss_pred --ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH---hcCc-ccccccCHHHHH
Confidence 223458999999999999888999999999999999999999998542 111111100 0111 122345677778
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWSMYQVYQSL 583 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~~evl~~L 583 (611)
++. ++|+.||.+|||+++|+.|=
T Consensus 248 LI~---~lL~~~P~~Rpsl~~vL~h~ 270 (592)
T KOG0575|consen 248 LIR---KLLRPNPSERPSLDEVLDHP 270 (592)
T ss_pred HHH---HHhcCCcccCCCHHHHhcCH
Confidence 777 99999999999999999873
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=362.91 Aligned_cols=197 Identities=23% Similarity=0.306 Sum_probs=176.1
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
..+|.....||+|+||+||+|++ +++..||||.+.+.. ...+-+..|+.+|+.++|||||++++++..++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 34677777899999999999996 468999999997653 33466889999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCC------CCeEEeecccccc
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDED------FDARIMDFGLAKL 472 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~------~~~kl~DFGla~~ 472 (611)
|||.+|||.+|++.++ .+++...+.++.|+|.||++|| +++||||||||+||||+.. -.+||+|||+|+.
T Consensus 89 EyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999998764 5999999999999999999999 8999999999999999764 4689999999999
Q ss_pred cCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHH
Q 035917 473 MTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLV 526 (611)
Q Consensus 473 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~ 526 (611)
+.... ...+.+|++.|||||++..++|+.|+|+||.|+|||++++|+.||.
T Consensus 165 L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 165 LQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred CCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 86433 2334579999999999999999999999999999999999999985
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=364.35 Aligned_cols=245 Identities=24% Similarity=0.311 Sum_probs=197.7
Q ss_pred hcCCCCCeeeecCCceEEEEE-eCCCCEEEEEeccccchh--------HHHHHHHHHHHhccCCCCccceeeEEEeCCee
Q 035917 324 NSFCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCKLG--------EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~~~--------~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~ 394 (611)
+.|...+.||+|+||.|-+|. ..+|+.||||++++.... ....++|+++|++++|||||++++++..++..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 345667899999999999998 568999999999764321 23467999999999999999999999999999
Q ss_pred EEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCC---CCeEEeeccccc
Q 035917 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDED---FDARIMDFGLAK 471 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~---~~~kl~DFGla~ 471 (611)
|+||||++||+|.+.+-.++ .+.+..-+.++.|++.|+.||| +.||+||||||+|||+..+ ..+||+|||+|+
T Consensus 252 YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred EEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 99999999999999987653 4667777889999999999999 8999999999999999755 789999999999
Q ss_pred ccCCCCCCccccCCCcccccccccccCCCCC---CcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhch-h--
Q 035917 472 LMTSSDESSFVNGDLGEFGYIAPEYSSTMVA---SLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDK-A-- 545 (611)
Q Consensus 472 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~-~-- 545 (611)
.... ...+.+.+||+.|.|||++.+..+ ..|.|+||+|||||-+++|..||.+..... ...+.+-. .
T Consensus 328 ~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~----sl~eQI~~G~y~ 400 (475)
T KOG0615|consen 328 VSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP----SLKEQILKGRYA 400 (475)
T ss_pred cccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc----cHHHHHhcCccc
Confidence 8752 345566789999999999876543 347899999999999999999986532111 01111111 0
Q ss_pred ---hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 546 ---LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 546 ---l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
......+++...+++ ++|..||++|||+.|+++|
T Consensus 401 f~p~~w~~Iseea~dlI~---~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 401 FGPLQWDRISEEALDLIN---WMLVVDPENRPSADEALNH 437 (475)
T ss_pred ccChhhhhhhHHHHHHHH---HhhEeCcccCcCHHHHhcC
Confidence 111223556666666 9999999999999999987
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=350.64 Aligned_cols=254 Identities=20% Similarity=0.326 Sum_probs=198.0
Q ss_pred cCCCCCeeeecCCceEEEEE-eCCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeE-EEeCCe-eEEEE
Q 035917 325 SFCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGY-CVVEEE-KLLIY 398 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~-~~~~~~-~~lv~ 398 (611)
+|.+.++||+|.||.|||+. +.+|..||.|.++-.. ...++...|+.+|++|+|||||+++++ +.++++ .+|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 45556789999999999998 6899999999997433 344678999999999999999999994 444444 78999
Q ss_pred eccCCCChHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCeEEeCCCCCeEEeeccccccc
Q 035917 399 KYMSSGTLYSLLQG---NATELDWPTRFRIGLGAARGLAWLHHGCQPP--FLHQNICSNVILVDEDFDARIMDFGLAKLM 473 (611)
Q Consensus 399 ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlkp~NILld~~~~~kl~DFGla~~~ 473 (611)
|||..|||..+++. ....+++..+++++.|++.||..+|... ++ |+||||||.||+++.+|.+||+|||+++.+
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999998853 2346899999999999999999999421 44 999999999999999999999999999988
Q ss_pred CCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHH
Q 035917 474 TSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDE 553 (611)
Q Consensus 474 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 553 (611)
... .+...+.+|||.||+||.+.+..|+.||||||+||++|||+.-..||...... .....+...--+.+....++.
T Consensus 179 ~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~-~L~~KI~qgd~~~~p~~~YS~ 255 (375)
T KOG0591|consen 179 SSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL-SLCKKIEQGDYPPLPDEHYST 255 (375)
T ss_pred cch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH-HHHHHHHcCCCCCCcHHHhhh
Confidence 543 34445678999999999999999999999999999999999888887532100 000011111011122244555
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 035917 554 EILQFLKVACNCVVSRPKDRWSMYQVYQSLNS 585 (611)
Q Consensus 554 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 585 (611)
.+..++. .|+..||+.||+...+++.+..
T Consensus 256 ~l~~li~---~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 256 DLRELIN---MCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHHHHHH---HHccCCcccCCCcchHHHHHHH
Confidence 6666555 9999999999986555555443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=381.71 Aligned_cols=256 Identities=25% Similarity=0.337 Sum_probs=209.0
Q ss_pred CCCeeeecCCceEEEEEeC------CCCEEEEEeccccch--hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 328 SENVIISTRTGTTYKAMLP------DGSVLAVKRLNTCKL--GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 328 ~~~~ig~G~~g~Vy~~~~~------~g~~vAvK~~~~~~~--~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
..+.||+|.||+||+|+.. +...||||.++.... ..++|++|++++..++|||||+|+|+|..++..++|+|
T Consensus 490 ~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFE 569 (774)
T KOG1026|consen 490 FKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFE 569 (774)
T ss_pred ehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEE
Confidence 3467999999999999943 457899999987543 45789999999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEee
Q 035917 400 YMSSGTLYSLLQGNA-------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMD 466 (611)
Q Consensus 400 y~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~D 466 (611)
||..|||.++|.... .+++-.+.+.||.|||.||+||- +..+|||||..+|+|+.++..+||+|
T Consensus 570 Ym~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VKIsD 646 (774)
T KOG1026|consen 570 YMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVKISD 646 (774)
T ss_pred ecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEEecc
Confidence 999999999996321 13888999999999999999999 88999999999999999999999999
Q ss_pred cccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchh
Q 035917 467 FGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKA 545 (611)
Q Consensus 467 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (611)
||++|..-..+.+.......-+..|||||.+..++||++||||||||||||+++ |+.|+.....+. +.+.+...
T Consensus 647 fGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-----VIe~i~~g 721 (774)
T KOG1026|consen 647 FGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-----VIECIRAG 721 (774)
T ss_pred cccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-----HHHHHHcC
Confidence 999997765554433323345789999999999999999999999999999995 566765432221 11122111
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 546 LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 546 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
-.-..++.+...+.+|+..||+.+|++||+++||-..|+...+..+
T Consensus 722 ~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 722 QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 1123344555667777789999999999999999999998887643
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=366.06 Aligned_cols=278 Identities=23% Similarity=0.301 Sum_probs=216.3
Q ss_pred HHHHhhhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchh---HHHHHHHHHHHhccCCCCccceeeEEEeCCee
Q 035917 318 DLMAASNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLG---EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394 (611)
Q Consensus 318 ~l~~~t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~---~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~ 394 (611)
+...-.+.+...+.||+|+||+||||++. -.||||.++..... .+.|.+||..+++-||.||+-++|||..++.
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 33334445566789999999999999973 36999999765433 3679999999999999999999999998877
Q ss_pred EEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccC
Q 035917 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~ 474 (611)
.+|..+|+|-+|+.+++.....++..+...||.|||+||.||| .++|||||||+.||++.+++++||+||||+..-.
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 9999999999999999987778999999999999999999999 8999999999999999999999999999997543
Q ss_pred CCCCCccccCCCcccccccccccCC---CCCCcccchHHHHHHHHHHhCCCCCHHHHHHHH--hhcCChhhhhchhhcCC
Q 035917 475 SSDESSFVNGDLGEFGYIAPEYSST---MVASLKGDVYGIGVVLLELAGFKGNLVDWVNQL--SSSGRSKEAIDKALCGK 549 (611)
Q Consensus 475 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~ 549 (611)
.-..........|...|||||+++. .+|++.+||||||+|+|||++|..||..-..+. ...++-.-..|......
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s 619 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRS 619 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhc
Confidence 2222222233458899999998764 468999999999999999999998874211110 00111101111111122
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCCCCCCCCcccccc
Q 035917 550 GYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFSERYDEFPLIFH 604 (611)
Q Consensus 550 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~~~ 604 (611)
..++++++ |+..||..++++||.+.+|+..|+++....+-..+....|-...
T Consensus 620 ~~pk~mk~---Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~RS~S~P~~~~ 671 (678)
T KOG0193|consen 620 NCPKAMKR---LLSDCWKFDREERPLFPQLLSKLEELLPSLPKINRSASEPVLLR 671 (678)
T ss_pred cCHHHHHH---HHHHHHhcCcccCccHHHHHHHHHHhhhcccccccCcCccchhh
Confidence 23344555 44599999999999999999999999998776677666665543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=349.04 Aligned_cols=255 Identities=24% Similarity=0.340 Sum_probs=203.3
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccch-hHHHHHHHHHHHhccCCCCccceeeEEEeCC--eeEEEEe
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKL-GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE--EKLLIYK 399 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~--~~~lv~e 399 (611)
.+|...+.||+|+||.||.+... +|...|||.+..... ..+.+.+|+.+|.+++|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 35667799999999999999965 499999999865421 1456899999999999999999999855544 5889999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC-CCCeEEeecccccccCCCC-
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE-DFDARIMDFGLAKLMTSSD- 477 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~-~~~~kl~DFGla~~~~~~~- 477 (611)
|+++|+|.+++.+.+..+++..+.++.+||++||+||| +++|+||||||+|||++. ++.+||+|||+++......
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 99999999999876557999999999999999999999 899999999999999999 7999999999998765311
Q ss_pred CCccccCCCcccccccccccCCCC-CCcccchHHHHHHHHHHhCCCCCHHHH---HHHHhhcCChhhhhchhhcCCCCHH
Q 035917 478 ESSFVNGDLGEFGYIAPEYSSTMV-ASLKGDVYGIGVVLLELAGFKGNLVDW---VNQLSSSGRSKEAIDKALCGKGYDE 553 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~SfGvvl~ell~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~~~~~~ 553 (611)
.........||+.|||||++..+. ...++|||||||++.||+||+.|+.+. .......+... .-| ..+...++
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~--~~P-~ip~~ls~ 250 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED--SLP-EIPDSLSD 250 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC--CCC-CCCcccCH
Confidence 111223457999999999998533 335999999999999999999887653 11111111000 112 22334667
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHch
Q 035917 554 EILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIA 587 (611)
Q Consensus 554 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 587 (611)
+..+|+. +|+..||++||||.++++|.--..
T Consensus 251 ~a~~Fl~---~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 251 EAKDFLR---KCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred HHHHHHH---HHhhcCcccCcCHHHHhhChhhhc
Confidence 8888888 999999999999999999965443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=371.78 Aligned_cols=270 Identities=22% Similarity=0.304 Sum_probs=224.1
Q ss_pred ccHHHHHHhhhcCC---------CCCeeeecCCceEEEEEeC----CCCEEEEEecccc--chhHHHHHHHHHHHhccCC
Q 035917 314 VKLADLMAASNSFC---------SENVIISTRTGTTYKAMLP----DGSVLAVKRLNTC--KLGEKKFRNEMNRLGQLRH 378 (611)
Q Consensus 314 ~~~~~l~~~t~~f~---------~~~~ig~G~~g~Vy~~~~~----~g~~vAvK~~~~~--~~~~~~~~~Ev~~l~~l~H 378 (611)
++++|--.|...|. ++++||.|.||.||+|+++ ....||||.++.. .....+|+.|+.||+++.|
T Consensus 610 ~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdH 689 (996)
T KOG0196|consen 610 HTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 689 (996)
T ss_pred ccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCC
Confidence 56666555555443 5689999999999999974 2468999999864 3445789999999999999
Q ss_pred CCccceeeEEEeCCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC
Q 035917 379 PNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE 458 (611)
Q Consensus 379 ~nIv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~ 458 (611)
|||++|.|+.......++|.|||+||+|+.+|+.+.+.+.+.+...+.++||.||.||- ..++|||||..+|||++.
T Consensus 690 PNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNs 766 (996)
T KOG0196|consen 690 PNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNS 766 (996)
T ss_pred CcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeecc
Confidence 99999999999999999999999999999999988778999999999999999999999 899999999999999999
Q ss_pred CCCeEEeecccccccCCCCCC-ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHh-CCCCCHHHHHHHHhhcC
Q 035917 459 DFDARIMDFGLAKLMTSSDES-SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELA-GFKGNLVDWVNQLSSSG 536 (611)
Q Consensus 459 ~~~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell-~~~~~~~~~~~~~~~~~ 536 (611)
+..+||+|||+++.+.++... ....+-.-+..|.|||.+...++|.++|||||||||||.+ .|+.|+-+|..+..
T Consensus 767 nLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV--- 843 (996)
T KOG0196|consen 767 NLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV--- 843 (996)
T ss_pred ceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH---
Confidence 999999999999988654421 1111222357899999999999999999999999999988 47778877655432
Q ss_pred ChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 537 RSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 537 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
...++...+-..+.++...+.+||+.||+.|-.+||.+.+|+.+|+++.+...
T Consensus 844 --IkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 844 --IKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred --HHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 22333333333455677788889999999999999999999999999887754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=340.07 Aligned_cols=247 Identities=21% Similarity=0.248 Sum_probs=203.2
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
.++|...++||+|+||.||.++. ++++.+|+|++++.. ...+....|..+|.+++||+||++...|.+++..|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 45788899999999999999995 569999999997654 2345688999999999999999999999999999999
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
+||+.||.|+.+|.+. +.+++..+.-++..|+.||.||| +.+||||||||+|||||.+|.++|+|||+++......
T Consensus 104 ld~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EeccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 9999999999999865 35888888889999999999999 8999999999999999999999999999999653332
Q ss_pred CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc-h-hhcCCCCHHHH
Q 035917 478 ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID-K-ALCGKGYDEEI 555 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~-~-~l~~~~~~~~~ 555 (611)
....+.+||+.|||||++.+..|+..+|.||+||++|||++|..||..--.... ...+.. + ...+...+.+.
T Consensus 180 --~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~----~~~I~~~k~~~~p~~ls~~a 253 (357)
T KOG0598|consen 180 --DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM----YDKILKGKLPLPPGYLSEEA 253 (357)
T ss_pred --CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH----HHHHhcCcCCCCCccCCHHH
Confidence 222346899999999999999999999999999999999999999843111100 011111 1 12233467788
Q ss_pred HHHHHHHhhcccCCCCCCC----CHHHHHHH
Q 035917 556 LQFLKVACNCVVSRPKDRW----SMYQVYQS 582 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RP----s~~evl~~ 582 (611)
+++++ +.+..||++|. .+.+|-+|
T Consensus 254 rdll~---~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 254 RDLLK---KLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred HHHHH---HHhccCHHHhcCCCCChHHhhcC
Confidence 88888 99999999996 56665544
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=357.22 Aligned_cols=260 Identities=20% Similarity=0.281 Sum_probs=198.2
Q ss_pred hhcCCCCCeeeecCCceEEEEEe------CCCCEEEEEeccccc--hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCC-
Q 035917 323 SNSFCSENVIISTRTGTTYKAML------PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEE- 392 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~------~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~- 392 (611)
.++|...+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|+.++.++ +||||++++++|...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 35678889999999999999973 235789999997532 2345789999999999 8999999999987654
Q ss_pred eeEEEEeccCCCChHHhhhcCC----------------------------------------------------------
Q 035917 393 EKLLIYKYMSSGTLYSLLQGNA---------------------------------------------------------- 414 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~~~---------------------------------------------------------- 414 (611)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 5789999999999999886421
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccCCCccccc
Q 035917 415 ---TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGY 491 (611)
Q Consensus 415 ---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 491 (611)
..+++..+..++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 24778889999999999999999 789999999999999999999999999999865432222222223467889
Q ss_pred ccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCC
Q 035917 492 IAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRP 570 (611)
Q Consensus 492 ~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP 570 (611)
+|||++.+..++.++|||||||++|||++ |..||..............+..... .....++ .+.+++.+||+.||
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~l~~li~~cl~~dp 318 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR-APENATP---EIYRIMLACWQGDP 318 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC-CCCCCCH---HHHHHHHHHccCCh
Confidence 99999998899999999999999999996 7777643110000000000000000 1112233 34556669999999
Q ss_pred CCCCCHHHHHHHHHHchhh
Q 035917 571 KDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 571 ~~RPs~~evl~~L~~i~~~ 589 (611)
++|||+.|+++.|+++.++
T Consensus 319 ~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 319 KERPTFSALVEILGDLLQE 337 (338)
T ss_pred hhCcCHHHHHHHHHHHHhc
Confidence 9999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=341.66 Aligned_cols=253 Identities=21% Similarity=0.336 Sum_probs=201.8
Q ss_pred hhcCCCCCeeeecCCceEEEEE-eCCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 323 SNSFCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
.+.|...++||.|..++||+|+ .+.++.||||+++..+ .+-+.+++|+..|+.++||||++++..|..+...|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 3467788999999999999999 5778999999997543 334789999999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 400 YMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 400 y~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||.+||+.++++... ..+++..+..|.+++++||.||| +.|.||||||+.|||||.+|.+||+|||.+..+.....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 999999999997543 35999999999999999999999 89999999999999999999999999998876654431
Q ss_pred -Cccc-cCCCcccccccccccC--CCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHh----hcCChhh----hhchhh
Q 035917 479 -SSFV-NGDLGEFGYIAPEYSS--TMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLS----SSGRSKE----AIDKAL 546 (611)
Q Consensus 479 -~~~~-~~~~gt~~y~aPE~~~--~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~----~~~~~~~----~~~~~l 546 (611)
.... ...+||+.|||||++. ...|+.|+||||||++..||++|..||.++-...+ -.+.... ..+..
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d- 260 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKD- 260 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChH-
Confidence 1111 5568999999999853 34599999999999999999999998865422111 0111100 00100
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 547 CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 547 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
....++..++++ +..|++.||++|||+++++++
T Consensus 261 ~~k~~~ksf~e~---i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 261 EDKKFSKSFREM---IALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred HhhhhcHHHHHH---HHHHhhcCcccCCCHHHHhcc
Confidence 011223344444 449999999999999999987
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=355.46 Aligned_cols=247 Identities=22% Similarity=0.315 Sum_probs=206.2
Q ss_pred cCCCCCeeeecCCceEEEEE-eCCCCEEEEEeccccchhH-HHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccC
Q 035917 325 SFCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCKLGE-KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~~~~-~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
.|..-..||+|..|.||.|+ ..+++.||||++....... +-+.+|+.+|+..+|+|||.+++.|..+++.|+|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 45556789999999999998 6679999999998765544 457999999999999999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccc
Q 035917 403 SGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482 (611)
Q Consensus 403 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 482 (611)
+|+|.|++... .+++.++..|++++++||+||| ..+|+|||||.+|||++.++.+||+|||++..+..... ..
T Consensus 354 ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR 426 (550)
T KOG0578|consen 354 GGSLTDVVTKT--RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KR 426 (550)
T ss_pred CCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--cc
Confidence 99999999754 4899999999999999999999 89999999999999999999999999999987754332 23
Q ss_pred cCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhc-CCCCHHHHHHHHHH
Q 035917 483 NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALC-GKGYDEEILQFLKV 561 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~l~~l 561 (611)
.+.+||++|||||+.....|++|.||||||++++||+.|+.||..- ..+..-..+...-.+.+. .+..+.++++|++
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE-~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~- 504 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE-NPLRALYLIATNGTPKLKNPEKLSPELKDFLD- 504 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC-ChHHHHHHHhhcCCCCcCCccccCHHHHHHHH-
Confidence 4557999999999999999999999999999999999999987420 000000011111122221 2345678888888
Q ss_pred HhhcccCCCCCCCCHHHHHHH
Q 035917 562 ACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 562 ~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+||+.|+++||++.|+++|
T Consensus 505 --~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 505 --RCLVVDVEQRASAKELLEH 523 (550)
T ss_pred --HHhhcchhcCCCHHHHhcC
Confidence 9999999999999999988
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=354.76 Aligned_cols=243 Identities=23% Similarity=0.339 Sum_probs=198.7
Q ss_pred CCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCChHH
Q 035917 329 ENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYS 408 (611)
Q Consensus 329 ~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL~~ 408 (611)
.+-||+|+.|.||+|++. ++.||||+++.- -+.+|+.|++|+||||+.+.|+|.....+|||||||+.|-|+.
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~el------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVREL------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhh------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 367999999999999994 678999998542 2568899999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccCCCcc
Q 035917 409 LLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGE 488 (611)
Q Consensus 409 ~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 488 (611)
+|+.. .++.......+..+||.||.||| .+.|||||||+-||||..+..+||+|||.++...+. .....++||
T Consensus 202 VLka~-~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGT 274 (904)
T KOG4721|consen 202 VLKAG-RPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAGT 274 (904)
T ss_pred HHhcc-CccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhhh
Confidence 99865 35777888899999999999999 889999999999999999999999999999876432 233456899
Q ss_pred cccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHHhhcccC
Q 035917 489 FGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVS 568 (611)
Q Consensus 489 ~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~ 568 (611)
..|||||++...+.++|.||||||||||||+|++.||.+.....+.-+.-...+... .+...++.++-+++ +||+.
T Consensus 275 VaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lp-vPstcP~GfklL~K---qcw~s 350 (904)
T KOG4721|consen 275 VAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLP-VPSTCPDGFKLLLK---QCWNS 350 (904)
T ss_pred HhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCccccc-CcccCchHHHHHHH---HHHhc
Confidence 999999999999999999999999999999999999876433322111111111111 12233444555555 99999
Q ss_pred CCCCCCCHHHHHHHHHHchhh
Q 035917 569 RPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 569 dP~~RPs~~evl~~L~~i~~~ 589 (611)
.|..||++++|+.||+-...+
T Consensus 351 KpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 351 KPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred CCCCCccHHHHHHHHhhcCHH
Confidence 999999999999999865544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=348.42 Aligned_cols=252 Identities=23% Similarity=0.294 Sum_probs=208.0
Q ss_pred HhhhcCCCCCeeeecCCceEEEEE-eCCCCEEEEEeccccchh----HHHHHHHHHHHhcc-CCCCccceeeEEEeCCee
Q 035917 321 AASNSFCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCKLG----EKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEK 394 (611)
Q Consensus 321 ~~t~~f~~~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~~~----~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~ 394 (611)
+..++|..++.||.|+|++||+|+ ...++.||||++.+.-.- .+-+..|-.+|.+| .||.|++|+..|.++...
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 345678888999999999999999 567999999999654322 23467888999999 899999999999999999
Q ss_pred EEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccC
Q 035917 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~ 474 (611)
|+|+||+++|+|.+++++. +.+++...+.++.+|+.||+||| +.|||||||||+|||+|++|++||+|||-|+.+.
T Consensus 150 YFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 9999999999999999865 46899999999999999999999 8999999999999999999999999999999875
Q ss_pred CCCCC-----------ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc
Q 035917 475 SSDES-----------SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID 543 (611)
Q Consensus 475 ~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~ 543 (611)
..... ....+++||..|.+||++.....+..+|+|+|||+||+|+.|..||..--.-.. ...+++
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli----FqkI~~ 301 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI----FQKIQA 301 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH----HHHHHH
Confidence 43211 112457899999999999999999999999999999999999999854211111 111222
Q ss_pred hhh-cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 035917 544 KAL-CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSL 583 (611)
Q Consensus 544 ~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 583 (611)
-.. .++..++.+.++++ +.|..||++|+|.++|.+|.
T Consensus 302 l~y~fp~~fp~~a~dLv~---KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 302 LDYEFPEGFPEDARDLIK---KLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred hcccCCCCCCHHHHHHHH---HHHccCccccccHHHHhhCc
Confidence 111 13345567777777 99999999999999999883
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=325.88 Aligned_cols=252 Identities=19% Similarity=0.219 Sum_probs=196.0
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchh---HHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLG---EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
.|....++|+|+||+|||++. ++|+.||||++-.+..+ .+-.++|+++|++++|+|+|.++++|......+||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 455667899999999999995 46999999999665433 35578999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
|+. ++.+-|......++.....+++.|+++|+.|+| +.+++||||||+|||+..++.+||||||+|+.+.... .
T Consensus 83 ~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg--d 156 (396)
T KOG0593|consen 83 CDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG--D 156 (396)
T ss_pred cch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCc--c
Confidence 988 555555544456899999999999999999999 8999999999999999999999999999999886322 2
Q ss_pred cccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHH--HHHHHh-----------------hc-CChh
Q 035917 481 FVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVD--WVNQLS-----------------SS-GRSK 539 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~--~~~~~~-----------------~~-~~~~ 539 (611)
..+..+.|..|.|||.+.+ .+|+...||||.||++.||++|..-|+. .++++. .. ....
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 3345578999999998877 7899999999999999999998764321 111110 00 0111
Q ss_pred hhhch-----hhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 540 EAIDK-----ALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 540 ~~~~~-----~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+.-| ......++.-..-+++++..|++.||++|++-+|++.|
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11111 10111122222356777779999999999999999876
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=348.28 Aligned_cols=245 Identities=22% Similarity=0.321 Sum_probs=205.9
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhH---HHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGE---KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~---~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
++|...+.||+|+||.||||+. .+.+.||+|.+.+....+ +.+.+|++++++++|||||.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4677788999999999999994 568999999997765444 558999999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
|+.+ +|+.+|... +.+++..+..|+.+++.||.||| +.+|+|||+||.|||++..+.+|++|||+|+.+.. .+
T Consensus 82 ~a~g-~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NT 154 (808)
T ss_pred hhhh-hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc--Cc
Confidence 9987 999999866 46999999999999999999999 89999999999999999999999999999998754 33
Q ss_pred ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHH-HHHhhcCChhhhhchhhcCCCCHHHHHHH
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWV-NQLSSSGRSKEAIDKALCGKGYDEEILQF 558 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 558 (611)
...+...||+.|||||+..+.+|+..+|.||+||++||++.|+.||..-. ..+... . .-|+...+...+.+...+
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~-I---~~d~v~~p~~~S~~f~nf 230 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKS-I---LKDPVKPPSTASSSFVNF 230 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHH-H---hcCCCCCcccccHHHHHH
Confidence 44556679999999999999999999999999999999999999985321 111110 0 112222223344455566
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 035917 559 LKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 559 ~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++ ..+..||.+|.+-.+++.|
T Consensus 231 l~---gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 231 LQ---GLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HH---HHhhcChhhcccHHHHhcC
Confidence 66 9999999999999999887
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=344.22 Aligned_cols=251 Identities=25% Similarity=0.295 Sum_probs=198.0
Q ss_pred hcCCCCCeeeecCCceEEEEE-eCCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeC--CeeEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE--EEKLLI 397 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~--~~~~lv 397 (611)
+.|...+.||+|.||.||||+ ..+|+.||+|+++... ....-..+||.||++|+||||++|.+...+. ...|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 345555789999999999999 6789999999997543 2345678999999999999999999999876 689999
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
+|||+. ||.-++....-.++..++..++.|++.||+|+| ..+|+|||||.+|||||.+|.+||+|||||+++....
T Consensus 197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 999998 999998876667999999999999999999999 8999999999999999999999999999999886544
Q ss_pred CCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhh-cCChhh----------
Q 035917 478 ESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSS-SGRSKE---------- 540 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~-~~~~~~---------- 540 (611)
.. ..+..+-|..|.|||++.+ ..|+...|+||.||||.||+.|+..|.. ....+.. .+...+
T Consensus 273 ~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 273 SA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred Cc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 32 3456678999999998876 4699999999999999999988865431 1111110 111110
Q ss_pred --hhchh------hc--CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 541 --AIDKA------LC--GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 541 --~~~~~------l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+.+. +. ....+....++++ .+|..||.+|.|+.++++.
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~---~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLE---KLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHH---HHhccCccccccHHHHhcC
Confidence 01100 00 1122334444555 9999999999999998865
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=338.27 Aligned_cols=247 Identities=19% Similarity=0.273 Sum_probs=194.9
Q ss_pred CCeeeecCCceEEEEEeCCCCEEEEEeccccchh----HHHHHHHHHHHhccCCCCccceeeEEEe----CCeeEEEEec
Q 035917 329 ENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLG----EKKFRNEMNRLGQLRHPNLAPLLGYCVV----EEEKLLIYKY 400 (611)
Q Consensus 329 ~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~----~~~~~~Ev~~l~~l~H~nIv~l~g~~~~----~~~~~lv~ey 400 (611)
...||+|++|.||+|.+ +|+.||||+++..... .+.|.+|+.+|.+++|||||+++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 47899999999999998 7899999999764332 3567899999999999999999999977 3467899999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
+++|+|.+++... ..++|....+++.+++.||.|||. ..+++||||||+|||+++++.+||+|||+++.+....
T Consensus 104 ~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 104 CTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred CCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 9999999999764 468999999999999999999993 2478899999999999999999999999998654321
Q ss_pred cccCCCcccccccccccCC--CCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHH
Q 035917 481 FVNGDLGEFGYIAPEYSST--MVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQF 558 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 558 (611)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..................+.+ +...++++.++
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~l~~l 254 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL-PLDCPLEIKCI 254 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC-CCcCcHHHHHH
Confidence 12358899999999876 67999999999999999999999887432110000000000001111 11234455555
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHchh
Q 035917 559 LKVACNCVVSRPKDRWSMYQVYQSLNSIAA 588 (611)
Q Consensus 559 ~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 588 (611)
++ +||+.||++|||+.|+++.|+.+..
T Consensus 255 i~---~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 255 VE---ACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HH---HHhcCCcccCcCHHHHHHHHHHHHh
Confidence 55 9999999999999999999987653
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=344.63 Aligned_cols=253 Identities=19% Similarity=0.254 Sum_probs=197.7
Q ss_pred hcCCCCCeeeecCCceEEEEE-eCCCCEEEEEeccccchhHHH--HHHHHHHHhccC-CCCccceeeEEEeCC-eeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCKLGEKK--FRNEMNRLGQLR-HPNLAPLLGYCVVEE-EKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~~~~~~--~~~Ev~~l~~l~-H~nIv~l~g~~~~~~-~~~lv~ 398 (611)
+.|...+.||.|.||.||+|+ ..+|+.||||+++..-..-++ =++|++.|++|. |||||++.+++.+.+ ..++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 455666889999999999999 677999999999765443333 478999999998 999999999999888 899999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
|||+. +|++++++++..+++..++.|+.||++||+|+| .+|+.|||+||+|||+.....+||+|||+||.+.+...
T Consensus 90 E~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 90 EFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP 165 (538)
T ss_pred Hhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccCCC
Confidence 99987 999999988779999999999999999999999 89999999999999999888999999999998765443
Q ss_pred CccccCCCccccccccccc-CCCCCCcccchHHHHHHHHHHhCCCCCHH-----HHHHHHh-hcCC-----------hhh
Q 035917 479 SSFVNGDLGEFGYIAPEYS-STMVASLKGDVYGIGVVLLELAGFKGNLV-----DWVNQLS-SSGR-----------SKE 540 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~-~~~~~t~ksDV~SfGvvl~ell~~~~~~~-----~~~~~~~-~~~~-----------~~~ 540 (611)
.+..+.|..|+|||++ +.+-|+.+.||||+|||++|+.+-+.-|+ |.+..+. --+. ...
T Consensus 166 ---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 166 ---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred ---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 3445789999999975 56789999999999999999986554332 1111100 0000 000
Q ss_pred hhchh---hcCCC----CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 035917 541 AIDKA---LCGKG----YDEEILQFLKVACNCVVSRPKDRWSMYQVYQSL 583 (611)
Q Consensus 541 ~~~~~---l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 583 (611)
.+.-. ..+.. .+....+.++++.+|+.+||++|||+.|+++|-
T Consensus 243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 11000 00000 111234555666699999999999999999883
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=347.05 Aligned_cols=248 Identities=20% Similarity=0.255 Sum_probs=202.7
Q ss_pred hhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEecccc----c--hhHHHHHHHHHHHhccC-CCCccceeeEEEeCCe
Q 035917 322 ASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTC----K--LGEKKFRNEMNRLGQLR-HPNLAPLLGYCVVEEE 393 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~----~--~~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~~~ 393 (611)
..+.|...+.||+|.||+||.|+. .++..||+|+++.. . ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 456788889999999999999984 57899999977653 1 12456778999999999 9999999999999999
Q ss_pred eEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCC-CCeEEeecccccc
Q 035917 394 KLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDED-FDARIMDFGLAKL 472 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~-~~~kl~DFGla~~ 472 (611)
.++||||+.+|+|++++.. .+.+.+....+++.|++.|++|+| +.+|+||||||+|||+|.+ +++||+|||++..
T Consensus 95 ~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 9999999999999999987 456888999999999999999999 8999999999999999999 9999999999997
Q ss_pred cCCCCCCccccCCCcccccccccccCCCC-CC-cccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-hcCC
Q 035917 473 MTSSDESSFVNGDLGEFGYIAPEYSSTMV-AS-LKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-LCGK 549 (611)
Q Consensus 473 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~ 549 (611)
.. .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||.+-....... .+.... ..+.
T Consensus 171 ~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~----ki~~~~~~~p~ 244 (370)
T KOG0583|consen 171 SP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYR----KIRKGEFKIPS 244 (370)
T ss_pred cC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHH----HHhcCCccCCC
Confidence 73 1223345568999999999999877 75 78999999999999999999986521111100 011111 1122
Q ss_pred CC-HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 550 GY-DEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 550 ~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.. +.+...++. +|+..||.+|+++.+|+++
T Consensus 245 ~~~S~~~~~Li~---~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 245 YLLSPEARSLIE---KMLVPDPSTRITLLEILEH 275 (370)
T ss_pred CcCCHHHHHHHH---HHcCCCcccCCCHHHHhhC
Confidence 23 566666666 9999999999999999943
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=340.41 Aligned_cols=258 Identities=19% Similarity=0.278 Sum_probs=194.5
Q ss_pred hcCCCCCeeeecCCceEEEEEeCC-----------------CCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccce
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPD-----------------GSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPL 384 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~-----------------g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l 384 (611)
+.|...+.||+|+||.||+|.+.+ +..||+|.+.... ....+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 356778899999999999998532 3479999987532 234679999999999999999999
Q ss_pred eeEEEeCCeeEEEEeccCCCChHHhhhcCC------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 035917 385 LGYCVVEEEKLLIYKYMSSGTLYSLLQGNA------------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLH 446 (611)
Q Consensus 385 ~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 446 (611)
++++.+.+..++||||+++|+|.+++.... ..++|..+.+++.|++.||.||| +.+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 999999999999999999999999885321 24788899999999999999999 789999
Q ss_pred cCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC--CCCC
Q 035917 447 QNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG--FKGN 524 (611)
Q Consensus 447 rDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~--~~~~ 524 (611)
|||||+|||+++++.+||+|||+++.+.............++..|+|||++....++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986543322222223346789999999988889999999999999999985 3445
Q ss_pred HHHHHHHHhhcCChhhhhch---hhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 035917 525 LVDWVNQLSSSGRSKEAIDK---ALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNS 585 (611)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~---~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 585 (611)
+.......... ...+.... .......+.....+.+++.+||+.||++|||+.||.+.|++
T Consensus 242 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDEQVIE-NAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHHHHHH-HHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 43211110000 00000000 00000111122345556669999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=373.58 Aligned_cols=253 Identities=24% Similarity=0.360 Sum_probs=204.2
Q ss_pred cCCCCCeeeecCCceEEEEEeCC--CC----EEEEEecccc--chhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEE
Q 035917 325 SFCSENVIISTRTGTTYKAMLPD--GS----VLAVKRLNTC--KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~~--g~----~vAvK~~~~~--~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
+-+....||+|.||.||+|.+.+ |. .||||.+++. .....+|.+|..+|++++|||||+++|+|.+....++
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 34456789999999999999643 43 4999999764 3455789999999999999999999999999999999
Q ss_pred EEeccCCCChHHhhhcC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccc
Q 035917 397 IYKYMSSGTLYSLLQGN------ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLA 470 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla 470 (611)
++|||++|||..+|++. ...+.....+.++.|||+|+.||+ ++++|||||..+|+||+....+||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999876 346899999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHH-----HhhcCChhhhhch
Q 035917 471 KLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQ-----LSSSGRSKEAIDK 544 (611)
Q Consensus 471 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~-----~~~~~~~~~~~~~ 544 (611)
+.+...+.........-+..|||||.+..+.+|.|+|||||||+|||+++ |..||.+.... ....+
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-------- 921 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-------- 921 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC--------
Confidence 95544333322222234568999999999999999999999999999997 44565432111 11111
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 545 ALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 545 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
++ ..+..+...+.+|+..||+.+|++||++..|++.+..+.+..
T Consensus 922 RL--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 922 RL--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred cc--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 11 122223345556777999999999999999999998887664
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=350.74 Aligned_cols=254 Identities=21% Similarity=0.304 Sum_probs=197.0
Q ss_pred hhcCCCCCeeeecCCceEEEEEe------CCCCEEEEEeccccc--hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCe
Q 035917 323 SNSFCSENVIISTRTGTTYKAML------PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEE 393 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~------~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~ 393 (611)
.++|...+.||+|+||.||+|+. +++..||||+++... ...+.+.+|+.++..+ +||||++++++|..++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34677889999999999999973 346789999996533 2345789999999999 89999999999999999
Q ss_pred eEEEEeccCCCChHHhhhcCC-----------------------------------------------------------
Q 035917 394 KLLIYKYMSSGTLYSLLQGNA----------------------------------------------------------- 414 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~----------------------------------------------------------- 414 (611)
.++|||||++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999885421
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 415 ---------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 415 ---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
..++|..+..++.||++||+||| +.+|+||||||+|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 14788999999999999999999 789999999999999999999999999999876433221
Q ss_pred ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchh---hcCCCCHHHH
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKA---LCGKGYDEEI 555 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~---l~~~~~~~~~ 555 (611)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||....... .....+... ......+.++
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l 346 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS----KFYKMIKEGYRMLSPECAPSEM 346 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH----HHHHHHHhCccCCCCCCCCHHH
Confidence 21222335678999999998899999999999999999997 666653210000 000111110 1112223344
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHHHHc
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 586 (611)
.+++.+||+.||++||++.||++.|++.
T Consensus 347 ---~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 347 ---YDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---HHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 4555599999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=351.22 Aligned_cols=255 Identities=25% Similarity=0.324 Sum_probs=203.3
Q ss_pred CCCeeeecCCceEEEEEeCC--C--CE-EEEEecccc----chhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 328 SENVIISTRTGTTYKAMLPD--G--SV-LAVKRLNTC----KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 328 ~~~~ig~G~~g~Vy~~~~~~--g--~~-vAvK~~~~~----~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
..++||+|.||.||+|++.. + .. ||||..+.. ....++|.+|.++|++++|||||+++|++......++||
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm 240 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM 240 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence 34899999999999999643 2 23 899998742 233478999999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
|+|+||+|.++|......++..++..++.++|.||+||| +.+++||||-.+|+|++.++.+||+|||+++.-.....
T Consensus 241 El~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~ 317 (474)
T KOG0194|consen 241 ELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVM 317 (474)
T ss_pred EecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCCcceee
Confidence 999999999999977667999999999999999999999 89999999999999999999999999999886431111
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQ 557 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 557 (611)
.. ....-+..|+|||.+....|+.++|||||||++||+++ |..|+..+-..........+... ...+...+.++..
T Consensus 318 ~~--~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r-~~~~~~~p~~~~~ 394 (474)
T KOG0194|consen 318 KK--FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYR-MPIPSKTPKELAK 394 (474)
T ss_pred cc--ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCcc-CCCCCCCHHHHHH
Confidence 11 01124678999999999999999999999999999996 66677553222111100011111 1122345556666
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 558 FLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
+++ +||..+|++||+|.++.+.|+.+.....
T Consensus 395 ~~~---~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 395 VMK---QCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred HHH---HhccCChhhccCHHHHHHHHHHHHhccc
Confidence 666 9999999999999999999999887754
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=349.18 Aligned_cols=255 Identities=21% Similarity=0.289 Sum_probs=199.1
Q ss_pred hhcCCCCCeeeecCCceEEEEEe------CCCCEEEEEeccccc--hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCe
Q 035917 323 SNSFCSENVIISTRTGTTYKAML------PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEE 393 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~------~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~ 393 (611)
.++|...+.||+|+||.||+|+. .++..||||+++... ...+.+.+|+++++.+ +|+|||+++++|...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 34788889999999999999883 234689999997533 2235688999999999 89999999999999999
Q ss_pred eEEEEeccCCCChHHhhhcCC-----------------------------------------------------------
Q 035917 394 KLLIYKYMSSGTLYSLLQGNA----------------------------------------------------------- 414 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~----------------------------------------------------------- 414 (611)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885321
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccC
Q 035917 415 ----------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNG 484 (611)
Q Consensus 415 ----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 484 (611)
..+++..+.+++.|+++||+||| +.+|+||||||+|||+++++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 14788899999999999999999 78999999999999999999999999999986543322112222
Q ss_pred CCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhh---cCCCCHHHHHHHHH
Q 035917 485 DLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKAL---CGKGYDEEILQFLK 560 (611)
Q Consensus 485 ~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l---~~~~~~~~~~~l~~ 560 (611)
..++..|+|||++.+..++.++|||||||++|||++ |+.||....... .....+.... .....+.++.+
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~--- 346 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS----KFYKMVKRGYQMSRPDFAPPEIYS--- 346 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH----HHHHHHHcccCccCCCCCCHHHHH---
Confidence 235678999999988889999999999999999996 888875432110 0111111111 11222344444
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHch
Q 035917 561 VACNCVVSRPKDRWSMYQVYQSLNSIA 587 (611)
Q Consensus 561 l~~~Cl~~dP~~RPs~~evl~~L~~i~ 587 (611)
++.+||+.||++||++.+|++.|+++.
T Consensus 347 li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 347 IMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 555999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=327.66 Aligned_cols=246 Identities=20% Similarity=0.305 Sum_probs=199.8
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
++|...+.||+|+||.||++...++..+|+|.+.......+++.+|+.++++++||||+++++++..++..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 35677789999999999999998888999999876666667899999999999999999999999999999999999999
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcccc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
|+|.+++......++|..+..++.+++.||+||| +.+|+||||||+||++++++.+||+|||+++........ ...
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~ 159 (256)
T cd05114 84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSS 159 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccC
Confidence 9999999765456899999999999999999999 789999999999999999999999999999865332211 112
Q ss_pred CCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHH-----HHHHhhcCChhhhhchhhcCCCCHHHHHH
Q 035917 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDW-----VNQLSSSGRSKEAIDKALCGKGYDEEILQ 557 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 557 (611)
...++..|+|||++.+..++.++||||||+++|||++ |+.||... ...... +. ........+. .
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~-~~------~~~~~~~~~~---~ 229 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-GF------RLYRPKLASM---T 229 (256)
T ss_pred CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CC------CCCCCCCCCH---H
Confidence 2235678999999988889999999999999999998 77776321 111111 00 0011112233 4
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWSMYQVYQSL 583 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~~evl~~L 583 (611)
+.+++.+||+.+|++||++.++++.|
T Consensus 230 ~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 230 VYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHhh
Confidence 55566699999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=330.25 Aligned_cols=254 Identities=20% Similarity=0.247 Sum_probs=197.9
Q ss_pred hcCCCCCeeeecCCceEEEEEeC----CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP----DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~----~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
++|...+.||+|+||.||+|.+. .+..||+|.++... ...+.|.+|+.++.+++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46778899999999999999853 46789999997543 2345789999999999999999999999999999999
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
|||+++|+|.+++......+++..++.++.|++.||+||| +.+++||||||+||+++.++.+|++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999999999865557899999999999999999999 8899999999999999999999999999876542221
Q ss_pred CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHH
Q 035917 478 ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEIL 556 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 556 (611)
.. ......++..|+|||.+.+..++.++|||||||++||+++ |+.||.......... ...+..... .....+.
T Consensus 162 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~-~~~~~~~~~-~~~~~~~--- 235 (266)
T cd05064 162 IY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIK-AVEDGFRLP-APRNCPN--- 235 (266)
T ss_pred hh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH-HHHCCCCCC-CCCCCCH---
Confidence 11 1112235678999999988899999999999999999774 887764211100000 000000001 1122233
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHHHc
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 586 (611)
.+.+++.+||+.+|++||++.+|++.|+++
T Consensus 236 ~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 236 LLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 344555599999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=339.93 Aligned_cols=247 Identities=22% Similarity=0.282 Sum_probs=206.0
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
.|+..+.||+|+||.||||.. ..++.||+|+++... ...+++++|+.+|..++++||.+++|.|..+...+++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 466668999999999999995 568999999997643 33478999999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
.+|++.+.|.... .+++..+.-|.+++..|+.||| ..+.+|||||+.|||+..+|.+|++|||++..+......
T Consensus 94 ~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r-- 167 (467)
T KOG0201|consen 94 GGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR-- 167 (467)
T ss_pred cCcchhhhhccCC-CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhhc--
Confidence 9999999997543 4577788889999999999999 789999999999999999999999999999887643322
Q ss_pred ccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHH
Q 035917 482 VNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKV 561 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l 561 (611)
..+.+||+.|||||++....|+.|+||||+|++.+||++|..|+.+....... -.+.+.-.|.+.+ .++..+++|++
T Consensus 168 r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl-flIpk~~PP~L~~-~~S~~~kEFV~- 244 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL-FLIPKSAPPRLDG-DFSPPFKEFVE- 244 (467)
T ss_pred cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE-EeccCCCCCcccc-ccCHHHHHHHH-
Confidence 25678999999999999889999999999999999999999998653221000 0111222333433 56667778887
Q ss_pred HhhcccCCCCCCCCHHHHHHH
Q 035917 562 ACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 562 ~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.|++.||+.||++.++++|
T Consensus 245 --~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 245 --ACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred --HHhhcCcccCcCHHHHhhh
Confidence 9999999999999999886
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=311.75 Aligned_cols=272 Identities=19% Similarity=0.237 Sum_probs=207.2
Q ss_pred cCCCCCeeeecCCceEEEEE-eCCCCEEEEEeccccchh---HHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 325 SFCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCKLG---EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~~~---~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
.|...+++|+|.||.||+|+ ..+|+.||||+++..+.. .....+|++.|+.++|+||+.++++|-..+...||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 45667899999999999999 567999999999764322 45689999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
|+. +|+.++++....++...+..++.++.+|++||| .+.|+||||||.|+|++.+|.+||+|||+|+.+.......
T Consensus 83 m~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 83 MPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred ccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 987 999999987778999999999999999999999 8999999999999999999999999999999886544322
Q ss_pred cccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCC------HHHHHHHHhhcCChhh-----------h-
Q 035917 481 FVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGN------LVDWVNQLSSSGRSKE-----------A- 541 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~------~~~~~~~~~~~~~~~~-----------~- 541 (611)
+..+-|..|.|||.+.+ ..|+...||||.|||+.||+-+..- +.+...-...-+...+ -
T Consensus 159 --~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 159 --THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred --ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 22367899999998766 5699999999999999999854432 2111111110110000 0
Q ss_pred ----hchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCCCCCCCCcccccc
Q 035917 542 ----IDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFSERYDEFPLIFH 604 (611)
Q Consensus 542 ----~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~~~ 604 (611)
+.........+....+.++++..++..||.+|++++|+++|=-- ...+...+....|.+..
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf--~~~P~pt~~~~lp~p~~ 301 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYF--KSLPLPTPPSKLPIPST 301 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhh--hcCCCCCChhhCcCCcc
Confidence 00000111222333455777779999999999999999987331 22444445556666554
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=337.87 Aligned_cols=258 Identities=19% Similarity=0.295 Sum_probs=201.2
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCC----EEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGS----VLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~----~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
.+|...+.||+|+||.||+|++. +++ .||+|.++... ...+++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 35888899999999999999853 344 48999986432 3346789999999999999999999999764 5779
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
++||+++|+|.+++......+++..++.++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 99999999999999876556899999999999999999999 889999999999999999999999999999976543
Q ss_pred CCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHH
Q 035917 477 DESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEI 555 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 555 (611)
..........++..|+|||++.+..++.++|||||||++|||++ |+.|+....... ....+.............
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 237 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISSILEKGERLPQPPICT 237 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHhCCCCCCCCCCCC
Confidence 32222222335678999999998899999999999999999987 777763211100 001111100000111122
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
..+.+++.+||+.+|++||++.+++.++..+.+..
T Consensus 238 ~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 238 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 34556666999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=333.76 Aligned_cols=243 Identities=21% Similarity=0.294 Sum_probs=195.9
Q ss_pred CCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 326 FCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
|...+.||+|+||.||+|.. .+|+.||||.+.... .....+.+|+.++.+++|+||+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66678999999999999995 579999999986432 2234578999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 401 MSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 401 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 99999998876433 36899999999999999999999 8899999999999999999999999999998753322
Q ss_pred ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh------cCCCCHH
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL------CGKGYDE 553 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l------~~~~~~~ 553 (611)
......||..|+|||++.+..++.++|||||||++|||++|+.||....... ..+.++..+ .....++
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~s~ 230 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-----KREEVDRRVKEDQEEYSEKFSE 230 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-----hHHHHHHHhhcccccCCccCCH
Confidence 1233468999999999999999999999999999999999999874311000 001111111 1122344
Q ss_pred HHHHHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 035917 554 EILQFLKVACNCVVSRPKDRWS-----MYQVYQS 582 (611)
Q Consensus 554 ~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 582 (611)
++.++++ +||+.||++||+ ++++++|
T Consensus 231 ~~~~li~---~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 231 DAKSICR---MLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHHHHHH---HHhhcCHHHhcCCCCCCHHHHhcC
Confidence 5555555 999999999997 8899886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=325.33 Aligned_cols=255 Identities=21% Similarity=0.316 Sum_probs=201.9
Q ss_pred hcCCCCCeeeecCCceEEEEEeC----CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP----DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~----~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
++|+..+.||+|+||.||+|.+. +...||||.++... ....+|.+|+.++.+++||||+++++++...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 56888999999999999999964 24689999986533 2346789999999999999999999999999999999
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
|||+++|+|.+++......+++..+.+++.|++.||+||| +.+|+|+||||+||++++++.+||+|||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999766557899999999999999999999 7899999999999999999999999999998774222
Q ss_pred CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHH
Q 035917 478 ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEIL 556 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 556 (611)
.........++..|+|||.+.+..++.++||||||+++|||++ |..|+.++........ ..+.... ......++
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~-~~~~~~~~--- 235 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKA-VEDGYRL-PPPMDCPS--- 235 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHH-HHcCCCC-CCCCCCCH---
Confidence 1111112235678999999998889999999999999999987 7777644322211000 0000000 00112233
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHHHc
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 586 (611)
.+.+++.+||+.+|++||++.||+++|+++
T Consensus 236 ~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 236 ALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 445566699999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=325.58 Aligned_cols=255 Identities=23% Similarity=0.347 Sum_probs=203.0
Q ss_pred hhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccC
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
.++|...+.||+|++|.||+|...+++.||+|.++......+++.+|+.++++++||||+++++++...+..+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 35678889999999999999998888899999997665566789999999999999999999999999999999999999
Q ss_pred CCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 403 SGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 403 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
+++|.+++.... ..+++..+..++.+++.|+.||| +.+++||||||+||++++++.+||+|||+++........ .
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~ 160 (261)
T cd05068 85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-A 160 (261)
T ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-c
Confidence 999999997643 46899999999999999999999 789999999999999999999999999999876532211 1
Q ss_pred ccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHH
Q 035917 482 VNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLK 560 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~ 560 (611)
..+...+..|+|||++.+..++.++||||||+++|||++ |+.|+....... ....++..............+.+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-----VLQQVDQGYRMPCPPGCPKELYD 235 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHHcCCCCCCCCcCCHHHHH
Confidence 112223467999999998899999999999999999998 777663211100 00011110000011112234555
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHc
Q 035917 561 VACNCVVSRPKDRWSMYQVYQSLNSI 586 (611)
Q Consensus 561 l~~~Cl~~dP~~RPs~~evl~~L~~i 586 (611)
++.+|++.+|++||++.++++.|+++
T Consensus 236 li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 236 IMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 66699999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=329.35 Aligned_cols=255 Identities=24% Similarity=0.351 Sum_probs=197.8
Q ss_pred hcCCCCCeeeecCCceEEEEEeCC------CCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPD------GSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~------g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~ 395 (611)
++|...+.||+|+||.||+|.... ...||+|.++... ....+|.+|+.++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 356777899999999999998533 2589999986543 23456899999999999999999999999888999
Q ss_pred EEEeccCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC
Q 035917 396 LIYKYMSSGTLYSLLQGNA---------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF 460 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~ 460 (611)
++|||+++|+|.+++.... ..+++..+..++.|++.||.||| ..+++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence 9999999999999986431 34788999999999999999999 78999999999999999999
Q ss_pred CeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChh
Q 035917 461 DARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSK 539 (611)
Q Consensus 461 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~ 539 (611)
.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||...... ...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-----~~~ 236 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-----EVI 236 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHH
Confidence 999999999986543322222233457889999999988889999999999999999997 77775321110 011
Q ss_pred hhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHc
Q 035917 540 EAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586 (611)
Q Consensus 540 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 586 (611)
+.+...............+.+++.+||+.||++||++.||+++|+.+
T Consensus 237 ~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 237 EMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 11111111111111223444555599999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=325.96 Aligned_cols=254 Identities=20% Similarity=0.321 Sum_probs=202.6
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
++|...+.||+|++|.||+|...+++.||+|.+.......+.+.+|+.++++++|+||+++++++...+..+++|||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence 46777899999999999999988889999999876555567899999999999999999999999999999999999999
Q ss_pred CChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccc
Q 035917 404 GTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482 (611)
Q Consensus 404 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 482 (611)
|+|.+++.... ..+++..+..++.++++||+||| ..+++||||||+||+++.++.+||+|||+++....... ...
T Consensus 86 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 161 (261)
T cd05072 86 GSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TAR 161 (261)
T ss_pred CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce-ecc
Confidence 99999997543 46899999999999999999999 78999999999999999999999999999987643221 112
Q ss_pred cCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHH
Q 035917 483 NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKV 561 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l 561 (611)
....++..|+|||++....++.++|||||||++|||++ |..||.......... ......... .....+++ +.++
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~---~~~l 236 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMS-ALQRGYRMP-RMENCPDE---LYDI 236 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHH-HHHcCCCCC-CCCCCCHH---HHHH
Confidence 22346778999999988889999999999999999998 777763211100000 000000000 11123344 4445
Q ss_pred HhhcccCCCCCCCCHHHHHHHHHHc
Q 035917 562 ACNCVVSRPKDRWSMYQVYQSLNSI 586 (611)
Q Consensus 562 ~~~Cl~~dP~~RPs~~evl~~L~~i 586 (611)
+.+||+.+|++||+++++.+.|+++
T Consensus 237 i~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 237 MKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHccCCcccCcCHHHHHHHHhcC
Confidence 5599999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=339.10 Aligned_cols=259 Identities=22% Similarity=0.260 Sum_probs=209.6
Q ss_pred cCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccC
Q 035917 325 SFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
.....+.||+|.||.|..+....+..||||.++... ....+|.+|+++|.+++|||||+++|+|..++..++|+|||+
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE 618 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME 618 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence 345568999999999999999888999999998653 345789999999999999999999999999999999999999
Q ss_pred CCChHHhhhcCCCC-CCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 403 SGTLYSLLQGNATE-LDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 403 ~gsL~~~l~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
+|+|.+++..+..+ .+-....+|+.||+.||+||. +.++||||+.++|||+|.++++||+|||+++-+...+....
T Consensus 619 nGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 619 NGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred cCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 99999999876433 355567789999999999999 88999999999999999999999999999997765554444
Q ss_pred ccCCCcccccccccccCCCCCCcccchHHHHHHHHHHh--CCCCCHHHHHHHHhhcCChhhhhchhh---cCCCCHHHHH
Q 035917 482 VNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELA--GFKGNLVDWVNQLSSSGRSKEAIDKAL---CGKGYDEEIL 556 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell--~~~~~~~~~~~~~~~~~~~~~~~~~~l---~~~~~~~~~~ 556 (611)
....+-+..|||||.+.-+++|.++|||+|||++||++ ..+.||.+..+...-+. ..+.++..- -...+.-+..
T Consensus 696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven-~~~~~~~~~~~~~l~~P~~cp~ 774 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN-AGEFFRDQGRQVVLSRPPACPQ 774 (807)
T ss_pred ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh-hhhhcCCCCcceeccCCCcCcH
Confidence 44455678999999999999999999999999999997 46677766544322111 111111110 0111223445
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHHHch
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQSLNSIA 587 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 587 (611)
.+.+++++||..|.++||+++++..+|++..
T Consensus 775 ~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 775 GLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred HHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 6667888999999999999999999998754
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=323.59 Aligned_cols=259 Identities=25% Similarity=0.354 Sum_probs=196.0
Q ss_pred CCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHh--ccCCCCccceeeEEEeCC----eeEEEEeccC
Q 035917 329 ENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLG--QLRHPNLAPLLGYCVVEE----EKLLIYKYMS 402 (611)
Q Consensus 329 ~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~--~l~H~nIv~l~g~~~~~~----~~~lv~ey~~ 402 (611)
.++||+|+||.||||.+. ++.||||++... ..+.|.+|-+|.+ .++|+||++++++-.... +++||+||.+
T Consensus 215 ~eli~~Grfg~V~KaqL~-~~~VAVKifp~~--~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~ 291 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ--EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP 291 (534)
T ss_pred HHHhhcCccceeehhhcc-CceeEEEecCHH--HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence 468999999999999994 599999999754 3455777776655 558999999999877655 7899999999
Q ss_pred CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhc------CCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 403 SGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHG------CQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 403 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
+|+|.++|+.+ .++|....+|+..+++||+|||++ ..++|+|||||++|||+..|+++.|+|||+|..+...
T Consensus 292 kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~ 369 (534)
T KOG3653|consen 292 KGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPG 369 (534)
T ss_pred CCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCC
Confidence 99999999865 589999999999999999999963 3568999999999999999999999999999988765
Q ss_pred CCCccccCCCcccccccccccCCCCC------CcccchHHHHHHHHHHhCCCC------------CHHHHHHHHhhcCCh
Q 035917 477 DESSFVNGDLGEFGYIAPEYSSTMVA------SLKGDVYGIGVVLLELAGFKG------------NLVDWVNQLSSSGRS 538 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~~~~------t~ksDV~SfGvvl~ell~~~~------------~~~~~~~~~~~~~~~ 538 (611)
.......+.+||..|||||++.+..- -.+.||||+|.|||||+++-. ||..-+......+..
T Consensus 370 ~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~m 449 (534)
T KOG3653|consen 370 KPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEM 449 (534)
T ss_pred CCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHH
Confidence 54444455789999999999876321 235999999999999984321 232111111000011
Q ss_pred hh-hhchhhcCCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCC
Q 035917 539 KE-AIDKALCGKGY-----DEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGF 592 (611)
Q Consensus 539 ~~-~~~~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 592 (611)
.+ ++....++... ...+..+.+.+..||+.||+.|.|+.=|.+.+.++....+.
T Consensus 450 q~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 450 QELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred HHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 11 11111111111 13345556666699999999999999999999888877654
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=331.26 Aligned_cols=244 Identities=27% Similarity=0.422 Sum_probs=186.9
Q ss_pred CCeeeecCCceEEEEEeC-----CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 329 ENVIISTRTGTTYKAMLP-----DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 329 ~~~ig~G~~g~Vy~~~~~-----~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
.+.||.|.||.||+|.+. .+..|+||.++... ...++|.+|++.+.+++||||++++|+|...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 468999999999999975 36789999996532 23578999999999999999999999999888899999999
Q ss_pred CCCChHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 402 SSGTLYSLLQGN-ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 402 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
++|+|.+++... ...+++..+..|+.||++||.||| +.+++|+||+++||++++++.+||+|||+++.........
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred ccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccc
Confidence 999999999876 457999999999999999999999 6789999999999999999999999999998763222222
Q ss_pred cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhh---cCCCCHHHHH
Q 035917 481 FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKAL---CGKGYDEEIL 556 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l---~~~~~~~~~~ 556 (611)
......+...|+|||.+....++.++||||||+++|||++ ++.|+.+..... ..+.+.... .....+..+.
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 235 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE-----IIEKLKQGQRLPIPDNCPKDIY 235 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH-----HHHHHHTTEETTSBTTSBHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc-----ccccccccccceeccchhHHHH
Confidence 2223346789999999988889999999999999999999 556653311110 001111111 1122344444
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHH
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQSL 583 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~L 583 (611)
. ++.+||+.||++||++.++++.|
T Consensus 236 ~---li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 236 S---LIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp H---HHHHHT-SSGGGS--HHHHHHHH
T ss_pred H---HHHHHcCCChhhCcCHHHHHhcC
Confidence 4 55599999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=343.92 Aligned_cols=259 Identities=19% Similarity=0.248 Sum_probs=199.6
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC------CCCEEEEEeccccc--hhHHHHHHHHHHHhccC-CCCccceeeEEEeCCe
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP------DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLR-HPNLAPLLGYCVVEEE 393 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~------~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~~~ 393 (611)
.+.|...++||+|+||.||+|+.. .+..||||+++... ...+.+.+|+++++++. ||||++++++|...+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 456778899999999999999842 23579999996533 23467999999999996 9999999999999999
Q ss_pred eEEEEeccCCCChHHhhhcCC-----------------------------------------------------------
Q 035917 394 KLLIYKYMSSGTLYSLLQGNA----------------------------------------------------------- 414 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~----------------------------------------------------------- 414 (611)
.++|||||++|+|.+++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999875321
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC
Q 035917 415 ------------------------------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE 458 (611)
Q Consensus 415 ------------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~ 458 (611)
..+++..+..++.|+++||+||| ..+|+||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence 13778888999999999999999 789999999999999999
Q ss_pred CCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCC
Q 035917 459 DFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGR 537 (611)
Q Consensus 459 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~ 537 (611)
++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~---- 348 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST---- 348 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH----
Confidence 99999999999987643322222223357788999999988889999999999999999986 7777643211100
Q ss_pred hhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchh
Q 035917 538 SKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAA 588 (611)
Q Consensus 538 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 588 (611)
....+...............+.+++.+||+.||++||++.+|.++|+.+.+
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 FYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 000000000001111122345556669999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=326.27 Aligned_cols=254 Identities=20% Similarity=0.286 Sum_probs=198.1
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCC----EEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGS----VLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~----~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
++|...+.||+|+||.||+|++ .+++ .|++|.+.... ....++..|+..+++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 3566778999999999999995 3454 47888875432 22356888999999999999999999885 455789
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
++||+++|+|.+++......++|..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||+++.....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999999999866567999999999999999999999 789999999999999999999999999999876443
Q ss_pred CCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHH----HHHHhhcCChhhhhchhhcCCCC
Q 035917 477 DESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDW----VNQLSSSGRSKEAIDKALCGKGY 551 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~----~~~~~~~~~~~~~~~~~l~~~~~ 551 (611)
..........++..|+|||.+.+..++.++|||||||++||+++ |..|+... .......+. ........
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~------~~~~~~~~ 236 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGE------RLAQPQIC 236 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC------cCCCCCCC
Confidence 32222233457788999999988889999999999999999997 77776321 111111110 00011112
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 552 DEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 552 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
+. .+.+++.+||..||++|||+.|+++.|..+.+..
T Consensus 237 ~~---~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 237 TI---DVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred CH---HHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 22 3455566999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=323.55 Aligned_cols=251 Identities=19% Similarity=0.289 Sum_probs=198.6
Q ss_pred cCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCC
Q 035917 325 SFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSG 404 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~g 404 (611)
+|...+.||+|+||.||+|...++..||+|.++......+++.+|+.++.+++||||+++++++...+..++||||+++|
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG 84 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCC
Confidence 46667899999999999999877778999999766556678999999999999999999999999888899999999999
Q ss_pred ChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccC
Q 035917 405 TLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNG 484 (611)
Q Consensus 405 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 484 (611)
+|.+++......+++..++.++.|++.||+||| +.+++|+||||+||++++++.+||+|||+++....... .....
T Consensus 85 ~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~ 160 (256)
T cd05113 85 CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSVG 160 (256)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eecCC
Confidence 999999765446899999999999999999999 88999999999999999999999999999986543321 11122
Q ss_pred CCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHHh
Q 035917 485 DLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVAC 563 (611)
Q Consensus 485 ~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~ 563 (611)
..++..|+|||+..+..++.++|||||||++|||++ |..|+.......... ........ ......++ .+.+++.
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~-~~~~~~~~-~~~~~~~~---~~~~li~ 235 (256)
T cd05113 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVE-KVSQGLRL-YRPHLASE---KVYAIMY 235 (256)
T ss_pred CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH-HHhcCCCC-CCCCCCCH---HHHHHHH
Confidence 335678999999988889999999999999999998 777753210000000 00000000 01112233 4455555
Q ss_pred hcccCCCCCCCCHHHHHHHHH
Q 035917 564 NCVVSRPKDRWSMYQVYQSLN 584 (611)
Q Consensus 564 ~Cl~~dP~~RPs~~evl~~L~ 584 (611)
+||+.+|++||++.++++.|+
T Consensus 236 ~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 236 SCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHcCCCcccCCCHHHHHHhhC
Confidence 999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=323.51 Aligned_cols=253 Identities=22% Similarity=0.338 Sum_probs=200.5
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
+|...+.||+|++|.||+|... +++.||+|.+.......+++.+|++++++++||||+++++++..++..+++|||+++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 86 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence 4667789999999999999964 588999999976655567899999999999999999999999999999999999999
Q ss_pred CChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccc
Q 035917 404 GTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482 (611)
Q Consensus 404 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 482 (611)
++|.+++.... ..+++..++.++.|+++||+||| ..+++||||||+||++++++.+||+|||+++........ ..
T Consensus 87 ~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~ 162 (263)
T cd05052 87 GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AH 162 (263)
T ss_pred CcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceee-cc
Confidence 99999987543 36899999999999999999999 789999999999999999999999999999876432211 11
Q ss_pred cCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHH
Q 035917 483 NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKV 561 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l 561 (611)
....++..|+|||.+.+..++.++|||||||++|||++ |..|+.......... .......+. .....+.++.+ +
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~---l 237 (263)
T cd05052 163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKGYRME-RPEGCPPKVYE---L 237 (263)
T ss_pred CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCCCC-CCCCCCHHHHH---H
Confidence 12234678999999988899999999999999999997 776653211100000 000000111 11223344555 4
Q ss_pred HhhcccCCCCCCCCHHHHHHHHHHc
Q 035917 562 ACNCVVSRPKDRWSMYQVYQSLNSI 586 (611)
Q Consensus 562 ~~~Cl~~dP~~RPs~~evl~~L~~i 586 (611)
+.+||+.||++||++.++++.|+++
T Consensus 238 i~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 238 MRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHccCCcccCCCHHHHHHHHHhh
Confidence 4599999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=315.17 Aligned_cols=277 Identities=22% Similarity=0.217 Sum_probs=211.4
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchh---HHHHHHHHHHHhccCCCCccceeeEEEeC--CeeEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLG---EKKFRNEMNRLGQLRHPNLAPLLGYCVVE--EEKLL 396 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~--~~~~l 396 (611)
.++|...+.|++|.||.||+|+. .+++.||+|+++..+.. .-.-.+||.+|.+++|||||.+..+.... +..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 34566678999999999999995 56899999999765422 23468999999999999999999888754 56899
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
|||||+. ||..++.....++...+...+..|+++|++||| ..-|+|||||++|+|+.+.|.+||+|||+|+.+...
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999998 999999877778999999999999999999999 889999999999999999999999999999988653
Q ss_pred CCCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHH-----HHHHHHh-hcCChhhhhchhh---
Q 035917 477 DESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLV-----DWVNQLS-SSGRSKEAIDKAL--- 546 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~-----~~~~~~~-~~~~~~~~~~~~l--- 546 (611)
. ...+..+-|..|.|||.+.+ ..|++..|+||+|||+.|+++++.-|. +....+. .-+...+.+.|..
T Consensus 231 ~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 231 L--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred c--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 2 22344567999999998776 469999999999999999997665332 1111111 1111111111111
Q ss_pred --------------------cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCCCCCCCCcccccccC
Q 035917 547 --------------------CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFSERYDEFPLIFHRQ 606 (611)
Q Consensus 547 --------------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~~~~~ 606 (611)
.....++...++++ ..+..||.+|.|+.|.++| ..-.+.+...+.+++|+...+.
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln---~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~P~~~Pt~P~k~ 383 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLN---KLLTYDPGKRITAEDGLKH--EYFRETPLPIDPSMFPTWPAKS 383 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHH---HHhccCccccccHHHhhcc--cccccCCCCCChhhcCCCcccc
Confidence 00112344455555 8999999999999999987 2334555666677788777666
Q ss_pred CCCC
Q 035917 607 DGGS 610 (611)
Q Consensus 607 ~~~~ 610 (611)
+++.
T Consensus 384 ~~~~ 387 (419)
T KOG0663|consen 384 EQQR 387 (419)
T ss_pred cccc
Confidence 6553
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=336.13 Aligned_cols=259 Identities=19% Similarity=0.260 Sum_probs=198.0
Q ss_pred hcCCCCCeeeecCCceEEEEEe------CCCCEEEEEeccccc--hhHHHHHHHHHHHhcc-CCCCccceeeEEEeC-Ce
Q 035917 324 NSFCSENVIISTRTGTTYKAML------PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVE-EE 393 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~------~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~-~~ 393 (611)
+.|...+.||+|+||.||+|+. .+++.||+|+++... ...+.+.+|+.++.++ +|+||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 3577789999999999999973 235789999997532 2235688899999999 899999999988754 46
Q ss_pred eEEEEeccCCCChHHhhhcCC-----------------------------------------------------------
Q 035917 394 KLLIYKYMSSGTLYSLLQGNA----------------------------------------------------------- 414 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~----------------------------------------------------------- 414 (611)
.+++|||+++|+|.+++....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 789999999999999885321
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccCCCccccccc
Q 035917 415 -TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIA 493 (611)
Q Consensus 415 -~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 493 (611)
..++|..+..++.||+.||+||| ..+|+||||||+|||+++++.+||+|||+++.+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 25789999999999999999999 78999999999999999999999999999987643322222223346778999
Q ss_pred ccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCC
Q 035917 494 PEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKD 572 (611)
Q Consensus 494 PE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~ 572 (611)
||++.+..++.++|||||||++|||++ |..||..... .......+...............+.+++.+||+.+|++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 319 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI----DEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPED 319 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc----cHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhh
Confidence 999999999999999999999999997 8777632000 00000111110010111112234566677999999999
Q ss_pred CCCHHHHHHHHHHchhh
Q 035917 573 RWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 573 RPs~~evl~~L~~i~~~ 589 (611)
||++.||+++|+.+.+.
T Consensus 320 RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 320 RPTFSELVEILGDLLQE 336 (337)
T ss_pred CcCHHHHHHHHHHHHhc
Confidence 99999999999987753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=333.08 Aligned_cols=195 Identities=21% Similarity=0.307 Sum_probs=171.4
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
++|...+.||+|+||.||+++.. +|..||+|.++... ...+++.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 57888899999999999999964 68899999986532 2346799999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
+++|+|.+++... ..+++..+..++.+++.||.|||+ ..+|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 158 (331)
T cd06649 85 MDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 158 (331)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc---
Confidence 9999999999754 358899999999999999999994 3469999999999999999999999999998653322
Q ss_pred cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCH
Q 035917 481 FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNL 525 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~ 525 (611)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 159 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 202 (331)
T cd06649 159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202 (331)
T ss_pred -cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 12346899999999999889999999999999999999999886
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=319.08 Aligned_cols=244 Identities=23% Similarity=0.305 Sum_probs=192.2
Q ss_pred CeeeecCCceEEEEEe-CCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCCh
Q 035917 330 NVIISTRTGTTYKAML-PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTL 406 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL 406 (611)
+.||+|+||.||+|+. .+++.||+|.+.... .....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3689999999999996 478999999886432 2346799999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccCCC
Q 035917 407 YSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDL 486 (611)
Q Consensus 407 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 486 (611)
.+++......+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++...............
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999765556899999999999999999999 8899999999999999999999999999987653221111111112
Q ss_pred cccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchh---hcCCCCHHHHHHHHHHH
Q 035917 487 GEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKA---LCGKGYDEEILQFLKVA 562 (611)
Q Consensus 487 gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~---l~~~~~~~~~~~l~~l~ 562 (611)
++..|+|||.+.+..++.++|||||||++|||++ +..|+....... ....+... ......+.. +.+++
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~---~~~li 229 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-----TREAIEQGVRLPCPELCPDA---VYRLM 229 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-----HHHHHHcCCCCCCcccCCHH---HHHHH
Confidence 3567999999988889999999999999999997 766664321110 01111111 111122334 44555
Q ss_pred hhcccCCCCCCCCHHHHHHHHH
Q 035917 563 CNCVVSRPKDRWSMYQVYQSLN 584 (611)
Q Consensus 563 ~~Cl~~dP~~RPs~~evl~~L~ 584 (611)
.+|++.+|++||++.++++.|+
T Consensus 230 ~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 230 ERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHcCCChhhCcCHHHHHHHHh
Confidence 5999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=335.07 Aligned_cols=240 Identities=19% Similarity=0.191 Sum_probs=192.7
Q ss_pred CeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCC
Q 035917 330 NVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSG 404 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~g 404 (611)
++||+|+||.||+|+. .+|+.||||+++... .....+.+|+.++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999985 578999999996532 22356788999999999999999999999999999999999999
Q ss_pred ChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccC
Q 035917 405 TLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNG 484 (611)
Q Consensus 405 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 484 (611)
+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~ 154 (323)
T cd05571 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT 154 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccccc
Confidence 999998754 46899999999999999999999 8899999999999999999999999999997542221 11223
Q ss_pred CCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc-hhhcCCCCHHHHHHHHHHHh
Q 035917 485 DLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID-KALCGKGYDEEILQFLKVAC 563 (611)
Q Consensus 485 ~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~~~~~~~~~~l~~l~~ 563 (611)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+.. ........+.++.++++
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~----~~~~~~~~~~p~~~~~~~~~li~--- 227 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPRTLSPEAKSLLA--- 227 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH----HHHHcCCCCCCCCCCHHHHHHHH---
Confidence 46999999999999989999999999999999999999887421110000 00000 00111234455666555
Q ss_pred hcccCCCCCCC-----CHHHHHHH
Q 035917 564 NCVVSRPKDRW-----SMYQVYQS 582 (611)
Q Consensus 564 ~Cl~~dP~~RP-----s~~evl~~ 582 (611)
+||+.||++|| ++.++++|
T Consensus 228 ~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 228 GLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHccCCHHHcCCCCCCCHHHHHcC
Confidence 99999999999 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=321.21 Aligned_cols=250 Identities=21% Similarity=0.286 Sum_probs=198.0
Q ss_pred cCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCC
Q 035917 325 SFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSG 404 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~g 404 (611)
+|...+.||+|+||.||+|...++..+|+|.+........++.+|++++++++||||+++++++...+..++||||++++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 46677899999999999999887889999998765555677899999999999999999999999999999999999999
Q ss_pred ChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccC
Q 035917 405 TLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNG 484 (611)
Q Consensus 405 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 484 (611)
+|.+++......+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||+++........ ....
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~~ 160 (256)
T cd05059 85 CLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQG 160 (256)
T ss_pred CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccccc-ccCC
Confidence 999999765556899999999999999999999 789999999999999999999999999999865432211 1112
Q ss_pred CCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHHh
Q 035917 485 DLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVAC 563 (611)
Q Consensus 485 ~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~ 563 (611)
..++..|+|||.+.+..++.++||||||+++||+++ |+.|+.......... ......... .....+.+ +.+++.
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~---~~~li~ 235 (256)
T cd05059 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE-SVSAGYRLY-RPKLAPTE---VYTIMY 235 (256)
T ss_pred CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH-HHHcCCcCC-CCCCCCHH---HHHHHH
Confidence 224567999999988899999999999999999998 676653211100000 000000111 11223344 445555
Q ss_pred hcccCCCCCCCCHHHHHHHH
Q 035917 564 NCVVSRPKDRWSMYQVYQSL 583 (611)
Q Consensus 564 ~Cl~~dP~~RPs~~evl~~L 583 (611)
+||..+|++|||+.|+++.|
T Consensus 236 ~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 236 SCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHhcCChhhCcCHHHHHHHh
Confidence 99999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=330.73 Aligned_cols=242 Identities=17% Similarity=0.183 Sum_probs=196.2
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
+|...+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 5778899999999999999964 68999999986432 223568899999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
|+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-- 155 (291)
T cd05612 82 YVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-- 155 (291)
T ss_pred CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc--
Confidence 99999999998754 35889999999999999999999 8899999999999999999999999999998764321
Q ss_pred ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHHHHH
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEILQF 558 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l 558 (611)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+..... .....+..+.++
T Consensus 156 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~l 228 (291)
T cd05612 156 ---WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI----YEKILAGKLEFPRHLDLYAKDL 228 (291)
T ss_pred ---ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCcCCCccCCHHHHHH
Confidence 123589999999999988899999999999999999999988743110000 000111000 112234455555
Q ss_pred HHHHhhcccCCCCCCCC-----HHHHHHH
Q 035917 559 LKVACNCVVSRPKDRWS-----MYQVYQS 582 (611)
Q Consensus 559 ~~l~~~Cl~~dP~~RPs-----~~evl~~ 582 (611)
++ +||+.||.+||+ +.|+++|
T Consensus 229 i~---~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 229 IK---KLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HH---HHcCCCHHHccCCccCCHHHHhcC
Confidence 55 999999999995 8999887
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=338.48 Aligned_cols=242 Identities=19% Similarity=0.242 Sum_probs=204.4
Q ss_pred hcCCCCCeeeecCCceEEEEE-eCCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
+-|..++.||+|+.|.|-.|+ ..+|+.+|||++.+.. .....+++|+-+|+.+.||||+++++++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 346677899999999999999 5789999999996542 22356899999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++|.|++++..+ +++++.+..+++.||+.|+.|+| ..+|+|||+||+|+|||...++||+|||+|..-..+.
T Consensus 92 Eyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk- 166 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK- 166 (786)
T ss_pred EecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCCc-
Confidence 999999999999865 46899999999999999999999 8899999999999999999999999999998754332
Q ss_pred CccccCCCcccccccccccCCCCC-CcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-----cCCCCH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVA-SLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-----CGKGYD 552 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-----~~~~~~ 552 (611)
...+.||++.|+|||++.+.+| +.++||||.|||||.|++|+-||.+. .+...+...- .+...+
T Consensus 167 --lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd--------Nir~LLlKV~~G~f~MPs~Is 236 (786)
T KOG0588|consen 167 --LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD--------NIRVLLLKVQRGVFEMPSNIS 236 (786)
T ss_pred --cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc--------cHHHHHHHHHcCcccCCCcCC
Confidence 3445689999999999999998 57899999999999999999998542 1111111111 123445
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 035917 553 EEILQFLKVACNCVVSRPKDRWSMYQVYQSL 583 (611)
Q Consensus 553 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 583 (611)
.+.++++. +|+..||+.|.|++||++|-
T Consensus 237 ~eaQdLLr---~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 237 SEAQDLLR---RMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred HHHHHHHH---HHhccCccccccHHHHhhCc
Confidence 66677666 99999999999999999984
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=325.61 Aligned_cols=257 Identities=21% Similarity=0.334 Sum_probs=202.2
Q ss_pred hcCCCCCeeeecCCceEEEEEe------CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML------PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~------~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
.+|...+.||+|+||.||++.. .++..+|+|.+.... ...+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4677889999999999999984 235679999986543 334679999999999999999999999999999999
Q ss_pred EEeccCCCChHHhhhcCC------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEE
Q 035917 397 IYKYMSSGTLYSLLQGNA------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARI 464 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl 464 (611)
||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence 999999999999986432 24899999999999999999999 789999999999999999999999
Q ss_pred eecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhc
Q 035917 465 MDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAID 543 (611)
Q Consensus 465 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~ 543 (611)
+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..|+........ ...+..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~----~~~i~~ 237 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV----IECITQ 237 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHc
Confidence 99999986543322222222346788999999998889999999999999999998 7777632111100 000000
Q ss_pred hh--hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 544 KA--LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 544 ~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
.. ......+.+ +.+++.+||+.||.+|||+.|+++.|+++.+..
T Consensus 238 ~~~~~~~~~~~~~---l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 238 GRVLQRPRTCPKE---VYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred CCcCCCCCCCCHH---HHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 00 011122334 555666999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=325.32 Aligned_cols=255 Identities=21% Similarity=0.362 Sum_probs=201.8
Q ss_pred cCCCCCeeeecCCceEEEEEe------CCCCEEEEEeccccch-hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEE
Q 035917 325 SFCSENVIISTRTGTTYKAML------PDGSVLAVKRLNTCKL-GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~------~~g~~vAvK~~~~~~~-~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
+|...+.||+|+||.||+|+. .++..+++|.++.... ..+.+.+|++++++++|+||+++++++...+..++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 466778999999999999984 2356799999875443 346799999999999999999999999999999999
Q ss_pred EeccCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCe
Q 035917 398 YKYMSSGTLYSLLQGNA---------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDA 462 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~ 462 (611)
|||+++++|.+++.... ..++|..++.++.+++.||+||| ..+|+||||||+||++++++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcE
Confidence 99999999999986432 24899999999999999999999 8899999999999999999999
Q ss_pred EEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHH----HHhhcCC
Q 035917 463 RIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVN----QLSSSGR 537 (611)
Q Consensus 463 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~----~~~~~~~ 537 (611)
||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.|+..... .....+.
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 242 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 242 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCC
Confidence 9999999986543322222223457889999999998899999999999999999998 8877532110 0000110
Q ss_pred hhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 538 SKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 538 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
.. . .....+. .+.+++.+||+.+|++||++.+|++.|+++.+..+
T Consensus 243 ~~-----~-~~~~~~~---~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~ 287 (291)
T cd05094 243 VL-----E-RPRVCPK---EVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287 (291)
T ss_pred CC-----C-CCccCCH---HHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence 00 0 0111233 34555559999999999999999999999977543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=321.85 Aligned_cols=255 Identities=24% Similarity=0.367 Sum_probs=203.6
Q ss_pred hhhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccch-hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 322 ASNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKL-GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~-~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
...+|...+.||.|+||.||+|...+++.+|+|.+..... ...++.+|+.+++.++||||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 4456778899999999999999988899999999976543 456799999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 401 MSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 401 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
+++|+|.+++.... ..+++..+..++.+++.||.||| +.+++|+||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 99999999997643 46899999999999999999999 789999999999999999999999999999876432211
Q ss_pred ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHH
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQF 558 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 558 (611)
.....++..|+|||......++.++||||||+++|+|++ |+.|+...... .....+...............+
T Consensus 161 --~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 233 (261)
T cd05148 161 --SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-----EVYDQITAGYRMPCPAKCPQEI 233 (261)
T ss_pred --ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-----HHHHHHHhCCcCCCCCCCCHHH
Confidence 113346778999999988889999999999999999998 67676321100 0000011111111111122345
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHc
Q 035917 559 LKVACNCVVSRPKDRWSMYQVYQSLNSI 586 (611)
Q Consensus 559 ~~l~~~Cl~~dP~~RPs~~evl~~L~~i 586 (611)
.+++.+||+.||++|||+.++++.|+.+
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 234 YKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 5566699999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=335.79 Aligned_cols=243 Identities=17% Similarity=0.200 Sum_probs=196.9
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||.||+|+.. +++.||||.++... ...+.+.+|+.++.+++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46777899999999999999964 68999999986532 22356889999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred cCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence 999999999998754 35888899999999999999999 8899999999999999999999999999998764322
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEILQ 557 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~ 557 (611)
....||+.|+|||++.+..++.++|||||||++|||++|..||.+...... ...+..... .+...+..+.+
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~i~~~~~~~p~~~~~~~~~ 244 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI----YEKILAGRLKFPNWFDGRARD 244 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH----HHHHhcCCcCCCCCCCHHHHH
Confidence 123589999999999998899999999999999999999988743110000 000111111 11223455555
Q ss_pred HHHHHhhcccCCCCCCCC-----HHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWS-----MYQVYQS 582 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs-----~~evl~~ 582 (611)
+++ +||+.||++||+ ++++++|
T Consensus 245 li~---~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 245 LVK---GLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHH---HHhhcCHHHcCCCCCCCHHHHhcC
Confidence 555 999999999996 7888877
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=323.77 Aligned_cols=250 Identities=21% Similarity=0.359 Sum_probs=197.3
Q ss_pred hcCCCCCeeeecCCceEEEEEeC------CCCEEEEEeccccch--hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP------DGSVLAVKRLNTCKL--GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~------~g~~vAvK~~~~~~~--~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~ 395 (611)
++|...+.||+|+||.||+|... +++.||||.++.... ..+.+.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45677789999999999999863 357899999975433 3468999999999999999999999999999999
Q ss_pred EEEeccCCCChHHhhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCe
Q 035917 396 LIYKYMSSGTLYSLLQGNA-------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDA 462 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~ 462 (611)
+||||+++|+|.+++.... ..+++..+..++.+++.|++||| ..+++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence 9999999999999986432 24789999999999999999999 8899999999999999999999
Q ss_pred EEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhh
Q 035917 463 RIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEA 541 (611)
Q Consensus 463 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~ 541 (611)
||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||....... ..+.
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-----~~~~ 236 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-----VIEC 236 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHH
Confidence 9999999986533222111223346788999999999999999999999999999998 887763211000 0000
Q ss_pred hch---hhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 035917 542 IDK---ALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLN 584 (611)
Q Consensus 542 ~~~---~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 584 (611)
+.. .......+.++. +++.+||+.||++||++.||++.|+
T Consensus 237 ~~~~~~~~~~~~~~~~~~---~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 237 ITQGRLLQRPRTCPSEVY---DIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHcCCcCCCCCCCCHHHH---HHHHHHcCCCcccCCCHHHHHHHhh
Confidence 000 001122334444 4555999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=324.14 Aligned_cols=254 Identities=21% Similarity=0.303 Sum_probs=196.4
Q ss_pred hhhcCCCCCeeeecCCceEEEEEeC------CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCe
Q 035917 322 ASNSFCSENVIISTRTGTTYKAMLP------DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEE 393 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~~------~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~ 393 (611)
++++|+..+.||+|+||.||+|... .++.||||+++... ....++.+|+.+++.++||||+++++++..+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4577889999999999999999753 35689999986432 234568999999999999999999999998899
Q ss_pred eEEEEeccCCCChHHhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEE
Q 035917 394 KLLIYKYMSSGTLYSLLQGNA---------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARI 464 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl 464 (611)
.++||||+++|+|.+++.... ..+++..+..++.|+++||+||| +.+++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999986422 13678899999999999999999 789999999999999999999999
Q ss_pred eecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhc
Q 035917 465 MDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAID 543 (611)
Q Consensus 465 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~ 543 (611)
+|||+++...............++..|+|||++.+..++.++|||||||++|||++ +..|+........ ......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~----~~~~~~ 236 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV----LRFVME 236 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH----HHHHHc
Confidence 99999986543222111112245788999999988889999999999999999998 5656532111000 000000
Q ss_pred hhh--cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 035917 544 KAL--CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNS 585 (611)
Q Consensus 544 ~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 585 (611)
... .....++. +.+++.+||+.||++|||+.|++++|++
T Consensus 237 ~~~~~~~~~~~~~---~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 237 GGLLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CCcCCCCCCCCHH---HHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 000 11122333 4555559999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=324.91 Aligned_cols=256 Identities=21% Similarity=0.216 Sum_probs=196.6
Q ss_pred HhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchh---------------HHHHHHHHHHHhccCCCCccce
Q 035917 321 AASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLG---------------EKKFRNEMNRLGQLRHPNLAPL 384 (611)
Q Consensus 321 ~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~---------------~~~~~~Ev~~l~~l~H~nIv~l 384 (611)
...+.|.....||+|.||.|-+|+. .+++.||||++.+.... .++..+||.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 4457888999999999999999994 57999999999653321 1578999999999999999999
Q ss_pred eeEEEeC--CeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCe
Q 035917 385 LGYCVVE--EEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDA 462 (611)
Q Consensus 385 ~g~~~~~--~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~ 462 (611)
+.+..++ +..|||+|||..|.+...-.. ...++..++++++++++.||+||| ..+|+||||||+|+|++++|++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcE
Confidence 9998764 568999999999877543221 123899999999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCCCC---CCccccCCCcccccccccccCCCC----CCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhc
Q 035917 463 RIMDFGLAKLMTSSD---ESSFVNGDLGEFGYIAPEYSSTMV----ASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSS 535 (611)
Q Consensus 463 kl~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~ 535 (611)
||+|||.+....... ........+||+.|+|||...++. .+.+.||||+||+||-|+.|+.||.+-.....
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l-- 327 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL-- 327 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH--
Confidence 999999998653221 112233467999999999876632 35789999999999999999999864322111
Q ss_pred CChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 035917 536 GRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLN 584 (611)
Q Consensus 536 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 584 (611)
...++...+.-...++.-..+-+|+.++|+.||++|.+..+|..|.-
T Consensus 328 --~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 328 --FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred --HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 12222222222222222333444444999999999999999987753
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=331.25 Aligned_cols=243 Identities=18% Similarity=0.215 Sum_probs=197.0
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
+|...+.||+|+||.||+|+.. +++.||||+++... ...+.+.+|++++..++||||+++++++..++..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 5778899999999999999965 58999999996532 223568899999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
|+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 82 YVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 99999999999754 35889999999999999999999 88999999999999999999999999999986533
Q ss_pred ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCChhhhhchhhcC---CCC
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGRSKEAIDKALCG---KGY 551 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~---~~~ 551 (611)
......||+.|+|||++.+..++.++|||||||++|||++|..||... ....... ...+...... ...
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~~~ 229 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW---KETLQRPVYDDPRFNL 229 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc---cccccCCCCCcccccc
Confidence 122346999999999999889999999999999999999999887321 1111000 0001000000 122
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 552 DEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 552 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++++.+++. +|+..+|++||++.++++|
T Consensus 230 s~~~~~li~---~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 230 SDEAWDLIT---KLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CHHHHHHHH---HHhhChhhhcCCHHHHHhC
Confidence 445555555 9999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=326.37 Aligned_cols=257 Identities=21% Similarity=0.273 Sum_probs=199.3
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC------CCCEEEEEeccccc--hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCe
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP------DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEE 393 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~------~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~ 393 (611)
.++|...+.||+|+||.||++... ....+|+|.+.... ....++.+|+.++.++ +|+||+++++++..++.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 456778899999999999999853 24689999986532 2335688999999999 79999999999999999
Q ss_pred eEEEEeccCCCChHHhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC
Q 035917 394 KLLIYKYMSSGTLYSLLQGN---------------ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE 458 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~ 458 (611)
.+++|||+++|+|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+||++++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcC
Confidence 99999999999999998632 236899999999999999999999 889999999999999999
Q ss_pred CCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCC
Q 035917 459 DFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGR 537 (611)
Q Consensus 459 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~ 537 (611)
++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+.......
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----- 242 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE----- 242 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-----
Confidence 99999999999987644322222222235678999999988889999999999999999997 666653211000
Q ss_pred hhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHch
Q 035917 538 SKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIA 587 (611)
Q Consensus 538 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 587 (611)
..+.+...............+.+++.+||+.||++||||.|+++.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 00111111111111112234556666999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=300.86 Aligned_cols=246 Identities=21% Similarity=0.262 Sum_probs=206.4
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch----hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL----GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
.++|..++.||+|.||.||.|+. +++-.||+|++.+++. .+.++.+|+++-+.|+||||+++++|+.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 45788999999999999999994 5688999999976542 347899999999999999999999999999999999
Q ss_pred EeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 398 YKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
+||.++|+++..|.+.. ..++......++.|+|.||.|+| .++++||||||+|+|++..+..|++|||-+..-..+
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~ 177 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN 177 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecCCC
Confidence 99999999999998544 46888889999999999999999 899999999999999999999999999998765432
Q ss_pred CCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHH
Q 035917 477 DESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEI 555 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~ 555 (611)
. ..+.+||..|.|||...+..++...|+|++||+.||++.|..||....... ...++....+ .+...+.++
T Consensus 178 k----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e----tYkrI~k~~~~~p~~is~~a 249 (281)
T KOG0580|consen 178 K----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE----TYKRIRKVDLKFPSTISGGA 249 (281)
T ss_pred C----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH----HHHHHHHccccCCcccChhH
Confidence 2 233479999999999999999999999999999999999999996543221 1111111111 123455666
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+++. +|+..+|.+|.+..|+++|
T Consensus 250 ~dlI~---~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 250 ADLIS---RLLVKNPIERLALTEVMDH 273 (281)
T ss_pred HHHHH---HHhccCccccccHHHHhhh
Confidence 66666 9999999999999999987
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=322.09 Aligned_cols=251 Identities=16% Similarity=0.186 Sum_probs=193.8
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
++|...+.||+|+||.||+|+.. +++.||||+++... ...+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 35778899999999999999975 68899999986532 234568899999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
|++++.+..+.. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 155 (287)
T cd07848 81 YVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN- 155 (287)
T ss_pred cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-
Confidence 999876665443 3346899999999999999999999 88999999999999999999999999999987643221
Q ss_pred ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHH-----HHhh-cCC--------------hh
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVN-----QLSS-SGR--------------SK 539 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~-----~~~~-~~~--------------~~ 539 (611)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .... .+. ..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 112234689999999999888899999999999999999999987742100 0000 000 00
Q ss_pred hhhchhhcC---------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 540 EAIDKALCG---------KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 540 ~~~~~~l~~---------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
....+.... ...+. .+.+++.+|++.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~---~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSG---VLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccccCcccCcccHHHhhhcccCH---HHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 01122 35556669999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=331.17 Aligned_cols=240 Identities=20% Similarity=0.201 Sum_probs=192.4
Q ss_pred CeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCC
Q 035917 330 NVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSG 404 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~g 404 (611)
++||+|+||.||+++. .+|+.||+|.++... .....+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999995 578999999996532 22346788999999999999999999999999999999999999
Q ss_pred ChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccC
Q 035917 405 TLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNG 484 (611)
Q Consensus 405 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 484 (611)
+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~ 154 (323)
T cd05595 81 ELFFHLSRE-RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT 154 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccccc
Confidence 999988754 36899999999999999999999 7899999999999999999999999999987542221 11223
Q ss_pred CCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHHHHHHHHHh
Q 035917 485 DLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEILQFLKVAC 563 (611)
Q Consensus 485 ~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~~l~~ 563 (611)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......... .....++++.++++
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~----~~~~~~~~~~~p~~~~~~~~~li~--- 227 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL----FELILMEEIRFPRTLSPEAKSLLA--- 227 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCCCCCCCCCCHHHHHHHH---
Confidence 4699999999999988999999999999999999999988743111100 000000000 11234456666666
Q ss_pred hcccCCCCCCC-----CHHHHHHH
Q 035917 564 NCVVSRPKDRW-----SMYQVYQS 582 (611)
Q Consensus 564 ~Cl~~dP~~RP-----s~~evl~~ 582 (611)
+||+.||++|| ++.++++|
T Consensus 228 ~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 228 GLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHccCCHHHhCCCCCCCHHHHHcC
Confidence 99999999998 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=321.36 Aligned_cols=256 Identities=20% Similarity=0.296 Sum_probs=199.5
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCC----EEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGS----VLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~----~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
++|...+.||+|+||.||+|+. .+|+ .||+|.++... ...+++.+|+.++..++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 4677789999999999999984 4554 48999986432 334678999999999999999999999975 45789
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
+|||+++|+|.+++......+++..++.++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 99999999999999865556899999999999999999999 889999999999999999999999999999876533
Q ss_pred CCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhh---cCCCCH
Q 035917 477 DESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKAL---CGKGYD 552 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l---~~~~~~ 552 (611)
..........++..|+|||...+..++.++|||||||++|||++ |..|+....... ....+.... .....+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 237 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-----IPDLLEKGERLPQPPICT 237 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHHCCCcCCCCccCC
Confidence 22222222235678999999988889999999999999999997 666653210000 000111000 011223
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 553 EEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 553 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
. .+.+++.+||+.||++||++.++++.|+++.+..+
T Consensus 238 ~---~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05109 238 I---DVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS 273 (279)
T ss_pred H---HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence 3 44555669999999999999999999998877653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=322.31 Aligned_cols=250 Identities=23% Similarity=0.368 Sum_probs=195.7
Q ss_pred cCCCCCeeeecCCceEEEEEe-----CCCCEEEEEeccccch--hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEE
Q 035917 325 SFCSENVIISTRTGTTYKAML-----PDGSVLAVKRLNTCKL--GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-----~~g~~vAvK~~~~~~~--~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
+|...+.||+|+||.||+|.. .++..||+|.++.... ...++.+|++++++++||||+++++++..++..++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 566678999999999999984 3568999999974332 235789999999999999999999999999999999
Q ss_pred EeccCCCChHHhhhcCC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCC
Q 035917 398 YKYMSSGTLYSLLQGNA----------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFD 461 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~ 461 (611)
|||+++|+|.+++.... ..+++...+.++.+++.||+||| +.+++||||||+|||+++++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCCc
Confidence 99999999999985221 24788999999999999999999 789999999999999999999
Q ss_pred eEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhh
Q 035917 462 ARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKE 540 (611)
Q Consensus 462 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~ 540 (611)
+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...... ...+
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~-----~~~~ 237 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-----EVIE 237 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-----HHHH
Confidence 99999999987643332222233346778999999988889999999999999999998 77665321000 0011
Q ss_pred hhchh---hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 035917 541 AIDKA---LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNS 585 (611)
Q Consensus 541 ~~~~~---l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 585 (611)
.++.. ......++.+.+++ .+||+.||++||++.+|.++|..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li---~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 MVRKRQLLPCSEDCPPRMYSLM---TECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHcCCcCCCCCCCCHHHHHHH---HHHcccCcccCcCHHHHHHHhhc
Confidence 11110 01122344455544 49999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=318.85 Aligned_cols=256 Identities=20% Similarity=0.341 Sum_probs=199.9
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CC---CEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DG---SVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g---~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
.++|+..+.||+|+||.||+|+.. ++ ..+|+|.++... ...+++.+|++++++++||||+++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 357788899999999999999964 33 379999986542 234678999999999999999999999999999999
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
||||+++++|.+++......+++..+..++.|++.|++||| +.+++||||||+||++++++.+|++|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999765557899999999999999999999 789999999999999999999999999999866432
Q ss_pred CCCcc-ccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHH
Q 035917 477 DESSF-VNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEE 554 (611)
Q Consensus 477 ~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 554 (611)
..... ......+..|+|||++....++.++|||||||++||+++ |+.|+...... .....+..........+.
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-----~~~~~i~~~~~~~~~~~~ 235 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-----EVMKAINDGFRLPAPMDC 235 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HHHHHHhcCCCCCCCCCC
Confidence 21111 111223567999999988889999999999999999987 88776321000 000111100111111112
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHHHc
Q 035917 555 ILQFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586 (611)
Q Consensus 555 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 586 (611)
...+.+++.+||+.+|++||++.+|++.|+++
T Consensus 236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 236 PSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 23456666699999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=307.85 Aligned_cols=234 Identities=19% Similarity=0.240 Sum_probs=196.4
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchh----HHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLG----EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~----~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|.....||.|+||.|..++. .+|..+|+|++++.+.- .+...+|..+|+.+.||+++++.+.|.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 3566678999999999999995 46899999999765432 245788999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||++||.|+.++++. +.++...++-+|.+|+.||+||| +..|++|||||+|||+|.+|.+||.|||+|+.+...
T Consensus 124 eyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred eccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence 999999999999865 35899999999999999999999 899999999999999999999999999999987532
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEILQ 557 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~ 557 (611)
..+.+||+.|+|||.+++..|...+|.|||||++|||+.|..||.++-.... ...++.-.+ .+...+.++++
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i----Y~KI~~~~v~fP~~fs~~~kd 270 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI----YEKILEGKVKFPSYFSSDAKD 270 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH----HHHHHhCcccCCcccCHHHHH
Confidence 2345799999999999999999999999999999999999999866432111 111221111 23455667777
Q ss_pred HHHHHhhcccCCCCCC
Q 035917 558 FLKVACNCVVSRPKDR 573 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~R 573 (611)
+++ +.++.|-.+|
T Consensus 271 Ll~---~LL~vD~t~R 283 (355)
T KOG0616|consen 271 LLK---KLLQVDLTKR 283 (355)
T ss_pred HHH---HHHhhhhHhh
Confidence 777 8899998888
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=326.10 Aligned_cols=198 Identities=19% Similarity=0.269 Sum_probs=169.7
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
.++|...+.||+|+||.||+|+.. +++.||||+++... .....+.+|+.+++.++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 457888899999999999999964 68999999986532 223567899999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
|++ ++|.+++......+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 157 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-- 157 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence 996 5888888765556899999999999999999999 8899999999999999999999999999997543221
Q ss_pred ccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHH
Q 035917 480 SFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLV 526 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~ 526 (611)
.......||+.|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 205 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFP 205 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 11233468999999998765 457899999999999999999998874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=329.82 Aligned_cols=238 Identities=20% Similarity=0.207 Sum_probs=190.3
Q ss_pred eeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCCh
Q 035917 332 IISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTL 406 (611)
Q Consensus 332 ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL 406 (611)
||+|+||.||+|+.. +++.||+|+++... .....+.+|+.++.+++||||+++++++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999964 58899999986432 2235678999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccCCC
Q 035917 407 YSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDL 486 (611)
Q Consensus 407 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 486 (611)
.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~ 154 (312)
T cd05585 81 FHHLQRE-GRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFC 154 (312)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccccc
Confidence 9999754 35899999999999999999999 8899999999999999999999999999998643222 1123346
Q ss_pred cccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc-hhhcCCCCHHHHHHHHHHHhhc
Q 035917 487 GEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID-KALCGKGYDEEILQFLKVACNC 565 (611)
Q Consensus 487 gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~~~~~~~~~~l~~l~~~C 565 (611)
||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...... +.......+.++.+++. +|
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~---~~ 227 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM----YRKILQEPLRFPDGFDRDAKDLLI---GL 227 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH----HHHHHcCCCCCCCcCCHHHHHHHH---HH
Confidence 99999999999998999999999999999999999998742110000 000111 11112234455566555 99
Q ss_pred ccCCCCCCCC---HHHHHHH
Q 035917 566 VVSRPKDRWS---MYQVYQS 582 (611)
Q Consensus 566 l~~dP~~RPs---~~evl~~ 582 (611)
|+.||++||+ +.|++.|
T Consensus 228 L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 228 LSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred cCCCHHHcCCCCCHHHHHcC
Confidence 9999999974 6777765
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=335.36 Aligned_cols=255 Identities=22% Similarity=0.346 Sum_probs=210.9
Q ss_pred CCCCeeeecCCceEEEEEeCC-CCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCC
Q 035917 327 CSENVIISTRTGTTYKAMLPD-GSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGT 405 (611)
Q Consensus 327 ~~~~~ig~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gs 405 (611)
.-.++||-|.||.||.|.|+. .-.||||.++.+....++|+.|..+|+.++|||+|+|+|+|..+...|||.|||.+|+
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGN 349 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGN 349 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCcc
Confidence 345789999999999999865 5689999999888788999999999999999999999999999999999999999999
Q ss_pred hHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccC
Q 035917 406 LYSLLQGNAT-ELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNG 484 (611)
Q Consensus 406 L~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 484 (611)
|.+||++... .++-...+.++.||+.||+||. .+.+|||||..+|+|+.++..+||+|||+++++..+.. +...+
T Consensus 350 LLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY-TAHAG 425 (1157)
T KOG4278|consen 350 LLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY-TAHAG 425 (1157)
T ss_pred HHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCce-ecccC
Confidence 9999987653 5777788899999999999999 89999999999999999999999999999999876543 33344
Q ss_pred CCcccccccccccCCCCCCcccchHHHHHHHHHHhCCC-CCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHHh
Q 035917 485 DLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFK-GNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVAC 563 (611)
Q Consensus 485 ~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~ 563 (611)
..-++.|.|||.+....++.|+|||+|||+|||+.|.. .|++..... .+-+.+....+.+.+..+...+.++++
T Consensus 426 AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-----qVY~LLEkgyRM~~PeGCPpkVYeLMr 500 (1157)
T KOG4278|consen 426 AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYGLLEKGYRMDGPEGCPPKVYELMR 500 (1157)
T ss_pred ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-----HHHHHHhccccccCCCCCCHHHHHHHH
Confidence 44567899999999999999999999999999999644 455432111 112222222233334445567777888
Q ss_pred hcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 564 NCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 564 ~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
.||+++|.+||++.|+.+.++.+....
T Consensus 501 aCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 501 ACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred HHhcCCcccCccHHHHHHHHHHHhccc
Confidence 999999999999999999998765443
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=330.08 Aligned_cols=241 Identities=18% Similarity=0.190 Sum_probs=192.8
Q ss_pred CeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCC
Q 035917 330 NVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSG 404 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~g 404 (611)
++||+|+||.||+++. .+|+.||||+++... .....+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999995 568999999996532 22356889999999999999999999999999999999999999
Q ss_pred ChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccC
Q 035917 405 TLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNG 484 (611)
Q Consensus 405 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 484 (611)
+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~ 154 (328)
T cd05593 81 ELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKT 154 (328)
T ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccccc
Confidence 999988754 36899999999999999999999 8899999999999999999999999999987543221 11223
Q ss_pred CCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHHhh
Q 035917 485 DLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACN 564 (611)
Q Consensus 485 ~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~ 564 (611)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.............. .+.. .....+.++.++++ +
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~--~~~~-~p~~~~~~~~~li~---~ 228 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EDIK-FPRTLSADAKSLLS---G 228 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc--CCcc-CCCCCCHHHHHHHH---H
Confidence 4699999999999988999999999999999999999998742111000000000 0001 11233455566555 9
Q ss_pred cccCCCCCCC-----CHHHHHHH
Q 035917 565 CVVSRPKDRW-----SMYQVYQS 582 (611)
Q Consensus 565 Cl~~dP~~RP-----s~~evl~~ 582 (611)
||+.||++|| ++.|+++|
T Consensus 229 ~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 229 LLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HcCCCHHHcCCCCCCCHHHHhcC
Confidence 9999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=318.27 Aligned_cols=249 Identities=21% Similarity=0.300 Sum_probs=190.7
Q ss_pred CCCCCeeeecCCceEEEEEeCC-CC--EEEEEecccc---chhHHHHHHHHHHHhccCCCCccceeeEEEeC------Ce
Q 035917 326 FCSENVIISTRTGTTYKAMLPD-GS--VLAVKRLNTC---KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE------EE 393 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~~~-g~--~vAvK~~~~~---~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~------~~ 393 (611)
|...+.||+|+||.||+|+..+ +. .||+|.++.. ....+.+.+|++++++++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3456899999999999999754 33 6999998653 23346789999999999999999999988542 24
Q ss_pred eEEEEeccCCCChHHhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecc
Q 035917 394 KLLIYKYMSSGTLYSLLQGN-----ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFG 468 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFG 468 (611)
.+++|||+++|+|.+++... ...+++.....++.|++.||+||| +.+|+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999887421 235899999999999999999999 7899999999999999999999999999
Q ss_pred cccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHH----HHhhcCChhhhhc
Q 035917 469 LAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVN----QLSSSGRSKEAID 543 (611)
Q Consensus 469 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~----~~~~~~~~~~~~~ 543 (611)
+++...............+++.|+|||+..+..++.++|||||||++|||++ ++.||..... .....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----- 232 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR----- 232 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence 9987643322111122246778999999998889999999999999999998 6666532100 00111000
Q ss_pred hhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHc
Q 035917 544 KALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586 (611)
Q Consensus 544 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 586 (611)
.......++. +.+++.+||+.||++|||+.+++++|+++
T Consensus 233 -~~~~~~~~~~---~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 -LKQPPDCLDG---LYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -CCCCCCCCHH---HHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011122333 45555599999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=322.26 Aligned_cols=250 Identities=17% Similarity=0.237 Sum_probs=193.1
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
++|...+.||+|+||.||+|+.. +++.||+|.++... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 45777899999999999999964 68999999986432 2345678999999999999999999999998999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
+++ +|.+++......+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-- 158 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-- 158 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--
Confidence 975 999988765556889999999999999999999 88999999999999999999999999999976532221
Q ss_pred cccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhhc-C--------------Chh
Q 035917 481 FVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSSS-G--------------RSK 539 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~~-~--------------~~~ 539 (611)
......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||.. ........ + ...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 1223458999999998765 5689999999999999999999887631 11111000 0 000
Q ss_pred hhhchhhc-------CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 540 EAIDKALC-------GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 540 ~~~~~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
....+... ....+.+.. +++.+|++.||.+|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~---dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGI---DLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHH---HHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000 011233444 45559999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=316.68 Aligned_cols=253 Identities=23% Similarity=0.345 Sum_probs=200.1
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
+.|...+.||+|+||.||+|+..++..||+|+++......+++.+|++++++++||||+++++++. .+..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCC
Confidence 457788999999999999999877778999999865556678999999999999999999999874 4567999999999
Q ss_pred CChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccc
Q 035917 404 GTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482 (611)
Q Consensus 404 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 482 (611)
|+|.+++.... ..+++..+..++.++++||+||| +.+++||||||+||++++++.+||+|||.++.+...... ..
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~ 160 (262)
T cd05071 85 GSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-AR 160 (262)
T ss_pred CcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccccc-cc
Confidence 99999997543 35899999999999999999999 789999999999999999999999999999866433211 11
Q ss_pred cCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHH
Q 035917 483 NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKV 561 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l 561 (611)
....++..|+|||+..+..++.++|||||||++|||++ |..||........ .+.+..........+....+.++
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~l 235 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-----LDQVERGYRMPCPPECPESLHDL 235 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-----HHHHhcCCCCCCccccCHHHHHH
Confidence 22346778999999988889999999999999999998 6666632211100 00000000011112223445666
Q ss_pred HhhcccCCCCCCCCHHHHHHHHHHc
Q 035917 562 ACNCVVSRPKDRWSMYQVYQSLNSI 586 (611)
Q Consensus 562 ~~~Cl~~dP~~RPs~~evl~~L~~i 586 (611)
+.+|++.||++||++.++++.|++.
T Consensus 236 i~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 236 MCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHHHccCCcccCCCHHHHHHHHHHh
Confidence 7799999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=328.60 Aligned_cols=196 Identities=19% Similarity=0.304 Sum_probs=171.2
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
++|...+.||+|+||.||++... +++.+|+|.+.... ...+++.+|++++++++||||++++++|..++..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 57888899999999999999965 68899999886532 2346789999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
+++|+|.+++... ..+++.....++.+++.||.|||+ ..+|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--- 158 (333)
T cd06650 85 MDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 158 (333)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc---
Confidence 9999999999754 358899999999999999999994 3479999999999999999999999999997653221
Q ss_pred cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHH
Q 035917 481 FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLV 526 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~ 526 (611)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 159 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~ 203 (333)
T cd06650 159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP 203 (333)
T ss_pred -cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 122358999999999998889999999999999999999988763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=322.14 Aligned_cols=254 Identities=20% Similarity=0.287 Sum_probs=197.7
Q ss_pred cCCCCCeeeecCCceEEEEEeC------CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEE
Q 035917 325 SFCSENVIISTRTGTTYKAMLP------DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~------~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
+|...+.||+|+||.||+|+.. ....+|+|.+.... ...+++.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 3667789999999999999842 23679999886433 234678999999999999999999999999999999
Q ss_pred EEeccCCCChHHhhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCe
Q 035917 397 IYKYMSSGTLYSLLQGNA-----------------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNV 453 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~N 453 (611)
+|||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence 999999999999875321 24789999999999999999999 7899999999999
Q ss_pred EEeCCCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHH
Q 035917 454 ILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQL 532 (611)
Q Consensus 454 ILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~ 532 (611)
|++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999986543222111122346778999999888889999999999999999998 776653211000
Q ss_pred hhcCChhhhhchhh---cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 533 SSSGRSKEAIDKAL---CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 533 ~~~~~~~~~~~~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
..+.+.... .....+.+ +.+++.+||+.+|++||++.|+++.|+++..+
T Consensus 238 -----~~~~~~~~~~~~~~~~~~~~---~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 238 -----LFNLLKTGYRMERPENCSEE---MYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred -----HHHHHhCCCCCCCCCCCCHH---HHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 001111100 11223334 44555599999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=317.60 Aligned_cols=253 Identities=22% Similarity=0.298 Sum_probs=193.7
Q ss_pred CCCCCeeeecCCceEEEEEeCC----CCEEEEEeccccch---hHHHHHHHHHHHhccCCCCccceeeEEEeCCe-----
Q 035917 326 FCSENVIISTRTGTTYKAMLPD----GSVLAVKRLNTCKL---GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEE----- 393 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~~~----g~~vAvK~~~~~~~---~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~----- 393 (611)
|...+.||+|+||.||+|.+.. +..||+|+++.... ..+.+.+|+..++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998642 37899999875432 23578999999999999999999999876554
Q ss_pred -eEEEEeccCCCChHHhhhcCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeec
Q 035917 394 -KLLIYKYMSSGTLYSLLQGNA-----TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDF 467 (611)
Q Consensus 394 -~~lv~ey~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DF 467 (611)
.+++|||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 789999999999999885321 35899999999999999999999 789999999999999999999999999
Q ss_pred ccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhh
Q 035917 468 GLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKAL 546 (611)
Q Consensus 468 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l 546 (611)
|+++...............++..|+|||++.+..++.++|||||||++|||++ |..|+.+..... ..+.+....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~-----~~~~~~~~~ 232 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE-----IYDYLRHGN 232 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHcCC
Confidence 99987643322111112235678999999988889999999999999999998 666653211100 000000000
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHc
Q 035917 547 CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586 (611)
Q Consensus 547 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 586 (611)
...........+.+++.+||+.||++||++.|++++|+++
T Consensus 233 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011112223455666699999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=316.35 Aligned_cols=249 Identities=22% Similarity=0.367 Sum_probs=198.4
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
++|...+.||+|+||.||+|...++..||+|.++......+++.+|+.++++++|+|++++++++. .+..+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence 356677899999999999999888889999999776666678999999999999999999999875 4568999999999
Q ss_pred CChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccc
Q 035917 404 GTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482 (611)
Q Consensus 404 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 482 (611)
++|.+++.+.. ..+++..+..++.+++.||+||| +.+++||||||+||++++++.++|+|||+++.+...... ..
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~ 160 (260)
T cd05070 85 GSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-AR 160 (260)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-cc
Confidence 99999997543 35899999999999999999999 789999999999999999999999999999876432211 11
Q ss_pred cCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhh---cCCCCHHHHHHH
Q 035917 483 NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKAL---CGKGYDEEILQF 558 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l---~~~~~~~~~~~l 558 (611)
....++..|+|||+..+..++.++||||||+++|||++ |..||.+.... ...+.+.... .....+.+ +
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~---~ 232 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-----EVLEQVERGYRMPCPQDCPIS---L 232 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHHcCCCCCCCCcCCHH---H
Confidence 22235678999999988889999999999999999998 77666321000 0011111111 11223334 4
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHH
Q 035917 559 LKVACNCVVSRPKDRWSMYQVYQSLNS 585 (611)
Q Consensus 559 ~~l~~~Cl~~dP~~RPs~~evl~~L~~ 585 (611)
.+++.+|++.+|++|||+.++.+.|++
T Consensus 233 ~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 233 HELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 455559999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=328.80 Aligned_cols=255 Identities=20% Similarity=0.279 Sum_probs=191.9
Q ss_pred CCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCC-----eeEE
Q 035917 326 FCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE-----EKLL 396 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~-----~~~l 396 (611)
|...+.||+|+||.||+|+. .+|+.||||+++... ....++.+|++++++++||||+++++++...+ ..++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 66778999999999999995 468999999986421 23456889999999999999999999886532 4799
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
|||||. ++|.+++... ..+++..+..++.|+++||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 v~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 82 VFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 999996 6899988754 35899999999999999999999 789999999999999999999999999999865322
Q ss_pred CC-CccccCCCcccccccccccCC--CCCCcccchHHHHHHHHHHhCCCCCHHHHH--------HHHhhc----------
Q 035917 477 DE-SSFVNGDLGEFGYIAPEYSST--MVASLKGDVYGIGVVLLELAGFKGNLVDWV--------NQLSSS---------- 535 (611)
Q Consensus 477 ~~-~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SfGvvl~ell~~~~~~~~~~--------~~~~~~---------- 535 (611)
.. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ......
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 21 112233469999999998765 678999999999999999999988763210 000000
Q ss_pred -CChhhhhc---hhhcC------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHchh
Q 035917 536 -GRSKEAID---KALCG------KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS--LNSIAA 588 (611)
Q Consensus 536 -~~~~~~~~---~~l~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~ 588 (611)
....+.+. ..... ...+. .+.+++.+||+.||++|||+.|+++| +..+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADP---LALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCCh---HHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 00000000 00000 01122 34456669999999999999999987 444333
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=333.02 Aligned_cols=243 Identities=17% Similarity=0.200 Sum_probs=196.6
Q ss_pred hcCCCCCeeeecCCceEEEEEeCC--CCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPD--GSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
++|...+.||+|+||.||+|+..+ +..||+|++.... ...+.+.+|+.++..++||||+++++++.+++..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 467788999999999999998543 4689999986432 2235688999999999999999999999999999999
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
|||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 110 ~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~ 185 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT 185 (340)
T ss_pred EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc
Confidence 9999999999999754 35899999999999999999999 8899999999999999999999999999998754221
Q ss_pred CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-hcCCCCHHHHH
Q 035917 478 ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-LCGKGYDEEIL 556 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~~ 556 (611)
....||+.|+|||++.+..++.++|||||||++|||++|..||........ ...+.... ..+...+++..
T Consensus 186 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~----~~~i~~~~~~~p~~~~~~~~ 256 (340)
T PTZ00426 186 -----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI----YQKILEGIIYFPKFLDNNCK 256 (340)
T ss_pred -----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH----HHHHhcCCCCCCCCCCHHHH
Confidence 234699999999999888899999999999999999999998743111000 00111110 01223445566
Q ss_pred HHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 035917 557 QFLKVACNCVVSRPKDRW-----SMYQVYQS 582 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 582 (611)
++++ +|++.||++|+ +++++++|
T Consensus 257 ~li~---~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 257 HLMK---KLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHH---HHcccCHHHcCCCCCCCHHHHHcC
Confidence 6666 99999999995 89999887
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=334.38 Aligned_cols=241 Identities=23% Similarity=0.389 Sum_probs=187.1
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
+|...+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 344557899999999999995 468999999985432 23467899999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
++|+|.+.. ..++..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++.+..... .
T Consensus 155 ~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~ 224 (353)
T PLN00034 155 DGGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--P 224 (353)
T ss_pred CCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--c
Confidence 999986532 2567788899999999999999 78999999999999999999999999999987643211 1
Q ss_pred ccCCCcccccccccccCC-----CCCCcccchHHHHHHHHHHhCCCCCHH-----HHHHHHhhcCChhhhhchhhcCCCC
Q 035917 482 VNGDLGEFGYIAPEYSST-----MVASLKGDVYGIGVVLLELAGFKGNLV-----DWVNQLSSSGRSKEAIDKALCGKGY 551 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~SfGvvl~ell~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~~~~ 551 (611)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||. +|....... ............
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 300 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI----CMSQPPEAPATA 300 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH----hccCCCCCCCcc
Confidence 223469999999998743 234568999999999999999998874 111110000 000001111223
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 552 DEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 552 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+.++.+++. +||+.||++||++.|+++|
T Consensus 301 ~~~l~~li~---~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 301 SREFRHFIS---CCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CHHHHHHHH---HHccCChhhCcCHHHHhcC
Confidence 445555555 9999999999999999987
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=322.88 Aligned_cols=254 Identities=21% Similarity=0.294 Sum_probs=199.2
Q ss_pred hhcCCCCCeeeecCCceEEEEEe--------CCCCEEEEEeccccc--hhHHHHHHHHHHHhcc-CCCCccceeeEEEeC
Q 035917 323 SNSFCSENVIISTRTGTTYKAML--------PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVE 391 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~--------~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~ 391 (611)
-++|...+.||+|+||.||+|+. .++..||+|.++... ...+++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 45677889999999999999973 134579999986532 3346789999999999 899999999999999
Q ss_pred CeeEEEEeccCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEe
Q 035917 392 EEKLLIYKYMSSGTLYSLLQGNA---------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV 456 (611)
Q Consensus 392 ~~~~lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl 456 (611)
+..++||||+++|+|.+++.... ..++|..+..++.|+++||.||| +.+++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence 99999999999999999986531 24788999999999999999999 7899999999999999
Q ss_pred CCCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHH-----HHHH
Q 035917 457 DEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLV-----DWVN 530 (611)
Q Consensus 457 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~-----~~~~ 530 (611)
++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+. ++..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 250 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 9999999999999987643322222222346778999999988889999999999999999997 555542 1111
Q ss_pred HHhhcCChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 531 QLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 531 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
... .... . ......+.++.. ++.+||+.+|++||++.|+++.|+++..-
T Consensus 251 ~~~-~~~~-----~-~~~~~~~~~~~~---li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 251 LLK-EGHR-----M-DKPANCTNELYM---MMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHH-cCCc-----C-CCCCCCCHHHHH---HHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 111 1100 0 011223344445 45599999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=320.57 Aligned_cols=253 Identities=21% Similarity=0.269 Sum_probs=195.9
Q ss_pred hhhcCCCCCeeeecCCceEEEEEeC------CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCe
Q 035917 322 ASNSFCSENVIISTRTGTTYKAMLP------DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEE 393 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~~------~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~ 393 (611)
.+++|...+.||+|++|.||+|... .+..||+|.++... .....|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3467888899999999999999964 36789999886433 234569999999999999999999999999889
Q ss_pred eEEEEeccCCCChHHhhhcCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC---CeEE
Q 035917 394 KLLIYKYMSSGTLYSLLQGNA------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF---DARI 464 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~---~~kl 464 (611)
.++||||+++|+|.+++.... ..++|..+..++.||+.||+||| +.+++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999986542 25899999999999999999999 78999999999999998654 6999
Q ss_pred eecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhc
Q 035917 465 MDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAID 543 (611)
Q Consensus 465 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~ 543 (611)
+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...... ...+.+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-----~~~~~~~ 235 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-----EVMEFVT 235 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHH
Confidence 99999987633221111112234578999999988889999999999999999996 77665321000 0001111
Q ss_pred hhh---cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 035917 544 KAL---CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNS 585 (611)
Q Consensus 544 ~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 585 (611)
... .....+. .+.+++.+||+.+|++||++.+|+++|++
T Consensus 236 ~~~~~~~~~~~~~---~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 236 GGGRLDPPKGCPG---PVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred cCCcCCCCCCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 000 0112233 44555559999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=312.43 Aligned_cols=246 Identities=23% Similarity=0.292 Sum_probs=193.1
Q ss_pred CeeeecCCceEEEEEeCCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCChH
Q 035917 330 NVIISTRTGTTYKAMLPDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLY 407 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL~ 407 (611)
++||+|+||.||+|...+++.||+|.++... .....+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998889999999986543 22356899999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccCCCc
Q 035917 408 SLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLG 487 (611)
Q Consensus 408 ~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 487 (611)
+++......+++..+..++.+++.||.|+| ..+++||||||+||++++++.+||+|||++........ .......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI 156 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence 998765556899999999999999999999 88999999999999999999999999999975432211 11111234
Q ss_pred ccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHHhhcc
Q 035917 488 EFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCV 566 (611)
Q Consensus 488 t~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl 566 (611)
+..|+|||++.+..++.++||||||+++||+++ |..||....... ....+...............+.+++.+||
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~l 231 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-----AREQVEKGYRMSCPQKCPDDVYKVMQRCW 231 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-----HHHHHHcCCCCCCCCCCCHHHHHHHHHHc
Confidence 678999999988889999999999999999998 776763211000 00000000011111112234555666999
Q ss_pred cCCCCCCCCHHHHHHHHH
Q 035917 567 VSRPKDRWSMYQVYQSLN 584 (611)
Q Consensus 567 ~~dP~~RPs~~evl~~L~ 584 (611)
..+|++||++.|+++.|.
T Consensus 232 ~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 232 DYKPENRPKFSELQKELA 249 (250)
T ss_pred ccCcccCCCHHHHHHHhc
Confidence 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=344.66 Aligned_cols=243 Identities=18% Similarity=0.180 Sum_probs=195.2
Q ss_pred CCCCCeeeecCCceEEEEEeC-C-CCEEEEEeccccch-hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccC
Q 035917 326 FCSENVIISTRTGTTYKAMLP-D-GSVLAVKRLNTCKL-GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~~-~-g~~vAvK~~~~~~~-~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
|...+.||+|++|.||+|... + ++.||+|.+..... ....+.+|+.+++.++|||||++++++..++..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 677889999999999999843 3 67889998754332 33567889999999999999999999999999999999999
Q ss_pred CCChHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 403 SGTLYSLLQGN---ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 403 ~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
+|+|.+++... ..++++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999988642 236889999999999999999999 789999999999999999999999999999876433222
Q ss_pred ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh------cCCCCHH
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL------CGKGYDE 553 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l------~~~~~~~ 553 (611)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.+...+ .....+.
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~--------~~~~~~~~~~~~~~~~~~~~s~ 297 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS--------QREIMQQVLYGKYDPFPCPVSS 297 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCCCccCCH
Confidence 22334569999999999999899999999999999999999998873211 011111111 1112334
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 554 EILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 554 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++.+++. +||+.||++||++.+++.+
T Consensus 298 ~~~~li~---~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 298 GMKALLD---PLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HHHHHHH---HHhccChhhCcCHHHHHhC
Confidence 4555555 9999999999999998754
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=323.80 Aligned_cols=256 Identities=21% Similarity=0.275 Sum_probs=198.8
Q ss_pred hcCCCCCeeeecCCceEEEEEeC--------CCCEEEEEeccccc--hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCC
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP--------DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEE 392 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~--------~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~ 392 (611)
++|...+.||+|+||.||+++.. ++..+|+|.++... ....++.+|++++.++ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56888899999999999999742 23579999997532 3345688999999999 7999999999999999
Q ss_pred eeEEEEeccCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC
Q 035917 393 EKLLIYKYMSSGTLYSLLQGNA---------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD 457 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld 457 (611)
..++||||+++|+|.+++.... ..++|..+++++.|++.||+||| +.+++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence 9999999999999999996532 24899999999999999999999 78999999999999999
Q ss_pred CCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcC
Q 035917 458 EDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSG 536 (611)
Q Consensus 458 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~ 536 (611)
.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+......
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~----- 249 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----- 249 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----
Confidence 999999999999976543221111112234568999999988889999999999999999997 66654211000
Q ss_pred Chhhhhchhhc---CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 537 RSKEAIDKALC---GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 537 ~~~~~~~~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
...+.+..... ....+.+ +.+++.+||+.+|++||+|.+|++.|+++.+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~---~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 250 ELFKLLKEGHRMDKPSNCTNE---LYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHHHHHcCCCCCCCCcCCHH---HHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 00001100101 1122334 444555999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=317.62 Aligned_cols=257 Identities=22% Similarity=0.342 Sum_probs=195.7
Q ss_pred hcCCCCCeeeecCCceEEEEEe-----CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeC--CeeE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-----PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE--EEKL 395 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-----~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~--~~~~ 395 (611)
.+|...+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 3567778999999999999984 358899999986543 3346789999999999999999999987643 4678
Q ss_pred EEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
+||||+++|+|.+++.+....+++..+..++.|++.||+||| ..+|+||||||+||++++++.+||+|||+++....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999999999765556899999999999999999999 78999999999999999999999999999987643
Q ss_pred CCCCccc-cCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHH----HHHHHHhhcCC-------hhhhhc
Q 035917 476 SDESSFV-NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLV----DWVNQLSSSGR-------SKEAID 543 (611)
Q Consensus 476 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~----~~~~~~~~~~~-------~~~~~~ 543 (611)
....... ....++..|+|||++.+..++.++|||||||++|||+++..+.. .+......... ..+.+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 3221111 11224556999999988889999999999999999998754321 11111110000 001111
Q ss_pred hhhc---CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHc
Q 035917 544 KALC---GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586 (611)
Q Consensus 544 ~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 586 (611)
.... ....+.+ +.+++.+||+.+|++||||.||++.|+.+
T Consensus 241 ~~~~~~~~~~~~~~---~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 241 NNGRLPAPPGCPAE---IYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cCCcCCCCCCCCHH---HHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1100 1122334 45555599999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=329.58 Aligned_cols=256 Identities=18% Similarity=0.249 Sum_probs=196.3
Q ss_pred hcCCCCCeeeecCCceEEEEEe------CCCCEEEEEeccccc--hhHHHHHHHHHHHhcc-CCCCccceeeEEEeC-Ce
Q 035917 324 NSFCSENVIISTRTGTTYKAML------PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVE-EE 393 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~------~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~-~~ 393 (611)
++|...+.||+|+||.||+|+. .+++.||||+++... .....+.+|+.++.++ +||||++++++|... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4678889999999999999973 357899999997533 2335688999999999 689999999988764 45
Q ss_pred eEEEEeccCCCChHHhhhcCC-----------------------------------------------------------
Q 035917 394 KLLIYKYMSSGTLYSLLQGNA----------------------------------------------------------- 414 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~----------------------------------------------------------- 414 (611)
.+++|||+++|+|.+++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 789999999999999886421
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccCCCc
Q 035917 415 -------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLG 487 (611)
Q Consensus 415 -------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 487 (611)
..++|..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++...............+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 13678888999999999999999 88999999999999999999999999999986543222111222335
Q ss_pred ccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhh---cCCCCHHHHHHHHHHHh
Q 035917 488 EFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKAL---CGKGYDEEILQFLKVAC 563 (611)
Q Consensus 488 t~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l---~~~~~~~~~~~l~~l~~ 563 (611)
+..|+|||.+.+..++.++||||||+++|||++ |..|+....... .....+.... .....+. .+.+++.
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 316 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----EFCRRLKEGTRMRAPDYTTP---EMYQTML 316 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH----HHHHHHhccCCCCCCCCCCH---HHHHHHH
Confidence 678999999988889999999999999999996 776653210000 0000000000 0111222 4566667
Q ss_pred hcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 564 NCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 564 ~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
+||+.||++||++.||+++|+.+.+.
T Consensus 317 ~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 317 DCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=335.90 Aligned_cols=249 Identities=16% Similarity=0.165 Sum_probs=193.7
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
.|...+.||+|+||.||+|+. .+++.||||+++... ...+.+.+|++++.+++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 477788999999999999985 568999999996532 223568899999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC-
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE- 478 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~- 478 (611)
|+++|+|.+++... ..+++..+..++.|++.||+||| ..+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 99999999998754 35888999999999999999999 88999999999999999999999999999764311000
Q ss_pred --------------------------------------------CccccCCCcccccccccccCCCCCCcccchHHHHHH
Q 035917 479 --------------------------------------------SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVV 514 (611)
Q Consensus 479 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvv 514 (611)
.......+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 000123469999999999988889999999999999
Q ss_pred HHHHhCCCCCHHHHHHHHhhcCChhhhhc----hhhc-CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 515 LLELAGFKGNLVDWVNQLSSSGRSKEAID----KALC-GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 515 l~ell~~~~~~~~~~~~~~~~~~~~~~~~----~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+|||++|+.||........ ...++. .... ....+.+..+++.-+ .|+..+|..||++.|+++|
T Consensus 238 l~elltG~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~~dli~~l-l~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTET----QLKVINWENTLHIPPQVKLSPEAVDLITKL-CCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHHhCCCCCcCCCHHHH----HHHHHccccccCCCCCCCCCHHHHHHHHHH-ccCcccccCCCCHHHHhcC
Confidence 9999999998743211100 001110 0010 112345566665511 2666777779999999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=314.53 Aligned_cols=252 Identities=21% Similarity=0.326 Sum_probs=199.8
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
++|...++||+|+||.||+|...+++.||+|.+.......+++.+|+.++++++|+||+++++++. .+..+++|||+++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMEN 84 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCC
Confidence 467778899999999999999989999999999876666778999999999999999999999864 5678999999999
Q ss_pred CChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccc
Q 035917 404 GTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482 (611)
Q Consensus 404 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 482 (611)
|+|.+++.... ..+++..+..++.+++.||+||| +.+++||||||+||++++++.++|+|||++........ ...
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~ 160 (260)
T cd05067 85 GSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TAR 160 (260)
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-ccc
Confidence 99999986543 46899999999999999999999 88999999999999999999999999999987642221 111
Q ss_pred cCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHH
Q 035917 483 NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKV 561 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l 561 (611)
....++..|+|||++....++.++||||||+++||+++ |+.||.......... ........ ......+.+ +.++
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~---~~~l 235 (260)
T cd05067 161 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ-NLERGYRM-PRPDNCPEE---LYEL 235 (260)
T ss_pred cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH-HHHcCCCC-CCCCCCCHH---HHHH
Confidence 22346778999999988889999999999999999998 887763211000000 00000000 011223344 4445
Q ss_pred HhhcccCCCCCCCCHHHHHHHHHH
Q 035917 562 ACNCVVSRPKDRWSMYQVYQSLNS 585 (611)
Q Consensus 562 ~~~Cl~~dP~~RPs~~evl~~L~~ 585 (611)
+.+||+.+|++||+++++++.|+.
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 236 MRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHccCChhhCCCHHHHHHHhhc
Confidence 559999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.34 Aligned_cols=253 Identities=20% Similarity=0.290 Sum_probs=198.7
Q ss_pred hcCCCCCeeeecCCceEEEEEe------CCCCEEEEEeccccc--hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCee
Q 035917 324 NSFCSENVIISTRTGTTYKAML------PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEK 394 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~------~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~ 394 (611)
++|...+.||+|+||.||+|.. .++..||||.++... ...+.+.+|+++++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 5688899999999999999974 235689999987543 2345789999999999 799999999999999999
Q ss_pred EEEEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccccc
Q 035917 395 LLIYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLM 473 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~ 473 (611)
++||||+++|+|.+++.... ..+++.++..++.+++.||+||| +.+|+|+||||+||+++.++.+|++|||+++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 99999999999999997543 34899999999999999999999 789999999999999999999999999999866
Q ss_pred CCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhh---cCC
Q 035917 474 TSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKAL---CGK 549 (611)
Q Consensus 474 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l---~~~ 549 (611)
.............++..|+|||.+.+..++.++|||||||++|||++ |..|+...... ....+.++... ...
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~ 267 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD----SKFYKLIKEGYRMAQPE 267 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch----HHHHHHHHcCCcCCCCC
Confidence 43322111222346788999999988889999999999999999997 77775321000 00001111111 111
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHc
Q 035917 550 GYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586 (611)
Q Consensus 550 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 586 (611)
..++++.+ ++.+||+.+|++||++.|+++.|+++
T Consensus 268 ~~~~~~~~---li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 268 HAPAEIYD---IMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCHHHHH---HHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 23344444 55599999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=313.76 Aligned_cols=252 Identities=22% Similarity=0.349 Sum_probs=197.8
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
+.|.....||+|++|.||+|....+..||+|.+.......+.+.+|++++++++|||++++++++. .+..+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 457777899999999999999877778999998765555678999999999999999999998875 5568899999999
Q ss_pred CChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccc
Q 035917 404 GTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482 (611)
Q Consensus 404 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 482 (611)
|+|.+++.... ..++|..+..++.+++.||+||| +.+++|+||||+||++++++.+||+|||+++....... ...
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~~ 160 (260)
T cd05069 85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TAR 160 (260)
T ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-ccc
Confidence 99999997543 35899999999999999999999 78999999999999999999999999999987643221 111
Q ss_pred cCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHH
Q 035917 483 NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKV 561 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l 561 (611)
....++..|+|||...+..++.++|||||||++|||++ |..|+.+........ ........ ......+.++.+ +
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~---l 235 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLE-QVERGYRM-PCPQGCPESLHE---L 235 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCC-CCCcccCHHHHH---H
Confidence 22346778999999988889999999999999999998 777764311110000 00000000 011223344444 5
Q ss_pred HhhcccCCCCCCCCHHHHHHHHHH
Q 035917 562 ACNCVVSRPKDRWSMYQVYQSLNS 585 (611)
Q Consensus 562 ~~~Cl~~dP~~RPs~~evl~~L~~ 585 (611)
+.+||+.||++||++++|++.|++
T Consensus 236 i~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 236 MKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHccCCcccCcCHHHHHHHHhc
Confidence 559999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=335.08 Aligned_cols=255 Identities=19% Similarity=0.257 Sum_probs=197.2
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC------CCCEEEEEeccccch--hHHHHHHHHHHHhccC-CCCccceeeEEEeCCe
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP------DGSVLAVKRLNTCKL--GEKKFRNEMNRLGQLR-HPNLAPLLGYCVVEEE 393 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~------~g~~vAvK~~~~~~~--~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~~~ 393 (611)
.++|...+.||+|+||.||+|++. .++.||||+++.... ..+.+.+|+++|.++. |||||+++++|...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 346777899999999999999853 346899999975432 2356889999999997 9999999999999999
Q ss_pred eEEEEeccCCCChHHhhhcCC-----------------------------------------------------------
Q 035917 394 KLLIYKYMSSGTLYSLLQGNA----------------------------------------------------------- 414 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~----------------------------------------------------------- 414 (611)
.++||||+++|+|.++++...
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999986421
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEe
Q 035917 415 --------------------------------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV 456 (611)
Q Consensus 415 --------------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl 456 (611)
..++|..+.+++.|++.||+||| ..+++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEE
Confidence 13677888999999999999999 7899999999999999
Q ss_pred CCCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhc
Q 035917 457 DEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSS 535 (611)
Q Consensus 457 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~ 535 (611)
++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ +..|+......
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~---- 348 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN---- 348 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch----
Confidence 9999999999999986533221111223357889999999988889999999999999999997 66665321000
Q ss_pred CChhhhhchhh---cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHch
Q 035917 536 GRSKEAIDKAL---CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIA 587 (611)
Q Consensus 536 ~~~~~~~~~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 587 (611)
....+.+.... .+...+.++.++ +.+||+.+|.+||+++||++.|+.+.
T Consensus 349 ~~~~~~~~~~~~~~~p~~~~~~l~~l---i~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 EQFYNAIKRGYRMAKPAHASDEIYEI---MQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHH---HHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 00001111111 111233444454 44999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=317.87 Aligned_cols=256 Identities=21% Similarity=0.258 Sum_probs=194.6
Q ss_pred CCCCeeeecCCceEEEEEe-----CCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeC--CeeEEE
Q 035917 327 CSENVIISTRTGTTYKAML-----PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE--EEKLLI 397 (611)
Q Consensus 327 ~~~~~ig~G~~g~Vy~~~~-----~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~--~~~~lv 397 (611)
...+.||+|+||+||++.. .+++.||+|.++... ...+.+.+|++++++++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 5678999999999988653 468899999997543 2456789999999999999999999988754 357899
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
|||+++|+|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++......
T Consensus 87 ~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 87 MEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred ecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 9999999999998754 4899999999999999999999 7899999999999999999999999999998764322
Q ss_pred CCcc-ccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHH---HHHhhc-------CChhhhhchhh
Q 035917 478 ESSF-VNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWV---NQLSSS-------GRSKEAIDKAL 546 (611)
Q Consensus 478 ~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~---~~~~~~-------~~~~~~~~~~l 546 (611)
.... .....++..|+|||.+....++.++||||||+++|||++|..|+.... ...... ....+..+...
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM 241 (283)
T ss_pred hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCC
Confidence 1111 112235677999999988889999999999999999999987642110 010000 00111111111
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHch
Q 035917 547 CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIA 587 (611)
Q Consensus 547 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 587 (611)
...........+.+++.+||+.+|++|||+++|++.|+++.
T Consensus 242 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111111234555555999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=314.00 Aligned_cols=243 Identities=20% Similarity=0.302 Sum_probs=189.9
Q ss_pred eeeecCCceEEEEEeC---CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCC
Q 035917 331 VIISTRTGTTYKAMLP---DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGT 405 (611)
Q Consensus 331 ~ig~G~~g~Vy~~~~~---~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gs 405 (611)
.||+|+||.||+|++. ++..||+|.+.... ...+.+.+|+.++++++||||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999853 35679999986543 23467999999999999999999999885 456899999999999
Q ss_pred hHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC-ccccC
Q 035917 406 LYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES-SFVNG 484 (611)
Q Consensus 406 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~-~~~~~ 484 (611)
|.+++......+++..+++++.|++.||+||| ..+++||||||+||+++.++.+||+|||+++........ .....
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99999765557899999999999999999999 789999999999999999999999999999865433211 11112
Q ss_pred CCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHH----HHhhcCChhhhhchhhcCCCCHHHHHHHH
Q 035917 485 DLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVN----QLSSSGRSKEAIDKALCGKGYDEEILQFL 559 (611)
Q Consensus 485 ~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~----~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 559 (611)
..++..|+|||.+....++.++|||||||++||+++ |..||.+... .....+. .+ ......++++.+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-----~~-~~~~~~~~~l~~-- 229 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-----RL-DCPAECPPEMYA-- 229 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-----CC-CCCCCCCHHHHH--
Confidence 234678999999988889999999999999999996 8777642111 0111110 00 011223445555
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHc
Q 035917 560 KVACNCVVSRPKDRWSMYQVYQSLNSI 586 (611)
Q Consensus 560 ~l~~~Cl~~dP~~RPs~~evl~~L~~i 586 (611)
++.+||..+|++||++.+|.+.|+.+
T Consensus 230 -li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 230 -LMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -HHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 44499999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=318.18 Aligned_cols=259 Identities=22% Similarity=0.307 Sum_probs=201.1
Q ss_pred hhcCCCCCeeeecCCceEEEEEeCC-----CCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEe-CCee
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLPD-----GSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVV-EEEK 394 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~~-----g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~-~~~~ 394 (611)
.++|...++||+|+||.||+|...+ +..|++|++.... ...+.+.+|+.++++++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 3567788999999999999999765 7899999986532 234668999999999999999999999876 4678
Q ss_pred EEEEeccCCCChHHhhhcCC-------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeec
Q 035917 395 LLIYKYMSSGTLYSLLQGNA-------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDF 467 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DF 467 (611)
++++||+++|+|.+++.... ..+++..+..++.+++.||+||| +.+++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence 89999999999999986432 35899999999999999999999 789999999999999999999999999
Q ss_pred ccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhh
Q 035917 468 GLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKAL 546 (611)
Q Consensus 468 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l 546 (611)
|+++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.|+.+........ ..........
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~~ 240 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAA-YLKDGYRLAQ 240 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHH-HHHcCCCCCC
Confidence 99986643332211222346778999999988889999999999999999998 887764311100000 0000000000
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 547 CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 547 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
....+++ +.+++.+||+.||++|||+.++++.|+++.++
T Consensus 241 -~~~~~~~---~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 241 -PINCPDE---LFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred -CCcCCHH---HHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 1112334 44555599999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=318.66 Aligned_cols=256 Identities=19% Similarity=0.281 Sum_probs=194.0
Q ss_pred hcCCCCCeeeecCCceEEEEEeCC---------------CCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceee
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPD---------------GSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLG 386 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~---------------g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g 386 (611)
+.|...+.||+|+||.||+++... ...||+|.++... .....|.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 467778899999999999987532 2358999986532 23457999999999999999999999
Q ss_pred EEEeCCeeEEEEeccCCCChHHhhhcCC-----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEE
Q 035917 387 YCVVEEEKLLIYKYMSSGTLYSLLQGNA-----------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVIL 455 (611)
Q Consensus 387 ~~~~~~~~~lv~ey~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIL 455 (611)
++...+..++||||+++++|.+++.... ..+++..++.++.+++.||+||| +.+++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence 9999999999999999999999986431 13789999999999999999999 789999999999999
Q ss_pred eCCCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC--CCCCHHHHHHHH-
Q 035917 456 VDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG--FKGNLVDWVNQL- 532 (611)
Q Consensus 456 ld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~--~~~~~~~~~~~~- 532 (611)
+++++.+||+|||+++...............++..|+|||+.....++.++|||||||++|||++ +..||.......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999986543322222222346778999999988889999999999999999987 444543211000
Q ss_pred hhc-CChhhhhchhh---cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 035917 533 SSS-GRSKEAIDKAL---CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNS 585 (611)
Q Consensus 533 ~~~-~~~~~~~~~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 585 (611)
... ........... .....++ .+.+++.+||+.||++||+|.+|++.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~---~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 242 IENTGEFFRNQGRQIYLSQTPLCPS---PVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHhhhhccccccCCCCCCCCH---HHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 000 00000000000 0111223 45556669999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=314.69 Aligned_cols=270 Identities=21% Similarity=0.247 Sum_probs=197.0
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCC-----eeEEEE
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE-----EKLLIY 398 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~-----~~~lv~ 398 (611)
.|...+++|.|+||.||+|++ ++++.||||++-.+.. --.+|+++|++++|||||++..+|.... ...+||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 455678999999999999995 4579999999854432 2247999999999999999998887532 234899
Q ss_pred eccCCCChHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCC-CCeEEeecccccccC
Q 035917 399 KYMSSGTLYSLLQGN---ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDED-FDARIMDFGLAKLMT 474 (611)
Q Consensus 399 ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~-~~~kl~DFGla~~~~ 474 (611)
||||. +|.++++.. +..++...++-+..|+.+||.||| ..+|+||||||+|+|+|.+ |.+||||||-|+.+.
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99998 999988732 245777788889999999999999 8999999999999999966 899999999999887
Q ss_pred CCCCCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhh---c----------
Q 035917 475 SSDESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSS---S---------- 535 (611)
Q Consensus 475 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~---~---------- 535 (611)
..+... +..-|..|+|||.+.+ ..|+.+.||||.|||+.||+-|+.-|.. ....+.. .
T Consensus 178 ~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 178 KGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred cCCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 655332 2346889999998766 5699999999999999999977654321 1111100 0
Q ss_pred CChhhhhchhhcCCC-----CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHchhhhCCCCCCCCcccccc
Q 035917 536 GRSKEAIDKALCGKG-----YDEEILQFLKVACNCVVSRPKDRWSMYQVYQS--LNSIAAQHGFSERYDEFPLIFH 604 (611)
Q Consensus 536 ~~~~~~~~~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~~~~~~~~~~~~~~~~~ 604 (611)
....+.-.+.+.... ......+.++++.+++..+|.+|.++.|++.| .+++........+....|..|+
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~lp~lf~ 330 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRPLPPLFN 330 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCcCCCccC
Confidence 000011111221111 11122345556669999999999999999987 5666655444344455565554
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=332.29 Aligned_cols=247 Identities=18% Similarity=0.217 Sum_probs=197.1
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch----hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL----GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||.||+++. .+|+.||+|+++.... ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 3677889999999999999995 4689999999975432 3356889999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999866557999999999999999999999 88999999999999999999999999999987643322
Q ss_pred CccccCCCcccccccccccC------CCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCChhhhhchhhc
Q 035917 479 SSFVNGDLGEFGYIAPEYSS------TMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGRSKEAIDKALC 547 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~ 547 (611)
. ......||+.|+|||++. ...++.++|||||||++|||++|+.||... ......... .... ..
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~---~~~~-~~ 232 (330)
T cd05601 158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR---FLKF-PE 232 (330)
T ss_pred e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC---ccCC-CC
Confidence 1 122346899999999876 456789999999999999999999887421 111111000 0000 00
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 548 GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 548 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
....+.++.++++ +|++ +|++||++.++++|
T Consensus 233 ~~~~~~~~~~li~---~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 233 DPKVSSDFLDLIQ---SLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCCCCHHHHHHHH---HHcc-ChhhCCCHHHHhCC
Confidence 1123455555555 8997 99999999999976
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.06 Aligned_cols=254 Identities=23% Similarity=0.346 Sum_probs=197.2
Q ss_pred hcCCCCCeeeecCCceEEEEEeCC-C--CEEEEEecccc--chhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPD-G--SVLAVKRLNTC--KLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~-g--~~vAvK~~~~~--~~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~lv 397 (611)
++|...++||+|+||.||+|+..+ + ..+++|.++.. ....+.+.+|++++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 467788999999999999999653 3 34788888642 23346789999999999 799999999999999999999
Q ss_pred EeccCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCe
Q 035917 398 YKYMSSGTLYSLLQGNA---------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDA 462 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~ 462 (611)
|||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 99999999999986432 24889999999999999999999 7899999999999999999999
Q ss_pred EEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhh
Q 035917 463 RIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEA 541 (611)
Q Consensus 463 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~ 541 (611)
||+|||++........ ......+..|+|||+..+..++.++|||||||++|||++ |..||....... ..+.
T Consensus 159 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-----~~~~ 230 (297)
T cd05089 159 KIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-----LYEK 230 (297)
T ss_pred EECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHH
Confidence 9999999864321111 111123567999999988889999999999999999997 777763211000 0001
Q ss_pred hchhhc---CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 542 IDKALC---GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 542 ~~~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
+..... ....+.++. +++.+||+.+|.+||++.++++.|+++.+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~---~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 231 LPQGYRMEKPRNCDDEVY---ELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HhcCCCCCCCCCCCHHHH---HHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 111111 112334444 45559999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=317.28 Aligned_cols=253 Identities=20% Similarity=0.304 Sum_probs=197.4
Q ss_pred HhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhcc-CCCCccceeeEEEeC------C
Q 035917 321 AASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVE------E 392 (611)
Q Consensus 321 ~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~------~ 392 (611)
.+++.|...+.||+|+||.||+|.. .+++.||+|++.........+.+|+.++.++ +||||+++++++... +
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 3566788888999999999999995 4689999999976655567789999999999 699999999998753 4
Q ss_pred eeEEEEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccc
Q 035917 393 EKLLIYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAK 471 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~ 471 (611)
..+++|||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+|+||||+||++++++.+||+|||+++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 5789999999999999987643 36899999999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCCCCccccCCCcccccccccccC-----CCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh
Q 035917 472 LMTSSDESSFVNGDLGEFGYIAPEYSS-----TMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL 546 (611)
Q Consensus 472 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l 546 (611)
...... .......|+..|+|||++. ...++.++|||||||++|||++|+.|+.+........ .......+..
T Consensus 160 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~ 236 (272)
T cd06637 160 QLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPAPRL 236 (272)
T ss_pred eccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-HHhcCCCCCC
Confidence 653221 1122346899999999875 3457889999999999999999998874321111000 0000011111
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 547 CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 547 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.....+.++.+ ++.+||..+|.+|||+.|+++|
T Consensus 237 ~~~~~~~~~~~---li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 237 KSKKWSKKFQS---FIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCcCHHHHH---HHHHHcCCChhhCCCHHHHhhC
Confidence 11223344444 4459999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=315.91 Aligned_cols=243 Identities=17% Similarity=0.245 Sum_probs=199.6
Q ss_pred CCCCCeeeecCCceEEEEE-eCCCCEEEEEeccccchhH----HHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 326 FCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCKLGE----KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~~~~----~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
|...+.||+|.||.|-+|. ...|+.||||.+++++... -.+++|++||+.|+||||+.++.+|...+...+||||
T Consensus 55 yE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEY 134 (668)
T KOG0611|consen 55 YEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEY 134 (668)
T ss_pred HHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEe
Confidence 4445689999999999998 4789999999998754322 3478999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
..+|.|+||+.+. +.+++.+...+++||..|+.|+| .++++|||||.+|||+|.++++||+|||++-++.+. .
T Consensus 135 aS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~---k 207 (668)
T KOG0611|consen 135 ASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK---K 207 (668)
T ss_pred cCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhccc---c
Confidence 9999999999865 46999999999999999999999 899999999999999999999999999999887543 3
Q ss_pred cccCCCcccccccccccCCCCC-CcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHH
Q 035917 481 FVNGDLGEFGYIAPEYSSTMVA-SLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFL 559 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 559 (611)
..++++|++.|.+||++.+.+| ++..|-||+||+||.|+.|..||........-++ +-.-.......+.....++
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQ----Is~GaYrEP~~PSdA~gLI 283 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQ----ISRGAYREPETPSDASGLI 283 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHH----hhcccccCCCCCchHHHHH
Confidence 4556789999999999999988 5789999999999999999999854322211110 0000011111222344444
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 035917 560 KVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 560 ~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
. +++..+|++|.|+.+|..|
T Consensus 284 R---wmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 284 R---WMLMVNPERRATIEDIASH 303 (668)
T ss_pred H---HHHhcCcccchhHHHHhhh
Confidence 4 9999999999999999887
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=314.40 Aligned_cols=256 Identities=17% Similarity=0.257 Sum_probs=200.2
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||.||+|+. .+++.||||.++... .....+.+|+++++.++||||+++++++...+..+++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4688889999999999999995 478999999875422 22356899999999999999999999999999999999
Q ss_pred eccCCCChHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 399 KYMSSGTLYSLLQG---NATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 399 ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
||+++|+|.+++.. ....+++..+..++.++++||+||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988753 2235788999999999999999999 88999999999999999999999999999987643
Q ss_pred CCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCC-CCHHH
Q 035917 476 SDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGK-GYDEE 554 (611)
Q Consensus 476 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~ 554 (611)
.. .......|++.|+|||.+.+..++.++||||||+++|||++|+.|+........ .....+....... .....
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd08228 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF---SLCQKIEQCDYPPLPTEHY 233 (267)
T ss_pred hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH---HHHHHHhcCCCCCCChhhc
Confidence 22 111234588999999999888899999999999999999999988632110000 0001111000011 11112
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHHHch
Q 035917 555 ILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIA 587 (611)
Q Consensus 555 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 587 (611)
...+.+++.+||+.+|++||++.+|++.++.+.
T Consensus 234 ~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 234 SEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 234455555999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=314.34 Aligned_cols=256 Identities=20% Similarity=0.308 Sum_probs=202.4
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|++|.||+|.. .+++.||||.+.... ...+++.+|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3577778999999999999994 589999999885422 23357889999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 399 KYMSSGTLYSLLQGN---ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 399 ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
||+++++|.+++... ...+++..+..++.++++||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988632 236899999999999999999999 88999999999999999999999999999886643
Q ss_pred CCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhh-cCChhhhhchhhcCCCCHHH
Q 035917 476 SDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSS-SGRSKEAIDKALCGKGYDEE 554 (611)
Q Consensus 476 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~ 554 (611)
.. .......|+..|+|||.+.+..++.++||||||+++|||++|..|+......... .........+.......+++
T Consensus 159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08229 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 236 (267)
T ss_pred CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHH
Confidence 22 1122345889999999998888999999999999999999999886421110000 00011111111222234445
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHHHch
Q 035917 555 ILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIA 587 (611)
Q Consensus 555 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 587 (611)
+.+++. +||+.||++||||.+|++.++++.
T Consensus 237 ~~~li~---~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 237 LRQLVN---MCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHHHHH---HhcCCCcccCCCHHHHHHHHhhhc
Confidence 555555 999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=320.84 Aligned_cols=250 Identities=21% Similarity=0.289 Sum_probs=193.6
Q ss_pred CCCCCeeeecCCceEEEEEeC------CCCEEEEEeccccch--hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEE
Q 035917 326 FCSENVIISTRTGTTYKAMLP------DGSVLAVKRLNTCKL--GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~~------~g~~vAvK~~~~~~~--~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
|...+.||+|+||.||+|... +++.||+|+++.... ..+.+.+|+.++.+++||||+++++++...+..+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 444578999999999999853 357899999975432 235689999999999999999999999999999999
Q ss_pred EeccCCCChHHhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCe
Q 035917 398 YKYMSSGTLYSLLQGN---------------ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDA 462 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~ 462 (611)
+||+++++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCce
Confidence 9999999999988521 124788899999999999999999 7899999999999999999999
Q ss_pred EEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhh
Q 035917 463 RIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEA 541 (611)
Q Consensus 463 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~ 541 (611)
||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..|+....... ....+
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----~~~~i 239 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD----VIEMI 239 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHH
Confidence 9999999886643332222233346789999999988889999999999999999997 655543211000 00011
Q ss_pred hchh--hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 035917 542 IDKA--LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNS 585 (611)
Q Consensus 542 ~~~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 585 (611)
.+.. ......+.++ .+++.+||+.+|++||++.+|++.|+.
T Consensus 240 ~~~~~~~~~~~~~~~~---~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 RNRQVLPCPDDCPAWV---YTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HcCCcCCCCCCCCHHH---HHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111 0112233444 445559999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=304.27 Aligned_cols=255 Identities=19% Similarity=0.259 Sum_probs=201.0
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc-----hh----HHHHHHHHHHHhcc-CCCCccceeeEEEeC
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-----LG----EKKFRNEMNRLGQL-RHPNLAPLLGYCVVE 391 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-----~~----~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~ 391 (611)
.++|...+++|.|..++|-++.. ++|+.+|+|++.... .. .+.-.+|+.||+++ .||+|+++.++|..+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 35677788999999999999884 578999999985321 11 24567899999999 599999999999999
Q ss_pred CeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccc
Q 035917 392 EEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAK 471 (611)
Q Consensus 392 ~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~ 471 (611)
...++|+|.|+.|.|+|+|... -.++++...+|++|+.+|++||| ...||||||||+|||+|++.++||+|||+|+
T Consensus 96 sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceee
Confidence 9999999999999999999754 36899999999999999999999 8999999999999999999999999999999
Q ss_pred ccCCCCCCccccCCCcccccccccccCC------CCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh
Q 035917 472 LMTSSDESSFVNGDLGEFGYIAPEYSST------MVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA 545 (611)
Q Consensus 472 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (611)
.+.....- ...+|||+|.|||.+.. ..|+...|+||.||++|.|+.|..||..--..++.+.... -...
T Consensus 172 ~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime--Gkyq 246 (411)
T KOG0599|consen 172 QLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME--GKYQ 246 (411)
T ss_pred ccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh--cccc
Confidence 88765533 33479999999997643 3478899999999999999999999843211111110000 0111
Q ss_pred hcCC---CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHchhh
Q 035917 546 LCGK---GYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS--LNSIAAQ 589 (611)
Q Consensus 546 l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~~ 589 (611)
.... ..++.+++++. +|++.||.+|.|++|+++| +..++++
T Consensus 247 F~speWadis~~~KdLIs---rlLqVdp~~Ritake~LaHpff~q~~~~ 292 (411)
T KOG0599|consen 247 FRSPEWADISATVKDLIS---RLLQVDPTKRITAKEALAHPFFIQIAQQ 292 (411)
T ss_pred cCCcchhhccccHHHHHH---HHHeeCchhcccHHHHhcChHHHHHHHh
Confidence 2222 23345555555 9999999999999999988 4444444
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=324.78 Aligned_cols=249 Identities=18% Similarity=0.219 Sum_probs=198.0
Q ss_pred hhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchh----HHHHHHHHHHHhccCCCCccceeeEEEeCCeeEE
Q 035917 322 ASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLG----EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~----~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
..++|....+||+|+||.||.|+- .+|+.+|+|+++++..- .+.++.|-.+|...++|+||+|+..|.+.+..||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 456788889999999999999994 56999999999876432 2457889999999999999999999999999999
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
||||.+|||+..+|... ..|++..+..++.+.+.|++-+| +.++|||||||+|+|||..|.+||+||||++-+...
T Consensus 219 iMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 99999999999999865 46888888899999999999999 899999999999999999999999999998643210
Q ss_pred ----------------------CCC-----c------------------cccCCCcccccccccccCCCCCCcccchHHH
Q 035917 477 ----------------------DES-----S------------------FVNGDLGEFGYIAPEYSSTMVASLKGDVYGI 511 (611)
Q Consensus 477 ----------------------~~~-----~------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~Sf 511 (611)
+.. . ...+.+|||-|||||++.+..|+..+|.||+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 000 0 0123479999999999999999999999999
Q ss_pred HHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-----hcCCCCHHHHHHHHHHHhhcccCCCCCCCC---HHHHHHH
Q 035917 512 GVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-----LCGKGYDEEILQFLKVACNCVVSRPKDRWS---MYQVYQS 582 (611)
Q Consensus 512 Gvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-----l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~ 582 (611)
|||+|||+.|..||..-..... ...++.-+ ......+++++++|. +|+. ||++|.. ++||.+|
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T----~rkI~nwr~~l~fP~~~~~s~eA~DLI~---rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQET----YRKIVNWRETLKFPEEVDLSDEAKDLIT---RLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhhhccCCCcCcccHHHHHHHH---HHhc-CHHHhcCcccHHHHhcC
Confidence 9999999999998742111100 00111100 111223466677666 9999 9999985 7777665
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=334.05 Aligned_cols=247 Identities=19% Similarity=0.227 Sum_probs=195.8
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||.||+|+. .+|+.||||+++... .....+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 3678889999999999999996 468999999996532 22345788999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 999999999998754 35899999999999999999999 88999999999999999999999999999876432110
Q ss_pred Cc------------------------------------cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCC
Q 035917 479 SS------------------------------------FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFK 522 (611)
Q Consensus 479 ~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~ 522 (611)
.. .....+||+.|+|||++....++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 00 011246999999999999889999999999999999999999
Q ss_pred CCHHHHHHHHhhcCChhhhhc--h--hh-cCCCCHHHHHHHHHHHhhcccCCCCCCCC---HHHHHHH
Q 035917 523 GNLVDWVNQLSSSGRSKEAID--K--AL-CGKGYDEEILQFLKVACNCVVSRPKDRWS---MYQVYQS 582 (611)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~--~--~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~ 582 (611)
.||........ ...+.. . .. .....++++.++++ +|+. +|.+|++ +.|+++|
T Consensus 237 ~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~~~li~---~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNPQET----YRKIINWKETLQFPDEVPLSPEAKDLIK---RLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCHHHH----HHHHHcCCCccCCCCCCCCCHHHHHHHH---HHcc-CHhhcCCCCCHHHHhcC
Confidence 88742110000 000000 0 00 01123556666666 8886 8999998 9999886
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=321.07 Aligned_cols=248 Identities=21% Similarity=0.259 Sum_probs=186.8
Q ss_pred cCCCCCeeeecCCceEEEEEe-C-CCCEEEEEeccccc---hhHHHHHHHHHHHhcc---CCCCccceeeEEEe-----C
Q 035917 325 SFCSENVIISTRTGTTYKAML-P-DGSVLAVKRLNTCK---LGEKKFRNEMNRLGQL---RHPNLAPLLGYCVV-----E 391 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~-~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l---~H~nIv~l~g~~~~-----~ 391 (611)
+|...+.||+|+||.||+|+. . +++.||+|+++... .....+.+|+.+++.+ +||||++++++|.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 577789999999999999985 3 47889999986432 1234566787777665 69999999999863 3
Q ss_pred CeeEEEEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccc
Q 035917 392 EEKLLIYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLA 470 (611)
Q Consensus 392 ~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla 470 (611)
...++||||++ ++|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 45789999997 59999887543 35899999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhhcC------Ch-
Q 035917 471 KLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSSSG------RS- 538 (611)
Q Consensus 471 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~~~------~~- 538 (611)
+...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.+|.. ......... ..
T Consensus 158 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 158 RIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred EeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 8654321 22234689999999999888899999999999999999999887632 111111000 00
Q ss_pred h------hhhchhh------cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 539 K------EAIDKAL------CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 539 ~------~~~~~~l------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
. ....+.. .....++. +.+++.+|++.||++|||+.|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDEL---GKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHH---HHHHHHHHhccCchhcCCHHHHhcC
Confidence 0 0000000 00112233 3455559999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=333.53 Aligned_cols=246 Identities=24% Similarity=0.269 Sum_probs=198.3
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
+|...+.||+|+||.||+|+.. +|+.||||+++... .....+.+|++++..++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 5778899999999999999964 69999999996532 233568899999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC--
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD-- 477 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~-- 477 (611)
|+++|+|.+++... ..+++..+..++.|++.||+||| ..+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 82 YMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 99999999999765 46899999999999999999999 7999999999999999999999999999998654322
Q ss_pred -------------------------CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHH
Q 035917 478 -------------------------ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQL 532 (611)
Q Consensus 478 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~ 532 (611)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 0011223469999999999999899999999999999999999998874321100
Q ss_pred hhcCChhhhhc--hhh-cC--CCCHHHHHHHHHHHhhcccCCCCCCCC-HHHHHHH
Q 035917 533 SSSGRSKEAID--KAL-CG--KGYDEEILQFLKVACNCVVSRPKDRWS-MYQVYQS 582 (611)
Q Consensus 533 ~~~~~~~~~~~--~~l-~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~ 582 (611)
. ...+.. ..+ .. ...++++.+++. +|+. ||.+||+ +.|+++|
T Consensus 238 ~----~~~i~~~~~~~~~p~~~~~~~~~~~li~---~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 238 T----YNKIINWKESLRFPPDPPVSPEAIDLIC---RLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H----HHHHhccCCcccCCCCCCCCHHHHHHHH---HHcc-ChhhcCCCHHHHhcC
Confidence 0 000111 000 01 113455555555 9997 9999999 9999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=331.17 Aligned_cols=250 Identities=18% Similarity=0.176 Sum_probs=193.3
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch----hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL----GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||+||+|+. .+++.||||+++.... ....+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 3678889999999999999985 4689999999965321 2346788999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 999999999999754 46899999999999999999999 88999999999999999999999999999976432110
Q ss_pred C---------------------------------ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCH
Q 035917 479 S---------------------------------SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNL 525 (611)
Q Consensus 479 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~ 525 (611)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0 0012347999999999999889999999999999999999999987
Q ss_pred HHHHHHHhhcCChhhhhc----hhhcC-CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 526 VDWVNQLSSSGRSKEAID----KALCG-KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~----~~l~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
..-..... ...+.. ..... ...+++..+++.-+ .|...++..||++.||++|
T Consensus 237 ~~~~~~~~----~~~i~~~~~~~~~p~~~~~s~~~~~li~~l-~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 237 CSETPQET----YKKVMNWKETLIFPPEVPISEKAKDLILRF-CCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCHHHH----HHHHHcCcCcccCCCcCCCCHHHHHHHHHH-cCChhhcCCCCCHHHHhCC
Confidence 42110000 000100 00111 12345666655521 1333444567999999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=345.76 Aligned_cols=248 Identities=21% Similarity=0.222 Sum_probs=197.2
Q ss_pred HhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCC----
Q 035917 321 AASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE---- 392 (611)
Q Consensus 321 ~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~---- 392 (611)
...++|...+.||+|+||+||+|+. .+|+.||||+++... .....+.+|+..+..++|+||+++.+.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3456888899999999999999984 579999999986543 23356889999999999999999887765432
Q ss_pred ----eeEEEEeccCCCChHHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEe
Q 035917 393 ----EKLLIYKYMSSGTLYSLLQGNA---TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIM 465 (611)
Q Consensus 393 ----~~~lv~ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~ 465 (611)
..++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEE
Confidence 3579999999999999986432 36899999999999999999999 8899999999999999999999999
Q ss_pred ecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh
Q 035917 466 DFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA 545 (611)
Q Consensus 466 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (611)
|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+.++..
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~--------~~~~~~~~~ 257 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE--------NMEEVMHKT 257 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHH
Confidence 999998764322222223456999999999999989999999999999999999999887421 111111111
Q ss_pred h------cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 546 L------CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 546 l------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+ .....+.++.+++. +||+.||++||++.+++++
T Consensus 258 ~~~~~~~~~~~~~~~l~~li~---~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 LAGRYDPLPPSISPEMQEIVT---ALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred hcCCCCCCCCCCCHHHHHHHH---HHcccChhhCcCHHHHHhC
Confidence 1 11223445555555 9999999999999999876
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=313.75 Aligned_cols=255 Identities=20% Similarity=0.312 Sum_probs=198.3
Q ss_pred hcCCCCCeeeecCCceEEEEEeC----CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP----DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~----~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
++|...+.||+|+||.||+|... .+..+|+|.++... ...+.+.+|+.++.+++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778899999999999999853 23479999986532 2346789999999999999999999999999999999
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
|||+++|+|.+++......+++..+..++.|++.||+||| +.+++||||||+||+++.++.++++|||+++.+....
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999866557899999999999999999999 8899999999999999999999999999998764332
Q ss_pred CCc-cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHH
Q 035917 478 ESS-FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEI 555 (611)
Q Consensus 478 ~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 555 (611)
... ......++..|+|||++.+..++.++|||||||++||+++ |..|+.+........ ...+..... .....++.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~- 237 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIK-AIEEGYRLP-APMDCPAA- 237 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHH-HHhCCCcCC-CCCCCCHH-
Confidence 111 1111224568999999998889999999999999999886 887764321110000 000000000 11122334
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHHHHc
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 586 (611)
+.+++.+|++.+|++||+|.++++.|+++
T Consensus 238 --~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 238 --LHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --HHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 44555599999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=315.23 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=195.8
Q ss_pred cCCCCCeeeecCCceEEEEEeCC-C---CEEEEEecccc--chhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 325 SFCSENVIISTRTGTTYKAMLPD-G---SVLAVKRLNTC--KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~~-g---~~vAvK~~~~~--~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
.|...+.||+|+||.||+|.... + ..||||.++.. ....++|..|+.++++++||||+++++++..++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46677899999999999999643 3 36999998653 223467999999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++|+|.+++......+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+|++|||+++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 999999999999765557899999999999999999999 78999999999999999999999999999986643221
Q ss_pred CccccCCC---cccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHH
Q 035917 479 SSFVNGDL---GEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEE 554 (611)
Q Consensus 479 ~~~~~~~~---gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 554 (611)
........ .+..|+|||++.+..++.++|||||||++||+++ |..||....... ..+.+..........+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~-----~~~~i~~~~~~~~~~~~ 236 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-----VINAIEQDYRLPPPMDC 236 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH-----HHHHHHcCCcCCCcccC
Confidence 11111111 2457999999998899999999999999999886 777763211000 00000000000011111
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHHHc
Q 035917 555 ILQFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586 (611)
Q Consensus 555 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 586 (611)
...+.+++.+||+.+|++||++.+|++.|+++
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 237 PTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 23345566699999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=318.99 Aligned_cols=256 Identities=21% Similarity=0.270 Sum_probs=196.1
Q ss_pred hcCCCCCeeeecCCceEEEEEeCC-----------------CCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccce
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPD-----------------GSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPL 384 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~-----------------g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l 384 (611)
++|...+.||+|+||.||+|...+ +..||+|.+.... ...+.+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 467888999999999999998542 3568999986543 334678999999999999999999
Q ss_pred eeEEEeCCeeEEEEeccCCCChHHhhhcCC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeE
Q 035917 385 LGYCVVEEEKLLIYKYMSSGTLYSLLQGNA----------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVI 454 (611)
Q Consensus 385 ~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NI 454 (611)
++++..++..+++|||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhce
Confidence 999999999999999999999999986543 15899999999999999999999 78999999999999
Q ss_pred EeCCCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC--CCCCHHHH----
Q 035917 455 LVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG--FKGNLVDW---- 528 (611)
Q Consensus 455 Lld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~--~~~~~~~~---- 528 (611)
+++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ +..|+...
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 999999999999999986543322222223346788999999988889999999999999999987 44444211
Q ss_pred HHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 035917 529 VNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLN 584 (611)
Q Consensus 529 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 584 (611)
....... ...................++.+++.+||+.||++|||+.||++.|+
T Consensus 242 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 242 VIENAGH--FFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHh--ccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1000000 00000000000011111234566666999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=317.38 Aligned_cols=259 Identities=21% Similarity=0.267 Sum_probs=200.4
Q ss_pred cCCCCCeeeecCCceEEEEEeC-----CCCEEEEEeccccchh--HHHHHHHHHHHhccCCCCccceeeEEEe--CCeeE
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-----DGSVLAVKRLNTCKLG--EKKFRNEMNRLGQLRHPNLAPLLGYCVV--EEEKL 395 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-----~g~~vAvK~~~~~~~~--~~~~~~Ev~~l~~l~H~nIv~l~g~~~~--~~~~~ 395 (611)
.|...+.||+|+||.||+|++. +++.||||.++..... .++|.+|++++++++||||+++++++.. +...+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4556688999999999999853 3789999999765543 5789999999999999999999999887 55789
Q ss_pred EEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
++|||+++++|.+++......+++..+..++.|++.||+||| ..+++|+||||+||+++.++.++|+|||++.....
T Consensus 85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 999999999999999866556999999999999999999999 78999999999999999999999999999987653
Q ss_pred CCCCc-cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhh----------cCChhhhhch
Q 035917 476 SDESS-FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSS----------SGRSKEAIDK 544 (611)
Q Consensus 476 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~----------~~~~~~~~~~ 544 (611)
..... ......++..|+|||...+..++.++||||||+++|||++|..|+..-...... .....+.+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 22111 111223566799999998888999999999999999999988765321111000 0001111111
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHc
Q 035917 545 ALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586 (611)
Q Consensus 545 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 586 (611)
.............+.+++.+||+.+|++||+|.||+++|+.+
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111111224566677799999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=319.45 Aligned_cols=243 Identities=19% Similarity=0.255 Sum_probs=189.3
Q ss_pred eeecCCceEEEEEe-CCCCEEEEEeccccch----hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCCh
Q 035917 332 IISTRTGTTYKAML-PDGSVLAVKRLNTCKL----GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTL 406 (611)
Q Consensus 332 ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL 406 (611)
||+|+||+||++.. .+++.||+|.+..... ..+.+..|++++++++||||+++.+++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 68999999999995 4789999999864322 225678899999999999999999999999999999999999999
Q ss_pred HHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcccc
Q 035917 407 YSLLQGN---ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 407 ~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++.+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 9877432 236899999999999999999999 78999999999999999999999999999986543221 122
Q ss_pred CCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-hcCCCCHHHHHHHHHHH
Q 035917 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-LCGKGYDEEILQFLKVA 562 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~~~l~~l~ 562 (611)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.................... ......+.++.+++.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~-- 233 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCE-- 233 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHH--
Confidence 34689999999999999999999999999999999999988742100000000000011110 111223444555554
Q ss_pred hhcccCCCCCCC-----CHHHHHHH
Q 035917 563 CNCVVSRPKDRW-----SMYQVYQS 582 (611)
Q Consensus 563 ~~Cl~~dP~~RP-----s~~evl~~ 582 (611)
+||+.||++|| +++++++|
T Consensus 234 -~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 234 -ALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred -HHhcCCHHHhcCCCCCCHHHHhcC
Confidence 99999999999 77888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=328.16 Aligned_cols=241 Identities=19% Similarity=0.190 Sum_probs=191.6
Q ss_pred CeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCC
Q 035917 330 NVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSG 404 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~g 404 (611)
+.||+|+||.||++.. .+|+.||+|.++... .....+.+|++++..++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 578999999996532 22356788999999999999999999999999999999999999
Q ss_pred ChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccC
Q 035917 405 TLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNG 484 (611)
Q Consensus 405 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 484 (611)
+|.+++... ..+++..+..++.|++.||+|||+ ..+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~ 155 (325)
T cd05594 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKT 155 (325)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--cccc
Confidence 999988654 358999999999999999999993 27999999999999999999999999999875432211 1223
Q ss_pred CCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-hcCCCCHHHHHHHHHHHh
Q 035917 485 DLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-LCGKGYDEEILQFLKVAC 563 (611)
Q Consensus 485 ~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~~~l~~l~~ 563 (611)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.... ......+.++.++++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~----~~~i~~~~~~~p~~~~~~~~~li~--- 228 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----FELILMEEIRFPRTLSPEAKSLLS--- 228 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH----HHHHhcCCCCCCCCCCHHHHHHHH---
Confidence 4699999999999988999999999999999999999988732111000 00000000 011234455566555
Q ss_pred hcccCCCCCCC-----CHHHHHHH
Q 035917 564 NCVVSRPKDRW-----SMYQVYQS 582 (611)
Q Consensus 564 ~Cl~~dP~~RP-----s~~evl~~ 582 (611)
+||+.||++|+ ++.++++|
T Consensus 229 ~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 229 GLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHhhcCHHHhCCCCCCCHHHHhcC
Confidence 99999999997 89999877
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=313.63 Aligned_cols=255 Identities=19% Similarity=0.239 Sum_probs=197.8
Q ss_pred HHHhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEE
Q 035917 319 LMAASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 319 l~~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
++.+++++.....||+|+||.||+|+. .++..||+|.+.... ...+.+.+|+.++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 455677888889999999999999995 467899999986543 344678999999999999999999999999999999
Q ss_pred EEeccCCCChHHhhhcCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC-CCCeEEeeccccccc
Q 035917 397 IYKYMSSGTLYSLLQGNATEL--DWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE-DFDARIMDFGLAKLM 473 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~-~~~~kl~DFGla~~~ 473 (611)
||||+++++|.+++......+ ++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 999999999999997654445 88889999999999999999 789999999999999976 679999999998765
Q ss_pred CCCCCCccccCCCcccccccccccCCCC--CCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCCh-hhhhchhhcCCC
Q 035917 474 TSSDESSFVNGDLGEFGYIAPEYSSTMV--ASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRS-KEAIDKALCGKG 550 (611)
Q Consensus 474 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~~ 550 (611)
..... ......|+..|+|||++.... ++.++|||||||++|||++|..|+............. .....+.+ ...
T Consensus 160 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ 236 (268)
T cd06624 160 AGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI-PES 236 (268)
T ss_pred ccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCC-Ccc
Confidence 33221 112234789999999986543 7889999999999999999998874321100000000 00001111 122
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 551 YDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 551 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.++++.+++ .+||+.+|++|||+.|+++|
T Consensus 237 ~~~~~~~li---~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 237 LSAEAKNFI---LRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred cCHHHHHHH---HHHcCCCchhCCCHHHHHhC
Confidence 334455554 59999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=341.86 Aligned_cols=261 Identities=20% Similarity=0.267 Sum_probs=202.5
Q ss_pred cCCCCCeeeecCCceEEEEEeCCC-CEEEEEeccc-cchhHHHHHHHHHHHhccC-CCCccceee-EEEe---C---Cee
Q 035917 325 SFCSENVIISTRTGTTYKAMLPDG-SVLAVKRLNT-CKLGEKKFRNEMNRLGQLR-HPNLAPLLG-YCVV---E---EEK 394 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~~g-~~vAvK~~~~-~~~~~~~~~~Ev~~l~~l~-H~nIv~l~g-~~~~---~---~~~ 394 (611)
+.+++++|.+|||+.||.|....+ ..||+|++-. ++..-+.+.+||++|++|+ |+|||.+++ .... . -+.
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 445678999999999999997665 9999999843 4445577899999999997 999999999 3322 1 257
Q ss_pred EEEEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccccc
Q 035917 395 LLIYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLM 473 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~ 473 (611)
+|.||||++|.|-|++..+. ..|++.++++|+.|+++|+++||. +.++|||||||.+||||+.++..||||||-|...
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 89999999999999997543 359999999999999999999994 5789999999999999999999999999988643
Q ss_pred CCCCCCc-c---c---cCCCccccccccccc---CCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc
Q 035917 474 TSSDESS-F---V---NGDLGEFGYIAPEYS---STMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID 543 (611)
Q Consensus 474 ~~~~~~~-~---~---~~~~gt~~y~aPE~~---~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~ 543 (611)
....... . . -...-|+.|+|||++ .+...++|+|||++||+||-|+.+..||.+- ....+++
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s--------g~laIln 268 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES--------GKLAILN 268 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC--------cceeEEe
Confidence 2211100 0 0 012468999999964 6778999999999999999999999888431 1222332
Q ss_pred hhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCCCC
Q 035917 544 KALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFSE 594 (611)
Q Consensus 544 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 594 (611)
-...-...+.....+.+|+..||+.||++||++-+|+.++-+++.......
T Consensus 269 g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~ 319 (738)
T KOG1989|consen 269 GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIP 319 (738)
T ss_pred ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcc
Confidence 222212223333444455559999999999999999999999988765554
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=324.40 Aligned_cols=240 Identities=19% Similarity=0.227 Sum_probs=190.6
Q ss_pred CeeeecCCceEEEEEe----CCCCEEEEEeccccc-----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 330 NVIISTRTGTTYKAML----PDGSVLAVKRLNTCK-----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~----~~g~~vAvK~~~~~~-----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
+.||+|+||.||+++. .+++.||||.++... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 358899999986532 2234578899999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
+++|+|.+++... ..+.+..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 155 (323)
T cd05584 82 LSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-- 155 (323)
T ss_pred CCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--
Confidence 9999999998754 35788888899999999999999 78999999999999999999999999999875432221
Q ss_pred cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHHHHHH
Q 035917 481 FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEILQFL 559 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~ 559 (611)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+..... .....++++.+++
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li 231 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK----TIDKILKGKLNLPPYLTPEARDLL 231 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH----HHHHHHcCCCCCCCCCCHHHHHHH
Confidence 1223468999999999998889999999999999999999998874311100 0011111111 1122344555555
Q ss_pred HHHhhcccCCCCCCC-----CHHHHHHH
Q 035917 560 KVACNCVVSRPKDRW-----SMYQVYQS 582 (611)
Q Consensus 560 ~l~~~Cl~~dP~~RP-----s~~evl~~ 582 (611)
. +||+.||++|| ++.++++|
T Consensus 232 ~---~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 232 K---KLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred H---HHcccCHhHcCCCCCCCHHHHhcC
Confidence 5 99999999999 88988876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=312.06 Aligned_cols=242 Identities=22% Similarity=0.295 Sum_probs=190.1
Q ss_pred eeeecCCceEEEEEe---CCCCEEEEEeccccch---hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCC
Q 035917 331 VIISTRTGTTYKAML---PDGSVLAVKRLNTCKL---GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSG 404 (611)
Q Consensus 331 ~ig~G~~g~Vy~~~~---~~g~~vAvK~~~~~~~---~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~g 404 (611)
.||+|+||.||+|.+ ++++.||+|+++.... ..+++.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999974 3578999999865432 2467899999999999999999999885 45678999999999
Q ss_pred ChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC-cccc
Q 035917 405 TLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES-SFVN 483 (611)
Q Consensus 405 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~-~~~~ 483 (611)
+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++.+...... ....
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 999999754 35899999999999999999999 789999999999999999999999999999876433211 1111
Q ss_pred CCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhh---cCCCCHHHHHHHH
Q 035917 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKAL---CGKGYDEEILQFL 559 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l---~~~~~~~~~~~l~ 559 (611)
...++..|+|||.+....++.++|||||||++|||++ |..||....... ..+.+.... .+...+.++.+++
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----~~~~i~~~~~~~~~~~~~~~l~~li 231 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-----VTQMIESGERMECPQRCPPEMYDLM 231 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHCCCCCCCCCCCCHHHHHHH
Confidence 2234678999999988889999999999999999997 887764321110 011111110 1122344555555
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHH
Q 035917 560 KVACNCVVSRPKDRWSMYQVYQSLNS 585 (611)
Q Consensus 560 ~l~~~Cl~~dP~~RPs~~evl~~L~~ 585 (611)
. +||+.||++||++.+|.+.|++
T Consensus 232 ~---~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 232 K---LCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred H---HHhccCchhCcCHHHHHHHHhc
Confidence 5 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=310.68 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=198.8
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
++|...+.||+|+||.||+|... |+.||+|.++......+++.+|+.++++++|+||+++++++...+..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 46777899999999999999874 78999999976655567899999999999999999999999988899999999999
Q ss_pred CChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccc
Q 035917 404 GTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482 (611)
Q Consensus 404 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 482 (611)
++|.+++.... ..+++..+..++.|++.||.||| ..+++|+||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---- 157 (256)
T cd05039 85 GSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---- 157 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccc----
Confidence 99999997654 26899999999999999999999 88999999999999999999999999999987632211
Q ss_pred cCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHH
Q 035917 483 NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKV 561 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l 561 (611)
...++..|+|||++....++.++||||||+++||+++ |..|+.......... .......... ....+++ +.++
T Consensus 158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~---~~~l 231 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-HVEKGYRMEA-PEGCPPE---VYKV 231 (256)
T ss_pred -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-HHhcCCCCCC-ccCCCHH---HHHH
Confidence 2235678999999988889999999999999999996 776653211110000 0000000000 1122344 4455
Q ss_pred HhhcccCCCCCCCCHHHHHHHHHHc
Q 035917 562 ACNCVVSRPKDRWSMYQVYQSLNSI 586 (611)
Q Consensus 562 ~~~Cl~~dP~~RPs~~evl~~L~~i 586 (611)
+.+||..+|++||++.|+++.|+.+
T Consensus 232 i~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 232 MKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHHhccChhhCcCHHHHHHHHhcC
Confidence 5599999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=317.24 Aligned_cols=242 Identities=18% Similarity=0.263 Sum_probs=188.8
Q ss_pred eeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCCh
Q 035917 332 IISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTL 406 (611)
Q Consensus 332 ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL 406 (611)
||+|+||.||+++. .+|+.||+|.+.... ...+.+..|++++++++||||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 68999999999995 469999999986432 1234567799999999999999999999999999999999999999
Q ss_pred HHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccCC
Q 035917 407 YSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGD 485 (611)
Q Consensus 407 ~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 485 (611)
.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eecc
Confidence 98886543 36899999999999999999999 88999999999999999999999999999986643221 1233
Q ss_pred CcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh--cCCCCHHHHHHHHHHHh
Q 035917 486 LGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL--CGKGYDEEILQFLKVAC 563 (611)
Q Consensus 486 ~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~~~~~l~~l~~ 563 (611)
.|+..|+|||++.+..++.++|||||||++|||++|+.||..+.................. .....++++.+++.
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~--- 231 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICR--- 231 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHH---
Confidence 5899999999998888999999999999999999999887432111000000001111111 11223445555555
Q ss_pred hcccCCCCCCCCHHHHHHH
Q 035917 564 NCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 564 ~Cl~~dP~~RPs~~evl~~ 582 (611)
+||+.||++||++.|++++
T Consensus 232 ~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 232 LFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred HHhccCHhhCCCCccchhh
Confidence 9999999999999766543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=310.99 Aligned_cols=250 Identities=21% Similarity=0.319 Sum_probs=198.8
Q ss_pred cCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCC
Q 035917 325 SFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSG 404 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~g 404 (611)
+|...+.||+|+||.||+|...+++.+|+|.+........+|.+|++++++++||||+++++++......++||||++++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG 84 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence 56667899999999999999877889999999766566678999999999999999999999999989999999999999
Q ss_pred ChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccC
Q 035917 405 TLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNG 484 (611)
Q Consensus 405 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 484 (611)
+|.+++......+++..+..++.+++.|++||| +.+++|+||||+||+++.++.+||+|||+++....... .....
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 160 (256)
T cd05112 85 CLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSSTG 160 (256)
T ss_pred cHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcc-cccCC
Confidence 999999765556899999999999999999999 78999999999999999999999999999886543221 11122
Q ss_pred CCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHHh
Q 035917 485 DLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVAC 563 (611)
Q Consensus 485 ~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~ 563 (611)
..++..|+|||++.+..++.++||||||+++|||++ |..|+.......... ...+... .......++ .+.+++.
T Consensus 161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~-~~~~~~~~~---~~~~l~~ 235 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVE-TINAGFR-LYKPRLASQ---SVYELMQ 235 (256)
T ss_pred CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH-HHhCCCC-CCCCCCCCH---HHHHHHH
Confidence 235678999999988889999999999999999997 777763211000000 0000000 011112233 4555666
Q ss_pred hcccCCCCCCCCHHHHHHHH
Q 035917 564 NCVVSRPKDRWSMYQVYQSL 583 (611)
Q Consensus 564 ~Cl~~dP~~RPs~~evl~~L 583 (611)
+||+.+|++||++.|++++|
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 236 HCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHcccChhhCCCHHHHHHhh
Confidence 99999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=332.95 Aligned_cols=249 Identities=16% Similarity=0.165 Sum_probs=197.0
Q ss_pred HhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeE
Q 035917 321 AASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395 (611)
Q Consensus 321 ~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~ 395 (611)
...++|...+.||+|+||.||+++. .+++.||+|+++... ...+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 3456888899999999999999996 468999999996432 22345789999999999999999999999999999
Q ss_pred EEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
+||||+++|+|.+++.+. .++...+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 120 lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999998754 4778888899999999999999 78999999999999999999999999999987643
Q ss_pred CCCCccccCCCcccccccccccCCC----CCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhch--hh--c
Q 035917 476 SDESSFVNGDLGEFGYIAPEYSSTM----VASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDK--AL--C 547 (611)
Q Consensus 476 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~--~l--~ 547 (611)
... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ....+.+. .+ .
T Consensus 195 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----~~~~i~~~~~~~~~~ 269 (370)
T cd05596 195 NGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----TYSKIMDHKNSLTFP 269 (370)
T ss_pred CCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH----HHHHHHcCCCcCCCC
Confidence 221 112234699999999987643 47899999999999999999999874311100 00111110 01 0
Q ss_pred -CCCCHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 035917 548 -GKGYDEEILQFLKVACNCVVSRPKD--RWSMYQVYQS 582 (611)
Q Consensus 548 -~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 582 (611)
....+.++.+++. +|++.+|++ ||++.|+++|
T Consensus 270 ~~~~~s~~~~~li~---~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 270 DDIEISKQAKDLIC---AFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CcCCCCHHHHHHHH---HHccChhhccCCCCHHHHhcC
Confidence 1123455666665 999999988 9999999887
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=317.22 Aligned_cols=256 Identities=20% Similarity=0.267 Sum_probs=196.5
Q ss_pred hhhcCCCCCeeeecCCceEEEEEeC------CCCEEEEEeccccch--hHHHHHHHHHHHhccCCCCccceeeEEEeCCe
Q 035917 322 ASNSFCSENVIISTRTGTTYKAMLP------DGSVLAVKRLNTCKL--GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEE 393 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~~------~g~~vAvK~~~~~~~--~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~ 393 (611)
.+++|...+.||+|+||.||+|... .+..||+|.++.... ....+.+|+.++++++||||+++++++...+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567888999999999999999743 255899999865432 23468899999999999999999999999999
Q ss_pred eEEEEeccCCCChHHhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEE
Q 035917 394 KLLIYKYMSSGTLYSLLQGNA---------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARI 464 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl 464 (611)
.++||||+++|+|.+++.... ...++..+..++.|++.||.||| +++|+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999996421 24577888999999999999999 889999999999999999999999
Q ss_pred eecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhc
Q 035917 465 MDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAID 543 (611)
Q Consensus 465 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~ 543 (611)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ +..|+....... ......+
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~----~~~~~~~ 236 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ----VLKFVMD 236 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHc
Confidence 99999986543322111122245778999999988889999999999999999997 555652100000 0000011
Q ss_pred hhh--cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHch
Q 035917 544 KAL--CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIA 587 (611)
Q Consensus 544 ~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 587 (611)
... .....++ .+.+++.+|++.||++|||+.++++.|++..
T Consensus 237 ~~~~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 237 GGYLDQPDNCPE---RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCCCCCCCCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 000 0112233 4455555999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=328.27 Aligned_cols=249 Identities=19% Similarity=0.274 Sum_probs=204.4
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCe-eEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEE-KLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~-~~lv~ 398 (611)
++|...+.+|+|+||.++..+. .+++.|++|.+.... ..++...+|+.++++++|||||.+.+.+..++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 4567778999999999999884 468899999997543 334568999999999999999999999998888 89999
Q ss_pred eccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 399 KYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
+||+||++.+.+.+.. ..+++..+.+++.|++.|+.||| +..|+|||||+.||++..+..+||+|||+|+.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998765 47899999999999999999999 8899999999999999999999999999999986543
Q ss_pred CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHH
Q 035917 478 ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQ 557 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 557 (611)
....+.+||+.||.||.+.+.+|..|+||||+||++|||++-+.+|...-............+. ..+..++.++..
T Consensus 161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~--Plp~~ys~el~~ 236 (426)
T KOG0589|consen 161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYS--PLPSMYSSELRS 236 (426)
T ss_pred --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCC--CCCccccHHHHH
Confidence 2334557999999999999999999999999999999999887766321000000000011111 123445667777
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+++ .|+..+|..||++.+++.+
T Consensus 237 lv~---~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 237 LVK---SMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHH---HHhhcCCccCCCHHHHhhC
Confidence 777 9999999999999999987
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=313.37 Aligned_cols=246 Identities=22% Similarity=0.256 Sum_probs=185.7
Q ss_pred eeeecCCceEEEEEeCC---CCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCC
Q 035917 331 VIISTRTGTTYKAMLPD---GSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGT 405 (611)
Q Consensus 331 ~ig~G~~g~Vy~~~~~~---g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gs 405 (611)
.||+|+||.||+|...+ +..+|+|.++... .....+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998643 4679999986543 233578999999999999999999999999889999999999999
Q ss_pred hHHhhhcCC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 406 LYSLLQGNA----TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 406 L~~~l~~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
|.+++.... ...++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||+++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999986432 24678888899999999999999 78999999999999999999999999999975433222111
Q ss_pred ccCCCcccccccccccCCC-------CCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHh----hcCChhhhhchhhcCC
Q 035917 482 VNGDLGEFGYIAPEYSSTM-------VASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLS----SSGRSKEAIDKALCGK 549 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~~~-------~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~ 549 (611)
.....|+..|+|||++... .++.++|||||||++|||++ |+.||........ .........++.+. .
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 237 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLK-L 237 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccC-C
Confidence 2234578889999987532 35789999999999999996 8877643211110 00000111111111 1
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 035917 550 GYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLN 584 (611)
Q Consensus 550 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 584 (611)
..++...++++ +|| .+|++|||++||++.|+
T Consensus 238 ~~~~~~~~l~~---~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 238 PLSDRWYEVMQ---FCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCChHHHHHHH---HHh-cCcccCCCHHHHHHHhc
Confidence 23344445554 999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=315.91 Aligned_cols=250 Identities=20% Similarity=0.314 Sum_probs=195.4
Q ss_pred cCCCCCeeeecCCceEEEEEe------CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEE
Q 035917 325 SFCSENVIISTRTGTTYKAML------PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~------~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
++...+.||+|+||.||++.. .++..+|+|.+.... ...+.+.+|++++++++|+||+++++++...+..+++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV 85 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence 456678999999999999973 246789999986543 3356799999999999999999999999999999999
Q ss_pred EeccCCCChHHhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeE
Q 035917 398 YKYMSSGTLYSLLQGNA--------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDAR 463 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~k 463 (611)
|||+++|+|.+++.... ..+++..++.++.|++.|++||| +.+++||||||+||++++++.+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCEE
Confidence 99999999999986532 24789999999999999999999 88999999999999999999999
Q ss_pred EeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhh
Q 035917 464 IMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAI 542 (611)
Q Consensus 464 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~ 542 (611)
|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.+...... .....
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~----~~~~~ 238 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA----IECIT 238 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH----HHHHH
Confidence 999999986543222111222345788999999998889999999999999999998 7777632111000 00000
Q ss_pred c--hhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 035917 543 D--KALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLN 584 (611)
Q Consensus 543 ~--~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 584 (611)
. +.......+..+.+++ .+||+.||++||++.||++.|+
T Consensus 239 ~~~~~~~~~~~~~~~~~li---~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 QGRELERPRTCPPEVYAIM---QGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred cCccCCCCCCCCHHHHHHH---HHHccCChhhCCCHHHHHHHHh
Confidence 0 0011122334445554 4999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=330.03 Aligned_cols=191 Identities=20% Similarity=0.272 Sum_probs=166.3
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccC
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
++|...+.||+|+||.||+|.. .+++.||+|... .+.+.+|++++++++|||||++++++..+...++|+||+.
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 5688999999999999999995 568999999753 2457899999999999999999999999999999999995
Q ss_pred CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccc
Q 035917 403 SGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482 (611)
Q Consensus 403 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 482 (611)
++|.+++... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 167 -~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~ 240 (391)
T PHA03212 167 -TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKY 240 (391)
T ss_pred -CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cccc
Confidence 6899888654 35899999999999999999999 7899999999999999999999999999997543221 1122
Q ss_pred cCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCH
Q 035917 483 NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNL 525 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~ 525 (611)
....||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 241 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~ 283 (391)
T PHA03212 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283 (391)
T ss_pred ccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 3346999999999999889999999999999999999988664
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=315.76 Aligned_cols=256 Identities=18% Similarity=0.302 Sum_probs=195.9
Q ss_pred cCCCCCeeeecCCceEEEEEe-----CCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeC--CeeE
Q 035917 325 SFCSENVIISTRTGTTYKAML-----PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE--EEKL 395 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-----~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~--~~~~ 395 (611)
.|...+.||+|+||.||+++. .++..||+|.++... ...+.+.+|++++++++||||+++.+++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 456778999999999999984 357899999986542 2336799999999999999999999998875 5678
Q ss_pred EEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
+||||+++++|.+++......++|..+..++.+++.||+||| +.+++||||||+||+++.++.+||+|||+++.+..
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 999999999999999765456899999999999999999999 88999999999999999999999999999987643
Q ss_pred CCCC-ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHH---Hh----hcCChh---hhhch
Q 035917 476 SDES-SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQ---LS----SSGRSK---EAIDK 544 (611)
Q Consensus 476 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~---~~----~~~~~~---~~~~~ 544 (611)
.... .......++..|+|||++.+..++.++|||||||++|||+++..+...-... .. ...... +.+..
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 2211 1112334677899999988888999999999999999999865432110000 00 000000 00000
Q ss_pred hh---cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHc
Q 035917 545 AL---CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586 (611)
Q Consensus 545 ~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 586 (611)
.. .....+. .+.+++.+||+.+|++||++.++++.|+++
T Consensus 242 ~~~~~~~~~~~~---~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 242 GKRLPRPPNCPE---EVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred CccCCCCCCCCH---HHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00 0112233 455555599999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=313.36 Aligned_cols=263 Identities=23% Similarity=0.345 Sum_probs=202.9
Q ss_pred hhhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHh--ccCCCCccceeeEEEeCC----eeE
Q 035917 322 ASNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLG--QLRHPNLAPLLGYCVVEE----EKL 395 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~--~l~H~nIv~l~g~~~~~~----~~~ 395 (611)
........+.||+|+||.||+|++ .|+.||||++... +++.+.+|.++.+ .|||+||+.+++.-..++ +.|
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr--dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR--DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hhheeEEEEEecCccccceeeccc-cCCceEEEEeccc--chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 334556678999999999999999 5889999999643 3455667777666 459999999988765443 578
Q ss_pred EEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhh-----cCCCCeeecCCCCCeEEeCCCCCeEEeecccc
Q 035917 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHH-----GCQPPFLHQNICSNVILVDEDFDARIMDFGLA 470 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~ivHrDlkp~NILld~~~~~kl~DFGla 470 (611)
||.+|.+.|||+|||... .++-...++++..+|.||++||. ...+.|.|||||+.|||+..++.+.|+|+|||
T Consensus 286 LvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred EeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 999999999999999863 58999999999999999999994 33678999999999999999999999999999
Q ss_pred cccCCCCC--CccccCCCcccccccccccCCCC----C--CcccchHHHHHHHHHHhC----------CCCCHHHHHHHH
Q 035917 471 KLMTSSDE--SSFVNGDLGEFGYIAPEYSSTMV----A--SLKGDVYGIGVVLLELAG----------FKGNLVDWVNQL 532 (611)
Q Consensus 471 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~--t~ksDV~SfGvvl~ell~----------~~~~~~~~~~~~ 532 (611)
-....... ....+..+||..|||||++.... + -..+||||||.|+||++. ...||.+++...
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 76644321 22334568999999999875432 1 245999999999999982 234666665443
Q ss_pred hhcCChhhhh-----chhhcC-CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 533 SSSGRSKEAI-----DKALCG-KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 533 ~~~~~~~~~~-----~~~l~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
...+...+++ .|.+.. ....+.+..+.+++..||..+|..|-|+-.|-+.|.++.+.
T Consensus 444 Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 444 PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 3222222221 222211 22356888999999999999999999999999999988853
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.23 Aligned_cols=249 Identities=20% Similarity=0.216 Sum_probs=193.1
Q ss_pred cCCCCCeeeecCCceEEEEEe----CCCCEEEEEeccccc-----hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCee
Q 035917 325 SFCSENVIISTRTGTTYKAML----PDGSVLAVKRLNTCK-----LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEK 394 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~----~~g~~vAvK~~~~~~-----~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~ 394 (611)
+|...+.||+|+||.||+++. .+++.||+|+++... ...+.+.+|+.++.++ +||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 467778999999999999984 368999999986432 2235678899999999 499999999999999999
Q ss_pred EEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccC
Q 035917 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~ 474 (611)
++||||+++|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 9999999999999998754 35899999999999999999999 7899999999999999999999999999998653
Q ss_pred CCCCCccccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhh--hchhhcCCCC
Q 035917 475 SSDESSFVNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEA--IDKALCGKGY 551 (611)
Q Consensus 475 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~~~~ 551 (611)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||................ .++.+ ....
T Consensus 157 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 234 (332)
T cd05614 157 SEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF-PSFI 234 (332)
T ss_pred ccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCC-CCCC
Confidence 32211 12234699999999998765 47889999999999999999998873210000000000000 01111 1223
Q ss_pred HHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 035917 552 DEEILQFLKVACNCVVSRPKDRW-----SMYQVYQS 582 (611)
Q Consensus 552 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 582 (611)
+..+.+++. +||+.||++|| +++++++|
T Consensus 235 ~~~~~~li~---~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 235 GPEAQDLLH---KLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CHHHHHHHH---HHcCCCHHHcCCCCCCCHHHHHcC
Confidence 455555555 99999999999 78888876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=319.97 Aligned_cols=254 Identities=26% Similarity=0.362 Sum_probs=196.4
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCC--EEEEEecccc--chhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGS--VLAVKRLNTC--KLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~--~vAvK~~~~~--~~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~lv 397 (611)
++|...+.||+|+||.||+|... ++. .+|+|.++.. ....+.+.+|++++.++ +||||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46777899999999999999964 454 4688877542 23346789999999999 899999999999999999999
Q ss_pred EeccCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCe
Q 035917 398 YKYMSSGTLYSLLQGNA---------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDA 462 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~ 462 (611)
|||+++|+|.+++.... ..+++..++.++.|++.|++||| +.+++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcE
Confidence 99999999999986432 25789999999999999999999 8899999999999999999999
Q ss_pred EEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhh
Q 035917 463 RIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEA 541 (611)
Q Consensus 463 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~ 541 (611)
||+|||+++...... ......++..|+|||++.+..++.++|||||||++|||++ |..||...... ...+.
T Consensus 164 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~~~ 235 (303)
T cd05088 164 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYEK 235 (303)
T ss_pred EeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-----HHHHH
Confidence 999999986432111 1111124677999999988889999999999999999997 77776321100 00001
Q ss_pred hchhh---cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 542 IDKAL---CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 542 ~~~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
+.... .....+.+ +.+++.+||+.+|++||++.+++++|+++.+...
T Consensus 236 ~~~~~~~~~~~~~~~~---~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 236 LPQGYRLEKPLNCDDE---VYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred HhcCCcCCCCCCCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 11000 01112334 4555569999999999999999999998876643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=311.06 Aligned_cols=251 Identities=24% Similarity=0.385 Sum_probs=201.9
Q ss_pred hhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccC
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
-++|...+.||+|+||.||+|...+++.||||.+.......+++.+|+.++++++|+||+++++++......++||||++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 35678889999999999999998888999999998766667789999999999999999999999998889999999999
Q ss_pred CCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 403 SGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 403 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
+++|.+++.... ..+++..+..++.+++.|+.||| +.+++|+||||+||++++++.+|++|||+++....... ..
T Consensus 85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~ 160 (261)
T cd05034 85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-TA 160 (261)
T ss_pred CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhh-hh
Confidence 999999997654 36899999999999999999999 78999999999999999999999999999987643211 11
Q ss_pred ccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchh---hcCCCCHHHHHH
Q 035917 482 VNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKA---LCGKGYDEEILQ 557 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~---l~~~~~~~~~~~ 557 (611)
.....++..|+|||.+.+..++.++|||||||++||+++ |+.||...... ...+.+... ......+++
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~--- 232 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-----EVLEQVERGYRMPRPPNCPEE--- 232 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHcCCCCCCCCCCCHH---
Confidence 112235678999999988889999999999999999998 77776321000 000001000 011112334
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWSMYQVYQSLNS 585 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 585 (611)
+.+++.+|++.+|++||+++++.+.|+.
T Consensus 233 ~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 233 LYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 4455559999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=332.74 Aligned_cols=247 Identities=17% Similarity=0.194 Sum_probs=192.4
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||.||+++. .+++.||||++.... ...+.+.+|++++.+++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3677889999999999999985 578999999986432 12356888999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 999999999998754 45888999999999999999999 88999999999999999999999999999964321000
Q ss_pred -------------C--------------------------------ccccCCCcccccccccccCCCCCCcccchHHHHH
Q 035917 479 -------------S--------------------------------SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGV 513 (611)
Q Consensus 479 -------------~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGv 513 (611)
. ......+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 0001246999999999999889999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHhhcCChhhhhc--hhh--cC-CCCHHHHHHHHHHHhhcccCCCCCC---CCHHHHHHH
Q 035917 514 VLLELAGFKGNLVDWVNQLSSSGRSKEAID--KAL--CG-KGYDEEILQFLKVACNCVVSRPKDR---WSMYQVYQS 582 (611)
Q Consensus 514 vl~ell~~~~~~~~~~~~~~~~~~~~~~~~--~~l--~~-~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~evl~~ 582 (611)
++|||++|..||........ ...+.. ..+ .. ...+.++.+++. +|+. +|.+| +++.|+++|
T Consensus 237 il~elltG~~Pf~~~~~~~~----~~~i~~~~~~~~~p~~~~~s~~~~dli~---~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 237 IMFECLIGWPPFCSENSHET----YRKIINWRETLYFPDDIHLSVEAEDLIR---RLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHH----HHHHHccCCccCCCCCCCCCHHHHHHHH---HHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999988742110000 000000 001 01 123455666666 8987 66665 599999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=317.86 Aligned_cols=248 Identities=19% Similarity=0.263 Sum_probs=195.3
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch----hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL----GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
+|...++||+|+||.||++.. .+++.||||++..... ....+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 366778999999999999995 4689999999965321 23457889999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 400 YMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 400 y~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
|+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 999999998886543 36899999999999999999999 78999999999999999999999999999987542221
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh--hcCCCCHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA--LCGKGYDEEIL 556 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~ 556 (611)
.....|+..|+|||++.+..++.++|||||||++|||++|..||......... ......+... ......++.+.
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd05605 158 ---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR-EEVERRVKEDQEEYSEKFSEAAR 233 (285)
T ss_pred ---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH-HHHHHHhhhcccccCcccCHHHH
Confidence 12346899999999998888999999999999999999999887431100000 0001111110 01112334444
Q ss_pred HHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 035917 557 QFLKVACNCVVSRPKDRW-----SMYQVYQS 582 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 582 (611)
+ ++.+||+.||++|| ++.++++|
T Consensus 234 ~---li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 234 S---ICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred H---HHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 4 55599999999999 88899876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=321.05 Aligned_cols=244 Identities=17% Similarity=0.213 Sum_probs=188.5
Q ss_pred CeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 330 NVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
+.||+|+||.||+|+. .+++.||+|+++... ...+.+.+|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999995 468899999997532 2234578899988877 799999999999999999999999999
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcccc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~ 154 (329)
T cd05618 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTS 154 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccc
Confidence 9999888654 35899999999999999999999 78999999999999999999999999999975422211 122
Q ss_pred CCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhh-----hhchhh-cCCCCHHHHHH
Q 035917 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKE-----AIDKAL-CGKGYDEEILQ 557 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~-----~~~~~l-~~~~~~~~~~~ 557 (611)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..............+ ...... .+...+.++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 234 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAAS 234 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 346899999999999989999999999999999999999887310000000000000 001000 11223344445
Q ss_pred HHHHHhhcccCCCCCCCC------HHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWS------MYQVYQS 582 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs------~~evl~~ 582 (611)
+++ +||+.||++||+ +.++++|
T Consensus 235 ll~---~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 235 VLK---SFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHH---HHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 444 999999999998 5788766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=309.49 Aligned_cols=247 Identities=24% Similarity=0.362 Sum_probs=195.7
Q ss_pred CeeeecCCceEEEEEeCC----CCEEEEEeccccchh--HHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 330 NVIISTRTGTTYKAMLPD----GSVLAVKRLNTCKLG--EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~----g~~vAvK~~~~~~~~--~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
+.||+|+||.||+|.... +..||+|.++..... .+++.+|++.+..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999999653 889999999765433 57899999999999999999999999998999999999999
Q ss_pred CChHHhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 404 GTLYSLLQGN--------ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 404 gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
++|.+++... ...+++..+..++.+++.||+||| +.+++|+||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999865 357899999999999999999999 89999999999999999999999999999987654
Q ss_pred CCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHH
Q 035917 476 SDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEE 554 (611)
Q Consensus 476 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 554 (611)
...........++..|+|||.+....++.++||||+||++|||++ |..|+.......... ........ ......+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-~~~~~~~~-~~~~~~~~- 234 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLE-YLRKGYRL-PKPEYCPD- 234 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHH-HHHcCCCC-CCCccCCh-
Confidence 332122233457889999999988889999999999999999998 466653321100000 00000000 01112233
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 035917 555 ILQFLKVACNCVVSRPKDRWSMYQVYQSLN 584 (611)
Q Consensus 555 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 584 (611)
++.+++.+||+.+|++||++.|++++|+
T Consensus 235 --~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 235 --ELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --HHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 4445555999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=317.52 Aligned_cols=258 Identities=18% Similarity=0.265 Sum_probs=194.1
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-----------------CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccce
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-----------------DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPL 384 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-----------------~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l 384 (611)
++|+..+.||+|+||.||++... ++..||+|.++... ....++.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 45788899999999999998532 24579999997532 334679999999999999999999
Q ss_pred eeEEEeCCeeEEEEeccCCCChHHhhhcCC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeE
Q 035917 385 LGYCVVEEEKLLIYKYMSSGTLYSLLQGNA----------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVI 454 (611)
Q Consensus 385 ~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NI 454 (611)
++++...+..++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence 999999999999999999999999986532 24778899999999999999999 78999999999999
Q ss_pred EeCCCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC--CCCCHHHHHHHH
Q 035917 455 LVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG--FKGNLVDWVNQL 532 (611)
Q Consensus 455 Lld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~--~~~~~~~~~~~~ 532 (611)
++++++.++|+|||+++.+.............++..|+|||...++.++.++|||||||++|||++ +..|+.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986543222111222235678999998888889999999999999999997 455553211000
Q ss_pred hhcCChhhhhch---hhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 035917 533 SSSGRSKEAIDK---ALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNS 585 (611)
Q Consensus 533 ~~~~~~~~~~~~---~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 585 (611)
... ...+.... .............+.+++.+||+.||++||++.||++.|++
T Consensus 242 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 VIE-NTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHH-HHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 000 00000000 00000011122345556669999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=296.07 Aligned_cols=258 Identities=19% Similarity=0.267 Sum_probs=203.2
Q ss_pred hhcCCCCCeeeecCCceEEEEE-eCCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCC-----eeE
Q 035917 323 SNSFCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE-----EKL 395 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~-----~~~ 395 (611)
.+.|.+.+.+|+|||+.||.++ +.+++.+|+|++.... .+.+..++|++..++++|||++++++++..+. ..|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 3567888999999999999999 7889999999997544 56678999999999999999999999886543 489
Q ss_pred EEEeccCCCChHHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccc
Q 035917 396 LIYKYMSSGTLYSLLQGNA---TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKL 472 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~ 472 (611)
|+++|...|+|.+.+.... ..+++.+++.|+.+|++||++||.. .+++.||||||.|||+.+.+.+++.|||.++.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 9999999999999886432 3699999999999999999999943 45699999999999999999999999998876
Q ss_pred cCCCCCC-------ccccCCCcccccccccccC---CCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChh-hh
Q 035917 473 MTSSDES-------SFVNGDLGEFGYIAPEYSS---TMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSK-EA 541 (611)
Q Consensus 473 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~-~~ 541 (611)
..-.-.. ........|..|.|||.+. +...++++|||||||+||+|+.|..||..... ..+.+. .+
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---~GgSlaLAv 255 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---QGGSLALAV 255 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---cCCeEEEee
Confidence 4321100 0112234688999999875 34578999999999999999999999855332 122211 11
Q ss_pred hchhh---cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHch
Q 035917 542 IDKAL---CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIA 587 (611)
Q Consensus 542 ~~~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 587 (611)
....+ ....+++.+.++++ +|++.||.+||++.+++.+++.+.
T Consensus 256 ~n~q~s~P~~~~yse~l~~lik---~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 256 QNAQISIPNSSRYSEALHQLIK---SMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eccccccCCCCCccHHHHHHHH---HHhcCCcccCCCHHHHHHHHHhhc
Confidence 12122 12235566666666 999999999999999999998763
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=336.98 Aligned_cols=192 Identities=21% Similarity=0.257 Sum_probs=165.9
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
..+|...+.||+|+||.||+|+.. .++.||||.... ..+.+|++++++++|+|||++++++..++..++||||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 346888899999999999999965 478999996432 34678999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
. ++|.+++......++|..++.|+.|++.||.||| ..+|+||||||+|||++.++.+||+|||+++..........
T Consensus 243 ~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 243 R-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 5 6999988765457999999999999999999999 78999999999999999999999999999987643322222
Q ss_pred ccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCC
Q 035917 482 VNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKG 523 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~ 523 (611)
.....||..|+|||++.+..++.++|||||||++|||+++..
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~ 360 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTA 360 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCC
Confidence 234569999999999999999999999999999999986553
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=309.14 Aligned_cols=256 Identities=20% Similarity=0.314 Sum_probs=201.4
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|++|.||+|... +|+.||+|.++... ...+.+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888899999999999999975 79999999886321 22467899999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 399 KYMSSGTLYSLLQGN---ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 399 ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
||+++|+|.+++... ...+++..+..++.++++||.||| +.+|+||||||+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988642 235899999999999999999999 88999999999999999999999999999886543
Q ss_pred CCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhh-cCChhhhhchhhcCCCCHHH
Q 035917 476 SDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSS-SGRSKEAIDKALCGKGYDEE 554 (611)
Q Consensus 476 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~ 554 (611)
... ......|+..|+|||.+.+..++.++|||||||++|||++|+.|+......... .........+.......+.+
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE 236 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHH
Confidence 221 112235888999999998888999999999999999999998876321100000 00000000001111122334
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHHHch
Q 035917 555 ILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIA 587 (611)
Q Consensus 555 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 587 (611)
+ .+++.+||..+|++||++.+|++.|+++.
T Consensus 237 ~---~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 237 L---RDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred H---HHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 4 44555999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=316.77 Aligned_cols=253 Identities=24% Similarity=0.343 Sum_probs=196.1
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC------CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCee
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP------DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~------~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~ 394 (611)
.++|...+.||+|+||.||+|... ++..||+|.+.... ...+++.+|+.++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 357888899999999999999853 46899999986543 2346799999999999999999999999998999
Q ss_pred EEEEeccCCCChHHhhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCe
Q 035917 395 LLIYKYMSSGTLYSLLQGNA---------------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNV 453 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~N 453 (611)
+++|||+++|+|.+++.... ..+++..++.++.|++.||+||| ..+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence 99999999999999986321 14788899999999999999999 7899999999999
Q ss_pred EEeCCCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHH
Q 035917 454 ILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQL 532 (611)
Q Consensus 454 ILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~ 532 (611)
|++++++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ +..|+.......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999886543221111122235678999999988889999999999999999997 655652110000
Q ss_pred hhcCChhhhhchhh--cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 035917 533 SSSGRSKEAIDKAL--CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNS 585 (611)
Q Consensus 533 ~~~~~~~~~~~~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 585 (611)
......+... .....+. .+.+++.+||+.+|++|||+.|+++.|++
T Consensus 241 ----~~~~~~~~~~~~~~~~~~~---~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 ----VIYYVRDGNVLSCPDNCPL---ELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ----HHHHHhcCCCCCCCCCCCH---HHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 0000000000 1112233 45556669999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=323.36 Aligned_cols=244 Identities=16% Similarity=0.183 Sum_probs=190.1
Q ss_pred CeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 330 NVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
++||+|+||.||+|+. .+++.||||+++... ...+.+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999995 468999999997532 2234578899999998 699999999999999999999999999
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcccc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTS 154 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC--Cccc
Confidence 9999988654 46899999999999999999999 8899999999999999999999999999987532211 1122
Q ss_pred CCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCC----hh-hhhchhh-cCCCCHHHHHH
Q 035917 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGR----SK-EAIDKAL-CGKGYDEEILQ 557 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~----~~-~~~~~~l-~~~~~~~~~~~ 557 (611)
...||+.|+|||++.+..++.++|||||||++|||++|+.||............ .. ....... .+...+.++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 234 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASS 234 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 346899999999999989999999999999999999999887421000000000 00 0111111 11223445555
Q ss_pred HHHHHhhcccCCCCCCCC------HHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWS------MYQVYQS 582 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs------~~evl~~ 582 (611)
++. +|++.||.+||+ +.++++|
T Consensus 235 li~---~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 235 VLK---GFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHH---HHhccCHHHcCCCCCCCCHHHHhcC
Confidence 555 999999999997 6788766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=309.60 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=190.0
Q ss_pred CeeeecCCceEEEEEeC----CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEe-CCeeEEEEeccC
Q 035917 330 NVIISTRTGTTYKAMLP----DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVV-EEEKLLIYKYMS 402 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~----~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~-~~~~~lv~ey~~ 402 (611)
+.||+|+||.||+|... ++..||+|++.... ...+.+.+|+.+++.++||||+++++++.. ++..+++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 24579999985422 234678899999999999999999998764 556789999999
Q ss_pred CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC--c
Q 035917 403 SGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES--S 480 (611)
Q Consensus 403 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~--~ 480 (611)
+|+|.+++.+.....++..+..++.++++||+||| +.+++||||||+|||+++++.+||+|||+++........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999765556788888999999999999999 789999999999999999999999999999865432211 1
Q ss_pred cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCC-CHHHHHHHHhhcCChhhhhc--hhhcCCCCHHHHHH
Q 035917 481 FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKG-NLVDWVNQLSSSGRSKEAID--KALCGKGYDEEILQ 557 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~-~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~ 557 (611)
......++..|+|||.+.+..++.++|||||||++|||+++.. ++........ ...... ........++ .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~---~ 230 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDI----TVYLLQGRRLLQPEYCPD---P 230 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH----HHHHhcCCCCCCCCcCCH---H
Confidence 1122346778999999988889999999999999999998644 4321100000 000000 0001112233 4
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHHHchh
Q 035917 558 FLKVACNCVVSRPKDRWSMYQVYQSLNSIAA 588 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 588 (611)
+.+++.+||+.+|++||++.||++.|+++..
T Consensus 231 ~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 231 LYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 5556669999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=330.01 Aligned_cols=240 Identities=25% Similarity=0.319 Sum_probs=202.0
Q ss_pred CCeeeecCCceEEEEE-eCCCCEEEEEeccccch-h---HHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 329 ENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCKL-G---EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 329 ~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~~-~---~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
...||.|+||.||-|+ ..+.+.||||++..+.. + -.++.+||..|.+++|||+|.+.|+|..+...|||||||-|
T Consensus 31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG 110 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG 110 (948)
T ss_pred HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc
Confidence 3569999999999999 46789999999975432 2 25789999999999999999999999999999999999965
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcccc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
+-.|++.-+.+++.+..+..|+.+.+.||+||| +.+.||||||..|||+.+.|.+||+|||.|....+ .+
T Consensus 111 -SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------An 180 (948)
T KOG0577|consen 111 -SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------AN 180 (948)
T ss_pred -cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc------hh
Confidence 888888766678999999999999999999999 88999999999999999999999999999876532 34
Q ss_pred CCCcccccccccccC---CCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHH
Q 035917 484 GDLGEFGYIAPEYSS---TMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLK 560 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~---~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~ 560 (611)
+++|||+|||||++. .+.|+-|.||||+|++..||...++|+...- .+..-..+...-.|.+....+++.+..|++
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN-AMSALYHIAQNesPtLqs~eWS~~F~~Fvd 259 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNESPTLQSNEWSDYFRNFVD 259 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch-HHHHHHHHHhcCCCCCCCchhHHHHHHHHH
Confidence 568999999999874 4689999999999999999999998865421 111111222233456667778899999999
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 035917 561 VACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 561 l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.|++.-|.+|||..++++|
T Consensus 260 ---~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 260 ---SCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ---HHHhhCcccCCcHHHHhhc
Confidence 9999999999999998876
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=322.58 Aligned_cols=243 Identities=18% Similarity=0.229 Sum_probs=189.1
Q ss_pred CCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHH---hccCCCCccceeeEEEeCCeeEEE
Q 035917 326 FCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRL---GQLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l---~~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
|...+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|++++ +.++||||+++++++..++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 45568999999999999995 468999999996532 1224566676654 567899999999999999999999
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
|||+++|+|..++.+. .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 9999999999888643 5899999999999999999999 8899999999999999999999999999987543221
Q ss_pred CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhch-hhcCCCCHHHHH
Q 035917 478 ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDK-ALCGKGYDEEIL 556 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~~~~~ 556 (611)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||........ ...+... .......+.++.
T Consensus 156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~----~~~i~~~~~~~p~~~~~~~~ 229 (324)
T cd05589 156 --DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV----FDSIVNDEVRYPRFLSREAI 229 (324)
T ss_pred --CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCCCCCHHHH
Confidence 112234699999999999988999999999999999999999988742110000 0000000 011122344555
Q ss_pred HHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 035917 557 QFLKVACNCVVSRPKDRW-----SMYQVYQS 582 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 582 (611)
+++. +||+.||++|| ++.+++++
T Consensus 230 ~li~---~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 230 SIMR---RLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHH---HHhhcCHhHcCCCCCCCHHHHhhC
Confidence 5555 99999999999 57777765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=312.35 Aligned_cols=256 Identities=20% Similarity=0.303 Sum_probs=201.2
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCC----EEEEEeccccch--hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGS----VLAVKRLNTCKL--GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~----~vAvK~~~~~~~--~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
..|...+.||+|+||.||+|... +|+ .||+|.++.... ...++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 45667789999999999999954 333 689998865432 34678999999999999999999999987 78899
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
||||+++|+|.+++......+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999999876557999999999999999999999 789999999999999999999999999999876533
Q ss_pred CCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchh---hcCCCCH
Q 035917 477 DESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKA---LCGKGYD 552 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~---l~~~~~~ 552 (611)
..........++..|+|||.+....++.++|||||||++||+++ |+.|+....... ....+... ......+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 237 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-----IPDLLEKGERLPQPPICT 237 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-----HHHHHhCCCCCCCCCCCC
Confidence 22222222234678999999988889999999999999999998 877764321110 00011000 0011122
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 553 EEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 553 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
. .+.+++.+||..+|++||++.++++.|+++.+...
T Consensus 238 ~---~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05057 238 I---DVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ 273 (279)
T ss_pred H---HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence 3 44555669999999999999999999999877644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=315.60 Aligned_cols=259 Identities=22% Similarity=0.304 Sum_probs=200.5
Q ss_pred ccHHHHHHhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhcc-CCCCccceeeEEEe-
Q 035917 314 VKLADLMAASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVV- 390 (611)
Q Consensus 314 ~~~~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~- 390 (611)
+.++.+..++++|...+.||+|+||.||+++. .+++.+|+|.++.......++.+|+.++.++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 44566677889999999999999999999986 4688999999876544556788999999999 69999999998853
Q ss_pred ----CCeeEEEEeccCCCChHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeE
Q 035917 391 ----EEEKLLIYKYMSSGTLYSLLQGN---ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDAR 463 (611)
Q Consensus 391 ----~~~~~lv~ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~k 463 (611)
++..++||||+++|+|.+++... ...+++..+..++.|+++||.||| +.+++||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEE
Confidence 45689999999999999987532 246889999999999999999999 78999999999999999999999
Q ss_pred EeecccccccCCCCCCccccCCCcccccccccccCC-----CCCCcccchHHHHHHHHHHhCCCCCHHHHH--HHHhhcC
Q 035917 464 IMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSST-----MVASLKGDVYGIGVVLLELAGFKGNLVDWV--NQLSSSG 536 (611)
Q Consensus 464 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~SfGvvl~ell~~~~~~~~~~--~~~~~~~ 536 (611)
|+|||+++....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.|+.... ......
T Consensus 165 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~- 241 (286)
T cd06638 165 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI- 241 (286)
T ss_pred EccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc-
Confidence 999999987643221 1123358999999998753 457889999999999999999988764211 010000
Q ss_pred Chhhhhchhh-cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 035917 537 RSKEAIDKAL-CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSL 583 (611)
Q Consensus 537 ~~~~~~~~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 583 (611)
.....+.. .....+.+ +.+++.+||+.||++||++.|++++.
T Consensus 242 --~~~~~~~~~~~~~~~~~---~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 242 --PRNPPPTLHQPELWSNE---FNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred --cccCCCcccCCCCcCHH---HHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00000111 11122334 44455599999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=312.68 Aligned_cols=254 Identities=21% Similarity=0.292 Sum_probs=197.2
Q ss_pred hcCCCCCeeeecCCceEEEEEeC------CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP------DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~------~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~ 395 (611)
++|...+.||+|+||.||+|... .+..||+|.+.... .....+.+|+.++..++||||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 46777899999999999999864 24789999986543 23457889999999999999999999999999999
Q ss_pred EEEeccCCCChHHhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEee
Q 035917 396 LIYKYMSSGTLYSLLQGNA---------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMD 466 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~D 466 (611)
+||||+++|+|.+++.... ..++|..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEECC
Confidence 9999999999999986432 24789999999999999999999 88999999999999999999999999
Q ss_pred cccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchh
Q 035917 467 FGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKA 545 (611)
Q Consensus 467 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (611)
||+++.+.............++..|+|||.+.+..++.++|||||||++||+++ |..|+.......... .........
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~ 241 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK-FVIDGGHLD 241 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHH-HHhcCCCCC
Confidence 999986644332222223346789999999988889999999999999999998 776663211110000 000000001
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 035917 546 LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNS 585 (611)
Q Consensus 546 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 585 (611)
. +...+. .+.+++.+||+.+|++|||+.++++.|++
T Consensus 242 ~-~~~~~~---~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 242 L-PENCPD---KLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred C-CCCCCH---HHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1 112233 44455559999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=309.21 Aligned_cols=248 Identities=22% Similarity=0.269 Sum_probs=197.1
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEecccc---chhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTC---KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~---~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
+|...+.||+|++|.||+|+. .+++.|++|.+... ....+++.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 466778999999999999996 46899999998643 23456789999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 401 MSSGTLYSLLQGN-ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 401 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
+++++|.+++... ...+++..+..++.+++.||.||| ..+++|+||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 9999999999764 346899999999999999999999 78999999999999999999999999999987643321
Q ss_pred ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHH
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFL 559 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 559 (611)
......|++.|+|||+..+..++.++|||||||++|||++|+.||........ ...... .............+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~ 230 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL----ILKIIR-GVFPPVSQMYSQQLA 230 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHc-CCCCCCccccCHHHH
Confidence 11233588999999999988899999999999999999999988632110000 000000 000111111223445
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 035917 560 KVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 560 ~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+++.+||+.+|++||++.+++++
T Consensus 231 ~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 231 QLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHHHccCCcccCcCHHHHhhC
Confidence 55559999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=322.71 Aligned_cols=240 Identities=18% Similarity=0.215 Sum_probs=189.8
Q ss_pred CeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 330 NVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
++||+|+||.||+|+.. +++.||||+++... ...+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 68999999986532 2235677888888877 699999999999999999999999999
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcccc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~ 154 (320)
T cd05590 81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTS 154 (320)
T ss_pred chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cccc
Confidence 9999988754 35899999999999999999999 8899999999999999999999999999987542221 1122
Q ss_pred CCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-hcCCCCHHHHHHHHHHH
Q 035917 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-LCGKGYDEEILQFLKVA 562 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~~~l~~l~ 562 (611)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.... ......+.++.++++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~li~-- 228 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL----FEAILNDEVVYPTWLSQDAVDILK-- 228 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH----HHHHhcCCCCCCCCCCHHHHHHHH--
Confidence 34699999999999988899999999999999999999988742111000 00011000 111223455555555
Q ss_pred hhcccCCCCCCCCH------HHHHHH
Q 035917 563 CNCVVSRPKDRWSM------YQVYQS 582 (611)
Q Consensus 563 ~~Cl~~dP~~RPs~------~evl~~ 582 (611)
+|++.||++||++ +++++|
T Consensus 229 -~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 229 -AFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred -HHcccCHHHCCCCCCCCCHHHHHcC
Confidence 9999999999998 677665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=308.74 Aligned_cols=244 Identities=22% Similarity=0.333 Sum_probs=191.3
Q ss_pred CeeeecCCceEEEEEeC--C--CCEEEEEeccccch--hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 330 NVIISTRTGTTYKAMLP--D--GSVLAVKRLNTCKL--GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~--~--g~~vAvK~~~~~~~--~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
+.||+|+||.||+|+.. + +..||+|.+..... ..+++.+|+++++++.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999843 2 36899999976543 4567999999999999999999999876 4568999999999
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc-cc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS-FV 482 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~-~~ 482 (611)
|+|.+++.... .+++..+..++.|++.||+||| ..+++|+||||+||+++.++.+||+|||+++......... ..
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999997653 6899999999999999999999 7889999999999999999999999999998764332111 11
Q ss_pred cCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHH----HHhhcCChhhhhchhhcCCCCHHHHHH
Q 035917 483 NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVN----QLSSSGRSKEAIDKALCGKGYDEEILQ 557 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~----~~~~~~~~~~~~~~~l~~~~~~~~~~~ 557 (611)
....++..|+|||.+.+..++.++|||||||++|||++ |..||..... ...... .+.......+. .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~---~ 226 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG------ERLPRPEECPQ---E 226 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC------CcCCCCCCCCH---H
Confidence 11224568999999988889999999999999999997 7777632110 000010 00011122233 4
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHHHch
Q 035917 558 FLKVACNCVVSRPKDRWSMYQVYQSLNSIA 587 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 587 (611)
+.+++.+||..+|++||++.++++.|+++.
T Consensus 227 l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 227 IYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 445555999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=321.31 Aligned_cols=240 Identities=20% Similarity=0.206 Sum_probs=186.8
Q ss_pred CeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 330 NVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
++||+|+||.||+|+. .+++.||||.++... ...+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999996 458899999996532 2234456677777654 899999999999999999999999999
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcccc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~ 154 (316)
T cd05592 81 GDLMFHIQSS-GRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS 154 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence 9999988754 35889999999999999999999 7899999999999999999999999999998643222 1223
Q ss_pred CCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc-hhhcCCCCHHHHHHHHHHH
Q 035917 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID-KALCGKGYDEEILQFLKVA 562 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~~~~~~~~~~l~~l~ 562 (611)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.. ........+.++.++++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~ll~-- 228 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL----FDSILNDRPHFPRWISKEAKDCLS-- 228 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCCCCCCHHHHHHHH--
Confidence 34699999999999988899999999999999999999988742110000 000000 00111223455556555
Q ss_pred hhcccCCCCCCCCHH-HHHHH
Q 035917 563 CNCVVSRPKDRWSMY-QVYQS 582 (611)
Q Consensus 563 ~~Cl~~dP~~RPs~~-evl~~ 582 (611)
+||+.||++||++. ++++|
T Consensus 229 -~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 229 -KLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred -HHccCCHHHcCCChHHHHcC
Confidence 99999999999875 56553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=311.19 Aligned_cols=247 Identities=25% Similarity=0.327 Sum_probs=189.5
Q ss_pred CeeeecCCceEEEEEeCC-CC--EEEEEecccc--chhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 330 NVIISTRTGTTYKAMLPD-GS--VLAVKRLNTC--KLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~-g~--~vAvK~~~~~--~~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
++||+|+||.||+|+..+ +. .+|+|.++.. ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999754 43 5788988643 23346789999999999 799999999999999999999999999
Q ss_pred CChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecc
Q 035917 404 GTLYSLLQGNA---------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFG 468 (611)
Q Consensus 404 gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFG 468 (611)
|+|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 24789999999999999999999 7899999999999999999999999999
Q ss_pred cccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhc
Q 035917 469 LAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALC 547 (611)
Q Consensus 469 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~ 547 (611)
+++...... .......+..|+|||++....++.++|||||||++|||++ |..||...... ...+.+.....
T Consensus 158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~~~~~~~~~~ 229 (270)
T cd05047 158 LSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYEKLPQGYR 229 (270)
T ss_pred Cccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----HHHHHHhCCCC
Confidence 986322110 0111124567999999988889999999999999999996 77776421100 00011111100
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHch
Q 035917 548 GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIA 587 (611)
Q Consensus 548 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 587 (611)
..........+.+++.+||+.+|.+||++.++++.|+++.
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 230 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0111111224555666999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=318.25 Aligned_cols=255 Identities=21% Similarity=0.325 Sum_probs=198.5
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCC----EEEEEeccccch--hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGS----VLAVKRLNTCKL--GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~----~vAvK~~~~~~~--~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
++|...+.||+|+||.||+|.. .+|. .||+|.+..... ...++.+|+.++++++||||++++|+|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 4566778999999999999985 3454 579998865432 234688999999999999999999998754 4679
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
++||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 99999999999999766556899999999999999999999 789999999999999999999999999999876433
Q ss_pred CCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHH----HHHHhhcCChhhhhchhhcCCCC
Q 035917 477 DESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDW----VNQLSSSGRSKEAIDKALCGKGY 551 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~----~~~~~~~~~~~~~~~~~l~~~~~ 551 (611)
..........++..|+|||++.+..++.++|||||||++|||++ |+.|+... .......... .......
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------~~~~~~~ 236 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGER------LPQPPIC 236 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC------CCCCCCC
Confidence 22212223346778999999988889999999999999999986 66665321 1111111100 0001112
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 552 DEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 552 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
+ .++.+++.+||..+|++||++.++++.|+++.+...
T Consensus 237 ~---~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 237 T---IDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred C---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 2 345556669999999999999999999999876643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=306.77 Aligned_cols=244 Identities=23% Similarity=0.346 Sum_probs=194.4
Q ss_pred CeeeecCCceEEEEEeCCCCEEEEEeccccch--hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCChH
Q 035917 330 NVIISTRTGTTYKAMLPDGSVLAVKRLNTCKL--GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLY 407 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~--~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL~ 407 (611)
++||+|+||.||++...+++.||+|.+..... ..+.+.+|++++++++|+||+++++++...+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46899999999999987799999999865433 3467999999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccCCCc
Q 035917 408 SLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLG 487 (611)
Q Consensus 408 ~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 487 (611)
+++......+++..+..++.+++.||+||| +.+++||||||+||+++.++.+||+|||+++...............+
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999765456899999999999999999999 78999999999999999999999999999986542211111111234
Q ss_pred ccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhh---cCCCCHHHHHHHHHHHh
Q 035917 488 EFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKAL---CGKGYDEEILQFLKVAC 563 (611)
Q Consensus 488 t~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l---~~~~~~~~~~~l~~l~~ 563 (611)
+..|+|||.+.+..++.++|||||||++|||++ +..|+..+..... .+.+.... .....+. .+.+++.
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~---~~~~li~ 229 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT-----RERIESGYRMPAPQLCPE---EIYRLML 229 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH-----HHHHhcCCCCCCCccCCH---HHHHHHH
Confidence 667999999988889999999999999999998 6667644321111 11111110 1112233 4555666
Q ss_pred hcccCCCCCCCCHHHHHHHHH
Q 035917 564 NCVVSRPKDRWSMYQVYQSLN 584 (611)
Q Consensus 564 ~Cl~~dP~~RPs~~evl~~L~ 584 (611)
+|++.+|++||++.|+++.|+
T Consensus 230 ~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 230 QCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHhccChhhCcCHHHHHHHhh
Confidence 999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=308.89 Aligned_cols=249 Identities=22% Similarity=0.301 Sum_probs=198.7
Q ss_pred hcCCCCCeeeecCCceEEEEEeCC-CCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccC
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPD-GSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
++|+..+.||+|+||.||+|+..+ ++.||+|.++.... .+++.+|++++++++||||+++++++..+...++++||++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 567888999999999999999754 89999999965433 6789999999999999999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccc
Q 035917 403 SGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482 (611)
Q Consensus 403 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 482 (611)
+++|.+++......+++..+..++.+++.||.||| ..+++|+||+|+||++++++.+||+|||++........ ..
T Consensus 82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~ 156 (256)
T cd06612 82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KR 156 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--cc
Confidence 99999999765567899999999999999999999 78999999999999999999999999999987643221 11
Q ss_pred cCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhc-CCCCHHHHHHHHHH
Q 035917 483 NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALC-GKGYDEEILQFLKV 561 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~l~~l 561 (611)
....|+..|+|||++.+..++.++|||||||++|||++|+.|+.......... .......+... ....+.+ +.++
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~---~~~~ 232 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-MIPNKPPPTLSDPEKWSPE---FNDF 232 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-hhccCCCCCCCchhhcCHH---HHHH
Confidence 22347889999999988889999999999999999999998864211100000 00000000000 0112234 4445
Q ss_pred HhhcccCCCCCCCCHHHHHHH
Q 035917 562 ACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 562 ~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+.+||+.||++|||+.||+++
T Consensus 233 i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 233 VKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred HHHHHhcChhhCcCHHHHhcC
Confidence 559999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=330.08 Aligned_cols=252 Identities=16% Similarity=0.170 Sum_probs=196.8
Q ss_pred HHHHhhhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCC
Q 035917 318 DLMAASNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE 392 (611)
Q Consensus 318 ~l~~~t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~ 392 (611)
++....++|...+.||+|+||.||+++.. +++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34445678999999999999999999964 58899999986422 22355889999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccc
Q 035917 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKL 472 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~ 472 (611)
..++||||+++|+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 999999999999999999754 4788899999999999999999 88999999999999999999999999999987
Q ss_pred cCCCCCCccccCCCcccccccccccCCC----CCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh--h
Q 035917 473 MTSSDESSFVNGDLGEFGYIAPEYSSTM----VASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA--L 546 (611)
Q Consensus 473 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~--l 546 (611)
...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ....+.+.. +
T Consensus 192 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~----~~~~i~~~~~~~ 266 (370)
T cd05621 192 MDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG----TYSKIMDHKNSL 266 (370)
T ss_pred cccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCccc
Confidence 643221 112345699999999988653 37889999999999999999999874311100 011111110 1
Q ss_pred --cC-CCCHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 035917 547 --CG-KGYDEEILQFLKVACNCVVSRPKD--RWSMYQVYQS 582 (611)
Q Consensus 547 --~~-~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 582 (611)
.. ...+.....++. .|+..++.+ ||++.|+++|
T Consensus 267 ~~p~~~~~s~~~~~li~---~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 NFPEDVEISKHAKNLIC---AFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCCCcccCCHHHHHHHH---HHccCchhccCCCCHHHHhcC
Confidence 00 123445555555 888755543 8999999998
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=318.70 Aligned_cols=254 Identities=21% Similarity=0.303 Sum_probs=196.9
Q ss_pred hcCCCCCeeeecCCceEEEEEeC--------CCCEEEEEeccccc--hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCC
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP--------DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEE 392 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~--------~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~ 392 (611)
++|...+.||+|+||.||+|+.. ....||+|.++... ....++.+|++++.++ +||||+++++++...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46777899999999999999741 24579999987533 2345688999999999 6999999999999988
Q ss_pred eeEEEEeccCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC
Q 035917 393 EKLLIYKYMSSGTLYSLLQGNA---------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD 457 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld 457 (611)
..+++|||+++|+|.+++.... ..++|..+.+++.|++.||.||| +.+++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEc
Confidence 9999999999999999986421 24889999999999999999999 78999999999999999
Q ss_pred CCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHH----HHHH
Q 035917 458 EDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDW----VNQL 532 (611)
Q Consensus 458 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~----~~~~ 532 (611)
+++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||... ....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~ 248 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999986643221111111234567999999988889999999999999999998 66665321 1111
Q ss_pred hhcCChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 533 SSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 533 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
...... ... ....+.+ +.+++.+||+.+|++||++.|+++.|+++...
T Consensus 249 ~~~~~~-----~~~-~~~~~~~---l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 249 LREGHR-----MDK-PSNCTHE---LYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHcCCC-----CCC-CCCCCHH---HHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 111000 000 1122334 44555599999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=308.60 Aligned_cols=243 Identities=24% Similarity=0.331 Sum_probs=193.3
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEe-CCeeEEEEeccC
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVV-EEEKLLIYKYMS 402 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~-~~~~~lv~ey~~ 402 (611)
.+|...+.||+|+||.||++... |+.||+|.++... ..+.+.+|+.++++++|+|++++++++.. ++..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 36777899999999999999874 7889999986533 34678999999999999999999998654 456899999999
Q ss_pred CCChHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 403 SGTLYSLLQGNAT-ELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 403 ~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
+|+|.+++..... .+++..+..++.+++.||+||| ..+++||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---- 156 (256)
T cd05082 84 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 156 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC----
Confidence 9999999876543 5899999999999999999999 7899999999999999999999999999988653221
Q ss_pred ccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHH-----HHHHHhhcCChhhhhchhhcCCCCHHHH
Q 035917 482 VNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVD-----WVNQLSSSGRSKEAIDKALCGKGYDEEI 555 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 555 (611)
....++..|+|||++.+..++.++|||||||++|||++ |+.|+.. ...... .+ ..+. .....+..+
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~-----~~~~-~~~~~~~~~ 228 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KG-----YKMD-APDGCPPVV 228 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cC-----CCCC-CCCCCCHHH
Confidence 11235678999999988889999999999999999996 7766532 111110 00 0000 111223344
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHHHHc
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 586 (611)
.+++.+||+.+|++|||+.++++.|+++
T Consensus 229 ---~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 229 ---YDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ---HHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 4455599999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=309.46 Aligned_cols=251 Identities=20% Similarity=0.249 Sum_probs=195.5
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
++|...+.||+|+||.||+|+. .+++.||+|++.... .....+.+|+.++++++||||+++++++..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4678889999999999999995 578999999986543 23456889999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
++++|.+++... ..+++..+..++.|++.||.||| ..+|+||||||+||++++++.+||+|||+++....... .
T Consensus 89 ~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~ 162 (267)
T cd06646 89 GGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--K 162 (267)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc--c
Confidence 999999998754 46899999999999999999999 78999999999999999999999999999986632211 1
Q ss_pred ccCCCcccccccccccC---CCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc-hhhc-CCCCHHHHH
Q 035917 482 VNGDLGEFGYIAPEYSS---TMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID-KALC-GKGYDEEIL 556 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~-~~l~-~~~~~~~~~ 556 (611)
.....|+..|+|||.+. ...++.++|||||||++|||++|+.|+.+................ +... ....+.++.
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH 242 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHH
Confidence 12235889999999874 345788999999999999999999887432111000000000001 1110 012234445
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHH
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQSL 583 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~L 583 (611)
++ +.+||+.+|++||++++++++|
T Consensus 243 ~l---i~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 243 NF---VKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HH---HHHHhhCChhhCcCHHHHhcCC
Confidence 54 4599999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=322.36 Aligned_cols=240 Identities=20% Similarity=0.218 Sum_probs=189.8
Q ss_pred CeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 330 NVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
++||+|+||.||+|+.. +++.||||+++... ...+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999964 58899999986532 2234577899998866 799999999999999999999999999
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcccc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~ 154 (321)
T cd05591 81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTT 154 (321)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCC--cccc
Confidence 9999988654 35899999999999999999999 7899999999999999999999999999987543222 1122
Q ss_pred CCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhch-hhcCCCCHHHHHHHHHHH
Q 035917 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDK-ALCGKGYDEEILQFLKVA 562 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~~~~~~l~~l~ 562 (611)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+... ...+...+.++.+++.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~----~~~i~~~~~~~p~~~~~~~~~ll~-- 228 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL----FESILHDDVLYPVWLSKEAVSILK-- 228 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH----HHHHHcCCCCCCCCCCHHHHHHHH--
Confidence 34689999999999988999999999999999999999988742110000 0001100 0111223445555555
Q ss_pred hhcccCCCCCCC-------CHHHHHHH
Q 035917 563 CNCVVSRPKDRW-------SMYQVYQS 582 (611)
Q Consensus 563 ~~Cl~~dP~~RP-------s~~evl~~ 582 (611)
+|++.||++|| ++.++++|
T Consensus 229 -~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 229 -AFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -HHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 99999999999 88888876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=308.87 Aligned_cols=252 Identities=21% Similarity=0.336 Sum_probs=198.5
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
++|...+.||+|+||.||++...++..+|+|.+.......+.+.+|++++++++|+||+++.+++.. ...+++|||+++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAK 84 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCC
Confidence 4677789999999999999998888899999987655556789999999999999999999999877 778999999999
Q ss_pred CChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccc
Q 035917 404 GTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482 (611)
Q Consensus 404 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 482 (611)
|+|.+++.... ..+++..++.++.+++.||.||| +.+++|+||||+||+++.++.+||+|||+++....... ...
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~ 160 (260)
T cd05073 85 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAR 160 (260)
T ss_pred CcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-ccc
Confidence 99999997543 36899999999999999999999 78999999999999999999999999999986543221 112
Q ss_pred cCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHH
Q 035917 483 NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKV 561 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l 561 (611)
....++..|+|||++....++.++|||||||++||+++ |..||.......... ......... .....+.+ +.++
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~---~~~~ 235 (260)
T cd05073 161 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR-ALERGYRMP-RPENCPEE---LYNI 235 (260)
T ss_pred cCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH-HHhCCCCCC-CcccCCHH---HHHH
Confidence 22346678999999988889999999999999999998 777763211000000 000000000 01122334 4455
Q ss_pred HhhcccCCCCCCCCHHHHHHHHHH
Q 035917 562 ACNCVVSRPKDRWSMYQVYQSLNS 585 (611)
Q Consensus 562 ~~~Cl~~dP~~RPs~~evl~~L~~ 585 (611)
+.+||+.+|++||++.++.+.|+.
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 236 MMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHcccCcccCcCHHHHHHHHhc
Confidence 559999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=303.88 Aligned_cols=249 Identities=18% Similarity=0.197 Sum_probs=199.3
Q ss_pred hcCCCCCeeeecCCceEEEEE-eCCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 324 NSFCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
+.|+..++||+|.|+.||++. .++|+.+|+|+++... .+.+++.+|++|.+.|+|||||++.+.+.+....++|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 455666789999999999998 4679999999996533 456889999999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC---CCCeEEeecccccccCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE---DFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~---~~~~kl~DFGla~~~~~~ 476 (611)
+|.||+|..-+-.+ ..+++..+-.++.||+++|.|+| ..+|||||+||+|+|+.. .--+||+|||+|..+..
T Consensus 91 ~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~- 165 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND- 165 (355)
T ss_pred cccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeCC-
Confidence 99999996544322 34677788889999999999999 899999999999999953 33589999999998862
Q ss_pred CCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHH
Q 035917 477 DESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEI 555 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~ 555 (611)
.....+.+|||+|||||++...+|+..+|||+.|||||-|+.|..||.+-......++.....+|..- .....+++.
T Consensus 166 --g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A 243 (355)
T KOG0033|consen 166 --GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA 243 (355)
T ss_pred --ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence 23345678999999999999999999999999999999999999998552111111111111122111 223456777
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+.++. +|+..||.+|.|+.|.++|
T Consensus 244 k~Lvr---rML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 244 KSLIR---RMLTVNPKKRITADEALKH 267 (355)
T ss_pred HHHHH---HHhccChhhhccHHHHhCC
Confidence 77777 9999999999999998865
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.54 Aligned_cols=243 Identities=21% Similarity=0.284 Sum_probs=192.9
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
+|...++||+|+||.||+|+. .+++.||+|.+.... ...+++.+|++++++++||||+++++++..++..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 466678999999999999985 578999999986432 23467899999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
++|+|..+. .+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---- 149 (279)
T cd06619 82 DGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---- 149 (279)
T ss_pred CCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----
Confidence 999997653 3788889999999999999999 8899999999999999999999999999998654322
Q ss_pred ccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcC--C-hhhhh---chhhcCCCCHHHH
Q 035917 482 VNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSG--R-SKEAI---DKALCGKGYDEEI 555 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~--~-~~~~~---~~~l~~~~~~~~~ 555 (611)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||........... . ..... .+.+.....+.++
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF 229 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHH
Confidence 2234689999999999988899999999999999999999988754211100000 0 00000 1111112233444
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
. +++.+|++.+|++||+++|++++
T Consensus 230 ~---~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 230 V---HFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred H---HHHHHHhhCChhhCCCHHHHhcC
Confidence 4 45559999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=319.60 Aligned_cols=241 Identities=21% Similarity=0.220 Sum_probs=188.0
Q ss_pred CeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 330 NVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
+.||+|+||.||+|+.. +++.||||.++... ...+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 57899999996532 2234567788888764 899999999999999999999999999
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcccc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (316)
T cd05619 81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTC 154 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Ccee
Confidence 9999998754 35889999999999999999999 7899999999999999999999999999987532211 1122
Q ss_pred CCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHHh
Q 035917 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVAC 563 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~ 563 (611)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ......+. .....+.++.+++.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~--~i~~~~~~-~~~~~~~~~~~li~--- 228 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQ--SIRMDNPC-YPRWLTREAKDILV--- 228 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhCCCC-CCccCCHHHHHHHH---
Confidence 3468999999999998899999999999999999999998874211100000 00000111 11223455555555
Q ss_pred hcccCCCCCCCCHH-HHHHH
Q 035917 564 NCVVSRPKDRWSMY-QVYQS 582 (611)
Q Consensus 564 ~Cl~~dP~~RPs~~-evl~~ 582 (611)
+||+.||++||++. ++.+|
T Consensus 229 ~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 229 KLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred HHhccCHhhcCCChHHHHcC
Confidence 99999999999997 66553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=323.69 Aligned_cols=253 Identities=21% Similarity=0.272 Sum_probs=206.9
Q ss_pred CCCCCeeeecCCceEEEEEeCC---C--CEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 326 FCSENVIISTRTGTTYKAMLPD---G--SVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~~~---g--~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
....++||.|.||.||+|++.+ | -.||||..+.+. .+.+.|+.|..+|+.++|||||+++|+|.+ ...|+||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEE
Confidence 3445789999999999999533 3 358899887632 346789999999999999999999999975 4689999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
|.++.|.|.++|..+...++......++.||+.||+||| +..+|||||..+|||+.....+||+|||+++.+.++..
T Consensus 470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence 999999999999987778999999999999999999999 89999999999999999999999999999999876554
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQ 557 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 557 (611)
.... ...-+..|||||.+...++|.++|||-|||.+||++. |..||.. +. ...+...+...-+...++.+...
T Consensus 547 YkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqg-vk----NsDVI~~iEnGeRlP~P~nCPp~ 620 (974)
T KOG4257|consen 547 YKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQG-VK----NSDVIGHIENGERLPCPPNCPPA 620 (974)
T ss_pred hhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccc-cc----ccceEEEecCCCCCCCCCCCChH
Confidence 3332 2234678999999999999999999999999999984 6667643 11 11222222222223344556667
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHHHchh
Q 035917 558 FLKVACNCVVSRPKDRWSMYQVYQSLNSIAA 588 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 588 (611)
+..++.+||.++|.+||.+.|+...|.++.+
T Consensus 621 LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 621 LYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred HHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 7778889999999999999999999998876
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=319.10 Aligned_cols=241 Identities=19% Similarity=0.192 Sum_probs=188.2
Q ss_pred CeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 330 NVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
++||+|+||.||+|+.. +|+.||+|.++... ...+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999964 68999999996532 2234567788888754 899999999999999999999999999
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcccc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
|+|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (316)
T cd05620 81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAS 154 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Ccee
Confidence 9999988754 35889999999999999999999 8899999999999999999999999999987532211 1223
Q ss_pred CCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHHh
Q 035917 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVAC 563 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~ 563 (611)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .. ....+. .....+.++.++++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~-~~-~~~~~~-~~~~~~~~~~~li~--- 228 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE-SI-RVDTPH-YPRWITKESKDILE--- 228 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH-HH-HhCCCC-CCCCCCHHHHHHHH---
Confidence 3469999999999999899999999999999999999998874321110000 00 000111 11223455566555
Q ss_pred hcccCCCCCCCCHH-HHHHH
Q 035917 564 NCVVSRPKDRWSMY-QVYQS 582 (611)
Q Consensus 564 ~Cl~~dP~~RPs~~-evl~~ 582 (611)
+||+.||++||++. ++.+|
T Consensus 229 ~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 229 KLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred HHccCCHHHcCCChHHHHcC
Confidence 99999999999984 66644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=328.04 Aligned_cols=194 Identities=18% Similarity=0.234 Sum_probs=167.9
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC---CCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP---DGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~---~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
...|...+.||+|+||.||++... .++.||+|.+... +.+.+|++++++++|||||++++++...+..++|||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 346888899999999999999753 4678999998543 345689999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
|+. ++|.+++.. ...+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 167 ~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 167 KYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred hcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 996 589988843 346999999999999999999999 789999999999999999999999999999866443322
Q ss_pred ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCH
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNL 525 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~ 525 (611)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf 287 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287 (392)
T ss_pred ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 2223456999999999999989999999999999999999998876
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=307.33 Aligned_cols=251 Identities=19% Similarity=0.228 Sum_probs=196.8
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch------hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL------GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~------~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
++|...+.||+|++|.||+|.. .+++.||+|.+..... ..+.+.+|++++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4788899999999999999995 4689999999864321 12468899999999999999999999999999999
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
||||+++++|.+++... ..+++..+..++.+++.||.||| ..+|+||||||+||++++++.++|+|||+++.....
T Consensus 82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 99999999999998754 35888999999999999999999 789999999999999999999999999999765332
Q ss_pred CCC-ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHH
Q 035917 477 DES-SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEI 555 (611)
Q Consensus 477 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 555 (611)
... .......|+..|+|||++.+..++.++||||||+++|||++|+.||.+................+. .....+.++
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 236 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQ-LPSHVSPDA 236 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCC-CCccCCHHH
Confidence 111 111233578899999999988899999999999999999999988743110000000000000011 112234445
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.++++ +||..+|++|||+.|++++
T Consensus 237 ~~li~---~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 237 RNFLR---RTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHH---HHhhcCcccCCCHHHHhhC
Confidence 55555 9999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.48 Aligned_cols=191 Identities=20% Similarity=0.263 Sum_probs=165.0
Q ss_pred hhhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 322 ASNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
...+|...+.||+|+||.||+|+.. +++.||+|..... ....|+.++++++||||+++++++...+..++||||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 3457999999999999999999964 5789999986432 245699999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
+. |+|.+++......+++..+..|+.||+.||.||| ..+|+||||||+|||++.++.+||+|||+++......
T Consensus 139 ~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 211 (357)
T PHA03209 139 YS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--- 211 (357)
T ss_pred cC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc---
Confidence 95 5999988766567999999999999999999999 7899999999999999999999999999997543221
Q ss_pred cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCC
Q 035917 481 FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGN 524 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~ 524 (611)
......||+.|+|||++.+..++.++|||||||++|||+++..+
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~ 255 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST 255 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCc
Confidence 12234589999999999998999999999999999999975443
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=312.23 Aligned_cols=248 Identities=21% Similarity=0.296 Sum_probs=193.4
Q ss_pred CCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 326 FCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
|...+.||+|+||.||+|... ++..+|+|.+.... ...+.+.+|+++++.++||||+++++++..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 344578999999999999965 57889999986543 3346789999999999999999999999999999999999999
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcccc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
|+|.+++.+...++++..+..++.|+++||.||| +.+++||||||+||+++.++.+||+|||++....... ....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~ 161 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRD 161 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc--cccc
Confidence 9999988755457999999999999999999999 7899999999999999999999999999987653221 1122
Q ss_pred CCCcccccccccccC-----CCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHHHH
Q 035917 484 GDLGEFGYIAPEYSS-----TMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEILQ 557 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~-----~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~ 557 (611)
...|+..|+|||++. +..++.++|||||||++|||++|+.|+.......... .......+.+ .....+.++.+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 240 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLL-KIAKSEPPTLAQPSRWSSEFKD 240 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHH-HHhhcCCCCCCCccccCHHHHH
Confidence 345899999999873 4457889999999999999999998864321100000 0000000111 11223445555
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++. +||+.||++||++.+++++
T Consensus 241 li~---~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 241 FLK---KCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHH---HHccCChhhCcCHHHHhcC
Confidence 555 9999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=315.40 Aligned_cols=261 Identities=23% Similarity=0.304 Sum_probs=201.7
Q ss_pred ccHHHHHHhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhcc-CCCCccceeeEEEeC
Q 035917 314 VKLADLMAASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVE 391 (611)
Q Consensus 314 ~~~~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~ 391 (611)
++++++..++++|...+.||+|+||.||++.. .+++.+|+|.+.........+.+|+.++.++ +|||++++++++...
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 45566777889999999999999999999996 5689999999976544556788999999999 799999999998754
Q ss_pred -----CeeEEEEeccCCCChHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeE
Q 035917 392 -----EEKLLIYKYMSSGTLYSLLQG---NATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDAR 463 (611)
Q Consensus 392 -----~~~~lv~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~k 463 (611)
+..++||||+++|+|.++++. ....+++..+..++.|++.||+||| ..+++||||||+||++++++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEE
Confidence 357999999999999998863 2246899999999999999999999 78999999999999999999999
Q ss_pred EeecccccccCCCCCCccccCCCcccccccccccCCC-----CCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCCh
Q 035917 464 IMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTM-----VASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRS 538 (611)
Q Consensus 464 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~ 538 (611)
|+|||+++........ .....|+..|+|||++... .++.++|||||||++|||++|+.|+.......... ..
T Consensus 169 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~-~~ 245 (291)
T cd06639 169 LVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF-KI 245 (291)
T ss_pred Eeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH-HH
Confidence 9999999865432211 1223588999999987543 36899999999999999999998874321100000 00
Q ss_pred hhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 539 KEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 539 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.....+.+. ...+....+.+++.+||+.+|++||++.|+++|
T Consensus 246 ~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 246 PRNPPPTLL--HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred hcCCCCCCC--cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 000000010 011122345556669999999999999999876
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=319.74 Aligned_cols=255 Identities=20% Similarity=0.272 Sum_probs=198.5
Q ss_pred cCCCCCeeeecCCceEEEEEeC--------CCCEEEEEeccccc--hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCe
Q 035917 325 SFCSENVIISTRTGTTYKAMLP--------DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEE 393 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~--------~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~ 393 (611)
.|...+.||+|+||.||+|... .+..||+|.++... ...+++.+|++++.++ +||||++++++|..++.
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 92 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCc
Confidence 5777899999999999999742 12379999886532 2346789999999999 79999999999999999
Q ss_pred eEEEEeccCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC
Q 035917 394 KLLIYKYMSSGTLYSLLQGNA---------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE 458 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~ 458 (611)
.+++|||+++|+|.+++.... ..++|..++.++.|++.||+||| ..+++||||||+||++++
T Consensus 93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~~ 169 (334)
T cd05100 93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTE 169 (334)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcC
Confidence 999999999999999986421 24789999999999999999999 789999999999999999
Q ss_pred CCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHH-----HHHHH
Q 035917 459 DFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVD-----WVNQL 532 (611)
Q Consensus 459 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~-----~~~~~ 532 (611)
++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ +..|+.. +....
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 249 (334)
T cd05100 170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 249 (334)
T ss_pred CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 99999999999986543221111122234578999999988889999999999999999997 6555421 11111
Q ss_pred hhcCChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCC
Q 035917 533 SSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGF 592 (611)
Q Consensus 533 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 592 (611)
.... .... ....+. .+.+++.+||+.+|++||++.|++++|+++......
T Consensus 250 ~~~~------~~~~-~~~~~~---~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~ 299 (334)
T cd05100 250 KEGH------RMDK-PANCTH---ELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299 (334)
T ss_pred HcCC------CCCC-CCCCCH---HHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence 1000 0000 111223 445556699999999999999999999999866543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=307.34 Aligned_cols=237 Identities=18% Similarity=0.276 Sum_probs=184.2
Q ss_pred CeeeecCCceEEEEEeCC-------------CCEEEEEeccccch-hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeE
Q 035917 330 NVIISTRTGTTYKAMLPD-------------GSVLAVKRLNTCKL-GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~-------------g~~vAvK~~~~~~~-~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~ 395 (611)
+.||+|+||.||+|++.+ ...||+|.+..... ....|.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 23589998865433 2356889999999999999999999999999999
Q ss_pred EEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCC-------eEEeecc
Q 035917 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFD-------ARIMDFG 468 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~-------~kl~DFG 468 (611)
+||||+++|+|..++......+++..++.++.||++||+||| +.+|+||||||+|||++.++. +|++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998765557899999999999999999999 889999999999999987654 8999999
Q ss_pred cccccCCCCCCccccCCCcccccccccccC-CCCCCcccchHHHHHHHHHHh-CCCCCHHHHHHHHhhcCChhhhhchhh
Q 035917 469 LAKLMTSSDESSFVNGDLGEFGYIAPEYSS-TMVASLKGDVYGIGVVLLELA-GFKGNLVDWVNQLSSSGRSKEAIDKAL 546 (611)
Q Consensus 469 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~SfGvvl~ell-~~~~~~~~~~~~~~~~~~~~~~~~~~l 546 (611)
++...... ....++..|+|||.+. +..++.++|||||||++|||+ ++..|+....... .........
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~~~~~~~~~ 226 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-----KERFYEGQC 226 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-----HHHHHhcCc
Confidence 98765321 1234788999999886 466899999999999999997 5666653211100 000000000
Q ss_pred -cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 035917 547 -CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSL 583 (611)
Q Consensus 547 -~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 583 (611)
......++ +.+++.+||+.||++||++.+|++++
T Consensus 227 ~~~~~~~~~---~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 227 MLVTPSCKE---LADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred cCCCCChHH---HHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 01112334 44555599999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=323.29 Aligned_cols=236 Identities=19% Similarity=0.214 Sum_probs=187.5
Q ss_pred CeeeecCCceEEEEEe----CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccC
Q 035917 330 NVIISTRTGTTYKAML----PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~----~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
+.||+|+||.||+++. .+|+.||+|+++... .....+.+|++++++++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 368999999996533 223457889999999999999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccc
Q 035917 403 SGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482 (611)
Q Consensus 403 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 482 (611)
+|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++...... ...
T Consensus 82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~ 155 (318)
T cd05582 82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKA 155 (318)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cce
Confidence 99999998654 35899999999999999999999 7899999999999999999999999999998653321 112
Q ss_pred cCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHHHHHHHH
Q 035917 483 NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEILQFLKV 561 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~~l 561 (611)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ...+..... .....+.++.++++
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~----~~~i~~~~~~~p~~~~~~~~~li~- 230 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET----MTMILKAKLGMPQFLSPEAQSLLR- 230 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH----HHHHHcCCCCCCCCCCHHHHHHHH-
Confidence 234689999999999888899999999999999999999988742110000 000111000 11223455555555
Q ss_pred HhhcccCCCCCCCCHHH
Q 035917 562 ACNCVVSRPKDRWSMYQ 578 (611)
Q Consensus 562 ~~~Cl~~dP~~RPs~~e 578 (611)
+||+.||++||++.+
T Consensus 231 --~~l~~~P~~R~~a~~ 245 (318)
T cd05582 231 --ALFKRNPANRLGAGP 245 (318)
T ss_pred --HHhhcCHhHcCCCCC
Confidence 999999999999433
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=310.46 Aligned_cols=245 Identities=26% Similarity=0.367 Sum_probs=190.7
Q ss_pred CeeeecCCceEEEEEeCC-------CCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 330 NVIISTRTGTTYKAMLPD-------GSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~-------g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
+.||+|+||.||+|+..+ ++.||+|.+.... ....++.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998643 2579999886533 3456789999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC-----CeEEeeccc
Q 035917 401 MSSGTLYSLLQGNA------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF-----DARIMDFGL 469 (611)
Q Consensus 401 ~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~-----~~kl~DFGl 469 (611)
+++|+|.+++.... ..++|..++.++.+++.||+||| +.+++|+||||+||+++.+. .+|++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986421 24789999999999999999999 78999999999999999877 899999999
Q ss_pred ccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchh---
Q 035917 470 AKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKA--- 545 (611)
Q Consensus 470 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~--- 545 (611)
++...............++..|+|||++.+..++.++|||||||++|||++ |+.|+....... ....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~-----~~~~~~~~~~~ 232 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-----VLQHVTAGGRL 232 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH-----HHHHHhcCCcc
Confidence 986543322222222346788999999998899999999999999999997 777763211000 00000000
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 035917 546 LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNS 585 (611)
Q Consensus 546 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 585 (611)
......++.+. +++.+||+.+|++||++.+|++.|++
T Consensus 233 ~~~~~~~~~~~---~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 233 QKPENCPDKIY---QLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CCcccchHHHH---HHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 01122334444 55559999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=344.80 Aligned_cols=260 Identities=20% Similarity=0.251 Sum_probs=200.9
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...++||+|+||.||+|+.. +|+.||||+++... ...+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46778899999999999999964 58999999996432 22467999999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcC----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecc
Q 035917 399 KYMSSGTLYSLLQGN----------ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFG 468 (611)
Q Consensus 399 ey~~~gsL~~~l~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFG 468 (611)
||+++|+|.+++... ...+++..++.++.||++||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988631 124677888999999999999999 7899999999999999999999999999
Q ss_pred cccccCCCCC----------------CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHH
Q 035917 469 LAKLMTSSDE----------------SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQL 532 (611)
Q Consensus 469 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~ 532 (611)
+++....... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986621110 001112469999999999999999999999999999999999999874311110
Q ss_pred hhcCChhhhhchhhc--CCCCHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHHHHchhhhC
Q 035917 533 SSSGRSKEAIDKALC--GKGYDEEILQFLKVACNCVVSRPKDRW-SMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 533 ~~~~~~~~~~~~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~i~~~~~ 591 (611)
... .....++... ....+. .+.+++.+|++.||++|| +++++.+.|+...+..+
T Consensus 239 i~~--~~~i~~P~~~~p~~~iP~---~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p 295 (932)
T PRK13184 239 ISY--RDVILSPIEVAPYREIPP---FLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSP 295 (932)
T ss_pred hhh--hhhccChhhccccccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCc
Confidence 000 0001111100 011223 344556699999999996 67788888888766543
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=306.17 Aligned_cols=238 Identities=21% Similarity=0.294 Sum_probs=186.7
Q ss_pred CeeeecCCceEEEEEeCCCC-----------EEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 330 NVIISTRTGTTYKAMLPDGS-----------VLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~g~-----------~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
+.||+|+||.||+|...+.. .|++|.+.........|.+|+.++++++||||+++++++.. +..++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46899999999999975433 58888876554446789999999999999999999999988 7789999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC-------CeEEeeccccc
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF-------DARIMDFGLAK 471 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~-------~~kl~DFGla~ 471 (611)
||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||+++
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 999999999999865446899999999999999999999 88999999999999999887 79999999998
Q ss_pred ccCCCCCCccccCCCcccccccccccCCC--CCCcccchHHHHHHHHHHhCC-CCCHHHHHHHHhhcCChhhhhchhhcC
Q 035917 472 LMTSSDESSFVNGDLGEFGYIAPEYSSTM--VASLKGDVYGIGVVLLELAGF-KGNLVDWVNQLSSSGRSKEAIDKALCG 548 (611)
Q Consensus 472 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~SfGvvl~ell~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~ 548 (611)
..... ....++..|+|||++... .++.++|||||||++|||+++ ..|+....... ............
T Consensus 157 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~----~~~~~~~~~~~~ 226 (259)
T cd05037 157 TVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE----KERFYQDQHRLP 226 (259)
T ss_pred ccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh----HHHHHhcCCCCC
Confidence 65431 122467789999998776 789999999999999999985 55543321000 000000111111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 035917 549 KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLN 584 (611)
Q Consensus 549 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 584 (611)
.... ..+.+++.+||..+|++|||+.+|++.|+
T Consensus 227 ~~~~---~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 227 MPDC---AELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCCc---hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1112 44555666999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=329.00 Aligned_cols=246 Identities=17% Similarity=0.185 Sum_probs=191.0
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
.|...+.||+|+||.||+|+. .+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 467788999999999999995 568999999996532 123568899999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC--
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD-- 477 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~-- 477 (611)
||++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 99999999998754 35788889999999999999999 7899999999999999999999999999975321000
Q ss_pred -------------------------------------------CCccccCCCcccccccccccCCCCCCcccchHHHHHH
Q 035917 478 -------------------------------------------ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVV 514 (611)
Q Consensus 478 -------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvv 514 (611)
........+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 0000122469999999999998899999999999999
Q ss_pred HHHHhCCCCCHHHHHHHHhhcCChhhhhc--hhh---cCCCCHHHHHHHHHHHhhcccCCCCCCCC---HHHHHHH
Q 035917 515 LLELAGFKGNLVDWVNQLSSSGRSKEAID--KAL---CGKGYDEEILQFLKVACNCVVSRPKDRWS---MYQVYQS 582 (611)
Q Consensus 515 l~ell~~~~~~~~~~~~~~~~~~~~~~~~--~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~ 582 (611)
+|||++|+.||........ ...+.. ... .....+++..+++. +++ .+|++|++ +.|+++|
T Consensus 238 l~elltG~~Pf~~~~~~~~----~~~i~~~~~~~~~p~~~~~s~~~~~li~---~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLET----QMKVINWQTSLHIPPQAKLSPEASDLII---KLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHHhCCCCCCCCCHHHH----HHHHHccCCCcCCCCcccCCHHHHHHHH---HHc-cCHhHcCCCCCHHHHhcC
Confidence 9999999998743110000 000100 000 11223455555554 544 48999997 8888876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=306.51 Aligned_cols=242 Identities=22% Similarity=0.307 Sum_probs=192.3
Q ss_pred CeeeecCCceEEEEEeCC--C--CEEEEEeccccch--hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 330 NVIISTRTGTTYKAMLPD--G--SVLAVKRLNTCKL--GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~--g--~~vAvK~~~~~~~--~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
+.||+|++|.||+|.+.+ + ..||||.+..... ..+++.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999643 3 3699999976543 34679999999999999999999999988 888999999999
Q ss_pred CChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC-cc
Q 035917 404 GTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES-SF 481 (611)
Q Consensus 404 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~-~~ 481 (611)
|+|.+++.+.. ..++|..+..++.|+++||+||| ..+++|+||||+||+++.++.+||+|||+++.+...... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997654 46899999999999999999999 889999999999999999999999999999876543211 11
Q ss_pred ccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHH-----HHHHHhhcCChhhhhchhhcCCCCHHHH
Q 035917 482 VNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVD-----WVNQLSSSGRSKEAIDKALCGKGYDEEI 555 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 555 (611)
.....++..|+|||++.+..++.++|||||||++|||++ |+.|+.. ......... .........+.
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------~~~~~~~~~~~-- 228 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG------ERLERPEACPQ-- 228 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC------CcCCCCccCCH--
Confidence 112347789999999988889999999999999999998 8877631 111111000 00001112233
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQSLN 584 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 584 (611)
.+.+++.+||+.+|++||++.++++.|.
T Consensus 229 -~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 229 -DIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -HHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 4445555999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=309.86 Aligned_cols=245 Identities=22% Similarity=0.299 Sum_probs=182.3
Q ss_pred eeeecCCceEEEEEeCC---CCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCC
Q 035917 331 VIISTRTGTTYKAMLPD---GSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGT 405 (611)
Q Consensus 331 ~ig~G~~g~Vy~~~~~~---g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gs 405 (611)
.||+|+||.||+|...+ ...+|+|.+.... .....+.+|+.+++.++||||+++++++...+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 4578899876432 234568899999999999999999999999999999999999999
Q ss_pred hHHhhhcCCC----CCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 406 LYSLLQGNAT----ELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 406 L~~~l~~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
|.+++..... ..++.....++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999975432 3567888999999999999999 78999999999999999999999999999875432221111
Q ss_pred ccCCCcccccccccccC-------CCCCCcccchHHHHHHHHHHhC-CCCCHHHHHH-----HHhhcCChhhhhchhhcC
Q 035917 482 VNGDLGEFGYIAPEYSS-------TMVASLKGDVYGIGVVLLELAG-FKGNLVDWVN-----QLSSSGRSKEAIDKALCG 548 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~-------~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~ 548 (611)
.....++..|+|||++. ...++.++|||||||++|||++ +..|+..... ..... ......++.+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~- 236 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE-QDIKLPKPQLD- 236 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhc-cCccCCCCccc-
Confidence 12234677899999864 2456889999999999999998 5556532211 11111 00011111111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 035917 549 KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLN 584 (611)
Q Consensus 549 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 584 (611)
...+..... ++..|| .||++||+++||++.|.
T Consensus 237 ~~~~~~~~~---~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 237 LKYSDRWYE---VMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ccCCHHHHH---HHHHHh-cCcccccCHHHHHHHhc
Confidence 123334444 444888 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=320.10 Aligned_cols=240 Identities=20% Similarity=0.206 Sum_probs=186.2
Q ss_pred CeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHH-HHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 330 NVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMN-RLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~-~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
++||+|+||.||+|+. .+|+.||||++.... ...+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999996 469999999996432 12234555554 56789999999999999999999999999999
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcccc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
|+|.+++... ..+++..+..++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (323)
T cd05575 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTS 154 (323)
T ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cccc
Confidence 9999988754 46889999999999999999999 7899999999999999999999999999987542221 1122
Q ss_pred CCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-hcCCCCHHHHHHHHHHH
Q 035917 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-LCGKGYDEEILQFLKVA 562 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~~~l~~l~ 562 (611)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.... ......+.++.++++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~li~-- 228 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM----YDNILNKPLRLKPNISVSARHLLE-- 228 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH----HHHHHcCCCCCCCCCCHHHHHHHH--
Confidence 34689999999999998999999999999999999999988742110000 00111110 011223455555555
Q ss_pred hhcccCCCCCCCCHH----HHHHH
Q 035917 563 CNCVVSRPKDRWSMY----QVYQS 582 (611)
Q Consensus 563 ~~Cl~~dP~~RPs~~----evl~~ 582 (611)
+|++.||++||++. |++++
T Consensus 229 -~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 229 -GLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred -HHhhcCHHhCCCCCCCHHHHHcC
Confidence 99999999999984 55543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=306.81 Aligned_cols=249 Identities=21% Similarity=0.350 Sum_probs=196.9
Q ss_pred cCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccch-------hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEE
Q 035917 325 SFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKL-------GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~-------~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
+|...+.||+|+||.||+|...+++.+|||.++.... ..+.+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 3677889999999999999988899999999864321 124688999999999999999999999999999999
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
|||+++++|.+++... ..+++..+..++.|++.||+||| ..+|+|+||+|+||++++++.+||+|||+++......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 9999999999999754 35889999999999999999999 7889999999999999999999999999988653211
Q ss_pred ----CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHH--HHHhhcCChhhhhchhhcCCCC
Q 035917 478 ----ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWV--NQLSSSGRSKEAIDKALCGKGY 551 (611)
Q Consensus 478 ----~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~ 551 (611)
.........|+..|+|||++.+..++.++|||||||++|||++|..||.... ........ .....+.+ ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~-~~~~ 234 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA-HRGLMPRL-PDSF 234 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh-ccCCCCCC-CCCC
Confidence 1111223458899999999998889999999999999999999998874210 00000000 00001111 1234
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 552 DEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 552 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++++.+++. +||+.+|++||++.|++++
T Consensus 235 ~~~~~~~i~---~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 235 SAAAIDFVT---SCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CHHHHHHHH---HHhcCCcccCCCHHHHhcC
Confidence 455555555 9999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=329.56 Aligned_cols=250 Identities=16% Similarity=0.159 Sum_probs=192.2
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
+|...+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|++++.+++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 577889999999999999995 468999999986532 123568899999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC--
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD-- 477 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~-- 477 (611)
|+++|+|.+++.+. ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 82 YIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 99999999999754 35788888999999999999999 8899999999999999999999999999975321000
Q ss_pred ---------------------------------------CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHH
Q 035917 478 ---------------------------------------ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL 518 (611)
Q Consensus 478 ---------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~el 518 (611)
........+||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 00001134699999999999998999999999999999999
Q ss_pred hCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHHHHHHHHHhhcccCCCCCCC---CHHHHHHH
Q 035917 519 AGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEILQFLKVACNCVVSRPKDRW---SMYQVYQS 582 (611)
Q Consensus 519 l~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---s~~evl~~ 582 (611)
++|+.||..................... .....+.+..+++. +|+ .+|.+|+ ++.|+++|
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~---~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLIL---RLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHH---HHh-cCHhhcCCCCCHHHHhCC
Confidence 9999987431110000000000000000 01123445555554 655 4999999 89999988
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=319.14 Aligned_cols=240 Identities=20% Similarity=0.221 Sum_probs=190.0
Q ss_pred CeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 330 NVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
++||+|+||.||+|+.. +++.||||+++... .....+.+|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 58899999997532 2234577899999888 699999999999999999999999999
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcccc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (318)
T cd05570 81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTS 154 (318)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--ccc
Confidence 9999988754 35899999999999999999999 88999999999999999999999999999875322111 122
Q ss_pred CCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-hcCCCCHHHHHHHHHHH
Q 035917 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-LCGKGYDEEILQFLKVA 562 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~~~l~~l~ 562 (611)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.... ......++++.++++
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~li~-- 228 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL----FQSILEDEVRYPRWLSKEAKSILK-- 228 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH----HHHHHcCCCCCCCcCCHHHHHHHH--
Confidence 34589999999999999999999999999999999999988742110000 00000000 111223445555555
Q ss_pred hhcccCCCCCCCCH-----HHHHHH
Q 035917 563 CNCVVSRPKDRWSM-----YQVYQS 582 (611)
Q Consensus 563 ~~Cl~~dP~~RPs~-----~evl~~ 582 (611)
+||+.||++||++ .+++++
T Consensus 229 -~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 229 -SFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred -HHccCCHHHcCCCCCCCHHHHhcC
Confidence 9999999999999 888776
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=307.98 Aligned_cols=255 Identities=20% Similarity=0.261 Sum_probs=197.0
Q ss_pred cCCCCCeeeecCCceEEEEEeCC----CCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 325 SFCSENVIISTRTGTTYKAMLPD----GSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~~----g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
+|...+.||+|+||.||+|...+ ...||||...... ...+.+.+|+.++++++||||+++++++.+ +..++||
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~ 85 (270)
T cd05056 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVM 85 (270)
T ss_pred hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEE
Confidence 46777899999999999998643 3579999886543 234679999999999999999999998865 5578999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++|+|.+++......+++..+..++.+++.||+||| +.+++|+||||+||+++.++.+||+|||+++.......
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 86 ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred EcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 999999999999765456899999999999999999999 78999999999999999999999999999987643321
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQ 557 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 557 (611)
.. .....++..|+|||.+....++.++|||||||++||+++ |..||......... ......... ......+.++.+
T Consensus 163 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~ 239 (270)
T cd05056 163 YK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI-GRIENGERL-PMPPNCPPTLYS 239 (270)
T ss_pred ee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHcCCcC-CCCCCCCHHHHH
Confidence 11 112234568999999988889999999999999999885 77776321110000 000000000 011223344445
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 558 FLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
++.+|+..+|++|||+.++++.|+++..+
T Consensus 240 ---li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 240 ---LMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ---HHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 45599999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=308.97 Aligned_cols=237 Identities=19% Similarity=0.252 Sum_probs=183.0
Q ss_pred eeeecCCceEEEEEeCC-------------------------CCEEEEEeccccch-hHHHHHHHHHHHhccCCCCccce
Q 035917 331 VIISTRTGTTYKAMLPD-------------------------GSVLAVKRLNTCKL-GEKKFRNEMNRLGQLRHPNLAPL 384 (611)
Q Consensus 331 ~ig~G~~g~Vy~~~~~~-------------------------g~~vAvK~~~~~~~-~~~~~~~Ev~~l~~l~H~nIv~l 384 (611)
.||+|+||.||+|.+.. ...||+|.++.... ...+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 23589999865432 23568899999999999999999
Q ss_pred eeEEEeCCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC----
Q 035917 385 LGYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF---- 460 (611)
Q Consensus 385 ~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~---- 460 (611)
+++|..++..++||||+++|+|.+++......+++..+..++.|+++||+||| +.+|+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999998765557899999999999999999999 78999999999999997643
Q ss_pred ---CeEEeecccccccCCCCCCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHh-CCCCCHHHHHHHHhhc
Q 035917 461 ---DARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELA-GFKGNLVDWVNQLSSS 535 (611)
Q Consensus 461 ---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell-~~~~~~~~~~~~~~~~ 535 (611)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.|+.......
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--- 229 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--- 229 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH---
Confidence 3799999988654221 11247788999998865 56899999999999999995 6777763211100
Q ss_pred CChhhhhchhh-cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 035917 536 GRSKEAIDKAL-CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLN 584 (611)
Q Consensus 536 ~~~~~~~~~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 584 (611)
......... ....... .+.+++.+||+.+|++||++.+|+++|.
T Consensus 230 --~~~~~~~~~~~~~~~~~---~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 --KERFYEKKHRLPEPSCK---ELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --HHHHHHhccCCCCCCCh---HHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 001111110 0111122 4555666999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=321.70 Aligned_cols=249 Identities=20% Similarity=0.256 Sum_probs=191.1
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCC-----eeE
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE-----EKL 395 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~-----~~~ 395 (611)
+|...+.||+|+||.||+|.. .+|+.||||++.... ...+++.+|+++++.++||||+++++++..++ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999995 579999999986432 23467889999999999999999999998776 789
Q ss_pred EEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
+||||+. ++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999997 5888887643 46899999999999999999999 78999999999999999999999999999986543
Q ss_pred CCCCccccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhh---cCChh-------
Q 035917 476 SDESSFVNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSS---SGRSK------- 539 (611)
Q Consensus 476 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~---~~~~~------- 539 (611)
.. ........+++.|+|||++.+. .++.++|||||||++|||++|+.||... ...... .....
T Consensus 156 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 156 DE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred Cc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 22 1222334688999999988764 4789999999999999999998776310 110000 00000
Q ss_pred ---hhhch-hh----------cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 540 ---EAIDK-AL----------CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 540 ---~~~~~-~l----------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
..+.. .. .....+++ +.+++.+|++.||++|||+.|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHE---AVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHH---HHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000 00 00112333 4455559999999999999999987
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=319.18 Aligned_cols=245 Identities=18% Similarity=0.180 Sum_probs=191.0
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCC-CccceeeEEEeCCeeEEEE
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHP-NLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~-nIv~l~g~~~~~~~~~lv~ 398 (611)
+|...+.||+|+||.||+|+.. +++.||||+++... ...+.+..|++++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4677789999999999999964 57899999996532 2345688899999999765 5888989998899999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 999999999988754 35889999999999999999999 78999999999999999999999999999875322111
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEILQ 557 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~ 557 (611)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+..... .....+.++.+
T Consensus 157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T cd05587 157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL----FQSIMEHNVSYPKSLSKEAVS 230 (324)
T ss_pred --ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCCCCCCHHHHH
Confidence 12234689999999999998999999999999999999999988742111000 000111000 11223445555
Q ss_pred HHHHHhhcccCCCCCCCCH-----HHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWSM-----YQVYQS 582 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~-----~evl~~ 582 (611)
++. +||+.||.+||+. +++.+|
T Consensus 231 li~---~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 231 ICK---GLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HHH---HHhhcCHHHcCCCCCCCHHHHhcC
Confidence 554 9999999999976 677665
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=313.41 Aligned_cols=195 Identities=20% Similarity=0.312 Sum_probs=169.9
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
+|...+.||+|+||.||++.. .++..||+|.++... ....++.+|++++.+++||||+++++++..++..++||||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 678889999999999999995 468899999986432 22356889999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
++++|.+++... ..+++..+..++.|+++||.|||+ ..+++||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---- 154 (308)
T cd06615 82 DGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---- 154 (308)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc----
Confidence 999999999755 458899999999999999999994 3589999999999999999999999999987653221
Q ss_pred ccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHH
Q 035917 482 VNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLV 526 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~ 526 (611)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.|+.
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~ 199 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP 199 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 123468899999999988889999999999999999999988763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.41 Aligned_cols=249 Identities=19% Similarity=0.253 Sum_probs=196.1
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
.+|...+.||+|++|.||+|+. .+++.||+|.+.... ...+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 3677778999999999999995 578999999986543 33467899999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
++++|.+++.+. .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 100 ~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~ 172 (296)
T cd06654 100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K 172 (296)
T ss_pred CCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--c
Confidence 999999998643 4789999999999999999999 78999999999999999999999999999886543221 1
Q ss_pred ccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHH
Q 035917 482 VNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKV 561 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l 561 (611)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||......... ....................+.++
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~l 249 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL---YLIATNGTPELQNPEKLSAIFRDF 249 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH---HHHhcCCCCCCCCccccCHHHHHH
Confidence 12235889999999998888999999999999999999999887421110000 000000000000111112334555
Q ss_pred HhhcccCCCCCCCCHHHHHHH
Q 035917 562 ACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 562 ~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+.+||..+|++||++.|++++
T Consensus 250 i~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 250 LNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HHHHCcCCcccCcCHHHHhhC
Confidence 669999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=310.57 Aligned_cols=260 Identities=21% Similarity=0.306 Sum_probs=201.5
Q ss_pred ccHHHHHHhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhcc-CCCCccceeeEEEe-
Q 035917 314 VKLADLMAASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVV- 390 (611)
Q Consensus 314 ~~~~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~- 390 (611)
.++.++..+.+.|...+.||+|+||.||+|+. .+++.||+|.+........++..|+.++.++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 45566666778899999999999999999996 5689999999876555556789999999999 69999999999863
Q ss_pred -----CCeeEEEEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEE
Q 035917 391 -----EEEKLLIYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARI 464 (611)
Q Consensus 391 -----~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl 464 (611)
.+..+++|||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+|+||||+||++++++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence 456799999999999999987543 35888889999999999999999 789999999999999999999999
Q ss_pred eecccccccCCCCCCccccCCCcccccccccccC-----CCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChh
Q 035917 465 MDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSS-----TMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSK 539 (611)
Q Consensus 465 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~ 539 (611)
+|||+++....... ......|+..|+|||.+. ...++.++|||||||++|||++|..||.+........ ...
T Consensus 163 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-~~~ 239 (282)
T cd06636 163 VDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-LIP 239 (282)
T ss_pred eeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-hHh
Confidence 99999876532211 122345899999999875 3467889999999999999999998874321110000 001
Q ss_pred hhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 540 EAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 540 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
....+.......+.++.+ ++.+||+.||.+||++.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~---li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 240 RNPPPKLKSKKWSKKFID---FIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred hCCCCCCcccccCHHHHH---HHHHHhCCChhhCcCHHHHhcC
Confidence 111111111223444445 4559999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=309.79 Aligned_cols=247 Identities=19% Similarity=0.293 Sum_probs=202.0
Q ss_pred CCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCC
Q 035917 326 FCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSG 404 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~g 404 (611)
|.+.+.||+|+||.||||.+ +.|..||||.+... .+-+++.+|+.+|++++.|++|+++|.|......|+|||||.-|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 33446899999999999995 56999999999643 45678999999999999999999999999999999999999999
Q ss_pred ChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccC
Q 035917 405 TLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNG 484 (611)
Q Consensus 405 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 484 (611)
+..++++-+++++.+.++..+.++.++||+||| ...-+|||||..|||++.+|.+||+|||.|..+++.- ...++
T Consensus 114 SiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AKRNT 188 (502)
T KOG0574|consen 114 SISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AKRNT 188 (502)
T ss_pred cHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhH--HhhCc
Confidence 999999877788999999999999999999999 6778999999999999999999999999998775321 12234
Q ss_pred CCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHHHHHHHHHh
Q 035917 485 DLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEILQFLKVAC 563 (611)
Q Consensus 485 ~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~~l~~ 563 (611)
..||+.|||||++..-.|..++||||+|++..||..|+.|+.+......... +.-.-.|.. .++.++.++.++++
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-IPT~PPPTF~KPE~WS~~F~DFi~--- 264 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-IPTKPPPTFKKPEEWSSEFNDFIR--- 264 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe-ccCCCCCCCCChHhhhhHHHHHHH---
Confidence 5799999999999988899999999999999999999999865321100000 000001111 11234455566666
Q ss_pred hcccCCCCCCCCHHHHHHH
Q 035917 564 NCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 564 ~Cl~~dP~~RPs~~evl~~ 582 (611)
.|+-..|++|-|+.++++|
T Consensus 265 ~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 265 SCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HHhcCCHHHHHHHHHHhhh
Confidence 9999999999999998876
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=311.32 Aligned_cols=248 Identities=20% Similarity=0.265 Sum_probs=193.8
Q ss_pred CCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 326 FCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
|...+.||+|+||+||+|.. .+++.||+|.+.... ...+.+.+|++++++++|+||+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 55568899999999999995 568999999986532 2234578899999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 401 MSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 401 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 99999998886543 36999999999999999999999 8899999999999999999999999999997653221
Q ss_pred ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-hcCCCCHHHHHHH
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-LCGKGYDEEILQF 558 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~~~l 558 (611)
......|+..|+|||++.+..++.++|||||||++|||++|..||.................... ......+.++.++
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSI 235 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHH
Confidence 11234689999999999888899999999999999999999988743111000000000000000 0112233444554
Q ss_pred HHHHhhcccCCCCCCCC-----HHHHHHH
Q 035917 559 LKVACNCVVSRPKDRWS-----MYQVYQS 582 (611)
Q Consensus 559 ~~l~~~Cl~~dP~~RPs-----~~evl~~ 582 (611)
+ .+|++.||++||+ +.+++++
T Consensus 236 i---~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 236 C---KMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred H---HHHccCCHhHcCCCcccChHHHHcC
Confidence 4 4999999999999 7787776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=318.80 Aligned_cols=245 Identities=18% Similarity=0.181 Sum_probs=191.2
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEEEE
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
+|...+.||+|+||.||+|+.. +++.||||.++... ...+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4677889999999999999964 57899999986532 1224567788888877 5899999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 999999999988654 35899999999999999999999 78999999999999999999999999999975432211
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEILQ 557 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~ 557 (611)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+..... .+...+.++.+
T Consensus 157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~ 230 (323)
T cd05616 157 --TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL----FQSIMEHNVAYPKSMSKEAVA 230 (323)
T ss_pred --ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCCcCCHHHHH
Confidence 12234689999999999999999999999999999999999988742111000 001111100 11223445555
Q ss_pred HHHHHhhcccCCCCCCCCH-----HHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWSM-----YQVYQS 582 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~-----~evl~~ 582 (611)
++. +|++.||++|++. .++.+|
T Consensus 231 li~---~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 231 ICK---GLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred HHH---HHcccCHHhcCCCCCCCHHHHhcC
Confidence 554 9999999999984 666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=312.85 Aligned_cols=247 Identities=19% Similarity=0.266 Sum_probs=195.1
Q ss_pred CCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 326 FCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
|...++||+|+||.||++.. .+++.||||.+.... ...+.+.+|+.++++++|+||+++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 56678999999999999995 468999999986432 1234578899999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 401 MSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 401 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 99999999886443 36899999999999999999999 88999999999999999999999999999976543221
Q ss_pred ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhch--hhcCCCCHHHHHH
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDK--ALCGKGYDEEILQ 557 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~~~~~~ 557 (611)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||......... .......+. .......+.++.+
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERLVKEVQEEYSEKFSPDARS 234 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-HHHHhhhhhhhhhcCccCCHHHHH
Confidence 12346899999999999889999999999999999999999987531110000 000000000 0111223444555
Q ss_pred HHHHHhhcccCCCCCCCC-----HHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWS-----MYQVYQS 582 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs-----~~evl~~ 582 (611)
+++ +||+.||++||| +.|+++|
T Consensus 235 li~---~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 235 LCK---MLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred HHH---HHhhcCHHHccCCCCCchHHHHcC
Confidence 555 999999999999 8899886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=303.11 Aligned_cols=255 Identities=22% Similarity=0.312 Sum_probs=197.1
Q ss_pred hhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccc---cchhHHHHHHHHHHHhccCCCCccceeeEEEe-----CC
Q 035917 322 ASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNT---CKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVV-----EE 392 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~---~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~-----~~ 392 (611)
+...|...+.||+|+||.|..+.. .+|+.||||++.. .....++..+|+++|+.++|+||+.+++.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 344555568899999999999995 5799999999963 23445788999999999999999999998865 34
Q ss_pred eeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccc
Q 035917 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKL 472 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~ 472 (611)
..|+|+|+|+. +|..+++.+ ..++......+..|+++||.|+| +.+|+||||||+|+|++.+...||+|||+|+.
T Consensus 100 DvYiV~elMet-DL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 100 DVYLVFELMET-DLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred eeEEehhHHhh-HHHHHHHcC-ccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceee
Confidence 68999999965 999999854 34888899999999999999999 88999999999999999999999999999998
Q ss_pred cCCCCCCccccCCCccccccccccc-CCCCCCcccchHHHHHHHHHHhCCCCCHH--HHHHHHh---h------------
Q 035917 473 MTSSDESSFVNGDLGEFGYIAPEYS-STMVASLKGDVYGIGVVLLELAGFKGNLV--DWVNQLS---S------------ 534 (611)
Q Consensus 473 ~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~t~ksDV~SfGvvl~ell~~~~~~~--~~~~~~~---~------------ 534 (611)
..........+..+.|..|.|||++ ....||...||||.|||+.||++|+.-|+ +.+.++. .
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 8644334445667889999999975 55789999999999999999999886442 1111110 0
Q ss_pred --cCChhhhhch--hhcC-------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 035917 535 --SGRSKEAIDK--ALCG-------KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLN 584 (611)
Q Consensus 535 --~~~~~~~~~~--~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 584 (611)
.......+.. .... ...+..+.++++ +++..||.+|+|++|.++|--
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLle---kmL~fdP~kRita~eAL~hPY 312 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLE---KMLVFDPKKRITAEEALAHPY 312 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHH---HHhccCccccCCHHHHhcChh
Confidence 0001111100 0000 112334455555 999999999999999999843
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=309.26 Aligned_cols=244 Identities=25% Similarity=0.358 Sum_probs=192.5
Q ss_pred CCCCeeeecCCceEEEEEeC-CCCEEEEEeccccchhHH---HHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccC
Q 035917 327 CSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLGEK---KFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 327 ~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~---~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
...+.||+|+||+||+++.. +++.||+|++........ ...+|+.++++++||||+++++++...+..++||||++
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence 34578999999999999965 467899999976554332 34569999999999999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccc
Q 035917 403 SGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482 (611)
Q Consensus 403 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 482 (611)
+++|.+++... ..+++..+..++.|+++||.||| +.+|+|+||||+||+++.++.++|+|||.+..... .....
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~~~ 155 (260)
T PF00069_consen 82 GGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNENF 155 (260)
T ss_dssp TEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTSEB
T ss_pred ccccccccccc-ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc--ccccc
Confidence 99999999822 45899999999999999999999 78999999999999999999999999999976421 12223
Q ss_pred cCCCcccccccccccC-CCCCCcccchHHHHHHHHHHhCCCCCHHHH--HHHHhhcCChhhhhchhh-----cCCCCHHH
Q 035917 483 NGDLGEFGYIAPEYSS-TMVASLKGDVYGIGVVLLELAGFKGNLVDW--VNQLSSSGRSKEAIDKAL-----CGKGYDEE 554 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~-~~~~t~ksDV~SfGvvl~ell~~~~~~~~~--~~~~~~~~~~~~~~~~~l-----~~~~~~~~ 554 (611)
....++..|+|||.+. +..++.++||||+|+++|+|++|..|+.+. ..... .......... .......+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLE---IIEKILKRPLPSSSQQSREKSEE 232 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHH---HHHHHHHTHHHHHTTSHTTSHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhh---hhhhcccccccccccccchhHHH
Confidence 3456899999999988 788999999999999999999998876542 00000 0111111000 00111244
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 555 ILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 555 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+.+++.+||+.||++||++.+++++
T Consensus 233 ---l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 233 ---LRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp ---HHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ---HHHHHHHHccCChhHCcCHHHHhcC
Confidence 4455559999999999999999865
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=312.97 Aligned_cols=250 Identities=17% Similarity=0.248 Sum_probs=192.4
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
++|...+.||+|+||.||+|+.. +++.||+|.++... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 45777889999999999999964 68899999986432 2335678999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
+++ +|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 159 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-- 159 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--
Confidence 975 898888765556899999999999999999999 78999999999999999999999999999976432221
Q ss_pred cccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhc-CC-hhhh----------h
Q 035917 481 FVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSS-GR-SKEA----------I 542 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~-~~-~~~~----------~ 542 (611)
......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||... ....... +. ..+. .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 1123357899999998754 46889999999999999999998876321 1111000 00 0000 0
Q ss_pred chhhc----------CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 543 DKALC----------GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 543 ~~~l~----------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+.... ....+.+.. +++.+|++.||.+|||+.|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~---~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGI---ELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHH---HHHHHhccCChhhCCCHHHHhcC
Confidence 00000 011233444 45559999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=307.13 Aligned_cols=238 Identities=18% Similarity=0.272 Sum_probs=184.4
Q ss_pred CeeeecCCceEEEEEeCC--------CCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 330 NVIISTRTGTTYKAMLPD--------GSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~--------g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
+.||+|+||.||+|.... ...||+|.+.... ...+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 468999999999998532 2358888886543 2346789999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCC--------eEEeecccccc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFD--------ARIMDFGLAKL 472 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~--------~kl~DFGla~~ 472 (611)
+++|+|.+++......+++..++.++.|++.||+||| +.+|+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999866557899999999999999999999 889999999999999987765 59999998875
Q ss_pred cCCCCCCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCC-CHHHHHHHHhhcCChhhhhchh-hcCC
Q 035917 473 MTSSDESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKG-NLVDWVNQLSSSGRSKEAIDKA-LCGK 549 (611)
Q Consensus 473 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~-~~~~~~~~~~~~~~~~~~~~~~-l~~~ 549 (611)
.... ....++..|+|||++.+ ..++.++|||||||++|||++|.. |+... .... ........ ..+.
T Consensus 158 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~-~~~~----~~~~~~~~~~~~~ 226 (258)
T cd05078 158 VLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL-DSQK----KLQFYEDRHQLPA 226 (258)
T ss_pred cCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc-cHHH----HHHHHHccccCCC
Confidence 4321 12347889999999876 457999999999999999999853 43221 0000 00000000 0111
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 035917 550 GYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLN 584 (611)
Q Consensus 550 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 584 (611)
....+ +.+++.+||+.||++|||++++++.|+
T Consensus 227 ~~~~~---~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 227 PKWTE---LANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred CCcHH---HHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 12233 455555999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=316.52 Aligned_cols=249 Identities=18% Similarity=0.172 Sum_probs=192.9
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||.||+++. .+++.||+|+++... ...+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 3677889999999999999995 468999999996422 22355889999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++|+|.+++.+....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999999999764456899999999999999999999 88999999999999999999999999999876543221
Q ss_pred CccccCCCcccccccccccCC-----CCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCChhhhhchhhcC
Q 035917 479 SSFVNGDLGEFGYIAPEYSST-----MVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGRSKEAIDKALCG 548 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~ 548 (611)
. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||... ......... ........
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~ 233 (331)
T cd05597 158 V-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE---HFQFPPDV 233 (331)
T ss_pred c-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC---cccCCCcc
Confidence 1 1122358999999998863 45788999999999999999999887431 111111100 00000011
Q ss_pred CCCHHHHHHHHHHHhhccc--CCCCCCCCHHHHHHH
Q 035917 549 KGYDEEILQFLKVACNCVV--SRPKDRWSMYQVYQS 582 (611)
Q Consensus 549 ~~~~~~~~~l~~l~~~Cl~--~dP~~RPs~~evl~~ 582 (611)
...++++.++++ +|+. .++..||++.++++|
T Consensus 234 ~~~~~~~~~li~---~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 234 TDVSEEAKDLIR---RLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCCCHHHHHHHH---HHccCcccccCCCCHHHHhcC
Confidence 124556666666 6554 444458899999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=307.31 Aligned_cols=250 Identities=24% Similarity=0.313 Sum_probs=192.9
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch-----------hHHHHHHHHHHHhccCCCCccceeeEEEeCC
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL-----------GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE 392 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~-----------~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~ 392 (611)
+|...+.||+|++|.||+|.. .+|+.||+|.++.... ..+.+.+|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 366778999999999999985 4689999998853210 1245788999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccc
Q 035917 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKL 472 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~ 472 (611)
..++||||+++|+|.+++.+. ..+++..+..++.+++.||.||| +.+++||||+|+||+++.++.++++|||+++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999999999765 46899999999999999999999 78999999999999999999999999999986
Q ss_pred cCCCCCCccccCCCcccccccccccCCCC--CCcccchHHHHHHHHHHhCCCCCHHHHHHH--Hhh--cCChhhhhchhh
Q 035917 473 MTSSDESSFVNGDLGEFGYIAPEYSSTMV--ASLKGDVYGIGVVLLELAGFKGNLVDWVNQ--LSS--SGRSKEAIDKAL 546 (611)
Q Consensus 473 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~SfGvvl~ell~~~~~~~~~~~~--~~~--~~~~~~~~~~~l 546 (611)
..............|+..|+|||.+.... ++.++||||||+++||+++|..|+...... ... .......+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence 53222111122345889999999887654 789999999999999999999886421110 000 000000011111
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 547 CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 547 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
. ...+.++.+ ++.+||..+|++||++.+|++|
T Consensus 238 ~-~~~~~~~~~---li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 238 S-MNLSPVALD---FLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred c-ccCCHHHHH---HHHHHhcCChhhCCCHHHHhhC
Confidence 0 112334444 4459999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=324.06 Aligned_cols=255 Identities=16% Similarity=0.183 Sum_probs=197.9
Q ss_pred HHHHHHhhhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEe
Q 035917 316 LADLMAASNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVV 390 (611)
Q Consensus 316 ~~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~ 390 (611)
+.++....++|...+.||+|+||.||+++.. +++.||+|++.... ...+.+.+|+.+++.++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3445556689999999999999999999964 68899999986422 223457899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccc
Q 035917 391 EEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLA 470 (611)
Q Consensus 391 ~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla 470 (611)
++..++||||+++|+|.+++... .++...+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 99999999999999999998754 4788888999999999999999 889999999999999999999999999999
Q ss_pred cccCCCCCCccccCCCcccccccccccCCC----CCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhch--
Q 035917 471 KLMTSSDESSFVNGDLGEFGYIAPEYSSTM----VASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDK-- 544 (611)
Q Consensus 471 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~-- 544 (611)
+....... .......||+.|+|||++... .++.++|||||||++|||++|+.||..-.... ....+...
T Consensus 190 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----~~~~i~~~~~ 264 (371)
T cd05622 190 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----TYSKIMNHKN 264 (371)
T ss_pred eEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH----HHHHHHcCCC
Confidence 87643221 112344699999999988653 37899999999999999999999874210000 00111100
Q ss_pred --hh-cCCCCHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHHH
Q 035917 545 --AL-CGKGYDEEILQFLKVACNCVVSRPKD--RWSMYQVYQSL 583 (611)
Q Consensus 545 --~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L 583 (611)
.. .....+.++..++. +|+..++.+ ||++.|+++|.
T Consensus 265 ~~~~~~~~~~s~~~~~li~---~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 265 SLTFPDDNDISKEAKNLIC---AFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred cccCCCcCCCCHHHHHHHH---HHcCChhhhcCCCCHHHHhcCc
Confidence 00 11234556666665 899744433 78999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=318.62 Aligned_cols=195 Identities=23% Similarity=0.258 Sum_probs=165.7
Q ss_pred hhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEecccc---chhHHHHHHHHHHHhccCCCCccceeeEEEeCC-----
Q 035917 322 ASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTC---KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE----- 392 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~---~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~----- 392 (611)
..++|...+.||+|+||.||+++. .+|+.||||++... ......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 456888899999999999999995 46899999999643 223456889999999999999999999986543
Q ss_pred -eeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccc
Q 035917 393 -EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAK 471 (611)
Q Consensus 393 -~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~ 471 (611)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 46899999975 67776653 3788899999999999999999 8899999999999999999999999999997
Q ss_pred ccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHH
Q 035917 472 LMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLV 526 (611)
Q Consensus 472 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~ 526 (611)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 172 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 223 (359)
T cd07876 172 TACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223 (359)
T ss_pred ccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 643221 1223468999999999999899999999999999999999988763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=317.31 Aligned_cols=249 Identities=21% Similarity=0.314 Sum_probs=201.9
Q ss_pred cCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchh---HHHHHHHHHHHhccC-CCCccceeeEEEeCCeeEEEEec
Q 035917 325 SFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLG---EKKFRNEMNRLGQLR-HPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~---~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
.|+..+.||+||.+.||++...+.+.||+|++.....+ ..-|.+|+..|.+|+ |.+||++++|-..++..|+||||
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~ 441 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC 441 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence 46677899999999999999999999999988654333 356999999999996 99999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCC-CHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 401 MSSGTLYSLLQGNATEL-DWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l-~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
-+- ||..+|....... +| .++.+..|++.++.++| ..+|||.||||.|.|+- .|.+||+|||+|..+..+...
T Consensus 442 Gd~-DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 442 GDI-DLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred ccc-cHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCccccc
Confidence 755 9999998776544 45 77889999999999999 89999999999999987 478999999999998776655
Q ss_pred ccccCCCcccccccccccCCC-----------CCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcC
Q 035917 480 SFVNGDLGEFGYIAPEYSSTM-----------VASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCG 548 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~-----------~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 548 (611)
......+||+.||+||.+... +.+.++||||+|||||+|+.|+.||.+...... ++..+.+|...-
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a---Kl~aI~~P~~~I 592 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA---KLHAITDPNHEI 592 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH---HHHhhcCCCccc
Confidence 555677899999999976432 256899999999999999999999977543322 234445553221
Q ss_pred CCCH-HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 549 KGYD-EEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 549 ~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++.. .+-..+++++..||..||++||++.|+++|
T Consensus 593 efp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 593 EFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred cccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1111 011227777779999999999999999987
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=306.62 Aligned_cols=250 Identities=18% Similarity=0.246 Sum_probs=193.2
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
++|...+.||+|+||.||+|+. .+++.||+|.++... .....+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 3566667899999999999985 568999999986543 23356889999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
++++|.+++... ..+++..+..++.|++.||.||| ..+++|+||||+||+++.++.+||+|||++....... ..
T Consensus 89 ~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~ 162 (267)
T cd06645 89 GGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AK 162 (267)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cc
Confidence 999999998654 36899999999999999999999 7899999999999999999999999999987653221 11
Q ss_pred ccCCCcccccccccccC---CCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc-hhhc-CCCCHHHHH
Q 035917 482 VNGDLGEFGYIAPEYSS---TMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID-KALC-GKGYDEEIL 556 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~-~~l~-~~~~~~~~~ 556 (611)
.....|+..|+|||++. ...++.++|||||||++|||++++.|+.................. +... ....++.+.
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence 22346899999999874 456889999999999999999998886321100000000000000 1110 012234444
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++ +.+|++.+|++||++++|++|
T Consensus 243 ~l---i~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 243 HF---VKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HH---HHHHccCCchhCcCHHHHhcC
Confidence 44 449999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.01 Aligned_cols=243 Identities=19% Similarity=0.254 Sum_probs=199.2
Q ss_pred hhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeE
Q 035917 322 ASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKL 395 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~ 395 (611)
..++|....+||+|+||+|+.+.+ .+++.+|||.+++.. .+.+....|.+|+... +||.++.++..+...++.+
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 346788889999999999999996 468899999998754 2346678888888777 5999999999999999999
Q ss_pred EEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
.||||+.||++..+.+. ..+++..+.-++..|+.||+||| +++||+||||.+|||||.+|.+||+|||+++....
T Consensus 446 fvmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCC
Confidence 99999999996655543 35999999999999999999999 89999999999999999999999999999986432
Q ss_pred CCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-----cCCC
Q 035917 476 SDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-----CGKG 550 (611)
Q Consensus 476 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-----~~~~ 550 (611)
.+ ....+.+||+.|||||++.+..|+...|.|||||+||||+.|..||.. +...+++|..+ .+..
T Consensus 521 ~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g--------ddEee~FdsI~~d~~~yP~~ 590 (694)
T KOG0694|consen 521 QG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG--------DDEEEVFDSIVNDEVRYPRF 590 (694)
T ss_pred CC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC--------CCHHHHHHHHhcCCCCCCCc
Confidence 22 234567899999999999999999999999999999999999999863 12233333322 2233
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCH-----HHHHHH
Q 035917 551 YDEEILQFLKVACNCVVSRPKDRWSM-----YQVYQS 582 (611)
Q Consensus 551 ~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~ 582 (611)
.+.|...+++ +.+..+|++|..+ .+|.+|
T Consensus 591 ls~ea~~il~---~ll~k~p~kRLG~~e~d~~~i~~h 624 (694)
T KOG0694|consen 591 LSKEAIAIMR---RLLRKNPEKRLGSGERDAEDIKKH 624 (694)
T ss_pred ccHHHHHHHH---HHhccCcccccCCCCCCchhhhhC
Confidence 4555555555 9999999999965 555554
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=307.96 Aligned_cols=250 Identities=18% Similarity=0.236 Sum_probs=193.8
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
+.|...+.||+|+||.||+|+.. +++.||+|.+.... ...+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 45667789999999999999964 58999999986543 33467889999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
++++|..++.+....+++..+..++.|++.||+||| ..+++||||||+||+++.++.+||+|||++....... ..
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~ 166 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QR 166 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc--cc
Confidence 999999888655456899999999999999999999 8899999999999999999999999999987543221 11
Q ss_pred ccCCCcccccccccccC-----CCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHH
Q 035917 482 VNGDLGEFGYIAPEYSS-----TMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEI 555 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~ 555 (611)
.....++..|+|||++. ...++.++|||||||++|||++|+.|+.......... .......+.. .....+.+
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~- 244 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL-KIAKSEPPTLSQPSKWSME- 244 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHH-HHhcCCCccCCCCcccCHH-
Confidence 12235788999999874 3456889999999999999999998863311000000 0000000111 01122233
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+.+++.+||+.+|++||++.|++++
T Consensus 245 --~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 245 --FRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred --HHHHHHHHhcCCcccCcCHHHHhcC
Confidence 4455559999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=329.52 Aligned_cols=253 Identities=17% Similarity=0.227 Sum_probs=187.9
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeC--------Ce
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE--------EE 393 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~--------~~ 393 (611)
..+|...+.||+|+||.||+|+. .+++.||||++.... ....+|+.+|++++|||||++++++... ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 45788899999999999999996 468999999885432 2345799999999999999999987542 13
Q ss_pred eEEEEeccCCCChHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC-CeEEeeccc
Q 035917 394 KLLIYKYMSSGTLYSLLQG---NATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF-DARIMDFGL 469 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~-~~kl~DFGl 469 (611)
.++||||+++ +|.+++.. ....+++..+..++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||+
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 5689999985 78776642 2346899999999999999999999 78999999999999998654 799999999
Q ss_pred ccccCCCCCCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhh-cCC-hhh-
Q 035917 470 AKLMTSSDESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSS-SGR-SKE- 540 (611)
Q Consensus 470 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~-~~~-~~~- 540 (611)
++.+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||... ...... .+. ..+
T Consensus 218 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~ 294 (440)
T PTZ00036 218 AKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ 294 (440)
T ss_pred chhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 987643221 123468999999998765 46899999999999999999998877421 111100 000 000
Q ss_pred --hhch--------hh--------cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHchh
Q 035917 541 --AIDK--------AL--------CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS--LNSIAA 588 (611)
Q Consensus 541 --~~~~--------~l--------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~ 588 (611)
...+ .. .+...+++ +.+++.+||+.||.+|||+.|+++| ++++..
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~---~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDD---AINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHhccCCCHH---HHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 0000 00 01112334 4455559999999999999999977 444433
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=324.01 Aligned_cols=246 Identities=17% Similarity=0.204 Sum_probs=192.6
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
+|...+.||+|+||.||+++.. +++.||+|+++... .....+.+|+.++..++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 5777899999999999999964 68999999996432 223567889999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
|+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 82 ~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 82 FLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred CCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 99999999998754 35899999999999999999999 899999999999999999999999999998754321100
Q ss_pred ---------------------------------ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHH
Q 035917 480 ---------------------------------SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLV 526 (611)
Q Consensus 480 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~ 526 (611)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00123469999999999999999999999999999999999998874
Q ss_pred HHHHHHhhcCChhhhhc--hh--hcC-CCCHHHHHHHHHHHhhcccCCCCCCCC---HHHHHHH
Q 035917 527 DWVNQLSSSGRSKEAID--KA--LCG-KGYDEEILQFLKVACNCVVSRPKDRWS---MYQVYQS 582 (611)
Q Consensus 527 ~~~~~~~~~~~~~~~~~--~~--l~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~ 582 (611)
....... ...+.. .. ... ...+++..+++. +++ .||++|++ +.|+++|
T Consensus 238 ~~~~~~~----~~~i~~~~~~~~~p~~~~~s~~~~~li~---~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 238 SETPQET----YRKVMNWKETLVFPPEVPISEKAKDLIL---RFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCHHHH----HHHHHcCCCceecCCCCCCCHHHHHHHH---Hhc-cChhhcCCCCCHHHHhcC
Confidence 3111100 000110 00 011 123455666554 655 49999984 7888877
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=310.77 Aligned_cols=192 Identities=22% Similarity=0.280 Sum_probs=157.9
Q ss_pred CCeeeecCCceEEEEEeC---CCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEe--CCeeEEEEeccCC
Q 035917 329 ENVIISTRTGTTYKAMLP---DGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVV--EEEKLLIYKYMSS 403 (611)
Q Consensus 329 ~~~ig~G~~g~Vy~~~~~---~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~--~~~~~lv~ey~~~ 403 (611)
+..||+|+||.||+|+.. +++.||+|.++... ....+.+|++++++++||||+++++++.. +...+++|||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 468999999999999854 46899999986543 23457899999999999999999998864 4567899999965
Q ss_pred CChHHhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEe----CCCCCeEEeeccccc
Q 035917 404 GTLYSLLQGN--------ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV----DEDFDARIMDFGLAK 471 (611)
Q Consensus 404 gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl----d~~~~~kl~DFGla~ 471 (611)
+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 888877422 125889999999999999999999 7899999999999999 456789999999998
Q ss_pred ccCCCCC-CccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCH
Q 035917 472 LMTSSDE-SSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNL 525 (611)
Q Consensus 472 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~ 525 (611)
....... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.+|
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f 216 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCc
Confidence 7643221 112234568999999998876 45899999999999999999998776
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=316.83 Aligned_cols=235 Identities=22% Similarity=0.203 Sum_probs=181.9
Q ss_pred CeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHH-HHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 330 NVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMN-RLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~-~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
++||+|+||.||+|+. .+++.||+|++.... .....+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999996 468999999986532 12234555654 67889999999999999999999999999999
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcccc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
|+|.+++... ..+++..+..++.||++||.||| +.+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (321)
T cd05603 81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTS 154 (321)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cccc
Confidence 9999888654 35788888999999999999999 7899999999999999999999999999987532221 1122
Q ss_pred CCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhch-hhcCCCCHHHHHHHHHHH
Q 035917 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDK-ALCGKGYDEEILQFLKVA 562 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~~~~~~l~~l~ 562 (611)
...||+.|+|||++.+..++.++|||||||++|||++|..||..-..... ...+... .......+.++.+++.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~li~-- 228 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM----YDNILHKPLQLPGGKTVAACDLLV-- 228 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH----HHHHhcCCCCCCCCCCHHHHHHHH--
Confidence 34689999999999988899999999999999999999988732100000 0011111 1111223444455444
Q ss_pred hhcccCCCCCCCCHH
Q 035917 563 CNCVVSRPKDRWSMY 577 (611)
Q Consensus 563 ~~Cl~~dP~~RPs~~ 577 (611)
+|++.||.+||++.
T Consensus 229 -~~l~~~p~~R~~~~ 242 (321)
T cd05603 229 -GLLHKDQRRRLGAK 242 (321)
T ss_pred -HHccCCHhhcCCCC
Confidence 99999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=304.74 Aligned_cols=245 Identities=21% Similarity=0.298 Sum_probs=183.1
Q ss_pred eeeecCCceEEEEEeCCC---CEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCC
Q 035917 331 VIISTRTGTTYKAMLPDG---SVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGT 405 (611)
Q Consensus 331 ~ig~G~~g~Vy~~~~~~g---~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gs 405 (611)
.||+|+||.||+|...++ ..+++|.++... ...+.+.+|+.+++.++||||++++++|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999985443 356677765432 345679999999999999999999999999999999999999999
Q ss_pred hHHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccc
Q 035917 406 LYSLLQGNA---TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482 (611)
Q Consensus 406 L~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 482 (611)
|.+++.+.. ...++..+..++.|++.||+||| +.+++||||||+|||++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999997542 24677788899999999999999 789999999999999999999999999998643222211112
Q ss_pred cCCCcccccccccccCC-------CCCCcccchHHHHHHHHHHhCC-CCCHHH-----HHHHHhhcCChhhhhchhhcCC
Q 035917 483 NGDLGEFGYIAPEYSST-------MVASLKGDVYGIGVVLLELAGF-KGNLVD-----WVNQLSSSGRSKEAIDKALCGK 549 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~~-------~~~t~ksDV~SfGvvl~ell~~-~~~~~~-----~~~~~~~~~~~~~~~~~~l~~~ 549 (611)
....++..|+|||++.. ..++.++|||||||++|||+++ ..|+.. ...... ........++.+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~- 236 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVI-KDQQVKLFKPQLEL- 236 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hhcccccCCCccCC-
Confidence 23457889999998743 2457899999999999999864 445421 111111 11111222233322
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 035917 550 GYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLN 584 (611)
Q Consensus 550 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 584 (611)
..++.+.+++. .|| .+|++||++++|++.|.
T Consensus 237 ~~~~~~~~l~~---~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 237 PYSERWYEVLQ---FCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCcHHHHHHHH---HHh-hCcccCCCHHHHHHHhc
Confidence 23444445444 899 67999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.28 Aligned_cols=237 Identities=21% Similarity=0.198 Sum_probs=183.9
Q ss_pred CeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHH-HHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 330 NVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMN-RLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~-~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
+.||+|+||.||+|+.. +++.||+|++.... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999964 67899999986532 12234445544 56788999999999999999999999999999
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcccc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
|+|.+++... ..+.+.....++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~ 154 (325)
T cd05602 81 GELFYHLQRE-RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTS 154 (325)
T ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCcc
Confidence 9999998754 35778888889999999999999 8899999999999999999999999999997543221 1122
Q ss_pred CCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHHHHHHHHH
Q 035917 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEILQFLKVA 562 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~~l~ 562 (611)
...||+.|+|||++.+..++.++|||||||++|||++|..||........ ...+..... .....+.++.++++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~li~-- 228 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM----YDNILNKPLQLKPNITNSARHLLE-- 228 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH----HHHHHhCCcCCCCCCCHHHHHHHH--
Confidence 34699999999999998999999999999999999999988742110000 001111111 11234456666666
Q ss_pred hhcccCCCCCCCCHHHH
Q 035917 563 CNCVVSRPKDRWSMYQV 579 (611)
Q Consensus 563 ~~Cl~~dP~~RPs~~ev 579 (611)
+|++.||.+||++.+.
T Consensus 229 -~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 229 -GLLQKDRTKRLGAKDD 244 (325)
T ss_pred -HHcccCHHHCCCCCCC
Confidence 9999999999987643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=313.61 Aligned_cols=244 Identities=17% Similarity=0.187 Sum_probs=189.0
Q ss_pred CeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 330 NVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
+.||+|+||.||+|+. .+++.||+|+++... ...+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999995 468899999997532 2234578999999888 699999999999999999999999999
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcccc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (327)
T cd05617 81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTS 154 (327)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--cee
Confidence 9999888644 35899999999999999999999 78999999999999999999999999999975322111 122
Q ss_pred CCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhc--CChhh-hhch-hhcCCCCHHHHHHHH
Q 035917 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSS--GRSKE-AIDK-ALCGKGYDEEILQFL 559 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~--~~~~~-~~~~-~l~~~~~~~~~~~l~ 559 (611)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ..... .... ...+...+..+.+++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li 234 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVL 234 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 3469999999999999899999999999999999999999873210000000 00000 0000 011122344555555
Q ss_pred HHHhhcccCCCCCCCCH------HHHHHH
Q 035917 560 KVACNCVVSRPKDRWSM------YQVYQS 582 (611)
Q Consensus 560 ~l~~~Cl~~dP~~RPs~------~evl~~ 582 (611)
. +||+.||++||++ .++++|
T Consensus 235 ~---~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 235 K---GFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred H---HHhccCHHHcCCCCCCCCHHHHHcC
Confidence 5 9999999999984 577665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.40 Aligned_cols=255 Identities=22% Similarity=0.337 Sum_probs=208.7
Q ss_pred CCCeeeecCCceEEEEEe-CCC----CEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 328 SENVIISTRTGTTYKAML-PDG----SVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 328 ~~~~ig~G~~g~Vy~~~~-~~g----~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
..++||+|+||+||||.+ ++| -+||+|++.... ...+++++|+-+|.+++|||+++++|+|.... ..||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 458999999999999984 554 478999986543 34678999999999999999999999998765 8899999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
|+.|+|.++++.++..+.-...+.|..|||+||.||| ..+++||||-.+|||+..-..+||.|||+++.+..+....
T Consensus 779 mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred cccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 9999999999988778889999999999999999999 8999999999999999999999999999999987766544
Q ss_pred cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCC-CCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHH
Q 035917 481 FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFK-GNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFL 559 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 559 (611)
...+-.-.+.|||-|.+....|+.++|||||||++||++|+. .|+... ....+.+.+....+-..++-...++.
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi-----~~~eI~dlle~geRLsqPpiCtiDVy 930 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI-----PAEEIPDLLEKGERLSQPPICTIDVY 930 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC-----CHHHhhHHHhccccCCCCCCccHHHH
Confidence 444444567899999999999999999999999999999754 454221 01112222222222233444566777
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 560 KVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 560 ~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
.++.+||..|++.||+++++...+.++++...
T Consensus 931 ~~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 931 MVMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred HHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 78889999999999999999999999887643
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=315.39 Aligned_cols=195 Identities=19% Similarity=0.249 Sum_probs=162.7
Q ss_pred CCeeeec--CCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccC
Q 035917 329 ENVIIST--RTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 329 ~~~ig~G--~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
.++||+| +|++||+++. .+|+.||+|+++... ...+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4689999 7889999985 579999999997542 223567889999999999999999999999999999999999
Q ss_pred CCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc-
Q 035917 403 SGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS- 480 (611)
Q Consensus 403 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~- 480 (611)
+|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.++++||+............
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 999999986543 35899999999999999999999 7899999999999999999999999998655432211100
Q ss_pred ----cccCCCcccccccccccCC--CCCCcccchHHHHHHHHHHhCCCCCHH
Q 035917 481 ----FVNGDLGEFGYIAPEYSST--MVASLKGDVYGIGVVLLELAGFKGNLV 526 (611)
Q Consensus 481 ----~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SfGvvl~ell~~~~~~~ 526 (611)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 211 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 0112246788999999875 458999999999999999999998874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=307.77 Aligned_cols=244 Identities=21% Similarity=0.265 Sum_probs=192.7
Q ss_pred CCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 327 CSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 327 ~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
...+.||+|+||.||+|.. .+++.||+|.++... ...+.+.+|++++++++||||+++++++..++..++||||+++
T Consensus 7 ~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06642 7 TKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGG 86 (277)
T ss_pred HHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCC
Confidence 3446799999999999985 458899999986432 3345789999999999999999999999999999999999999
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcccc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
++|.+++.. ..+++..+..++.++++|+.||| +.+++|+||+|+||++++++.+|++|||+++.+..... ...
T Consensus 87 ~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~ 159 (277)
T cd06642 87 GSALDLLKP--GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRN 159 (277)
T ss_pred CcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch--hhh
Confidence 999998864 35899999999999999999999 78999999999999999999999999999986643221 112
Q ss_pred CCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHHh
Q 035917 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVAC 563 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~ 563 (611)
...|+..|+|||++.+..++.++|||||||++|||++|+.|+.+........ .......+.+. ...+.+ +.+++.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~---~~~li~ 234 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-LIPKNSPPTLE-GQYSKP---FKEFVE 234 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-hhhcCCCCCCC-cccCHH---HHHHHH
Confidence 2357889999999998889999999999999999999998864321110000 00000011111 112233 445555
Q ss_pred hcccCCCCCCCCHHHHHHH
Q 035917 564 NCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 564 ~Cl~~dP~~RPs~~evl~~ 582 (611)
+||+.+|++||+|.+++++
T Consensus 235 ~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 235 ACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHccCCcccCcCHHHHHHh
Confidence 9999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.83 Aligned_cols=236 Identities=21% Similarity=0.197 Sum_probs=183.8
Q ss_pred CeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHH-HHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 330 NVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMN-RLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~-~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
++||+|+||.||+|+. .+|+.||+|++.... ...+.+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999995 578999999986432 22345566665 46779999999999999999999999999999
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcccc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~ 154 (325)
T cd05604 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTT 154 (325)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCcc
Confidence 9999888654 46899999999999999999999 8899999999999999999999999999987542211 1122
Q ss_pred CCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-hcCCCCHHHHHHHHHHH
Q 035917 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-LCGKGYDEEILQFLKVA 562 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~~~l~~l~ 562 (611)
...||+.|+|||++.+..++.++|||||||++|||++|..||........ ........ ......+.++.+++.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ll~-- 228 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM----YDNILHKPLVLRPGASLTAWSILE-- 228 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH----HHHHHcCCccCCCCCCHHHHHHHH--
Confidence 34699999999999998999999999999999999999988742110000 00011110 111223444555555
Q ss_pred hhcccCCCCCCCCHHH
Q 035917 563 CNCVVSRPKDRWSMYQ 578 (611)
Q Consensus 563 ~~Cl~~dP~~RPs~~e 578 (611)
+|++.+|++||++++
T Consensus 229 -~ll~~~p~~R~~~~~ 243 (325)
T cd05604 229 -ELLEKDRQRRLGAKE 243 (325)
T ss_pred -HHhccCHHhcCCCCC
Confidence 999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=302.05 Aligned_cols=243 Identities=23% Similarity=0.344 Sum_probs=192.3
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
++|...+.||+|+||.||++.. +++.||+|.++... ..+.+.+|+.++++++||||+++++++... ..+++|||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 4678889999999999999975 67889999986532 346789999999999999999999998654 57999999999
Q ss_pred CChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccc
Q 035917 404 GTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482 (611)
Q Consensus 404 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 482 (611)
|+|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----- 154 (254)
T cd05083 83 GNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----- 154 (254)
T ss_pred CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC-----
Confidence 99999997554 36899999999999999999999 7899999999999999999999999999987643211
Q ss_pred cCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhc---CCCCHHHHHHH
Q 035917 483 NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALC---GKGYDEEILQF 558 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~---~~~~~~~~~~l 558 (611)
.....+..|+|||.+.+..++.++|||||||++|||++ |..|+....... ..+.+..... ....++++.
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~-- 227 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-----VKECVEKGYRMEPPEGCPADVY-- 227 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-----HHHHHhCCCCCCCCCcCCHHHH--
Confidence 11234578999999988889999999999999999997 777764321110 0001110000 112234444
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHH
Q 035917 559 LKVACNCVVSRPKDRWSMYQVYQSLNS 585 (611)
Q Consensus 559 ~~l~~~Cl~~dP~~RPs~~evl~~L~~ 585 (611)
+++.+||+.+|++||++.++++.|++
T Consensus 228 -~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 228 -VLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -HHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 55559999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=308.59 Aligned_cols=255 Identities=18% Similarity=0.227 Sum_probs=196.9
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEecccc--chhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTC--KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
++|...+.||+|+||.||++.. ++|+.||+|++... ....+++.+|++++..++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 3556668899999999999995 46899999987543 23356789999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
+++|+|.+++... +.+++..+..++.+++.||.|||+ ..+++||||||+||++++++.++|+|||++........
T Consensus 85 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~-- 159 (284)
T cd06620 85 MDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA-- 159 (284)
T ss_pred CCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc--
Confidence 9999999988754 468999999999999999999994 35899999999999999999999999999875432211
Q ss_pred cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhh---c----CChhhhhchhhcCCCCHH
Q 035917 481 FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSS---S----GRSKEAIDKALCGKGYDE 553 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~---~----~~~~~~~~~~l~~~~~~~ 553 (611)
....|+..|+|||++.+..++.++|||||||++||+++|+.||......... . ......+..........+
T Consensus 160 --~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd06620 160 --DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD 237 (284)
T ss_pred --CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchh
Confidence 1235899999999998888999999999999999999999887431110000 0 001111111000000111
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 035917 554 EILQFLKVACNCVVSRPKDRWSMYQVYQSLNS 585 (611)
Q Consensus 554 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 585 (611)
....+.+++.+||+.||++||++.|++++..-
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 238 FPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 22345555569999999999999999988543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=310.07 Aligned_cols=248 Identities=19% Similarity=0.257 Sum_probs=196.7
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
.+|...+.||+|+||.||+|+. .+++.||+|.+.... ...+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5677889999999999999995 579999999996533 33466889999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
++++|.+++.+. .+++..+..++.+++.||.||| +.+++||||||+||+++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-- 171 (297)
T cd06656 99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 171 (297)
T ss_pred CCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC--
Confidence 999999998643 4889999999999999999999 789999999999999999999999999999865433211
Q ss_pred ccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHHHHHHH
Q 035917 482 VNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEILQFLK 560 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~~ 560 (611)
.....+++.|+|||.+.+..++.++|||||||++|++++|+.||.......... .......+.. .....+..+.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~--- 247 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNPERLSAVFRD--- 247 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-eeccCCCCCCCCccccCHHHHH---
Confidence 122358899999999988889999999999999999999998873211000000 0000000000 11122334444
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 035917 561 VACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 561 l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++.+||+.+|++||++.+++++
T Consensus 248 li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 248 FLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred HHHHHccCChhhCcCHHHHhcC
Confidence 4559999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=307.99 Aligned_cols=250 Identities=20% Similarity=0.268 Sum_probs=195.8
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
++|...+.||.|++|.||+|.. .+++.||+|.++... ...+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 4577778899999999999996 468999999986543 23467899999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
++++|.+++......+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++........ .
T Consensus 85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~ 159 (280)
T cd06611 85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--K 159 (280)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--c
Confidence 999999998765557999999999999999999999 78999999999999999999999999999876533221 1
Q ss_pred ccCCCcccccccccccC-----CCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHH
Q 035917 482 VNGDLGEFGYIAPEYSS-----TMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEI 555 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~ 555 (611)
.....|+..|+|||.+. ...++.++|||||||++|||++|+.|+.......... .......+.+ .....+.++
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLL-KILKSEPPTLDQPSKWSSSF 238 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHH-HHhcCCCCCcCCcccCCHHH
Confidence 12235889999999864 3457889999999999999999998874321100000 0000000011 111233444
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.++ +.+||+.+|++||++.+++++
T Consensus 239 ~~l---i~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 239 NDF---LKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHH---HHHHhccChhhCcCHHHHhcC
Confidence 554 449999999999999999887
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=304.89 Aligned_cols=247 Identities=24% Similarity=0.284 Sum_probs=197.1
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
+|...+.||.|++|.||+|+.. +++.||+|.+.... .....+.+|++++++++|+||+++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5667788999999999999954 68999999986532 23457889999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
++++|.+++... .+++..+..++.|++.|+.||| +.+++|+||+|+||++++++.++|+|||+++...... ..
T Consensus 82 ~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~ 154 (274)
T cd06609 82 GGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SK 154 (274)
T ss_pred CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--cc
Confidence 999999998754 6899999999999999999999 7899999999999999999999999999998765322 11
Q ss_pred ccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHH
Q 035917 482 VNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKV 561 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l 561 (611)
.....|+..|+|||++.+..++.++|||||||++|||++|+.|+......... ........+.+.....++++.+ +
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~---~ 230 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL-FLIPKNNPPSLEGNKFSKPFKD---F 230 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH-HHhhhcCCCCCcccccCHHHHH---H
Confidence 22345888999999999888999999999999999999999887432110000 0000011111111113344444 4
Q ss_pred HhhcccCCCCCCCCHHHHHHH
Q 035917 562 ACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 562 ~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+.+||..+|++||++++++++
T Consensus 231 l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 231 VSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HHHHhhCChhhCcCHHHHhhC
Confidence 559999999999999999885
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=307.21 Aligned_cols=249 Identities=18% Similarity=0.288 Sum_probs=190.2
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc--hhHHHHHHHHHH-HhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK--LGEKKFRNEMNR-LGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~Ev~~-l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
++|...+.||+|+||.||+|+.. +|+.||+|+++... ....++..|+.+ ++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36778899999999999999964 69999999987543 234456667765 566689999999999999999999999
Q ss_pred ccCCCChHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 400 YMSSGTLYSLLQGN---ATELDWPTRFRIGLGAARGLAWLHHGCQP-PFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 400 y~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
|++ |+|.+++... ...+++..+..++.|++.||+||| +. +++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 5888877542 246899999999999999999999 55 899999999999999999999999999986532
Q ss_pred CCCCccccCCCcccccccccccCC----CCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCC
Q 035917 476 SDESSFVNGDLGEFGYIAPEYSST----MVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGY 551 (611)
Q Consensus 476 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 551 (611)
.. ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.|+..+...............+.+.....
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF 233 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCcccc
Confidence 21 1122358899999998764 4568899999999999999999988754321111000001111111212223
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 552 DEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 552 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++++.+++. +||..+|++||++.+++++
T Consensus 234 ~~~l~~li~---~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 234 SPEFQDFVN---KCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CHHHHHHHH---HHccCChhhCcCHHHHhcC
Confidence 445555555 9999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=314.52 Aligned_cols=245 Identities=17% Similarity=0.175 Sum_probs=189.9
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeEEEE
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLR-HPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~~~~~lv~ 398 (611)
+|...+.||+|+||.||+|+. .+|+.||+|+++... ...+.+..|..++..+. |++|+++.+++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 366678999999999999995 468999999986532 22345788999998886 577888999998889999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 999999999998754 35899999999999999999999 78999999999999999999999999999875432211
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEILQ 557 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~ 557 (611)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+..... .....+.++.+
T Consensus 157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~----~~~~i~~~~~~~p~~~~~~~~~ 230 (323)
T cd05615 157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE----LFQSIMEHNVSYPKSLSKEAVS 230 (323)
T ss_pred --cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCccCCHHHHH
Confidence 1223458999999999998889999999999999999999998874211000 0011111111 11223344444
Q ss_pred HHHHHhhcccCCCCCCCCH-----HHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWSM-----YQVYQS 582 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~-----~evl~~ 582 (611)
++.+|++.+|.+|++. .++.+|
T Consensus 231 ---li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 231 ---ICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred ---HHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 4459999999999974 555554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=305.75 Aligned_cols=253 Identities=23% Similarity=0.332 Sum_probs=196.5
Q ss_pred HhhhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccchhHHHHHHHHHHHhcc-CCCCccceeeEEEeCC------
Q 035917 321 AASNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEE------ 392 (611)
Q Consensus 321 ~~t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~------ 392 (611)
.++++|...+.||+|++|.||+|... +++.+++|.+.......+++.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 35688999999999999999999964 678999999976665667899999999999 6999999999997644
Q ss_pred eeEEEEeccCCCChHHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccc
Q 035917 393 EKLLIYKYMSSGTLYSLLQGNA---TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGL 469 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGl 469 (611)
..++||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 4799999999999999886432 46899999999999999999999 88999999999999999999999999999
Q ss_pred ccccCCCCCCccccCCCcccccccccccCC-----CCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhch
Q 035917 470 AKLMTSSDESSFVNGDLGEFGYIAPEYSST-----MVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDK 544 (611)
Q Consensus 470 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (611)
+....... .......|+..|+|||++.. ..++.++|||||||++|||++|..||.......... .......+
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~ 236 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF-KIPRNPPP 236 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH-HhhccCCC
Confidence 87653322 11223458899999998753 346789999999999999999998874311100000 00000011
Q ss_pred hhcC-CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 545 ALCG-KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 545 ~l~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+.. ...++++. +++.+||..||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~---~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 237 TLKSPENWSKKFN---DFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred CCCchhhcCHHHH---HHHHHHhhcChhhCcCHHHHhcC
Confidence 1111 11223444 45559999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=309.66 Aligned_cols=247 Identities=19% Similarity=0.279 Sum_probs=195.9
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccC
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
+|...+.||.|++|.||+|+. .+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 477778999999999999984 578999999986543 334678999999999999999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccc
Q 035917 403 SGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482 (611)
Q Consensus 403 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 482 (611)
+++|.+++... .+++.++..++.+++.||+||| +.+++|+||||+||+++.++.+||+|||++........ ..
T Consensus 100 ~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~ 172 (296)
T cd06655 100 GGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KR 172 (296)
T ss_pred CCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--cC
Confidence 99999988643 4899999999999999999999 88999999999999999999999999999886543321 11
Q ss_pred cCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHHHHHHHH
Q 035917 483 NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEILQFLKV 561 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~~l 561 (611)
....|+..|+|||.+.+..++.++|||||||++|||++|+.||.......... .......+.+ .....+..+.++
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l--- 248 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNPEKLSPIFRDF--- 248 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcCCcccCCcccCCHHHHHH---
Confidence 22358899999999988889999999999999999999998863210000000 0000000001 112233444444
Q ss_pred HhhcccCCCCCCCCHHHHHHH
Q 035917 562 ACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 562 ~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+.+||..||++||++.+++++
T Consensus 249 i~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 249 LNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HHHHhhcChhhCCCHHHHhhC
Confidence 459999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=316.24 Aligned_cols=245 Identities=20% Similarity=0.245 Sum_probs=202.9
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccch----hHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKL----GEKKFRNEMNRLGQLR-HPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~----~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~~~~~l 396 (611)
...|...+.||+|.||.||+++.. +|+.+|+|.+.+... +.+.+.+|+.+|+++. |||||.+.+.+.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 446777789999999999999965 499999999976432 3468999999999998 9999999999999999999
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCC----CCeEEeecccccc
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDED----FDARIMDFGLAKL 472 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~----~~~kl~DFGla~~ 472 (611)
|||+|.||.|++.+... .+++.....++.|++.++.||| +.+|+|||+||+|+|+... +.+|++|||++..
T Consensus 114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 99999999999988755 3899999999999999999999 8999999999999999633 5799999999998
Q ss_pred cCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhch--hhcC--
Q 035917 473 MTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDK--ALCG-- 548 (611)
Q Consensus 473 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~--~l~~-- 548 (611)
... .......+||+.|+|||++....|+..+||||.||++|.|++|..||..-....... .+... ....
T Consensus 189 ~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~----~i~~~~~~f~~~~ 261 (382)
T KOG0032|consen 189 IKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL----AILRGDFDFTSEP 261 (382)
T ss_pred ccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH----HHHcCCCCCCCCC
Confidence 765 223445689999999999999999999999999999999999999985322111110 11111 1111
Q ss_pred -CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 549 -KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 549 -~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
...++.+.+++. .++..||.+|+|+.++++|
T Consensus 262 w~~is~~akd~i~---~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 262 WDDISESAKDFIR---KLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ccccCHHHHHHHH---HhcccCcccCCCHHHHhcC
Confidence 223566777777 9999999999999999996
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=316.42 Aligned_cols=249 Identities=19% Similarity=0.169 Sum_probs=192.2
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||.||+++.. +++.||+|++.... ...+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36778899999999999999965 57899999986422 12345888999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++|+|.+++.+....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999999999765456899999999999999999999 88999999999999999999999999999976533221
Q ss_pred CccccCCCcccccccccccC-----CCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCChhhhhchhhcC
Q 035917 479 SSFVNGDLGEFGYIAPEYSS-----TMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGRSKEAIDKALCG 548 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~ 548 (611)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||... ......... ........
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~---~~~~p~~~ 233 (332)
T cd05623 158 -VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE---RFQFPAQV 233 (332)
T ss_pred -ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc---cccCCCcc
Confidence 1122346999999999875 346789999999999999999999887421 111110000 00000001
Q ss_pred CCCHHHHHHHHHHHhhcccCC--CCCCCCHHHHHHH
Q 035917 549 KGYDEEILQFLKVACNCVVSR--PKDRWSMYQVYQS 582 (611)
Q Consensus 549 ~~~~~~~~~l~~l~~~Cl~~d--P~~RPs~~evl~~ 582 (611)
...++++.++++ +|+..+ +..|+++.|+++|
T Consensus 234 ~~~s~~~~~li~---~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 234 TDVSEDAKDLIR---RLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ccCCHHHHHHHH---HHccChhhhcCCCCHHHHhCC
Confidence 123456666665 766544 4447899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=308.25 Aligned_cols=248 Identities=21% Similarity=0.266 Sum_probs=185.8
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc---hhHHHHHHHHHHHhcc---CCCCccceeeEEEe-----CC
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK---LGEKKFRNEMNRLGQL---RHPNLAPLLGYCVV-----EE 392 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l---~H~nIv~l~g~~~~-----~~ 392 (611)
+|...+.||+|+||.||+|+.. +++.||+|.++... .....+.+|+.+++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 3667789999999999999954 68999999986432 1234566787777665 69999999998864 23
Q ss_pred eeEEEEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccc
Q 035917 393 EKLLIYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAK 471 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~ 471 (611)
..+++|||+++ +|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 57899999985 8988887543 35899999999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhc-CC-hhhh---
Q 035917 472 LMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSS-GR-SKEA--- 541 (611)
Q Consensus 472 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~-~~-~~~~--- 541 (611)
....... .....||..|+|||++.+..++.++|||||||++|||++|+.+|... ....... +. ....
T Consensus 157 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 157 IYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred cccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 7643221 12335889999999998888999999999999999999988775311 1111000 00 0000
Q ss_pred --------hchhh------cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 542 --------IDKAL------CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 542 --------~~~~l------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
..+.. .....+++ +.+++.+|++.||++|||+.|++.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEES---GAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHH---HHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 00112233 4455559999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=302.14 Aligned_cols=253 Identities=23% Similarity=0.290 Sum_probs=197.5
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
++|...+.||+|+||.||+|.. .+++.+|+|.+.... ...+.+.+|++++++++||||+++++++...+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 4677888999999999999996 457899999986543 23467899999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
++++|.+++......+++..+..++.|++.||+||| +.+++|+||||+||++++++.+||+|||++....... ..
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~ 157 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AK 157 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh--hc
Confidence 999999998765456899999999999999999999 7899999999999999999999999999998654321 11
Q ss_pred ccCCCcccccccccccCCC---CCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHH
Q 035917 482 VNGDLGEFGYIAPEYSSTM---VASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQF 558 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~~~---~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 558 (611)
.....++..|+|||.+... .++.++|||||||++|||++|+.|+.+................+.. ..........+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK-LKDKEKWSPVF 236 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcc-ccchhhhhHHH
Confidence 1234588899999998776 7899999999999999999999886431100000000000001000 00111122345
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 035917 559 LKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 559 ~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+++.+||..+|.+||++.+|+.+
T Consensus 237 ~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 237 HDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHhcC
Confidence 555669999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=305.42 Aligned_cols=245 Identities=20% Similarity=0.296 Sum_probs=196.6
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
+|...+.||+|++|.||++... +++.||+|.+.... ...+++.+|++++++++||||+++++++..++..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 4566688999999999999965 68999999986542 33467899999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQ-PPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
++++|.+++......+++..+..++.++++||+||| + .+++|+||||+||++++++.+||+|||.+.........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 157 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK- 157 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-
Confidence 999999999765457899999999999999999999 6 89999999999999999999999999998765322111
Q ss_pred cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc-------hhhcCCCCHH
Q 035917 481 FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID-------KALCGKGYDE 553 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~-------~~l~~~~~~~ 553 (611)
...++..|+|||.+.+..++.++||||||+++|+|++|+.|+...... .....+.+. +.+.....+.
T Consensus 158 ---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (265)
T cd06605 158 ---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP---PDGIFELLQYIVNEPPPRLPSGKFSP 231 (265)
T ss_pred ---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc---cccHHHHHHHHhcCCCCCCChhhcCH
Confidence 145889999999998889999999999999999999999887542100 000111111 1111111334
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 554 EILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 554 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++.+ ++.+||..||++|||+.+++.+
T Consensus 232 ~~~~---li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 232 DFQD---FVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHH---HHHHHcCCCchhCcCHHHHhhC
Confidence 4444 4459999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=300.58 Aligned_cols=247 Identities=19% Similarity=0.273 Sum_probs=196.6
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
+|+..++||.|+||.||.++. .+++.+++|.+.... ...+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 366778999999999999984 568999999986432 3346789999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 401 MSSGTLYSLLQGN-ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 401 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
+++|+|.+++... ...+++..+..++.|+++||.||| +.+++|+||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999765 246899999999999999999999 78999999999999999999999999999987643321
Q ss_pred ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh--cCCCCHHHHHH
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL--CGKGYDEEILQ 557 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~~~~~ 557 (611)
......|++.|+|||+..+..++.++||||||+++|||++|..++..-.... .......... .....+.++.+
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN----LVVKIVQGNYTPVVSVYSSELIS 231 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHcCCCCCCccccCHHHHH
Confidence 2233458999999999988888999999999999999999988763210000 0000000000 01222344455
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWSMYQVYQSL 583 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~~evl~~L 583 (611)
++. +||+.+|++||++.|+++++
T Consensus 232 ~i~---~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 232 LVH---SLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHH---HHcccCcccCCCHHHHhhCc
Confidence 444 99999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=301.82 Aligned_cols=250 Identities=18% Similarity=0.239 Sum_probs=191.1
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc------hhHHHHHHHHHHHhccCCCCccceeeEEEe--CCee
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK------LGEKKFRNEMNRLGQLRHPNLAPLLGYCVV--EEEK 394 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~------~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~--~~~~ 394 (611)
.+|...+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|+.++++++||||+++++++.. ++..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4788899999999999999985 468999999885421 122468899999999999999999998875 3567
Q ss_pred EEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccC
Q 035917 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~ 474 (611)
+++|||+++++|.+++... ..+++.....++.|++.||+||| ..+|+||||||+||+++.++.+||+|||+++.+.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 8999999999999998754 35889999999999999999999 7899999999999999999999999999997653
Q ss_pred CCC-CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHH
Q 035917 475 SSD-ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDE 553 (611)
Q Consensus 475 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 553 (611)
... .........++..|+|||++.+..++.++|||||||++|||++|+.||..................+.+ ....++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 236 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQL-PSHISE 236 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCC-chhcCH
Confidence 211 111122345889999999999888999999999999999999999887432110000000000001111 111122
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 554 EILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 554 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+..+ .+||..+|++||+|+||++|
T Consensus 237 ~~~~l----i~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 237 HARDF----LGCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHHHH----HHHhcCChhhCcCHHHHhcC
Confidence 33333 26888999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=310.52 Aligned_cols=192 Identities=22% Similarity=0.283 Sum_probs=157.5
Q ss_pred CCeeeecCCceEEEEEeC---CCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEe--CCeeEEEEeccCC
Q 035917 329 ENVIISTRTGTTYKAMLP---DGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVV--EEEKLLIYKYMSS 403 (611)
Q Consensus 329 ~~~ig~G~~g~Vy~~~~~---~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~--~~~~~lv~ey~~~ 403 (611)
+..||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 468999999999999964 45789999986543 23457899999999999999999999864 4567899999975
Q ss_pred CChHHhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEe----CCCCCeEEeeccccc
Q 035917 404 GTLYSLLQGN--------ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV----DEDFDARIMDFGLAK 471 (611)
Q Consensus 404 gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl----d~~~~~kl~DFGla~ 471 (611)
+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 788776421 125889999999999999999999 7899999999999999 566799999999998
Q ss_pred ccCCCCC-CccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCH
Q 035917 472 LMTSSDE-SSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNL 525 (611)
Q Consensus 472 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~ 525 (611)
....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.+|
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f 216 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCc
Confidence 7643221 112233468999999998876 45799999999999999999998776
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=299.60 Aligned_cols=244 Identities=26% Similarity=0.388 Sum_probs=193.9
Q ss_pred CCCCCeeeecCCceEEEEEeCC-----CCEEEEEeccccch--hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 326 FCSENVIISTRTGTTYKAMLPD-----GSVLAVKRLNTCKL--GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~~~-----g~~vAvK~~~~~~~--~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
|...+.||.|+||.||+++..+ +..||+|.++.... ..+.+.+|+..+..++|+||+++++++...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456889999999999999653 48899999976543 4568999999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCC-CCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 399 KYMSSGTLYSLLQGNATE-LDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
||+++++|.+++...... +++..+..++.|++.||+||| +.+++|+||||+||++++++.++|+|||+++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999765433 899999999999999999999 8899999999999999999999999999998765432
Q ss_pred CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHH-----HHHHHhhcCChhhhhchhhcCCCC
Q 035917 478 ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVD-----WVNQLSSSGRSKEAIDKALCGKGY 551 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~~~~ 551 (611)
.... ....+++.|+|||.+.+..++.++||||+|++++||++ |..|+.. ...... .... . ......
T Consensus 158 ~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~-----~-~~~~~~ 229 (258)
T smart00219 158 YYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLK-KGYR-----L-PKPENC 229 (258)
T ss_pred cccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCC-----C-CCCCcC
Confidence 2111 12237789999999988889999999999999999997 5555531 111111 1000 0 011123
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 035917 552 DEEILQFLKVACNCVVSRPKDRWSMYQVYQSL 583 (611)
Q Consensus 552 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 583 (611)
+.+ +.+++.+|+..||++|||+.|+++.|
T Consensus 230 ~~~---~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 230 PPE---IYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CHH---HHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 344 44455599999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=315.47 Aligned_cols=195 Identities=22% Similarity=0.254 Sum_probs=165.6
Q ss_pred HhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeC-----
Q 035917 321 AASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE----- 391 (611)
Q Consensus 321 ~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~----- 391 (611)
...++|...+.||+|+||.||++.. ..++.||||++.... ...+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3456888899999999999999985 468999999996532 2345688999999999999999999988643
Q ss_pred -CeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccc
Q 035917 392 -EEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLA 470 (611)
Q Consensus 392 -~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla 470 (611)
...++||||+++ +|.+.+.. .+++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 246899999975 77777653 4888999999999999999999 889999999999999999999999999999
Q ss_pred cccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCH
Q 035917 471 KLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNL 525 (611)
Q Consensus 471 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~ 525 (611)
+...... ......||..|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 167 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf 218 (355)
T cd07874 167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 218 (355)
T ss_pred ccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 8653321 122346899999999999888999999999999999999998775
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=315.24 Aligned_cols=249 Identities=19% Similarity=0.171 Sum_probs=192.5
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||.||+++.. +++.||+|.+.... ...+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36778899999999999999964 68899999986532 22345888999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999999765456899999999999999999999 89999999999999999999999999999986643221
Q ss_pred CccccCCCcccccccccccCC-----CCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCChhhhhchhhcC
Q 035917 479 SSFVNGDLGEFGYIAPEYSST-----MVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGRSKEAIDKALCG 548 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~ 548 (611)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||... ........ .........
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~---~~~~~p~~~ 233 (331)
T cd05624 158 -VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE---ERFQFPSHI 233 (331)
T ss_pred -eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCC---CcccCCCcc
Confidence 11122469999999998865 46788999999999999999999887421 11111000 000000000
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 035917 549 KGYDEEILQFLKVACNCVVSRPKD--RWSMYQVYQS 582 (611)
Q Consensus 549 ~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 582 (611)
...++++.+++. +|+..++++ |++++++++|
T Consensus 234 ~~~~~~~~~li~---~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 234 TDVSEEAKDLIQ---RLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ccCCHHHHHHHH---HHccCchhhcCCCCHHHHhcC
Confidence 123455555555 888765544 5689999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=323.47 Aligned_cols=243 Identities=23% Similarity=0.338 Sum_probs=198.1
Q ss_pred CCeeeecCCceEEEEEeC-CCCEEEEEeccc-----cchhHHHHHHHHHHHhccCCCCccceeeEEEeCCe--eEEEEec
Q 035917 329 ENVIISTRTGTTYKAMLP-DGSVLAVKRLNT-----CKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEE--KLLIYKY 400 (611)
Q Consensus 329 ~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~-----~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~--~~lv~ey 400 (611)
..+||+|.|-+||||... +|..||--.++. .....++|..|+.+|+.|+|||||+++.++.+... .-+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 468999999999999964 577887544322 22334789999999999999999999999998765 5689999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC-CCCeEEeecccccccCCCCCC
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE-DFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~-~~~~kl~DFGla~~~~~~~~~ 479 (611)
|..|+|+.|+++.+ .++.+.++.|++||++||.|||+. .++|+|||||.+||+++. .|.+||+|+|||+.+....
T Consensus 125 ~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-- 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-- 200 (632)
T ss_pred ccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc--
Confidence 99999999998764 588899999999999999999975 789999999999999974 5899999999999875432
Q ss_pred ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHH
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFL 559 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 559 (611)
....+|||.|||||++. ..|.+..||||||+.++||+|+..||.+.........++...+.|.-..+..+.+++++|
T Consensus 201 --aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fI 277 (632)
T KOG0584|consen 201 --AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFI 277 (632)
T ss_pred --cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHH
Confidence 23357999999999988 689999999999999999999999997654333222222233333333344567888888
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 035917 560 KVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 560 ~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+ +|+.. .++|||+.|++++
T Consensus 278 e---kCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 278 E---KCLAT-KSERLSAKELLKD 296 (632)
T ss_pred H---HHhcC-chhccCHHHHhhC
Confidence 8 99999 9999999999986
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=299.43 Aligned_cols=246 Identities=22% Similarity=0.321 Sum_probs=194.8
Q ss_pred CCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc------hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 326 FCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK------LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~------~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
|...+.||+|++|.||+|... +++.||+|.+.... ...+.+.+|+.++++++|+||+++++++..++..+++|
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 666789999999999999975 79999999885432 13367899999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++++|.+++... ..+++..+..++.++++||+||| +.+++|+||+|+||+++.++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 82 ELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 999999999999754 35889999999999999999999 7899999999999999999999999999988654322
Q ss_pred CccccCCCcccccccccccCCCC-CCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMV-ASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQ 557 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 557 (611)
......|+..|+|||.+.... ++.++|+|||||++|+|++|+.||.......... ...............++.+.+
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF-KIGRSKELPPIPDHLSDEAKD 233 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHH-HHHhcccCCCcCCCcCHHHHH
Confidence 122345889999999887766 8999999999999999999998874322110000 000000000111223344555
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++ .+||+.+|++||++.+++.+
T Consensus 234 li---~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 234 FI---LKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HH---HHHhhcCcccCcCHHHHhcC
Confidence 44 49999999999999999865
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=301.50 Aligned_cols=248 Identities=21% Similarity=0.300 Sum_probs=194.7
Q ss_pred CCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch----------hHHHHHHHHHHHhccCCCCccceeeEEEeCCee
Q 035917 326 FCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL----------GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~----------~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~ 394 (611)
|.....||+|++|.||+|.. .+++.||+|.+..... ..+.+.+|+.++++++||||+++++++...+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 66778999999999999985 4689999998854321 114688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccC
Q 035917 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~ 474 (611)
+++|||+++++|.+++... ..+++..+..++.+++.||+||| +.+++||||+|+||++++++.+||+|||+++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred EEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 9999999999999999754 45889999999999999999999 7899999999999999999999999999998765
Q ss_pred CCCCCc----cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCC
Q 035917 475 SSDESS----FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKG 550 (611)
Q Consensus 475 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 550 (611)
...... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||......... ........+.+ ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~-~~~ 235 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI-FKIGENASPEI-PSN 235 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH-HHHhccCCCcC-Ccc
Confidence 322111 111235788999999998888999999999999999999999887431110000 00000111111 122
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 551 YDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 551 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.++++.++++ +||+.||++||++.||+++
T Consensus 236 ~~~~~~~li~---~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 236 ISSEAIDFLE---KTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred cCHHHHHHHH---HHccCCchhCcCHHHHhhC
Confidence 3445555555 9999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=304.26 Aligned_cols=249 Identities=20% Similarity=0.248 Sum_probs=190.2
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
+|...+.||+|++|.||+|+.. +++.||||+++... ...+.+.+|+.++.+++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4667789999999999999964 68999999986432 2236788999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 401 MSSGTLYSLLQGNA--TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 401 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
++ ++|.+++.... ..+++..+..++.|+++||+||| ..+++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 58988886432 46899999999999999999999 8899999999999999999999999999997653221
Q ss_pred CccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhh-cCCh--------h--hh
Q 035917 479 SSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSS-SGRS--------K--EA 541 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~-~~~~--------~--~~ 541 (611)
.......+++.|+|||.+.+ ..++.++|||||||++|||++|+.+|..- ...... .+.. . ..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 11223357899999998765 45789999999999999999998776310 000000 0000 0 00
Q ss_pred hchhh----------cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 542 IDKAL----------CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 542 ~~~~l----------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
..... .....+.+..+ ++.+||+.||++|||+.+|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~---li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLD---LLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHH---HHHHHhcCChhhCCCHHHHhcC
Confidence 00000 00112334444 5559999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=303.04 Aligned_cols=253 Identities=22% Similarity=0.282 Sum_probs=191.2
Q ss_pred CCCCCeeeecCCceEEEEEeC----CCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCC------
Q 035917 326 FCSENVIISTRTGTTYKAMLP----DGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE------ 392 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~~----~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~------ 392 (611)
|...+.||+|+||.||+|.+. +++.||||++.... ...+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999853 36899999986532 23457889999999999999999999886542
Q ss_pred eeEEEEeccCCCChHHhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeec
Q 035917 393 EKLLIYKYMSSGTLYSLLQGN-----ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDF 467 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DF 467 (611)
..++++||+++|+|.+++... ...+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 247899999999998887422 125789999999999999999999 789999999999999999999999999
Q ss_pred ccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhh
Q 035917 468 GLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKAL 546 (611)
Q Consensus 468 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l 546 (611)
|+++...............++..|++||.+....++.++|||||||++|||++ |+.|+........ ........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~----~~~~~~~~- 232 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI----YNYLIKGN- 232 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH----HHHHHcCC-
Confidence 99986643322111122345678999999988889999999999999999998 6666532110000 00000000
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHc
Q 035917 547 CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586 (611)
Q Consensus 547 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 586 (611)
...........+.+++.+||+.+|++||++.|+++.|+++
T Consensus 233 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000111223556666699999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=330.34 Aligned_cols=199 Identities=16% Similarity=0.146 Sum_probs=163.3
Q ss_pred HHHHhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhccCC------CCccceeeEEEe
Q 035917 318 DLMAASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRH------PNLAPLLGYCVV 390 (611)
Q Consensus 318 ~l~~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H------~nIv~l~g~~~~ 390 (611)
++...+++|...++||+|+||.||+|+. .+++.||||+++......+++..|++++.+++| .+++++++++..
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3444567899999999999999999995 468899999996543344556677877777755 458888888876
Q ss_pred C-CeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC---------
Q 035917 391 E-EEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF--------- 460 (611)
Q Consensus 391 ~-~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~--------- 460 (611)
+ ++.++|||++ +++|.+++... ..+++..+..|+.||+.||+|||+ ..+|+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCccccccccc
Confidence 4 5688999998 67899988754 468999999999999999999993 25999999999999998665
Q ss_pred -------CeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCH
Q 035917 461 -------DARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNL 525 (611)
Q Consensus 461 -------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~ 525 (611)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf 345 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345 (467)
T ss_pred ccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 499999998764321 122346999999999999999999999999999999999999887
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=301.88 Aligned_cols=257 Identities=17% Similarity=0.189 Sum_probs=196.2
Q ss_pred CCCCCeeeecCCceEEEEE-eCCCCEEEEEeccccch---hHHHHHHHHHHHhccCCCC-ccceeeEEEeCC------ee
Q 035917 326 FCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCKL---GEKKFRNEMNRLGQLRHPN-LAPLLGYCVVEE------EK 394 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~~---~~~~~~~Ev~~l~~l~H~n-Iv~l~g~~~~~~------~~ 394 (611)
|...+.||+|.||+||+|+ ..+|+.||+|+++.... ......+|+.++++++|+| ||++++++...+ ..
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 4444679999999999999 56789999999976433 3456789999999999999 999999999877 77
Q ss_pred EEEEeccCCCChHHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccc
Q 035917 395 LLIYKYMSSGTLYSLLQGNA---TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAK 471 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~ 471 (611)
++||||+.. +|..++.... ..++...++.++.|+++||+||| +++|+||||||+|||++++|.+||+|||+|+
T Consensus 93 ~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 93 YLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 899999977 9999997654 35777889999999999999999 8999999999999999999999999999999
Q ss_pred ccCCCCCCccccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHHHHHH-----HHhh-cCCh-----h
Q 035917 472 LMTSSDESSFVNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLVDWVN-----QLSS-SGRS-----K 539 (611)
Q Consensus 472 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~~~~~-----~~~~-~~~~-----~ 539 (611)
...-.. ...+..++|..|.|||++.+. .|+...||||+|||+.||++++.-|+.... .+.. -+.. .
T Consensus 169 a~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 169 AFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 664222 223455789999999998775 699999999999999999987765432111 1100 0000 0
Q ss_pred hhh-----chhh---c-CCCCHHH----HHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHchh
Q 035917 540 EAI-----DKAL---C-GKGYDEE----ILQFLKVACNCVVSRPKDRWSMYQVYQS--LNSIAA 588 (611)
Q Consensus 540 ~~~-----~~~l---~-~~~~~~~----~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~ 588 (611)
.+. +... . ....... ..+..+++.+|++.+|.+|.|+..++.| +.++..
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 000 0000 0 0111111 1255667779999999999999999998 555533
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=315.90 Aligned_cols=194 Identities=21% Similarity=0.239 Sum_probs=165.6
Q ss_pred hhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEecccc---chhHHHHHHHHHHHhccCCCCccceeeEEEeC------
Q 035917 322 ASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTC---KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE------ 391 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~---~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~------ 391 (611)
..++|...+.||+|+||.||+|.. ..++.||||++... ....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 356788899999999999999995 46889999999643 22345688999999999999999999987643
Q ss_pred CeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccc
Q 035917 392 EEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAK 471 (611)
Q Consensus 392 ~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~ 471 (611)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 356999999975 78777753 4788999999999999999999 8899999999999999999999999999998
Q ss_pred ccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCH
Q 035917 472 LMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNL 525 (611)
Q Consensus 472 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~ 525 (611)
...... ......||..|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 175 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf 225 (364)
T cd07875 175 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225 (364)
T ss_pred ccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCC
Confidence 653321 123346899999999999989999999999999999999998876
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=301.25 Aligned_cols=248 Identities=19% Similarity=0.303 Sum_probs=194.0
Q ss_pred cCCCCCeeeecCCceEEEEEeCC--CCEEEEEeccccc-----------hhHHHHHHHHHHHhc-cCCCCccceeeEEEe
Q 035917 325 SFCSENVIISTRTGTTYKAMLPD--GSVLAVKRLNTCK-----------LGEKKFRNEMNRLGQ-LRHPNLAPLLGYCVV 390 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~~--g~~vAvK~~~~~~-----------~~~~~~~~Ev~~l~~-l~H~nIv~l~g~~~~ 390 (611)
+|+..+.||+|+||.||+|.... ++.+|+|.+.... ....++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 46777899999999999999754 7899999875321 122457789988875 799999999999999
Q ss_pred CCeeEEEEeccCCCChHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeec
Q 035917 391 EEEKLLIYKYMSSGTLYSLLQG---NATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDF 467 (611)
Q Consensus 391 ~~~~~lv~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DF 467 (611)
++..+++|||+++++|.+++.. ....+++..++.++.|++.||.|||+ ..+++|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999988743 23468999999999999999999993 367999999999999999999999999
Q ss_pred ccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh--
Q 035917 468 GLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-- 545 (611)
Q Consensus 468 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-- 545 (611)
|++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+..-..... .....+..
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~----~~~~~~~~~~ 231 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL----ATKIVEAVYE 231 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH----HHHHhhccCC
Confidence 9998764332 22334588999999999988899999999999999999999888632110000 00111111
Q ss_pred -hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 035917 546 -LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLN 584 (611)
Q Consensus 546 -l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 584 (611)
......+.++.+ ++.+||+.||++||++.|+.++++
T Consensus 232 ~~~~~~~~~~l~~---li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 232 PLPEGMYSEDVTD---VITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCCcccCCHHHHH---HHHHHCCCCCccCCCHHHHHHHhc
Confidence 111123344444 455999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=304.75 Aligned_cols=247 Identities=20% Similarity=0.326 Sum_probs=193.0
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
+|...+.||+|+||.||++... +++.||+|.++... ....++.+|+.++.+++||||+++++++..++..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 4667789999999999999965 78999999886432 23467899999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 402 SSGTLYSLLQGNA--TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 402 ~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
++++|.+++.... ..+++..+..++.+++.||.|||+ +.+|+|+||||+||+++.++.+||+|||+++.+.....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA- 158 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc-
Confidence 9999999887542 368999999999999999999994 35899999999999999999999999999976532211
Q ss_pred ccccCCCcccccccccccCCC------CCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc---hhhcCCC
Q 035917 480 SFVNGDLGEFGYIAPEYSSTM------VASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID---KALCGKG 550 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~---~~l~~~~ 550 (611)
....|+..|+|||.+.+. .++.++|||||||++|||++|+.||......... .......+ +.+ ...
T Consensus 159 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~-~~~ 233 (286)
T cd06622 159 ---KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF-AQLSAIVDGDPPTL-PSG 233 (286)
T ss_pred ---ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH-HHHHHHhhcCCCCC-Ccc
Confidence 223578899999988544 3588999999999999999999887321100000 00001111 111 112
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 551 YDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 551 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.++++.+++ .+||+.+|++||++.+++++
T Consensus 234 ~~~~~~~li---~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 234 YSDDAQDFV---AKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred cCHHHHHHH---HHHcccCcccCCCHHHHhcC
Confidence 334445544 49999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=300.94 Aligned_cols=249 Identities=23% Similarity=0.366 Sum_probs=197.9
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
++|+..+.||.|+||.||+|.. .++..+|+|++.... ...+.+.+|+++++.++|+||+++++.+..++..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 3678889999999999999995 468899999986433 2446789999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 401 MSSGTLYSLLQGNA--TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 401 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
+++++|.+++.... ..+++.....++.|++.||+||| +.+++|+||||+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999997542 36899999999999999999999 88999999999999999999999999999987654332
Q ss_pred Cc--cccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhh---chhhcC----
Q 035917 479 SS--FVNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAI---DKALCG---- 548 (611)
Q Consensus 479 ~~--~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~---~~~l~~---- 548 (611)
.. ......|+..|+|||++... .++.++|||||||++|||++|+.|+....... ...+.. .+....
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK----VLMLTLQNDPPSLETGADY 233 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh----hHHHHhcCCCCCcCCcccc
Confidence 21 12233588999999988776 78999999999999999999998874321100 000000 011111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 549 KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 549 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
...+.+ +.+++.+||+.||++||++.++++|
T Consensus 234 ~~~~~~---~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 234 KKYSKS---FRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ccccHH---HHHHHHHHcCCChhhCcCHHHHhhC
Confidence 112334 4455559999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=300.15 Aligned_cols=246 Identities=18% Similarity=0.239 Sum_probs=194.8
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEecccc--chhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTC--KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
+|...+.||+|+||.||++.. .+++.||+|.++.. ....+.+.+|+.++++++|+||+++++++..++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 366778999999999999995 46899999998543 234467889999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 402 SSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 402 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
++|+|.+++.... ..+++...+.++.+++.||.||| +.+|+|+||||+||++++++.++++|||+++.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-- 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-- 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence 9999999886533 35889999999999999999999 88999999999999999999999999999986643221
Q ss_pred cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhch--hhcCCCCHHHHHHH
Q 035917 481 FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDK--ALCGKGYDEEILQF 558 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~~~~~~l 558 (611)
......|++.|+|||++.+..++.++||||||+++|+|++|..||..-..... ....... .......+..+.+
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~- 230 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL----ILKVCQGSYKPLPSHYSYELRS- 230 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH----HHHHhcCCCCCCCcccCHHHHH-
Confidence 11234588999999999888899999999999999999999988742100000 0000000 0011123334444
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 035917 559 LKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 559 ~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++.+||+.||++||++.+++..
T Consensus 231 --li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 231 --LIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --HHHHHHhCCcccCCCHHHHhhc
Confidence 5559999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=301.69 Aligned_cols=253 Identities=21% Similarity=0.305 Sum_probs=195.5
Q ss_pred hcCCCCCeeeecCCceEEEEEeC------CCCEEEEEeccccch--hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP------DGSVLAVKRLNTCKL--GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~------~g~~vAvK~~~~~~~--~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~ 395 (611)
++|.....||+|+||.||+|+.. +.+.||+|.+..... ..+.+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46777889999999999999953 356899999865433 2467999999999999999999999999888999
Q ss_pred EEEeccCCCChHHhhhcCC--------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeec
Q 035917 396 LIYKYMSSGTLYSLLQGNA--------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDF 467 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~--------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DF 467 (611)
+||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999987543 15899999999999999999999 789999999999999999999999999
Q ss_pred ccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhh
Q 035917 468 GLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKAL 546 (611)
Q Consensus 468 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l 546 (611)
|+++...... ........++..|+|||.+.+..++.++||||||+++|||++ +..||.+................ ..
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~-~~ 239 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE-LP 239 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcC-CC
Confidence 9987543221 112223356788999999888888999999999999999997 55565321111000000000000 00
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 035917 547 CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLN 584 (611)
Q Consensus 547 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 584 (611)
.....+..+. +++.+||+.+|++||++.|++++|.
T Consensus 240 ~~~~~~~~l~---~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 240 VPEGCPSRLY---KLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCCCHHHH---HHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1122334444 4555999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.95 Aligned_cols=248 Identities=21% Similarity=0.288 Sum_probs=190.4
Q ss_pred HhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeC-----
Q 035917 321 AASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE----- 391 (611)
Q Consensus 321 ~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~----- 391 (611)
...+.|...+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 4557788889999999999999985 568899999986532 2335678999999999999999999987543
Q ss_pred -CeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccc
Q 035917 392 -EEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLA 470 (611)
Q Consensus 392 -~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla 470 (611)
...++++|++ +++|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccc
Confidence 3468999998 6799988764 35899999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhh-cC-Chhhhh
Q 035917 471 KLMTSSDESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSS-SG-RSKEAI 542 (611)
Q Consensus 471 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~-~~-~~~~~~ 542 (611)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. ....... .+ ...+..
T Consensus 166 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07878 166 RQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL 240 (343)
T ss_pred eecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 865422 123468999999999876 5689999999999999999999877631 1111100 00 000000
Q ss_pred c-----------hhhc---C-------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 543 D-----------KALC---G-------KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 543 ~-----------~~l~---~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
. ..+. . ...++ .+.+++.+|++.||++|||+.|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 241 KKISSEHARKYIQSLPHMPQQDLKKIFRGANP---LAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HhcchhhHHHHhhccccccchhHHHhccCCCH---HHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000 0 01112 24556669999999999999999987
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.97 Aligned_cols=250 Identities=16% Similarity=0.224 Sum_probs=192.2
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
+.|...+.||+|+||.||+|+.. +++.||+|.++... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 35777889999999999999864 68899999986432 2345678999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
++ ++|.+++......+++..+..++.|+++||+||| +.+|+|+||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-- 159 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-- 159 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--
Confidence 97 5999988765556899999999999999999999 88999999999999999999999999999976432221
Q ss_pred cccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhh---c---CChhhhhc-----
Q 035917 481 FVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSS---S---GRSKEAID----- 543 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~---~---~~~~~~~~----- 543 (611)
......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||... ...... . ........
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 1123357899999998765 45788999999999999999998876321 110000 0 00000000
Q ss_pred ----hhh-------cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 544 ----KAL-------CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 544 ----~~l-------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+.. .....+.++. +++.+|++.||.+|||+.|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~---~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGA---ELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHH---HHHHHHhcCCcccCcCHHHHhcC
Confidence 000 0011233444 45559999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=301.19 Aligned_cols=246 Identities=21% Similarity=0.233 Sum_probs=196.3
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
.|...+.||+|+||.||+|... +++.||+|.++... ...+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4556678999999999999964 68899999986432 33467899999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
++|+|.+++... ++++.....++.+++.||+||| +.+++|+||+|+||+++.++.++++|||++........ .
T Consensus 85 ~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~ 157 (277)
T cd06640 85 GGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--K 157 (277)
T ss_pred CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--c
Confidence 999999998643 5889999999999999999999 78999999999999999999999999999976643221 1
Q ss_pred ccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHH
Q 035917 482 VNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKV 561 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l 561 (611)
.....++..|+|||++.+..++.++|||||||++|||++|+.|+....... ....+...............+.++
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~l 232 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-----VLFLIPKNNPPTLTGEFSKPFKEF 232 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-----HhhhhhcCCCCCCchhhhHHHHHH
Confidence 122357889999999988889999999999999999999998864211100 000111011111122233455566
Q ss_pred HhhcccCCCCCCCCHHHHHHH
Q 035917 562 ACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 562 ~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+.+||+.+|++||++.+++++
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 233 IDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHHHcccCcccCcCHHHHHhC
Confidence 669999999999999999887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=296.40 Aligned_cols=242 Identities=20% Similarity=0.312 Sum_probs=195.4
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEecccc---chhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTC---KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~---~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
+|+..+.||+|+||.+|+++. .+|+.||+|.+... ....+++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 366778999999999999995 46899999998643 22345789999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 401 MSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 401 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 99999999987543 35889999999999999999999 78999999999999999999999999999986643221
Q ss_pred ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhc------CCCCHH
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALC------GKGYDE 553 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~------~~~~~~ 553 (611)
......|++.|+|||+..+..++.++|||||||+++||++|+.|+... ...+.++..+. ....+.
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG--------NMKNLVLKIIRGSYPPVSSHYSY 227 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC--------CHHHHHHHHhcCCCCCCcccCCH
Confidence 112235788999999998888999999999999999999998876321 11111111111 112233
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 554 EILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 554 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++.+ ++.+||+.+|++||+|.||+++
T Consensus 228 ~~~~---li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 228 DLRN---LVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHHH---HHHHHhhCChhhCcCHHHHhhC
Confidence 4444 5559999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=308.31 Aligned_cols=243 Identities=19% Similarity=0.277 Sum_probs=192.2
Q ss_pred CCeeeecCCceEEEEEe-CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCCh
Q 035917 329 ENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTL 406 (611)
Q Consensus 329 ~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL 406 (611)
...||+|+||.||++.. .+++.||||.+.... ...+.+.+|+.++++++|+||+++++.+..++..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 36799999999999985 468999999986533 3346689999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccCCC
Q 035917 407 YSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDL 486 (611)
Q Consensus 407 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 486 (611)
.+++... .+++..+..++.+++.||+||| +.+|+||||||+||++++++.+||+|||++........ ......
T Consensus 107 ~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~ 179 (292)
T cd06658 107 TDIVTHT--RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLV 179 (292)
T ss_pred HHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCceee
Confidence 9988643 4889999999999999999999 78999999999999999999999999999876532211 112345
Q ss_pred cccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcC-CCCHHHHHHHHHHHhhc
Q 035917 487 GEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCG-KGYDEEILQFLKVACNC 565 (611)
Q Consensus 487 gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~l~~l~~~C 565 (611)
|+..|+|||+..+..++.++|||||||++|||++|+.|+......... ........+.... ...++.+..++. +|
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~---~~ 255 (292)
T cd06658 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM-RRIRDNLPPRVKDSHKVSSVLRGFLD---LM 255 (292)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcCCCccccccccCHHHHHHHH---HH
Confidence 889999999998888999999999999999999999886321100000 0001111111111 123345555555 99
Q ss_pred ccCCCCCCCCHHHHHHH
Q 035917 566 VVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 566 l~~dP~~RPs~~evl~~ 582 (611)
|..||++|||+.|++++
T Consensus 256 l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 256 LVREPSQRATAQELLQH 272 (292)
T ss_pred ccCChhHCcCHHHHhhC
Confidence 99999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=298.34 Aligned_cols=248 Identities=20% Similarity=0.284 Sum_probs=192.7
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEe-CCeeEEEEe
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVV-EEEKLLIYK 399 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~-~~~~~lv~e 399 (611)
+|...+.||+|++|.||+++.. +++.||+|++.... ...+.+.+|++++++++|+|++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 3677789999999999999954 57899999986533 234568899999999999999999988764 446789999
Q ss_pred ccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 400 YMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 400 y~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
|+++++|.+++.... ..+++.++..++.+++.|++||| +.+++|+||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 999999999987543 36899999999999999999999 78999999999999999999999999999987643221
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQF 558 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 558 (611)
......|++.|+|||+..+..++.++||||||++++||++|+.||................. +.. ....+.++.+
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~- 232 (257)
T cd08223 158 --MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL-PPM-PKDYSPELGE- 232 (257)
T ss_pred --ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCC-ccccCHHHHH-
Confidence 12234588999999999988899999999999999999999887632100000000000000 011 1123344444
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 035917 559 LKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 559 ~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++.+|++.+|++||++.+++++
T Consensus 233 --li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 233 --LIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --HHHHHhccCcccCCCHHHHhcC
Confidence 5559999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=305.31 Aligned_cols=248 Identities=19% Similarity=0.232 Sum_probs=189.3
Q ss_pred CCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch---hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 326 FCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL---GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
|...+.||+|+||.||+|+. .+|+.||+|+++.... ....+.+|++++++++||||+++++++.+.+..++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 56678899999999999996 4689999999864322 2356788999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
+ ++|.+++......+++..+..++.||++||.||| ..+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~ 155 (284)
T cd07839 82 D-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--C 155 (284)
T ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--C
Confidence 7 4888888655456899999999999999999999 78999999999999999999999999999986533221 1
Q ss_pred ccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHHH------HHHHHhhc-CC--------hhhhhchh
Q 035917 482 VNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLVD------WVNQLSSS-GR--------SKEAIDKA 545 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~~------~~~~~~~~-~~--------~~~~~~~~ 545 (611)
.....++..|+|||++.+. .++.++|||||||++|||++|+.|+.. ........ +. ..+..+..
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence 2233578899999987664 468999999999999999998776411 11100000 00 00000000
Q ss_pred ----hc--------CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 546 ----LC--------GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 546 ----l~--------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.. ....++++.++ +.+||+.||.+|||+.++++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~l---i~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDL---LQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHH---HHHHhcCChhhcCCHHHHhcC
Confidence 00 01123344444 559999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=316.21 Aligned_cols=238 Identities=20% Similarity=0.190 Sum_probs=183.6
Q ss_pred eeecCCceEEEEEe-CCCCEEEEEeccccch----hHHHHHHHHHHHhcc---CCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 332 IISTRTGTTYKAML-PDGSVLAVKRLNTCKL----GEKKFRNEMNRLGQL---RHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 332 ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ev~~l~~l---~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
||+|+||.||+|+. .+++.||||++..... ....+..|..++.+. +||||+++++++..++..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999995 4689999999864321 123455677777665 699999999999999999999999999
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcccc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
|+|.+++... ..+++..+..++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~ 154 (330)
T cd05586 81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTN 154 (330)
T ss_pred ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Ccc
Confidence 9999988754 45899999999999999999999 78999999999999999999999999999975432221 122
Q ss_pred CCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhh--chhhcCCCCHHHHHHHHH
Q 035917 484 GDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAI--DKALCGKGYDEEILQFLK 560 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~--~~~l~~~~~~~~~~~l~~ 560 (611)
...||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ...+. +..+.....+++..++++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~~li~ 230 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM----YRNIAFGKVRFPKNVLSDEGRQFVK 230 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH----HHHHHcCCCCCCCccCCHHHHHHHH
Confidence 34699999999988754 479999999999999999999988632100000 00000 111112223455666666
Q ss_pred HHhhcccCCCCCCC----CHHHHHHH
Q 035917 561 VACNCVVSRPKDRW----SMYQVYQS 582 (611)
Q Consensus 561 l~~~Cl~~dP~~RP----s~~evl~~ 582 (611)
+||+.||++|| ++.++++|
T Consensus 231 ---~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 231 ---GLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred ---HHcCCCHHHCCCCCCCHHHHhcC
Confidence 99999999998 57777665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=299.29 Aligned_cols=250 Identities=16% Similarity=0.142 Sum_probs=190.3
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc------hhHHHHHHHHHHHhccCCCCccceeeEEEeC--Cee
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK------LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE--EEK 394 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~------~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~--~~~ 394 (611)
.+|...+.||+|+||.||+|.. .+++.||||.+.... ...+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688889999999999999995 468999999885321 1235688999999999999999999988763 457
Q ss_pred EEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccC
Q 035917 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~ 474 (611)
+++|||+++|+|.+++... ..+++..+..++.+++.||+||| +.+++|+||||+||+++.++.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 7999999999999998754 35788899999999999999999 7899999999999999999999999999998653
Q ss_pred CCCC-CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHH
Q 035917 475 SSDE-SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDE 553 (611)
Q Consensus 475 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 553 (611)
.... ........|+..|+|||.+.+..++.++|||||||++|||++|+.||........ ..+.............
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~ 233 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA----IFKIATQPTNPVLPPH 233 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH----HHHHhcCCCCCCCchh
Confidence 2111 1112223588999999999888899999999999999999999988743211110 0000000001111111
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 554 EILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 554 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
....+.+++.+|+. +|++||+++||+++
T Consensus 234 ~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 234 VSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred hCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 22233444448884 89999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=303.56 Aligned_cols=254 Identities=22% Similarity=0.308 Sum_probs=200.6
Q ss_pred HhhhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 321 AASNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 321 ~~t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
..+++|...+.||+|++|.||+|... +++.||+|.++......+.+.+|++++++++|+||+++++++...+..++++|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 34566777889999999999999976 68999999997654456778999999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
|+++++|.+++......+++..+..++.+++.||.||| ..+++|+||+|+||+++.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 99999999999865446999999999999999999999 79999999999999999999999999999876543221
Q ss_pred ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHH
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFL 559 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 559 (611)
......++..|+|||++.+..++.++|||||||++|+|++|+.|+..........................+.++..
T Consensus 172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-- 248 (286)
T cd06614 172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKD-- 248 (286)
T ss_pred -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHH--
Confidence 11223478899999999888899999999999999999999887532110000000000000000001113344444
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 035917 560 KVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 560 ~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++.+||+.+|.+||++.+++++
T Consensus 249 -li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 249 -FLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -HHHHHhccChhhCcCHHHHhhC
Confidence 4559999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=306.40 Aligned_cols=253 Identities=15% Similarity=0.140 Sum_probs=192.3
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||.||++... +++.||+|.+.... ...+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36777899999999999999954 58899999986542 22356889999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++++|.+++... ..+++..+..++.+++.||.||| +.+++||||||+||+++.++.+||+|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 999999999999754 46899999999999999999999 78999999999999999999999999999874211000
Q ss_pred -------------CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhh-hhch
Q 035917 479 -------------SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKE-AIDK 544 (611)
Q Consensus 479 -------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~-~~~~ 544 (611)
........|+..|+|||++....++.++|||||||++||+++|..||............... ...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 236 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Confidence 00111235788999999998888999999999999999999999887421110000000000 0001
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 035917 545 ALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLN 584 (611)
Q Consensus 545 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 584 (611)
. .....+.++.+++. +||+.||++||++.++.+.|+
T Consensus 237 ~-~~~~~~~~~~~li~---~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 237 E-GDEALPADAQDLIS---RLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred C-ccccCCHHHHHHHH---HHhccChhhccCccCHHHHHh
Confidence 1 11123445555555 999999999998544444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=302.05 Aligned_cols=199 Identities=20% Similarity=0.250 Sum_probs=167.9
Q ss_pred hhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 322 ASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++++|...+.||+|+||.||+|.. .+|+.||+|++.... .....+.+|+.+++.++|+||+++.+++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 457888899999999999999985 468999999986432 22346789999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+. ++|.+++......+++..+..++.|++.||.||| ..+|+|+||||+||+++.++++||+|||+++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9996 6887777654446788889999999999999999 78999999999999999999999999999976433221
Q ss_pred CccccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLV 526 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~ 526 (611)
......+++.|+|||.+.+. .++.++|||||||++|||++|..||.
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~ 205 (291)
T cd07870 159 --TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFP 205 (291)
T ss_pred --CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 11233578999999988653 47889999999999999999988763
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.61 Aligned_cols=249 Identities=18% Similarity=0.281 Sum_probs=189.5
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc--hhHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeEEEEec
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLR-HPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
+|...+.||+|+||.||+++. .+++.||+|.+.... .....+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 344557899999999999995 468999999986532 33467899999999996 99999999999999999999999
Q ss_pred cCCCChHHhh---hcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 401 MSSGTLYSLL---QGN-ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 401 ~~~gsL~~~l---~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
+.. ++.++. ... ...+++..+..++.++++||+|||+ ..+++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 655433 222 2468999999999999999999994 358999999999999999999999999999865432
Q ss_pred CCCccccCCCcccccccccccCCC---CCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCC---C
Q 035917 477 DESSFVNGDLGEFGYIAPEYSSTM---VASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGK---G 550 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~ 550 (611)
... ....|+..|+|||++.+. .++.++|||||||++|||++|+.||..+...............+.+... .
T Consensus 162 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd06616 162 IAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE 238 (288)
T ss_pred Ccc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence 211 223588999999998765 6899999999999999999999998654311111000000011112111 1
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 551 YDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 551 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+.++.+ ++.+||+.+|++|||+.+|+++
T Consensus 239 ~~~~l~~---li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 239 FSPSFVN---FINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCHHHHH---HHHHHccCChhhCcCHHHHhcC
Confidence 3344444 5559999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=298.73 Aligned_cols=253 Identities=20% Similarity=0.285 Sum_probs=195.0
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch-------hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEE
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL-------GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~-------~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
+|...+.||+|++|.||+|.. .+++.||+|.+..... ..+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999984 6789999999864321 23578999999999999999999999999999999
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC-CeEEeecccccccCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF-DARIMDFGLAKLMTS 475 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~-~~kl~DFGla~~~~~ 475 (611)
||||+++++|.+++.+. .++++..+..++.|++.||.||| +.+++|+||||+||+++.++ .+||+|||++..+..
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 99999999999998754 36899999999999999999999 78999999999999998775 599999999987643
Q ss_pred CCCC--ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHH
Q 035917 476 SDES--SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDE 553 (611)
Q Consensus 476 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 553 (611)
.... .......|+..|+|||.+.+..++.++||||+|+++|||++|..|+........ .....+.............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-LALIFKIASATTAPSIPEH 235 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-HHHHHHHhccCCCCCCchh
Confidence 3211 111223578899999999888899999999999999999999887632100000 0000000000001111122
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 554 EILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 554 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
....+.+++.+|++.+|++||++.|++++
T Consensus 236 ~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 236 LSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred hCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 22345556669999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=296.43 Aligned_cols=251 Identities=20% Similarity=0.272 Sum_probs=194.9
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEe--CCeeEEEE
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVV--EEEKLLIY 398 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~--~~~~~lv~ 398 (611)
+|...+.||+|+||.||++.. .+++.||+|.++... ...+++.+|++++++++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 366778999999999999985 568999999986432 234568899999999999999999998864 34578999
Q ss_pred eccCCCChHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeecCCCCCeEEeCCCCCeEEeeccccccc
Q 035917 399 KYMSSGTLYSLLQGN---ATELDWPTRFRIGLGAARGLAWLHHGC--QPPFLHQNICSNVILVDEDFDARIMDFGLAKLM 473 (611)
Q Consensus 399 ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~ 473 (611)
||+++++|.+++... ...+++..++.++.+++.||.|||..+ ..+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998643 246899999999999999999999543 678999999999999999999999999999876
Q ss_pred CCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHH
Q 035917 474 TSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDE 553 (611)
Q Consensus 474 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 553 (611)
..... ......|+..|+|||.+.+..++.++||||||+++|+|++|..|+...... ...+.+...........
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~ 233 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL-----QLASKIKEGKFRRIPYR 233 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH-----HHHHHHhcCCCCCCccc
Confidence 54321 122345899999999998888999999999999999999998876421100 00011111111111111
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 554 EILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 554 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
....+.+++.+|++.+|++||++.+|+++
T Consensus 234 ~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 234 YSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 22344555559999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.40 Aligned_cols=242 Identities=19% Similarity=0.257 Sum_probs=190.9
Q ss_pred CeeeecCCceEEEEEe-CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCChH
Q 035917 330 NVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLY 407 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL~ 407 (611)
..||+|+||.||+|.. .+++.||+|.++... ...+.+.+|+.++..++||||+++++++..++..++||||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 4799999999999995 468999999986432 33467889999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccCCCc
Q 035917 408 SLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLG 487 (611)
Q Consensus 408 ~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 487 (611)
+++.. ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++........ ......|
T Consensus 107 ~~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~ 179 (297)
T cd06659 107 DIVSQ--TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVG 179 (297)
T ss_pred HHHhh--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccceec
Confidence 98764 35899999999999999999999 78999999999999999999999999999876543221 1123458
Q ss_pred ccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-hcCCCCHHHHHHHHHHHhhcc
Q 035917 488 EFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-LCGKGYDEEILQFLKVACNCV 566 (611)
Q Consensus 488 t~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~~~l~~l~~~Cl 566 (611)
+..|+|||++.+..++.++|||||||++|||++|+.||.......... .......+. ......+..+.+++. +||
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~i~---~~l 255 (297)
T cd06659 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-RLRDSPPPKLKNAHKISPVLRDFLE---RML 255 (297)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHhccCCCCccccCCCCHHHHHHHH---HHh
Confidence 899999999988889999999999999999999998863210000000 000000000 011123344555555 999
Q ss_pred cCCCCCCCCHHHHHHH
Q 035917 567 VSRPKDRWSMYQVYQS 582 (611)
Q Consensus 567 ~~dP~~RPs~~evl~~ 582 (611)
+.+|++||++.+++++
T Consensus 256 ~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 256 TREPQERATAQELLDH 271 (297)
T ss_pred cCCcccCcCHHHHhhC
Confidence 9999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=295.20 Aligned_cols=245 Identities=21% Similarity=0.295 Sum_probs=193.7
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
+|...+.||+|++|.||++.. .+++.+|||.+.... ...+.+.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 366778999999999999985 468999999986532 2346789999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCC-CCeEEeecccccccCCCCC
Q 035917 401 MSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDED-FDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 401 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~-~~~kl~DFGla~~~~~~~~ 478 (611)
+++++|.+++.... ..+++..+..++.++++||.||| +.+++|+||||+||+++++ +.+||+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999997643 35899999999999999999999 7899999999999999854 4689999999987643321
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh--cCCCCHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL--CGKGYDEEIL 556 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~~~~ 556 (611)
. ....|+..|+|||.+.+..++.++||||||+++|+|++++.++........ ......... .....+.++.
T Consensus 158 ~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~ 230 (256)
T cd08220 158 A---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL----VLKIMSGTFAPISDRYSPDLR 230 (256)
T ss_pred c---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH----HHHHHhcCCCCCCCCcCHHHH
Confidence 1 123588899999999888899999999999999999999887632111000 000000000 1112334444
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+ ++.+||+.+|++|||+.|++++
T Consensus 231 ~---li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 231 Q---LILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred H---HHHHHccCChhhCCCHHHHhhC
Confidence 4 4459999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=300.59 Aligned_cols=249 Identities=20% Similarity=0.243 Sum_probs=192.2
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccch---hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKL---GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
+|...+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 5777899999999999999975 589999999854322 245688999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
+++++|.++.... ..++|..+..++.|+++||+||| +.+++|+||+|+||++++++.++|+|||+++...... .
T Consensus 82 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~ 155 (286)
T cd07846 82 VDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--E 155 (286)
T ss_pred CCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--c
Confidence 9999998876543 35899999999999999999999 7899999999999999999999999999998764322 1
Q ss_pred cccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHHH-----HHHhh-cCC----hhhhhc------
Q 035917 481 FVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDWV-----NQLSS-SGR----SKEAID------ 543 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~~-----~~~~~-~~~----~~~~~~------ 543 (611)
......++..|+|||++.+ ..++.++|||||||++|||++|+.++.... ..... ... .....+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 2223458899999998765 457889999999999999999987653110 00000 000 000000
Q ss_pred ----hhhc--------CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 544 ----KALC--------GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 544 ----~~l~--------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+... ....+ ..+.+++.+||+.+|++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLS---GLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccccccccCcchHHHhCCCcC---HHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000 01112 345556669999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=317.97 Aligned_cols=246 Identities=20% Similarity=0.311 Sum_probs=195.6
Q ss_pred CCCCCeeeecCCceEEEEEeCC-CCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 326 FCSENVIISTRTGTTYKAMLPD-GSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~~~-g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
|.+...||.|+||.||||+-++ +-..|.|.|.... ..-++|.-||+||..+.||+||+|++.|+.++..|+..|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 3344678999999999999654 4556778886543 3457899999999999999999999999999999999999999
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcccc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
|-...++-.-+..+...++..++.+++.||.||| +..|||||||..|||+.-+|.++|+|||.+...... .....
T Consensus 114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~qkRD 188 (1187)
T KOG0579|consen 114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQKRD 188 (1187)
T ss_pred chHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhH--Hhhhc
Confidence 9999888766667999999999999999999999 889999999999999999999999999987643221 11223
Q ss_pred CCCccccccccccc-----CCCCCCcccchHHHHHHHHHHhCCCCCHHHH--HHHHhhcCChhhhhchhh-cCCCCHHHH
Q 035917 484 GDLGEFGYIAPEYS-----STMVASLKGDVYGIGVVLLELAGFKGNLVDW--VNQLSSSGRSKEAIDKAL-CGKGYDEEI 555 (611)
Q Consensus 484 ~~~gt~~y~aPE~~-----~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~--~~~~~~~~~~~~~~~~~l-~~~~~~~~~ 555 (611)
++.||++|||||+. ...+|+.++||||||++|.||..+.+|-.+. ++-+. .+...-.|.+ .+..++..+
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVll---KiaKSePPTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL---KIAKSEPPTLLQPSHWSRSF 265 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHH---HHhhcCCCcccCcchhhhHH
Confidence 56799999999974 4578999999999999999999888774321 11111 0111111222 334456666
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+|++ +|+..||..||++.++++|
T Consensus 266 ~DfLk---~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 266 SDFLK---RCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHH---HHHhcCCccCCCHHHHhhC
Confidence 67766 9999999999999999876
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=297.47 Aligned_cols=249 Identities=20% Similarity=0.182 Sum_probs=197.6
Q ss_pred CCCCeeeecCCceEEEEEeCC-CCEEEEEeccccchh----HHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 327 CSENVIISTRTGTTYKAMLPD-GSVLAVKRLNTCKLG----EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 327 ~~~~~ig~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~----~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
...+.||.|.-|+||.+++.+ +..+|+|++.+.... ..+.+.|-+||+.++||.+..|++.+..+...||+||||
T Consensus 80 ~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyC 159 (459)
T KOG0610|consen 80 RLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYC 159 (459)
T ss_pred HHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecC
Confidence 334679999999999999754 689999999765433 245778999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC---
Q 035917 402 SSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD--- 477 (611)
Q Consensus 402 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~--- 477 (611)
+||+|..+++++. ..++...+.-++..|+-||+||| -.|||.|||||+|||+-++|.+.|+||.|+.......
T Consensus 160 pGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~ 236 (459)
T KOG0610|consen 160 PGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLV 236 (459)
T ss_pred CCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeee
Confidence 9999999988765 47999999999999999999999 8999999999999999999999999999876431100
Q ss_pred ----------------------------C-C----------------------ccccCCCcccccccccccCCCCCCccc
Q 035917 478 ----------------------------E-S----------------------SFVNGDLGEFGYIAPEYSSTMVASLKG 506 (611)
Q Consensus 478 ----------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~~~~t~ks 506 (611)
. . ....+.+||-.|.|||++.+...+.+.
T Consensus 237 ~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAV 316 (459)
T KOG0610|consen 237 KSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAV 316 (459)
T ss_pred ccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchh
Confidence 0 0 011235799999999999999999999
Q ss_pred chHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCC----HHHHHHH
Q 035917 507 DVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWS----MYQVYQS 582 (611)
Q Consensus 507 DV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~evl~~ 582 (611)
|.|+|||++|||+.|..||...- .+.....++...+.-...+.......+|+.+.|..||++|.. +.||-+|
T Consensus 317 DWWtfGIflYEmLyG~TPFKG~~----~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 317 DWWTFGIFLYEMLYGTTPFKGSN----NKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred hHHHHHHHHHHHHhCCCCcCCCC----chhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence 99999999999999999985421 111223333332222222222233444444999999999998 8898877
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=304.31 Aligned_cols=245 Identities=25% Similarity=0.303 Sum_probs=190.6
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
.|...+.||+|+||.||+|+.. +++.||+|.+.... ...+++.+|+++++.++||||+++.++|..++..++|||
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 4677789999999999999964 68999999985432 223568899999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
|++ |++.+++......+++..+..++.|++.||.||| ..+|+||||+|+||++++++.+||+|||++......
T Consensus 96 ~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 96 YCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred hhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 997 5888877654456899999999999999999999 789999999999999999999999999998765322
Q ss_pred ccccCCCcccccccccccC---CCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHH
Q 035917 480 SFVNGDLGEFGYIAPEYSS---TMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEIL 556 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 556 (611)
....|+..|+|||++. ...++.++||||||+++|||++|+.|+.......... .......+.......+++
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~-- 242 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNDSPTLSSNDWSDY-- 242 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH-HHhcCCCCCCCchhhCHH--
Confidence 1234788999999874 4568899999999999999999998763210000000 000000011111122334
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHH
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQSL 583 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~L 583 (611)
+.+++.+||+.+|++||++.+|+.+.
T Consensus 243 -~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 243 -FRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred -HHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 44555599999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=295.51 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=199.1
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
++|...+.||+|++|.||+|+.. +++.||||++.... ...+.+.+|+..+.+++|+||+++++++..++..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36778899999999999999965 59999999987643 2456799999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQ-PPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
+++++|.+++... ..+++..+..++.|+++|++||| + .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999999754 46899999999999999999999 7 99999999999999999999999999999876433221
Q ss_pred ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhh---chhhcCCCCHHHHH
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAI---DKALCGKGYDEEIL 556 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~---~~~l~~~~~~~~~~ 556 (611)
. ....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... .......... .+.......++.+.
T Consensus 157 ~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~ 233 (264)
T cd06623 157 C--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICDGPPPSLPAEEFSPEFR 233 (264)
T ss_pred c--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHhcCCCCCCCcccCCHHHH
Confidence 1 2235788999999998888999999999999999999998876332100 0000000011 11111111334455
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+++. +||+.+|++||++.|++++
T Consensus 234 ~li~---~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 234 DFIS---ACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHH---HHccCChhhCCCHHHHHhC
Confidence 5555 9999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=292.41 Aligned_cols=245 Identities=24% Similarity=0.355 Sum_probs=197.6
Q ss_pred CCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccch-hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 326 FCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKL-GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
|...+.||+|++|.||++... +++.|++|+++.... ..+.+.+|++++++++|+||+++++++...+..++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 667789999999999999975 689999999976543 456799999999999999999999999999999999999999
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcccc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
++|.+++......+++..+..++.+++.||.||| ..+++|+||+|+||++++++.++|+|||.+........ ..
T Consensus 82 ~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~ 155 (253)
T cd05122 82 GSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RN 155 (253)
T ss_pred CcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---cc
Confidence 9999998765457899999999999999999999 78999999999999999999999999999987654321 22
Q ss_pred CCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHH--HHHhhcCChhhhhchhhc-CCCCHHHHHHHHH
Q 035917 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWV--NQLSSSGRSKEAIDKALC-GKGYDEEILQFLK 560 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~--~~~~~~~~~~~~~~~~l~-~~~~~~~~~~l~~ 560 (611)
...|+..|+|||++.+..++.++||||||+++|+|++|+.|+.... ...... .....+... ....+.++.+++
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~i- 231 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI---ATNGPPGLRNPEKWSDEFKDFL- 231 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---HhcCCCCcCcccccCHHHHHHH-
Confidence 3358899999999988889999999999999999999988764320 000000 000000111 111134444544
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 035917 561 VACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 561 l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+||+.||++|||+.|++++
T Consensus 232 --~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 232 --KKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred --HHHccCChhhCCCHHHHhcC
Confidence 59999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=300.63 Aligned_cols=249 Identities=18% Similarity=0.220 Sum_probs=192.0
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
+|.....||+|++|.||+|+.. +|+.||+|++.... ...+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 5777889999999999999965 68999999986432 2235688999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
+++++|..+.... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 155 (286)
T cd07847 82 CDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-- 155 (286)
T ss_pred cCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--
Confidence 9998888776543 35899999999999999999999 78999999999999999999999999999987644321
Q ss_pred cccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHHH-----HHHhh--cCCh---hhhh-------
Q 035917 481 FVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDWV-----NQLSS--SGRS---KEAI------- 542 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~~-----~~~~~--~~~~---~~~~------- 542 (611)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..... .... .+..
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 1122357889999998765 557899999999999999999987763110 00000 0000 0000
Q ss_pred ---chhhc--------CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 543 ---DKALC--------GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 543 ---~~~l~--------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+... ....+ ..+.+++.+||+.+|++||++.|++.|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 236 GLSIPEPETREPLESKFPNIS---SPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccCCCcccccCHHHHhccCC---HHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000 00112 234556669999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=296.77 Aligned_cols=250 Identities=19% Similarity=0.213 Sum_probs=193.3
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
+|...+.||+|++|.||+|.. .+|+.||+|++.... ...+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 366778999999999999996 478999999986543 2346799999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
+ +++|.+++......+++..+..++.|+++||+||| +.+++|+||||+||+++.++.++|+|||++........ .
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R 155 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence 9 99999998765567999999999999999999999 78999999999999999999999999999987643321 1
Q ss_pred cccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHHHH------HHHHhhcCCh--------------h
Q 035917 481 FVNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLVDW------VNQLSSSGRS--------------K 539 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~~~------~~~~~~~~~~--------------~ 539 (611)
......|+..|+|||.+.+. .++.++||||+||++|||++|..++... .......+.. .
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence 12234689999999987654 4689999999999999999996554210 0000000000 0
Q ss_pred hhhchh-----h--cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 540 EAIDKA-----L--CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 540 ~~~~~~-----l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
....+. + .....+ ..+.+++.+|++.+|++||+++++++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 236 KITFPESKPIPLEEIFPDAS---PEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cccCCCCCcchHHHhCCCcc---HHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 0 001122 344555559999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=302.53 Aligned_cols=196 Identities=20% Similarity=0.291 Sum_probs=166.9
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
++|...+.||+|++|.||+|... +++.||||.+.... .....+.+|++++++++|+||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 46778899999999999999965 68999999986432 2234577899999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
+++ +|.+++......+++.....++.|+++||.||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-- 158 (291)
T cd07844 85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-- 158 (291)
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--
Confidence 985 999998765557899999999999999999999 78999999999999999999999999999875432111
Q ss_pred cccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCH
Q 035917 481 FVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNL 525 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~ 525 (611)
......++..|+|||++.+ ..++.++|||||||++|||++|+.+|
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~ 204 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF 204 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCC
Confidence 1122346889999998765 45789999999999999999998776
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=317.89 Aligned_cols=242 Identities=22% Similarity=0.277 Sum_probs=192.4
Q ss_pred CeeeecCCceEEEEEe-CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCChH
Q 035917 330 NVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLY 407 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL~ 407 (611)
-+||+|.||+||.|+. .+...+|||.+.... ...+-+..|+.+-+.++|.|||+++|.+..+++.-+.||-+|||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 3799999999999995 456779999996543 23355788999999999999999999999999889999999999999
Q ss_pred HhhhcCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC-CCCCeEEeecccccccCCCCCCccccC
Q 035917 408 SLLQGNATEL--DWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD-EDFDARIMDFGLAKLMTSSDESSFVNG 484 (611)
Q Consensus 408 ~~l~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld-~~~~~kl~DFGla~~~~~~~~~~~~~~ 484 (611)
++|...-+++ .+..+-.+.+||++||.||| ...|||||||-+|||++ -.|.+||+|||.++.+..- .....+
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TET 735 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTET 735 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccC--Cccccc
Confidence 9998776666 77888889999999999999 88999999999999997 5689999999999877432 222334
Q ss_pred CCcccccccccccCCC--CCCcccchHHHHHHHHHHhCCCCCHHHHHHH---HhhcCChhhhhchhhcCCCCHHHHHHHH
Q 035917 485 DLGEFGYIAPEYSSTM--VASLKGDVYGIGVVLLELAGFKGNLVDWVNQ---LSSSGRSKEAIDKALCGKGYDEEILQFL 559 (611)
Q Consensus 485 ~~gt~~y~aPE~~~~~--~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 559 (611)
+.||..|||||++..+ .|+..+|||||||++.||.||++||.+.-.. +..-+.. .+.|.+ ++..+.+.+.|+
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmy--KvHP~i-Peelsaeak~Fi 812 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMY--KVHPPI-PEELSAEAKNFI 812 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcce--ecCCCC-cHHHHHHHHHHH
Confidence 5699999999998654 4889999999999999999999998653111 1111110 011111 122334555555
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 035917 560 KVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 560 ~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
. +|+.+||.+||++.++++.
T Consensus 813 l---rcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 813 L---RCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred H---HHcCCCcccCccHHHhccC
Confidence 5 9999999999999999864
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=299.15 Aligned_cols=248 Identities=21% Similarity=0.266 Sum_probs=191.6
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeC--CeeEEEEe
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE--EEKLLIYK 399 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~--~~~~lv~e 399 (611)
+|...+.||.|++|.||++.. .+++.||+|.+.... ....++.+|++++++++||||++++++|... +..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 566778999999999999997 468999999986533 2346789999999999999999999998654 46799999
Q ss_pred ccCCCChHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 400 YMSSGTLYSLLQG---NATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 400 y~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
|+++++|.+++.. ....+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999988753 2246889999999999999999999 789999999999999999999999999998765322
Q ss_pred CCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHH---------HHhhcCChhhhhchhhc
Q 035917 477 DESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVN---------QLSSSGRSKEAIDKALC 547 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~---------~~~~~~~~~~~~~~~l~ 547 (611)
.. ....++..|+|||.+.+..++.++|||||||++|||++|+.|+..-.. ............+....
T Consensus 159 ~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd06621 159 LA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234 (287)
T ss_pred cc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCC
Confidence 11 123478899999999888899999999999999999999887642100 00000000000000000
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 548 GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 548 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
....+++ +.+++.+||+.+|++|||+.|++++
T Consensus 235 ~~~~~~~---~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 235 GIKWSEE---FKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CCchHHH---HHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0112334 4455559999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=298.12 Aligned_cols=247 Identities=21% Similarity=0.303 Sum_probs=194.2
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEecccc--chhHHHHHHHHHHHhccC---CCCccceeeEEEeCCeeEEEE
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTC--KLGEKKFRNEMNRLGQLR---HPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~~~Ev~~l~~l~---H~nIv~l~g~~~~~~~~~lv~ 398 (611)
.|+..+.||+|+||.||+|.. .+++.||+|.++.. ....+++.+|+.++++++ |||++++++++..++..++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 466678999999999999995 57899999998643 233467889999999997 999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++++|.+++... .+++.....++.+++.||.||| +.+|+|+||+|+||++++++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 999999999998653 6899999999999999999999 88999999999999999999999999999987654321
Q ss_pred CccccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQ 557 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 557 (611)
......|+..|+|||.+.++ .++.++|||||||++|+|++|..|+......... ........+.+.....+.+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~--- 230 (277)
T cd06917 157 --KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-MLIPKSKPPRLEDNGYSKL--- 230 (277)
T ss_pred --ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh-hccccCCCCCCCcccCCHH---
Confidence 12233588999999987654 4689999999999999999999887431110000 0000001111211123334
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+.+++.+||+.||++||++.|++++
T Consensus 231 ~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 231 LREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhhC
Confidence 4455559999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=316.56 Aligned_cols=246 Identities=19% Similarity=0.278 Sum_probs=196.1
Q ss_pred CCeeeecCCceEEEEEeCC--CC--EEEEEeccccchh--HHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccC
Q 035917 329 ENVIISTRTGTTYKAMLPD--GS--VLAVKRLNTCKLG--EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 329 ~~~ig~G~~g~Vy~~~~~~--g~--~vAvK~~~~~~~~--~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
.++||+|.||.|++|.|.. |+ .||||.++..... ..+|++|+.+|.+|+|||+++|||+..+ ....+|||+++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 4689999999999999753 44 6899999876543 4789999999999999999999999987 66889999999
Q ss_pred CCChHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 403 SGTLYSLLQGN-ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 403 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
.|+|.+.|++. ...+-......++.|||.||.||. .+++|||||..+|+|+.....+||+||||.+.+...+....
T Consensus 194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 99999999873 346777888899999999999999 89999999999999999999999999999999876654433
Q ss_pred ccC-CCcccccccccccCCCCCCcccchHHHHHHHHHHhCC-CCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHH
Q 035917 482 VNG-DLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGF-KGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFL 559 (611)
Q Consensus 482 ~~~-~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 559 (611)
+.. ..-.+.|.|||.+...+++.++|||+|||++|||+++ +.|+...-.. .+.+.+|...+-.....+..++.
T Consensus 271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~-----qIL~~iD~~erLpRPk~csedIY 345 (1039)
T KOG0199|consen 271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI-----QILKNIDAGERLPRPKYCSEDIY 345 (1039)
T ss_pred ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-----HHHHhccccccCCCCCCChHHHH
Confidence 322 2346789999999999999999999999999999964 5565431100 12223332222222233444566
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHH
Q 035917 560 KVACNCVVSRPKDRWSMYQVYQSL 583 (611)
Q Consensus 560 ~l~~~Cl~~dP~~RPs~~evl~~L 583 (611)
+|++.||..+|.+|||+..|.+.+
T Consensus 346 ~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 346 QIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHHHhccCCccccccHHHHHHhH
Confidence 666699999999999999998553
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=297.08 Aligned_cols=245 Identities=20% Similarity=0.265 Sum_probs=194.0
Q ss_pred CCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccC
Q 035917 326 FCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
|...+.||+|+||.||+|.. .+++.||+|.+.... ...+.+.+|+.++.+++||||+++++++..++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 55667899999999999985 468999999986432 234578999999999999999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccc
Q 035917 403 SGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482 (611)
Q Consensus 403 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 482 (611)
+++|.+++... .+++..+..++.+++.|+.||| +.+++|+||||+||+++.++.++|+|||++..+..... ..
T Consensus 86 ~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~ 158 (277)
T cd06641 86 GGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KR 158 (277)
T ss_pred CCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh--hh
Confidence 99999998643 5899999999999999999999 88999999999999999999999999999876543221 11
Q ss_pred cCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHH
Q 035917 483 NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVA 562 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~ 562 (611)
....|+..|+|||.+.+..++.++|||||||++|||++|..|+........... ......+.+ ....+.++.+ ++
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~---~i 233 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL-IPKNNPPTL-EGNYSKPLKE---FV 233 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH-HhcCCCCCC-CcccCHHHHH---HH
Confidence 223578899999999888889999999999999999999988643111100000 000000111 1122344444 45
Q ss_pred hhcccCCCCCCCCHHHHHHH
Q 035917 563 CNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 563 ~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+||+.+|++||++.+++++
T Consensus 234 ~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 234 EACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHccCChhhCcCHHHHHhC
Confidence 59999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=337.94 Aligned_cols=252 Identities=19% Similarity=0.202 Sum_probs=192.1
Q ss_pred HhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeC--Cee
Q 035917 321 AASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE--EEK 394 (611)
Q Consensus 321 ~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~--~~~ 394 (611)
...+.|...+.||+|+||.||+|+. .++..||+|.+.... .....|..|+.++.+++|||||++++++... ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3446788889999999999999995 457899999986432 2346789999999999999999999988653 568
Q ss_pred EEEEeccCCCChHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcC----CCCeeecCCCCCeEEeCC---------
Q 035917 395 LLIYKYMSSGTLYSLLQGN---ATELDWPTRFRIGLGAARGLAWLHHGC----QPPFLHQNICSNVILVDE--------- 458 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~ivHrDlkp~NILld~--------- 458 (611)
++||||+++|+|.+++... ...+++..++.|+.||+.||+|||... ..+|+||||||+|||++.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 8999999999999998643 236999999999999999999999421 146999999999999964
Q ss_pred --------CCCeEEeecccccccCCCCCCccccCCCcccccccccccCC--CCCCcccchHHHHHHHHHHhCCCCCHHHH
Q 035917 459 --------DFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSST--MVASLKGDVYGIGVVLLELAGFKGNLVDW 528 (611)
Q Consensus 459 --------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SfGvvl~ell~~~~~~~~~ 528 (611)
...+||+|||+++.+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 33589999999987643221 123469999999998854 45889999999999999999999987421
Q ss_pred HHHHhhcCChhhhh--chhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 529 VNQLSSSGRSKEAI--DKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 529 ~~~~~~~~~~~~~~--~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.... .....+ .+.+.....+.++.+++. .||+.+|.+||++.|++.+
T Consensus 247 ~~~~----qli~~lk~~p~lpi~~~S~eL~dLI~---~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 247 NNFS----QLISELKRGPDLPIKGKSKELNILIK---NLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CcHH----HHHHHHhcCCCCCcCCCCHHHHHHHH---HHhcCChhHCcCHHHHhcc
Confidence 0000 000000 011111223445555554 9999999999999999954
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=343.08 Aligned_cols=255 Identities=26% Similarity=0.321 Sum_probs=207.1
Q ss_pred HHhhhcCCCCCeeeecCCceEEEEE-eCCCCEEEEEeccccch---hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeE
Q 035917 320 MAASNSFCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCKL---GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395 (611)
Q Consensus 320 ~~~t~~f~~~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~~---~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~ 395 (611)
...+-+|..+.+||.|.||.||-|. .++|...|||-++-... ..+...+|+.++..|+|||+|+++|+-..++..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 3455678889999999999999999 67899999998865432 2356789999999999999999999999999999
Q ss_pred EEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
|.||||++|+|.+.+... ...++.....+..|++.|++||| +.+||||||||+||+|+.+|.+|++|||.|..+..
T Consensus 1311 IFMEyC~~GsLa~ll~~g-ri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHG-RIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHHHhccCcHHHHHHhc-chhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecC
Confidence 999999999999998633 34677777788899999999999 89999999999999999999999999999987754
Q ss_pred CC--CCccccCCCcccccccccccCCCC---CCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCC
Q 035917 476 SD--ESSFVNGDLGEFGYIAPEYSSTMV---ASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKG 550 (611)
Q Consensus 476 ~~--~~~~~~~~~gt~~y~aPE~~~~~~---~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 550 (611)
.. .........||+.|||||++.+.. ...++||||+|||++||+||+.|+.+..........+...-.|.+. ..
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P-~~ 1465 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIP-ER 1465 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCc-hh
Confidence 42 122345568999999999987643 4567999999999999999999987543322222222222233332 23
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 551 YDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 551 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+.+-++|++ +|++.||+.|.++.|++++
T Consensus 1466 ls~~g~dFle---~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1466 LSSEGRDFLE---HCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hhHhHHHHHH---HHHhcCchhhhHHHHHHHh
Confidence 6778889999 9999999999999888776
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=301.70 Aligned_cols=251 Identities=20% Similarity=0.236 Sum_probs=191.2
Q ss_pred CCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccchh------HHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 326 FCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLG------EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~------~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
|...+.||+|++|.||+|... +++.||||.++..... ...+.+|++++.+++|+||+++++++.+.+..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 666789999999999999964 6899999999654322 345788999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+ +|+|.+++......+++..+..++.|+++||.||| ..+++|+||||+||+++.++.+||+|||+++.......
T Consensus 82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 999 88999999765446999999999999999999999 78999999999999999999999999999987643321
Q ss_pred CccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhc-CC-----------hhh
Q 035917 479 SSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSS-GR-----------SKE 540 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~-~~-----------~~~ 540 (611)
......+++.|+|||.+.+ ..++.++|||||||++|||++|..++..- ....... .. ...
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 158 --KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred --cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 1222346788999998754 45789999999999999999986544210 0000000 00 000
Q ss_pred hhchhhcCCC-----CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 541 AIDKALCGKG-----YDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 541 ~~~~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.......... .......+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000 01112345556669999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=304.84 Aligned_cols=248 Identities=21% Similarity=0.223 Sum_probs=196.2
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccch----hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKL----GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~----~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
+|...+.||+|++|.||+|... +++.||+|.+..... ..+.+.+|++++.+++||||+++++++...+..++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5777889999999999999965 589999999965432 33568999999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 400 YMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 400 y~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
|+.+++|.+++.... ..+++..+..++.|+++||+||| ..+++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999999999987543 46899999999999999999999 78999999999999999999999999999876532211
Q ss_pred C---------------------------ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHH
Q 035917 479 S---------------------------SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQ 531 (611)
Q Consensus 479 ~---------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~ 531 (611)
. .......||..|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0 0111235889999999998888999999999999999999999887421111
Q ss_pred HhhcCChhhhhchhhcCC---CCHHHHHHHHHHHhhcccCCCCCCCC----HHHHHHH
Q 035917 532 LSSSGRSKEAIDKALCGK---GYDEEILQFLKVACNCVVSRPKDRWS----MYQVYQS 582 (611)
Q Consensus 532 ~~~~~~~~~~~~~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~evl~~ 582 (611)
. ...+..+...... ..++++.++++ +||+.||++||+ +.|++++
T Consensus 239 ~----~~~~~~~~~~~~~~~~~~~~~~~~li~---~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 239 E----TFSNILKKEVTFPGSPPVSSSARDLIR---KLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred H----HHHHHhcCCccCCCccccCHHHHHHHH---HHccCCHhHCCCchhhHHHHHcC
Confidence 0 0111111111111 12445555555 999999999999 7777775
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=301.32 Aligned_cols=248 Identities=19% Similarity=0.268 Sum_probs=195.7
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
++|...+.||+|+||.||++.. .+++.||+|.+.... ...+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5677788999999999999985 468899999986432 33467899999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
++++|.+++.+. .+++..+..++.+++.||.||| +.+++|+||||+||+++.++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~ 171 (293)
T cd06647 99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K 171 (293)
T ss_pred CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--c
Confidence 999999998753 4789999999999999999999 88999999999999999999999999999876543321 1
Q ss_pred ccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHHHHHHH
Q 035917 482 VNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEILQFLK 560 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~~ 560 (611)
.....|++.|+|||.+....++.++|||||||++||+++|+.||.......... .....-.+.. .....+.. +.+
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~---l~~ 247 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNPEKLSAI---FRD 247 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-ehhcCCCCCCCCccccCHH---HHH
Confidence 122358889999999988889999999999999999999998874211000000 0000000000 01112233 444
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 035917 561 VACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 561 l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++.+||+.+|++||++.+++.|
T Consensus 248 li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 248 FLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHHHHccCChhhCcCHHHHhcC
Confidence 5559999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=297.76 Aligned_cols=249 Identities=20% Similarity=0.270 Sum_probs=190.0
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccch---hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKL---GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
+|...+.||+|++|.||+|+.. +|+.||||+++.... ..+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4777889999999999999964 689999999864322 235788999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 401 MSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 401 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
+. ++|.+++.... ..+++..+..++.++++||+||| ..+++|+||+|+||++++++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 96 58998886543 46899999999999999999999 78999999999999999999999999999876543221
Q ss_pred ccccCCCcccccccccccCCCC-CCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhh-cCChhhhhch--------
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMV-ASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSS-SGRSKEAIDK-------- 544 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~-~~~~~~~~~~-------- 544 (611)
......++..|+|||++.+.. ++.++|||||||++|||++|+.||.. ....... .+.......+
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 112234788999999876644 58899999999999999999877621 1111000 0000000000
Q ss_pred -----hhc-------CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 545 -----ALC-------GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 545 -----~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
... ....+.++ .+++.+||+.||++|||+.|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~---~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDG---RDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HhhcccccccCHHHHcccCCHHH---HHHHHHhcCCCcccCCCHHHHhcC
Confidence 000 01122333 445559999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=313.87 Aligned_cols=190 Identities=22% Similarity=0.294 Sum_probs=169.0
Q ss_pred cCCCCCeeeecCCceEEEEE-eCCCCEEEEEeccccchhHHHHHHHHHHHhccC-C-----CCccceeeEEEeCCeeEEE
Q 035917 325 SFCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLR-H-----PNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~-H-----~nIv~l~g~~~~~~~~~lv 397 (611)
.|.+.++||+|.||.|-||. ..+++.||||+++....-..+-..|+.+|..|+ | -|+|++++|+...++.|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 67888999999999999999 467999999999887766777889999999997 4 3899999999999999999
Q ss_pred EeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCC--CCeEEeecccccccC
Q 035917 398 YKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDED--FDARIMDFGLAKLMT 474 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~--~~~kl~DFGla~~~~ 474 (611)
+|.+.. +|+++++.+. ..++...+..++.||+.||.+|| +.+|||+||||+||||.+. ..+||+|||.|....
T Consensus 267 fELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred ehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 999976 9999999776 47999999999999999999999 8999999999999999643 379999999998764
Q ss_pred CCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCC
Q 035917 475 SSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKG 523 (611)
Q Consensus 475 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~ 523 (611)
..-. ..+-+..|+|||++.+.+|+.+.||||||||+.||++|..
T Consensus 343 q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~P 386 (586)
T KOG0667|consen 343 QRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEP 386 (586)
T ss_pred Ccce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcc
Confidence 3221 3456789999999999999999999999999999998854
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=293.30 Aligned_cols=250 Identities=27% Similarity=0.321 Sum_probs=195.1
Q ss_pred CCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch---hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 326 FCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL---GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
|...+.||+|+||.||+|.. .+++.||+|.++.... ..+.+.+|+.++++++|+||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 66778999999999999996 4789999999875443 3567899999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
++++|.+++... ..+++..+..++.+++.||.||| +.+++|+||+|+||++++++.+||+|||++...........
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 82 SGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 999999999754 34789999999999999999999 78999999999999999999999999999987643322111
Q ss_pred --ccCCCcccccccccccCCCC---CCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcC-CCCHHHH
Q 035917 482 --VNGDLGEFGYIAPEYSSTMV---ASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCG-KGYDEEI 555 (611)
Q Consensus 482 --~~~~~gt~~y~aPE~~~~~~---~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~ 555 (611)
.....++..|+|||++.+.. ++.++||||||+++||+++|..||..................+.+.. ...+..+
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEG 237 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHH
Confidence 12345788999999987766 88999999999999999999988742100000000000000111111 1113444
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+++ .+||+.+|++||++.|++.+
T Consensus 238 ~~li---~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 238 KDFL---DRCLESDPKKRPTASELLQH 261 (264)
T ss_pred HHHH---HHHccCCcccCCCHHHHhcC
Confidence 4444 49999999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=294.97 Aligned_cols=246 Identities=19% Similarity=0.278 Sum_probs=193.9
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
+|...+.||+|+||.||+|... +|..||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 3667789999999999999964 58999999986532 2345788999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC-CeEEeecccccccCCCCC
Q 035917 401 MSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF-DARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 401 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~-~~kl~DFGla~~~~~~~~ 478 (611)
+++++|.+++.... ..+++..+..++.++++||.||| +.+++|+||||+||++++++ .+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999987543 35899999999999999999999 78999999999999998875 569999999987643221
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh--cCCCCHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL--CGKGYDEEIL 556 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~~~~ 556 (611)
......|++.|+|||+..+..++.++|||||||++|||++|..|+....... ...+...... .....+.++.
T Consensus 158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 231 (257)
T cd08225 158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ----LVLKICQGYFAPISPNFSRDLR 231 (257)
T ss_pred --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH----HHHHHhcccCCCCCCCCCHHHH
Confidence 1122358899999999988889999999999999999999988763210000 0001111111 0112234445
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+++ .+||..+|++|||+.|++++
T Consensus 232 ~~i---~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 232 SLI---SQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHH---HHHhccChhhCcCHHHHhhC
Confidence 544 49999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=299.43 Aligned_cols=243 Identities=19% Similarity=0.232 Sum_probs=195.9
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|++|.||++... +++.||+|.+.... ...+.+.+|++++++++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 35777899999999999999964 68999999986532 22356889999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++++|.+++... ..+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999999999998755 46899999999999999999999 789999999999999999999999999999876433
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-hcCCCCHHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-LCGKGYDEEILQ 557 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~~~ 557 (611)
.....|++.|+|||.+.+...+.++||||||+++|||++|+.|+........ ........ ......+..+.+
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~ 227 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI----YEKILEGKVRFPSFFSPDAKD 227 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCCccCCccCCHHHHH
Confidence 1223588999999999888889999999999999999999988632110000 00011100 111223455555
Q ss_pred HHHHHhhcccCCCCCCC-----CHHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRW-----SMYQVYQS 582 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RP-----s~~evl~~ 582 (611)
+++ +||+.||++|| +++|+++|
T Consensus 228 li~---~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 228 LIR---NLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred HHH---HHccCCHHHccCcccCCHHHHHcC
Confidence 555 99999999999 78888766
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=290.61 Aligned_cols=248 Identities=24% Similarity=0.307 Sum_probs=197.8
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeC--CeeEEEE
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE--EEKLLIY 398 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~--~~~~lv~ 398 (611)
+|...+.||+|++|.||+|... +++.|++|++.... ...+.+.+|+.++++++||||+++++++... +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999965 79999999986544 3356789999999999999999999999988 8899999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++++|.+++.... .+++..+..++.+++.||+||| +.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999987654 7899999999999999999999 78999999999999999999999999999987654332
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHH---HHHhhcCChhhhhchhhcCCCCHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWV---NQLSSSGRSKEAIDKALCGKGYDEEI 555 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~~~~~~~~ 555 (611)
........++..|+|||...+..++.++||||||+++++|++|..|+.... ........ ... .+. .....+.++
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~-~~~-~~~~~~~~l 233 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS-SGE-PPE-IPEHLSEEA 233 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc-cCC-CcC-CCcccCHHH
Confidence 111223458899999999988889999999999999999999988763311 00000000 000 000 111223444
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+ ++.+|++.+|++||++.|++++
T Consensus 234 ~~---~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 234 KD---FLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HH---HHHHhCcCChhhCCCHHHHhhC
Confidence 44 4559999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=299.25 Aligned_cols=196 Identities=24% Similarity=0.265 Sum_probs=167.0
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccchh---HHHHHHHHHHHhccCCCCccceeeEEEeC--CeeEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLG---EKKFRNEMNRLGQLRHPNLAPLLGYCVVE--EEKLLI 397 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~---~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~--~~~~lv 397 (611)
++|...+.||+|+||.||+|... +++.||+|.++..... ...+.+|+.++.+++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46777889999999999999965 6899999999654322 24577899999999999999999999887 889999
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
|||+++ +|.+++......+++..+..++.|++.||+||| ..+++|+||||+||+++.++.+||+|||+++......
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 999975 999988765556899999999999999999999 7899999999999999999999999999998764432
Q ss_pred CCccccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCH
Q 035917 478 ESSFVNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNL 525 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~ 525 (611)
.......+++.|+|||.+.+. .++.++||||||+++|||++|..+|
T Consensus 161 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f 207 (293)
T cd07843 161 --KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLF 207 (293)
T ss_pred --cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCC
Confidence 112233578899999988654 4689999999999999999998765
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=301.36 Aligned_cols=248 Identities=23% Similarity=0.294 Sum_probs=192.8
Q ss_pred CCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 326 FCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
|...+.||+|+||.||+|+. .++..||+|.+.... ...+.+.+|++++++++|||++++++++..++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 55567899999999999995 468999999986432 1235688999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
++ |+|.+.+......++|..+..++.+++.||.||| ..+|+||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 97 5888887655557999999999999999999999 789999999999999999999999999998754321
Q ss_pred cccCCCcccccccccccC---CCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHH
Q 035917 481 FVNGDLGEFGYIAPEYSS---TMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQ 557 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 557 (611)
....|+..|+|||++. .+.++.++|||||||++|||++|+.|+.......... .......+.......++.+.+
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~ 255 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPTLQSNEWSDYFRN 255 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH-HHHhccCCCCCCccccHHHHH
Confidence 1235888999999873 4568899999999999999999998863211000000 000000011111223344455
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHHHch
Q 035917 558 FLKVACNCVVSRPKDRWSMYQVYQSLNSIA 587 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 587 (611)
++.+||+.+|.+||++.++++++..+.
T Consensus 256 ---li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 256 ---FVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ---HHHHHccCCcccCcCHHHHHhChhhhc
Confidence 444999999999999999999865544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=299.30 Aligned_cols=199 Identities=20% Similarity=0.255 Sum_probs=164.8
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCC------
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE------ 392 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~------ 392 (611)
.++|...+.||+|+||.||+|+. .+++.||||.+.... .....+.+|++++++++||||++++++|...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 34688889999999999999995 469999999985432 22345678999999999999999999987654
Q ss_pred --eeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccc
Q 035917 393 --EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLA 470 (611)
Q Consensus 393 --~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla 470 (611)
..++||||+.+ +|.+++......+++..+..++.|+++||+||| +.+++|+||||+||+++.++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 34999999975 898888765456899999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCC--ccccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCH
Q 035917 471 KLMTSSDES--SFVNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNL 525 (611)
Q Consensus 471 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~ 525 (611)
......... .......++..|+|||.+.+. .++.++||||||+++|||++|..++
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~ 224 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIM 224 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCC
Confidence 866432211 112234578899999987654 4688999999999999999987665
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=297.48 Aligned_cols=246 Identities=18% Similarity=0.269 Sum_probs=192.5
Q ss_pred CCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 326 FCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
|...+.||+|++|.||++.. .+++.||+|+++... ...+.+.+|+.+++.++||||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457999999999999995 578999999986433 2345688999999999999999999999999999999999999
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcccc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
++|.+++.. ..+++..+..++.+++.||+||| +.+++||||+|+||+++.++.++|+|||++........ ...
T Consensus 101 ~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~ 173 (285)
T cd06648 101 GALTDIVTH--TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRK 173 (285)
T ss_pred CCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccc
Confidence 999999876 35899999999999999999999 78999999999999999999999999998876533221 112
Q ss_pred CCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhc-CCCCHHHHHHHHHHH
Q 035917 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALC-GKGYDEEILQFLKVA 562 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~l~~l~ 562 (611)
...|+..|+|||...+..++.++|||||||++|||++|+.|+..-....... .......+... ....+..+ .+++
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l---~~li 249 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK-RIRDNLPPKLKNLHKVSPRL---RSFL 249 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH-HHHhcCCCCCcccccCCHHH---HHHH
Confidence 2458899999999988889999999999999999999988763210000000 00000011111 11123344 4455
Q ss_pred hhcccCCCCCCCCHHHHHHH
Q 035917 563 CNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 563 ~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+||+.+|++||++.+++++
T Consensus 250 ~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 250 DRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred HHHcccChhhCcCHHHHccC
Confidence 59999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=297.72 Aligned_cols=253 Identities=20% Similarity=0.198 Sum_probs=192.5
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
+|...+.||+|++|.||+|... +++.||||+++... ...+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5777889999999999999965 58899999986532 2346789999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
++++.+..+... ...+++..+..++.+++.||.||| ..+++|+||+|+||++++++.+||+|||++........ .
T Consensus 82 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~ 156 (288)
T cd07833 82 VERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-S 156 (288)
T ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-c
Confidence 998766655543 345899999999999999999999 78999999999999999999999999999987654322 1
Q ss_pred cccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhh---------------cCChh
Q 035917 481 FVNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSS---------------SGRSK 539 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~---------------~~~~~ 539 (611)
......++..|+|||++.+. .++.++||||||+++|||++|+.++... ...... .....
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 12234578899999998887 7899999999999999999998765310 000000 00000
Q ss_pred -----hhhchhh-cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 540 -----EAIDKAL-CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 540 -----~~~~~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+..++.. ...........+.+++.+||..+|++||++++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000000 000000012345556669999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=298.75 Aligned_cols=240 Identities=20% Similarity=0.231 Sum_probs=182.2
Q ss_pred eeeecCCceEEEEEe-CCCCEEEEEeccccch----hHHHHHHHHHHHh---ccCCCCccceeeEEEeCCeeEEEEeccC
Q 035917 331 VIISTRTGTTYKAML-PDGSVLAVKRLNTCKL----GEKKFRNEMNRLG---QLRHPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 331 ~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ev~~l~---~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
+||+|+||.||++.. .+++.||+|.+..... ....+.+|..++. ..+||||+.+.+++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999996 4689999998864321 1233445554433 3479999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccc
Q 035917 403 SGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482 (611)
Q Consensus 403 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 482 (611)
+|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~---- 152 (279)
T cd05633 81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---- 152 (279)
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc----
Confidence 99999988754 35899999999999999999999 78999999999999999999999999999875532211
Q ss_pred cCCCcccccccccccC-CCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhc-CChhhhhchhhcCCCCHHHHHHHHH
Q 035917 483 NGDLGEFGYIAPEYSS-TMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSS-GRSKEAIDKALCGKGYDEEILQFLK 560 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~-~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~~~~~~~~l~~ 560 (611)
....|+..|+|||.+. +..++.++|||||||++|||++|..||.......... ..........+ ....+.++.++++
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~ 231 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVEL-PDSFSPELKSLLE 231 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCC-ccccCHHHHHHHH
Confidence 2235899999999886 4568899999999999999999998874311000000 00000001111 1223445555555
Q ss_pred HHhhcccCCCCCCC-----CHHHHHHH
Q 035917 561 VACNCVVSRPKDRW-----SMYQVYQS 582 (611)
Q Consensus 561 l~~~Cl~~dP~~RP-----s~~evl~~ 582 (611)
+|++.||++|| +++|+++|
T Consensus 232 ---~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 232 ---GLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ---HHhcCCHHHhcCCCCCCHHHHHhC
Confidence 99999999999 69999887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=300.58 Aligned_cols=249 Identities=20% Similarity=0.290 Sum_probs=205.2
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
+.|..-.+||+|+||.||-++. .+|+.+|.|++.+.. .+....++|-.+|.+++.+.||.+--.|..++..|+|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 4577789999999999999995 469999999986532 34456789999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 399 KYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
..|.||||.-++...+ ..+++..+..++.+|+.||++|| ..+||.||+||+|||+|+.|+++|+|+|+|..+....
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 9999999988887665 36999999999999999999999 8999999999999999999999999999999876544
Q ss_pred CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhh--hchhhcCCCCHHHH
Q 035917 478 ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEA--IDKALCGKGYDEEI 555 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~~~~~~~~ 555 (611)
. ..+.+||.+|||||++..+.|+...|.||+||++|||+.|+.||...-..... ..+... -++...++..+++.
T Consensus 342 ~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~-eEvdrr~~~~~~ey~~kFS~ea 417 (591)
T KOG0986|consen 342 P---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR-EEVDRRTLEDPEEYSDKFSEEA 417 (591)
T ss_pred c---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH-HHHHHHHhcchhhcccccCHHH
Confidence 2 34458999999999999999999999999999999999999999653222111 011111 12222335567788
Q ss_pred HHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 035917 556 LQFLKVACNCVVSRPKDRW-----SMYQVYQS 582 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 582 (611)
+.+.+ ..++.||++|. .+++|.+|
T Consensus 418 kslc~---~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 418 KSLCE---GLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred HHHHH---HHHccCHHHhccCCCcCcchhhhC
Confidence 88877 88999999998 45666655
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=296.01 Aligned_cols=245 Identities=21% Similarity=0.219 Sum_probs=194.3
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
+|...+.||.|+||.||+|+.. +++.||+|.+.... ...+.+.+|++++++++||||+++++++..++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4677789999999999999965 58999999996532 234678999999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
|+++++|.+++... ..+++..+..++.++++||.||| ..+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999999755 46899999999999999999999 7899999999999999999999999999988654332
Q ss_pred ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc--hhhcCCCCHHHHHH
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID--KALCGKGYDEEILQ 557 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~ 557 (611)
......|+..|+|||.+.+..++.++||||||+++|+|++|..|+....... ......... ........+..+.+
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI--RDQIRAKQETADVLYPATWSTEAID 231 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH--HHHHHHHhccccccCcccCcHHHHH
Confidence 1223458889999999988889999999999999999999998864321000 000000000 01111223344444
Q ss_pred HHHHHhhcccCCCCCCCCH--HHHHH
Q 035917 558 FLKVACNCVVSRPKDRWSM--YQVYQ 581 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~--~evl~ 581 (611)
++.+||+.||.+||++ +|+++
T Consensus 232 ---~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 232 ---AINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ---HHHHHccCChhHcCCccHHHHhc
Confidence 5559999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=303.10 Aligned_cols=276 Identities=19% Similarity=0.220 Sum_probs=200.0
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEe----CCee
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVV----EEEK 394 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~----~~~~ 394 (611)
.++|...+.||+|++|.||+|+. .+|+.||+|++.... ...+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 36788889999999999999995 469999999986532 234567889999999999999999998763 3467
Q ss_pred EEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccC
Q 035917 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~ 474 (611)
++||||+. |+|.+++... ..+++..+..++.|++.||+||| ..+|+||||||+||++++++.+||+|||+++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 99999996 5899988654 35899999999999999999999 7899999999999999999999999999998654
Q ss_pred CCCC--CccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHHH-----HHHh-------------
Q 035917 475 SSDE--SSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDWV-----NQLS------------- 533 (611)
Q Consensus 475 ~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~~-----~~~~------------- 533 (611)
.... ........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 3221 111223468899999998755 468899999999999999999988763210 0000
Q ss_pred -hcCChhhhhchhh-cC--------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCCCCCCCCccccc
Q 035917 534 -SSGRSKEAIDKAL-CG--------KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFSERYDEFPLIF 603 (611)
Q Consensus 534 -~~~~~~~~~~~~l-~~--------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~~ 603 (611)
......+..+... .. ...++ .+.+++.+||+.+|++||++.+++.+----.......+.....|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 315 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASP---EALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTCPPPFDF 315 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCH---HHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccccCCCCCCC
Confidence 0000000000000 00 11233 34455559999999999999999987432222222323334444444
Q ss_pred ccC
Q 035917 604 HRQ 606 (611)
Q Consensus 604 ~~~ 606 (611)
+.+
T Consensus 316 ~~~ 318 (334)
T cd07855 316 DFE 318 (334)
T ss_pred Chh
Confidence 433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=303.69 Aligned_cols=258 Identities=18% Similarity=0.252 Sum_probs=192.3
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEecccc--chhHHHHHHHHHHHhccCCCCccceeeEEEeCC-----ee
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTC--KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE-----EK 394 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~-----~~ 394 (611)
+++|...+.||+|+||.||+|+. .+|+.||+|.+... .....++.+|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46788899999999999999985 57899999998642 223456889999999999999999999876543 57
Q ss_pred EEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccC
Q 035917 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~ 474 (611)
++++||+++ +|.+++... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~lv~e~~~~-~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEehhccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 899999975 888887643 5899999999999999999999 7899999999999999999999999999998654
Q ss_pred CCCC-CccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHH-----HH---HHHhhcCC---hhhh
Q 035917 475 SSDE-SSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVD-----WV---NQLSSSGR---SKEA 541 (611)
Q Consensus 475 ~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~---~~~~~~~~---~~~~ 541 (611)
.... ........|+..|+|||.+.+ ..++.++|||||||++|||++|+.+|.. .. ........ ....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 3221 112223468999999998654 5688999999999999999999877631 00 00000000 0000
Q ss_pred hchh-------hc--CCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHc
Q 035917 542 IDKA-------LC--GKGY-----DEEILQFLKVACNCVVSRPKDRWSMYQVYQS--LNSI 586 (611)
Q Consensus 542 ~~~~-------l~--~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i 586 (611)
.+.. .. .... +.....+.+++.+||+.||++|||+.|+++| ++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 0000 00 0000 0011235556669999999999999999998 5543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=297.40 Aligned_cols=247 Identities=19% Similarity=0.315 Sum_probs=189.9
Q ss_pred hcCCCCCeeeecCCceEEEEEeCC-CCEEEEEeccccc--hhHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeEEEEe
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPD-GSVLAVKRLNTCK--LGEKKFRNEMNRLGQLR-HPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~-g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~~~~~lv~e 399 (611)
++|...+.||+|++|.||+|...+ ++.||||.++... ....++..|+.++.+.. ||||+++++++..+...+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 456778999999999999999764 8999999996543 23356777888777775 9999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
|+++ +|.+++......+++..+..++.+++.||+|||+ ..+|+||||+|+||++++++.+||+|||++..+......
T Consensus 95 ~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~ 171 (296)
T cd06618 95 LMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK 171 (296)
T ss_pred ccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc
Confidence 9854 7877776544578999999999999999999993 258999999999999999999999999999765432211
Q ss_pred ccccCCCcccccccccccCCCC----CCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhch---hhcC-CCC
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMV----ASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDK---ALCG-KGY 551 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~----~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~---~l~~-~~~ 551 (611)
....++..|+|||++.+.. ++.++||||||+++|||++|+.||........ ........ .... ...
T Consensus 172 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 245 (296)
T cd06618 172 ---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE---VLTKILQEEPPSLPPNEGF 245 (296)
T ss_pred ---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH---HHHHHhcCCCCCCCCCCCC
Confidence 2234788999999987554 78999999999999999999988743211100 00111111 1111 123
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 552 DEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 552 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++++.+ ++.+||+.||++||++.+++++
T Consensus 246 ~~~l~~---li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 246 SPDFCS---FVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CHHHHH---HHHHHccCChhhCCCHHHHhcC
Confidence 344444 4459999999999999999877
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=301.44 Aligned_cols=256 Identities=19% Similarity=0.273 Sum_probs=192.4
Q ss_pred hhhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEecccc---chhHHHHHHHHHHHhcc-CCCCccceeeEEEeC--Cee
Q 035917 322 ASNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTC---KLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVE--EEK 394 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~--~~~ 394 (611)
..++|...+.||+|+||.||+|... +++.||||++... ......+.+|+.++.++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467788899999999999999965 6889999988542 22335677899999999 999999999998654 367
Q ss_pred EEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccC
Q 035917 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~ 474 (611)
++||||++ ++|.+++... .++|..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 99999997 5999988754 5889999999999999999999 7899999999999999999999999999998764
Q ss_pred CCCCC---ccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhc-CC-------
Q 035917 475 SSDES---SFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSS-GR------- 537 (611)
Q Consensus 475 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~-~~------- 537 (611)
..... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.+|... ....... +.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 33211 12233468999999998754 55789999999999999999998776310 0000000 00
Q ss_pred ------hhhhhchhhc---------CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHc
Q 035917 538 ------SKEAIDKALC---------GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS--LNSI 586 (611)
Q Consensus 538 ------~~~~~~~~l~---------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i 586 (611)
....++.... ....+. .+.+++.+||+.||++|||+.+++++ ++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASD---DALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCH---HHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0000000000 001223 34556669999999999999999987 4444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=293.75 Aligned_cols=248 Identities=21% Similarity=0.276 Sum_probs=190.0
Q ss_pred CCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 326 FCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
|...+.||.|++|.||+|.. .+|+.||+|++.... ...+.+.+|++++++++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 45668999999999999995 479999999986543 22356889999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 402 SSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 402 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
+ ++|.+++.... ..+++..+..++.|+++||+||| +.+++||||+|+||+++.++.++|+|||+++.......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 154 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-- 154 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence 5 69999987554 36899999999999999999999 78999999999999999999999999999976532221
Q ss_pred cccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHHHHH--H---HHhh-cCChh-----------hh-
Q 035917 481 FVNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLVDWV--N---QLSS-SGRSK-----------EA- 541 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~~~~--~---~~~~-~~~~~-----------~~- 541 (611)
......++..|+|||++.+. .++.++|||||||++|||++|+.||.... . .... ..... +.
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 11223468899999987654 56899999999999999999988763110 0 0000 00000 00
Q ss_pred --hc----hh--hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 542 --ID----KA--LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 542 --~~----~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+. .. ......+. .+.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~---~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDE---DGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhcccccccchhhhcCCCCH---HHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 00 00011223 34456669999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=299.09 Aligned_cols=246 Identities=17% Similarity=0.227 Sum_probs=201.8
Q ss_pred hcCCCCCeeeecCCceEEEEE-eCCCCEEEEEeccccchh---HHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 324 NSFCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCKLG---EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~~~---~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
+-|..++.||+|.|+.|-.|+ .-+|..||||++.+.+.+ ...+.+|++-|+.++|||||++|.+.......|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 345666889999999999998 358999999999876543 4678999999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEe-CCCCCeEEeecccccccCCCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV-DEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl-d~~~~~kl~DFGla~~~~~~~~ 478 (611)
+-.+|+|++|+-++...+.+....+++.||+.|+.|+| +..+|||||||+||.+ ..-|-+||.|||++-.+.+..
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~- 173 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK- 173 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc-
Confidence 99999999999877777999999999999999999999 8889999999999876 466899999999997765443
Q ss_pred CccccCCCcccccccccccCCCCCC-cccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVAS-LKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEIL 556 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~ 556 (611)
..+..+|+..|-|||++.+..|+ ++.||||+|||||.|++|+.||.+-- ..+.+..++|-.. .+...+.+-+
T Consensus 174 --kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN----DSETLTmImDCKYtvPshvS~eCr 247 (864)
T KOG4717|consen 174 --KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN----DSETLTMIMDCKYTVPSHVSKECR 247 (864)
T ss_pred --hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc----chhhhhhhhcccccCchhhhHHHH
Confidence 33456899999999999998886 67999999999999999999985421 1112222333221 1223345555
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+++. .|+..||++|.+.+||+.+
T Consensus 248 dLI~---sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 248 DLIQ---SMLVRDPKKRASLEEIVST 270 (864)
T ss_pred HHHH---HHHhcCchhhccHHHHhcc
Confidence 5555 9999999999999998754
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=291.02 Aligned_cols=249 Identities=19% Similarity=0.235 Sum_probs=186.6
Q ss_pred CCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc--hhHHHHHHHHHHHhccC-CCCccceeeEEEeC--CeeEEEEe
Q 035917 326 FCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLR-HPNLAPLLGYCVVE--EEKLLIYK 399 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~--~~~~lv~e 399 (611)
|...+.||+|+||.||+|+. .+++.||+|+++... .......+|+.++.++. |+||+++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 44567899999999999995 468999999986532 22334567999999995 99999999999987 88999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
|++ |+|.+.+......++|..+..++.|++.||+||| ..+++||||||+||+++. +.+||+|||+++........
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 997 5888888765457899999999999999999999 789999999999999999 99999999999876432211
Q ss_pred ccccCCCcccccccccccC-CCCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhh-cCChhh----hhch----
Q 035917 480 SFVNGDLGEFGYIAPEYSS-TMVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSS-SGRSKE----AIDK---- 544 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~-~~~~~~----~~~~---- 544 (611)
....++..|+|||++. +..++.++|||||||++|||++|..||.. .+..... .+...+ ....
T Consensus 156 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 156 ---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred ---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 2235788999999764 45678999999999999999998877631 1111100 000000 0000
Q ss_pred -----hhcCCC----CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 545 -----ALCGKG----YDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 545 -----~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
...... .......+.+++.+||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000 00112345556669999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=301.75 Aligned_cols=273 Identities=19% Similarity=0.261 Sum_probs=200.9
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEecccc---chhHHHHHHHHHHHhccCCCCccceeeEEEeC-----Ce
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTC---KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE-----EE 393 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~---~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~-----~~ 393 (611)
.+.|...+.||+|+||.||+|+. .+++.||||.++.. ......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35688889999999999999995 56899999998642 22345678899999999999999999988654 34
Q ss_pred eEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccccc
Q 035917 394 KLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLM 473 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~ 473 (611)
.++||||+. ++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 799999996 6899888754 46899999999999999999999 789999999999999999999999999999866
Q ss_pred CCCCCCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHH--H------HHHh-----------
Q 035917 474 TSSDESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDW--V------NQLS----------- 533 (611)
Q Consensus 474 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~--~------~~~~----------- 533 (611)
.... .......++..|+|||.+.. ..++.++|||||||++|||++|+.+|..- . ....
T Consensus 159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 159 SEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred CCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 4321 11223357889999998754 46889999999999999999998776310 0 0000
Q ss_pred hcCChhhhhc-------hh--hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHchhhhCCCCCCCCcccc
Q 035917 534 SSGRSKEAID-------KA--LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS--LNSIAAQHGFSERYDEFPLI 602 (611)
Q Consensus 534 ~~~~~~~~~~-------~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~~~~~~~~~~~~~~~ 602 (611)
......+.++ .. ......+ ..+.+++.+||+.+|++|||+.|+++| ++.+...... .....|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~--~~~~~~~~ 311 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHAN---PLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDE--PVCQTPFS 311 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCC---HHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccC--ccCCCccc
Confidence 0000000000 00 0001122 334556669999999999999999999 7766444332 23344555
Q ss_pred cccCC
Q 035917 603 FHRQD 607 (611)
Q Consensus 603 ~~~~~ 607 (611)
|+-++
T Consensus 312 ~~~~~ 316 (337)
T cd07858 312 FDFEE 316 (337)
T ss_pred hhhhh
Confidence 54443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=282.72 Aligned_cols=253 Identities=19% Similarity=0.321 Sum_probs=196.2
Q ss_pred ccHHHHHHhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch--hHHHHHHHHHHHhccC-CCCccceeeEEE
Q 035917 314 VKLADLMAASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL--GEKKFRNEMNRLGQLR-HPNLAPLLGYCV 389 (611)
Q Consensus 314 ~~~~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~ 389 (611)
..+.||+.. ..||+|..|.|++++. ..|...|||.+..... ..++++..+.++.+-+ +|.||+.+|||.
T Consensus 89 ~dindl~~l-------~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi 161 (391)
T KOG0983|consen 89 ADINDLENL-------GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI 161 (391)
T ss_pred cChHHhhhH-------HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence 445565544 4599999999999995 4689999999976543 3467888888877765 899999999999
Q ss_pred eCCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccc
Q 035917 390 VEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGL 469 (611)
Q Consensus 390 ~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGl 469 (611)
.+...++.||.|.. -+..+++.-..++++...-++...+++||.||.+ .++|+|||+||+|||+|+.|++|++|||+
T Consensus 162 ~n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGI 238 (391)
T KOG0983|consen 162 TNTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGI 238 (391)
T ss_pred eCchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccc
Confidence 99999999999854 5666666555678888888999999999999996 78999999999999999999999999999
Q ss_pred ccccCCCCCCccccCCCcccccccccccCC---CCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh
Q 035917 470 AKLMTSSDESSFVNGDLGEFGYIAPEYSST---MVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL 546 (611)
Q Consensus 470 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l 546 (611)
+..+.++.. .+...|.+.|||||.+.- .+|+.++||||||+.|+||+||..||...-.....-..+.+...|.+
T Consensus 239 sGrlvdSkA---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L 315 (391)
T KOG0983|consen 239 SGRLVDSKA---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLL 315 (391)
T ss_pred cceeecccc---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCC
Confidence 988765432 233469999999998753 46899999999999999999999987531111100001111112333
Q ss_pred cCC-CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 547 CGK-GYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 547 ~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+. .++..+.+|++ .|+..|+.+||...++++|
T Consensus 316 ~~~~gFSp~F~~fv~---~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 316 PGHMGFSPDFQSFVK---DCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CcccCcCHHHHHHHH---HHhhcCcccCcchHHHhcC
Confidence 222 25566666666 9999999999999998876
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=293.96 Aligned_cols=241 Identities=19% Similarity=0.252 Sum_probs=188.1
Q ss_pred eeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCCh
Q 035917 332 IISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTL 406 (611)
Q Consensus 332 ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL 406 (611)
||+|+||+||++.. .+|+.||+|.+.... ...+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999985 468999999986432 2234578899999999999999999999999999999999999999
Q ss_pred HHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccCC
Q 035917 407 YSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGD 485 (611)
Q Consensus 407 ~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 485 (611)
.+++.... ..+++..+..++.|++.||.||| ..+++||||+|+||++++++.+||+|||++....... .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccc
Confidence 99987554 36899999999999999999999 7899999999999999999999999999988654321 11233
Q ss_pred CcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhh-h-chhhcCCCCHHHHHHHHHHHh
Q 035917 486 LGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEA-I-DKALCGKGYDEEILQFLKVAC 563 (611)
Q Consensus 486 ~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~-~-~~~l~~~~~~~~~~~l~~l~~ 563 (611)
.++..|+|||++.+..++.++|||||||++|+|++|+.||..-..... ....... . .+.......++++.++++
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~--- 230 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEELKRRTLEMAVEYPDKFSPEAKDLCE--- 230 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHHHHhccccccccCCccCCHHHHHHHH---
Confidence 578899999999888899999999999999999999988732110000 0000000 0 000111223455555555
Q ss_pred hcccCCCCCCC-----CHHHHHHH
Q 035917 564 NCVVSRPKDRW-----SMYQVYQS 582 (611)
Q Consensus 564 ~Cl~~dP~~RP-----s~~evl~~ 582 (611)
+||+.||++|| ++.++++|
T Consensus 231 ~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 231 ALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred HHccCChhHccCCCcccHHHHHhC
Confidence 99999999999 67777654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=318.49 Aligned_cols=197 Identities=19% Similarity=0.222 Sum_probs=157.6
Q ss_pred hhhcCCCCCeeeecCCceEEEEEeCC--CCEEEEE------------------eccccchhHHHHHHHHHHHhccCCCCc
Q 035917 322 ASNSFCSENVIISTRTGTTYKAMLPD--GSVLAVK------------------RLNTCKLGEKKFRNEMNRLGQLRHPNL 381 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~~~--g~~vAvK------------------~~~~~~~~~~~~~~Ev~~l~~l~H~nI 381 (611)
..++|...+.||+|+||.||+|.... +..+++| .+.........+.+|+.+|++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 34689999999999999999987532 2222222 222222234568899999999999999
Q ss_pred cceeeEEEeCCeeEEEEeccCCCChHHhhhcCC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC
Q 035917 382 APLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNA----TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD 457 (611)
Q Consensus 382 v~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld 457 (611)
|++++++...+..++|+|++. ++|.+++.... ..........|+.|++.||.||| +.+|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence 999999999999999999995 47888775432 12335567789999999999999 78999999999999999
Q ss_pred CCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCC
Q 035917 458 EDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKG 523 (611)
Q Consensus 458 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~ 523 (611)
.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++++.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~ 366 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366 (501)
T ss_pred CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 999999999999987643221 11223469999999999999899999999999999999997753
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=294.32 Aligned_cols=252 Identities=22% Similarity=0.226 Sum_probs=191.7
Q ss_pred CCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeC--CeeEEEEe
Q 035917 326 FCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE--EEKLLIYK 399 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~--~~~~lv~e 399 (611)
|...+.||+|++|.||+|+.. +++.||+|++.... ...+.+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 455678999999999999965 58999999997642 2345688999999999999999999999988 78999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
|+++ +|.+++......+++..+..++.++++||+||| ..+++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~- 155 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS- 155 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence 9975 899988765457899999999999999999999 78999999999999999999999999999987644321
Q ss_pred ccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhc-CC--------hhh----
Q 035917 480 SFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSS-GR--------SKE---- 540 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~-~~--------~~~---- 540 (611)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+... ....... .. ...
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 11223357888999997654 45789999999999999999998776311 1111000 00 000
Q ss_pred -hhc------hhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 541 -AID------KALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 541 -~~~------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
... ..+...........+++++.+||..+|++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000 000000000013456667779999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=297.26 Aligned_cols=246 Identities=25% Similarity=0.300 Sum_probs=191.5
Q ss_pred CCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 326 FCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
|...+.||+|++|.||+|+. .+++.||+|.+.... ...+++.+|+++++.++|+|++++.+++...+..++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 55557899999999999995 468899999985421 2235688999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
+. |+|.+++......+++..+..++.+++.||.||| +.+++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---- 168 (308)
T cd06634 97 CL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (308)
T ss_pred cC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc----
Confidence 96 5888877654456899999999999999999999 789999999999999999999999999998765322
Q ss_pred cccCCCcccccccccccC---CCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHH
Q 035917 481 FVNGDLGEFGYIAPEYSS---TMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQ 557 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 557 (611)
....|+..|+|||.+. ...++.++|||||||++|||++|..|+.......... .......+.......+.++.+
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 245 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQSGHWSEYFRN 245 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH-HHhhcCCCCcCcccccHHHHH
Confidence 1234788999999864 3567889999999999999999998864321100000 000001111112234445555
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWSMYQVYQSLNS 585 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 585 (611)
+++ +||+.+|++||++.+++++...
T Consensus 246 li~---~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 246 FVD---SCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred HHH---HHhhCCcccCCCHHHHhhCccc
Confidence 555 9999999999999999988443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=288.15 Aligned_cols=247 Identities=19% Similarity=0.228 Sum_probs=193.3
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEecccc------chhHHHHHHHHHHHhccCCCCccceeeEEEeC--Cee
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTC------KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE--EEK 394 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~------~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~--~~~ 394 (611)
.+|...+.||+|+||.||+|.. .+++.||+|.+... ....+.+.+|++++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688889999999999999995 56999999987432 12235788999999999999999999998764 457
Q ss_pred EEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccC
Q 035917 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~ 474 (611)
++++||+++++|.+++... ..+++.....++.+++.||.||| +.+++|+||||+||+++.++.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 8999999999999998754 35889999999999999999999 7899999999999999999999999999998653
Q ss_pred CCCC-CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc---hhhcCCC
Q 035917 475 SSDE-SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID---KALCGKG 550 (611)
Q Consensus 475 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~---~~l~~~~ 550 (611)
.... ........|+..|+|||++.+..++.++|||||||++|||++|+.||.+..... ....... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~p~~ 233 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA----AIFKIATQPTKPMLPDG 233 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH----HHHHHHcCCCCCCCCcc
Confidence 2111 111123458899999999988889999999999999999999998874321110 0011110 0111233
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 551 YDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 551 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.++++.++++ +||. +|..||++.+++.|
T Consensus 234 ~~~~~~~~i~---~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 234 VSDACRDFLK---QIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred cCHHHHHHHH---HHhc-CcccCccHHHHhcC
Confidence 4456666666 9999 57999999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=295.97 Aligned_cols=250 Identities=19% Similarity=0.199 Sum_probs=187.4
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch---hHHHHHHHHHHHhccC-CCCccceeeEEEeCCe-----
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL---GEKKFRNEMNRLGQLR-HPNLAPLLGYCVVEEE----- 393 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~~~----- 393 (611)
++|...+.||+|+||.||+|.. .+++.||+|.++.... ....+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3677889999999999999996 4689999999865322 2357889999999995 6999999999987665
Q ss_pred eEEEEeccCCCChHHhhhcCC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC-CCCeEEeecc
Q 035917 394 KLLIYKYMSSGTLYSLLQGNA----TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE-DFDARIMDFG 468 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~-~~~~kl~DFG 468 (611)
.++||||+++ +|.+++.... ..+++..+..++.||++||.||| ..+|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 8988875432 35899999999999999999999 789999999999999998 8899999999
Q ss_pred cccccCCCCCCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhc-CCh-hh
Q 035917 469 LAKLMTSSDESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSS-GRS-KE 540 (611)
Q Consensus 469 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~-~~~-~~ 540 (611)
+++....... ......+++.|+|||++.+ ..++.++|||||||++|||++|..||... ....... ... ..
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9986532211 1122346889999998754 45789999999999999999998776311 1110000 000 00
Q ss_pred hhc-----------hh-------hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 541 AID-----------KA-------LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 541 ~~~-----------~~-------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
... +. ......+++ +.+++.+||+.||++||++.|++.|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPE---GLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHH---HHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 00 000112333 4455559999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=290.07 Aligned_cols=238 Identities=16% Similarity=0.178 Sum_probs=188.0
Q ss_pred eeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCCh
Q 035917 332 IISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTL 406 (611)
Q Consensus 332 ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL 406 (611)
||.|++|.||+|+.. +++.||+|.+.... ...+.+.+|+.++++++||||+++++++.+++..+++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999964 48999999986532 2346789999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccCCC
Q 035917 407 YSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDL 486 (611)
Q Consensus 407 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 486 (611)
.+++.+. ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.+||+|||+++...... ......
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~ 153 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC 153 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence 9999754 35889999999999999999999 7899999999999999999999999999998764432 112235
Q ss_pred cccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc---hhhcCCCCHHHHHHHHHHHh
Q 035917 487 GEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID---KALCGKGYDEEILQFLKVAC 563 (611)
Q Consensus 487 gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~---~~l~~~~~~~~~~~l~~l~~ 563 (611)
|+..|+|||.+.+..++.++|+||||+++|||++|..|+....... ........+ ....+...++++.. ++.
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~---~i~ 228 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP--MEIYNDILKGNGKLEFPNYIDKAAKD---LIK 228 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH--HHHHHHHhccCCCCCCCcccCHHHHH---HHH
Confidence 7889999999988889999999999999999999998874321000 000011110 00011112344445 444
Q ss_pred hcccCCCCCCCC-----HHHHHH
Q 035917 564 NCVVSRPKDRWS-----MYQVYQ 581 (611)
Q Consensus 564 ~Cl~~dP~~RPs-----~~evl~ 581 (611)
+||+.+|++||+ +.|+++
T Consensus 229 ~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 229 QLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHccCChhhCcCCcccCHHHHhc
Confidence 999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=292.14 Aligned_cols=250 Identities=21% Similarity=0.277 Sum_probs=189.7
Q ss_pred CCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccch--hHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeEEEEecc
Q 035917 326 FCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKL--GEKKFRNEMNRLGQLR-HPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
|...+.||+|++|.||+|+.. +++.||||++..... ......+|+..+.+++ ||||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456788999999999999975 588999999865432 2334567999999999 999999999999999999999999
Q ss_pred CCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 402 SSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 402 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
+|+|.+++.... ..+++..+..++.|++.+|.||| +.+++|+||+|+||++++++.++|+|||+++.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 789999887654 46899999999999999999999 78999999999999999999999999999986643221
Q ss_pred cccCCCcccccccccccC-CCCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhh-cCC-----------hhhhh
Q 035917 481 FVNGDLGEFGYIAPEYSS-TMVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSS-SGR-----------SKEAI 542 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~-~~~-----------~~~~~ 542 (611)
.....++..|+|||.+. ...++.++||||||++++||++|+.++.. ....... .+. ....+
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 12235788999999874 45578999999999999999999876521 0000000 000 00000
Q ss_pred chhhcC-------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 543 DKALCG-------KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 543 ~~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+..+.. .........+.+++.+||+.+|++|||+.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000 0000112345666669999999999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=305.24 Aligned_cols=244 Identities=20% Similarity=0.275 Sum_probs=202.5
Q ss_pred HhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchh---HHHHHHHHHHHhccCCCCccceeeEEEeCCeeEE
Q 035917 321 AASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLG---EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 321 ~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
.....|.....||+|.|+.|..|+. .++..||||.+++.... .+.+.+|+++|..++|||||+++.+...+...|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 3456788889999999999999995 46999999999876543 3558999999999999999999999999999999
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
||||+.+|.+++++..++. +.......++.|+..|++||| .+.|+|||||++||||+.++++||+|||++..+...
T Consensus 133 V~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeeccc
Confidence 9999999999999987754 444888889999999999999 899999999999999999999999999999987633
Q ss_pred CCCccccCCCcccccccccccCCCCC-CcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcC-----CC
Q 035917 477 DESSFVNGDLGEFGYIAPEYSSTMVA-SLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCG-----KG 550 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-----~~ 550 (611)
....+.+|++.|+|||++.+..| ++++|+||+||++|-|+.|.-||.... +.+.-++.+.+ .+
T Consensus 209 ---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~--------lk~Lr~rvl~gk~rIp~~ 277 (596)
T KOG0586|consen 209 ---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN--------LKELRPRVLRGKYRIPFY 277 (596)
T ss_pred ---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc--------cccccchheeeeecccce
Confidence 23445689999999999998876 578999999999999999998885321 11111222211 22
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 551 YDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 551 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+.+-..+++ +.+..+|.+|++++++.++
T Consensus 278 ms~dce~lLr---k~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 278 MSCDCEDLLR---KFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eechhHHHHH---HhhccCccccCCHHHhhhh
Confidence 3444455555 9999999999999999876
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=287.10 Aligned_cols=246 Identities=20% Similarity=0.245 Sum_probs=195.6
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
+|...+.||+|++|.||+++. .+++.+|+|.+.... ....++.+|++++++++|+||+++.+++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 366778999999999999984 478899999986532 2345688999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 401 MSSGTLYSLLQGN---ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 401 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
+++++|.+++.+. ...+++..+..++.+++.||+||| +.+++|+||+|+||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 9999999988652 236899999999999999999999 8899999999999999999999999999998765431
Q ss_pred CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHH
Q 035917 478 ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQ 557 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 557 (611)
.....++..|+|||.+.+..++.++|+||||+++|||++|+.|+....... ....+..............+
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 228 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-----LRYKVQRGKYPPIPPIYSQD 228 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHhcCCCCCCchhhCHH
Confidence 122358899999999998889999999999999999999998763211100 00000000111111122234
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+.+++.+|++.+|++||++.|++++
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 229 LQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhcC
Confidence 5556669999999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=296.97 Aligned_cols=251 Identities=24% Similarity=0.271 Sum_probs=190.4
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch---hHHHHHHHHHHHhccCCCCccceeeEEEeC--CeeEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL---GEKKFRNEMNRLGQLRHPNLAPLLGYCVVE--EEKLL 396 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~--~~~~l 396 (611)
.++|...+.||+|+||.||+|.. .+|+.||+|.++.... ....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 45788889999999999999996 4699999999864322 123567899999999999999999998765 46799
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
||||+.+ +|.+++......+++..+..++.|+++||+||| +.+++||||||+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9999975 898888765457899999999999999999999 789999999999999999999999999999876432
Q ss_pred CCCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhhc-CChhhhhch-----
Q 035917 477 DESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSSS-GRSKEAIDK----- 544 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~~-~~~~~~~~~----- 544 (611)
.. ......++..|+|||.+.+ ..++.++|||||||++|||++|..+|.. ........ +.......+
T Consensus 162 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 162 AK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred cC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 21 1122346788999998765 4578999999999999999999877631 11111100 000000000
Q ss_pred ------hhcC----------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 545 ------ALCG----------KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 545 ------~l~~----------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+.. ...+++ +.+++.+|++.||++|||+.|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEA---GLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccCCCCCchHHhccccCHH---HHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 011233 3445559999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=291.53 Aligned_cols=252 Identities=13% Similarity=0.143 Sum_probs=180.7
Q ss_pred hcCCCCCeeeecCCceEEEEEeCC----CCEEEEEeccccchh---H---------HHHHHHHHHHhccCCCCccceeeE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPD----GSVLAVKRLNTCKLG---E---------KKFRNEMNRLGQLRHPNLAPLLGY 387 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~----g~~vAvK~~~~~~~~---~---------~~~~~Ev~~l~~l~H~nIv~l~g~ 387 (611)
+.|...++||+|+||.||+|...+ +..+|+|........ + .....+...+..++|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 568888999999999999999644 456677754322110 0 112334455667789999999997
Q ss_pred EEeCC----eeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeE
Q 035917 388 CVVEE----EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDAR 463 (611)
Q Consensus 388 ~~~~~----~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~k 463 (611)
+.... ..++++|++.. ++.+.+... ...++..+..++.|+++||+||| +.+|+||||||+|||++.++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEE
Confidence 76543 34678888754 676666533 23678889999999999999999 78999999999999999999999
Q ss_pred EeecccccccCCCCCC-----ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHH-H-Hhh--
Q 035917 464 IMDFGLAKLMTSSDES-----SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVN-Q-LSS-- 534 (611)
Q Consensus 464 l~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~-~-~~~-- 534 (611)
|+|||+++.+...... .......||+.|+|||+..+..++.++|||||||++|||++|+.||..... . ...
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 9999999876432211 111223699999999999999999999999999999999999999743210 0 000
Q ss_pred -cCChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 035917 535 -SGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSL 583 (611)
Q Consensus 535 -~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 583 (611)
.+...............++++.++++ .|+..+|++||++.++++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 247 KCDFIKRLHEGKIKIKNANKFIYDFIE---CVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHHHhhhhhhccCCCCHHHHHHHH---HHHhCCCCCCCCHHHHHHhh
Confidence 00011111111112233445555555 99999999999999999876
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=296.57 Aligned_cols=249 Identities=20% Similarity=0.219 Sum_probs=184.0
Q ss_pred CeeeecCCceEEEEEeCCCCEEEEEecccc---chhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCCh
Q 035917 330 NVIISTRTGTTYKAMLPDGSVLAVKRLNTC---KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTL 406 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~---~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL 406 (611)
+.+|.|+++.||++.. +++.||||+++.. ....+.+.+|++++++++|+||+++++++...+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3344555555555554 7999999998654 23346799999999999999999999999999999999999999999
Q ss_pred HHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC-----Cc
Q 035917 407 YSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE-----SS 480 (611)
Q Consensus 407 ~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~-----~~ 480 (611)
.+++.... ..+++.....++.|+++||+||| +.+|+||||||+||+++.++.+|++|||.+..+..... ..
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 99997543 36889999999999999999999 78999999999999999999999999998876532211 11
Q ss_pred cccCCCcccccccccccCC--CCCCcccchHHHHHHHHHHhCCCCCHHHHHHH--Hhh--cCChhhhh------------
Q 035917 481 FVNGDLGEFGYIAPEYSST--MVASLKGDVYGIGVVLLELAGFKGNLVDWVNQ--LSS--SGRSKEAI------------ 542 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~--~~~--~~~~~~~~------------ 542 (611)
......++..|+|||++.. ..++.++|||||||++|||++|+.||...... ... .+.....+
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence 1123357788999998865 35889999999999999999999887421110 000 00000000
Q ss_pred --------chhhc----CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 543 --------DKALC----GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 543 --------~~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++... .......-.++.+++.+||+.||++|||+.++++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00000 00000111245556669999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=291.76 Aligned_cols=252 Identities=17% Similarity=0.202 Sum_probs=190.4
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
+|...+.||.|++|.||+|+.. +|+.||||.++... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4677889999999999999964 68999999986532 23456789999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 402 SSGTLYSLLQGNA--TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 402 ~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
++ +|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 8988886543 36899999999999999999999 78999999999999999999999999999976533211
Q ss_pred ccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhc---C---Chhhhhc-hhh
Q 035917 480 SFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSS---G---RSKEAID-KAL 546 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~---~---~~~~~~~-~~l 546 (611)
......++..|+|||++.+ ..++.++|||||||++|||++|+.+|..- ....... . ......+ +..
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 1123357889999998765 35688999999999999999998775310 0000000 0 0000000 000
Q ss_pred cCC-----------CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 547 CGK-----------GYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 547 ~~~-----------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
... ..+.....+.+++.+|++.||.+||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 000111234455669999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=299.18 Aligned_cols=194 Identities=22% Similarity=0.252 Sum_probs=165.3
Q ss_pred hhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEecccc---chhHHHHHHHHHHHhccCCCCccceeeEEEeC------
Q 035917 322 ASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTC---KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE------ 391 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~---~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~------ 391 (611)
..+.|...+.||+|+||.||+|+. .+++.||+|.+... ....+++.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 456788889999999999999995 47899999998642 22335678899999999999999999988643
Q ss_pred CeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccc
Q 035917 392 EEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAK 471 (611)
Q Consensus 392 ~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~ 471 (611)
...++||||+.+ +|.+.+... +++..+..++.|++.||+||| ..+|+||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 346899999964 888887643 888999999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCH
Q 035917 472 LMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNL 525 (611)
Q Consensus 472 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~ 525 (611)
....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.+|
T Consensus 167 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf 217 (353)
T cd07850 167 TAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLF 217 (353)
T ss_pred eCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCC
Confidence 7543221 22335789999999999889999999999999999999998765
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=288.93 Aligned_cols=249 Identities=18% Similarity=0.205 Sum_probs=187.3
Q ss_pred HHHHHhhhcCCCCCee--eecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhcc-CCCCccceeeEEEeCC
Q 035917 317 ADLMAASNSFCSENVI--ISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEE 392 (611)
Q Consensus 317 ~~l~~~t~~f~~~~~i--g~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~ 392 (611)
.++....++|...+.+ |+|+||.||+++. .+++.+|+|.+........ |+.....+ +||||+++++++..++
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 4444555677776666 9999999999995 5688999999865432211 22222222 6999999999999999
Q ss_pred eeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC-CeEEeeccccc
Q 035917 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF-DARIMDFGLAK 471 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~-~~kl~DFGla~ 471 (611)
..++||||+++|+|.+++.... .+++..+..++.|+++||.||| +.+++||||||+||+++.++ .++|+|||+++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 9999999999999999997653 7999999999999999999999 78999999999999999988 99999999988
Q ss_pred ccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCC
Q 035917 472 LMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKG 550 (611)
Q Consensus 472 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~ 550 (611)
...... ...|+..|+|||++.+..++.++|||||||++|||++|+.|+..................... ....
T Consensus 159 ~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (267)
T PHA03390 159 IIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKN 232 (267)
T ss_pred ecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccc
Confidence 654221 224889999999999888999999999999999999999887421000000000000001000 1112
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCC-HHHHHHH
Q 035917 551 YDEEILQFLKVACNCVVSRPKDRWS-MYQVYQS 582 (611)
Q Consensus 551 ~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~ 582 (611)
.+..+.+++. +||+.+|.+||+ ++|+++|
T Consensus 233 ~~~~~~~li~---~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 233 VSKNANDFVQ---SMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred cCHHHHHHHH---HHhccChhhCCchHHHHhcC
Confidence 3445555555 999999999996 6998864
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=298.48 Aligned_cols=256 Identities=20% Similarity=0.219 Sum_probs=189.0
Q ss_pred Ceeeec--CCceEEEEEe-CCCCEEEEEeccccch---hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 330 NVIIST--RTGTTYKAML-PDGSVLAVKRLNTCKL---GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 330 ~~ig~G--~~g~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
..||+| +||+||+++. .+|+.||+|.+..... ..+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 8999999996 5799999999865332 236788999999999999999999999999999999999999
Q ss_pred CChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc-c
Q 035917 404 GTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS-F 481 (611)
Q Consensus 404 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~-~ 481 (611)
|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+|++||+.+.......... .
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999987543 35899999999999999999999 7899999999999999999999999998654332111100 0
Q ss_pred ----ccCCCcccccccccccCCC--CCCcccchHHHHHHHHHHhCCCCCHHHHHHHH-----hhcCCh------------
Q 035917 482 ----VNGDLGEFGYIAPEYSSTM--VASLKGDVYGIGVVLLELAGFKGNLVDWVNQL-----SSSGRS------------ 538 (611)
Q Consensus 482 ----~~~~~gt~~y~aPE~~~~~--~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~-----~~~~~~------------ 538 (611)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||....... ......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 0111356679999998763 47899999999999999999998874321100 000000
Q ss_pred --------------h----------hhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHchh
Q 035917 539 --------------K----------EAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS--LNSIAA 588 (611)
Q Consensus 539 --------------~----------~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~ 588 (611)
. ...+..+...........+.+++.+||+.||++|||+.|+++| ++.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 0 0000000011111233456677779999999999999999877 444444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=293.99 Aligned_cols=243 Identities=25% Similarity=0.310 Sum_probs=189.2
Q ss_pred CCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 326 FCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
|...+.||+|+||.||+|+. .+++.||+|++.... ...+.+.+|++++++++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 44557899999999999995 468999999986432 2235688999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
+. |+|.+++.....++++..+..++.|++.|+.||| ..+++|+||||+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 96 5888888655557999999999999999999999 78999999999999999999999999999864321
Q ss_pred cccCCCcccccccccccC---CCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHH
Q 035917 481 FVNGDLGEFGYIAPEYSS---TMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQ 557 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 557 (611)
.....|+..|+|||++. ...++.++|||||||++|||++|..|+..+....... .......+.......+..+.+
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~ 251 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNDSPTLQSNEWTDSFRG 251 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhcCCCCCCccccCHHHHH
Confidence 12335889999999874 4568889999999999999999998864321100000 000000111111223344455
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++. +||+.+|++||++.+++.+
T Consensus 252 li~---~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 252 FVD---YCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHH---HHccCChhhCcCHHHHhcC
Confidence 555 9999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=295.54 Aligned_cols=197 Identities=22% Similarity=0.263 Sum_probs=163.4
Q ss_pred CCCCCeeeecCCceEEEEEeC---CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeC--CeeEE
Q 035917 326 FCSENVIISTRTGTTYKAMLP---DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE--EEKLL 396 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~~---~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~--~~~~l 396 (611)
|...+.||+|++|.||+|+.. +++.||+|.+.... ...+.+.+|+.++.+++||||+++++++.+. +..++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 666788999999999999964 58999999997532 2235678899999999999999999999988 78999
Q ss_pred EEeccCCCChHHhhhcCC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC----CCCeEEeecc
Q 035917 397 IYKYMSSGTLYSLLQGNA----TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE----DFDARIMDFG 468 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~----~~~~kl~DFG 468 (611)
||||+++ +|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999975 7777664321 25888999999999999999999 789999999999999999 9999999999
Q ss_pred cccccCCCCC-CccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHH
Q 035917 469 LAKLMTSSDE-SSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLV 526 (611)
Q Consensus 469 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~ 526 (611)
+++....... ........++..|+|||++.+ ..++.++|||||||+++||++|..+|.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 217 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFK 217 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 9987643222 111223457899999998765 457899999999999999999887763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=288.68 Aligned_cols=241 Identities=20% Similarity=0.246 Sum_probs=187.5
Q ss_pred eeecCCceEEEEEeC-CCCEEEEEeccccch----hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCCh
Q 035917 332 IISTRTGTTYKAMLP-DGSVLAVKRLNTCKL----GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTL 406 (611)
Q Consensus 332 ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~----~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL 406 (611)
||+|+||.||+++.. +|+.||+|.+..... ..+.+.+|++++.+++||||+++++.+..++..+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 589999999999976 499999999965432 345789999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC------Cc
Q 035917 407 YSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE------SS 480 (611)
Q Consensus 407 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~------~~ 480 (611)
.+++.+.. .+++..+..++.|+++||+||| ..+++|+||+|+||++++++.+||+|||++........ ..
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99997653 6899999999999999999999 78999999999999999999999999999876533211 11
Q ss_pred cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhc-CCC--CHHHHHH
Q 035917 481 FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALC-GKG--YDEEILQ 557 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~--~~~~~~~ 557 (611)
......++..|+|||......++.++||||||+++||+++|..|+........ .......... ... .+.++..
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 232 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI----FQNILNGKIEWPEDVEVSDEAID 232 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCCcCCCccccCCHHHHH
Confidence 12234578899999999888899999999999999999999887632100000 0000000000 011 1344455
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWSMYQVYQSL 583 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~~evl~~L 583 (611)
++. +||+.+|++|||+.++.+.|
T Consensus 233 ~i~---~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 233 LIS---KLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred HHH---HHhcCCHhhcCCCccHHHHh
Confidence 444 99999999999995544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=290.09 Aligned_cols=240 Identities=19% Similarity=0.217 Sum_probs=182.0
Q ss_pred eeeecCCceEEEEEe-CCCCEEEEEeccccch----hHHHHHHHHH---HHhccCCCCccceeeEEEeCCeeEEEEeccC
Q 035917 331 VIISTRTGTTYKAML-PDGSVLAVKRLNTCKL----GEKKFRNEMN---RLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 331 ~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ev~---~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
+||+|+||.||+|.. .+++.||+|.+..... ....+..|.. .++...||||+++.+++..++..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 4689999999864321 1223444443 4445579999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccc
Q 035917 403 SGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482 (611)
Q Consensus 403 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 482 (611)
+|+|.+++... ..+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~---- 152 (278)
T cd05606 81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---- 152 (278)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC----
Confidence 99999988654 46899999999999999999999 78999999999999999999999999999876533221
Q ss_pred cCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHHHHHHHH-hhcCChhhhhchhhcCCCCHHHHHHHHH
Q 035917 483 NGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLVDWVNQL-SSSGRSKEAIDKALCGKGYDEEILQFLK 560 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~~~~~~~~l~~ 560 (611)
....|+..|+|||.+.++ .++.++|||||||++|||++|+.||....... .............+ ....+.++.++++
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~ 231 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL-PDSFSPELRSLLE 231 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCC-CCcCCHHHHHHHH
Confidence 223589999999998754 68999999999999999999998874310000 00000000011111 1123445555555
Q ss_pred HHhhcccCCCCCCC-----CHHHHHHH
Q 035917 561 VACNCVVSRPKDRW-----SMYQVYQS 582 (611)
Q Consensus 561 l~~~Cl~~dP~~RP-----s~~evl~~ 582 (611)
+|+..+|.+|| ++.+++++
T Consensus 232 ---~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 232 ---GLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ---HHhhcCHHhccCCCCCCHHHHHhC
Confidence 99999999999 99999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=283.24 Aligned_cols=247 Identities=22% Similarity=0.322 Sum_probs=196.6
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccch---hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKL---GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
+|...+.||+|++|.||+++.. +++.||+|.+..... ..+.+.+|++++.+++|||++++++++.+++..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 3667789999999999999864 688999999976543 346799999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
+++++|.+++... ..+++..+..++.+++.||.||| +.+|+||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999999998755 46899999999999999999999 889999999999999999999999999999876543221
Q ss_pred cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHH
Q 035917 481 FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLK 560 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~ 560 (611)
.....++..|+|||...+..++.++||||||+++|+|++|..|+.......... .......+. .....++++..++.
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~i~ 232 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALF-RIVQDDHPP-LPEGISPELKDFLM 232 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHH-HHhccCCCC-CCCCCCHHHHHHHH
Confidence 123358899999999888778999999999999999999988764211100000 000000011 11223445555554
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 035917 561 VACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 561 l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+||..+|++||++.+++.+
T Consensus 233 ---~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 233 ---QCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred ---HHHhCChhhCcCHHHHhcC
Confidence 9999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=289.04 Aligned_cols=251 Identities=21% Similarity=0.241 Sum_probs=192.2
Q ss_pred CCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch---hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 326 FCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL---GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
|...+.||+|++|.||+|.. .+++.+|+|.++.... ....+.+|++++++++|+||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 45567899999999999996 4789999999865432 3467889999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
++ +|.+++......+++..+..++.+++.||.||| ..+|+|+||||+||++++++.+||+|||.+....... ..
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP 154 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence 75 898888765457899999999999999999999 7899999999999999999999999999998765432 11
Q ss_pred ccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHHH--HHH---HHhh-cCCh-----hhhhc------
Q 035917 482 VNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLVD--WVN---QLSS-SGRS-----KEAID------ 543 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~~--~~~---~~~~-~~~~-----~~~~~------ 543 (611)
.....++..|+|||.+.+. .++.++||||||+++|+|++|+.+|.. ... .... .+.. ....+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 2234578899999988766 789999999999999999999876521 000 0000 0000 00000
Q ss_pred hhhcC-------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 544 KALCG-------KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 544 ~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
..... ...+.....+.+++.+||+.||.+||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000 0001112345556669999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=296.19 Aligned_cols=250 Identities=21% Similarity=0.271 Sum_probs=191.7
Q ss_pred HHHHhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEe-CC
Q 035917 318 DLMAASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVV-EE 392 (611)
Q Consensus 318 ~l~~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~-~~ 392 (611)
++..++++|...+.||.|+||.||+|.. .+++.||||++.... ...+.+.+|++++.+++||||+++.+++.. .+
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 4456788899999999999999999985 479999999885422 234678899999999999999999999876 45
Q ss_pred eeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccc
Q 035917 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKL 472 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~ 472 (611)
..+++|||+ +++|.+++... .+++.....++.|+++||+||| +.+|+||||+|+||++++++.+||+|||+++.
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 788999999 56899888643 4788888899999999999999 78999999999999999999999999999875
Q ss_pred cCCCCCCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHH--------------------HHH
Q 035917 473 MTSSDESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDW--------------------VNQ 531 (611)
Q Consensus 473 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~--------------------~~~ 531 (611)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.+|... ...
T Consensus 158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 4321 122357889999998765 56899999999999999999998776310 000
Q ss_pred HhhcCChhhhhchh-hcC--------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 532 LSSSGRSKEAIDKA-LCG--------KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 532 ~~~~~~~~~~~~~~-l~~--------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.... ...+.+... ... ...++ .+.+++.+||+.+|++||++.+++.+
T Consensus 233 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSE-NTLRFVQSLPKREPVPFSEKFKNADP---SAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccch-hhHHHHhhccccCCCcHHHHcCCCCH---HHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 000000000 000 11223 44455559999999999999999887
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=293.45 Aligned_cols=242 Identities=18% Similarity=0.274 Sum_probs=190.0
Q ss_pred CeeeecCCceEEEEEe-CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCChH
Q 035917 330 NVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLY 407 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL~ 407 (611)
..||+|+||.||++.. .+++.||||++.... ...+.+.+|+.++++++|+||+++++++..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999986 578999999986433 33466899999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccCCCc
Q 035917 408 SLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLG 487 (611)
Q Consensus 408 ~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 487 (611)
+++... .+++.....++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++........ ......|
T Consensus 106 ~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~ 178 (292)
T cd06657 106 DIVTHT--RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVG 178 (292)
T ss_pred HHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccccc
Confidence 987543 4899999999999999999999 78999999999999999999999999999876543221 1122458
Q ss_pred ccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHHHHHHHHHhhcc
Q 035917 488 EFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEILQFLKVACNCV 566 (611)
Q Consensus 488 t~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~~l~~~Cl 566 (611)
+..|+|||++.+..++.++|||||||++|||++|..|+..-..... .........+.+ .....+..+.+++ .+||
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li---~~~l 254 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-MKMIRDNLPPKLKNLHKVSPSLKGFL---DRLL 254 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhhCCcccCCcccCCHHHHHHH---HHHH
Confidence 8999999999888889999999999999999999887631000000 000000111111 0111233444544 4999
Q ss_pred cCCCCCCCCHHHHHHH
Q 035917 567 VSRPKDRWSMYQVYQS 582 (611)
Q Consensus 567 ~~dP~~RPs~~evl~~ 582 (611)
+.+|.+||++.+++++
T Consensus 255 ~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 255 VRDPAQRATAAELLKH 270 (292)
T ss_pred hCCcccCcCHHHHhcC
Confidence 9999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=284.31 Aligned_cols=246 Identities=20% Similarity=0.279 Sum_probs=196.8
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
+|...+.||.|++|.||++... +++.||+|++.... ...+++.+|++++++++|||++++.+.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 3667789999999999999964 68999999996543 3446789999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 401 MSSGTLYSLLQGNA---TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 401 ~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
+++++|.+++.... ..+++..+..++.+++.||.||| ..+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999987642 57999999999999999999999 7899999999999999999999999999998764332
Q ss_pred CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhch--hhcCCCCHHHH
Q 035917 478 ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDK--ALCGKGYDEEI 555 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~~~~ 555 (611)
.......|++.|+|||...+..++.++||||+|+++++|++|+.|+........ ....... .......+.++
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 231 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL----ALKILKGQYPPIPSQYSSEL 231 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH----HHHHhcCCCCCCCCCCCHHH
Confidence 112223588999999999888899999999999999999999887632110000 0000000 00111233444
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+ ++.+||..+|++||++.|++++
T Consensus 232 ~~---~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 232 RN---LVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HH---HHHHHcCCChhhCcCHHHHhcC
Confidence 44 4559999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=292.79 Aligned_cols=254 Identities=21% Similarity=0.218 Sum_probs=192.2
Q ss_pred HhhhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCC----
Q 035917 321 AASNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE---- 392 (611)
Q Consensus 321 ~~t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~---- 392 (611)
...++|...+.||+|+||.||+|... +|+.||+|+++... .....+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678889999999999999999964 58999999996432 23356788999999999999999999987654
Q ss_pred ------eeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEee
Q 035917 393 ------EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMD 466 (611)
Q Consensus 393 ------~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~D 466 (611)
..++|+||+++ ++.+.+......+++..+..++.|++.||+||| +.+|+|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999986 787877755457899999999999999999999 78999999999999999999999999
Q ss_pred cccccccCCCCCCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhh--cCCh
Q 035917 467 FGLAKLMTSSDESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSS--SGRS 538 (611)
Q Consensus 467 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~--~~~~ 538 (611)
||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.+|... ...... ....
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999987643321 11122346788999998754 45789999999999999999998776311 000000 0000
Q ss_pred hhh------------hch------hh--cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 539 KEA------------IDK------AL--CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 539 ~~~------------~~~------~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
... .+. .. .....+.. +.+++.+||+.||++||++.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTP---ALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHH---HHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 000 00 00112334 4455559999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=290.46 Aligned_cols=250 Identities=17% Similarity=0.205 Sum_probs=188.3
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccch---hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKL---GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
++|...+.||+|++|.||+|... +|+.||+|.+..... ..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46778889999999999999964 689999999865322 23568899999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC-CCCeEEeecccccccCCCC
Q 035917 400 YMSSGTLYSLLQGNAT-ELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE-DFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~-~~~~kl~DFGla~~~~~~~ 477 (611)
|++ ++|.+++..... .+++.....++.||+.||+||| +.+++||||+|+||+++. ++.+||+|||+++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 588887754432 4688888999999999999999 789999999999999985 5578999999997653221
Q ss_pred CCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhh--cCChhhhh-------
Q 035917 478 ESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSS--SGRSKEAI------- 542 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~--~~~~~~~~------- 542 (611)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|..||..- ...... ........
T Consensus 158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 158 --RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred --cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence 11223357889999998765 45789999999999999999998776310 000000 00000000
Q ss_pred ------------chhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 543 ------------DKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 543 ------------~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+........+++ +.+++.+|++.+|++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPA---GVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChH---HHHHHHHHccCChhhCcCHHHHhcC
Confidence 000001112333 4445559999999999999999975
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=321.41 Aligned_cols=253 Identities=21% Similarity=0.246 Sum_probs=185.7
Q ss_pred HhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEe-------
Q 035917 321 AASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVV------- 390 (611)
Q Consensus 321 ~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~------- 390 (611)
+-.++|.+.++||+||||.|||++- -||+.||||+|.... ....++.+|+..|.+|+|||||+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 4556788889999999999999994 489999999997653 333578999999999999999998763321
Q ss_pred ------------------------------------------------C-------------------------------
Q 035917 391 ------------------------------------------------E------------------------------- 391 (611)
Q Consensus 391 ------------------------------------------------~------------------------------- 391 (611)
.
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ---------------------------------CeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 035917 392 ---------------------------------EEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHH 438 (611)
Q Consensus 392 ---------------------------------~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 438 (611)
-..|+-||||+.-.|.++++++...-.-...++++++|++||+|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH- 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH- 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH-
Confidence 0136889999997777777654321135677899999999999999
Q ss_pred cCCCCeeecCCCCCeEEeCCCCCeEEeecccccccC----C------------CCCCccccCCCcccccccccccCCC--
Q 035917 439 GCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMT----S------------SDESSFVNGDLGEFGYIAPEYSSTM-- 500 (611)
Q Consensus 439 ~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~~-- 500 (611)
+.+||||||||.||++|++..+||+|||+|+... . .......++.+||.-|+|||++.+.
T Consensus 715 --~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 715 --DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred --hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 8899999999999999999999999999998721 0 0112234567899999999998764
Q ss_pred -CCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhc--CCCCHHHHHHHHHHHhhcccCCCCCCCCHH
Q 035917 501 -VASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALC--GKGYDEEILQFLKVACNCVVSRPKDRWSMY 577 (611)
Q Consensus 501 -~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 577 (611)
+|+.|.|+||+|||++||+. ||..-+.... .+...-+..+. .....++...-.+++.++++.||.+|||+.
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~---iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~ 866 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTSMERAS---ILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTAT 866 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCchHHHHH---HHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHH
Confidence 49999999999999999983 3322111111 01111111111 111333344444555599999999999999
Q ss_pred HHHHH
Q 035917 578 QVYQS 582 (611)
Q Consensus 578 evl~~ 582 (611)
|+++.
T Consensus 867 eLL~s 871 (1351)
T KOG1035|consen 867 ELLNS 871 (1351)
T ss_pred HHhhc
Confidence 99863
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=297.01 Aligned_cols=253 Identities=20% Similarity=0.263 Sum_probs=191.3
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCC------
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE------ 392 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~------ 392 (611)
.++|...+.||+|+||.||+|+. .+|+.||||++.... .....+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36788889999999999999995 579999999986432 22356889999999999999999999987543
Q ss_pred eeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccc
Q 035917 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKL 472 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~ 472 (611)
..++|+||+.. +|.++.. ..+++..+..++.|++.||+||| ..+++||||||+||+++.++.+||+|||+++.
T Consensus 94 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred eEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 46899999975 7877653 24889999999999999999999 78999999999999999999999999999876
Q ss_pred cCCCCCCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhhc-C-C-------
Q 035917 473 MTSSDESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSSS-G-R------- 537 (611)
Q Consensus 473 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~~-~-~------- 537 (611)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.. ........ + .
T Consensus 167 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 167 ADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 4321 123357889999998865 4688999999999999999999887632 11111000 0 0
Q ss_pred -----hhhhhc--hhhcC-------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHchhhh
Q 035917 538 -----SKEAID--KALCG-------KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS--LNSIAAQH 590 (611)
Q Consensus 538 -----~~~~~~--~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~~~ 590 (611)
.....+ +.... ...+. .+.+++.+||+.||++||++.|++.| ++.+.+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASP---QAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCH---HHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence 000000 00000 01122 34556669999999999999999977 77765543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=287.72 Aligned_cols=250 Identities=21% Similarity=0.224 Sum_probs=188.2
Q ss_pred CCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccch---hHHHHHHHHHHHhcc---CCCCccceeeEEEeCCe-----
Q 035917 326 FCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKL---GEKKFRNEMNRLGQL---RHPNLAPLLGYCVVEEE----- 393 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~Ev~~l~~l---~H~nIv~l~g~~~~~~~----- 393 (611)
|...+.||+|+||.||+|+.. +++.||+|+++.... ....+.+|+.++.++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 456688999999999999976 489999999964321 234567788777666 59999999999988776
Q ss_pred eEEEEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccc
Q 035917 394 KLLIYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKL 472 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~ 472 (611)
.+++|||+.+ +|.+++.... ..+++..+..++.|+++||.||| +.+++|+||+|+||++++++.+||+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999975 8999887543 36899999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCC----h-----
Q 035917 473 MTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGR----S----- 538 (611)
Q Consensus 473 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~----~----- 538 (611)
...... .....++..|+|||.+.+..++.++|||||||++|||+++..++... ......... .
T Consensus 157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence 643321 12234788999999998888999999999999999999987765321 111110000 0
Q ss_pred ----hhhhchhhcC---CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 539 ----KEAIDKALCG---KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 539 ----~~~~~~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.......... ...++....+.+++.+||+.||++||++.|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000000000 0001112345566669999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=317.55 Aligned_cols=258 Identities=21% Similarity=0.281 Sum_probs=199.2
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC--------CCCEEEEEeccccc--hhHHHHHHHHHHHhcc-CCCCccceeeEEEeC
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP--------DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVE 391 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~--------~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~ 391 (611)
.++....+.+|+|.||.|++|.+. ....||||.++... ...+.+..|+++|..+ +|+||+.++|+|..+
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 334455569999999999999842 14579999997543 3457899999999999 599999999999999
Q ss_pred CeeEEEEeccCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEe
Q 035917 392 EEKLLIYKYMSSGTLYSLLQGNA---------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV 456 (611)
Q Consensus 392 ~~~~lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl 456 (611)
+..++|+||+..|+|.++|+..+ ..++....+.++.|||.|++||+ +.+++||||..+|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEe
Confidence 99999999999999999998665 23888999999999999999999 8899999999999999
Q ss_pred CCCCCeEEeecccccccCCCCCCccccCCCc--ccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHh
Q 035917 457 DEDFDARIMDFGLAKLMTSSDESSFVNGDLG--EFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLS 533 (611)
Q Consensus 457 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~ 533 (611)
.++..+||+|||+|+........... ...| +..|||||.+....|+.|+|||||||+||||++ |..|+..+...
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~-- 528 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT-- 528 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH--
Confidence 99999999999999966544332211 1122 456999999999999999999999999999996 44565432100
Q ss_pred hcCChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchh
Q 035917 534 SSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAA 588 (611)
Q Consensus 534 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 588 (611)
..+.+.+...-+.+.+..+..++.++++.||+.+|++||++.++.+.++...+
T Consensus 529 --~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 529 --EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred --HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 00011111111111122223445566669999999999999999999998544
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=292.60 Aligned_cols=259 Identities=20% Similarity=0.274 Sum_probs=196.2
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCC-----eeE
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE-----EKL 395 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~-----~~~ 395 (611)
+|...+.||.|++|.||+|+.. +++.||||++.... ...+.+.+|+.+++.++|+||+++.+++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 3667789999999999999964 58999999986532 23467899999999999999999999998775 789
Q ss_pred EEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
++|||+++ +|.+++.... .+++..+..++.+++.||+||| ..+|+||||||+||+++.++.++|+|||++.....
T Consensus 81 lv~e~~~~-~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchhh-hHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 99999984 8999887543 7999999999999999999999 78999999999999999999999999999987654
Q ss_pred CCC-CccccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhc-C-----------
Q 035917 476 SDE-SSFVNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSS-G----------- 536 (611)
Q Consensus 476 ~~~-~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~-~----------- 536 (611)
... ........++..|+|||.+.+. .++.++||||||+++|+|++|..+|..- ....... +
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence 321 0112334588899999998877 7899999999999999999998776311 1110000 0
Q ss_pred --ChhhhhchhhcCC------CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHchh
Q 035917 537 --RSKEAIDKALCGK------GYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS--LNSIAA 588 (611)
Q Consensus 537 --~~~~~~~~~l~~~------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~ 588 (611)
...+.+....... ..+.....+.+++.+||+.+|++||++.+++++ ++.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0000000000000 000011234555559999999999999999987 555444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=283.35 Aligned_cols=237 Identities=19% Similarity=0.181 Sum_probs=178.9
Q ss_pred CeeeecCCceEEEEEe-CCCCEEEEEeccccchh----HHHHHHHHHHH-hccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 330 NVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLG----EKKFRNEMNRL-GQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~----~~~~~~Ev~~l-~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
+.||+|+||.||+|.. .+|+.||||.++..... ...+..|..++ ...+|+||+++++++..++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999996 46899999998654321 23345555544 455899999999999999999999999999
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcccc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.+||+|||+++.... ..
T Consensus 82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~ 151 (260)
T cd05611 82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK 151 (260)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence 9999998754 35889999999999999999999 78999999999999999999999999999875432 11
Q ss_pred CCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc-hhhcCCCCHHHHHHHHHHH
Q 035917 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID-KALCGKGYDEEILQFLKVA 562 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~~~~~~~~~~l~~l~ 562 (611)
...|+..|+|||.+.+..++.++||||||+++|||++|..||..-............... +.......+.++.+++.
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-- 229 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLIN-- 229 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHH--
Confidence 235788999999998888899999999999999999999886321000000000000000 00001123344555554
Q ss_pred hhcccCCCCCCCCHHHH
Q 035917 563 CNCVVSRPKDRWSMYQV 579 (611)
Q Consensus 563 ~~Cl~~dP~~RPs~~ev 579 (611)
+||+.+|++||++.++
T Consensus 230 -~~l~~~p~~R~~~~~~ 245 (260)
T cd05611 230 -RLLCMDPAKRLGANGY 245 (260)
T ss_pred -HHccCCHHHccCCCcH
Confidence 9999999999976544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=288.69 Aligned_cols=252 Identities=22% Similarity=0.204 Sum_probs=191.1
Q ss_pred CCCCCeeeecCCceEEEEEe----CCCCEEEEEeccccc-----hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeE
Q 035917 326 FCSENVIISTRTGTTYKAML----PDGSVLAVKRLNTCK-----LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKL 395 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~----~~g~~vAvK~~~~~~-----~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~ 395 (611)
|...+.||+|++|.||+++. .+++.||||.++... ...+.+.+|++++.++ +||||+++.+.+..++..+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 56678999999999999984 357899999986432 2235688999999999 5999999999999889999
Q ss_pred EEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
+||||+++|+|.+++... ..+++..+..++.|+++||.||| ..+++||||||+||+++.++.++|+|||+++....
T Consensus 82 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 82 LILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 999999999999998754 35889999999999999999999 78999999999999999999999999999886543
Q ss_pred CCCCccccCCCcccccccccccCCCC--CCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-hcCCCCH
Q 035917 476 SDESSFVNGDLGEFGYIAPEYSSTMV--ASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-LCGKGYD 552 (611)
Q Consensus 476 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~ 552 (611)
... .......|+..|+|||...+.. .+.++||||||+++|||++|..|+.................... ......+
T Consensus 158 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd05583 158 EEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMS 236 (288)
T ss_pred ccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccC
Confidence 221 1112235889999999987655 78899999999999999999888632100000000000000000 0111223
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 035917 553 EEILQFLKVACNCVVSRPKDRWSMYQVYQSLNS 585 (611)
Q Consensus 553 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 585 (611)
.++.++ +.+||+.||++|||+.++.+.|+.
T Consensus 237 ~~l~~l---i~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 237 AEARDF---IQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHHHHH---HHHHhcCCHhhccCcchHHHHhcC
Confidence 444554 449999999999998877665543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=283.83 Aligned_cols=246 Identities=18% Similarity=0.205 Sum_probs=189.9
Q ss_pred cCCCCCeeeecCCceEEEEEe----CCCCEEEEEeccccc-----hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCee
Q 035917 325 SFCSENVIISTRTGTTYKAML----PDGSVLAVKRLNTCK-----LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEK 394 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~----~~g~~vAvK~~~~~~-----~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~ 394 (611)
+|...+.||+|+||.||+++. .+|+.||+|+++... ...+.+.+|++++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 466778999999999999985 478999999986432 2236688999999999 599999999999988889
Q ss_pred EEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccC
Q 035917 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~ 474 (611)
++||||+++++|.+++... ..+++..+..++.|+++||.||| +.+++||||||+|||++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 9999999999999998754 35888999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCCCccccCCCcccccccccccCCC--CCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-----c
Q 035917 475 SSDESSFVNGDLGEFGYIAPEYSSTM--VASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-----C 547 (611)
Q Consensus 475 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-----~ 547 (611)
.... .......|+..|+|||.+... .++.++||||||+++|||++|..|+..-. ......+..+... .
T Consensus 157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~ 231 (290)
T cd05613 157 EDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG----EKNSQAEISRRILKSEPPY 231 (290)
T ss_pred cccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC----ccccHHHHHHHhhccCCCC
Confidence 3221 112234588999999988653 46789999999999999999988863100 0000111111100 0
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 035917 548 GKGYDEEILQFLKVACNCVVSRPKDRW-----SMYQVYQS 582 (611)
Q Consensus 548 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 582 (611)
....+..+.. ++.+||+.||++|| ++.+++.+
T Consensus 232 ~~~~~~~~~~---ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 232 PQEMSALAKD---IIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CccCCHHHHH---HHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 1122334444 44599999999997 77887766
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=287.24 Aligned_cols=247 Identities=19% Similarity=0.271 Sum_probs=195.8
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeEEEE
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLR-HPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~~~~~lv~ 398 (611)
+|...+.||+|++|.||+|+.. +++.||+|++.... ...+.+.+|++++.+++ ||||+++++++..++..++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 5777889999999999999964 79999999986532 23456889999999998 999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++........
T Consensus 82 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 82 EYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 999999999999755 36999999999999999999999 78999999999999999999999999999886543221
Q ss_pred C------------------ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhh
Q 035917 479 S------------------SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKE 540 (611)
Q Consensus 479 ~------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~ 540 (611)
. .......|+..|+|||......++.++||||||++++++++|..|+........ ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~ 233 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT----FQK 233 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH----HHH
Confidence 0 111233578899999998888899999999999999999999888643211000 001
Q ss_pred hhchh-hcCCCCHHHHHHHHHHHhhcccCCCCCCCCH----HHHHHH
Q 035917 541 AIDKA-LCGKGYDEEILQFLKVACNCVVSRPKDRWSM----YQVYQS 582 (611)
Q Consensus 541 ~~~~~-l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~evl~~ 582 (611)
..+.. ......++.+.++++ +||+.+|++||++ .++++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~li~---~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 234 ILKLEYSFPPNFPPDAKDLIE---KLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHhcCCCCCCccCHHHHHHHH---HHhcCCHhhCCCcccCHHHHhcC
Confidence 11100 011222344455444 9999999999999 887764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=292.66 Aligned_cols=255 Identities=21% Similarity=0.238 Sum_probs=189.0
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCC------
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE------ 392 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~------ 392 (611)
.++|...+.||+|+||.||+|+. .+++.||||++.... .....+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 46788889999999999999995 468999999985432 12346789999999999999999999876543
Q ss_pred --eeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccc
Q 035917 393 --EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLA 470 (611)
Q Consensus 393 --~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla 470 (611)
..++||||+.+ +|.+.+......+++..+..++.|+++||+||| +.+|+|+||||+||++++++.+||+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 46899999975 788877655557999999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCCc---------cccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhc
Q 035917 471 KLMTSSDESS---------FVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSS 535 (611)
Q Consensus 471 ~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~ 535 (611)
+......... ..+...|++.|+|||.+.+ ..++.++|||||||++|||++|+.+|... .......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 8654322111 1122357888999998765 45789999999999999999998775311 1110000
Q ss_pred -CC-----------hhhhh--------chhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 536 -GR-----------SKEAI--------DKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 536 -~~-----------~~~~~--------~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+. ..... .+.+.. ........+.+++.+|++.||++|||+.|++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 00 00000 000000 000111345566669999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=292.27 Aligned_cols=254 Identities=19% Similarity=0.266 Sum_probs=193.4
Q ss_pred cHHHHHHhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEe
Q 035917 315 KLADLMAASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVV 390 (611)
Q Consensus 315 ~~~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~ 390 (611)
...++..++++|...+.||+|+||.||+|.. .+++.||+|+++... ...+.+.+|+.++.+++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456677889999999999999999999984 578999999986532 224568899999999999999999998864
Q ss_pred C------CeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEE
Q 035917 391 E------EEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARI 464 (611)
Q Consensus 391 ~------~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl 464 (611)
. ...+++++++ +++|.+++... .+++..+..++.|+++||+||| +.+|+||||||+||++++++.+||
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEE
Confidence 3 3467888887 77999888643 4899999999999999999999 789999999999999999999999
Q ss_pred eecccccccCCCCCCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhh-cCC
Q 035917 465 MDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSS-SGR 537 (611)
Q Consensus 465 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~-~~~ 537 (611)
+|||+++..... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.. ....... ...
T Consensus 162 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 162 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred eccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999998864321 122357889999998765 5678999999999999999999887631 0111000 000
Q ss_pred -hhhhh---c--------h---hhcC-------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 538 -SKEAI---D--------K---ALCG-------KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 538 -~~~~~---~--------~---~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
..... . . .... ...+.++ .+++.+|++.||++||++.+++.|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLA---VDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHH---HHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000 0 0 0000 0122334 455559999999999999999988
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=305.51 Aligned_cols=259 Identities=22% Similarity=0.319 Sum_probs=207.7
Q ss_pred cHHHHHHhhhcCCCCCeeeecCCceEEEEE-eCCCCEEEEEeccccchhHHHHHHHHHHHhcc-CCCCccceeeEEEe--
Q 035917 315 KLADLMAASNSFCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVV-- 390 (611)
Q Consensus 315 ~~~~l~~~t~~f~~~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~-- 390 (611)
.++.+...++.|.+.++||+|.+|.||+++ .++++.+|+|+.......+++++.|.++++.. .|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 344445567778889999999999999999 67899999999988877788899999999988 59999999999874
Q ss_pred ---CCeeEEEEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEee
Q 035917 391 ---EEEKLLIYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMD 466 (611)
Q Consensus 391 ---~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~D 466 (611)
++..|||||||.+||..|++++-. ..+.|..+..|++.++.|+.+|| ...++|||+|-.|||+..++.+|+.|
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEee
Confidence 568999999999999999997644 36899999999999999999999 88999999999999999999999999
Q ss_pred cccccccCCCCCCccccCCCcccccccccccCCC-----CCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhh
Q 035917 467 FGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTM-----VASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEA 541 (611)
Q Consensus 467 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~ 541 (611)
||++..++... ....+.+||+.|||||++... .|+.++|+||+|++..||..|..|+.+........... ..
T Consensus 167 FGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip-RN 243 (953)
T KOG0587|consen 167 FGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-RN 243 (953)
T ss_pred eeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC-CC
Confidence 99998875432 222345799999999987543 47788999999999999999999987643321111100 01
Q ss_pred hchhh-cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 542 IDKAL-CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 542 ~~~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
-.|.+ .++.+.+++.+++ ..|+..|.++||++.++++|
T Consensus 244 PPPkLkrp~kWs~~FndFI---s~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 244 PPPKLKRPKKWSKKFNDFI---STCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred CCccccchhhHHHHHHHHH---HHHHhhccccCcchhhhccC
Confidence 11122 1233444445544 49999999999999998865
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=277.47 Aligned_cols=254 Identities=20% Similarity=0.290 Sum_probs=196.3
Q ss_pred ccccHHHHHHhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc--hhHHHHHHHHHHHhcc-CCCCccceeeE
Q 035917 312 VKVKLADLMAASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQL-RHPNLAPLLGY 387 (611)
Q Consensus 312 ~~~~~~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l-~H~nIv~l~g~ 387 (611)
..|+-++|+.- ..||.|.||+|+|-.+ +.|+..|||+++... ..+++++.|.+...+- +.||||+++|.
T Consensus 59 ~~F~~~~Lqdl-------g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 59 HTFTSDNLQDL-------GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred cccccchHHHH-------HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 34665555543 4699999999999885 579999999997543 4567899999875554 79999999999
Q ss_pred EEeCCeeEEEEeccCCCChHHhhh---cC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeE
Q 035917 388 CVVEEEKLLIYKYMSSGTLYSLLQ---GN-ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDAR 463 (611)
Q Consensus 388 ~~~~~~~~lv~ey~~~gsL~~~l~---~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~k 463 (611)
+..++..|+-||+|.- ||..+.+ .. ...+++...-+|....+.||.||.. ...|+|||+||+|||+|..|.+|
T Consensus 132 ~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vK 208 (361)
T KOG1006|consen 132 LFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVK 208 (361)
T ss_pred hhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEe
Confidence 9999999999999964 7655432 11 1357888888888889999999986 67899999999999999999999
Q ss_pred EeecccccccCCCCCCccccCCCcccccccccccCC--CCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhh
Q 035917 464 IMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSST--MVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEA 541 (611)
Q Consensus 464 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~ 541 (611)
|||||++..+..+ ...+...|...|||||.+.. ..|+.+|||||+|++|+|++||+.|+..|...+.+-..+ ..
T Consensus 209 LCDFGIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~V-v~ 284 (361)
T KOG1006|consen 209 LCDFGICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQV-VI 284 (361)
T ss_pred eecccchHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHH-Hc
Confidence 9999999876532 23344569999999998753 348999999999999999999999999997643321111 11
Q ss_pred hchh-hcC----CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 542 IDKA-LCG----KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 542 ~~~~-l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
-|+. +.. -..+..+..++. .|+..|-++||...++.++
T Consensus 285 gdpp~l~~~~~~~~~s~~~~~fin---tCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 285 GDPPILLFDKECVHYSFSMVRFIN---TCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CCCCeecCcccccccCHHHHHHHH---HHhhcccccCcchhhhhcC
Confidence 1222 111 123455666666 9999999999999998876
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=282.48 Aligned_cols=251 Identities=21% Similarity=0.232 Sum_probs=191.4
Q ss_pred CCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 326 FCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
|...+.||+|++|.||+|+.. +++.||+|.+.... ...+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 445678999999999999965 59999999997542 23467889999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
+ ++|.+++......+++..+..++.+++.||+||| ..+|+||||+|+||++++++.+||+|||+++....... .
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~ 154 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T 154 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence 8 5999999865456999999999999999999999 78999999999999999999999999999987643221 1
Q ss_pred ccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHHHHH-----HHHhhc-C-Chhhh---------hch
Q 035917 482 VNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLVDWV-----NQLSSS-G-RSKEA---------IDK 544 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~~~~-----~~~~~~-~-~~~~~---------~~~ 544 (611)
.....++..|+|||.+.+. .++.++|||||||++||++++..++.... ...... . ...+. .+.
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 2223467889999988766 78999999999999999999977653210 000000 0 00000 000
Q ss_pred hh---cCCCC----HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 545 AL---CGKGY----DEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 545 ~l---~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.. ..... +.....+.+++.+||+.||++||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00 00000 0112345666669999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=301.59 Aligned_cols=196 Identities=21% Similarity=0.300 Sum_probs=169.5
Q ss_pred cCCCCCeeeecCCceEEEEE-eCCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCC------eeE
Q 035917 325 SFCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE------EKL 395 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~------~~~ 395 (611)
.|...+.||+|+||.||+|+ -..|+.||||.++... ...+...+|+++|++++|+|||++++.-.... ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 34456889999999999999 6689999999997632 34567889999999999999999998765433 568
Q ss_pred EEEeccCCCChHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC--CCC--CeEEeeccc
Q 035917 396 LIYKYMSSGTLYSLLQGNA--TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD--EDF--DARIMDFGL 469 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld--~~~--~~kl~DFGl 469 (611)
+|||||.+|||+..|.+.. ..+++.+.+.+..+++.||.||| +.+|+||||||.||++- .+| .-||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999998654 47999999999999999999999 89999999999999983 333 479999999
Q ss_pred ccccCCCCCCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHH
Q 035917 470 AKLMTSSDESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLV 526 (611)
Q Consensus 470 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~ 526 (611)
||-+.++. ...+.+||..|.+||++.. ..|+...|.|||||++||.+||..||.
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 99886543 4566789999999999985 788999999999999999999999874
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=276.57 Aligned_cols=267 Identities=18% Similarity=0.266 Sum_probs=204.4
Q ss_pred cHHHHHHhhhcCCCCCeeeecCCceEEEEE-eCCCCEEEEEeccccc-hhHHHHHHHHHHHhccC-CCCccceeeEEEeC
Q 035917 315 KLADLMAASNSFCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLR-HPNLAPLLGYCVVE 391 (611)
Q Consensus 315 ~~~~l~~~t~~f~~~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~ 391 (611)
+++|+.+.|+ ++||+|+|+.|--++ +.+|..||||++.+.. ....+..+|++++...+ |+||+.+++||+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 4678888876 899999999999998 7899999999997654 34577999999999996 99999999999999
Q ss_pred CeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC---CeEEeecc
Q 035917 392 EEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF---DARIMDFG 468 (611)
Q Consensus 392 ~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~---~~kl~DFG 468 (611)
...|||||-|.||.|..+++++ ..+++.++.++..+|+.||.||| .++|.|||+||+|||..+.. -+||+||.
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred ceEEEEEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccc
Confidence 9999999999999999998865 45899999999999999999999 89999999999999996433 48999998
Q ss_pred cccccCCCC-----CCccccCCCcccccccccccC-----CCCCCcccchHHHHHHHHHHhCCCCCHHHHHHH--HhhcC
Q 035917 469 LAKLMTSSD-----ESSFVNGDLGEFGYIAPEYSS-----TMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQ--LSSSG 536 (611)
Q Consensus 469 la~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~--~~~~~ 536 (611)
+..-+.... .+....+.+|+..|||||+.. ...|+.++|.||+|||||-|+.|..||...-.. -..++
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG 304 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG 304 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence 875432221 222334568999999999642 345899999999999999999999998532110 01111
Q ss_pred Chhh-----hhchhhcC---------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHchhhhCCC
Q 035917 537 RSKE-----AIDKALCG---------KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS--LNSIAAQHGFS 593 (611)
Q Consensus 537 ~~~~-----~~~~~l~~---------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~~~~~~ 593 (611)
..-. .+.....+ ...+++..+++. ..+..|+.+|-++.++++| .+.+.++..++
T Consensus 305 e~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlis---nLlvrda~~rlsa~~vlnhPw~~~~~~ekalp 374 (463)
T KOG0607|consen 305 EVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLIS---NLLVRDAKQRLSAAQVLNHPWVQRCAPEKALP 374 (463)
T ss_pred CccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHH---HHHhccHHhhhhhhhccCCccccccchhccCC
Confidence 1111 11111111 112455666666 7888999999999999984 45555444333
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=281.82 Aligned_cols=246 Identities=17% Similarity=0.205 Sum_probs=186.1
Q ss_pred CCCCCeeeecCCceEEEEEeC-CCCEEEEEecccc------chhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 326 FCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTC------KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~------~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
|...+.||+|+||.||+++.. .+..+++|.++.. .....++..|+.++++++||||+++++++.+.+..++||
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 667789999999999999854 3445555555431 122345778999999999999999999999999999999
Q ss_pred eccCCCChHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 399 KYMSSGTLYSLLQG---NATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 399 ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
||+++++|.+++.. ....+++..++.++.|+++||.||| +.+++|+||||+||++++ +.+||+|||+++....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999998863 2246899999999999999999999 789999999999999985 5699999999987643
Q ss_pred CCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHH
Q 035917 476 SDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEI 555 (611)
Q Consensus 476 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 555 (611)
... ......|+..|+|||...+..++.++||||||+++|+|+++..++.......... .......+.. ....+.++
T Consensus 158 ~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~ 233 (260)
T cd08222 158 SCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVL-RIVEGPTPSL-PETYSRQL 233 (260)
T ss_pred Ccc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH-HHHcCCCCCC-cchhcHHH
Confidence 221 1122357889999999888888999999999999999999988763210000000 0000001111 11223344
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+++.+||+.+|++||++.|++++
T Consensus 234 ---~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 234 ---NSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ---HHHHHHHhcCChhhCcCHHHHhhC
Confidence 445559999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=287.66 Aligned_cols=250 Identities=20% Similarity=0.251 Sum_probs=185.0
Q ss_pred cCCCCCeeeecCCceEEEEEeC-C--CCEEEEEeccccc---hhHHHHHHHHHHHhcc-CCCCccceeeEEEeC----Ce
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-D--GSVLAVKRLNTCK---LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVE----EE 393 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~--g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~----~~ 393 (611)
+|...+.||+|+||.||+++.. + +..||+|++.... ...+.+.+|+.++.++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3666789999999999999954 3 7899999986421 2245688999999999 599999999876432 34
Q ss_pred eEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccccc
Q 035917 394 KLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLM 473 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~ 473 (611)
.++++||+. ++|.+++... ..+++..+..++.|++.||+||| ..+|+||||||+||++++++.+||+|||+++..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 678899986 5899988644 46899999999999999999999 789999999999999999999999999999865
Q ss_pred CCCCC--CccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhhc-C-Chhhhh-
Q 035917 474 TSSDE--SSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSSS-G-RSKEAI- 542 (611)
Q Consensus 474 ~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~~-~-~~~~~~- 542 (611)
..... ........|+..|+|||+..+ ..++.++|||||||++|+|++|+.+|.. ........ + ...+.+
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 43221 111233468999999998765 4689999999999999999998876521 00000000 0 000000
Q ss_pred ---ch-----------------hhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 543 ---DK-----------------ALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 543 ---~~-----------------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+ .......+. .+.+++.+|++.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANP---LALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCH---HHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 000011123 34455559999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=291.89 Aligned_cols=250 Identities=17% Similarity=0.214 Sum_probs=185.8
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeC----------
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE---------- 391 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~---------- 391 (611)
.+|...+.||.|+||.||+|.. .+|+.||+|.+.... ...+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5677889999999999999995 568999999986543 3346688999999999999999999876543
Q ss_pred ----CeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC-CCCCeEEee
Q 035917 392 ----EEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD-EDFDARIMD 466 (611)
Q Consensus 392 ----~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld-~~~~~kl~D 466 (611)
...++||||++ ++|.+++... .+++..+..++.|+++||.||| +.+|+||||||+||+++ +++.+|++|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECC
Confidence 35789999997 5999888643 4889999999999999999999 78999999999999997 456789999
Q ss_pred cccccccCCCCC-CccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcC---
Q 035917 467 FGLAKLMTSSDE-SSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSG--- 536 (611)
Q Consensus 467 FGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~--- 536 (611)
||+++.+..... ........|+..|+|||.+.. ..++.++|||||||++|||++|+.||... ........
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999986532211 111122357889999997644 56788999999999999999999877311 00000000
Q ss_pred ------Chhhhhchhh-----c--------CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 537 ------RSKEAIDKAL-----C--------GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 537 ------~~~~~~~~~l-----~--------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.......... . ....+. ++.+++.+|++.||++|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNP---EALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCH---HHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000000000 0 011223 34455559999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=291.21 Aligned_cols=246 Identities=18% Similarity=0.206 Sum_probs=185.5
Q ss_pred CCeeeecCCceEEEEEeC-CCCEEEEEeccccchh---------------HHHHHHHHHHHhccCCCCccceeeEEEeCC
Q 035917 329 ENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLG---------------EKKFRNEMNRLGQLRHPNLAPLLGYCVVEE 392 (611)
Q Consensus 329 ~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~---------------~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~ 392 (611)
.+.||+|+||.||+|+.. +++.||||.++..... ...+.+|++++++++||||+++++++..++
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 478999999999999954 6899999998543211 124789999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccc
Q 035917 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKL 472 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~ 472 (611)
..++||||+. |+|.+++... ..+++.....++.|++.||+||| +.+++|+||||+||+++.++.+||+|||+++.
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~ 168 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARR 168 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECCccceee
Confidence 9999999997 5999988643 35889999999999999999999 78999999999999999999999999999986
Q ss_pred cCCCC------------CCccccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHHHHH-----HHHhh
Q 035917 473 MTSSD------------ESSFVNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLVDWV-----NQLSS 534 (611)
Q Consensus 473 ~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~~~~-----~~~~~ 534 (611)
..... .........++..|+|||++.+. .++.++|||||||++|||++|+.++.... .....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~ 248 (335)
T PTZ00024 169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE 248 (335)
T ss_pred cccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 54111 01111223468899999988764 46899999999999999999887763210 00000
Q ss_pred ---cCC---hhhh--------hch----hh--cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 535 ---SGR---SKEA--------IDK----AL--CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 535 ---~~~---~~~~--------~~~----~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
... .... ... .. .....++ .+.+++.+||+.+|++||++.|++.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 249 LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASD---DAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCCh---HHHHHHHHHcCCCchhccCHHHHhcC
Confidence 000 0000 000 00 0011123 34556669999999999999999975
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=289.61 Aligned_cols=248 Identities=20% Similarity=0.253 Sum_probs=189.3
Q ss_pred HhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCC----
Q 035917 321 AASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE---- 392 (611)
Q Consensus 321 ~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~---- 392 (611)
...++|...+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+.++++++||||+++++++..+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3456788889999999999999984 579999999985432 22356889999999999999999999987543
Q ss_pred --eeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccc
Q 035917 393 --EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLA 470 (611)
Q Consensus 393 --~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla 470 (611)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+||| ..+|+||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 358999999 6799988864 35899999999999999999999 889999999999999999999999999999
Q ss_pred cccCCCCCCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhhc-CChhhhhc
Q 035917 471 KLMTSSDESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSSS-GRSKEAID 543 (611)
Q Consensus 471 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~~-~~~~~~~~ 543 (611)
....... ....+++.|+|||.+.+ ..++.++|||||||++|++++|+.||.. ........ ......+.
T Consensus 166 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07880 166 RQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240 (343)
T ss_pred cccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 8653221 22357889999998765 4588999999999999999999887631 11111000 00000000
Q ss_pred hh---------------hc-------CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 544 KA---------------LC-------GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 544 ~~---------------l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.. .. ....+. .+.+++.+|++.||++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANP---LAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HhhcchhHHHHHHhccccCcchHHHhccCCCh---HHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 00 011122 34556669999999999999999965
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=274.57 Aligned_cols=237 Identities=21% Similarity=0.229 Sum_probs=187.5
Q ss_pred eeecCCceEEEEEeC-CCCEEEEEeccccch----hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCCh
Q 035917 332 IISTRTGTTYKAMLP-DGSVLAVKRLNTCKL----GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTL 406 (611)
Q Consensus 332 ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~----~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL 406 (611)
||.|+||.||++... +++.||+|.++.... ....+.+|+.++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999965 589999999865432 335789999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccCCC
Q 035917 407 YSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDL 486 (611)
Q Consensus 407 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 486 (611)
.+++... ..+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~ 154 (250)
T cd05123 81 FSHLSKE-GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFC 154 (250)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCCc
Confidence 9999755 35899999999999999999999 78999999999999999999999999999987643211 122345
Q ss_pred cccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHHHHHHHHHhhc
Q 035917 487 GEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEILQFLKVACNC 565 (611)
Q Consensus 487 gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~~l~~~C 565 (611)
++..|+|||...+...+.++|+||||+++||+++|..||....... .......... .....++++.+++ .+|
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~~i---~~~ 227 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE----IYEKILKDPLRFPEFLSPEARDLI---SGL 227 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHhcCCCCCCCCCCHHHHHHH---HHH
Confidence 7889999999988888999999999999999999988863211000 0000111011 1122234445544 499
Q ss_pred ccCCCCCCCCH---HHHHH
Q 035917 566 VVSRPKDRWSM---YQVYQ 581 (611)
Q Consensus 566 l~~dP~~RPs~---~evl~ 581 (611)
|..||++||++ .++++
T Consensus 228 l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 228 LQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred hcCCHhhCCCcccHHHHHh
Confidence 99999999999 55544
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=288.65 Aligned_cols=250 Identities=20% Similarity=0.286 Sum_probs=189.7
Q ss_pred hhhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCe----
Q 035917 322 ASNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEE---- 393 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~---- 393 (611)
..++|.....||+|++|.||+|+.. +++.||||++.... ...+.+.+|+.++++++||||+++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4567888899999999999999964 68899999986432 233567889999999999999999998876554
Q ss_pred --eEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccc
Q 035917 394 --KLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAK 471 (611)
Q Consensus 394 --~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~ 471 (611)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+||| +.+|+||||||+||++++++.+||+|||++.
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence 89999999 5699998875 35899999999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCCCCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhc-CC-hhhh--
Q 035917 472 LMTSSDESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSS-GR-SKEA-- 541 (611)
Q Consensus 472 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~-~~-~~~~-- 541 (611)
..... .....++..|+|||.+.+ ..++.++|||||||++||+++|+.||... ....... +. ....
T Consensus 167 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 167 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred ccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence 65322 223357889999998754 36789999999999999999998876321 1111000 00 0000
Q ss_pred ----------hchh--hcCCCCH----HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 542 ----------IDKA--LCGKGYD----EEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 542 ----------~~~~--l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+... ....... .....+.+++.+|++.||++|||+.||++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000 0000000 012345556669999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=311.81 Aligned_cols=144 Identities=20% Similarity=0.277 Sum_probs=129.4
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||.||+|... +++.||||+++... .....+.+|+.++..++||||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 46777899999999999999965 68999999996532 22367889999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccc
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAK 471 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~ 471 (611)
||+++++|.+++... ..+++..++.|+.||+.||+||| ..+|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998754 35889999999999999999999 7899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=271.78 Aligned_cols=219 Identities=19% Similarity=0.195 Sum_probs=172.7
Q ss_pred cCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCChHHhhhcC
Q 035917 335 TRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGN 413 (611)
Q Consensus 335 G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~ 413 (611)
|.+|.||+++. .+++.||+|+++... .+.+|...+....||||+++++++...+..++||||+++|+|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 88999999995 568999999996542 3345555566667999999999999999999999999999999998654
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccCCCccccccc
Q 035917 414 ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIA 493 (611)
Q Consensus 414 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 493 (611)
..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.++++|||.+...... .....++..|+|
T Consensus 80 -~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~a 150 (237)
T cd05576 80 -LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCA 150 (237)
T ss_pred -cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccC
Confidence 35899999999999999999999 889999999999999999999999999988665322 122346778999
Q ss_pred ccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCC
Q 035917 494 PEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDR 573 (611)
Q Consensus 494 PE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 573 (611)
||...+..++.++||||+|+++|||++|..++....... .......+ +...++.+.++++ +|++.||++|
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~~~~~~~~-~~~~~~~~~~li~---~~l~~dp~~R 220 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------NTHTTLNI-PEWVSEEARSLLQ---QLLQFNPTER 220 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------ccccccCC-cccCCHHHHHHHH---HHccCCHHHh
Confidence 999988889999999999999999999986642210000 00000011 1223445555555 9999999999
Q ss_pred CCH
Q 035917 574 WSM 576 (611)
Q Consensus 574 Ps~ 576 (611)
|++
T Consensus 221 ~~~ 223 (237)
T cd05576 221 LGA 223 (237)
T ss_pred cCC
Confidence 997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=270.65 Aligned_cols=251 Identities=16% Similarity=0.165 Sum_probs=191.1
Q ss_pred hhhcCCC-CCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhcc-CCCCccceeeEEEe----CCee
Q 035917 322 ASNSFCS-ENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVV----EEEK 394 (611)
Q Consensus 322 ~t~~f~~-~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~----~~~~ 394 (611)
.|++|.+ .++||-|-.|.|-.+.. .+++.+|+|++..+ .+.++|+++--.. .|||||.++++|.+ ....
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4555554 36899999999999885 56899999999543 4567899886666 59999999999864 3456
Q ss_pred EEEEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC---CCCeEEeecccc
Q 035917 395 LLIYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE---DFDARIMDFGLA 470 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~---~~~~kl~DFGla 470 (611)
++|||.|+||.|++.+.+++ ..+++.++-.|+.||+.|+.||| +.+|.||||||+|+|... +-..||+|||+|
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccc
Confidence 79999999999999998765 47999999999999999999999 899999999999999963 557999999999
Q ss_pred cccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc--hhhcC
Q 035917 471 KLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID--KALCG 548 (611)
Q Consensus 471 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~ 548 (611)
+.-.. .....+.+-|++|.|||++...+|+..+|+||+||++|-|+.|..||..........+....+.. .....
T Consensus 212 K~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~ 288 (400)
T KOG0604|consen 212 KETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE 288 (400)
T ss_pred cccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence 86532 23344567899999999999999999999999999999999999998542211111110000000 00111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 549 KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 549 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
..++..-.+..++++..+..+|++|.|+.++++|
T Consensus 289 pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 289 PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1122222233344448999999999999999876
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-33 Score=287.09 Aligned_cols=240 Identities=19% Similarity=0.266 Sum_probs=190.4
Q ss_pred CCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCC
Q 035917 329 ENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSG 404 (611)
Q Consensus 329 ~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~g 404 (611)
+++||+|.||+||-|+. ++|+.||||++.+-. ..+.++++|+.||++++||.||.+...|+..+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 58999999999999995 579999999996533 3456799999999999999999999999999999999999965
Q ss_pred ChHH-hhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC---CCCeEEeecccccccCCCCCCc
Q 035917 405 TLYS-LLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE---DFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 405 sL~~-~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~---~~~~kl~DFGla~~~~~~~~~~ 480 (611)
+..+ +|....+.+++.....++.||+.||.||| .++|+|+||||+|||+.. --.+||+|||+|+.+....
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--- 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--- 721 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh---
Confidence 6555 44444457999999999999999999999 899999999999999963 3479999999999986543
Q ss_pred cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhch-h-hc-CCCCHHHHHH
Q 035917 481 FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDK-A-LC-GKGYDEEILQ 557 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~-~-l~-~~~~~~~~~~ 557 (611)
...+.+||+.|.|||+++.+.|...-|+||.|||+|--+.|..||.+. +.+.+.+.. . +. ...+.+.-..
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd-------EdIndQIQNAaFMyPp~PW~eis~~ 794 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED-------EDINDQIQNAAFMYPPNPWSEISPE 794 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc-------cchhHHhhccccccCCCchhhcCHH
Confidence 234457999999999999999999999999999999999999888431 111111111 0 11 1122222234
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.++++...++..-.+|.+.++.+.|
T Consensus 795 AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 795 AIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred HHHHHHHHHHHHHHHhcchHhhccc
Confidence 4455558999999999998877654
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=302.39 Aligned_cols=258 Identities=19% Similarity=0.157 Sum_probs=204.5
Q ss_pred HHHHHHhhhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEecccc----chhHHHHHHHHHHHhccCCCCccceeeEEEe
Q 035917 316 LADLMAASNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTC----KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVV 390 (611)
Q Consensus 316 ~~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~----~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~ 390 (611)
+.++....++|.+.++||+|+||.|..++++ +++.||+|++++. ......|..|-.+|..-+.+-||.+.-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3556666778999999999999999999964 6899999999763 2344679999999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccc
Q 035917 391 EEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLA 470 (611)
Q Consensus 391 ~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla 470 (611)
+.+.|+|||||+||||..++.+.. .+++.-+..++..|+.||.-+| +.|+|||||||+|||||.+|.+||+|||.+
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhH
Confidence 999999999999999999998665 6888888889999999999999 899999999999999999999999999988
Q ss_pred cccCCCCCCccccCCCcccccccccccC----C-CCCCcccchHHHHHHHHHHhCCCCCHHHHH--HHHhhcCChhhhhc
Q 035917 471 KLMTSSDESSFVNGDLGEFGYIAPEYSS----T-MVASLKGDVYGIGVVLLELAGFKGNLVDWV--NQLSSSGRSKEAID 543 (611)
Q Consensus 471 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~~--~~~~~~~~~~~~~~ 543 (611)
-.+..++ .......+|||-|++||++. + +.|+..+|.||+||++|||+.|..||.... ..+-.-....+.+.
T Consensus 223 lkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~ 301 (1317)
T KOG0612|consen 223 LKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLS 301 (1317)
T ss_pred HhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcC
Confidence 7775443 22334458999999999874 2 578999999999999999999999985321 11110001111111
Q ss_pred hhhcCCCCHHHHHHHHHHHhhcccCCCCCCCC---HHHHHHHH
Q 035917 544 KALCGKGYDEEILQFLKVACNCVVSRPKDRWS---MYQVYQSL 583 (611)
Q Consensus 544 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~L 583 (611)
-. .....+++..++|. +.+ -+|+.|.. +.++-.|-
T Consensus 302 FP-~~~~VSeeakdLI~---~ll-~~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 302 FP-DETDVSEEAKDLIE---ALL-CDREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred CC-cccccCHHHHHHHH---HHh-cChhhhcccccHHHHHhCc
Confidence 11 11235677888777 433 45788887 99998874
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=266.13 Aligned_cols=245 Identities=20% Similarity=0.221 Sum_probs=197.8
Q ss_pred hcCCCCCeeeecCCceEEEEE-eCCCCEEEEEeccccch-hH---HHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCKL-GE---KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~~-~~---~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...++||+|.||.|-.++ ...|+.+|+|++++.-. .. ..-..|-++|+..+||.+..+.-.+...+..|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 567777899999999999998 55799999999976432 12 23567899999999999999988888999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||..||.|+-+|.+. ..+++.....+-..|+.||.||| +.+||.||+|.+|.|+|.+|.+||+|||+++.-...
T Consensus 248 eyanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~-- 321 (516)
T KOG0690|consen 248 EYANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY-- 321 (516)
T ss_pred EEccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcccc--
Confidence 999999999888754 35777778888999999999999 789999999999999999999999999999854322
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc--hhhcCCCCHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID--KALCGKGYDEEIL 556 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~ 556 (611)
.......+||+.|.|||++....|+...|.|.+|||+|||++|+.||...... ...+.+- ..-.+...+.+.+
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-----kLFeLIl~ed~kFPr~ls~eAk 396 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-----KLFELILMEDLKFPRTLSPEAK 396 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh-----HHHHHHHhhhccCCccCCHHHH
Confidence 22345678999999999999999999999999999999999999998542211 1111111 0111233456777
Q ss_pred HHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 035917 557 QFLKVACNCVVSRPKDRW-----SMYQVYQS 582 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 582 (611)
.++. ..+..||++|. .+.||.+|
T Consensus 397 tLLs---GLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 397 TLLS---GLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred HHHH---HHhhcChHhhcCCCchhHHHHHhh
Confidence 7777 88999999997 46777665
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=263.84 Aligned_cols=196 Identities=23% Similarity=0.309 Sum_probs=162.1
Q ss_pred hhcCCCCCeeeecCCceEEEEEeCC-----CCEEEEEeccccchh---HHHHHHHHHHHhccCCCCccceeeEEEe-CCe
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLPD-----GSVLAVKRLNTCKLG---EKKFRNEMNRLGQLRHPNLAPLLGYCVV-EEE 393 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~~-----g~~vAvK~~~~~~~~---~~~~~~Ev~~l~~l~H~nIv~l~g~~~~-~~~ 393 (611)
-..|.....||+|.||.||+|+-.+ .+.+|+|+++..+.. .....+|+.+++.++||||+.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3467778899999999999997332 347999999765322 2457899999999999999999999887 778
Q ss_pred eEEEEeccCCCChHHhhhcCC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCC----CCeEEe
Q 035917 394 KLLIYKYMSSGTLYSLLQGNA----TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDED----FDARIM 465 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~----~~~kl~ 465 (611)
.++++||.+. +|.++++-++ ..++-.....|..||+.|+.||| +.=|+||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEee
Confidence 8999999998 9999886432 36888899999999999999999 7889999999999999776 899999
Q ss_pred ecccccccCCCCCC-ccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCC
Q 035917 466 DFGLAKLMTSSDES-SFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFK 522 (611)
Q Consensus 466 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~ 522 (611)
|||+++.+...-.. ......+-|..|.|||.+.+ ..||.+.||||.|||..||++-+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~ 237 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLE 237 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccC
Confidence 99999987543211 12233467899999998876 46899999999999999999543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=287.83 Aligned_cols=240 Identities=15% Similarity=0.164 Sum_probs=192.9
Q ss_pred hhcCCCCCeeeecCCceEEEEE-eCCCCEEEEEeccccchhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEEEEec
Q 035917 323 SNSFCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
++.|.....+|.|+|+.|-++. ..+++..+||++... ..+-.+|+.++... +||||+++.+.+.++.+.|+|||+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 5667777889999999999988 457899999999665 23345678776666 699999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEe-CCCCCeEEeecccccccCCCCCC
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV-DEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl-d~~~~~kl~DFGla~~~~~~~~~ 479 (611)
+.+|-+.+.+..... .. ..+..|+.+++.|+.||| ..++|||||||+|||+ ++.+.++|+|||.++.....
T Consensus 398 l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 398 LDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred ccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 999988887764432 22 677789999999999999 8999999999999999 68899999999999977543
Q ss_pred ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHH
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFL 559 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 559 (611)
..+.+-|..|.|||+.....|++++|+||||++||+|++|..|+...-.. ..+...+...-.....++++++++
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~ei~~~i~~~~~s~~vS~~AKdLl 543 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IEIHTRIQMPKFSECVSDEAKDLL 543 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----HHHHHhhcCCccccccCHHHHHHH
Confidence 22335688999999999999999999999999999999999887432111 011111111111145677888888
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 035917 560 KVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 560 ~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
. +||+.||.+||+|.++..|
T Consensus 544 ~---~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 544 Q---QLLQVDPALRLGADEIGAH 563 (612)
T ss_pred H---HhccCChhhCcChhhhccC
Confidence 8 9999999999999999876
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=240.73 Aligned_cols=192 Identities=20% Similarity=0.273 Sum_probs=165.2
Q ss_pred cCCCCCeeeecCCceEEEEE-eCCCCEEEEEeccccch---hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 325 SFCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCKL---GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~~---~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
+|...+.||+|.||+||||+ .++++.||+|+++.+.. -.....+|+.+++.++|+|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 34455789999999999999 56789999999965432 246789999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
|.. +|..+...-.+.++......++.|+.+||.|+| ++.++|||+||.|.|++.+|+.|++|||+++.+.-.- .
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipv--r 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--R 156 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--E
Confidence 976 898888766677999999999999999999999 8899999999999999999999999999999764321 2
Q ss_pred cccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCC
Q 035917 481 FVNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFK 522 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~ 522 (611)
.....+-|..|.+|.++.+. -|++..|+||-||++.|+....
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanag 199 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcC
Confidence 22344578999999998775 4899999999999999998433
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-33 Score=261.98 Aligned_cols=251 Identities=20% Similarity=0.247 Sum_probs=189.6
Q ss_pred CCCCCeeeecCCceEEEEEeC-CCCEEEEEeccc---cchhHHHHHHHHHHHhccCCCCccceeeEEEeC--------Ce
Q 035917 326 FCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNT---CKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE--------EE 393 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~---~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~--------~~ 393 (611)
|....+||+|.||.||+|+.+ .|+.||+|++-. ...-.....+|+++|..++|+|++.+++.|... ..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 344568999999999999954 578899987632 222345678999999999999999999988642 34
Q ss_pred eEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccccc
Q 035917 394 KLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLM 473 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~ 473 (611)
.++||++|+. +|.-+|......++..++.+++.++..||.|+| ...|+|||+|++|+|++.++.+||+|||+++.+
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 7899999988 999999876667899999999999999999999 889999999999999999999999999999876
Q ss_pred CCCC--CCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHHH--------HHH----------
Q 035917 474 TSSD--ESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDWV--------NQL---------- 532 (611)
Q Consensus 474 ~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~~--------~~~---------- 532 (611)
.... .....+..+-|..|.+||.+.+ ..|+++.|||.-|||+.||.++..-+..-. ..+
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP 254 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP 254 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence 5433 1222344566999999998776 468999999999999999997654321100 000
Q ss_pred -hhcCCh-------------hhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 035917 533 -SSSGRS-------------KEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSL 583 (611)
Q Consensus 533 -~~~~~~-------------~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 583 (611)
...-.. ...+...+.+-..+++..++++ +.+..||.+|+++++++.|-
T Consensus 255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle---~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLE---KLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHH---HHhccCcccCcchHhhhchh
Confidence 000000 1111112222223455666666 89999999999999998774
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=260.48 Aligned_cols=236 Identities=23% Similarity=0.294 Sum_probs=185.9
Q ss_pred CCceEEEEEeC-CCCEEEEEeccccchh--HHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCChHHhhhc
Q 035917 336 RTGTTYKAMLP-DGSVLAVKRLNTCKLG--EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQG 412 (611)
Q Consensus 336 ~~g~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~ 412 (611)
+||.||+|+.. +|+.+|+|++...... .+.+.+|++.+++++|+||+++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999975 5899999999754322 57899999999999999999999999999999999999999999999875
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccCCCcccccc
Q 035917 413 NATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYI 492 (611)
Q Consensus 413 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 492 (611)
.. .+++..+..++.++++++.||| ..+++|+||+|+||++++++.++++|||.+....... ......++..|+
T Consensus 81 ~~-~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ 153 (244)
T smart00220 81 RG-RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM 153 (244)
T ss_pred cc-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence 43 3899999999999999999999 7899999999999999999999999999998765432 222345888999
Q ss_pred cccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcC-CCCHH-HHHHHHHHHhhcccCCC
Q 035917 493 APEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCG-KGYDE-EILQFLKVACNCVVSRP 570 (611)
Q Consensus 493 aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~-~~~~l~~l~~~Cl~~dP 570 (611)
+||......++.++||||||+++++++++..|+...... ....+........ ..... ....+.+++.+|+..+|
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 229 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL----LELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDP 229 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCc
Confidence 999998888899999999999999999998776321000 0000001000000 00000 22345556669999999
Q ss_pred CCCCCHHHHHHH
Q 035917 571 KDRWSMYQVYQS 582 (611)
Q Consensus 571 ~~RPs~~evl~~ 582 (611)
++||++.+++++
T Consensus 230 ~~Rp~~~~~~~~ 241 (244)
T smart00220 230 EKRLTAEEALQH 241 (244)
T ss_pred hhccCHHHHhhC
Confidence 999999999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=291.99 Aligned_cols=254 Identities=18% Similarity=0.135 Sum_probs=164.5
Q ss_pred hhhcCCCCCeeeecCCceEEEEEeC-C----CCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeE------EEe
Q 035917 322 ASNSFCSENVIISTRTGTTYKAMLP-D----GSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGY------CVV 390 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~~-~----g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~------~~~ 390 (611)
..++|...+.||+|+||.||+|++. + +..||||++...... +.+..| .+....+.+++.+... +..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 4568889999999999999999964 4 689999998643221 111111 1122222333322221 234
Q ss_pred CCeeEEEEeccCCCChHHhhhcCCCC-------------------CCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 035917 391 EEEKLLIYKYMSSGTLYSLLQGNATE-------------------LDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICS 451 (611)
Q Consensus 391 ~~~~~lv~ey~~~gsL~~~l~~~~~~-------------------l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp 451 (611)
++..++||||+++++|.+++...... .....+..++.|++.||+||| +.+|+||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCCH
Confidence 56789999999999999988643211 112345679999999999999 78999999999
Q ss_pred CeEEeCC-CCCeEEeecccccccCCCCCCccccCCCcccccccccccCCC----------------------CCCcccch
Q 035917 452 NVILVDE-DFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTM----------------------VASLKGDV 508 (611)
Q Consensus 452 ~NILld~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~ksDV 508 (611)
+|||++. ++.+||+|||+|+.+.... ........|++.|+|||.+... .++.++||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 9999985 5799999999998654322 1222345689999999965321 23456799
Q ss_pred HHHHHHHHHHhCCCCCHHHHH----HHHhhcCChh----hhhchhhcCC------CCHHHHHHHHHHHhhcccCCCCCCC
Q 035917 509 YGIGVVLLELAGFKGNLVDWV----NQLSSSGRSK----EAIDKALCGK------GYDEEILQFLKVACNCVVSRPKDRW 574 (611)
Q Consensus 509 ~SfGvvl~ell~~~~~~~~~~----~~~~~~~~~~----~~~~~~l~~~------~~~~~~~~l~~l~~~Cl~~dP~~RP 574 (611)
|||||++|||+++..+..+.. ......+... ..+.+..... ..+.......+++.+|++.||++||
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ 442 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI 442 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC
Confidence 999999999997654322211 1111111000 0011100000 0000111233555699999999999
Q ss_pred CHHHHHHH
Q 035917 575 SMYQVYQS 582 (611)
Q Consensus 575 s~~evl~~ 582 (611)
|+.|+++|
T Consensus 443 ta~e~L~H 450 (566)
T PLN03225 443 SAKAALAH 450 (566)
T ss_pred CHHHHhCC
Confidence 99999987
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=284.86 Aligned_cols=253 Identities=20% Similarity=0.194 Sum_probs=175.5
Q ss_pred hhhcCCCCCeeeecCCceEEEEEe-----------------CCCCEEEEEeccccch-hHH--------------HHHHH
Q 035917 322 ASNSFCSENVIISTRTGTTYKAML-----------------PDGSVLAVKRLNTCKL-GEK--------------KFRNE 369 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~-----------------~~g~~vAvK~~~~~~~-~~~--------------~~~~E 369 (611)
..++|...++||+|+||.||+|.+ .+++.||||+++.... ..+ .+..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 2457899999864322 122 23457
Q ss_pred HHHHhccCCCCc-----cceeeEEEe--------CCeeEEEEeccCCCChHHhhhcCC----------------------
Q 035917 370 MNRLGQLRHPNL-----APLLGYCVV--------EEEKLLIYKYMSSGTLYSLLQGNA---------------------- 414 (611)
Q Consensus 370 v~~l~~l~H~nI-----v~l~g~~~~--------~~~~~lv~ey~~~gsL~~~l~~~~---------------------- 414 (611)
+.++.+++|.++ +++++||.. .+..+|||||+++|+|.+++++..
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888876654 678888753 356899999999999999886421
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccCCCccccccc
Q 035917 415 -TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIA 493 (611)
Q Consensus 415 -~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 493 (611)
..++|..+..++.|++.||.||| ..+|+||||||+|||++.++.+||+|||+++.......... ....+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNP-LYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCc-cccCCCcceeC
Confidence 12467888999999999999999 78999999999999999999999999999976533221111 11235789999
Q ss_pred ccccCCCC--------------------C--CcccchHHHHHHHHHHhCCCC-CHHHH--HHHHh-hcCChhh-------
Q 035917 494 PEYSSTMV--------------------A--SLKGDVYGIGVVLLELAGFKG-NLVDW--VNQLS-SSGRSKE------- 540 (611)
Q Consensus 494 PE~~~~~~--------------------~--t~ksDV~SfGvvl~ell~~~~-~~~~~--~~~~~-~~~~~~~------- 540 (611)
||.+.... + ..+.||||+||++|||+++.. ++... ..... .......
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99875322 1 234799999999999998764 43211 01000 0000000
Q ss_pred -hhchhhcCCCCHHHHHHHHHHHhhcccCCC---CCCCCHHHHHHH
Q 035917 541 -AIDKALCGKGYDEEILQFLKVACNCVVSRP---KDRWSMYQVYQS 582 (611)
Q Consensus 541 -~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPs~~evl~~ 582 (611)
..+... ....++..++++. +++..+| .+|+|++|+++|
T Consensus 459 ~~~~~~~-~d~~s~~~~dLi~---~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 459 QKYDFSL-LDRNKEAGWDLAC---KLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cCCCccc-ccccChHHHHHHH---HHhccCCCCcccCCCHHHHhCC
Confidence 000000 1122344555555 8888765 789999999987
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=267.28 Aligned_cols=251 Identities=16% Similarity=0.202 Sum_probs=196.5
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhccC-C-C----CccceeeEEEeCCeeE
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLR-H-P----NLAPLLGYCVVEEEKL 395 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~-H-~----nIv~l~g~~~~~~~~~ 395 (611)
++.|.+...+|+|.||.|-++.. +.+..||||+++....-.+..+-|+++|+++. + | -+|.+.+|+...++.|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 56788888999999999999985 44799999999877767778889999999994 2 2 3788889999999999
Q ss_pred EEEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC----------------
Q 035917 396 LIYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE---------------- 458 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~---------------- 458 (611)
+|+|.+ |-|+++++..+. .+++...+..++.|++++++||| +.+++|-||||+|||+-+
T Consensus 168 ivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred EEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCcccee
Confidence 999999 459999998765 47999999999999999999999 899999999999999831
Q ss_pred ----CCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHH-----H--
Q 035917 459 ----DFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLV-----D-- 527 (611)
Q Consensus 459 ----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~-----~-- 527 (611)
+..+||.|||-|+...... ...+.|..|.|||++.+..++.++||||+||||+|+.+|..-|. +
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL 318 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL 318 (415)
T ss_pred ccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence 3358999999998653322 23457999999999999999999999999999999998764321 0
Q ss_pred -HHHHHh-----------------hcCCh-----------hhhhch----hhcCCCCHHHHHHHHHHHhhcccCCCCCCC
Q 035917 528 -WVNQLS-----------------SSGRS-----------KEAIDK----ALCGKGYDEEILQFLKVACNCVVSRPKDRW 574 (611)
Q Consensus 528 -~~~~~~-----------------~~~~~-----------~~~~~~----~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 574 (611)
.+.... ..+.+ ..+.++ .......+.+..++++|+.+++..||.+|+
T Consensus 319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri 398 (415)
T KOG0671|consen 319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI 398 (415)
T ss_pred HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence 000000 00000 000000 001122356777899999999999999999
Q ss_pred CHHHHHHH
Q 035917 575 SMYQVYQS 582 (611)
Q Consensus 575 s~~evl~~ 582 (611)
|+.|++.|
T Consensus 399 Tl~EAL~H 406 (415)
T KOG0671|consen 399 TLREALSH 406 (415)
T ss_pred cHHHHhcC
Confidence 99999876
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=245.89 Aligned_cols=201 Identities=20% Similarity=0.310 Sum_probs=166.5
Q ss_pred CCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc--hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEEEEecc
Q 035917 326 FCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
......||+|++|.|-+-++ .+|+..|||+++..- ...++..+|+.+..+. .+|.+|.++|.+......|+.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 33446799999999988884 689999999997543 3456788899875554 7999999999999999999999999
Q ss_pred CCCChHHhhh---cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 402 SSGTLYSLLQ---GNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 402 ~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
.- ||..+-. +.+..+++...-+|+..+.+||.|||+ +..++|||+||+|||++.+|++|+||||++..+.++-
T Consensus 128 ~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi- 203 (282)
T KOG0984|consen 128 DT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI- 203 (282)
T ss_pred hh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhh-
Confidence 65 7766543 234568889999999999999999997 6789999999999999999999999999998875432
Q ss_pred CccccCCCcccccccccccCC----CCCCcccchHHHHHHHHHHhCCCCCHHHHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSST----MVASLKGDVYGIGVVLLELAGFKGNLVDWVNQL 532 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~----~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~ 532 (611)
..+-..|...|||||.+.. ..|+.|+||||+|+++.||++++.|+..|-...
T Consensus 204 --Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF 259 (282)
T KOG0984|consen 204 --AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPF 259 (282)
T ss_pred --HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHH
Confidence 2222458899999998643 368999999999999999999999988875443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=286.71 Aligned_cols=246 Identities=21% Similarity=0.241 Sum_probs=186.0
Q ss_pred cCCCCCeeeecCCce-EEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEEEEeccC
Q 035917 325 SFCSENVIISTRTGT-TYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~-Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
-|...+++|.|+.|+ ||+|.+ +|+.||||++-.. ......+||..|+.- +|||||++++.-.++...|+..|.|.
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e--~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE--FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhH--hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 466678899999886 799999 6789999998432 234567999999988 59999999988888899999999997
Q ss_pred CCChHHhhhcCCCCC---CHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC---C--CCeEEeecccccccC
Q 035917 403 SGTLYSLLQGNATEL---DWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE---D--FDARIMDFGLAKLMT 474 (611)
Q Consensus 403 ~gsL~~~l~~~~~~l---~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~---~--~~~kl~DFGla~~~~ 474 (611)
. +|.+++....... .-.....+..|+++||++|| +.+||||||||.||||+. + .+++|+|||+++.+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 6 9999998642111 11345678889999999999 789999999999999975 2 579999999999886
Q ss_pred CCCCC-ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCC-CCCHHHHHHHHhhcCChhhhhchhhcCCCCH
Q 035917 475 SSDES-SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGF-KGNLVDWVNQLSSSGRSKEAIDKALCGKGYD 552 (611)
Q Consensus 475 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 552 (611)
.+..+ ....+..||-+|+|||++....-+...||||+|||+|..++| ..||-+-..... .......+-.......+
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~~~d 740 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEPLPD 740 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeeccCch
Confidence 55422 223456799999999999988888899999999999999876 567754322110 00111111111111222
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 553 EEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 553 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.++.+++. ++++.+|..||++.+|+.|
T Consensus 741 ~eA~dLI~---~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 741 CEAKDLIS---RMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred HHHHHHHH---HhcCCCcccCCCHHHHhCC
Confidence 26666666 9999999999999999866
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=257.85 Aligned_cols=265 Identities=18% Similarity=0.227 Sum_probs=202.3
Q ss_pred HHHHHhhhcCCCCCeeeecCCceEEEEEeCC------CCEEEEEecccc--chhHHHHHHHHHHHhccCCCCccceeeEE
Q 035917 317 ADLMAASNSFCSENVIISTRTGTTYKAMLPD------GSVLAVKRLNTC--KLGEKKFRNEMNRLGQLRHPNLAPLLGYC 388 (611)
Q Consensus 317 ~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~~~------g~~vAvK~~~~~--~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~ 388 (611)
.++...-..+....++-+|.||.||+|.+.+ .+.|-||.++.. +..-..+..|.-.+..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 3444444557777889999999999997643 445667777542 22335688999999999999999999999
Q ss_pred EeC-CeeEEEEeccCCCChHHhhh-----cCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC
Q 035917 389 VVE-EEKLLIYKYMSSGTLYSLLQ-----GNA--TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF 460 (611)
Q Consensus 389 ~~~-~~~~lv~ey~~~gsL~~~l~-----~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~ 460 (611)
.++ ...+.+|.++.-|+|..+|. +.. ..++-.+...++.|++.|++||| ..++||.||..+|+++|+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhe
Confidence 764 56789999999999999997 222 24666788899999999999999 89999999999999999999
Q ss_pred CeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChh
Q 035917 461 DARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSK 539 (611)
Q Consensus 461 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~ 539 (611)
++||+|=.+++.+-+.+....-...-.+..||+||.+....|+..+|||||||+||||++ |+.|+.+.....+ ....+
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm-~~ylk 512 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM-EHYLK 512 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH-HHHHh
Confidence 999999999998766665444334446788999999999999999999999999999996 5666644211100 00011
Q ss_pred hhhchhh-cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 540 EAIDKAL-CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 540 ~~~~~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
+.. ++ .+...++ ++..++.-||..+|++||+.++++..|.+...+.
T Consensus 513 dGy--RlaQP~NCPD---eLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 513 DGY--RLAQPFNCPD---ELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred ccc--eecCCCCCcH---HHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 110 11 1122333 4555666999999999999999999999877654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=270.88 Aligned_cols=253 Identities=17% Similarity=0.196 Sum_probs=200.1
Q ss_pred ccccHHHHHHhhhcCCCCCeeeecCCceEEEEEeCCCC-EEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceee
Q 035917 312 VKVKLADLMAASNSFCSENVIISTRTGTTYKAMLPDGS-VLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLG 386 (611)
Q Consensus 312 ~~~~~~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~~~g~-~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g 386 (611)
...++.++... ..||-|+||.|-.+.....+ .+|+|++++.. ...+.+..|-.+|...+.|.||++|.
T Consensus 415 a~v~l~dl~~i-------aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYr 487 (732)
T KOG0614|consen 415 AQVKLSDLKRI-------ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYR 487 (732)
T ss_pred cccchhhhhhh-------hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHH
Confidence 34555555443 56999999999998865433 48999987643 22355788999999999999999999
Q ss_pred EEEeCCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEee
Q 035917 387 YCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMD 466 (611)
Q Consensus 387 ~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~D 466 (611)
.|.+....|+.||-|-||.|...|.++ +.++......++..+.+|++||| +++||.|||||+|.++|.+|-+||.|
T Consensus 488 Tfrd~kyvYmLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVD 563 (732)
T KOG0614|consen 488 TFRDSKYVYMLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVD 563 (732)
T ss_pred HhccchhhhhhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEee
Confidence 999999999999999999999999866 45888888889999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh
Q 035917 467 FGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL 546 (611)
Q Consensus 467 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l 546 (611)
||+|+.+.....+ .+.+||+.|.|||++.....+...|.||+|+++|||++|..||..- ..+.....+..-+|..-
T Consensus 564 FGFAKki~~g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~-dpmktYn~ILkGid~i~ 639 (732)
T KOG0614|consen 564 FGFAKKIGSGRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV-DPMKTYNLILKGIDKIE 639 (732)
T ss_pred hhhHHHhccCCce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC-chHHHHHHHHhhhhhhh
Confidence 9999998765443 3568999999999999888999999999999999999999998531 11111111222233222
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 035917 547 CGKGYDEEILQFLKVACNCVVSRPKDRWS-----MYQVYQS 582 (611)
Q Consensus 547 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 582 (611)
.+........++++ +.+..+|.+|.. +.||-+|
T Consensus 640 ~Pr~I~k~a~~Lik---~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 640 FPRRITKTATDLIK---KLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred cccccchhHHHHHH---HHHhcCcHhhhccccCChHHHHhh
Confidence 22333444444444 888999999985 7788776
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=261.60 Aligned_cols=249 Identities=21% Similarity=0.267 Sum_probs=192.3
Q ss_pred CCeeeecCCceEEEEE-eCCCCEEEEEeccccch--h------HHHHHHHHHHHhccCCCCccceeeEEE-eCCeeEEEE
Q 035917 329 ENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCKL--G------EKKFRNEMNRLGQLRHPNLAPLLGYCV-VEEEKLLIY 398 (611)
Q Consensus 329 ~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~~--~------~~~~~~Ev~~l~~l~H~nIv~l~g~~~-~~~~~~lv~ 398 (611)
.++||+|+|+.||||. +...+.||||+-...+. + .+...+|.+|-+.|.||.||++++|+. +.+..|-|+
T Consensus 468 LhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVL 547 (775)
T KOG1151|consen 468 LHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVL 547 (775)
T ss_pred HHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeee
Confidence 4689999999999998 56788999998643221 1 245688999999999999999999986 456688999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC---CCCCeEEeecccccccCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD---EDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld---~~~~~kl~DFGla~~~~~ 475 (611)
|||+|.+|.=+|+.+ ..+++.++..|+.||+.||.||..- .++|||-||||.|||+- ..|.+||.|||+++.+..
T Consensus 548 EYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdd 625 (775)
T KOG1151|consen 548 EYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDD 625 (775)
T ss_pred eecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhccC
Confidence 999999999999866 4589999999999999999999854 78999999999999994 467899999999999865
Q ss_pred CCCCc-----cccCCCcccccccccccCC----CCCCcccchHHHHHHHHHHhCCCCCHHHHHH--HHhhcCChhhhhch
Q 035917 476 SDESS-----FVNGDLGEFGYIAPEYSST----MVASLKGDVYGIGVVLLELAGFKGNLVDWVN--QLSSSGRSKEAIDK 544 (611)
Q Consensus 476 ~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~--~~~~~~~~~~~~~~ 544 (611)
+.... ......||..|.+||.+.- .+.+.|.||||.|||+|..+.|+.||-.-.. .+.....+.....-
T Consensus 626 dSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEV 705 (775)
T KOG1151|consen 626 DSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEV 705 (775)
T ss_pred CccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceec
Confidence 44221 1233469999999997643 3578999999999999999999999843211 12222222111111
Q ss_pred hhc-CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 545 ALC-GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 545 ~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
... ....+.+..+|+. +|+++.-++|....++..+
T Consensus 706 qFP~KPvVsseAkaFIR---RCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 706 QFPPKPVVSSEAKAFIR---RCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred cCCCCCccCHHHHHHHH---HHHHhhhhhhhhHHHHccC
Confidence 111 1234567888888 9999999999998887654
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=256.72 Aligned_cols=245 Identities=19% Similarity=0.192 Sum_probs=190.0
Q ss_pred HHHHHhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch----hHHHHHHHHHHHhcc-CCCCccceeeEEEe
Q 035917 317 ADLMAASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL----GEKKFRNEMNRLGQL-RHPNLAPLLGYCVV 390 (611)
Q Consensus 317 ~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~ 390 (611)
.+..+++ +|....+||+|+||.|..|.. .+.+.+|||+++++-. +.+--+.|-++|..- +-|.++++..++..
T Consensus 343 ~d~i~~t-DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT 421 (683)
T KOG0696|consen 343 RDRIKAT-DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT 421 (683)
T ss_pred ccceeec-ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh
Confidence 3444444 688889999999999999984 4578999999976432 123345677777666 57889999999999
Q ss_pred CCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccc
Q 035917 391 EEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLA 470 (611)
Q Consensus 391 ~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla 470 (611)
-+..|.||||+.+|+|.-++.+-+ .+.++.+..+|..||-||-||| +++|+.||||..||++|.+|.+||+|||++
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccc
Confidence 999999999999999988887543 4777788899999999999999 899999999999999999999999999999
Q ss_pred cccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-hcCC
Q 035917 471 KLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-LCGK 549 (611)
Q Consensus 471 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~ 549 (611)
+.-..... ...+.+||+.|+|||++..++|+...|.|||||+||||+.|..||..-..... ...+.+.. ..++
T Consensus 498 KEni~~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el----F~aI~ehnvsyPK 571 (683)
T KOG0696|consen 498 KENIFDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL----FQAIMEHNVSYPK 571 (683)
T ss_pred cccccCCc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH----HHHHHHccCcCcc
Confidence 85332222 23456899999999999999999999999999999999999999853211111 01111111 1233
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCC
Q 035917 550 GYDEEILQFLKVACNCVVSRPKDRWS 575 (611)
Q Consensus 550 ~~~~~~~~l~~l~~~Cl~~dP~~RPs 575 (611)
..+.|...+.+ ..+...|.+|..
T Consensus 572 slSkEAv~ick---g~ltK~P~kRLG 594 (683)
T KOG0696|consen 572 SLSKEAVAICK---GLLTKHPGKRLG 594 (683)
T ss_pred cccHHHHHHHH---HHhhcCCccccC
Confidence 44566666655 888899999973
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=236.73 Aligned_cols=210 Identities=29% Similarity=0.422 Sum_probs=180.9
Q ss_pred eeecCCceEEEEEeCC-CCEEEEEeccccch--hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCChHH
Q 035917 332 IISTRTGTTYKAMLPD-GSVLAVKRLNTCKL--GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYS 408 (611)
Q Consensus 332 ig~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~--~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL~~ 408 (611)
||+|.+|.||++...+ ++.+++|++..... ..+.+.+|++.++.++|++|+++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 89999999976543 24679999999999999999999999999899999999999999999
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC-CCCeEEeecccccccCCCCCCccccCCCc
Q 035917 409 LLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE-DFDARIMDFGLAKLMTSSDESSFVNGDLG 487 (611)
Q Consensus 409 ~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~-~~~~kl~DFGla~~~~~~~~~~~~~~~~g 487 (611)
++......+++..+..++.++++++.||| ..+++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~ 155 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG 155 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence 98765345899999999999999999999 789999999999999998 89999999999986643321 1122347
Q ss_pred ccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHHhhcc
Q 035917 488 EFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCV 566 (611)
Q Consensus 488 t~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl 566 (611)
...|++||..... .++.++|+|++|++++++ ..+.+++.+|+
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------~~~~~~l~~~l 198 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------PELKDLIRKML 198 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------HHHHHHHHHHh
Confidence 8899999998776 788999999999999998 34555556999
Q ss_pred cCCCCCCCCHHHHHHHH
Q 035917 567 VSRPKDRWSMYQVYQSL 583 (611)
Q Consensus 567 ~~dP~~RPs~~evl~~L 583 (611)
+.+|++||++.++++++
T Consensus 199 ~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 199 QKDPEKRPSAKEILEHL 215 (215)
T ss_pred hCCcccCcCHHHHhhCC
Confidence 99999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=257.40 Aligned_cols=199 Identities=19% Similarity=0.233 Sum_probs=167.6
Q ss_pred cCCCCCeeeecCCceEEEEE-eCCCCEEEEEeccccchh----HHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 325 SFCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCKLG----EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~~~----~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
-|...+.||-|+||.|..++ .++...||+|.+++...- ......|-.||.....+.||+|+-.|.+++.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 47777889999999999998 556789999999764322 1236779999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccccc------
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLM------ 473 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~------ 473 (611)
|++||++..+|.+. +.+++..+..++..+..|+++.| ..|+|||||||+|||||.+|.+||.||||+.-+
T Consensus 710 YIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred ccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 99999999999765 35788888888889999999999 899999999999999999999999999997532
Q ss_pred ---CCCCCCc-------------------------------cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHh
Q 035917 474 ---TSSDESS-------------------------------FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELA 519 (611)
Q Consensus 474 ---~~~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell 519 (611)
....... .....+||+.|+|||++....|+..+|.||.|||||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 1110000 001236999999999999989999999999999999999
Q ss_pred CCCCCHHH
Q 035917 520 GFKGNLVD 527 (611)
Q Consensus 520 ~~~~~~~~ 527 (611)
.|..||.+
T Consensus 866 ~g~~pf~~ 873 (1034)
T KOG0608|consen 866 VGQPPFLA 873 (1034)
T ss_pred hCCCCccC
Confidence 99998854
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-29 Score=265.93 Aligned_cols=250 Identities=20% Similarity=0.277 Sum_probs=198.2
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchh-HHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLG-EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~-~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
++|.....+|+|.||.|||++. ..++..|||.++....+ ..-..+|+-+++..+|||||.++|.|...+..|+.||||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 4566778999999999999994 56999999999765433 355788999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
.+|+|.+.-+.- +++++.++..+++...+||.||| +.+-+|||||-.|||+.+.+.+|++|||.+..++.. ...
T Consensus 95 gggslQdiy~~T-gplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i~K 168 (829)
T KOG0576|consen 95 GGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IAK 168 (829)
T ss_pred CCCcccceeeec-ccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhh--hhh
Confidence 999999987744 47899999999999999999999 888999999999999999999999999998766421 122
Q ss_pred ccCCCccccccccccc---CCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhc--CCCCHHHHH
Q 035917 482 VNGDLGEFGYIAPEYS---STMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALC--GKGYDEEIL 556 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~---~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~--~~~~~~~~~ 556 (611)
...+.||+.|||||+. ..+.|..++|||+.|+...|+-.-.+|..+........-..+...++.-. ...+.+.+.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh 248 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFH 248 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHH
Confidence 3456799999999975 34568999999999999999986666654322221111112222232221 123456667
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.|++ .|+-.+|++||+++.+++|
T Consensus 249 ~fvK---~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 249 NFVK---GALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred HHHH---HHhcCCCccCCChhhheec
Confidence 7777 8999999999999887764
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=228.21 Aligned_cols=243 Identities=16% Similarity=0.245 Sum_probs=186.1
Q ss_pred hhcCCCCCeeeecCCceEEEEE-eCCCCEEEEEeccccchhHHHHHHHHHHHhccC-CCCccceeeEEEeCC--eeEEEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLR-HPNLAPLLGYCVVEE--EKLLIY 398 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~~--~~~lv~ 398 (611)
.++|...+.+|+|.++.||.|. ..+.+.++||+++..+ .+++.+|+.+|..++ ||||+++++...++. ...||+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 3466677889999999999999 6788999999997643 567899999999997 999999999988765 356999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC-CCCeEEeecccccccCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE-DFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~-~~~~kl~DFGla~~~~~~~ 477 (611)
||+.+.+...+.. .++...+..++.++++||.|+| +.||+|||+||.|+++|. .-..+|+|+|+|.++.+..
T Consensus 115 E~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 115 EYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 9999977766542 4777788899999999999999 899999999999999995 4579999999999886554
Q ss_pred CCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHH-------HHHH-----------HHhhcCCh
Q 035917 478 ESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLV-------DWVN-----------QLSSSGRS 538 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~-------~~~~-----------~~~~~~~~ 538 (611)
... -.+.+..|.-||.+-. ..|+..-|+|||||++.+|+..+.||. +.+. .......
T Consensus 188 eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~- 263 (338)
T KOG0668|consen 188 EYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ- 263 (338)
T ss_pred eee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc-
Confidence 322 2356788999998755 457889999999999999997776652 1111 0000000
Q ss_pred hhhhchhhcC-------------------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 539 KEAIDKALCG-------------------KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 539 ~~~~~~~l~~-------------------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
-.+|+.... .-.+.++.++++ +.+..|-.+|||++|.+.|
T Consensus 264 -i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlld---klLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 264 -IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLD---KLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred -cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHH---HHHhhccccccchHHHhcC
Confidence 001221100 012355566666 9999999999999999987
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-28 Score=250.40 Aligned_cols=194 Identities=18% Similarity=0.243 Sum_probs=166.5
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccchhH---------HHHHHHHHHHhccC---CCCccceeeEEEe
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLGE---------KKFRNEMNRLGQLR---HPNLAPLLGYCVV 390 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~---------~~~~~Ev~~l~~l~---H~nIv~l~g~~~~ 390 (611)
.+|+..+.+|.|+||.|+.|.++ +...|+||.+.+.+.-. -..-.|++||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45788899999999999999964 57789999996643211 12567999999997 9999999999999
Q ss_pred CCeeEEEEecc-CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccc
Q 035917 391 EEEKLLIYKYM-SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGL 469 (611)
Q Consensus 391 ~~~~~lv~ey~-~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGl 469 (611)
++.+||+||-. ++-+|++++..+ ..+++.+...|++||+.|+++|| ..+|||||||-+|+.+|.+|-+||+|||-
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccc
Confidence 99999999975 567999999755 46899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCCccccCCCcccccccccccCCCCC-CcccchHHHHHHHHHHhCCCCCH
Q 035917 470 AKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVA-SLKGDVYGIGVVLLELAGFKGNL 525 (611)
Q Consensus 470 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SfGvvl~ell~~~~~~ 525 (611)
|.+...... ...+||..|.|||++.+.+| +..-|||++|++||.++..+.||
T Consensus 717 aa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 717 AAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred hhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 877644332 23469999999999999888 45589999999999999877775
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=226.10 Aligned_cols=197 Identities=24% Similarity=0.313 Sum_probs=169.9
Q ss_pred CCCCCeeeecCCceEEEEEeCC-CCEEEEEeccccch--hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccC
Q 035917 326 FCSENVIISTRTGTTYKAMLPD-GSVLAVKRLNTCKL--GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~--~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
|...+.||+|++|.||++...+ ++.+|+|.+..... ..+.+.+|++.+.+++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4556889999999999999765 89999999976543 35688999999999999999999999998899999999999
Q ss_pred CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccc
Q 035917 403 SGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482 (611)
Q Consensus 403 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 482 (611)
+++|.+++......+++.....++.+++.++.||| ..+++|+|++|+||+++.++.++|+|||.+........ ...
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALL 156 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccc
Confidence 99999999765333899999999999999999999 77999999999999999999999999999987654320 011
Q ss_pred cCCCccccccccccc-CCCCCCcccchHHHHHHHHHHhCCCCCHH
Q 035917 483 NGDLGEFGYIAPEYS-STMVASLKGDVYGIGVVLLELAGFKGNLV 526 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~-~~~~~t~ksDV~SfGvvl~ell~~~~~~~ 526 (611)
....++..|++||.. ....++.++|||+||++++||++|+.||.
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 223577889999988 66678889999999999999999998873
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=232.63 Aligned_cols=197 Identities=18% Similarity=0.218 Sum_probs=168.7
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch----hHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL----GEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~lv 397 (611)
++|....+||+|+|++|..+++ ++.+.+|+|++++.-. +..-.+.|-.+..+. +||.+|-+..++..+...++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 4677889999999999999995 5688999999976432 223356677777666 699999999999999999999
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
.||+++|+|.-++.++ ..+++..+..+...|..||.||| +.+|+.||||..|+|+|..|.+|+.|+|+.+.-....
T Consensus 330 ieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence 9999999997777654 35889999899999999999999 8999999999999999999999999999998643332
Q ss_pred CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHH
Q 035917 478 ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLV 526 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~ 526 (611)
. ...+.+||+.|+|||.+.+..|....|.|++||+++||+.|+.||.
T Consensus 406 d--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 406 D--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred c--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 2 2345689999999999999999999999999999999999999873
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-28 Score=233.16 Aligned_cols=189 Identities=23% Similarity=0.283 Sum_probs=157.4
Q ss_pred CCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCC-----eeEEEE
Q 035917 328 SENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE-----EKLLIY 398 (611)
Q Consensus 328 ~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~-----~~~lv~ 398 (611)
..+-||-|.||.||.... .+|+.||.|++.... .+.+.+.+|+++|.-++|.|++..++...... +.|++.
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 457899999999999986 479999999986532 34578999999999999999999988765432 467889
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
|.|.. +|..++-.. ..++-..++-+..||++||.||| +.+|+||||||.|.|++.+...||+|||+++.-..++
T Consensus 137 ELmQS-DLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~- 210 (449)
T KOG0664|consen 137 ELMQS-DLHKIIVSP-QALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD- 210 (449)
T ss_pred HHHHh-hhhheeccC-CCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchhh-
Confidence 99966 888877643 46777888889999999999999 8899999999999999999999999999999764433
Q ss_pred CccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCC
Q 035917 479 SSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFK 522 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~ 522 (611)
...++..+-|..|.|||.+.+ ..|+...||||.||++.|++..+
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRr 255 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRK 255 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhh
Confidence 233334456889999999877 46899999999999999998554
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-27 Score=274.05 Aligned_cols=197 Identities=17% Similarity=0.120 Sum_probs=140.9
Q ss_pred ccCC-CCccceeeEEE-------eCCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 035917 375 QLRH-PNLAPLLGYCV-------VEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLH 446 (611)
Q Consensus 375 ~l~H-~nIv~l~g~~~-------~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 446 (611)
.++| +||++++++|. ..+..+.++||+ +++|.+++......+++..++.++.||++||+||| +.+|+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeee
Confidence 4456 68888888872 234567788988 55999999765556999999999999999999999 899999
Q ss_pred cCCCCCeEEeCC-------------------CCCeEEeecccccccCCCCC--------------CccccCCCccccccc
Q 035917 447 QNICSNVILVDE-------------------DFDARIMDFGLAKLMTSSDE--------------SSFVNGDLGEFGYIA 493 (611)
Q Consensus 447 rDlkp~NILld~-------------------~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~a 493 (611)
|||||+|||++. ++.+|++|||+++....... .......+||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999954 45667777777764211000 000112358899999
Q ss_pred ccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCC
Q 035917 494 PEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDR 573 (611)
Q Consensus 494 PE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 573 (611)
||++.+..++.++|||||||+||||+++..++.......... ......+. ..........++.+||+.+|.+|
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~--~~~~~~~~-----~~~~~~~~~~~~~~~L~~~P~~R 256 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSL--RHRVLPPQ-----ILLNWPKEASFCLWLLHPEPSCR 256 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHH--HHhhcChh-----hhhcCHHHHHHHHHhCCCChhhC
Confidence 999999999999999999999999999877754321111000 00011111 11122334566679999999999
Q ss_pred CCHHHHHHH
Q 035917 574 WSMYQVYQS 582 (611)
Q Consensus 574 Ps~~evl~~ 582 (611)
|+|.||++|
T Consensus 257 ps~~eil~h 265 (793)
T PLN00181 257 PSMSELLQS 265 (793)
T ss_pred cChHHHhhc
Confidence 999999876
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=236.16 Aligned_cols=130 Identities=15% Similarity=0.199 Sum_probs=112.8
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhccC-----C---CCccceeeEEEe----
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLR-----H---PNLAPLLGYCVV---- 390 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~-----H---~nIv~l~g~~~~---- 390 (611)
+.|...++||-|.|++||.|.. .+.+.||+|+.+..+.-.+..+.||++|++++ | .+||+|+++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 4677889999999999999994 56789999999877777788899999999994 3 379999999975
Q ss_pred CCeeEEEEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEe
Q 035917 391 EEEKLLIYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV 456 (611)
Q Consensus 391 ~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl 456 (611)
+.+.|+|+|+. |-+|..++.... ..++...++.|+.||+.||.|||.. .+|||-||||+|||+
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLL 221 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeee
Confidence 45789999999 558999887654 4799999999999999999999984 589999999999998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=244.19 Aligned_cols=202 Identities=20% Similarity=0.201 Sum_probs=170.5
Q ss_pred cccHHHHHHhhhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccchhHHHHHHHHHHHhccC------CCCcccee
Q 035917 313 KVKLADLMAASNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLGEKKFRNEMNRLGQLR------HPNLAPLL 385 (611)
Q Consensus 313 ~~~~~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~------H~nIv~l~ 385 (611)
.+.+.|+. -..|.+....|+|-|++|.+|... .|..||||+|+......+.=+.|+++|++|+ --|+++++
T Consensus 423 rv~igE~L--D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 423 RVRIGELL--DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEehhhhh--cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 34444443 346777778899999999999954 4889999999888777778889999999995 34899999
Q ss_pred eEEEeCCeeEEEEeccCCCChHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC-Ce
Q 035917 386 GYCVVEEEKLLIYKYMSSGTLYSLLQGNA--TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF-DA 462 (611)
Q Consensus 386 g~~~~~~~~~lv~ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~-~~ 462 (611)
..|...+++|||||-+.- +|.++|+.-+ ..|....+..++.|+..||..|. ..+|+|.||||.|||+++.. .+
T Consensus 501 r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCccee
Confidence 999999999999998865 9999998654 36788899999999999999999 88999999999999998654 67
Q ss_pred EEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCC
Q 035917 463 RIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGN 524 (611)
Q Consensus 463 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~ 524 (611)
||||||-|........+.. .-+.+|.|||++.+.+|+...|+||.||.||||.||+.-
T Consensus 577 KLCDfGSA~~~~eneitPY----LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIl 634 (752)
T KOG0670|consen 577 KLCDFGSASFASENEITPY----LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKIL 634 (752)
T ss_pred eeccCccccccccccccHH----HHHHhccCcceeecCcccCCccceeeceeeEEeecccee
Confidence 9999999988765543332 346789999999999999999999999999999988743
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=225.97 Aligned_cols=245 Identities=22% Similarity=0.261 Sum_probs=178.3
Q ss_pred CCCCeeeecCCceEEEEEe-CCCCEEEEEecccc---chhHHHHHHHHHHHhccCCCCccceeeEEEeCC------eeEE
Q 035917 327 CSENVIISTRTGTTYKAML-PDGSVLAVKRLNTC---KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE------EKLL 396 (611)
Q Consensus 327 ~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~---~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~------~~~l 396 (611)
.....+|.|.- .|-.+.. -.++.||+|++... ....++..+|...+..++|+||++++.++.-.. +.|+
T Consensus 20 ~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~ 98 (369)
T KOG0665|consen 20 VNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYL 98 (369)
T ss_pred eeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHH
Confidence 33455666665 4444432 24789999988432 233467789999999999999999999986532 5689
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
|||||.. +|.+.+.- .++-..+..|..|++.|+.||| +.+|+||||||+||++..+..+||.|||+|+.-...
T Consensus 99 v~e~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 99 VMELMDA-NLCQVILM---ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred HHHhhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccCcc
Confidence 9999965 99988872 3777888999999999999999 899999999999999999999999999999864322
Q ss_pred CCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCC------CCHHHHHHHHhhcCChhhhhchhh----
Q 035917 477 DESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFK------GNLVDWVNQLSSSGRSKEAIDKAL---- 546 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~------~~~~~~~~~~~~~~~~~~~~~~~l---- 546 (611)
...+..+.|..|.|||++.+..+.+.+||||.||++.||+.|+ .....|......-+.....+-..+
T Consensus 172 ---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 172 ---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred ---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 3445567899999999998888999999999999999999654 333444332222211111000000
Q ss_pred -------------------cC-------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 547 -------------------CG-------KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 547 -------------------~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.. +.........-+++.++|..||++|.+++++++|
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00 0000111223345559999999999999999998
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=214.74 Aligned_cols=248 Identities=16% Similarity=0.201 Sum_probs=181.8
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccchhHHHHHHHHHHHhcc-CCCCccceeeE-EEeCCeeEEEEec
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGY-CVVEEEKLLIYKY 400 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l-~H~nIv~l~g~-~~~~~~~~lv~ey 400 (611)
+.|++.+.+|+|.||.+-.+.++ ..+.+++|.+.......++|.+|...--.| .|.||+.-++. |...+.+++++||
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 35677789999999999999964 578899999988777788999999876666 59999987765 4456677899999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC--CCCCeEEeecccccccCCCCC
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD--EDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld--~~~~~kl~DFGla~~~~~~~~ 478 (611)
+|.|+|.+-+... .+.+....+++.|++.|+.|+| ++.+||||||.+|||+- +..++||+|||+.+.....
T Consensus 104 aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t-- 176 (378)
T KOG1345|consen 104 APRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT-- 176 (378)
T ss_pred CccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCce--
Confidence 9999999988654 3778888999999999999999 89999999999999993 3458999999998754321
Q ss_pred CccccCCCcccccccccccCC---C--CCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhh------hhchhhc
Q 035917 479 SSFVNGDLGEFGYIAPEYSST---M--VASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKE------AIDKALC 547 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~---~--~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~------~~~~~l~ 547 (611)
.....-+..|.|||.... + ...+.+|||.||+++|.+++|+.|+..-. .......+ ...+.+.
T Consensus 177 ---V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~---~~d~~Y~~~~~w~~rk~~~~P 250 (378)
T KOG1345|consen 177 ---VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS---IMDKPYWEWEQWLKRKNPALP 250 (378)
T ss_pred ---ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh---ccCchHHHHHHHhcccCccCc
Confidence 111124567899996532 2 24677999999999999999998864210 00000000 0001111
Q ss_pred C--CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHch
Q 035917 548 G--KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIA 587 (611)
Q Consensus 548 ~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 587 (611)
. ...++.+.++.+ +-+..+|++|-.+.++.++....-
T Consensus 251 ~~F~~fs~~a~r~Fk---k~lt~~~~drcki~~~kk~rk~~w 289 (378)
T KOG1345|consen 251 KKFNPFSEKALRLFK---KSLTPRFKDRCKIWTAKKMRKCLW 289 (378)
T ss_pred hhhcccCHHHHHHHH---HhcCCcccccchhHHHHHHHHHHH
Confidence 1 112344444444 889999999977777776654433
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-25 Score=209.94 Aligned_cols=165 Identities=18% Similarity=0.172 Sum_probs=123.8
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcccc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
|+|.+++......++|..+..|+.|+++||+||| +.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc------
Confidence 7899999865567999999999999999999999 444 999999999999999 99998754321
Q ss_pred CCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc---hhhcC-CCCHHHH---H
Q 035917 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID---KALCG-KGYDEEI---L 556 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~---~~l~~-~~~~~~~---~ 556 (611)
..||+.|||||++.+..++.++|||||||++|||++|+.|+...... ......... +.... ....... .
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL---SAILEILLNGMPADDPRDRSNLESVSAAR 139 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh---cHHHHHHHHHhccCCccccccHHHHHhhh
Confidence 25899999999999999999999999999999999999887421100 000000100 00000 0111111 1
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
.+.+++.+||+.+|++||++.|+++++..+..+
T Consensus 140 ~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 140 SFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred hHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 466677799999999999999999999877554
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-26 Score=217.87 Aligned_cols=245 Identities=22% Similarity=0.364 Sum_probs=186.6
Q ss_pred CeeeecCCceEEEEEeCCCCEEEEEeccccch---hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCCh
Q 035917 330 NVIISTRTGTTYKAMLPDGSVLAVKRLNTCKL---GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTL 406 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~---~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL 406 (611)
.+|.+...|..|+|++. |..+++|+++..+. -.++|..|.-.|+-+.||||+.++|.|..+....++..||+.|+|
T Consensus 196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 35778889999999995 55566788765432 236799999999999999999999999999999999999999999
Q ss_pred HHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccCC
Q 035917 407 YSLLQGNAT-ELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGD 485 (611)
Q Consensus 407 ~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 485 (611)
+.+|++... .++-.+..+++.++|+|++|||+- ++-|..--|.+..+++|++.+++|+- +-+++ +....+.
T Consensus 275 ynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kf------sfqe~gr 346 (448)
T KOG0195|consen 275 YNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKF------SFQEVGR 346 (448)
T ss_pred HHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-cccee------eeecccc
Confidence 999997754 577889999999999999999963 45555667899999999999988752 11111 1112233
Q ss_pred CcccccccccccCCCCCC---cccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHH
Q 035917 486 LGEFGYIAPEYSSTMVAS---LKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVA 562 (611)
Q Consensus 486 ~gt~~y~aPE~~~~~~~t---~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~ 562 (611)
.-.+.||+||.++..+-+ ..+|+|||.+++||+.|.+.||.+|...........+.+...+. ...+..+.++++
T Consensus 347 ~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ip-pgis~hm~klm~-- 423 (448)
T KOG0195|consen 347 AYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIP-PGISRHMNKLMN-- 423 (448)
T ss_pred ccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCC-CCccHHHHHHHH--
Confidence 456899999998775543 56999999999999999999998875433222222222333222 233444555555
Q ss_pred hhcccCCCCCCCCHHHHHHHHHHch
Q 035917 563 CNCVVSRPKDRWSMYQVYQSLNSIA 587 (611)
Q Consensus 563 ~~Cl~~dP~~RPs~~evl~~L~~i~ 587 (611)
-|+..||.+||.++.|+-.||++.
T Consensus 424 -icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 424 -ICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -HHhcCCCCcCCCcceehhhHHHhc
Confidence 899999999999999999998764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-25 Score=222.87 Aligned_cols=199 Identities=22% Similarity=0.252 Sum_probs=163.3
Q ss_pred HHHhhhcCCCCCeeeecCCceEEEEEeC----CCCEEEEEeccccchhHHHHHHHHHHHhccC-CCCccceeeEEEeCCe
Q 035917 319 LMAASNSFCSENVIISTRTGTTYKAMLP----DGSVLAVKRLNTCKLGEKKFRNEMNRLGQLR-HPNLAPLLGYCVVEEE 393 (611)
Q Consensus 319 l~~~t~~f~~~~~ig~G~~g~Vy~~~~~----~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~~~ 393 (611)
+....+.|...++||.|.|++||++.+. ..+.||+|.+.... ....+.+|++.|..+. +.||+++.+++..++.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 4455667888999999999999999843 47899999996532 3456899999999995 9999999999999999
Q ss_pred eEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC-CCCeEEeecccccc
Q 035917 394 KLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE-DFDARIMDFGLAKL 472 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~-~~~~kl~DFGla~~ 472 (611)
.++|+||++.-+..++... ++...+..++..+.+||.++| ..+||||||||+|+|.+. .++-.|.|||+|..
T Consensus 110 v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred eEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHH
Confidence 9999999999888888753 678899999999999999999 899999999999999984 46778999999982
Q ss_pred cCCCC------C------------------------------------CccccCCCcccccccccccCC-CCCCcccchH
Q 035917 473 MTSSD------E------------------------------------SSFVNGDLGEFGYIAPEYSST-MVASLKGDVY 509 (611)
Q Consensus 473 ~~~~~------~------------------------------------~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~ 509 (611)
..... . ........||++|.|||++.. ...+++.|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 11000 0 000112369999999998754 5568999999
Q ss_pred HHHHHHHHHhCCCCCH
Q 035917 510 GIGVVLLELAGFKGNL 525 (611)
Q Consensus 510 SfGvvl~ell~~~~~~ 525 (611)
|-|||++-++++..||
T Consensus 263 s~GVI~Lslls~~~PF 278 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPF 278 (418)
T ss_pred eccceeehhhcccccc
Confidence 9999999999887765
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=217.77 Aligned_cols=166 Identities=20% Similarity=0.169 Sum_probs=129.3
Q ss_pred HhhhcCCCCCeeeecCCceEEEEEeC--CCCEEEEEecccc------chhHHHHHHHHHHHhccCCCCccceeeEEEeCC
Q 035917 321 AASNSFCSENVIISTRTGTTYKAMLP--DGSVLAVKRLNTC------KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE 392 (611)
Q Consensus 321 ~~t~~f~~~~~ig~G~~g~Vy~~~~~--~g~~vAvK~~~~~------~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~ 392 (611)
...++|...+.||+|+||+||+|... +++.||||++... ....+.|.+|+++|++++|+|+++.+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 44567999999999999999999864 5788899987532 1234569999999999999999863322 24
Q ss_pred eeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCC-CCCeEEeCCCCCeEEeeccccc
Q 035917 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNI-CSNVILVDEDFDARIMDFGLAK 471 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl-kp~NILld~~~~~kl~DFGla~ 471 (611)
..++||||+++++|... ... . ...++.++++||.||| +.+|+|||| ||+|||++.++.+||+|||+|+
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred CcEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 67999999999999732 111 1 1467889999999999 889999999 9999999999999999999999
Q ss_pred ccCCCCCC------ccccCCCcccccccccccCCC
Q 035917 472 LMTSSDES------SFVNGDLGEFGYIAPEYSSTM 500 (611)
Q Consensus 472 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~ 500 (611)
.+...... ...+...+++.|+|||++...
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 76543311 112345688899999987643
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=228.83 Aligned_cols=167 Identities=34% Similarity=0.511 Sum_probs=120.3
Q ss_pred CCChhHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCcccceecCCCC-C--CcEEEEEecCCcccccCCccCcCCCCC
Q 035917 46 TVAEDDVKCLEGVKSSLNDPQRKLSSWSFGNSTIGFICQFVGVSCWNDK-E--NRILNLELREMKLSGKIPEPLKFCKSM 122 (611)
Q Consensus 46 ~~~~~d~~aL~~~k~~l~~~~~~l~~W~~~~~~~~~~c~w~Gv~C~~~~-~--~~v~~l~l~~~~l~g~~p~~l~~l~~L 122 (611)
...+.|+.||+.+|+++.++.. .+|+. +++....|.|.||+|..+. . .+|+.|+|++++|+|.+|+.++.|++|
T Consensus 368 ~t~~~~~~aL~~~k~~~~~~~~--~~W~g-~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L 444 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLGLPLR--FGWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHL 444 (623)
T ss_pred ccCchHHHHHHHHHHhcCCccc--CCCCC-CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCC
Confidence 3456799999999999976642 48964 3222223479999995321 1 247788888888888888888888888
Q ss_pred CEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccccccccCCCCChhhhcC-CCccccccc
Q 035917 123 QRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNL-GRLKKFSVA 201 (611)
Q Consensus 123 ~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l-~~L~~L~l~ 201 (611)
+.|+|++|+|+|.+|..+.. +++|+.|||++|+|+|.+|..+++|++|+.|+|++|+|+|.+|..++.+ .++..
T Consensus 445 ~~L~Ls~N~l~g~iP~~~~~-l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~---- 519 (623)
T PLN03150 445 QSINLSGNSIRGNIPPSLGS-ITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRAS---- 519 (623)
T ss_pred CEEECCCCcccCcCChHHhC-CCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCce----
Confidence 88888888888888877777 7888888888888888888888888888888888888888888776543 22222
Q ss_pred ccccCCCCCccCCCCCcccCCCCCCCCCCCCCCCcC
Q 035917 202 NNDLTGTIPSSFKGFDKADFDGNSDLCGGPLGSKCG 237 (611)
Q Consensus 202 ~N~l~g~ip~~~~~~~~~~~~~n~~lc~~~~~~~c~ 237 (611)
+.+.+|+.+|+.|....|.
T Consensus 520 -----------------l~~~~N~~lc~~p~l~~C~ 538 (623)
T PLN03150 520 -----------------FNFTDNAGLCGIPGLRACG 538 (623)
T ss_pred -----------------EEecCCccccCCCCCCCCc
Confidence 3455677777765545675
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.2e-21 Score=195.21 Aligned_cols=251 Identities=24% Similarity=0.287 Sum_probs=189.2
Q ss_pred CCCCCeeeecCCceEEEEEeCCCCEEEEEeccccch----hHHHHHHHHHHHhccCCC-CccceeeEEEeCCeeEEEEec
Q 035917 326 FCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKL----GEKKFRNEMNRLGQLRHP-NLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~----~~~~~~~Ev~~l~~l~H~-nIv~l~g~~~~~~~~~lv~ey 400 (611)
|.....||.|+||.||++... ..+++|.+..... ....+.+|+.++..+.|+ +|+++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 455678999999999999976 8899999965432 356799999999999988 799999999777778999999
Q ss_pred cCCCChHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC-CeEEeecccccccCCCC
Q 035917 401 MSSGTLYSLLQGNA--TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF-DARIMDFGLAKLMTSSD 477 (611)
Q Consensus 401 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~-~~kl~DFGla~~~~~~~ 477 (611)
+.++++.+++.... ..++......+..+++.++.|+| ..+++|||+||+||+++... .+++.|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997776543 25888999999999999999999 78899999999999999888 79999999998654333
Q ss_pred CCc----cccCCCcccccccccccCC---CCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh----
Q 035917 478 ESS----FVNGDLGEFGYIAPEYSST---MVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL---- 546 (611)
Q Consensus 478 ~~~----~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l---- 546 (611)
... ......||..|+|||.+.+ ..++...|+||+|+++++++.+..|+...... .......+.+....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-SATSQTLKIILELPTPSL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-ccHHHHHHHHHhcCCccc
Confidence 211 2345579999999999887 57889999999999999999888774322110 00000001111000
Q ss_pred cCCCCH----HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 547 CGKGYD----EEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 547 ~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
...... .....+.++...|+..+|..|.++.+...+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000011 111234455559999999999999888776
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=233.26 Aligned_cols=159 Identities=38% Similarity=0.632 Sum_probs=118.2
Q ss_pred CChhHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCcccceecCCCCCCcEEEEEecCCcccccCCccCcCCCCCCEEE
Q 035917 47 VAEDDVKCLEGVKSSLNDPQRKLSSWSFGNSTIGFICQFVGVSCWNDKENRILNLELREMKLSGKIPEPLKFCKSMQRLD 126 (611)
Q Consensus 47 ~~~~d~~aL~~~k~~l~~~~~~l~~W~~~~~~~~~~c~w~Gv~C~~~~~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~ 126 (611)
..++|..||++||+++.+|.+.+.+|+.. .+||.|.||+|++ .++|+.|+|++++++|.+|+.+..+++|+.|+
T Consensus 26 ~~~~~~~~l~~~~~~~~~~~~~~~~w~~~----~~~c~w~gv~c~~--~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~ 99 (968)
T PLN00113 26 LHAEELELLLSFKSSINDPLKYLSNWNSS----ADVCLWQGITCNN--SSRVVSIDLSGKNISGKISSAIFRLPYIQTIN 99 (968)
T ss_pred CCHHHHHHHHHHHHhCCCCcccCCCCCCC----CCCCcCcceecCC--CCcEEEEEecCCCccccCChHHhCCCCCCEEE
Confidence 35689999999999998888788999642 3589999999964 46899999999999999999999999999999
Q ss_pred ccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccC
Q 035917 127 LSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLT 206 (611)
Q Consensus 127 Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~ 206 (611)
|++|+++|.+|..++..+++|++|+|++|+++|.+|. +.+++|++|+|++|.++|.+|..++++++|++|+|++|.++
T Consensus 100 Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~ 177 (968)
T PLN00113 100 LSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLV 177 (968)
T ss_pred CCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCccc
Confidence 9999999999988873377788877777777766653 23445555555555555555554555555555555555554
Q ss_pred CCCCccC
Q 035917 207 GTIPSSF 213 (611)
Q Consensus 207 g~ip~~~ 213 (611)
+.+|..+
T Consensus 178 ~~~p~~~ 184 (968)
T PLN00113 178 GKIPNSL 184 (968)
T ss_pred ccCChhh
Confidence 4444443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-20 Score=196.19 Aligned_cols=261 Identities=17% Similarity=0.144 Sum_probs=192.5
Q ss_pred cCCCCCeeeecCCceEEEEEeCCC--CEEEEEeccccc-hhHHHHHHHHHHHhccCC----CCccceeeEE-EeCCeeEE
Q 035917 325 SFCSENVIISTRTGTTYKAMLPDG--SVLAVKRLNTCK-LGEKKFRNEMNRLGQLRH----PNLAPLLGYC-VVEEEKLL 396 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~~g--~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H----~nIv~l~g~~-~~~~~~~l 396 (611)
.|.....||+|+||.||.+...+. +.+|+|...... .....+..|+.++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788899999999999999996553 578888875432 222267888998888863 5788888887 46778899
Q ss_pred EEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCC-----CCeEEeecccc
Q 035917 397 IYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDED-----FDARIMDFGLA 470 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~-----~~~kl~DFGla 470 (611)
||+.+ |.+|.++..... ..++..+..+|+.|++.+|+++| +.+++||||||+|+++... ..+.+.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 669999885444 57899999999999999999999 8999999999999999854 46899999999
Q ss_pred c--ccCCCCC---Cc--c-ccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhh
Q 035917 471 K--LMTSSDE---SS--F-VNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAI 542 (611)
Q Consensus 471 ~--~~~~~~~---~~--~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~ 542 (611)
+ .+..... .. . .....||..|+++....+...+.+.|+||++.++.|+..|..|+........ .....+..
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHHh
Confidence 8 3322111 00 1 1234599999999999999999999999999999999988877532110000 00011111
Q ss_pred chhh---cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCCC
Q 035917 543 DKAL---CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFS 593 (611)
Q Consensus 543 ~~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 593 (611)
.... .....+.++..+.. .+-..+..++|....+...++......+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~ 304 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILE---YIDSLDYEDKPDYEKLAELLKDVFDSEGSK 304 (322)
T ss_pred hhhccccccCCChHHHHHHHH---HhhccCCcCCCCHHHHHHHHHHHHHhcCCC
Confidence 1111 11223445555555 566689999999999999998888776433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-21 Score=207.64 Aligned_cols=211 Identities=26% Similarity=0.339 Sum_probs=158.7
Q ss_pred HhccCCCCccceeeEEEeCCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 035917 373 LGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSN 452 (611)
Q Consensus 373 l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~ 452 (611)
|+.+.|.|+.+++|.+.+++..+.|.+||..|+|.|.+......++|.....++++|++||+|+|+ ++-..|+.++++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeeccc
Confidence 467899999999999999999999999999999999998766689999999999999999999994 333499999999
Q ss_pred eEEeCCCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCC-------CCCcccchHHHHHHHHHHhCCCCCH
Q 035917 453 VILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTM-------VASLKGDVYGIGVVLLELAGFKGNL 525 (611)
Q Consensus 453 NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~t~ksDV~SfGvvl~ell~~~~~~ 525 (611)
|+++|..+.+|++|||+.................-..-|.|||.+... ..+.++||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998876421111111111234569999987653 1467899999999999999988887
Q ss_pred HHHHHHHhhcCChhhhhch-------hhcCCCC-H-HHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 526 VDWVNQLSSSGRSKEAIDK-------ALCGKGY-D-EEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~-------~l~~~~~-~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
..-...... .+++.+ ..++... . +....++.++..||..+|.+||++++|-..++.+...
T Consensus 159 ~~~~~~~~~----~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 159 DLRNLVEDP----DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccCCh----HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 432111110 111111 1111111 1 2223577778899999999999999999888877654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-21 Score=216.57 Aligned_cols=248 Identities=19% Similarity=0.128 Sum_probs=179.6
Q ss_pred CCCCeeeecCCceEEEEEe-CCCCEEEEEeccc---cchhH----HHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 327 CSENVIISTRTGTTYKAML-PDGSVLAVKRLNT---CKLGE----KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 327 ~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~---~~~~~----~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
....++|.|.+|.|+.... ...+..+.|..+. ..... ..+..|+.+-..++|||++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3568999999998877763 3344455554331 11111 23667888889999999988887777666666669
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
|||++ +|+.++... ..+.-..+..++.|+..|+.|+| ..+|.|||+|++|+++..++.+||+|||.+....-...
T Consensus 401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 99999 999998764 24777788899999999999999 89999999999999999999999999999876543322
Q ss_pred C--ccccCCCcccccccccccCCCCCCcc-cchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhch-hhcCC-----
Q 035917 479 S--SFVNGDLGEFGYIAPEYSSTMVASLK-GDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDK-ALCGK----- 549 (611)
Q Consensus 479 ~--~~~~~~~gt~~y~aPE~~~~~~~t~k-sDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~~----- 549 (611)
. ....+.+|+..|+|||.+.+..|.+. .||||.||++..|++++.||..--.. .....+.... .....
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~---~~~~~~~~~~~~~~~~~~~~~ 552 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS---DNSFKTNNYSDQRNIFEGPNR 552 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc---ccchhhhccccccccccChHH
Confidence 2 44556789999999999999988765 89999999999999998775321110 0000000000 00000
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 550 GYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 550 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
...........++.++++.||.+|.||.+|++.
T Consensus 553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 553 LLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred HHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 011222344566779999999999999999863
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-20 Score=180.32 Aligned_cols=139 Identities=16% Similarity=0.159 Sum_probs=108.9
Q ss_pred CCeeeecCCceEEEEEeCCCCEEEEEeccccch---h-------HH-----------------HHHHHHHHHhccCCCCc
Q 035917 329 ENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKL---G-------EK-----------------KFRNEMNRLGQLRHPNL 381 (611)
Q Consensus 329 ~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~---~-------~~-----------------~~~~Ev~~l~~l~H~nI 381 (611)
...||+|++|.||+|...+|+.||||+++.... . .. ...+|++++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 367999999999999988999999999965321 1 01 22459999999988877
Q ss_pred cceeeEEEeCCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCC
Q 035917 382 APLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFD 461 (611)
Q Consensus 382 v~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~ 461 (611)
.....+.. ...++||||++++++....... ..+++.....++.|++.+|.|+|| ..+|+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEE-CCc
Confidence 54433322 2348999999988776543222 358899999999999999999943 67999999999999998 478
Q ss_pred eEEeeccccccc
Q 035917 462 ARIMDFGLAKLM 473 (611)
Q Consensus 462 ~kl~DFGla~~~ 473 (611)
++|+|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-19 Score=177.13 Aligned_cols=264 Identities=13% Similarity=0.138 Sum_probs=199.2
Q ss_pred hcCCCCCeeeecCCceEEEEE-eCCCCEEEEEeccccchhHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeEEEEecc
Q 035917 324 NSFCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLR-HPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
-+|.++++||+|.||.++.|+ +-+++.||||.-... ....++..|.+..+.|. .++|..++-|-.++-+-.||+|+.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc-CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 368889999999999999999 678999999986443 23356788888888885 688887766655666778999998
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCC-----CCeEEeecccccccCCC
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDED-----FDARIMDFGLAKLMTSS 476 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~-----~~~kl~DFGla~~~~~~ 476 (611)
|.||+|+..-.+..++.+....||.|+..-++|+| .+.+|.|||||+|.||... ..+.+.|||+|+.+.+.
T Consensus 107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 66999988766667999999999999999999999 8999999999999999743 35899999999987654
Q ss_pred CC-----CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHH-----HhhcCChhhhhchhh
Q 035917 477 DE-----SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQ-----LSSSGRSKEAIDKAL 546 (611)
Q Consensus 477 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~-----~~~~~~~~~~~~~~l 546 (611)
.. .....+..||..||+--...+..-+.+.|.=|+|-++...+-|..||...-.. ...-+..+.......
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~ 262 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEV 262 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHH
Confidence 41 22334556999999988888888899999999999888888888886432110 111111111111111
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCCCCC
Q 035917 547 CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFSER 595 (611)
Q Consensus 547 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~ 595 (611)
.-...++++...++.+++ .+-.+-|..+-+...+.++....+...+
T Consensus 263 Lc~g~P~efa~Yl~yvR~---L~F~E~PDYdylr~Lf~dvldr~g~t~D 308 (449)
T KOG1165|consen 263 LCEGFPEEFATYLRYVRR---LDFFETPDYDYLRKLFDDVLDRLGETDD 308 (449)
T ss_pred HHhcCHHHHHHHHHHHHh---cCcccCCCHHHHHHHHHHHHHhcCCccc
Confidence 223467777777775544 6677889988888888888777666543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5e-20 Score=173.61 Aligned_cols=253 Identities=16% Similarity=0.189 Sum_probs=187.1
Q ss_pred hhcCCCCCeeeecCCceEEEEE-eCCCCEEEEEeccccchhHHHHHHHHHHHhccCC-CCccceeeEEEeCCeeEEEEec
Q 035917 323 SNSFCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRH-PNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H-~nIv~l~g~~~~~~~~~lv~ey 400 (611)
.++|...+.||+|+||.+|.|. ..+|+.||||.-... ....++..|.++.+.++| ..|..+..|..+...-.+|||.
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 4578888999999999999999 788999999986432 334567889999999975 5677777777788888999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC---CCCeEEeecccccccCCCC
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE---DFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~---~~~~kl~DFGla~~~~~~~ 477 (611)
. |.+|.++..-....++..+.+-++-|++.-++|+| .++++||||||+|.|+.- ...+.++|||+|+.+.+..
T Consensus 93 L-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 93 L-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred c-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 8 67999988655456888999999999999999999 889999999999999963 3468899999999875433
Q ss_pred C-----CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhch-------h
Q 035917 478 E-----SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDK-------A 545 (611)
Q Consensus 478 ~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~-------~ 545 (611)
. ...-....||..|++--...+...+.+.|+=|+|.+|...--|.-|+....... .....+.+... .
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t-k~QKyEkI~EkK~s~~ie~ 247 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT-KKQKYEKISEKKMSTPIEV 247 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh-HHHHHHHHHHhhcCCCHHH
Confidence 1 111233469999998777776677889999999998888878888875432211 11122222221 1
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHH
Q 035917 546 LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNS 585 (611)
Q Consensus 546 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 585 (611)
++ +..+.|....+. -|-..--++-|...-+-+...-
T Consensus 248 LC-~G~P~EF~myl~---Y~R~L~F~E~Pdy~ylrqlFri 283 (341)
T KOG1163|consen 248 LC-KGFPAEFAMYLN---YCRGLGFEEKPDYMYLRQLFRI 283 (341)
T ss_pred Hh-CCCcHHHHHHHH---HHhhcCCCCCCcHHHHHHHHHH
Confidence 22 334455555555 7877778888876655554443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.4e-20 Score=175.23 Aligned_cols=138 Identities=19% Similarity=0.193 Sum_probs=111.1
Q ss_pred CCeeeecCCceEEEEEeCCCCEEEEEeccccchh---------------------------HHHHHHHHHHHhccCCCCc
Q 035917 329 ENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLG---------------------------EKKFRNEMNRLGQLRHPNL 381 (611)
Q Consensus 329 ~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~---------------------------~~~~~~Ev~~l~~l~H~nI 381 (611)
...||+|++|.||+|+..+|+.||||+++..... ...+.+|.+.+.+++|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999879999999998653210 1224679999999999988
Q ss_pred cceeeEEEeCCeeEEEEeccCCCChHHh-hhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeeecCCCCCeEEeCCC
Q 035917 382 APLLGYCVVEEEKLLIYKYMSSGTLYSL-LQGNATELDWPTRFRIGLGAARGLAWLHHGCQ-PPFLHQNICSNVILVDED 459 (611)
Q Consensus 382 v~l~g~~~~~~~~~lv~ey~~~gsL~~~-l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivHrDlkp~NILld~~ 459 (611)
.....+... ..++||||++++++... +.. ..++......++.+++.++.++| . .+|+||||||+||+++ +
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-C
Confidence 655444433 34899999998865433 332 34778889999999999999999 6 8999999999999999 7
Q ss_pred CCeEEeecccccccC
Q 035917 460 FDARIMDFGLAKLMT 474 (611)
Q Consensus 460 ~~~kl~DFGla~~~~ 474 (611)
+.++|+|||+++...
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 899999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3e-20 Score=180.92 Aligned_cols=170 Identities=13% Similarity=0.149 Sum_probs=131.7
Q ss_pred hhhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHH----------HHHHHHHHHhccCCCCccceeeEEEeC
Q 035917 322 ASNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEK----------KFRNEMNRLGQLRHPNLAPLLGYCVVE 391 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~----------~~~~Ev~~l~~l~H~nIv~l~g~~~~~ 391 (611)
..+.|...+++|.|+||.||.... ++..+|||.++......+ .+++|+..+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 356788999999999999999655 677899999965432222 268999999999999999999886643
Q ss_pred --------CeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeE
Q 035917 392 --------EEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDAR 463 (611)
Q Consensus 392 --------~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~k 463 (611)
+..+++|||++|.+|.++.. ++. ....+++.++..+| ..+++|||+||+||+++.++ ++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EE
Confidence 35789999999999988742 222 24568999999999 89999999999999999888 99
Q ss_pred EeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHh
Q 035917 464 IMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELA 519 (611)
Q Consensus 464 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell 519 (611)
|+|||..+........ ..+.....+..++|+||||+++.-..
T Consensus 175 liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9999988754321110 01233345667999999999876553
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-19 Score=201.18 Aligned_cols=247 Identities=22% Similarity=0.221 Sum_probs=173.2
Q ss_pred cCCCCCeeeecCCceEEEEEeCCCCEEEEEecccc--chhHHHHH---HHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 325 SFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTC--KLGEKKFR---NEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~--~~~~~~~~---~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
++...+.+|+++|=+|.||+.++|. |+||++-+. ...-+.|. .|++ ...++|||.+++..+-......|||=+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4566788999999999999998887 889988432 22333343 4444 555689999998877766777788989
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccc--cCCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKL--MTSSD 477 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~--~~~~~ 477 (611)
|..+ +|+|.+.-+ .-+...+.+-|+.|+..||..+| ..+|+|+|||.+|||+..-..+.|+||---|. ++.+.
T Consensus 102 yvkh-nLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHhh-hhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 9977 999988643 34677788889999999999999 89999999999999999988999999976553 22221
Q ss_pred C---CccccCCCcccccccccccCC----------CC-CCcccchHHHHHHHHHHhCCCCCHHHHHHHH-hhcCChhhhh
Q 035917 478 E---SSFVNGDLGEFGYIAPEYSST----------MV-ASLKGDVYGIGVVLLELAGFKGNLVDWVNQL-SSSGRSKEAI 542 (611)
Q Consensus 478 ~---~~~~~~~~gt~~y~aPE~~~~----------~~-~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~-~~~~~~~~~~ 542 (611)
. .....+...-..|+|||.+.. .. .+++.||||.|||+.||++...|+.....-. ++.+. ..
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~---~~ 253 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGN---AD 253 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccC---cc
Confidence 1 111111123347999997543 11 5788999999999999997655543322211 11111 11
Q ss_pred chh-hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 035917 543 DKA-LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLN 584 (611)
Q Consensus 543 ~~~-l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 584 (611)
++. +..+..+..++ +++..|++.||++|.++++.++.-.
T Consensus 254 ~~e~~Le~Ied~~~R---nlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 254 DPEQLLEKIEDVSLR---NLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred CHHHHHHhCcCccHH---HHHHHHHccCchhccCHHHHHHhhh
Confidence 111 11222223344 4555999999999999999998843
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.5e-18 Score=165.01 Aligned_cols=136 Identities=14% Similarity=0.114 Sum_probs=106.2
Q ss_pred CCCCCeeeecCCceEEEEEeCCCCEEEEEecccc-chhHHHHHHHHHHHhcc-----CCCCccceeeEEEeCC---e-eE
Q 035917 326 FCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTC-KLGEKKFRNEMNRLGQL-----RHPNLAPLLGYCVVEE---E-KL 395 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~-~~~~~~~~~Ev~~l~~l-----~H~nIv~l~g~~~~~~---~-~~ 395 (611)
.+....||+|+||.||. .-.++.. +||++... ....+++.+|+.+++.+ .||||++++|++..+. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34568999999999996 3234444 79988653 23456799999999999 5799999999998763 3 33
Q ss_pred EEEec--cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCCeeecCCCCCeEEeCC----CCCeEEeecc
Q 035917 396 LIYKY--MSSGTLYSLLQGNATELDWPTRFRIGLGAARGL-AWLHHGCQPPFLHQNICSNVILVDE----DFDARIMDFG 468 (611)
Q Consensus 396 lv~ey--~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivHrDlkp~NILld~----~~~~kl~DFG 468 (611)
+|+|| +++|+|.+++.+. .+++. ..++.+++.++ +||| +.+|+||||||+|||++. +..++|+||+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 78999 6689999999753 35554 35677888888 9999 899999999999999974 3489999954
Q ss_pred cc
Q 035917 469 LA 470 (611)
Q Consensus 469 la 470 (611)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 44
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=5e-18 Score=162.01 Aligned_cols=182 Identities=17% Similarity=0.116 Sum_probs=134.9
Q ss_pred CCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhH-----HHHHHHHHHHhccC-CCCccceeeEEEeCCeeEEEEec
Q 035917 327 CSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGE-----KKFRNEMNRLGQLR-HPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 327 ~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~-----~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
.....|++|+||+||.+.- .+..++.+.+.....-. ..+.+|+++|+++. |++|.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999997665 67788888876544322 35889999999995 5889999886 346999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCC-CCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl-kp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
+.|.+|.+.+.. ....++.+++++|.++| ..+|+|||| ||+|||++.++.++|+|||+|.........
T Consensus 80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred ecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 999998765421 11356788999999999 889999999 799999999999999999999854332210
Q ss_pred ------cc-----ccCCCcccccccccccCCC-CCC-cccchHHHHHHHHHHhCCCCC
Q 035917 480 ------SF-----VNGDLGEFGYIAPEYSSTM-VAS-LKGDVYGIGVVLLELAGFKGN 524 (611)
Q Consensus 480 ------~~-----~~~~~gt~~y~aPE~~~~~-~~t-~ksDV~SfGvvl~ell~~~~~ 524 (611)
.. ..-...++.|++|+...-. ..+ ...+.++-|.-+|.++|+..+
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~ 206 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVL 206 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCC
Confidence 00 0001256778888743321 223 456778999999999987754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.8e-19 Score=191.56 Aligned_cols=223 Identities=18% Similarity=0.201 Sum_probs=170.4
Q ss_pred eeeecCCceEEEEE----eCCCCEEEEEeccccch---hHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeEEEEeccC
Q 035917 331 VIISTRTGTTYKAM----LPDGSVLAVKRLNTCKL---GEKKFRNEMNRLGQLR-HPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 331 ~ig~G~~g~Vy~~~----~~~g~~vAvK~~~~~~~---~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
++|+|.||.|+.++ .+.|..+|+|.+++... .......|..++..++ ||.+|++.-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 36899999998765 34588899998865321 1124556888888887 9999999988888999999999999
Q ss_pred CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccc
Q 035917 403 SGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482 (611)
Q Consensus 403 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 482 (611)
+|+|...+... ..++......+...++-+++++| +.+|+|||+|++||+++.+|.+++.|||+++........
T Consensus 81 gg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKE-VMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred cchhhhccccC-CchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence 99999988754 34566666677778899999999 899999999999999999999999999999976543322
Q ss_pred cCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHH-HHHHhhcCChhhhhchhhcCCCCHHHHHHHHHH
Q 035917 483 NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDW-VNQLSSSGRSKEAIDKALCGKGYDEEILQFLKV 561 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l 561 (611)
+||..|||||++. .....+|.||||++++||++|..||... +..+... ....+.....+++.++.
T Consensus 154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~~~~Il~~--------~~~~p~~l~~~a~~~~~- 219 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDTMKRILKA--------ELEMPRELSAEARSLFR- 219 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHHHHHHhhh--------ccCCchhhhHHHHHHHH-
Confidence 6999999999998 3577899999999999999999888551 1111110 00111223344555555
Q ss_pred HhhcccCCCCCCCCH
Q 035917 562 ACNCVVSRPKDRWSM 576 (611)
Q Consensus 562 ~~~Cl~~dP~~RPs~ 576 (611)
..+..+|..|--.
T Consensus 220 --~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 220 --QLFKRNPENRLGA 232 (612)
T ss_pred --HHHhhCHHHHhcc
Confidence 6777788877744
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-17 Score=187.43 Aligned_cols=251 Identities=16% Similarity=0.201 Sum_probs=179.7
Q ss_pred HhhhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccC---CCCccceeeEEEeCCeeEEE
Q 035917 321 AASNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLR---HPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 321 ~~t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~---H~nIv~l~g~~~~~~~~~lv 397 (611)
.-...|.+...||+|+||.||+|...+|+.||+|+=+..... +|---.+++.+|+ -+-|..+...+...+.-+||
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 344578889999999999999999888999999997543221 2222223333333 23455555566667788999
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC-------CCCCeEEeecccc
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD-------EDFDARIMDFGLA 470 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld-------~~~~~kl~DFGla 470 (611)
+||.+.|+|.+++. ..+.++|...+.++.++++-++.|| ..+|||+||||+|.||. +...++|+|||.+
T Consensus 773 ~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 773 SEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred eeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 99999999999998 3357999999999999999999999 89999999999999993 3456899999998
Q ss_pred cccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCC
Q 035917 471 KLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKG 550 (611)
Q Consensus 471 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 550 (611)
-.+.--.......+.++|-.+-.+|+..+..++...|.|.+.-+++-|+.|+ ++. ...+... .++..+ ..+
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~-----y~q--~~~g~~~-~~~~~~-~Ry 919 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK-----YME--VKNGSSW-MVKTNF-PRY 919 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH-----HHH--hcCCcce-eccccc-hhh
Confidence 6553322233445567889999999999999999999999999999999665 222 1122111 112111 122
Q ss_pred CHHHHH-HHHHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 551 YDEEIL-QFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 551 ~~~~~~-~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
...+++ ++++ ..|..|-..=|...++...++++..+
T Consensus 920 ~~~~~W~~~F~---~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 920 WKRDMWNKFFD---LLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred hhHHHHHHHHH---HHhCcCcccchhHHHHHHHHHHHHHH
Confidence 333332 4555 45555555566777777777776654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.7e-17 Score=163.32 Aligned_cols=140 Identities=17% Similarity=0.187 Sum_probs=109.6
Q ss_pred cCCCCCeeeecCCceEEEEE--eCCCCEEEEEeccccch-------------------------hHHHHHHHHHHHhccC
Q 035917 325 SFCSENVIISTRTGTTYKAM--LPDGSVLAVKRLNTCKL-------------------------GEKKFRNEMNRLGQLR 377 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~--~~~g~~vAvK~~~~~~~-------------------------~~~~~~~Ev~~l~~l~ 377 (611)
.|...+.||+|++|.||+|. ..+|+.||||+++.... ....+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 36677899999999999998 57899999999864321 0123578999999997
Q ss_pred CCC--ccceeeEEEeCCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-eeecCCCCCeE
Q 035917 378 HPN--LAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPP-FLHQNICSNVI 454 (611)
Q Consensus 378 H~n--Iv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHrDlkp~NI 454 (611)
+.. +.+++++ ...++||||+++++|....... ..++......++.+++.++.||| ..+ |+||||||+||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhE
Confidence 633 3333332 2358999999998887654322 23555667889999999999999 788 99999999999
Q ss_pred EeCCCCCeEEeeccccccc
Q 035917 455 LVDEDFDARIMDFGLAKLM 473 (611)
Q Consensus 455 Lld~~~~~kl~DFGla~~~ 473 (611)
+++ +++++|+|||.+...
T Consensus 181 li~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEE-CCCEEEEEChhhhcc
Confidence 999 789999999998754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.6e-17 Score=158.34 Aligned_cols=143 Identities=17% Similarity=0.153 Sum_probs=111.8
Q ss_pred HHHHhhhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccch-----------------------hHHHHHHHHHHHh
Q 035917 318 DLMAASNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKL-----------------------GEKKFRNEMNRLG 374 (611)
Q Consensus 318 ~l~~~t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~-----------------------~~~~~~~Ev~~l~ 374 (611)
++......|...+.||+|+||.||++..++|+.||||+++.... ....+.+|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 34344344777899999999999999988999999998754221 0123678999999
Q ss_pred ccCCCC--ccceeeEEEeCCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 035917 375 QLRHPN--LAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSN 452 (611)
Q Consensus 375 ~l~H~n--Iv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~ 452 (611)
++.|++ +.+.++ ....++||||+++++|.+.... .....++.+++.++.++| ..+|+||||||+
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~ 154 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEF 154 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcc
Confidence 998874 444433 2456899999999999775431 234578889999999999 789999999999
Q ss_pred eEEeCCCCCeEEeecccccccC
Q 035917 453 VILVDEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 453 NILld~~~~~kl~DFGla~~~~ 474 (611)
||++++++.++|+|||++....
T Consensus 155 Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 155 NILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.5e-17 Score=159.91 Aligned_cols=133 Identities=17% Similarity=0.286 Sum_probs=113.7
Q ss_pred CeeeecCCceEEEEEeCCCCEEEEEeccccch---------hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 330 NVIISTRTGTTYKAMLPDGSVLAVKRLNTCKL---------GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~---------~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
+.||+|++|.||+|.. +|..|++|+...... ....+.+|++++..++|++|.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999987 677899997643211 124588999999999999998888888788888999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKL 472 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~ 472 (611)
+++++|.+++... .+ .+..++.+++.+|.++| ..+++|+|++|.||+++ ++.++|+|||.++.
T Consensus 81 ~~G~~L~~~~~~~----~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN----GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc----cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998643 22 78899999999999999 88999999999999999 78999999998864
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.6e-17 Score=181.18 Aligned_cols=140 Identities=19% Similarity=0.260 Sum_probs=113.6
Q ss_pred HhhhcCCCCCeeeecCCceEEEEEeCCCCEEEEEecccc-c-------hhHHHHHHHHHHHhccCCCCccceeeEEEeCC
Q 035917 321 AASNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTC-K-------LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE 392 (611)
Q Consensus 321 ~~t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~-~-------~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~ 392 (611)
.....|...+.||+|+||.||+|.+.+...++.+++... . ...+++.+|++++.+++|++++....++..++
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 334455678999999999999999755443332222211 1 11256889999999999999998888888877
Q ss_pred eeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccc
Q 035917 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKL 472 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~ 472 (611)
..++||||+++++|.+++. ....++.+++++|.||| +.+++|||+||+|||+ +++.++|+|||+++.
T Consensus 410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 8899999999999999875 35678999999999999 8899999999999999 577999999999975
Q ss_pred c
Q 035917 473 M 473 (611)
Q Consensus 473 ~ 473 (611)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 3
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.3e-17 Score=156.17 Aligned_cols=129 Identities=20% Similarity=0.307 Sum_probs=107.6
Q ss_pred eeeecCCceEEEEEeCCCCEEEEEeccccc---------hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 331 VIISTRTGTTYKAMLPDGSVLAVKRLNTCK---------LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 331 ~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~---------~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
+||+|++|.||+|.+ +|..|++|...... ...+++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999995 67889999864321 11256788999999999988766666666777789999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccc
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKL 472 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~ 472 (611)
++++|.+++..... .++.+++.+|.++| ..+++|+|++|.||+++ ++.+++.|||+++.
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998764311 78899999999999 89999999999999999 78999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.7e-18 Score=175.55 Aligned_cols=173 Identities=20% Similarity=0.273 Sum_probs=126.8
Q ss_pred eeEEEEeccCCCChHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccc
Q 035917 393 EKLLIYKYMSSGTLYSLLQGNA--TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLA 470 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla 470 (611)
..++.|++|...+|.+++.+.. ...+|...+.++.|++.|++| ++.+|||+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 4679999999999999997544 367899999999999999998 57899999999999999999999999998
Q ss_pred cccCCCC----CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchh
Q 035917 471 KLMTSSD----ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKA 545 (611)
Q Consensus 471 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (611)
....... .....+..+||..||+||.+.+..|+.|+||||+|++|+|++. ....+...... ...-...+++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~---~d~r~g~ip~~ 480 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATL---TDIRDGIIPPE 480 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhh---hhhhcCCCChH
Confidence 8765433 1223455679999999999999999999999999999999984 33332211000 00001111211
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHH
Q 035917 546 LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQV 579 (611)
Q Consensus 546 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev 579 (611)
...+ ++ +-..|+. +++...|.+||++.++
T Consensus 481 ~~~d-~p-~e~~ll~---~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 481 FLQD-YP-EEYTLLQ---QLLSPSPEERPSAIEV 509 (516)
T ss_pred Hhhc-Cc-HHHHHHH---HhcCCCcccCchHHHH
Confidence 1111 11 2234444 8999999999954443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.3e-16 Score=160.23 Aligned_cols=197 Identities=20% Similarity=0.189 Sum_probs=132.1
Q ss_pred CCCCccceeeEEEeC---------------------------CeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHH
Q 035917 377 RHPNLAPLLGYCVVE---------------------------EEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGA 429 (611)
Q Consensus 377 ~H~nIv~l~g~~~~~---------------------------~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i 429 (611)
+|||||++.++|.+. ...|+||.-++. +|.+++-.+ ..+...+.-+..|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHH
Confidence 699999999987651 135899988876 899998644 24555666788899
Q ss_pred HHHHHHHhhcCCCCeeecCCCCCeEEe--CCCC--CeEEeecccccccCCCC----CCccccCCCcccccccccccCCCC
Q 035917 430 ARGLAWLHHGCQPPFLHQNICSNVILV--DEDF--DARIMDFGLAKLMTSSD----ESSFVNGDLGEFGYIAPEYSSTMV 501 (611)
Q Consensus 430 a~gL~yLH~~~~~~ivHrDlkp~NILl--d~~~--~~kl~DFGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~ 501 (611)
++|+.||| +++|.|||+|++|||+ |+|. ...|+|||.+-...... ..+..-..-|.-.-||||+....+
T Consensus 351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999 8999999999999998 4444 56799999765332211 111111223667789999876432
Q ss_pred ------CCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCC
Q 035917 502 ------ASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWS 575 (611)
Q Consensus 502 ------~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 575 (611)
--.|+|.|+.|.+.||+++...||...-..........+.--|.+ ++..+..+++ ++...++.||++|++
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPal-p~~vpp~~rq---lV~~lL~r~pskRvs 503 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPAL-PSRVPPVARQ---LVFDLLKRDPSKRVS 503 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCC-cccCChHHHH---HHHHHhcCCccccCC
Confidence 136899999999999999988888652111111111111111111 1222333444 445899999999998
Q ss_pred HHHHHHHH
Q 035917 576 MYQVYQSL 583 (611)
Q Consensus 576 ~~evl~~L 583 (611)
..-....|
T Consensus 504 p~iAANvl 511 (598)
T KOG4158|consen 504 PNIAANVL 511 (598)
T ss_pred ccHHHhHH
Confidence 76554443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.68 E-value=6.6e-17 Score=162.20 Aligned_cols=228 Identities=17% Similarity=0.180 Sum_probs=140.0
Q ss_pred CCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCC----------CCccceeeEEE--
Q 035917 327 CSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRH----------PNLAPLLGYCV-- 389 (611)
Q Consensus 327 ~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H----------~nIv~l~g~~~-- 389 (611)
..+..||.|+++.||.++.. +|+.+|||++.... ..-+++.+|.-....+.+ -.++.-++...
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 34578999999999999975 58999999884322 233567777765555433 11221122211
Q ss_pred -------eCC--------eeEEEEeccCCCChHHhhh---cCCC---CCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecC
Q 035917 390 -------VEE--------EKLLIYKYMSSGTLYSLLQ---GNAT---ELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQN 448 (611)
Q Consensus 390 -------~~~--------~~~lv~ey~~~gsL~~~l~---~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD 448 (611)
... ..+++|+-+. +||.+++. .... .+....++.+..|+++.+++|| ..+++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST
T ss_pred CCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecc
Confidence 111 2367788775 48887753 1111 2445567778899999999999 78999999
Q ss_pred CCCCeEEeCCCCCeEEeecccccccCCCCCCccccCCCcccccccccccCC--------CCCCcccchHHHHHHHHHHhC
Q 035917 449 ICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSST--------MVASLKGDVYGIGVVLLELAG 520 (611)
Q Consensus 449 lkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDV~SfGvvl~ell~ 520 (611)
|||+|++++.+|.++|+||+........ .. . ...+..|.+||.... -.++.+.|.|++|+++|.|.+
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~--~~-~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTR--YR-C--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEE--EE-G--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCce--ee-c--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 9999999999999999999876644221 11 1 224578999996533 247899999999999999998
Q ss_pred CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCC
Q 035917 521 FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDR 573 (611)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 573 (611)
+..|+.... .. .....+-..+. ..++.++.++. ..++.+|.+|
T Consensus 246 ~~lPf~~~~----~~--~~~~~~f~~C~-~~Pe~v~~LI~---~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSS----PE--ADPEWDFSRCR-DMPEPVQFLIR---GLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCG----GG--STSGGGGTTSS----HHHHHHHH---HHT-SSGGGS
T ss_pred ccCCCCCCC----cc--ccccccchhcC-CcCHHHHHHHH---HHccCCcccC
Confidence 887763100 00 00000222333 55666667666 9999999988
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.1e-16 Score=175.93 Aligned_cols=209 Identities=18% Similarity=0.147 Sum_probs=137.8
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
..+|...+.|..|+||.||..+++ ..+.+|+| +++...- .+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li----lRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI----LRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh----hhc--cccccCCccee-------------------
Confidence 457888899999999999999865 46778884 3332111 110 22222233332
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC----
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD---- 477 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~---- 477 (611)
||=.+.++..+ +++- +.+.+++||| ..+|+|||+||+|.++..-|.+|+.|||+.+......
T Consensus 136 --gDc~tllk~~g-~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 --GDCATLLKNIG-PLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred --chhhhhcccCC-CCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 55555565432 2221 1267899999 8999999999999999999999999999987532111
Q ss_pred ---------CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhh-hhchhhc
Q 035917 478 ---------ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKE-AIDKALC 547 (611)
Q Consensus 478 ---------~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~-~~~~~l~ 547 (611)
....-...+||+.|+|||++..+.|....|.|++|+|+||.+.|..||...........-+.+ +.-+. .
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE-~ 280 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE-E 280 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc-c
Confidence 011113347999999999999989999999999999999999888776432111110000111 11111 1
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCC
Q 035917 548 GKGYDEEILQFLKVACNCVVSRPKDRWS 575 (611)
Q Consensus 548 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 575 (611)
.+....|++++++ +.++.+|..|--
T Consensus 281 dea~p~Ea~dli~---~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 281 DEALPPEAQDLIE---QLLRQNPLCRLG 305 (1205)
T ss_pred CcCCCHHHHHHHH---HHHHhChHhhcc
Confidence 2233456666666 899999999973
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=9.9e-16 Score=146.64 Aligned_cols=135 Identities=19% Similarity=0.201 Sum_probs=98.1
Q ss_pred CCeeeecCCceEEEEEeCCCCEEEEEeccccchhH---HH----------------------HHHHHHHHhccCCCC--c
Q 035917 329 ENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGE---KK----------------------FRNEMNRLGQLRHPN--L 381 (611)
Q Consensus 329 ~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~---~~----------------------~~~Ev~~l~~l~H~n--I 381 (611)
.+.||+|+||.||+|...+|+.||||+++...... .. ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999986532111 11 135666666665433 3
Q ss_pred cceeeEEEeCCeeEEEEeccCCCChHHh-hhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeeecCCCCCeEEeCCC
Q 035917 382 APLLGYCVVEEEKLLIYKYMSSGTLYSL-LQGNATELDWPTRFRIGLGAARGLAWLHHGCQ-PPFLHQNICSNVILVDED 459 (611)
Q Consensus 382 v~l~g~~~~~~~~~lv~ey~~~gsL~~~-l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivHrDlkp~NILld~~ 459 (611)
.+.+++ ...++||||++++++... +.... .. .....++.+++.++.++| . .+|+|+||||+||+++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence 333332 346899999999654321 11110 11 567789999999999999 6 8999999999999999 8
Q ss_pred CCeEEeecccccccC
Q 035917 460 FDARIMDFGLAKLMT 474 (611)
Q Consensus 460 ~~~kl~DFGla~~~~ 474 (611)
+.++++|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 899999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.8e-15 Score=136.13 Aligned_cols=135 Identities=19% Similarity=0.103 Sum_probs=114.0
Q ss_pred CCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCC--CCccceeeEEEeCCeeEEEEeccCCCCh
Q 035917 329 ENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRH--PNLAPLLGYCVVEEEKLLIYKYMSSGTL 406 (611)
Q Consensus 329 ~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H--~nIv~l~g~~~~~~~~~lv~ey~~~gsL 406 (611)
.+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++.+++++...++..+++|||++++.+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 4679999999999999855 7899999865433 5678999999999976 5899998888877889999999998777
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccccc
Q 035917 407 YSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLM 473 (611)
Q Consensus 407 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~ 473 (611)
..+ +......++.+++++++++|.....+++|+|++|+||++++.+.+++.|||.++..
T Consensus 81 ~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 81 DEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 544 45667788999999999999543357999999999999999899999999988743
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.5e-14 Score=142.34 Aligned_cols=135 Identities=21% Similarity=0.252 Sum_probs=105.9
Q ss_pred CCeee-ecCCceEEEEEeCCCCEEEEEeccccc--------------hhHHHHHHHHHHHhccCCCCc--cceeeEEEeC
Q 035917 329 ENVII-STRTGTTYKAMLPDGSVLAVKRLNTCK--------------LGEKKFRNEMNRLGQLRHPNL--APLLGYCVVE 391 (611)
Q Consensus 329 ~~~ig-~G~~g~Vy~~~~~~g~~vAvK~~~~~~--------------~~~~~~~~Ev~~l~~l~H~nI--v~l~g~~~~~ 391 (611)
..+|| .|+.|+||++... +..++||++.... .....+.+|++++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46788 8999999999884 6788999874311 122467889999999998875 6677765433
Q ss_pred C----eeEEEEeccCC-CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEee
Q 035917 392 E----EKLLIYKYMSS-GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMD 466 (611)
Q Consensus 392 ~----~~~lv~ey~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~D 466 (611)
. ..++||||+++ .+|.+++.+. .++.. .+.+++.++.+|| ..+|+||||||.|||++.++.++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence 2 23599999997 6999888643 34433 3568999999999 89999999999999999888999999
Q ss_pred ccccccc
Q 035917 467 FGLAKLM 473 (611)
Q Consensus 467 FGla~~~ 473 (611)
||.++..
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9988753
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=8e-15 Score=165.29 Aligned_cols=95 Identities=36% Similarity=0.581 Sum_probs=91.5
Q ss_pred CCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCcccccc
Q 035917 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSV 200 (611)
Q Consensus 121 ~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 200 (611)
.++.|+|++|.|+|.+|..+.. +++|+.|+|++|+|+|.+|..++++++|+.|||++|+|+|.+|..+++|++|+.|+|
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~-L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~L 497 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISK-LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNL 497 (623)
T ss_pred EEEEEECCCCCccccCCHHHhC-CCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEEC
Confidence 5789999999999999999998 999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccCCCC
Q 035917 201 ANNDLTGTIPSSFKGF 216 (611)
Q Consensus 201 ~~N~l~g~ip~~~~~~ 216 (611)
++|+|+|.+|..++..
T Consensus 498 s~N~l~g~iP~~l~~~ 513 (623)
T PLN03150 498 NGNSLSGRVPAALGGR 513 (623)
T ss_pred cCCcccccCChHHhhc
Confidence 9999999999988653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=7.3e-16 Score=171.49 Aligned_cols=250 Identities=20% Similarity=0.190 Sum_probs=184.6
Q ss_pred cCCCCCeeeecCCceEEEEEe--CCCCEEEEEeccccc---hhHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeEEEE
Q 035917 325 SFCSENVIISTRTGTTYKAML--PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLR-HPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~--~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~~~~~lv~ 398 (611)
.|...+.||+|.|+.|-.... .....+|+|.+.... ...+....|..+-..+. |+|++++++...+.+..++..
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 445556699999999987764 335567777775443 22344556888878886 999999999999999999999
Q ss_pred eccCCCChHHhh-hcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC-CeEEeecccccccCC-
Q 035917 399 KYMSSGTLYSLL-QGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF-DARIMDFGLAKLMTS- 475 (611)
Q Consensus 399 ey~~~gsL~~~l-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~-~~kl~DFGla~~~~~- 475 (611)
+|..+|++.+.+ +......+......+..|+..++.|+|. ..++.|||+||+|.+++..+ ..|++|||+|..+..
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 999999999988 5443245556677889999999999995 57899999999999999999 999999999988765
Q ss_pred CCCCccccCCCc-ccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhch-----hhcC
Q 035917 476 SDESSFVNGDLG-EFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDK-----ALCG 548 (611)
Q Consensus 476 ~~~~~~~~~~~g-t~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~-----~l~~ 548 (611)
..........+| ++.|+|||...+. ......|+||.|+++.-+++|..|+..-.... ......... ....
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~ 255 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD---GRYSSWKSNKGRFTQLPW 255 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc---ccceeecccccccccCcc
Confidence 444444555678 9999999998774 44677999999999999999887653211111 111111111 1111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 549 KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 549 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.........++. +++..+|..|.+.+++...
T Consensus 256 ~~~~~~~~~~l~---k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 256 NSISDQAHDLLH---KILKENPSNRLSIEELKLD 286 (601)
T ss_pred ccCChhhhhccc---ccccCCchhcccccccccc
Confidence 223334444444 8999999999999887654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.4e-13 Score=144.08 Aligned_cols=143 Identities=21% Similarity=0.229 Sum_probs=102.4
Q ss_pred cCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchh-----------------------------------------H
Q 035917 325 SFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLG-----------------------------------------E 363 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~-----------------------------------------~ 363 (611)
.|. .+.||+|++|.||+|++.+|+.||||+.+..-.. +
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 344 3689999999999999999999999998543100 0
Q ss_pred HHHHHHHHHHhccC----CCCccceeeEEE-eCCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHH-HHHHHh
Q 035917 364 KKFRNEMNRLGQLR----HPNLAPLLGYCV-VEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAAR-GLAWLH 437 (611)
Q Consensus 364 ~~~~~Ev~~l~~l~----H~nIv~l~g~~~-~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~-gL~yLH 437 (611)
-+|.+|.+.+.+++ |.+-+.+-.+|. .....+|||||++|++|.++........ .+..++..++. .+..+|
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH
Confidence 12556676666663 333233333332 2345799999999999988765321122 23456666665 467788
Q ss_pred hcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccC
Q 035917 438 HGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 438 ~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~ 474 (611)
..+++|+|+||.||++++++++++.|||++..+.
T Consensus 275 ---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 275 ---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 7899999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.5e-13 Score=134.02 Aligned_cols=206 Identities=22% Similarity=0.292 Sum_probs=137.0
Q ss_pred HHHHHhccCCCCccceeeEEEeC-----CeeEEEEeccCCCChHHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 035917 369 EMNRLGQLRHPNLAPLLGYCVVE-----EEKLLIYKYMSSGTLYSLLQGNA---TELDWPTRFRIGLGAARGLAWLHHGC 440 (611)
Q Consensus 369 Ev~~l~~l~H~nIv~l~g~~~~~-----~~~~lv~ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~ 440 (611)
-...+-.+.|-|||++..|+.+. ....++.|||..|++.++|++.. ..+....-.+++.||..||.|||+ |
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~ 195 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-C 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-c
Confidence 34456667899999999988653 34678999999999999997543 246667778899999999999995 5
Q ss_pred CCCeeecCCCCCeEEeCCCCCeEEeecccccccCC--CCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHH
Q 035917 441 QPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS--SDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL 518 (611)
Q Consensus 441 ~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~el 518 (611)
.++|+|+++..+-|++..++-+|+.----...-.. ...........+-++|.|||+=.....+..+|||+||...+||
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 89999999999999999998888753211110000 0000011112367899999987777778899999999999999
Q ss_pred hCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 035917 519 AGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSL 583 (611)
Q Consensus 519 l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 583 (611)
..++..... -.......+.+...+.... ..--+.++. +|++..|..||+|++++.|.
T Consensus 276 ailEiq~tn----seS~~~~ee~ia~~i~~le-n~lqr~~i~---kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 276 AILEIQSTN----SESKVEVEENIANVIIGLE-NGLQRGSIT---KCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHheeccCC----Ccceeehhhhhhhheeecc-CccccCcCc---ccccCCCCCCcchhhhhcCc
Confidence 744321000 0000011111111111100 011123344 89999999999999998773
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=6.9e-14 Score=125.97 Aligned_cols=123 Identities=25% Similarity=0.449 Sum_probs=109.9
Q ss_pred CcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccc
Q 035917 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
..++.|.|++|.|+ .+||.++.|.+|+.|++++|++. .+|.++.+ +++|+.|+++-|++. .+|..+|.++.|++||
T Consensus 33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~iss-l~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISS-LPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhh-chhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 36889999999998 67888999999999999999999 89999998 999999999999998 8999999999999999
Q ss_pred ccccccC-CCCChhhhcCCCcccccccccccCCCCCccCCCCCcccCCC
Q 035917 176 LSNNKLS-GPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKADFDG 223 (611)
Q Consensus 176 L~~N~l~-g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~~~~~~~ 223 (611)
|..|+++ ..+|..|..+..|+.|.|+.|.|. .+|+.+++++.+++-+
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~ 156 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILS 156 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEe
Confidence 9999997 568888888888999999999998 6788888777766543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.33 E-value=3.1e-11 Score=132.13 Aligned_cols=143 Identities=19% Similarity=0.196 Sum_probs=95.1
Q ss_pred hhcCCCCCeeeecCCceEEEEEeCC-CCEEEEEeccccchh-----------------------------------H---
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLPD-GSVLAVKRLNTCKLG-----------------------------------E--- 363 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~-----------------------------------~--- 363 (611)
...|+. +.||+|++|.||+|++.+ |+.||||+++..... .
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345766 789999999999999987 999999999643100 0
Q ss_pred ---HHHHHHHHHHhccC----CCCccceeeEEEe-CCeeEEEEeccCCCChHHh--hhcCCCCCCHHHHHHHHHHHHHH-
Q 035917 364 ---KKFRNEMNRLGQLR----HPNLAPLLGYCVV-EEEKLLIYKYMSSGTLYSL--LQGNATELDWPTRFRIGLGAARG- 432 (611)
Q Consensus 364 ---~~~~~Ev~~l~~l~----H~nIv~l~g~~~~-~~~~~lv~ey~~~gsL~~~--l~~~~~~l~~~~~~~i~~~ia~g- 432 (611)
-+|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++ +...+ .+. ..++...++.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--~d~---~~la~~~v~~~ 272 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--TDM---KLLAERGVEVF 272 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--CCH---HHHHHHHHHHH
Confidence 12455665555553 3444444334432 4567899999999999874 22221 221 1222222221
Q ss_pred HHHHhhcCCCCeeecCCCCCeEEeCCCC----CeEEeecccccccC
Q 035917 433 LAWLHHGCQPPFLHQNICSNVILVDEDF----DARIMDFGLAKLMT 474 (611)
Q Consensus 433 L~yLH~~~~~~ivHrDlkp~NILld~~~----~~kl~DFGla~~~~ 474 (611)
+.-++ ..+++|+|+||.||+++.++ ++++.|||+...+.
T Consensus 273 ~~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 273 FTQVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 22233 57899999999999999888 99999999987663
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.31 E-value=7.4e-12 Score=117.60 Aligned_cols=130 Identities=16% Similarity=0.134 Sum_probs=95.6
Q ss_pred CeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccc-eeeEEEeCCeeEEEEeccCCCChHH
Q 035917 330 NVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAP-LLGYCVVEEEKLLIYKYMSSGTLYS 408 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~-l~g~~~~~~~~~lv~ey~~~gsL~~ 408 (611)
+.++.|.++.||++... ++.|++|...........+.+|+.++..+.+.++++ ++.+ .....++||||+++.++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcccc
Confidence 46788999999999875 778999998654323345788999999987666543 4433 3344689999999988764
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeecCCCCCeEEeCCCCCeEEeecccccc
Q 035917 409 LLQGNATELDWPTRFRIGLGAARGLAWLHHGC--QPPFLHQNICSNVILVDEDFDARIMDFGLAKL 472 (611)
Q Consensus 409 ~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlkp~NILld~~~~~kl~DFGla~~ 472 (611)
.. . ....++.+++++|+.||... ...++|+|++|.||+++ ++.+++.|||.+..
T Consensus 81 ~~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 ED------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 30 1 11245678999999999321 12259999999999999 56899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.23 E-value=7.9e-12 Score=133.60 Aligned_cols=242 Identities=19% Similarity=0.187 Sum_probs=172.5
Q ss_pred CCCCCeeee--cCCceEEEEEe---CCCCEEEEEeccccc---hhHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeEE
Q 035917 326 FCSENVIIS--TRTGTTYKAML---PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLR-HPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 326 f~~~~~ig~--G~~g~Vy~~~~---~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~~~~~l 396 (611)
|....-+|. |.+|.||.+.. .++..+|+|+-+... .....=.+|+....+++ |+|.++....+...+..++
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi 195 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI 195 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence 445577888 99999999986 468899999843211 22233356777777775 9999998889999999999
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHH----HHHHHhhcCCCCeeecCCCCCeEEeCCC-CCeEEeeccccc
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAAR----GLAWLHHGCQPPFLHQNICSNVILVDED-FDARIMDFGLAK 471 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivHrDlkp~NILld~~-~~~kl~DFGla~ 471 (611)
-.|+|. .+|.++.+.....++....+.+..+... ||.++| ...++|-|+||.||++..+ ...++.|||+..
T Consensus 196 qtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 196 QTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred eecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcceeE
Confidence 999996 5888888765444667777777777777 999999 8899999999999999988 889999999998
Q ss_pred ccCCCCCCccc---cCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCH-----HHHHHHHhhcCChhhhhc
Q 035917 472 LMTSSDESSFV---NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNL-----VDWVNQLSSSGRSKEAID 543 (611)
Q Consensus 472 ~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~-----~~~~~~~~~~~~~~~~~~ 543 (611)
.+......... ....|...|++||...+ .++..+|+||+|.+..|...+-... ..|... +.. . +.
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~--r~~-~---ip 344 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL--RQG-Y---IP 344 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc--ccc-c---Cc
Confidence 87654422111 22247788999998876 5788999999999999887543211 122110 000 0 11
Q ss_pred hhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 544 KALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 544 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
...+. ..+.++.. ....+++.+|..|++.+++.++
T Consensus 345 ~e~~~-~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 345 LEFCE-GGSSSLRS---VTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred hhhhc-Ccchhhhh---HHHHhcCcchhhhhHHHHHhcc
Confidence 11111 12222333 4448999999999998876554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.16 E-value=2e-11 Score=130.60 Aligned_cols=248 Identities=15% Similarity=0.072 Sum_probs=173.7
Q ss_pred HHhhhcCCCCCeeeecCCceEEEEEe--CCCCEEEEEeccccc---hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCe
Q 035917 320 MAASNSFCSENVIISTRTGTTYKAML--PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEE 393 (611)
Q Consensus 320 ~~~t~~f~~~~~ig~G~~g~Vy~~~~--~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~ 393 (611)
..-+.+|.....||.|.|+.||+... .++..|++|.+...- .++..-..|+.+...+ .|.++++....+..-..
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34456788888999999999999874 468899999885532 2233345677776666 48888888777777777
Q ss_pred eEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCC-CCeEEeecccccc
Q 035917 394 KLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDED-FDARIMDFGLAKL 472 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~-~~~kl~DFGla~~ 472 (611)
.++--|||.++++..... -...++...++++..+++.++.++| ++.++|+|+||+||++..+ +..++.|||.++.
T Consensus 341 ~~ip~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred ccCchhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccc
Confidence 789999999998876552 1135777788999999999999999 8999999999999999876 8889999999875
Q ss_pred cCCCCCCccccCCCccccc-ccccccCCCCCCcccchHHHHHHHHHHhCCCCC---HHHHHHHHhhcCChhhhhchhhcC
Q 035917 473 MTSSDESSFVNGDLGEFGY-IAPEYSSTMVASLKGDVYGIGVVLLELAGFKGN---LVDWVNQLSSSGRSKEAIDKALCG 548 (611)
Q Consensus 473 ~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~ 548 (611)
+........ .++..| .+|+......+-.++|+||||.-+.|.+++..- ...|.. +....-+ ..
T Consensus 417 ~~~~~~~~~----~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~-------i~~~~~p--~~ 483 (524)
T KOG0601|consen 417 LAFSSGVFH----HIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT-------IRSGDTP--NL 483 (524)
T ss_pred cceeccccc----ccccccccchhhccccccccccccccccccccccccCcccCccccccee-------eeccccc--CC
Confidence 322111111 123344 356666667788999999999999999877542 112110 0000001 11
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHch
Q 035917 549 KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIA 587 (611)
Q Consensus 549 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 587 (611)
.....+ +..++......++..||.+.+...+.+...
T Consensus 484 ~~~~~~---~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 484 PGLKLQ---LQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred CchHHh---hhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 112233 344444788999999999998877765443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.9e-10 Score=110.54 Aligned_cols=141 Identities=20% Similarity=0.233 Sum_probs=110.1
Q ss_pred CeeeecCCceEEEEEeCCCCEEEEEeccccch--hHHHHHHHHHHHhccCCC--CccceeeEEEeC---CeeEEEEeccC
Q 035917 330 NVIISTRTGTTYKAMLPDGSVLAVKRLNTCKL--GEKKFRNEMNRLGQLRHP--NLAPLLGYCVVE---EEKLLIYKYMS 402 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~--~~~~~~~Ev~~l~~l~H~--nIv~l~g~~~~~---~~~~lv~ey~~ 402 (611)
+.|+.|..+.||++...+|+.+++|....... ...++.+|+++++.+++. ++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46889999999999987778999999865432 345789999999999763 456677776553 25689999999
Q ss_pred CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhc-------------------------------------------
Q 035917 403 SGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHG------------------------------------------- 439 (611)
Q Consensus 403 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------- 439 (611)
+.++.+.+.. ..++...+..++.++++.|.+||+.
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9888776532 2467777888888888888888842
Q ss_pred ----------CCCCeeecCCCCCeEEeCC--CCCeEEeecccccc
Q 035917 440 ----------CQPPFLHQNICSNVILVDE--DFDARIMDFGLAKL 472 (611)
Q Consensus 440 ----------~~~~ivHrDlkp~NILld~--~~~~kl~DFGla~~ 472 (611)
....++|+|+++.||+++. ++.+.|.||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 0245799999999999998 56689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.5e-12 Score=114.39 Aligned_cols=100 Identities=29% Similarity=0.543 Sum_probs=48.8
Q ss_pred CCccCcCCCCCCEEEccCCCCCc-cCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccccccccCCCCChhhh
Q 035917 112 IPEPLKFCKSMQRLDLSANDLSG-NIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLS 190 (611)
Q Consensus 112 ~p~~l~~l~~L~~L~Ls~N~l~g-~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~ 190 (611)
+|..++.++.|+.|||++|+|+- .+|..|+- ++.|+.|+|++|.|. .+|+.++++++|+.|.|..|.+- .+|.+++
T Consensus 94 lprgfgs~p~levldltynnl~e~~lpgnff~-m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig 170 (264)
T KOG0617|consen 94 LPRGFGSFPALEVLDLTYNNLNENSLPGNFFY-MTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIG 170 (264)
T ss_pred CccccCCCchhhhhhccccccccccCCcchhH-HHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHH
Confidence 34444444444444444444432 23444433 444444444444443 45555555555555555555544 4555555
Q ss_pred cCCCcccccccccccCCCCCccCCC
Q 035917 191 NLGRLKKFSVANNDLTGTIPSSFKG 215 (611)
Q Consensus 191 ~l~~L~~L~l~~N~l~g~ip~~~~~ 215 (611)
.|++|+.|.+.+|+|+ .+|+.+++
T Consensus 171 ~lt~lrelhiqgnrl~-vlppel~~ 194 (264)
T KOG0617|consen 171 DLTRLRELHIQGNRLT-VLPPELAN 194 (264)
T ss_pred HHHHHHHHhcccceee-ecChhhhh
Confidence 5555555555555555 34444443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.09 E-value=1e-09 Score=104.95 Aligned_cols=134 Identities=13% Similarity=0.125 Sum_probs=96.9
Q ss_pred CeeeecCCceEEEEEeCC-------CCEEEEEeccccch----------------------h-HHHH----HHHHHHHhc
Q 035917 330 NVIISTRTGTTYKAMLPD-------GSVLAVKRLNTCKL----------------------G-EKKF----RNEMNRLGQ 375 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~-------g~~vAvK~~~~~~~----------------------~-~~~~----~~Ev~~l~~ 375 (611)
..||.|.-+.||.|.-.+ +..+|||+.+.... + .+.+ ++|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999998553 57999998743110 0 1122 389999999
Q ss_pred cCC--CCccceeeEEEeCCeeEEEEeccCCCChHH-hhhcCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeeecCCCC
Q 035917 376 LRH--PNLAPLLGYCVVEEEKLLIYKYMSSGTLYS-LLQGNATELDWPTRFRIGLGAARGLAWL-HHGCQPPFLHQNICS 451 (611)
Q Consensus 376 l~H--~nIv~l~g~~~~~~~~~lv~ey~~~gsL~~-~l~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDlkp 451 (611)
+.. -++.+.+++ ...++||||+.++.+.. .+++. .++......+..+++.+|..+ | ..+++|+||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence 853 355555543 45789999997654422 23221 244455667788999999999 6 78999999999
Q ss_pred CeEEeCCCCCeEEeeccccccc
Q 035917 452 NVILVDEDFDARIMDFGLAKLM 473 (611)
Q Consensus 452 ~NILld~~~~~kl~DFGla~~~ 473 (611)
.||+++ ++.+.|+|||.+...
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeC
Confidence 999997 468999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.3e-09 Score=115.98 Aligned_cols=165 Identities=18% Similarity=0.196 Sum_probs=121.5
Q ss_pred eCCCCEEEEEeccccch-hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCChHHhhhcCCCCCCHHHHH
Q 035917 345 LPDGSVLAVKRLNTCKL-GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRF 423 (611)
Q Consensus 345 ~~~g~~vAvK~~~~~~~-~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~ 423 (611)
..++.+|.|...+.... ......+-++.|+.+|||||++++..+...+..|||+|-+. -|..++... ......
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l----~~~~v~ 107 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL----GKEEVC 107 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh----HHHHHH
Confidence 55788888888765433 23456778899999999999999999999999999999985 366677643 233444
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCC
Q 035917 424 RIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVAS 503 (611)
Q Consensus 424 ~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t 503 (611)
-.+.||+.||.|||+ ..+++|++|.-+.|+++..|.-||++|.++........ ......--..|..|+.+....
T Consensus 108 ~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 108 LGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--
Confidence 567899999999997 56899999999999999999999999988764322111 000001112355565443322
Q ss_pred cccchHHHHHHHHHHhCC
Q 035917 504 LKGDVYGIGVVLLELAGF 521 (611)
Q Consensus 504 ~ksDV~SfGvvl~ell~~ 521 (611)
...|.|-||++++|++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 346999999999999977
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.98 E-value=5.6e-11 Score=125.89 Aligned_cols=90 Identities=36% Similarity=0.479 Sum_probs=54.1
Q ss_pred CCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccC-ccCCcCcccccccccccCCCCChhhh
Q 035917 112 IPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPAD-LGNCTYLNTLILSNNKLSGPIPYQLS 190 (611)
Q Consensus 112 ~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~-~~~l~~L~~L~L~~N~l~g~iP~~l~ 190 (611)
||+.+..|..|+.||||+|+|. +.|..+.. .+++-+|+||+|++. .||.. +-+|+-|-.||||+|+|. .+|+.+.
T Consensus 95 iP~diF~l~dLt~lDLShNqL~-EvP~~LE~-AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~R 170 (1255)
T KOG0444|consen 95 IPTDIFRLKDLTILDLSHNQLR-EVPTNLEY-AKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIR 170 (1255)
T ss_pred CCchhcccccceeeecchhhhh-hcchhhhh-hcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHH
Confidence 5555666666666666666665 55666555 566666666666665 55544 245566666666666665 5555566
Q ss_pred cCCCccccccccccc
Q 035917 191 NLGRLKKFSVANNDL 205 (611)
Q Consensus 191 ~l~~L~~L~l~~N~l 205 (611)
.|..|++|+|++|.|
T Consensus 171 RL~~LqtL~Ls~NPL 185 (1255)
T KOG0444|consen 171 RLSMLQTLKLSNNPL 185 (1255)
T ss_pred HHhhhhhhhcCCChh
Confidence 666666666666654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=5.6e-09 Score=96.74 Aligned_cols=130 Identities=20% Similarity=0.312 Sum_probs=97.9
Q ss_pred CeeeecCCceEEEEEeCCCCEEEEEe-cccc----ch----hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 330 NVIISTRTGTTYKAMLPDGSVLAVKR-LNTC----KL----GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~g~~vAvK~-~~~~----~~----~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
..+++|+-+.+|.+.+. |..+++|. +++. .. ..++-.+|+.++.+++--.|....=|..+++...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35788999999998764 33466664 2221 11 124578899999998765555555566778888999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKL 472 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~ 472 (611)
+++..|.+.+... +..++..+-.-+.-|| ..+|+|+||.++||++... .+.++|||++..
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCC-cEEEEECCcccc
Confidence 9998888888644 2455666666777899 8999999999999999865 499999999974
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.8e-10 Score=122.10 Aligned_cols=106 Identities=31% Similarity=0.383 Sum_probs=81.1
Q ss_pred EEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcc------------------
Q 035917 98 ILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG------------------ 159 (611)
Q Consensus 98 v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G------------------ 159 (611)
...|+||+|++.....+-+-+|+.|-.||||+|.|. .+|+++.+ |..|++|+||+|.|..
T Consensus 128 ~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RR-L~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms 205 (1255)
T KOG0444|consen 128 SIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRR-LSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMS 205 (1255)
T ss_pred cEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHH-HhhhhhhhcCCChhhHHHHhcCccchhhhhhhcc
Confidence 456777777776433344677888888888888887 78888887 8888888888887642
Q ss_pred -------cCccCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccC
Q 035917 160 -------PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLT 206 (611)
Q Consensus 160 -------~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~ 206 (611)
.||.++-.+.+|..+|||.|+|. .+|..+.++++|+.|+||+|+++
T Consensus 206 ~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it 258 (1255)
T KOG0444|consen 206 NTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT 258 (1255)
T ss_pred cccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee
Confidence 46777777888888888888888 78888888888877777777654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.1e-08 Score=94.29 Aligned_cols=141 Identities=16% Similarity=0.209 Sum_probs=104.2
Q ss_pred CCCeeeecCCceEEEEEeCCCCEEEEEec-ccc--------chhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 328 SENVIISTRTGTTYKAMLPDGSVLAVKRL-NTC--------KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 328 ~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~-~~~--------~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
...++-+|+-+.|+++.+ .|+...||.- .+. +...++..+|++.|.+++--.|.--.=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457899999999999998 5777777743 221 123456789999999987555555445666777778999
Q ss_pred eccCC-CChHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC---CeEEeecccccc
Q 035917 399 KYMSS-GTLYSLLQGNAT-ELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF---DARIMDFGLAKL 472 (611)
Q Consensus 399 ey~~~-gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~---~~kl~DFGla~~ 472 (611)
||+++ .++.+++..... ..+.......+..|-+.+.-|| ...|+|+||..+||++..++ .+.+.|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 477777764432 2222233677888888899999 88999999999999996544 468999999864
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.92 E-value=3.5e-10 Score=114.62 Aligned_cols=125 Identities=30% Similarity=0.436 Sum_probs=95.1
Q ss_pred cEEEEEecCCccc-----------------------ccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECc
Q 035917 97 RILNLELREMKLS-----------------------GKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLS 153 (611)
Q Consensus 97 ~v~~l~l~~~~l~-----------------------g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls 153 (611)
-|+.++++.|+|. +.+|..++.++.|..|+|++|-|. .+|.+++. +..|+.||||
T Consensus 389 ~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~-lv~Lq~LnlS 466 (565)
T KOG0472|consen 389 IVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGS-LVRLQTLNLS 466 (565)
T ss_pred ceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhh-hhhhheeccc
Confidence 3888999888764 345556777888888888888777 78888887 7778888888
Q ss_pred CCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccCCCCCccCCCCCcc---cCCCCC
Q 035917 154 NNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKA---DFDGNS 225 (611)
Q Consensus 154 ~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~~~---~~~~n~ 225 (611)
+|+|. .+|..+-.+..|+.+-.++|++...-|+.+.++.+|..|||.+|.+. .||+.++++.++ .+.||+
T Consensus 467 ~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNp 539 (565)
T KOG0472|consen 467 FNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNP 539 (565)
T ss_pred ccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCc
Confidence 88886 77777666666676666667776444455889999999999999998 789998887664 456665
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.9e-10 Score=126.73 Aligned_cols=247 Identities=17% Similarity=0.119 Sum_probs=160.9
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
+.|...+-+-+|.++.++-+.- ..|...+.|...... ...+....+-.++-..+||-+++..--+......+|++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 4555556677888888877662 234444444432211 11223333444444445677776655545567789999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC--
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS-- 476 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~-- 476 (611)
+|..+++|...|+... ..+..-.......+..+++||| ...+.|||++|.|++...++..+++|||+.....-.
T Consensus 884 ~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred HHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 9999999999998654 3444444455566788999999 666999999999999999999999999843321100
Q ss_pred -------------------C----CC----ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHH
Q 035917 477 -------------------D----ES----SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWV 529 (611)
Q Consensus 477 -------------------~----~~----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~ 529 (611)
. .. .......||+.|.+||...+......+|.|++|++++|.++|..||..-.
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 0 00 01122368999999999999999999999999999999999998875432
Q ss_pred HHHhhcCChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHH
Q 035917 530 NQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMY 577 (611)
Q Consensus 530 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 577 (611)
.+...+......+.........+.++..++. .-+..+|.+|-.|.
T Consensus 1040 pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~---~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPEEGSYEAQDLIN---RLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhhhccccCCCCCCCCccccChhhhhhhh---hhhccCchhccCcc
Confidence 2222221111111111112223455666666 77788999998876
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=3.1e-10 Score=119.82 Aligned_cols=127 Identities=24% Similarity=0.224 Sum_probs=89.8
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
....|+|+.|+++..-...+..|+.|+.|+||+|.+.---++...- +++|++||||+|+++---|.++..|+.|++|+|
T Consensus 270 kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsf-tqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnL 348 (873)
T KOG4194|consen 270 KMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSF-TQKLKELDLSSNRITRLDEGSFRVLSQLEELNL 348 (873)
T ss_pred ccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhh-cccceeEeccccccccCChhHHHHHHHhhhhcc
Confidence 3456777777777666667778888888888888887555555554 788888888888888555556777778888888
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCCcc------CCCCCcccCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSS------FKGFDKADFDGN 224 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~------~~~~~~~~~~~n 224 (611)
++|.++-.--..|-.+.+|+.|||.+|.+++.|-+. +..+..+.+.||
T Consensus 349 s~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gN 402 (873)
T KOG4194|consen 349 SHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGN 402 (873)
T ss_pred cccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCc
Confidence 888777554555677778888888888887776542 223344555555
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=4.3e-10 Score=118.77 Aligned_cols=108 Identities=24% Similarity=0.297 Sum_probs=79.5
Q ss_pred EEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccccc
Q 035917 98 ILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILS 177 (611)
Q Consensus 98 v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~ 177 (611)
+..|+||.|.+...-+.++..++.|++||||+|+++ .+|++-...|..|+.|+|++|+++..--..+-.+++|+.|||+
T Consensus 295 L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~-~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr 373 (873)
T KOG4194|consen 295 LEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRIT-RLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLR 373 (873)
T ss_pred hhhhccchhhhheeecchhhhcccceeEeccccccc-cCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCc
Confidence 345789999998888888999999999999999998 5655444447777777777777764433445567777777777
Q ss_pred ccccCCCCCh---hhhcCCCcccccccccccC
Q 035917 178 NNKLSGPIPY---QLSNLGRLKKFSVANNDLT 206 (611)
Q Consensus 178 ~N~l~g~iP~---~l~~l~~L~~L~l~~N~l~ 206 (611)
+|.+++.|-+ .|.+|++|+.|+|.+|++.
T Consensus 374 ~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk 405 (873)
T KOG4194|consen 374 SNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK 405 (873)
T ss_pred CCeEEEEEecchhhhccchhhhheeecCceee
Confidence 7777777654 2556777777777777776
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.3e-09 Score=75.33 Aligned_cols=41 Identities=39% Similarity=0.602 Sum_probs=30.2
Q ss_pred hhHHHHHHHHHHhCC-CCCCCCCCCCCCCCCCCCCCcccceecC
Q 035917 49 EDDVKCLEGVKSSLN-DPQRKLSSWSFGNSTIGFICQFVGVSCW 91 (611)
Q Consensus 49 ~~d~~aL~~~k~~l~-~~~~~l~~W~~~~~~~~~~c~w~Gv~C~ 91 (611)
++|++||++||+++. +|.+.+.+|+.+. ..+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~--~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSS--DSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT----S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcC--CCCCeeeccEEeC
Confidence 579999999999998 5778899998642 2469999999994
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=5e-10 Score=124.10 Aligned_cols=125 Identities=30% Similarity=0.408 Sum_probs=99.0
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.+..|.|.+|.|.-..-|.|.+.++|+.|+|++|+|. ++|+...+.+..|+.|+||+|.|+ .||..+.+|..|++|..
T Consensus 360 ~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~a 437 (1081)
T KOG0618|consen 360 ALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRA 437 (1081)
T ss_pred HHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhh
Confidence 5667888888888887778888888999999999887 788776666888888899999888 88888888888888888
Q ss_pred cccccCCCCChhhhcCCCcccccccccccC-CCCCccC--CCCCcccCCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLT-GTIPSSF--KGFDKADFDGNS 225 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~-g~ip~~~--~~~~~~~~~~n~ 225 (611)
.+|++. .+| .+..++.|+.+|+|.|+|+ +.+|... .++.-+++.||.
T Consensus 438 hsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 438 HSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred cCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 888888 777 7888888888888888886 3445433 345556666765
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.6e-09 Score=120.12 Aligned_cols=65 Identities=23% Similarity=0.275 Sum_probs=36.1
Q ss_pred CCCEEECcCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccCCCCCccCCC
Q 035917 146 YLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215 (611)
Q Consensus 146 ~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~ 215 (611)
+|+.|+|++|+|+ .||... .+|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|+|.+|..+..
T Consensus 403 ~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~ 467 (788)
T PRK15387 403 ELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALRE 467 (788)
T ss_pred CCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHH
Confidence 4455555555554 244321 34555666666665 55666666666666666666666666655533
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.8e-08 Score=112.36 Aligned_cols=96 Identities=25% Similarity=0.440 Sum_probs=54.6
Q ss_pred EEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccccc
Q 035917 98 ILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILS 177 (611)
Q Consensus 98 v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~ 177 (611)
.+.|+|++++|+. +|..+. +.|+.|+|++|+|+ .+|..+ .++|+.|+|++|+|+ .||..+. .+|+.|+|+
T Consensus 180 ~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l---~~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 180 KTELRLKILGLTT-IPACIP--EQITTLILDNNELK-SLPENL---QGNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred ceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cCChhh---ccCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 4567787777773 554442 46777777777777 566554 345666666666666 4554432 245555555
Q ss_pred ccccCCCCChhhhcCCCcccccccccccC
Q 035917 178 NNKLSGPIPYQLSNLGRLKKFSVANNDLT 206 (611)
Q Consensus 178 ~N~l~g~iP~~l~~l~~L~~L~l~~N~l~ 206 (611)
+|+++ .+|..+. .+|+.|++++|+|+
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~ 275 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKIS 275 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccC
Confidence 55555 4444433 24555555555554
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.5e-07 Score=99.09 Aligned_cols=166 Identities=23% Similarity=0.286 Sum_probs=126.2
Q ss_pred CCceEEEEE-eCCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEe----CCeeEEEEeccCC-CChHH
Q 035917 336 RTGTTYKAM-LPDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVV----EEEKLLIYKYMSS-GTLYS 408 (611)
Q Consensus 336 ~~g~Vy~~~-~~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~----~~~~~lv~ey~~~-gsL~~ 408 (611)
...+.||+. -.||..|+.|+++..+ ........-+++++++.|.|+|++..++.. +...++||+|+|+ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 455789998 4589999999994432 222234556889999999999999988763 4567899999985 57777
Q ss_pred hhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccC
Q 035917 409 LLQGN--------------ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 409 ~l~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~ 474 (611)
+-... +...++...+.++.|+..||.++| +.|..-+-|.+.+||++.+.+++|+..|+...+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 54311 124677889999999999999999 7888889999999999999999999988876654
Q ss_pred CCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCC
Q 035917 475 SSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKG 523 (611)
Q Consensus 475 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~ 523 (611)
.+.. |-+.. -.+-|.--||.+++-|.+|..
T Consensus 445 ~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDPT----------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCCC----------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 3320 11111 235688999999999998853
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=2.8e-08 Score=94.58 Aligned_cols=124 Identities=23% Similarity=0.301 Sum_probs=80.8
Q ss_pred eEEEEEeCCCCEEEEEeccccch---------------------------hHHHHHHHHHHHhccCCC--CccceeeEEE
Q 035917 339 TTYKAMLPDGSVLAVKRLNTCKL---------------------------GEKKFRNEMNRLGQLRHP--NLAPLLGYCV 389 (611)
Q Consensus 339 ~Vy~~~~~~g~~vAvK~~~~~~~---------------------------~~~~~~~Ev~~l~~l~H~--nIv~l~g~~~ 389 (611)
.||.|..++|..+|||+.+.... ......+|.+.|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999999999999997643110 013467899999999765 455555432
Q ss_pred eCCeeEEEEeccC--CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHH-HhhcCCCCeeecCCCCCeEEeCCCCCeEEee
Q 035917 390 VEEEKLLIYKYMS--SGTLYSLLQGNATELDWPTRFRIGLGAARGLAW-LHHGCQPPFLHQNICSNVILVDEDFDARIMD 466 (611)
Q Consensus 390 ~~~~~~lv~ey~~--~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~ivHrDlkp~NILld~~~~~kl~D 466 (611)
..++||||++ +..+..+.... ++......++.++...+.. +| ..+|+|+|+.+.||+++++ .+.++|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence 3579999998 54444333211 1123445667777776665 46 7899999999999999987 999999
Q ss_pred ccccccc
Q 035917 467 FGLAKLM 473 (611)
Q Consensus 467 FGla~~~ 473 (611)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.1e-07 Score=96.06 Aligned_cols=139 Identities=13% Similarity=0.082 Sum_probs=100.7
Q ss_pred CeeeecCCceEEEEEeCCCCEEEEEeccccchh------------HHHHHHHHHHHhccCCCC--ccceeeEEEe-----
Q 035917 330 NVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLG------------EKKFRNEMNRLGQLRHPN--LAPLLGYCVV----- 390 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~------------~~~~~~Ev~~l~~l~H~n--Iv~l~g~~~~----- 390 (611)
+++-......|++..+ +|+.|.||+....... ...+.+|...+.++...+ ..+++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4555445555777766 6788999977432211 124789999998885433 3344555543
Q ss_pred CCeeEEEEeccCCC-ChHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC-------CCC
Q 035917 391 EEEKLLIYKYMSSG-TLYSLLQGN-ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE-------DFD 461 (611)
Q Consensus 391 ~~~~~lv~ey~~~g-sL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~-------~~~ 461 (611)
....++|+|++++- +|.+++... ..+.+...+..++.+++..+.-|| ..+|+|+|++++|||++. +..
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence 23468999999886 798887532 123456677789999999999999 899999999999999975 468
Q ss_pred eEEeecccccc
Q 035917 462 ARIMDFGLAKL 472 (611)
Q Consensus 462 ~kl~DFGla~~ 472 (611)
+.++||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998753
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.2e-09 Score=108.95 Aligned_cols=108 Identities=31% Similarity=0.426 Sum_probs=93.5
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccC-ccCCcCccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPAD-LGNCTYLNTLI 175 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~-~~~l~~L~~L~ 175 (611)
+++.|+|++|-|. .+|.+++.+..|+.||||+|+|. .+|..+-. +..|+.+-.++|++. .+|++ +.++.+|..||
T Consensus 436 kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~-lq~lEtllas~nqi~-~vd~~~l~nm~nL~tLD 511 (565)
T KOG0472|consen 436 KLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYE-LQTLETLLASNNQIG-SVDPSGLKNMRNLTTLD 511 (565)
T ss_pred cceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhh-HHHHHHHHhcccccc-ccChHHhhhhhhcceec
Confidence 5677889877665 78999999999999999999998 78988776 666777777778875 66666 99999999999
Q ss_pred ccccccCCCCChhhhcCCCcccccccccccCCCCCc
Q 035917 176 LSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPS 211 (611)
Q Consensus 176 L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~ 211 (611)
|.+|.+. .||..++++++|++|++++|.|. .|.
T Consensus 512 L~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr--~Pr 544 (565)
T KOG0472|consen 512 LQNNDLQ-QIPPILGNMTNLRHLELDGNPFR--QPR 544 (565)
T ss_pred cCCCchh-hCChhhccccceeEEEecCCccC--CCH
Confidence 9999998 89999999999999999999999 554
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.71 E-value=7.7e-09 Score=96.96 Aligned_cols=104 Identities=38% Similarity=0.486 Sum_probs=31.7
Q ss_pred cEEEEEecCCcccccCCccCc-CCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCc-cCCcCcccc
Q 035917 97 RILNLELREMKLSGKIPEPLK-FCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADL-GNCTYLNTL 174 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~-~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~-~~l~~L~~L 174 (611)
+...|+|.+|.++- + ..++ .|.+|+.||||+|.++ .|+ .+.. +++|++|+|++|.++ .+++.+ ..+++|+.|
T Consensus 20 ~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~-L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 20 KLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQIT-KLE-GLPG-LPRLKTLDLSNNRIS-SISEGLDKNLPNLQEL 93 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T-----TT--EEE--SS----S-CHHHHHH-TT--EE
T ss_pred cccccccccccccc-c-cchhhhhcCCCEEECCCCCCc-ccc-CccC-hhhhhhcccCCCCCC-ccccchHHhCCcCCEE
Confidence 45567777776653 2 2344 4667777777777776 343 3444 677777777777776 344333 356777777
Q ss_pred cccccccCCCCC-hhhhcCCCcccccccccccC
Q 035917 175 ILSNNKLSGPIP-YQLSNLGRLKKFSVANNDLT 206 (611)
Q Consensus 175 ~L~~N~l~g~iP-~~l~~l~~L~~L~l~~N~l~ 206 (611)
+|++|++...-- ..+..+++|+.|++.+|.++
T Consensus 94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp E-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred ECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 777777653111 33566677777777666554
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.65 E-value=8.8e-09 Score=79.34 Aligned_cols=60 Identities=43% Similarity=0.525 Sum_probs=32.3
Q ss_pred CCCEEECcCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCccccccccccc
Q 035917 146 YLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDL 205 (611)
Q Consensus 146 ~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l 205 (611)
+|+.|+|++|+++..-+..+.++++|++|+|++|.++..-|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455555555555533333455555555555555555544444555555555555555543
|
... |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.63 E-value=3.7e-08 Score=112.50 Aligned_cols=98 Identities=31% Similarity=0.459 Sum_probs=61.7
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.++.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .||..+. ++|+.|+|++|+++ .||..+. ++|+.|+|
T Consensus 200 ~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~---~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~L 269 (754)
T PRK15370 200 QITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP---DTIQEMELSINRIT-ELPERLP--SALQSLDL 269 (754)
T ss_pred CCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh---ccccEEECcCCccC-cCChhHh--CCCCEEEC
Confidence 5778888888888 4665543 47788888888777 5676543 34666666666665 5565543 35666666
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTG 207 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g 207 (611)
++|+|+ .+|..+. ++|+.|++++|+|++
T Consensus 270 s~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~ 297 (754)
T PRK15370 270 FHNKIS-CLPENLP--EELRYLSVYDNSIRT 297 (754)
T ss_pred cCCccC-ccccccC--CCCcEEECCCCcccc
Confidence 666666 3554443 356666666666553
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.61 E-value=7.4e-08 Score=109.61 Aligned_cols=37 Identities=24% Similarity=0.548 Sum_probs=28.4
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCch
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPA 138 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~ 138 (611)
.++.|+|++|+|+. +|. .+++|++|+|++|+|+ .+|.
T Consensus 223 ~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~ 259 (788)
T PRK15387 223 HITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPV 259 (788)
T ss_pred CCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccC
Confidence 57788999998885 554 2578899999999888 4664
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.5e-08 Score=78.06 Aligned_cols=61 Identities=44% Similarity=0.577 Sum_probs=47.1
Q ss_pred CCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccccccccc
Q 035917 120 KSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKL 181 (611)
Q Consensus 120 ~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l 181 (611)
++|+.|+|++|+++ .||+..+..+++|++|++++|.++..-|..+..+++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 46788888888888 56654443488888888888888866666788888888888888875
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.1e-07 Score=88.69 Aligned_cols=131 Identities=20% Similarity=0.217 Sum_probs=92.2
Q ss_pred CCCCeeeecCCceEEEEEeCCCCEEEEEeccccc-----------------------hhHHHHHHHHHHHhccCCC--Cc
Q 035917 327 CSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCK-----------------------LGEKKFRNEMNRLGQLRHP--NL 381 (611)
Q Consensus 327 ~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~-----------------------~~~~~~~~Ev~~l~~l~H~--nI 381 (611)
..++.||-|.-+.||.|..++|.++|||.=+... .+....++|.++|.+|.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 3468999999999999999999999999642210 0123467899999999644 55
Q ss_pred cceeeEEEeCCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCC
Q 035917 382 APLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFD 461 (611)
Q Consensus 382 v~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~ 461 (611)
.+.+++ +...+||||+++--|...-- +-...-.|+..|.+-+.-+- ..+|||+|+.+-||+++++|.
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCcccc----ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCCC
Confidence 555543 45689999999866654321 11122233333333333333 468999999999999999999
Q ss_pred eEEeecccc
Q 035917 462 ARIMDFGLA 470 (611)
Q Consensus 462 ~kl~DFGla 470 (611)
+.++||--+
T Consensus 241 ~~vIDwPQ~ 249 (304)
T COG0478 241 IVVIDWPQA 249 (304)
T ss_pred EEEEeCccc
Confidence 999999544
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.4e-08 Score=112.95 Aligned_cols=103 Identities=29% Similarity=0.394 Sum_probs=90.9
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
++..|+|+.|.|.-.....+.+|..|+.|+||+|.|+ .||..+.. ++.|++|...+|+++ .+| ++.+++.|+++||
T Consensus 384 hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~-~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDl 459 (1081)
T KOG0618|consen 384 HLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVAN-LGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDL 459 (1081)
T ss_pred ceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHh-hhhhHHHhhcCCcee-ech-hhhhcCcceEEec
Confidence 5788999999987444455899999999999999999 89999998 999999999999998 888 8999999999999
Q ss_pred cccccC-CCCChhhhcCCCcccccccccc
Q 035917 177 SNNKLS-GPIPYQLSNLGRLKKFSVANND 204 (611)
Q Consensus 177 ~~N~l~-g~iP~~l~~l~~L~~L~l~~N~ 204 (611)
|.|+|+ +.+|..+.. ++|++|||++|.
T Consensus 460 S~N~L~~~~l~~~~p~-p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 460 SCNNLSEVTLPEALPS-PNLKYLDLSGNT 487 (1081)
T ss_pred ccchhhhhhhhhhCCC-cccceeeccCCc
Confidence 999997 556654443 899999999996
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.2e-07 Score=112.68 Aligned_cols=124 Identities=19% Similarity=0.256 Sum_probs=77.6
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.++.|+|+++.+. .++..+..+++|+.|+|++|+.-+.+|. +.. +++|+.|+|++|.....+|..++++++|+.|+|
T Consensus 612 ~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~-l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L 688 (1153)
T PLN03210 612 NLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSM-ATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688 (1153)
T ss_pred CCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-ccc-CCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence 4556666666654 4555566677777777776654456663 444 667777777766655667777777777777777
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCCccCCCCCcccCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKADFDGN 224 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~~~~~~~n 224 (611)
++|..-+.+|..+ ++++|+.|++++|...+.+|....++..+.+.+|
T Consensus 689 ~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n 735 (1153)
T PLN03210 689 SRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDISTNISWLDLDET 735 (1153)
T ss_pred CCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccccCCcCeeecCCC
Confidence 7665555666544 5667777777766655566655555555554444
|
syringae 6; Provisional |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=5e-08 Score=106.19 Aligned_cols=150 Identities=19% Similarity=0.240 Sum_probs=97.1
Q ss_pred HHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC------Cccc-cCCCcccccccccccCC
Q 035917 427 LGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE------SSFV-NGDLGEFGYIAPEYSST 499 (611)
Q Consensus 427 ~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~------~~~~-~~~~gt~~y~aPE~~~~ 499 (611)
.+++.|+.|+|. +.++||++|.|++|.++..+..||+.|+.+........ .... ....-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 345589999996 78899999999999999999999999998765433111 0000 00123457999999999
Q ss_pred CCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhch--hhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHH
Q 035917 500 MVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDK--ALCGKGYDEEILQFLKVACNCVVSRPKDRWSMY 577 (611)
Q Consensus 500 ~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 577 (611)
...+.++|+||+||++|.+..+..+...--.............+. .......+.++.+-+. +.+..++..||++.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~---k~l~~~~~~rp~~~ 260 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLK---KLLNGDSAVRPTLD 260 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHH---HHhcCCcccCcchh
Confidence 888999999999999999884443322100000000000000010 1111334455665555 88999999999887
Q ss_pred HHHH
Q 035917 578 QVYQ 581 (611)
Q Consensus 578 evl~ 581 (611)
++..
T Consensus 261 ~l~~ 264 (700)
T KOG2137|consen 261 LLLS 264 (700)
T ss_pred hhhc
Confidence 7654
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.48 E-value=3e-08 Score=102.94 Aligned_cols=112 Identities=26% Similarity=0.291 Sum_probs=71.8
Q ss_pred CcEEEEEecCCcccccCCccCcCCCC---CCEEEccCCCCCc----cCchhHHhcC-CCCCEEECcCCcCccc----Ccc
Q 035917 96 NRILNLELREMKLSGKIPEPLKFCKS---MQRLDLSANDLSG----NIPAQICNWL-PYLVLLDLSNNDLSGP----IPA 163 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~p~~l~~l~~---L~~L~Ls~N~l~g----~ip~~~~~~l-~~L~~L~Ls~N~l~G~----iP~ 163 (611)
..++.|+|+++.+.+..+..+..+.. |+.|++++|++++ .+...+.. + ++|+.|+|++|.+++. ++.
T Consensus 81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~-~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKD-LPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHh-CCCCceEEEcCCCcCCchHHHHHHH
Confidence 36777777777777655555554444 7777777777763 23334444 4 6777777777777743 233
Q ss_pred CccCCcCcccccccccccCCC----CChhhhcCCCcccccccccccCCC
Q 035917 164 DLGNCTYLNTLILSNNKLSGP----IPYQLSNLGRLKKFSVANNDLTGT 208 (611)
Q Consensus 164 ~~~~l~~L~~L~L~~N~l~g~----iP~~l~~l~~L~~L~l~~N~l~g~ 208 (611)
.+..+.+|+.|+|++|.+++. ++..+..+++|+.|++++|.+++.
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~ 208 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDE 208 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChH
Confidence 445566777777777777742 334455566777777777777643
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=8e-07 Score=97.08 Aligned_cols=145 Identities=19% Similarity=0.253 Sum_probs=97.3
Q ss_pred hhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhH---------------------------------------
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGE--------------------------------------- 363 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~--------------------------------------- 363 (611)
-..|+. +-|+.++-|-||+|++++|+.||||+.+..-...
T Consensus 125 F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~ 203 (517)
T COG0661 125 FSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR 203 (517)
T ss_pred HHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence 334543 6789999999999999999999999875421100
Q ss_pred --HHHHHHHHHHhccC-----CCCccceeeEEE-eCCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHH-H
Q 035917 364 --KKFRNEMNRLGQLR-----HPNLAPLLGYCV-VEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGL-A 434 (611)
Q Consensus 364 --~~~~~Ev~~l~~l~-----H~nIv~l~g~~~-~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL-~ 434 (611)
-++.+|...+.+++ .+++ ++=.+|. ......|+|||++|-.+.+...-.....+ +..++..++++. .
T Consensus 204 ~ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d---~k~ia~~~~~~f~~ 279 (517)
T COG0661 204 EELDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGID---RKELAELLVRAFLR 279 (517)
T ss_pred HHhCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCC---HHHHHHHHHHHHHH
Confidence 12456666666663 3333 2222332 34677999999999888887422222344 333443333322 2
Q ss_pred HHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 435 WLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 435 yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
.+- ..+++|.|..|.||+++.+++.-+.|||+...+.+
T Consensus 280 q~~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 280 QLL---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHH---hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 222 45899999999999999999999999999887654
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.8e-07 Score=111.74 Aligned_cols=95 Identities=27% Similarity=0.320 Sum_probs=59.7
Q ss_pred ccceecCCCCCCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccC
Q 035917 85 FVGVSCWNDKENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPAD 164 (611)
Q Consensus 85 w~Gv~C~~~~~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~ 164 (611)
|.|+.+ -..+..|+|++++.-+.+| .++.+++|+.|+|++|..-..+|..+.. +++|+.|+|++|..-+.+|..
T Consensus 627 ~~~~~~----l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~-L~~L~~L~L~~c~~L~~Lp~~ 700 (1153)
T PLN03210 627 WDGVHS----LTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQY-LNKLEDLDMSRCENLEILPTG 700 (1153)
T ss_pred cccccc----CCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhc-cCCCCEEeCCCCCCcCccCCc
Confidence 666543 1246677777665555565 3677777777777776655677777776 777777777776555566665
Q ss_pred ccCCcCcccccccccccCCCCC
Q 035917 165 LGNCTYLNTLILSNNKLSGPIP 186 (611)
Q Consensus 165 ~~~l~~L~~L~L~~N~l~g~iP 186 (611)
+ ++++|+.|+|++|...+.+|
T Consensus 701 i-~l~sL~~L~Lsgc~~L~~~p 721 (1153)
T PLN03210 701 I-NLKSLYRLNLSGCSRLKSFP 721 (1153)
T ss_pred C-CCCCCCEEeCCCCCCccccc
Confidence 4 45555555555554333333
|
syringae 6; Provisional |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.46 E-value=7e-08 Score=90.55 Aligned_cols=105 Identities=31% Similarity=0.419 Sum_probs=35.3
Q ss_pred CcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccccccccCCCCChhh-hcCCC
Q 035917 116 LKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQL-SNLGR 194 (611)
Q Consensus 116 l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l-~~l~~ 194 (611)
+.++..++.|+|++|.++ .|. .++..+.+|+.||||+|.++ .|+ .+..+++|++|+|++|.++ .++..+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence 456678999999999998 453 45533789999999999998 554 5778999999999999999 465545 46999
Q ss_pred cccccccccccCCCCC----ccCCCCCcccCCCCC
Q 035917 195 LKKFSVANNDLTGTIP----SSFKGFDKADFDGNS 225 (611)
Q Consensus 195 L~~L~l~~N~l~g~ip----~~~~~~~~~~~~~n~ 225 (611)
|+.|++++|++...-- ..+.++..+.+.|||
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NP 124 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNP 124 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-G
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCc
Confidence 9999999999975311 123444455566664
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.6e-08 Score=102.38 Aligned_cols=111 Identities=27% Similarity=0.294 Sum_probs=84.9
Q ss_pred cEEEEEecCCcccc------cCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCC---CCEEECcCCcCcc----cCcc
Q 035917 97 RILNLELREMKLSG------KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPY---LVLLDLSNNDLSG----PIPA 163 (611)
Q Consensus 97 ~v~~l~l~~~~l~g------~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~---L~~L~Ls~N~l~G----~iP~ 163 (611)
.++.++++++.+.+ .++..+..+++|+.|+|++|.+.+..+..+.. +.+ |+.|+|++|++++ .+..
T Consensus 52 ~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~-l~~~~~L~~L~ls~~~~~~~~~~~l~~ 130 (319)
T cd00116 52 SLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLES-LLRSSSLQELKLNNNGLGDRGLRLLAK 130 (319)
T ss_pred CceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHH-HhccCcccEEEeeCCccchHHHHHHHH
Confidence 36777887777662 34456777889999999999998777777766 555 9999999999883 3444
Q ss_pred CccCC-cCcccccccccccCCCC----ChhhhcCCCcccccccccccCCC
Q 035917 164 DLGNC-TYLNTLILSNNKLSGPI----PYQLSNLGRLKKFSVANNDLTGT 208 (611)
Q Consensus 164 ~~~~l-~~L~~L~L~~N~l~g~i----P~~l~~l~~L~~L~l~~N~l~g~ 208 (611)
.+..+ ++|+.|+|++|.+++.. +..+..+++|+.|++++|.+++.
T Consensus 131 ~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 180 (319)
T cd00116 131 GLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDA 180 (319)
T ss_pred HHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchH
Confidence 55666 88999999999998543 34566778899999999999853
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.1e-07 Score=96.84 Aligned_cols=140 Identities=26% Similarity=0.417 Sum_probs=109.4
Q ss_pred eecCCCC--------CCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEEC-cCCcCc
Q 035917 88 VSCWNDK--------ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDL-SNNDLS 158 (611)
Q Consensus 88 v~C~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~L-s~N~l~ 158 (611)
|+|++.+ +...+.|+|..|+++-..|.+++.+++|++||||+|+++--=|..|.. +++|..|-| ++|+++
T Consensus 51 VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~G-L~~l~~Lvlyg~NkI~ 129 (498)
T KOG4237|consen 51 VDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKG-LASLLSLVLYGNNKIT 129 (498)
T ss_pred EEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhh-hHhhhHHHhhcCCchh
Confidence 8886532 225689999999999888889999999999999999999544666655 777766655 559998
Q ss_pred ccCcc-CccCCcCcccccccccccCCCCChhhhcCCCcccccccccccCCCCCc-cCCCC---CcccCCCCCCCCCC
Q 035917 159 GPIPA-DLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPS-SFKGF---DKADFDGNSDLCGG 230 (611)
Q Consensus 159 G~iP~-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~-~~~~~---~~~~~~~n~~lc~~ 230 (611)
.+|. .|++|.+|+-|.|.-|++.-.....|..|++|..|.+..|.+. .|+. ++..+ +.+..+-|+..|..
T Consensus 130 -~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdC 204 (498)
T KOG4237|consen 130 -DLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDC 204 (498)
T ss_pred -hhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCcccccc
Confidence 6665 5899999999999999999888889999999999999999887 3443 44443 33445667766543
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.31 E-value=7.8e-08 Score=101.90 Aligned_cols=90 Identities=38% Similarity=0.637 Sum_probs=48.8
Q ss_pred cCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccccccccCCCCChhhh
Q 035917 111 KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLS 190 (611)
Q Consensus 111 ~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~ 190 (611)
.+|..+++|..|+.|||+.|+++ .+|..++. |+ |++|-+++|+++ .+|..++-+.+|..||.+.|.+. .+|+.++
T Consensus 112 ~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~-lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~ 186 (722)
T KOG0532|consen 112 TIPEAICNLEALTFLDLSSNQLS-HLPDGLCD-LP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLG 186 (722)
T ss_pred ecchhhhhhhHHHHhhhccchhh-cCChhhhc-Cc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhh
Confidence 45555666666666666666665 55555554 44 555666666554 55555555555555555555554 4444454
Q ss_pred cCCCccccccccccc
Q 035917 191 NLGRLKKFSVANNDL 205 (611)
Q Consensus 191 ~l~~L~~L~l~~N~l 205 (611)
+|.+|+.|++..|++
T Consensus 187 ~l~slr~l~vrRn~l 201 (722)
T KOG0532|consen 187 YLTSLRDLNVRRNHL 201 (722)
T ss_pred hHHHHHHHHHhhhhh
Confidence 444444444444433
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.29 E-value=5e-06 Score=80.90 Aligned_cols=107 Identities=24% Similarity=0.276 Sum_probs=83.7
Q ss_pred HHHHHHHHHHHhccCCC--CccceeeEEEeCC----eeEEEEeccCCC-ChHHhhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 035917 363 EKKFRNEMNRLGQLRHP--NLAPLLGYCVVEE----EKLLIYKYMSSG-TLYSLLQGNATELDWPTRFRIGLGAARGLAW 435 (611)
Q Consensus 363 ~~~~~~Ev~~l~~l~H~--nIv~l~g~~~~~~----~~~lv~ey~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~y 435 (611)
.....+|...+.+++.. .+.+.+++..... ..++|+|++++- +|.+++.+... .+......++.+++..+.-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence 35678899888888533 3456666665532 347999999874 79998875322 5556778899999999999
Q ss_pred HhhcCCCCeeecCCCCCeEEeCCCC---CeEEeeccccccc
Q 035917 436 LHHGCQPPFLHQNICSNVILVDEDF---DARIMDFGLAKLM 473 (611)
Q Consensus 436 LH~~~~~~ivHrDlkp~NILld~~~---~~kl~DFGla~~~ 473 (611)
|| ..+|+|+|+++.|||++.+. .+.++||+-++..
T Consensus 134 lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99 89999999999999999876 8999999977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.1e-05 Score=75.69 Aligned_cols=136 Identities=15% Similarity=0.128 Sum_probs=100.9
Q ss_pred eeecCCceEEEEEeCCCCEEEEEecccc-------chhHHHHHHHHHHHhccCCC--CccceeeEEE-eC----CeeEEE
Q 035917 332 IISTRTGTTYKAMLPDGSVLAVKRLNTC-------KLGEKKFRNEMNRLGQLRHP--NLAPLLGYCV-VE----EEKLLI 397 (611)
Q Consensus 332 ig~G~~g~Vy~~~~~~g~~vAvK~~~~~-------~~~~~~~~~Ev~~l~~l~H~--nIv~l~g~~~-~~----~~~~lv 397 (611)
-|+||.+-|++-.+. |+.+=+|+-... ..+...|.+|+..+.++... .+.+.. ++. .. -..+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 467888889997774 446888876411 23457899999999999533 244444 332 11 135799
Q ss_pred EeccCC-CChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCC--eEEeecccccc
Q 035917 398 YKYMSS-GTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFD--ARIMDFGLAKL 472 (611)
Q Consensus 398 ~ey~~~-gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~--~kl~DFGla~~ 472 (611)
+|-+++ -+|.+++.+.. .+.+...+..+..++++.+.-|| ..++.|+|+.+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997753 58999886543 35677788899999999999999 899999999999999986666 99999976653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.3e-05 Score=79.12 Aligned_cols=137 Identities=11% Similarity=0.106 Sum_probs=84.5
Q ss_pred CeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCC--ccceeeEEEeCCeeEEEEeccCCCC-h
Q 035917 330 NVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPN--LAPLLGYCVVEEEKLLIYKYMSSGT-L 406 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~n--Iv~l~g~~~~~~~~~lv~ey~~~gs-L 406 (611)
..||+|..+.||+. .|..+++|..... .......+|.+++..+..-. +.+.+++....+...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~-~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPG-FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCC-CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 57899999999984 2456778887642 23456789999999886443 4566777777777789999999863 2
Q ss_pred HHh---------------------hhcCC-CCCCHHHHHH-HHH----------HHHH-HHHHHhh-cCCCCeeecCCCC
Q 035917 407 YSL---------------------LQGNA-TELDWPTRFR-IGL----------GAAR-GLAWLHH-GCQPPFLHQNICS 451 (611)
Q Consensus 407 ~~~---------------------l~~~~-~~l~~~~~~~-i~~----------~ia~-gL~yLH~-~~~~~ivHrDlkp 451 (611)
... +|.-. .......... +.. .+.. ...+|.. .....++|+|+.|
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~ 162 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI 162 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence 111 11110 0111111000 000 0111 1122221 1134578999999
Q ss_pred CeEEeCCCCCeEEeeccccc
Q 035917 452 NVILVDEDFDARIMDFGLAK 471 (611)
Q Consensus 452 ~NILld~~~~~kl~DFGla~ 471 (611)
.||++++++ +.|.||+.+.
T Consensus 163 ~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 163 GNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CcEEEcCCC-cEEEechhcC
Confidence 999999877 9999998775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.5e-07 Score=99.75 Aligned_cols=121 Identities=29% Similarity=0.489 Sum_probs=92.9
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
..+-|||+.|.++ .+|..++.|+ |+.|.+++|+++ .+|.+++. +..|..||.|.|++- .+|+.++++.+|+.|++
T Consensus 122 ~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~-~~tl~~ld~s~nei~-slpsql~~l~slr~l~v 196 (722)
T KOG0532|consen 122 ALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGL-LPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNV 196 (722)
T ss_pred HHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCccccc-chhHHHhhhhhhhhh-hchHHhhhHHHHHHHHH
Confidence 3566888888887 5677777764 788888888887 78888884 888888888888887 78888888888888888
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCCccCCCCC---cccCCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFD---KADFDGNS 225 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~---~~~~~~n~ 225 (611)
..|++. .+|.++..|+ |..||+|.|+++ .||..|..+. .+.++.|+
T Consensus 197 rRn~l~-~lp~El~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNP 245 (722)
T KOG0532|consen 197 RRNHLE-DLPEELCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNP 245 (722)
T ss_pred hhhhhh-hCCHHHhCCc-eeeeecccCcee-ecchhhhhhhhheeeeeccCC
Confidence 888887 6777777654 788888888887 6787765544 34455555
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.4e-07 Score=91.02 Aligned_cols=102 Identities=28% Similarity=0.395 Sum_probs=57.5
Q ss_pred EEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccccc
Q 035917 98 ILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILS 177 (611)
Q Consensus 98 v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~ 177 (611)
++.+|||+|.++ .+..++.-++.++.|+||+|.+. .+-. +.. |++|+.||||+|.|+ .+-..-.+|-+.+.|.|+
T Consensus 286 LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~-L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 286 LTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAE-LPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhh-cccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 445677766655 45555666667777777777765 3332 444 677777777777765 333333344555556666
Q ss_pred ccccCCCCChhhhcCCCcccccccccccC
Q 035917 178 NNKLSGPIPYQLSNLGRLKKFSVANNDLT 206 (611)
Q Consensus 178 ~N~l~g~iP~~l~~l~~L~~L~l~~N~l~ 206 (611)
+|.+. .+ +.+++|=+|..||+++|++.
T Consensus 361 ~N~iE-~L-SGL~KLYSLvnLDl~~N~Ie 387 (490)
T KOG1259|consen 361 QNKIE-TL-SGLRKLYSLVNLDLSSNQIE 387 (490)
T ss_pred hhhHh-hh-hhhHhhhhheeccccccchh
Confidence 66543 11 12444455566666666553
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.21 E-value=7.8e-06 Score=89.12 Aligned_cols=142 Identities=18% Similarity=0.172 Sum_probs=91.9
Q ss_pred cCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhH--------------------------------------HHH
Q 035917 325 SFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGE--------------------------------------KKF 366 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~--------------------------------------~~~ 366 (611)
.|+ .+-||.-+.|.||+|++++|+.||||+-+..-... -+|
T Consensus 163 ~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF 241 (538)
T KOG1235|consen 163 EFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDF 241 (538)
T ss_pred hcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcch
Confidence 344 36789999999999999999999999875421100 135
Q ss_pred HHHHHHHhcc----CCCCc---cceeeEEE-eCCeeEEEEeccCCCChHHhh--hcCCCCCCHHHHHHHHHHHHHHHHHH
Q 035917 367 RNEMNRLGQL----RHPNL---APLLGYCV-VEEEKLLIYKYMSSGTLYSLL--QGNATELDWPTRFRIGLGAARGLAWL 436 (611)
Q Consensus 367 ~~Ev~~l~~l----~H~nI---v~l~g~~~-~~~~~~lv~ey~~~gsL~~~l--~~~~~~l~~~~~~~i~~~ia~gL~yL 436 (611)
.+|.+...++ +|-+. |++=.++. ....+.|+||||+|.-+.|.- .+. .++-.. |+..+.++...+
T Consensus 242 ~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~---i~~~l~~~~~~q 316 (538)
T KOG1235|consen 242 TKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR--GISPHD---ILNKLVEAYLEQ 316 (538)
T ss_pred HHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc--CCCHHH---HHHHHHHHHHHH
Confidence 6666655554 34441 11222222 234689999999998776643 333 244443 333333322111
Q ss_pred hhcCCCCeeecCCCCCeEEeC----CCCCeEEeecccccccC
Q 035917 437 HHGCQPPFLHQNICSNVILVD----EDFDARIMDFGLAKLMT 474 (611)
Q Consensus 437 H~~~~~~ivHrDlkp~NILld----~~~~~kl~DFGla~~~~ 474 (611)
-...|++|+|-.|-||++. .++++.+-|||+...+.
T Consensus 317 --If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 317 --IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred --HHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 1145799999999999998 36789999999988664
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.18 E-value=4.7e-07 Score=97.68 Aligned_cols=191 Identities=18% Similarity=0.104 Sum_probs=133.3
Q ss_pred cHHHHHHhhhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCC-ccceeeEEEeCCe
Q 035917 315 KLADLMAASNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPN-LAPLLGYCVVEEE 393 (611)
Q Consensus 315 ~~~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~n-Iv~l~g~~~~~~~ 393 (611)
+++|-.+.+..| +-.++++.+++||.+-...+...+|.+... ....-++++|.+++||| .++.++-+..++.
T Consensus 236 ~lkDk~kws~~f---h~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~ 308 (829)
T KOG0576|consen 236 TLKDKTKWSEFF---HNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDY 308 (829)
T ss_pred cccCCccchHHH---HHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccc
Confidence 334433444444 346789999999988544444446666432 44567889999999999 7777777777788
Q ss_pred eEEEEeccCCC-ChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccc
Q 035917 394 KLLIYKYMSSG-TLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKL 472 (611)
Q Consensus 394 ~~lv~ey~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~ 472 (611)
.+++++|+..| +-..-.......+...+...+.+.-.++++|+| +..-+|+| ||+..+ ...|..||+.+..
T Consensus 309 ~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~ 380 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQ 380 (829)
T ss_pred cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcc
Confidence 89999999887 222111111112344455566777788999999 44458998 777765 6789999999877
Q ss_pred cCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCC
Q 035917 473 MTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKG 523 (611)
Q Consensus 473 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~ 523 (611)
+.... ......+|+.++|||+.....+..+.|+|+.|+--.++.-+..
T Consensus 381 L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~p 428 (829)
T KOG0576|consen 381 LTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLP 428 (829)
T ss_pred cCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCC
Confidence 65332 2234568999999999999999999999999986666664443
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.17 E-value=4.1e-07 Score=79.82 Aligned_cols=107 Identities=25% Similarity=0.365 Sum_probs=77.0
Q ss_pred EEEecCCcccccCCcc---CcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 100 NLELREMKLSGKIPEP---LKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 100 ~l~l~~~~l~g~~p~~---l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.++|++..|- .++.. +.....|+..+||+|.|. .+|+.+...++-++.|+|++|.++ .+|.++..++.|+.|++
T Consensus 31 ~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl 107 (177)
T KOG4579|consen 31 FLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNL 107 (177)
T ss_pred hcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhccc
Confidence 3555555432 23332 445566777788888887 677777664567888888888887 78888888888888888
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCCc
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPS 211 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~ 211 (611)
+.|.|. ..|.-+..|.+|-.|+..+|... +||.
T Consensus 108 ~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~ 140 (177)
T KOG4579|consen 108 RFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDV 140 (177)
T ss_pred ccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcH
Confidence 888888 56666777888888888887766 5553
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.13 E-value=4.3e-07 Score=79.69 Aligned_cols=117 Identities=17% Similarity=0.205 Sum_probs=89.7
Q ss_pred CcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccc
Q 035917 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
-.++.++|++|.+....+..-...+.++.|+|++|.++ .+|.++.. ++.|+.|+++.|.|+ ..|.-+..|.+|-.||
T Consensus 53 ~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aa-m~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Ld 129 (177)
T KOG4579|consen 53 YELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAA-MPALRSLNLRFNPLN-AEPRVIAPLIKLDMLD 129 (177)
T ss_pred ceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhh-hHHhhhcccccCccc-cchHHHHHHHhHHHhc
Confidence 36888899999887443333344568899999999998 78988887 899999999999998 6677777788999999
Q ss_pred ccccccCCCCChhhhcCCCcccccccccccCCCCCccCCCC
Q 035917 176 LSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF 216 (611)
Q Consensus 176 L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~ 216 (611)
..+|.+. +||..+..-+.+-..++.+|.+.+.-|..+..+
T Consensus 130 s~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klqa~ 169 (177)
T KOG4579|consen 130 SPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQAL 169 (177)
T ss_pred CCCCccc-cCcHHHhccccHHHHHhcCCcccccCccccccc
Confidence 8888877 788765555555566678888888777655443
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.13 E-value=2.2e-05 Score=81.18 Aligned_cols=250 Identities=13% Similarity=0.122 Sum_probs=146.5
Q ss_pred CCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhcc-CCCCccceeeEE----E--eCCe-eEEEEe
Q 035917 328 SENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYC----V--VEEE-KLLIYK 399 (611)
Q Consensus 328 ~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~----~--~~~~-~~lv~e 399 (611)
.+.-||+|+.+.+|-.-- -+..| .|+...-....+ .+-+..|.+. .||-+-.=+.|= . +++. .-+.|.
T Consensus 15 ~gr~LgqGgea~ly~l~e-~~d~V-AKIYh~Pppa~~--aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE-VRDQV-AKIYHAPPPAAQ--AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CCccccCCccceeeecch-hhchh-heeecCCCchHH--HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 356799999999996321 12233 365533221111 1122233333 466443311110 1 1122 346677
Q ss_pred ccCCCC-hHHhhh---c--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccccc
Q 035917 400 YMSSGT-LYSLLQ---G--NATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLM 473 (611)
Q Consensus 400 y~~~gs-L~~~l~---~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~ 473 (611)
.+++.. ..+++. + +....+|...+++++.+|.+.+-|| ..+.+-+|+.++|+|+.++..+.|.|=.--...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceeec
Confidence 666542 222222 1 1135899999999999999999999 788999999999999999999999885432222
Q ss_pred CCCCCCccccCCCcccccccccccC-----CCCCCcccchHHHHHHHHHHhCC-CCCHHHHHHH---------HhhcCCh
Q 035917 474 TSSDESSFVNGDLGEFGYIAPEYSS-----TMVASLKGDVYGIGVVLLELAGF-KGNLVDWVNQ---------LSSSGRS 538 (611)
Q Consensus 474 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SfGvvl~ell~~-~~~~~~~~~~---------~~~~~~~ 538 (611)
. ........+|...|.+||.-. +..-+...|-|.+||++++++.| +.||...... .+..+..
T Consensus 168 ~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f 244 (637)
T COG4248 168 A---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF 244 (637)
T ss_pred c---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence 1 122333457999999999643 34457789999999999999865 5554321100 0001111
Q ss_pred hhhhchh--hc--C-----CCCHHHHHHHHHHHhhcccCC--CCCCCCHHHHHHHHHHchhhh
Q 035917 539 KEAIDKA--LC--G-----KGYDEEILQFLKVACNCVVSR--PKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 539 ~~~~~~~--l~--~-----~~~~~~~~~l~~l~~~Cl~~d--P~~RPs~~evl~~L~~i~~~~ 590 (611)
...-+.. .. + ...+..+..+.. +|+... +.-||+++.-+..|.++.++.
T Consensus 245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~---qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQ---QAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred eechhccCCCCCCCCCCChhhcCHHHHHHHH---HHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 1111110 00 0 011233444444 787543 678999999999998888774
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.10 E-value=9.1e-08 Score=103.80 Aligned_cols=110 Identities=30% Similarity=0.398 Sum_probs=76.1
Q ss_pred CccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccC-ccCCcCcccccccccccCCCCChhhhc
Q 035917 113 PEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPAD-LGNCTYLNTLILSNNKLSGPIPYQLSN 191 (611)
Q Consensus 113 p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~-~~~l~~L~~L~L~~N~l~g~iP~~l~~ 191 (611)
..++.-|+.|+.||||+|.|+. .- .+.. |++|++||||+|.|. .+|.. ...| +|+.|+|++|-++-.. .+.+
T Consensus 180 D~SLqll~ale~LnLshNk~~~-v~-~Lr~-l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~lrnN~l~tL~--gie~ 252 (1096)
T KOG1859|consen 180 DESLQLLPALESLNLSHNKFTK-VD-NLRR-LPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNLRNNALTTLR--GIEN 252 (1096)
T ss_pred HHHHHHHHHhhhhccchhhhhh-hH-HHHh-cccccccccccchhc-cccccchhhh-hheeeeecccHHHhhh--hHHh
Confidence 3456777888888888888873 32 5554 888888888888887 55532 2334 3888888888877332 3667
Q ss_pred CCCcccccccccccCCCC---C-ccCCCCCcccCCCCCCCCC
Q 035917 192 LGRLKKFSVANNDLTGTI---P-SSFKGFDKADFDGNSDLCG 229 (611)
Q Consensus 192 l~~L~~L~l~~N~l~g~i---p-~~~~~~~~~~~~~n~~lc~ 229 (611)
|.+|+.|||++|-|++-- | .++..+..+.+.||+..|.
T Consensus 253 LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 253 LKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred hhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 888888888888877642 2 1244555667788886653
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.9e-06 Score=92.51 Aligned_cols=90 Identities=36% Similarity=0.529 Sum_probs=49.1
Q ss_pred cCCCCCCEEEccCCCCCccCchhHHhcCC-CCCEEECcCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCc
Q 035917 117 KFCKSMQRLDLSANDLSGNIPAQICNWLP-YLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRL 195 (611)
Q Consensus 117 ~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~-~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L 195 (611)
..++.++.|++.+|+++ .||+.... ++ +|+.|++++|.+. .+|..++++++|+.|++++|+++ .+|...+.+++|
T Consensus 113 ~~~~~l~~L~l~~n~i~-~i~~~~~~-~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L 188 (394)
T COG4886 113 LELTNLTSLDLDNNNIT-DIPPLIGL-LKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNL 188 (394)
T ss_pred hcccceeEEecCCcccc-cCcccccc-chhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhh
Confidence 33455555566555555 45555543 42 5566666666555 45455555556666666666555 444444455555
Q ss_pred ccccccccccCCCCCc
Q 035917 196 KKFSVANNDLTGTIPS 211 (611)
Q Consensus 196 ~~L~l~~N~l~g~ip~ 211 (611)
+.|++++|+++ .+|.
T Consensus 189 ~~L~ls~N~i~-~l~~ 203 (394)
T COG4886 189 NNLDLSGNKIS-DLPP 203 (394)
T ss_pred hheeccCCccc-cCch
Confidence 55666665555 3443
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.09 E-value=4.3e-05 Score=74.63 Aligned_cols=152 Identities=18% Similarity=0.207 Sum_probs=99.9
Q ss_pred cccHHHHHHhhhcCCCCCe---eeecCCceEEEEEeCCCCEEEEEeccccchh--------------------HH-----
Q 035917 313 KVKLADLMAASNSFCSENV---IISTRTGTTYKAMLPDGSVLAVKRLNTCKLG--------------------EK----- 364 (611)
Q Consensus 313 ~~~~~~l~~~t~~f~~~~~---ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~--------------------~~----- 364 (611)
..++..+....+......+ |.+|.-+.||+|.-.++..+|||+.+..... .+
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 3555666666655555555 4467777899999889999999998542211 01
Q ss_pred HHHHHHHHHhccC--CCCccceeeEEEeCCeeEEEEeccCCCCh-HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 035917 365 KFRNEMNRLGQLR--HPNLAPLLGYCVVEEEKLLIYKYMSSGTL-YSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQ 441 (611)
Q Consensus 365 ~~~~Ev~~l~~l~--H~nIv~l~g~~~~~~~~~lv~ey~~~gsL-~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 441 (611)
-..+|+..|.++. +-.+.+-+++. .-.|||||+..... .-.|.+. +++......+..++++.+.-|-. .
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv--~~e~~e~~~~~~~~v~~~~~l~~--~ 185 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV--PLELEEAEGLYEDVVEYMRRLYK--E 185 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC--CcCchhHHHHHHHHHHHHHHHHH--h
Confidence 1356777777774 33344444433 34799999965311 1112211 12222566677778888877773 4
Q ss_pred CCeeecCCCCCeEEeCCCCCeEEeeccccccc
Q 035917 442 PPFLHQNICSNVILVDEDFDARIMDFGLAKLM 473 (611)
Q Consensus 442 ~~ivHrDlkp~NILld~~~~~kl~DFGla~~~ 473 (611)
.++||+||+.=|||+. ++.+.++|||-|...
T Consensus 186 a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 186 AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred cCcccccchhhheEEE-CCeEEEEECcccccc
Confidence 7899999999999999 789999999977543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.05 E-value=1.6e-05 Score=75.99 Aligned_cols=103 Identities=23% Similarity=0.365 Sum_probs=82.9
Q ss_pred HHHHHHHhccCC-CCccceeeEEEeCCeeEEEEeccCCCChHHhhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 035917 367 RNEMNRLGQLRH-PNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQG--NATELDWPTRFRIGLGAARGLAWLHHGCQPP 443 (611)
Q Consensus 367 ~~Ev~~l~~l~H-~nIv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 443 (611)
.+|.-+|+.+++ +++.+++|+| ..++|.||...+++...-.. +...-+|..|.+||.++++.+.++++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888999976 6999999999 34789999987766432100 1123689999999999999999999765566
Q ss_pred eeecCCCCCeEEeCCCCCeEEeeccccccc
Q 035917 444 FLHQNICSNVILVDEDFDARIMDFGLAKLM 473 (611)
Q Consensus 444 ivHrDlkp~NILld~~~~~kl~DFGla~~~ 473 (611)
+.-.|++++|+-+++++++|+.|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.03 E-value=4.6e-05 Score=74.85 Aligned_cols=140 Identities=19% Similarity=0.154 Sum_probs=84.8
Q ss_pred CeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCC--ccceeeEEEe---CCeeEEEEeccCCC
Q 035917 330 NVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPN--LAPLLGYCVV---EEEKLLIYKYMSSG 404 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~n--Iv~l~g~~~~---~~~~~lv~ey~~~g 404 (611)
+.++.|..+.||+....+ ..+++|..... .....+.+|..++..+.... +.+++.++.. ....+++|+++++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 468999999999999877 68999998655 45567889999988885333 4566665433 23468999999998
Q ss_pred ChHH----------------hh---hcC---CCCCCHHH---------HHHH------------HHHHHH-HHHHHhh--
Q 035917 405 TLYS----------------LL---QGN---ATELDWPT---------RFRI------------GLGAAR-GLAWLHH-- 438 (611)
Q Consensus 405 sL~~----------------~l---~~~---~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~-- 438 (611)
.+.. .+ +.. .....+.. .... ...+.+ .++.++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 7776 11 111 11111111 0000 111222 2333331
Q ss_pred --cCCCCeeecCCCCCeEEeC-CCCCeEEeeccccc
Q 035917 439 --GCQPPFLHQNICSNVILVD-EDFDARIMDFGLAK 471 (611)
Q Consensus 439 --~~~~~ivHrDlkp~NILld-~~~~~kl~DFGla~ 471 (611)
.....++|+|+.|.||+++ +++.+.|.||+.+.
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1256799999999999999 55666899998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.03 E-value=2.4e-06 Score=91.78 Aligned_cols=103 Identities=38% Similarity=0.592 Sum_probs=89.0
Q ss_pred cEEEEEecCCcccccCCccCcCCC-CCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCK-SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
.++.|++.+++++ .+|+....+. +|+.|++++|.+. .+|..+.. +++|+.|++++|+++ .+|...+.++.|+.|+
T Consensus 117 ~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~-l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 117 NLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRN-LPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred ceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhc-cccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 4788899988877 5677777775 9999999999998 78777777 999999999999998 8887777899999999
Q ss_pred ccccccCCCCChhhhcCCCcccccccccc
Q 035917 176 LSNNKLSGPIPYQLSNLGRLKKFSVANND 204 (611)
Q Consensus 176 L~~N~l~g~iP~~l~~l~~L~~L~l~~N~ 204 (611)
+++|+++ .+|.....+..|+.|.+++|.
T Consensus 193 ls~N~i~-~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 193 LSGNKIS-DLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred ccCCccc-cCchhhhhhhhhhhhhhcCCc
Confidence 9999999 888776677779999999995
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.99 E-value=5.3e-05 Score=73.20 Aligned_cols=136 Identities=16% Similarity=0.207 Sum_probs=89.1
Q ss_pred hhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhH----------HHHHHHHHHHhccCCC---CccceeeEEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGE----------KKFRNEMNRLGQLRHP---NLAPLLGYCV 389 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~----------~~~~~Ev~~l~~l~H~---nIv~l~g~~~ 389 (611)
.++|...+++-......|.+-.. +|+.+++|..+...... ....+++..+.+++-. ..+.++.+..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 35566666676666666666555 67889999886533222 1234455555555432 2233332222
Q ss_pred e-----CCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEE
Q 035917 390 V-----EEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARI 464 (611)
Q Consensus 390 ~-----~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl 464 (611)
. ....+++|||++|..|.++.. ++. .++..+++++.-+| ..|++|+|..|.|+++.++ .+++
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~-~i~i 175 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN-GIRI 175 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC-cEEE
Confidence 2 234568999999988876542 222 24456778899999 8999999999999999865 5999
Q ss_pred eecccccc
Q 035917 465 MDFGLAKL 472 (611)
Q Consensus 465 ~DFGla~~ 472 (611)
.||+..+.
T Consensus 176 ID~~~k~~ 183 (229)
T PF06176_consen 176 IDTQGKRM 183 (229)
T ss_pred EECccccc
Confidence 99987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.94 E-value=1.9e-06 Score=84.90 Aligned_cols=86 Identities=28% Similarity=0.317 Sum_probs=69.1
Q ss_pred CcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCc
Q 035917 116 LKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRL 195 (611)
Q Consensus 116 l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L 195 (611)
+-..+.|+.||||+|.++ .|-.+..- +|+++.|+||+|.+. .+- ++..|++|+.||||+|.|+ .+-.+=.+|.|.
T Consensus 280 ~dTWq~LtelDLS~N~I~-~iDESvKL-~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNI 354 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLIT-QIDESVKL-APKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNI 354 (490)
T ss_pred cchHhhhhhccccccchh-hhhhhhhh-ccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCE
Confidence 344567899999999998 67777665 899999999999987 343 3778899999999999998 444445667889
Q ss_pred ccccccccccC
Q 035917 196 KKFSVANNDLT 206 (611)
Q Consensus 196 ~~L~l~~N~l~ 206 (611)
+.|.|+.|.+.
T Consensus 355 KtL~La~N~iE 365 (490)
T KOG1259|consen 355 KTLKLAQNKIE 365 (490)
T ss_pred eeeehhhhhHh
Confidence 99999999764
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00022 Score=68.54 Aligned_cols=134 Identities=16% Similarity=0.193 Sum_probs=94.5
Q ss_pred CCCCeeeecCCceEEEEEeCCCCEEEEEeccccc-----------------hhHHHHHHHHHHHhccC------CCCccc
Q 035917 327 CSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCK-----------------LGEKKFRNEMNRLGQLR------HPNLAP 383 (611)
Q Consensus 327 ~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~-----------------~~~~~~~~Ev~~l~~l~------H~nIv~ 383 (611)
+....||+|+.=.||. +++.....||+..... ...++..+|+.....+. +.+|.+
T Consensus 4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 3457899999999996 6667778889886544 22456778887766665 889999
Q ss_pred eeeEEEeCCeeEEEEeccCC------CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC
Q 035917 384 LLGYCVVEEEKLLIYKYMSS------GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD 457 (611)
Q Consensus 384 l~g~~~~~~~~~lv~ey~~~------gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld 457 (611)
++|+...+-..-+|+|.+.+ .+|.+++... .++. ...+.+.+.. .||- ...|+.+|++|+||++.
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~~~~L~~f~---~~l~---~~~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-ELRQALDEFK---RYLL---DHHIVIRDLNPHNIVVQ 152 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HHHHHHHHHH---HHHH---HcCCeecCCCcccEEEE
Confidence 99999998888899988643 3578888544 2544 3334444443 4554 56799999999999995
Q ss_pred CC--C--CeEEee-ccccc
Q 035917 458 ED--F--DARIMD-FGLAK 471 (611)
Q Consensus 458 ~~--~--~~kl~D-FGla~ 471 (611)
.. + .+.|.| ||-..
T Consensus 153 ~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred ecCCCceEEEEEeCCCCcc
Confidence 32 2 466666 55443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.89 E-value=6.1e-06 Score=58.71 Aligned_cols=36 Identities=44% Similarity=0.796 Sum_probs=15.3
Q ss_pred CCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCc
Q 035917 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLS 158 (611)
Q Consensus 121 ~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~ 158 (611)
+|++|+|++|+++ .||+.+.. |++|+.|+|++|+++
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~-l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSN-LPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTT-CTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhC-CCCCCEEEecCCCCC
Confidence 3444444444444 34444443 444444444444443
|
... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 611 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-49 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-48 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-33 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-32 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-19 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-19 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-17 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-13 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-10 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-10 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-10 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-10 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-10 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-09 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-06 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-06 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-06 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-06 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-06 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-06 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-06 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-06 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-06 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-06 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-06 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-06 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-06 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-06 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-06 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-06 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-06 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-06 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-06 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-06 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-06 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-06 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-06 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-06 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-06 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-06 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-06 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-06 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-05 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-05 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-05 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-05 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-05 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-05 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-05 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-05 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-05 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-05 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-05 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-05 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-05 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-05 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-05 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-05 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-05 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-05 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-05 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-05 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-04 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-04 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-04 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-04 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-04 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-04 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-04 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-04 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-04 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-04 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-04 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-04 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-04 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-04 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-04 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-04 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-04 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-04 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-04 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-04 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-04 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-04 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-04 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-04 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-04 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-04 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-04 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 5e-85
Identities = 116/303 (38%), Positives = 171/303 (56%), Gaps = 27/303 (8%)
Query: 316 LADLMAASNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKL--GEKKFRNEMNRL 373
L +L AS++F ++N++ G YK L DG+++AVKRL + GE +F+ E+ +
Sbjct: 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMI 81
Query: 374 GQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATE---LDWPTRFRIGLGAA 430
H NL L G+C+ E+LL+Y YM++G++ S L+ LDWP R RI LG+A
Sbjct: 82 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141
Query: 431 RGLAWLHHGCQPPFLHQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDL-GE 488
RGLA+LH C P +H+++ +N IL+DE+F+A + DFGLAKLM + + V + G
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAAN-ILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGT 198
Query: 489 FGYIAPEYSSTMVASLKGDVYGIGVVLLEL-------------AGFKGNLVDWVNQLSSS 535
G+IAPEY ST +S K DV+G GV+LLEL L+DWV L
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258
Query: 536 GRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFSER 595
+ + +D L G DEE+ Q ++VA C S P +R M +V + L G +ER
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD----GLAER 314
Query: 596 YDE 598
++E
Sbjct: 315 WEE 317
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 7e-76
Identities = 98/287 (34%), Positives = 142/287 (49%), Gaps = 26/287 (9%)
Query: 316 LADLMAASNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKL-GEKKFRNEMNRLG 374
L DL A+N+F + +I G YK +L DG+ +A+KR G ++F E+ L
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 375 QLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQG---NATELDWPTRFRIGLGAAR 431
RHP+L L+G+C E +LIYKYM +G L L G + W R I +GAAR
Sbjct: 91 FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 432 GLAWLHHGCQPPFLHQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDE---SSFVNGDLG 487
GL +LH +H+++ N IL+DE+F +I DFG++K T D+ S+ V G
Sbjct: 151 GLHYLHTRA---IIHRDVKSIN-ILLDENFVPKITDFGISKKGTELDQTHLSTVV---KG 203
Query: 488 EFGYIAPEYSSTMVASLKGDVYGIGVVLLEL-----------AGFKGNLVDWVNQLSSSG 536
GYI PEY + K DVY GVVL E+ NL +W + ++G
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263
Query: 537 RSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSL 583
+ ++ +D L K E + +F A C+ +DR SM V L
Sbjct: 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 1e-69
Identities = 79/298 (26%), Positives = 135/298 (45%), Gaps = 33/298 (11%)
Query: 316 LADLMAASNSFCSENVIISTRT------GTTYKAMLPDGSVLAVKRLNTCKL-----GEK 364
+L +N+F + + G YK + + + +AVK+L ++
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQ 75
Query: 365 KFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLL--QGNATELDWPTR 422
+F E+ + + +H NL LLG+ ++ L+Y YM +G+L L L W R
Sbjct: 76 QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135
Query: 423 FRIGLGAARGLAWLHHGCQPPFLHQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481
+I GAA G+ +LH +H++I +N IL+DE F A+I DFGLA+ ++
Sbjct: 136 CKIAQGAANGINFLHENH---HIHRDIKSAN-ILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 482 VNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL-AGFK--------GNLVDWVNQL 532
+ +G Y+APE + + K D+Y GVVLLE+ G L+D ++
Sbjct: 192 TSRIVGTTAYMAPEALRGEI-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEI 250
Query: 533 SSSGRS-KEAIDKALCGKGYD-EEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAA 588
++ ++ IDK + D + VA C+ + R + +V Q L + A
Sbjct: 251 EDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 7e-55
Identities = 68/312 (21%), Positives = 112/312 (35%), Gaps = 44/312 (14%)
Query: 316 LADLMAASNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQ 375
+L S V R G +KA +AVK + E+ L
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQNEYEVYSLPG 74
Query: 376 LRHPNLAPLLGYCV----VEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAAR 431
++H N+ +G V+ + LI + G+L L+ N + W I AR
Sbjct: 75 MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV--VSWNELCHIAETMAR 132
Query: 432 GLAWLHH-------GCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNG 484
GLA+LH G +P H++I S +L+ + A I DFGLA + + +G
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHG 192
Query: 485 DLGEFGYIAPEY-----SSTMVASLKGDVYGIGVVLLELA-----------GFKGNLVDW 528
+G Y+APE + A L+ D+Y +G+VL ELA + +
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252
Query: 529 VNQLSSSGRSKEAIDKALCGKGYDEEI----------LQFLKVACNCVVSRPKDRWSMYQ 578
+ Q S E + + + K + + C + R S
Sbjct: 253 IGQ----HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308
Query: 579 VYQSLNSIAAQH 590
V + + +
Sbjct: 309 VGERITQMQRLT 320
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 54/170 (31%), Positives = 78/170 (45%), Gaps = 10/170 (5%)
Query: 49 EDDVKCLEGVKSSLNDPQRKLSSWSFGNSTIGF-ICQFVGVSCWND-KENRILNLELREM 106
D + L +K L +P LSSW T ++GV C D + R+ NL+L +
Sbjct: 5 PQDKQALLQIKKDLGNPT-TLSSW---LPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGL 60
Query: 107 KLSG--KIPEPLKFCKSMQRLDLS-ANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPA 163
L IP L + L + N+L G IP I L L L +++ ++SG IP
Sbjct: 61 NLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAK-LTQLHYLYITHTNVSGAIPD 119
Query: 164 DLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213
L L TL S N LSG +P +S+L L + N ++G IP S+
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 35/183 (19%), Positives = 57/183 (31%), Gaps = 50/183 (27%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
L+ LSG +P + ++ + N +SG IP ++ + +S N L+G
Sbjct: 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGK 189
Query: 161 IPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPS--------- 211
IP N L + LS N L G + +K +A N L +
Sbjct: 190 IPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNG 248
Query: 212 ----------------------------------------SFKGFDKADFDGNSDLCGGP 231
+ + FD + + N LCG P
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308
Query: 232 LGS 234
L +
Sbjct: 309 LPA 311
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 7e-38
Identities = 61/320 (19%), Positives = 118/320 (36%), Gaps = 51/320 (15%)
Query: 317 ADLMAASNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNE--MNRLG 374
++ ++ +I R G YK L D +AVK + + F NE + R+
Sbjct: 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA--NRQNFINEKNIYRVP 62
Query: 375 QLRHPNLAPLLGYCV-----VEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGA 429
+ H N+A + E LL+ +Y +G+L L + DW + R+
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSV 120
Query: 430 ARGLAWLH------HGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS------D 477
RGLA+LH +P H+++ S +LV D I DFGL+ +T + +
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180
Query: 478 ESSFVNGDLGEFGYIAPEY-------SSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVN 530
E + ++G Y+APE A + D+Y +G++ E+ +L +
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240
Query: 531 ---------QLSSSGRSKEAIDKALCGKGY----------DEEILQFL-KVACNCVVSRP 570
+ + E + + + + ++ L + +C
Sbjct: 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDA 300
Query: 571 KDRWSMYQVYQSLNSIAAQH 590
+ R + + + +
Sbjct: 301 EARLTAQXAEERMAELMMIW 320
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 7e-36
Identities = 47/202 (23%), Positives = 76/202 (37%), Gaps = 31/202 (15%)
Query: 68 KLSSWSFGNSTIGFICQFVGVSCWNDKENRILNLELREMKLSGKIPEPLKFCKSMQRLDL 127
K S N G ++ ND + + ++ G E L + ++
Sbjct: 560 KQSGKIAANFIAGKRYVYIK----NDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNI 615
Query: 128 SANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPY 187
++ G+ N ++ LD+S N LSG IP ++G+ YL L L +N +SG IP
Sbjct: 616 TSRVYGGHTSPTFDN-NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD 674
Query: 188 QLSNLGRLKKFSVANNDLTGTIPSS--------------------------FKGFDKADF 221
++ +L L +++N L G IP + F+ F A F
Sbjct: 675 EVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKF 734
Query: 222 DGNSDLCGGPLGSKCGGLSKKN 243
N LCG PL +
Sbjct: 735 LNNPGLCGYPLPRCDPSNADGY 756
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-33
Identities = 52/134 (38%), Positives = 66/134 (49%), Gaps = 4/134 (2%)
Query: 83 CQFVGV---SCWNDKENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQ 139
F G + + +N + L L+ +GKIP L C + L LS N LSG IP+
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSS 437
Query: 140 ICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFS 199
+ + L L L L N L G IP +L L TLIL N L+G IP LSN L S
Sbjct: 438 LGS-LSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWIS 496
Query: 200 VANNDLTGTIPSSF 213
++NN LTG IP
Sbjct: 497 LSNNRLTGEIPKWI 510
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-33
Identities = 44/113 (38%), Positives = 62/113 (54%), Gaps = 1/113 (0%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
L+L L G+IP+ L + K+++ L L NDL+G IP+ + N L + LSNN L+G
Sbjct: 447 LKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN-CTNLNWISLSNNRLTGE 505
Query: 161 IPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213
IP +G L L LSNN SG IP +L + L + N GTIP++
Sbjct: 506 IPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAM 558
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-32
Identities = 43/110 (39%), Positives = 58/110 (52%), Gaps = 1/110 (0%)
Query: 107 KLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLG 166
LSG IP L ++ L L N L G IP ++ + L L L NDL+G IP+ L
Sbjct: 429 YLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY-VKTLETLILDFNDLTGEIPSGLS 487
Query: 167 NCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF 216
NCT LN + LSNN+L+G IP + L L ++NN +G IP+
Sbjct: 488 NCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDC 537
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-31
Identities = 45/116 (38%), Positives = 57/116 (49%), Gaps = 3/116 (2%)
Query: 101 LELREMKLSGKIPEPLKFC--KSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLS 158
L+L SG I L ++Q L L N +G IP + N LV L LS N LS
Sbjct: 373 LDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSN-CSELVSLHLSFNYLS 431
Query: 159 GPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFK 214
G IP+ LG+ + L L L N L G IP +L + L+ + NDLTG IPS
Sbjct: 432 GTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLS 487
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-30
Identities = 38/114 (33%), Positives = 56/114 (49%), Gaps = 3/114 (2%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
L + + G IP KS+Q L L+ N +G IP + L LDLS N G
Sbjct: 252 LNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA 309
Query: 161 IPADLGNCTYLNTLILSNNKLSGPIPYQ-LSNLGRLKKFSVANNDLTGTIPSSF 213
+P G+C+ L +L LS+N SG +P L + LK ++ N+ +G +P S
Sbjct: 310 VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESL 363
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-30
Identities = 46/186 (24%), Positives = 79/186 (42%), Gaps = 17/186 (9%)
Query: 40 SSLASETVA-EDDVKCLEGVKSSLNDPQRKLSSWSFGNSTIGFICQFVGVSCWNDKENRI 98
S AS + + ++ L K L D L WS + C F GV+C + +++
Sbjct: 1 SFQASPSQSLYREIHQLISFKDVLPDKNL-LPDWSSNKN----PCTFDGVTCRD---DKV 52
Query: 99 LNLELREMKLS---GKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNN 155
+++L L+ + L ++ L LS + ++G++ L LDLS N
Sbjct: 53 TSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKC-SASLTSLDLSRN 110
Query: 156 DLSGPIPAD--LGNCTYLNTLILSNNKLSGPIPYQ-LSNLGRLKKFSVANNDLTGTIPSS 212
LSGP+ LG+C+ L L +S+N L P L L+ ++ N ++G
Sbjct: 111 SLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVG 170
Query: 213 FKGFDK 218
+ D
Sbjct: 171 WVLSDG 176
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-29
Identities = 41/114 (35%), Positives = 55/114 (48%), Gaps = 5/114 (4%)
Query: 100 NLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG 159
L L L+G+IP L C ++ + LS N L+G IP I L L +L LSNN SG
Sbjct: 470 TLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR-LENLAILKLSNNSFSG 528
Query: 160 PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213
IPA+LG+C L L L+ N +G IP + +A N + G
Sbjct: 529 NIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYI 578
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-28
Identities = 40/115 (34%), Positives = 59/115 (51%), Gaps = 6/115 (5%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
L + K+SG + + C +++ LD+S+N+ S IP + + L LD+S N LSG
Sbjct: 183 LAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGD-CSALQHLDISGNKLSGD 238
Query: 161 IPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
+ CT L L +S+N+ GPIP L L+ S+A N TG IP G
Sbjct: 239 FSRAISTCTELKLLNISSNQFVGPIP--PLPLKSLQYLSLAENKFTGEIPDFLSG 291
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-27
Identities = 41/116 (35%), Positives = 58/116 (50%), Gaps = 3/116 (2%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
L+L G +P C ++ L LS+N+ SG +P + L +LDLS N+ SG
Sbjct: 299 LDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGE 358
Query: 161 IPADLGNCTY-LNTLILSNNKLSGPIPYQLSN--LGRLKKFSVANNDLTGTIPSSF 213
+P L N + L TL LS+N SGPI L L++ + NN TG IP +
Sbjct: 359 LPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-27
Identities = 34/115 (29%), Positives = 55/115 (47%), Gaps = 4/115 (3%)
Query: 100 NLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG 159
+L++ KLSG + C ++ L++S+N G IP L L L L+ N +G
Sbjct: 227 HLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP---LKSLQYLSLAENKFTG 283
Query: 160 PIPADL-GNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213
IP L G C L L LS N G +P + L+ ++++N+ +G +P
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDT 338
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-24
Identities = 32/118 (27%), Positives = 55/118 (46%), Gaps = 7/118 (5%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
+ L +L+G+IP+ + +++ L LS N SGNIPA++ + L+ LDL+ N +G
Sbjct: 495 ISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGD-CRSLIWLDLNTNLFNGT 553
Query: 161 IPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANND--LTGTIPSSFKGF 216
IPA + + ++ N ++G + N G K+ A N G
Sbjct: 554 IPAAMFKQ----SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRL 607
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 51/200 (25%), Positives = 79/200 (39%), Gaps = 18/200 (9%)
Query: 329 ENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKK---FRNEMNRLGQLRHPNLAPLL 385
+ +G +K G+ + VK L +K F E RL HPN+ P+L
Sbjct: 15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 386 GYCVVEEEKLL--IYKYMSSGTLYSLLQ-GNATELDWPTRFRIGLGAARGLAWLHHGCQP 442
G C I +M G+LY++L G +D + L ARG+A+LH +P
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEP 132
Query: 443 PFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPE---YSST 499
+ S +++DED ARI + S G + ++APE
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-------GRMYAPAWVAPEALQKKPE 185
Query: 500 MVASLKGDVYGIGVVLLELA 519
D++ V+L EL
Sbjct: 186 DTNRRSADMWSFAVLLWELV 205
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 61/193 (31%), Positives = 98/193 (50%), Gaps = 21/193 (10%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEKK---FRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394
GT ++A GS +AVK L ++ F E+ + +LRHPN+ +G
Sbjct: 51 GTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109
Query: 395 LLIYKYMSSGTLYSLLQGNAT--ELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSN 452
++ +Y+S G+LY LL + +LD R + A+G+ +LH+ PP +H+N+ S
Sbjct: 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSP 168
Query: 453 VILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPE------YSSTMVASLKG 506
+LVD+ + ++ DFGL++L S+ SS G ++APE + K
Sbjct: 169 NLLVDKKYTVKVCDFGLSRLKASTFLSS--KSAAGTPEWMAPEVLRDEPSNE------KS 220
Query: 507 DVYGIGVVLLELA 519
DVY GV+L ELA
Sbjct: 221 DVYSFGVILWELA 233
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 9e-33
Identities = 64/264 (24%), Positives = 110/264 (41%), Gaps = 24/264 (9%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEKK---FRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394
GT YK G V AVK LN ++ F+NE+ L + RH N+ +GY +
Sbjct: 38 GTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQL 94
Query: 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVI 454
++ ++ +LY L + T+ + I ARG+ +LH +H+++ SN I
Sbjct: 95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNI 151
Query: 455 LVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPE---YSSTMVASLKGDVYGI 511
+ ED +I DFGLA + S G ++APE + S + DVY
Sbjct: 152 FLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAF 211
Query: 512 GVVLLELA-G---FKG--NLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNC 565
G+VL EL G + N + + S D + + + + + C
Sbjct: 212 GIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP---DLSKVRSNCPKRMKRLMA---EC 265
Query: 566 VVSRPKDRWSMYQVYQSLNSIAAQ 589
+ + +R S ++ + +A +
Sbjct: 266 LKKKRDERPSFPRILAEIEELARE 289
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 55/201 (27%), Positives = 82/201 (40%), Gaps = 20/201 (9%)
Query: 336 RTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK- 394
R G ++ G +AVK ++ E+ LRH N+ + +
Sbjct: 20 RYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78
Query: 395 ---LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLH-----HGCQPPFLH 446
LI Y G+LY LQ LD + RI L A GLA LH +P H
Sbjct: 79 TQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAH 136
Query: 447 QNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV--NGDLGEFGYIAPE------YSS 498
+++ S ILV ++ I D GLA + + S V N +G Y+APE
Sbjct: 137 RDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVD 196
Query: 499 TMVASLKGDVYGIGVVLLELA 519
+ + D++ G+VL E+A
Sbjct: 197 CFDSYKRVDIWAFGLVLWEVA 217
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 62/288 (21%), Positives = 106/288 (36%), Gaps = 36/288 (12%)
Query: 336 RTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK- 394
R G + G +AVK T + E+ + +RH N+ + +
Sbjct: 49 RYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107
Query: 395 ---LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLH-----HGCQPPFLH 446
LI Y +G+LY L+ LD + ++ + GL LH +P H
Sbjct: 108 TQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAH 165
Query: 447 QNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV--NGDLGEFGYIAPE------YSS 498
+++ S ILV ++ I D GLA S + N +G Y+ PE +
Sbjct: 166 RDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRN 225
Query: 499 TMVASLKGDVYGIGVVLLELA-GFKGNLVDWVNQLSSSGR-----SKEAIDKALCGKGY- 551
+ + D+Y G++L E+A + QL S E + + +C K
Sbjct: 226 HFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLR 285
Query: 552 ---------DEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590
DE + Q K+ C P R + +V ++L ++
Sbjct: 286 PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 8e-32
Identities = 56/272 (20%), Positives = 108/272 (39%), Gaps = 40/272 (14%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGE--------KKFRNEMNRLGQLRHPNLAPLLGYC 388
G +K + D SV+A+K L ++F+ E+ + L HPN+ L G
Sbjct: 33 GLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92
Query: 389 VVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQN 448
++ +++ G LY L A + W + R+ L A G+ ++ + PP +H++
Sbjct: 93 H--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRD 149
Query: 449 ICSNVILVDE-----DFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPE--YSSTMV 501
+ S I + A++ DFGL++ S V+G LG F ++APE +
Sbjct: 150 LRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEES 204
Query: 502 ASLKGDVYGIGVVLLEL-------AGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEE 554
+ K D Y ++L + + + ++N + G +
Sbjct: 205 YTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP------EDCPPR 258
Query: 555 ILQFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586
+ ++ C PK R + + L+ +
Sbjct: 259 LRNVIE---LCWSGDPKKRPHFSYIVKELSEL 287
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 60/290 (20%), Positives = 113/290 (38%), Gaps = 38/290 (13%)
Query: 336 RTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK- 394
R G ++ G +AVK ++ + E+ + LRH N+ + +
Sbjct: 54 RFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112
Query: 395 ---LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLH-----HGCQPPFLH 446
L+ Y G+L+ L + ++ L A GLA LH +P H
Sbjct: 113 TQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 170
Query: 447 QNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV--NGDLGEFGYIAPE------YSS 498
+++ S ILV ++ I D GLA S+ ++ + N +G Y+APE
Sbjct: 171 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK 230
Query: 499 TMVASLKGDVYGIGVVLLELA-------GFKGNLVDWVNQLSSSGRSKEAIDKALCGKGY 551
+ + D+Y +G+V E+A + + + + L S S E + K +C +
Sbjct: 231 HFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-LVPSDPSVEEMRKVVCEQKL 289
Query: 552 ----------DEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591
E + K+ C + R + ++ ++L+ ++ Q G
Sbjct: 290 RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 48/189 (25%), Positives = 83/189 (43%), Gaps = 22/189 (11%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLG-----YCVVEE 392
G KA +A+K++ + K F E+ +L ++ HPN+ L G C+V E
Sbjct: 22 GVVCKAKW-RAKDVAIKQIESESE-RKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVME 79
Query: 393 EKLLIYKYMSSGTLYSLLQG--NATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNI- 449
Y G+LY++L G L ++G+A+LH +H+++
Sbjct: 80 -------YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLK 132
Query: 450 CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVY 509
N++LV +I DFG A + + + + G ++APE S K DV+
Sbjct: 133 PPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVF 187
Query: 510 GIGVVLLEL 518
G++L E+
Sbjct: 188 SWGIILWEV 196
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 7e-31
Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 20/195 (10%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGE-----KKFRNEMNRLGQLRHPNLAPLLGYCVVEE 392
G Y+A G +AVK + + R E L+HPN+ L G C+ E
Sbjct: 21 GKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP 79
Query: 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSN 452
L+ ++ G L +L G + + ARG+ +LH P +H+++ S+
Sbjct: 80 NLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSS 137
Query: 453 VILVDEDFDAR--------IMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASL 504
IL+ + + I DFGLA+ + + S G + ++APE + S
Sbjct: 138 NILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMAPEVIRASMFSK 193
Query: 505 KGDVYGIGVVLLELA 519
DV+ GV+L EL
Sbjct: 194 GSDVWSYGVLLWELL 208
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 55/272 (20%), Positives = 101/272 (37%), Gaps = 33/272 (12%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGE---KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394
G Y G V A++ ++ + E K F+ E+ Q RH N+ +G C+
Sbjct: 47 GQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104
Query: 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVI 454
+I TLYS+++ LD +I +G+ +LH LH+++ S +
Sbjct: 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNV 161
Query: 455 LVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFG---YIAPEYSSTMVA--------- 502
D I DFGL + + + G ++APE +
Sbjct: 162 FYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPF 220
Query: 503 SLKGDVYGIGVVLLELAG----FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQF 558
S DV+ +G + EL FK + + +G K + + GK + +L
Sbjct: 221 SKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG-MKPNLSQIGMGKEISDILLF- 278
Query: 559 LKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590
C ++R + ++ L + ++
Sbjct: 279 ------CWAFEQEERPTFTKLMDMLEKLPKRN 304
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 60/269 (22%), Positives = 104/269 (38%), Gaps = 32/269 (11%)
Query: 338 GTTYKAML-PDGSVLAVKRL-NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395
G K G V+ +K L + ++ F E+ + L HPN+ +G ++
Sbjct: 24 GQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83
Query: 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVIL 455
I +Y+ GTL +++ ++ W R A G+A+LH +H+++ S+ L
Sbjct: 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCL 140
Query: 456 VDEDFDARIMDFGLAKLMTSSDESSFVNGDL------------GEFGYIAPE------YS 497
V E+ + + DFGLA+LM L G ++APE Y
Sbjct: 141 VRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD 200
Query: 498 STMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQ 557
K DV+ G+VL E+ G D++ + G + C
Sbjct: 201 E------KVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPS--- 251
Query: 558 FLKVACNCVVSRPKDRWSMYQVYQSLNSI 586
F + C P+ R S ++ L ++
Sbjct: 252 FFPITVRCCDLDPEKRPSFVKLEHWLETL 280
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-24
Identities = 22/116 (18%), Positives = 38/116 (32%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
L++ S++ L ++ N N I L L LDLS L
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 485
Query: 161 IPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF 216
P + + L L +S+N + L L+ + N + + + F
Sbjct: 486 SPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF 541
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-22
Identities = 25/118 (21%), Positives = 44/118 (37%), Gaps = 2/118 (1%)
Query: 100 NLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG 159
NL+L L +Q LDLS ++ + L +L L L+ N +
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQS-LSHLSTLILTGNPIQS 90
Query: 160 PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGT-IPSSFKGF 216
+ L L+ L+ + + +L LK+ +VA+N + +P F
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-20
Identities = 20/119 (16%), Positives = 40/119 (33%), Gaps = 5/119 (4%)
Query: 103 LREMKLSG----KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLS 158
L+ + LS + + ++ LD ++L + L L+ LD+S+
Sbjct: 375 LKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
Query: 159 GPIPADLGNCTYLNTLILSNNKLSGPI-PYQLSNLGRLKKFSVANNDLTGTIPSSFKGF 216
+ L L ++ N P + L L ++ L P++F
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 493
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 9e-20
Identities = 24/95 (25%), Positives = 37/95 (38%), Gaps = 1/95 (1%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNK 180
S + LDLS N L + P L +LDLS ++ + ++L+TLIL+ N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFS-FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 181 LSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
+ S L L+K +L
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-19
Identities = 27/121 (22%), Positives = 48/121 (39%), Gaps = 6/121 (4%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDL-SG 159
L L + S+Q+L +L+ I + L L L++++N + S
Sbjct: 81 LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH-LKTLKELNVAHNLIQSF 139
Query: 160 PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSV----ANNDLTGTIPSSFKG 215
+P N T L L LS+NK+ L L ++ ++ + N + P +FK
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199
Query: 216 F 216
Sbjct: 200 I 200
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 7e-19
Identities = 18/111 (16%), Positives = 40/111 (36%), Gaps = 2/111 (1%)
Query: 107 KLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLG 166
++ + + L L+ N + L L L +L+ +G
Sbjct: 63 EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG-LSSLQKLVAVETNLASLENFPIG 121
Query: 167 NCTYLNTLILSNNKL-SGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF 216
+ L L +++N + S +P SNL L+ +++N + + +
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVL 172
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-17
Identities = 21/118 (17%), Positives = 38/118 (32%), Gaps = 3/118 (2%)
Query: 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNND 156
L+L + G + S++ LDLS N + + + L L LD +++
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLG-LEQLEHLDFQHSN 407
Query: 157 LSGPIPAD-LGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213
L + L L +S+ + L L+ +A N
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-17
Identities = 29/118 (24%), Positives = 51/118 (43%), Gaps = 7/118 (5%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDL-SGNIPAQICNWLPYLVLLDLSNNDLSG 159
L E L+ P+ K+++ L+++ N + S +P N L L LDLS+N +
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN-LTNLEHLDLSSNKIQS 163
Query: 160 PIPADLGNCTYL----NTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213
DL + +L LS N ++ P + RL K ++ NN + + +
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTC 220
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 25/133 (18%), Positives = 40/133 (30%), Gaps = 23/133 (17%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNW----------------- 143
L + + + + Q L+L ++ +
Sbjct: 287 FSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV 344
Query: 144 -LPYLVLLDLSNNDLS--GPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSV 200
LP L LDLS N LS G T L L LS N + + L +L+
Sbjct: 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDF 403
Query: 201 ANNDLTGTIPSSF 213
+++L S
Sbjct: 404 QHSNLKQMSEFSV 416
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 21/128 (16%), Positives = 37/128 (28%), Gaps = 10/128 (7%)
Query: 95 ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSN 154
L+L+L ++ P K + +L L N S N+ L L + L
Sbjct: 176 PLLNLSLDLSLNPMNFIQPGAFK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL 234
Query: 155 NDLSG------PIPADLGNCTYLNTLILSNNKLS---GPIPYQLSNLGRLKKFSVANNDL 205
+ + L L L I + L + FS+ + +
Sbjct: 235 GEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI 294
Query: 206 TGTIPSSF 213
S+
Sbjct: 295 ERVKDFSY 302
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 20/133 (15%), Positives = 35/133 (26%), Gaps = 13/133 (9%)
Query: 89 SCWNDKENRILNLELREMKLSGKIPEPLKFC------KSMQRLDLSANDLSGNIPAQICN 142
+ L L E + G + + K +++ L+ D + + N
Sbjct: 220 CIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN 279
Query: 143 WLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVAN 202
L + L + + L L N K +L +L RL
Sbjct: 280 CLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLT-----F 332
Query: 203 NDLTGTIPSSFKG 215
G S
Sbjct: 333 TSNKGGNAFSEVD 345
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 18/98 (18%), Positives = 36/98 (36%), Gaps = 4/98 (4%)
Query: 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNND 156
++LN+ P K S+Q LD S N + + ++ ++ L L+L+ ND
Sbjct: 497 QVLNM--SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 554
Query: 157 LSGPIPAD--LGNCTYLNTLILSNNKLSGPIPYQLSNL 192
+ L L++ ++ P +
Sbjct: 555 FACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM 592
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 19/138 (13%), Positives = 39/138 (28%), Gaps = 11/138 (7%)
Query: 97 RILNLELREMKLSGKIPE-PLKFCKSMQRLDLSANDLSG--NIPAQICNWLPYLVLLDLS 153
R+ L LR S + + ++ ++ L + N+ + L L L +
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 154 NNDLS------GPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTG 207
L+ I T +++ L + + S + + N
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQ 318
Query: 208 TIPSSFKGFDKADFDGNS 225
K + F N
Sbjct: 319 FPTLKLKSLKRLTFTSNK 336
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 56/252 (22%), Positives = 102/252 (40%), Gaps = 29/252 (11%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEK---KFRNEMNRLGQLRHPNLAPLLGYCVV--- 390
T YK + +A L KL + +F+ E L L+HPN+
Sbjct: 40 KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99
Query: 391 EEEKLLIY-KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNI 449
++ +++ + M+SGTL + L+ + +GL +LH PP +H+++
Sbjct: 100 GKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDL 157
Query: 450 -CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDV 508
C N+ + +I D GLA L +S + + G ++APE DV
Sbjct: 158 KCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFMAPEMYEEK-YDESVDV 212
Query: 509 YGIGVVLLELAGFK--GNLVDWVNQL---SSSGRSKEAIDKALCGKGYDEEILQFLKVAC 563
Y G+ +LE+A + + Q+ +SG + DK E+ + ++
Sbjct: 213 YAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA-----IPEVKEIIE--- 264
Query: 564 NCVVSRPKDRWS 575
C+ +R+S
Sbjct: 265 GCIRQNKDERYS 276
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 5e-21
Identities = 18/123 (14%), Positives = 39/123 (31%), Gaps = 10/123 (8%)
Query: 98 ILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDL 157
N + K + +++ +P + LP + L++++ N
Sbjct: 227 WENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA-LPEMQLINVACNRG 285
Query: 158 --------SGPIPADLGNCTYLNTLILSNNKL-SGPIPYQLSNLGRLKKFSVANNDLTGT 208
AD + + + N L + P+ L + +L N L G
Sbjct: 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGK 345
Query: 209 IPS 211
+P+
Sbjct: 346 LPA 348
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-21
Identities = 26/120 (21%), Positives = 54/120 (45%), Gaps = 6/120 (5%)
Query: 95 ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDL-SGNIPAQICNWLPYLVLLDLS 153
NR ++ E ++K + + +Q + + N+L + + + + L +L+
Sbjct: 282 CNRGISGE--QLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQK-MKKLGMLECL 338
Query: 154 NNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213
N L G +PA G+ L +L L+ N+++ +++ S A+N L IP+ F
Sbjct: 339 YNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIF 396
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 5e-20
Identities = 29/140 (20%), Positives = 43/140 (30%), Gaps = 10/140 (7%)
Query: 112 IPEPLKFCKSMQRLDLSANDLSGNIPAQICNW-LPYLVLLDLSNNDLSGPIPADLGNCTY 170
E K + +DL N L+ + LPYLV +DLS N S P N +
Sbjct: 480 ENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSST 537
Query: 171 L------NTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKADFDGN 224
L N N+ P ++ L + + +ND+ D N
Sbjct: 538 LKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNISVLDIKDN 597
Query: 225 SDLCGGPLGSKCGGLSKKNL 244
L C +
Sbjct: 598 P-NISIDLSYVCPYIEAGMY 616
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 9e-19
Identities = 27/199 (13%), Positives = 58/199 (29%), Gaps = 22/199 (11%)
Query: 29 TAKSDSTQITFSSLASETVAEDDVKCLEGVKSSLNDP--------QRKLSSWSFGNSTIG 80
I S A D L+ + +LN + ++W+F N +
Sbjct: 12 LTDDAIVPIKLSRTAEYI---KDYLALKEIWDALNGKNWSQQGFGTQPGANWNF-NKELD 67
Query: 81 FICQFVGVSCWNDKENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGN----I 136
GVS + R+ L L SG++P+ + ++ L L ++ N
Sbjct: 68 MWGAQPGVSL--NSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFG 125
Query: 137 PAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLN--TLILSNNKLSGPIPYQLSNLGR 194
P I + + ++++ I +
Sbjct: 126 PKGISA-NMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLK 184
Query: 195 LKKFSVANNDLTGTIPSSF 213
+ +N++T + +
Sbjct: 185 DTQIGQLSNNITF-VSKAV 202
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 25/151 (16%), Positives = 45/151 (29%), Gaps = 21/151 (13%)
Query: 98 ILNLE-LREMKLSG----KIPEPLKFCK--SMQRLDLSANDLSGNIPAQICN-----WLP 145
N L + L K+ + + + +DLS N S P Q N
Sbjct: 484 FKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFG 542
Query: 146 YLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDL 205
D N P + C L L + +N + + ++ + + +N
Sbjct: 543 IRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPN 599
Query: 206 TGTIPSSFKGFDKA-----DFDGNSDLCGGP 231
S + +A +D D+ G
Sbjct: 600 ISIDLSYVCPYIEAGMYMLFYDKTQDIRGCD 630
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 19/122 (15%), Positives = 44/122 (36%), Gaps = 10/122 (8%)
Query: 100 NLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG 159
+ + K + ++ ++LS N +S ++ + L ++L N L+
Sbjct: 413 EIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPK-ELFSTGSPLSSINLMGNMLTE 471
Query: 160 -------PIPADLGNCTYLNTLILSNNKLSG-PIPYQLSNLGRLKKFSVANNDLTGTIPS 211
+ N L ++ L NKL+ ++ + L L ++ N + P+
Sbjct: 472 IPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPT 530
Query: 212 SF 213
Sbjct: 531 QP 532
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 24/129 (18%), Positives = 48/129 (37%), Gaps = 10/129 (7%)
Query: 107 KLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNW-LPYLVLLDLSNNDLSG------ 159
+++ F + ++ L + N L IP + + +D S N++
Sbjct: 364 QITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNF 422
Query: 160 -PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDK 218
P+ ++++ LSNN++S S L ++ N LT IP + +
Sbjct: 423 DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-IPKNSLKDEN 481
Query: 219 ADFDGNSDL 227
+F L
Sbjct: 482 ENFKNTYLL 490
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 11/129 (8%), Positives = 31/129 (24%), Gaps = 7/129 (5%)
Query: 99 LNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLS 158
+ ++ + + + +++ + + + +
Sbjct: 186 TQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWE------NENSEYAQQY 238
Query: 159 GPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDK 218
N L + + N +P L L ++ +VA N
Sbjct: 239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298
Query: 219 ADFDGNSDL 227
AD +
Sbjct: 299 ADAPVGEKI 307
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-20
Identities = 26/116 (22%), Positives = 41/116 (35%), Gaps = 1/116 (0%)
Query: 100 NLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG 159
L L +L + LD+ N +S P LP L +L+L +N+LS
Sbjct: 29 VLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQK-LPMLKVLNLQHNELSQ 87
Query: 160 PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
CT L L L +N + L +++N L+ T +
Sbjct: 88 LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-18
Identities = 24/120 (20%), Positives = 42/120 (35%), Gaps = 2/120 (1%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
L L + K+S + + ++ LDL N++ + Q L + + LS N
Sbjct: 386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQL 445
Query: 161 IPADLGNCTYLNTLILSNNKLSG--PIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDK 218
L L+L L P L L ++NN++ +G +K
Sbjct: 446 TRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEK 505
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-18
Identities = 24/115 (20%), Positives = 44/115 (38%), Gaps = 4/115 (3%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
+ +KL+ ++P+ L ++ L+L+ N L A L LD+ N +S
Sbjct: 9 ADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTR-YSQLTSLDVGFNTISKL 64
Query: 161 IPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
P L L L +N+LS + L + + +N + + F
Sbjct: 65 EPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-18
Identities = 32/169 (18%), Positives = 50/169 (29%), Gaps = 15/169 (8%)
Query: 90 CWNDKENRILNLELREMKLSGKIPEPLKFCK--SMQRLDLSANDLSGNIPAQICNWLPYL 147
C I NL L +LS K ++ LDLS N+L+ LP L
Sbjct: 216 CLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAW-LPQL 274
Query: 148 VLLDLSNNDLSGPIPADLGNCTYLNTLILSNN---------KLSGPIPYQLSNLGRLKKF 198
L N++ L + L L + L + L L+
Sbjct: 275 EYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHL 334
Query: 199 SVANNDLTGTIPSSFKGFDKA---DFDGNSDLCGGPLGSKCGGLSKKNL 244
++ +ND+ G + F G + L+ L
Sbjct: 335 NMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPL 383
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-18
Identities = 26/135 (19%), Positives = 48/135 (35%), Gaps = 11/135 (8%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLS-------GNIPAQICNWLPYLVLLDLS 153
L+L ++ + L+ + ++ LDL N+L+ P L +L +L+L
Sbjct: 485 LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLE 544
Query: 154 NNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213
+N + L + L N L+ +N LK ++ N +T F
Sbjct: 545 SNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVF 604
Query: 214 KGFDKA----DFDGN 224
+ D N
Sbjct: 605 GPAFRNLTELDMRFN 619
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-17
Identities = 26/116 (22%), Positives = 45/116 (38%), Gaps = 1/116 (0%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
L++ +S PE + ++ L+L N+LS + + + L L L +N +
Sbjct: 54 LDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQ-LSDKTFAFCTNLTELHLMSNSIQKI 112
Query: 161 IPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF 216
L TL LS+N LS L L++ ++NN + F
Sbjct: 113 KNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIF 168
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-17
Identities = 31/120 (25%), Positives = 48/120 (40%), Gaps = 3/120 (2%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
L L+ +LS + FC ++ L L +N + L+ LDLS+N LS
Sbjct: 78 LNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK-QKNLITLDLSHNGLSST 136
Query: 161 IPADLGNCTYLNTLILSNNKLSGPIPYQLSNLG--RLKKFSVANNDLTGTIPSSFKGFDK 218
L L+LSNNK+ +L LKK +++N + P F +
Sbjct: 137 KLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGR 196
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 25/113 (22%), Positives = 47/113 (41%), Gaps = 4/113 (3%)
Query: 107 KLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNW-LPYLVLLDLSNNDLSGPIPADL 165
LS +++Q L LS N + ++ + L L+LS+N + P
Sbjct: 132 GLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCF 191
Query: 166 GNCTYLNTLILSNNKLSGPIPYQLS---NLGRLKKFSVANNDLTGTIPSSFKG 215
L L L+N +L + +L ++ S++N+ L+ T ++F G
Sbjct: 192 HAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLG 244
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 28/132 (21%), Positives = 45/132 (34%), Gaps = 5/132 (3%)
Query: 101 LELREMKLSGKIPEPLKF---CKSMQRLDLSANDLSGNIPAQICNW-LPYLVLLDLSNND 156
L L ++L + E L S++ L LS + LS L +LDLS N+
Sbjct: 200 LFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNN 259
Query: 157 LSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPS-SFKG 215
L+ L L N + + L L ++ ++ + +I S
Sbjct: 260 LNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPK 319
Query: 216 FDKADFDGNSDL 227
D F L
Sbjct: 320 IDDFSFQWLKCL 331
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 26/130 (20%), Positives = 47/130 (36%), Gaps = 4/130 (3%)
Query: 101 LELREMKLSGKIP-EPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG 159
L+L ++ ++ + + +++ + LS N +P L L L L
Sbjct: 410 LDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFAL-VPSLQRLMLRRVALKN 468
Query: 160 --PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFD 217
P+ L L LSNN ++ L L +L+ + +N+L + G
Sbjct: 469 VDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGP 528
Query: 218 KADFDGNSDL 227
G S L
Sbjct: 529 IYFLKGLSHL 538
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 8e-16
Identities = 21/120 (17%), Positives = 43/120 (35%), Gaps = 4/120 (3%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLS-GNIPAQICNWLPYLVL--LDLSNNDL 157
L + + + G +++ L LS + S + + L + L L+L+ N +
Sbjct: 334 LNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKI 393
Query: 158 SGPIPADLGNCTYLNTLILSNNKLSGPIPYQ-LSNLGRLKKFSVANNDLTGTIPSSFKGF 216
S +L L L N++ + Q L + + ++ N +SF
Sbjct: 394 SKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALV 453
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-15
Identities = 21/95 (22%), Positives = 41/95 (43%), Gaps = 4/95 (4%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNK 180
S + D S L+ +P + + +L+L++N L A+ + L +L + N
Sbjct: 5 SHEVADCSHLKLT-QVPDDL---PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 181 LSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
+S P L LK ++ +N+L+ +F
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAF 95
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 11/83 (13%), Positives = 26/83 (31%), Gaps = 3/83 (3%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
++L L+ S++ L+L N ++ L LD+ N
Sbjct: 565 IDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624
Query: 161 IPADLGNCTYLNTLILSNNKLSG 183
+ ++N ++ +
Sbjct: 625 CESIAWFVNWIN---ETHTNIPE 644
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-19
Identities = 59/271 (21%), Positives = 104/271 (38%), Gaps = 40/271 (14%)
Query: 338 GTTYKAMLPDGSVL-AVKRLN--TCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394
G + L + L AVK + KF E L Q HPN+ L+G C ++
Sbjct: 128 GEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187
Query: 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVI 454
++ + + G + L+ L T ++ AA G+ +L +H+++ +
Sbjct: 188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNC 244
Query: 455 LVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGY--IAPEYSSTMVASLKGDVYGIG 512
LV E +I DFG+++ +D +G L + APE + S + DV+ G
Sbjct: 245 LVTEKNVLKISDFGMSREE--ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFG 302
Query: 513 VVLLELAGFKGNLVDWVNQLSSSGRS-------KEAIDKALCG------KGYDEEILQFL 559
++L E S G S ++ + G + + + + +
Sbjct: 303 ILLWETF--------------SLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLM 348
Query: 560 KVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590
+ C P R S +YQ L SI +H
Sbjct: 349 E---QCWAYEPGQRPSFSTIYQELQSIRKRH 376
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-18
Identities = 19/116 (16%), Positives = 32/116 (27%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
L++ S+ L ++ N N + + L LDLS L
Sbjct: 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQI 488
Query: 161 IPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF 216
L L +S+N L + L L + N + +
Sbjct: 489 SWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFP 544
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-17
Identities = 23/131 (17%), Positives = 40/131 (30%), Gaps = 2/131 (1%)
Query: 89 SCWNDKENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLV 148
S + N + +L+L + + +Q LD + L L L+
Sbjct: 369 SYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLL 427
Query: 149 LLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQ-LSNLGRLKKFSVANNDLTG 207
LD+S + T LNTL ++ N +N L ++ L
Sbjct: 428 YLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ 487
Query: 208 TIPSSFKGFDK 218
F +
Sbjct: 488 ISWGVFDTLHR 498
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 7e-16
Identities = 29/117 (24%), Positives = 48/117 (41%), Gaps = 2/117 (1%)
Query: 100 NLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG 159
N++L L +Q LDLS ++ I + + L +L L L+ N +
Sbjct: 36 NIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET-IEDKAWHGLHHLSNLILTGNPIQS 94
Query: 160 PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTG-TIPSSFKG 215
P T L L+ KL+ + + L LKK +VA+N + +P+ F
Sbjct: 95 FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 29/127 (22%), Positives = 42/127 (33%), Gaps = 6/127 (4%)
Query: 89 SCWNDKENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLV 148
C N + KLS K+P+ + S + +DLS N L N L
Sbjct: 6 PCIEVVPNITYQC--MDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSN-FSELQ 59
Query: 149 LLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGT 208
LDLS ++ +L+ LIL+ N + P S L L+ L
Sbjct: 60 WLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASL 119
Query: 209 IPSSFKG 215
Sbjct: 120 ESFPIGQ 126
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 25/110 (22%), Positives = 44/110 (40%), Gaps = 7/110 (6%)
Query: 103 LREMKLSG------KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNND 156
L +K++G + ++ LDLS L I + + L L LL++S+N+
Sbjct: 450 LNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ-ISWGVFDTLHRLQLLNMSHNN 508
Query: 157 LSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLT 206
L + L+TL S N++ L F++ NN +
Sbjct: 509 LLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 19/117 (16%), Positives = 39/117 (33%), Gaps = 2/117 (1%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
L+L ++ + + L L+ N + + L L L L+
Sbjct: 61 LDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS-FSPGSFSGLTSLENLVAVETKLASL 119
Query: 161 IPADLGNCTYLNTLILSNNKLSG-PIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF 216
+G L L +++N + +P SNL L ++ N + + +
Sbjct: 120 ESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-12
Identities = 24/116 (20%), Positives = 34/116 (29%), Gaps = 5/116 (4%)
Query: 101 LELREMKLSGKIPEPLKF--CKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLS 158
L+L LS S++ LDLS N + A L L LD ++ L
Sbjct: 355 LDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMG-LEELQHLDFQHSTLK 412
Query: 159 GPIPAD-LGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213
+ L L +S L L +A N S+
Sbjct: 413 RVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNV 468
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 31/118 (26%), Positives = 45/118 (38%), Gaps = 12/118 (10%)
Query: 103 LREMKLSG---KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG 159
+ M L+G K E + Q L + L P LP+L L L+ N S
Sbjct: 287 VSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLK-QFPT---LDLPFLKSLTLTMNKGS- 341
Query: 160 PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLG--RLKKFSVANNDLTGTIPSSFKG 215
I L+ L LS N LS S+LG L+ ++ N + ++F G
Sbjct: 342 -ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMG 397
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 25/118 (21%), Positives = 48/118 (40%), Gaps = 7/118 (5%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSG-NIPAQICNWLPYLVLLDLSNNDLSG 159
L E KL+ P+ ++++L+++ N + +PA N L LV +DLS N +
Sbjct: 109 LVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN-LTNLVHVDLSYNYIQT 167
Query: 160 PIPADLGNCTYLN----TLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213
DL +L +S N + + +L + ++ N + I +
Sbjct: 168 ITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTC 224
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 16/104 (15%), Positives = 29/104 (27%), Gaps = 9/104 (8%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI----- 175
+ L L N S NI L L + L + ++ + + L
Sbjct: 205 KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTID 264
Query: 176 ---LSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF 216
L+ + L + S+A + + K F
Sbjct: 265 EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHF 307
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 21/106 (19%), Positives = 29/106 (27%), Gaps = 11/106 (10%)
Query: 120 KSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPAD-LGNCTYLNTLILS- 177
+ LD+S N + I Q L L L N S I L N L+ L
Sbjct: 181 QVNLSLDMSLNPID-FIQDQAFQ-GIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLIL 238
Query: 178 -----NNKLSGPIPYQLSNLGRLKK--FSVANNDLTGTIPSSFKGF 216
L P + L + F + + F
Sbjct: 239 GEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCL 284
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 6e-18
Identities = 46/193 (23%), Positives = 80/193 (41%), Gaps = 26/193 (13%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397
G +AVK + + E +F E + +L HP L G C E ++
Sbjct: 22 GVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81
Query: 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWL--HHGCQPPFLHQNICSNVIL 455
+Y+S+G L + L+ + L+ + G+A+L H F+H+++ + L
Sbjct: 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ-----FIHRDLAARNCL 136
Query: 456 VDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYI---APE------YSSTMVASLKG 506
VD D ++ DFG+ + + S V + APE YSS K
Sbjct: 137 VDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP----VKWSAPEVFHYFKYSS------KS 186
Query: 507 DVYGIGVVLLELA 519
DV+ G+++ E+
Sbjct: 187 DVWAFGILMWEVF 199
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 8e-18
Identities = 22/123 (17%), Positives = 40/123 (32%), Gaps = 14/123 (11%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSG---------NIPAQICNWLPYLVLLD 151
+EL ++P+ L +Q L+++ N + P + +
Sbjct: 496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDT-GPKIQIFY 554
Query: 152 LSNNDLSG-PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIP 210
+ N+L P A L L L +NK+ +L + N + IP
Sbjct: 555 MGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLEA--FGTNVKLTDLKLDYNQIE-EIP 611
Query: 211 SSF 213
F
Sbjct: 612 EDF 614
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 5e-17
Identities = 22/126 (17%), Positives = 41/126 (32%), Gaps = 13/126 (10%)
Query: 95 ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNW-LPYLVLLDLS 153
N + ++ K + +DL N L+ + LPYL +D+S
Sbjct: 706 NNLMTSIPEN---SLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVS 761
Query: 154 NNDLSGPIPADLGNCTYLNTL------ILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTG 207
N S P N + L N++ P ++ L + + +ND+
Sbjct: 762 YNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR- 819
Query: 208 TIPSSF 213
+
Sbjct: 820 KVDEKL 825
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 5e-17
Identities = 27/144 (18%), Positives = 51/144 (35%), Gaps = 17/144 (11%)
Query: 101 LELREMKLSGKIPEPLKFCK--SMQRLDLSANDLSGNIPAQICN-----WLPYLVLLDLS 153
++LR KL+ + + + + +D+S N S P Q N D
Sbjct: 733 IDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAE 790
Query: 154 NNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213
N + P + C L L + +N + + +L +L +A+N +S
Sbjct: 791 GNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSV 847
Query: 214 KGFDKA-----DFDGNSDLCGGPL 232
+ +A +D D+ G
Sbjct: 848 CPYIEAGMYVLLYDKTQDIRGCDA 871
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 1e-15
Identities = 27/184 (14%), Positives = 55/184 (29%), Gaps = 33/184 (17%)
Query: 59 KSSLNDPQRKLSSWSFGNSTIGFICQFVGVSCWNDKENRILNLELREMKLSGKIPEPLKF 118
S + +W+F N + GV D R+ L L G++P+ +
Sbjct: 289 YSGTINNTIHSLNWNF-NKELDMWGDQPGVDL--DNNGRVTGLSLAGFGAKGRVPDAIGQ 345
Query: 119 CKSMQRLDLSANDLSG------------------------NIPAQICNWLPYLVLLDLSN 154
++ L + + + ++ L L DL
Sbjct: 346 LTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQ 405
Query: 155 NDLS-----GPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTI 209
+ ++ PI D + N+++ I + L +L+ AN+ T
Sbjct: 406 DAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDN 464
Query: 210 PSSF 213
+
Sbjct: 465 IAVD 468
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 1e-15
Identities = 26/132 (19%), Positives = 44/132 (33%), Gaps = 17/132 (12%)
Query: 96 NRILNLELREMKLSGKIPEPLKF--CKSMQRLDLSANDLSGNIPAQICNWLPY-----LV 148
+++ L KL IP M +D S N + I +
Sbjct: 619 DQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINAS 676
Query: 149 LLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLS-------GPIPYQLSNLGRLKKFSVA 201
+ LS N++ + ++T+ILSNN ++ P N L +
Sbjct: 677 TVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLR 736
Query: 202 NNDLTGTIPSSF 213
N LT ++ F
Sbjct: 737 FNKLT-SLSDDF 747
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 5e-15
Identities = 24/120 (20%), Positives = 48/120 (40%), Gaps = 8/120 (6%)
Query: 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSG-NIPAQICNWLPYLVLLDLSN 154
NR ++ + + ++ + +Q + N+L A + + L LLD +
Sbjct: 525 NRGISAAQLKADWT-RLADDEDTGPKIQIFYMGYNNLEEFPASASLQK-MVKLGLLDCVH 582
Query: 155 NDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQL-SNLGRLKKFSVANNDLTGTIPSSF 213
N + + A G L L L N++ IP + +++ ++N L IP+ F
Sbjct: 583 NKVRH-LEA-FGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIF 638
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 1e-14
Identities = 18/142 (12%), Positives = 45/142 (31%), Gaps = 31/142 (21%)
Query: 99 LNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSG-------------------NIPAQ 139
+ +++ I + ++ +Q + + + + N
Sbjct: 428 TQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELS 486
Query: 140 ICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGP---------IPYQLS 190
N L L ++L N +P L + L +L ++ N+ +
Sbjct: 487 WSN-LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDED 545
Query: 191 NLGRLKKFSVANNDLTGTIPSS 212
+++ F + N+L P+S
Sbjct: 546 TGPKIQIFYMGYNNLEE-FPAS 566
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 3e-13
Identities = 25/135 (18%), Positives = 47/135 (34%), Gaps = 11/135 (8%)
Query: 103 LREMKLSG----KIPEPL-KFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDL 157
L ++KL +IPE F ++ L S N L + + +D S N +
Sbjct: 597 LTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKI 656
Query: 158 SG-----PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSS 212
D +T+ LS N++ + + ++NN +T +IP +
Sbjct: 657 GSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPEN 715
Query: 213 FKGFDKADFDGNSDL 227
++ L
Sbjct: 716 SLKPKDGNYKNTYLL 730
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 10/186 (5%)
Query: 338 GTTYKAMLPDGSVL-AVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396
G Y+ + S+ AVK L + ++F E + +++HPNL LLG C E +
Sbjct: 234 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293
Query: 397 IYKYMSSGTLYSLLQ-GNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVIL 455
I ++M+ G L L+ N E+ + + + +L F+H+N+ + L
Sbjct: 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCL 350
Query: 456 VDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGY--IAPEYSSTMVASLKGDVYGIGV 513
V E+ ++ DFGL++LM ++ +F APE + S+K DV+ GV
Sbjct: 351 VGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 407
Query: 514 VLLELA 519
+L E+A
Sbjct: 408 LLWEIA 413
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 42/192 (21%), Positives = 78/192 (40%), Gaps = 26/192 (13%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397
G + + +A+K + + E+ F E + +L HP L L G C+ + L+
Sbjct: 22 GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81
Query: 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWL--HHGCQPPFLHQNICSNVIL 455
++M G L L+ T + L G+A+L +H+++ + L
Sbjct: 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC-----VIHRDLAARNCL 136
Query: 456 VDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYI---APE------YSSTMVASLKG 506
V E+ ++ DFG+ + + +S + +PE YSS K
Sbjct: 137 VGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP----VKWASPEVFSFSRYSS------KS 186
Query: 507 DVYGIGVVLLEL 518
DV+ GV++ E+
Sbjct: 187 DVWSFGVLMWEV 198
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 20/115 (17%), Positives = 31/115 (26%), Gaps = 1/115 (0%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
LE L ++ LDL+ + I L L L+ N L
Sbjct: 38 LEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW-IHEDTFQSQHRLDTLVLTANPLIFM 96
Query: 161 IPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
L L L +S L N L+ + +N ++
Sbjct: 97 AETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 27/121 (22%), Positives = 40/121 (33%), Gaps = 3/121 (2%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
L L + E K C ++ LDL+ L L L +L+LS++ L
Sbjct: 381 LNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDIS 440
Query: 161 IPADLGNCTYLNTLILSNNKLSGPI---PYQLSNLGRLKKFSVANNDLTGTIPSSFKGFD 217
L L L N L LGRL+ ++ DL+ +F
Sbjct: 441 SEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLK 500
Query: 218 K 218
Sbjct: 501 M 501
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-16
Identities = 27/127 (21%), Positives = 42/127 (33%), Gaps = 6/127 (4%)
Query: 89 SCWNDKENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLV 148
C + N+ N + L+ +IP L S + L+ S N L L L
Sbjct: 7 KCIEKEVNKTYNC--ENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSR-LINLT 60
Query: 149 LLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGT 208
LDL+ + + L+TL+L+ N L LS LK ++
Sbjct: 61 FLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSI 120
Query: 209 IPSSFKG 215
Sbjct: 121 DFIPLHN 127
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 25/124 (20%), Positives = 43/124 (34%), Gaps = 4/124 (3%)
Query: 92 NDKENRILNLELREMKLSGKIPEPLKFCK--SMQRLDLSANDLSGNIPAQICNWLPYLVL 149
N + +M P + S++ ++L + I + + L
Sbjct: 224 NSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFN-ISSNTFHCFSGLQE 282
Query: 150 LDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTI 209
LDL+ LS +P+ L + L L+LS NK SN L S+ N +
Sbjct: 283 LDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLEL 341
Query: 210 PSSF 213
+
Sbjct: 342 GTGC 345
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-15
Identities = 25/115 (21%), Positives = 38/115 (33%), Gaps = 2/115 (1%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDL--S 158
L L K S+ L + N + L L LDLS++D+ S
Sbjct: 306 LVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETS 365
Query: 159 GPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213
L N ++L +L LS N+ +L+ +A L S
Sbjct: 366 DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSP 420
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-14
Identities = 29/139 (20%), Positives = 46/139 (33%), Gaps = 5/139 (3%)
Query: 107 KLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLG 166
L L K+++ L +S I + L L L +N +S
Sbjct: 92 PLIFMAETALSGPKALKHLFFIQTGISS-IDFIPLHNQKTLESLYLGSNHISSIKLPKGF 150
Query: 167 NCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSV--ANNDLTGTIPSSFKG--FDKADFD 222
L L NN + +S+L + S+ ND+ G P +F F +F
Sbjct: 151 PTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFG 210
Query: 223 GNSDLCGGPLGSKCGGLSK 241
G +L G K +
Sbjct: 211 GTQNLLVIFKGLKNSTIQS 229
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 27/118 (22%), Positives = 47/118 (39%), Gaps = 3/118 (2%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQI--CNWLPYLVLLDLSNNDLS 158
L L L + ++Q L+L N + L L +L LS DLS
Sbjct: 430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489
Query: 159 GPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF 216
+ +N + LS+N+L+ LS+L + ++A+N ++ +PS
Sbjct: 490 SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPIL 546
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 30/136 (22%), Positives = 54/136 (39%), Gaps = 17/136 (12%)
Query: 96 NRILNLE---------LREMKLSG----KIPEPLKFCKSMQRLDLSANDLSGNIPAQICN 142
+ N+ L+E+ L+ ++P L ++++L LSAN + +
Sbjct: 264 HYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFEN-LCQISAS 322
Query: 143 WLPYLVLLDLSNNDLSGPIPAD-LGNCTYLNTLILSNNKL--SGPIPYQLSNLGRLKKFS 199
P L L + N + L N L L LS++ + S QL NL L+ +
Sbjct: 323 NFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLN 382
Query: 200 VANNDLTGTIPSSFKG 215
++ N+ +FK
Sbjct: 383 LSYNEPLSLKTEAFKE 398
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 8e-14
Identities = 23/124 (18%), Positives = 39/124 (31%), Gaps = 6/124 (4%)
Query: 97 RILNLELREMKLSGKIPEPLKFCK--SMQRLDLSANDLSGNIPAQICNWLPYLVL--LDL 152
+L + I + LK S+ D +I + L + + ++L
Sbjct: 203 VFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE-DISPAVFEGLCEMSVESINL 261
Query: 153 SNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSS 212
+ + L L L+ LS +P L L LKK ++ N S
Sbjct: 262 QKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQIS 320
Query: 213 FKGF 216
F
Sbjct: 321 ASNF 324
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 9e-13
Identities = 28/114 (24%), Positives = 48/114 (42%), Gaps = 10/114 (8%)
Query: 103 LREMKLSG--------KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSN 154
L+ + L G + L+ ++ L LS DLS I L + +DLS+
Sbjct: 451 LQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS-IDQHAFTSLKMMNHVDLSH 509
Query: 155 NDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGT 208
N L+ L + + L L++N +S +P L L + + ++ N L T
Sbjct: 510 NRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 8e-12
Identities = 20/125 (16%), Positives = 37/125 (29%), Gaps = 5/125 (4%)
Query: 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICN-WLPYLVLLDLSNN 155
L+L L ++G I Q L+ I + N + L L +
Sbjct: 180 TNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
Query: 156 DLSGPIPADLGNCTYLN--TLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213
D PA ++ ++ L + L++ + L+ +PS
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGL 297
Query: 214 KGFDK 218
G
Sbjct: 298 VGLST 302
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 22/120 (18%), Positives = 41/120 (34%), Gaps = 6/120 (5%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVL--LDLSNNDLS 158
L L +S + ++ LD N + + + L L+L+ ND++
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSS-LQQATNLSLNLNGNDIA 192
Query: 159 GPIPADLGNCTYLNTLILSNNKLSGPIPYQLSN--LGRLKKFSVANNDLTGTIPSSFKGF 216
G I + +L + I L N + L + + D P+ F+G
Sbjct: 193 G-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 22/83 (26%), Positives = 36/83 (43%), Gaps = 2/83 (2%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
L L LS K M +DLS N L+ + + + L + L +L++N +S
Sbjct: 481 LVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSH-LKGIYL-NLASNHISII 538
Query: 161 IPADLGNCTYLNTLILSNNKLSG 183
+P+ L + T+ L N L
Sbjct: 539 LPSLLPILSQQRTINLRQNPLDC 561
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 5e-17
Identities = 38/189 (20%), Positives = 73/189 (38%), Gaps = 14/189 (7%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397
G +A+K + + E +F E + L H L L G C + +I
Sbjct: 38 GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97
Query: 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWL--HHGCQPPFLHQNICSNVIL 455
+YM++G L + L+ + + +L FLH+++ + L
Sbjct: 98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ-----FLHRDLAARNCL 152
Query: 456 VDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYI---APEYSSTMVASLKGDVYGIG 512
V++ ++ DFGL++ + + +S V + PE S K D++ G
Sbjct: 153 VNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP----VRWSPPEVLMYSKFSSKSDIWAFG 208
Query: 513 VVLLELAGF 521
V++ E+
Sbjct: 209 VLMWEIYSL 217
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 46/185 (24%), Positives = 85/185 (45%), Gaps = 6/185 (3%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397
G + + +A+K L + + F E + +LRH L L EE ++
Sbjct: 281 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 339
Query: 398 YKYMSSGTLYSLLQGN-ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV 456
+YMS G+L L+G L P + A G+A++ ++H+++ + ILV
Sbjct: 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILV 396
Query: 457 DEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLL 516
E+ ++ DFGLA+L+ ++ ++ + APE + ++K DV+ G++L
Sbjct: 397 GENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLT 455
Query: 517 ELAGF 521
EL
Sbjct: 456 ELTTK 460
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 46/185 (24%), Positives = 85/185 (45%), Gaps = 6/185 (3%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397
G + + +A+K L + + F E + +LRH L L EE ++
Sbjct: 198 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 256
Query: 398 YKYMSSGTLYSLLQGN-ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV 456
+YMS G+L L+G L P + A G+A++ ++H+++ + ILV
Sbjct: 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILV 313
Query: 457 DEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLL 516
E+ ++ DFGLA+L+ ++ ++ + APE + ++K DV+ G++L
Sbjct: 314 GENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLT 372
Query: 517 ELAGF 521
EL
Sbjct: 373 ELTTK 377
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 47/197 (23%), Positives = 76/197 (38%), Gaps = 24/197 (12%)
Query: 338 GTTYKAMLPDGS----VLAVKRLNTCKLG-----EKKFRNEMNRLGQLRHPNLAPLLGYC 388
G Y D + A+K + + F E + L HPN+ L+G
Sbjct: 35 GVVYHGEYIDQAQNRIQCAIK---SLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIM 91
Query: 389 VVEEE-KLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWL--HHGCQPPFL 445
+ E ++ YM G L ++ GL ARG+ +L F+
Sbjct: 92 LPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK-----FV 146
Query: 446 HQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEF--GYIAPEYSSTMVA 502
H+++ N ++DE F ++ DFGLA+ + + S + A E T
Sbjct: 147 HRDLAARN-CMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRF 205
Query: 503 SLKGDVYGIGVVLLELA 519
+ K DV+ GV+L EL
Sbjct: 206 TTKSDVWSFGVLLWELL 222
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 53/197 (26%), Positives = 82/197 (41%), Gaps = 24/197 (12%)
Query: 338 GTTYKAML--PDGSVL--AVKRLNTCKLG-----EKKFRNEMNRLGQLRHPNLAPLLGYC 388
G Y L DG + AVK + +F E + HPN+ LLG C
Sbjct: 103 GCVYHGTLLDNDGKKIHCAVK---SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 159
Query: 389 VVEEEKLL-IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWL--HHGCQPPFL 445
+ E L + YM G L + ++ GL A+G+ +L F+
Sbjct: 160 LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK-----FV 214
Query: 446 HQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEF--GYIAPEYSSTMVA 502
H+++ N ++DE F ++ DFGLA+ M + S N + ++A E T
Sbjct: 215 HRDLAARN-CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 273
Query: 503 SLKGDVYGIGVVLLELA 519
+ K DV+ GV+L EL
Sbjct: 274 TTKSDVWSFGVLLWELM 290
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 50/194 (25%), Positives = 88/194 (45%), Gaps = 26/194 (13%)
Query: 338 GTTYKAMLPDGSVL-AVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396
G Y+ + S+ AVK L + ++F E + +++HPNL LLG C E +
Sbjct: 27 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86
Query: 397 IYKYMSSGTLYSLLQ-GNATELDWPTRFRIGLGAARGLAWL--HHGCQPPFLHQNICSNV 453
I ++M+ G L L+ N E+ + + + +L + F+H+++ +
Sbjct: 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-----FIHRDLAARN 141
Query: 454 ILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGY--IAPE------YSSTMVASLK 505
LV E+ ++ DFGL++LM ++ +F APE +S K
Sbjct: 142 CLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKFSI------K 192
Query: 506 GDVYGIGVVLLELA 519
DV+ GV+L E+A
Sbjct: 193 SDVWAFGVLLWEIA 206
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 42/185 (22%), Positives = 83/185 (44%), Gaps = 36/185 (19%)
Query: 352 AVKRLNTCKLG-----EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTL 406
A+K K G + F +E + +GQ HPN+ L G +++ +YM +G+L
Sbjct: 81 AIK---ALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL 137
Query: 407 YSLLQGNATELDWPTRFRIGLGAARGLAWL--HHGCQPPFLHQNICSNVILVDEDFDARI 464
+ L+ + + + G G+ +L ++H+++ + +LVD + ++
Sbjct: 138 DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG-----YVHRDLAARNVLVDSNLVCKV 192
Query: 465 MDFGLAKLMTSSDESSFVNGDLGEFGYI-----APE------YSSTMVASLKGDVYGIGV 513
DFGL++++ ++++ G I APE +SS DV+ GV
Sbjct: 193 SDFGLSRVLEDDPDAAYTTTG----GKIPIRWTAPEAIAFRTFSS------ASDVWSFGV 242
Query: 514 VLLEL 518
V+ E+
Sbjct: 243 VMWEV 247
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 53/197 (26%), Positives = 82/197 (41%), Gaps = 24/197 (12%)
Query: 338 GTTYKAML--PDGSVL--AVKRLNTCKLG-----EKKFRNEMNRLGQLRHPNLAPLLGYC 388
G Y L DG + AVK + +F E + HPN+ LLG C
Sbjct: 39 GCVYHGTLLDNDGKKIHCAVK---SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 95
Query: 389 VVEEEKLL-IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWL--HHGCQPPFL 445
+ E L + YM G L + ++ GL A+G+ +L F+
Sbjct: 96 LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-----FV 150
Query: 446 HQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEF--GYIAPEYSSTMVA 502
H+++ N ++DE F ++ DFGLA+ M + S N + ++A E T
Sbjct: 151 HRDLAARN-CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 209
Query: 503 SLKGDVYGIGVVLLELA 519
+ K DV+ GV+L EL
Sbjct: 210 TTKSDVWSFGVLLWELM 226
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 40/172 (23%), Positives = 75/172 (43%), Gaps = 12/172 (6%)
Query: 352 AVKRL--NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSL 409
A+K L T K+ +E + + +P++ LLG C + LI + M G L
Sbjct: 48 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDY 106
Query: 410 LQGNATELDWPTRFRIGLGAARGLAWL--HHGCQPPFLHQNI-CSNVILVDEDFDARIMD 466
++ + + + A+G+ +L +H+++ N +LV +I D
Sbjct: 107 VREHKDNIGSQYLLNWCVQIAKGMNYLEDRR-----LVHRDLAARN-VLVKTPQHVKITD 160
Query: 467 FGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
FGLAKL+ + ++ G ++A E + + + DV+ GV + EL
Sbjct: 161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 212
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 44/185 (23%), Positives = 89/185 (48%), Gaps = 10/185 (5%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397
G + A + +AVK + + + F E N + L+H L L V +E +I
Sbjct: 202 GEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA-VVTKEPIYII 260
Query: 398 YKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV 456
++M+ G+L L+ + ++ P A G+A++ Q ++H+++ + ILV
Sbjct: 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILV 317
Query: 457 DEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGY--IAPEYSSTMVASLKGDVYGIGVV 514
+I DFGLA+++ +++ + + +F APE + ++K DV+ G++
Sbjct: 318 SASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGIL 374
Query: 515 LLELA 519
L+E+
Sbjct: 375 LMEIV 379
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 6e-15
Identities = 48/195 (24%), Positives = 82/195 (42%), Gaps = 21/195 (10%)
Query: 338 GTTYKAML--PDGSVL--AVKRLNTCKLG-----EKKFRNEMNRLGQLRHPNLAPLLGYC 388
G ++ + P+ + A+K TCK +KF E + Q HP++ L+G
Sbjct: 404 GDVHQGIYMSPENPAMAVAIK---TCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 460
Query: 389 VVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWL--HHGCQPPFLH 446
E +I + + G L S LQ LD + + LA+L F+H
Sbjct: 461 -TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR-----FVH 514
Query: 447 QNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKG 506
++I + +LV + ++ DFGL++ M S G L ++APE + +
Sbjct: 515 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSAS 573
Query: 507 DVYGIGVVLLELAGF 521
DV+ GV + E+
Sbjct: 574 DVWMFGVCMWEILMH 588
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 6e-15
Identities = 51/202 (25%), Positives = 85/202 (42%), Gaps = 35/202 (17%)
Query: 338 GTTYKAML--PDGSVL--AVKRLNTCKLG-----EKKFRNEMNRLGQLRHPNLAPLLGYC 388
G ++ + P+ L A+K TCK +KF E + Q HP++ L+G
Sbjct: 29 GDVHQGIYMSPENPALAVAIK---TCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG-- 83
Query: 389 VVEEEKLLI-YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWL--HHGCQPPFL 445
V+ E + I + + G L S LQ LD + + LA+L F+
Sbjct: 84 VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR-----FV 138
Query: 446 HQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPE------YSST 499
H++I + +LV + ++ DFGL++ M S G L ++APE ++S
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTS- 196
Query: 500 MVASLKGDVYGIGVVLLELAGF 521
DV+ GV + E+
Sbjct: 197 -----ASDVWMFGVCMWEILMH 213
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 25/140 (17%), Positives = 57/140 (40%), Gaps = 22/140 (15%)
Query: 352 AVKRLNTCKLG----EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLY 407
+K + F + + +L H +L G CV +E +L+ +++ G+L
Sbjct: 44 LLK---VLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLD 100
Query: 408 SLLQGNATELDWPTRFRIGLGAARGLAWL--HHGCQPPFLHQNICSNVILVDEDFDAR-- 463
+ L+ N ++ + + A + +L + +H N+C+ IL+ + D +
Sbjct: 101 TYLKKNKNCINILWKLEVAKQLAAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTG 155
Query: 464 ------IMDFGLAKLMTSSD 477
+ D G++ + D
Sbjct: 156 NPPFIKLSDPGISITVLPKD 175
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 45/186 (24%), Positives = 82/186 (44%), Gaps = 38/186 (20%)
Query: 352 AVKRLNTCKLG-----EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTL 406
A+K T K G F E +GQ H N+ L G + ++I +YM +G L
Sbjct: 77 AIK---TLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL 133
Query: 407 YSLLQGNATELDWPTRFRIGLGAARGLAWL--HHGCQPPFLHQNICSNVILVDEDFDARI 464
L+ E + G A G+ +L + ++H+++ + ILV+ + ++
Sbjct: 134 DKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN-----YVHRDLAARNILVNSNLVCKV 188
Query: 465 MDFGLAKLMTSSDESSFV-NGDLGEFGYI-----APE------YSSTMVASLKGDVYGIG 512
DFGL++++ E+++ +G G I APE ++S DV+ G
Sbjct: 189 SDFGLSRVLEDDPEATYTTSG-----GKIPIRWTAPEAISYRKFTS------ASDVWSFG 237
Query: 513 VVLLEL 518
+V+ E+
Sbjct: 238 IVMWEV 243
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 37/175 (21%), Positives = 74/175 (42%), Gaps = 12/175 (6%)
Query: 352 AVKRL--NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSL 409
+K + + + + + M +G L H ++ LLG L+ +Y+ G+L
Sbjct: 46 CIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDH 104
Query: 410 LQGNATELDWPTRFRIGLGAARGLAWL--HHGCQPPFLHQNI-CSNVILVDEDFDARIMD 466
++ + L G+ A+G+ +L H +H+N+ N +L+ ++ D
Sbjct: 105 VRQHRGALGPQLLLNWGVQIAKGMYYLEEHG-----MVHRNLAARN-VLLKSPSQVQVAD 158
Query: 467 FGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGF 521
FG+A L+ D+ + ++A E + + DV+ GV + EL F
Sbjct: 159 FGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTF 213
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 46/185 (24%), Positives = 88/185 (47%), Gaps = 10/185 (5%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397
G + + +AVK L + F E N + QL+H L L V +E +I
Sbjct: 27 GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYII 85
Query: 398 YKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV 456
+YM +G+L L+ + +L + A G+A++ + ++H+++ + ILV
Sbjct: 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILV 142
Query: 457 DEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGY--IAPEYSSTMVASLKGDVYGIGVV 514
+ +I DFGLA+L+ +++ + + +F APE + ++K DV+ G++
Sbjct: 143 SDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199
Query: 515 LLELA 519
L E+
Sbjct: 200 LTEIV 204
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 40/172 (23%), Positives = 75/172 (43%), Gaps = 12/172 (6%)
Query: 352 AVKRL--NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSL 409
A+K L T K+ +E + + +P++ LLG C + LI + M G L
Sbjct: 48 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDY 106
Query: 410 LQGNATELDWPTRFRIGLGAARGLAWL--HHGCQPPFLHQNI-CSNVILVDEDFDARIMD 466
++ + + + A+G+ +L +H+++ N +LV +I D
Sbjct: 107 VREHKDNIGSQYLLNWCVQIAKGMNYLEDRR-----LVHRDLAARN-VLVKTPQHVKITD 160
Query: 467 FGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
FGLAKL+ + ++ G ++A E + + + DV+ GV + EL
Sbjct: 161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 212
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 45/197 (22%), Positives = 87/197 (44%), Gaps = 30/197 (15%)
Query: 338 GTTYKAML--PDGSVL-AVKRL--NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE 392
G+ + + + A+K L T K ++ E + QL +P + L+G V +
Sbjct: 24 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG--VCQA 81
Query: 393 EKLLI-YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWL--HHGCQPPFLHQNI 449
E L++ + G L+ L G E+ + + G+ +L + F+H+++
Sbjct: 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN-----FVHRDL 136
Query: 450 CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEF--GYIAPE------YSSTMV 501
+ +L+ A+I DFGL+K + +D+S + G++ + APE +SS
Sbjct: 137 AARNVLLVNRHYAKISDFGLSKAL-GADDSYYTARSAGKWPLKWYAPECINFRKFSS--- 192
Query: 502 ASLKGDVYGIGVVLLEL 518
+ DV+ GV + E
Sbjct: 193 ---RSDVWSYGVTMWEA 206
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 52/188 (27%), Positives = 83/188 (44%), Gaps = 20/188 (10%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLG--EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395
G V AVK K + F E + + QLRH NL LLG V E+ L
Sbjct: 207 GDVMLGDYRGNKV-AVK---CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 262
Query: 396 -LIYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNV 453
++ +YM+ G+L L+ + L + L + +L F+H+++ +
Sbjct: 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARN 319
Query: 454 ILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGY--IAPEYSSTMVASLKGDVYGI 511
+LV ED A++ DFGL K +S+ ++ G+ APE S K DV+
Sbjct: 320 VLVSEDNVAKVSDFGLTKEASSTQDT-------GKLPVKWTAPEALREKKFSTKSDVWSF 372
Query: 512 GVVLLELA 519
G++L E+
Sbjct: 373 GILLWEIY 380
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 3e-14
Identities = 54/198 (27%), Positives = 87/198 (43%), Gaps = 36/198 (18%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLG--EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395
G V AVK K + F E + + QLRH NL LLG V E+ L
Sbjct: 35 GDVMLGDYRGNKV-AVK---CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 90
Query: 396 LI-YKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWL--HHGCQPPFLHQNICS 451
I +YM+ G+L L+ + L + L + +L ++ F+H+++ +
Sbjct: 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN-----FVHRDLAA 145
Query: 452 NVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGY--IAPE------YSSTMVAS 503
+LV ED A++ DFGL K +S+ ++ G+ APE +S+
Sbjct: 146 RNVLVSEDNVAKVSDFGLTKEASSTQDT-------GKLPVKWTAPEALREKKFST----- 193
Query: 504 LKGDVYGIGVVLLELAGF 521
K DV+ G++L E+ F
Sbjct: 194 -KSDVWSFGILLWEIYSF 210
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 43/195 (22%), Positives = 73/195 (37%), Gaps = 27/195 (13%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEK---KFRNEMNRLGQL-RHPNLAPLLGYCVVEE 392
G +K DG + AVKR + G K + E+ ++ +HP L E
Sbjct: 71 GEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ-AWEEG 129
Query: 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLH-HGCQPPFLHQNI-C 450
L + + +L + L + LA LH G +H ++
Sbjct: 130 GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG----LVHLDVKP 185
Query: 451 SNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPE-----YSSTMVASLK 505
+N I + ++ DFGL + ++ GD Y+APE Y +
Sbjct: 186 AN-IFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDP---RYMAPELLQGSYGT------A 235
Query: 506 GDVYGIGVVLLELAG 520
DV+ +G+ +LE+A
Sbjct: 236 ADVFSLGLTILEVAC 250
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 50/278 (17%), Positives = 93/278 (33%), Gaps = 45/278 (16%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKL-GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK- 394
L DG A+KR+ + ++ + E + HPN+ L+ YC+ E
Sbjct: 43 SYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102
Query: 395 ---LLIYKYMSSGTLYSLLQ---GNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLH-- 446
L+ + GTL++ ++ L + LG RGL +H + H
Sbjct: 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRD 159
Query: 447 ---QNICSNVILVDEDFDARIMDFGLAKL----MTSSDESSFVNGDLGEFG---YIAPE- 495
NI L+ ++ +MD G + S ++ + + Y APE
Sbjct: 160 LKPTNI-----LLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPEL 214
Query: 496 --YSSTMVASLKGDVYGIGVVLLELAGFK-----GNLVDWVNQLSSSGRSKEAIDKALCG 548
S V + DV+ +G VL + + L+ +
Sbjct: 215 FSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPR--- 271
Query: 549 KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586
+ + Q L + + P R + + L ++
Sbjct: 272 --HSSALWQLLN---SMMTVDPHQRPHIPLLLSQLEAL 304
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 43/185 (23%), Positives = 85/185 (45%), Gaps = 36/185 (19%)
Query: 352 AVKRLNTCKLG-----EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTL 406
A+K T K+G + F E + +GQ HPN+ L G + +++ +YM +G+L
Sbjct: 77 AIK---TLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 407 YSLLQGNATELDWPTRFRIGLGAARGLAWL--HHGCQPPFLHQNICSNVILVDEDFDARI 464
S L+ + + + G A G+ +L ++H+++ + IL++ + ++
Sbjct: 134 DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG-----YVHRDLAARNILINSNLVCKV 188
Query: 465 MDFGLAKLMTSSDESSFVNGDLGEFGYI-----APE------YSSTMVASLKGDVYGIGV 513
DFGL +++ E+++ G I +PE ++S DV+ G+
Sbjct: 189 SDFGLGRVLEDDPEAAYT----TRGGKIPIRWTSPEAIAYRKFTS------ASDVWSYGI 238
Query: 514 VLLEL 518
VL E+
Sbjct: 239 VLWEV 243
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 44/186 (23%), Positives = 79/186 (42%), Gaps = 11/186 (5%)
Query: 340 TYKAMLPDGSVL-AVKRL--NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK-- 394
Y + AVK L + + E+ L L H N+ G C +
Sbjct: 41 RYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100
Query: 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVI 454
LI +++ SG+L L N +++ + + + +G+ +L ++H+++ + +
Sbjct: 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNV 157
Query: 455 LVDEDFDARIMDFGLAKLMTSSDE--SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIG 512
LV+ + +I DFGL K + + E + + D F Y APE + DV+ G
Sbjct: 158 LVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY-APECLMQSKFYIASDVWSFG 216
Query: 513 VVLLEL 518
V L EL
Sbjct: 217 VTLHEL 222
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 6e-14
Identities = 26/133 (19%), Positives = 48/133 (36%), Gaps = 20/133 (15%)
Query: 96 NRILNLE---------LREMKLSG----KIPEPLKF--CKSMQRLDLSANDLSGNIPAQI 140
N+I L ++ + L + +++ L+L N + ++ Q+
Sbjct: 130 NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV 188
Query: 141 CNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSV 200
L LDLS+N L+ + + + + + L NNKL I L L+ F +
Sbjct: 189 V--FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDL 244
Query: 201 ANNDLTGTIPSSF 213
N F
Sbjct: 245 RGNGFHCGTLRDF 257
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 33/120 (27%), Positives = 54/120 (45%), Gaps = 8/120 (6%)
Query: 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNN 155
NR ++ + L + + +++ LDLS N LS I A L LL+LS+N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKLELLNLSSN 68
Query: 156 DLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
L DL + + L TL L+NN + +L ++ ANN+++ S +G
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQG 121
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 20/126 (15%), Positives = 45/126 (35%), Gaps = 15/126 (11%)
Query: 96 NRILNLE-------LREMKLSG-KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYL 147
N + LR + L+ + E L S++ L + N++S +
Sbjct: 68 NVLYETLDLESLSTLRTLDLNNNYVQE-LLVGPSIETLHAANNNIS-RVSCSR---GQGK 122
Query: 148 VLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSG-PIPYQLSNLGRLKKFSVANNDLT 206
+ L+NN ++ D G + + L L N++ ++ L+ ++ N +
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
Query: 207 GTIPSS 212
+
Sbjct: 183 -DVKGQ 187
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 24/132 (18%), Positives = 47/132 (35%), Gaps = 21/132 (15%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSAN-----------------DLSGNIPAQICNW 143
L+L LS L ++ L+LS+N DL+ N ++
Sbjct: 39 LDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLV- 97
Query: 144 LPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANN 203
P + L +NN++S + G + L+NNK++ R++ + N
Sbjct: 98 GPSIETLHAANNNISR-VSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLN 154
Query: 204 DLTGTIPSSFKG 215
++ +
Sbjct: 155 EIDTVNFAELAA 166
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 11/68 (16%), Positives = 27/68 (39%), Gaps = 1/68 (1%)
Query: 144 LPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANN 203
+ ++++ L + + + + L LS N LS L+ +L+ ++++N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 204 DLTGTIPS 211
L
Sbjct: 69 VLY-ETLD 75
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 7e-14
Identities = 45/190 (23%), Positives = 84/190 (44%), Gaps = 16/190 (8%)
Query: 338 GTTYKAML--PDGSVL-AVKRL--NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE 392
G+ + + + A+K L T K ++ E + QL +P + L+G C E
Sbjct: 350 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AE 408
Query: 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWL--HHGCQPPFLHQNIC 450
+L+ + G L+ L G E+ + + G+ +L + F+H+N+
Sbjct: 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN-----FVHRNLA 463
Query: 451 SNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGY--IAPEYSSTMVASLKGDV 508
+ +L+ A+I DFGL+K + +D+S + G++ APE + S + DV
Sbjct: 464 ARNVLLVNRHYAKISDFGLSKAL-GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDV 522
Query: 509 YGIGVVLLEL 518
+ GV + E
Sbjct: 523 WSYGVTMWEA 532
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 47/174 (27%), Positives = 75/174 (43%), Gaps = 29/174 (16%)
Query: 364 KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL--LIYKYMSSGTLYSLLQGNATELDWPT 421
K+F E++ QL H N+ + V EE+ L+ +Y+ TL ++ + L T
Sbjct: 56 KRFEREVHNSSQLSHQNIVSM--IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-LSVDT 112
Query: 422 RFRIGLGAARGLAWLH-HGCQPPFLH-----QNICSNVILVDEDFDARIMDFGLAKLMTS 475
G+ H +H QNI L+D + +I DFG+AK ++
Sbjct: 113 AINFTNQILDGIKHAHDMR----IVHRDIKPQNI-----LIDSNKTLKIFDFGIAKALSE 163
Query: 476 SD--ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLE-LAG---FKG 523
+ +++ V LG Y +PE + D+Y IG+VL E L G F G
Sbjct: 164 TSLTQTNHV---LGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG 214
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 27/133 (20%), Positives = 49/133 (36%), Gaps = 17/133 (12%)
Query: 96 NRILNLE-------LREMKLSG-KI--PEPLKFCKSMQRLDLSANDLSGNIPAQICNWLP 145
N+I ++ L +I P+ + L + N ++ P + N L
Sbjct: 187 NQIEDISPLASLTSLHYFTAYVNQITDITPVANMTRLNSLKIGNNKITDLSP--LAN-LS 243
Query: 146 YLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDL 205
L L++ N +S + + T L L + +N++S L+NL +L + NN L
Sbjct: 244 QLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQL 299
Query: 206 TGTIPSSFKGFDK 218
G
Sbjct: 300 GNEDMEVIGGLTN 312
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 6e-13
Identities = 27/127 (21%), Positives = 49/127 (38%), Gaps = 18/127 (14%)
Query: 95 ENRILNLE-------LREMKLSG----KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNW 143
E+ I ++ + + L PL + L ++ + + P I N
Sbjct: 119 EDNISDISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IAN- 175
Query: 144 LPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANN 203
L L L L+ N + P L + T L+ N+++ P ++N+ RL + NN
Sbjct: 176 LTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNN 231
Query: 204 DLTGTIP 210
+T P
Sbjct: 232 KITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 1e-12
Identities = 30/125 (24%), Positives = 55/125 (44%), Gaps = 15/125 (12%)
Query: 96 NRILNLE-------LREMKLSG---KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLP 145
N+I ++ L +K+ PL + L++ N +S +I A + + L
Sbjct: 209 NQITDITPVANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQIS-DINA-VKD-LT 265
Query: 146 YLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDL 205
L +L++ +N +S L N + LN+L L+NN+L + L L ++ N +
Sbjct: 266 KLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHI 323
Query: 206 TGTIP 210
T P
Sbjct: 324 TDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 1e-12
Identities = 31/122 (25%), Positives = 55/122 (45%), Gaps = 15/122 (12%)
Query: 95 ENRILNLE-------LREMKLSG-KI--PEPLKFCKSMQRLDLSANDLSGNIPAQICNWL 144
N+I +L L +++ +I +K ++ L++ +N +S +I + N L
Sbjct: 230 NNKITDLSPLANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSNQIS-DISV-LNN-L 286
Query: 145 PYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANND 204
L L L+NN L +G T L TL LS N ++ P L++L ++ AN
Sbjct: 287 SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQV 344
Query: 205 LT 206
+
Sbjct: 345 IK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 9e-12
Identities = 27/125 (21%), Positives = 52/125 (41%), Gaps = 16/125 (12%)
Query: 96 NRILNLE-------LREMKLSG---KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLP 145
N+I ++ L + + L+ +++ L L+ +++S P + N L
Sbjct: 76 NQITDISPLSNLVKLTNLYIGTNKITDISALQNLTNLRELYLNEDNISDISP--LAN-LT 132
Query: 146 YLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDL 205
+ L+L N + L N T LN L ++ +K+ P ++NL L S+ N +
Sbjct: 133 KMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQI 189
Query: 206 TGTIP 210
P
Sbjct: 190 EDISP 194
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 23/111 (20%), Positives = 50/111 (45%), Gaps = 9/111 (8%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
L + K++ + +++ +++ L+L+ N ++ P + N L L L + N ++
Sbjct: 49 LVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITDISP--LSN-LVKLTNLYIGTNKITDI 103
Query: 161 IPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPS 211
L N T L L L+ + +S P L+NL ++ ++ N +
Sbjct: 104 SA--LQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP 150
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 6e-11
Identities = 22/113 (19%), Positives = 50/113 (44%), Gaps = 9/113 (7%)
Query: 98 ILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDL 157
+ L++ ++ + +S+ +L ++ ++ +I I L L L+L+ N +
Sbjct: 24 GIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA-SIQG-IEY-LTNLEYLNLNGNQI 78
Query: 158 SGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIP 210
+ P L N L L + NK++ L NL L++ + ++++ P
Sbjct: 79 TDISP--LSNLVKLTNLYIGTNKITDISA--LQNLTNLRELYLNEDNISDISP 127
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 60.6 bits (148), Expect = 5e-10
Identities = 20/102 (19%), Positives = 38/102 (37%), Gaps = 9/102 (8%)
Query: 114 EPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNT 173
P R L ++ + L + L ++ ++ I + T L
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVT---QEELESITKLVVAGEKVAS-IQG-IEYLTNLEY 70
Query: 174 LILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
L L+ N+++ P LSNL +L + N + T S+ +
Sbjct: 71 LNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQN 108
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 23/119 (19%), Positives = 44/119 (36%), Gaps = 11/119 (9%)
Query: 103 LREMKLSG----KIPEP--LKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNND 156
++ + L + +++ L+L N + ++ Q+ L LDLS+N
Sbjct: 146 VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV--FAKLKTLDLSSNK 202
Query: 157 LSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
L+ + + + + + L NNKL I L L+ F + N F
Sbjct: 203 LAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 31/120 (25%), Positives = 54/120 (45%), Gaps = 8/120 (6%)
Query: 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNN 155
NR ++ + L + + +++ LDLS N LS A + L LL+LS+N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAP-FTKLELLNLSSN 68
Query: 156 DLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
L + L + + L TL L+NN + +L ++ ANN+++ S +G
Sbjct: 69 VLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQG 121
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 20/126 (15%), Positives = 45/126 (35%), Gaps = 15/126 (11%)
Query: 96 NRILNLE-------LREMKLSG-KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYL 147
N + LR + L+ + E L S++ L + N++S +
Sbjct: 68 NVLYETLDLESLSTLRTLDLNNNYVQE-LLVGPSIETLHAANNNIS-RVSCSR---GQGK 122
Query: 148 VLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSG-PIPYQLSNLGRLKKFSVANNDLT 206
+ L+NN ++ D G + + L L N++ ++ L+ ++ N +
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
Query: 207 GTIPSS 212
+
Sbjct: 183 -DVKGQ 187
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 20/117 (17%), Positives = 44/117 (37%), Gaps = 12/117 (10%)
Query: 102 ELREMKLSG---KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLS 158
+L + LS L+ +++ LDL+ N + + P + L +NN++S
Sbjct: 59 KLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-ELLV-----GPSIETLHAANNNIS 112
Query: 159 GPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
+ G + L+NNK++ R++ + N++ +
Sbjct: 113 R-VSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAA 166
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 12/67 (17%), Positives = 29/67 (43%)
Query: 144 LPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANN 203
+ ++++ L + + + + L LS N LS L+ +L+ ++++N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 204 DLTGTIP 210
L T+
Sbjct: 69 VLYETLD 75
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 15/131 (11%), Positives = 35/131 (26%), Gaps = 14/131 (10%)
Query: 96 NRILNLE--------LREMKLSG----KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNW 143
N++ + + + L I + L+F ++++ DL N +
Sbjct: 201 NKLAFMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDF--F 258
Query: 144 LPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANN 203
+ ++ + + CT L LK+ A
Sbjct: 259 SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALL 318
Query: 204 DLTGTIPSSFK 214
G+ +
Sbjct: 319 SGQGSETERLE 329
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 12/128 (9%), Positives = 31/128 (24%), Gaps = 7/128 (5%)
Query: 91 WNDKENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLL 150
+ K R+ + + + + + C A ++PA + L L
Sbjct: 257 FFSKNQRVQTVAKQ--TVKKLTGQNEEECTVPTLGHYGAYCCE-DLPAPFADRLIALKRK 313
Query: 151 DLSNNDLSG----PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLT 206
+ + G + + N + + I L
Sbjct: 314 EHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALD 373
Query: 207 GTIPSSFK 214
+ + +
Sbjct: 374 EQVSNGRR 381
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 47/176 (26%), Positives = 75/176 (42%), Gaps = 17/176 (9%)
Query: 352 AVKRLNTCKLG----EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK--LLIYKYMSSGT 405
AVK + ++ F+ E+ L L + G + L+ +Y+ SG
Sbjct: 56 AVK---QLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGC 112
Query: 406 LYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNI-CSNVILVDEDFDARI 464
L LQ + LD +G+ +L +H+++ N ILV+ + +I
Sbjct: 113 LRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARN-ILVESEAHVKI 168
Query: 465 MDFGLAKLMTSSDESSFVNGDLGEF--GYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
DFGLAKL+ + V G+ + APE S + S + DV+ GVVL EL
Sbjct: 169 ADFGLAKLLPLDKDYYVVREP-GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 223
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 47/199 (23%), Positives = 81/199 (40%), Gaps = 35/199 (17%)
Query: 338 GTTYKAML--PDGSVL--AVKRLNTCKLG-----EKKFRNEMNRLGQLRHPNLAPLLGYC 388
G Y+ + G + AVK TCK ++KF +E + L HP++ L+G
Sbjct: 26 GEVYEGVYTNHKGEKINVAVK---TCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG-- 80
Query: 389 VVEEE-KLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWL--HHGCQPPFL 445
++EEE +I + G L L+ N L T L + +A+L + +
Sbjct: 81 IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN-----CV 135
Query: 446 HQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYI-----APEYSST 499
H++I N ILV ++ DFGL++ + D + +PE +
Sbjct: 136 HRDIAVRN-ILVASPECVKLGDFGLSRYIEDEDYYK------ASVTRLPIKWMSPESINF 188
Query: 500 MVASLKGDVYGIGVVLLEL 518
+ DV+ V + E+
Sbjct: 189 RRFTTASDVWMFAVCMWEI 207
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 42/230 (18%), Positives = 78/230 (33%), Gaps = 65/230 (28%)
Query: 342 KAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNL-------------APLLGYC 388
K ++ G A E L ++ HP++ +GY
Sbjct: 112 KGLVHSGDAEAQAM----------AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYI 161
Query: 389 VVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLH-HGCQPPFLH- 446
V+E Y+ +L +L L L++LH G ++
Sbjct: 162 VME--------YVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG----LVYN 206
Query: 447 ----QNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTM-- 500
+NI ++ E+ +++D G + S ++ G G+ APE T
Sbjct: 207 DLKPENI-----MLTEE-QLKLIDLGAVSRINS---FGYL---YGTPGFQAPEIVRTGPT 254
Query: 501 VASLKGDVYGIGVVLLELA----GFKGNLVDWVNQLSSSGRSKEAIDKAL 546
VA+ D+Y +G L L G VD + + ++ ++ + L
Sbjct: 255 VAT---DIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLL 301
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 11/173 (6%)
Query: 352 AVKRLNTCKLGEKK-FRNEMNRLGQLRHPNLAPLLGYCVVEEEK--LLIYKYMSSGTLYS 408
AVK+L + F E+ L L+H N+ G C + LI +Y+ G+L
Sbjct: 74 AVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD 133
Query: 409 LLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNI-CSNVILVDEDFDARIMDF 467
LQ + +D + +G+ +L ++H+++ N ILV+ + +I DF
Sbjct: 134 YLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRN-ILVENENRVKIGDF 189
Query: 468 GLAKLMTSSDESSFVNGDLGEF--GYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
GL K++ D+ + + GE + APE + S+ DV+ GVVL EL
Sbjct: 190 GLTKVLP-QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 241
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 17/176 (9%)
Query: 352 AVKRLNTCKLG----EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK--LLIYKYMSSGT 405
AVK + + F E+ L L+H N+ G C + LI +Y+ G+
Sbjct: 43 AVK---KLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 99
Query: 406 LYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNI-CSNVILVDEDFDARI 464
L LQ + +D + +G+ +L ++H+++ N ILV+ + +I
Sbjct: 100 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRN-ILVENENRVKI 155
Query: 465 MDFGLAKLMTSSDESSFVNGDLGEF--GYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
DFGL K++ E V GE + APE + S+ DV+ GVVL EL
Sbjct: 156 GDFGLTKVLPQDKEFFKVKEP-GESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 58/284 (20%), Positives = 109/284 (38%), Gaps = 43/284 (15%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKKFR----NEMNRLGQLRHPNLAPLLGYCVVEE 392
Y+A L DG +A+K++ L + K R E++ L QL HPN+ +E+
Sbjct: 46 SEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA-SFIED 104
Query: 393 EKLLIY-KYMSSGTLYSLLQGNATELDWPTRF------RIGLGAARGLAWLHHGCQPPFL 445
+L I + +G L +++ + + + L +H +
Sbjct: 105 NELNIVLELADAGDLSRMIKHFKKQ---KRLIPERTVWKYFVQLCSALEHMH---SRRVM 158
Query: 446 HQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDE--SSFVNGDLGEFG---YIAPEYSST 499
H++I +N + + ++ D GL + +S S V G Y++PE
Sbjct: 159 HRDIKPAN-VFITATGVVKLGDLGLGRFFSSKTTAAHSLV-------GTPYYMSPERIHE 210
Query: 500 MVASLKGDVYGIGVVLLELAG----FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEI 555
+ K D++ +G +L E+A F G+ ++ + L + L Y EE+
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEQCDY--PPLPSDHYSEEL 267
Query: 556 LQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFSERYDEF 599
Q + C+ P+ R + VY + A S +
Sbjct: 268 RQLVN---MCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHH 308
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 25/121 (20%), Positives = 42/121 (34%), Gaps = 8/121 (6%)
Query: 103 LREMKLSG----KIPEPLKFC--KSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNND 156
L + ++ E F +++ LD+S I N L L +L ++ N
Sbjct: 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNS 456
Query: 157 LSGPIPAD-LGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
D L L LS +L P ++L L+ ++A+N L F
Sbjct: 457 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDR 516
Query: 216 F 216
Sbjct: 517 L 517
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 26/117 (22%), Positives = 44/117 (37%), Gaps = 2/117 (1%)
Query: 100 NLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG 159
NL+L L +Q LDLS ++ I L +L L L+ N +
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQS 90
Query: 160 PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLT-GTIPSSFKG 215
+ L L+ L+ + + +L LK+ +VA+N + +P F
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 18/98 (18%), Positives = 40/98 (40%), Gaps = 2/98 (2%)
Query: 120 KSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNN 179
+ L L+ N + ++ + L L L +L+ +G+ L L +++N
Sbjct: 76 SHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHN 134
Query: 180 KL-SGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF 216
+ S +P SNL L+ +++N + + +
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVL 172
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 24/95 (25%), Positives = 39/95 (41%), Gaps = 1/95 (1%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNK 180
S + LDLS N L ++ + P L +LDLS ++ + ++L+TLIL+ N
Sbjct: 29 STKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 181 LSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
+ S L L+K +L
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 20/118 (16%), Positives = 40/118 (33%), Gaps = 5/118 (4%)
Query: 103 LREMKLSGK----IPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLS 158
L+ + LS + + ++ LD ++L + L L+ LD+S+
Sbjct: 375 LKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
Query: 159 GPIPADLGNCTYLNTLILSNNKLSGPI-PYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
+ L L ++ N P + L L ++ L P++F
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 23/111 (20%), Positives = 38/111 (34%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
L++ S++ L ++ N N I L L LDLS L
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 485
Query: 161 IPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPS 211
P + + L L +++N+L L L+K + N + P
Sbjct: 486 SPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 40/181 (22%), Positives = 69/181 (38%), Gaps = 19/181 (10%)
Query: 38 TFSSLASETVAEDDVKCLEGVKSSLND---PQRKLSSWSFGNSTIGFICQFVGVSCWNDK 94
L + T+ E + L+ + D +SS+S + TI + F + +
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQ 307
Query: 95 ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSN 154
++N + + P KS++RL ++N N +++ LP L LDLS
Sbjct: 308 HLELVNCKFGQF--------PTLKLKSLKRLTFTSNKGG-NAFSEV--DLPSLEFLDLSR 356
Query: 155 NDLS--GPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSS 212
N LS G T L L LS N + + L +L+ +++L S
Sbjct: 357 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFS 415
Query: 213 F 213
Sbjct: 416 V 416
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 26/117 (22%), Positives = 49/117 (41%), Gaps = 5/117 (4%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
L E L+ P+ K+++ L+++ N + + + L L LDLS+N +
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164
Query: 161 IPADLGNCTYL----NTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213
DL + +L LS N ++ P + RL K ++ NN + + +
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTC 220
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 17/102 (16%), Positives = 30/102 (29%), Gaps = 9/102 (8%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDL------SNNDLSGPIPADLGNCTYLNTL 174
+ +L L N S N+ L L + L + +L + L L
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 175 ILSNNKLSG---PIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213
L I + L + FS+ + + S+
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY 302
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 46/216 (21%), Positives = 77/216 (35%), Gaps = 44/216 (20%)
Query: 338 GTTYKAM-LPDGSVLAVK--RLNTCKLGEKKFRNEMNRLGQLRHPN---------LAPLL 385
G ++A D A+K RL +L +K E+ L +L HP
Sbjct: 19 GVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78
Query: 386 GYCVVEEEKLLIY---KYMSSGTLYSLL--QGNATELDWPTRFRIGLGAARGLAWLHHGC 440
K+ +Y + L + + E + I L A + +LH
Sbjct: 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH--- 135
Query: 441 QPPFLHQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFG--------- 490
+H+++ SN I D ++ DFGL M +E V + +
Sbjct: 136 SKGLMHRDLKPSN-IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTK 194
Query: 491 -YIAPE------YSSTMVASLKGDVYGIGVVLLELA 519
Y++PE YS K D++ +G++L EL
Sbjct: 195 LYMSPEQIHGNSYSH------KVDIFSLGLILFELL 224
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 5e-13
Identities = 39/175 (22%), Positives = 66/175 (37%), Gaps = 25/175 (14%)
Query: 364 KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY----KYMSSGTLYSLLQGNATELDW 419
+FR E L HP + + E + +Y+ TL ++ +
Sbjct: 57 LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTP 115
Query: 420 PTRFRIGLGAARGLAWLH-HGCQPPFLH-----QNICSNVILVDEDFDARIMDFGLAKLM 473
+ A + L + H +G +H NI ++ ++MDFG+A+ +
Sbjct: 116 KRAIEVIADACQALNFSHQNG----IIHRDVKPANI-----MISATNAVKVMDFGIARAI 166
Query: 474 TSSDESSFVNGD-LGEFGYIAPEYSSTMVASLKGDVYGIGVVLLE-LAG---FKG 523
S S +G Y++PE + + DVY +G VL E L G F G
Sbjct: 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 5e-13
Identities = 45/204 (22%), Positives = 77/204 (37%), Gaps = 41/204 (20%)
Query: 338 GTTYKAML--PDGSVL--AVKRLNTCKLG-------EKKFRNEMNRLGQLRHPNLAPLLG 386
G + P G + AVK K F E+N + L H NL L G
Sbjct: 32 GVVRRGEWDAPSGKTVSVAVK---CLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 88
Query: 387 YCVVEEEKL-LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWL--HHGCQPP 443
VV + ++ + G+L L+ + T R + A G+ +L
Sbjct: 89 --VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR----- 141
Query: 444 FLHQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGY--IAPE----- 495
F+H+++ N +L+ +I DFGL + + ++ +V + + + APE
Sbjct: 142 FIHRDLAARN-LLLATRDLVKIGDFGLMRAL-PQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 496 -YSSTMVASLKGDVYGIGVVLLEL 518
+S D + GV L E+
Sbjct: 200 TFSH------ASDTWMFGVTLWEM 217
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 48/206 (23%), Positives = 87/206 (42%), Gaps = 33/206 (16%)
Query: 338 GTTYKAML--PDGSVL--AVKRLNTCKLG------EKKFRNEMNRLGQLRHPNLAPLLGY 387
G+ +A L DGS + AVK K ++F E + + HP++A L+G
Sbjct: 37 GSVREAQLKQEDGSFVKVAVK---MLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV 93
Query: 388 CVVEEEK------LLIYKYMSSGTLYSLLQ-----GNATELDWPTRFRIGLGAARGLAWL 436
+ K ++I +M G L++ L N L T R + A G+ +L
Sbjct: 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL 153
Query: 437 --HHGCQPPFLHQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIA 493
+ F+H+++ N ++ ED + DFGL++ + S D ++A
Sbjct: 154 SSRN-----FIHRDLAARN-CMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207
Query: 494 PEYSSTMVASLKGDVYGIGVVLLELA 519
E + + ++ DV+ GV + E+
Sbjct: 208 LESLADNLYTVHSDVWAFGVTMWEIM 233
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 26/115 (22%), Positives = 57/115 (49%), Gaps = 9/115 (7%)
Query: 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNN 155
+++ L+ + + + +++ ++ +++ S N L+ P + N L LV + ++NN
Sbjct: 46 DQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTDITP--LKN-LTKLVDILMNNN 100
Query: 156 DLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIP 210
++ P L N T L L L NN+++ P L NL L + +++N ++
Sbjct: 101 QIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISA 151
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 35/126 (27%), Positives = 54/126 (42%), Gaps = 17/126 (13%)
Query: 95 ENRILNLE-------LREMKLSG---KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWL 144
N+I ++ L E+ L+G K L ++ LDL+ N +S P + L
Sbjct: 208 NNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSG-L 264
Query: 145 PYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANND 204
L L L N +S P L T L L L+ N+L P +SNL L ++ N+
Sbjct: 265 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNN 320
Query: 205 LTGTIP 210
++ P
Sbjct: 321 ISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 32/110 (29%), Positives = 49/110 (44%), Gaps = 10/110 (9%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
+ +L+ P LK + + ++ N ++ P + N L L L L NN ++
Sbjct: 73 INFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LAN-LTNLTGLTLFNNQITDI 127
Query: 161 IPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIP 210
P L N T LN L LS+N +S LS L L++ S N +T P
Sbjct: 128 DP--LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFGNQ-VTDLKP 172
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 8e-11
Identities = 33/119 (27%), Positives = 49/119 (41%), Gaps = 12/119 (10%)
Query: 100 NLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG 159
LEL +S L S+Q+L N ++ P + N L L LD+S+N +S
Sbjct: 138 RLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP--LAN-LTTLERLDISSNKVSD 191
Query: 160 PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDK 218
L T L +LI +NN++S P L L L + S+ N L +
Sbjct: 192 ISV--LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTN 244
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 16/97 (16%), Positives = 30/97 (30%), Gaps = 7/97 (7%)
Query: 114 EPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNT 173
+ L +++ + L + L + + L
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS---QTDLDQVTTLQADRLGIKSIDG--VEYLNNLTQ 72
Query: 174 LILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIP 210
+ SNN+L+ P L NL +L + NN + P
Sbjct: 73 INFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP 107
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 5e-10
Identities = 22/129 (17%), Positives = 42/129 (32%), Gaps = 15/129 (11%)
Query: 96 NRILNLE-------LREMKLSG---KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLP 145
N I ++ L+ + L ++ L N +S P + N L
Sbjct: 319 NNISDISPVSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISDLTP--LAN-LT 375
Query: 146 YLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDL 205
+ L L++ + N + NT+ L P +S+ G + + N
Sbjct: 376 RITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPA--TISDGGSYTEPDITWNLP 433
Query: 206 TGTIPSSFK 214
+ T S+
Sbjct: 434 SYTNEVSYT 442
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 8e-13
Identities = 22/123 (17%), Positives = 45/123 (36%), Gaps = 14/123 (11%)
Query: 103 LREMKLSG----KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNW--------LPYLVLL 150
L + L+ +P + ++ L + A +P + + L L L
Sbjct: 129 LETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSL 188
Query: 151 DLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIP 210
L + +PA + N L +L + N+ LS + + +L +L++ + P
Sbjct: 189 RLEWTGIRS-LPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYP 246
Query: 211 SSF 213
F
Sbjct: 247 PIF 249
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 25/125 (20%), Positives = 46/125 (36%), Gaps = 6/125 (4%)
Query: 91 WNDKENRILNLELREMKLSGKIPEPLKFCKSM--QRLDLSANDLSGNIPAQICNWLPYLV 148
W + +E R + + L+ L+L + L P Q L +L
Sbjct: 50 WRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFR-LSHLQ 107
Query: 149 LLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGT 208
+ + L +P + L TL L+ N L +P +++L RL++ S+
Sbjct: 108 HMTIDAAGLME-LPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTE 165
Query: 209 IPSSF 213
+P
Sbjct: 166 LPEPL 170
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 26/116 (22%), Positives = 47/116 (40%), Gaps = 8/116 (6%)
Query: 103 LREMKLSG----KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLS 158
L+ ++L +P + ++++ L + + LS + I + LP L LDL
Sbjct: 185 LQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSA-LGPAIHH-LPKLEELDLRGCTAL 242
Query: 159 GPIPADLGNCTYLNTLILSN-NKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213
P G L LIL + + L +P + L +L+K + +PS
Sbjct: 243 RNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLPSLI 297
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 23/106 (21%), Positives = 40/106 (37%), Gaps = 5/106 (4%)
Query: 109 SGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNC 168
S + ++Q L L + ++PA I N L L L + N+ LS + + +
Sbjct: 172 STDASGEHQGLVNLQSLRLEWTGIR-SLPASIAN-LQNLKSLKIRNSPLSA-LGPAIHHL 228
Query: 169 TYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVAN-NDLTGTIPSSF 213
L L L P LK+ + + ++L T+P
Sbjct: 229 PKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDI 273
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 22/107 (20%), Positives = 37/107 (34%), Gaps = 4/107 (3%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSN-NDLSG 159
L++R LS + + ++ LDL N P L L L + ++L
Sbjct: 211 LKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGG-RAPLKRLILKDCSNLLT 268
Query: 160 PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLT 206
+P D+ T L L L +P ++ L V +
Sbjct: 269 -LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 19/103 (18%), Positives = 36/103 (34%), Gaps = 9/103 (8%)
Query: 98 ILNLE-LREMKLSG-----KIPEPLKFCKSMQRLDLS-ANDLSGNIPAQICNWLPYLVLL 150
I +L L E+ L G P ++RL L ++L +P I L L L
Sbjct: 225 IHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHR-LTQLEKL 282
Query: 151 DLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLG 193
DL +P+ + +++ + + ++
Sbjct: 283 DLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 6e-06
Identities = 14/116 (12%), Positives = 26/116 (22%), Gaps = 24/116 (20%)
Query: 119 CKSMQRLDLSANDLSGNIPAQICNW-------------------LPYLVLLDLSNNDLSG 159
+ L + + W + + L
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKA 70
Query: 160 PIPADLGNCTYLN--TLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213
L + T L L + L P Q L L+ ++ L +P +
Sbjct: 71 -TADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 32/101 (31%), Positives = 41/101 (40%), Gaps = 7/101 (6%)
Query: 108 LSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGN 167
SG +Q LDLS N L A C+W L L+LS L +P L
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLP- 273
Query: 168 CTYLNTLILSNNKLSG-PIPYQLSNLGRLKKFSVANNDLTG 207
L+ L LS N+L P P +L +G L S+ N
Sbjct: 274 -AKLSVLDLSYNRLDRNPSPDELPQVGNL---SLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 6e-10
Identities = 27/147 (18%), Positives = 48/147 (32%), Gaps = 8/147 (5%)
Query: 67 RKLSSWSFGNSTIGFICQFVGVSCWNDKENRILNLELREMKLSGKIPEPLKFCKSMQRLD 126
L+ + N + ++ + + L + + E ++ ++ LD
Sbjct: 121 PDLNILNLRNVSWATRDAWLA-ELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLD 179
Query: 127 LSANDLSGNIP--AQIC-NWLPYLVLLDLSNN---DLSGPIPADLGNCTYLNTLILSNNK 180
LS N G + +C P L +L L N SG A L L LS+N
Sbjct: 180 LSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNS 239
Query: 181 LSG-PIPYQLSNLGRLKKFSVANNDLT 206
L +L +++ L
Sbjct: 240 LRDAAGAPSCDWPSQLNSLNLSFTGLK 266
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 24/133 (18%), Positives = 46/133 (34%), Gaps = 12/133 (9%)
Query: 96 NRILNLELREMKLSGKIPEPLKFC--KSMQRLDLSANDLSG--NIPAQICNWL-PYLVLL 150
+ + L L ++++G P PL + L+L + A++ WL P L +L
Sbjct: 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVL 154
Query: 151 DLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIP----YQLSNLGRLKKFSVANNDLT 206
++ + L+TL LS+N G L+ ++ N +
Sbjct: 155 SIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214
Query: 207 ---GTIPSSFKGF 216
G +
Sbjct: 215 TPSGVCSALAAAR 227
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 25/104 (24%), Positives = 37/104 (35%), Gaps = 8/104 (7%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPY--LVLLDLSNNDLSGPIPADLGNCTY--LNTLIL 176
S++RL + A + I L L L L N +++G P L T LN L L
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 177 SNNKLSGPIPY--QLSNL--GRLKKFSVANNDLTGTIPSSFKGF 216
N + + +L LK S+A + F
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF 172
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 41/202 (20%), Positives = 79/202 (39%), Gaps = 31/202 (15%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPN---------------L 381
G +KA DG +KR+ +K E+ L +L H N
Sbjct: 25 GQVFKAKHRIDGKTYVIKRVK---YNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81
Query: 382 APLLGYCVVEEEKLLIY-KYMSSGTLYSLLQG-NATELDWPTRFRIGLGAARGLAWLHHG 439
+ + L I ++ GTL ++ +LD + +G+ ++H
Sbjct: 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH-- 139
Query: 440 CQPPFLHQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDE-SSFVNGDLGEFGYIAPEYS 497
+++++ SN I + + +I DFGL + + + + G Y++PE
Sbjct: 140 -SKKLINRDLKPSN-IFLVDTKQVKIGDFGLVTSLKNDGKRTRSK----GTLRYMSPEQI 193
Query: 498 STMVASLKGDVYGIGVVLLELA 519
S+ + D+Y +G++L EL
Sbjct: 194 SSQDYGKEVDLYALGLILAELL 215
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 45/196 (22%), Positives = 78/196 (39%), Gaps = 22/196 (11%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEK---KFRNEMNRLGQLRHPNLAPLLGY--CVVE 391
G DG +K +N ++ K + R E+ L ++HPN+ + Y E
Sbjct: 38 GKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI---VQYRESFEE 94
Query: 392 EEKLLIY-KYMSSGTLYSLLQG-NATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNI 449
L I Y G L+ + + L +H LH++I
Sbjct: 95 NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDI 151
Query: 450 -CSNVILVDEDFDARIMDFGLAKLMTSSDE--SSFVNGDLGEFGYIAPEYSSTMVASLKG 506
N I + +D ++ DFG+A+++ S+ E + + G Y++PE + K
Sbjct: 152 KSQN-IFLTKDGTVQLGDFGIARVLNSTVELARACI----GTPYYLSPEICENKPYNNKS 206
Query: 507 DVYGIGVVLLELAGFK 522
D++ +G VL EL K
Sbjct: 207 DIWALGCVLYELCTLK 222
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 47/206 (22%), Positives = 82/206 (39%), Gaps = 33/206 (16%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEK---KFRNEMNRLGQLRHPNLAPLLGYCVVEEE 393
G K DG +L K L+ + E +E+N L +L+HPN+ +++
Sbjct: 20 GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD-RIIDRT 78
Query: 394 KLLIYKYM---SSGTLYSLLQ---GNATELDWPTRFRIGLGAARGLAWLHHGCQPPF--L 445
+Y M G L S++ LD R+ L H L
Sbjct: 79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVL 138
Query: 446 HQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDE--SSFVNGDLGEFGYIAPE------Y 496
H+++ +N + +D + ++ DFGLA+++ +FV G Y++PE Y
Sbjct: 139 HRDLKPAN-VFLDGKQNVKLGDFGLARILNHDTSFAKTFV----GTPYYMSPEQMNRMSY 193
Query: 497 SSTMVASLKGDVYGIGVVLLELAGFK 522
+ K D++ +G +L EL
Sbjct: 194 NE------KSDIWSLGCLLYELCALM 213
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 43/176 (24%), Positives = 74/176 (42%), Gaps = 27/176 (15%)
Query: 364 KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY---KYMSSGTLYSLLQGNATELDWP 420
+ + E G+L+ P++ P+ + E + L Y + ++ L ++L+ L P
Sbjct: 79 TRMQREARTAGRLQEPHVVPI--HDFGEIDGQL-YVDMRLINGVDLAAMLRRQGP-LAPP 134
Query: 421 TRFRIGLGAARGLAWLH-HGCQPPFLH-----QNICSNVILVDEDFDARIMDFGLAKLMT 474
I L H G H +NI LV D A ++DFG+A T
Sbjct: 135 RAVAIVRQIGSALDAAHAAG----ATHRDVKPENI-----LVSADDFAYLVDFGIASATT 185
Query: 475 SSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLE-LAG---FKGNLV 526
+ + +G Y+APE S A+ + D+Y + VL E L G ++G+ +
Sbjct: 186 DEKLTQ-LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL 240
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 25/189 (13%), Positives = 52/189 (27%), Gaps = 21/189 (11%)
Query: 347 DGSVLAVKRLNTCKLGE-KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGT 405
+ +K E M RL + + +L+ + S GT
Sbjct: 94 NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT 153
Query: 406 LYSLLQ--GNATE--LDWPTRFRIGLGAARGLAWLH-----HG---CQPPFLHQNICSNV 453
L + + N E + + + +H HG L
Sbjct: 154 LLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213
Query: 454 ILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVA----SLKGDVY 509
D ++D G + M + + G+ E M++ + + D +
Sbjct: 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE----MLSNKPWNYQIDYF 269
Query: 510 GIGVVLLEL 518
G+ + +
Sbjct: 270 GVAATVYCM 278
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 46/174 (26%), Positives = 72/174 (41%), Gaps = 14/174 (8%)
Query: 352 AVKRL--NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK--LLIYKYMSSGTLY 407
AVK L + ++ E++ L L H ++ G C L+ +Y+ G+L
Sbjct: 64 AVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLR 123
Query: 408 SLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNI-CSNVILVDEDFDARIMD 466
L + + G+A+LH ++H+++ N +L+D D +I D
Sbjct: 124 DYLPRH--SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARN-VLLDNDRLVKIGD 177
Query: 467 FGLAKLMTSSDE--SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
FGLAK + E +GD F Y APE DV+ GV L EL
Sbjct: 178 FGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKEYKFYYASDVWSFGVTLYEL 230
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 49/202 (24%), Positives = 85/202 (42%), Gaps = 40/202 (19%)
Query: 338 GTTYKAMLPDGSVL---AVKRLNTCKLG------EKKFRNEMNRLGQLRHPNLAPLLGYC 388
GT K V+ AVK K + + E N + QL +P + ++G
Sbjct: 31 GTVKKGYYQMKKVVKTVAVK---ILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG-- 85
Query: 389 VVEEEKL-LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWL--HHGCQPPFL 445
+ E E L+ + G L LQ N + + + G+ +L + F+
Sbjct: 86 ICEAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESN-----FV 139
Query: 446 HQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEF--GYIAPE------Y 496
H+++ N +L+ A+I DFGL+K + +DE+ + G++ + APE +
Sbjct: 140 HRDLAARN-VLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYAPECINYYKF 197
Query: 497 SSTMVASLKGDVYGIGVVLLEL 518
SS K DV+ GV++ E
Sbjct: 198 SS------KSDVWSFGVLMWEA 213
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 36/207 (17%)
Query: 338 GTTYKAML--PDGSVL--AVKRLNTCKLG------EKKFRNEMNRLGQLRHPNLAPLLGY 387
G+ + L DG+ L AVK T KL ++F +E + HPN+ LLG
Sbjct: 48 GSVMEGNLKQEDGTSLKVAVK---TMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104
Query: 388 CVVEE-----EKLLIYKYMSSGTLYSLLQ-----GNATELDWPTRFRIGLGAARGLAWL- 436
C+ + ++I +M G L++ L + T + + A G+ +L
Sbjct: 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS 164
Query: 437 -HHGCQPPFLHQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEF--GYI 492
+ FLH+++ N ++ +D + DFGL+K + S D + G + + +I
Sbjct: 165 NRN-----FLHRDLAARN-CMLRDDMTVCVADFGLSKKIYSGDY--YRQGRIAKMPVKWI 216
Query: 493 APEYSSTMVASLKGDVYGIGVVLLELA 519
A E + V + K DV+ GV + E+A
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIA 243
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 31/135 (22%), Positives = 51/135 (37%), Gaps = 4/135 (2%)
Query: 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNND 156
R+ LE+ + + ++ L ++ +L+ +P L YL L+LS N
Sbjct: 201 RLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNP 259
Query: 157 LSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF 216
+S + L L + L +L+ PY L L+ +V+ N LT S F
Sbjct: 260 ISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSV 319
Query: 217 DK---ADFDGNSDLC 228
D N C
Sbjct: 320 GNLETLILDSNPLAC 334
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 20/138 (14%), Positives = 50/138 (36%), Gaps = 15/138 (10%)
Query: 95 ENRILNLE---------LREMKLSG----KIPEP-LKFCKSMQRLDLSANDLSGNIPAQI 140
+N ++ + L ++ L IP L + L L +++ I
Sbjct: 137 DNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYS 195
Query: 141 CNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSV 200
L L +L++S+ + + L +L +++ L+ + +L L+ ++
Sbjct: 196 FKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNL 255
Query: 201 ANNDLTGTIPSSFKGFDK 218
+ N ++ S +
Sbjct: 256 SYNPISTIEGSMLHELLR 273
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 25/119 (21%), Positives = 48/119 (40%), Gaps = 3/119 (2%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
L LR + ++ K ++ L++S + L L +++ +L+
Sbjct: 181 LRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLY-GLNLTSLSITHCNLTA- 238
Query: 161 IPAD-LGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDK 218
+P + + YL L LS N +S L L RL++ + L P +F+G +
Sbjct: 239 VPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNY 297
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 30/116 (25%), Positives = 49/116 (42%), Gaps = 3/116 (2%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
L+L + ++ + ++ L+L+ N +S + N L L L L +N L
Sbjct: 37 LDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKL- 94
Query: 161 IPAD-LGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
IP + L L +S NK+ + Y +L LK V +NDL +F G
Sbjct: 95 IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSG 150
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 24/105 (22%), Positives = 42/105 (40%), Gaps = 5/105 (4%)
Query: 112 IPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPAD-LGNCTY 170
+PE + + LDL N + + P+L L+L+ N +S + N
Sbjct: 26 VPEGI--PTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSA-VEPGAFNNLFN 81
Query: 171 LNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
L TL L +N+L + L L K ++ N + + F+
Sbjct: 82 LRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQD 126
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 23/100 (23%), Positives = 43/100 (43%), Gaps = 3/100 (3%)
Query: 120 KSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNN 179
+++ L L +N L IP + L L LD+S N + + + L +L + +N
Sbjct: 80 FNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDN 138
Query: 180 KLSGPIPYQLSNLGRLKKFSVANNDLTGTIPS-SFKGFDK 218
L S L L++ ++ +LT +IP+ +
Sbjct: 139 DLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHG 177
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 20/93 (21%), Positives = 33/93 (35%), Gaps = 4/93 (4%)
Query: 123 QRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLS 182
+ + +P I LLDL N + + + +L L L+ N +S
Sbjct: 14 RAVLCHRKRFV-AVPEGI---PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS 69
Query: 183 GPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
P +NL L+ + +N L F G
Sbjct: 70 AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTG 102
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 42/198 (21%), Positives = 68/198 (34%), Gaps = 30/198 (15%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLL 396
GT + D +AVKR+ E+ L + HPN+ E+++
Sbjct: 38 GTIVYRGMFDNRDVAVKRIL--PECFSFADREVQLLRESDEHPNVIRYFC---TEKDRQF 92
Query: 397 IYKYMS--SGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNIC---- 450
Y + + TL ++ + GLA LH NI
Sbjct: 93 QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS--------LNIVHRDL 144
Query: 451 --SNVILVDEDFDAR----IMDFGLAKLMTSSDES-SFVNGDLGEFGYIAPEY---SSTM 500
N+++ + + I DFGL K + S S +G G G+IAPE
Sbjct: 145 KPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKE 204
Query: 501 VASLKGDVYGIGVVLLEL 518
+ D++ G V +
Sbjct: 205 NPTYTVDIFSAGCVFYYV 222
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 5e-12
Identities = 41/192 (21%), Positives = 76/192 (39%), Gaps = 18/192 (9%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGE-KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395
G Y L + +A+K + + E+ L+H N+ LG E +
Sbjct: 36 GIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-SFSENGFI 94
Query: 396 LIY-KYMSSGTLYSLLQGN--ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNI-CS 451
I+ + + G+L +LL+ + + T GL +LH +H++I
Sbjct: 95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGD 151
Query: 452 NVILVDEDFDARIMDFGLAKLMT--SSDESSFVNGDLGEFGYIAPE--YSSTMVASLKGD 507
NV++ +I DFG +K + + +F G Y+APE D
Sbjct: 152 NVLINTYSGVLKISDFGTSKRLAGINPCTETFT----GTLQYMAPEIIDKGPRGYGKAAD 207
Query: 508 VYGIGVVLLELA 519
++ +G ++E+A
Sbjct: 208 IWSLGCTIIEMA 219
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 7e-12
Identities = 48/200 (24%), Positives = 87/200 (43%), Gaps = 30/200 (15%)
Query: 340 TYKAMLPDGSVL--AVKRLN--TCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395
K ++ D A+K +N +F NE + + + ++ LLG + L
Sbjct: 45 VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 104
Query: 396 LIYKYMSSGTLYSLLQ------GNATELDWPTR---FRIGLGAARGLAWLHHGCQPPFLH 446
+I + M+ G L S L+ N L P+ ++ A G+A+L+ F+H
Sbjct: 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVH 161
Query: 447 QNI-CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPE------YSST 499
+++ N +V EDF +I DFG+ + + +D L +++PE +++
Sbjct: 162 RDLAARNC-MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT- 219
Query: 500 MVASLKGDVYGIGVVLLELA 519
DV+ GVVL E+A
Sbjct: 220 -----YSDVWSFGVVLWEIA 234
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 46/198 (23%), Positives = 75/198 (37%), Gaps = 40/198 (20%)
Query: 338 GTTYKA-MLPDGSVLAVKRLNTCKLGEK----KFRNEMNRLGQLRHPNLAPLLGYCVVEE 392
G G AVK ++ ++ +K E+ L QL HPN+ L + +
Sbjct: 40 GEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG 99
Query: 393 EKLLIYKYMSSGTLYSLL--QGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNIC 450
L+ + + G L+ + + +E+D R L + ++H I
Sbjct: 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG---ITYMH--------KNKIV 148
Query: 451 ------SNVILVDEDFDARIM--DFGLAKLMTSSDESSFVNGDLGEFGYIAPE-----YS 497
N++L + DA I DFGL+ + S + +G YIAPE Y
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIAPEVLHGTYD 205
Query: 498 STMVASLKGDVYGIGVVL 515
K DV+ GV+L
Sbjct: 206 E------KCDVWSTGVIL 217
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 34/145 (23%), Positives = 62/145 (42%), Gaps = 25/145 (17%)
Query: 352 AVKRLNTCKLGEKK-FRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLL 410
AVK L L +K F+ E L L+H ++ G C + +++++YM G L L
Sbjct: 49 AVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFL 108
Query: 411 QGNATELDWPTRFR---------------IGLGAARGLAWL--HHGCQPPFLHQNI-CSN 452
+ + + + I A G+ +L H F+H+++ N
Sbjct: 109 RAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH-----FVHRDLATRN 163
Query: 453 VILVDEDFDARIMDFGLAKLMTSSD 477
LV + +I DFG+++ + S+D
Sbjct: 164 -CLVGANLLVKIGDFGMSRDVYSTD 187
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 31/121 (25%), Positives = 47/121 (38%), Gaps = 6/121 (4%)
Query: 101 LELREMKLSG-KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG 159
+ L E +L I L +Q L L+ N S Q + P L L L N L
Sbjct: 406 IHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQL 465
Query: 160 PIPADL-----GNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFK 214
+L ++L L L++N L+ P S+L L+ S+ +N LT +
Sbjct: 466 AWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP 525
Query: 215 G 215
Sbjct: 526 A 526
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 21/103 (20%), Positives = 36/103 (34%), Gaps = 2/103 (1%)
Query: 113 PEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLN 172
F + +Q L+L + I + LP L +LDL ++ + P +L
Sbjct: 41 ASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLF 100
Query: 173 TLILSNNKLSGPI--PYQLSNLGRLKKFSVANNDLTGTIPSSF 213
L L LS + NL L + ++ N +
Sbjct: 101 ELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPS 143
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 9e-11
Identities = 24/120 (20%), Positives = 41/120 (34%), Gaps = 5/120 (4%)
Query: 101 LELREMKLSGKI-PEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG 159
LEL I E + +++ LDL ++ + + L +L L L LS
Sbjct: 53 LELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSD 111
Query: 160 PI--PADLGNCTYLNTLILSNNKLSG-PIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF 216
+ N L L LS N++ + L LK ++N + +
Sbjct: 112 AVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 32/195 (16%), Positives = 64/195 (32%), Gaps = 16/195 (8%)
Query: 103 LREMKLSG-KI----PEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDL 157
L+ + L+ + P +++ L L++N L+ + + L +LD+S N L
Sbjct: 482 LQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSH--NDLPANLEILDISRNQL 538
Query: 158 SGPIPADLGNCTYLNTLILSNNKLSGPIPYQ-LSNLGRLKKFSVANN--DLTGTIPSSFK 214
P P + + L+ +++NK N ++A D+ P SF
Sbjct: 539 LAPNPDVFVSLSVLD---ITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFS 595
Query: 215 GFDKADFDGNSDLCGGPLGSKCGGLSKKNLAIIIAAGIFGAAASMLLAFGLWWWYHLRWV 274
G L S L + + ++ G + +
Sbjct: 596 GVSLFSLSTEGCDEEEVLKSLKFSLF--IVCTVTLTLFLMTILTVTKFRGFCFICYKTAQ 653
Query: 275 RRRKRGYGIGRDDDD 289
R + + G + D
Sbjct: 654 RLVFKDHPQGTEPDM 668
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 20/96 (20%), Positives = 38/96 (39%), Gaps = 1/96 (1%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNK 180
S++ LDLS + ++ +++ L L +L+L+ N ++ L L LS N
Sbjct: 267 SVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNL 325
Query: 181 LSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF 216
L L ++ + N + +FK
Sbjct: 326 LGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFL 361
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 21/115 (18%), Positives = 46/115 (40%), Gaps = 1/115 (0%)
Query: 92 NDKENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLD 151
+ + +L+L + + K ++ L+L+ N ++ I + L L +L+
Sbjct: 262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLN 320
Query: 152 LSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLT 206
LS N L ++ + + L N ++ L +L+ + +N LT
Sbjct: 321 LSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 21/104 (20%), Positives = 30/104 (28%), Gaps = 6/104 (5%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG-PIPADLGNCTYLNTLILSNN 179
+ + LS N L +P+L +L L+ N S L L L N
Sbjct: 402 TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGEN 461
Query: 180 KLSGPI-----PYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDK 218
L L L+ + +N L P F
Sbjct: 462 MLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTA 505
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 17/92 (18%), Positives = 30/92 (32%), Gaps = 6/92 (6%)
Query: 125 LDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGP 184
+L+ +P L L LS N + + L L L +
Sbjct: 9 AFYRFCNLT-QVPQV----LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63
Query: 185 I-PYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
I NL L+ + ++ + P +F+G
Sbjct: 64 IDKEAFRNLPNLRILDLGSSKIYFLHPDAFQG 95
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 18/111 (16%), Positives = 35/111 (31%), Gaps = 3/111 (2%)
Query: 108 LSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQI--CNWLPYLVLLDLSNNDLSGPIPADL 165
+S L + +++ + + LDLS+ +
Sbjct: 228 ISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVF 286
Query: 166 GNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF 216
L L L+ NK++ L L+ +++ N L S+F G
Sbjct: 287 ETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGL 337
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 27/128 (21%), Positives = 42/128 (32%), Gaps = 14/128 (10%)
Query: 97 RILNL---ELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLS 153
L L L + L + K++ RLDLS N + L L +D S
Sbjct: 100 FELRLYFCGLSDAVLK---DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFS 156
Query: 154 NNDLSGPIPADLGNCT--YLNTLILSNNKLSGPIPYQLSNLG------RLKKFSVANNDL 205
+N + +L L+ L+ N L + L+ V+ N
Sbjct: 157 SNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGW 216
Query: 206 TGTIPSSF 213
T I +F
Sbjct: 217 TVDITGNF 224
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 44/191 (23%), Positives = 74/191 (38%), Gaps = 21/191 (10%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396
G ++ G AVK++ E E+ L P + PL G V E +
Sbjct: 72 GEVHRMKDKQTGFQCAVKKVRL----EVFRVEELVACAGLSSPRIVPLYG-AVREGPWVN 126
Query: 397 IY-KYMSSGTLYSLLQ--GNATELDWPTRFRIGLGAA-RGLAWLHHGCQPPFLHQNICSN 452
I+ + + G+L L++ G E R LG A GL +LH LH ++ ++
Sbjct: 127 IFMELLEGGSLGQLIKQMGCLPE----DRALYYLGQALEGLEYLHTRR---ILHGDVKAD 179
Query: 453 VILVDED-FDARIMDFGLAKLMTSSDESSFVNGDLGEFG---YIAPEYSSTMVASLKGDV 508
+L+ D A + DFG A + + G ++APE K D+
Sbjct: 180 NVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDI 239
Query: 509 YGIGVVLLELA 519
+ ++L +
Sbjct: 240 WSSCCMMLHML 250
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 46/200 (23%), Positives = 72/200 (36%), Gaps = 39/200 (19%)
Query: 338 GTTYKA-MLPDGSVLAVKRLNTCKLGEK---KFRNEMNRLGQLRHPNLAPLLGYCVVEEE 393
G A+K + + K E+ L L HPN+ L + +
Sbjct: 51 GEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN 110
Query: 394 KLLIYKYMSSGTLYSLL--QGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNIC- 450
L+ + G L+ + + E+D + L + +LH NI
Sbjct: 111 YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG---VTYLHK--------HNIVH 159
Query: 451 -----SNVILVDEDFDARIM--DFGLAKLMTSSDESSFVNGDLGEFGYIAPE-----YSS 498
N++L ++ DA I DFGL+ + + + LG YIAPE Y
Sbjct: 160 RDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGTAYYIAPEVLRKKYDE 216
Query: 499 TMVASLKGDVYGIGVVLLEL 518
K DV+ IGV+L L
Sbjct: 217 ------KCDVWSIGVILFIL 230
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 27/125 (21%), Positives = 47/125 (37%), Gaps = 17/125 (13%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
L + E L+ +P+ + L + N+L+ ++PA L L++S N L+
Sbjct: 45 LNVGESGLT-TLPD--CLPAHITTLVIPDNNLT-SLPALPPE----LRTLEVSGNQLTS- 95
Query: 161 IPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKAD 220
+P L+ L P S L +L + N LT ++P G +
Sbjct: 96 LPVLPPGLLELSIFSNPLTHL----PALPSGLCKL---WIFGNQLT-SLPVLPPGLQELS 147
Query: 221 FDGNS 225
N
Sbjct: 148 VSDNQ 152
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 26/145 (17%), Positives = 44/145 (30%), Gaps = 42/145 (28%)
Query: 100 NLELREMKLSGKIPEPLKFCKSMQRLDLSAN------------DLSGN----IPAQICN- 142
LE+ +L+ +P + + GN +P
Sbjct: 85 TLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGL 143
Query: 143 ---------------WLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPY 187
L L NN L+ +P L L +S+N+L+ +P
Sbjct: 144 QELSVSDNQLASLPALPSELCKLWAYNNQLTS-LPMLPSG---LQELSVSDNQLAS-LP- 197
Query: 188 QLSNLGRLKKFSVANNDLTGTIPSS 212
+ L K NN LT ++P+
Sbjct: 198 --TLPSELYKLWAYNNRLT-SLPAL 219
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 33/125 (26%), Positives = 50/125 (40%), Gaps = 18/125 (14%)
Query: 100 NLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG 159
L +L+ +P +Q L +S N L+ ++P L L NN L+
Sbjct: 165 KLWAYNNQLT-SLPMLPS---GLQELSVSDNQLA-SLPTLPSE----LYKLWAYNNRLT- 214
Query: 160 PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKA 219
+PA L LI+S N+L+ +P S L L V+ N LT ++P G
Sbjct: 215 SLPALPSG---LKELIVSGNRLTS-LPVLPSELKEL---MVSGNRLT-SLPMLPSGLLSL 266
Query: 220 DFDGN 224
N
Sbjct: 267 SVYRN 271
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 23/101 (22%), Positives = 42/101 (41%), Gaps = 13/101 (12%)
Query: 103 LREMKLSG----KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLS 158
L+E+ +SG +P ++ L +S N L+ ++P L+ L + N L+
Sbjct: 223 LKELIVSGNRLTSLPV---LPSELKELMVSGNRLT-SLPMLPSG----LLSLSVYRNQLT 274
Query: 159 GPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFS 199
+P L + + T+ L N LS L + +S
Sbjct: 275 R-LPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYS 314
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 43/211 (20%), Positives = 81/211 (38%), Gaps = 34/211 (16%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNL----------APLLG 386
G KA D A+K++ + +E+ L L H + +
Sbjct: 20 GQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79
Query: 387 YCVVEEEKLLIY---KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLH-HGCQP 442
++K ++ +Y +GTLY L+ +R+ L+++H G
Sbjct: 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--- 136
Query: 443 PFLHQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFG----------- 490
+H+++ N I +DE + +I DFGLAK + S + ++
Sbjct: 137 -IIHRDLKPMN-IFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTA 194
Query: 491 -YIAPE-YSSTMVASLKGDVYGIGVVLLELA 519
Y+A E T + K D+Y +G++ E+
Sbjct: 195 MYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 28/119 (23%), Positives = 52/119 (43%), Gaps = 17/119 (14%)
Query: 94 KENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLS 153
N+ L+L + LS +P+ + L+++ N L ++P + L LD
Sbjct: 57 LINQFSELQLNRLNLS-SLPD--NLPPQITVLEITQNALI-SLPELPAS----LEYLDAC 108
Query: 154 NNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSS 212
+N LS +P + +L+ + NN+L+ +P L+ + NN LT +P
Sbjct: 109 DNRLST-LPELPASLKHLD---VDNNQLTM-LP---ELPALLEYINADNNQLT-MLPEL 158
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 25/109 (22%), Positives = 45/109 (41%), Gaps = 9/109 (8%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNW---LPYLVLLDLSNNDL 157
L +R +L+ +PE + S++ LD+S N L ++PA + N +
Sbjct: 165 LSVRNNQLT-FLPELPE---SLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRI 219
Query: 158 SGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLT 206
+ IP ++ + T+IL +N LS I LS + +
Sbjct: 220 TH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 33/112 (29%), Positives = 50/112 (44%), Gaps = 18/112 (16%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
LE+ + L +PE S++ LD N LS +P + L LD+ NN L+
Sbjct: 85 LEITQNALI-SLPELPA---SLEYLDACDNRLS-TLPELPAS----LKHLDVDNNQLTM- 134
Query: 161 IPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSS 212
+P L + NN+L+ +P ++L L SV NN LT +P
Sbjct: 135 LPELPAL---LEYINADNNQLTM-LPELPTSLEVL---SVRNNQLT-FLPEL 178
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 17/116 (14%), Positives = 28/116 (24%), Gaps = 9/116 (7%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQR----LDLSANDLSGNIPAQICNWLPYLVLLDLSNND 156
L++ L +P + N ++ +IP I + L + L +N
Sbjct: 185 LDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILS-LDPTCTIILEDNP 241
Query: 157 LSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSS 212
LS I L T + N S
Sbjct: 242 LSSRIRESLSQQTAQPDYHGPRIYF--SMSDGQQNTLHRPLADAVTAWFPENKQSD 295
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 32/144 (22%), Positives = 59/144 (40%), Gaps = 24/144 (16%)
Query: 352 AVKRLNTCKLGEKK-FRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLL 410
AVK L ++ F+ E L L+H ++ G C L++++YM G L L
Sbjct: 75 AVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFL 134
Query: 411 QGNATELDWPTR--------------FRIGLGAARGLAWL--HHGCQPPFLHQNI-CSNV 453
+ + + + A G+ +L H F+H+++ N
Sbjct: 135 RSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH-----FVHRDLATRN- 188
Query: 454 ILVDEDFDARIMDFGLAKLMTSSD 477
LV + +I DFG+++ + S+D
Sbjct: 189 CLVGQGLVVKIGDFGMSRDIYSTD 212
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 38/202 (18%), Positives = 78/202 (38%), Gaps = 29/202 (14%)
Query: 337 TGTTYKAM-LPDGSVLAVKRLNTCKLGEKKF---RNEMNRLGQLRHPNLAPLLGYCVVEE 392
T A P G + V+R+N + + E++ HPN+ P + +
Sbjct: 40 LMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 99
Query: 393 EKLLIYKYMSSGTLYSLLQGNATE-LDWPTRFRIGLGAARGLAWLH-HGCQPPFLHQNIC 450
E ++ +M+ G+ L+ + + ++ I G + L ++H G +H+++
Sbjct: 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGY----VHRSVK 155
Query: 451 SNVILVDEDFDARIMDFGLAKLMTSSDE-----SSFVNGDLGEFGYIAPE--------YS 497
++ IL+ D + M S + F + +++PE Y
Sbjct: 156 ASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD 215
Query: 498 STMVASLKGDVYGIGVVLLELA 519
+ K D+Y +G+ ELA
Sbjct: 216 A------KSDIYSVGITACELA 231
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 5e-11
Identities = 36/160 (22%), Positives = 66/160 (41%), Gaps = 28/160 (17%)
Query: 340 TYKAMLPDGSVL--AVKRL--NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395
P A+K L ++FR+E +L+HPN+ LLG ++
Sbjct: 29 HLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 88
Query: 396 LIYKYMSSGTLYSLLQGNA---------------TELDWPTRFRIGLGAARGLAWL--HH 438
+I+ Y S G L+ L + + L+ P + A G+ +L HH
Sbjct: 89 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH 148
Query: 439 GCQPPFLHQNI-CSNVILVDEDFDARIMDFGLAKLMTSSD 477
+H+++ N +LV + + +I D GL + + ++D
Sbjct: 149 -----VVHKDLATRN-VLVYDKLNVKISDLGLFREVYAAD 182
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 25/115 (21%), Positives = 45/115 (39%), Gaps = 14/115 (12%)
Query: 100 NLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG 159
+ +L ++PE L+ + + N L +P + L + NN L
Sbjct: 177 FIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLS----LESIVAGNNILE- 228
Query: 160 PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFK 214
+L N +L T+ NN L +P + L+ +V +N LT +P +
Sbjct: 229 -ELPELQNLPFLTTIYADNNLLKT-LPDLPPS---LEALNVRDNYLT-DLPELPQ 277
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 28/112 (25%), Positives = 48/112 (42%), Gaps = 16/112 (14%)
Query: 100 NLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG 159
+L L+ ++PE + KS+ + + LS P L L +SNN L
Sbjct: 95 SLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPL--------LEYLGVSNNQLEK 145
Query: 160 PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPS 211
+P +L N ++L + + NN L +P +L + + NN L +P
Sbjct: 146 -LP-ELQNSSFLKIIDVDNNSLKK-LPDLPPSLEFI---AAGNNQLE-ELPE 190
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 24/130 (18%), Positives = 43/130 (33%), Gaps = 21/130 (16%)
Query: 98 ILNLELREMKLSG----KIPEPLKFCKSMQRLDLSANDLSGNIPAQICN----------- 142
+ N L+E ++P + KS + ++ N P
Sbjct: 8 VSNTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67
Query: 143 -WLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVA 201
L+L+N LS +P + L +L+ S N L+ +P +L L +
Sbjct: 68 CLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNN 122
Query: 202 NNDLTGTIPS 211
L+ P
Sbjct: 123 LKALSDLPPL 132
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 31/114 (27%), Positives = 48/114 (42%), Gaps = 18/114 (15%)
Query: 100 NLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG 159
L++ E S + E ++ L+ S+N++ +C+ P L L++SNN L
Sbjct: 281 FLDVSENIFS-GLSE---LPPNLYYLNASSNEIR-----SLCDLPPSLEELNVSNNKLIE 331
Query: 160 PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213
+PA L LI S N L+ +P NL +L V N L P
Sbjct: 332 -LPALPPR---LERLIASFNHLAE-VPELPQNLKQL---HVEYNPLR-EFPDIP 376
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 33/141 (23%), Positives = 51/141 (36%), Gaps = 27/141 (19%)
Query: 91 WNDKENRIL--NLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLV 148
W++ E N E REM +S ++ + L + L+L+ LS ++P + L
Sbjct: 43 WSEWERNAPPGNGEQREMAVS-RLRDCL--DRQAHELELNNLGLS-SLPELPPH----LE 94
Query: 149 LLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPY---------------QLSNLG 193
L S N L+ +P + L + LS P +L N
Sbjct: 95 SLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSS 153
Query: 194 RLKKFSVANNDLTGTIPSSFK 214
LK V NN L +P
Sbjct: 154 FLKIIDVDNNSLK-KLPDLPP 173
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 22/115 (19%), Positives = 48/115 (41%), Gaps = 16/115 (13%)
Query: 100 NLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG 159
++ L ++PE L+ + + N L +P + L L++ +N L+
Sbjct: 219 SIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLK-TLPDLPPS----LEALNVRDNYLTD 271
Query: 160 PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFK 214
+P + T+L+ +S N SG + NL L + ++N++ ++
Sbjct: 272 -LPELPQSLTFLD---VSENIFSG-LSELPPNLYYL---NASSNEIR-SLCDLPP 317
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 9/93 (9%), Positives = 33/93 (35%), Gaps = 10/93 (10%)
Query: 95 ENRILNL-----ELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVL 149
N + + +++++ + E + +++++L + N L P + +
Sbjct: 366 YNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPES----VED 420
Query: 150 LDLSNNDLSGPIPADLGNCTYLNTLILSNNKLS 182
L +++ + P L + ++
Sbjct: 421 LRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 14/108 (12%), Positives = 35/108 (32%), Gaps = 17/108 (15%)
Query: 103 LREMKLSG----KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLS 158
L+++ + + P+ + + L N +P N L L + N L
Sbjct: 359 LKQLHVEYNPLREFPDIPESVED-----LRMNSHLAEVPELPQN----LKQLHVETNPLR 409
Query: 159 GPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLT 206
P + L +++ ++ P + +L+ ++
Sbjct: 410 E-FPDIPESVEDLR---MNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 6e-11
Identities = 29/131 (22%), Positives = 51/131 (38%), Gaps = 15/131 (11%)
Query: 96 NRILNLE----LREMKLSG----KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYL 147
N + L + E+ S + P+ + L L N+L+ + P L
Sbjct: 202 NLLSTLAIPIAVEELDASHNSINVVRGPV--NVELTILKLQHNNLT-DTAW--LLNYPGL 256
Query: 148 VLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTG 207
V +DLS N+L + L L +SNN+L + + LK +++N L
Sbjct: 257 VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL- 314
Query: 208 TIPSSFKGFDK 218
+ + FD+
Sbjct: 315 HVERNQPQFDR 325
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 7e-10
Identities = 34/150 (22%), Positives = 58/150 (38%), Gaps = 19/150 (12%)
Query: 96 NRILNL-------ELREMKLSG----KIPE-PLKFCKSMQRLDLSANDLSGNIPAQICNW 143
N + + L E+ LS KI P + ++RL +S N L +
Sbjct: 242 NNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQP- 299
Query: 144 LPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANN 203
+P L +LDLS+N L + + L L L +N + + LS LK ++++N
Sbjct: 300 IPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHN 355
Query: 204 DLTGT-IPSSFKGFDKADFDGNSDLCGGPL 232
D + + F+ + D C
Sbjct: 356 DWDCNSLRALFRNVARPAVDDADQHCKIDY 385
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 7e-10
Identities = 22/121 (18%), Positives = 44/121 (36%), Gaps = 3/121 (2%)
Query: 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNN 155
N + + + L + ++ L+L+ + I + + L + N
Sbjct: 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFN 109
Query: 156 DLSGPIPADL-GNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFK 214
+ +P + N L L+L N LS N +L S++NN+L +F+
Sbjct: 110 AIRY-LPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ 168
Query: 215 G 215
Sbjct: 169 A 169
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 9e-09
Identities = 28/107 (26%), Positives = 45/107 (42%), Gaps = 3/107 (2%)
Query: 120 KSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADL-GNCTYLNTLILSN 178
++Q+L + N + +P + +P L +L L NDLS +P + N L TL +SN
Sbjct: 99 HTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSN 156
Query: 179 NKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKADFDGNS 225
N L L+ +++N LT S A+ N
Sbjct: 157 NNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNL 203
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 33/126 (26%), Positives = 56/126 (44%), Gaps = 20/126 (15%)
Query: 96 NRILNLE---------LREMKLSG-KI----PEPLKFCKSMQRLDLSANDLSGNIPAQIC 141
+I ++ ++++ + I P + + L L NDLS ++P I
Sbjct: 85 LQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIF 143
Query: 142 NWLPYLVLLDLSNNDLSGPIPAD-LGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSV 200
+ P L L +SNN+L I D T L L LS+N+L+ + LS + L +V
Sbjct: 144 HNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLTH-VD--LSLIPSLFHANV 199
Query: 201 ANNDLT 206
+ N L+
Sbjct: 200 SYNLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 27/125 (21%), Positives = 50/125 (40%), Gaps = 26/125 (20%)
Query: 96 NRILNLE---------LREMKLSG----KIPEP-LKFCKSMQRLDLSANDLSGNIPAQIC 141
N + +L L + +S +I + + S+Q L LS+N L+ ++
Sbjct: 133 NDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL--- 188
Query: 142 NWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVA 201
+ +P L ++S N LS L + L S+N ++ L L +
Sbjct: 189 SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTIL---KLQ 240
Query: 202 NNDLT 206
+N+LT
Sbjct: 241 HNNLT 245
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 12/95 (12%), Positives = 34/95 (35%), Gaps = 1/95 (1%)
Query: 125 LDLSANDLSGNIPAQICNW-LPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSG 183
D+ + + ++ + L ++ N+ + A L + + L L++ ++
Sbjct: 30 YDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE 89
Query: 184 PIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDK 218
Y + ++K + N + P F+
Sbjct: 90 IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL 124
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 28/113 (24%), Positives = 45/113 (39%), Gaps = 2/113 (1%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
L+L K++ L+ C ++Q L L ++ ++ I L L LDLS+N LS
Sbjct: 31 LDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSL 89
Query: 161 IPADLGNCTYLNTLILSNNKLSG-PIPYQLSNLGRLKKFSVANNDLTGTIPSS 212
+ G + L L L N + NL L+ + N + I
Sbjct: 90 SSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRI 142
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 23/97 (23%), Positives = 43/97 (44%), Gaps = 4/97 (4%)
Query: 119 CKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSN 178
C + D + + +IP+ + + LDLS N ++ DL C L LIL +
Sbjct: 4 CDASGVCDGRSRSFT-SIPSGL---TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 179 NKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
++++ +LG L+ +++N L+ S F
Sbjct: 60 SRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGP 96
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 17/120 (14%), Positives = 38/120 (31%), Gaps = 6/120 (5%)
Query: 103 LREMKLSG----KIPEPLKF--CKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNND 156
L+ + L G + F ++Q L + + I L L L++
Sbjct: 100 LKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALS 159
Query: 157 LSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF 216
L L + ++ L L ++ + + L ++ + + +L S
Sbjct: 160 LRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVD 219
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 29/117 (24%), Positives = 45/117 (38%), Gaps = 7/117 (5%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
+ R + IP L +M+ LDLS N ++ I L +L L ++ ++
Sbjct: 10 CDGRSRSFT-SIPSGL--TAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINT- 64
Query: 161 IPAD-LGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTG-TIPSSFKG 215
I D + L L LS+N LS L LK ++ N + S F
Sbjct: 65 IEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPN 121
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 26/106 (24%), Positives = 43/106 (40%), Gaps = 10/106 (9%)
Query: 111 KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTY 170
+P+ ++ + M+ L+LS+ + + I L +LD+SNN+L L
Sbjct: 401 PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI---PQTLEVLDVSNNNLDS-FSLFLPR--- 452
Query: 171 LNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF 216
L L +S NKL +P S L ++ N L F
Sbjct: 453 LQELYISRNKLKT-LP-DASLFPVLLVMKISRNQLKSVPDGIFDRL 496
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 8e-08
Identities = 25/105 (23%), Positives = 41/105 (39%), Gaps = 9/105 (8%)
Query: 103 LREMKLSG-KIPE-PLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
+R + LS I ++++ LD+S N+L + LP L L +S N L
Sbjct: 412 MRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLD-SFSLF----LPRLQELYISRNKLKT- 465
Query: 161 IPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDL 205
+P L + +S N+L L L+K + N
Sbjct: 466 LPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 30/115 (26%), Positives = 48/115 (41%), Gaps = 12/115 (10%)
Query: 101 LELREMKLS--GKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLS 158
L L + L K E L K++ LD+S N +P C W + L+LS+ +
Sbjct: 366 LVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDS-CQWPEKMRFLNLSSTGIR 423
Query: 159 GPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213
+ + L L +SNN L L RL++ ++ N L T+P +
Sbjct: 424 V-VKTCI--PQTLEVLDVSNNNLDS-FS---LFLPRLQELYISRNKLK-TLPDAS 470
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 16/192 (8%), Positives = 57/192 (29%), Gaps = 13/192 (6%)
Query: 39 FSSLASETVAEDDVKCLEGVKSSLNDPQRKLSSWSFGNSTIGFI----CQFVGVSCWNDK 94
SS+ + + ++ + +++ + +F S + +
Sbjct: 195 LSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELS 254
Query: 95 ENRILNLELREMK-LSGKIPEPLKFCKSMQRLDLSANDLSGN----IPAQICNWLPYLVL 149
E + L + + + + ++ + + + + + + L +
Sbjct: 255 EVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKR 314
Query: 150 LDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQ---LSNLGRLKKFSVANNDLT 206
+ + N+ + + + L L LS N + L+ ++ N L
Sbjct: 315 ITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR 374
Query: 207 GTIPSSFKGFDK 218
++ + +
Sbjct: 375 -SMQKTGEILLT 385
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 9e-07
Identities = 14/97 (14%), Positives = 29/97 (29%), Gaps = 1/97 (1%)
Query: 120 KSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNN 179
S+ L++ A L N +Q + + L L ++ + + + + L L +
Sbjct: 148 TSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206
Query: 180 KLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF 216
L+ L + SF
Sbjct: 207 NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL 243
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 15/106 (14%), Positives = 43/106 (40%), Gaps = 1/106 (0%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
LE++ + L + LK + + L L ++ + + + L + L+L + +L+
Sbjct: 153 LEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARF 211
Query: 161 IPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLT 206
+ L + + + S + L +L ++ + +++
Sbjct: 212 QFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE 257
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 7e-11
Identities = 37/198 (18%), Positives = 69/198 (34%), Gaps = 43/198 (21%)
Query: 338 GTTYKA-MLPDGSVLAVKRLNTCKL-GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395
G A A K++ + +F+ E+ + L HPN+ L E+
Sbjct: 23 GEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF---EDNT 79
Query: 396 LIY---KYMSSGTLYS--LLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNIC 450
IY + + G L+ + + E D + L A +A+ H N+
Sbjct: 80 DIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA---VAYCH--------KLNVA 128
Query: 451 ------SNVILVDEDFDARIM--DFGLAKLMTSSDESSFVNGDLGEFGYIAPE-----YS 497
N + + + D+ + DFGLA + +G Y++P+ Y
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARF---KPGKMMRTKVGTPYYVSPQVLEGLY- 184
Query: 498 STMVASLKGDVYGIGVVL 515
+ D + GV++
Sbjct: 185 -----GPECDEWSAGVMM 197
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 31/132 (23%), Positives = 53/132 (40%), Gaps = 17/132 (12%)
Query: 96 NRILNLE----LREMKLSG----KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYL 147
N + L + E+ S + P+ + L L N+L+ + + N P L
Sbjct: 196 NLLSTLAIPIAVEELDASHNSINVVRGPV--NVELTILKLQHNNLT-DTAW-LLN-YPGL 250
Query: 148 VLLDLSNNDLSGPIPAD-LGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLT 206
V +DLS N+L I L L +SNN+L + + LK +++N L
Sbjct: 251 VEVDLSYNELEK-IMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL 308
Query: 207 GTIPSSFKGFDK 218
+ + FD+
Sbjct: 309 -HVERNQPQFDR 319
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 22/121 (18%), Positives = 43/121 (35%), Gaps = 3/121 (2%)
Query: 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNN 155
N + + + L + ++ L+L+ + I + + L + N
Sbjct: 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFN 103
Query: 156 DLSGPIPAD-LGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFK 214
+ +P N L L+L N LS N +L S++NN+L +F+
Sbjct: 104 AIRY-LPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ 162
Query: 215 G 215
Sbjct: 163 A 163
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 34/149 (22%), Positives = 58/149 (38%), Gaps = 19/149 (12%)
Query: 96 NRILNL-------ELREMKLSG----KIPE-PLKFCKSMQRLDLSANDLSGNIPAQICNW 143
N + + L E+ LS KI P + ++RL +S N L +
Sbjct: 236 NNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQP- 293
Query: 144 LPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANN 203
+P L +LDLS+N L + + L L L +N + + LS LK ++++N
Sbjct: 294 IPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHN 349
Query: 204 DLTGT-IPSSFKGFDKADFDGNSDLCGGP 231
D + + F+ + D C
Sbjct: 350 DWDCNSLRALFRNVARPAVDDADQHCKID 378
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 30/126 (23%), Positives = 52/126 (41%), Gaps = 3/126 (2%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
L L ++++ + ++Q+L + N + +P + +P L +L L NDLS
Sbjct: 74 LNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS- 131
Query: 161 IPADL-GNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKA 219
+P + N L TL +SNN L L+ +++N LT S A
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHA 191
Query: 220 DFDGNS 225
+ N
Sbjct: 192 NVSYNL 197
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 25/109 (22%), Positives = 46/109 (42%), Gaps = 17/109 (15%)
Query: 103 LREMKLSG----KIPEP-LKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDL 157
L + +S +I + + S+Q L LS+N L+ ++ + +P L ++S N L
Sbjct: 143 LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL---SLIPSLFHANVSYNLL 198
Query: 158 SGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLT 206
S L + L S+N ++ L L + +N+LT
Sbjct: 199 S-----TLAIPIAVEELDASHNSINVVRGPVNVELTIL---KLQHNNLT 239
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 9e-05
Identities = 13/93 (13%), Positives = 36/93 (38%), Gaps = 3/93 (3%)
Query: 125 LDLSANDLSGNIPAQICN-WLPYLVLLDLSNNDLSGPIPAD-LGNCTYLNTLILSNNKLS 182
D+ + + ++ + L ++ N+ + +PA L + + L L++ ++
Sbjct: 24 YDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIE 82
Query: 183 GPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
Y + ++K + N + P F+
Sbjct: 83 EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQN 115
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 40/205 (19%), Positives = 75/205 (36%), Gaps = 35/205 (17%)
Query: 347 DGSVLAVKRLNTCKL-GEKKFRNEMNRLGQLR-HPNLAPLLGYCVVEEEK-------LLI 397
G A+KRL + + + E+ + +L HPN+ + +E+ L+
Sbjct: 52 SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLL 111
Query: 398 YKYMSSGTLYSLL--QGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLH-----QNIC 450
+ G L L + L T +I R + +H +PP +H +N+
Sbjct: 112 LTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENL- 169
Query: 451 SNVILVDEDFDARIMDFGLAKLMT-------SSDESSFVNGDLGEFG---YIAPE---YS 497
L+ ++ DFG A ++ S+ + V ++ Y PE
Sbjct: 170 ----LLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY 225
Query: 498 STMVASLKGDVYGIGVVLLELAGFK 522
S K D++ +G +L L +
Sbjct: 226 SNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 9e-11
Identities = 45/210 (21%), Positives = 75/210 (35%), Gaps = 50/210 (23%)
Query: 340 TYKAMLPDGSVL--AVKRLNTCKLG-----EKKFRNEMNRLGQLRHPNLAPLLGYCVVEE 392
M D S L AVK T E F E + + H N+ +G +
Sbjct: 50 QVSGMPNDPSPLQVAVK---TLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106
Query: 393 EKLLIYKYMSSGTLYSLLQ------GNATELDWPTRFRIGLGAARGLAWL--HHGCQPPF 444
+ ++ + M+ G L S L+ + L + A G +L +H F
Sbjct: 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH-----F 161
Query: 445 LHQNI-CSNVILVD---EDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYI-----APE 495
+H++I N L+ A+I DFG+A+ + + G + PE
Sbjct: 162 IHRDIAARN-CLLTCPGPGRVAKIGDFGMARDIYRASYYRK-----GGCAMLPVKWMPPE 215
Query: 496 ------YSSTMVASLKGDVYGIGVVLLELA 519
++S K D + GV+L E+
Sbjct: 216 AFMEGIFTS------KTDTWSFGVLLWEIF 239
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 1e-10
Identities = 85/506 (16%), Positives = 144/506 (28%), Gaps = 143/506 (28%)
Query: 40 SSLASETVAEDDVKCL--EGVKSSLNDPQRKLSSW-SFGNSTIGFICQFVGVSCWNDKEN 96
+ +A + V+C + W + N C N E
Sbjct: 164 TWVALDVCLSYKVQCKMDFKI------------FWLNLKN------C--------NSPET 197
Query: 97 RILNLELREMKLSGKI-PEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPY----LVLLD 151
+ L+ KL +I P + L + + + + + PY LVLL+
Sbjct: 198 VLEMLQ----KLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK-PYENCLLVLLN 252
Query: 152 LSNNDLSGPIPA-DLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIP 210
+ N A +L C L+ + K + LS S+ ++
Sbjct: 253 VQNAKA---WNAFNLS-CK---ILLTTRFK---QVTDFLSAATT-THISLDHHS------ 295
Query: 211 SSFKGFDKADFDGNSDLCGGPLGSKCGGLSKKNLAII-IAAGIFGAAASMLLAFGLWWWY 269
+ L L + L ++ L I + GL W
Sbjct: 296 ---MTLTPDE---VKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAE----SIRDGLATWD 345
Query: 270 HLRWVRRRKRGYGIGRDDDDSRWLERLRSHKLAQV----SLFQKPLVKVKLA-------- 317
+ + V K I + S L L + ++ S+F +
Sbjct: 346 NWKHVNCDKLTTII----ESS--LNVLEPAEYRKMFDRLSVFPPS-AHIPTILLSLIWFD 398
Query: 318 ----DLMAASNSFCSENVIISTRTGTTYKAMLPDGSV-LAVKRLNTCKLGEKKFRNEMNR 372
D+M N +++ +T +P + L VK N L + + N
Sbjct: 399 VIKSDVMVVVNKLHKYSLVEKQPKESTIS--IPSIYLELKVKLENEYAL-HRSIVDHYNI 455
Query: 373 LGQLRHPNLAPLL--GYCVVEEEKLLIYKYMSSGTLYSLLQGNATE---------LDWPT 421
+L P Y Y ++ + L E LD+
Sbjct: 456 PKTFDSDDLIPPYLDQY---------FYSHIG----HHLKNIEHPERMTLFRMVFLDF-- 500
Query: 422 RFRIGLGA---ARGLAWLHHGCQPPFLHQ------NICSNVILVDEDFDAR---IMDFGL 469
RF L AW G L Q IC N D ++ I+DF L
Sbjct: 501 RF---LEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDN----DPKYERLVNAILDF-L 552
Query: 470 AKLMTSSDESSFVNGDLGEFGYIAPE 495
K+ + S + DL +A +
Sbjct: 553 PKIEENLICSKYT--DLLRIALMAED 576
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 3e-04
Identities = 60/424 (14%), Positives = 117/424 (27%), Gaps = 119/424 (28%)
Query: 7 EAIIMNQE--LTIIDKNTQKAPPATA----KSDSTQITFSSLASETVAE------DDVKC 54
E ++ + L ID N ++ + S Q L E +V+
Sbjct: 196 ETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQN 255
Query: 55 LEGVKSSLNDPQRKLSSWSFGNSTIGFICQFVGVSCWNDKEN-RILNLELREMKLSGKIP 113
+ + F S C+ + + K+ L+
Sbjct: 256 AKAWNA-------------FNLS-----CKILLTT--RFKQVTDFLSAATTTHISLDHHS 295
Query: 114 EPLKFCKSM----QRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADL--GN 167
L + + LD DL P ++ P + + I + G
Sbjct: 296 MTLTPDEVKSLLLKYLDCRPQDL----PREVLTTNPRRLSI----------IAESIRDGL 341
Query: 168 CTYLNTLILSNNKLSGPIPYQLSNL------GRLKKFSVANNDLTGTIPSS--------- 212
T+ N ++ +KL+ I L+ L + SV IP+
Sbjct: 342 ATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAH--IPTILLSLIWFDV 399
Query: 213 --------FKGFDK---ADFDGNSDLCGGP---LGSKCGGLSKKNL--AII----IAAGI 252
K + P L K ++ L +I+ I
Sbjct: 400 IKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTF 459
Query: 253 FGAAASMLLAFGLWWW---YHLRWVRRRKRGYGIGRDDDDSRWLER-LR----------- 297
++ +HL+ + +R D R+LE+ +R
Sbjct: 460 DSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGS 519
Query: 298 -SHKLAQVSLFQK------PLVKVKLADLMAASNSF---CSENVIISTRTGTTYKAMLPD 347
+ L Q+ ++ P + + ++ F EN+I S T A++ +
Sbjct: 520 ILNTLQQLKFYKPYICDNDPKYERLVNAIL----DFLPKIEENLICSKYTDLLRIALMAE 575
Query: 348 GSVL 351
+
Sbjct: 576 DEAI 579
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 42/208 (20%), Positives = 73/208 (35%), Gaps = 50/208 (24%)
Query: 338 GTTYKA-MLPDGSVLAVKRLNTCKLG--------------EKKFRNEMNRLGQLRHPNLA 382
G S A+K + + ++ NE++ L L HPN+
Sbjct: 50 GEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNII 109
Query: 383 PLLGYCVVEEEKLLIYKYMSSGTLYSLL--QGNATELDWPTRFRIGLGAARGLAWLHHGC 440
L ++ L+ ++ G L+ + + E D + L + +LH
Sbjct: 110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSG---ICYLH--- 163
Query: 441 QPPFLHQNIC------SNVILVDEDFDARIM--DFGLAKLMTSSDESSFVNGDLGEFGYI 492
NI N++L +++ I DFGL+ + + LG YI
Sbjct: 164 -----KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF---SKDYKLRDRLGTAYYI 215
Query: 493 APE-----YSSTMVASLKGDVYGIGVVL 515
APE Y+ K DV+ GV++
Sbjct: 216 APEVLKKKYNE------KCDVWSCGVIM 237
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 44/200 (22%), Positives = 71/200 (35%), Gaps = 45/200 (22%)
Query: 338 GTTYKA-MLPDGSVLAVKRLNTCKLGEK---KFRNEMNRLGQLRHPNLAPLLGYCVVEEE 393
G K AVK +N K E+ L +L HPN+ L E+
Sbjct: 36 GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL---ED 92
Query: 394 KLLIY---KYMSSGTLYSLL--QGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQN 448
Y + + G L+ + + +E D + + ++H N
Sbjct: 93 SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG---ITYMHK--------HN 141
Query: 449 IC------SNVILVDEDFDARIM--DFGLAKLMTSSDESSFVNGDLGEFGYIAPE----- 495
I N++L ++ D I DFGL+ +++ + +G YIAPE
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 496 YSSTMVASLKGDVYGIGVVL 515
Y K DV+ GV+L
Sbjct: 199 YDE------KCDVWSAGVIL 212
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 40/196 (20%), Positives = 70/196 (35%), Gaps = 48/196 (24%)
Query: 352 AVKRLNTCKLG-----EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTL 406
AVK T E F E + + H N+ +G + + ++ + M+ G L
Sbjct: 105 AVK---TLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDL 161
Query: 407 YSLLQGNATELDWPTRF------RIGLGAARGLAWL--HHGCQPPFLHQNI-CSNVILVD 457
S L+ P+ + A G +L +H F+H++I N L+
Sbjct: 162 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH-----FIHRDIAARN-CLLT 215
Query: 458 EDFDARIM---DFGLAKLMTSSDESSFVNGDLGEFGYI-----APE------YSSTMVAS 503
R+ DFG+A+ + + G + PE ++S
Sbjct: 216 CPGPGRVAKIGDFGMARDIYRAGYYRK-----GGCAMLPVKWMPPEAFMEGIFTS----- 265
Query: 504 LKGDVYGIGVVLLELA 519
K D + GV+L E+
Sbjct: 266 -KTDTWSFGVLLWEIF 280
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 20/94 (21%), Positives = 43/94 (45%), Gaps = 4/94 (4%)
Query: 114 EPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNT 173
P+ +++RL + D++ + + L L LLD+S++ I + +N+
Sbjct: 82 NPISGLSNLERLRIMGKDVTSDKIPNLSG-LTSLTLLDISHSAHDDSILTKINTLPKVNS 140
Query: 174 LILS-NNKLSGPIPYQLSNLGRLKKFSVANNDLT 206
+ LS N ++ +P L L LK ++ + +
Sbjct: 141 IDLSYNGAITDIMP--LKTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 16/98 (16%), Positives = 39/98 (39%), Gaps = 3/98 (3%)
Query: 114 EPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNT 173
+++ +++ L ++ + N I L L L + D++ +L T L
Sbjct: 60 TGIEYAHNIKDLTINNIHAT-NYNP-ISG-LSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116
Query: 174 LILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPS 211
L +S++ I +++ L ++ ++ N I
Sbjct: 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP 154
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 16/99 (16%), Positives = 35/99 (35%), Gaps = 11/99 (11%)
Query: 120 KSMQRLDLSAN---DLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176
S+ + L+ DL+G I + L ++N + P + + L L +
Sbjct: 44 NSLTYITLANINVTDLTG-----IEY-AHNIKDLTINNIHATNYNP--ISGLSNLERLRI 95
Query: 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
++ LS L L ++++ +I +
Sbjct: 96 MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 15/84 (17%), Positives = 30/84 (35%), Gaps = 4/84 (4%)
Query: 100 NLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG 159
L++ I + + +DLS N +I + LP L L++ + +
Sbjct: 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKT-LPELKSLNIQFDGVHD 173
Query: 160 PIPADLGNCTYLNTLILSNNKLSG 183
+ + LN L + + G
Sbjct: 174 YRG--IEDFPKLNQLYAFSQTIGG 195
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 43/186 (23%), Positives = 85/186 (45%), Gaps = 12/186 (6%)
Query: 338 GTTYKAML-PDGSVLAVK--RLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394
G +K P G V+A K L + E+ L + P + G + E
Sbjct: 47 GVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106
Query: 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNI-CSNV 453
+ ++M G+L +L+ + ++ + +GL +L + +H+++ SN
Sbjct: 107 SICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSN- 162
Query: 454 ILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGV 513
ILV+ + ++ DFG++ + S +SFV G Y++PE S++ D++ +G+
Sbjct: 163 ILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHYSVQSDIWSMGL 218
Query: 514 VLLELA 519
L+E+A
Sbjct: 219 SLVEMA 224
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 24/136 (17%), Positives = 47/136 (34%), Gaps = 16/136 (11%)
Query: 95 ENRILNLE--------LREMKLSG----KIPEPLKF--CKSMQRLDLSANDLSGNIPAQI 140
N ++ + L + ++ E F +++ LD+S I
Sbjct: 87 FNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGI 145
Query: 141 CNWLPYLVLLDLSNNDLSGPIPAD-LGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFS 199
N L L +L ++ N D L L LS +L P ++L L+ +
Sbjct: 146 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 205
Query: 200 VANNDLTGTIPSSFKG 215
+++N+ +K
Sbjct: 206 MSHNNFFSLDTFPYKC 221
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 24/132 (18%), Positives = 42/132 (31%), Gaps = 4/132 (3%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
L++ S++ L ++ N N I L L LDLS L
Sbjct: 131 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 190
Query: 161 IPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKA- 219
P + + L L +S+N + L L+ + N + + + F +
Sbjct: 191 SPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSL 250
Query: 220 ---DFDGNSDLC 228
+ N C
Sbjct: 251 AFLNLTQNDFAC 262
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 25/117 (21%), Positives = 41/117 (35%), Gaps = 3/117 (2%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLS-GNIPAQICNWLPYLVLLDLSNNDLSG 159
LEL KL + +L LS+N LS +Q L LDLS N +
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 92
Query: 160 PIPADLGNCTYLNTLILSNNKLSGPIPYQL-SNLGRLKKFSVANNDLTGTIPSSFKG 215
+ ++ L L ++ L + + +L L +++ F G
Sbjct: 93 -MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 148
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 20/119 (16%), Positives = 41/119 (34%), Gaps = 7/119 (5%)
Query: 103 LREMKLSG----KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLS 158
L+ + LS + + ++ LD ++L + L L+ LD+S+
Sbjct: 80 LKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 139
Query: 159 GPIPAD-LGNCTYLNTLILSNNK-LSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
+ L L ++ N +P + L L ++ L P++F
Sbjct: 140 V-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 197
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 24/100 (24%), Positives = 40/100 (40%), Gaps = 7/100 (7%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNK 180
S + ++ L+ ++P I L+L +N L T L L LS+N
Sbjct: 8 SGTEIRCNSKGLT-SVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNG 63
Query: 181 LS--GPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDK 218
LS G LK ++ N + T+ S+F G ++
Sbjct: 64 LSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQ 102
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 41/202 (20%), Positives = 71/202 (35%), Gaps = 40/202 (19%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEK---------KFRNEMNRLGQLRHPNLAPLLGY 387
G A +A++ ++ K E+ L +L HP + +
Sbjct: 149 GEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI--K 206
Query: 388 CVVEEEKL-LIYKYMSSGTLYSLL--QGNATELDWPTRFRIGLGAARGLAWLHHGCQPPF 444
+ E ++ + M G L+ + E F L A + +LH
Sbjct: 207 NFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA---VQYLHE------ 257
Query: 445 LHQNIC------SNVILVDEDFDARIM--DFGLAKLMTSSDESSFVNGDLGEFGYIAPE- 495
I NV+L ++ D I DFG +K++ E+S + G Y+APE
Sbjct: 258 --NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTPTYLAPEV 312
Query: 496 --YSSTMVASLKGDVYGIGVVL 515
T + D + +GV+L
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVIL 334
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 45/207 (21%), Positives = 76/207 (36%), Gaps = 63/207 (30%)
Query: 352 AVKRL--NTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYS 408
AVK L + + +EM + + +H N+ LLG C + +I +Y S G L
Sbjct: 71 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 130
Query: 409 LLQ---------------GNATELDWPTRFRIGLGAARGLAWL--HHGCQPPFLHQNI-C 450
L+ ++ + ARG+ +L +H+++
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAA 185
Query: 451 SNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYI------------APE--- 495
NV LV E+ +I DFGLA+ + + D Y APE
Sbjct: 186 RNV-LVTENNVMKIADFGLARDINNIDY------------YKKTTNGRLPVKWMAPEALF 232
Query: 496 ---YSSTMVASLKGDVYGIGVVLLELA 519
Y+ + DV+ GV++ E+
Sbjct: 233 DRVYTH------QSDVWSFGVLMWEIF 253
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 4e-10
Identities = 42/197 (21%), Positives = 70/197 (35%), Gaps = 39/197 (19%)
Query: 338 GTTYKA-MLPDGSVLAVKRLNTCKLGEK---KFRNEMNRLGQLRHPNLAPLLGYCVVEEE 393
G K AVK +N K E+ L +L HPN+ L
Sbjct: 36 GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95
Query: 394 KLLIYKYMSSGTLYS--LLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNIC- 450
++ + + G L+ + + +E D + + ++H NI
Sbjct: 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG---ITYMH--------KHNIVH 144
Query: 451 -----SNVILVDEDFDARIM--DFGLAKLMTSSDESSFVNGDLGEFGYIAPE-----YSS 498
N++L ++ D I DFGL+ +++ + +G YIAPE Y
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPEVLRGTY-- 199
Query: 499 TMVASLKGDVYGIGVVL 515
K DV+ GV+L
Sbjct: 200 ----DEKCDVWSAGVIL 212
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 5e-10
Identities = 26/115 (22%), Positives = 42/115 (36%), Gaps = 16/115 (13%)
Query: 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICN--WLPYLVLLDLSN 154
R L+ K + ++ L L+ DL+ +C+ L + LDLS+
Sbjct: 418 RAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-----VLCHLEQLLLVTHLDLSH 472
Query: 155 NDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKK---FSVANNDLT 206
N L +P L L L S+N L + + L + + NN L
Sbjct: 473 NRLRA-LPPALAALRCLEVLQASDNALE-----NVDGVANLPRLQELLLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 7e-07
Identities = 25/109 (22%), Positives = 34/109 (31%), Gaps = 19/109 (17%)
Query: 94 KENRILNLE-------LREMKLSG----KIPEPLKFCKSMQRLDLSANDLS--GNIPAQI 140
+ L + + LS +P L + ++ L S N L +
Sbjct: 449 AHKDLTVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVAN-- 506
Query: 141 CNWLPYLVLLDLSNNDLSG-PIPADLGNCTYLNTLILSNNKLSGPIPYQ 188
LP L L L NN L L +C L L L N L Q
Sbjct: 507 ---LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 552
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 52/214 (24%), Positives = 85/214 (39%), Gaps = 49/214 (22%)
Query: 338 GTTYKAML--PDGSVL-AVKRL--NTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVE 391
G KA + + A+KR+ K + F E+ L +L HPN+ LLG C
Sbjct: 39 GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 98
Query: 392 EEKLLIYKYMSSGTLYSLLQ---------------GNATELDWPTRFRIGLGAARGLAWL 436
L +Y G L L+ A+ L ARG+ +L
Sbjct: 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 158
Query: 437 --HHGCQPPFLHQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEF--GY 491
F+H+++ N+ LV E++ A+I DFGL++ + +V +G +
Sbjct: 159 SQKQ-----FIHRDLAARNI-LVGENYVAKIADFGLSR-----GQEVYVKKTMGRLPVRW 207
Query: 492 IAPE------YSSTMVASLKGDVYGIGVVLLELA 519
+A E Y++ DV+ GV+L E+
Sbjct: 208 MAIESLNYSVYTT------NSDVWSYGVLLWEIV 235
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 49/266 (18%), Positives = 105/266 (39%), Gaps = 37/266 (13%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEK---KFRNEMNRLGQLRHPNLA--PLLGYCVVEE 392
++ + + A+K +N + + +RNE+ L +L+ + L Y + +
Sbjct: 23 SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY-EITD 81
Query: 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLH-HGCQPPFLHQNI-C 450
+ + + + L S L+ +D R + +H HG +H ++
Sbjct: 82 QYIYMVMECGNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKP 136
Query: 451 SNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPE-----------YSST 499
+N L+ + +++DFG+A M S + +G Y+ PE S
Sbjct: 137 AN-FLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSK 194
Query: 500 MVASLKGDVYGIGVVLLELA-G---FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEI 555
S K DV+ +G +L + G F +++ +++L + I+ ++++
Sbjct: 195 SKISPKSDVWSLGCILYYMTYGKTPF-QQIINQISKLHAIIDPNHEIEFP---DIPEKDL 250
Query: 556 LQFLKVACNCVVSRPKDRWSMYQVYQ 581
LK C+ PK R S+ ++
Sbjct: 251 QDVLK---CCLKRDPKQRISIPELLA 273
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 45/207 (21%), Positives = 76/207 (36%), Gaps = 63/207 (30%)
Query: 352 AVKRL--NTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYS 408
AVK L + + +EM + + +H N+ LLG C + +I +Y S G L
Sbjct: 117 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 176
Query: 409 LLQGN---------------ATELDWPTRFRIGLGAARGLAWL--HHGCQPPFLHQNI-C 450
L+ ++ + ARG+ +L +H+++
Sbjct: 177 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAA 231
Query: 451 SNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYI------------APE--- 495
NV LV E+ +I DFGLA+ + + D Y APE
Sbjct: 232 RNV-LVTENNVMKIADFGLARDINNIDY------------YKKTTNGRLPVKWMAPEALF 278
Query: 496 ---YSSTMVASLKGDVYGIGVVLLELA 519
Y+ + DV+ GV++ E+
Sbjct: 279 DRVYTH------QSDVWSFGVLMWEIF 299
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 49/274 (17%), Positives = 106/274 (38%), Gaps = 53/274 (19%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEK---KFRNEMNRLGQLRHPNLA--PLLGYCVVEE 392
++ + + A+K +N + + +RNE+ L +L+ + L Y + +
Sbjct: 70 SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY-EITD 128
Query: 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAAR--------GLAWLH-HGCQPP 443
+ + + + L S L+ + I + + +H HG
Sbjct: 129 QYIYMVMECGNIDLNSWLK---------KKKSIDPWERKSYWKNMLEAVHTIHQHG---- 175
Query: 444 FLHQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPE------- 495
+H ++ +N ++VD +++DFG+A M S + +G Y+ PE
Sbjct: 176 IVHSDLKPANFLIVDGML--KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 496 ----YSSTMVASLKGDVYGIGVVLLELA-G---FKGNLVDWVNQLSSSGRSKEAIDKALC 547
S S K DV+ +G +L + G F +++ +++L + I+
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-QQIINQISKLHAIIDPNHEIEFP-- 290
Query: 548 GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQ 581
++++ LK C+ PK R S+ ++
Sbjct: 291 -DIPEKDLQDVLK---CCLKRDPKQRISIPELLA 320
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 7e-10
Identities = 53/272 (19%), Positives = 101/272 (37%), Gaps = 49/272 (18%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEK---KFRNEMNRLGQLRHPNLA--PLLGYCVVEE 392
++ + + A+K +N + + +RNE+ L +L+ + L Y E
Sbjct: 42 SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY---EI 98
Query: 393 EKLLIYKYM--SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLH-HGCQPPFLH--- 446
IY M + L S L+ +D R + +H HG +H
Sbjct: 99 TDQYIYMVMECGNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIHQHG----IVHSDL 153
Query: 447 --QNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPE--------- 495
N L+ + +++DFG+A M S + +G Y+ PE
Sbjct: 154 KPANF-----LIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207
Query: 496 --YSSTMVASLKGDVYGIGVVLLELA-G---FKGNLVDWVNQLSSSGRSKEAIDKALCGK 549
S S K DV+ +G +L + G F +++ +++L + I+
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-QQIINQISKLHAIIDPNHEIEFP---D 263
Query: 550 GYDEEILQFLKVACNCVVSRPKDRWSMYQVYQ 581
++++ LK C+ PK R S+ ++
Sbjct: 264 IPEKDLQDVLK---CCLKRDPKQRISIPELLA 292
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 7e-10
Identities = 29/226 (12%), Positives = 63/226 (27%), Gaps = 50/226 (22%)
Query: 337 TGTTYKAM-LPDGSVLAVKRLNTCKLGE----KKFRNE---MNRLGQLRHPNLAPLL--- 385
+A G V + K+ + E + L +++ A +
Sbjct: 91 PYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 150
Query: 386 -----------------------GYCVVEEEKLLIYKYMSSGTLYSLLQGNATE---LDW 419
V+ L + T +L +++ L
Sbjct: 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVH 210
Query: 420 PTRFRIGLGAARGLAWLH-HGCQPPFLHQNI-CSNVILVDEDFDARIMDFGLAKLMTSSD 477
R ++ L R LA LH +G +H + + I++D+ + F +S
Sbjct: 211 HARLQLTLQVIRLLASLHHYG----LVHTYLRPVD-IVLDQRGGVFLTGFEHLVRDGASA 265
Query: 478 ESSFVNGDLGEFGYIAPE-----YSSTMVASLKGDVYGIGVVLLEL 518
S + A + + D + +G+ + +
Sbjct: 266 VSP-IGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 9e-10
Identities = 47/199 (23%), Positives = 77/199 (38%), Gaps = 42/199 (21%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEK---KFRNEMNRLGQLRHPNLAPLLGYCVVEEE 393
+ + G A K +NT KL + K E +L+HPN+ L E
Sbjct: 20 SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF 79
Query: 394 KLLIYKYMSSGTLYSLL--QGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNIC- 450
L++ ++ G L+ + + +E D + L + +A+ H I
Sbjct: 80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES---IAYCH--------SNGIVH 128
Query: 451 -----SNVILVDEDFDARIM--DFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVAS 503
N++L + A + DFGLA + ++S +G G GY++PE V
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPGYLSPE-----V-- 178
Query: 504 LKGDVYG-------IGVVL 515
LK D Y GV+L
Sbjct: 179 LKKDPYSKPVDIWACGVIL 197
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 42/202 (20%), Positives = 70/202 (34%), Gaps = 40/202 (19%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLG---------EKKFRNEMNRLGQLRHPNLAPLLGY 387
G A +A+K ++ K E+ L +L HP + +
Sbjct: 24 GEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI--K 81
Query: 388 CVVEEEKL-LIYKYMSSGTL--YSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPF 444
+ E ++ + M G L + E F L A + +LH
Sbjct: 82 NFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA---VQYLHE------ 132
Query: 445 LHQNIC------SNVILVDEDFDARIM--DFGLAKLMTSSDESSFVNGDLGEFGYIAPE- 495
I NV+L ++ D I DFG +K++ E+S + G Y+APE
Sbjct: 133 --NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTPTYLAPEV 187
Query: 496 --YSSTMVASLKGDVYGIGVVL 515
T + D + +GV+L
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVIL 209
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 30/116 (25%), Positives = 53/116 (45%), Gaps = 10/116 (8%)
Query: 103 LREMKLSG----KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLS 158
L ++++ IP+ L S+ L L N ++ + A L L L LS N +S
Sbjct: 173 LSYIRIADTNITTIPQGL-P-PSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS 229
Query: 159 GPIPAD-LGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213
+ L N +L L L+NNKL +P L++ ++ + NN+++ + F
Sbjct: 230 A-VDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDF 283
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 26/123 (21%), Positives = 56/123 (45%), Gaps = 14/123 (11%)
Query: 103 LREMKLSG----KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDL- 157
L + LS ++PE + K++Q L + N+++ + + N L +++++L N L
Sbjct: 102 LERLYLSKNQLKELPEKM-P-KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLK 158
Query: 158 SGPIPAD-LGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPS-SFKG 215
S I L+ + +++ ++ IP L L + + N +T + + S KG
Sbjct: 159 SSGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKIT-KVDAASLKG 214
Query: 216 FDK 218
+
Sbjct: 215 LNN 217
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 21/96 (21%), Positives = 37/96 (38%), Gaps = 4/96 (4%)
Query: 121 SMQRLDLSANDL-SGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNN 179
M ++L N L S I + L + +++ +++ IP L L L L N
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGN 202
Query: 180 KLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
K++ L L L K ++ N ++ S
Sbjct: 203 KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN 238
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 29/105 (27%), Positives = 46/105 (43%), Gaps = 6/105 (5%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNK 180
++ + S L +P + P LLDL NN ++ D N L+TLIL NNK
Sbjct: 32 HLRVVQCSDLGLE-KVPKDL---PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK 87
Query: 181 LSGPIPYQLSNLGRLKKFSVANNDLTGTIPSS-FKGFDKADFDGN 224
+S P + L +L++ ++ N L +P K + N
Sbjct: 88 ISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHEN 131
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 20/111 (18%), Positives = 38/111 (34%), Gaps = 10/111 (9%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG- 159
L L +S L ++ L L+ N L +P + + Y+ ++ L NN++S
Sbjct: 221 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD-HKYIQVVYLHNNNISAI 278
Query: 160 -----PIPADLGNCTYLNTLILSNNKLS-GPI-PYQLSNLGRLKKFSVANN 203
P + + L +N + I P + + N
Sbjct: 279 GSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 20/90 (22%), Positives = 32/90 (35%), Gaps = 13/90 (14%)
Query: 103 LREMKLSG----KIPEPLKFCKSMQRLDLSANDLSGNIPAQ------ICNWLPYLVLLDL 152
LRE+ L+ K+P L K +Q + L N++S I + + L
Sbjct: 242 LRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSL 300
Query: 153 SNNDLS-GPIPADLGNC-TYLNTLILSNNK 180
+N + I C + L N K
Sbjct: 301 FSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 30/127 (23%), Positives = 46/127 (36%), Gaps = 17/127 (13%)
Query: 103 LREMKLSG----KIPEP-LKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDL 157
L E+ L I L + RL L N + I ++LP L L L NN L
Sbjct: 195 LNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKL 253
Query: 158 SGPIPADLGNCTYLNTLILSNNKLSGPIP-------YQLSNLGRLKKFSVANNDLTGTI- 209
S +PA L + L + L N ++ + S+ NN +
Sbjct: 254 SR-VPAGLPDLKLLQVVYLHTNNITK-VGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEV 311
Query: 210 -PSSFKG 215
P++F+
Sbjct: 312 QPATFRC 318
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 30/106 (28%), Positives = 45/106 (42%), Gaps = 6/106 (5%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNK 180
++ + S L +P +I P LLDL NND+S D +L L+L NNK
Sbjct: 34 HLRVVQCSDLGLK-AVPKEI---SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNK 89
Query: 181 LSGPIPYQLSNLGRLKKFSVANNDLTGTIPSS-FKGFDKADFDGNS 225
+S S L +L+K ++ N L IP + + N
Sbjct: 90 ISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSSLVELRIHDNR 134
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 24/122 (19%), Positives = 47/122 (38%), Gaps = 13/122 (10%)
Query: 103 LREMKLSG----KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDL- 157
L+++ +S +IP L S+ L + N + +P + + L + +++ N L
Sbjct: 104 LQKLYISKNHLVEIPPNL-P-SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLE 160
Query: 158 SGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPS-SFKGF 216
+ + LN L +S KL+G L L + +N + I +
Sbjct: 161 NSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNEL---HLDHNKIQ-AIELEDLLRY 216
Query: 217 DK 218
K
Sbjct: 217 SK 218
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 18/90 (20%), Positives = 31/90 (34%), Gaps = 13/90 (14%)
Query: 103 LREMKLSG----KIPEPLKFCKSMQRLDLSANDLSGNIPA------QICNWLPYLVLLDL 152
LRE+ L ++P L K +Q + L N+++ + Y + L
Sbjct: 243 LRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISL 301
Query: 153 SNNDLS-GPIPADLGNC-TYLNTLILSNNK 180
NN + + C T + N K
Sbjct: 302 FNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 39/203 (19%), Positives = 66/203 (32%), Gaps = 48/203 (23%)
Query: 338 GTTYKA-MLPDGSVLAVKRLNTCKL--GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394
G + G +K +N + ++ E+ L L HPN+ + E+
Sbjct: 36 GDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF---EDY 92
Query: 395 LLIY---KYMSSGTLY------SLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFL 445
+Y + G L +E + + A LA+ H
Sbjct: 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA---LAYFH-------- 141
Query: 446 HQNIC------SNVILVDEDFDARIM--DFGLAKLMTSSDESSFVNGDLGEFGYIAPE-- 495
Q++ N++ D + I DFGLA+L G Y+APE
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF---KSDEHSTNAAGTALYMAPEVF 198
Query: 496 ---YSSTMVASLKGDVYGIGVVL 515
+ K D++ GVV+
Sbjct: 199 KRDV------TFKCDIWSAGVVM 215
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 49/205 (23%), Positives = 80/205 (39%), Gaps = 61/205 (29%)
Query: 352 AVKRLN-TCKLGEKK-FRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYS 408
AVK L T EK+ +E+ + L +H N+ LLG C L+I +Y G L +
Sbjct: 80 AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 409 LLQGNATELDWPTRF-------------RIGLGAARGLAWL--HHGCQPPFLHQNI-CSN 452
L+ + L+ F A+G+A+L + +H+++ N
Sbjct: 140 FLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN-----CIHRDVAARN 194
Query: 453 VILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYI------------APE----- 495
V L+ A+I DFGLA+ + + YI APE
Sbjct: 195 V-LLTNGHVAKIGDFGLARDIMNDSN------------YIVKGNARLPVKWMAPESIFDC 241
Query: 496 -YSSTMVASLKGDVYGIGVVLLELA 519
Y+ + DV+ G++L E+
Sbjct: 242 VYTV------QSDVWSYGILLWEIF 260
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 5/98 (5%)
Query: 120 KSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNN 179
KS+Q+LD+S N +S + C+W L+ L++S+N L+ I L + L L +N
Sbjct: 374 KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSN 431
Query: 180 KLSGPIPYQLSNLGRLKKFSVANNDLTGTIP-SSFKGF 216
K+ IP Q+ L L++ +VA+N L ++P F
Sbjct: 432 KIKS-IPKQVVKLEALQELNVASNQLK-SVPDGIFDRL 467
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 23/99 (23%), Positives = 37/99 (37%), Gaps = 6/99 (6%)
Query: 120 KSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNN 179
+ L++S N +S + L L +L +S+N + + L L LS+N
Sbjct: 21 QKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79
Query: 180 KLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDK 218
KL I LK ++ N +P K F
Sbjct: 80 KLVK-ISCH--PTVNLKHLDLSFNAFD-ALPIC-KEFGN 113
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 31/118 (26%), Positives = 45/118 (38%), Gaps = 6/118 (5%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDL-SG 159
L + ++ KF + ++ LDLS N L I C+ L LDLS N +
Sbjct: 50 LIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KIS---CHPTVNLKHLDLSFNAFDAL 105
Query: 160 PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTI-PSSFKGF 216
PI + GN + L L LS L +++L K V P + F
Sbjct: 106 PICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDF 163
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 23/146 (15%), Positives = 48/146 (32%), Gaps = 15/146 (10%)
Query: 83 CQFVGVSCWND--------KENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSG 134
+ G + D K I + + +M + + +
Sbjct: 257 VKLQGQLDFRDFDYSGTSLKALSIHQVVSD--VFGFPQSYIYEIFSNMNIKNFTVSGTR- 313
Query: 135 NIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLS--GPIPYQLSNL 192
+ + + + LD SNN L+ + + G+ T L TLIL N+L I + +
Sbjct: 314 MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQM 373
Query: 193 GRLKKFSVANNDLTGTIPSSFKGFDK 218
L++ ++ N ++
Sbjct: 374 KSLQQLDISQNSVSYDEKKGD--CSW 397
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 19/87 (21%), Positives = 39/87 (44%), Gaps = 5/87 (5%)
Query: 125 LDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGP 184
+D S N L ++P + +L++S N +S +D+ + + L LI+S+N++
Sbjct: 5 VDRSKNGLI-HVPKDL---SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL 60
Query: 185 IPYQLSNLGRLKKFSVANNDLTGTIPS 211
L+ +++N L I
Sbjct: 61 DISVFKFNQELEYLDLSHNKLV-KISC 86
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 47/199 (23%), Positives = 77/199 (38%), Gaps = 42/199 (21%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEK---KFRNEMNRLGQLRHPNLAPLLGYCVVEEE 393
+ + G A K +NT KL + K E +L+HPN+ L E
Sbjct: 43 SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF 102
Query: 394 KLLIYKYMSSGTLYSLL--QGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNIC- 450
L++ ++ G L+ + + +E D + L + +A+ H I
Sbjct: 103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES---IAYCH--------SNGIVH 151
Query: 451 -----SNVILVDEDFDARIM--DFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVAS 503
N++L + A + DFGLA + ++S +G G GY++PE V
Sbjct: 152 RNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPGYLSPE-----V-- 201
Query: 504 LKGDVYG-------IGVVL 515
LK D Y GV+L
Sbjct: 202 LKKDPYSKPVDIWACGVIL 220
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 46/216 (21%), Positives = 71/216 (32%), Gaps = 47/216 (21%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLL 396
GT G +AVKR+ E+ L + HPN+ YC E
Sbjct: 29 GTVVFQGSFQGRPVAVKRML--IDFCDIALMEIKLLTESDDHPNVIRY--YCS-ETTDRF 83
Query: 397 IY-----------KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLH-HGCQPPF 444
+Y + S + E + + R A G+A LH
Sbjct: 84 LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLR---QIASGVAHLHSLK----I 136
Query: 445 LH-----QNI--------CSNVILVDEDFDARIMDFGLAKLMTSSDES--SFVNGDLGEF 489
+H QNI ++ E+ I DFGL K + S S + +N G
Sbjct: 137 IHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTS 196
Query: 490 GYIAPE-------YSSTMVASLKGDVYGIGVVLLEL 518
G+ APE + + D++ +G V +
Sbjct: 197 GWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 41/209 (19%), Positives = 77/209 (36%), Gaps = 29/209 (13%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEK---KFRNEMNRLGQL-RHPNLAPLLGYCVVEE 392
G+ +K + DG + A+KR G E+ L +H ++ E+
Sbjct: 25 GSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS-AWAED 83
Query: 393 EKLLIY-KYMSSGTLYSLLQ---GNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQN 448
+ +LI +Y + G+L + + + L RGL ++H +H +
Sbjct: 84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMD 140
Query: 449 I-CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLG----------EFG---YIAP 494
I SN I + + +S++ F GDLG E G ++A
Sbjct: 141 IKPSN-IFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLAN 199
Query: 495 E-YSSTMVASLKGDVYGIGVVLLELAGFK 522
E K D++ + + ++ AG +
Sbjct: 200 EVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 45/196 (22%), Positives = 76/196 (38%), Gaps = 40/196 (20%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396
Y+ A+K L + +K R E+ L +L HPN+ L E L
Sbjct: 67 SIVYRCKQKGTQKPYALKVLKK-TVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125
Query: 397 IYKYMSSGTLYS--LLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNIC---- 450
+ + ++ G L+ + +G +E D + L A +A+LH I
Sbjct: 126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEA---VAYLH--------ENGIVHRDL 174
Query: 451 --SNVILVDEDFDARIM--DFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKG 506
N++ DA + DFGL+K++ + + G GY APE + L+G
Sbjct: 175 KPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTPGYCAPE-----I--LRG 224
Query: 507 DVYG-------IGVVL 515
YG +G++
Sbjct: 225 CAYGPEVDMWSVGIIT 240
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 3e-09
Identities = 49/184 (26%), Positives = 76/184 (41%), Gaps = 23/184 (12%)
Query: 348 GSVLAVKRLNTCKLG----EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403
+LA+K L +L E + R E+ LRHPN+ L GY LI +Y
Sbjct: 34 KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 93
Query: 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLH-HGCQPPFLHQNICSNVILVDEDFDA 462
GT+Y LQ ++ D A L++ H +H++I +L+ +
Sbjct: 94 GTVYRELQ-KLSKFDEQRTATYITELANALSYCHSKRV----IHRDIKPENLLLGSAGEL 148
Query: 463 RIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVAS----LKGDVYGIGVVLLE- 517
+I DFG + SS + G Y+ PE M+ K D++ +GV+ E
Sbjct: 149 KIADFGWSVHAPSSRRTDLC----GTLDYLPPE----MIEGRMHDEKVDLWSLGVLCYEF 200
Query: 518 LAGF 521
L G
Sbjct: 201 LVGK 204
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 41/174 (23%), Positives = 69/174 (39%), Gaps = 40/174 (22%)
Query: 338 GTTYKA----MLPDGSVL--AVKRL--NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCV 389
G ++A +LP AVK L + F+ E + + +PN+ LLG C
Sbjct: 61 GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120
Query: 390 VEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRF-----------------------RIG 426
V + L+++YM+ G L L+ + I
Sbjct: 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA 180
Query: 427 LGAARGLAWL--HHGCQPPFLHQNI-CSNVILVDEDFDARIMDFGLAKLMTSSD 477
A G+A+L F+H+++ N LV E+ +I DFGL++ + S+D
Sbjct: 181 RQVAAGMAYLSERK-----FVHRDLATRNC-LVGENMVVKIADFGLSRNIYSAD 228
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 29/182 (15%), Positives = 66/182 (36%), Gaps = 42/182 (23%)
Query: 363 EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK--LLIYKYMSSGTLYSLLQGNATELDWP 420
F+NE+ + +++ ++ +IY+YM + ++ + LD
Sbjct: 87 YDDFKNELQIITDIKNEYCLTC--EGIITNYDEVYIIYEYMENDSILKFDE-YFFVLDKN 143
Query: 421 TRFRIGLGAAR--------GLAWLHHGCQPPFLHQNIC------SNVILVDEDFDARIMD 466
I + + +++H+ +NIC SN IL+D++ ++ D
Sbjct: 144 YTCFIPIQVIKCIIKSVLNSFSYIHN-------EKNICHRDVKPSN-ILMDKNGRVKLSD 195
Query: 467 FGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKG------DVYGIGVVLLE-LA 519
FG ++ M G + ++ PE ++ D++ +G+ L
Sbjct: 196 FGESEYMVDKKIKGSR----GTYEFMPPE----FFSNESSYNGAKVDIWSLGICLYVMFY 247
Query: 520 GF 521
Sbjct: 248 NV 249
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 45/214 (21%), Positives = 75/214 (35%), Gaps = 70/214 (32%)
Query: 352 AVKRL--NTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSL 409
AVK L N + +E N L Q+ HP++ L G C + LLI +Y G+L
Sbjct: 57 AVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGF 116
Query: 410 LQ-----------------------GNATELDWPTRFRIGLGAARGLAWL--HHGCQPPF 444
L+ + L ++G+ +L
Sbjct: 117 LRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK-----L 171
Query: 445 LHQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGY------------ 491
+H+++ N+ LV E +I DFGL++ + D Y
Sbjct: 172 VHRDLAARNI-LVAEGRKMKISDFGLSRDVYEEDS------------YVKRSQGRIPVKW 218
Query: 492 IAPE------YSSTMVASLKGDVYGIGVVLLELA 519
+A E Y++ + DV+ GV+L E+
Sbjct: 219 MAIESLFDHIYTT------QSDVWSFGVLLWEIV 246
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 28/122 (22%), Positives = 51/122 (41%), Gaps = 6/122 (4%)
Query: 100 NLELREMKLSGKIPEPLKFC--KSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDL 157
L+L LS ++ ++ L LS N L+ I ++ +P L LDLS+N L
Sbjct: 43 LLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHL 100
Query: 158 SGPIPAD-LGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF 216
+ + L L+L NN + ++ +L+K ++ N ++ K
Sbjct: 101 HT-LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDG 159
Query: 217 DK 218
+K
Sbjct: 160 NK 161
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 8e-08
Identities = 27/96 (28%), Positives = 41/96 (42%), Gaps = 2/96 (2%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPAD-LGNCTYLNTLILSNN 179
LDLS N+LS L L L LS+N L+ I ++ L L LS+N
Sbjct: 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSSN 98
Query: 180 KLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
L + S+L L+ + NN + ++F+
Sbjct: 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFED 134
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 20/82 (24%), Positives = 28/82 (34%), Gaps = 6/82 (7%)
Query: 123 QRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPAD----LGNCTYLNTLILSN 178
+ L L N + + + L L LS N +S P + L L LS+
Sbjct: 115 EVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLPKLMLLDLSS 172
Query: 179 NKLSGPIPYQLSNLGRLKKFSV 200
NKL L L K +
Sbjct: 173 NKLKKLPLTDLQKLPAWVKNGL 194
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 20/122 (16%), Positives = 38/122 (31%), Gaps = 6/122 (4%)
Query: 100 NLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG 159
++L ++ + +Q L + I L L++L L N
Sbjct: 34 YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQ 93
Query: 160 PIPAD-LGNCTYLNTLILSNNKL-SGPIPYQL-SNLGRLKKFSVANNDLTGTIPSSFKGF 216
+ L L L+ L + L L+ + +N++ P+SF F
Sbjct: 94 -LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF--F 150
Query: 217 DK 218
Sbjct: 151 LN 152
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 20/99 (20%), Positives = 39/99 (39%), Gaps = 6/99 (6%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPAD-LGNCTYLNTLILSNN 179
++ DLS + + + + + L L L+ N+++ I + T+L L LS N
Sbjct: 276 GVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQN 333
Query: 180 KLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDK 218
L NL +L+ ++ N + + F
Sbjct: 334 FLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQS--FLG 369
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 23/87 (26%), Positives = 37/87 (42%), Gaps = 5/87 (5%)
Query: 119 CKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADL-GNCTYLNTLILS 177
+ +L+LS N L +I +++ L L +LDLS N + + L L L
Sbjct: 322 LTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALD 379
Query: 178 NNKLSGPIPYQ-LSNLGRLKKFSVANN 203
N+L +P L L+K + N
Sbjct: 380 TNQLKS-VPDGIFDRLTSLQKIWLHTN 405
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 49/197 (24%), Positives = 77/197 (39%), Gaps = 43/197 (21%)
Query: 352 AVKRL--NTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYS 408
AVK L + + +EM + + +H N+ LLG C + +I +Y S G L
Sbjct: 105 AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 164
Query: 409 LLQ---------------GNATELDWPTRFRIGLGAARGLAWL--HHGCQPPFLHQNI-C 450
LQ +L ARG+ +L +H+++
Sbjct: 165 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-----CIHRDLAA 219
Query: 451 SNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEF--GYIAPE------YSSTMVA 502
NV LV ED +I DFGLA+ + D + G ++APE Y+
Sbjct: 220 RNV-LVTEDNVMKIADFGLARDIHHIDY--YKKTTNGRLPVKWMAPEALFDRIYTH---- 272
Query: 503 SLKGDVYGIGVVLLELA 519
+ DV+ GV+L E+
Sbjct: 273 --QSDVWSFGVLLWEIF 287
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 22/104 (21%), Positives = 35/104 (33%), Gaps = 3/104 (2%)
Query: 113 PEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPAD-LGNCTYL 171
P + L L L + + L L L L +N L +P D + L
Sbjct: 98 PATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNL 155
Query: 172 NTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
L L N++S L L + + N + P +F+
Sbjct: 156 THLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 28/118 (23%), Positives = 46/118 (38%), Gaps = 4/118 (3%)
Query: 100 NLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG 159
+ L ++S + C+++ L L +N L+ I A L L LDLS+N
Sbjct: 36 RIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLR 94
Query: 160 PIPAD-LGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPS-SFKG 215
+ L+TL L L P L L+ + +N L +P +F+
Sbjct: 95 SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRD 151
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 9e-08
Identities = 22/98 (22%), Positives = 37/98 (37%), Gaps = 4/98 (4%)
Query: 120 KSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPAD-LGNCTYLNTLILSN 178
+++LDLS N ++ + L L L L L + L L L +
Sbjct: 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQD 138
Query: 179 NKLSGPIPYQ-LSNLGRLKKFSVANNDLTGTIPSSFKG 215
N L +P +LG L + N ++ +F+G
Sbjct: 139 NALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRG 175
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 24/91 (26%), Positives = 40/91 (43%), Gaps = 2/91 (2%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNK 180
++Q L L N L +P L L L L N +S L+ L+L N+
Sbjct: 130 ALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNR 188
Query: 181 LSGPIPYQLSNLGRLKKFSVANNDLTGTIPS 211
++ P+ +LGRL + N+L+ +P+
Sbjct: 189 VAHVHPHAFRDLGRLMTLYLFANNLS-ALPT 218
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 18/92 (19%), Positives = 32/92 (34%), Gaps = 5/92 (5%)
Query: 125 LDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGP 184
L +P I + L N +S A C L L L +N L+
Sbjct: 16 TSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 185 IPYQLSNLGRLKKFSVANNDLTGTIPSS-FKG 215
+ L L++ +++N ++ + F G
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHG 103
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 46/199 (23%), Positives = 72/199 (36%), Gaps = 41/199 (20%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLG---EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEE 393
+ + + G A +NT KL +K E L+HPN+ L E
Sbjct: 25 SVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGH 84
Query: 394 KLLIYKYMSSGTLYS--LLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNIC- 450
LI+ ++ G L+ + + +E D + L A + H +
Sbjct: 85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA---VLHCH--------QMGVVH 133
Query: 451 -----SNVILVDEDFDARIM--DFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVAS 503
N++L + A + DFGLA + E G G GY++PE V
Sbjct: 134 RNLKPENLLLASKLKGAAVKLADFGLAIEV--EGEQQAWFGFAGTPGYLSPE-----V-- 184
Query: 504 LKGDVYG-------IGVVL 515
L+ D YG GV+L
Sbjct: 185 LRKDPYGKPVDLWACGVIL 203
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 47/211 (22%), Positives = 86/211 (40%), Gaps = 45/211 (21%)
Query: 337 TGTTYKAM-LPDGSVLAVKRLNTCKLGEKK--FRNEMNRLGQLRHPNLAPLLGYCVVEEE 393
T A P +A+KR+N K E+ + Q HPN+ V ++
Sbjct: 28 TAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT-SFVVKD 86
Query: 394 KL-LIYKYMSSGTLYSLLQGNATELDWPTRF-------RIGLGAARGLAWLHHGCQPPFL 445
+L L+ K +S G++ +++ + + + I GL +LH Q +
Sbjct: 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---I 143
Query: 446 HQNICSNVILVDEDFDARIMDFGLAKLMTSSDES-------SFVNGDLGEFG---YIAPE 495
H+++ + IL+ ED +I DFG++ + + + +FV G ++APE
Sbjct: 144 HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-------GTPCWMAPE 196
Query: 496 -------YSSTMVASLKGDVYGIGVVLLELA 519
Y K D++ G+ +ELA
Sbjct: 197 VMEQVRGYDF------KADIWSFGITAIELA 221
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 5e-09
Identities = 42/190 (22%), Positives = 78/190 (41%), Gaps = 27/190 (14%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLG-EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395
+ G + A+K + + NE+ L +++H N+ L
Sbjct: 23 SEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY 82
Query: 396 LIYKYMSSGTLYS--LLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNIC--- 450
L+ + +S G L+ L +G TE D + L A + +LH I
Sbjct: 83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSA---VKYLHE--------NGIVHRD 131
Query: 451 ---SNVILVDEDFDARIM--DFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLK 505
N++ + + +++IM DFGL+K+ +++ ++ G GY+APE + S
Sbjct: 132 LKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLAQKPYSKA 187
Query: 506 GDVYGIGVVL 515
D + IGV+
Sbjct: 188 VDCWSIGVIT 197
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-09
Identities = 31/109 (28%), Positives = 41/109 (37%), Gaps = 13/109 (11%)
Query: 92 NDKENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLS--GNIPAQICNWLPYLVL 149
R L L+ + GKI +++ L L L N+P LP L
Sbjct: 22 TPAAVRELVLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLISVSNLPK-----LPKLKK 75
Query: 150 LDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKF 198
L+LS N + G + L L LS NKL +S L LKK
Sbjct: 76 LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK-----DISTLEPLKKL 119
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 6e-05
Identities = 25/113 (22%), Positives = 41/113 (36%), Gaps = 19/113 (16%)
Query: 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICN---WLPYLVLLDLS 153
R ++LELR + +++ L L D + +I L L L
Sbjct: 12 RRIHLELRNRTPA-----------AVRELVL---DNCKSNDGKIEGLTAEFVNLEFLSLI 57
Query: 154 NNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLT 206
N L ++L L L LS N++ G + L L +++ N L
Sbjct: 58 NVGLI--SVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 21/85 (24%), Positives = 35/85 (41%), Gaps = 2/85 (2%)
Query: 114 EPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPAD-LGNCTYLN 172
L +++L+LS N + + LP L L+LS N L + L L
Sbjct: 65 SNLPKLPKLKKLELSENRIF-GGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLK 123
Query: 173 TLILSNNKLSGPIPYQLSNLGRLKK 197
+L L N +++ Y+ S L +
Sbjct: 124 SLDLFNCEVTNLNDYRESVFKLLPQ 148
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 43/192 (22%), Positives = 86/192 (44%), Gaps = 24/192 (12%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKK--FRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394
G +K + V+A+K ++ + ++ + E+ L Q P + G +++ K
Sbjct: 36 GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG-SYLKDTK 94
Query: 395 L-LIYKYMSSGTLYSLLQGNATELDWPTRFRIGL---GAARGLAWLH-HGCQPPFLHQNI 449
L +I +Y+ G+ LL+ + I +GL +LH +H++I
Sbjct: 95 LWIIMEYLGGGSALDLLEPGPLDETQ-----IATILREILKGLDYLHSEKK----IHRDI 145
Query: 450 CSNVILVDEDFDARIMDFGLAKLMTS--SDESSFVNGDLGEFGYIAPEYSSTMVASLKGD 507
+ +L+ E + ++ DFG+A +T ++FV G ++APE K D
Sbjct: 146 KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV----GTPFWMAPEVIKQSAYDSKAD 201
Query: 508 VYGIGVVLLELA 519
++ +G+ +ELA
Sbjct: 202 IWSLGITAIELA 213
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 37/186 (19%), Positives = 89/186 (47%), Gaps = 13/186 (6%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396
G+ YKA+ G ++A+K++ + ++ E++ + Q P++ G + +
Sbjct: 43 GSVYKAIHKETGQIVAIKQVPV-ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101
Query: 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLH-HGCQPPFLHQNICSNVIL 455
+ +Y +G++ +++ L I +GL +LH +H++I + IL
Sbjct: 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK----IHRDIKAGNIL 157
Query: 456 VDEDFDARIMDFGLAKLMTS--SDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGV 513
++ + A++ DFG+A +T + ++ + G ++APE + + D++ +G+
Sbjct: 158 LNTEGHAKLADFGVAGQLTDTMAKRNTVI----GTPFWMAPEVIQEIGYNCVADIWSLGI 213
Query: 514 VLLELA 519
+E+A
Sbjct: 214 TAIEMA 219
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 7e-09
Identities = 55/289 (19%), Positives = 95/289 (32%), Gaps = 65/289 (22%)
Query: 348 GSVLAVKRLNTCKLGEK--KFRNEMNRLGQLRHPNLAPLLGYCVVEEE----KLLIYKYM 401
G + A+K N E L +L H N+ L + + EE K+LI ++
Sbjct: 34 GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL--FAIEEETTTRHKVLIMEFC 91
Query: 402 SSGTLYSLLQ--GNATELDWPTRFRIGLGAARGLAWLH-HGCQPPFLH-----QNICSNV 453
G+LY++L+ NA L + G+ L +G +H NI +
Sbjct: 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG----IVHRNIKPGNI---M 144
Query: 454 ILVDEDFDARIM--DFGLAKLMTSSDESSFVNGDLGEFGYIAPE-YSSTMVASLKGDVYG 510
++ ED + DFG A+ + ++ G Y+ P+ Y ++ YG
Sbjct: 145 RVIGEDGQSVYKLTDFGAAREL---EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYG 201
Query: 511 -------IGVVLLELA-GF----------------------KGNLVDWVNQLSSSGR--- 537
IGV A G K + Q + +G
Sbjct: 202 ATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDW 261
Query: 538 SKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586
S + +G + L N + + + W Q + + I
Sbjct: 262 SGDMPVSCSLSRGLQVLLTPVLA---NILEADQEKCWGFDQFFAETSDI 307
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 57.8 bits (139), Expect = 7e-09
Identities = 30/124 (24%), Positives = 58/124 (46%), Gaps = 23/124 (18%)
Query: 96 NRILNLE-------LREMKLSG-KIP--EPLKFCKSMQRLDLSANDLSGNIPAQICNWLP 145
+ I +++ + ++ L+G K+ +PL K++ L L N + ++ + L
Sbjct: 53 SDIKSVQGIQYLPNVTKLFLNGNKLTDIKPLTNLKNLGWLFLDENKIK-DLSSL--KDLK 109
Query: 146 YLVLLDLSNN---DLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVAN 202
L L L +N D++G L + L +L L NNK++ LS L +L S+ +
Sbjct: 110 KLKSLSLEHNGISDING-----LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLED 162
Query: 203 NDLT 206
N ++
Sbjct: 163 NQIS 166
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 17/96 (17%), Positives = 34/96 (35%), Gaps = 13/96 (13%)
Query: 114 EPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNN---DLSGPIPADLGNCTY 170
P + +L ++ + N L + + +N+ + G +
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVT---QNELNSIDQIIANNSDIKSVQG-----IQYLPN 66
Query: 171 LNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLT 206
+ L L+ NKL+ P L+NL L + N +
Sbjct: 67 VTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK 100
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 8e-06
Identities = 30/162 (18%), Positives = 48/162 (29%), Gaps = 37/162 (22%)
Query: 96 NRILNLE-------LREMKLSG-KI--PEPLKFCKSMQRLDLSAN--------------- 130
N I ++ L + L KI L + L L N
Sbjct: 119 NGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQ 178
Query: 131 --DLSGNIPAQICNW-----LPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSG 183
LS N I + L L +L+L + + N NT+ ++ L
Sbjct: 179 NLYLSKN---HISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL-- 233
Query: 184 PIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKADFDGNS 225
P +S+ G +K +V + T SF +
Sbjct: 234 VTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAK 275
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 7e-09
Identities = 44/197 (22%), Positives = 74/197 (37%), Gaps = 41/197 (20%)
Query: 352 AVKRL--NTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYS 408
AVK L + + +E+ L L H N+ LLG C + L+I +Y G L +
Sbjct: 57 AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN 116
Query: 409 LLQGNATELDWPTRFRIGLGA-----------------ARGLAWLHHGCQPPFLHQNI-C 450
L+ + A+G+A+L +H+++
Sbjct: 117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAA 173
Query: 451 SNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEF--GYIAPE------YSSTMVA 502
N IL+ +I DFGLA+ + + +V ++APE Y+
Sbjct: 174 RN-ILLTHGRITKICDFGLARDIKNDSN--YVVKGNARLPVKWMAPESIFNCVYTF---- 226
Query: 503 SLKGDVYGIGVVLLELA 519
+ DV+ G+ L EL
Sbjct: 227 --ESDVWSYGIFLWELF 241
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 57.0 bits (137), Expect = 8e-09
Identities = 25/221 (11%), Positives = 53/221 (23%), Gaps = 50/221 (22%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLG----EKKFRNEMNRLGQLRHPNLAPLLGYC---- 388
+ + A+K ++ +L +
Sbjct: 76 SVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLL 135
Query: 389 ---VVEEEK-------------------LLIYKYMSS--GTLYSLLQGNATE---LDWPT 421
V + LL+ S L+S L
Sbjct: 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILA 195
Query: 422 RFRIGLGAARGLAWLH-HGCQPPFLHQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDES 479
+ R A L G +H + N + + D + D + + +
Sbjct: 196 LHILTAQLIRLAANLQSKG----LVHGHFTPDN-LFIMPDGRLMLGDVSALWKVGTRGPA 250
Query: 480 SFVNGDLGEFGYIAPEY--SSTMVASLKGDVYGIGVVLLEL 518
S V Y E+ +ST + + + +G+ + +
Sbjct: 251 SSVPVT-----YAPREFLNASTATFTHALNAWQLGLSIYRV 286
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 9e-09
Identities = 20/113 (17%), Positives = 41/113 (36%), Gaps = 9/113 (7%)
Query: 98 ILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDL 157
+ + + ++ + L ++ I + L L+ L+L +N +
Sbjct: 21 AIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQY-LNNLIGLELKDNQI 75
Query: 158 SGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIP 210
+ P L N T + L LS N L ++ L +K + + +T P
Sbjct: 76 TDLAP--LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTP 124
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 27/93 (29%), Positives = 44/93 (47%), Gaps = 7/93 (7%)
Query: 114 EPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNT 173
PLK + L+LS N L N+ A I L + LDL++ ++ P L + L
Sbjct: 79 APLKNLTKITELELSGNPLK-NVSA-IAG-LQSIKTLDLTSTQITDVTP--LAGLSNLQV 133
Query: 174 LILSNNKLSGPIPYQLSNLGRLKKFSVANNDLT 206
L L N+++ P L+ L L+ S+ N ++
Sbjct: 134 LYLDLNQITNISP--LAGLTNLQYLSIGNAQVS 164
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 27/128 (21%), Positives = 51/128 (39%), Gaps = 17/128 (13%)
Query: 96 NRILNLE-------LREMKLSG-KIP--EPLKFCKSMQRLDLSANDLSGNIPAQICNWLP 145
N+I N+ L+ + + ++ PL + L N +S +I + + LP
Sbjct: 139 NQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKIS-DISP-LAS-LP 195
Query: 146 YLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDL 205
L+ + L NN +S P L N + L + L+N ++ + +NL V
Sbjct: 196 NLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPN--VVKGPSG 251
Query: 206 TGTIPSSF 213
P++
Sbjct: 252 APIAPATI 259
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 14/93 (15%), Positives = 36/93 (38%), Gaps = 7/93 (7%)
Query: 114 EPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNT 173
P + ++ ++++ + + L + L ++ I + L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT--QAD-LDGITTLSAFGTGVTT-IEG-VQYLNNLIG 67
Query: 174 LILSNNKLSGPIPYQLSNLGRLKKFSVANNDLT 206
L L +N+++ P L NL ++ + ++ N L
Sbjct: 68 LELKDNQITDLAP--LKNLTKITELELSGNPLK 98
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 26/129 (20%), Positives = 47/129 (36%), Gaps = 12/129 (9%)
Query: 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNN 155
++ L+ K K+ + + LD S N ++ + + L L+ N
Sbjct: 148 TQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-ELD--VSQ-NKLLNRLNCDTN 201
Query: 156 DLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
+++ DL L L S+NKL+ I ++ L +L F + N LT S+
Sbjct: 202 NITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSK 255
Query: 216 FDKADFDGN 224
Sbjct: 256 LTTLHCIQT 264
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 27/137 (19%), Positives = 48/137 (35%), Gaps = 12/137 (8%)
Query: 100 NLELREMKLSG-KIPE-PLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDL 157
+L + S KI E + K + RL+ N+++ + + L LD S+N L
Sbjct: 169 QTQLTTLDCSFNKITELDVSQNKLLNRLNCDTNNIT-KLD--LNQ-NIQLTFLDCSSNKL 224
Query: 158 SGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFD 217
+ D+ T L S N L+ + +S L +L DL +
Sbjct: 225 TE---IDVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLEIDLTHNTQLI 278
Query: 218 KADFDGNSDLCGGPLGS 234
+G + +
Sbjct: 279 YFQAEGCRKIKELDVTH 295
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 21/107 (19%), Positives = 42/107 (39%), Gaps = 9/107 (8%)
Query: 119 CKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSN 178
++ LD + ++ ++ L L L ++N+++ DL T L L +
Sbjct: 41 LATLTSLDCHNSSIT-DMTG--IEKLTGLTKLICTSNNITTL---DLSQNTNLTYLACDS 94
Query: 179 NKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKADFDGNS 225
NKL+ + ++ L +L + N LT S + N+
Sbjct: 95 NKLTN-LD--VTPLTKLTYLNCDTNKLTKLDVSQNPLLTYLNCARNT 138
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 19/93 (20%), Positives = 37/93 (39%), Gaps = 10/93 (10%)
Query: 114 EPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNT 173
++ + +L ++N+++ + + L L +N L+ D+ T L
Sbjct: 58 TGIEKLTGLTKLICTSNNIT-TLD--LSQ-NTNLTYLACDSNKLTNL---DVTPLTKLTY 110
Query: 174 LILSNNKLSGPIPYQLSNLGRLKKFSVANNDLT 206
L NKL+ + +S L + A N LT
Sbjct: 111 LNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT 140
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 20/92 (21%), Positives = 35/92 (38%), Gaps = 9/92 (9%)
Query: 115 PLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTL 174
+ + L+ + N L+ I L LD N + D+ T L TL
Sbjct: 122 DVSQNPLLTYLNCARNTLT-EIDVSHN---TQLTELDCHLNKKITKL--DVTPQTQLTTL 175
Query: 175 ILSNNKLSGPIPYQLSNLGRLKKFSVANNDLT 206
S NK++ + +S L + + N++T
Sbjct: 176 DCSFNKITE-LD--VSQNKLLNRLNCDTNNIT 204
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 23/118 (19%), Positives = 42/118 (35%), Gaps = 12/118 (10%)
Query: 100 NLELREMKLSG--KIPE-PLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNND 156
N +L + G KI E + + LD A ++ + + P LV L L+N +
Sbjct: 274 NTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQ-NPKLVYLYLNNTE 329
Query: 157 LSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFK 214
L+ + D+ + T L +L N + + + L A +
Sbjct: 330 LTE-L--DVSHNTKLKSLSCVNAHIQD-FS-SVGKIPALNNNFEAEGQTITMPKETLT 382
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 17/98 (17%), Positives = 28/98 (28%), Gaps = 10/98 (10%)
Query: 115 PLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTL 174
+ + L DL I L Y D+ + T L L
Sbjct: 249 DVSTLSKLTTLHCIQTDLL-EIDLTHNTQLIYFQAEGCRKIKEL-----DVTHNTQLYLL 302
Query: 175 ILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSS 212
++ + LS +L + N +LT + S
Sbjct: 303 DCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELDVS 336
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 21/144 (14%), Positives = 47/144 (32%), Gaps = 19/144 (13%)
Query: 68 KLSSWSFGNSTIGFICQFVGVSCWNDKENRILNL----ELREMKLSG-KIPE-PLKFCKS 121
L ++T Q + ++ + L++ +L + I E L
Sbjct: 265 DLLEIDLTHNT-----QLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPK 319
Query: 122 MQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKL 181
+ L L+ +L+ + + + L L N + + +G LN + +
Sbjct: 320 LVYLYLNNTELT-ELD--VSH-NTKLKSLSCVNAHIQD-FSS-VGKIPALNNNFEAEGQT 373
Query: 182 SGPIPYQLSNLGRLKKFSVANNDL 205
L+N +V+ + L
Sbjct: 374 ITMPKETLTNN--SLTIAVSPDLL 395
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 41/190 (21%), Positives = 72/190 (37%), Gaps = 26/190 (13%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEK-KFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395
G ++ G+ A K + T +K R E+ + LRHP L L + E +
Sbjct: 171 GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230
Query: 396 LIYKYMSSGTLYSLL---QGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNIC-- 450
+IY++MS G L+ + +E + R GL +H N
Sbjct: 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK---GLCHMH--------ENNYVHL 279
Query: 451 ----SNVILVDEDFDA-RIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLK 505
N++ + + +++DFGL + D V G + APE +
Sbjct: 280 DLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEGKPVGYY 336
Query: 506 GDVYGIGVVL 515
D++ +GV+
Sbjct: 337 TDMWSVGVLS 346
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-08
Identities = 29/113 (25%), Positives = 45/113 (39%), Gaps = 9/113 (7%)
Query: 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLS--GNIPAQICNWLPYLVLLDLSN 154
+ L L+ GK+ + ++ L L+ N+P L L L+LS+
Sbjct: 20 KELVLDNSRSNE-GKLEGLTDEFEELEFLSTINVGLTSIANLPK-----LNKLKKLELSD 73
Query: 155 NDLSGPIPADLGNCTYLNTLILSNNKLSGP-IPYQLSNLGRLKKFSVANNDLT 206
N +SG + C L L LS NK+ L L LK + N ++T
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 28/133 (21%), Positives = 52/133 (39%), Gaps = 19/133 (14%)
Query: 400 YMSSGTLYSLL--QGNATELDWPTRFRIGLGAARGLAWLH-HGCQPPFLHQNI-CSNVIL 455
L + + + + + I + A + +LH G +H+++ SN I
Sbjct: 142 LCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG----LMHRDLKPSN-IF 196
Query: 456 VDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFG----------YIAPEYSSTMVASLK 505
D ++ DFGL M +E V + + Y++PE S K
Sbjct: 197 FTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK 256
Query: 506 GDVYGIGVVLLEL 518
D++ +G++L EL
Sbjct: 257 VDIFSLGLILFEL 269
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 41/196 (20%), Positives = 71/196 (36%), Gaps = 40/196 (20%)
Query: 352 AVKRL--NTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKL-LIYKYMSSGTLY 407
AVK L + +E+ L + H N+ LLG C L +I ++ G L
Sbjct: 61 AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 120
Query: 408 SLLQ---------------GNATELDWPTRFRIGLGAARGLAWL--HHGCQPPFLHQNI- 449
+ L+ L A+G+ +L +H+++
Sbjct: 121 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-----CIHRDLA 175
Query: 450 CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPE------YSSTMVAS 503
N+ L+ E +I DFGLA+ + + ++APE Y+
Sbjct: 176 ARNI-LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI----- 229
Query: 504 LKGDVYGIGVVLLELA 519
+ DV+ GV+L E+
Sbjct: 230 -QSDVWSFGVLLWEIF 244
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 32/119 (26%), Positives = 45/119 (37%), Gaps = 9/119 (7%)
Query: 103 LREMKLSG----KIPE-PLKFCKSMQRLDLS-ANDLSGNIPAQICNWLPYLVLLDLSNND 156
LRE+ L IP S+ RLDL L I L L L+L +
Sbjct: 149 LRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCN 207
Query: 157 LSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
+ +P +L L L +S N P L LKK V N+ ++ ++F G
Sbjct: 208 IKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDG 264
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 21/111 (18%), Positives = 42/111 (37%), Gaps = 6/111 (5%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNK 180
+++ L+L ++ ++P L L L++S N P + L L + N++
Sbjct: 197 NLKYLNLGMCNIK-DMPN--LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ 253
Query: 181 LSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDK---ADFDGNSDLC 228
+S L L + ++A+N+L+ F N C
Sbjct: 254 VSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC 304
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 29/132 (21%), Positives = 46/132 (34%), Gaps = 19/132 (14%)
Query: 96 NRILNLE---------LREMKLSG-KI----PEPLKFCKSMQRLDLSANDLSGNIPAQIC 141
N I ++ L ++L I S+ L+L N L+ IP+
Sbjct: 85 NNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAF 143
Query: 142 NWLPYLVLLDLSNNDLSGPIPAD-LGNCTYLNTLILS-NNKLSGPIPYQLSNLGRLKKFS 199
+L L L L NN + IP+ L L L KL L LK +
Sbjct: 144 EYLSKLRELWLRNNPIES-IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLN 202
Query: 200 VANNDLTGTIPS 211
+ ++ +P+
Sbjct: 203 LGMCNIK-DMPN 213
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 18/98 (18%), Positives = 33/98 (33%), Gaps = 4/98 (4%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNK 180
++ + LS +P I L+L N++ + +L L L N
Sbjct: 55 QFSKVVCTRRGLS-EVPQGI---PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 181 LSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDK 218
+ + L L + +N LT +F+ K
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSK 148
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 38/199 (19%), Positives = 68/199 (34%), Gaps = 34/199 (17%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEK------KFRNEMNRLGQLRHPNLAPLLGYCVV 390
+ + G AVK ++ K + E + L+HP++ LL
Sbjct: 38 SVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS 97
Query: 391 EEEKLLIYKYMSSGTLY------SLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPF 444
+ +++++M L + +E R L A L + H
Sbjct: 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA---LRYCHD------ 148
Query: 445 LHQNIC------SNVILVDEDFDARIM--DFGLAKLMTSSDESSFVNGDLGEFGYIAPEY 496
NI V+L ++ A + FG+A + + G +G ++APE
Sbjct: 149 --NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPHFMAPEV 204
Query: 497 SSTMVASLKGDVYGIGVVL 515
DV+G GV+L
Sbjct: 205 VKREPYGKPVDVWGCGVIL 223
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 43/196 (21%), Positives = 72/196 (36%), Gaps = 36/196 (18%)
Query: 348 GSVLAVKRLNTCKLGEK--KFRNEMNRLGQLRHPNLAPLLGYCVVEEEK----LLIYKYM 401
G + A+K N E L +L H N+ L + + EE +LI ++
Sbjct: 34 GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL--FAIEEETTTRHKVLIMEFC 91
Query: 402 SSGTLYSLLQ--GNATELDWPTRFRIGLGAARGLAWLH-HGCQPPFLH-----QNICSNV 453
G+LY++L+ NA L + G+ L +G +H NI +
Sbjct: 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG----IVHRNIKPGNI---M 144
Query: 454 ILVDEDFDARIM--DFGLAKLMTSSDESSFVNGDLGEFGYIAPE-YSSTMVASLKGDVYG 510
++ ED + DFG A+ + ++ G Y+ P+ Y ++ YG
Sbjct: 145 RVIGEDGQSVYKLTDFGAAREL---EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYG 201
Query: 511 -------IGVVLLELA 519
IGV A
Sbjct: 202 ATVDLWSIGVTFYHAA 217
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 30/124 (24%), Positives = 58/124 (46%), Gaps = 23/124 (18%)
Query: 96 NRILNLE-------LREMKLSG-KIP--EPLKFCKSMQRLDLSANDLSGNIPAQICNWLP 145
+ I +++ + ++ L+G K+ +PL K++ L L N + ++ + L
Sbjct: 56 SDIKSVQGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVK-DLSSL--KDLK 112
Query: 146 YLVLLDLSNN---DLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVAN 202
L L L +N D++G L + L +L L NNK++ LS L +L S+ +
Sbjct: 113 KLKSLSLEHNGISDING-----LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLED 165
Query: 203 NDLT 206
N ++
Sbjct: 166 NQIS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 16/96 (16%), Positives = 33/96 (34%), Gaps = 13/96 (13%)
Query: 114 EPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNN---DLSGPIPADLGNCTY 170
+ +L ++ + N L + + +N+ + G +
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT---QNELNSIDQIIANNSDIKSVQG-----IQYLPN 69
Query: 171 LNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLT 206
+ L L+ NKL+ P L+NL L + N +
Sbjct: 70 VTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK 103
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 28/123 (22%), Positives = 50/123 (40%), Gaps = 15/123 (12%)
Query: 96 NRILNLE-------LREMKLSG-KIP--EPLKFCKSMQRLDLSANDLSGNIPAQICNWLP 145
N+I ++ L + L +I PL +Q L LS N +S ++ A + L
Sbjct: 144 NKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLRA-LAG-LK 200
Query: 146 YLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDL 205
L +L+L + + N NT+ ++ L P +S+ G +K +V +
Sbjct: 201 NLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEI--ISDDGDYEKPNVKWHLP 258
Query: 206 TGT 208
T
Sbjct: 259 EFT 261
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 42/187 (22%), Positives = 86/187 (45%), Gaps = 13/187 (6%)
Query: 337 TGTTYKAM-LPDGSVLAVKRLNTCKLGEKK-FRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394
TG A G +AVK ++ K ++ NE+ + +H N+ + +V EE
Sbjct: 58 TGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117
Query: 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVI 454
++ +++ G L ++ L+ + + LA+LH +H++I S+ I
Sbjct: 118 WVLMEFLQGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSI 172
Query: 455 LVDEDFDARIMDFGL-AKLM-TSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIG 512
L+ D ++ DFG A++ S V G ++APE S + + + D++ +G
Sbjct: 173 LLTLDGRVKLSDFGFCAQISKDVPKRKSLV----GTPYWMAPEVISRSLYATEVDIWSLG 228
Query: 513 VVLLELA 519
++++E+
Sbjct: 229 IMVIEMV 235
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 27/111 (24%), Positives = 43/111 (38%), Gaps = 6/111 (5%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNK 180
+++ L+L+ +L IP L L LDLS N LS P +L L + ++
Sbjct: 186 NLRYLNLAMCNLR-EIPN--LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQ 242
Query: 181 LSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDK---ADFDGNSDLC 228
+ NL L + ++A+N+LT F N C
Sbjct: 243 IQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC 293
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 31/132 (23%), Positives = 49/132 (37%), Gaps = 19/132 (14%)
Query: 96 NRILNLE---------LREMKLSG-KI----PEPLKFCKSMQRLDLSANDLSGNIPAQIC 141
N+I ++ L ++LS I ++ L+L N L+ IP
Sbjct: 74 NQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAF 132
Query: 142 NWLPYLVLLDLSNNDLSGPIPADL-GNCTYLNTLILS-NNKLSGPIPYQLSNLGRLKKFS 199
+L L L L NN + IP+ L L L +LS L L+ +
Sbjct: 133 VYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLN 191
Query: 200 VANNDLTGTIPS 211
+A +L IP+
Sbjct: 192 LAMCNLR-EIPN 202
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 18/95 (18%), Positives = 31/95 (32%), Gaps = 4/95 (4%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNK 180
++ +L +P I LL+L N + + +L L LS N
Sbjct: 44 QFSKVICVRKNLR-EVPDGI---STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 181 LSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
+ + L L + +N LT +F
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVY 134
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 32/232 (13%), Positives = 64/232 (27%), Gaps = 61/232 (26%)
Query: 337 TGTTYKAM-LPDGSVLAVKRLNTCKL----GEKKFRNEMNRLGQLR---HPNLAPLLGYC 388
+A G V + K+ + E+ RL LR + A +
Sbjct: 86 PYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 145
Query: 389 VVEEEKLLIYK-----------------------YMSSGTLYSLLQ------GNATELDW 419
+ + + + L + + L
Sbjct: 146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVH 205
Query: 420 PTRFRIGLGAARGLAWLH-HGCQPPFLHQNI-CSNVILVDEDFDARIMDFGLAKLMTSSD 477
R ++ L R LA LH +G +H + + I++D+ + F +
Sbjct: 206 HARLQLTLQVIRLLASLHHYG----LVHTYLRPVD-IVLDQRGGVFLTGFEHLVRDGARV 260
Query: 478 ESSFVNGDLGEFGYIAPEYSSTMV-----------ASLKGDVYGIGVVLLEL 518
SS G+ PE + + D + +G+V+ +
Sbjct: 261 VSS------VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 41/204 (20%), Positives = 73/204 (35%), Gaps = 54/204 (26%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEK-KFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395
G ++ + G V K +NT +K +NE++ + QL HP L L + E +
Sbjct: 65 GVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 124
Query: 396 LIYKYMSSGTLYSLL---QGNATELDWPTRFRIGLGAAR-------GLAWLHHGCQPPFL 445
LI +++S G L+ + +E + GL +H
Sbjct: 125 LILEFLSGGELFDRIAAEDYKMSEAE----------VINYMRQACEGLKHMH-------- 166
Query: 446 HQNIC------SNVILVD-EDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSS 498
+I N++ + +I+DFGLA + + V + APE
Sbjct: 167 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPE--- 220
Query: 499 TMVASLKGDVYG-------IGVVL 515
+ + + G IGV+
Sbjct: 221 --I--VDREPVGFYTDMWAIGVLG 240
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 36/192 (18%), Positives = 63/192 (32%), Gaps = 33/192 (17%)
Query: 348 GSVLAVKRLNTCKLGE--KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK--------LLI 397
G +A+K+ + +++ E+ + +L HPN+ V + + LL
Sbjct: 39 GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA--REVPDGLQKLAPNDLPLLA 96
Query: 398 YKYMSSGTLYSLLQ--GNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNIC----- 450
+Y G L L N L + + L +LH I
Sbjct: 97 MEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--------ENRIIHRDLK 148
Query: 451 -SNVILVDEDFDARIM--DFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGD 507
N++L D G AK + D+ +G Y+APE ++ D
Sbjct: 149 PENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLAPELLEQKKYTVTVD 205
Query: 508 VYGIGVVLLELA 519
+ G + E
Sbjct: 206 YWSFGTLAFECI 217
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 20/93 (21%), Positives = 41/93 (44%), Gaps = 7/93 (7%)
Query: 114 EPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNT 173
P + + +L ++ ++ +Q L + + N+++ + T L
Sbjct: 13 FPDPGLANAVKQNLGKQSVT-DLVSQ--KELSGVQNFNGDNSNIQSLAG--MQFFTNLKE 67
Query: 174 LILSNNKLSGPIPYQLSNLGRLKKFSVANNDLT 206
L LS+N++S P L +L +L++ SV N L
Sbjct: 68 LHLSHNQISDLSP--LKDLTKLEELSVNRNRLK 98
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 24/126 (19%), Positives = 43/126 (34%), Gaps = 14/126 (11%)
Query: 96 NRILNLE------LREMKLSG-KIP--EPLKFCKSMQRLDLSANDLSGNIPAQICNWLPY 146
NR+ NL L + L ++ + L K+++ L + N L +I +L
Sbjct: 95 NRLKNLNGIPSACLSRLFLDNNELRDTDSLIHLKNLEILSIRNNKLK-SIVM--LGFLSK 151
Query: 147 LVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLT 206
L +LDL N+++ L +N + L+ K L +
Sbjct: 152 LEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWI 209
Query: 207 GTIPSS 212
S
Sbjct: 210 SPYYIS 215
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 8e-06
Identities = 21/98 (21%), Positives = 39/98 (39%), Gaps = 18/98 (18%)
Query: 114 EPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNN---DLSGPIPADLGNCTY 170
K +Q + +++ ++ + L L LS+N DLS L + T
Sbjct: 35 VSQKELSGVQNFNGDNSNIQ-SLAG--MQFFTNLKELHLSHNQISDLSP-----LKDLTK 86
Query: 171 LNTLILSNNKLSGPIPYQLSNLG--RLKKFSVANNDLT 206
L L ++ N+L L+ + L + + NN+L
Sbjct: 87 LEELSVNRNRLK-----NLNGIPSACLSRLFLDNNELR 119
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 9e-08
Identities = 43/204 (21%), Positives = 79/204 (38%), Gaps = 47/204 (23%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEK-------KFRNEMNRLGQLRHPNLAPLLGYCV 389
K G A K + +L + E+N L ++RHPN+ L
Sbjct: 19 AIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE 78
Query: 390 VEEEKLLIYKYMSSGTLYSLL--QGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQ 447
+ + +LI + +S G L+ L + + TE + + L G+ +LH +
Sbjct: 79 NKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVHYLH--------SK 127
Query: 448 NIC------SNVILVDEDF-DARIM--DFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSS 498
I N++L+D++ + RI DFG+A + + + G ++APE
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI---EAGNEFKNIFGTPEFVAPE--- 181
Query: 499 TMVASLKGDVYG-------IGVVL 515
+ + + G IGV+
Sbjct: 182 --I--VNYEPLGLEADMWSIGVIT 201
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 9e-08
Identities = 44/204 (21%), Positives = 74/204 (36%), Gaps = 50/204 (24%)
Query: 352 AVKRL--NTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYS 408
AVK L + +E+ + QL H N+ LLG C + LI++Y G L +
Sbjct: 79 AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN 138
Query: 409 LLQGNATELDWPTRFRIGLGA----------------------ARGLAWL--HHGCQPPF 444
L+ + A+G+ +L
Sbjct: 139 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-----C 193
Query: 445 LHQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEF--GYIAPE------ 495
+H+++ N +LV +I DFGLA+ + S +V ++APE
Sbjct: 194 VHRDLAARN-VLVTHGKVVKICDFGLARDIMSDSN--YVVRGNARLPVKWMAPESLFEGI 250
Query: 496 YSSTMVASLKGDVYGIGVVLLELA 519
Y+ K DV+ G++L E+
Sbjct: 251 YTI------KSDVWSYGILLWEIF 268
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 42/185 (22%), Positives = 73/185 (39%), Gaps = 25/185 (13%)
Query: 348 GSVLAVKRLNTCKLG----EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403
++A+K L +L E + R E+ LRHPN+ + Y + L+ ++
Sbjct: 39 KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98
Query: 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLH-HGCQPPFLHQNICSNVILVDEDFDA 462
G LY LQ + + + + A L + H +H++I +L+ +
Sbjct: 99 GELYKELQKHGRFDEQRSATFMEE-LADALHYCHERKV----IHRDIKPENLLMGYKGEL 153
Query: 463 RIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKG-----DVYGIGVVLLE 517
+I DFG + S + G Y+ PE M+ K D++ GV+ E
Sbjct: 154 KIADFGWSVHAPSLRRRTMC----GTLDYLPPE----MIEG-KTHDEKVDLWCAGVLCYE 204
Query: 518 -LAGF 521
L G
Sbjct: 205 FLVGM 209
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 39/211 (18%), Positives = 70/211 (33%), Gaps = 63/211 (29%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEK---KFRNEMNRLGQLRH-PNLAPLLGYCVVEE 392
+ + G A K L + G+ + +E+ L + P + L + V E
Sbjct: 43 AVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL--HEVYEN 100
Query: 393 EK--LLIYKYMSSGTLY----SLLQGNATELDWPTRFRIGLGAAR-------GLAWLHHG 439
+LI +Y + G ++ L +E D R G+ +LH
Sbjct: 101 TSEIILILEYAAGGEIFSLCLPELAEMVSEND----------VIRLIKQILEGVYYLHQ- 149
Query: 440 CQPPFLHQNIC------SNVILVDEDFDARIM--DFGLAKLMTSSDESSFVNGDLGEFGY 491
NI N++L I DFG+++ + + + +G Y
Sbjct: 150 -------NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI---GHACELREIMGTPEY 199
Query: 492 IAPEYSSTMVASLKGDVYG-------IGVVL 515
+APE + L D IG++
Sbjct: 200 LAPE-----I--LNYDPITTATDMWNIGIIA 223
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 38/204 (18%), Positives = 76/204 (37%), Gaps = 47/204 (23%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEK-------KFRNEMNRLGQLRHPNLAPLLGYCV 389
K G A K + + + E++ L Q+ H N+ L
Sbjct: 26 AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE 85
Query: 390 VEEEKLLIYKYMSSGTLYSLL--QGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQ 447
+ +LI + +S G L+ L + + +E + + + L G+ +LH +
Sbjct: 86 NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---GVNYLH--------TK 134
Query: 448 NIC------SNVILVDEDFDA---RIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSS 498
I N++L+D++ +++DFGLA + ++ G ++APE
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPE--- 188
Query: 499 TMVASLKGDVYG-------IGVVL 515
+ + + G IGV+
Sbjct: 189 --I--VNYEPLGLEADMWSIGVIT 208
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 44/196 (22%), Positives = 83/196 (42%), Gaps = 26/196 (13%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKK--FRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394
G YKA G++ A K + T K E+ + E+ L HP + LLG + +
Sbjct: 33 GKVYKAKNKETGALAAAKVIET-KSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL 91
Query: 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLH-HGCQPPFLHQNICSNV 453
++ ++ G + +++ L P + L +LH +H+++ +
Sbjct: 92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRI----IHRDLKAGN 147
Query: 454 ILVDEDFDARIMDFGL-AKLM-TSSDESSFVNGDLGEFG---YIAPEYSSTMVASLKG-- 506
+L+ + D R+ DFG+ AK + T SF+ G ++APE
Sbjct: 148 VLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-------GTPYWMAPEVVMCETMKDTPYD 200
Query: 507 ---DVYGIGVVLLELA 519
D++ +G+ L+E+A
Sbjct: 201 YKADIWSLGITLIEMA 216
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 45/187 (24%), Positives = 94/187 (50%), Gaps = 13/187 (6%)
Query: 337 TGTTYKAM-LPDGSVLAVKRLNTCKLGEKK-FRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394
+GT Y AM + G +A++++N + +K+ NE+ + + ++PN+ L +V +E
Sbjct: 33 SGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92
Query: 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVI 454
++ +Y++ G+L ++ T +D + + L +LH +H++I S+ I
Sbjct: 93 WVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQV---IHRDIKSDNI 147
Query: 455 LVDEDFDARIMDFGLAKLMTS--SDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIG 512
L+ D ++ DFG +T S S+ V G ++APE + K D++ +G
Sbjct: 148 LLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEVVTRKAYGPKVDIWSLG 203
Query: 513 VVLLELA 519
++ +E+
Sbjct: 204 IMAIEMI 210
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 39/204 (19%), Positives = 77/204 (37%), Gaps = 47/204 (23%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEK-------KFRNEMNRLGQLRHPNLAPLLGYCV 389
K G A K + + + E++ L Q+ HPN+ L
Sbjct: 26 AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE 85
Query: 390 VEEEKLLIYKYMSSGTLYSLL--QGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQ 447
+ +LI + +S G L+ L + + +E + + + L G+ +LH +
Sbjct: 86 NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---GVNYLH--------TK 134
Query: 448 NIC------SNVILVDEDFDA---RIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSS 498
I N++L+D++ +++DFGLA + ++ G ++APE
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPE--- 188
Query: 499 TMVASLKGDVYG-------IGVVL 515
+ + + G IGV+
Sbjct: 189 --I--VNYEPLGLEADMWSIGVIT 208
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 32/204 (15%), Positives = 61/204 (29%), Gaps = 55/204 (26%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396
G ++ + K + + + E++ L RH N+ L EE ++
Sbjct: 19 GIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78
Query: 397 IYKYMSSGTLYSLL---QGNATELDWPTRFRIGLGAAR-------GLAWLHHGCQPPFLH 446
I++++S ++ + E + L +LH
Sbjct: 79 IFEFISGLDIFERINTSAFELNERE----------IVSYVHQVCEALQFLH--------S 120
Query: 447 QNIC------SNVILVDEDFDARIM--DFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSS 498
NI N+I + I +FG A+ + Y APE
Sbjct: 121 HNIGHFDIRPENIIYQTRR-SSTIKIIEFGQARQL---KPGDNFRLLFTAPEYYAPE--- 173
Query: 499 TMVASLKGDVYG-------IGVVL 515
V + DV +G ++
Sbjct: 174 --V--HQHDVVSTATDMWSLGTLV 193
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 23/154 (14%), Positives = 42/154 (27%), Gaps = 37/154 (24%)
Query: 366 FRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRI 425
+ RL ++ P +A +L L++ +++ G+L + + R
Sbjct: 78 TLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRA 134
Query: 426 GLGAARGLAWLH-HGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNG 484
A H G + + V D G L
Sbjct: 135 MQSLAAAADAAHRAG----VALSIDHPSRVRVSID--------GDVVLAY---------- 172
Query: 485 DLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLEL 518
+ A+ + D+ GIG L L
Sbjct: 173 ----PATMPD-------ANPQDDIRGIGASLYAL 195
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 42/233 (18%), Positives = 71/233 (30%), Gaps = 61/233 (26%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLG------EKKFRNEMNRLGQLRHPNLAPLLGYCVV 390
G A+ ++ A+K +N K+ ++ + E+ + +L HPN+A L
Sbjct: 40 GVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99
Query: 391 EEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPP------- 443
E+ L+ + G L L + + +
Sbjct: 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRE 159
Query: 444 -----------------------FLH-QNIC------SNVILVDEDFDARIM--DFGLAK 471
+LH Q IC N L + I DFGL+K
Sbjct: 160 SLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPEN-FLFSTNKSFEIKLVDFGLSK 218
Query: 472 LMTSSD--ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYG-------IGVVL 515
+ E + G ++APE V + + YG GV+L
Sbjct: 219 EFYKLNNGEYYGMTTKAGTPYFVAPE-----VLNTTNESYGPKCDAWSAGVLL 266
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 58/237 (24%), Positives = 93/237 (39%), Gaps = 80/237 (33%)
Query: 338 GTTYKAML-PDGSVLAVKRLNTCKLGEKKFRN-EMNRLGQLRHPNLAPLLGYCVVEEEKL 395
G Y+A L G ++A+K++ L +K+F+N E+ + +L H N+ L + EK
Sbjct: 68 GVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 123
Query: 396 ------LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAA----------RGLAWLHHG 439
L+ Y+ T+Y + +R + L R LA++H
Sbjct: 124 DEVYLNLVLDYVPE-TVYRVA-------RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS- 174
Query: 440 CQPPFLHQNIC------SNVILVDEDFDA-RIMDFGLAKLMTSSDESSFVNGDLGEFGYI 492
IC N +L+D D ++ DFG AK + + + YI
Sbjct: 175 -------FGICHRDIKPQN-LLLDPDTAVLKLCDFGSAKQLVRGEPNV---------SYI 217
Query: 493 ------APE-------YSSTMVASLKGDVYGIGVVLLELAG----FKGNLVDWVNQL 532
APE Y+S++ DV+ G VL EL F G+ V+QL
Sbjct: 218 CSRYYRAPELIFGATDYTSSI------DVWSAGCVLAELLLGQPIFPGD--SGVDQL 266
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 46/202 (22%), Positives = 79/202 (39%), Gaps = 50/202 (24%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKK-FRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395
G +K G LA K + T + +K+ +NE++ + QL H NL L + + +
Sbjct: 103 GQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIV 162
Query: 396 LIYKYMSSGTL--------YSLLQGNATELDWPTRFRIGLGAAR-------GLAWLHHGC 440
L+ +Y+ G L Y+L TELD G+ +H
Sbjct: 163 LVMEYVDGGELFDRIIDESYNL-----TELD----------TILFMKQICEGIRHMH--- 204
Query: 441 QPPFLHQNIC------SNVILVDEDFDA-RIMDFGLAKLMTSSDESSFVNGDLGEFGYIA 493
I N++ V+ D +I+DFGLA+ + + G ++A
Sbjct: 205 -----QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY---KPREKLKVNFGTPEFLA 256
Query: 494 PEYSSTMVASLKGDVYGIGVVL 515
PE + S D++ +GV+
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIA 278
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-07
Identities = 24/113 (21%), Positives = 35/113 (30%), Gaps = 20/113 (17%)
Query: 96 NRILNLE----LREMKLSG----KIPEPLKFCKSMQRLDLSANDLS--GNIPAQICNWLP 145
+ RE+ L G I +D S N++ P L
Sbjct: 10 EQAAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFPL-----LR 64
Query: 146 YLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKF 198
L L ++NN + L LIL+NN L +L +L L
Sbjct: 65 RLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-----ELGDLDPLASL 112
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 5e-06
Identities = 19/79 (24%), Positives = 31/79 (39%), Gaps = 5/79 (6%)
Query: 131 DLSGNIPAQICN---WLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPY 187
DL G I N L +D S+N++ + L TL+++NN++
Sbjct: 25 DLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEG 82
Query: 188 QLSNLGRLKKFSVANNDLT 206
L L + + NN L
Sbjct: 83 LDQALPDLTELILTNNSLV 101
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 5e-07
Identities = 39/204 (19%), Positives = 74/204 (36%), Gaps = 47/204 (23%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEK-------KFRNEMNRLGQLRHPNLAPLLGYCV 389
K G A K + + E++ L +++HPN+ L
Sbjct: 25 AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 84
Query: 390 VEEEKLLIYKYMSSGTLYSLL--QGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQ 447
+ + +LI + ++ G L+ L + + TE + + L + +LH
Sbjct: 85 NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG---VYYLH--------SL 133
Query: 448 NIC------SNVILVDEDFDA---RIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSS 498
I N++L+D + +I+DFGLA + D + G ++APE
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPE--- 187
Query: 499 TMVASLKGDVYG-------IGVVL 515
+ + + G IGV+
Sbjct: 188 --I--VNYEPLGLEADMWSIGVIT 207
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 5e-07
Identities = 50/234 (21%), Positives = 87/234 (37%), Gaps = 68/234 (29%)
Query: 338 GTTYKAML-PDGSVLAVKRLNTCKLGEKKFRN----EMNRLGQLRHPNLAPLL------G 386
GT G +A+K++ + + +FRN M L L HPN+ L G
Sbjct: 37 GTVQLGKEKSTGMSVAIKKV----IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92
Query: 387 YCVVEEEKL-LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGA---ARGLAWLHHGCQP 442
+ L ++ +Y+ TL+ + P I + R + LH
Sbjct: 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV- 150
Query: 443 PFLHQNIC------SNVILVD-EDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYI--- 492
N+C N +LV+ D ++ DFG AK ++ S+ + YI
Sbjct: 151 -----NVCHRDIKPHN-VLVNEADGTLKLCDFGSAKKLSPSEPNV---------AYICSR 195
Query: 493 ---APE-------YSSTMVASLKGDVYGIGVVLLELAG----FKGNLVDWVNQL 532
APE Y++ + D++ +G + E+ F+G+ + QL
Sbjct: 196 YYRAPELIFGNQHYTTAV------DIWSVGCIFAEMMLGEPIFRGD--NSAGQL 241
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 46/212 (21%), Positives = 77/212 (36%), Gaps = 44/212 (20%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLG----------EKKFRNEMNRLGQL-RHPNLAPLL 385
+ + P AVK ++ G + E++ L ++ HPN+ L
Sbjct: 31 SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 90
Query: 386 GYCVVEEEKLLIYKYMSSGTL--YSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPP 443
L++ M G L Y + +E + R L + LH
Sbjct: 91 DTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV---ICALHK----- 142
Query: 444 FLHQNIC------SNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPE-Y 496
NI N IL+D+D + ++ DFG + + D + G Y+APE
Sbjct: 143 ---LNIVHRDLKPEN-ILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSYLAPEII 195
Query: 497 SSTMVASLKG-----DVYGIGVVL--LELAGF 521
+M + G D++ GV++ L LAG
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTL-LAGS 226
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 41/195 (21%), Positives = 81/195 (41%), Gaps = 23/195 (11%)
Query: 338 GTTYKAM-LPDGSVLAVK--RLNTCKLGEKKFRNEMNRL-GQLRHPNLAPLLGYCVVEEE 393
G +K G V+AVK R + K K+ +++ + P + G + +
Sbjct: 39 GQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98
Query: 394 KLLIYKYMSSGT--LYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNI-C 450
+ + M + L +QG E ++ + + L +L + +H+++
Sbjct: 99 VFIAMELMGTCAEKLKKRMQGPIPE---RILGKMTVAIVKALYYLKE--KHGVIHRDVKP 153
Query: 451 SNVILVDEDFDARIMDFGLAKLMTSS-DESSFVNGDLGEFGYIAPE-----YSSTMVASL 504
SN IL+DE ++ DFG++ + + G Y+APE + +
Sbjct: 154 SN-ILLDERGQIKLCDFGISGRLVDDKAKDRSA----GCAAYMAPERIDPPDPTKPDYDI 208
Query: 505 KGDVYGIGVVLLELA 519
+ DV+ +G+ L+ELA
Sbjct: 209 RADVWSLGISLVELA 223
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 49.8 bits (120), Expect = 9e-07
Identities = 37/190 (19%), Positives = 72/190 (37%), Gaps = 39/190 (20%)
Query: 348 GSVLAVKRLNTCKLG----EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK--LLIYKYM 401
G +A+K ++ + ++ +NE+ QL+HP++ L Y E+ L+ +
Sbjct: 36 GLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL--YNYFEDSNYVYLVLEMC 93
Query: 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVI------- 454
+G + L+ A + + G +LH + ++
Sbjct: 94 HNGEMNRYLKNRVKPFSENE-------ARHFMHQIITGML--YLHSH---GILHRDLTLS 141
Query: 455 --LVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVA----SLKGDV 508
L+ + + +I DFGLA + E G YI+PE + L+ DV
Sbjct: 142 NLLLTRNMNIKIADFGLATQLKMPHE--KHYTLCGTPNYISPE----IATRSAHGLESDV 195
Query: 509 YGIGVVLLEL 518
+ +G + L
Sbjct: 196 WSLGCMFYTL 205
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 48/214 (22%), Positives = 80/214 (37%), Gaps = 49/214 (22%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKL---------GEKKFRNEMNRLGQLR-HPNLAPLLG 386
+ + G AVK + + R E + L Q+ HP++ L+
Sbjct: 108 SVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167
Query: 387 YCVVEEEKLLIY---KYMSSGTL--YSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQ 441
E ++ M G L Y + +E + + R L A +++LH
Sbjct: 168 SY---ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEA---VSFLHA--- 218
Query: 442 PPFLHQNIC------SNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPE 495
NI N IL+D++ R+ DFG + + + + G GY+APE
Sbjct: 219 -----NNIVHRDLKPEN-ILLDDNMQIRLSDFGFSCHL---EPGEKLRELCGTPGYLAPE 269
Query: 496 -YSSTMVASLKG-----DVYGIGVVL--LELAGF 521
+M + G D++ GV+L L LAG
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTL-LAGS 302
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 35/197 (17%), Positives = 68/197 (34%), Gaps = 41/197 (20%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLR-HPNLAPLLGYCVVEEEKL 395
K + AVK ++ + E+ L HPN+ L +
Sbjct: 25 SICRKCVHKKSNQAFAVKIISKRME--ANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82
Query: 396 LIYKYMSSGTLYS--LLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNIC--- 450
L+ + ++ G L+ + + +E + R + A ++ +H +
Sbjct: 83 LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSA---VSHMHD--------VGVVHRD 131
Query: 451 ---SNVILVDEDFDARIM--DFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLK 505
N++ DE+ + I DFG A+L ++ + Y APE + L
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGFARLKP--PDNQPLKTPCFTLHYAAPE-----L--LN 182
Query: 506 GDVYG-------IGVVL 515
+ Y +GV+L
Sbjct: 183 QNGYDESCDLWSLGVIL 199
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 30/98 (30%), Positives = 55/98 (56%), Gaps = 6/98 (6%)
Query: 120 KSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNN 179
S++ LD+S N L+ + + C W +++L+LS+N L+G + L + L L NN
Sbjct: 403 SSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNN 460
Query: 180 KLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFD 217
++ IP +++L L++ +VA+N L ++P FD
Sbjct: 461 RIMS-IPKDVTHLQALQELNVASNQLK-SVPDGV--FD 494
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 25/67 (37%), Positives = 32/67 (47%), Gaps = 5/67 (7%)
Query: 117 KFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDL-SGPIPADLGNCTYLNTLI 175
F + ++ LD+S N L NI C + L LDLS ND P+ + GN T L L
Sbjct: 97 LFNQDLEYLDVSHNRLQ-NIS---CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLG 152
Query: 176 LSNNKLS 182
LS K
Sbjct: 153 LSAAKFR 159
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 19/91 (20%), Positives = 39/91 (42%), Gaps = 5/91 (5%)
Query: 123 QRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADL-GNCTYLNTLILSNNKL 181
L L+ N + ++ + L L L +L+ + G+ L L +++N +
Sbjct: 79 STLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLI 136
Query: 182 -SGPIPYQLSNLGRLKKFSVANNDLTGTIPS 211
S +P SNL L+ +++N + +I
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYC 166
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 24/115 (20%), Positives = 40/115 (34%), Gaps = 26/115 (22%)
Query: 121 SMQRLDLSAN-------------------DLSGN----IPAQICNWLPYLVLLDLSNNDL 157
S + LDLS N DLS I L +L L L+ N +
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 158 SGPIPADL-GNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPS 211
+ + L L+ L+ + + +L LK+ +VA+N + +
Sbjct: 89 QS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKL 141
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 25/96 (26%), Positives = 44/96 (45%), Gaps = 8/96 (8%)
Query: 120 KSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPAD----LGNCTYLN-TL 174
K+++ L+++ N + + + L L LDLS+N + I L LN +L
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPLLNLSL 182
Query: 175 ILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIP 210
LS N ++ I RLK+ ++ N L ++P
Sbjct: 183 DLSLNPMNF-IQPGAFKEIRLKELALDTNQLK-SVP 216
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 36/201 (17%), Positives = 72/201 (35%), Gaps = 34/201 (16%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKL-GEKKFRNEMNRLGQLR-HPNLAPLLGYCVVEEEK 394
+ L AVK + + E+ L Q + H N+ L+ + E+
Sbjct: 27 ARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86
Query: 395 LLIYKYMSSGTLYS--LLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNIC-- 450
L+++ M G++ S + + EL+ + A L +LH+ + I
Sbjct: 87 YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASA---LDFLHN--------KGIAHR 135
Query: 451 ----SNVILVDEDFDARIM--DFGLAKLMTSSDESSFVNGDL-----GEFGYIAPEYSST 499
N++ + + + DF L + + + S ++ G Y+APE
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195
Query: 500 MVASLKG-----DVYGIGVVL 515
D++ +GV+L
Sbjct: 196 FSEEASIYDKRCDLWSLGVIL 216
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 18/100 (18%), Positives = 32/100 (32%), Gaps = 4/100 (4%)
Query: 120 KSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPAD-LGNCTYLNTLILSN 178
S+ L+L N + + L L +L + N D I T+L L +
Sbjct: 124 SSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDA 183
Query: 179 NKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDK 218
+ L P L ++ + + + F D
Sbjct: 184 SDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIF--VDV 220
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 19/120 (15%), Positives = 41/120 (34%), Gaps = 11/120 (9%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP 160
LE+ L P+ LK +++ L L + + + L+L + DL
Sbjct: 179 LEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTF 237
Query: 161 ----IPAD----LGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSS 212
+ L + +++ L + L+ + L + + N L ++P
Sbjct: 238 HFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDG 295
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 16/129 (12%), Positives = 38/129 (29%), Gaps = 11/129 (8%)
Query: 96 NRILNLELREMKLSGKIPE-PLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSN 154
++ L + M KI ++ L++ A+DL + + + + L L
Sbjct: 149 TKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHM 207
Query: 155 NDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLS--------NLGRLKKFSVANNDLT 206
+ + + + L L + L +LS + + + L
Sbjct: 208 KQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF 267
Query: 207 GTIPSSFKG 215
+
Sbjct: 268 -QVMKLLNQ 275
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 26/94 (27%), Positives = 46/94 (48%), Gaps = 5/94 (5%)
Query: 119 CKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSN 178
C S+ L+ +IP+ + + LDLSNN ++ +DL C L L+L++
Sbjct: 30 CDRNGICKGSSGSLN-SIPSGL---TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTS 85
Query: 179 NKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSS 212
N ++ S+LG L+ ++ N L+ + SS
Sbjct: 86 NGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSS 118
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 22/117 (18%), Positives = 41/117 (35%), Gaps = 6/117 (5%)
Query: 103 LREMKLSG----KIPEPLKF--CKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNND 156
L + L G + E F +Q L + D I + L +L L++ +D
Sbjct: 126 LTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185
Query: 157 LSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213
L P L + ++ LIL + + + ++ + + DL S
Sbjct: 186 LQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSEL 242
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 26/95 (27%), Positives = 38/95 (40%), Gaps = 3/95 (3%)
Query: 123 QRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADL-GNCTYLNTLILSNNKL 181
+ LDLS N LS N+ + L L L+L N L + T L L + N
Sbjct: 103 EHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDT 161
Query: 182 SGPIPYQ-LSNLGRLKKFSVANNDLTGTIPSSFKG 215
I + + L L++ + +DL P S K
Sbjct: 162 FTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKS 196
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 17/91 (18%), Positives = 33/91 (36%), Gaps = 10/91 (10%)
Query: 121 SMQRLDLSANDLSGNIPAQICN-------WLPYLVLLDLSNNDLSGPIPADLGNCTYLNT 173
S++ L+L DL +++ + +++ L + L + L
Sbjct: 223 SVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLE 281
Query: 174 LILSNNKLSGPIPYQ-LSNLGRLKKFSVANN 203
L S N+L +P L L+K + N
Sbjct: 282 LEFSRNQLKS-VPDGIFDRLTSLQKIWLHTN 311
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 49/236 (20%), Positives = 93/236 (39%), Gaps = 79/236 (33%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEKKFRN-EMNRLGQLRHPNLAPLLGYCVVEEEKL- 395
G ++A L + +A+K++ L +K+F+N E+ + ++HPN+ L + +K
Sbjct: 54 GVVFQAKLVESDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109
Query: 396 -----LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAA----------RGLAWLH-HG 439
L+ +Y+ T+Y + + + R LA++H G
Sbjct: 110 EVFLNLVLEYVPE-TVYRAS-------RHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG 161
Query: 440 CQPPFLH-----QNICSNVILVDEDFDA-RIMDFGLAKLMTSSDESSFVNGDLGEFGYI- 492
H QN+ L+D +++DFG AK++ + + + YI
Sbjct: 162 ----ICHRDIKPQNL-----LLDPPSGVLKLIDFGSAKILIAGEPNV---------SYIC 203
Query: 493 -----APE-------YSSTMVASLKGDVYGIGVVLLELAG----FKGNLVDWVNQL 532
APE Y++ + D++ G V+ EL F G ++QL
Sbjct: 204 SRYYRAPELIFGATNYTTNI------DIWSTGCVMAELMQGQPLFPGE--SGIDQL 251
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 32/140 (22%), Positives = 53/140 (37%), Gaps = 35/140 (25%)
Query: 94 KENRILNLELREMKLSG------KIPEPLKFCKSMQRLDLSAN----------------- 130
+ ++ E +++L G K+ L K+ + L LS N
Sbjct: 16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKISSLSGMENLRIL 75
Query: 131 DLSGNIPAQICNW---LPYLVLLDLSNN---DLSGPIPADLGNCTYLNTLILSNNKLSGP 184
L N+ +I N L L +S N LSG + L L +SNNK++
Sbjct: 76 SLGRNLIKKIENLDAVADTLEELWISYNQIASLSG-----IEKLVNLRVLYMSNNKITNW 130
Query: 185 IP-YQLSNLGRLKKFSVANN 203
+L+ L +L+ +A N
Sbjct: 131 GEIDKLAALDKLEDLLLAGN 150
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 24/125 (19%), Positives = 45/125 (36%), Gaps = 13/125 (10%)
Query: 89 SCWNDKENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLV 148
C +++ R+ +++ IP S Q L L L IP+ + LP +
Sbjct: 9 ECHQEEDFRVTCKDIQR------IPSLPP---STQTLKLIETHLR-TIPSHAFSNLPNIS 58
Query: 149 LLDLSNNDLSGPIPADL-GNCTYLNTLILSNNKLSGPIPYQ-LSNLGRLKKFSVANNDLT 206
+ +S + + + N + + + + N + I L L LK + N L
Sbjct: 59 RIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK 118
Query: 207 GTIPS 211
P
Sbjct: 119 -MFPD 122
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 4e-06
Identities = 18/113 (15%), Positives = 33/113 (29%), Gaps = 5/113 (4%)
Query: 119 CKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPA-DLGNCTYLNTLILS 177
L + + + + L L + N + DL L L +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHL-PGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 178 NNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFD--KADFDGNSDLC 228
+ L P RL + +++ N L + +G + GN C
Sbjct: 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.7 bits (110), Expect = 1e-05
Identities = 17/96 (17%), Positives = 33/96 (34%), Gaps = 3/96 (3%)
Query: 112 IPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPAD-LGNCTY 170
L +++ L + ++ + L L L + + L + D
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81
Query: 171 LNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLT 206
L+ L LS N L + L L++ ++ N L
Sbjct: 82 LSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 31/119 (26%), Positives = 47/119 (39%), Gaps = 7/119 (5%)
Query: 100 NLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG 159
L L E L L + +L+L +L+ + LP L LDLS+N L
Sbjct: 35 ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD--GTLPVLGTLDLSHNQLQS 91
Query: 160 PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDK 218
+P L L +S N+L+ L LG L++ + N+L T+P
Sbjct: 92 -LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGL--LTP 146
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 22/96 (22%), Positives = 38/96 (39%), Gaps = 9/96 (9%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNK 180
S ++ +L+ +P + +L LS N L A L T L L L +
Sbjct: 11 SHLEVNCDKRNLT-ALPPDL---PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
Query: 181 LSG-PIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
L+ + L LG L +++N L ++P +
Sbjct: 67 LTKLQVDGTLPVLGTL---DLSHNQLQ-SLPLLGQT 98
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 7e-04
Identities = 26/82 (31%), Positives = 36/82 (43%), Gaps = 4/82 (4%)
Query: 123 QRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADL-GNCTYLNTLILSNNKL 181
Q L L N+L +P + P L L L+NN+L+ +PA L L+TL+L N L
Sbjct: 127 QELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSL 184
Query: 182 SGPIPYQLSNLGRLKKFSVANN 203
IP L + N
Sbjct: 185 YT-IPKGFFGSHLLPFAFLHGN 205
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 8e-06
Identities = 37/146 (25%), Positives = 64/146 (43%), Gaps = 16/146 (10%)
Query: 338 GTTYKAM-LPDGSVLAVK--RLNTCKLGEKK--FRNEMNRLGQLRHPNLAPLLGYCVVEE 392
G +K G ++A+K + KK R E+ L QL+HPNL LL +
Sbjct: 17 GVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVNLLE-VFRRK 74
Query: 393 EKL-LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLH-HGCQPPFLHQNI- 449
+L L+++Y T+ L + I + + + H H C +H+++
Sbjct: 75 RRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC----IHRDVK 129
Query: 450 CSNVILVDEDFDARIMDFGLAKLMTS 475
N IL+ + ++ DFG A+L+T
Sbjct: 130 PEN-ILITKHSVIKLCDFGFARLLTG 154
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 8e-06
Identities = 43/206 (20%), Positives = 73/206 (35%), Gaps = 46/206 (22%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKL 395
+ + AVK ++ K E+ L + +HPN+ L +
Sbjct: 36 SVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92
Query: 396 LIYKYMSSGTLYS--LLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNIC--- 450
++ + M G L L Q +E + + +LH Q +
Sbjct: 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKT---VEYLHA--------QGVVHRD 141
Query: 451 ---SNVILVDEDFDA---RIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASL 504
SN++ VDE + RI DFG AK + E+ + ++APE V L
Sbjct: 142 LKPSNILYVDESGNPESIRICDFGFAKQLR--AENGLLMTPCYTANFVAPE-----V--L 192
Query: 505 KGDVYG-------IGVVL--LELAGF 521
+ Y +GV+L + L G+
Sbjct: 193 ERQGYDAACDIWSLGVLLYTM-LTGY 217
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 9e-06
Identities = 40/200 (20%), Positives = 78/200 (39%), Gaps = 31/200 (15%)
Query: 338 GTTYKAM-LPDGSVLAVK--RLNTCKLGEKKFRNEMN-RLGQLRHPNLAPLLGYCVVEEE 393
G K +P G ++AVK R +K+ +++ + + P G E +
Sbjct: 21 GVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD 80
Query: 394 KLLIYKYM--SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNI-C 450
+ + M S Y + + +I + + L LH +H+++
Sbjct: 81 VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKP 138
Query: 451 SNVILVDEDFDARIMDFGLAK-LMTSSDESSFVNGDLGEFGYIAPE----------YSST 499
SN +L++ ++ DFG++ L+ + G Y+APE YS
Sbjct: 139 SN-VLINALGQVKMCDFGISGYLVDDVAKDIDA----GCKPYMAPERINPELNQKGYSV- 192
Query: 500 MVASLKGDVYGIGVVLLELA 519
K D++ +G+ ++ELA
Sbjct: 193 -----KSDIWSLGITMIELA 207
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 9e-06
Identities = 21/102 (20%), Positives = 39/102 (38%), Gaps = 11/102 (10%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPA----DLGNCTYLNTLIL 176
L L+ N+ + I LP L ++ SNN ++ I +N ++L
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGASG---VNEILL 88
Query: 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDK 218
++N+L L LK + +N +T + + F
Sbjct: 89 TSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGND--SFIG 127
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 17/84 (20%), Positives = 36/84 (42%), Gaps = 3/84 (3%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADL-GNCTYLNTLILSNN 179
+ + L++N L N+ ++ L L L L +N ++ + D + + L L +N
Sbjct: 82 GVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLSLYDN 139
Query: 180 KLSGPIPYQLSNLGRLKKFSVANN 203
+++ P L L ++ N
Sbjct: 140 QITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 38/180 (21%), Positives = 71/180 (39%), Gaps = 43/180 (23%)
Query: 431 RGLAWLHHGCQPPFLHQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEF 489
R + LH +H+++ SN +L++ + D ++ DFGLA+++ S +
Sbjct: 123 RAVKVLHGSN---VIHRDLKPSN-LLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 490 --GYI------APE-------YSSTMVASLKGDVYGIGVVLLELAG----FKGNLVDWVN 530
++ APE YS M DV+ G +L EL F G D+ +
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAM------DVWSCGCILAELFLRRPIFPGR--DYRH 230
Query: 531 QLSSSGRSKEAIDKALCGKGYDEEILQFLK--VACNCVVSRP-KDRWSMYQVYQSLNSIA 587
QL I + G + + L+ ++ A + S P + +++ +N
Sbjct: 231 QL-------LLIFGII-GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKG 282
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 53/191 (27%), Positives = 89/191 (46%), Gaps = 20/191 (10%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKK----FRNEMNRLGQLRHPNLAPLLGYCVVEE 392
G Y A + + V+A+K+++ + E+ L +LRHPN G + E
Sbjct: 68 GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 127
Query: 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLH-HGCQPPFLHQNICS 451
L+ +Y G+ LL+ + L + GA +GLA+LH H +H+++ +
Sbjct: 128 TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM----IHRDVKA 182
Query: 452 NVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVAS---LKGDV 508
IL+ E ++ DFG A +M ++ SFV G ++APE M K DV
Sbjct: 183 GNILLSEPGLVKLGDFGSASIMAPAN--SFV----GTPYWMAPEVILAMDEGQYDGKVDV 236
Query: 509 YGIGVVLLELA 519
+ +G+ +ELA
Sbjct: 237 WSLGITCIELA 247
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 23/85 (27%), Positives = 38/85 (44%), Gaps = 3/85 (3%)
Query: 120 KSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADL-GNCTYLNTLILSN 178
+S+ L L N ++ +P + L L LL L+ N ++ + D + LN L L +
Sbjct: 80 RSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYD 137
Query: 179 NKLSGPIPYQLSNLGRLKKFSVANN 203
NKL S L ++ +A N
Sbjct: 138 NKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 36/141 (25%), Positives = 62/141 (43%), Gaps = 16/141 (11%)
Query: 338 GTTYKAM-LPDGSVLAVK--RLNTCKLGEKK--FRNEMNRLGQLRHPNLAPLLGYCVVEE 392
G K G ++A+K + KK R E+ L QLRH NL LL ++
Sbjct: 39 GMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHENLVNLLE-VCKKK 96
Query: 393 EKL-LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLH-HGCQPPFLHQNI- 449
++ L+++++ T+ L+ LD+ + G+ + H H +H++I
Sbjct: 97 KRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNI----IHRDIK 151
Query: 450 CSNVILVDEDFDARIMDFGLA 470
N ILV + ++ DFG A
Sbjct: 152 PEN-ILVSQSGVVKLCDFGFA 171
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 40/183 (21%), Positives = 72/183 (39%), Gaps = 19/183 (10%)
Query: 348 GSVLAVKRLNTCKLG----EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK--LLIYKYM 401
V A K + L +K E++ L H ++ + E+ ++ +
Sbjct: 66 KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF--HGFFEDNDFVFVVLELC 123
Query: 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLH-HGCQPPFLHQNI-CSNVILVDED 459
+L L + + R+ + G +LH + +H+++ N + ++ED
Sbjct: 124 RRRSLLELHKRRKALTEPEARYYL-RQIVLGCQYLHRNR----VIHRDLKLGN-LFLNED 177
Query: 460 FDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLE-L 518
+ +I DFGLA + E G YIAPE S S + DV+ IG ++ L
Sbjct: 178 LEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL 235
Query: 519 AGF 521
G
Sbjct: 236 VGK 238
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 3e-05
Identities = 40/183 (21%), Positives = 72/183 (39%), Gaps = 19/183 (10%)
Query: 348 GSVLAVKRLNTCKLG----EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK--LLIYKYM 401
V A K + L +K E++ L H ++ + E+ ++ +
Sbjct: 40 KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF--HGFFEDNDFVFVVLELC 97
Query: 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLH-HGCQPPFLHQNI-CSNVILVDED 459
+L L + + R+ + G +LH + +H+++ N + ++ED
Sbjct: 98 RRRSLLELHKRRKALTEPEARYYL-RQIVLGCQYLHRNR----VIHRDLKLGN-LFLNED 151
Query: 460 FDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLE-L 518
+ +I DFGLA + E G YIAPE S S + DV+ IG ++ L
Sbjct: 152 LEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL 209
Query: 519 AGF 521
G
Sbjct: 210 VGK 212
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 3e-05
Identities = 43/198 (21%), Positives = 64/198 (32%), Gaps = 49/198 (24%)
Query: 352 AVK-----RLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVV-EEEKLLIYKYMSSGT 405
AVK +L GE + E+ L +LRH N+ L V+ EEK +Y M
Sbjct: 34 AVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL--VDVLYNEEKQKMYMVME--- 88
Query: 406 LYSLLQGNATEL-DWPTRFRIGLGAAR--------GLAWLHHGCQPPFLHQNIC------ 450
E+ D R + A GL +LH Q I
Sbjct: 89 ---YCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS--------QGIVHKDIKP 137
Query: 451 SNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKG---- 506
N +L+ +I G+A+ + G + PE + L
Sbjct: 138 GN-LLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE----IANGLDTFSGF 192
Query: 507 --DVYGIGVVLLEL-AGF 521
D++ GV L + G
Sbjct: 193 KVDIWSAGVTLYNITTGL 210
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 45/196 (22%), Positives = 71/196 (36%), Gaps = 48/196 (24%)
Query: 347 DGSVLAVKRLNTCKLGEKK----FRNEMNRLGQLRHPNLAPLLGYCVVEEEKL-LIYKYM 401
+ A+K +N K E+ E+ + L HP L L Y +EE + ++ +
Sbjct: 39 TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLL 97
Query: 402 SSGTLYSLLQ--GNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVI----- 454
G L LQ + E + I +A L + L +I
Sbjct: 98 LGGDLRYHLQQNVHFKEET--VKLFI---CELVMA-LDY------LQNQ---RIIHRDMK 142
Query: 455 ----LVDEDFDARIMDFGLAKLMTSSDE-SSFVNGDLGEFGYIAPEYSSTMVASLKGDVY 509
L+DE I DF +A ++ + ++ G Y+APE M +S KG Y
Sbjct: 143 PDNILLDEHGHVHITDFNIAAMLPRETQITTMA----GTKPYMAPE----MFSSRKGAGY 194
Query: 510 G-------IGVVLLEL 518
+GV EL
Sbjct: 195 SFAVDWWSLGVTAYEL 210
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 48/209 (22%), Positives = 69/209 (33%), Gaps = 61/209 (29%)
Query: 348 GSVLAVKRLNT-----CKLGEKKF----------RNEMNRLGQLRHPNLAPLLGYCVVEE 392
G V A + T CK EKK NE L ++ + L Y +
Sbjct: 198 GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-AYAYETK 256
Query: 393 EKL-LIYKYMSSGTL-YSLLQGNATELDWP-TRFRIGLGAARGLAWLHHGCQPPFLHQNI 449
+ L L+ M+ G L + + F AA L LH+
Sbjct: 257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY----AAEICCGLED------LHRE- 305
Query: 450 CSNV---------ILVDEDFDARIMDFGLAKLMTSSDE-SSFVNGDLGEFGYIAPEYSST 499
+ IL+D+ RI D GLA + V G GY+APE
Sbjct: 306 --RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV----GTVGYMAPEV--- 356
Query: 500 MVASLKGDVYG-------IGVVLLE-LAG 520
+K + Y +G +L E +AG
Sbjct: 357 ----VKNERYTFSPDWWALGCLLYEMIAG 381
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 41/200 (20%), Positives = 67/200 (33%), Gaps = 44/200 (22%)
Query: 347 DGSVLAVKRLNTCKLGEKK----FRNEMNRLGQLRHPNLAPLLGYCVVEEEKL-LIYKYM 401
G V A+K +N + ++ FR E + L + L + +E L L+ +Y
Sbjct: 85 TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYY 143
Query: 402 SSGTLYSLLQGNATELDWP-TRFRIGLGAARGLAWLHHGCQPPFLHQNICSNV------- 453
G L +LL + RF + A +A + +H+
Sbjct: 144 VGGDLLTLLSKFGERIPAEMARFYL---AEIVMA-IDS------VHRL---GYVHRDIKP 190
Query: 454 --ILVDEDFDARIMDFGLAKLMTSSDE---SSFVNGDLGEFGYIAPEYSSTMVASLKGDV 508
IL+D R+ DFG + + V G Y++PE +
Sbjct: 191 DNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV----GTPDYLSPEILQAVGGGPGTGS 246
Query: 509 YG-------IGVVLLE-LAG 520
YG +GV E G
Sbjct: 247 YGPECDWWALGVFAYEMFYG 266
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 53/231 (22%), Positives = 92/231 (39%), Gaps = 56/231 (24%)
Query: 313 KVKLADLMAASNSFCSENV---IIS----TRTGTTYKAMLPDGSVLAVKRLNTCKLGEKK 365
VKLA N + ++S R + P G+ A + ++
Sbjct: 28 VVKLA-----YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ 82
Query: 366 FRNEMNRLGQLRHPNLAPLLGYCVVE---EEKL-LIYKYMSSGTLYSLLQGNATELDWPT 421
E+ L +L HPN+ L V++ E+ L ++++ ++ G + ++ PT
Sbjct: 83 VYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPV----------MEVPT 130
Query: 422 RFRIGLGAAR--------GLAWLHHGCQPPFLHQNIC------SNVILVDEDFDARIMDF 467
+ AR G+ +LH+ Q I SN +LV ED +I DF
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHY--------QKIIHRDIKPSN-LLVGEDGHIKIADF 181
Query: 468 GLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKG---DVYGIGVVL 515
G++ SD + ++ +G ++APE S G DV+ +GV L
Sbjct: 182 GVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 46/198 (23%), Positives = 70/198 (35%), Gaps = 42/198 (21%)
Query: 347 DGSVLAVKRLNTCKLGEKK----FRNEMNRLGQLRHPNLAPLLGYCVVEEEKL-LIYKYM 401
V A+K LN ++ ++ FR E + L + L Y ++ L L+ Y
Sbjct: 98 ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYY 156
Query: 402 SSGTLYSLLQGNATELDWP-TRFRIGLGAARGLAWLHHGCQPPFLHQNICSNV------- 453
G L +LL L RF + A +A + +HQ +
Sbjct: 157 VGGDLLTLLSKFEDRLPEEMARFYL---AEMVIA-IDS------VHQL---HYVHRDIKP 203
Query: 454 --ILVDEDFDARIMDFGLAKLMTSSDE---SSFVNGDLGEFGYIAPEYSSTMVASLKG-- 506
IL+D + R+ DFG + S V G YI+PE M
Sbjct: 204 DNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV----GTPDYISPEILQAMEGGKGRYG 259
Query: 507 ---DVYGIGVVLLE-LAG 520
D + +GV + E L G
Sbjct: 260 PECDWWSLGVCMYEMLYG 277
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 42/210 (20%), Positives = 92/210 (43%), Gaps = 47/210 (22%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQL-RHPNLAPLLG-----YCVV 390
G YK + G + A+K ++ E++ + E+N L + H N+A G
Sbjct: 38 GQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97
Query: 391 EEEKL-LIYKYMSSGTLYSLLQGNATELDWPTRFR---------IGLGAARGLAWLH-HG 439
+++L L+ ++ +G++ L++ T+ I RGL+ LH H
Sbjct: 98 MDDQLWLVMEFCGAGSVTDLIK--------NTKGNTLKEEWIAYICREILRGLSHLHQHK 149
Query: 440 CQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE--SSFVNGDLGEFG---YIAP 494
+H++I +L+ E+ + +++DFG++ + + ++F+ G ++AP
Sbjct: 150 V----IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-------GTPYWMAP 198
Query: 495 EYSSTMVASLKG-----DVYGIGVVLLELA 519
E + D++ +G+ +E+A
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMA 228
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 9e-05
Identities = 33/166 (19%), Positives = 65/166 (39%), Gaps = 21/166 (12%)
Query: 431 RGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFG 490
G+ LH +H+++ + I+V D +I+DFGLA+ ++ S + +
Sbjct: 138 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRY 191
Query: 491 YIAPEYSSTMVASLKGDVYGIGVVLLELAG----FKGNLVDWVNQLSSSGRSKEAIDKAL 546
Y APE M D++ +G ++ E+ F G D ++Q + +
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT--DHIDQW-------NKVIE-Q 241
Query: 547 CGKGYDEEILQFLKVACNCVVSRP-KDRWSMYQVYQSLNSIAAQHG 591
G E + + V +RP +S +++ + A
Sbjct: 242 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 287
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 24/110 (21%), Positives = 39/110 (35%), Gaps = 10/110 (9%)
Query: 123 QRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPAD-LGNCTYLNTLILSNNKL 181
L L+ N + I N L NN+L +P D + L +S ++
Sbjct: 157 VILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEE-LPNDVFHGASGPVILDISRTRI 214
Query: 182 SGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF---DKADFDGNSDLC 228
Y L NL +L+ S +L +P + + +A S C
Sbjct: 215 HSLPSYGLENLKKLRARS--TYNLK-KLP-TLEKLVALMEASLTYPSHCC 260
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 19/97 (19%), Positives = 33/97 (34%), Gaps = 3/97 (3%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADL--GNCTYLNTLILSN 178
++Q L +S + ++P VLLD+ +N I + G L L+
Sbjct: 105 NLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNK 163
Query: 179 NKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
N + + + NN+L F G
Sbjct: 164 NGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHG 200
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 5e-04
Identities = 18/104 (17%), Positives = 35/104 (33%), Gaps = 7/104 (6%)
Query: 115 PLKFCK-SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNT 173
+ C S + + ++ IP+ + + L L L
Sbjct: 3 HHRICHCSNRVFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEK 58
Query: 174 LILSNNKLSGPIPYQ-LSNLGRLKKFSVAN-NDLTGTIPSSFKG 215
+ +S N + I SNL +L + + N+L P +F+
Sbjct: 59 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQN 102
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 49/209 (23%), Positives = 74/209 (35%), Gaps = 60/209 (28%)
Query: 348 GSVLAVKRLNT-----CKLGEKKF-------------RNEMNRLGQLRHPNLAPLLGYCV 389
G V ++ +T K +KK R ++ + P + + Y
Sbjct: 203 GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM-SYAF 261
Query: 390 VEEEKL-LIYKYMSSGTLYSLLQ--GNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLH 446
+KL I M+ G L+ L G +E D RF AA + L H +H
Sbjct: 262 HTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD--MRFY----AAEIILGLEH------MH 309
Query: 447 QNICSNV---------ILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYS 497
V IL+DE RI D GLA + + V G GY+APE
Sbjct: 310 NR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPE-- 360
Query: 498 STMVASLKG-----DVYGIGVVLLE-LAG 520
++ D + +G +L + L G
Sbjct: 361 --VLQKGVAYDSSADWFSLGCMLFKLLRG 387
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 45/195 (23%), Positives = 84/195 (43%), Gaps = 20/195 (10%)
Query: 338 GTTYKAM-LPDGSVLAVK--RLNTCKLGEKKFRNEMN-RLGQLRHPNLAPLLGYCVVEEE 393
G+ K + P G ++AVK R + +K+ +++ + P + G E +
Sbjct: 36 GSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95
Query: 394 KLLIYKYMSSGTLYSLLQGNATELDWPTR----FRIGLGAARGLAWLHHGCQPPFLHQNI 449
+ + MS + + + LD +I L + L L + +H++I
Sbjct: 96 CWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDI 152
Query: 450 -CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPE----YSSTMVASL 504
SN IL+D + ++ DFG++ + S + D G Y+APE +S +
Sbjct: 153 KPSN-ILLDRSGNIKLCDFGISGQLVDSIAKTR---DAGCRPYMAPERIDPSASRQGYDV 208
Query: 505 KGDVYGIGVVLLELA 519
+ DV+ +G+ L ELA
Sbjct: 209 RSDVWSLGITLYELA 223
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 29/89 (32%), Positives = 44/89 (49%), Gaps = 5/89 (5%)
Query: 123 QRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADL-GNCTYLNTLILSNNKL 181
L L N + +P ++ + +L L+DLSNN +S + N T L TLILS N+L
Sbjct: 34 TELYLDGNQFT-LVPKEL-SNYKHLTLIDLSNNRIST-LSNQSFSNMTQLLTLILSYNRL 90
Query: 182 SGPIPYQLSNLGRLKKFSVANNDLTGTIP 210
P L L+ S+ ND++ +P
Sbjct: 91 RCIPPRTFDGLKSLRLLSLHGNDIS-VVP 118
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 46/236 (19%), Positives = 85/236 (36%), Gaps = 69/236 (29%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEKK---FRN---------EMNRLGQLRHPNLAPLL 385
G + +G +A+KR+ + + E+ L HPN+ L
Sbjct: 36 GAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR 95
Query: 386 G-YCVVEEEKL----LIYKYMSSGTLYSLLQGNATELDWPTRFRIG------LGAARGLA 434
+ EE + L+ + M + L ++ + + I L GL
Sbjct: 96 DIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVI---SPQHIQYFMYHIL---LGLH 148
Query: 435 WLHHGCQPPFLHQNIC-SNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYI- 492
LH +H+++ N IL+ ++ D I DF LA+ T+ + Y+
Sbjct: 149 VLHEAG---VVHRDLHPGN-ILLADNNDITICDFNLAREDTADANKT---------HYVT 195
Query: 493 -----APE-------YSSTMVASLKGDVYGIGVVLLELAG----FKGNLVDWVNQL 532
APE ++ + D++ G V+ E+ F+G+ + NQL
Sbjct: 196 HRWYRAPELVMQFKGFTKLV------DMWSAGCVMAEMFNRKALFRGS--TFYNQL 243
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 28/114 (24%), Positives = 50/114 (43%), Gaps = 26/114 (22%)
Query: 431 RGLAWLHHGCQPPFLHQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEF 489
G+ LH +H+++ SN I+V D +I+DFGLA+ +S +
Sbjct: 175 CGIKHLHSAG---IIHRDLKPSN-IVVKSDCTLKILDFGLARTAGTSFMMT--------- 221
Query: 490 GYI------APEYSSTMVASLKGDVYGIGVVLLELAG----FKGNLVDWVNQLS 533
Y+ APE M D++ +G ++ E+ F G D+++Q +
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR--DYIDQWN 273
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 41/195 (21%), Positives = 80/195 (41%), Gaps = 39/195 (20%)
Query: 347 DGSVLAVKRLNTCKLGEKK----FRNEMNRLGQLRHPNLAPLLGYCVVEEEKL-LIYKYM 401
A+K L + ++ E + + +L HP L + ++EKL Y
Sbjct: 54 TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYA 112
Query: 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVI------- 454
+G L ++ + + TRF A ++ L + LH +I
Sbjct: 113 KNGELLKYIRKIGSFDETCTRFY----TAEIVSALEY------LHGK---GIIHRDLKPE 159
Query: 455 --LVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKG-----D 507
L++ED +I DFG AK+++ + + N +G Y++PE + + K D
Sbjct: 160 NILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-----LLTEKSACKSSD 214
Query: 508 VYGIGVVLLE-LAGF 521
++ +G ++ + +AG
Sbjct: 215 LWALGCIIYQLVAGL 229
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 46/208 (22%), Positives = 72/208 (34%), Gaps = 56/208 (26%)
Query: 348 GSVLAVKRLNT-----CKLGEKKF----------RNEMNRLGQLRHPNLAPLLGYCVVEE 392
G V A + T CK KK E L ++ + L Y +
Sbjct: 199 GEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETK 257
Query: 393 EKL-LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICS 451
L L+ M+ G + + + R A+ ++ L H LHQ
Sbjct: 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH------LHQR--- 308
Query: 452 NV---------ILVDEDFDARIMDFGLAKLMTSSDE--SSFVNGDLGEFGYIAPEYSSTM 500
N+ +L+D+D + RI D GLA + + + G G++APE
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA----GTPGFMAPEL---- 360
Query: 501 VASLKGDVYG-------IGVVLLE-LAG 520
L G+ Y +GV L E +A
Sbjct: 361 ---LLGEEYDFSVDYFALGVTLYEMIAA 385
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 3e-04
Identities = 23/92 (25%), Positives = 43/92 (46%), Gaps = 5/92 (5%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADL-GNCTYLNTLILSNN 179
L L+ N+L + LP+LV L+L N L+G I + +++ L L N
Sbjct: 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGEN 88
Query: 180 KLSGPIPYQL-SNLGRLKKFSVANNDLTGTIP 210
K+ I ++ L +LK ++ +N ++ +
Sbjct: 89 KIKE-ISNKMFLGLHQLKTLNLYDNQIS-CVM 118
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 4e-04
Identities = 40/143 (27%), Positives = 67/143 (46%), Gaps = 19/143 (13%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEKK-------FRNEMNRLGQLRHPNLAPLLGYCVV 390
G YKA G ++A+KR+ +L + R E++ L +L HPN+ L+ +
Sbjct: 35 GVVYKAKDSQGRIVALKRI---RLDAEDEGIPSTAIR-EISLLKELHHPNIVSLID-VIH 89
Query: 391 EEEKL-LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNI 449
E L L++++M L +L N T L RG+A H LH+++
Sbjct: 90 SERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDL 145
Query: 450 -CSNVILVDEDFDARIMDFGLAK 471
N +L++ D ++ DFGLA+
Sbjct: 146 KPQN-LLINSDGALKLADFGLAR 167
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 44/203 (21%), Positives = 72/203 (35%), Gaps = 51/203 (25%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYC----VVE 391
G + G A+K L K R E++ Q P++ +L +
Sbjct: 43 GKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGK 98
Query: 392 EEKLLIYKYMSSGTLYS--LLQGNA--TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQ 447
L+I + M G L+S +G+ TE + R A + +LH
Sbjct: 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA---IQFLHS--------H 147
Query: 448 NIC------SNVILVDEDFDARIM--DFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSST 499
NI N++ ++ DA + DFG AK T + + Y+APE
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC----YTPYYVAPE---- 199
Query: 500 MVASLKGDVYG-------IGVVL 515
V L + Y +GV++
Sbjct: 200 -V--LGPEKYDKSCDMWSLGVIM 219
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 28/98 (28%), Positives = 43/98 (43%), Gaps = 8/98 (8%)
Query: 123 QRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADL-GNCTYLNTLILSNNKL 181
+ L ++ N L +P + + L L L L N L +P + + T L L L N+L
Sbjct: 88 ETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNEL 145
Query: 182 SGPIPYQL-SNLGRLKKFSVANNDLTGTIPSSFKGFDK 218
+P + L LK+ + NN L +P FDK
Sbjct: 146 QS-LPKGVFDKLTSLKELRLYNNQLK-RVPEGA--FDK 179
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 31/126 (24%), Positives = 48/126 (38%), Gaps = 50/126 (39%)
Query: 431 RGLAWLHHGCQPPFLHQNIC------SNVILVD-EDFDARIMDFGLAKLMTSSDESSFVN 483
R + ++H IC N +LV+ +D ++ DFG AK + S+ S
Sbjct: 152 RAVGFIHS--------LGICHRDIKPQN-LLVNSKDNTLKLCDFGSAKKLIPSEPSV--- 199
Query: 484 GDLGEFGYI------APE-------YSSTMVASLKGDVYGIGVVLLELAG----FKGNLV 526
YI APE Y+ ++ D++ IG V EL F G
Sbjct: 200 ------AYICSRFYRAPELMLGATEYTPSI------DLWSIGCVFGELILGKPLFSGE-- 245
Query: 527 DWVNQL 532
++QL
Sbjct: 246 TSIDQL 251
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 34/165 (20%), Positives = 65/165 (39%), Gaps = 36/165 (21%)
Query: 348 GSVLAVKRLNTCKLGEKK----FRNEMNRLGQLRHPNLAPLLGYCVVEEEKL-LIYKYMS 402
V A+K L+ ++ ++ F E + + P + L Y ++ L ++ +YM
Sbjct: 94 RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMP 152
Query: 403 SGTLYSLLQGNATELDWPTRFRIGLGAAR--------GLAWLH-HGCQPPFLHQNICSNV 453
G L +L+ + + AR L +H G F+H+++ +
Sbjct: 153 GGDLVNLMS----------NYDVPEKWARFYTAEVVLALDAIHSMG----FIHRDVKPDN 198
Query: 454 ILVDEDFDARIMDFGLAKLMTSSDE---SSFVNGDLGEFGYIAPE 495
+L+D+ ++ DFG M + V G YI+PE
Sbjct: 199 MLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV----GTPDYISPE 239
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 7e-04
Identities = 32/144 (22%), Positives = 65/144 (45%), Gaps = 20/144 (13%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKK-------FRNEMNRLGQLRHPNLAPLLGYCV 389
GT +KA ++A+KR+ +L + R E+ L +L+H N+ L +
Sbjct: 16 GTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSALR-EICLLKELKHKNIVRLHD-VL 70
Query: 390 VEEEKL-LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQN 448
++KL L++++ L +LD +GL + H LH++
Sbjct: 71 HSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRD 126
Query: 449 I-CSNVILVDEDFDARIMDFGLAK 471
+ N +L++ + + ++ +FGLA+
Sbjct: 127 LKPQN-LLINRNGELKLANFGLAR 149
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 8e-04
Identities = 33/118 (27%), Positives = 56/118 (47%), Gaps = 31/118 (26%)
Query: 431 RGLAWLHHGCQPPFLHQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEF 489
RGL ++H LH+++ SN +L++ D +I DFGLA+ +D G L E+
Sbjct: 139 RGLKYIHSAN---VLHRDLKPSN-LLLNTTCDLKICDFGLAR---VADPDHDHTGFLTEY 191
Query: 490 ----GYIAPE-------YSSTMVASLKGDVYGIGVVLLELAG----FKGNLVDWVNQL 532
Y APE Y+ ++ D++ +G +L E+ F G +++QL
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSI------DIWSVGCILAEMLSNRPIFPGK--HYLDQL 241
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 8e-04
Identities = 36/143 (25%), Positives = 69/143 (48%), Gaps = 19/143 (13%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEKK-------FRNEMNRLGQLRHPNLAPLLGYCVV 390
G YKA G A+K++ +L ++ R E++ L +L+H N+ L +
Sbjct: 16 GVVYKAQNNYGETFALKKI---RLEKEDEGIPSTTIR-EISILKELKHSNIVKLYD-VIH 70
Query: 391 EEEKL-LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNI 449
+++L L+++++ L LL L+ T L G+A+ H LH+++
Sbjct: 71 TKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDL 126
Query: 450 -CSNVILVDEDFDARIMDFGLAK 471
N +L++ + + +I DFGLA+
Sbjct: 127 KPQN-LLINREGELKIADFGLAR 148
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 9e-04
Identities = 24/92 (26%), Positives = 46/92 (50%), Gaps = 7/92 (7%)
Query: 430 ARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEF 489
A+G+ +L +H+++ + IL+ E +I DFGLA+ + + +V
Sbjct: 203 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD--YVRKGDARL 257
Query: 490 --GYIAPEYSSTMVASLKGDVYGIGVVLLELA 519
++APE V +++ DV+ GV+L E+
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 611 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.9 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.89 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.84 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.75 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.72 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.72 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.72 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.72 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.69 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.67 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.66 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.62 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.61 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.6 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.6 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.59 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.58 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.58 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.57 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.56 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.56 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.55 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.55 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.54 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.53 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.51 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.51 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.5 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.5 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.5 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.5 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.5 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.5 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.5 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.5 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.5 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.49 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.49 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.49 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.49 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.48 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.48 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.48 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.48 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.48 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.47 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.47 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.47 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.47 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.47 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.47 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.47 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.46 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.45 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.45 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.45 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.44 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.43 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.43 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.42 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.42 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.42 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.42 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.42 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.41 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.41 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.41 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.41 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.4 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.4 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.4 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.39 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.39 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.38 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.38 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.38 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.38 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.38 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.37 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.37 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.37 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.36 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.35 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.35 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.35 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.33 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.32 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.32 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.32 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.32 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.32 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.31 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.31 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.31 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.31 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.3 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.27 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.26 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.23 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.22 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.21 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.21 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.21 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.2 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.2 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.19 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.18 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.18 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.18 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.17 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.17 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.17 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.16 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.15 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.15 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.15 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.15 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.13 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.11 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.11 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.1 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.09 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.09 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.08 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.07 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.06 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.05 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.04 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.02 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.02 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.02 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.98 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.82 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.79 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.78 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.77 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.67 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.6 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.56 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.52 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.41 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.35 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.34 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.34 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.28 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.25 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.06 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.03 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.0 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.98 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.92 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.89 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.89 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.89 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.76 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.72 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.52 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.41 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.33 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.32 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.26 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.12 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.1 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.88 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.87 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 96.85 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.82 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 96.82 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.72 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.7 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.63 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.48 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.44 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.24 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.17 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.14 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.02 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.18 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.62 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.48 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 93.32 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 92.3 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 92.06 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 91.42 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 90.59 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.94 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 88.69 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 86.08 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 85.36 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 83.49 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-55 Score=453.57 Aligned_cols=259 Identities=20% Similarity=0.314 Sum_probs=200.1
Q ss_pred hcCCCCCeeeecCCceEEEEEeC------CCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP------DGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
++|...+.||+|+||.||+|++. +++.||||+++... ...++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 35666789999999999999864 47899999997643 345789999999999999999999999999999999
Q ss_pred EEeccCCCChHHhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCe
Q 035917 397 IYKYMSSGTLYSLLQGNA--------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDA 462 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~ 462 (611)
|||||++|+|.++++... .+++|.+++.|+.|||+||+||| +.+|+||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence 999999999999997532 35999999999999999999999 7899999999999999999999
Q ss_pred EEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhh
Q 035917 463 RIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEA 541 (611)
Q Consensus 463 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~ 541 (611)
||+|||+|+.+.............||+.|||||++.+..|+.++|||||||++|||++ |+.||.+........ .+.+.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~-~i~~g 276 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID-CITQG 276 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH-HHHHT
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH-HHHcC
Confidence 9999999997654433333344579999999999999999999999999999999998 788874311100000 00000
Q ss_pred hchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 542 IDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 542 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
..+. .+...++++. +|+.+||+.||++||||+||+++|+.+.+..
T Consensus 277 ~~~~-~p~~~~~~~~---~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 277 RELE-RPRACPPEVY---AIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp CCCC-CCTTCCHHHH---HHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred CCCC-CcccccHHHH---HHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 0111 1223344444 4555999999999999999999999998763
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-55 Score=450.36 Aligned_cols=257 Identities=23% Similarity=0.347 Sum_probs=207.0
Q ss_pred hcCCCCCeeeecCCceEEEEEeC------CCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP------DGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
++|...+.||+|+||.||+|++. +++.||||+++... ...++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 35667789999999999999863 47899999997643 345789999999999999999999999999999999
Q ss_pred EEeccCCCChHHhhhcCC------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEE
Q 035917 397 IYKYMSSGTLYSLLQGNA------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARI 464 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl 464 (611)
|||||++|+|.++|+..+ ..++|..++.|+.|||+||+||| +++|+||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 36999999999999999999999 789999999999999999999999
Q ss_pred eecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhc
Q 035917 465 MDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAID 543 (611)
Q Consensus 465 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~ 543 (611)
+|||+|+...............||+.|||||++.+..|+.++|||||||++|||++ |+.||....... ....+.
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~-----~~~~i~ 244 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-----VIECIT 244 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----HHHHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHH
Confidence 99999997654333222233469999999999999999999999999999999998 788874321110 000111
Q ss_pred hh---hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 544 KA---LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 544 ~~---l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
.. ..+...++++.+ ++.+||+.||++||||+||++.|+++.+..+
T Consensus 245 ~~~~~~~p~~~~~~~~~---li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 245 QGRVLQRPRTCPQEVYE---LMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp HTCCCCCCTTCCHHHHH---HHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred cCCCCCCCccchHHHHH---HHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 00 112233444444 5559999999999999999999999988754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-55 Score=448.18 Aligned_cols=254 Identities=25% Similarity=0.335 Sum_probs=198.7
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
+++...+.||+|+||+||+|++.+ .||||+++... ...++|.+|+++|++++|||||+++|+|.+ +..+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 456667899999999999999753 69999997533 234679999999999999999999998854 568999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
|++|+|.++|+.....++|..++.|+.|||+||+||| +.+||||||||+|||+++++.+||+|||+|+.........
T Consensus 113 ~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 113 CEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp CSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999999999876667999999999999999999999 7899999999999999999999999999998765433333
Q ss_pred cccCCCcccccccccccCC---CCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCChhhhhchhh--cCCC
Q 035917 481 FVNGDLGEFGYIAPEYSST---MVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGRSKEAIDKAL--CGKG 550 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~~~~~~~~~l--~~~~ 550 (611)
.....+||+.|||||++.+ .+|+.++|||||||++|||++|+.||.+. +......+ ...+.+ ....
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~----~~~p~~~~~~~~ 265 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRG----YASPDLSKLYKN 265 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTT----CCCCCSTTSCTT
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcC----CCCCCccccccc
Confidence 3445679999999998853 46899999999999999999999998431 11111111 011111 1122
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 551 YDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 551 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
.++++.+ ++.+||+.||++||||.||+++|+.+....
T Consensus 266 ~~~~l~~---li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 266 CPKAMKR---LVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp SCHHHHH---HHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred chHHHHH---HHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 3344444 555999999999999999999999886543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-55 Score=449.42 Aligned_cols=252 Identities=23% Similarity=0.291 Sum_probs=201.7
Q ss_pred CCCCeeeecCCceEEEEEeC------CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 327 CSENVIISTRTGTTYKAMLP------DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 327 ~~~~~ig~G~~g~Vy~~~~~------~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
...+.||+|+||+||+|++. +++.||||+++... ...++|.+|+.+|++++|||||+++|+|.+++..+|||
T Consensus 29 ~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~ 108 (308)
T 4gt4_A 29 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIF 108 (308)
T ss_dssp EEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEE
Confidence 34578999999999999862 46899999996533 33578999999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeE
Q 035917 399 KYMSSGTLYSLLQGNA---------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDAR 463 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~k 463 (611)
|||++|+|.++|.... ..++|..+++|+.|||+||+||| +.+||||||||+|||+++++.+|
T Consensus 109 Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~~K 185 (308)
T 4gt4_A 109 SYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVK 185 (308)
T ss_dssp ECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEE
T ss_pred EcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCCEE
Confidence 9999999999996431 25899999999999999999999 78999999999999999999999
Q ss_pred EeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhh
Q 035917 464 IMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAI 542 (611)
Q Consensus 464 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~ 542 (611)
|+|||+|+.+.............||+.|||||++.++.|+.++|||||||++|||++ |..||....... ..+.+
T Consensus 186 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~-----~~~~i 260 (308)
T 4gt4_A 186 ISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-----VVEMI 260 (308)
T ss_dssp ECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH-----HHHHH
T ss_pred ECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH-----HHHHH
Confidence 999999997654433333445579999999999999999999999999999999998 777875321110 01111
Q ss_pred chhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHc
Q 035917 543 DKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586 (611)
Q Consensus 543 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 586 (611)
........++.....+.+++.+||+.||++||||.||+++|+.+
T Consensus 261 ~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 261 RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11111111122223455566699999999999999999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=430.55 Aligned_cols=265 Identities=22% Similarity=0.294 Sum_probs=199.6
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCC----eeEEEEe
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE----EKLLIYK 399 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~----~~~lv~e 399 (611)
+++...+.||+|+||+||+|++ +|+.||||+++........++.|+..+.+++|||||+++|+|..++ ..+||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 3456678999999999999998 6899999999765444444566777788999999999999998754 5799999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeeecCCCCCeEEeCCCCCeEEeecccccccC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHG-----CQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~ 474 (611)
||++|+|.++++.. .++|..+.+++.|+++||+|||+. ..++|+||||||+|||+|.++++||+|||+|+...
T Consensus 82 y~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 99999999999864 589999999999999999999943 13499999999999999999999999999998765
Q ss_pred CCCCC--ccccCCCcccccccccccCCC------CCCcccchHHHHHHHHHHhCCCCCH----------HHHHHH-----
Q 035917 475 SSDES--SFVNGDLGEFGYIAPEYSSTM------VASLKGDVYGIGVVLLELAGFKGNL----------VDWVNQ----- 531 (611)
Q Consensus 475 ~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~SfGvvl~ell~~~~~~----------~~~~~~----- 531 (611)
..... ......+||+.|||||++.+. .++.++|||||||++|||++|..++ .++...
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 239 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence 43322 122345799999999998654 4678999999999999999875432 111000
Q ss_pred HhhcCChhhhhchhhcCC-CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 532 LSSSGRSKEAIDKALCGK-GYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 532 ~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
........+..++.+... ...+....+.+++.+||+.||++||||.||+++|+++.++.+
T Consensus 240 ~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~ 300 (303)
T 3hmm_A 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp HHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence 000000001111111111 112345667788889999999999999999999999987654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-52 Score=429.68 Aligned_cols=255 Identities=16% Similarity=0.122 Sum_probs=205.9
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccC
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
+.|...+.||+|+||.||+|+. .+|+.||||+++.... ..+|+.+|++++|||||++++++.+++..|||||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 4677778999999999999996 5699999999975432 2579999999999999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC-CeEEeecccccccCCCCCCc-
Q 035917 403 SGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF-DARIMDFGLAKLMTSSDESS- 480 (611)
Q Consensus 403 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~-~~kl~DFGla~~~~~~~~~~- 480 (611)
+|+|.++++.. ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||+|+.+.......
T Consensus 134 gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 134 GGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp TCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 99999999754 46999999999999999999999 89999999999999999887 69999999999875433211
Q ss_pred --cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc----hhhcCCCCHHH
Q 035917 481 --FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID----KALCGKGYDEE 554 (611)
Q Consensus 481 --~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~----~~l~~~~~~~~ 554 (611)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||.... .......+.. ........+++
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~~s~~ 285 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF----RGPLCLKIASEPPPIREIPPSCAPL 285 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC----CSCCHHHHHHSCCGGGGSCTTSCHH
T ss_pred eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC----HHHHHHHHHcCCCCchhcCccCCHH
Confidence 1223579999999999999999999999999999999999999984310 0001111111 01112344556
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCCC
Q 035917 555 ILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFS 593 (611)
Q Consensus 555 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 593 (611)
+.+++. +||+.||++|||+.|++++|....++.+..
T Consensus 286 ~~~li~---~~L~~dP~~R~sa~el~~~l~~~l~~~~~l 321 (336)
T 4g3f_A 286 TAQAIQ---EGLRKEPVHRASAMELRRKVGKALQEVGGL 321 (336)
T ss_dssp HHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHHTTSS
T ss_pred HHHHHH---HHccCCHhHCcCHHHHHHHHHHHHhhhhhc
Confidence 666666 999999999999999999999988775543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=437.67 Aligned_cols=265 Identities=18% Similarity=0.233 Sum_probs=210.2
Q ss_pred HHHHHhhhcCCCCCeeeecCCceEEEEEeC------CCCEEEEEeccccc--hhHHHHHHHHHHHhccCC-CCccceeeE
Q 035917 317 ADLMAASNSFCSENVIISTRTGTTYKAMLP------DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRH-PNLAPLLGY 387 (611)
Q Consensus 317 ~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~~------~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H-~nIv~l~g~ 387 (611)
.+.+-..++|...+.||+|+||.||+|++. .++.||||+++... ...++|.+|+++|.+++| ||||+++|+
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 344444567888899999999999999853 24689999997543 334679999999999965 899999999
Q ss_pred EEeC-CeeEEEEeccCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 035917 388 CVVE-EEKLLIYKYMSSGTLYSLLQGNA---------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICS 451 (611)
Q Consensus 388 ~~~~-~~~~lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp 451 (611)
|..+ +..++|||||++|+|.++|+... ..++|..++.++.|||+||+||| +.+||||||||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~ 213 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAA 213 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCc
Confidence 9765 56899999999999999996431 24899999999999999999999 78999999999
Q ss_pred CeEEeCCCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHH
Q 035917 452 NVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVN 530 (611)
Q Consensus 452 ~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~ 530 (611)
+|||+++++.+||+|||+|+.+............+||+.|||||++.+..|+.++|||||||++|||++ |+.||.....
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999997755443333444579999999999999999999999999999999998 7888743100
Q ss_pred HHhhcCChhhhhchhh---cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 531 QLSSSGRSKEAIDKAL---CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 531 ~~~~~~~~~~~~~~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
.......+.... .+...++++. +++.+||+.||++|||+.||+++|+++.+...
T Consensus 294 ----~~~~~~~i~~g~~~~~p~~~~~~~~---~li~~c~~~dP~~RPt~~eil~~L~~llq~~~ 350 (353)
T 4ase_A 294 ----DEEFCRRLKEGTRMRAPDYTTPEMY---QTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350 (353)
T ss_dssp ----SHHHHHHHHHTCCCCCCTTCCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred ----HHHHHHHHHcCCCCCCCccCCHHHH---HHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence 000111111111 1223344444 45559999999999999999999999987643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-52 Score=430.24 Aligned_cols=248 Identities=18% Similarity=0.265 Sum_probs=202.5
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
+.|...+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 3577778999999999999996 479999999996543 33456899999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
++|+|.+++... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.+.... ..
T Consensus 154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~ 226 (346)
T 4fih_A 154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PR 226 (346)
T ss_dssp TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CC
T ss_pred CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC--Cc
Confidence 999999999753 5999999999999999999999 7899999999999999999999999999999775432 22
Q ss_pred ccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhc-CCCCHHHHHHHHH
Q 035917 482 VNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALC-GKGYDEEILQFLK 560 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~l~~ 560 (611)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||.......... .+.+...+.+. ....++++.+++.
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~-~i~~~~~~~~~~~~~~s~~~~dli~ 305 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLPPRLKNLHKVSPSLKGFLD 305 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHHHSSCCCCSCGGGSCHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH-HHHcCCCCCCCccccCCHHHHHHHH
Confidence 345689999999999999999999999999999999999999984311000000 00011111111 1123456666665
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 035917 561 VACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 561 l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+||+.||++|||+.|+++|
T Consensus 306 ---~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 306 ---RLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp ---HHSCSSTTTSCCHHHHTTC
T ss_pred ---HHcCCChhHCcCHHHHhcC
Confidence 9999999999999999886
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=418.76 Aligned_cols=238 Identities=23% Similarity=0.320 Sum_probs=190.3
Q ss_pred CCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEe----CCeeEEEEe
Q 035917 328 SENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVV----EEEKLLIYK 399 (611)
Q Consensus 328 ~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~----~~~~~lv~e 399 (611)
..+.||+|+||+||+|+. .++..||||++.... ...+.|.+|+++|++++|||||+++++|.+ ++..+||||
T Consensus 30 ~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmE 109 (290)
T 3fpq_A 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 109 (290)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEe
Confidence 346799999999999996 468999999996533 234679999999999999999999999875 345789999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCeEEeC-CCCCeEEeecccccccCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPP--FLHQNICSNVILVD-EDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlkp~NILld-~~~~~kl~DFGla~~~~~~ 476 (611)
||++|+|.+++.+. ..+++..+..++.||+.||+||| +.+ |+||||||+|||++ .++.+||+|||+|+.....
T Consensus 110 y~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~ 185 (290)
T 3fpq_A 110 LMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred CCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence 99999999999754 46999999999999999999999 555 99999999999998 4789999999999865322
Q ss_pred CCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCChhhhhchhhcCCCC
Q 035917 477 DESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGRSKEAIDKALCGKGY 551 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~~~ 551 (611)
.....+||+.|||||++.+ +|+.++|||||||++|||++|+.||.+. +......+ ..+.......
T Consensus 186 ----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~-----~~~~~~~~~~ 255 (290)
T 3fpq_A 186 ----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-----VKPASFDKVA 255 (290)
T ss_dssp ----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-----CCCGGGGGCC
T ss_pred ----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcC-----CCCCCCCccC
Confidence 2234579999999998865 6999999999999999999999998431 11111111 1111111223
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 552 DEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 552 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++++.+++. +||+.||++|||++|+++|
T Consensus 256 ~~~~~~li~---~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 256 IPEVKEIIE---GCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CHHHHHHHH---HHSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHH---HHccCChhHCcCHHHHhcC
Confidence 345555555 9999999999999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-52 Score=432.66 Aligned_cols=247 Identities=19% Similarity=0.289 Sum_probs=197.1
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
++|...+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++|++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5788889999999999999995 579999999996543 234679999999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 400 YMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 400 y~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||++|+|.+++.... ..+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 999999999997544 46899999999999999999999 7899999999999999999999999999998764221
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh--hcCCCCHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA--LCGKGYDEEIL 556 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~ 556 (611)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||........ ...+.... ......++++.
T Consensus 180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~----~~~i~~~~~~~~~~~~s~~~~ 254 (350)
T 4b9d_A 180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL----VLKIISGSFPPVSLHYSYDLR 254 (350)
T ss_dssp -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHTCCCCCCTTSCHHHH
T ss_pred -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH----HHHHHcCCCCCCCccCCHHHH
Confidence 112334699999999999999999999999999999999999998742100000 00011100 11223456666
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+++. +||+.||++|||+.|+++|
T Consensus 255 ~li~---~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 255 SLVS---QLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHHH---HHTCSSGGGSCCHHHHHTS
T ss_pred HHHH---HHccCChhHCcCHHHHhcC
Confidence 6666 9999999999999999976
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=422.32 Aligned_cols=248 Identities=17% Similarity=0.205 Sum_probs=205.5
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||+||+|+. .+|+.||||++++.. ...+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5688999999999999999995 579999999996532 23467999999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
|||++|+|.+++... +.+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 112 Ey~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 999999999999754 46999999999999999999999 78999999999999999999999999999998755444
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-hcCCCCHHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-LCGKGYDEEILQ 557 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~~~ 557 (611)
.....+.+||+.|||||++.+..|+.++||||+||++|||++|+.||........ ...+.... ..+...++++.+
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~----~~~i~~~~~~~p~~~s~~~~d 263 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI----FAKIIKLEYDFPEKFFPKARD 263 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHTCCCCCTTCCHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCCcccCHHHHH
Confidence 3444566899999999999999999999999999999999999999842110000 00011100 012334566666
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++. +||+.||++|||++|++.+
T Consensus 264 li~---~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 264 LVE---KLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp HHH---HHSCSSGGGSTTSGGGTCH
T ss_pred HHH---HHccCCHhHCcChHHHcCC
Confidence 666 9999999999999987544
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=431.32 Aligned_cols=248 Identities=18% Similarity=0.266 Sum_probs=203.9
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
+.|...+.||+|+||.||+|+. .+|+.||||+++... ...+.+.+|+.+|++++|||||++++++.+++..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 4577888999999999999996 569999999996543 33456899999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
++|+|.+++... .+++..+..|+.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.+.... ..
T Consensus 231 ~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~ 303 (423)
T 4fie_A 231 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PR 303 (423)
T ss_dssp TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CC
T ss_pred CCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC--cc
Confidence 999999999754 4999999999999999999999 7899999999999999999999999999999775432 22
Q ss_pred ccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHHHHHHH
Q 035917 482 VNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEILQFLK 560 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~~ 560 (611)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||.......... .+.....+.+ .....++++.+|++
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~-~i~~~~~~~~~~~~~~s~~~~dli~ 382 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLPPRLKNLHKVSPSLKGFLD 382 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHHHSCCCCCSCTTSSCHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH-HHHcCCCCCCcccccCCHHHHHHHH
Confidence 345679999999999999999999999999999999999999984311000000 0011111111 11234566666666
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 035917 561 VACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 561 l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+||+.||++|||+.|+++|
T Consensus 383 ---~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 383 ---RLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp ---HHSCSSTTTSCCHHHHTTC
T ss_pred ---HHcCCChhHCcCHHHHhcC
Confidence 9999999999999999886
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=405.38 Aligned_cols=244 Identities=20% Similarity=0.295 Sum_probs=188.0
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5788899999999999999995 579999999996543 22467999999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||| +|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp ECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred eCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence 999 67999998765 46999999999999999999999 7899999999999999999999999999998764322
Q ss_pred CccccCCCcccccccccccCCCCC-CcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-hcCCCCHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVA-SLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-LCGKGYDEEIL 556 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~~ 556 (611)
.....+||+.|||||++.+..+ +.++||||+||++|||++|+.||..-..... ...+.... ..+...++++.
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~----~~~i~~~~~~~p~~~s~~~~ 240 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL----FKNISNGVYTLPKFLSPGAA 240 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHTCCCCCTTSCHHHH
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHcCCCCCCCCCCHHHH
Confidence 2234579999999999998876 5799999999999999999998742100000 00000000 01233456666
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+++. +||+.||++|||++|+++|
T Consensus 241 ~li~---~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 241 GLIK---RMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp HHHH---HHSCSSGGGSCCHHHHHHC
T ss_pred HHHH---HHccCChhHCcCHHHHHcC
Confidence 6666 9999999999999999986
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=407.76 Aligned_cols=249 Identities=18% Similarity=0.280 Sum_probs=185.0
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCC--------
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE-------- 392 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~-------- 392 (611)
++|...+.||+|+||+||+|+. .+|+.||||+++... ...+++.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4688889999999999999995 579999999996432 33467999999999999999999999987644
Q ss_pred ----eeEEEEeccCCCChHHhhhcCCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEee
Q 035917 393 ----EKLLIYKYMSSGTLYSLLQGNAT--ELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMD 466 (611)
Q Consensus 393 ----~~~lv~ey~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~D 466 (611)
..|+|||||++|+|.+++.+... ..++..++.|+.||++||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999986542 4677888999999999999999 78999999999999999999999999
Q ss_pred cccccccCCCCCC----------ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcC
Q 035917 467 FGLAKLMTSSDES----------SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSG 536 (611)
Q Consensus 467 FGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~ 536 (611)
||+|+.+...... ...++.+||+.|||||++.+..|+.++|||||||++|||++ ||.........
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~-- 236 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT-- 236 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH--
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHH--
Confidence 9999977543211 11234579999999999999999999999999999999996 43211111000
Q ss_pred ChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 537 RSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 537 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
......... +...........+++.+||+.||++|||+.|+++|
T Consensus 237 -~~~~~~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 237 -LTDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp -HHHHHTTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHHHhcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000000000 00111222334456669999999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=411.55 Aligned_cols=246 Identities=17% Similarity=0.187 Sum_probs=193.3
Q ss_pred hcCCCCCeeeecCCceEEEEEe----CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML----PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~----~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
++|...+.||+|+||+||+|+. .+++.||||+++... ....++.+|+++|++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4688889999999999999985 247899999996532 223468899999999999999999999999999999
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
|||||++|+|.+++.+. ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 99999999999999754 46999999999999999999999 789999999999999999999999999999865432
Q ss_pred CCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-hcCCCCHHHH
Q 035917 477 DESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-LCGKGYDEEI 555 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~ 555 (611)
. ....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||........ ...+.... ..+...++++
T Consensus 180 ~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~----~~~i~~~~~~~p~~~s~~~ 253 (304)
T 3ubd_A 180 E--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET----MTMILKAKLGMPQFLSPEA 253 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCTTSCHHH
T ss_pred C--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH----HHHHHcCCCCCCCcCCHHH
Confidence 2 223345799999999999999999999999999999999999999842110000 00011100 1123345666
Q ss_pred HHHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 035917 556 LQFLKVACNCVVSRPKDRWS-----MYQVYQS 582 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 582 (611)
.+++. +||+.||++||| ++|+++|
T Consensus 254 ~~li~---~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 254 QSLLR---MLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp HHHHH---HHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred HHHHH---HHcccCHHHCCCCCcCCHHHHHcC
Confidence 66666 999999999998 4677765
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=382.96 Aligned_cols=281 Identities=40% Similarity=0.646 Sum_probs=235.4
Q ss_pred cccccHHHHHHhhhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccch--hHHHHHHHHHHHhccCCCCccceeeEE
Q 035917 311 LVKVKLADLMAASNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKL--GEKKFRNEMNRLGQLRHPNLAPLLGYC 388 (611)
Q Consensus 311 ~~~~~~~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~--~~~~~~~Ev~~l~~l~H~nIv~l~g~~ 388 (611)
...+++.++..++++|...+.||+|+||.||+|+..+|+.||||++..... ....+.+|++++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456889999999999999999999999999999988899999999975432 224689999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEe
Q 035917 389 VVEEEKLLIYKYMSSGTLYSLLQGNA---TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIM 465 (611)
Q Consensus 389 ~~~~~~~lv~ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~ 465 (611)
..++..++||||+++|+|.+++.... ..++|..+..++.|++.||+|||+.+.++|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999997653 259999999999999999999995434499999999999999999999999
Q ss_pred ecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHH-------------HHHHHH
Q 035917 466 DFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLV-------------DWVNQL 532 (611)
Q Consensus 466 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~-------------~~~~~~ 532 (611)
|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||. +|....
T Consensus 177 Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 177 DFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 999998764332 222334469999999999988889999999999999999999998874 233333
Q ss_pred hhcCChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCC
Q 035917 533 SSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGF 592 (611)
Q Consensus 533 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 592 (611)
..........+..+......+....+.+++.+||+.||++|||+.||+++|+.......+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~ 315 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERW 315 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSC
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhh
Confidence 333344455555555566777888899999999999999999999999999875544433
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=396.01 Aligned_cols=251 Identities=18% Similarity=0.256 Sum_probs=194.4
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEe------CCe
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVV------EEE 393 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~------~~~ 393 (611)
++|...+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 4688889999999999999995 579999999996543 234678899999999999999999998764 356
Q ss_pred eEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccccc
Q 035917 394 KLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLM 473 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~ 473 (611)
.|||||||+ |+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+.+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 899999996 6899999754 46999999999999999999999 789999999999999999999999999999876
Q ss_pred CCCC--CCccccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhh-cCCh------
Q 035917 474 TSSD--ESSFVNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSS-SGRS------ 538 (611)
Q Consensus 474 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~-~~~~------ 538 (611)
.... ........+||+.|||||++.+. .++.++||||+||++|||++|+.||.. ....+.. .+..
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 4322 12233456899999999998765 469999999999999999999988731 1111110 0000
Q ss_pred -------hhhhchh--h-------cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 539 -------KEAIDKA--L-------CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 539 -------~~~~~~~--l-------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
...+... . .....++++.+|+. +||+.||++|||+.|+++|
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~---~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLG---RMLRFEPSARISAAAALRH 345 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHH---HHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHH---HHCcCChhHCcCHHHHhcC
Confidence 0000000 0 00112344455544 9999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=381.15 Aligned_cols=275 Identities=35% Similarity=0.568 Sum_probs=229.5
Q ss_pred cccHHHHHHhhhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeC
Q 035917 313 KVKLADLMAASNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE 391 (611)
Q Consensus 313 ~~~~~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~ 391 (611)
.+.+.++..++++|...+.||+|+||.||+|+..+++.||||++.... ...+.+.+|+.++++++||||+++++++..+
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 344556667889999999999999999999998889999999986543 3457799999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecc
Q 035917 392 EEKLLIYKYMSSGTLYSLLQGNA---TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFG 468 (611)
Q Consensus 392 ~~~~lv~ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFG 468 (611)
+..++||||+++|+|.+++.... ..++|..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecc
Confidence 99999999999999999997553 25899999999999999999999 7899999999999999999999999999
Q ss_pred cccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHH-----------HHHHHHhhcCC
Q 035917 469 LAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLV-----------DWVNQLSSSGR 537 (611)
Q Consensus 469 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~-----------~~~~~~~~~~~ 537 (611)
+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||. .|.........
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 9987543322222333458999999999988899999999999999999999987652 23333333333
Q ss_pred hhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 538 SKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 538 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
....+++.+......+....+.+++.+||+.||++|||+.|++++|+.+.+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 44445555555556677778888888999999999999999999999987654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=386.64 Aligned_cols=197 Identities=19% Similarity=0.230 Sum_probs=168.9
Q ss_pred HhhhcCCCCCeeeecCCceEEEEEe----CCCCEEEEEeccccchhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeE
Q 035917 321 AASNSFCSENVIISTRTGTTYKAML----PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKL 395 (611)
Q Consensus 321 ~~t~~f~~~~~ig~G~~g~Vy~~~~----~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~ 395 (611)
...+.|...+.||+|+||+||+|+. .+++.||||++.... ...++.+|+++|..+ +|||||++++++.+++..+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4567799999999999999999984 247899999986543 345688999999998 6999999999999999999
Q ss_pred EEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCC-CCeEEeecccccccC
Q 035917 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDED-FDARIMDFGLAKLMT 474 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~-~~~kl~DFGla~~~~ 474 (611)
+|||||++|+|.+++. .+++..+..++.|++.||+||| +.+|+||||||+|||++.+ +.+||+|||+|+...
T Consensus 97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 9999999999999984 3899999999999999999999 8899999999999999876 799999999998654
Q ss_pred CCCC--------------------------CccccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCH
Q 035917 475 SSDE--------------------------SSFVNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNL 525 (611)
Q Consensus 475 ~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~ 525 (611)
.... ....+..+||+.|||||++.+. .|+.++||||+||++|||++|+.||
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 3210 0112345799999999998775 4899999999999999999999887
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=404.31 Aligned_cols=243 Identities=19% Similarity=0.233 Sum_probs=198.1
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch----hHHHH---HHHHHHHhccCCCCccceeeEEEeCCeeE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL----GEKKF---RNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~---~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~ 395 (611)
++|...++||+|+||.||+|+. .+|+.||||++++... ....+ .+++.+++.++|||||++++++.+++..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 5788899999999999999995 4699999999965321 12223 34467778889999999999999999999
Q ss_pred EEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
+|||||+||+|.+++... ..+++..+..++.||+.||+||| +.+||||||||+|||++.+|.+||+|||+|+.+..
T Consensus 269 lVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 999999999999999754 46999999999999999999999 89999999999999999999999999999997754
Q ss_pred CCCCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhh----c-hhhcCC
Q 035917 476 SDESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAI----D-KALCGK 549 (611)
Q Consensus 476 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~----~-~~l~~~ 549 (611)
.. ..+.+||+.|||||++.. ..|+.++||||+||++|||++|..||.... .....++. . +...+.
T Consensus 345 ~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~-----~~~~~~i~~~i~~~~~~~p~ 415 (689)
T 3v5w_A 345 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK-----TKDKHEIDRMTLTMAVELPD 415 (689)
T ss_dssp CC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG-----CCCHHHHHHHHHHCCCCCCT
T ss_pred CC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhhcCCCCCCCc
Confidence 32 234579999999999864 579999999999999999999999984310 00111111 1 111223
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 035917 550 GYDEEILQFLKVACNCVVSRPKDRWS-----MYQVYQS 582 (611)
Q Consensus 550 ~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 582 (611)
..+.++.+++. +||+.||++|++ ++||++|
T Consensus 416 ~~S~~a~dLI~---~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 416 SFSPELRSLLE---GLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp TSCHHHHHHHH---HHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred cCCHHHHHHHH---HHccCCHhHCCCCCCCCHHHHhcC
Confidence 45667777666 999999999998 7899877
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=405.67 Aligned_cols=247 Identities=19% Similarity=0.306 Sum_probs=203.9
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ...+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 35788889999999999999995 579999999996543 3456789999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCC--CCeEEeecccccccCCCCC
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDED--FDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~--~~~kl~DFGla~~~~~~~~ 478 (611)
|++|+|.+++......+++..+..++.||+.||+||| +.+|+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 9999999999766567999999999999999999999 7899999999999999854 899999999999875432
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCChhhhhchhhcCCCCHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGRSKEAIDKALCGKGYDE 553 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~~~~~ 553 (611)
.....+||+.|||||++.+..|+.++||||+||++|||++|..||... ..... .... .+.. ......++
T Consensus 312 --~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~-~~~~--~~~~-~~~~~~s~ 385 (573)
T 3uto_A 312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK-SCDW--NMDD-SAFSGISE 385 (573)
T ss_dssp --EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH-TTCC--CCCS-GGGTTSCH
T ss_pred --ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH-hCCC--CCCc-ccccCCCH
Confidence 223347999999999999999999999999999999999999987421 11111 1000 0000 01123455
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 554 EILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 554 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++.+|+. +||+.||++|||+.|+++|
T Consensus 386 ~~~dli~---~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 386 DGKDFIR---KLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHHHHHH---TTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHH---HHccCChhHCcCHHHHhcC
Confidence 6666666 9999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=367.61 Aligned_cols=261 Identities=23% Similarity=0.382 Sum_probs=209.2
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEecccc-chhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTC-KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~-~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
++|...+.||+|+||.||+|+. .+++.||+|++... ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 4677789999999999999996 46999999988653 344578999999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc-
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS- 480 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~- 480 (611)
++|+|.+++......+++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 999999999876567999999999999999999999 7899999999999999999999999999998764332111
Q ss_pred -----------cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcC-ChhhhhchhhcC
Q 035917 481 -----------FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSG-RSKEAIDKALCG 548 (611)
Q Consensus 481 -----------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 548 (611)
......||+.|+|||++.+..++.++|||||||++|||++|..++........... ......+. ...
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 245 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR-YCP 245 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH-TCC
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc-cCC
Confidence 01134699999999999999999999999999999999998877643211111111 11111111 112
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 549 KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 549 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
...++++.+ ++.+||+.||++|||+.|+++.|+.+.+...
T Consensus 246 ~~~~~~l~~---li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 246 PNCPPSFFP---ITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp TTCCTTHHH---HHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHHH---HHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 233344444 5559999999999999999999999987753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=370.32 Aligned_cols=262 Identities=23% Similarity=0.280 Sum_probs=205.8
Q ss_pred hhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCC----eeEEEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE----EKLLIY 398 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~----~~~lv~ 398 (611)
.++|...+.||+|+||.||+|+.. ++.||||+++........+.+|+.++.+++||||+++++++.... ..++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 357888899999999999999975 799999999776656667788999999999999999999998754 369999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC----------CeeecCCCCCeEEeCCCCCeEEeecc
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQP----------PFLHQNICSNVILVDEDFDARIMDFG 468 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~----------~ivHrDlkp~NILld~~~~~kl~DFG 468 (611)
||+++|+|.+++... .++|..+..++.|++.||+||| +. +|+||||||+|||++.++.+||+|||
T Consensus 102 e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 102 AFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred ecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 999999999999764 4899999999999999999999 66 99999999999999999999999999
Q ss_pred cccccCCCCCCccccCCCcccccccccccCC-----CCCCcccchHHHHHHHHHHhCCCCCHHHH--------HHHHhhc
Q 035917 469 LAKLMTSSDESSFVNGDLGEFGYIAPEYSST-----MVASLKGDVYGIGVVLLELAGFKGNLVDW--------VNQLSSS 535 (611)
Q Consensus 469 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~SfGvvl~ell~~~~~~~~~--------~~~~~~~ 535 (611)
+++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||... .......
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 9987754433333344579999999999876 35667899999999999999997765210 0000000
Q ss_pred CChhhhhch----hhcCC-----CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 536 GRSKEAIDK----ALCGK-----GYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 536 ~~~~~~~~~----~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
....+..+. ..... ........+.+++.+||+.||++|||+.||++.|+++.+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 011111100 00000 01123345666777999999999999999999999998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=357.86 Aligned_cols=273 Identities=28% Similarity=0.453 Sum_probs=221.9
Q ss_pred CcccccHHHHHHhhhcCCCC------CeeeecCCceEEEEEeCCCCEEEEEeccccc-----hhHHHHHHHHHHHhccCC
Q 035917 310 PLVKVKLADLMAASNSFCSE------NVIISTRTGTTYKAMLPDGSVLAVKRLNTCK-----LGEKKFRNEMNRLGQLRH 378 (611)
Q Consensus 310 ~~~~~~~~~l~~~t~~f~~~------~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~-----~~~~~~~~Ev~~l~~l~H 378 (611)
....|++.++..++++|... +.||+|+||.||+|.. +++.||||++.... ...+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34578999999999999988 8999999999999987 68899999986421 234679999999999999
Q ss_pred CCccceeeEEEeCCeeEEEEeccCCCChHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEe
Q 035917 379 PNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNA--TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV 456 (611)
Q Consensus 379 ~nIv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl 456 (611)
|||+++++++...+..++||||+++|+|.+++.... ..++|..+..++.|++.||.||| +.+|+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEE
Confidence 999999999999999999999999999999986432 46999999999999999999999 7899999999999999
Q ss_pred CCCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHH---------
Q 035917 457 DEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVD--------- 527 (611)
Q Consensus 457 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~--------- 527 (611)
+.++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|..||..
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence 9999999999999987654333323334569999999998875 589999999999999999999887632
Q ss_pred HHHHHhh-cCChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchh
Q 035917 528 WVNQLSS-SGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAA 588 (611)
Q Consensus 528 ~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 588 (611)
+...... .....+.+++.+ ..........+.+++.+||+.||++|||+.+|+++|+++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 1111111 111222222222 22344555667778889999999999999999999998754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=373.84 Aligned_cols=256 Identities=20% Similarity=0.272 Sum_probs=205.6
Q ss_pred hcCCCCCeeeecCCceEEEEEe--------CCCCEEEEEeccccc--hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCC
Q 035917 324 NSFCSENVIISTRTGTTYKAML--------PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEE 392 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~--------~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~ 392 (611)
++|...+.||+|+||.||+|+. .++..||||+++... ...+++.+|+++++++ +||||++++++|..++
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 5677889999999999999985 235689999997543 2346799999999999 8999999999999999
Q ss_pred eeEEEEeccCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC
Q 035917 393 EKLLIYKYMSSGTLYSLLQGNA---------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD 457 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld 457 (611)
..++||||+++|+|.+++.... ..+++..++.++.||+.||+||| +.+|+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEEC
Confidence 9999999999999999997542 24899999999999999999999 78999999999999999
Q ss_pred CCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcC
Q 035917 458 EDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSG 536 (611)
Q Consensus 458 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~ 536 (611)
.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... .
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~-----~ 312 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-----E 312 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----G
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH-----H
Confidence 999999999999987654332222333457889999999988899999999999999999998 7777643100 0
Q ss_pred Chhhhhchhh---cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 537 RSKEAIDKAL---CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 537 ~~~~~~~~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
.....+.... .....++++.+ ++.+||+.||++||++.|++++|+.+....
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~l~~---li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 313 ELFKLLKEGHRMDKPANCTNELYM---MMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp GHHHHHHTTCCCCCCTTSCHHHHH---HHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHH---HHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 0111111111 11223344555 445999999999999999999999988654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=357.54 Aligned_cols=257 Identities=21% Similarity=0.317 Sum_probs=210.1
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
++|...+.||+|+||.||+|+..+++.||+|++.......+++.+|++++++++||||+++++++.+++..++||||+++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence 46777789999999999999998899999999987766778899999999999999999999999999999999999999
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcccc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 165 (269)
T 4hcu_A 90 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSST 165 (269)
T ss_dssp CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTT
T ss_pred CcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc-ccccc
Confidence 9999999876667999999999999999999999 7899999999999999999999999999998764321 11223
Q ss_pred CCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHH
Q 035917 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVA 562 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~ 562 (611)
...+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......... ...... ........++++.+++.
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~li~-- 241 (269)
T 4hcu_A 166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE-DISTGF-RLYKPRLASTHVYQIMN-- 241 (269)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-HHHTTC-CCCCCTTSCHHHHHHHH--
T ss_pred CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHH-HHhcCc-cCCCCCcCCHHHHHHHH--
Confidence 3457889999999988899999999999999999998 787764211110000 000000 01112223455555555
Q ss_pred hhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 563 CNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 563 ~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
+||+.||++||++.|++++|+++.+.
T Consensus 242 -~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 242 -HCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp -HHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -HHccCCcccCcCHHHHHHHHHHHHHc
Confidence 99999999999999999999998864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=366.63 Aligned_cols=260 Identities=20% Similarity=0.319 Sum_probs=204.7
Q ss_pred hcCCCCCeeeecCCceEEEEEeC----CCCEEEEEecccc--chhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP----DGSVLAVKRLNTC--KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~----~g~~vAvK~~~~~--~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
+.|...+.||+|+||.||+|+.. .+..||||+++.. ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 45667799999999999999974 3556999999753 23456799999999999999999999999998999999
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
|||+++|+|.+++......+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 9999999999999766567999999999999999999999 7899999999999999999999999999998765432
Q ss_pred C-CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHH
Q 035917 478 E-SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEI 555 (611)
Q Consensus 478 ~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 555 (611)
. ........+|+.|+|||++.+..++.++|||||||++|||++ |..||.......... ........ ......++++
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~l 283 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVIS-SVEEGYRL-PAPMGCPHAL 283 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH-HHHTTCCC-CCCTTCCHHH
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHH-HHHcCCCC-CCCCCcCHHH
Confidence 2 112223356889999999988889999999999999999998 888874311110000 00000000 0112234445
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
.+ ++.+||+.||++|||+.||++.|+.+.+...
T Consensus 284 ~~---li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 284 HQ---LMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp HH---HHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred HH---HHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 55 4459999999999999999999999987644
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=373.58 Aligned_cols=261 Identities=20% Similarity=0.311 Sum_probs=196.8
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC----CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP----DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~----~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
.++|...+.||+|+||.||+|+.. ++..||||+++... ...++|.+|+.++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357889999999999999999864 57789999997542 334679999999999999999999999999999999
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
||||+++|+|.+++......+++..++.++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999999999876667999999999999999999999 789999999999999999999999999999876533
Q ss_pred CCC-ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHH
Q 035917 477 DES-SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEE 554 (611)
Q Consensus 477 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 554 (611)
... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... ..+.+............
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-----~~~~i~~~~~~~~~~~~ 275 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-----VIKAVDEGYRLPPPMDC 275 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-----HHHHHHTTEECCCCTTC
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHcCCCCCCCccc
Confidence 211 11122246778999999998899999999999999999997 888874321110 11111111111111112
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 555 ILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 555 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
...+.+++.+||+.||++||++.||++.|+.+.+..+
T Consensus 276 ~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 276 PAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp BHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred cHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 2344555559999999999999999999999987643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=378.26 Aligned_cols=257 Identities=23% Similarity=0.326 Sum_probs=205.7
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
.++|...+.||+|+||.||+|+.. +++.||||.++... ...++|.+|+++|++++||||+++++++..++..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 356777899999999999999975 79999999997542 223568999999999999999999999999899999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
|+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999999999765456899999999999999999999 789999999999999999999999999999865332111
Q ss_pred ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchh---hcCCCCHHHH
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKA---LCGKGYDEEI 555 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~---l~~~~~~~~~ 555 (611)
.......+++.|+|||.+.+..++.++|||||||++|||++ |..||....... ..+.+... ..+...++++
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l 344 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-----TREFVEKGGRLPCPELCPDAV 344 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-----HHHHHHTTCCCCCCTTCCHHH
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHcCCCCCCCCCCCHHH
Confidence 11111235778999999988889999999999999999998 787764321110 00111110 1122234445
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
.+ ++.+||+.||++|||+.+|++.|+++.+++
T Consensus 345 ~~---li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 345 FR---LMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp HH---HHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HH---HHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 55 555999999999999999999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=353.70 Aligned_cols=258 Identities=20% Similarity=0.301 Sum_probs=210.0
Q ss_pred hhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccC
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
.++|...+.||+|+||.||+|...++..||||+++......+++.+|++++.+++||||+++++++..++..++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 35677789999999999999999888899999998776677889999999999999999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccc
Q 035917 403 SGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482 (611)
Q Consensus 403 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 482 (611)
+|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~ 162 (268)
T 3sxs_A 87 NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VSS 162 (268)
T ss_dssp TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-EEC
T ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhh-hcc
Confidence 99999999765556999999999999999999999 78999999999999999999999999999987654332 222
Q ss_pred cCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHH
Q 035917 483 NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKV 561 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l 561 (611)
....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......... .... ..........++++.+++.
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~l~~li~- 239 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL-KVSQ-GHRLYRPHLASDTIYQIMY- 239 (268)
T ss_dssp CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HHHT-TCCCCCCTTSCHHHHHHHH-
T ss_pred cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH-HHHc-CCCCCCCCcChHHHHHHHH-
Confidence 33457788999999988889999999999999999998 887763211110000 0000 0011112223455555555
Q ss_pred HhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 562 ACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 562 ~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
+||+.||++|||+.|++++|+.+.++
T Consensus 240 --~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 240 --SCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp --HTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred --HHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 99999999999999999999998765
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=357.56 Aligned_cols=249 Identities=19% Similarity=0.273 Sum_probs=200.8
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
.+.|...+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 35788899999999999999994 679999999986433 3456789999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
+++|+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171 (297)
T ss_dssp CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--
Confidence 9999999999764 4899999999999999999999 78999999999999999999999999999987654322
Q ss_pred cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHHHHHH
Q 035917 481 FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEILQFL 559 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~ 559 (611)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .......+.. .....++++.+++
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li 250 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPEKLSAIFRDFL 250 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHHHHCSCCCSCGGGSCHHHHHHH
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhCCCCCCCCccccCHHHHHHH
Confidence 2234569999999999999999999999999999999999998874210000000 0000000000 0112334455555
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 035917 560 KVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 560 ~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
. +||+.||++|||+.|+++|
T Consensus 251 ~---~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 251 N---RCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp H---HHSCSSTTTSCCHHHHTTC
T ss_pred H---HHccCChhHCcCHHHHhhC
Confidence 5 9999999999999999876
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=360.26 Aligned_cols=261 Identities=24% Similarity=0.360 Sum_probs=198.5
Q ss_pred hhhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccch---hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 322 ASNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKL---GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~---~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
..++|...+.||+|+||.||+|+. +|+.||||++..... ..+++.+|++++++++||||+++++++...+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 345788889999999999999987 688999999965432 2357899999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCeEEeCCCCCeEEeecccccccC
Q 035917 399 KYMSSGTLYSLLQGNAT--ELDWPTRFRIGLGAARGLAWLHHGCQPP--FLHQNICSNVILVDEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlkp~NILld~~~~~kl~DFGla~~~~ 474 (611)
||+++|+|.+++..... .+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999999999986542 4899999999999999999999 677 9999999999999999999999999998653
Q ss_pred CCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHH
Q 035917 475 SSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEE 554 (611)
Q Consensus 475 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 554 (611)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ...............+.+
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 267 (309)
T 3p86_A 191 STF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA-AVGFKCKRLEIPRNLNPQ 267 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH-HHHHSCCCCCCCTTSCHH
T ss_pred ccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcCCCCCCCccCCHH
Confidence 321 11233469999999999999999999999999999999999998874311110000 000000000112234455
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCC
Q 035917 555 ILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGF 592 (611)
Q Consensus 555 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 592 (611)
+.++++ +||+.||++|||+.|+++.|+.+.+....
T Consensus 268 l~~li~---~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 268 VAAIIE---GCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp HHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred HHHHHH---HHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 555555 99999999999999999999999876543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=359.53 Aligned_cols=259 Identities=20% Similarity=0.247 Sum_probs=207.7
Q ss_pred cccHHHHHHhhhc----------CCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCC
Q 035917 313 KVKLADLMAASNS----------FCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPN 380 (611)
Q Consensus 313 ~~~~~~l~~~t~~----------f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~n 380 (611)
.++.+++..+++. |...+.||+|+||.||+|+.. +|+.||||+++... ...+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 5788888888865 556678999999999999975 79999999996543 34567999999999999999
Q ss_pred ccceeeEEEeCCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC
Q 035917 381 LAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF 460 (611)
Q Consensus 381 Iv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~ 460 (611)
|+++++++...+..++||||+++|+|.+++... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~ 178 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDG 178 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTC
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCC
Confidence 999999999999999999999999999998753 5899999999999999999999 78999999999999999999
Q ss_pred CeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhh
Q 035917 461 DARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKE 540 (611)
Q Consensus 461 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~ 540 (611)
.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....
T Consensus 179 ~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~-~~~~~ 255 (321)
T 2c30_A 179 RVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-KRLRD 255 (321)
T ss_dssp CEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHHHH
T ss_pred cEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHhc
Confidence 999999999987643321 223456999999999999989999999999999999999999887421000000 00000
Q ss_pred hhchhhc-CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 541 AIDKALC-GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 541 ~~~~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
...+.+. ....++++.+++. +||+.||++|||+.|++++
T Consensus 256 ~~~~~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 256 SPPPKLKNSHKVSPVLRDFLE---RMLVRDPQERATAQELLDH 295 (321)
T ss_dssp SSCCCCTTGGGSCHHHHHHHH---HHSCSSTTTSCCHHHHHTS
T ss_pred CCCCCcCccccCCHHHHHHHH---HHccCChhhCcCHHHHhcC
Confidence 0011110 1122345555555 9999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=355.95 Aligned_cols=258 Identities=16% Similarity=0.267 Sum_probs=207.5
Q ss_pred hhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccC
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
.++|...+.||+|+||.||+|...++..||||+++......+++.+|++++.+++||||+++++++.+++..++||||++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 34677789999999999999999888899999998776677889999999999999999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccc
Q 035917 403 SGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482 (611)
Q Consensus 403 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 482 (611)
+|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~ 178 (283)
T 3gen_A 103 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSS 178 (283)
T ss_dssp TCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HHST
T ss_pred CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc-cccc
Confidence 99999999865456999999999999999999999 7899999999999999999999999999998764322 1112
Q ss_pred cCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHH
Q 035917 483 NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKV 561 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l 561 (611)
....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......... ....... .......++.+.+++.
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~l~~li~- 255 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE-HIAQGLR-LYRPHLASEKVYTIMY- 255 (283)
T ss_dssp TSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HHHTTCC-CCCCTTCCHHHHHHHH-
T ss_pred cCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH-HHhcccC-CCCCCcCCHHHHHHHH-
Confidence 23357889999999988889999999999999999998 888864321110000 0000000 1112223445555554
Q ss_pred HhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 562 ACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 562 ~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
+||+.||++|||+.|++++|+++.++
T Consensus 256 --~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 256 --SCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp --HTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHccCChhHCcCHHHHHHHHHHHhhc
Confidence 99999999999999999999998865
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=370.74 Aligned_cols=267 Identities=18% Similarity=0.237 Sum_probs=210.2
Q ss_pred ccHHHHHHhhhcCCCCCeeeecCCceEEEEEe------CCCCEEEEEeccccc--hhHHHHHHHHHHHhcc-CCCCccce
Q 035917 314 VKLADLMAASNSFCSENVIISTRTGTTYKAML------PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQL-RHPNLAPL 384 (611)
Q Consensus 314 ~~~~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~------~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l-~H~nIv~l 384 (611)
+...+.....++|...+.||+|+||.||+|++ .+++.||||+++... ...+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34445555677899999999999999999973 346899999997543 2346799999999999 79999999
Q ss_pred eeEEEeCCe-eEEEEeccCCCChHHhhhcCCC------------------------------------------------
Q 035917 385 LGYCVVEEE-KLLIYKYMSSGTLYSLLQGNAT------------------------------------------------ 415 (611)
Q Consensus 385 ~g~~~~~~~-~~lv~ey~~~gsL~~~l~~~~~------------------------------------------------ 415 (611)
++++...+. .++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 8999999999999999975421
Q ss_pred -----------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 416 -----------------ELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 416 -----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
.+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 1889999999999999999999 78999999999999999999999999999987654433
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchh---hcCCCCHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKA---LCGKGYDEE 554 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~---l~~~~~~~~ 554 (611)
........||+.|+|||++.+..++.++|||||||++|||++ |..||...... ......+... ......+++
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 324 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----EEFCRRLKEGTRMRAPDYTTPE 324 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS----HHHHHHHHHTCCCCCCTTCCHH
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh----HHHHHHHHcCCCCCCCCCCCHH
Confidence 333344568999999999988899999999999999999998 88887421000 0000111110 111223444
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 555 ILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 555 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
+.+ ++.+||+.||++|||+.|++++|+++.+..
T Consensus 325 l~~---li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 325 MYQ---TMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHH---HHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHH---HHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 445 455999999999999999999999998764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=363.76 Aligned_cols=257 Identities=19% Similarity=0.301 Sum_probs=198.2
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCE----EEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSV----LAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~----vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
++|...+.||+|+||.||+|+.. +++. ||+|.++... ...+++.+|+.++++++||||++++++|..++ .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 46777899999999999999953 4443 6888885432 34578999999999999999999999998754 789
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
|+||+++|+|.+++......+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 99999999999999876667999999999999999999999 789999999999999999999999999999987544
Q ss_pred CCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHH
Q 035917 477 DESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEI 555 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 555 (611)
..........||+.|+|||++.+..++.++|||||||++|||++ |+.||..... ......+.............
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 245 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISSILEKGERLPQPPICT 245 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHHHHTTCCCCCCTTBC
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH-----HHHHHHHHcCCCCCCCccCC
Confidence 43333334457889999999999999999999999999999999 8888743110 11111111111111111222
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
..+.+++.+||+.||++||++.|++++|+.+.+.
T Consensus 246 ~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 246 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 3455566699999999999999999999998754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=367.63 Aligned_cols=260 Identities=22% Similarity=0.286 Sum_probs=208.9
Q ss_pred hhcCCCCCeeeecCCceEEEEEe--------CCCCEEEEEeccccc--hhHHHHHHHHHHHhcc-CCCCccceeeEEEeC
Q 035917 323 SNSFCSENVIISTRTGTTYKAML--------PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVE 391 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~--------~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~ 391 (611)
.++|...+.||+|+||.||+|+. .++..||||+++... ...+++.+|+++++++ +||||+++++++..+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 35777889999999999999985 234689999997543 2346799999999999 899999999999999
Q ss_pred CeeEEEEeccCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEe
Q 035917 392 EEKLLIYKYMSSGTLYSLLQGNA---------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV 456 (611)
Q Consensus 392 ~~~~lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl 456 (611)
+..++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence 99999999999999999997543 25899999999999999999999 7899999999999999
Q ss_pred CCCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHH----HHH
Q 035917 457 DEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDW----VNQ 531 (611)
Q Consensus 457 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~----~~~ 531 (611)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||... ...
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~ 304 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999987654332233334468899999999999899999999999999999998 87776321 111
Q ss_pred HhhcCChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCCCC
Q 035917 532 LSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFSE 594 (611)
Q Consensus 532 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 594 (611)
...... .. ......++++.+++ .+||+.||++|||+.||+++|+++.......+
T Consensus 305 ~~~~~~-----~~-~~~~~~~~~l~~li---~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 305 LLKEGH-----RM-DKPSNCTNELYMMM---RDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp HHHTTC-----CC-CCCSSCCHHHHHHH---HHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred HHHcCC-----CC-CCCccCCHHHHHHH---HHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 111100 00 01122344555544 49999999999999999999999988765444
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=349.83 Aligned_cols=259 Identities=26% Similarity=0.348 Sum_probs=195.3
Q ss_pred hhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhc--cCCCCccceeeEEEeC----CeeEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQ--LRHPNLAPLLGYCVVE----EEKLL 396 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~--l~H~nIv~l~g~~~~~----~~~~l 396 (611)
.++|...+.||+|+||.||+|+. +++.||||++.... .+.+.+|.+++.. ++||||+++++++... ...++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 45788889999999999999998 78999999996543 3445556666555 8999999999997653 45789
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeeecCCCCCeEEeCCCCCeEEeeccccc
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGC-----QPPFLHQNICSNVILVDEDFDARIMDFGLAK 471 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDlkp~NILld~~~~~kl~DFGla~ 471 (611)
||||+++|+|.+++... .+++..++.++.|++.||+|||... +.+|+||||||+|||++.++.+||+|||+++
T Consensus 84 v~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 161 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 161 (301)
T ss_dssp EECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCee
Confidence 99999999999999643 5899999999999999999999321 5789999999999999999999999999998
Q ss_pred ccCCCCCCc--cccCCCcccccccccccCCC------CCCcccchHHHHHHHHHHhCC----------CCCHHHHHHHHh
Q 035917 472 LMTSSDESS--FVNGDLGEFGYIAPEYSSTM------VASLKGDVYGIGVVLLELAGF----------KGNLVDWVNQLS 533 (611)
Q Consensus 472 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~SfGvvl~ell~~----------~~~~~~~~~~~~ 533 (611)
......... ......||+.|+|||++.+. .++.++|||||||++|||++| +.||.+......
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~ 241 (301)
T 3q4u_A 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241 (301)
T ss_dssp EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCc
Confidence 765433211 12234699999999998776 455799999999999999998 666632110000
Q ss_pred hcCChhhhh-----chhhcCC-CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHc
Q 035917 534 SSGRSKEAI-----DKALCGK-GYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586 (611)
Q Consensus 534 ~~~~~~~~~-----~~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 586 (611)
......... .+.+... ........+.+++.+||+.||++|||+.||++.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred chhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 000000000 0001000 1122445566677799999999999999999999976
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=362.21 Aligned_cols=266 Identities=14% Similarity=0.149 Sum_probs=209.7
Q ss_pred hhhcCCCCCeeeecCCceEEEEEeCC------CCEEEEEeccccchh------------HHHHHHHHHHHhccCCCCccc
Q 035917 322 ASNSFCSENVIISTRTGTTYKAMLPD------GSVLAVKRLNTCKLG------------EKKFRNEMNRLGQLRHPNLAP 383 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~~~------g~~vAvK~~~~~~~~------------~~~~~~Ev~~l~~l~H~nIv~ 383 (611)
..++|...+.||+|+||.||+|...+ ++.||||++...... ...+.+|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34578888999999999999999754 478999998654311 123556777888889999999
Q ss_pred eeeEEEeC----CeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC--
Q 035917 384 LLGYCVVE----EEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD-- 457 (611)
Q Consensus 384 l~g~~~~~----~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld-- 457 (611)
+++++... ...++||||+ +|+|.+++......+++..++.++.|++.||+||| +.+|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESS
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecC
Confidence 99999764 4579999999 99999999876567999999999999999999999 78999999999999998
Q ss_pred CCCCeEEeecccccccCCCCCC-----ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHH---
Q 035917 458 EDFDARIMDFGLAKLMTSSDES-----SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWV--- 529 (611)
Q Consensus 458 ~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~--- 529 (611)
.++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 8899999999999876432211 11123459999999999999999999999999999999999999885311
Q ss_pred ---H--HHhhcCChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCCCC
Q 035917 530 ---N--QLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFSE 594 (611)
Q Consensus 530 ---~--~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 594 (611)
. .........+.+++.+.....++++.++++ .||+.||++||++.+|++.|+++.+..+...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~ 335 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYME---TVKLLDYTEKPLYENLRDILLQGLKAIGSKD 335 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHH---HHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHH---HHhcCCCCCCCCHHHHHHHHHHHHHHcCCCc
Confidence 0 000111233333443333445556666555 9999999999999999999999999876654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=362.36 Aligned_cols=261 Identities=23% Similarity=0.328 Sum_probs=206.4
Q ss_pred HhhhcCCCCCeeeecCCceEEEEEeC------CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCC
Q 035917 321 AASNSFCSENVIISTRTGTTYKAMLP------DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE 392 (611)
Q Consensus 321 ~~t~~f~~~~~ig~G~~g~Vy~~~~~------~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~ 392 (611)
...++|...+.||+|+||.||+|+.. +++.||||+++... ...+.+.+|+.++++++||||+++++++..++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34578888999999999999999963 35899999997543 23467999999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHhhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 035917 393 EKLLIYKYMSSGTLYSLLQGNA-----------------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNI 449 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl 449 (611)
..++||||+++|+|.+++.... ..+++..++.++.|+++||.||| +.+|+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence 9999999999999999997532 46899999999999999999999 789999999
Q ss_pred CCCeEEeCCCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHH
Q 035917 450 CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDW 528 (611)
Q Consensus 450 kp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~ 528 (611)
||+|||++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999987643322222233468999999999988889999999999999999998 88776421
Q ss_pred HHHHhhcCChhhhhchh--hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 529 VNQLSSSGRSKEAIDKA--LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 529 ~~~~~~~~~~~~~~~~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
..... ...+.+.. ......+.++.++ +.+||+.||++||++.+++++|+++.+...
T Consensus 281 ~~~~~----~~~~~~~~~~~~~~~~~~~l~~l---i~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 281 AHEEV----IYYVRDGNILACPENCPLELYNL---MRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp CHHHH----HHHHHTTCCCCCCTTCCHHHHHH---HHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred ChHHH----HHHHhCCCcCCCCCCCCHHHHHH---HHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 11000 00000000 1112334455554 459999999999999999999999987653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=356.87 Aligned_cols=261 Identities=21% Similarity=0.316 Sum_probs=200.1
Q ss_pred hcCCCCCeeeecCCceEEEEEe-----CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeC--CeeE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-----PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE--EEKL 395 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-----~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~--~~~~ 395 (611)
++|...+.||+|+||.||+|++ .+++.||||++.... ...+.+.+|++++++++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 4677788999999999999984 368999999997643 3346799999999999999999999998653 4589
Q ss_pred EEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
+||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 999999999999999876556999999999999999999999 78999999999999999999999999999987644
Q ss_pred CCCC-ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHH---HhhcCC--------hhhhhc
Q 035917 476 SDES-SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQ---LSSSGR--------SKEAID 543 (611)
Q Consensus 476 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~---~~~~~~--------~~~~~~ 543 (611)
.... .......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ...... ..+.+.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh
Confidence 3211 1222335788899999999889999999999999999999987664221111 111110 001111
Q ss_pred hhh---cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 544 KAL---CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 544 ~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
... .....++++.+ ++.+||+.||++|||+.|+++.|+++.+..
T Consensus 247 ~~~~~~~~~~~~~~l~~---li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 247 NNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp TTCCCCCCTTCCHHHHH---HHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ccCcCCCCcCcCHHHHH---HHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 111 11223444555 455999999999999999999999998764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=355.38 Aligned_cols=247 Identities=17% Similarity=0.223 Sum_probs=202.6
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
.++|...+.||+|+||.||+|+.. +++.||+|.++......+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 356788899999999999999964 6889999999876666678999999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC--CCCeEEeecccccccCCCCCC
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE--DFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~--~~~~kl~DFGla~~~~~~~~~ 479 (611)
++|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~- 159 (321)
T 1tki_A 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN- 159 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE-
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc-
Confidence 999999999866557999999999999999999999 789999999999999987 78999999999987654322
Q ss_pred ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCChhhhhchhhcCCCCHHH
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGRSKEAIDKALCGKGYDEE 554 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~~~~~~ 554 (611)
.....||+.|+|||++.+..++.++|||||||++|||++|..||... .......... .+... ....+++
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~-~~~~s~~ 233 (321)
T 1tki_A 160 --FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT---FDEEA-FKEISIE 233 (321)
T ss_dssp --EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC---CCHHH-HTTSCHH
T ss_pred --cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCC---CChhh-hccCCHH
Confidence 22235899999999999888999999999999999999999887321 1111110000 00000 0123344
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 555 ILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 555 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+.+++. +||+.||++|||+.|+++|
T Consensus 234 ~~~li~---~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 234 AMDFVD---RLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHHH---TTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHH---HHcCCChhHCcCHHHHhcC
Confidence 555554 9999999999999999987
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=378.67 Aligned_cols=259 Identities=20% Similarity=0.328 Sum_probs=207.7
Q ss_pred hhhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 322 ASNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
..++|...+.||+|+||.||+|...++..||||+++......++|.+|+.+|++++|||||++++++. .+..++|||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 34577788999999999999999988999999999876666788999999999999999999999986 66789999999
Q ss_pred CCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 402 SSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 402 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
++|+|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~ 340 (454)
T 1qcf_A 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YT 340 (454)
T ss_dssp TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-HH
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-ee
Confidence 9999999997543 26899999999999999999999 7899999999999999999999999999998764321 11
Q ss_pred cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHH
Q 035917 481 FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFL 559 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 559 (611)
......+|..|+|||.+....++.++|||||||++|||++ |+.||.......... ........ ......++++.+
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~-~i~~~~~~-~~~~~~~~~l~~-- 416 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR-ALERGYRM-PRPENCPEELYN-- 416 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH-HHHHTCCC-CCCTTSCHHHHH--
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCC-CCCCCCCHHHHH--
Confidence 1223347889999999988899999999999999999998 888874311110000 00000000 011223444444
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 560 KVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 560 ~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
++.+||+.||++|||+.+|++.|+++....
T Consensus 417 -li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 417 -IMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp -HHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred -HHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 555999999999999999999999887654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=353.28 Aligned_cols=250 Identities=18% Similarity=0.252 Sum_probs=197.0
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEecccc--chhHHHHHHHHHHHhccCCCCccceeeEEEeCC-------
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTC--KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE------- 392 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~------- 392 (611)
.++|...+.||+|+||.||+|+.. +|+.||||+++.. ....+.+.+|++++++++||||+++++++.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457888899999999999999975 7999999998643 234578999999999999999999999986643
Q ss_pred --------------------------------------------------eeEEEEeccCCCChHHhhhcCCC--CCCHH
Q 035917 393 --------------------------------------------------EKLLIYKYMSSGTLYSLLQGNAT--ELDWP 420 (611)
Q Consensus 393 --------------------------------------------------~~~lv~ey~~~gsL~~~l~~~~~--~l~~~ 420 (611)
..++|||||++|+|.+++..... ..++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 27899999999999999986542 56788
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC----------ccccCCCcccc
Q 035917 421 TRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES----------SFVNGDLGEFG 490 (611)
Q Consensus 421 ~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~ 490 (611)
.++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999 789999999999999999999999999999877543211 12234569999
Q ss_pred cccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCC
Q 035917 491 YIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRP 570 (611)
Q Consensus 491 y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP 570 (611)
|+|||++.+..++.++|||||||++|||+++..++.+......... .. ............+.+++.+||+.||
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~------~~-~~~~~~~~~~~~~~~li~~~l~~~p 314 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVR------NL-KFPLLFTQKYPQEHMMVQDMLSPSP 314 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHH------TT-CCCHHHHHHCHHHHHHHHHHHCSSG
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhh------cc-CCCcccccCChhHHHHHHHHccCCC
Confidence 9999999988999999999999999999999887654332211100 00 0000011222344556669999999
Q ss_pred CCCCCHHHHHHH
Q 035917 571 KDRWSMYQVYQS 582 (611)
Q Consensus 571 ~~RPs~~evl~~ 582 (611)
++|||+.|+++|
T Consensus 315 ~~Rps~~~~l~~ 326 (332)
T 3qd2_B 315 TERPEATDIIEN 326 (332)
T ss_dssp GGSCCHHHHHHS
T ss_pred CcCCCHHHHhhc
Confidence 999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=355.08 Aligned_cols=263 Identities=24% Similarity=0.322 Sum_probs=198.5
Q ss_pred HhhhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhc--cCCCCccceeeEEEeC----Cee
Q 035917 321 AASNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQ--LRHPNLAPLLGYCVVE----EEK 394 (611)
Q Consensus 321 ~~t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~--l~H~nIv~l~g~~~~~----~~~ 394 (611)
...++|...+.||+|+||.||+|+.. ++.||||++.... ...+.+|.+++.. ++||||+++++++... ...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 44578999999999999999999985 8999999986543 3344455555554 4899999999999887 678
Q ss_pred EEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC--------CeeecCCCCCeEEeCCCCCeEEee
Q 035917 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQP--------PFLHQNICSNVILVDEDFDARIMD 466 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~--------~ivHrDlkp~NILld~~~~~kl~D 466 (611)
++||||+++|+|.+++... .+++..++.++.|++.||+||| .. +|+||||||+|||++.++.+||+|
T Consensus 111 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 9999999999999999754 5899999999999999999999 56 999999999999999999999999
Q ss_pred cccccccCCCCCCc--cccCCCcccccccccccCCCCCCcc------cchHHHHHHHHHHhCC----------CCCHHHH
Q 035917 467 FGLAKLMTSSDESS--FVNGDLGEFGYIAPEYSSTMVASLK------GDVYGIGVVLLELAGF----------KGNLVDW 528 (611)
Q Consensus 467 FGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~k------sDV~SfGvvl~ell~~----------~~~~~~~ 528 (611)
||+++......... ......||+.|+|||++.+..++.+ +|||||||++|||++| ..|+...
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 99998764332211 1123469999999999887766655 9999999999999998 4454321
Q ss_pred HHHHhhcCChhhhhc-hhhcCCC-----CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 529 VNQLSSSGRSKEAID-KALCGKG-----YDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 529 ~~~~~~~~~~~~~~~-~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
...........+.+. ....... ..+....+.+++.+||+.||++|||+.||+++|+.+.+...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred cCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 100000000000000 0001111 11344556667779999999999999999999999998764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=354.57 Aligned_cols=256 Identities=20% Similarity=0.293 Sum_probs=205.8
Q ss_pred hhcCCCCCeeeecCCceEEEEEe------CCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCee
Q 035917 323 SNSFCSENVIISTRTGTTYKAML------PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~------~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~ 394 (611)
.++|...+.||+|+||.||+|.. .+++.||||+++... ...+++.+|++++++++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45677889999999999999985 345899999997543 2346789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHhhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 035917 395 LLIYKYMSSGTLYSLLQGNA-----------------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICS 451 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp 451 (611)
++||||+++|+|.+++.... ..+++..++.++.|+++||.||| +.+|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence 99999999999999997532 23889999999999999999999 78999999999
Q ss_pred CeEEeCCCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHH
Q 035917 452 NVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVN 530 (611)
Q Consensus 452 ~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~ 530 (611)
+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654332222233457889999999988889999999999999999998 8877643110
Q ss_pred HHhhcCChhhhhchhh---cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 531 QLSSSGRSKEAIDKAL---CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 531 ~~~~~~~~~~~~~~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
. ...+.+.... .....++++.+++ .+||+.||++||++.|++++|+++.++
T Consensus 259 ~-----~~~~~~~~~~~~~~~~~~~~~~~~li---~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 259 E-----RLFNLLKTGHRMERPDNCSEEMYRLM---LQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp G-----GHHHHHHTTCCCCCCTTCCHHHHHHH---HHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred H-----HHHHHhhcCCcCCCCccCCHHHHHHH---HHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 0 0111111111 1122344555554 499999999999999999999998765
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=346.23 Aligned_cols=257 Identities=21% Similarity=0.304 Sum_probs=209.0
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
++|...+.||+|+||.||+|...+++.||+|+++......+++.+|++++++++||||+++++++..++..++||||+++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 46777889999999999999998899999999987666678899999999999999999999999999999999999999
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcccc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 88 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~ 163 (267)
T 3t9t_A 88 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSST 163 (267)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTT
T ss_pred CcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc-ccccc
Confidence 9999999876567899999999999999999999 7899999999999999999999999999998764321 11122
Q ss_pred CCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHH
Q 035917 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVA 562 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~ 562 (611)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||.......... ....... .......+.++.+++.
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-~i~~~~~-~~~~~~~~~~l~~li~-- 239 (267)
T 3t9t_A 164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE-DISTGFR-LYKPRLASTHVYQIMN-- 239 (267)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-HHHTTCC-CCCCTTSCHHHHHHHH--
T ss_pred cccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHH-HHhcCCc-CCCCccCcHHHHHHHH--
Confidence 3457889999999988889999999999999999999 777764211000000 0000000 0112223445555555
Q ss_pred hhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 563 CNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 563 ~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
+||+.||++||++.|++++|+++.++
T Consensus 240 -~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 240 -HCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp -HHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -HHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999998864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=369.70 Aligned_cols=257 Identities=18% Similarity=0.226 Sum_probs=202.9
Q ss_pred hcCCCCCeeeecCCceEEEEEeC------CCCEEEEEecccc--chhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP------DGSVLAVKRLNTC--KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~------~g~~vAvK~~~~~--~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~ 395 (611)
++|...+.||+|+||.||+|++. +++.||||+++.. .....++.+|+.++++++||||+++++++...+..+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 56778899999999999999953 4678999999653 234467899999999999999999999999999999
Q ss_pred EEEeccCCCChHHhhhcCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC---CeEEee
Q 035917 396 LIYKYMSSGTLYSLLQGNA------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF---DARIMD 466 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~---~~kl~D 466 (611)
+||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999997432 35899999999999999999999 78999999999999999544 599999
Q ss_pred cccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchh
Q 035917 467 FGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKA 545 (611)
Q Consensus 467 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (611)
||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||....... ..+.+...
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-----~~~~i~~~ 302 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-----VLEFVTSG 302 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----HHHHHHTT
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHcC
Confidence 999986533222222223357899999999988899999999999999999998 877763211000 00001000
Q ss_pred ---hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 546 ---LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 546 ---l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
......+.++.+ ++.+||+.||++||++.||+++|+.+.+...
T Consensus 303 ~~~~~~~~~~~~l~~---li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 303 GRMDPPKNCPGPVYR---IMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp CCCCCCTTCCHHHHH---HHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred CCCCCCccCCHHHHH---HHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 011223344444 5559999999999999999999999887653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=380.63 Aligned_cols=255 Identities=24% Similarity=0.368 Sum_probs=208.7
Q ss_pred hhcCCCCCeeeecCCceEEEEEeCC-CCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLPD-GSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
.++|...+.||+|+||.||+|++.. +..||||.++......++|.+|+.+|++++|||||+++++|...+..++|||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 3467778999999999999999764 889999999876666788999999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 402 SSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 402 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
++|+|.+++.... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 299 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~ 374 (495)
T 1opk_A 299 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YT 374 (495)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-EE
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-ee
Confidence 9999999997643 46899999999999999999999 7899999999999999999999999999998764332 12
Q ss_pred cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhc---CCCCHHHHH
Q 035917 481 FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALC---GKGYDEEIL 556 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~---~~~~~~~~~ 556 (611)
......+++.|+|||.+.+..++.++|||||||++|||++ |..||..... ....+.+..... ....++++.
T Consensus 375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~ 449 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELLEKDYRMERPEGCPEKVY 449 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcCCCCCCCCCCCHHHH
Confidence 2233457889999999988889999999999999999998 7777643110 011111111111 122334444
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
+ ++.+||+.||++|||+.+|++.|+.+.+.
T Consensus 450 ~---li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 450 E---LMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp H---HHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred H---HHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 4 55599999999999999999999987644
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=354.87 Aligned_cols=246 Identities=19% Similarity=0.228 Sum_probs=200.2
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ...+++.+|++++++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35788889999999999999996 679999999996543 23467889999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 94 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 168 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG- 168 (328)
T ss_dssp CCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred ECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence 999999999998654 35899999999999999999999 7899999999999999999999999999998764332
Q ss_pred CccccCCCcccccccccccCCCCCC-cccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-hcCCCCHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVAS-LKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-LCGKGYDEEIL 556 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~~ 556 (611)
.....+||+.|+|||++.+..++ .++|||||||++|||++|+.||........ ...+.... ..+...+.++.
T Consensus 169 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~~ 242 (328)
T 3fe3_A 169 --KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL----RERVLRGKYRIPFYMSTDCE 242 (328)
T ss_dssp --GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCTTSCHHHH
T ss_pred --ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCCCCCHHHH
Confidence 23445799999999999887765 789999999999999999988732100000 00000000 01123345555
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++++ +||+.||++|||+.|+++|
T Consensus 243 ~li~---~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 243 NLLK---RFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHH---HHCCSSTTTSCCHHHHTTC
T ss_pred HHHH---HHCCCChhHCcCHHHHhcC
Confidence 5555 9999999999999999987
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=353.93 Aligned_cols=258 Identities=22% Similarity=0.321 Sum_probs=207.6
Q ss_pred hhcCCCCCeeeecCCceEEEEEe------CCCCEEEEEeccccc--hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCe
Q 035917 323 SNSFCSENVIISTRTGTTYKAML------PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEE 393 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~------~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~ 393 (611)
.++|...+.||+|+||.||+|+. .+++.||||+++... ...+.+.+|+.++.++ +||||+++++++..++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 35677889999999999999984 357899999997543 2346799999999999 89999999999999999
Q ss_pred eEEEEeccCCCChHHhhhcCCC-----------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEe
Q 035917 394 KLLIYKYMSSGTLYSLLQGNAT-----------------ELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV 456 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~~-----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl 456 (611)
.++||||+++|+|.+++..... .+++..++.++.|++.||.||| +.+|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence 9999999999999999975432 4899999999999999999999 7899999999999999
Q ss_pred CCCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhc
Q 035917 457 DEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSS 535 (611)
Q Consensus 457 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~ 535 (611)
+.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++ |..||..... .
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~ 254 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV----D 254 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS----S
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc----h
Confidence 9999999999999987754433333334457889999999988899999999999999999998 7777632100 0
Q ss_pred CChhhhhchh---hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 536 GRSKEAIDKA---LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 536 ~~~~~~~~~~---l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
......+... ......++++.+++. +||+.||++|||+.|++++|+++..+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHHHHHHHHTCCCCCCTTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred hHHHHHhccCCCCCCcccCCHHHHHHHH---HHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 0001111111 112233445555555 999999999999999999999988764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=354.57 Aligned_cols=256 Identities=11% Similarity=0.085 Sum_probs=207.3
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEEEEecc
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
++|...+.||+|+||.||+|+. .+|+.||||++.... ..+++.+|+++++++ +||||+++++++..++..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 5678889999999999999995 679999999986432 234688999999999 8999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCC-----eEEeecccccccCCC
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFD-----ARIMDFGLAKLMTSS 476 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~-----~kl~DFGla~~~~~~ 476 (611)
+|+|.+++......+++..++.++.|++.||+||| +.+|+||||||+|||++.++. +||+|||+++.+...
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 88 -GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 89999999865557999999999999999999999 789999999999999998887 999999999876443
Q ss_pred CCCc-----cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhh---------
Q 035917 477 DESS-----FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAI--------- 542 (611)
Q Consensus 477 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~--------- 542 (611)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .....+.+
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~-----~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK-----ADTLKERYQKIGDTKRA 238 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CSSHHHHHHHHHHHHHH
T ss_pred CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc-----cccHHHHHHHHHhhhcc
Confidence 2111 1234579999999999999999999999999999999999998874310 00111100
Q ss_pred -chhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCCC
Q 035917 543 -DKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFS 593 (611)
Q Consensus 543 -~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 593 (611)
.........+ .+.+++.+||+.||.+||++.+|++.|+++.++.+..
T Consensus 239 ~~~~~~~~~~p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~ 286 (330)
T 2izr_A 239 TPIEVLCENFP----EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYM 286 (330)
T ss_dssp SCHHHHTTTCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred CCHHHHhccCh----HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 0011111223 4455555999999999999999999999999887654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=359.27 Aligned_cols=259 Identities=21% Similarity=0.272 Sum_probs=203.7
Q ss_pred hhhcCCCCCeeeecCCceEEEEEe------CCCCEEEEEeccccc--hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCC
Q 035917 322 ASNSFCSENVIISTRTGTTYKAML------PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEE 392 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~------~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~ 392 (611)
..++|...+.||+|+||.||+|+. .++..||||+++... ...+.+.+|+.++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 346788889999999999999995 246689999997532 2336799999999999 8999999999999999
Q ss_pred eeEEEEeccCCCChHHhhhcCCC----------------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 035917 393 EKLLIYKYMSSGTLYSLLQGNAT----------------------ELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNIC 450 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~~~~----------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk 450 (611)
..++||||+++|+|.+++..... .+++..++.++.|++.||+||| +.+|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence 99999999999999999975432 3799999999999999999999 7899999999
Q ss_pred CCeEEeCCCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHH
Q 035917 451 SNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWV 529 (611)
Q Consensus 451 p~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~ 529 (611)
|+|||++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987654433333333457889999999988889999999999999999998 887763210
Q ss_pred HHHhhcCChhhhhchhh---cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 530 NQLSSSGRSKEAIDKAL---CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 530 ~~~~~~~~~~~~~~~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
. .......+.... .....++++.+++. +||+.||++|||+.|++++|+.+....
T Consensus 280 ~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 280 V----DANFYKLIQNGFKMDQPFYATEEIYIIMQ---SCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp C----SHHHHHHHHTTCCCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred c----HHHHHHHHhcCCCCCCCCCCCHHHHHHHH---HHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 0 000011111111 11223445555555 999999999999999999999987654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=359.87 Aligned_cols=249 Identities=20% Similarity=0.239 Sum_probs=197.1
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
++|...+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 56788899999999999999965 79999999986433 2236689999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.......
T Consensus 87 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 87 CSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp CTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred CCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 9999999999754 35899999999999999999999 7899999999999999999999999999998764333223
Q ss_pred cccCCCcccccccccccCCCCC-CcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhc---CCCCHHHHH
Q 035917 481 FVNGDLGEFGYIAPEYSSTMVA-SLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALC---GKGYDEEIL 556 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~---~~~~~~~~~ 556 (611)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... ............ ....++++.
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 239 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYSDWKEKKTYLNPWKKIDSAPL 239 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS---HHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH---HHHHHHhcccccCCccccCCHHHH
Confidence 3345579999999999877665 788999999999999999998873210000 000000000000 012234444
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+ ++.+||+.||++|||+.|++++
T Consensus 240 ~---li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 240 A---LLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp H---HHHHHSCSSTTTSCCHHHHTTC
T ss_pred H---HHHHHccCChhhCcCHHHHhhC
Confidence 4 4559999999999999999876
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=345.04 Aligned_cols=263 Identities=12% Similarity=0.088 Sum_probs=208.8
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEEEEecc
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
++|...+.||+|+||.||+|+. .+|+.||||++.... ..+.+.+|+.++.++ +|+|++++++++......++||||+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 4677889999999999999995 679999999985432 334688999999999 7999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCC-----eEEeecccccccCCC
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFD-----ARIMDFGLAKLMTSS 476 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~-----~kl~DFGla~~~~~~ 476 (611)
+++|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||+++.....
T Consensus 89 -~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 89 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 99999999866557999999999999999999999 889999999999999987766 999999999876543
Q ss_pred CCC-----ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHH----HHHhhcC-Chhhhhchhh
Q 035917 477 DES-----SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWV----NQLSSSG-RSKEAIDKAL 546 (611)
Q Consensus 477 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~----~~~~~~~-~~~~~~~~~l 546 (611)
... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ....... ..........
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 244 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHH
Confidence 221 12234569999999999999899999999999999999999998874310 0000000 0000000000
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCCCC
Q 035917 547 CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFSE 594 (611)
Q Consensus 547 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 594 (611)
.....++++.+++. +||+.||++||++++|++.|+++.++.+..+
T Consensus 245 ~~~~~~~~l~~li~---~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~ 289 (298)
T 1csn_A 245 LCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLERLNTTE 289 (298)
T ss_dssp HTTTSCHHHHHHHH---HHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred HHhhCcHHHHHHHH---HHhcCCcccCCCHHHHHHHHHHHHHhcCCCC
Confidence 11233445555555 9999999999999999999999998876544
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=369.40 Aligned_cols=249 Identities=24% Similarity=0.321 Sum_probs=201.4
Q ss_pred hhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCC-eeEEEEecc
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE-EKLLIYKYM 401 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~-~~~lv~ey~ 401 (611)
.++|...+.||+|+||.||+|... |+.||||+++... ..++|.+|+.+|++++||||+++++++...+ ..++|||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 356777899999999999999984 7899999997643 4567999999999999999999999988765 689999999
Q ss_pred CCCChHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 402 SSGTLYSLLQGNAT-ELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 402 ~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
++|+|.+++..... .+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 343 (450)
T 1k9a_A 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 343 (450)
T ss_dssp TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc---
Confidence 99999999976543 4799999999999999999999 7899999999999999999999999999998643211
Q ss_pred cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhh---cCCCCHHHHH
Q 035917 481 FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKAL---CGKGYDEEIL 556 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l---~~~~~~~~~~ 556 (611)
....+++.|+|||.+.+..++.++|||||||++|||++ |+.||.... .......+.... .....+.++.
T Consensus 344 --~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~-----~~~~~~~i~~~~~~~~p~~~~~~l~ 416 (450)
T 1k9a_A 344 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPRVEKGYKMDAPDGCPPAVY 416 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC-----TTTHHHHHHTTCCCCCCTTCCHHHH
T ss_pred --cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 11247889999999999899999999999999999998 888774311 001111111111 1122344555
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
+ ++.+||+.||++|||+.++++.|+.+...
T Consensus 417 ~---li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 417 D---VMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp H---HHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred H---HHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 5 45599999999999999999999998765
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=373.60 Aligned_cols=259 Identities=22% Similarity=0.348 Sum_probs=202.1
Q ss_pred hhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccC
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
.++|...+.||+|+||.||+|...++..||||+++......++|.+|+++|++++||||+++++++.+ +..++||||++
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 35677788999999999999999888899999998766667889999999999999999999999865 67899999999
Q ss_pred CCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 403 SGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 403 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
+|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~ 337 (452)
T 1fmk_A 262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TA 337 (452)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce-ec
Confidence 999999997432 35899999999999999999999 78999999999999999999999999999987643221 12
Q ss_pred ccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHH
Q 035917 482 VNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLK 560 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~ 560 (611)
.....+|..|+|||.+.+..++.++|||||||++|||++ |+.||.......... ........ ......++++.+
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~-~i~~~~~~-~~~~~~~~~l~~--- 412 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-QVERGYRM-PCPPECPESLHD--- 412 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-HHHTTCCC-CCCTTSCHHHHH---
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCC-CCCCCCCHHHHH---
Confidence 223357889999999988899999999999999999999 787774311100000 00000000 011223444444
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 561 VACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 561 l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
++.+||+.||++|||+.++++.|+++.....
T Consensus 413 li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 413 LMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 5559999999999999999999999876543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=353.29 Aligned_cols=262 Identities=21% Similarity=0.281 Sum_probs=189.9
Q ss_pred hhhcCCCCCeeeecCCceEEEEEeCC-C---CEEEEEecccc---chhHHHHHHHHHHHhccCCCCccceeeEEEeCCee
Q 035917 322 ASNSFCSENVIISTRTGTTYKAMLPD-G---SVLAVKRLNTC---KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~~~-g---~~vAvK~~~~~---~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~ 394 (611)
..++|...+.||+|+||.||+|+... + ..||||+++.. ....+++.+|++++++++||||+++++++...+..
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 34578888999999999999999644 3 28999999653 23457799999999999999999999999877655
Q ss_pred ------EEEEeccCCCChHHhhhcCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeE
Q 035917 395 ------LLIYKYMSSGTLYSLLQGNA-----TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDAR 463 (611)
Q Consensus 395 ------~lv~ey~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~k 463 (611)
++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEE
Confidence 99999999999999985321 25899999999999999999999 78999999999999999999999
Q ss_pred EeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhh
Q 035917 464 IMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAI 542 (611)
Q Consensus 464 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~ 542 (611)
|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||....... ......
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~~~~~~ 253 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE----IYNYLI 253 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHHH
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH----HHHHHh
Confidence 999999987654332222233457889999999998899999999999999999999 777764211000 000000
Q ss_pred ch--hhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCCC
Q 035917 543 DK--ALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFS 593 (611)
Q Consensus 543 ~~--~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 593 (611)
.. .......++++.+ ++.+||+.||++|||+.++++.|+++.+.....
T Consensus 254 ~~~~~~~~~~~~~~l~~---li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~ 303 (323)
T 3qup_A 254 GGNRLKQPPECMEEVYD---LMYQCWSADPKQRPSFTCLRMELENILGHLSVL 303 (323)
T ss_dssp TTCCCCCCTTCCHHHHH---HHHHTTCSSGGGSCCHHHHHHHHHHHHHC----
T ss_pred cCCCCCCCCccCHHHHH---HHHHHccCChhhCcCHHHHHHHHHHHHHHhhhc
Confidence 00 0111223344444 555999999999999999999999998875444
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=346.10 Aligned_cols=254 Identities=20% Similarity=0.267 Sum_probs=192.3
Q ss_pred hcCCCCCeeeecCCceEEEEEeCC----CCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPD----GSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~----g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
++|...+.||+|+||.||+|+... +..||+|+++... ...+.+.+|+.++++++||||+++++++ .++..++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv 93 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWII 93 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEE
Confidence 467778999999999999999643 4579999986532 3346799999999999999999999998 45678999
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
|||+++|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCccc
Confidence 9999999999999866557999999999999999999999 7899999999999999999999999999998764332
Q ss_pred CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhch---hhcCCCCHH
Q 035917 478 ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDK---ALCGKGYDE 553 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~---~l~~~~~~~ 553 (611)
.. ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||...... .....+.. .......++
T Consensus 171 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~-----~~~~~i~~~~~~~~~~~~~~ 244 (281)
T 1mp8_A 171 YY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DVIGRIENGERLPMPPNCPP 244 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GHHHHHHTTCCCCCCTTCCH
T ss_pred cc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH-----HHHHHHHcCCCCCCCCCCCH
Confidence 11 1122347889999999988889999999999999999996 77776421000 00000100 001123344
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 554 EILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 554 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
++.+++ .+||+.||++|||+.|++++|+++.++.
T Consensus 245 ~l~~li---~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 245 TLYSLM---TKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp HHHHHH---HHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHH---HHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 555554 4999999999999999999999988753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=350.90 Aligned_cols=255 Identities=24% Similarity=0.372 Sum_probs=189.4
Q ss_pred hhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
.++|...+.||+|+||.||+|+.. ..||||+++... ...+.+.+|+.++++++||||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 346778899999999999999864 359999996543 2346799999999999999999999965 4566899999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
|+++++|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++........
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence 99999999999766667999999999999999999999 789999999999999999999999999999865432222
Q ss_pred ccccCCCcccccccccccC---CCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCChhhhhchhhcCCCC
Q 035917 480 SFVNGDLGEFGYIAPEYSS---TMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGRSKEAIDKALCGKGY 551 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~~~ 551 (611)
.......||+.|+|||.+. +..++.++||||||+++|||++|+.||... ............ +........
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 254 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP--DLSKVRSNC 254 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC--CTTSSCTTS
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc--chhhccccC
Confidence 2233446999999999886 567889999999999999999999887321 111111111000 000011223
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchh
Q 035917 552 DEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAA 588 (611)
Q Consensus 552 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 588 (611)
++++.+++ .+||+.||++|||+.|+++.|+++.+
T Consensus 255 ~~~l~~li---~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 255 PKRMKRLM---AECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CHHHHHHH---HHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CHHHHHHH---HHHccCChhhCCCHHHHHHHHHHHhh
Confidence 34455544 49999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=358.92 Aligned_cols=254 Identities=18% Similarity=0.275 Sum_probs=198.6
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCE----EEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSV----LAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~----vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
++|...+.||+|+||.||+|+.. +++. ||+|.+.... ...+.+.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 35667789999999999999953 4543 7888875432 22356789999999999999999999986 556889
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 99999999999999876557899999999999999999999 789999999999999999999999999999987554
Q ss_pred CCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchh---hcCCCCH
Q 035917 477 DESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKA---LCGKGYD 552 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~---l~~~~~~ 552 (611)
..........||..|+|||++.+..++.++|||||||++|||++ |..||.... .....+.+... ......+
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 243 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR-----LAEVPDLLEKGERLAQPQICT 243 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----TTHHHHHHHTTCBCCCCTTBC
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC-----HHHHHHHHHcCCCCCCCCcCc
Confidence 43333344568889999999998899999999999999999999 888874310 00111111111 0111222
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 553 EEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 553 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
.+ +.+++.+||+.||++||++.|++++|+.+.+.
T Consensus 244 ~~---~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 244 ID---VYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp TT---TTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred HH---HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 33 34455599999999999999999999998754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=349.73 Aligned_cols=258 Identities=21% Similarity=0.309 Sum_probs=196.8
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
++|...+.||+|+||.||+|+.. ++.||||++... ...+.|.+|++++++++||||+++++++. +..++||||+++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~ 83 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEG 83 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCC
Confidence 46777889999999999999984 788999999643 34567999999999999999999999886 458999999999
Q ss_pred CChHHhhhcCCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCC-eEEeecccccccCCCCCCc
Q 035917 404 GTLYSLLQGNAT--ELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFD-ARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 404 gsL~~~l~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~-~kl~DFGla~~~~~~~~~~ 480 (611)
|+|.+++..... .+++..++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||+++.....
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---- 159 (307)
T 2eva_A 84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---- 159 (307)
T ss_dssp CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----
Confidence 999999986542 5789999999999999999999432279999999999999988876 799999999765322
Q ss_pred cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhc-CChhhhhchhhcCCCCHHHHHHHH
Q 035917 481 FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSS-GRSKEAIDKALCGKGYDEEILQFL 559 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~~~~~~~~l~ 559 (611)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ........+.. ....++++.++
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l- 236 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL-IKNLPKPIESL- 236 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCC-BTTCCHHHHHH-
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCc-ccccCHHHHHH-
Confidence 122358999999999999899999999999999999999998874210000000 00000000111 12233445554
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHHHchhhhCCCC
Q 035917 560 KVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFSE 594 (611)
Q Consensus 560 ~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 594 (611)
+.+||+.||++|||+.|++++|+.+.+.....+
T Consensus 237 --i~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 269 (307)
T 2eva_A 237 --MTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269 (307)
T ss_dssp --HHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred --HHHHhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence 459999999999999999999999988765443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=357.47 Aligned_cols=246 Identities=18% Similarity=0.250 Sum_probs=200.0
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccch-------hHHHHHHHHHHHhccCCCCccceeeEEEeCCee
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKL-------GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~-------~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~ 394 (611)
.+.|...+.||+|+||.||+|+.. +|+.||||+++.... ..+.+.+|+.++++++||||+++++++.+++..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 456888899999999999999964 699999999965322 346799999999999999999999999999999
Q ss_pred EEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC----CeEEeecccc
Q 035917 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF----DARIMDFGLA 470 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~----~~kl~DFGla 470 (611)
++||||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++ .+||+|||++
T Consensus 91 ~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999999754 46999999999999999999999 78999999999999998776 7999999999
Q ss_pred cccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCChhhhhchh
Q 035917 471 KLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGRSKEAIDKA 545 (611)
Q Consensus 471 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 545 (611)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|..||... ..... .... ..++.
T Consensus 167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~-~~~~--~~~~~ 240 (361)
T 2yab_A 167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT-AVSY--DFDEE 240 (361)
T ss_dssp EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH-TTCC--CCCHH
T ss_pred eEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hcCC--CCCch
Confidence 8765432 123456999999999999889999999999999999999999887321 11111 0000 00011
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 546 LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 546 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
. ....++++.+++. +||..||++|||+.|+++|
T Consensus 241 ~-~~~~s~~~~~li~---~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 241 F-FSQTSELAKDFIR---KLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp H-HTTSCHHHHHHHH---HHSCSSTTTSCCHHHHHTS
T ss_pred h-ccCCCHHHHHHHH---HHCCCChhHCcCHHHHhcC
Confidence 0 0123445555555 9999999999999999875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=348.28 Aligned_cols=251 Identities=21% Similarity=0.263 Sum_probs=195.3
Q ss_pred hhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccch---hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKL---GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~---~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
.++|...+.||+|+||.||+|+..+|+.||||+++.... ..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 356778899999999999999998899999999965432 23678999999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
|+++ +|.+++......+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-- 173 (311)
T 3niz_A 100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-- 173 (311)
T ss_dssp CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC--
T ss_pred CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc--
Confidence 9985 898888766667999999999999999999999 7899999999999999999999999999998764322
Q ss_pred ccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHH---hhcCCh---hhhh-----
Q 035917 480 SFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQL---SSSGRS---KEAI----- 542 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~---~~~~~~---~~~~----- 542 (611)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||... .... ...... ....
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 12233468999999998876 56899999999999999999998876321 0000 000000 0000
Q ss_pred -chh---h-------cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 543 -DKA---L-------CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 543 -~~~---l-------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+.. . .....++++ .+++.+||+.||++|||+.|+++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~---~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEG---IDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHH---HHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhcccccccCCcHHHhCcccCHHH---HHHHHHHcCCChhHCCCHHHHhcC
Confidence 000 0 001122344 445559999999999999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=347.73 Aligned_cols=261 Identities=19% Similarity=0.257 Sum_probs=203.6
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEecccc----chhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTC----KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~----~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
+.|...+.||+|+||.||+|+. .+++.||+|++... ....+.+.+|+.++.+++||||+++++++..++..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 4577789999999999999995 46899999998432 223467999999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 91 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 91 EYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp ECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 999999999999754 36899999999999999999999 78999999999999999999999999999987643221
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHH-----HHHhhcCChhhhhchhhcCCCCHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWV-----NQLSSSGRSKEAIDKALCGKGYDE 553 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~~~~~ 553 (611)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ....... ... ... ......++
T Consensus 167 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~-~~~-~~~~~~~~ 242 (294)
T 4eqm_A 167 -TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS-VPN-VTT-DVRKDIPQ 242 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC-CCC-HHH-HSCTTSCH
T ss_pred -cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc-CCC-cch-hcccCCCH
Confidence 12233469999999999999899999999999999999999998874211 1111110 000 000 11122344
Q ss_pred HHHHHHHHHhhcccCCCCCCC-CHHHHHHHHHHchhhhCCCCC
Q 035917 554 EILQFLKVACNCVVSRPKDRW-SMYQVYQSLNSIAAQHGFSER 595 (611)
Q Consensus 554 ~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~i~~~~~~~~~ 595 (611)
.+.+++. +||+.||++|| +++++.+.|+.+..+....+.
T Consensus 243 ~l~~li~---~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~ 282 (294)
T 4eqm_A 243 SLSNVIL---RATEKDKANRYKTIQEMKDDLSSVLHENRANED 282 (294)
T ss_dssp HHHHHHH---HHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCC
T ss_pred HHHHHHH---HHhcCCHhHccccHHHHHHHHHHHHhhccCCcc
Confidence 5555554 99999999999 899999999988776655443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=349.71 Aligned_cols=243 Identities=19% Similarity=0.149 Sum_probs=190.9
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc---hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK---LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||+||+|+.. +|+.||||++.... ....++..|+..+.++ +||||++++++|.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57888999999999999999975 79999999986532 2234566677666665 8999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+ +|+|.+++......++|..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA 212 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC
Confidence 999 67999988766567999999999999999999999 78999999999999999999999999999987643221
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCH-HHHHHHHhhcCChhhhhchhhcCCCCHHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNL-VDWVNQLSSSGRSKEAIDKALCGKGYDEEILQ 557 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 557 (611)
.....||+.|+|||++.+ .++.++|||||||++|||++|..++ ............. .+... ...++++.+
T Consensus 213 ---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~----~~~~~-~~~~~~l~~ 283 (311)
T 3p1a_A 213 ---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL----PPEFT-AGLSSELRS 283 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCC----CHHHH-TTSCHHHHH
T ss_pred ---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCC----Ccccc-cCCCHHHHH
Confidence 223459999999998876 7899999999999999999986543 2211111111111 11111 123444555
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++. +||+.||++|||+.|++++
T Consensus 284 li~---~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 284 VLV---MMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHH---HHSCSSTTTSCCHHHHHTS
T ss_pred HHH---HHcCCChhhCcCHHHHHhC
Confidence 554 9999999999999999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=348.97 Aligned_cols=259 Identities=17% Similarity=0.242 Sum_probs=202.8
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCC--eeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE--EKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~--~~~lv~ 398 (611)
+.|...++||+|+||.||+|+.. +++.||||+++... ...+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 46777899999999999999965 58999999997533 33567889999999999999999999998765 679999
Q ss_pred eccCCCChHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEe----CCCCCeEEeecccccc
Q 035917 399 KYMSSGTLYSLLQGNA--TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV----DEDFDARIMDFGLAKL 472 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl----d~~~~~kl~DFGla~~ 472 (611)
||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999999999997643 24999999999999999999999 7899999999999999 7888899999999987
Q ss_pred cCCCCCCccccCCCcccccccccccC--------CCCCCcccchHHHHHHHHHHhCCCCCHHHH---------HHHHhhc
Q 035917 473 MTSSDESSFVNGDLGEFGYIAPEYSS--------TMVASLKGDVYGIGVVLLELAGFKGNLVDW---------VNQLSSS 535 (611)
Q Consensus 473 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~ksDV~SfGvvl~ell~~~~~~~~~---------~~~~~~~ 535 (611)
...... .....||+.|+|||++. +..++.++|||||||++|||++|+.||... .......
T Consensus 166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred cCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 654332 22346999999999875 567899999999999999999999887421 1111110
Q ss_pred CC---hhh-------hh--chhh--cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchh
Q 035917 536 GR---SKE-------AI--DKAL--CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAA 588 (611)
Q Consensus 536 ~~---~~~-------~~--~~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 588 (611)
.. ... .+ ...+ ...........+.+++.+||+.||++|||++|++++..+.+-
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 00 000 00 0000 011123344455666679999999999999999999986553
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=353.38 Aligned_cols=269 Identities=20% Similarity=0.275 Sum_probs=195.3
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEe-----CCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVV-----EEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~-----~~~~~lv~ 398 (611)
++|...+.||+|+||.||+|+. +++.||||+++.........+.|+..+..++||||+++++++.. ....++||
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 91 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM 91 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence 5677889999999999999987 68999999996544333333445555666899999999986643 23568999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC---------CeeecCCCCCeEEeCCCCCeEEeeccc
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQP---------PFLHQNICSNVILVDEDFDARIMDFGL 469 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~---------~ivHrDlkp~NILld~~~~~kl~DFGl 469 (611)
||+++|+|.+++.... .++..+..++.|+++||+||| +. +|+||||||+|||++.++.+||+|||+
T Consensus 92 e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~ 166 (336)
T 3g2f_A 92 EYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166 (336)
T ss_dssp CCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence 9999999999997553 689999999999999999999 66 999999999999999999999999999
Q ss_pred ccccCCCCC------CccccCCCcccccccccccCC-------CCCCcccchHHHHHHHHHHhCCCCCHHHHHH------
Q 035917 470 AKLMTSSDE------SSFVNGDLGEFGYIAPEYSST-------MVASLKGDVYGIGVVLLELAGFKGNLVDWVN------ 530 (611)
Q Consensus 470 a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~------ 530 (611)
++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..|+.....
T Consensus 167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~ 246 (336)
T 3g2f_A 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246 (336)
T ss_dssp CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence 987643221 112223469999999999876 4567899999999999999988655421000
Q ss_pred ----HHhhcCChhh--------hhchhhcC--CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCCCCCC
Q 035917 531 ----QLSSSGRSKE--------AIDKALCG--KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFSERY 596 (611)
Q Consensus 531 ----~~~~~~~~~~--------~~~~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~ 596 (611)
.........+ ...+.+.. .........+.+++.+||+.||++|||+.|+++.|+++...+...+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~~ 326 (336)
T 3g2f_A 247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSV 326 (336)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC----
T ss_pred hhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcccC
Confidence 0000000000 00000000 011223345666666999999999999999999999999988776644
Q ss_pred CC
Q 035917 597 DE 598 (611)
Q Consensus 597 ~~ 598 (611)
..
T Consensus 327 ~~ 328 (336)
T 3g2f_A 327 SP 328 (336)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=353.20 Aligned_cols=262 Identities=20% Similarity=0.257 Sum_probs=205.4
Q ss_pred hhcCCCCCeeeecCCceEEEEEe--------CCCCEEEEEeccccc--hhHHHHHHHHHHHhcc-CCCCccceeeEEEeC
Q 035917 323 SNSFCSENVIISTRTGTTYKAML--------PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVE 391 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~--------~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~ 391 (611)
.++|...+.||+|+||.||+|+. .++..||||+++... ...+++.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 35788889999999999999986 357789999997543 3346789999999999 899999999999999
Q ss_pred CeeEEEEeccCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEe
Q 035917 392 EEKLLIYKYMSSGTLYSLLQGNA---------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV 456 (611)
Q Consensus 392 ~~~~lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl 456 (611)
+..++||||+++|+|.+++.... ..+++..++.++.|+++||.||| +.+|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence 99999999999999999997543 14899999999999999999999 7899999999999999
Q ss_pred CCCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhc
Q 035917 457 DEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSS 535 (611)
Q Consensus 457 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~ 535 (611)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||..........
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 270 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence 9999999999999987654332222233457889999999988889999999999999999998 877763211000000
Q ss_pred CChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCC
Q 035917 536 GRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGF 592 (611)
Q Consensus 536 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 592 (611)
......... .....+.++.++ +.+||+.||++|||+.|++++|+++......
T Consensus 271 -~~~~~~~~~-~~~~~~~~l~~l---i~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 271 -LLKEGHRMD-KPANCTNELYMM---MRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp -HHHHTCCCC-CCTTCCHHHHHH---HHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred -HHhcCCCCC-CCccCCHHHHHH---HHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 000000001 112234445554 4499999999999999999999999887543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=352.91 Aligned_cols=246 Identities=20% Similarity=0.193 Sum_probs=200.7
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||.||+|+.. +|+.||||+++... ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57888899999999999999964 69999999996532 23467899999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 85 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 159 (337)
T 1o6l_A 85 EYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp ECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-
Confidence 999999999998754 35899999999999999999999 7899999999999999999999999999998643222
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-hcCCCCHHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-LCGKGYDEEILQ 557 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~~~ 557 (611)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.... ..+...+.++.+
T Consensus 160 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~ 234 (337)
T 1o6l_A 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL----FELILMEEIRFPRTLSPEAKS 234 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCTTSCHHHHH
T ss_pred -CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH----HHHHHcCCCCCCCCCCHHHHH
Confidence 122345699999999999999999999999999999999999988732100000 00000000 112234556666
Q ss_pred HHHHHhhcccCCCCCCC-----CHHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRW-----SMYQVYQS 582 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RP-----s~~evl~~ 582 (611)
+++ +||+.||++|| ++.||++|
T Consensus 235 li~---~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 235 LLA---GLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHH---HHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHH---HHhhcCHHHhcCCCCCCHHHHHcC
Confidence 666 99999999999 89999887
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=357.86 Aligned_cols=248 Identities=17% Similarity=0.252 Sum_probs=197.5
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc------hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK------LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~------~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
+.|...+.||+|+||.||+|+. .+|+.||||+++... ...+.+.+|+.++++++||||+++++++.+++..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4688889999999999999996 469999999985422 235779999999999999999999999999999999
Q ss_pred EEeccCCCChHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCC---eEEeecccc
Q 035917 397 IYKYMSSGTLYSLLQGN---ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFD---ARIMDFGLA 470 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~---~kl~DFGla 470 (611)
|||||++|+|.+++... ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999998877532 235899999999999999999999 789999999999999986554 999999999
Q ss_pred cccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHh---hcCChhhhhchhhc
Q 035917 471 KLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLS---SSGRSKEAIDKALC 547 (611)
Q Consensus 471 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~---~~~~~~~~~~~~l~ 547 (611)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|..||........ ..... ...+..
T Consensus 181 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~--~~~~~~- 255 (351)
T 3c0i_A 181 IQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKY--KMNPRQ- 255 (351)
T ss_dssp EECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCC--CCCHHH-
T ss_pred eEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCC--CCCccc-
Confidence 8765432 122345799999999999998999999999999999999999988743111110 00000 000000
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 548 GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 548 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
....++++.+++. +||+.||++|||+.|+++|
T Consensus 256 ~~~~s~~~~~li~---~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 256 WSHISESAKDLVR---RMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HTTSCHHHHHHHH---HHTCSSTTTSCCHHHHHTS
T ss_pred cccCCHHHHHHHH---HHCCCChhHCcCHHHHhcC
Confidence 0123344555554 9999999999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=352.49 Aligned_cols=267 Identities=18% Similarity=0.235 Sum_probs=209.0
Q ss_pred HHHHHHhhhcCCCCCeeeecCCceEEEEEe------CCCCEEEEEeccccc--hhHHHHHHHHHHHhcc-CCCCccceee
Q 035917 316 LADLMAASNSFCSENVIISTRTGTTYKAML------PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQL-RHPNLAPLLG 386 (611)
Q Consensus 316 ~~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~------~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l-~H~nIv~l~g 386 (611)
..+.....++|...+.||+|+||.||+|+. .+++.||||+++... ...+.+.+|+.++.++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 334444567888999999999999999984 357899999997543 2346799999999999 7999999999
Q ss_pred EEEeCC-eeEEEEeccCCCChHHhhhcCCC---------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 035917 387 YCVVEE-EKLLIYKYMSSGTLYSLLQGNAT---------------ELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNIC 450 (611)
Q Consensus 387 ~~~~~~-~~~lv~ey~~~gsL~~~l~~~~~---------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk 450 (611)
++...+ ..++||||+++|+|.+++..... .+++..+..++.|+++||.||| +.+|+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCc
Confidence 998755 48999999999999999976532 2789999999999999999999 7899999999
Q ss_pred CCeEEeCCCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHH
Q 035917 451 SNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWV 529 (611)
Q Consensus 451 p~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~ 529 (611)
|+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999999987654333333334458899999999988899999999999999999998 887763210
Q ss_pred HHHhhcCChhhhhchh---hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCC
Q 035917 530 NQLSSSGRSKEAIDKA---LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGF 592 (611)
Q Consensus 530 ~~~~~~~~~~~~~~~~---l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 592 (611)
. .......+... ......+.++.+ ++.+||+.||++|||+.|++++|+++.+....
T Consensus 256 ~----~~~~~~~~~~~~~~~~~~~~~~~l~~---li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 314 (316)
T 2xir_A 256 I----DEEFCRRLKEGTRMRAPDYTTPEMYQ---TMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 314 (316)
T ss_dssp C----SHHHHHHHHHTCCCCCCTTCCHHHHH---HHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred h----hHHHHHHhccCccCCCCCCCCHHHHH---HHHHHcCCChhhCcCHHHHHHHHHHHHhhhcc
Confidence 0 00000011100 011223444445 45599999999999999999999999887643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=353.44 Aligned_cols=264 Identities=21% Similarity=0.266 Sum_probs=204.5
Q ss_pred hcCCCCCeeeecCCceEEEEEe-----CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEe--CCeeE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-----PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVV--EEEKL 395 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-----~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~--~~~~~ 395 (611)
++|...+.||+|+||.||+|++ .+++.||||++.... ...+.+.+|++++++++||||+++++++.. .+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4677788999999999999984 468899999997654 334679999999999999999999999874 45688
Q ss_pred EEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
+||||+++|+|.+++......+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 999999999999999765456999999999999999999999 78999999999999999999999999999987654
Q ss_pred CCCC-ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcC-------C---hhhhhch
Q 035917 476 SDES-SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSG-------R---SKEAIDK 544 (611)
Q Consensus 476 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~-------~---~~~~~~~ 544 (611)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|..|+........... . ..+.+..
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 3321 122334588899999999888899999999999999999999988643322211100 0 0111111
Q ss_pred hhc---CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCCC
Q 035917 545 ALC---GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFS 593 (611)
Q Consensus 545 ~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 593 (611)
... ....++++.+ ++.+||+.||++|||+.|++++|+.+.......
T Consensus 260 ~~~~~~~~~~~~~l~~---li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 308 (327)
T 3lxl_A 260 GQRLPAPPACPAEVHE---LMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308 (327)
T ss_dssp TCCCCCCTTCCHHHHH---HHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred ccCCCCCCcccHHHHH---HHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence 111 1223444555 445999999999999999999999988765433
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=343.01 Aligned_cols=252 Identities=24% Similarity=0.362 Sum_probs=188.1
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccch-----hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKL-----GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~-----~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||.||+|+.. ++.||||+++.... ..+.+.+|+++++.++||||+++++++..++..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 46777899999999999999974 88999999865322 2367899999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC--------CCCeEEeecccc
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE--------DFDARIMDFGLA 470 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~--------~~~~kl~DFGla 470 (611)
||+++|+|.+++.+. .+++..+..++.|++.||+|||+....+|+||||||+||+++. ++.+||+|||++
T Consensus 86 e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 86 EFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp ECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred EcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 999999999999643 5899999999999999999999421123999999999999986 678999999999
Q ss_pred cccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCC
Q 035917 471 KLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKG 550 (611)
Q Consensus 471 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 550 (611)
+....... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.................... ....
T Consensus 164 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~ 238 (271)
T 3dtc_A 164 REWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP-IPST 238 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC-CCTT
T ss_pred cccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC-CCcc
Confidence 86643222 133589999999999888899999999999999999999988743111100000000000000 1122
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHc
Q 035917 551 YDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586 (611)
Q Consensus 551 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 586 (611)
.++++.+++. +||+.||++|||+.|++++|+++
T Consensus 239 ~~~~~~~li~---~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 239 CPEPFAKLME---DCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHC-
T ss_pred cCHHHHHHHH---HHhcCCcccCcCHHHHHHHHhcC
Confidence 3445555555 99999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=346.35 Aligned_cols=258 Identities=23% Similarity=0.368 Sum_probs=210.5
Q ss_pred hhhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 322 ASNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
..++|...+.||+|+||.||+|... ++..||+|.+.......+++.+|++++++++||||+++++++.+++..++||||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 3456778899999999999999975 488999999987766678899999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 401 MSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 401 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
+++|+|.+++.... ..+++..+..++.+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 166 (288)
T 3kfa_A 91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY- 166 (288)
T ss_dssp CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS-
T ss_pred CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc-
Confidence 99999999997643 46999999999999999999999 78999999999999999999999999999987653322
Q ss_pred ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhh---cCCCCHHHH
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKAL---CGKGYDEEI 555 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l---~~~~~~~~~ 555 (611)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |..|+..... ....+.+.... .....++++
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l 241 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELLEKDYRMERPEGCPEKV 241 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GGHHHHHHTTCCCCCCTTCCHHH
T ss_pred ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHhccCCCCCCCCCCHHH
Confidence 22233457889999999988899999999999999999998 7777632100 01111111111 112234455
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
.+++. +||+.||++|||+.|+++.|+.+.++..
T Consensus 242 ~~li~---~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 242 YELMR---ACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp HHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHH---HHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 55554 9999999999999999999999887643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=350.04 Aligned_cols=246 Identities=19% Similarity=0.285 Sum_probs=199.1
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc-------hhHHHHHHHHHHHhccCCCCccceeeEEEeCCee
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK-------LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-------~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~ 394 (611)
.+.|...+.||+|+||.||+|+.. +|+.||||+++... ...+.+.+|+.++++++||||+++++++..++..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356888899999999999999964 68999999986432 1357899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC----CeEEeecccc
Q 035917 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF----DARIMDFGLA 470 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~----~~kl~DFGla 470 (611)
++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++ .+||+|||++
T Consensus 90 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 9999999999999999754 46999999999999999999999 78999999999999999877 8999999999
Q ss_pred cccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhhcCChhhhhchh
Q 035917 471 KLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSSSGRSKEAIDKA 545 (611)
Q Consensus 471 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 545 (611)
+....... .....||+.|+|||++.+..++.++|||||||++|||++|..||.. .......... .....
T Consensus 166 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~---~~~~~ 239 (326)
T 2y0a_A 166 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY---EFEDE 239 (326)
T ss_dssp EECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC---CCCHH
T ss_pred eECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC---CcCcc
Confidence 87643221 2334699999999999988999999999999999999999988732 1111110000 00000
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 546 LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 546 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
. ....+.++.+++. +||+.||++|||+.|+++|
T Consensus 240 ~-~~~~~~~~~~li~---~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 240 Y-FSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp H-HTTSCHHHHHHHH---HHSCSSGGGSCCHHHHHHS
T ss_pred c-cccCCHHHHHHHH---HHccCChhhCCCHHHHhcC
Confidence 0 0123344455544 9999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=340.30 Aligned_cols=250 Identities=23% Similarity=0.365 Sum_probs=199.1
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeC--CeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE--EEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~--~~~~lv~ 398 (611)
++|...+.||+|+||.||+|+.. ++.||||+++... ...+++.+|+.++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 46777899999999999999984 8899999997543 3346799999999999999999999999877 6789999
Q ss_pred eccCCCChHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 399 KYMSSGTLYSLLQGNAT-ELDWPTRFRIGLGAARGLAWLHHGCQPP--FLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
||+++|+|.+++..... .+++..+..++.|++.||+||| +.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999999999987643 6899999999999999999999 667 99999999999999999999999998764321
Q ss_pred CCCCccccCCCcccccccccccCCCCCCc---ccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCH
Q 035917 476 SDESSFVNGDLGEFGYIAPEYSSTMVASL---KGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYD 552 (611)
Q Consensus 476 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~---ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 552 (611)
....||+.|+|||.+.+..++. ++|||||||++|||++|+.||..................+.. ....+
T Consensus 166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 237 (271)
T 3kmu_A 166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI-PPGIS 237 (271)
T ss_dssp -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCC-CTTCC
T ss_pred -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCC-CCCCC
Confidence 2235899999999987655444 799999999999999999887432111100000000011111 12334
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchh
Q 035917 553 EEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAA 588 (611)
Q Consensus 553 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 588 (611)
+++.+++. +||+.||++|||+.|+++.|+++.+
T Consensus 238 ~~~~~li~---~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 238 PHVSKLMK---ICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHHH---HHcCCChhhCcCHHHHHHHHHHhhc
Confidence 45555555 9999999999999999999998864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=357.84 Aligned_cols=257 Identities=24% Similarity=0.311 Sum_probs=192.7
Q ss_pred cCCCCCeeeecCCceEEEEEeC--C--CCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEe-CCeeEEE
Q 035917 325 SFCSENVIISTRTGTTYKAMLP--D--GSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVV-EEEKLLI 397 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~--~--g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~-~~~~~lv 397 (611)
.|...+.||+|+||.||+|+.. + +..||||.++... ...++|.+|+.++++++||||++++++|.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3555689999999999999853 2 2468999986532 345779999999999999999999999765 4578999
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
|||+++|+|.+++......+++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999876667899999999999999999999 7899999999999999999999999999998664332
Q ss_pred CC--ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhc---hhhcCCCC
Q 035917 478 ES--SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAID---KALCGKGY 551 (611)
Q Consensus 478 ~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~---~~l~~~~~ 551 (611)
.. .......+|+.|+|||.+.+..++.++|||||||++|||++ +..||... ........+. ........
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~-----~~~~~~~~~~~~~~~~~p~~~ 321 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----NTFDITVYLLQGRRLLQPEYC 321 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-----CSSCHHHHHHTTCCCCCCTTC
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC-----CHHHHHHHHHcCCCCCCCCCC
Confidence 11 11223457889999999998899999999999999999999 45554321 0000100000 01112233
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCC
Q 035917 552 DEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGF 592 (611)
Q Consensus 552 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 592 (611)
++++.+ ++.+||+.||++||++.|++++|+++......
T Consensus 322 ~~~l~~---li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 322 PDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp CHHHHH---HHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred CHHHHH---HHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 445555 45599999999999999999999999987653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=351.74 Aligned_cols=255 Identities=11% Similarity=0.072 Sum_probs=207.4
Q ss_pred hhhcCCCCCeeeecCCceEEEEE------eCCCCEEEEEeccccchhHHHHHHHHHHHhccC---CCCccceeeEEEeCC
Q 035917 322 ASNSFCSENVIISTRTGTTYKAM------LPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLR---HPNLAPLLGYCVVEE 392 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~------~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~---H~nIv~l~g~~~~~~ 392 (611)
..+.|...+.||+|+||.||+|+ ..+++.||||+++.. ...++.+|++++.+++ |+||+++++++..++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 35678888999999999999994 456899999999654 3556888888888887 999999999999999
Q ss_pred eeEEEEeccCCCChHHhhhc----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC----------
Q 035917 393 EKLLIYKYMSSGTLYSLLQG----NATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE---------- 458 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~---------- 458 (611)
..++|||||++|+|.+++.. ....++|..++.|+.|++.||+||| +.+|+||||||+|||++.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCcccccc
Confidence 99999999999999999964 2346999999999999999999999 889999999999999998
Q ss_pred -CCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCC
Q 035917 459 -DFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGR 537 (611)
Q Consensus 459 -~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~ 537 (611)
++.+||+|||+++.+............+||+.|+|||++.+..++.++|||||||++|||++|+.||.... .
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-------~ 290 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE-------G 290 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEE-------T
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCC-------C
Confidence 89999999999986543333334455679999999999999999999999999999999999998873210 0
Q ss_pred hhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCC-CCHHHHHHHHHHchhhhC
Q 035917 538 SKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDR-WSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 538 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~evl~~L~~i~~~~~ 591 (611)
....+...+.....++...++++ .|++.+|.+| |+++++.+.|+++.+...
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~---~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 291 GECKPEGLFRRLPHLDMWNEFFH---VMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp TEEEECSCCTTCSSHHHHHHHHH---HHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred CceeechhccccCcHHHHHHHHH---HHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 00111122222234566666666 9999999998 578888999998877643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=347.70 Aligned_cols=257 Identities=19% Similarity=0.329 Sum_probs=201.4
Q ss_pred cCCCCCeeeecCCceEEEEEe-----CCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeC--CeeE
Q 035917 325 SFCSENVIISTRTGTTYKAML-----PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE--EEKL 395 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-----~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~--~~~~ 395 (611)
.|...+.||+|+||.||+|++ .+++.||||+++... ...+.+.+|++++++++||||+++++++... +..+
T Consensus 22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 101 (302)
T 4e5w_A 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 101 (302)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence 466778999999999999983 468999999997533 3347799999999999999999999999876 5689
Q ss_pred EEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
+||||+++|+|.+++......+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 102 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 102 LIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 999999999999999665557999999999999999999999 78999999999999999999999999999987654
Q ss_pred CCCC-ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHh---hcC----Ch---hhhhch
Q 035917 476 SDES-SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLS---SSG----RS---KEAIDK 544 (611)
Q Consensus 476 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~---~~~----~~---~~~~~~ 544 (611)
.... .......||..|+|||.+.+..++.++||||||+++|||++|..|+........ ... .. ...+..
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE 258 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHT
T ss_pred CCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhc
Confidence 3321 222334688899999999888899999999999999999999876432211110 000 00 001111
Q ss_pred hh---cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHch
Q 035917 545 AL---CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIA 587 (611)
Q Consensus 545 ~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 587 (611)
.. .....++++.+++ .+||+.||++|||+.|+++.|+++.
T Consensus 259 ~~~~~~~~~~~~~l~~li---~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 259 GKRLPCPPNCPDEVYQLM---RKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp TCCCCCCTTCCHHHHHHH---HHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCHHHHHHH---HHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 00 1122344555544 4999999999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=352.20 Aligned_cols=254 Identities=20% Similarity=0.325 Sum_probs=195.5
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCE----EEEEecccc--chhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSV----LAVKRLNTC--KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~----vAvK~~~~~--~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
++|...+.||+|+||.||+|+. .+++. ||+|.+... ....+++.+|+.++++++||||+++++++..+. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 4677889999999999999995 34543 577777542 234678999999999999999999999998654 789
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
|+||+++|+|.+++......+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 99999999999999876667999999999999999999999 789999999999999999999999999999876543
Q ss_pred CCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhh---cCCCCH
Q 035917 477 DESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKAL---CGKGYD 552 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l---~~~~~~ 552 (611)
..........||+.|+|||.+.+..++.++|||||||++|||++ |..||..... ......+.... .....+
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 245 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISSILEKGERLPQPPICT 245 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHHHHTTCCCCCCTTBC
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHcCCCCCCCccCC
Confidence 33333334457889999999999899999999999999999999 8888743110 01111111111 112234
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 553 EEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 553 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
.++.. ++.+||+.||++||++.|+++.|+++.+.
T Consensus 246 ~~l~~---li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 246 IDVYM---IMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHH---HHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHH---HHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 44444 55599999999999999999999998854
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=344.41 Aligned_cols=250 Identities=20% Similarity=0.263 Sum_probs=194.6
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchh---HHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLG---EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~---~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
++|...+.||+|+||.||+|+..+|+.||||+++..... .+.+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 357778899999999999999988999999999654322 36788999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
+++ +|.+++......+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R 155 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--c
Confidence 986 999998866567999999999999999999999 7899999999999999999999999999998764321 1
Q ss_pred cccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhh---cCC---hhh-----hhc
Q 035917 481 FVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSS---SGR---SKE-----AID 543 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~---~~~---~~~-----~~~ 543 (611)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. ....... ... ... ..+
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 1223468999999999865 4589999999999999999999887632 1111100 000 000 000
Q ss_pred hhh----------cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 544 KAL----------CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 544 ~~l----------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+.. .....++++.+++. +||+.||++|||+.|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHH---HHTCSSTTTSCCHHHHHTS
T ss_pred cccccccCccHHHHhhhcCHHHHHHHH---HHcCCCcccCCCHHHHhcC
Confidence 000 01123445555555 9999999999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=343.00 Aligned_cols=257 Identities=21% Similarity=0.338 Sum_probs=206.5
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
++|...+.||+|+||.||+|...+++.||||.++......+.+.+|++++++++||||+++++++. .+..++||||+++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 91 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMEN 91 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTT
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCC
Confidence 467778999999999999999988889999999876666788999999999999999999999986 4568999999999
Q ss_pred CChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccc
Q 035917 404 GTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482 (611)
Q Consensus 404 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 482 (611)
|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++....... ...
T Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 167 (279)
T 1qpc_A 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAR 167 (279)
T ss_dssp CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECC
T ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-ccc
Confidence 99999997543 26899999999999999999999 78999999999999999999999999999987654321 122
Q ss_pred cCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHH
Q 035917 483 NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKV 561 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l 561 (611)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||.......... ....... .......++++.+++.
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~l~~li~- 244 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ-NLERGYR-MVRPDNCPEELYQLMR- 244 (279)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-HHHTTCC-CCCCTTCCHHHHHHHH-
T ss_pred cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHH-HHhcccC-CCCcccccHHHHHHHH-
Confidence 23457889999999988889999999999999999998 777764211100000 0000000 0112233455555555
Q ss_pred HhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 562 ACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 562 ~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
+||+.||++|||+.++++.|+++....
T Consensus 245 --~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 245 --LCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp --HHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --HHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 999999999999999999999988764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=341.51 Aligned_cols=257 Identities=21% Similarity=0.282 Sum_probs=201.9
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CC---CEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCee-EEE
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DG---SVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK-LLI 397 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g---~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~-~lv 397 (611)
.|...++||+|+||.||+|+.. ++ ..||+|.++... ...+.+.+|+.++++++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 3445689999999999999853 33 379999997533 2346799999999999999999999999876655 899
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
|||+.+|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 9999999999999876667899999999999999999999 7899999999999999999999999999998654322
Q ss_pred --CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhch---hhcCCCCH
Q 035917 478 --ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDK---ALCGKGYD 552 (611)
Q Consensus 478 --~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~---~l~~~~~~ 552 (611)
.........+|+.|+|||.+.+..++.++||||||+++|||++|..|+..... .......+.. .......+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 254 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID----PFDLTHFLAQGRRLPQPEYCP 254 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC----GGGHHHHHHTTCCCCCCTTCC
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC----HHHHHHHhhcCCCCCCCccch
Confidence 11122334588999999999999999999999999999999996655321000 0001111110 11122334
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 553 EEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 553 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
+++.+++. +||+.||++|||+.++++.|+++.++..
T Consensus 255 ~~l~~li~---~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 255 DSLYQVMQ---QCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp HHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHH---HHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 45555555 9999999999999999999999988864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=343.24 Aligned_cols=257 Identities=19% Similarity=0.277 Sum_probs=204.4
Q ss_pred cCCCCC-eeeecCCceEEEEEeC---CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 325 SFCSEN-VIISTRTGTTYKAMLP---DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 325 ~f~~~~-~ig~G~~g~Vy~~~~~---~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
+|...+ .||+|+||.||+|... ++..||||+++... ...+++.+|++++++++||||+++++++ ..+..++||
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 88 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM 88 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence 343444 8999999999999853 57889999997642 3456799999999999999999999999 556789999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 89 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165 (287)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence 999999999999766567999999999999999999999 78999999999999999999999999999987643322
Q ss_pred C-ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhch---hhcCCCCHH
Q 035917 479 S-SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDK---ALCGKGYDE 553 (611)
Q Consensus 479 ~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~---~l~~~~~~~ 553 (611)
. .......||+.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+.. .......++
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~~~~i~~~~~~~~~~~~~~ 240 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----VMAFIEQGKRMECPPECPP 240 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-----HHHHHHTTCCCCCCTTCCH
T ss_pred eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-----HHHHHhcCCcCCCCCCcCH
Confidence 1 11223357899999999988889999999999999999998 888874211000 0000100 011123344
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCCC
Q 035917 554 EILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFS 593 (611)
Q Consensus 554 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 593 (611)
++.+++. +||+.||++||++.|++++|+++..+....
T Consensus 241 ~l~~li~---~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 241 ELYALMS---DCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp HHHHHHH---HTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHH---HHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 5555555 999999999999999999999998886544
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=367.18 Aligned_cols=258 Identities=18% Similarity=0.166 Sum_probs=207.6
Q ss_pred ccHHHHHHhhhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccch----hHHHHHHHHHHHhccCCCCccceeeEE
Q 035917 314 VKLADLMAASNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKL----GEKKFRNEMNRLGQLRHPNLAPLLGYC 388 (611)
Q Consensus 314 ~~~~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~----~~~~~~~Ev~~l~~l~H~nIv~l~g~~ 388 (611)
+++.++...+++|...++||+|+||.||+|+.. +++.||||+++.... ..+.+.+|+.++..++||||++++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345566667889999999999999999999975 488999999965322 123488999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecc
Q 035917 389 VVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFG 468 (611)
Q Consensus 389 ~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFG 468 (611)
.+++..++|||||++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchh
Confidence 9999999999999999999999875557999999999999999999999 7899999999999999999999999999
Q ss_pred cccccCCCCCCccccCCCcccccccccccC-----CCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc
Q 035917 469 LAKLMTSSDESSFVNGDLGEFGYIAPEYSS-----TMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID 543 (611)
Q Consensus 469 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~ 543 (611)
+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||........ ...++.
T Consensus 221 la~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~----~~~i~~ 295 (437)
T 4aw2_A 221 SCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET----YGKIMN 295 (437)
T ss_dssp TCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHT
T ss_pred hhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH----HHhhhh
Confidence 9987643322 2223457999999999986 56789999999999999999999998742100000 001111
Q ss_pred h----hhc--CCCCHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 035917 544 K----ALC--GKGYDEEILQFLKVACNCVVSRPKD--RWSMYQVYQS 582 (611)
Q Consensus 544 ~----~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 582 (611)
. ... ....++++.++++ +|+..+|++ ||+++|+++|
T Consensus 296 ~~~~~~~p~~~~~~s~~~~dLi~---~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 296 HKERFQFPTQVTDVSENAKDLIR---RLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHHHCCCCSSCCCSCHHHHHHHH---TTSSCGGGCTTTTTTHHHHTS
T ss_pred ccccccCCcccccCCHHHHHHHH---HHhcccccccCCCCHHHHhCC
Confidence 0 010 1224566667666 999888888 9999999987
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=343.09 Aligned_cols=250 Identities=18% Similarity=0.220 Sum_probs=194.6
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
++|...+.||+|+||.||+|+.. +++.||||+++... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 35777889999999999999964 68999999996432 234678999999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
|+++ +|.+.+......+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-- 155 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--
Confidence 9986 676766655567999999999999999999999 7899999999999999999999999999998764322
Q ss_pred ccccCCCcccccccccccCCCC-CCcccchHHHHHHHHHHhCCCCCHH------HHHHHHhh---cC---Chhhhh---c
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMV-ASLKGDVYGIGVVLLELAGFKGNLV------DWVNQLSS---SG---RSKEAI---D 543 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~SfGvvl~ell~~~~~~~------~~~~~~~~---~~---~~~~~~---~ 543 (611)
.......||+.|+|||++.+.. ++.++|||||||++|||+++..|+. +....... .. ...... +
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 2223446899999999987765 7999999999999999998877641 11111110 00 000000 0
Q ss_pred hh------------hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 544 KA------------LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 544 ~~------------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.. ......++++.++++ +||+.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQ---NLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHH---HHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccCCcchhhcccccChHHHHHHH---HHhccChhhCCCHHHHhcC
Confidence 00 000123445555555 9999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=340.77 Aligned_cols=252 Identities=19% Similarity=0.303 Sum_probs=203.5
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEe-----------
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVV----------- 390 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~----------- 390 (611)
.++|...+.||+|+||.||+|+.. +++.||+|+++... +.+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 457888899999999999999975 79999999996543 457899999999999999999998864
Q ss_pred -----CCeeEEEEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEE
Q 035917 391 -----EEEKLLIYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARI 464 (611)
Q Consensus 391 -----~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl 464 (611)
....++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEEE
Confidence 345789999999999999997543 46999999999999999999999 789999999999999999999999
Q ss_pred eecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhch
Q 035917 465 MDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDK 544 (611)
Q Consensus 465 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (611)
+|||+++....... .....||+.|+|||.+.+..++.++||||||+++|||+++..++........ ...+
T Consensus 164 ~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~------~~~~- 233 (284)
T 2a19_B 164 GDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFT------DLRD- 233 (284)
T ss_dssp CCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHH------HHHT-
T ss_pred Ccchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHH------Hhhc-
Confidence 99999987654321 2234689999999999888899999999999999999999988754221110 1111
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCCC
Q 035917 545 ALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFS 593 (611)
Q Consensus 545 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 593 (611)
.......+.++.+++. +||+.||++|||+.|++++|+.+.+.....
T Consensus 234 ~~~~~~~~~~~~~li~---~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~ 279 (284)
T 2a19_B 234 GIISDIFDKKEKTLLQ---KLLSKKPEDRPNTSEILRTLTVWKKSPEKN 279 (284)
T ss_dssp TCCCTTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred ccccccCCHHHHHHHH---HHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence 1112234455555555 999999999999999999999987765433
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=347.27 Aligned_cols=259 Identities=19% Similarity=0.260 Sum_probs=204.1
Q ss_pred CCCCCeeeecCCceEEEEEe-----CCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeC--CeeEE
Q 035917 326 FCSENVIISTRTGTTYKAML-----PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE--EEKLL 396 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~-----~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~--~~~~l 396 (611)
|...+.||+|+||.||++.+ .+++.||||+++... ...+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 36678999999999999874 268899999997543 3346799999999999999999999999874 57899
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
||||+++|+|.+++... .+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 113 v~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 99999999999999764 4899999999999999999999 789999999999999999999999999999877543
Q ss_pred CCC-ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHh---hcC-------Chhhhhchh
Q 035917 477 DES-SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLS---SSG-------RSKEAIDKA 545 (611)
Q Consensus 477 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~---~~~-------~~~~~~~~~ 545 (611)
... .......||..|+|||.+.+..++.++||||||+++|||++|..|+........ ... ...+.++..
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence 321 122334588899999999888899999999999999999999887643221110 000 011111111
Q ss_pred hc---CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCC
Q 035917 546 LC---GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGF 592 (611)
Q Consensus 546 l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 592 (611)
.. ....+.++.+ ++.+||+.||++|||+.|+++.|+.+.+++..
T Consensus 268 ~~~~~~~~~~~~l~~---li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 268 ERLPRPDKCPAEVYH---LMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp CCCCCCTTCCHHHHH---HHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred cCCCCCccccHHHHH---HHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 11 1223344444 55599999999999999999999999888643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=363.21 Aligned_cols=248 Identities=18% Similarity=0.180 Sum_probs=199.6
Q ss_pred hhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEE
Q 035917 322 ASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
..++|...+.||+|+||.||+|.. .+|+.||+|++.... ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 456788899999999999999985 578999999996543 2346789999999999999999999999999999999
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC---CCCCeEEeecccccccC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD---EDFDARIMDFGLAKLMT 474 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld---~~~~~kl~DFGla~~~~ 474 (611)
||||++|+|.+.+... ..+++..+..++.||+.||.||| +.+|+||||||+|||++ .++.+||+|||+++...
T Consensus 89 ~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp ECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 9999999999988765 45899999999999999999999 78999999999999998 46789999999998764
Q ss_pred CCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCChhhhhchhhcCC
Q 035917 475 SSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGRSKEAIDKALCGK 549 (611)
Q Consensus 475 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~ 549 (611)
... .......||+.|+|||++.+..++.++|||||||++|||++|..||... ..... .+... .+.....
T Consensus 165 ~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~-~~~~~---~~~~~~~ 238 (444)
T 3soa_A 165 GEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK-AGAYD---FPSPEWD 238 (444)
T ss_dssp TTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-HTCCC---CCTTTTT
T ss_pred CCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-hCCCC---CCccccc
Confidence 332 2223457999999999999989999999999999999999999887321 11111 00000 0000112
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 550 GYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 550 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
..++++.+++. +||+.||++|||+.|+++|
T Consensus 239 ~~s~~~~~li~---~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 239 TVTPEAKDLIN---KMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TSCHHHHHHHH---HHSCSSTTTSCCHHHHHHS
T ss_pred cCCHHHHHHHH---HHcCCChhHCCCHHHHhcC
Confidence 33455566555 9999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=343.28 Aligned_cols=244 Identities=24% Similarity=0.405 Sum_probs=195.5
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchh---H-----HHHHHHHHHHhccCCCCccceeeEEEeCCee
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLG---E-----KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~---~-----~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~ 394 (611)
++|...+.||+|+||.||+|+. .+++.||||++...... . +++.+|+.++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 5677788999999999999996 57999999998543211 1 67899999999999999999999986554
Q ss_pred EEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCeEEeCCCCC-----eEEeec
Q 035917 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPP--FLHQNICSNVILVDEDFD-----ARIMDF 467 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlkp~NILld~~~~-----~kl~DF 467 (611)
++||||+++|+|.+++......+++..+..++.|++.||+||| +.+ |+||||||+||+++.++. +||+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 7999999999999998776667999999999999999999999 677 999999999999987776 999999
Q ss_pred ccccccCCCCCCccccCCCccccccccccc--CCCCCCcccchHHHHHHHHHHhCCCCCHHHHH-------HHHhhcCCh
Q 035917 468 GLAKLMTSSDESSFVNGDLGEFGYIAPEYS--STMVASLKGDVYGIGVVLLELAGFKGNLVDWV-------NQLSSSGRS 538 (611)
Q Consensus 468 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~-------~~~~~~~~~ 538 (611)
|+++.... ......||+.|+|||.+ ....++.++|||||||++|||++|+.||.... ......
T Consensus 174 g~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--- 245 (287)
T 4f0f_A 174 GLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE--- 245 (287)
T ss_dssp TTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS---
T ss_pred Cccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc---
Confidence 99985432 12334699999999998 44567899999999999999999998874211 000000
Q ss_pred hhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHc
Q 035917 539 KEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586 (611)
Q Consensus 539 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 586 (611)
...+. .....++++.+++. +||+.||++|||+.|+++.|+++
T Consensus 246 --~~~~~-~~~~~~~~l~~li~---~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 246 --GLRPT-IPEDCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp --CCCCC-CCTTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHTC
T ss_pred --CCCCC-CCcccCHHHHHHHH---HHhcCChhhCcCHHHHHHHHHhC
Confidence 00111 11233445555555 99999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=345.25 Aligned_cols=260 Identities=20% Similarity=0.275 Sum_probs=192.5
Q ss_pred HhhhcCCCCCeeeecCCceEEEEEeC----CCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCe
Q 035917 321 AASNSFCSENVIISTRTGTTYKAMLP----DGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEE 393 (611)
Q Consensus 321 ~~t~~f~~~~~ig~G~~g~Vy~~~~~----~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~ 393 (611)
...++|...+.||+|+||.||+|... ++..||||+++... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34567888899999999999999853 34589999997543 233678999999999999999999999987553
Q ss_pred -----eEEEEeccCCCChHHhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeE
Q 035917 394 -----KLLIYKYMSSGTLYSLLQG-----NATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDAR 463 (611)
Q Consensus 394 -----~~lv~ey~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~k 463 (611)
.++||||+++|+|.+++.. ....+++..++.++.|+++||.||| +.+|+||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEE
Confidence 4999999999999999842 2246999999999999999999999 88999999999999999999999
Q ss_pred EeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhh
Q 035917 464 IMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAI 542 (611)
Q Consensus 464 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~ 542 (611)
|+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||...... ...+.+
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~~~~~~ 262 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH-----EMYDYL 262 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----GHHHHH
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH-----HHHHHH
Confidence 999999987644332222223457889999999998899999999999999999999 77666321000 000000
Q ss_pred chh---hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 543 DKA---LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 543 ~~~---l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
... ......++++.+ ++.+||+.||++|||+.+++++|+++.+..+
T Consensus 263 ~~~~~~~~~~~~~~~l~~---li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 263 LHGHRLKQPEDCLDELYE---IMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HTTCCCCCBTTCCHHHHH---HHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HcCCCCCCCccccHHHHH---HHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 000 011223344444 5559999999999999999999999987753
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=350.50 Aligned_cols=260 Identities=21% Similarity=0.295 Sum_probs=197.6
Q ss_pred cCCCCCeeeecCCceEEEEEeCC-----CCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEE
Q 035917 325 SFCSENVIISTRTGTTYKAMLPD-----GSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~~-----g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
.|...+.||+|+||.||+|+... +..||||+++... ....++.+|+.++++++||||+++++++...+..++|
T Consensus 45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 124 (333)
T 1mqb_A 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 124 (333)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEE
Confidence 44556899999999999998642 2469999997543 2345789999999999999999999999999999999
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
|||+++|+|.+++......+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 125 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 201 (333)
T 1mqb_A 125 TEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201 (333)
T ss_dssp EECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence 9999999999999876567999999999999999999999 7899999999999999999999999999998764332
Q ss_pred CC-ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHH
Q 035917 478 ES-SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEI 555 (611)
Q Consensus 478 ~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 555 (611)
.. .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.......... ........ ......++++
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~-~~~~~~~~-~~~~~~~~~l 279 (333)
T 1mqb_A 202 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK-AINDGFRL-PTPMDCPSAI 279 (333)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-HHHTTCCC-CCCTTCBHHH
T ss_pred ccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHH-HHHCCCcC-CCcccCCHHH
Confidence 11 11122346889999999988899999999999999999998 888874211100000 00000000 0112233444
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCC
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGF 592 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 592 (611)
.+ ++.+||+.||++||++.|++++|+++.+....
T Consensus 280 ~~---li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 280 YQ---LMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp HH---HHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred HH---HHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 44 55599999999999999999999998876543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=355.30 Aligned_cols=247 Identities=20% Similarity=0.224 Sum_probs=199.0
Q ss_pred hhhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEE
Q 035917 322 ASNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
..++|...+.||+|+||.||+|+.. +|+.||||+++... ...+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3567889999999999999999964 68999999996543 2346789999999999999999999999999999999
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCC---CCeEEeecccccccC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDED---FDARIMDFGLAKLMT 474 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~---~~~kl~DFGla~~~~ 474 (611)
|||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.+ +.+||+|||+++...
T Consensus 107 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp ECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 9999999999998754 46899999999999999999999 7899999999999999865 459999999998765
Q ss_pred CCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCChhhhhchhhcCC
Q 035917 475 SSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGRSKEAIDKALCGK 549 (611)
Q Consensus 475 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~ 549 (611)
.... .....||+.|+|||++.+..++.++|||||||++|||++|..||... ..... .+... .+.....
T Consensus 183 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~-~~~~~---~~~~~~~ 255 (362)
T 2bdw_A 183 DSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK-AGAYD---YPSPEWD 255 (362)
T ss_dssp TCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HTCCC---CCTTGGG
T ss_pred CCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-hCCCC---CCccccc
Confidence 3321 23346999999999999989999999999999999999999887321 11111 00000 0000001
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 550 GYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 550 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
..++++.+++. +||+.||++||++.|+++|
T Consensus 256 ~~~~~~~~li~---~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 256 TVTPEAKSLID---SMLTVNPKKRITADQALKV 285 (362)
T ss_dssp GSCHHHHHHHH---HHSCSSGGGSCCHHHHTTS
T ss_pred CCCHHHHHHHH---HHcCCChhhCcCHHHHhcC
Confidence 22345555555 9999999999999999876
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=341.66 Aligned_cols=257 Identities=23% Similarity=0.319 Sum_probs=200.0
Q ss_pred hcCCCCCeeeecCCceEEEEEeCC----CCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEe-CCeeEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPD----GSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVV-EEEKLL 396 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~----g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~-~~~~~l 396 (611)
..|...+.||+|+||.||+|+..+ ...||+|.++... ...+++.+|+.++++++||||+++++++.. ++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 356677899999999999999643 2368999987533 234679999999999999999999999754 557899
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 99999999999999876667899999999999999999999 789999999999999999999999999999876432
Q ss_pred CC--CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCC-CHHHHHHHHhhcCChhhhhc---hhhcCCC
Q 035917 477 DE--SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKG-NLVDWVNQLSSSGRSKEAID---KALCGKG 550 (611)
Q Consensus 477 ~~--~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~-~~~~~~~~~~~~~~~~~~~~---~~l~~~~ 550 (611)
.. ........||+.|+|||.+.+..++.++||||||+++|||++|.. ++... ........+. .......
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 256 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----NTFDITVYLLQGRRLLQPEY 256 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS-----CTTTHHHHHHTTCCCCCCTT
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC-----CHHHHHHHHhcCCCCCCCcc
Confidence 21 112233468889999999988899999999999999999999554 43210 0000000000 1111223
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 551 YDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 551 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
.++++.+++ .+||+.||++|||+.|+++.|+++.....
T Consensus 257 ~~~~l~~li---~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 257 CPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp CCHHHHHHH---HHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred CCHHHHHHH---HHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 344555544 49999999999999999999999988753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=355.22 Aligned_cols=248 Identities=20% Similarity=0.281 Sum_probs=192.1
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccc---hhHHHHHHHHHHHhccCC--CCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRH--PNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H--~nIv~l~g~~~~~~~~~lv~ 398 (611)
+.|...+.||+|+||.||+|...+++.||||+++... ...+.+.+|+.++.+++| |||+++++++..++..++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 4577889999999999999999889999999986533 233678999999999986 99999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
| +.+|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++ ++.+||+|||+++.......
T Consensus 89 e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 89 E-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp C-CCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred e-CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 9 4578999999865 46899999999999999999999 78999999999999997 57899999999987654333
Q ss_pred CccccCCCcccccccccccCC-----------CCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhc
Q 035917 479 SSFVNGDLGEFGYIAPEYSST-----------MVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALC 547 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 547 (611)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .....+++...
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~ 239 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHE 239 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHHHHHCTTSC
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH---HHHHHhcCCcc
Confidence 223334579999999998754 6789999999999999999999998743111100 11112222111
Q ss_pred ---CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 035917 548 ---GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSL 583 (611)
Q Consensus 548 ---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 583 (611)
....++++.+++ .+||+.||++|||+.|+++|-
T Consensus 240 ~~~~~~~~~~l~~li---~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 240 IEFPDIPEKDLQDVL---KCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp CCCCCCSCHHHHHHH---HHHTCSSTTTSCCHHHHHTSH
T ss_pred cCCcccCCHHHHHHH---HHHcCCChhHCCCHHHHHhCc
Confidence 122334455544 499999999999999999874
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=353.21 Aligned_cols=258 Identities=19% Similarity=0.265 Sum_probs=204.8
Q ss_pred hhcCCCCCeeeecCCceEEEEEeCC------CCEEEEEeccccc--hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCe
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLPD------GSVLAVKRLNTCK--LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEE 393 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~~------g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~ 393 (611)
.++|...+.||+|+||.||+|.... ++.||+|.++... ...+.+.+|+.+++++ +||||+++++++..++.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 4678888999999999999999532 3489999997543 2346799999999999 89999999999999999
Q ss_pred eEEEEeccCCCChHHhhhcC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC
Q 035917 394 KLLIYKYMSSGTLYSLLQGN-------------ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF 460 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~ 460 (611)
.++||||+++|+|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCCC
Confidence 99999999999999998642 135799999999999999999999 78999999999999999999
Q ss_pred CeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChh
Q 035917 461 DARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSK 539 (611)
Q Consensus 461 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~ 539 (611)
.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++ |..||..... .....
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----~~~~~ 277 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV----NSKFY 277 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS----SHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch----hHHHH
Confidence 999999999987644333223334457889999999988889999999999999999998 7777632100 00001
Q ss_pred hhhchhh---cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 540 EAIDKAL---CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 540 ~~~~~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
..+.... .....++++.+ ++.+||+.||++|||+.||+++|+++.++.
T Consensus 278 ~~~~~~~~~~~~~~~~~~l~~---li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 278 KLVKDGYQMAQPAFAPKNIYS---IMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp HHHHHTCCCCCCTTCCHHHHH---HHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCCCCCCCCHHHHH---HHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 1111111 11223444444 555999999999999999999999987764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=358.09 Aligned_cols=250 Identities=19% Similarity=0.184 Sum_probs=191.5
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
.++|...+.||+|+||.||+++.. +++.||||++.......+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 456888899999999999999965 7999999999766555677899999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCC--eEEeecccccccCCCCCC
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFD--ARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~--~kl~DFGla~~~~~~~~~ 479 (611)
++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++. +||+|||+++......
T Consensus 99 ~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~-- 172 (361)
T 3uc3_A 99 SGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 172 (361)
T ss_dssp CSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--
Confidence 999999998654 35899999999999999999999 789999999999999987765 9999999998543221
Q ss_pred ccccCCCcccccccccccCCCCCCcc-cchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhc---CCCCHHHH
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMVASLK-GDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALC---GKGYDEEI 555 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~~t~k-sDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~---~~~~~~~~ 555 (611)
......||+.|+|||++.+..++.+ +|||||||++|||++|+.||...................... ....+.++
T Consensus 173 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 251 (361)
T 3uc3_A 173 -QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPEC 251 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHH
T ss_pred -CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHH
Confidence 1223469999999999888777665 899999999999999998875321100000000111111110 11234555
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+++. +||+.||++|||+.|+++|
T Consensus 252 ~~li~---~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 252 CHLIS---RIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHHH---HHSCSCTTTSCCHHHHHTS
T ss_pred HHHHH---HHccCChhHCcCHHHHHhC
Confidence 55555 9999999999999999987
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=343.88 Aligned_cols=243 Identities=21% Similarity=0.283 Sum_probs=190.8
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch---------------------------hHHHHHHHHHHHhc
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL---------------------------GEKKFRNEMNRLGQ 375 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~---------------------------~~~~~~~Ev~~l~~ 375 (611)
++|...+.||+|+||.||+|+. .+++.||||++..... ..+++.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 4677889999999999999995 4689999999864321 12468899999999
Q ss_pred cCCCCccceeeEEEe--CCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCe
Q 035917 376 LRHPNLAPLLGYCVV--EEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNV 453 (611)
Q Consensus 376 l~H~nIv~l~g~~~~--~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~N 453 (611)
++||||+++++++.+ .+..++||||+++|+|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+|
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSN 167 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHH
Confidence 999999999999987 5678999999999999887653 36999999999999999999999 7899999999999
Q ss_pred EEeCCCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCC---CCcccchHHHHHHHHHHhCCCCCHHHH--
Q 035917 454 ILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMV---ASLKGDVYGIGVVLLELAGFKGNLVDW-- 528 (611)
Q Consensus 454 ILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~ksDV~SfGvvl~ell~~~~~~~~~-- 528 (611)
||++.++.+||+|||+++...... .......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||...
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 999999999999999998764322 1223456999999999987655 478899999999999999999886321
Q ss_pred ---HHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 529 ---VNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 529 ---~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
....... . .. .......++++.+++. +||+.||++|||+.|+++|
T Consensus 246 ~~~~~~~~~~-~----~~-~~~~~~~~~~l~~li~---~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 246 MCLHSKIKSQ-A----LE-FPDQPDIAEDLKDLIT---RMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHHHHHHHC-C----CC-CCSSSCCCHHHHHHHH---HHTCSCTTTSCCHHHHTTC
T ss_pred HHHHHHHhcc-c----CC-CCCccccCHHHHHHHH---HHhhcChhhCCCHHHHhcC
Confidence 1111000 0 00 0011223455555555 9999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=353.14 Aligned_cols=263 Identities=20% Similarity=0.291 Sum_probs=206.7
Q ss_pred HHHHHhhhcCCCCCeeeecCCceEEEEEeC------CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEE
Q 035917 317 ADLMAASNSFCSENVIISTRTGTTYKAMLP------DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYC 388 (611)
Q Consensus 317 ~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~~------~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~ 388 (611)
++.....++|...+.||+|+||.||+|+.. +++.||||.+.... ....++.+|+.++++++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 334445678888999999999999999853 37889999997543 2345789999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCC
Q 035917 389 VVEEEKLLIYKYMSSGTLYSLLQGNA---------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDED 459 (611)
Q Consensus 389 ~~~~~~~lv~ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~ 459 (611)
.+++..++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCC
Confidence 99999999999999999999986421 35799999999999999999999 7899999999999999999
Q ss_pred CCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCCh
Q 035917 460 FDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRS 538 (611)
Q Consensus 460 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~ 538 (611)
+.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++ |..|+........ .
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~----~ 250 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV----L 250 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH----H
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH----H
Confidence 9999999999986643322222233457889999999988889999999999999999998 6777632110000 0
Q ss_pred hhhhchh--hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 539 KEAIDKA--LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 539 ~~~~~~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
....... ......++++.+++. +||+.||++|||+.|++++|+++...
T Consensus 251 ~~~~~~~~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 251 RFVMEGGLLDKPDNCPDMLFELMR---MCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHH---HHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 0000000 011223445555554 99999999999999999999987553
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=357.23 Aligned_cols=242 Identities=20% Similarity=0.309 Sum_probs=192.6
Q ss_pred CCCeeeecCCceEEEEEe-CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCC
Q 035917 328 SENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGT 405 (611)
Q Consensus 328 ~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gs 405 (611)
..+.||+|+||.||+|+. .+|+.||+|+++... ...+++.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 356899999999999996 569999999997644 345679999999999999999999999999999999999999999
Q ss_pred hHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEe--CCCCCeEEeecccccccCCCCCCcccc
Q 035917 406 LYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV--DEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 406 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl--d~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
|.+++......+++..+..++.|+++||+||| +.+|+||||||+|||+ +.++.+||+|||+++....... ..
T Consensus 173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~ 246 (373)
T 2x4f_A 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LK 246 (373)
T ss_dssp EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cc
Confidence 99998765556999999999999999999999 7899999999999999 6778999999999987654322 22
Q ss_pred CCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhhcCChhhhhchhhcCCCCHHHHHHH
Q 035917 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSSSGRSKEAIDKALCGKGYDEEILQF 558 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 558 (611)
...||+.|+|||++.+..++.++|||||||++|||++|..||.. ........... .... .....++++.++
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~---~~~~-~~~~~~~~~~~l 322 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD---LEDE-EFQDISEEAKEF 322 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC---SCSG-GGTTSCHHHHHH
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC---CChh-hhccCCHHHHHH
Confidence 34699999999999988999999999999999999999988732 11111111000 0000 012234555665
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 035917 559 LKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 559 ~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+. +||+.||++|||+.|+++|
T Consensus 323 i~---~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 323 IS---KLLIKEKSWRISASEALKH 343 (373)
T ss_dssp HH---TTSCSSGGGSCCHHHHHHS
T ss_pred HH---HHcCCChhhCCCHHHHhcC
Confidence 55 9999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=376.62 Aligned_cols=258 Identities=22% Similarity=0.352 Sum_probs=206.0
Q ss_pred hhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccC
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
.++|...+.||+|+||.||+|.+.++..||||+++......++|.+|+++|++++||||+++++++.+ +..++|||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~ 344 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 344 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence 45677788999999999999999888899999998766667889999999999999999999999865 67899999999
Q ss_pred CCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 403 SGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 403 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
+|+|.+++.... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~ 420 (535)
T 2h8h_A 345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTA 420 (535)
T ss_dssp TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HHT
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-eec
Confidence 999999997532 35899999999999999999999 7899999999999999999999999999998764221 111
Q ss_pred ccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHH
Q 035917 482 VNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLK 560 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~ 560 (611)
.....++..|+|||.+.+..++.++|||||||++|||++ |+.||.......... .+...... ......++++.+
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~-~i~~~~~~-~~~~~~~~~l~~--- 495 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-QVERGYRM-PCPPECPESLHD--- 495 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHH-HHHTTCCC-CCCTTCCHHHHH---
T ss_pred ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCC-CCCCCCCHHHHH---
Confidence 223357889999999988899999999999999999999 777764311100000 00000000 011223444444
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 561 VACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 561 l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
++.+||+.||++|||+.+|++.|+++....
T Consensus 496 li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 496 LMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 555999999999999999999999887654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=346.04 Aligned_cols=255 Identities=17% Similarity=0.277 Sum_probs=197.6
Q ss_pred hcCCCCCeeeecCCceEEEEEeCC-C-------CEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCee
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPD-G-------SVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~-g-------~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~ 394 (611)
++|...+.||+|+||.||+|+... + ..||+|+++... ...+.+.+|+.++++++||||+++++++..++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 467778999999999999998543 3 579999996543 4457899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCC--------eEEee
Q 035917 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFD--------ARIMD 466 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~--------~kl~D 466 (611)
++||||+++|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+|||++.++. +||+|
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence 9999999999999999876556999999999999999999999 789999999999999998877 99999
Q ss_pred cccccccCCCCCCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh
Q 035917 467 FGLAKLMTSSDESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA 545 (611)
Q Consensus 467 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (611)
||+++..... ....||+.|+|||.+.+ ..++.++|||||||++|||++|..++......... ........
T Consensus 165 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~---~~~~~~~~ 235 (289)
T 4fvq_A 165 PGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK---LQFYEDRH 235 (289)
T ss_dssp CCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HHHHHTTC
T ss_pred CcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH---HHHhhccC
Confidence 9999755321 11237889999999877 67899999999999999999965443211000000 00000011
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCCC
Q 035917 546 LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFS 593 (611)
Q Consensus 546 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 593 (611)
......++++.+++ .+||+.||++|||+.|++++|+++....+..
T Consensus 236 ~~~~~~~~~l~~li---~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~ 280 (289)
T 4fvq_A 236 QLPAPKAAELANLI---NNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280 (289)
T ss_dssp CCCCCSSCTTHHHH---HHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred CCCCCCCHHHHHHH---HHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence 11122233444544 4999999999999999999999988765433
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=358.27 Aligned_cols=248 Identities=20% Similarity=0.285 Sum_probs=193.5
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccc---hhHHHHHHHHHHHhccC--CCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLR--HPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~--H~nIv~l~g~~~~~~~~~lv~ 398 (611)
..|...+.||+|+||.||+|...+++.||||++.... ...+.+.+|+.+|.+++ ||||+++++++..++..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 3588889999999999999998889999999996533 23467999999999996 599999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
| +.+|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++ ++.+||+|||+++.+.....
T Consensus 136 E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp E-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred e-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 9 5678999999865 36899999999999999999999 88999999999999996 57999999999987654332
Q ss_pred CccccCCCcccccccccccCC-----------CCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhc
Q 035917 479 SSFVNGDLGEFGYIAPEYSST-----------MVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALC 547 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 547 (611)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ......+++...
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~~~~~~~~~~~ 286 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNHE 286 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHHHCTTSC
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH---HHHHHHhCcccc
Confidence 222344579999999998754 468999999999999999999999884321110 011122222211
Q ss_pred ---CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 035917 548 ---GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSL 583 (611)
Q Consensus 548 ---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 583 (611)
....++++.+++. +||+.||++|||+.|+++|-
T Consensus 287 ~~~~~~~~~~~~~li~---~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 287 IEFPDIPEKDLQDVLK---CCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp CCCCCCSCHHHHHHHH---HHTCSSTTTSCCHHHHHTSH
T ss_pred CCCCccchHHHHHHHH---HHcccChhhCCCHHHHhhCc
Confidence 1223445555544 99999999999999999873
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=339.49 Aligned_cols=254 Identities=19% Similarity=0.223 Sum_probs=199.7
Q ss_pred hhcCCCCCeeeecCCceEEEEEeCC----CCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLPD----GSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~~----g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
.++|...+.||+|+||.||+|+..+ +..||||.++... ...+++.+|+.++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4578888999999999999998543 3469999997542 345679999999999999999999999764 45789
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
||||+++|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 99999999999999765556999999999999999999999 789999999999999999999999999999876433
Q ss_pred CCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhch---hhcCCCCH
Q 035917 477 DESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDK---ALCGKGYD 552 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~---~l~~~~~~ 552 (611)
.. .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ...+.+.. .......+
T Consensus 167 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 240 (281)
T 3cc6_A 167 DY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-----DVIGVLEKGDRLPKPDLCP 240 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-----GHHHHHHHTCCCCCCTTCC
T ss_pred cc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-----HHHHHHhcCCCCCCCCCCC
Confidence 21 11223357889999999988889999999999999999998 88887321000 00111110 01112234
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 553 EEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 553 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
+.+.+++. +||+.||++||++.|++++|+++.+.
T Consensus 241 ~~l~~li~---~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 241 PVLYTLMT---RCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp HHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHH---HHccCCchhCcCHHHHHHHHHHHHHh
Confidence 45555554 99999999999999999999998765
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=352.75 Aligned_cols=247 Identities=20% Similarity=0.246 Sum_probs=184.2
Q ss_pred hhhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 322 ASNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
..+.|...+.||+|+||.||+|+.. +++.||||+++... ..+.+.+|++++++++||||+++++++..++..++||||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 3467888899999999999999975 58899999996542 346788999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC---CCCeEEeecccccccCCCC
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE---DFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~---~~~~kl~DFGla~~~~~~~ 477 (611)
+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||+++......
T Consensus 130 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 130 VTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp CCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 9999999999754 45899999999999999999999 789999999999999975 8899999999998764322
Q ss_pred CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh--h---cCCCCH
Q 035917 478 ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA--L---CGKGYD 552 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~--l---~~~~~~ 552 (611)
......||+.|+|||++.+..++.++|||||||++|||++|..||........ ....+.... . .....+
T Consensus 206 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~i~~~~~~~~~~~~~~~~ 279 (349)
T 2w4o_A 206 ---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF---MFRRILNCEYYFISPWWDEVS 279 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH---HHHHHHTTCCCCCTTTTTTSC
T ss_pred ---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH---HHHHHHhCCCccCCchhhhCC
Confidence 12234699999999999998999999999999999999999988732100000 000000000 0 012234
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 553 EEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 553 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.++.+++. +||+.||++|||+.|+++|
T Consensus 280 ~~~~~li~---~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 280 LNAKDLVR---KLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHHHHH---TTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHH---HHccCChhhCcCHHHHhcC
Confidence 45555555 9999999999999999875
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=350.55 Aligned_cols=243 Identities=17% Similarity=0.287 Sum_probs=197.8
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch----hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL----GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||.||+|+. .+++.||||++..... ..+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4677889999999999999996 6789999999865321 2357899999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+ +|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 89 E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~- 162 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN- 162 (336)
T ss_dssp CCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-
T ss_pred ECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc-
Confidence 999 67999988654 35999999999999999999999 7899999999999999999999999999998764332
Q ss_pred CccccCCCcccccccccccCCCCC-CcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhch--hhcCCCCHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVA-SLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDK--ALCGKGYDEEI 555 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~~~~ 555 (611)
.....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+.... .....+.. ...+...+.++
T Consensus 163 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-----~~~~~i~~~~~~~p~~~s~~~ 235 (336)
T 3h4j_B 163 --FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-----NLFKKVNSCVYVMPDFLSPGA 235 (336)
T ss_dssp --TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-----TCBCCCCSSCCCCCTTSCHHH
T ss_pred --ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH-----HHHHHHHcCCCCCcccCCHHH
Confidence 2234569999999999988776 78999999999999999999987431000 00000100 01122344555
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+++. +||+.||++|||+.|+++|
T Consensus 236 ~~li~---~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 236 QSLIR---RMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp HHHHH---TTSCSSGGGSCCHHHHTTC
T ss_pred HHHHH---HHcCCChhHCcCHHHHHhC
Confidence 55555 9999999999999999987
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=352.35 Aligned_cols=203 Identities=18% Similarity=0.232 Sum_probs=178.6
Q ss_pred ccHHHHHHhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhccC-----CCCccceeeE
Q 035917 314 VKLADLMAASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLR-----HPNLAPLLGY 387 (611)
Q Consensus 314 ~~~~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~-----H~nIv~l~g~ 387 (611)
+++.+.....++|...+.||+|+||.||+|+. .+++.||||+++......+.+..|+.++++++ ||||++++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 44444445567899999999999999999996 57899999999866666677889999999996 9999999999
Q ss_pred EEeCCeeEEEEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC--------
Q 035917 388 CVVEEEKLLIYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE-------- 458 (611)
Q Consensus 388 ~~~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~-------- 458 (611)
+...+..++||||+ +++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.
T Consensus 105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 105 FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEE
T ss_pred eeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccccccccc
Confidence 99999999999999 889999997654 36999999999999999999999 789999999999999975
Q ss_pred -----------------CCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCC
Q 035917 459 -----------------DFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGF 521 (611)
Q Consensus 459 -----------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~ 521 (611)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 255 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHC
Confidence 7899999999998653321 234689999999999999999999999999999999999
Q ss_pred CCCH
Q 035917 522 KGNL 525 (611)
Q Consensus 522 ~~~~ 525 (611)
+.||
T Consensus 256 ~~pf 259 (360)
T 3llt_A 256 SLLF 259 (360)
T ss_dssp SCSC
T ss_pred CCCC
Confidence 8876
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=344.91 Aligned_cols=243 Identities=20% Similarity=0.251 Sum_probs=200.3
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||.||+|+.. +|+.||+|+++... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56788899999999999999964 69999999996532 23467889999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp CCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence 999999999999754 35899999999999999999999 889999999999999999999999999999876432
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEILQ 557 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~ 557 (611)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+..... .+...++++.+
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~~~p~~~~~~~~~ 232 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----TYEKILNAELRFPPFFNEDVKD 232 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHCCCCCCTTSCHHHHH
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCCCCCHHHHH
Confidence 123469999999999999999999999999999999999998873210000 0001111111 12234556666
Q ss_pred HHHHHhhcccCCCCCCC-----CHHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRW-----SMYQVYQS 582 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RP-----s~~evl~~ 582 (611)
+++ +|++.||++|| +++|+++|
T Consensus 233 li~---~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 233 LLS---RLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHH---HHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHH---HHhccCHHHcCCCcCCCHHHHhcC
Confidence 666 99999999999 89999876
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=362.16 Aligned_cols=254 Identities=16% Similarity=0.183 Sum_probs=204.7
Q ss_pred HHHHHHhhhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccch----hHHHHHHHHHHHhccCCCCccceeeEEEe
Q 035917 316 LADLMAASNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKL----GEKKFRNEMNRLGQLRHPNLAPLLGYCVV 390 (611)
Q Consensus 316 ~~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~----~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~ 390 (611)
+.++....++|...++||+|+||.||+|+.. +++.||+|+++.... ..+.+.+|+.++..++|||||++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3455566788999999999999999999965 589999999965321 22458899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccc
Q 035917 391 EEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLA 470 (611)
Q Consensus 391 ~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla 470 (611)
++..++|||||++|+|.+++... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEecccee
Confidence 99999999999999999999754 4899999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCCccccCCCcccccccccccCCCC----CCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhch--
Q 035917 471 KLMTSSDESSFVNGDLGEFGYIAPEYSSTMV----ASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDK-- 544 (611)
Q Consensus 471 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~-- 544 (611)
+...... .......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||....... ....++..
T Consensus 216 ~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----~~~~i~~~~~ 290 (410)
T 3v8s_A 216 MKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----TYSKIMNHKN 290 (410)
T ss_dssp EECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHTHHH
T ss_pred EeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh----HHHHHHhccc
Confidence 8764332 11223457999999999987654 7899999999999999999999874210000 00111111
Q ss_pred --hh-cCCCCHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 035917 545 --AL-CGKGYDEEILQFLKVACNCVVSRPKD--RWSMYQVYQS 582 (611)
Q Consensus 545 --~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 582 (611)
.. .....++++.+++. +||+.+|++ ||+++||++|
T Consensus 291 ~~~~p~~~~~s~~~~~li~---~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 291 SLTFPDDNDISKEAKNLIC---AFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HCCCCTTCCCCHHHHHHHH---HHSSCGGGCTTSSCHHHHHTS
T ss_pred cccCCCcccccHHHHHHHH---HHccChhhhCCCCCHHHHhcC
Confidence 01 11234566666666 999999988 9999999988
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=361.15 Aligned_cols=257 Identities=19% Similarity=0.179 Sum_probs=205.2
Q ss_pred ccHHHHHHhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch----hHHHHHHHHHHHhccCCCCccceeeEE
Q 035917 314 VKLADLMAASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL----GEKKFRNEMNRLGQLRHPNLAPLLGYC 388 (611)
Q Consensus 314 ~~~~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ev~~l~~l~H~nIv~l~g~~ 388 (611)
+.+.+.....++|...++||+|+||.||+|+. .+|+.||||++++... ..+.+.+|+.++.+++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 44556666778999999999999999999997 4799999999965322 123488999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecc
Q 035917 389 VVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFG 468 (611)
Q Consensus 389 ~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFG 468 (611)
.+.+..++||||+++|+|.+++......+++..+..++.+|+.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeech
Confidence 9999999999999999999999765446999999999999999999999 7899999999999999999999999999
Q ss_pred cccccCCCCCCccccCCCcccccccccccC-------CCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhh
Q 035917 469 LAKLMTSSDESSFVNGDLGEFGYIAPEYSS-------TMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEA 541 (611)
Q Consensus 469 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~ 541 (611)
+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||........ ...+
T Consensus 208 la~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~----~~~i 282 (412)
T 2vd5_A 208 SCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET----YGKI 282 (412)
T ss_dssp TCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHH
T ss_pred hheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH----HHHH
Confidence 9987643322 1223457999999999886 45689999999999999999999998742110000 0011
Q ss_pred hc------hhhcCCCCHHHHHHHHHHHhhcccCCCCCC---CCHHHHHHH
Q 035917 542 ID------KALCGKGYDEEILQFLKVACNCVVSRPKDR---WSMYQVYQS 582 (611)
Q Consensus 542 ~~------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~evl~~ 582 (611)
+. ........++++.++++ +||+ +|++| |+++||++|
T Consensus 283 ~~~~~~~~~p~~~~~~s~~~~dli~---~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 283 VHYKEHLSLPLVDEGVPEEARDFIQ---RLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HTHHHHCCCC----CCCHHHHHHHH---TTSS-CGGGCTTTTTHHHHHTS
T ss_pred HhcccCcCCCccccCCCHHHHHHHH---HHcC-ChhhcCCCCCHHHHhcC
Confidence 11 00011234566666666 9999 99998 599999887
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=374.07 Aligned_cols=251 Identities=20% Similarity=0.290 Sum_probs=197.6
Q ss_pred eeeecCCceEEEEEeC---CCCEEEEEecccc--chhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCCC
Q 035917 331 VIISTRTGTTYKAMLP---DGSVLAVKRLNTC--KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGT 405 (611)
Q Consensus 331 ~ig~G~~g~Vy~~~~~---~g~~vAvK~~~~~--~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~gs 405 (611)
.||+|+||.||+|.+. ++..||||+++.. ....++|.+|+++|++++|||||+++++|.. +..++|||||++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999863 4678999999753 2346789999999999999999999999976 56899999999999
Q ss_pred hHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC-CccccC
Q 035917 406 LYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE-SSFVNG 484 (611)
Q Consensus 406 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~-~~~~~~ 484 (611)
|.+++......+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.+..... ......
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 99999866667999999999999999999999 78999999999999999999999999999987643321 111122
Q ss_pred CCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhh---cCCCCHHHHHHHHH
Q 035917 485 DLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKAL---CGKGYDEEILQFLK 560 (611)
Q Consensus 485 ~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l---~~~~~~~~~~~l~~ 560 (611)
..+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ...+.+.... .....++++.+
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-----~~~~~i~~~~~~~~p~~~~~~l~~--- 570 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-----EVMAFIEQGKRMECPPECPPELYA--- 570 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-----HHHHHHHTTCCCCCCTTCCHHHHH---
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHcCCCCCCCCcCCHHHHH---
Confidence 346789999999988899999999999999999998 88887431110 0111111111 11223344444
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHHHchhhhCCC
Q 035917 561 VACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFS 593 (611)
Q Consensus 561 l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 593 (611)
++.+||+.||++||++.+|++.|+.+.......
T Consensus 571 li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~ 603 (613)
T 2ozo_A 571 LMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603 (613)
T ss_dssp HHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCS
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHHHHHhccc
Confidence 555999999999999999999999988776543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=354.84 Aligned_cols=247 Identities=21% Similarity=0.295 Sum_probs=201.0
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
.+.|...+.||+|+||.||+|... +|+.||+|++.... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 457888899999999999999964 68999999996543 3446789999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC--CCCeEEeecccccccCCCCC
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE--DFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~--~~~~kl~DFGla~~~~~~~~ 478 (611)
+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 9999999999866557999999999999999999999 789999999999999974 57899999999987654322
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCChhhhhchhhcCCCCHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGRSKEAIDKALCGKGYDE 553 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~~~~~ 553 (611)
.....||+.|+|||++.+..++.++|||||||++|||++|..||... ......... ..++. .....++
T Consensus 207 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~---~~~~~-~~~~~s~ 279 (387)
T 1kob_A 207 ---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW---EFDED-AFSSVSP 279 (387)
T ss_dssp ---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC---CCCSS-TTTTSCH
T ss_pred ---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCcc-ccccCCH
Confidence 12235999999999999989999999999999999999999887321 111111000 00000 0122345
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 554 EILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 554 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++.+++. +||+.||++|||+.|+++|
T Consensus 280 ~~~~li~---~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 280 EAKDFIK---NLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHHHHH---TTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHH---HHcCCChhHCcCHHHHhhC
Confidence 5555555 9999999999999999986
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=354.01 Aligned_cols=244 Identities=23% Similarity=0.262 Sum_probs=197.4
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46788899999999999999964 58999999986532 23467899999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 95 e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET- 169 (384)
T ss_dssp CCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred ecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC-
Confidence 999999999999854 46999999999999999999999 7899999999999999999999999999998764332
Q ss_pred CccccCCCcccccccccccCC---CCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhch-----hhcCCC
Q 035917 479 SSFVNGDLGEFGYIAPEYSST---MVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDK-----ALCGKG 550 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~-----~l~~~~ 550 (611)
.....+||+.|+|||++.. ..++.++|||||||++|||++|+.||... ......+.+.. ...+..
T Consensus 170 --~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~-----~~~~~~~~~~~~~~~~~~~p~~ 242 (384)
T 4fr4_A 170 --QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR-----SSTSSKEIVHTFETTVVTYPSA 242 (384)
T ss_dssp --CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC-----TTSCHHHHHHHHHHCCCCCCTT
T ss_pred --ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC-----CCccHHHHHHHHhhcccCCCCc
Confidence 2234579999999999864 45899999999999999999999887310 00001111100 011223
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCC-HHHHHHH
Q 035917 551 YDEEILQFLKVACNCVVSRPKDRWS-MYQVYQS 582 (611)
Q Consensus 551 ~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~ 582 (611)
.+.++..++. +||+.||++||+ +++|.+|
T Consensus 243 ~s~~~~~li~---~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 243 WSQEMVSLLK---KLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp SCHHHHHHHH---HHSCSSGGGSCCSHHHHHTS
T ss_pred CCHHHHHHHH---HHhcCCHhHhcccHHHHHcC
Confidence 4455555555 999999999998 7777654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=351.82 Aligned_cols=241 Identities=25% Similarity=0.333 Sum_probs=197.4
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
+.|...+.||+|+||.||+|+. .+|+.||||++.... ...+++.+|++++++++||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4577888999999999999995 679999999996432 22357899999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+. |+|.+++......+++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 9997 6898888655557999999999999999999999 789999999999999999999999999999865421
Q ss_pred CccccCCCcccccccccccC---CCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCChhhhhchhhcCCC
Q 035917 479 SSFVNGDLGEFGYIAPEYSS---TMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGRSKEAIDKALCGKG 550 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~~ 550 (611)
....||+.|+|||++. ...++.++|||||||++|||++|+.||... ....... ..+......
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~ 277 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN------ESPALQSGH 277 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------CCCCCCCTT
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc------CCCCCCCCC
Confidence 2346999999999873 567899999999999999999999886421 1111111 111222234
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 035917 551 YDEEILQFLKVACNCVVSRPKDRWSMYQVYQSL 583 (611)
Q Consensus 551 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 583 (611)
.++++.++++ +||+.||++|||+.+++++.
T Consensus 278 ~~~~l~~li~---~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 278 WSEYFRNFVD---SCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp SCHHHHHHHH---HHTCSSGGGSCCHHHHTTCH
T ss_pred CCHHHHHHHH---HHcccChhhCcCHHHHhhCh
Confidence 4556666655 99999999999999998764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=350.11 Aligned_cols=257 Identities=19% Similarity=0.250 Sum_probs=199.4
Q ss_pred hhcCCCCCeeeecCCceEEEEEe------CCCCEEEEEecccc--chhHHHHHHHHHHHhccCCCCccceeeEEEeCCee
Q 035917 323 SNSFCSENVIISTRTGTTYKAML------PDGSVLAVKRLNTC--KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~------~~g~~vAvK~~~~~--~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~ 394 (611)
.++|...+.||+|+||.||+|+. .+++.||||++... .....++.+|+.++++++||||+++++++...+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 35788889999999999999984 35779999999643 23456799999999999999999999999999999
Q ss_pred EEEEeccCCCChHHhhhcCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC---CCCeEEe
Q 035917 395 LLIYKYMSSGTLYSLLQGNA------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE---DFDARIM 465 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~---~~~~kl~ 465 (611)
++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 99999999999999997543 34899999999999999999999 789999999999999984 4569999
Q ss_pred ecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHH----HHhhcCChhh
Q 035917 466 DFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVN----QLSSSGRSKE 540 (611)
Q Consensus 466 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~----~~~~~~~~~~ 540 (611)
|||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |..||..... .......
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--- 262 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG--- 262 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC---
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC---
Confidence 9999986543322222223357899999999988889999999999999999998 7777632110 0000000
Q ss_pred hhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 541 AIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 541 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
.. ......+.++.+ ++.+||+.||++||++.|++++|+.+.+...
T Consensus 263 --~~-~~~~~~~~~l~~---li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 263 --RM-DPPKNCPGPVYR---IMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp --CC-CCCTTCCHHHHH---HHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred --CC-CCCCCCCHHHHH---HHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 00 011223444555 4459999999999999999999999887643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=338.42 Aligned_cols=264 Identities=17% Similarity=0.211 Sum_probs=204.1
Q ss_pred hhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEE-EeCCeeEEEEe
Q 035917 322 ASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYC-VVEEEKLLIYK 399 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~-~~~~~~~lv~e 399 (611)
..++|...+.||+|+||.||+|+. .+++.||||++.... ..+++.+|+.++.+++|++++..++++ ...+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 456889999999999999999995 678999999875432 224588999999999998888777766 55677899999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEe---CCCCCeEEeecccccccCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV---DEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl---d~~~~~kl~DFGla~~~~~~ 476 (611)
|+ +|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99 89999999865557999999999999999999999 7899999999999999 78899999999999876543
Q ss_pred CCC-----ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-----
Q 035917 477 DES-----SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL----- 546 (611)
Q Consensus 477 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l----- 546 (611)
... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ..............
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 240 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA-TKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS-SSSSHHHHHHHHHHHSCHH
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchh-hhhhhhhhhhcccccchhh
Confidence 221 1123456999999999999999999999999999999999999887421000 00000011111111
Q ss_pred -cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCCCC
Q 035917 547 -CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFSE 594 (611)
Q Consensus 547 -~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 594 (611)
.....++++.++++ +||+.||++|||+.+|++.|+++.++.+...
T Consensus 241 ~~~~~~~~~l~~li~---~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~ 286 (296)
T 4hgt_A 241 VLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp HHTTTSCHHHHHHHH---HHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred hhhccCCHHHHHHHH---HHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence 11223445555555 9999999999999999999999999987654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=353.90 Aligned_cols=251 Identities=16% Similarity=0.192 Sum_probs=198.2
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccchh----HHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLG----EKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~----~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~l 396 (611)
.++|...++||+|+||.||+|+.. +++.||||+++..... .+.+.+|..++.++ +|||||++++++.+++..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 357888899999999999999965 5889999999754322 24578999999887 89999999999999999999
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
||||+++|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 131 V~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 99999999999998754 35999999999999999999999 789999999999999999999999999999863322
Q ss_pred CCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHh-hcCCh----hhhhchh-hcCCC
Q 035917 477 DESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLS-SSGRS----KEAIDKA-LCGKG 550 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~-~~~~~----~~~~~~~-l~~~~ 550 (611)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... ..+.... ..+..
T Consensus 207 ~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 284 (396)
T 4dc2_A 207 G--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284 (396)
T ss_dssp T--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred C--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence 2 123345799999999999999999999999999999999999999831100000 00000 0011111 11223
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCH------HHHHHH
Q 035917 551 YDEEILQFLKVACNCVVSRPKDRWSM------YQVYQS 582 (611)
Q Consensus 551 ~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~~ 582 (611)
.+.++.++++ +||+.||++||++ .||++|
T Consensus 285 ~s~~~~~li~---~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 285 LSVKAASVLK---SFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp SCHHHHHHHH---HHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred CCHHHHHHHH---HHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 4555666555 9999999999985 677776
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=353.91 Aligned_cols=201 Identities=18% Similarity=0.239 Sum_probs=173.6
Q ss_pred hhcCCCCCeeeec--CCceEEEEEeC-CCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEE
Q 035917 323 SNSFCSENVIIST--RTGTTYKAMLP-DGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 323 t~~f~~~~~ig~G--~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
.++|...+.||+| +||.||+|+.. +|+.||||+++... ...+.+.+|+.++++++|||||++++++..++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4567788999999 99999999965 79999999996543 223668899999999999999999999999999999
Q ss_pred EEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 397 IYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
|||||++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 999999999999997653 46999999999999999999999 78999999999999999999999999999875432
Q ss_pred CCC-----CccccCCCcccccccccccCC--CCCCcccchHHHHHHHHHHhCCCCCHH
Q 035917 476 SDE-----SSFVNGDLGEFGYIAPEYSST--MVASLKGDVYGIGVVLLELAGFKGNLV 526 (611)
Q Consensus 476 ~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SfGvvl~ell~~~~~~~ 526 (611)
... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 238 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence 211 111122468999999999887 678999999999999999999998874
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=351.03 Aligned_cols=247 Identities=18% Similarity=0.205 Sum_probs=196.0
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~l 396 (611)
.++|...++||+|+||.||+|+.. +|+.||||+++... ...+.+.+|..++..+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 357888899999999999999964 68999999996532 2345688999999988 69999999999999999999
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
||||+++|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 102 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 99999999999999754 35899999999999999999999 789999999999999999999999999999864322
Q ss_pred CCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-hcCCCCHHHH
Q 035917 477 DESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-LCGKGYDEEI 555 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~ 555 (611)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.... ..+...++++
T Consensus 178 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~----~~~i~~~~~~~p~~~~~~~ 251 (353)
T 3txo_A 178 G--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL----FEAILNDEVVYPTWLHEDA 251 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCTTSCHHH
T ss_pred C--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCCCCCCHHH
Confidence 2 122345799999999999888899999999999999999999988732110000 00111111 1122345556
Q ss_pred HHHHHHHhhcccCCCCCCCCH------HHHHHH
Q 035917 556 LQFLKVACNCVVSRPKDRWSM------YQVYQS 582 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~------~evl~~ 582 (611)
.++++ +||+.||++||++ .|+++|
T Consensus 252 ~~li~---~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 252 TGILK---SFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HHHHH---HHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred HHHHH---HHhhhCHHHccCCcccCCHHHHhhC
Confidence 66555 9999999999998 888876
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.62 Aligned_cols=267 Identities=22% Similarity=0.326 Sum_probs=205.3
Q ss_pred HHhhhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhc--cCCCCccceeeEEEeCC----e
Q 035917 320 MAASNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQ--LRHPNLAPLLGYCVVEE----E 393 (611)
Q Consensus 320 ~~~t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~--l~H~nIv~l~g~~~~~~----~ 393 (611)
....++|...+.||+|+||.||+|+. +|+.||||+++.. ..+.+.+|++++.. ++||||+++++++...+ .
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 34567899999999999999999998 5899999999643 34567888888887 78999999999998876 7
Q ss_pred eEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeeecCCCCCeEEeCCCCCeEEeecc
Q 035917 394 KLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGC-----QPPFLHQNICSNVILVDEDFDARIMDFG 468 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDlkp~NILld~~~~~kl~DFG 468 (611)
.++||||+++|+|.+++... .+++..++.++.|++.||+|||... +.+|+||||||+|||++.++.+||+|||
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred eEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 89999999999999999754 5899999999999999999999321 4689999999999999999999999999
Q ss_pred cccccCCCCCCc--cccCCCcccccccccccCCC------CCCcccchHHHHHHHHHHhCC----------CCCHHHHHH
Q 035917 469 LAKLMTSSDESS--FVNGDLGEFGYIAPEYSSTM------VASLKGDVYGIGVVLLELAGF----------KGNLVDWVN 530 (611)
Q Consensus 469 la~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~SfGvvl~ell~~----------~~~~~~~~~ 530 (611)
+++......... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||.....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 998765433211 12344699999999998765 234789999999999999998 555532100
Q ss_pred HHhhcCChhh-hhchhhcCCC-----CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 531 QLSSSGRSKE-AIDKALCGKG-----YDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 531 ~~~~~~~~~~-~~~~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
.........+ .......... ..+....+.+++.+||+.||++|||+.||+++|+++.++.+
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred CcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence 0000000000 0011111111 12344566677779999999999999999999999988764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=341.45 Aligned_cols=261 Identities=17% Similarity=0.224 Sum_probs=195.8
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccch----hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKL----GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~----~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
.++|...+.||+|+||.||+|+.. +++.||||+++.... ..+.+.+|+.++++++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 357888899999999999999964 689999999965432 236789999999999999999999999999999999
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
|||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 113 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 9999999999999754 35899999999999999999999 7899999999999999999999999999998764322
Q ss_pred CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHH
Q 035917 478 ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQ 557 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 557 (611)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..................+.......+.++.+
T Consensus 189 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 267 (309)
T 2h34_A 189 L-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDA 267 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHH
T ss_pred c-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHH
Confidence 1 122334689999999999998999999999999999999999988742111100000000000111112233445555
Q ss_pred HHHHHhhcccCCCCCCC-CHHHHHHHHHHchhhhC
Q 035917 558 FLKVACNCVVSRPKDRW-SMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RP-s~~evl~~L~~i~~~~~ 591 (611)
++. +||+.||++|| +++++++.|+.+.....
T Consensus 268 li~---~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 268 VIA---RGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp HHH---HHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred HHH---HhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 555 99999999999 99999999998776643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=336.06 Aligned_cols=247 Identities=19% Similarity=0.266 Sum_probs=180.1
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch----hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL----GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||.||+|+. .+|+.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5688889999999999999996 5799999999965322 2367899999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++++|.+++......+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 999999999999876567999999999999999999999 78999999999999999999999999999987643221
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-hcCCCCHHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-LCGKGYDEEILQ 557 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~~~ 557 (611)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ........... ......+.++.+
T Consensus 168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 241 (278)
T 3cok_A 168 --KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV----KNTLNKVVLADYEMPSFLSIEAKD 241 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC----C-----CCSSCCCCCTTSCHHHHH
T ss_pred --cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH----HHHHHHHhhcccCCccccCHHHHH
Confidence 11234589999999999988899999999999999999999888632100 00000010000 011223455555
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++. +||+.||++|||+.++++|
T Consensus 242 li~---~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 242 LIH---QLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp HHH---HHSCSSGGGSCCHHHHTTS
T ss_pred HHH---HHcccCHhhCCCHHHHhcC
Confidence 555 9999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=339.28 Aligned_cols=263 Identities=20% Similarity=0.296 Sum_probs=197.2
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEecccc----chhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTC----KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~----~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
.++|...+.||+|+||.||+|.. .+|+.||||+++.. ....+++.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35788889999999999999995 57999999998642 22346789999999999999999999999999999999
Q ss_pred EeccCCCChHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccC
Q 035917 398 YKYMSSGTLYSLLQG---NATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~ 474 (611)
|||+++|+|.+++.. ....+++..++.++.+++.||.||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999998863 2346899999999999999999999 7899999999999999999999999999998664
Q ss_pred CCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhh-cCChhhhhchhhcCCCCHH
Q 035917 475 SSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSS-SGRSKEAIDKALCGKGYDE 553 (611)
Q Consensus 475 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~ 553 (611)
.... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......... .........+.......++
T Consensus 188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (310)
T 2wqm_A 188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 265 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence 3221 122346899999999999889999999999999999999999887431100000 0000000001111223445
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCCC
Q 035917 554 EILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFS 593 (611)
Q Consensus 554 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 593 (611)
++.+++. +||+.||++|||+.+|+++|+++......+
T Consensus 266 ~l~~li~---~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 266 ELRQLVN---MCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp HHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred HHHHHHH---HHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 5555555 999999999999999999999998886533
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=345.89 Aligned_cols=261 Identities=22% Similarity=0.315 Sum_probs=204.8
Q ss_pred hcCCCCCeeeecCCceEEEEEe-----CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCC--eeE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-----PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE--EKL 395 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-----~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~--~~~ 395 (611)
++|...+.||+|+||.||+|++ .+++.||||++.... ...+.+.+|++++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4577788999999999999984 468999999997643 34467999999999999999999999987654 679
Q ss_pred EEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
+||||+++|+|.+++......+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 999999999999999876567999999999999999999999 78999999999999999999999999999987654
Q ss_pred CCCCc-cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHH---HhhcCC--------hhhhhc
Q 035917 476 SDESS-FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQ---LSSSGR--------SKEAID 543 (611)
Q Consensus 476 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~---~~~~~~--------~~~~~~ 543 (611)
..... ......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ...... ..+.+.
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence 33211 122335788899999998888999999999999999999998765322111 111100 011111
Q ss_pred hhh---cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 544 KAL---CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 544 ~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
... .....++++.+ ++.+||+.||++|||+.|+++.|+++.++.
T Consensus 278 ~~~~~~~~~~~~~~l~~---li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 278 NNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp TTCCCCCCTTCCHHHHH---HHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCcccHHHHH---HHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 111 11223344555 555999999999999999999999998763
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=336.16 Aligned_cols=250 Identities=20% Similarity=0.243 Sum_probs=198.7
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
.++|...+.||+|+||.||+|+.. +++.||||+++... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 457888899999999999999965 78999999986433 335779999999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
|+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++........
T Consensus 86 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 99999999998754 45899999999999999999999 789999999999999999999999999999876433222
Q ss_pred ccccCCCcccccccccccCCCCC-CcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh---cCCCCHHHH
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMVA-SLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL---CGKGYDEEI 555 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l---~~~~~~~~~ 555 (611)
.......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....... ........... .....++++
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 238 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYSDWKEKKTYLNPWKKIDSAP 238 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS---HHHHHHHTTCTTSTTGGGSCHHH
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH---HHHHHhhhcccccCchhhcCHHH
Confidence 22334569999999999987665 788999999999999999988863210000 00000000000 001233445
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.++++ +||+.||++|||+.|++++
T Consensus 239 ~~li~---~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 239 LALLH---KILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHHH---HHSCSSTTTSCCHHHHTTC
T ss_pred HHHHH---HHCCCCchhCCCHHHHhcC
Confidence 55554 9999999999999999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=338.68 Aligned_cols=249 Identities=19% Similarity=0.228 Sum_probs=191.5
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
+.|...+.||+|+||.||+|+. .+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 4677889999999999999996 468999999986543 3457899999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEe---CCCCCeEEeecccccccC
Q 035917 401 MSSGTLYSLLQGN---ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV---DEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 401 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl---d~~~~~kl~DFGla~~~~ 474 (611)
+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988532 246999999999999999999999 7899999999999999 456789999999998764
Q ss_pred CCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHH
Q 035917 475 SSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEE 554 (611)
Q Consensus 475 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 554 (611)
.... .....||+.|+|||.+. ..++.++|||||||++|||++|+.||..........................+++
T Consensus 179 ~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (285)
T 3is5_A 179 SDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQ 254 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHH
T ss_pred Cccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHH
Confidence 3321 22346899999999886 4689999999999999999999988732110000000000000000111123445
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 555 ILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 555 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+.+++. +||+.||++|||+.|++++
T Consensus 255 ~~~li~---~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 255 AVDLLK---QMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHHHH---HHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHH---HHccCChhhCcCHHHHhcC
Confidence 555554 9999999999999999875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=346.52 Aligned_cols=241 Identities=19% Similarity=0.260 Sum_probs=200.0
Q ss_pred hhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch---------hHHHHHHHHHHHhccCCCCccceeeEEEeC
Q 035917 322 ASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL---------GEKKFRNEMNRLGQLRHPNLAPLLGYCVVE 391 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~---------~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~ 391 (611)
..++|...+.||+|+||.||+|+. .+++.||||+++.... ..+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 456788899999999999999995 5789999999965431 223578899999999999999999999999
Q ss_pred CeeEEEEeccCCC-ChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccc
Q 035917 392 EEKLLIYKYMSSG-TLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLA 470 (611)
Q Consensus 392 ~~~~lv~ey~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla 470 (611)
+..++||||+.+| +|.+++... ..+++..+..++.|++.||.||| ..+|+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 9999999999877 999999755 35999999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCCccccCCCcccccccccccCCCCC-CcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cC
Q 035917 471 KLMTSSDESSFVNGDLGEFGYIAPEYSSTMVA-SLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CG 548 (611)
Q Consensus 471 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~ 548 (611)
+........ ....||+.|+|||++.+..+ +.++|||||||++|||++|+.||... .+...... ..
T Consensus 178 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~----------~~~~~~~~~~~ 244 (335)
T 3dls_A 178 AYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL----------EETVEAAIHPP 244 (335)
T ss_dssp EECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG----------GGGTTTCCCCS
T ss_pred eECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH----------HHHHhhccCCC
Confidence 876543321 22359999999999988776 78999999999999999999987431 11111111 12
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 549 KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 549 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
...++++.+++. +||+.||++|||+.|++++
T Consensus 245 ~~~~~~l~~li~---~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 245 YLVSKELMSLVS---GLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp SCCCHHHHHHHH---HHTCSSGGGSCCHHHHHHC
T ss_pred cccCHHHHHHHH---HHccCChhhCcCHHHHhcC
Confidence 234555666555 9999999999999999987
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=343.95 Aligned_cols=250 Identities=19% Similarity=0.267 Sum_probs=182.7
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
.++|...+.||+|+||.||+|+. .+|+.||||+++... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 46788889999999999999995 468999999986432 234678899999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccC
Q 035917 400 YMSSGTLYSLLQGNA-----TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 400 y~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~ 474 (611)
|++ |+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999885321 35899999999999999999999 7899999999999999999999999999998764
Q ss_pred CCCCCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhh-cCC----------
Q 035917 475 SSDESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSS-SGR---------- 537 (611)
Q Consensus 475 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~-~~~---------- 537 (611)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. ....... .+.
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 3221 1233468999999999876 4689999999999999999999987631 1111100 000
Q ss_pred ----------------hhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 538 ----------------SKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 538 ----------------~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
..+.+.+. .....+.++.+++ .+||+.||++|||+.|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li---~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPH-TKEPLDGNLMDFL---HGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGG-CSSCCCHHHHHHH---HHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccchhHHHhhccc-ccccCCHHHHHHH---HHHCCCCcccCCCHHHHhCC
Confidence 00000000 0112334444544 49999999999999999876
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=341.93 Aligned_cols=259 Identities=19% Similarity=0.264 Sum_probs=200.5
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEe----CCeeEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVV----EEEKLL 396 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~----~~~~~l 396 (611)
.++|...+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|++++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 35788889999999999999996 679999999986433 345679999999999999999999999973 346789
Q ss_pred EEeccCCCChHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccccc
Q 035917 397 IYKYMSSGTLYSLLQG---NATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLM 473 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~ 473 (611)
||||+++|+|.+++.. ....+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999998865 2356999999999999999999999 789999999999999999999999999998765
Q ss_pred CCCCCCc-------cccCCCcccccccccccCCCC---CCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc
Q 035917 474 TSSDESS-------FVNGDLGEFGYIAPEYSSTMV---ASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID 543 (611)
Q Consensus 474 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~ 543 (611)
....... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||...... .......+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~ 261 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK---GDSVALAVQ 261 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT---TSCHHHHHH
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc---cchhhHHhh
Confidence 3211000 011224799999999987544 689999999999999999999998543211 111111111
Q ss_pred hhhc---CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 544 KALC---GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 544 ~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
.... ....+.++.+++. +||+.||++|||+.|++++|+.+....
T Consensus 262 ~~~~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 262 NQLSIPQSPRHSSALWQLLN---SMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp CC--CCCCTTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred ccCCCCccccCCHHHHHHHH---HHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 1111 1223445555554 999999999999999999999886543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=343.26 Aligned_cols=250 Identities=17% Similarity=0.196 Sum_probs=197.7
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~lv 397 (611)
++|...+.||+|+||.||+|+.. +++.||||+++... ...+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46778899999999999999964 68999999996532 2235688999999988 899999999999999999999
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
|||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 9999999999998754 35899999999999999999999 7899999999999999999999999999998643222
Q ss_pred CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHh-hcCCh----hhhhchhh-cCCCC
Q 035917 478 ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLS-SSGRS----KEAIDKAL-CGKGY 551 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~-~~~~~----~~~~~~~l-~~~~~ 551 (611)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... ..+..... .+...
T Consensus 165 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~ 242 (345)
T 3a8x_A 165 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 242 (345)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTS
T ss_pred --CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCC
Confidence 122345799999999999998999999999999999999999998732000000 00000 00111111 12234
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCH------HHHHHH
Q 035917 552 DEEILQFLKVACNCVVSRPKDRWSM------YQVYQS 582 (611)
Q Consensus 552 ~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~~ 582 (611)
+.++.++++ +||+.||++||++ .|+++|
T Consensus 243 s~~~~~li~---~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 243 SVKAASVLK---SFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp CHHHHHHHH---HHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CHHHHHHHH---HHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 455566555 9999999999995 778776
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=351.59 Aligned_cols=259 Identities=15% Similarity=0.130 Sum_probs=196.1
Q ss_pred hcCCCCCeeeecCCceEEEEEeC----CCCEEEEEeccccch------------hHHHHHHHHHHHhccCCCCccceeeE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP----DGSVLAVKRLNTCKL------------GEKKFRNEMNRLGQLRHPNLAPLLGY 387 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~----~g~~vAvK~~~~~~~------------~~~~~~~Ev~~l~~l~H~nIv~l~g~ 387 (611)
++|...+.||+|+||.||+|+.. ++..||||++..... ..+.+.+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56888899999999999999975 578999999865321 11347789999999999999999999
Q ss_pred EEe----CCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC--C
Q 035917 388 CVV----EEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF--D 461 (611)
Q Consensus 388 ~~~----~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~--~ 461 (611)
+.. ....++||||+ +++|.+++.... .+++..++.++.|++.||+||| +.+|+||||||+|||++.++ .
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCc
Confidence 988 67889999999 999999997553 6999999999999999999999 78999999999999998877 9
Q ss_pred eEEeecccccccCCCCC-----CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHH----HH
Q 035917 462 ARIMDFGLAKLMTSSDE-----SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVN----QL 532 (611)
Q Consensus 462 ~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~----~~ 532 (611)
+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 99999999987643221 1112344699999999999988899999999999999999999999842100 00
Q ss_pred hhcCC----hhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 533 SSSGR----SKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 533 ~~~~~----~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
..... ....+.........++++.+++. +||+.||++||++.+|++.|+++....
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~~l~~~L~~~~~~~ 330 (345)
T 2v62_A 272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLV---CAHSLAYDEKPNYQALKKILNPHGIPL 330 (345)
T ss_dssp HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHH---HHHTCCTTCCCCHHHHHHHHCTTCCCC
T ss_pred HHHHhhcccccHHHHhhccccccHHHHHHHHH---HHhhcCcccCCCHHHHHHHHhccCCcc
Confidence 00000 00111111111134445555555 999999999999999999999866543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=335.87 Aligned_cols=263 Identities=17% Similarity=0.211 Sum_probs=206.4
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEE-EeCCeeEEEEec
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYC-VVEEEKLLIYKY 400 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~-~~~~~~~lv~ey 400 (611)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ..+++.+|+.++.+++|++++..++++ ...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 46788889999999999999995 679999999986533 234689999999999998877777666 456778999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEe---CCCCCeEEeecccccccCCCC
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV---DEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl---d~~~~~kl~DFGla~~~~~~~ 477 (611)
+ +++|.+++......+++..+..++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||+++......
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred c-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 9 89999999755567999999999999999999999 7899999999999999 488899999999998765433
Q ss_pred CC-----ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh------
Q 035917 478 ES-----SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL------ 546 (611)
Q Consensus 478 ~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l------ 546 (611)
.. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ...............
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA-ATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC-SSSSSHHHHHHHHHHHSCHHH
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCc-hhhhhhhhhhcccccCCchHH
Confidence 21 112345699999999999998999999999999999999999988742100 000000011111111
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCCCC
Q 035917 547 CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFSE 594 (611)
Q Consensus 547 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 594 (611)
.....++++.++++ +||+.||++|||+.+|++.|+++.++.+...
T Consensus 242 ~~~~~~~~l~~li~---~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~ 286 (296)
T 3uzp_A 242 LCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp HTTTSCHHHHHHHH---HHHTSCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred HHhhCCHHHHHHHH---HHHhcCcCcCCCHHHHHHHHHHHHHhcCCcc
Confidence 11233445555554 9999999999999999999999999887653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=347.42 Aligned_cols=243 Identities=16% Similarity=0.181 Sum_probs=199.7
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||.||+|+.. +|+.||||+++... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888899999999999999964 69999999996532 23467899999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence 999999999999754 35899999999999999999999 789999999999999999999999999999876432
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEILQ 557 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~ 557 (611)
....+||+.|+|||++.+..++.++|||||||++|||++|..||........ ...+..... .+...+.++.+
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~i~~~~~~~p~~~~~~~~~ 267 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI----YEKIVSGKVRFPSHFSSDLKD 267 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCTTCCHHHHH
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH----HHHHHcCCCCCCCCCCHHHHH
Confidence 1234699999999999998999999999999999999999988732100000 000111000 12234556666
Q ss_pred HHHHHhhcccCCCCCCCC-----HHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWS-----MYQVYQS 582 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs-----~~evl~~ 582 (611)
++. +||+.||++||+ ++||++|
T Consensus 268 li~---~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 268 LLR---NLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHH---HHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHH---HHhhcCHHhccCCccCCHHHHHhC
Confidence 655 999999999998 8999876
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=350.93 Aligned_cols=260 Identities=14% Similarity=0.183 Sum_probs=203.5
Q ss_pred hcCCCCCeeeecCCceEEEEEeC---------CCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccc-----------
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP---------DGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAP----------- 383 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~---------~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~----------- 383 (611)
++|...+.||+|+||.||+|+.. +++.||||++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 57888899999999999999965 3889999998653 46889999999999999988
Q ss_pred ----eeeEEEe-CCeeEEEEeccCCCChHHhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC
Q 035917 384 ----LLGYCVV-EEEKLLIYKYMSSGTLYSLLQGN-ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD 457 (611)
Q Consensus 384 ----l~g~~~~-~~~~~lv~ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld 457 (611)
+++++.. ++..++||||+ +|+|.+++... ...+++..++.++.|++.||.||| +.+|+||||||+|||++
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVD 193 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEEE
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEEc
Confidence 6777776 67889999999 99999999865 246999999999999999999999 78999999999999999
Q ss_pred CCC--CeEEeecccccccCCCCCC-----ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHH-
Q 035917 458 EDF--DARIMDFGLAKLMTSSDES-----SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWV- 529 (611)
Q Consensus 458 ~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~- 529 (611)
.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 988 9999999999876432211 11133469999999999999899999999999999999999998875321
Q ss_pred --HHHhhc-----CChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCCCC
Q 035917 530 --NQLSSS-----GRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFSE 594 (611)
Q Consensus 530 --~~~~~~-----~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 594 (611)
...... .......+........++++.+++. +||+.||++||++.+|++.|+++.+..+...
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 342 (352)
T 2jii_A 274 NTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLK---VVMALTYEEKPPYAMLRNNLEALLQDLRVSP 342 (352)
T ss_dssp CHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHH---HHHTCCTTCCCCHHHHHHHHHHHHHHTTCCT
T ss_pred CHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHH---HHHhCChhhCCCHHHHHHHHHHHHHhcCCCc
Confidence 000000 0000000000000123455556555 9999999999999999999999999987553
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.90 Aligned_cols=248 Identities=20% Similarity=0.221 Sum_probs=199.4
Q ss_pred hhhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeE
Q 035917 322 ASNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKL 395 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~ 395 (611)
..++|...+.||+|+||.||+|+.. +|+.||||+++... ...+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4567888899999999999999964 68999999996532 2345688899999887 8999999999999999999
Q ss_pred EEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
+||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 95 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 999999999999999754 35899999999999999999999 78999999999999999999999999999986432
Q ss_pred CCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc-hhhcCCCCHHH
Q 035917 476 SDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID-KALCGKGYDEE 554 (611)
Q Consensus 476 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~~~~~~~ 554 (611)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|..||........ ...+.. ....+...+++
T Consensus 171 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~ 244 (345)
T 1xjd_A 171 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL----FHSIRMDNPFYPRWLEKE 244 (345)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCTTSCHH
T ss_pred CC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH----HHHHHhCCCCCCcccCHH
Confidence 22 122345799999999999998999999999999999999999988742100000 000000 00112234556
Q ss_pred HHHHHHHHhhcccCCCCCCCCHH-HHHHH
Q 035917 555 ILQFLKVACNCVVSRPKDRWSMY-QVYQS 582 (611)
Q Consensus 555 ~~~l~~l~~~Cl~~dP~~RPs~~-evl~~ 582 (611)
+.+++. +||+.||++||++. ||++|
T Consensus 245 ~~~li~---~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 245 AKDLLV---KLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp HHHHHH---HHSCSSGGGSBTTBSCGGGS
T ss_pred HHHHHH---HHhcCCHhHcCCChHHHHcC
Confidence 666665 99999999999997 77654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=341.78 Aligned_cols=242 Identities=17% Similarity=0.241 Sum_probs=176.1
Q ss_pred CCeeeecCCceEEEEEeC-CCCEEEEEeccccchhHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeEEEEeccCCCCh
Q 035917 329 ENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLGEKKFRNEMNRLGQLR-HPNLAPLLGYCVVEEEKLLIYKYMSSGTL 406 (611)
Q Consensus 329 ~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~~~~~lv~ey~~~gsL 406 (611)
++.||+|+||.||+|+.. +++.||||++... ....+.+|+.++.+++ ||||+++++++.+++..++||||+++|+|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 478999999999999964 6899999999643 3467889999999997 99999999999999999999999999999
Q ss_pred HHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC---CeEEeecccccccCCCCCCcccc
Q 035917 407 YSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF---DARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 407 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~---~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||+++...... ....
T Consensus 94 ~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~ 167 (325)
T 3kn6_A 94 FERIKKK-KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLK 167 (325)
T ss_dssp HHHHHHC-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--Cccc
Confidence 9999765 46999999999999999999999 78999999999999997655 89999999998654322 1223
Q ss_pred CCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcC---------CCCHHH
Q 035917 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCG---------KGYDEE 554 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~---------~~~~~~ 554 (611)
...||+.|+|||++.+..++.++|||||||++|||++|..||........ .....+.+...... ...+++
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 246 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-CTSAVEIMKKIKKGDFSFEGEAWKNVSQE 246 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHHHTTTCCCCCSHHHHTSCHH
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-cccHHHHHHHHHcCCCCCCcccccCCCHH
Confidence 44689999999999999999999999999999999999998854221110 01111111111111 012344
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 555 ILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 555 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+.+ ++.+||+.||++|||+.|+++|
T Consensus 247 ~~~---li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 247 AKD---LIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHH---HHHHHHCCCTTTCCCTTTSTTC
T ss_pred HHH---HHHHHCCCChhHCCCHHHHhcC
Confidence 444 5559999999999999999865
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=337.08 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=194.0
Q ss_pred hhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeC-CeeEEEEecc
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE-EEKLLIYKYM 401 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~-~~~~lv~ey~ 401 (611)
.++|...+.||+|+||.||+|.. +|+.||||+++... ..+.+.+|++++++++||||+++++++... +..++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 35677889999999999999987 48899999997543 456799999999999999999999997654 4689999999
Q ss_pred CCCChHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 402 SSGTLYSLLQGNAT-ELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 402 ~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
++|+|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--- 171 (278)
T 1byg_A 98 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 171 (278)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccccc---
Confidence 99999999975432 4889999999999999999999 7899999999999999999999999999998653321
Q ss_pred cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchh---hcCCCCHHHHH
Q 035917 481 FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKA---LCGKGYDEEIL 556 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~---l~~~~~~~~~~ 556 (611)
....+++.|+|||.+.+..++.++||||||+++|||++ |..||...... .....+... ......++++.
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~ 244 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPRVEKGYKMDAPDGCPPAVY 244 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----GHHHHHTTTCCCCCCTTCCHHHH
T ss_pred --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHhcCCCCCCcccCCHHHH
Confidence 12247889999999988889999999999999999998 88776321000 000111110 01122344555
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
++++ +||+.||++||++.|+++.|+++...
T Consensus 245 ~li~---~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 245 EVMK---NCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HHHH---HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHH---HHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 5555 99999999999999999999998765
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=335.24 Aligned_cols=247 Identities=23% Similarity=0.268 Sum_probs=196.8
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
.++|...+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 457888899999999999999864 57899999986432 2246789999999999999999999999999999999
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
|||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 9999999999998754 35899999999999999999999 8899999999999999999999999999986543322
Q ss_pred CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHH
Q 035917 478 ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQ 557 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 557 (611)
.....||+.|+|||.+.+..++.++||||||+++|||++|..||.......... .. ...... .....++++.+
T Consensus 164 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~-~~~~~~-~~~~~~~~~~~ 236 (279)
T 3fdn_A 164 ----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK-RI-SRVEFT-FPDFVTEGARD 236 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-HH-HHTCCC-CCTTSCHHHHH
T ss_pred ----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHH-HH-HhCCCC-CCCcCCHHHHH
Confidence 123468999999999999899999999999999999999998863211000000 00 000001 12234455555
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWSMYQVYQSL 583 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~~evl~~L 583 (611)
++. +||+.||++|||+.|+++|-
T Consensus 237 li~---~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 237 LIS---RLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp HHH---HHCCSSGGGSCCHHHHHHCH
T ss_pred HHH---HHhccChhhCCCHHHHhhCc
Confidence 555 99999999999999999883
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=334.77 Aligned_cols=247 Identities=20% Similarity=0.221 Sum_probs=198.0
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccch---hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKL---GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
.++|...+.||+|+||.||+|... +|+.||+|++..... ..+.+.+|+.++++++||||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467888899999999999999964 689999999965432 3367889999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCC---eEEeecccccccCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFD---ARIMDFGLAKLMTS 475 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~---~kl~DFGla~~~~~ 475 (611)
||+++|+|.+.+... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++. +||+|||++.....
T Consensus 85 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999999888654 35899999999999999999999 789999999999999976655 99999999987643
Q ss_pred CCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHH----HHHhhcCChhhhhchhhcCCCC
Q 035917 476 SDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWV----NQLSSSGRSKEAIDKALCGKGY 551 (611)
Q Consensus 476 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~~~~ 551 (611)
... .....||+.|+|||.+.+..++.++||||||+++|||++|..||.... .......... .+.......
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 234 (284)
T 3kk8_A 161 SEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD---YPSPEWDTV 234 (284)
T ss_dssp SCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---CCTTTTTTS
T ss_pred Ccc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcccc---CCchhhccc
Confidence 322 233469999999999999999999999999999999999998863210 0000000000 000011223
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 552 DEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 552 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++++.+++. +||+.||++|||+.|+++|
T Consensus 235 ~~~~~~li~---~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 235 TPEAKSLID---SMLTVNPKKRITADQALKV 262 (284)
T ss_dssp CHHHHHHHH---HHSCSSTTTSCCHHHHTTS
T ss_pred CHHHHHHHH---HHcccChhhCCCHHHHhcC
Confidence 455555555 9999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=333.37 Aligned_cols=243 Identities=19% Similarity=0.260 Sum_probs=194.9
Q ss_pred hhhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEecccc---chhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEE
Q 035917 322 ASNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTC---KLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~l 396 (611)
..++|...+.||+|+||.||+|+.. +++.||||+++.. .....++.+|+..+.++ +||||+++++++.+++..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3467888899999999999999975 7999999998653 23456789999999999 89999999999999999999
Q ss_pred EEeccCCCChHHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC---------------
Q 035917 397 IYKYMSSGTLYSLLQGNA---TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE--------------- 458 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~--------------- 458 (611)
||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999997532 45899999999999999999999 789999999999999984
Q ss_pred ----CCCeEEeecccccccCCCCCCccccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHHHH-HHHH
Q 035917 459 ----DFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLVDW-VNQL 532 (611)
Q Consensus 459 ----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~~~-~~~~ 532 (611)
...+||+|||+++...... ...||+.|+|||.+.+. .++.++|||||||++|||+++..++... ....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~ 239 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE 239 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHH
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHH
Confidence 4479999999998764322 22489999999998765 5678999999999999999887653211 0011
Q ss_pred hhcCChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 533 SSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 533 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
..... .+.+ ....++++.+++. +||+.||++|||+.|+++|
T Consensus 240 ~~~~~-----~~~~-~~~~~~~~~~li~---~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 240 IRQGR-----LPRI-PQVLSQEFTELLK---VMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHTTC-----CCCC-SSCCCHHHHHHHH---HHTCSSGGGSCCHHHHHTC
T ss_pred HHcCC-----CCCC-CcccCHHHHHHHH---HHhCCCcccCCCHHHHhhC
Confidence 11111 0111 1234455555555 9999999999999999876
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=342.58 Aligned_cols=254 Identities=19% Similarity=0.183 Sum_probs=195.3
Q ss_pred HHHhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc------hhHHHHHHHHHHHhccCCCCccceeeEEEeC
Q 035917 319 LMAASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK------LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE 391 (611)
Q Consensus 319 l~~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~------~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~ 391 (611)
+....++|...+.||+|+||.||+|+. .+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 445677899999999999999999996 568899999986432 2346799999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHhhhcC---------------------------------------CCCCCHHHHHHHHHHHHHH
Q 035917 392 EEKLLIYKYMSSGTLYSLLQGN---------------------------------------ATELDWPTRFRIGLGAARG 432 (611)
Q Consensus 392 ~~~~lv~ey~~~gsL~~~l~~~---------------------------------------~~~l~~~~~~~i~~~ia~g 432 (611)
+..++||||+++|+|.+++... ...+++..+..++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999988520 0123567788899999999
Q ss_pred HHHHhhcCCCCeeecCCCCCeEEeCCCC--CeEEeecccccccCCCC--CCccccCCCcccccccccccCC--CCCCccc
Q 035917 433 LAWLHHGCQPPFLHQNICSNVILVDEDF--DARIMDFGLAKLMTSSD--ESSFVNGDLGEFGYIAPEYSST--MVASLKG 506 (611)
Q Consensus 433 L~yLH~~~~~~ivHrDlkp~NILld~~~--~~kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~t~ks 506 (611)
|+||| +.+|+||||||+||+++.++ .+||+|||+++.+.... .........||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999 78999999999999998766 89999999998654322 1112234569999999998865 6789999
Q ss_pred chHHHHHHHHHHhCCCCCHHH-----HHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 035917 507 DVYGIGVVLLELAGFKGNLVD-----WVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQ 581 (611)
Q Consensus 507 DV~SfGvvl~ell~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 581 (611)
|||||||++|||++|+.||.. ............ ..+ .....++++.++++ +||+.||++||++.|+++
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~--~~~~~~~~~~~li~---~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCF--ENP--NYNVLSPLARDLLS---NLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCT--TSG--GGGGSCHHHHHHHH---HHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhccccc--CCc--ccccCCHHHHHHHH---HHcCCChhHCCCHHHHhc
Confidence 999999999999999988732 111111111000 000 00113445555555 999999999999999998
Q ss_pred H
Q 035917 582 S 582 (611)
Q Consensus 582 ~ 582 (611)
|
T Consensus 331 h 331 (345)
T 3hko_A 331 H 331 (345)
T ss_dssp S
T ss_pred C
Confidence 6
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=343.53 Aligned_cols=257 Identities=25% Similarity=0.356 Sum_probs=200.2
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCE--EEEEecccc--chhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSV--LAVKRLNTC--KLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~--vAvK~~~~~--~~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~lv 397 (611)
++|...+.||+|+||.||+|+.. ++.. ||||.++.. ....+.+.+|++++.++ +||||+++++++...+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 47888899999999999999954 5654 499998643 22345789999999999 899999999999999999999
Q ss_pred EeccCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCe
Q 035917 398 YKYMSSGTLYSLLQGNA---------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDA 462 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~ 462 (611)
|||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence 99999999999997543 36899999999999999999999 7899999999999999999999
Q ss_pred EEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhh
Q 035917 463 RIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEA 541 (611)
Q Consensus 463 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~ 541 (611)
||+|||+++...... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.......... .....
T Consensus 182 kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~-~~~~~ 257 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE-KLPQG 257 (327)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-HGGGT
T ss_pred EEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHH-HhhcC
Confidence 999999997532211 1122347889999999988889999999999999999998 888873211100000 00000
Q ss_pred hchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 542 IDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 542 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
... ......++++.+++. +||+.||++|||+.|++++|+++.++..
T Consensus 258 ~~~-~~~~~~~~~l~~li~---~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 258 YRL-EKPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp CCC-CCCTTBCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CCC-CCCCCCCHHHHHHHH---HHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 000 011223445555554 9999999999999999999999988754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=338.97 Aligned_cols=251 Identities=21% Similarity=0.259 Sum_probs=191.9
Q ss_pred hhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc------hhHHHHHHHHHHHhccC---CCCccceeeEEEeC
Q 035917 322 ASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK------LGEKKFRNEMNRLGQLR---HPNLAPLLGYCVVE 391 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~------~~~~~~~~Ev~~l~~l~---H~nIv~l~g~~~~~ 391 (611)
.+++|...+.||+|+||.||+|+. .+++.||||+++... .....+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 356889999999999999999995 579999999986322 11346778888777764 99999999999876
Q ss_pred C-----eeEEEEeccCCCChHHhhhcCCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEe
Q 035917 392 E-----EKLLIYKYMSSGTLYSLLQGNAT-ELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIM 465 (611)
Q Consensus 392 ~-----~~~lv~ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~ 465 (611)
. ..++||||+. |+|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence 5 4789999997 599999986543 5999999999999999999999 7889999999999999999999999
Q ss_pred ecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhhc-CC-h
Q 035917 466 DFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSSS-GR-S 538 (611)
Q Consensus 466 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~~-~~-~ 538 (611)
|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.. ........ +. .
T Consensus 163 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (308)
T 3g33_A 163 DFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239 (308)
T ss_dssp SCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999987643322 2234689999999999888999999999999999999999988631 11111100 00 0
Q ss_pred hh-----------hhchh------hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 539 KE-----------AIDKA------LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 539 ~~-----------~~~~~------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.. .+.+. ......++++.+ ++.+||+.||++|||+.|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQ---LLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHH---HHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHH---HHHHHhcCCCccCCCHHHHhcC
Confidence 00 00000 000123344444 4459999999999999999875
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=343.99 Aligned_cols=246 Identities=18% Similarity=0.212 Sum_probs=190.2
Q ss_pred hcCCCCCeeeecCCceEEEEEe----CCCCEEEEEeccccc-----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCee
Q 035917 324 NSFCSENVIISTRTGTTYKAML----PDGSVLAVKRLNTCK-----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~----~~g~~vAvK~~~~~~-----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~ 394 (611)
++|...+.||+|+||.||+|+. .+|+.||+|+++... .....+.+|+.++++++||||+++++++..++..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 5688889999999999999996 479999999997542 2235688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccC
Q 035917 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~ 474 (611)
++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 97 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 97 YLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 9999999999999999754 35889999999999999999999 7899999999999999999999999999998643
Q ss_pred CCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHH
Q 035917 475 SSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDE 553 (611)
Q Consensus 475 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~ 553 (611)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+..... .....+.
T Consensus 173 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~i~~~~~~~p~~~~~ 246 (327)
T 3a62_A 173 HDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT----IDKILKCKLNLPPYLTQ 246 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHTCCCCCTTSCH
T ss_pred cCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH----HHHHHhCCCCCCCCCCH
Confidence 222 122334699999999999988999999999999999999999988732100000 000111000 1123445
Q ss_pred HHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 035917 554 EILQFLKVACNCVVSRPKDRW-----SMYQVYQS 582 (611)
Q Consensus 554 ~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 582 (611)
++.+++. +||+.||++|| ++.|+++|
T Consensus 247 ~~~~li~---~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 247 EARDLLK---KLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHHHHHH---HHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHHHHHH---HHHhcCHhhccCCCCCCHHHHHcC
Confidence 5666555 99999999999 78899886
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=337.51 Aligned_cols=254 Identities=21% Similarity=0.271 Sum_probs=198.9
Q ss_pred hcCCCCC-eeeecCCceEEEEEe---CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEE
Q 035917 324 NSFCSEN-VIISTRTGTTYKAML---PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 324 ~~f~~~~-~ig~G~~g~Vy~~~~---~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
+.|...+ .||+|+||.||+|.. .+++.||||+++... ...+++.+|++++++++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4556666 899999999999964 347899999997542 2246799999999999999999999999 5677899
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 95 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp EEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 99999999999999764 45899999999999999999999 789999999999999999999999999999876543
Q ss_pred CCC-ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhch---hhcCCCC
Q 035917 477 DES-SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDK---ALCGKGY 551 (611)
Q Consensus 477 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~---~l~~~~~ 551 (611)
... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ..+.+.. .......
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~ 245 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----VTAMLEKGERMGCPAGC 245 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHHHTTCCCCCCTTC
T ss_pred CCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHHcCCCCCCCCCC
Confidence 321 11122346789999999988889999999999999999998 888874311100 0001100 0111233
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 552 DEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 552 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
++++.+++. +||+.||++||++.++++.|+++....
T Consensus 246 ~~~l~~li~---~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 246 PREMYDLMN---LCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp CHHHHHHHH---HHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 445555555 999999999999999999999987653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=346.20 Aligned_cols=255 Identities=18% Similarity=0.263 Sum_probs=191.8
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCe----e
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEE----K 394 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~----~ 394 (611)
+.|...+.||+|+||.||+|+. .+++.||||+++... ...+.+.+|+.++.+++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 5677889999999999999995 678999999996542 223578999999999999999999999876543 4
Q ss_pred EEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccC
Q 035917 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~ 474 (611)
++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 92 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 9999999999999999754 35899999999999999999999 7899999999999999999999999999998764
Q ss_pred CCCCC-ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCChhhhhchhhcC
Q 035917 475 SSDES-SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGRSKEAIDKALCG 548 (611)
Q Consensus 475 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~ 548 (611)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... ........ ...+....
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~----~~~~~~~~ 243 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED----PIPPSARH 243 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC----CCCHHHHS
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC----CCCccccc
Confidence 43211 1223346899999999999889999999999999999999999886321 11111111 01111112
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH-HHHHchhh
Q 035917 549 KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQ-SLNSIAAQ 589 (611)
Q Consensus 549 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~-~L~~i~~~ 589 (611)
...++++.+++. +||+.||++||++.++++ .+..+...
T Consensus 244 ~~~~~~l~~li~---~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 244 EGLSADLDAVVL---KALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp TTCCHHHHHHHH---HHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred CCCCHHHHHHHH---HHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 233445555555 999999999997666554 46555443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=340.48 Aligned_cols=246 Identities=18% Similarity=0.262 Sum_probs=199.4
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccch-------hHHHHHHHHHHHhccCCCCccceeeEEEeCCee
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKL-------GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~-------~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~ 394 (611)
.+.|...+.||+|+||.||+|+.. +|+.||||+++.... ..+++.+|+.++++++||||+++++++.+++..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456888899999999999999964 689999999864321 357799999999999999999999999999999
Q ss_pred EEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC----CeEEeecccc
Q 035917 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF----DARIMDFGLA 470 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~----~~kl~DFGla 470 (611)
++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999999754 46899999999999999999999 78999999999999999887 7999999999
Q ss_pred cccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhhcCChhhhhchh
Q 035917 471 KLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSSSGRSKEAIDKA 545 (611)
Q Consensus 471 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 545 (611)
+....... .....||+.|+|||.+.+..++.++|||||||++|||++|..||.. ........ .. ..++.
T Consensus 167 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~-~~--~~~~~ 240 (321)
T 2a2a_A 167 HEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV-SY--DFDEE 240 (321)
T ss_dssp EECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT-CC--CCCHH
T ss_pred eecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-cc--ccChh
Confidence 87654321 2334699999999999988999999999999999999999988732 11111100 00 00111
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 546 LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 546 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.. ...++++.+++. +||+.||++|||+.|+++|
T Consensus 241 ~~-~~~~~~~~~li~---~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 241 FF-SHTSELAKDFIR---KLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HH-TTCCHHHHHHHH---TTSCSSTTTSCCHHHHHHS
T ss_pred hh-cccCHHHHHHHH---HHcCCChhhCcCHHHHhcC
Confidence 11 123344455554 9999999999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=360.72 Aligned_cols=247 Identities=19% Similarity=0.187 Sum_probs=191.4
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
.++|...+.||+|+||.||+|+. .+|+.||||+++... .....+.+|+.++++++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 45788889999999999999995 569999999996532 2235678999999999999999999999999999999
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQ-PPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
|||+++|+|.+++... ..+++..+..++.|++.||+||| + .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 227 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp ECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 9999999999998754 36899999999999999999999 5 88999999999999999999999999999864322
Q ss_pred CCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-hcCCCCHHHH
Q 035917 477 DESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-LCGKGYDEEI 555 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~ 555 (611)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.... ..+...++++
T Consensus 303 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~i~~~~~~~p~~~~~~~ 376 (446)
T 4ejn_A 303 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----FELILMEEIRFPRTLGPEA 376 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCTTSCHHH
T ss_pred C--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH----HHHHHhCCCCCCccCCHHH
Confidence 2 222345799999999999999999999999999999999999988732100000 00000000 0122344555
Q ss_pred HHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 035917 556 LQFLKVACNCVVSRPKDRW-----SMYQVYQS 582 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 582 (611)
.+++. +||+.||++|| ++.|+++|
T Consensus 377 ~~li~---~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 377 KSLLS---GLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHHHH---HHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHH---HHcccCHHHhCCCCCCCHHHHHhC
Confidence 56555 99999999999 99999986
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=354.89 Aligned_cols=245 Identities=22% Similarity=0.331 Sum_probs=199.4
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccch----hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKL----GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~----~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||.||+|+.. +|+.||||+++.... ..+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46777899999999999999965 799999999965322 2367899999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 96 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~- 170 (476)
T 2y94_A 96 EYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE- 170 (476)
T ss_dssp ECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC-
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc-
Confidence 999999999999754 46999999999999999999999 8899999999999999999999999999998764332
Q ss_pred CccccCCCcccccccccccCCCCC-CcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVA-SLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEIL 556 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~ 556 (611)
.....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+..... ....+.+... .+...+.++.
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~----~~~~i~~~~~~~p~~~s~~~~ 244 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT----LFKKICDGIFYTPQYLNPSVI 244 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH----HHHHHHTTCCCCCTTCCHHHH
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH----HHHHHhcCCcCCCccCCHHHH
Confidence 2234579999999999988765 689999999999999999998874210000 0001111100 1122345555
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+++. +||+.||++|||+.|+++|
T Consensus 245 ~Li~---~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 245 SLLK---HMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp HHHH---HHTCSSTTTSCCHHHHHTC
T ss_pred HHHH---HHcCCCchhCcCHHHHHhC
Confidence 5555 9999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=372.94 Aligned_cols=247 Identities=21% Similarity=0.272 Sum_probs=193.7
Q ss_pred CeeeecCCceEEEEEe---CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 330 NVIISTRTGTTYKAML---PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~---~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
+.||+|+||.||+|.+ ..++.||||+++... ...+++.+|+++|++++|||||+++++|. .+..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 4799999999999975 346789999997543 23578999999999999999999999996 4568899999999
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC-Cccc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE-SSFV 482 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~-~~~~ 482 (611)
|+|.+++... ..+++..+..|+.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.+..... ....
T Consensus 454 g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 9999999754 46899999999999999999999 78999999999999999999999999999987654331 1122
Q ss_pred cCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhh---cCCCCHHHHHHH
Q 035917 483 NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKAL---CGKGYDEEILQF 558 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l---~~~~~~~~~~~l 558 (611)
....||+.|+|||++.+..++.++|||||||++|||++ |+.||....... ..+.+.... .....++++.+
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-----~~~~i~~~~~~~~p~~~~~~l~~- 603 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----VTAMLEKGERMGCPAGCPREMYD- 603 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHHHTTCCCCCCTTCCHHHHH-
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHcCCCCCCCCCCCHHHHH-
Confidence 23357889999999998899999999999999999998 888874311110 011111111 12233444555
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 559 LKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 559 ~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
++.+||+.||++||++.+|++.|+++...
T Consensus 604 --li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 604 --LMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp --HHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 55599999999999999999999987654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=334.21 Aligned_cols=245 Identities=22% Similarity=0.274 Sum_probs=189.6
Q ss_pred CCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEe----CCeeEEE
Q 035917 326 FCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVV----EEEKLLI 397 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~----~~~~~lv 397 (611)
|...+.||+|+||.||+|.. .++..||+|.+.... ...+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 55567899999999999996 468899999986533 234678999999999999999999999875 3457899
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCeEEeC-CCCCeEEeecccccccC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPP--FLHQNICSNVILVD-EDFDARIMDFGLAKLMT 474 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlkp~NILld-~~~~~kl~DFGla~~~~ 474 (611)
|||+++|+|.+++... ..+++..+..++.+++.||.||| +.+ |+||||||+||+++ .++.+||+|||+++...
T Consensus 108 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 9999999999999754 35899999999999999999999 666 99999999999997 78999999999997653
Q ss_pred CCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHH
Q 035917 475 SSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEE 554 (611)
Q Consensus 475 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 554 (611)
... .....||+.|+|||.+.+ .++.++|||||||++|||++|+.||..................+.......+++
T Consensus 184 ~~~----~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (290)
T 1t4h_A 184 ASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258 (290)
T ss_dssp TTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred ccc----cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHH
Confidence 322 123358999999998764 589999999999999999999988742100000000000000111111122344
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 555 ILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 555 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+.+ ++.+||+.||++|||+.|+++|
T Consensus 259 l~~---li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 259 VKE---IIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHH---HHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHH---HHHHHccCChhhCCCHHHHhhC
Confidence 444 5559999999999999999875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=351.53 Aligned_cols=246 Identities=17% Similarity=0.213 Sum_probs=186.2
Q ss_pred hcCCCC-CeeeecCCceEEEEEeC-CCCEEEEEeccccchhHHHHHHHHHHHhc-cCCCCccceeeEEEe----CCeeEE
Q 035917 324 NSFCSE-NVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLGEKKFRNEMNRLGQ-LRHPNLAPLLGYCVV----EEEKLL 396 (611)
Q Consensus 324 ~~f~~~-~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~-l~H~nIv~l~g~~~~----~~~~~l 396 (611)
++|... ++||+|+||.||+|+.. +|+.||||+++.. ..+.+|+.++.+ .+||||+++++++.. .+..++
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 345444 68999999999999964 6899999999643 457788888744 489999999999875 556899
Q ss_pred EEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC---CCCeEEeecccccc
Q 035917 397 IYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE---DFDARIMDFGLAKL 472 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~---~~~~kl~DFGla~~ 472 (611)
|||||++|+|.+++.... ..+++..+..++.||+.||.||| +.+|+||||||+|||++. ++.+||+|||+++.
T Consensus 137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 999999999999998654 36999999999999999999999 789999999999999997 78999999999987
Q ss_pred cCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc------hhh
Q 035917 473 MTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID------KAL 546 (611)
Q Consensus 473 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~------~~l 546 (611)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......+. +..
T Consensus 214 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~i~~~~~~~~~~ 289 (400)
T 1nxk_A 214 TTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPGMKTRIRMGQYEFPNP 289 (400)
T ss_dssp CC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS-CCSHHHHHHHTCCCCCTT
T ss_pred cCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc-cHHHHHHHHcCcccCCCc
Confidence 54322 22345689999999999999999999999999999999999988732100000 000000000 000
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 035917 547 CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSL 583 (611)
Q Consensus 547 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 583 (611)
.....++++.++++ +||+.||++|||+.|+++|-
T Consensus 290 ~~~~~s~~~~~li~---~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 290 EWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp TTTTSCHHHHHHHH---TTSCSSGGGSCCHHHHHHSH
T ss_pred ccccCCHHHHHHHH---HHCCCChhHCcCHHHHhcCc
Confidence 11224455555555 99999999999999999873
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=351.33 Aligned_cols=259 Identities=17% Similarity=0.237 Sum_probs=203.6
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCC--eeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE--EKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~--~~~lv~ 398 (611)
+.|...++||+|+||.||+|+.. +|+.||||+++... ...+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 46777899999999999999965 59999999997533 33567889999999999999999999998765 679999
Q ss_pred eccCCCChHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEe----CCCCCeEEeecccccc
Q 035917 399 KYMSSGTLYSLLQGNA--TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV----DEDFDARIMDFGLAKL 472 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl----d~~~~~kl~DFGla~~ 472 (611)
||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999997543 24999999999999999999999 7899999999999999 7788899999999987
Q ss_pred cCCCCCCccccCCCcccccccccccCC--------CCCCcccchHHHHHHHHHHhCCCCCHHH---------HHHHHhhc
Q 035917 473 MTSSDESSFVNGDLGEFGYIAPEYSST--------MVASLKGDVYGIGVVLLELAGFKGNLVD---------WVNQLSSS 535 (611)
Q Consensus 473 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDV~SfGvvl~ell~~~~~~~~---------~~~~~~~~ 535 (611)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. ........
T Consensus 166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 166 LEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp CCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred ccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 64322 2233469999999998764 5678899999999999999999988742 11111111
Q ss_pred CChhhhh-------------chhh--cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 536 GRSKEAI-------------DKAL--CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 536 ~~~~~~~-------------~~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
. ....+ ...+ ...........+.+++.+||+.||++||++.|+++.++++...
T Consensus 243 ~-p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 243 K-PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp C-CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred C-CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 0 00000 0000 0011233444556677799999999999999999999988765
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=341.66 Aligned_cols=258 Identities=19% Similarity=0.219 Sum_probs=186.9
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc-hhHHHHHHHHHHHhccC-CCCccceeeEEEe--------CC
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLR-HPNLAPLLGYCVV--------EE 392 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~--------~~ 392 (611)
.+|...+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|+.++.++. ||||+++++++.. ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 4677889999999999999995 479999999985443 34567899999999996 9999999999953 33
Q ss_pred eeEEEEeccCCCChHHhhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCeEEeCCCCCeEEeecc
Q 035917 393 EKLLIYKYMSSGTLYSLLQG--NATELDWPTRFRIGLGAARGLAWLHHGCQPP--FLHQNICSNVILVDEDFDARIMDFG 468 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlkp~NILld~~~~~kl~DFG 468 (611)
..++||||+. |+|.+++.. ....+++..++.++.|++.||.||| +.+ |+||||||+|||++.++.+||+|||
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence 4789999996 699998864 2346999999999999999999999 667 9999999999999999999999999
Q ss_pred cccccCCCCCCc----------cccCCCccccccccccc---CCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhc
Q 035917 469 LAKLMTSSDESS----------FVNGDLGEFGYIAPEYS---STMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSS 535 (611)
Q Consensus 469 la~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~ 535 (611)
+++......... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||..........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~ 263 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN 263 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc
Confidence 998765432111 11133589999999988 56678999999999999999999999985422111100
Q ss_pred CChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCCC
Q 035917 536 GRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFS 593 (611)
Q Consensus 536 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 593 (611)
..... ......+..+.+ ++.+||+.||++|||+.|++++|+++.+.....
T Consensus 264 ----~~~~~-~~~~~~~~~~~~---li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 264 ----GKYSI-PPHDTQYTVFHS---LIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp ------CCC-CTTCCSSGGGHH---HHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred ----CcccC-CcccccchHHHH---HHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence 00000 011122333444 455999999999999999999999999876544
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=331.91 Aligned_cols=253 Identities=19% Similarity=0.238 Sum_probs=190.3
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEe-----------
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVV----------- 390 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~----------- 390 (611)
.++|...+.||+|+||.||+|+. .+++.||||+++......+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 46788889999999999999996 479999999997655556789999999999999999999999865
Q ss_pred --CCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecc
Q 035917 391 --EEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFG 468 (611)
Q Consensus 391 --~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFG 468 (611)
.+..++||||+++|+|.+++......+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 34678999999999999999865556888999999999999999999 7899999999999999999999999999
Q ss_pred cccccCCCCC------------CccccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhc
Q 035917 469 LAKLMTSSDE------------SSFVNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSS 535 (611)
Q Consensus 469 la~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~ 535 (611)
+++....... ........||+.|+|||.+.+. .++.++|||||||++|||++...+..+........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p~~~~~~~~~~~~~~ 241 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKL 241 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhccCCchhHHHHHHhc
Confidence 9986542210 1112334689999999998764 68999999999999999998433221111110000
Q ss_pred CChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 536 GRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 536 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
........+. .....++.+.+ ++.+||+.||++|||+.|+++|
T Consensus 242 ~~~~~~~~~~-~~~~~~~~~~~---li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 242 RSVSIEFPPD-FDDNKMKVEKK---IIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HSTTCCCCTT-CCTTTSHHHHH---HHHHHTCSSGGGSCCHHHHHHS
T ss_pred cccccccCcc-ccccchHHHHH---HHHHHHhcCcccCcCHHHHhCC
Confidence 0000000111 11122334444 5559999999999999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=345.83 Aligned_cols=247 Identities=17% Similarity=0.168 Sum_probs=199.0
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~l 396 (611)
.++|...+.||+|+||.||+|+.. +|+.||||+++... ...+.+.+|..++..+ +||||+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 357888899999999999999975 48899999996532 2346688999999988 79999999999999999999
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
||||+++|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 99 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 99999999999999754 35899999999999999999999 789999999999999999999999999999864322
Q ss_pred CCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHH
Q 035917 477 DESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEI 555 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~ 555 (611)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+..... .+...+.++
T Consensus 175 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~ 248 (353)
T 2i0e_A 175 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL----FQSIMEHNVAYPKSMSKEA 248 (353)
T ss_dssp T--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCTTSCHHH
T ss_pred C--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH----HHHHHhCCCCCCCCCCHHH
Confidence 2 122345799999999999999999999999999999999999988742100000 001111110 122345566
Q ss_pred HHHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 035917 556 LQFLKVACNCVVSRPKDRWS-----MYQVYQS 582 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 582 (611)
.+++. +||+.||++||+ ++||++|
T Consensus 249 ~~li~---~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 249 VAICK---GLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHH---HHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHH---HHhhcCHHHcCCCCCCCHHHHhcC
Confidence 66655 999999999995 5888776
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=349.82 Aligned_cols=195 Identities=18% Similarity=0.277 Sum_probs=163.8
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeC-----Ce
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE-----EE 393 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~-----~~ 393 (611)
.++|...+.||+|+||.||+|+. .+++.||||+++... ...+++.+|+++|++++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 45788889999999999999995 468899999996532 3346799999999999999999999999776 56
Q ss_pred eEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccccc
Q 035917 394 KLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLM 473 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~ 473 (611)
.++||||+. |+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 899999997 5999999754 46999999999999999999999 789999999999999999999999999999876
Q ss_pred CCCCCC--------------------ccccCCCccccccccccc-CCCCCCcccchHHHHHHHHHHhCCC
Q 035917 474 TSSDES--------------------SFVNGDLGEFGYIAPEYS-STMVASLKGDVYGIGVVLLELAGFK 522 (611)
Q Consensus 474 ~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDV~SfGvvl~ell~~~ 522 (611)
...... ...+..+||+.|+|||++ ....++.++|||||||++|||++|.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~ 249 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcc
Confidence 433211 123456799999999985 5667999999999999999999753
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=352.86 Aligned_cols=194 Identities=20% Similarity=0.294 Sum_probs=153.6
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeC-----Ce
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE-----EE 393 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~-----~~ 393 (611)
.++|...+.||+|+||.||+|+. .+++.||||++.... ...+++.+|+++|++++|||||++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 36788899999999999999995 478999999986532 3346789999999999999999999998543 46
Q ss_pred eEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccccc
Q 035917 394 KLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLM 473 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~ 473 (611)
.|+||||+. |+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEEeccc-cchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 899999985 6999998754 46999999999999999999999 789999999999999999999999999999876
Q ss_pred CCCCCC-------------------------ccccCCCccccccccccc-CCCCCCcccchHHHHHHHHHHhCC
Q 035917 474 TSSDES-------------------------SFVNGDLGEFGYIAPEYS-STMVASLKGDVYGIGVVLLELAGF 521 (611)
Q Consensus 474 ~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDV~SfGvvl~ell~~ 521 (611)
...... ...+..+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 432110 123445789999999975 566799999999999999999983
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=336.96 Aligned_cols=250 Identities=18% Similarity=0.283 Sum_probs=181.9
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchh--H-HHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLG--E-KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~--~-~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
.++|...+.||+|+||.||+|+. .+|+.||||+++..... . +.+.++...++.++||||+++++++..++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 35788889999999999999996 57999999999754322 2 33455556688899999999999999999999999
Q ss_pred eccCCCChHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeeecCCCCCeEEeCCCCCeEEeecccccccC
Q 035917 399 KYMSSGTLYSLLQG---NATELDWPTRFRIGLGAARGLAWLHHGCQP-PFLHQNICSNVILVDEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 399 ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDlkp~NILld~~~~~kl~DFGla~~~~ 474 (611)
||+++ +|.+++.. ....+++..+..++.|++.||+||| +. +|+||||||+||+++.++.+||+|||+++...
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99975 88887753 3357999999999999999999999 65 99999999999999999999999999998764
Q ss_pred CCCCCccccCCCccccccccccc----CCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCC
Q 035917 475 SSDESSFVNGDLGEFGYIAPEYS----STMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKG 550 (611)
Q Consensus 475 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 550 (611)
.... .....||+.|+|||.+ .+..++.++|||||||++|||++|+.||..+...............+......
T Consensus 162 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (290)
T 3fme_A 162 DDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK 238 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTT
T ss_pred cccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccccc
Confidence 3321 1223589999999985 56678999999999999999999998874211110000000000011111223
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 551 YDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 551 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.++++.+++. +||+.||++|||+.|+++|
T Consensus 239 ~~~~~~~li~---~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 239 FSAEFVDFTS---QCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp SCHHHHHHHH---HHTCSSGGGSCCHHHHTTS
T ss_pred CCHHHHHHHH---HHhhcChhhCcCHHHHHhC
Confidence 4455555555 9999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=326.86 Aligned_cols=245 Identities=16% Similarity=0.196 Sum_probs=196.5
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEecccc-chhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTC-KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
.+.|...+.||+|+||.||+|+.. ++..||+|++... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 456888899999999999999964 5789999998654 34467899999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEe---CCCCCeEEeecccccccCCCC
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV---DEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl---d~~~~~kl~DFGla~~~~~~~ 477 (611)
+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 88 CTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 9999999988754 35899999999999999999999 7899999999999999 788999999999998764332
Q ss_pred CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCChhhhhchhhcCCCCH
Q 035917 478 ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGRSKEAIDKALCGKGYD 552 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~~~~ 552 (611)
......||+.|+|||.+.+. ++.++||||||+++|||++|+.||... ....... ... .+.......+
T Consensus 164 ---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~ 235 (277)
T 3f3z_A 164 ---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG-TFT---FPEKDWLNVS 235 (277)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCC---CCHHHHTTSC
T ss_pred ---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC-CCC---CCchhhhcCC
Confidence 22334699999999988764 899999999999999999998886321 1111000 000 0000001223
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 553 EEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 553 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+++.+ ++.+||+.||++|||+.|+++|
T Consensus 236 ~~~~~---li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 236 PQAES---LIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHHH---HHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHH---HHHHHccCChhhCcCHHHHhcC
Confidence 44445 4459999999999999999876
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=331.46 Aligned_cols=249 Identities=17% Similarity=0.228 Sum_probs=193.2
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccC
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
.|....+||+|+||.||+|+. .+++.||||.++... ...+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 345556999999999999995 568999999996543 335679999999999999999999999999999999999999
Q ss_pred CCChHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC-CCCeEEeecccccccCCCCCC
Q 035917 403 SGTLYSLLQGNA--TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE-DFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 403 ~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~-~~~~kl~DFGla~~~~~~~~~ 479 (611)
+++|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++. ++.+||+|||+++......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-- 177 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-- 177 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence 999999997653 25678999999999999999999 789999999999999987 8999999999998764322
Q ss_pred ccccCCCcccccccccccCCCC--CCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCCh-hhhhchhhcCCCCHHHHH
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMV--ASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRS-KEAIDKALCGKGYDEEIL 556 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~~~~~~~~ 556 (611)
.......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||............. .....+.+ ....++++.
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 256 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEI-PESMSAEAK 256 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCC-CTTSCHHHH
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccc-cccCCHHHH
Confidence 1122346899999999986643 7899999999999999999998874311000000000 00001111 123345555
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+++. +||+.||++||++.|++++
T Consensus 257 ~li~---~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 257 AFIL---KCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHHH---HTTCSSTTTSCCHHHHHTS
T ss_pred HHHH---HHccCChhhCCCHHHHhcC
Confidence 5555 9999999999999999875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=343.51 Aligned_cols=260 Identities=21% Similarity=0.330 Sum_probs=198.7
Q ss_pred ccHHHHHHhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhcc-CCCCccceeeEEEe-
Q 035917 314 VKLADLMAASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVV- 390 (611)
Q Consensus 314 ~~~~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~- 390 (611)
+++.++....+.|...+.||+|+||.||+|+. .+|+.||||++.......+.+.+|+.++.++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 33444455677888999999999999999996 5799999999976655667899999999999 79999999999987
Q ss_pred -----CCeeEEEEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEE
Q 035917 391 -----EEEKLLIYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARI 464 (611)
Q Consensus 391 -----~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl 464 (611)
.+..++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEE
Confidence 467899999999999999997643 36899999999999999999999 789999999999999999999999
Q ss_pred eecccccccCCCCCCccccCCCcccccccccccC-----CCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChh
Q 035917 465 MDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSS-----TMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSK 539 (611)
Q Consensus 465 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~ 539 (611)
+|||++....... .......||+.|+|||++. +..++.++|||||||++|||++|..||.......... ...
T Consensus 171 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~ 247 (326)
T 2x7f_A 171 VDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIP 247 (326)
T ss_dssp CCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHH
T ss_pred eeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH-Hhh
Confidence 9999998654321 1122346899999999886 5678999999999999999999998874211000000 000
Q ss_pred hhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 540 EAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 540 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
....+.......++++.+++. +||+.||++||++.|+++|
T Consensus 248 ~~~~~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 248 RNPAPRLKSKKWSKKFQSFIE---SCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HSCCCCCSCSCSCHHHHHHHH---HHCCSSGGGSCCHHHHHTS
T ss_pred cCccccCCccccCHHHHHHHH---HHhccChhhCCCHHHHhhC
Confidence 001111222334556666655 9999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=334.68 Aligned_cols=250 Identities=20% Similarity=0.248 Sum_probs=191.0
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccch---hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKL---GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
++|...+.||+|+||.||+|+.. +|+.||||++..... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 46777899999999999999964 599999999865432 24668899999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
|+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 157 (311)
T 4agu_A 83 YCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD- 157 (311)
T ss_dssp CCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred eCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence 99999999988644 45899999999999999999999 78999999999999999999999999999987643221
Q ss_pred ccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHh---hc-----------CChh
Q 035917 480 SFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLS---SS-----------GRSK 539 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~---~~-----------~~~~ 539 (611)
......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||... ..... .. ....
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 1233468999999998865 66899999999999999999998876311 00000 00 0000
Q ss_pred hhh---ch------hhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 540 EAI---DK------ALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 540 ~~~---~~------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
... ++ .......+.+ +.+++.+||+.||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYP---ALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHH---HHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccCcCCCccccchhhhhcccccHH---HHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 00 0000122333 4455559999999999999999987
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=331.05 Aligned_cols=252 Identities=19% Similarity=0.301 Sum_probs=199.3
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc-------hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK-------LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-------~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~ 395 (611)
++|...+.||+|+||.||+|+.. +|+.||+|.++... ...+.+.+|+.++++++||||+++++++..++..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46788899999999999999975 69999999986432 13578999999999999999999999999999999
Q ss_pred EEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC----CeEEeeccccc
Q 035917 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF----DARIMDFGLAK 471 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~----~~kl~DFGla~ 471 (611)
+||||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++ .+||+|||+++
T Consensus 85 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 999999999999999753 35899999999999999999999 78999999999999998877 89999999998
Q ss_pred ccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCChhhhhchhh
Q 035917 472 LMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGRSKEAIDKAL 546 (611)
Q Consensus 472 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~~~~~~~~~l 546 (611)
....... .....||+.|+|||.+.+..++.++||||||+++|||++|..||... ..... .... ......
T Consensus 161 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~--~~~~~~ 234 (283)
T 3bhy_A 161 KIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS-AVNY--DFDEEY 234 (283)
T ss_dssp ECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-TTCC--CCCHHH
T ss_pred eccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhH-hccc--CCcchh
Confidence 7643221 22345899999999999889999999999999999999998886321 11100 0000 000111
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHchhh
Q 035917 547 CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS--LNSIAAQ 589 (611)
Q Consensus 547 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~~ 589 (611)
. ...++++.+ ++.+||+.||++||++.|+++| ++.+.++
T Consensus 235 ~-~~~~~~~~~---li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 235 F-SNTSELAKD---FIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp H-TTCCHHHHH---HHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred c-ccCCHHHHH---HHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 0 122344444 4459999999999999999986 5655544
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=342.85 Aligned_cols=253 Identities=22% Similarity=0.270 Sum_probs=191.2
Q ss_pred HhhhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccchh------HHHHHHHHHHHhccCCCCccceeeEEEeCCe
Q 035917 321 AASNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLG------EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEE 393 (611)
Q Consensus 321 ~~t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~------~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~ 393 (611)
...+.|...+.||+|+||.||+|+.. +|+.||||+++..... .+.+.+|++++++++||||+++++++...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34567889999999999999999964 6899999999653221 2468899999999999999999999999999
Q ss_pred eEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccccc
Q 035917 394 KLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLM 473 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~ 473 (611)
.++||||+++ +|.+++......+++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999999986 899998876567899999999999999999999 789999999999999999999999999999876
Q ss_pred CCCCCCccccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhhc-CCh-hhhh---
Q 035917 474 TSSDESSFVNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSSS-GRS-KEAI--- 542 (611)
Q Consensus 474 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~~-~~~-~~~~--- 542 (611)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|..+|.. ........ +.. .+..
T Consensus 163 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 163 GSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp TSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred cCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence 4322 122334689999999998654 589999999999999999998876531 11111100 000 0000
Q ss_pred ----ch---hh--------cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 543 ----DK---AL--------CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 543 ----~~---~l--------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+. .. .....++++.+ ++.+||+.||++|||+.|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLD---LIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHH---HHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHH---HHHHHhccChhhCCCHHHHhcC
Confidence 00 00 00112344444 4559999999999999999987
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=338.21 Aligned_cols=251 Identities=19% Similarity=0.209 Sum_probs=188.0
Q ss_pred cCCC-CCeeeecCCceEEEEEe-CCCCEEEEEeccccc-hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEEEEec
Q 035917 325 SFCS-ENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 325 ~f~~-~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
.|.. +++||+|+||.||+|+. .+++.||||+++... ...+.+.+|++++.++ +||||+++++++.+++..++||||
T Consensus 13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 92 (316)
T 2ac3_A 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEK 92 (316)
T ss_dssp SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEc
Confidence 4554 47899999999999994 579999999996543 3457799999999985 799999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCC---eEEeecccccccCCCC
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFD---ARIMDFGLAKLMTSSD 477 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~---~kl~DFGla~~~~~~~ 477 (611)
+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++. +||+|||+++......
T Consensus 93 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 93 MRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp CTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred CCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence 9999999999754 35899999999999999999999 789999999999999988765 9999999998654221
Q ss_pred C-----CccccCCCcccccccccccCC-----CCCCcccchHHHHHHHHHHhCCCCCHHHHH-------HHHhh---cCC
Q 035917 478 E-----SSFVNGDLGEFGYIAPEYSST-----MVASLKGDVYGIGVVLLELAGFKGNLVDWV-------NQLSS---SGR 537 (611)
Q Consensus 478 ~-----~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~SfGvvl~ell~~~~~~~~~~-------~~~~~---~~~ 537 (611)
. ........||+.|+|||++.. ..++.++|||||||++|||++|+.||.... ..... ...
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 248 (316)
T 2ac3_A 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248 (316)
T ss_dssp -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence 1 111223459999999998864 458899999999999999999988873210 00000 000
Q ss_pred hhhhh-chhhc-----CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 538 SKEAI-DKALC-----GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 538 ~~~~~-~~~l~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
..+.+ ..... ....+.++.+ ++.+||+.||++|||+.|+++|
T Consensus 249 ~~~~i~~~~~~~~~~~~~~~~~~~~~---li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 249 LFESIQEGKYEFPDKDWAHISCAAKD---LISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHCCCCCCHHHHTTSCHHHHH---HHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhccCcccCchhcccCCHHHHH---HHHHHhhCChhhCCCHHHHhcC
Confidence 00000 00000 0122334444 5559999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=340.83 Aligned_cols=264 Identities=20% Similarity=0.226 Sum_probs=197.5
Q ss_pred cHHHHHHhhhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccch------------hHHHHHHHHHHHhccCCCCcc
Q 035917 315 KLADLMAASNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKL------------GEKKFRNEMNRLGQLRHPNLA 382 (611)
Q Consensus 315 ~~~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~------------~~~~~~~Ev~~l~~l~H~nIv 382 (611)
.+.++....++|...+.||+|+||.||+|...+|+.||||++..... ..+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 45677888899999999999999999999988899999999854211 126799999999999999999
Q ss_pred ceeeEEEeC-----CeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC
Q 035917 383 PLLGYCVVE-----EEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD 457 (611)
Q Consensus 383 ~l~g~~~~~-----~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld 457 (611)
++++++... ...++||||++ |+|.+++......+++..+..++.|++.||.||| +.+|+||||||+|||++
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLA 168 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEC
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEc
Confidence 999998653 35799999998 5999988866567999999999999999999999 78999999999999999
Q ss_pred CCCCeEEeecccccccCCCCCCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHH
Q 035917 458 EDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQ 531 (611)
Q Consensus 458 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~ 531 (611)
.++.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. ....
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 245 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245 (362)
T ss_dssp TTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred CCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999985533221 223468999999998876 6789999999999999999999887631 1111
Q ss_pred Hhh---cCChh-----------hhhchhh----------cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHH
Q 035917 532 LSS---SGRSK-----------EAIDKAL----------CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS--LNS 585 (611)
Q Consensus 532 ~~~---~~~~~-----------~~~~~~l----------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~ 585 (611)
... ..... +.+.... .....++. +.+++.+||+.||++|||+.|+++| ++.
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 322 (362)
T 3pg1_A 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPV---ALDLIAKMLEFNPQRRISTEQALRHPYFES 322 (362)
T ss_dssp HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHH---HHHHHHHHhcCChhhCCCHHHHHcCchhhh
Confidence 100 00000 0000000 00112233 4455559999999999999999987 444
Q ss_pred chh
Q 035917 586 IAA 588 (611)
Q Consensus 586 i~~ 588 (611)
+..
T Consensus 323 ~~~ 325 (362)
T 3pg1_A 323 LFD 325 (362)
T ss_dssp TCC
T ss_pred ccC
Confidence 433
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=336.01 Aligned_cols=254 Identities=20% Similarity=0.289 Sum_probs=191.3
Q ss_pred hcCCCCCeeeecCCceEEEEEeC--CCC--EEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP--DGS--VLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~--~g~--~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~ 395 (611)
++|...+.||+|+||.||+|++. +++ .||||+++... ...+++.+|++++++++||||+++++++..++ .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 46778899999999999999853 333 69999996532 23467999999999999999999999997654 88
Q ss_pred EEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
+||||+++|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 999999999999999765456899999999999999999999 78999999999999999999999999999987654
Q ss_pred CCCCc-cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHH-----HHHHhhcCChhhhhchhhcC
Q 035917 476 SDESS-FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDW-----VNQLSSSGRSKEAIDKALCG 548 (611)
Q Consensus 476 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~ 548 (611)
..... ......+|..|+|||.+.+..++.++||||||+++|||++ |..||... ........ ......
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~------~~~~~~ 247 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG------ERLPRP 247 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC------CCCCCC
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC------CCCCCC
Confidence 33211 1223457889999999988889999999999999999998 88887421 11111100 000111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 549 KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 549 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
...++++.+ ++.+||+.||++|||+.+++++|+++....
T Consensus 248 ~~~~~~l~~---li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 248 EDCPQDIYN---VMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp TTCCHHHHH---HHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred cCcCHHHHH---HHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 223444555 445999999999999999999999887654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=342.81 Aligned_cols=257 Identities=16% Similarity=0.228 Sum_probs=192.5
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccchhH--HHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLGE--KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~--~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
++|...+.||+|+||.||+|+.. +++.||||+++...... ..+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 45777889999999999999965 78999999996543222 2466899999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
++ |+|.+++......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--K 155 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--c
Confidence 97 5999998876667999999999999999999999 7899999999999999999999999999998654322 1
Q ss_pred cccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhh---c---CChhhhhch----
Q 035917 481 FVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSS---S---GRSKEAIDK---- 544 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~---~---~~~~~~~~~---- 544 (611)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||... ...... . .........
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 2233468999999998876 56899999999999999999998876321 111100 0 000000000
Q ss_pred -----h-------hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHchhh
Q 035917 545 -----A-------LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS--LNSIAAQ 589 (611)
Q Consensus 545 -----~-------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~~ 589 (611)
. ......++++.+ ++.+||+.||++|||+.|+++| +.++.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~---li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGAD---LLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHH---HHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred ccccccccchhhhhhcCCCCHHHHH---HHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 0 000122344444 4559999999999999999986 5555444
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=336.13 Aligned_cols=250 Identities=20% Similarity=0.294 Sum_probs=195.0
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
.+.|...+.||+|+||.||+|+.. +|+.||||.+.... ..+++.+|+.++.+++||||+++++++...+..++||||+
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 456888899999999999999965 59999999996533 3467899999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
++|+|.+++......+++..+..++.+++.||.||| +.+|+|+||||+||+++.++.+||+|||+++...... ..
T Consensus 107 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~ 181 (314)
T 3com_A 107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--AK 181 (314)
T ss_dssp TTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--SC
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--cc
Confidence 999999998744457999999999999999999999 7899999999999999999999999999998764322 11
Q ss_pred ccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHHHHHHH
Q 035917 482 VNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEILQFLK 560 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~~ 560 (611)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .......+.. .....++++.+++.
T Consensus 182 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~ 260 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF-MIPTNPPPTFRKPELWSDNFTDFVK 260 (314)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHHHSCCCCCSSGGGSCHHHHHHHH
T ss_pred cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHhcCCCcccCCcccCCHHHHHHHH
Confidence 233468999999999998899999999999999999999998874211000000 0000000000 01112344555544
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 035917 561 VACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 561 l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+||+.||++|||+.++++|
T Consensus 261 ---~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 261 ---QCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp ---HHTCSCTTTSCCHHHHTTS
T ss_pred ---HHccCChhhCcCHHHHHhC
Confidence 9999999999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=345.82 Aligned_cols=195 Identities=19% Similarity=0.311 Sum_probs=170.8
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
++|...+.||+|+||.||+|+.. +++.||+|+++... ...+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 46788899999999999999965 68999999996542 3346799999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
+++|+|.+++... ..+++..+..++.+++.||.|||+ ..+|+||||||+|||++.++.+||+|||+++......
T Consensus 113 ~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 186 (360)
T 3eqc_A 113 MDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 186 (360)
T ss_dssp CTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC---
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc---
Confidence 9999999999754 358999999999999999999993 2389999999999999999999999999997653221
Q ss_pred cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCH
Q 035917 481 FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNL 525 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~ 525 (611)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 187 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 230 (360)
T 3eqc_A 187 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230 (360)
T ss_dssp -----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCS
T ss_pred -ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 12346899999999999999999999999999999999998876
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=362.95 Aligned_cols=250 Identities=18% Similarity=0.258 Sum_probs=202.2
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
.++|...++||+|+||.||+|+.. +|+.||||++.... .....+.+|+++|++++|||||++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 356888899999999999999964 79999999996532 2345688999999999999999999999999999999
Q ss_pred EeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 398 YKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
|||+++|+|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999997654 35999999999999999999999 789999999999999999999999999999876433
Q ss_pred CCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc--hhhcCCCCHHH
Q 035917 477 DESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID--KALCGKGYDEE 554 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~ 554 (611)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|..||....... ........+. +.......+.+
T Consensus 340 ~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~~~~i~~~i~~~~~~~p~~~s~~ 415 (576)
T 2acx_A 340 QT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEVERLVKEVPEEYSERFSPQ 415 (576)
T ss_dssp CC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-CHHHHHHHHHHCCCCCCTTSCHH
T ss_pred cc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-hHHHHHHHhhcccccCCccCCHH
Confidence 21 233479999999999999899999999999999999999998874310000 0000000110 00112334556
Q ss_pred HHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 035917 555 ILQFLKVACNCVVSRPKDRW-----SMYQVYQS 582 (611)
Q Consensus 555 ~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 582 (611)
+.+++. +||+.||++|| ++.||++|
T Consensus 416 ~~dLI~---~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 416 ARSLCS---QLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHHH---HHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HHHHHH---HhccCCHHHcCCCCCCCHHHHHhC
Confidence 666666 99999999999 78999877
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=330.44 Aligned_cols=244 Identities=19% Similarity=0.248 Sum_probs=198.7
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999965 57899999986432 22467899999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 168 (284)
T 2vgo_A 94 EFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR- 168 (284)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-
T ss_pred EeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcccc-
Confidence 999999999998754 35899999999999999999999 8899999999999999999999999999997654322
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEILQ 557 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~ 557 (611)
.....|++.|+|||.+.+..++.++||||||+++|||++|..||........ ...+..... .....++++.+
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET----HRRIVNVDLKFPPFLSDGSKD 241 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHTTCCCCCTTSCHHHHH
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH----HHHHhccccCCCCcCCHHHHH
Confidence 1234689999999999998999999999999999999999988732100000 000111000 11234455555
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++. +||+.||++||++.|+++|
T Consensus 242 li~---~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 242 LIS---KLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp HHH---HHSCSSGGGSCCHHHHHTC
T ss_pred HHH---HHhhcCHhhCCCHHHHhhC
Confidence 555 9999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=349.35 Aligned_cols=198 Identities=20% Similarity=0.300 Sum_probs=160.3
Q ss_pred hhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEecccc---chhHHHHHHHHHHHhccC-CCCccceeeEEEeCC--ee
Q 035917 322 ASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTC---KLGEKKFRNEMNRLGQLR-HPNLAPLLGYCVVEE--EK 394 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~---~~~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~~--~~ 394 (611)
..++|...+.||+|+||.||+|.. .+|+.||||++... ....+++.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 456788889999999999999995 57999999998643 233467889999999997 999999999998654 68
Q ss_pred EEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccC
Q 035917 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~ 474 (611)
++|||||+ |+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 87 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 99999998 5999998753 5899999999999999999999 7899999999999999999999999999998753
Q ss_pred CCC-------------------CCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCH
Q 035917 475 SSD-------------------ESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNL 525 (611)
Q Consensus 475 ~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~ 525 (611)
... .....+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 231 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence 211 1112234579999999998876 67899999999999999999998876
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=341.74 Aligned_cols=251 Identities=18% Similarity=0.258 Sum_probs=198.3
Q ss_pred HHHhhhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccch---------hHHHHHHHHHHHhcc-CCCCccceeeE
Q 035917 319 LMAASNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKL---------GEKKFRNEMNRLGQL-RHPNLAPLLGY 387 (611)
Q Consensus 319 l~~~t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---------~~~~~~~Ev~~l~~l-~H~nIv~l~g~ 387 (611)
.....++|...+.||+|+||.||+|+.. +|+.||||+++.... ..+.+.+|+.++.++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3455678999999999999999999975 799999999854321 135688999999999 79999999999
Q ss_pred EEeCCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeec
Q 035917 388 CVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDF 467 (611)
Q Consensus 388 ~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DF 467 (611)
+...+..++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+||
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~Df 244 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDF 244 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEec
Confidence 99999999999999999999999754 35899999999999999999999 789999999999999999999999999
Q ss_pred ccccccCCCCCCccccCCCcccccccccccCC------CCCCcccchHHHHHHHHHHhCCCCCHHHHH----HHHhhcCC
Q 035917 468 GLAKLMTSSDESSFVNGDLGEFGYIAPEYSST------MVASLKGDVYGIGVVLLELAGFKGNLVDWV----NQLSSSGR 537 (611)
Q Consensus 468 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDV~SfGvvl~ell~~~~~~~~~~----~~~~~~~~ 537 (611)
|++..+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||.... ........
T Consensus 245 G~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 321 (365)
T 2y7j_A 245 GFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ 321 (365)
T ss_dssp TTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred CcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence 99987654322 233569999999998753 358899999999999999999998873210 00000000
Q ss_pred hhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 538 SKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 538 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.. ...+ .....+.++.+ ++.+||+.||++|||+.|+++|
T Consensus 322 ~~-~~~~--~~~~~~~~~~~---li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 322 YQ-FSSP--EWDDRSSTVKD---LISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp CC-CCHH--HHSSSCHHHHH---HHHHHSCSSTTTSCCHHHHHHS
T ss_pred CC-CCCc--ccccCCHHHHH---HHHHHcCCChhHCcCHHHHhcC
Confidence 00 0000 00122334444 5559999999999999999875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=343.91 Aligned_cols=244 Identities=16% Similarity=0.210 Sum_probs=195.2
Q ss_pred hhhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccchhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEEEEe
Q 035917 322 ASNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
..++|...+.||+|+||.||+|+.. +|+.||||+++.... .+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 3467888899999999999999964 689999999965432 345788888888 79999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCC----CCeEEeecccccccCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDED----FDARIMDFGLAKLMTS 475 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~----~~~kl~DFGla~~~~~ 475 (611)
|+++|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||+.++ +.+||+|||+++....
T Consensus 97 ~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 97 LMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 99999999998755 46899999999999999999999 7899999999999998433 3599999999987643
Q ss_pred CCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhch------hhc--
Q 035917 476 SDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDK------ALC-- 547 (611)
Q Consensus 476 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~------~l~-- 547 (611)
... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.... .....+.+.. ...
T Consensus 173 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~~~~~i~~~~~~~~~~ 245 (342)
T 2qr7_A 173 ENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP-----DDTPEEILARIGSGKFSLSGG 245 (342)
T ss_dssp TTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST-----TSCHHHHHHHHHHCCCCCCST
T ss_pred CCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC-----cCCHHHHHHHHccCCcccCcc
Confidence 321 2234568999999999988788999999999999999999998874200 0011111110 001
Q ss_pred -CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 548 -GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 548 -~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
....++++.++++ +||+.||++||++.|+++|
T Consensus 246 ~~~~~s~~~~~li~---~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 246 YWNSVSDTAKDLVS---KMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp TTTTSCHHHHHHHH---HHTCSSTTTSCCHHHHTTS
T ss_pred ccccCCHHHHHHHH---HHCCCChhHCcCHHHHhcC
Confidence 1234556666655 9999999999999999987
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=351.35 Aligned_cols=245 Identities=15% Similarity=0.156 Sum_probs=189.2
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEecccc----chhHHHHHHHH---HHHhccCCCCcccee-------eE
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTC----KLGEKKFRNEM---NRLGQLRHPNLAPLL-------GY 387 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~----~~~~~~~~~Ev---~~l~~l~H~nIv~l~-------g~ 387 (611)
.++|...+.||+|+||.||+|+. .+|+.||||+++.. ....+.+.+|+ +++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46778889999999999999995 57999999999632 23457799999 556666899999998 66
Q ss_pred EEeCC-----------------eeEEEEeccCCCChHHhhhcCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 035917 388 CVVEE-----------------EKLLIYKYMSSGTLYSLLQGNA------TELDWPTRFRIGLGAARGLAWLHHGCQPPF 444 (611)
Q Consensus 388 ~~~~~-----------------~~~lv~ey~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 444 (611)
+..++ ..++||||+ +|+|.+++.... ..+++..++.|+.||+.||+||| +.+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 55543 278999999 679999997432 12446888999999999999999 7899
Q ss_pred eecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCC-----------CCCcccchHHHHH
Q 035917 445 LHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTM-----------VASLKGDVYGIGV 513 (611)
Q Consensus 445 vHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~ksDV~SfGv 513 (611)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986422 2234467 999999999877 8999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHch
Q 035917 514 VLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS--LNSIA 587 (611)
Q Consensus 514 vl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~ 587 (611)
++|||++|+.||...... ........ .....++++.+++. +||+.||++|||+.|+++| ++++.
T Consensus 302 il~elltg~~Pf~~~~~~----~~~~~~~~---~~~~~~~~~~~li~---~~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 302 VIYWIWCADLPITKDAAL----GGSEWIFR---SCKNIPQPVRALLE---GFLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp HHHHHHHSSCCC----------CCSGGGGS---SCCCCCHHHHHHHH---HHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred HHHHHHHCCCCCcccccc----cchhhhhh---hccCCCHHHHHHHH---HHcCCCchhCCCHHHHhhChHHHHHH
Confidence 999999999998542211 11111111 11234455555555 9999999999999999975 44443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=351.55 Aligned_cols=194 Identities=22% Similarity=0.260 Sum_probs=162.8
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEecccc---chhHHHHHHHHHHHhccCCCCccceeeEEEeC------C
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTC---KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE------E 392 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~---~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~------~ 392 (611)
.++|...+.||+|+||.||+|+. .+|+.||||++... ....+++.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 45788889999999999999985 46899999999653 23346789999999999999999999999654 3
Q ss_pred eeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccc
Q 035917 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKL 472 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~ 472 (611)
..++||||+++ +|.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 56999999986 57777753 3899999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHH
Q 035917 473 MTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLV 526 (611)
Q Consensus 473 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~ 526 (611)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 214 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~ 264 (464)
T 3ttj_A 214 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 264 (464)
T ss_dssp ---CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCC
Confidence 64322 2234579999999999999999999999999999999999988763
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=340.09 Aligned_cols=252 Identities=18% Similarity=0.179 Sum_probs=187.1
Q ss_pred HhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchh---HHHHHHHHHHHhccCCCCccceeeEEEeCCeeEE
Q 035917 321 AASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLG---EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 321 ~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
...++|...+.||+|+||.||+|+. .+++.||||+++..... .+.+.+|++++++++||||+++++++..++..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 4456888999999999999999995 57899999999654322 3567899999999999999999999999999999
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEe-----CCCCCeEEeeccccc
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV-----DEDFDARIMDFGLAK 471 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl-----d~~~~~kl~DFGla~ 471 (611)
||||+++ +|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||+++
T Consensus 111 v~e~~~~-~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEECCSE-EHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEecCCC-CHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 9999985 999999765 35899999999999999999999 7899999999999999 455569999999998
Q ss_pred ccCCCCCCccccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhc-CC-----hh
Q 035917 472 LMTSSDESSFVNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSS-GR-----SK 539 (611)
Q Consensus 472 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~-~~-----~~ 539 (611)
...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||... ....... +. ..
T Consensus 186 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 186 AFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp HHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence 764322 122334689999999998764 4899999999999999999998876321 1111000 00 00
Q ss_pred hhh--------chhhcC--------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 540 EAI--------DKALCG--------KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 540 ~~~--------~~~l~~--------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
... .+.... ...++++ .+++.+||+.||++|||+.|+++|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEG---LDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHH---HHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHH---HHHHHHHccCChhhCCCHHHHhCC
Confidence 000 000000 0123344 445559999999999999999875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=333.13 Aligned_cols=246 Identities=18% Similarity=0.253 Sum_probs=195.8
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
.+.|...+.||+|+||.||+|+.. +|+.||+|+++... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 356888899999999999999964 79999999997543 2346789999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEe---CCCCCeEEeecccccccCCCC
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV---DEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl---d~~~~~kl~DFGla~~~~~~~ 477 (611)
+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.+||+|||+++......
T Consensus 88 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 163 (304)
T 2jam_A 88 VSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163 (304)
T ss_dssp CCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred CCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence 9999999988654 35899999999999999999999 7899999999999999 788999999999997643221
Q ss_pred CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHH----HhhcCChhhhhchhhcCCCCHH
Q 035917 478 ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQ----LSSSGRSKEAIDKALCGKGYDE 553 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~~~~~~ 553 (611)
. ....||+.|+|||.+.+..++.++|||||||++|||++|..||...... ....+... .. .......++
T Consensus 164 ~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~--~~-~~~~~~~~~ 236 (304)
T 2jam_A 164 M----STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE--FE-SPFWDDISE 236 (304)
T ss_dssp T----HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC--CC-TTTTTTSCH
T ss_pred c----ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC--CC-ccccccCCH
Confidence 1 1224899999999999999999999999999999999999887421110 00000000 00 001122344
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 554 EILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 554 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++.+++. +||+.||++|||+.|+++|
T Consensus 237 ~~~~li~---~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 237 SAKDFIC---HLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp HHHHHHH---HHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHHH---HHcCCChhHCcCHHHHhcC
Confidence 5555555 9999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=339.30 Aligned_cols=255 Identities=18% Similarity=0.236 Sum_probs=194.5
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEe--------C
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVV--------E 391 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~--------~ 391 (611)
++|...+.||+|+||.||+|+. .+|+.||||++.... .....+.+|++++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5788889999999999999996 579999999985432 223578899999999999999999999987 3
Q ss_pred CeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccc
Q 035917 392 EEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAK 471 (611)
Q Consensus 392 ~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~ 471 (611)
+..++||||+++ +|.+.+......+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 468999999985 888888766567999999999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCC--CCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhh-cCCh-hhh
Q 035917 472 LMTSSD--ESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSS-SGRS-KEA 541 (611)
Q Consensus 472 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~-~~~~-~~~ 541 (611)
.+.... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||... ...... .+.. .+.
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 764322 1122234568999999998876 45799999999999999999998876321 000000 0000 000
Q ss_pred ---hc-hhh--------c-CCCCHHHH------HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 542 ---ID-KAL--------C-GKGYDEEI------LQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 542 ---~~-~~l--------~-~~~~~~~~------~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+ ... . .....+.+ ..+.+++.+||+.||++|||+.|+++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00 000 0 00011111 235556669999999999999999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=351.40 Aligned_cols=246 Identities=18% Similarity=0.267 Sum_probs=186.6
Q ss_pred hhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch---------hHHHHHHHHHHHhccCCCCccceeeEEEeC
Q 035917 322 ASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL---------GEKKFRNEMNRLGQLRHPNLAPLLGYCVVE 391 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~---------~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~ 391 (611)
..++|...+.||+|+||.||+|.. .+++.||||++..... ....+.+|+.+|++++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 456888899999999999999995 4689999999865321 1124889999999999999999999975 5
Q ss_pred CeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCC---CCeEEeecc
Q 035917 392 EEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDED---FDARIMDFG 468 (611)
Q Consensus 392 ~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~---~~~kl~DFG 468 (611)
+..++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.+ +.+||+|||
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred CceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeecc
Confidence 5689999999999999998754 46999999999999999999999 7899999999999999654 459999999
Q ss_pred cccccCCCCCCccccCCCcccccccccccCC---CCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh
Q 035917 469 LAKLMTSSDESSFVNGDLGEFGYIAPEYSST---MVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA 545 (611)
Q Consensus 469 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (611)
+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.... ......+.+...
T Consensus 288 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~----~~~~~~~~i~~~ 360 (419)
T 3i6u_A 288 HSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR----TQVSLKDQITSG 360 (419)
T ss_dssp TTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS----SSCCHHHHHHTT
T ss_pred cceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc----chHHHHHHHhcC
Confidence 998764322 2233469999999999853 568899999999999999999998874210 000111111110
Q ss_pred hcC------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 546 LCG------KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 546 l~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
... ...++++. +++.+||+.||++|||+.|+++|
T Consensus 361 ~~~~~~~~~~~~~~~~~---~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 361 KYNFIPEVWAEVSEKAL---DLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp CCCCCHHHHTTSCHHHH---HHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCchhhcccCHHHH---HHHHHHccCChhHCcCHHHHhCC
Confidence 000 11233444 45559999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=330.47 Aligned_cols=249 Identities=20% Similarity=0.263 Sum_probs=200.7
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
+.|...+.||+|+||.||+|+. .+++.||||+++... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 4577788999999999999985 468999999996532 3457899999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
+++++|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 102 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 174 (303)
T 3a7i_A 102 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-- 174 (303)
T ss_dssp CTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcccc--
Confidence 999999999874 35899999999999999999999 78999999999999999999999999999987643221
Q ss_pred cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHH
Q 035917 481 FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLK 560 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~ 560 (611)
......||+.|+|||.+.+..++.++||||||+++|||++|+.|+.......... .......+. .....+.++.+++.
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~l~~li~ 252 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-LIPKNNPPT-LEGNYSKPLKEFVE 252 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHHHSCCCC-CCSSCCHHHHHHHH
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH-HhhcCCCCC-CccccCHHHHHHHH
Confidence 1233468999999999999899999999999999999999998864211000000 000000111 11233455555555
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHH
Q 035917 561 VACNCVVSRPKDRWSMYQVYQSLN 584 (611)
Q Consensus 561 l~~~Cl~~dP~~RPs~~evl~~L~ 584 (611)
+||+.||++|||+.|++++.-
T Consensus 253 ---~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 253 ---ACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp ---HHCCSSGGGSCCHHHHTTCHH
T ss_pred ---HHcCCChhhCcCHHHHhhChh
Confidence 999999999999999998743
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=334.55 Aligned_cols=254 Identities=22% Similarity=0.338 Sum_probs=180.2
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
.++|...+.||+|+||.||+|.. .+++.||||++.... ...+++.+|+.++++++||||+++++++...+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 45788889999999999999995 478999999986532 334678999999999999999999999999999999999
Q ss_pred ccCCCChHHhhhc-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccc
Q 035917 400 YMSSGTLYSLLQG-------NATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKL 472 (611)
Q Consensus 400 y~~~gsL~~~l~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~ 472 (611)
|+++|+|.+++.. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999999863 2246899999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCC---CccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHHHH-----HHhhcC--Chhhh
Q 035917 473 MTSSDE---SSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDWVN-----QLSSSG--RSKEA 541 (611)
Q Consensus 473 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~-----~~~~~~--~~~~~ 541 (611)
...... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...... .....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccc
Confidence 643221 111223468999999998865 5689999999999999999999988743110 000000 00000
Q ss_pred hchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 542 IDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 542 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
..........++++.+++. +||+.||++||++.|+++|
T Consensus 251 ~~~~~~~~~~~~~~~~li~---~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 251 VQDKEMLKKYGKSFRKMIS---LCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp ----CCCCCCCHHHHHHHH---HHCCSSGGGSCCHHHHHTS
T ss_pred cccchhhhhhhHHHHHHHH---HHccCChhhCcCHHHHhhC
Confidence 0000011223444555554 9999999999999999875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=336.59 Aligned_cols=247 Identities=19% Similarity=0.271 Sum_probs=192.8
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
.+.|...+.||+|+||.||+|+.. +++.||+|++.... ...+++.+|+.++++++||||+++++++..++..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 356778899999999999999975 58999999986543 3457899999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
+++++|.+++......+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++....... .
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 172 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--Q 172 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--H
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc--c
Confidence 9999999998765456999999999999999999999 7899999999999999999999999999976432110 1
Q ss_pred cccCCCccccccccccc-----CCCCCCcccchHHHHHHHHHHhCCCCCHHHHH-----HHHhhcCChhhhhchhhcCCC
Q 035917 481 FVNGDLGEFGYIAPEYS-----STMVASLKGDVYGIGVVLLELAGFKGNLVDWV-----NQLSSSGRSKEAIDKALCGKG 550 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~-----~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~~ 550 (611)
......||+.|+|||++ ....++.++||||||+++|||++|+.|+.... ........ ........
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~ 247 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP-----PTLLTPSK 247 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-----CCCSSGGG
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCC-----cccCCccc
Confidence 11223589999999987 46678999999999999999999998864211 11111100 00001112
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 551 YDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 551 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+.++.+++. +||+.||++|||+.|+++|
T Consensus 248 ~~~~l~~li~---~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 248 WSVEFRDFLK---IALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp SCHHHHHHHH---HHSCSCTTTSCCHHHHTTS
T ss_pred cCHHHHHHHH---HHcccChhhCCCHHHHhcC
Confidence 3344555554 9999999999999999875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.30 Aligned_cols=242 Identities=21% Similarity=0.207 Sum_probs=187.2
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccch----hHHHHHHHHHH-HhccCCCCccceeeEEEeCCeeEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKL----GEKKFRNEMNR-LGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~----~~~~~~~Ev~~-l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
.++|...+.||+|+||.||+|+.. +++.||||+++.... ..+.+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357888899999999999999964 588999999965432 23456777776 577899999999999999999999
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
||||+++|+|.+++... ..+++..+..++.+|+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 117 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999999754 35889999999999999999999 789999999999999999999999999999864322
Q ss_pred CCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHH
Q 035917 477 DESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEI 555 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~ 555 (611)
. ......+||+.|+|||++.+..++.++|||||||++|||++|..||....... ....++.... .....+.++
T Consensus 193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~ 266 (373)
T 2r5t_A 193 N--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----MYDNILNKPLQLKPNITNSA 266 (373)
T ss_dssp C--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH----HHHHHHHSCCCCCSSSCHHH
T ss_pred C--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHhcccCCCCCCCHHH
Confidence 2 12234479999999999999999999999999999999999998873210000 0001111111 122345566
Q ss_pred HHHHHHHhhcccCCCCCCCCHH
Q 035917 556 LQFLKVACNCVVSRPKDRWSMY 577 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~ 577 (611)
.++++ +||+.||++||++.
T Consensus 267 ~~li~---~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 267 RHLLE---GLLQKDRTKRLGAK 285 (373)
T ss_dssp HHHHH---HHTCSSGGGSTTTT
T ss_pred HHHHH---HHcccCHHhCCCCC
Confidence 66666 99999999999974
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=327.35 Aligned_cols=249 Identities=17% Similarity=0.211 Sum_probs=193.5
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc-----hhHHHHHHHHHHHhccCCCCccceeeEEE--eCCee
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-----LGEKKFRNEMNRLGQLRHPNLAPLLGYCV--VEEEK 394 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~--~~~~~ 394 (611)
.++|...+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|++++++++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 36799999999999999999996 468999999996542 23467999999999999999999999985 34578
Q ss_pred EEEEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccccc
Q 035917 395 LLIYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLM 473 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~ 473 (611)
++||||+++| |.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999886 777775432 46999999999999999999999 789999999999999999999999999999876
Q ss_pred CCCCCCccccCCCcccccccccccCCCC--CCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-hcCCC
Q 035917 474 TSSDESSFVNGDLGEFGYIAPEYSSTMV--ASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-LCGKG 550 (611)
Q Consensus 474 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~ 550 (611)
.............||+.|+|||++.+.. ++.++||||||+++|||++|+.||........ ...+.... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~i~~~~~~~~~~ 235 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL----FENIGKGSYAIPGD 235 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHCCCCCCSS
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH----HHHHhcCCCCCCCc
Confidence 5433333334456999999999987643 47899999999999999999888632100000 00000000 01122
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 551 YDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 551 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.++++.++++ +||+.||++|||+.|+++|
T Consensus 236 ~~~~l~~li~---~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 236 CGPPLSDLLK---GMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp SCHHHHHHHH---HHTCSSTTTSCCHHHHHHS
T ss_pred cCHHHHHHHH---HHccCChhhCCCHHHHhcC
Confidence 3445555555 9999999999999999987
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=323.65 Aligned_cols=244 Identities=19% Similarity=0.268 Sum_probs=189.7
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||.||+|+.. +|+.||||++.... ...+.+.+|+.++++++||||+++++++..++..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 46777899999999999999975 79999999996532 22467899999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 91 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 91 EYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166 (276)
T ss_dssp ECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred eccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence 999999999999754 35899999999999999999999 78999999999999999999999999999987643221
Q ss_pred CccccCCCcccccccccccCCCCC-CcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh--hcCCCCHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVA-SLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA--LCGKGYDEEI 555 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~ 555 (611)
.....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....... ..+.+... ......+.++
T Consensus 167 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l 238 (276)
T 2h6d_A 167 ---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-----LFKKIRGGVFYIPEYLNRSV 238 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHCCCCCCTTSCHHH
T ss_pred ---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-----HHHHhhcCcccCchhcCHHH
Confidence 223458999999999987765 689999999999999999988763210000 00000000 0122234455
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+++. +||+.||++|||+.|+++|
T Consensus 239 ~~li~---~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 239 ATLLM---HMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHH---HHTCSSGGGSCCHHHHHHS
T ss_pred HHHHH---HHccCChhhCCCHHHHHhC
Confidence 55555 9999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=348.34 Aligned_cols=262 Identities=18% Similarity=0.192 Sum_probs=203.8
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhccCC-CCccceeeEEEeCCeeEEEEec
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRH-PNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H-~nIv~l~g~~~~~~~~~lv~ey 400 (611)
.++|...+.||+|+||.||+|+. .+++.||||+++... ..+++.+|++++..++| ++|..+..++...+..++||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 35788899999999999999995 679999999875432 22458899999999987 5566666666778888999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEe---CCCCCeEEeecccccccCCCC
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV---DEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl---d~~~~~kl~DFGla~~~~~~~ 477 (611)
+ +++|.+++......+++..++.|+.||+.||+||| +.+|+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 85 ~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred C-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 9 89999999865567999999999999999999999 7899999999999999 588999999999998765433
Q ss_pred CC-----ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh------
Q 035917 478 ES-----SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL------ 546 (611)
Q Consensus 478 ~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l------ 546 (611)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+....+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~~ 239 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVATSIEA 239 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH-HHHHHHHHHHHHHSCHHH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH-HHHHHHHhhccccccHHH
Confidence 21 112245799999999999999999999999999999999999988743100000 000000000000
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCCC
Q 035917 547 CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFS 593 (611)
Q Consensus 547 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 593 (611)
.....++++.+ ++.+||+.||++||++.+|++.|+++....+..
T Consensus 240 l~~~~p~~l~~---li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~ 283 (483)
T 3sv0_A 240 LCRGYPTEFAS---YFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQ 283 (483)
T ss_dssp HHTTSCHHHHH---HHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HhcCCcHHHHH---HHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCC
Confidence 00223344444 555999999999999999999999998876544
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=339.53 Aligned_cols=260 Identities=20% Similarity=0.271 Sum_probs=195.3
Q ss_pred hhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
.++|...+.||+|+||.||+|+..+ .||+|+++... ...+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4578888999999999999999754 49999986532 223568899999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC--
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD-- 477 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~-- 477 (611)
|+++++|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++ ++.+||+|||+++......
T Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp CCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred cccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 99999999999876557999999999999999999999 78999999999999998 6799999999987653211
Q ss_pred -CCccccCCCcccccccccccCC---------CCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhc
Q 035917 478 -ESSFVNGDLGEFGYIAPEYSST---------MVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALC 547 (611)
Q Consensus 478 -~~~~~~~~~gt~~y~aPE~~~~---------~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 547 (611)
.........||+.|+|||.+.. ..++.++|||||||++|||++|+.||.......... .......+...
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~ 264 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW-QMGTGMKPNLS 264 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH-HHHTTCCCCCC
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HhccCCCCCCC
Confidence 1112233458999999998764 457899999999999999999988863211000000 00001111121
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCC
Q 035917 548 GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGF 592 (611)
Q Consensus 548 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 592 (611)
....+.++.+++. +||+.||++|||+.++++.|+++.++...
T Consensus 265 ~~~~~~~l~~li~---~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 265 QIGMGKEISDILL---FCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp CSSCCTTHHHHHH---HHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred cCCCCHHHHHHHH---HHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 2223444555554 99999999999999999999999887543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=356.55 Aligned_cols=245 Identities=21% Similarity=0.289 Sum_probs=198.3
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEecccc----chhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTC----KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~----~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
.+.|...+.||+|+||.||+|+.. +|+.||||++... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 356888899999999999999965 7999999998543 23457899999999999999999999999999999999
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEe---CCCCCeEEeecccccccC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV---DEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl---d~~~~~kl~DFGla~~~~ 474 (611)
|||+.+|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||+++...
T Consensus 105 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp ECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 9999999999998754 46899999999999999999999 7899999999999999 567899999999998765
Q ss_pred CCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCChhhhhchhhcCC
Q 035917 475 SSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGRSKEAIDKALCGK 549 (611)
Q Consensus 475 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~ 549 (611)
.... .....||+.|+|||++.+ .++.++|||||||++|||++|..||... ..... .+...- . .....
T Consensus 181 ~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-~~~~~~--~-~~~~~ 252 (484)
T 3nyv_A 181 ASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE-KGKYTF--E-LPQWK 252 (484)
T ss_dssp CCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HCCCCC--C-SGGGG
T ss_pred cccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-cCCCCC--C-Ccccc
Confidence 4332 222369999999999876 6899999999999999999999887321 11111 110000 0 00001
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 550 GYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 550 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
..++++.+++. +||+.||++|||+.|+++|
T Consensus 253 ~~s~~~~~li~---~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 253 KVSESAKDLIR---KMLTYVPSMRISARDALDH 282 (484)
T ss_dssp GSCHHHHHHHH---HHTCSSGGGSCCHHHHHTS
T ss_pred cCCHHHHHHHH---HHCCCChhHCcCHHHHhhC
Confidence 23455555555 9999999999999999987
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=357.25 Aligned_cols=247 Identities=19% Similarity=0.260 Sum_probs=200.3
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...++||+|+||.||+|+.. +|+.||||+++... ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56788889999999999999974 69999999996532 23467899999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 399 KYMSSGTLYSLLQGNA---TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
||+++|+|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999987542 36999999999999999999999 78999999999999999999999999999987643
Q ss_pred CCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhh----chh-hcCCC
Q 035917 476 SDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAI----DKA-LCGKG 550 (611)
Q Consensus 476 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~----~~~-l~~~~ 550 (611)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......+.. ... ..+..
T Consensus 342 ~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~----~~~~~~~~~~~i~~~~~~~p~~ 415 (543)
T 3c4z_A 342 GQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG----EKVENKELKQRVLEQAVTYPDK 415 (543)
T ss_dssp TCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT----CCCCHHHHHHHHHHCCCCCCTT
T ss_pred CCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc----cchhHHHHHHHHhhcccCCCcc
Confidence 321 1233479999999999999999999999999999999999998874210 000001111 111 11233
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCH-----HHHHHH
Q 035917 551 YDEEILQFLKVACNCVVSRPKDRWSM-----YQVYQS 582 (611)
Q Consensus 551 ~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~ 582 (611)
.+.++.+++. +||+.||++||++ .+|++|
T Consensus 416 ~s~~~~~li~---~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 416 FSPASKDFCE---ALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp SCHHHHHHHH---HHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred cCHHHHHHHH---HhccCCHhHCCCCcccCHHHHHcC
Confidence 4556666665 9999999999964 777765
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=329.01 Aligned_cols=247 Identities=17% Similarity=0.194 Sum_probs=199.2
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
+.|...+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 56778899999999999999965 58899999986532 23467899999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++++|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 95 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 95 ELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp ECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 999999999988654 35899999999999999999999 78999999999999999999999999999987643221
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-hcCCCCHHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-LCGKGYDEEILQ 557 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~~~ 557 (611)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ........ ......+.++.+
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 244 (294)
T 2rku_A 171 --RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET----YLRIKKNEYSIPKHINPVAAS 244 (294)
T ss_dssp --CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHTTCCCCCTTSCHHHHH
T ss_pred --ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhhccCCCccccCHHHHH
Confidence 12234689999999999988899999999999999999999888632100000 00000000 011233445555
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWSMYQVYQSL 583 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~~evl~~L 583 (611)
++. +||+.||++|||+.|++++-
T Consensus 245 li~---~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 245 LIQ---KMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp HHH---HHTCSSGGGSCCGGGGGGSH
T ss_pred HHH---HHcccChhhCcCHHHHhhCh
Confidence 555 99999999999999999873
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=333.91 Aligned_cols=250 Identities=20% Similarity=0.246 Sum_probs=191.0
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccch---hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKL---GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
++|...+.||+|+||.||+|+.. +|+.||||++..... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 46778899999999999999965 589999999854332 24568899999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
|+++++|.+++... ..+++..+..++.+++.||.||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 105 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 179 (331)
T 4aaa_A 105 FVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 179 (331)
T ss_dssp CCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred cCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-
Confidence 99999998887644 35999999999999999999999 78999999999999999999999999999986643221
Q ss_pred ccccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHh-hcCC--------------h
Q 035917 480 SFVNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLS-SSGR--------------S 538 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~-~~~~--------------~ 538 (611)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||... ..... ..+. .
T Consensus 180 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 180 -VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred -ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 12334689999999998765 7899999999999999999998876311 00000 0000 0
Q ss_pred hhhhchhhc--------CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 539 KEAIDKALC--------GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 539 ~~~~~~~l~--------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.....+.+. ....+++ +.+++.+||+.||++|||+.|+++|
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~---l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEV---VIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHH---HHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccCccccccchhhhcccchhHH---HHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000 0122344 4445559999999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=336.41 Aligned_cols=254 Identities=19% Similarity=0.226 Sum_probs=196.3
Q ss_pred HHhhhcCCCC-CeeeecCCceEEEEEeC-CCCEEEEEeccccc---hhHHHHHHHHHHHhccC-CCCccceeeEEEeCCe
Q 035917 320 MAASNSFCSE-NVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLR-HPNLAPLLGYCVVEEE 393 (611)
Q Consensus 320 ~~~t~~f~~~-~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~~~ 393 (611)
....+.|... +.||+|+||.||+|+.. +++.||||+++... ....++.+|+.++.+++ ||||+++++++...+.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3444556655 78999999999999964 69999999996532 33578999999999995 6999999999999999
Q ss_pred eEEEEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC---CCCeEEeeccc
Q 035917 394 KLLIYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE---DFDARIMDFGL 469 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~---~~~~kl~DFGl 469 (611)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||+
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~ 180 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence 999999999999999986543 47999999999999999999999 789999999999999997 78999999999
Q ss_pred ccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc-hhhcC
Q 035917 470 AKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID-KALCG 548 (611)
Q Consensus 470 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~ 548 (611)
++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.................+ +....
T Consensus 181 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 257 (327)
T 3lm5_A 181 SRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETF 257 (327)
T ss_dssp CEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTT
T ss_pred ccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhh
Confidence 987643321 22346999999999999999999999999999999999999887321100000000000000 00011
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 549 KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 549 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
...++++.+++. +||+.||++|||+.|+++|
T Consensus 258 ~~~~~~~~~li~---~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 258 SSVSQLATDFIQ---SLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp TTSCHHHHHHHH---HHSCSSGGGSCCHHHHTTC
T ss_pred cccCHHHHHHHH---HHcCCChhhCcCHHHHhCC
Confidence 123445555555 9999999999999999886
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=347.70 Aligned_cols=194 Identities=20% Similarity=0.210 Sum_probs=170.3
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccchhHHHHHHHHHHHhcc------CCCCccceeeEEEeCCeeE
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLGEKKFRNEMNRLGQL------RHPNLAPLLGYCVVEEEKL 395 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l------~H~nIv~l~g~~~~~~~~~ 395 (611)
...|...+.||+|+||.||+|+.. +++.||||+++......+++.+|+++++.+ +|+||+++++++...+..+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 346788899999999999999854 589999999987665567788899988887 5779999999999999999
Q ss_pred EEEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCC--eEEeecccccc
Q 035917 396 LIYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFD--ARIMDFGLAKL 472 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~--~kl~DFGla~~ 472 (611)
+||||+. ++|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++. +||+|||+++.
T Consensus 176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 9999996 59999987654 36999999999999999999999 789999999999999999887 99999999976
Q ss_pred cCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCH
Q 035917 473 MTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNL 525 (611)
Q Consensus 473 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~ 525 (611)
.... .....||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 252 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf 299 (429)
T 3kvw_A 252 EHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLL 299 (429)
T ss_dssp TTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCC
Confidence 5322 22346899999999999989999999999999999999998776
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=337.42 Aligned_cols=247 Identities=17% Similarity=0.197 Sum_probs=199.5
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
.+.|...+.||+|+||.||+++.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 357888899999999999999965 58899999986532 2346789999999999999999999999999999999
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
|||+++++|.+++... ..+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 120 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 120 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp ECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 9999999999988654 35899999999999999999999 7899999999999999999999999999998764322
Q ss_pred CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-hcCCCCHHHHH
Q 035917 478 ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-LCGKGYDEEIL 556 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~~ 556 (611)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ........ ......+.++.
T Consensus 196 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 269 (335)
T 2owb_A 196 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET----YLRIKKNEYSIPKHINPVAA 269 (335)
T ss_dssp C--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHHTCCCCCTTSCHHHH
T ss_pred c--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH----HHHHhcCCCCCCccCCHHHH
Confidence 1 12334699999999999888899999999999999999999888632100000 00000000 01123344555
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++++ +||+.||++||++.|++++
T Consensus 270 ~li~---~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 270 SLIQ---KMLQTDPTARPTINELLND 292 (335)
T ss_dssp HHHH---HHTCSSGGGSCCGGGGGGS
T ss_pred HHHH---HHccCChhHCcCHHHHhcC
Confidence 5555 9999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=353.36 Aligned_cols=245 Identities=19% Similarity=0.284 Sum_probs=196.0
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEecccc---chhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTC---KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
.+.|...+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 356888899999999999999964 7999999998542 234577999999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC---CCCCeEEeecccccccCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD---EDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld---~~~~~kl~DFGla~~~~~ 475 (611)
|||++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++ .++.+||+|||+++....
T Consensus 101 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 999999999988654 35899999999999999999999 78999999999999995 456799999999987643
Q ss_pred CCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCChhhhhchhhcCCC
Q 035917 476 SDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGRSKEAIDKALCGKG 550 (611)
Q Consensus 476 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~~ 550 (611)
.. ......||+.|+|||++.+ .++.++|||||||++|||++|..||... ...... +... .+ ......
T Consensus 177 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~-~~~~--~~-~~~~~~ 248 (486)
T 3mwu_A 177 NT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET-GKYA--FD-LPQWRT 248 (486)
T ss_dssp C-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-TCCC--SC-SGGGGG
T ss_pred CC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCC--CC-CcccCC
Confidence 32 2234469999999999876 5999999999999999999999887321 111110 0000 00 000012
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 551 YDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 551 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.++++.+++. +||+.||++|||+.|+++|
T Consensus 249 ~s~~~~~li~---~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 249 ISDDAKDLIR---KMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp SCHHHHHHHH---HHTCSSTTTSCCHHHHHHC
T ss_pred CCHHHHHHHH---HHcCCChhhCcCHHHHhcC
Confidence 3445555555 9999999999999999987
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=351.09 Aligned_cols=246 Identities=21% Similarity=0.262 Sum_probs=195.0
Q ss_pred hhhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc--------------hhHHHHHHHHHHHhccCCCCccceee
Q 035917 322 ASNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK--------------LGEKKFRNEMNRLGQLRHPNLAPLLG 386 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--------------~~~~~~~~Ev~~l~~l~H~nIv~l~g 386 (611)
..+.|...+.||+|+||.||+|+.. +++.||||+++... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3567888899999999999999964 58899999986532 22467899999999999999999999
Q ss_pred EEEeCCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC---CeE
Q 035917 387 YCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF---DAR 463 (611)
Q Consensus 387 ~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~---~~k 463 (611)
++.+++..++|||||++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++ .+|
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEE
Confidence 999999999999999999999988654 35999999999999999999999 78999999999999998765 699
Q ss_pred EeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCCh
Q 035917 464 IMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGRS 538 (611)
Q Consensus 464 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~~ 538 (611)
|+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|||++|..||... ..... .+..
T Consensus 190 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-~~~~ 264 (504)
T 3q5i_A 190 IVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE-KGKY 264 (504)
T ss_dssp ECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HCCC
T ss_pred EEECCCCEEcCCCC---ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCC
Confidence 99999998765332 2234469999999999874 6899999999999999999999887321 11111 1000
Q ss_pred hhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 539 KEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 539 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
. .+. ......++++.+++. +||+.||++|||+.|+++|
T Consensus 265 ~--~~~-~~~~~~s~~~~~li~---~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 265 Y--FDF-NDWKNISDEAKELIK---LMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp C--CCH-HHHTTSCHHHHHHHH---HHTCSSTTTSCCHHHHHTS
T ss_pred C--CCc-cccCCCCHHHHHHHH---HHcCCChhHCCCHHHHhcC
Confidence 0 000 000123445555555 9999999999999999976
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=335.98 Aligned_cols=248 Identities=17% Similarity=0.270 Sum_probs=197.6
Q ss_pred hhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchh------------------HHHHHHHHHHHhccCCCCccce
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLG------------------EKKFRNEMNRLGQLRHPNLAPL 384 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~------------------~~~~~~Ev~~l~~l~H~nIv~l 384 (611)
.++|...+.||+|+||.||+|+. +|+.||||++...... .+.+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35788889999999999999999 9999999998643211 1789999999999999999999
Q ss_pred eeEEEeCCeeEEEEeccCCCChHHh------hhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeeecCCCCCeEEe
Q 035917 385 LGYCVVEEEKLLIYKYMSSGTLYSL------LQGN-ATELDWPTRFRIGLGAARGLAWLHHGCQ-PPFLHQNICSNVILV 456 (611)
Q Consensus 385 ~g~~~~~~~~~lv~ey~~~gsL~~~------l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivHrDlkp~NILl 456 (611)
++++.+.+..++||||+++|+|.++ +... ...+++..+..++.|++.||.||| + .+|+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence 9999999999999999999999998 6543 347999999999999999999999 6 899999999999999
Q ss_pred CCCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCC-CCCc-ccchHHHHHHHHHHhCCCCCHH------HH
Q 035917 457 DEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTM-VASL-KGDVYGIGVVLLELAGFKGNLV------DW 528 (611)
Q Consensus 457 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-ksDV~SfGvvl~ell~~~~~~~------~~ 528 (611)
+.++.+||+|||+++..... ......||+.|+|||.+.+. .++. ++|||||||++|||++|..||. +.
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 99999999999999876432 22344699999999999876 5666 9999999999999999988873 21
Q ss_pred HHHHhhcCChhhhh------chh------hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 529 VNQLSSSGRSKEAI------DKA------LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 529 ~~~~~~~~~~~~~~------~~~------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
..... ........ .+. ......+.++.+++. +||+.||++|||+.|+++|
T Consensus 262 ~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~---~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 262 FNNIR-TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLK---LFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHT-SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHH---HHCCSSGGGSCCHHHHHTS
T ss_pred HHHHh-ccCcCCccchhhhhccccccccccchhhcCHHHHHHHH---HHccCChhhCCCHHHHhcC
Confidence 11111 11100000 000 000223444555554 9999999999999999985
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=341.01 Aligned_cols=251 Identities=15% Similarity=0.145 Sum_probs=196.3
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhccC--------CCCccceeeEEE----
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLR--------HPNLAPLLGYCV---- 389 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~--------H~nIv~l~g~~~---- 389 (611)
.++|...+.||+|+||.||+|+. .+++.||||+++......+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 35788889999999999999985 56899999999876666678999999999996 788999999987
Q ss_pred eCCeeEEEEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeeecCCCCCeEEeCCCC-------
Q 035917 390 VEEEKLLIYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQP-PFLHQNICSNVILVDEDF------- 460 (611)
Q Consensus 390 ~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDlkp~NILld~~~------- 460 (611)
.....++||||+ +|+|.+.+.... ..+++..++.++.||+.||+||| +. +|+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 455789999999 557766665443 56999999999999999999999 66 999999999999999775
Q ss_pred ------------------------------------------CeEEeecccccccCCCCCCccccCCCcccccccccccC
Q 035917 461 ------------------------------------------DARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSS 498 (611)
Q Consensus 461 ------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 498 (611)
.+||+|||+++..... .....||+.|+|||++.
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHH
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhc
Confidence 8999999999876432 22346999999999999
Q ss_pred CCCCCcccchHHHHHHHHHHhCCCCCHHH-----------HHHHHhh-cCCh-hh----------hhchh----------
Q 035917 499 TMVASLKGDVYGIGVVLLELAGFKGNLVD-----------WVNQLSS-SGRS-KE----------AIDKA---------- 545 (611)
Q Consensus 499 ~~~~t~ksDV~SfGvvl~ell~~~~~~~~-----------~~~~~~~-~~~~-~~----------~~~~~---------- 545 (611)
+..++.++|||||||++|||++|+.||.. ....... .+.. .. .+...
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 88899999999999999999999887631 0000000 0000 00 00000
Q ss_pred ---------hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 546 ---------LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 546 ---------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
-......+....+.+++.+||+.||++|||+.|+++|
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0001234455667788889999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=337.75 Aligned_cols=251 Identities=20% Similarity=0.281 Sum_probs=192.9
Q ss_pred HhhhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccc---hhHHHHHHHHHHHhccC--CCCccceeeEEEeCCeeE
Q 035917 321 AASNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLR--HPNLAPLLGYCVVEEEKL 395 (611)
Q Consensus 321 ~~t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~--H~nIv~l~g~~~~~~~~~ 395 (611)
...+.|...+.||+|+||.||+|+..+++.||||++.... ...+.+.+|++++.+++ ||||+++++++..++..+
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 3456788889999999999999998889999999996432 23467899999999997 599999999999999999
Q ss_pred EEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
+||| +.+++|.+++... ..+++..+..++.|+++||.||| +.+|+||||||+|||+++ +.+||+|||+++....
T Consensus 105 lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP 178 (313)
T ss_dssp EEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred EEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence 9999 5678999999765 36899999999999999999999 789999999999999975 8999999999987644
Q ss_pred CCCCccccCCCcccccccccccCC-----------CCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhch
Q 035917 476 SDESSFVNGDLGEFGYIAPEYSST-----------MVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDK 544 (611)
Q Consensus 476 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (611)
...........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........ .....+++
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~~ 255 (313)
T 3cek_A 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDP 255 (313)
T ss_dssp -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHHHHHCT
T ss_pred ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH---HHHHHHhc
Confidence 332222234469999999998765 4688999999999999999999988743111100 01112222
Q ss_pred hhc---CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 035917 545 ALC---GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSL 583 (611)
Q Consensus 545 ~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 583 (611)
... ....++++.+++. +||+.||++||++.|++++-
T Consensus 256 ~~~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 256 NHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp TSCCCCCCCSCHHHHHHHH---HHTCSSTTTSCCHHHHHTSH
T ss_pred ccccCCcccchHHHHHHHH---HHccCCcccCcCHHHHhcCc
Confidence 111 1223445555555 99999999999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=329.47 Aligned_cols=190 Identities=18% Similarity=0.278 Sum_probs=167.3
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhccC-CCCccceeeEEEe--CCeeEEEEe
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLR-HPNLAPLLGYCVV--EEEKLLIYK 399 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~--~~~~~lv~e 399 (611)
++|...+.||+|+||.||+|+. .+++.||||+++.. ..+.+.+|+.++++++ ||||+++++++.+ ....++|||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 5788889999999999999985 67999999999743 3567899999999997 9999999999987 567899999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC-CeEEeecccccccCCCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF-DARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~-~~kl~DFGla~~~~~~~~ 478 (611)
|+++++|.+++. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||+++.......
T Consensus 114 ~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~ 186 (330)
T 3nsz_A 114 HVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186 (330)
T ss_dssp CCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred ccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc
Confidence 999999999885 3889999999999999999999 78999999999999999766 899999999987643322
Q ss_pred CccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCH
Q 035917 479 SSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNL 525 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~ 525 (611)
.....||..|+|||.+.+ ..++.++|||||||++|||++|+.||
T Consensus 187 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~ 231 (330)
T 3nsz_A 187 ---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231 (330)
T ss_dssp ---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred ---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCc
Confidence 223468999999999876 67899999999999999999998876
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=332.66 Aligned_cols=255 Identities=20% Similarity=0.301 Sum_probs=196.6
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEe--CCeeEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVV--EEEKLL 396 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~--~~~~~l 396 (611)
.++|...+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.. .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 457888899999999999999964 78999999996533 234678999999999999999999998865 567899
Q ss_pred EEeccCCCChHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-----eeecCCCCCeEEeCCCCCeEEeecc
Q 035917 397 IYKYMSSGTLYSLLQGN---ATELDWPTRFRIGLGAARGLAWLHHGCQPP-----FLHQNICSNVILVDEDFDARIMDFG 468 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-----ivHrDlkp~NILld~~~~~kl~DFG 468 (611)
||||+++|+|.+++... ...+++..++.++.|++.||+||| +.+ |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999998643 235999999999999999999999 555 9999999999999999999999999
Q ss_pred cccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcC
Q 035917 469 LAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCG 548 (611)
Q Consensus 469 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 548 (611)
+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .......+. ..
T Consensus 162 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~i~~~~~~~-~~ 237 (279)
T 2w5a_A 162 LARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG-KIREGKFRR-IP 237 (279)
T ss_dssp HHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHHTCCCC-CC
T ss_pred hheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHH-HHhhccccc-CC
Confidence 998764322 11122358999999999988889999999999999999999988763211000000 000000001 11
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHch
Q 035917 549 KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIA 587 (611)
Q Consensus 549 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 587 (611)
...++++.+++. +||+.||++||++.||++++....
T Consensus 238 ~~~~~~l~~li~---~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 238 YRYSDELNEIIT---RMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp TTSCHHHHHHHH---HHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred cccCHHHHHHHH---HHcCCCcccCCCHHHHHhChhhhh
Confidence 234455555555 999999999999999998775443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=344.26 Aligned_cols=249 Identities=18% Similarity=0.207 Sum_probs=196.1
Q ss_pred hhcCCCCCeeeecCCceEEEEEe----CCCCEEEEEeccccc-----hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCC
Q 035917 323 SNSFCSENVIISTRTGTTYKAML----PDGSVLAVKRLNTCK-----LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEE 392 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~----~~g~~vAvK~~~~~~-----~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~ 392 (611)
.++|...+.||+|+||.||+|+. .+++.||||+++... ...+.+.+|++++.++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35788899999999999999996 478999999996532 2345678899999999 6999999999999999
Q ss_pred eeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccc
Q 035917 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKL 472 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~ 472 (611)
..++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 999999999999999999754 35899999999999999999999 78999999999999999999999999999986
Q ss_pred cCCCCCCccccCCCcccccccccccCC--CCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-----
Q 035917 473 MTSSDESSFVNGDLGEFGYIAPEYSST--MVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA----- 545 (611)
Q Consensus 473 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~----- 545 (611)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ......+.....
T Consensus 209 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~----~~~~~~~~~~~~~~~~~ 283 (355)
T 1vzo_A 209 FVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG----EKNSQAEISRRILKSEP 283 (355)
T ss_dssp CCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT----SCCCHHHHHHHHHHCCC
T ss_pred cccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC----ccchHHHHHHHHhccCC
Confidence 543221 12223469999999999875 347899999999999999999998873100 000111111100
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHHH
Q 035917 546 LCGKGYDEEILQFLKVACNCVVSRPKDRW-----SMYQVYQSL 583 (611)
Q Consensus 546 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 583 (611)
......+..+.+++. +||+.||++|| +++|+++|.
T Consensus 284 ~~~~~~~~~~~~li~---~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 284 PYPQEMSALAKDLIQ---RLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CCCTTSCHHHHHHHH---HHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CCCcccCHHHHHHHH---HHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 011223344555554 99999999999 999999885
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=348.54 Aligned_cols=248 Identities=9% Similarity=0.011 Sum_probs=176.5
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhcc--CCCCcccee-------eEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQL--RHPNLAPLL-------GYC 388 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l--~H~nIv~l~-------g~~ 388 (611)
..+|...+.||+|+||.||+|+. .+|+.||||+++... ...+.+.+|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34577889999999999999996 478999999997643 2345677885444444 699988754 444
Q ss_pred EeC-----------------CeeEEEEeccCCCChHHhhhcCCCCCCHHHH------HHHHHHHHHHHHHHhhcCCCCee
Q 035917 389 VVE-----------------EEKLLIYKYMSSGTLYSLLQGNATELDWPTR------FRIGLGAARGLAWLHHGCQPPFL 445 (611)
Q Consensus 389 ~~~-----------------~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~iv 445 (611)
..+ ...++|||||+ |+|.+++......+++..+ ..++.|++.||+||| +.+|+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCc
Confidence 433 23799999999 8999999754334566666 788899999999999 78999
Q ss_pred ecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccCCCcccccccccccCC--CCCCcccchHHHHHHHHHHhCCCC
Q 035917 446 HQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSST--MVASLKGDVYGIGVVLLELAGFKG 523 (611)
Q Consensus 446 HrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SfGvvl~ell~~~~ 523 (611)
||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998763211 12247799999999987 679999999999999999999998
Q ss_pred CHHHHHHHHhhcCC---hhhhhchhhc---CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 524 NLVDWVNQLSSSGR---SKEAIDKALC---GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 524 ~~~~~~~~~~~~~~---~~~~~~~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
||............ .......... ....++++.+++. +||+.||++|||+.|+++|
T Consensus 292 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG---RFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp STTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHH---HHTCSSTTTCCCHHHHTTS
T ss_pred CCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHH---HHcCCChhhCCCHHHHhcC
Confidence 87432111000000 0000000110 0133455555555 9999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=364.39 Aligned_cols=258 Identities=20% Similarity=0.251 Sum_probs=200.0
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC----CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP----DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~----~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
.+.|...+.||+|+||.||+|+.. .+..||||+++... ...+.+.+|+.++++++||||+++++++. ++..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 456778899999999999999963 25679999986533 23467999999999999999999999984 566899
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
||||+++|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 99999999999999866557999999999999999999999 789999999999999999999999999999876433
Q ss_pred CCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHH
Q 035917 477 DESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEI 555 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 555 (611)
... ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||.......... ......... .....+.++
T Consensus 545 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~-~i~~~~~~~-~~~~~~~~l 621 (656)
T 2j0j_A 545 TYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG-RIENGERLP-MPPNCPPTL 621 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-HHHHTCCCC-CCTTCCHHH
T ss_pred cce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHcCCCCC-CCccccHHH
Confidence 221 1223357889999999988899999999999999999996 777764211100000 000000001 112233444
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
.+ ++.+||+.||++|||+.|+++.|+++.++.
T Consensus 622 ~~---li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 622 YS---LMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp HH---HHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HH---HHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 44 555999999999999999999999987653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=353.08 Aligned_cols=251 Identities=20% Similarity=0.265 Sum_probs=196.1
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
.+.|...+.||+|+||.||+|+.. ++..||||+++... ...+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456888899999999999999964 68999999996542 23467899999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC---CCCeEEeecccccccCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE---DFDARIMDFGLAKLMTS 475 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~---~~~~kl~DFGla~~~~~ 475 (611)
|||++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||+++....
T Consensus 116 e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 116 ECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999999988654 35899999999999999999999 789999999999999976 45599999999987653
Q ss_pred CCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCChhhhhchhhcCCC
Q 035917 476 SDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGRSKEAIDKALCGKG 550 (611)
Q Consensus 476 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~~ 550 (611)
.. ......||+.|+|||++. ..++.++|||||||++|||++|..||... ...... +... .+. .....
T Consensus 192 ~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~-~~~~--~~~-~~~~~ 263 (494)
T 3lij_A 192 QK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK-GKYT--FDS-PEWKN 263 (494)
T ss_dssp TB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-TCCC--CCS-GGGTT
T ss_pred Cc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCC--CCc-hhccc
Confidence 22 223456999999999886 46999999999999999999999887321 111110 0000 000 00122
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHchh
Q 035917 551 YDEEILQFLKVACNCVVSRPKDRWSMYQVYQS--LNSIAA 588 (611)
Q Consensus 551 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~ 588 (611)
.++++.+++. +||+.||++|||+.|+++| +.+...
T Consensus 264 ~s~~~~~li~---~~L~~dp~~R~s~~e~l~hp~~~~~~~ 300 (494)
T 3lij_A 264 VSEGAKDLIK---QMLQFDSQRRISAQQALEHPWIKEMCS 300 (494)
T ss_dssp SCHHHHHHHH---HHTCSSTTTSCCHHHHHTCHHHHHHHH
T ss_pred CCHHHHHHHH---HHCCCChhhCccHHHHhcCcccccCcc
Confidence 3455555555 9999999999999999977 555443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=341.78 Aligned_cols=256 Identities=18% Similarity=0.215 Sum_probs=191.4
Q ss_pred HHhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeC-------
Q 035917 320 MAASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE------- 391 (611)
Q Consensus 320 ~~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~------- 391 (611)
....++|...+.||+|+||.||+|+. .+|+.||||++.... +...+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP---RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 34567888899999999999999995 679999999986432 2234799999999999999999998543
Q ss_pred -------------------------------CeeEEEEeccCCCChHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHh
Q 035917 392 -------------------------------EEKLLIYKYMSSGTLYSLLQG---NATELDWPTRFRIGLGAARGLAWLH 437 (611)
Q Consensus 392 -------------------------------~~~~lv~ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH 437 (611)
...++||||+++ +|.+.+.. ....+++..+..++.|+++||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 337899999984 88777653 2346999999999999999999999
Q ss_pred hcCCCCeeecCCCCCeEEeC-CCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCC-CCCcccchHHHHHHH
Q 035917 438 HGCQPPFLHQNICSNVILVD-EDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVL 515 (611)
Q Consensus 438 ~~~~~~ivHrDlkp~NILld-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl 515 (611)
+.+|+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||.+.+. .++.++|||||||++
T Consensus 159 ---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 ---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp ---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred ---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 88999999999999997 688999999999987643322 2234689999999988764 489999999999999
Q ss_pred HHHhCCCCCHHH-----HHHHHhh---cCChhhhh--c--------hh--------hcCCCCHHHHHHHHHHHhhcccCC
Q 035917 516 LELAGFKGNLVD-----WVNQLSS---SGRSKEAI--D--------KA--------LCGKGYDEEILQFLKVACNCVVSR 569 (611)
Q Consensus 516 ~ell~~~~~~~~-----~~~~~~~---~~~~~~~~--~--------~~--------l~~~~~~~~~~~l~~l~~~Cl~~d 569 (611)
|||++|+.||.. ....... ........ + +. ......+.++.+ ++.+||+.|
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---li~~~L~~d 309 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAID---LLEQILRYE 309 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHH---HHHHHCCSS
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHH---HHHHHccCC
Confidence 999999887632 1111100 00000000 0 00 011123344444 555999999
Q ss_pred CCCCCCHHHHHHH--HHHchh
Q 035917 570 PKDRWSMYQVYQS--LNSIAA 588 (611)
Q Consensus 570 P~~RPs~~evl~~--L~~i~~ 588 (611)
|++|||+.|+++| ++++..
T Consensus 310 P~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 310 PDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp GGGSCCHHHHHTSGGGHHHHH
T ss_pred hhhCCCHHHHhcCHHHHHHHh
Confidence 9999999999976 555544
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=335.58 Aligned_cols=246 Identities=21% Similarity=0.286 Sum_probs=187.3
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCC------
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE------ 392 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~------ 392 (611)
.+.|...+.||+|+||.||+|+. .+|+.||||++.... ...+++.+|++++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 35678889999999999999996 579999999995432 23467899999999999999999999997653
Q ss_pred eeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccc
Q 035917 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKL 472 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~ 472 (611)
..++||||+ +++|.+++... .+++..+..++.|+++||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 459999999 78999998753 5899999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhh-cCCh-hhh---
Q 035917 473 MTSSDESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSS-SGRS-KEA--- 541 (611)
Q Consensus 473 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~-~~~~-~~~--- 541 (611)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. ....... .+.. .+.
T Consensus 178 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 178 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 5422 233468999999998876 6799999999999999999999887631 1111110 0000 000
Q ss_pred ---------hc--hhh-------cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 542 ---------ID--KAL-------CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 542 ---------~~--~~l-------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+. +.. .....+.++.++++ +||+.||++|||+.|+++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~---~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHH---HHSCSSTTTSCCHHHHHHS
T ss_pred hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHH---HHccCChhHCCCHHHHhcC
Confidence 00 000 00122344555555 9999999999999999987
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=335.04 Aligned_cols=250 Identities=20% Similarity=0.194 Sum_probs=185.9
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCC------
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE------ 392 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~------ 392 (611)
.++|...+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 35788889999999999999995 468999999996532 23467889999999999999999999997654
Q ss_pred eeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccc
Q 035917 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKL 472 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~ 472 (611)
..++||||+++ +|.+++.. .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 67999999975 78888863 4899999999999999999999 78999999999999999999999999999986
Q ss_pred cCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhhc-CC---------
Q 035917 473 MTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSSS-GR--------- 537 (611)
Q Consensus 473 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~~-~~--------- 537 (611)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.. ........ +.
T Consensus 177 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 177 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred ccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 54321 12334699999999999998999999999999999999999887631 11111100 00
Q ss_pred ------------------hhhhhchhhcCCCC---HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 538 ------------------SKEAIDKALCGKGY---DEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 538 ------------------~~~~~~~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
..........+... ......+.+++.+||+.||++|||++|+++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000000000 1112345566669999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=331.59 Aligned_cols=193 Identities=17% Similarity=0.233 Sum_probs=169.9
Q ss_pred hcCCCCCeeeecCCceEEEEEe--CCCCEEEEEeccccchhHHHHHHHHHHHhccCCCC------ccceeeEEEeCCeeE
Q 035917 324 NSFCSENVIISTRTGTTYKAML--PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPN------LAPLLGYCVVEEEKL 395 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~--~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~n------Iv~l~g~~~~~~~~~ 395 (611)
++|...+.||+|+||.||+|.. .+++.||||+++......+.+.+|+++++.++|++ ++++++++...+..+
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~ 93 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC 93 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence 4677889999999999999986 36889999999776555678899999999987654 999999999999999
Q ss_pred EEEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC----------------
Q 035917 396 LIYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE---------------- 458 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~---------------- 458 (611)
+||||+ +++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.
T Consensus 94 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 999999 889999997654 36899999999999999999999 789999999999999987
Q ss_pred ---CCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCH
Q 035917 459 ---DFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNL 525 (611)
Q Consensus 459 ---~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~ 525 (611)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 234 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234 (339)
T ss_dssp EESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 6789999999998653321 2346899999999999989999999999999999999998876
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=327.63 Aligned_cols=246 Identities=16% Similarity=0.267 Sum_probs=195.3
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc----------hhHHHHHHHHHHHhccC-CCCccceeeEEEe
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK----------LGEKKFRNEMNRLGQLR-HPNLAPLLGYCVV 390 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----------~~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~ 390 (611)
.++|...+.||+|+||.||+|+.. +|+.||||+++... ...+.+.+|++++++++ ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 457888899999999999999964 68999999986432 12356889999999996 9999999999999
Q ss_pred CCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccc
Q 035917 391 EEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLA 470 (611)
Q Consensus 391 ~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla 470 (611)
++..++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999999754 46899999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCCccccCCCcccccccccccC------CCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCChh
Q 035917 471 KLMTSSDESSFVNGDLGEFGYIAPEYSS------TMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGRSK 539 (611)
Q Consensus 471 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~~~ 539 (611)
+....... .....||+.|+|||++. ...++.++||||||+++|||++|..||... ....... ...
T Consensus 172 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~ 247 (298)
T 1phk_A 172 CQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG-NYQ 247 (298)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-CCC
T ss_pred hhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC-Ccc
Confidence 87643321 23346899999999874 456889999999999999999998876321 1111100 000
Q ss_pred hhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 540 EAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 540 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.. .......++++.+ ++.+||+.||++|||+.|+++|
T Consensus 248 --~~-~~~~~~~~~~l~~---li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 248 --FG-SPEWDDYSDTVKD---LVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp --CC-TTTGGGSCHHHHH---HHHHHCCSSGGGSCCHHHHTTS
T ss_pred --cC-cccccccCHHHHH---HHHHHccCCcccCCCHHHHHhC
Confidence 00 0000122344445 4459999999999999999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=333.03 Aligned_cols=249 Identities=19% Similarity=0.295 Sum_probs=174.2
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc--hhHHHHHHHHH-HHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK--LGEKKFRNEMN-RLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ev~-~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
++|...+.||+|+||.||+|.. .+|+.||||+++... ....++..|+. +++.++||||+++++++..++..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 5677889999999999999997 478999999996542 23345666666 7788899999999999999999999999
Q ss_pred ccCCCChHHhhhc----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeeecCCCCCeEEeCCCCCeEEeecccccccC
Q 035917 400 YMSSGTLYSLLQG----NATELDWPTRFRIGLGAARGLAWLHHGCQP-PFLHQNICSNVILVDEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 400 y~~~gsL~~~l~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDlkp~NILld~~~~~kl~DFGla~~~~ 474 (611)
|+++ +|.+++.. ....+++..+..++.+++.||.||| +. +|+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9986 88877752 2346899999999999999999999 56 99999999999999999999999999998764
Q ss_pred CCCCCccccCCCccccccccccc----CCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcC--
Q 035917 475 SSDESSFVNGDLGEFGYIAPEYS----STMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCG-- 548 (611)
Q Consensus 475 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-- 548 (611)
.... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||..+...............+.+..
T Consensus 178 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3aln_A 178 DSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSE 254 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCS
T ss_pred cccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcc
Confidence 3221 1223589999999998 456789999999999999999999988754321111100111111111111
Q ss_pred -CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 549 -KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 549 -~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
...+.++.+++. +||+.||++||++.|++++
T Consensus 255 ~~~~~~~l~~li~---~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 255 EREFSPSFINFVN---LCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp SCCCCHHHHHHHH---HHTCSSGGGSCCHHHHTTS
T ss_pred cccCCHHHHHHHH---HHhhCChhhCcCHHHHHhC
Confidence 123445555554 9999999999999999876
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=337.21 Aligned_cols=195 Identities=23% Similarity=0.292 Sum_probs=151.7
Q ss_pred CCC-CCeeeecCCceEEEEEeC---CCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEe--CCeeEEEEe
Q 035917 326 FCS-ENVIISTRTGTTYKAMLP---DGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVV--EEEKLLIYK 399 (611)
Q Consensus 326 f~~-~~~ig~G~~g~Vy~~~~~---~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~--~~~~~lv~e 399 (611)
|.. +++||+|+||.||+|+.. +++.||||+++.... .+.+.+|+.+|++++||||+++++++.. ....++|||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e 100 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 100 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEe
Confidence 443 568999999999999965 578999999975432 3468899999999999999999999965 668899999
Q ss_pred ccCCCChHHhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEe----CCCCCeEEeec
Q 035917 400 YMSSGTLYSLLQGN--------ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV----DEDFDARIMDF 467 (611)
Q Consensus 400 y~~~gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl----d~~~~~kl~DF 467 (611)
|+.+ +|.+++... ...+++..++.++.||+.||+||| +.+|+||||||+|||+ +.++.+||+||
T Consensus 101 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 101 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp CCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred CCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 9975 888877521 124899999999999999999999 7899999999999999 77889999999
Q ss_pred ccccccCCCCC-CccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCH
Q 035917 468 GLAKLMTSSDE-SSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNL 525 (611)
Q Consensus 468 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~ 525 (611)
|+++....... .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 236 (405)
T 3rgf_A 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 236 (405)
T ss_dssp TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCC
Confidence 99987643221 122234579999999999877 45899999999999999999998887
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=333.21 Aligned_cols=251 Identities=18% Similarity=0.252 Sum_probs=193.1
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeC-----Cee
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE-----EEK 394 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~-----~~~ 394 (611)
.+.|...+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 45788889999999999999995 468899999997533 2346789999999999999999999999765 367
Q ss_pred EEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccC
Q 035917 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~ 474 (611)
++||||+.+ +|.+++... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 106 ~iv~e~~~~-~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEECCSE-EHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEcccCc-CHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 999999974 999998754 4899999999999999999999 7899999999999999999999999999998764
Q ss_pred CCCC-CccccCCCcccccccccccC-CCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHh---hcCChhh----
Q 035917 475 SSDE-SSFVNGDLGEFGYIAPEYSS-TMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLS---SSGRSKE---- 540 (611)
Q Consensus 475 ~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~---~~~~~~~---- 540 (611)
.... ........||+.|+|||++. ...++.++|||||||++|||++|+.||... ..... .......
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 3321 11223457999999999864 455899999999999999999998876321 11100 0000000
Q ss_pred -------hhch---------hhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 541 -------AIDK---------ALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 541 -------~~~~---------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.... .......+.++ .+++.+||+.||++|||+.|+++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKA---LDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHH---HHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHH---HHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 00001123344 445559999999999999999987
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=339.93 Aligned_cols=246 Identities=21% Similarity=0.236 Sum_probs=185.5
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeC----C--eeEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE----E--EKLL 396 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~----~--~~~l 396 (611)
..|...+.||+|+||.||+|+.. +|+.||||++.... +.+.+|+++|++++|||||++++++... + ..++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 35777899999999999999974 69999999986432 2245799999999999999999998642 2 3569
Q ss_pred EEeccCCCChHHhhh---cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCC-CCeEEeecccccc
Q 035917 397 IYKYMSSGTLYSLLQ---GNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDED-FDARIMDFGLAKL 472 (611)
Q Consensus 397 v~ey~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~-~~~kl~DFGla~~ 472 (611)
||||+++ +|.+.+. .....+++..+..++.||++||+||| +.+|+||||||+|||++.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999986 6766554 23356999999999999999999999 8899999999999999955 5689999999987
Q ss_pred cCCCCCCccccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhhc-C-Chhhh---
Q 035917 473 MTSSDESSFVNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSSS-G-RSKEA--- 541 (611)
Q Consensus 473 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~~-~-~~~~~--- 541 (611)
+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.. ........ + ...+.
T Consensus 207 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 207 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp CCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred cccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 643322 2234689999999998664 789999999999999999999988632 11111100 0 00000
Q ss_pred hch--------hh--------cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 542 IDK--------AL--------CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 542 ~~~--------~l--------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
..+ .+ .....+.++.+ ++.+||+.||++|||+.|+++|
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~---Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIA---LCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHH---HHHHHSCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHH---HHHHhccCChhHCCCHHHHhCC
Confidence 000 00 01112344444 5559999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=335.39 Aligned_cols=198 Identities=18% Similarity=0.209 Sum_probs=171.0
Q ss_pred hhhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccchhHHHHHHHHHHHhccC-CC-----CccceeeEEEeCCee
Q 035917 322 ASNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLGEKKFRNEMNRLGQLR-HP-----NLAPLLGYCVVEEEK 394 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~-H~-----nIv~l~g~~~~~~~~ 394 (611)
..++|...+.||+|+||.||+|+.. +++.||||+++......+++.+|+.++..++ |+ +|+++++++...+..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 4568888999999999999999964 6889999999866555677888999998885 55 499999999999999
Q ss_pred EEEEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC--CCCCeEEeeccccc
Q 035917 395 LLIYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD--EDFDARIMDFGLAK 471 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld--~~~~~kl~DFGla~ 471 (611)
++||||++ |+|.+++.... ..+++..+..++.|++.||.|||.. ..+|+||||||+|||++ .++.+||+|||+++
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 99999996 59999997654 4699999999999999999999942 46899999999999994 57889999999998
Q ss_pred ccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHH
Q 035917 472 LMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLV 526 (611)
Q Consensus 472 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~ 526 (611)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 210 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~ 259 (382)
T 2vx3_A 210 QLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFS 259 (382)
T ss_dssp ETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 76432 123468999999999999899999999999999999999998863
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=328.38 Aligned_cols=245 Identities=19% Similarity=0.272 Sum_probs=189.2
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch---------hHHHHHHHHHHHhccCCCCccceeeEEEeCC
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL---------GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE 392 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~---------~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~ 392 (611)
.++|...+.||+|+||.||+|+. .+++.||||++..... ....+.+|++++++++||||+++++++..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 45788899999999999999996 4689999999865321 1235889999999999999999999987654
Q ss_pred eeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCC---eEEeeccc
Q 035917 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFD---ARIMDFGL 469 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~---~kl~DFGl 469 (611)
.++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++. +||+|||+
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred -eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 89999999999999998754 46899999999999999999999 789999999999999987654 99999999
Q ss_pred ccccCCCCCCccccCCCccccccccccc---CCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh
Q 035917 470 AKLMTSSDESSFVNGDLGEFGYIAPEYS---STMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL 546 (611)
Q Consensus 470 a~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l 546 (611)
++...... ......||+.|+|||++ ....++.++|||||||++|||++|..||.... ......+.+....
T Consensus 164 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~ 236 (322)
T 2ycf_A 164 SKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR----TQVSLKDQITSGK 236 (322)
T ss_dssp CEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT----CSSCHHHHHHHTC
T ss_pred ceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc----hHHHHHHHHHhCc
Confidence 98764321 11223589999999986 35678999999999999999999988873210 0001111111000
Q ss_pred c------CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 547 C------GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 547 ~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
. ....++++. +++.+||+.||++||++.|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~---~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 237 YNFIPEVWAEVSEKAL---DLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp CCCCHHHHTTSCHHHH---HHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccCchhhhhcCHHHH---HHHHHHcccCHhhCCCHHHHhhC
Confidence 0 012233444 45559999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=330.98 Aligned_cols=251 Identities=18% Similarity=0.220 Sum_probs=191.5
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeC-----Cee
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE-----EEK 394 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~-----~~~ 394 (611)
.++|...+.||+|+||.||+|+.. +|+.||||+++... ....++.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 457888899999999999999964 68999999996433 2346788999999999999999999988754 568
Q ss_pred EEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccC
Q 035917 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~ 474 (611)
++||||+. |+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 99999997 5999998753 5899999999999999999999 7899999999999999999999999999998764
Q ss_pred CCCCC--------ccccCCCcccccccccccC-CCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHh---hcCC
Q 035917 475 SSDES--------SFVNGDLGEFGYIAPEYSS-TMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLS---SSGR 537 (611)
Q Consensus 475 ~~~~~--------~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~---~~~~ 537 (611)
..... .......||+.|+|||++. +..++.++|||||||++|||++|+.||... ..... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 32211 1122346899999999865 467899999999999999999998876321 10000 0000
Q ss_pred ------------hhhhhchh---------hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 538 ------------SKEAIDKA---------LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 538 ------------~~~~~~~~---------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
..+.+... ......+.++. +++.+||+.||++|||+.|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGI---DLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH---HHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHH---HHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000 00012233444 45559999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=335.23 Aligned_cols=248 Identities=13% Similarity=0.138 Sum_probs=196.3
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhccC-----------CCCccceeeEEEeC
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLR-----------HPNLAPLLGYCVVE 391 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~-----------H~nIv~l~g~~~~~ 391 (611)
++|...+.||+|+||.||+|+. .+++.||||++.......+.+.+|+.++++++ ||||+++++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 4677889999999999999995 57899999999876666678899999999886 89999999999865
Q ss_pred C----eeEEEEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeeecCCCCCeEEeC------CC
Q 035917 392 E----EKLLIYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQP-PFLHQNICSNVILVD------ED 459 (611)
Q Consensus 392 ~----~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDlkp~NILld------~~ 459 (611)
+ ..++||||+ +++|.+++.... ..+++..+..++.||+.||+||| +. +|+||||||+|||++ ..
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCcCc
Confidence 4 688999999 889999997643 36999999999999999999999 66 999999999999994 44
Q ss_pred CCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHH--------
Q 035917 460 FDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQ-------- 531 (611)
Q Consensus 460 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~-------- 531 (611)
+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 175 ~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 58999999999876432 12336899999999999889999999999999999999999887532100
Q ss_pred ---Hhh-cCCh--------------------------------hhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCC
Q 035917 532 ---LSS-SGRS--------------------------------KEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWS 575 (611)
Q Consensus 532 ---~~~-~~~~--------------------------------~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 575 (611)
... .+.. .+.... ...........+.+++.+||+.||++|||
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHhccCccccCC
Confidence 000 0000 000000 01122344556777778999999999999
Q ss_pred HHHHHHH
Q 035917 576 MYQVYQS 582 (611)
Q Consensus 576 ~~evl~~ 582 (611)
+.|+++|
T Consensus 328 ~~ell~h 334 (373)
T 1q8y_A 328 AGGLVNH 334 (373)
T ss_dssp HHHHHTC
T ss_pred HHHHhhC
Confidence 9999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=328.80 Aligned_cols=266 Identities=18% Similarity=0.186 Sum_probs=188.8
Q ss_pred HHHHHhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCe--
Q 035917 317 ADLMAASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEE-- 393 (611)
Q Consensus 317 ~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~-- 393 (611)
.+.....++|...+.||+|+||.||+|+. .+|+.||||++.........+.+|++.+..++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34556778999999999999999999996 468999999986654444567888999999999999999999976443
Q ss_pred -----eEEEEeccCCCChHHhhh---cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC-CCCeEE
Q 035917 394 -----KLLIYKYMSSGTLYSLLQ---GNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE-DFDARI 464 (611)
Q Consensus 394 -----~~lv~ey~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~-~~~~kl 464 (611)
.++||||+++ +|.+.+. .....+++..+..++.|++.||.|||.. +.+|+||||||+|||++. ++.+||
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEEE
Confidence 7899999986 5554443 2334689999999999999999999932 578999999999999996 899999
Q ss_pred eecccccccCCCCCCccccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhh-cC-
Q 035917 465 MDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSS-SG- 536 (611)
Q Consensus 465 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~-~~- 536 (611)
+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.. ....... .+
T Consensus 174 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 250 (360)
T 3e3p_A 174 CDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250 (360)
T ss_dssp CCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred eeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence 99999987653322 2234689999999988654 489999999999999999999887631 1111100 00
Q ss_pred Chhhh---hchh----------------hcC---CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHchhhh
Q 035917 537 RSKEA---IDKA----------------LCG---KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS--LNSIAAQH 590 (611)
Q Consensus 537 ~~~~~---~~~~----------------l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~~~ 590 (611)
...+. +++. ... ...+++ +.+++.+||+.||++|||+.|+++| ++++....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 325 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKE---AYDLLSALLQYLPEERMKPYEALCHPYFDELHDPA 325 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHH---HHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTT
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHH---HHHHHHHHhccCccccCCHHHHhcCccccccCCcc
Confidence 00000 0000 000 012334 4455559999999999999999987 55554443
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=329.94 Aligned_cols=247 Identities=17% Similarity=0.196 Sum_probs=169.8
Q ss_pred hhcCCC-CCeeeecCCceEEEEEeC-CCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEe----CCeeEE
Q 035917 323 SNSFCS-ENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVV----EEEKLL 396 (611)
Q Consensus 323 t~~f~~-~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~----~~~~~l 396 (611)
.++|.. .++||+|+||.||+|+.. +|+.||||++.......+ +....+..++||||+++++++.. +...++
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 456766 457999999999999965 699999999965432222 22234566789999999999976 445789
Q ss_pred EEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC---CCCeEEeecccccc
Q 035917 397 IYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE---DFDARIMDFGLAKL 472 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~---~~~~kl~DFGla~~ 472 (611)
||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||+++.
T Consensus 104 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 999999999999998654 36999999999999999999999 789999999999999976 45699999999986
Q ss_pred cCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc-----hhhc
Q 035917 473 MTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID-----KALC 547 (611)
Q Consensus 473 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~-----~~l~ 547 (611)
..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.................. +...
T Consensus 181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (336)
T 3fhr_A 181 TTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 256 (336)
T ss_dssp C--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTT
T ss_pred ccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchh
Confidence 54322 22345899999999998888999999999999999999999988543222111100000000 0001
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 548 GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 548 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
....++++.+++. +||+.||++|||+.|+++|
T Consensus 257 ~~~~~~~~~~li~---~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 257 WSEVSEDAKQLIR---LLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp STTCCHHHHHHHH---HHSCSSGGGSCCHHHHHHS
T ss_pred hccCCHHHHHHHH---HHCCCChhHCcCHHHHhcC
Confidence 1223455555555 9999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=359.22 Aligned_cols=247 Identities=17% Similarity=0.163 Sum_probs=200.2
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~l 396 (611)
.++|...++||+|+||.||+|+. .+++.||||+++... ...+.+..|..++..+ +||||+++++++.+.+..++
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 45788889999999999999996 468899999996532 2335688999999988 79999999999999999999
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
||||+++|+|.+++... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 420 V~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 99999999999999754 35999999999999999999999 789999999999999999999999999999864322
Q ss_pred CCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-hcCCCCHHHH
Q 035917 477 DESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-LCGKGYDEEI 555 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~ 555 (611)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|..||........ ...++... ..+...+.++
T Consensus 496 ~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~ 569 (674)
T 3pfq_A 496 GV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL----FQSIMEHNVAYPKSMSKEA 569 (674)
T ss_dssp TC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHSSCCCCCTTSCHHH
T ss_pred Cc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH----HHHHHhCCCCCCccCCHHH
Confidence 21 23345799999999999999999999999999999999999998742100000 01111111 1123345666
Q ss_pred HHHHHHHhhcccCCCCCCCCH-----HHHHHH
Q 035917 556 LQFLKVACNCVVSRPKDRWSM-----YQVYQS 582 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~-----~evl~~ 582 (611)
.++++ +||+.||++||++ +||++|
T Consensus 570 ~~li~---~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 570 VAICK---GLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHHHH---HHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHHHH---HHccCCHHHCCCCCCCcHHHHhcC
Confidence 66666 9999999999997 788765
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=337.08 Aligned_cols=253 Identities=15% Similarity=0.209 Sum_probs=188.4
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCe------eEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEE------KLLI 397 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~------~~lv 397 (611)
..|...++||+|+||.||+|+..++..||+|++.... +...+|+++++.++||||+++++++...+. .++|
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~---~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK---RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT---TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc---chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 4677889999999999999998777779999885432 123479999999999999999999976443 7899
Q ss_pred EeccCCCChHHhhh--cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC-CCCCeEEeecccccccC
Q 035917 398 YKYMSSGTLYSLLQ--GNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD-EDFDARIMDFGLAKLMT 474 (611)
Q Consensus 398 ~ey~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld-~~~~~kl~DFGla~~~~ 474 (611)
|||++++.+..... .....+++..+..++.|+++||+||| +.+|+||||||+|||++ .++.+||+|||+++...
T Consensus 117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 99998754333221 12346999999999999999999999 78999999999999999 79999999999998764
Q ss_pred CCCCCccccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhh---cCChh--hhhc
Q 035917 475 SSDESSFVNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSS---SGRSK--EAID 543 (611)
Q Consensus 475 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~---~~~~~--~~~~ 543 (611)
.... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.. ....... ..... ....
T Consensus 194 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 194 AGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp TTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred CCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 3322 2234689999999988664 589999999999999999999988732 1111110 00000 0000
Q ss_pred hh----------------hcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHchh
Q 035917 544 KA----------------LCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS--LNSIAA 588 (611)
Q Consensus 544 ~~----------------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~ 588 (611)
+. ......+.++.+ ++.+||+.||++|||+.|+++| ++++..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAID---LISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHH---HHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHH---HHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 00 001112344444 5559999999999999999987 555443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=331.79 Aligned_cols=245 Identities=20% Similarity=0.251 Sum_probs=188.5
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCee----
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK---- 394 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~---- 394 (611)
.+.|...+.||+|+||.||+|+. .+|+.||||++.... ...+++.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 35677889999999999999995 468999999997532 2346789999999999999999999999876654
Q ss_pred --EEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccc
Q 035917 395 --LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKL 472 (611)
Q Consensus 395 --~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~ 472 (611)
++||||+. |+|.+++.. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999997 589888853 4899999999999999999999 78999999999999999999999999999986
Q ss_pred cCCCCCCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhh-cCCh-hhh---
Q 035917 473 MTSSDESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSS-SGRS-KEA--- 541 (611)
Q Consensus 473 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~-~~~~-~~~--- 541 (611)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. ....... .+.. .+.
T Consensus 194 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 194 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence 5322 223468999999998876 6789999999999999999999887631 1111100 0000 000
Q ss_pred --------hchhh----------cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 542 --------IDKAL----------CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 542 --------~~~~l----------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
....+ .....++++.+ ++.+||+.||++|||+.|+++|
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAAD---LLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHH---HHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHH---HHHHHCCCChhhcCCHHHHhcC
Confidence 00000 00112344444 5559999999999999999987
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=327.74 Aligned_cols=252 Identities=21% Similarity=0.266 Sum_probs=193.9
Q ss_pred HhhhcCCCCCeeeecCCceEEEEEe--CCCCEEEEEeccccch---hHHHHHHHHHHHhcc---CCCCccceeeEEE---
Q 035917 321 AASNSFCSENVIISTRTGTTYKAML--PDGSVLAVKRLNTCKL---GEKKFRNEMNRLGQL---RHPNLAPLLGYCV--- 389 (611)
Q Consensus 321 ~~t~~f~~~~~ig~G~~g~Vy~~~~--~~g~~vAvK~~~~~~~---~~~~~~~Ev~~l~~l---~H~nIv~l~g~~~--- 389 (611)
.+.++|...+.||+|+||.||+|+. .+|+.||||+++.... ....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3456788899999999999999997 4688999999864322 123567788777766 8999999999987
Q ss_pred --eCCeeEEEEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEee
Q 035917 390 --VEEEKLLIYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMD 466 (611)
Q Consensus 390 --~~~~~~lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~D 466 (611)
.....++||||++ |+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEec
Confidence 4567889999998 69999987654 35899999999999999999999 78999999999999999999999999
Q ss_pred cccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhh---cCCh
Q 035917 467 FGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSS---SGRS 538 (611)
Q Consensus 467 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~---~~~~ 538 (611)
||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.. ....... ....
T Consensus 164 fg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 164 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred CcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 9999865422 122345689999999999988999999999999999999999887631 1111110 0000
Q ss_pred h----------hhhch------hhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 539 K----------EAIDK------ALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 539 ~----------~~~~~------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
. ..... .......++++.+++. +||+.||++|||+.|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL---KCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHH---HHSCSSTTTSCCHHHHHTS
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHH---HHcCCCcccCCCHHHHhcC
Confidence 0 00000 0001223445555555 9999999999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=321.59 Aligned_cols=246 Identities=19% Similarity=0.274 Sum_probs=195.6
Q ss_pred hhhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEE
Q 035917 322 ASNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
..++|...+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|++++++++||||+++++++...+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3467888999999999999999965 78999999986432 3457899999999999999999999999999999999
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCC---CCeEEeecccccccC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDED---FDARIMDFGLAKLMT 474 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~---~~~kl~DFGla~~~~ 474 (611)
|||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.+ +.+||+|||+++...
T Consensus 100 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 100 GELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 9999999999988644 35899999999999999999999 7899999999999999754 479999999998764
Q ss_pred CCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCChhhhhchhhcCC
Q 035917 475 SSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGRSKEAIDKALCGK 549 (611)
Q Consensus 475 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~ 549 (611)
..... ....||+.|+|||.+.+ .++.++||||||+++|||++|..||... ...... +... .+ .....
T Consensus 176 ~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~--~~-~~~~~ 247 (287)
T 2wei_A 176 QNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET-GKYA--FD-LPQWR 247 (287)
T ss_dssp CCSSC---SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-CCCC--CC-SGGGT
T ss_pred CCCcc---ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-CCCC--CC-chhhh
Confidence 33211 22248999999998876 4899999999999999999998886321 111111 0000 00 00012
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 550 GYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 550 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
..++++.+++. +||+.||++|||+.|++++
T Consensus 248 ~~~~~~~~li~---~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 248 TISDDAKDLIR---KMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp TSCHHHHHHHH---HHTCSSGGGSCCHHHHHHS
T ss_pred hcCHHHHHHHH---HHcccChhhCcCHHHHhcC
Confidence 23445555555 9999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=342.87 Aligned_cols=250 Identities=20% Similarity=0.195 Sum_probs=181.5
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEEEEeccC
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
.+|...++||+|+||+||.....+|+.||||++..... ..+.+|+++|+++ +|||||++++++.+.+..++|||||.
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence 45777899999999997655566899999999965322 2356899999999 79999999999999999999999996
Q ss_pred CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC-----CCCCeEEeecccccccCCCC
Q 035917 403 SGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD-----EDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 403 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld-----~~~~~kl~DFGla~~~~~~~ 477 (611)
|+|.+++........+..+..++.||+.||.||| +.+|+||||||+|||++ ....+||+|||+++......
T Consensus 102 -g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 102 -ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp -EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred -CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 5999999866545555667789999999999999 78999999999999994 33468899999998765332
Q ss_pred C-CccccCCCcccccccccccC---CCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCH
Q 035917 478 E-SSFVNGDLGEFGYIAPEYSS---TMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYD 552 (611)
Q Consensus 478 ~-~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 552 (611)
. ........||+.|+|||++. ...++.++|||||||++|||++ |..||.......... ........... ...
T Consensus 178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~--~~~~~~~~~~~-~~~ 254 (432)
T 3p23_A 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI--LLGACSLDCLH-PEK 254 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH--HTTCCCCTTSC-TTC
T ss_pred cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH--HhccCCccccC-ccc
Confidence 1 12233456999999999987 4567889999999999999999 777763211000000 00000000000 011
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 553 EEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 553 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
..-..+.+++.+||+.||++|||+.||++|
T Consensus 255 ~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 255 HEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp HHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 112234455559999999999999999965
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=333.81 Aligned_cols=246 Identities=20% Similarity=0.287 Sum_probs=175.7
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeC------C
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE------E 392 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~------~ 392 (611)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ...+++.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 35788889999999999999995 568999999996532 2346788999999999999999999998754 5
Q ss_pred eeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccc
Q 035917 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKL 472 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~ 472 (611)
..++|+||+ +++|.+++.. ..+++..+..++.||++||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 579999999 6799998875 35999999999999999999999 78999999999999999999999999999986
Q ss_pred cCCCCCCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhh-cCC-hhhhhc-
Q 035917 473 MTSSDESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSS-SGR-SKEAID- 543 (611)
Q Consensus 473 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~-~~~-~~~~~~- 543 (611)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. ....... .+. ..+.+.
T Consensus 182 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 182 TADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred cccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 5322 223468999999999876 6789999999999999999999887632 1111110 000 000000
Q ss_pred ----------hhhc---C-------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 544 ----------KALC---G-------KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 544 ----------~~l~---~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
..+. . ...+.++ .+++.+||+.||++|||+.|+++|
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLA---VDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHH---HHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHH---HHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000 0 1122334 445559999999999999999987
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=324.18 Aligned_cols=250 Identities=18% Similarity=0.232 Sum_probs=183.8
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEE------------
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCV------------ 389 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~------------ 389 (611)
+.|...+.||+|+||.||+|+.. +++.||||++.... ...+++.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 46777899999999999999975 48999999986543 34467899999999999999999999874
Q ss_pred --eCCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC-CCCCeEEee
Q 035917 390 --VEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD-EDFDARIMD 466 (611)
Q Consensus 390 --~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld-~~~~~kl~D 466 (611)
..+..++||||++ |+|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+||+++ +++.+||+|
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 3467899999998 599999864 35899999999999999999999 78999999999999997 567999999
Q ss_pred cccccccCCCCC-CccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhhcCC-h
Q 035917 467 FGLAKLMTSSDE-SSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSSSGR-S 538 (611)
Q Consensus 467 FGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~~~~-~ 538 (611)
||+++....... ........+|..|+|||.+.+ ..++.++|||||||++|||++|+.||.. .......... .
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999987643211 111222357899999998754 6789999999999999999999887631 1111110000 0
Q ss_pred -----hh-------hhchhh---------cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 539 -----KE-------AIDKAL---------CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 539 -----~~-------~~~~~l---------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+ .+.... .....+.++.+++ .+||+.||++|||+.|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li---~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFL---EQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHH---HTTSCSSGGGSCCHHHHHTS
T ss_pred chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHH---HHHcCCCccccCCHHHHhCC
Confidence 00 000000 0112334445544 49999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.25 Aligned_cols=193 Identities=17% Similarity=0.223 Sum_probs=168.1
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CC-CEEEEEeccccchhHHHHHHHHHHHhccCCCC------ccceeeEEEeCCeeE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DG-SVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPN------LAPLLGYCVVEEEKL 395 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g-~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~n------Iv~l~g~~~~~~~~~ 395 (611)
++|...+.||+|+||.||+|+.. ++ +.||||+++......+.+.+|+.++++++|++ ++.+.+++...+..+
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC 98 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence 56788899999999999999964 34 68999999876556678899999999997766 899999999999999
Q ss_pred EEEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEe------------------
Q 035917 396 LIYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV------------------ 456 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl------------------ 456 (611)
+||||+ +++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||+
T Consensus 99 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 99 IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred EEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccccc
Confidence 999999 567777776543 46999999999999999999999 8899999999999999
Q ss_pred -CCCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCH
Q 035917 457 -DEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNL 525 (611)
Q Consensus 457 -d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~ 525 (611)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 175 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 239 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF 239 (355)
T ss_dssp EESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 567899999999998653321 2346999999999999989999999999999999999998886
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=329.67 Aligned_cols=241 Identities=16% Similarity=0.236 Sum_probs=195.7
Q ss_pred hhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch-------hHHHHHHHHHHHhccC--CCCccceeeEEEeC
Q 035917 322 ASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL-------GEKKFRNEMNRLGQLR--HPNLAPLLGYCVVE 391 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~-------~~~~~~~Ev~~l~~l~--H~nIv~l~g~~~~~ 391 (611)
..++|...+.||+|+||.||+|+. .+++.||||+++.... ..+.+.+|+.++++++ ||||+++++++..+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 345688889999999999999985 5789999999965432 2245778999999996 59999999999999
Q ss_pred CeeEEEEeccCC-CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC-CCCCeEEeeccc
Q 035917 392 EEKLLIYKYMSS-GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD-EDFDARIMDFGL 469 (611)
Q Consensus 392 ~~~~lv~ey~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld-~~~~~kl~DFGl 469 (611)
+..++||||+.+ ++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++ +++.+||+|||+
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred CcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 999999999976 8999998754 45899999999999999999999 78999999999999999 788999999999
Q ss_pred ccccCCCCCCccccCCCcccccccccccCCCCC-CcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcC
Q 035917 470 AKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVA-SLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCG 548 (611)
Q Consensus 470 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 548 (611)
++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... .....
T Consensus 197 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---------~~~~~ 263 (320)
T 3a99_A 197 GALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG---------QVFFR 263 (320)
T ss_dssp CEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHC---------CCCCS
T ss_pred cccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcc---------ccccc
Confidence 98764322 223469999999999877665 68899999999999999999887432111110 01112
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 549 KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 549 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
...++++.+++. +||+.||++|||+.|++++
T Consensus 264 ~~~~~~~~~li~---~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 264 QRVSSECQHLIR---WCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp SCCCHHHHHHHH---HHTCSSGGGSCCHHHHHTS
T ss_pred ccCCHHHHHHHH---HHccCChhhCcCHHHHhcC
Confidence 234455555555 9999999999999999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=324.62 Aligned_cols=244 Identities=20% Similarity=0.261 Sum_probs=188.1
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCe------
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEE------ 393 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~------ 393 (611)
++|...+.||+|+||.||+|+. .+|+.||||++.... ...+++.+|+.++++++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 4677789999999999999996 468999999996532 224678999999999999999999999987654
Q ss_pred eEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccccc
Q 035917 394 KLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLM 473 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~ 473 (611)
.++||||+. |+|.+++.. .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 104 ~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred EEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 499999997 599888753 4899999999999999999999 789999999999999999999999999999865
Q ss_pred CCCCCCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhhc-CCh-h------
Q 035917 474 TSSDESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSSS-GRS-K------ 539 (611)
Q Consensus 474 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~~-~~~-~------ 539 (611)
... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.. ........ +.. .
T Consensus 177 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 251 (353)
T 3coi_A 177 DAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 251 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred CCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence 322 223468999999998876 6789999999999999999999887631 11111000 000 0
Q ss_pred ------hhhc-------hhh--cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 540 ------EAID-------KAL--CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 540 ------~~~~-------~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
..+. +.. .....+.++.+++. +||+.||++|||+.|+++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLE---KMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp SCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHH---HHSCSCTTTSCCHHHHHTS
T ss_pred hhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHH---HHcCCCcccCCCHHHHhcC
Confidence 0000 000 00123445555555 9999999999999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=324.37 Aligned_cols=243 Identities=17% Similarity=0.224 Sum_probs=188.4
Q ss_pred HHhhhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch-------hHHHHHHHHHHHhcc----CCCCccceeeE
Q 035917 320 MAASNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL-------GEKKFRNEMNRLGQL----RHPNLAPLLGY 387 (611)
Q Consensus 320 ~~~t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~-------~~~~~~~Ev~~l~~l----~H~nIv~l~g~ 387 (611)
....++|...+.||+|+||.||+|+. .+++.||||+++.... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34456799999999999999999985 5789999999965432 123467899999998 89999999999
Q ss_pred EEeCCeeEEEEec-cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC-CCCCeEEe
Q 035917 388 CVVEEEKLLIYKY-MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD-EDFDARIM 465 (611)
Q Consensus 388 ~~~~~~~~lv~ey-~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld-~~~~~kl~ 465 (611)
+...+..++|||| +.+++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++ .++.+||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEEC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEEE
Confidence 9999999999999 7899999999754 35899999999999999999999 78999999999999999 88999999
Q ss_pred ecccccccCCCCCCccccCCCcccccccccccCCCCCC-cccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhch
Q 035917 466 DFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVAS-LKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDK 544 (611)
Q Consensus 466 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (611)
|||+++...... .....||..|+|||++.+..+. .++|||||||++|||++|+.||.......... .
T Consensus 183 dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--------~ 250 (312)
T 2iwi_A 183 DFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAE--------L 250 (312)
T ss_dssp CCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHTC--------C
T ss_pred EcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhhc--------c
Confidence 999998765432 2234589999999988766664 58999999999999999998874321111100 0
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 545 ALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 545 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
......+.++.+++. +||+.||++|||+.|++++
T Consensus 251 -~~~~~~~~~~~~li~---~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 251 -HFPAHVSPDCCALIR---RCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -CCCTTSCHHHHHHHH---HHTCSSTTTSCCHHHHHHS
T ss_pred -CCcccCCHHHHHHHH---HHccCChhhCcCHHHHhcC
Confidence 011233445555555 9999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=323.32 Aligned_cols=244 Identities=17% Similarity=0.273 Sum_probs=175.0
Q ss_pred hhcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccchh--H-HHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLG--E-KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~--~-~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
.++|...+.||+|+||.||+|+.. +|+.||||++...... . +.+.++..+++.++||||+++++++..++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 356777889999999999999974 7999999999654322 2 33445556788889999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQP-PFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
||+ ++.+..+.......+++..+..++.+++.||.||| +. +|+||||||+||+++.++.+||+|||+++......
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 999 44566555443456899999999999999999999 54 89999999999999999999999999997664322
Q ss_pred CCccccCCCcccccccccccC-----CCCCCcccchHHHHHHHHHHhCCCCCHHHH------HHHHhhcCChhhhhchhh
Q 035917 478 ESSFVNGDLGEFGYIAPEYSS-----TMVASLKGDVYGIGVVLLELAGFKGNLVDW------VNQLSSSGRSKEAIDKAL 546 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SfGvvl~ell~~~~~~~~~------~~~~~~~~~~~~~~~~~l 546 (611)
. .....||+.|+|||.+. ...++.++|||||||++|||++|+.||... ........ .+..
T Consensus 180 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------~~~~ 250 (318)
T 2dyl_A 180 A---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE------PPLL 250 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC------CCCC
T ss_pred c---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC------CCCC
Confidence 1 12335899999999984 456889999999999999999998887421 11111000 0011
Q ss_pred c-CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 547 C-GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 547 ~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
. ....+.++.+++. +||+.||.+||++.|+++|
T Consensus 251 ~~~~~~~~~l~~li~---~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 251 PGHMGFSGDFQSFVK---DCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CSSSCCCHHHHHHHH---HHTCSCTTTSCCHHHHTTS
T ss_pred CccCCCCHHHHHHHH---HHccCChhHCcCHHHHhhC
Confidence 0 1123455555555 9999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.16 Aligned_cols=249 Identities=20% Similarity=0.184 Sum_probs=180.3
Q ss_pred CCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEEEEeccCCC
Q 035917 326 FCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIYKYMSSG 404 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ey~~~g 404 (611)
|...++||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +|||||++++++.+++..++|||||. |
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 3345789999999998777778999999998653 235678999999986 89999999999999999999999996 6
Q ss_pred ChHHhhhcCCC---C---CCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC-------------CCCeEEe
Q 035917 405 TLYSLLQGNAT---E---LDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE-------------DFDARIM 465 (611)
Q Consensus 405 sL~~~l~~~~~---~---l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~-------------~~~~kl~ 465 (611)
+|.+++..... . .++..++.++.||+.||+||| +.+|+||||||+|||++. ++.+||+
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 99999976532 1 133346789999999999999 789999999999999965 3589999
Q ss_pred ecccccccCCCCCC--ccccCCCcccccccccccCC-------CCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhc
Q 035917 466 DFGLAKLMTSSDES--SFVNGDLGEFGYIAPEYSST-------MVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSS 535 (611)
Q Consensus 466 DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~ 535 (611)
|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.......
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~- 249 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN- 249 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHH-
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHH-
Confidence 99999977543211 11234469999999998865 568999999999999999998 78776321100000
Q ss_pred CChhhhhc-hhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 536 GRSKEAID-KALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 536 ~~~~~~~~-~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
....... +.............+.+++.+||+.||++|||+.||++|
T Consensus 250 -i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 250 -IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp -HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 0000000 000111122233455566669999999999999999874
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=346.05 Aligned_cols=237 Identities=16% Similarity=0.228 Sum_probs=187.1
Q ss_pred hcCCCCCeeeecCCceEEEEEeC--CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCe-----e
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP--DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEE-----K 394 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~--~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~-----~ 394 (611)
++|...+.||+|+||.||+|+.. +|+.||||++.... ...+.+.+|++++.+++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 57888899999999999999975 68999999986432 334678999999999999999999999987665 6
Q ss_pred EEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccC
Q 035917 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~ 474 (611)
++||||+++++|.+++.. .++|..++.++.||+.||.||| +.+|+||||||+|||++.+ .+||+|||+++...
T Consensus 160 ~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp EEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred EEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 999999999999988764 5999999999999999999999 7899999999999999986 89999999998764
Q ss_pred CCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCC-HH
Q 035917 475 SSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGY-DE 553 (611)
Q Consensus 475 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-~~ 553 (611)
.. ....||+.|+|||++.+. ++.++|||||||++|||++|..++... .... +..... ..
T Consensus 233 ~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~---------~~~~----~~~~~~~~~ 292 (681)
T 2pzi_A 233 SF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGR---------YVDG----LPEDDPVLK 292 (681)
T ss_dssp CC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTE---------ECSS----CCTTCHHHH
T ss_pred cC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccc---------cccc----ccccccccc
Confidence 32 234699999999998765 489999999999999999987765320 0000 000000 11
Q ss_pred HHHHHHHHHhhcccCCCCCCCC-HHHHHHHHHHch
Q 035917 554 EILQFLKVACNCVVSRPKDRWS-MYQVYQSLNSIA 587 (611)
Q Consensus 554 ~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~L~~i~ 587 (611)
....+.+++.+||+.||++||+ ++++...|..+.
T Consensus 293 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 293 TYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp HCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 1234555666999999999995 566666666654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=306.53 Aligned_cols=229 Identities=14% Similarity=0.056 Sum_probs=178.0
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccch----hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKL----GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~----~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
+.|...+.||+|+||.||+|+.. +++.||||+++.... ..+.+.+|+.++.+++||||+++++++..++..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 46778899999999999999975 489999999975432 2367999999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+++++|.+++... .....+.+++.|++.||+||| +.+|+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 999999999999643 355578899999999999999 7899999999999999999999997443
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHH-h-h--cCChhhhhchhhcCCCCHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQL-S-S--SGRSKEAIDKALCGKGYDEE 554 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~-~-~--~~~~~~~~~~~l~~~~~~~~ 554 (611)
|++| ++.++|||||||++|||++|+.||....... . . .........+.......+++
T Consensus 175 ------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T 3uqc_A 175 ------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ 235 (286)
T ss_dssp ------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHH
T ss_pred ------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHH
Confidence 3333 6889999999999999999998874310000 0 0 00000000011111233455
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 555 ILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 555 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
+.+++. +||+.||++| |+.|+++.|+++.....
T Consensus 236 l~~li~---~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 236 ISAVAA---RSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp HHHHHH---HHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred HHHHHH---HHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 555555 9999999999 99999999999876643
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=337.93 Aligned_cols=260 Identities=16% Similarity=0.200 Sum_probs=193.1
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEecccc--chhHHHHHHHHHHHhccCCCCccceeeEEEe------CCee
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTC--KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVV------EEEK 394 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~------~~~~ 394 (611)
++|...+.||+|+||.||+|.. .+|+.||||+++.. ....+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6799999999999999999996 56899999998653 2334679999999999999999999998765 5677
Q ss_pred EEEEeccCCCChHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCC---eEEeeccc
Q 035917 395 LLIYKYMSSGTLYSLLQGNA--TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFD---ARIMDFGL 469 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~---~kl~DFGl 469 (611)
++||||+++|+|.+++.... ..+++..+..++.+++.||+||| +.+|+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999997643 26889999999999999999999 789999999999999987664 99999999
Q ss_pred ccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHH------HHHHHhhcCChhhhhc
Q 035917 470 AKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVD------WVNQLSSSGRSKEAID 543 (611)
Q Consensus 470 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~------~~~~~~~~~~~~~~~~ 543 (611)
++....... .....||+.|+|||.+.+..++.++|||||||++|||++|..||.. |...............
T Consensus 171 a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 171 AKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred ccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 987654322 2334699999999999999999999999999999999999988732 1100000000000000
Q ss_pred ----------hhhc--CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHH-----HHHHHHchhh
Q 035917 544 ----------KALC--GKGYDEEILQFLKVACNCVVSRPKDRWSMYQV-----YQSLNSIAAQ 589 (611)
Q Consensus 544 ----------~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev-----l~~L~~i~~~ 589 (611)
..+. ..........+.+++.+||+.||++|||+.|+ .+.++.+...
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 0000 00111122344455559999999999999884 4455555443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=324.21 Aligned_cols=240 Identities=16% Similarity=0.149 Sum_probs=178.2
Q ss_pred hhhcCCCCCeeeecCCceEEEEE-eCCCCEEEEEeccccc----hhHHHHHHHHHHHhccCC-CCccceeeE--------
Q 035917 322 ASNSFCSENVIISTRTGTTYKAM-LPDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRH-PNLAPLLGY-------- 387 (611)
Q Consensus 322 ~t~~f~~~~~ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H-~nIv~l~g~-------- 387 (611)
.+.+|...++||+|+||.||+|+ ..+|+.||||+++... ...+.+.+|+.+++.++| +|...+..+
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 34557777899999999999999 4579999999987332 123679999999999987 322211111
Q ss_pred -------------EEe-----CCeeEEEEeccCCCChHHhhh------cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 035917 388 -------------CVV-----EEEKLLIYKYMSSGTLYSLLQ------GNATELDWPTRFRIGLGAARGLAWLHHGCQPP 443 (611)
Q Consensus 388 -------------~~~-----~~~~~lv~ey~~~gsL~~~l~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 443 (611)
+.. ....+++|+++ +++|.+++. .....+++..++.++.|+++||+||| +.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYG 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence 111 12346777766 579999884 22235888999999999999999999 789
Q ss_pred eeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccCCCccccccccccc----------CCCCCCcccchHHHHH
Q 035917 444 FLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYS----------STMVASLKGDVYGIGV 513 (611)
Q Consensus 444 ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~ksDV~SfGv 513 (611)
|+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ ....++.++|||||||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 999999999999999999999999999865322 334468 999999998 6667899999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhc-CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 514 VLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALC-GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 514 vl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++|||++|+.||.... ..+..+..+. ....++++.+++. +||+.||++||++.|++++
T Consensus 306 il~elltg~~Pf~~~~--------~~~~~~~~~~~~~~~~~~~~~li~---~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDA--------ALGGSEWIFRSCKNIPQPVRALLE---GFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHHSSCCCCTTG--------GGSCSGGGGSSCCCCCHHHHHHHH---HHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHCCCCCCCcc--------hhhhHHHHHhhcccCCHHHHHHHH---HHccCChhhCcCHHHHHhC
Confidence 9999999999874311 1111111111 1234455555555 9999999999998887654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=302.23 Aligned_cols=226 Identities=16% Similarity=0.215 Sum_probs=174.3
Q ss_pred hcCCCC-CeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHH-hccCCCCccceeeEEEe----CCeeEE
Q 035917 324 NSFCSE-NVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRL-GQLRHPNLAPLLGYCVV----EEEKLL 396 (611)
Q Consensus 324 ~~f~~~-~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l-~~l~H~nIv~l~g~~~~----~~~~~l 396 (611)
++|... ++||+|+||.||+|.. .+++.||||+++.. ..+.+|+.++ +..+||||+++++++.. ....++
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 92 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 92 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence 345554 7899999999999996 57899999999643 4577889888 55689999999999987 667899
Q ss_pred EEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC---CCCeEEeecccccc
Q 035917 397 IYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE---DFDARIMDFGLAKL 472 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~---~~~~kl~DFGla~~ 472 (611)
||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++. ++.+||+|||+++.
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 93 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp EECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 999999999999997654 36999999999999999999999 789999999999999998 78999999999875
Q ss_pred cCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-----c
Q 035917 473 MTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-----C 547 (611)
Q Consensus 473 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-----~ 547 (611)
.. +..++.++|||||||++|||++|+.||..................... .
T Consensus 170 ~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (299)
T 3m2w_A 170 TT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 225 (299)
T ss_dssp CT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred cc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence 42 134678999999999999999999887432211111100000000000 0
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 035917 548 GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSL 583 (611)
Q Consensus 548 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 583 (611)
....++++.+++. +||+.||++|||+.|+++|-
T Consensus 226 ~~~~~~~~~~li~---~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 226 WSEVSEEVKMLIR---NLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp HTTSCHHHHHHHH---HHTCSSTTTSCCHHHHHTSH
T ss_pred cccCCHHHHHHHH---HHcccChhhCCCHHHHhcCh
Confidence 0123444555554 99999999999999999873
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=314.83 Aligned_cols=240 Identities=11% Similarity=0.030 Sum_probs=178.4
Q ss_pred hhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccc---------hhHHHHHHHHHHHhccC---------CCCccce
Q 035917 323 SNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCK---------LGEKKFRNEMNRLGQLR---------HPNLAPL 384 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~---------~~~~~~~~Ev~~l~~l~---------H~nIv~l 384 (611)
.++|...+.||+|+||.||+|+. +|+.||||+++... ...+.+.+|+.++++++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35677889999999999999998 78999999996532 12367899999998886 6666666
Q ss_pred eeEEE-----------------e-------------CCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 035917 385 LGYCV-----------------V-------------EEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLA 434 (611)
Q Consensus 385 ~g~~~-----------------~-------------~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~ 434 (611)
.+.+. . .+..++|||||++|++.+.+.+ ..+++..++.++.||+.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence 66543 2 6789999999999987776653 35899999999999999999
Q ss_pred HHhhcCCCCeeecCCCCCeEEeCCCC--------------------CeEEeecccccccCCCCCCccccCCCcccccccc
Q 035917 435 WLHHGCQPPFLHQNICSNVILVDEDF--------------------DARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAP 494 (611)
Q Consensus 435 yLH~~~~~~ivHrDlkp~NILld~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 494 (611)
|||+ +.+|+||||||+|||++.++ .+||+|||+|+..... ..+||+.|+||
T Consensus 176 ~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aP 246 (336)
T 2vuw_A 176 VAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDE 246 (336)
T ss_dssp HHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCS
T ss_pred HHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccCh
Confidence 9993 36899999999999999887 8999999999876432 12599999999
Q ss_pred cccCCCCCCcccchHHHHHH-HHHHhCCCCCHHHHHH--HHhhcCChhhh--hchhhcCCCCHHHHHHHHHHHhhcccCC
Q 035917 495 EYSSTMVASLKGDVYGIGVV-LLELAGFKGNLVDWVN--QLSSSGRSKEA--IDKALCGKGYDEEILQFLKVACNCVVSR 569 (611)
Q Consensus 495 E~~~~~~~t~ksDV~SfGvv-l~ell~~~~~~~~~~~--~~~~~~~~~~~--~~~~l~~~~~~~~~~~l~~l~~~Cl~~d 569 (611)
|++.+.. +.++||||++++ .+++..|..||..... ..... .... ................+.+++.+||+.|
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d 323 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDK--MLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS 323 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHH--HHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHh--hhhhhccCcccchhhhhhcCHHHHHHHHHHhccC
Confidence 9998766 899999998777 6778889889865321 11100 0000 0000000001122334555555999976
Q ss_pred CCCCCCHHHHH-HH
Q 035917 570 PKDRWSMYQVY-QS 582 (611)
Q Consensus 570 P~~RPs~~evl-~~ 582 (611)
|+.|++ +|
T Consensus 324 -----sa~e~l~~H 332 (336)
T 2vuw_A 324 -----SATDLLCQH 332 (336)
T ss_dssp -----SHHHHHHHC
T ss_pred -----CHHHHHhcC
Confidence 999998 64
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-30 Score=285.87 Aligned_cols=181 Identities=18% Similarity=0.118 Sum_probs=128.2
Q ss_pred eeecCCceEEEEE-eCCCCEEEEEeccccc-----------hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEEEE
Q 035917 332 IISTRTGTTYKAM-LPDGSVLAVKRLNTCK-----------LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 332 ig~G~~g~Vy~~~-~~~g~~vAvK~~~~~~-----------~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
.+.|+.|.++.++ .-.|+.||||.+.... ...++|.+|+++|+++ .|+||+++++++.+++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556666666554 3458899999995431 2235799999999999 6999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||++||+|.+++... ++++.. +|+.||+.||+|+| +.+||||||||+|||+++++.+||+|||+|+......
T Consensus 322 Eyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~- 393 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC- 393 (569)
T ss_dssp ECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred ecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-
Confidence 999999999999865 356654 58899999999999 8999999999999999999999999999998764332
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCC
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFK 522 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~ 522 (611)
....+.+||++|||||++.+ .+..++|+||+|++++++.++.
T Consensus 394 -~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 394 -SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred -ccccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence 12233469999999999876 4677899999999998886554
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-26 Score=237.70 Aligned_cols=166 Identities=33% Similarity=0.520 Sum_probs=152.1
Q ss_pred CCChhHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCc--ccceecCCCC-CCcEEEEEecCCcccc--cCCccCcCCC
Q 035917 46 TVAEDDVKCLEGVKSSLNDPQRKLSSWSFGNSTIGFICQ--FVGVSCWNDK-ENRILNLELREMKLSG--KIPEPLKFCK 120 (611)
Q Consensus 46 ~~~~~d~~aL~~~k~~l~~~~~~l~~W~~~~~~~~~~c~--w~Gv~C~~~~-~~~v~~l~l~~~~l~g--~~p~~l~~l~ 120 (611)
.|.++|.+||++||+++.||. .+++|+.+ .+||. |.||+|+... .++|+.|+|++++++| .+|+.++.++
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~----~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~ 76 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPT----TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLP 76 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTT----SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCT
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCCC----CCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCC
Confidence 367889999999999998886 78999642 35788 9999996421 2689999999999999 9999999999
Q ss_pred CCCEEEccC-CCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCccccc
Q 035917 121 SMQRLDLSA-NDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFS 199 (611)
Q Consensus 121 ~L~~L~Ls~-N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 199 (611)
+|++|+|++ |++.|.+|..+.. +++|++|+|++|+++|.+|..++++++|++|+|++|.++|.+|..+..+++|++|+
T Consensus 77 ~L~~L~L~~~n~l~~~~p~~l~~-l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 155 (313)
T 1ogq_A 77 YLNFLYIGGINNLVGPIPPAIAK-LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155 (313)
T ss_dssp TCSEEEEEEETTEESCCCGGGGG-CTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEE
T ss_pred CCCeeeCCCCCcccccCChhHhc-CCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEE
Confidence 999999995 9999999999998 99999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCccCCCCC
Q 035917 200 VANNDLTGTIPSSFKGFD 217 (611)
Q Consensus 200 l~~N~l~g~ip~~~~~~~ 217 (611)
+++|+++|.+|..+..+.
T Consensus 156 L~~N~l~~~~p~~l~~l~ 173 (313)
T 1ogq_A 156 FDGNRISGAIPDSYGSFS 173 (313)
T ss_dssp CCSSCCEEECCGGGGCCC
T ss_pred CcCCcccCcCCHHHhhhh
Confidence 999999999999887654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-27 Score=262.34 Aligned_cols=182 Identities=14% Similarity=0.156 Sum_probs=141.4
Q ss_pred CCCCeeeecCCceEEEEEeCCCCEEEEEeccccch---------hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEE
Q 035917 327 CSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKL---------GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 327 ~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~---------~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
...++||+|+||.||+|.. .++.+|+|+...... ..+++.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467999999999999954 578889998643211 124589999999999999999877777788889999
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
|||+++|+|.+++.. +..++.|+++||+||| +.+|+||||||+|||++. .+||+|||+++......
T Consensus 418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 999999999999974 5689999999999999 789999999999999998 99999999999874322
Q ss_pred CCc-----cccCCCcccccccccccCC--CCCCcccchHHHHHHHHHHhCCCC
Q 035917 478 ESS-----FVNGDLGEFGYIAPEYSST--MVASLKGDVYGIGVVLLELAGFKG 523 (611)
Q Consensus 478 ~~~-----~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SfGvvl~ell~~~~ 523 (611)
... ......||+.|||||++.. ..|+..+|+||..+-.++-+..++
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~ 536 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRA 536 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCS
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcc
Confidence 111 1123469999999999876 567888999998887777664443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.90 E-value=6.3e-25 Score=254.35 Aligned_cols=161 Identities=19% Similarity=0.302 Sum_probs=142.7
Q ss_pred CChhHHHHHHHHHHhCCCCCCCCCCCCCCCC-CCCCC--Ccc------------cceecCCCCCCcEEEEEecCCccccc
Q 035917 47 VAEDDVKCLEGVKSSLNDPQRKLSSWSFGNS-TIGFI--CQF------------VGVSCWNDKENRILNLELREMKLSGK 111 (611)
Q Consensus 47 ~~~~d~~aL~~~k~~l~~~~~~l~~W~~~~~-~~~~~--c~w------------~Gv~C~~~~~~~v~~l~l~~~~l~g~ 111 (611)
...+|+.||++||+++.+| +|+.++. ...+| |.| .||+|+. .+||+.|+|++++|+|.
T Consensus 266 ~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~--~~~V~~L~Ls~~~L~G~ 338 (876)
T 4ecn_A 266 EYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN--NGRVTGLSLAGFGAKGR 338 (876)
T ss_dssp HHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT--TSCEEEEECTTTCCEEE
T ss_pred cchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecC--CCCEEEEECccCCCCCc
Confidence 3458999999999999877 7975430 01234 999 9999964 57999999999999999
Q ss_pred CCccCcCCCCCCEEEc-cCCCCCcc-------------------------------------------------------
Q 035917 112 IPEPLKFCKSMQRLDL-SANDLSGN------------------------------------------------------- 135 (611)
Q Consensus 112 ~p~~l~~l~~L~~L~L-s~N~l~g~------------------------------------------------------- 135 (611)
+|+++++|++|+.|+| ++|.|+|.
T Consensus 339 ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~ 418 (876)
T 4ecn_A 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIK 418 (876)
T ss_dssp ECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCC
T ss_pred CchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccc
Confidence 9999999999999999 88866665
Q ss_pred ---------------------CchhHHhcCCCCCEEECcCCcCcc-----------------cCccCcc--CCcCccccc
Q 035917 136 ---------------------IPAQICNWLPYLVLLDLSNNDLSG-----------------PIPADLG--NCTYLNTLI 175 (611)
Q Consensus 136 ---------------------ip~~~~~~l~~L~~L~Ls~N~l~G-----------------~iP~~~~--~l~~L~~L~ 175 (611)
||..+++ +++|+.|+|++|+|+| .||..++ ++++|++|+
T Consensus 419 ~~~~l~l~~l~l~~~~N~L~~IP~~l~~-L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~ 497 (876)
T 4ecn_A 419 KDSRISLKDTQIGNLTNRITFISKAIQR-LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVE 497 (876)
T ss_dssp CCCCCCCCTTTTTCCSCEEEEECGGGGG-CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEE
T ss_pred cccccchhhceeccccCcccchhHHHhc-CCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEE
Confidence 8889988 9999999999999999 4999988 999999999
Q ss_pred ccccccCCCCChhhhcCCCcccccccccc-cCC-CCCccCCC
Q 035917 176 LSNNKLSGPIPYQLSNLGRLKKFSVANND-LTG-TIPSSFKG 215 (611)
Q Consensus 176 L~~N~l~g~iP~~l~~l~~L~~L~l~~N~-l~g-~ip~~~~~ 215 (611)
|++|++.|.+|..|+++++|+.|+|++|+ |+| .+|..+++
T Consensus 498 Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~ 539 (876)
T 4ecn_A 498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTR 539 (876)
T ss_dssp EESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHH
T ss_pred CcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHh
Confidence 99999999999999999999999999998 999 89986653
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.7e-24 Score=243.27 Aligned_cols=169 Identities=20% Similarity=0.290 Sum_probs=146.9
Q ss_pred hhHHHHHHHHHHhCCCCCC--------CCCCCCCCCCCCCCCCcc---cceecCCCCCCcEEEEEecCCcccccCCccCc
Q 035917 49 EDDVKCLEGVKSSLNDPQR--------KLSSWSFGNSTIGFICQF---VGVSCWNDKENRILNLELREMKLSGKIPEPLK 117 (611)
Q Consensus 49 ~~d~~aL~~~k~~l~~~~~--------~l~~W~~~~~~~~~~c~w---~Gv~C~~~~~~~v~~l~l~~~~l~g~~p~~l~ 117 (611)
..|+.||.+|+.++.++.- ...+|+.+ .++|.| .||+|+. .++|+.|+|++++++|.+|++++
T Consensus 29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~----~~~c~w~~~~GV~C~~--~~~V~~L~L~~~~l~g~lp~~l~ 102 (636)
T 4eco_A 29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN----KELDMWGAQPGVSLNS--NGRVTGLSLEGFGASGRVPDAIG 102 (636)
T ss_dssp HHHHHHHHHHHHHTTGGGCCCCC------CCCCCS----SCGGGTTCCTTEEECT--TCCEEEEECTTSCCEEEECGGGG
T ss_pred HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC----CCcccccCCCCeEEcC--CCCEEEEEecCcccCCcCChHHh
Confidence 4799999999999975531 23479743 358999 9999965 37999999999999999999999
Q ss_pred CCCCCCEEEccCC-------------------------------------------------------------------
Q 035917 118 FCKSMQRLDLSAN------------------------------------------------------------------- 130 (611)
Q Consensus 118 ~l~~L~~L~Ls~N------------------------------------------------------------------- 130 (611)
+|++|+.|+|++|
T Consensus 103 ~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~ 182 (636)
T 4eco_A 103 QLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182 (636)
T ss_dssp GCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCC
T ss_pred cCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccc
Confidence 9999999999988
Q ss_pred -----------CCCccCchhHHhcCCCCCEEECcCCcCccc-----------------CccCcc--CCcCcccccccccc
Q 035917 131 -----------DLSGNIPAQICNWLPYLVLLDLSNNDLSGP-----------------IPADLG--NCTYLNTLILSNNK 180 (611)
Q Consensus 131 -----------~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~-----------------iP~~~~--~l~~L~~L~L~~N~ 180 (611)
+|+| ||..+++ +++|++|+|++|.|+|. +|..++ ++++|++|+|++|.
T Consensus 183 l~~l~l~~~~n~l~~-ip~~l~~-l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~ 260 (636)
T 4eco_A 183 LKDTQIGQLSNNITF-VSKAVMR-LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCP 260 (636)
T ss_dssp CCTTTTTCCSCEEEE-ECGGGGG-CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCT
T ss_pred hhhhhhccccCCCcc-CCHHHhc-ccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCc
Confidence 4456 8999998 99999999999999997 999999 99999999999999
Q ss_pred cCCCCChhhhcCCCcccccccccc-cCC-CCCccCC---------CCCcccCCCCC
Q 035917 181 LSGPIPYQLSNLGRLKKFSVANND-LTG-TIPSSFK---------GFDKADFDGNS 225 (611)
Q Consensus 181 l~g~iP~~l~~l~~L~~L~l~~N~-l~g-~ip~~~~---------~~~~~~~~~n~ 225 (611)
++|.+|..|+++++|++|++++|+ ++| .+|..++ ++..+.+.+|.
T Consensus 261 l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~ 316 (636)
T 4eco_A 261 NLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN 316 (636)
T ss_dssp TCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSC
T ss_pred CCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCc
Confidence 999999999999999999999998 999 9998764 44455566654
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=8.3e-24 Score=244.52 Aligned_cols=171 Identities=26% Similarity=0.378 Sum_probs=138.5
Q ss_pred cCCChhHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCCcccceecCCCCCCcEEEEEecCCccccc---CC--------
Q 035917 45 ETVAEDDVKCLEGVKSSLNDPQRKLSSWSFGNSTIGFICQFVGVSCWNDKENRILNLELREMKLSGK---IP-------- 113 (611)
Q Consensus 45 ~~~~~~d~~aL~~~k~~l~~~~~~l~~W~~~~~~~~~~c~w~Gv~C~~~~~~~v~~l~l~~~~l~g~---~p-------- 113 (611)
+++.++|++||++||+++.||. .+++|+.+ .+||+|.||+|+ .++|+.|+|+++++.|. +|
T Consensus 7 ~~~~~~~~~all~~k~~~~~~~-~l~~W~~~----~~~C~w~gv~C~---~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~ 78 (768)
T 3rgz_A 7 SQSLYREIHQLISFKDVLPDKN-LLPDWSSN----KNPCTFDGVTCR---DDKVTSIDLSSKPLNVGFSAVSSSLLSLTG 78 (768)
T ss_dssp -CCHHHHHHHHHHHHTTCSCTT-SSTTCCTT----SCGGGSTTEEEE---TTEEEEEECTTSCCCEEHHHHHHHTTTCTT
T ss_pred ccCCHHHHHHHHHHHhhCCCcc-cccCCCCC----CCCcCCcceEEC---CCcEEEEECCCCCcCCccCccChhHhccCc
Confidence 3345689999999999999998 89999732 358999999996 47999999999999987 44
Q ss_pred ---------------ccCcCCCCCCEEEccCCCCCccCch--hHHhcCCCCCEEECcCCcCcccCccCc-cCCcCccccc
Q 035917 114 ---------------EPLKFCKSMQRLDLSANDLSGNIPA--QICNWLPYLVLLDLSNNDLSGPIPADL-GNCTYLNTLI 175 (611)
Q Consensus 114 ---------------~~l~~l~~L~~L~Ls~N~l~g~ip~--~~~~~l~~L~~L~Ls~N~l~G~iP~~~-~~l~~L~~L~ 175 (611)
+.++.+++|++|||++|.++|.+|. .++. +++|++|||++|.++|.+|..+ +++++|++||
T Consensus 79 L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~-l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~ 157 (768)
T 3rgz_A 79 LESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGS-CSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLD 157 (768)
T ss_dssp CCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGG-CTTCCEEECCSSEEECCSSCCSCCCCTTCSEEE
T ss_pred ccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhC-CCCCCEEECcCCccCCcCCHHHhccCCCCCEEE
Confidence 5678889999999999999999998 8888 9999999999999999999876 7888999999
Q ss_pred ccccccCCCCChh---hhcCCCcccccccccccCCCCCc-cCCCCCcccCCCC
Q 035917 176 LSNNKLSGPIPYQ---LSNLGRLKKFSVANNDLTGTIPS-SFKGFDKADFDGN 224 (611)
Q Consensus 176 L~~N~l~g~iP~~---l~~l~~L~~L~l~~N~l~g~ip~-~~~~~~~~~~~~n 224 (611)
|++|.++|.+|.. +.++++|++|++++|.++|.+|. .+.++..+.+.+|
T Consensus 158 Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n 210 (768)
T 3rgz_A 158 LSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSN 210 (768)
T ss_dssp CCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSS
T ss_pred CCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCC
Confidence 9999988888876 66777777777777777766653 2334444444444
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=212.79 Aligned_cols=151 Identities=13% Similarity=0.065 Sum_probs=121.5
Q ss_pred HHHHHhhhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccch-------------------hHHHHHHHHHHHhccC
Q 035917 317 ADLMAASNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKL-------------------GEKKFRNEMNRLGQLR 377 (611)
Q Consensus 317 ~~l~~~t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~-------------------~~~~~~~Ev~~l~~l~ 377 (611)
..+.....-|...+.||+|+||.||+|...+|+.||||.++.... ....+.+|++++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 334444455666799999999999999997899999999964221 2456899999999999
Q ss_pred CCCccceeeEEEeCCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC
Q 035917 378 HPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD 457 (611)
Q Consensus 378 H~nIv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld 457 (611)
| +++.+++.. +..++||||+++|+|.+ +.. .....++.|++.||.||| +.+|+||||||+|||++
T Consensus 163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~ 227 (282)
T 1zar_A 163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS 227 (282)
T ss_dssp --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE
T ss_pred --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE
Confidence 5 777776543 56799999999999998 432 124479999999999999 78999999999999999
Q ss_pred CCCCeEEeecccccccCCCCCCccccCCCcccccccccccC
Q 035917 458 EDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSS 498 (611)
Q Consensus 458 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 498 (611)
++.+||+|||+++. +..|+|||++.
T Consensus 228 -~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp -TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred -CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 99999999999873 33468898764
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.84 E-value=3.6e-22 Score=207.38 Aligned_cols=167 Identities=20% Similarity=0.278 Sum_probs=139.9
Q ss_pred CChhHHHHHHHHHHhC-CCCCCCCCCCCCCCCCCCCCCcccceecCC-------CCCCcEEEEEecCCcccccCCccCcC
Q 035917 47 VAEDDVKCLEGVKSSL-NDPQRKLSSWSFGNSTIGFICQFVGVSCWN-------DKENRILNLELREMKLSGKIPEPLKF 118 (611)
Q Consensus 47 ~~~~d~~aL~~~k~~l-~~~~~~l~~W~~~~~~~~~~c~w~Gv~C~~-------~~~~~v~~l~l~~~~l~g~~p~~l~~ 118 (611)
+..+|..||++||+++ .||.+.+++|.........+|.|.|++|+. ....+|+.|+|++|++. .+|+.++.
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~ 102 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFR 102 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGG
T ss_pred cCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhh
Confidence 4458999999999998 477666788942222335689999999941 12358999999999998 88888999
Q ss_pred CCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccccccccCCCCChhhhc-------
Q 035917 119 CKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSN------- 191 (611)
Q Consensus 119 l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~------- 191 (611)
+++|++|+|++|.++ .+|..++. +++|++|+|++|.++ .+|..++++++|++|+|++|++.|.+|..++.
T Consensus 103 l~~L~~L~L~~n~l~-~lp~~~~~-l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~ 179 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLM-ELPDTMQQ-FAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179 (328)
T ss_dssp GTTCSEEEEESSCCC-CCCSCGGG-GTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCE
T ss_pred CCCCCEEECCCCCcc-chhHHHhc-cCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhh
Confidence 999999999999999 89998888 899999999999998 88999999999999999999999999987765
Q ss_pred --CCCcccccccccccCCCCCccCCCCCc
Q 035917 192 --LGRLKKFSVANNDLTGTIPSSFKGFDK 218 (611)
Q Consensus 192 --l~~L~~L~l~~N~l~g~ip~~~~~~~~ 218 (611)
+++|++|++++|.++ .+|..+++++.
T Consensus 180 ~~l~~L~~L~L~~n~l~-~lp~~l~~l~~ 207 (328)
T 4fcg_A 180 QGLVNLQSLRLEWTGIR-SLPASIANLQN 207 (328)
T ss_dssp EESTTCCEEEEEEECCC-CCCGGGGGCTT
T ss_pred ccCCCCCEEECcCCCcC-cchHhhcCCCC
Confidence 889999999999998 88877765544
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=8e-21 Score=219.55 Aligned_cols=137 Identities=41% Similarity=0.662 Sum_probs=128.8
Q ss_pred EEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccccccc
Q 035917 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNK 180 (611)
Q Consensus 101 l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~ 180 (611)
++++.+.++|.+|+.++.++.|+.||||+|+|+|.||.+++. +++|+.|||++|+|+|.||..++++++|++|||++|+
T Consensus 613 ~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~-l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~ 691 (768)
T 3rgz_A 613 CNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGS-MPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691 (768)
T ss_dssp SCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGG-CTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccceecccCchhhhccccccEEECcCCcccccCCHHHhc-cccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCc
Confidence 355668899999999999999999999999999999999998 9999999999999999999999999999999999999
Q ss_pred cCCCCChhhhcCCCcccccccccccCCCCCcc--CCCCCcccCCCCCCCCCCCCCCCcCCC
Q 035917 181 LSGPIPYQLSNLGRLKKFSVANNDLTGTIPSS--FKGFDKADFDGNSDLCGGPLGSKCGGL 239 (611)
Q Consensus 181 l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~--~~~~~~~~~~~n~~lc~~~~~~~c~~~ 239 (611)
|+|.+|..++++++|++|++++|+|+|.||.. +..++...|.||+++||.|+. .|...
T Consensus 692 l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~~ 751 (768)
T 3rgz_A 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDPS 751 (768)
T ss_dssp CEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCSC
T ss_pred ccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCCC
Confidence 99999999999999999999999999999974 677888899999999999986 89754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=2.3e-19 Score=179.72 Aligned_cols=136 Identities=17% Similarity=0.171 Sum_probs=105.9
Q ss_pred CCCCCeeeecCCceEEEEEe-CCCCE--EEEEeccccchh-------------------------HHHHHHHHHHHhccC
Q 035917 326 FCSENVIISTRTGTTYKAML-PDGSV--LAVKRLNTCKLG-------------------------EKKFRNEMNRLGQLR 377 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~-~~g~~--vAvK~~~~~~~~-------------------------~~~~~~Ev~~l~~l~ 377 (611)
|...+.||+|+||.||+|.. .+|+. ||||+++..... ...+.+|+.+|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45668999999999999997 78999 999987542111 136889999999999
Q ss_pred CCCc--cceeeEEEeCCeeEEEEeccCC-C----ChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 035917 378 HPNL--APLLGYCVVEEEKLLIYKYMSS-G----TLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNIC 450 (611)
Q Consensus 378 H~nI--v~l~g~~~~~~~~~lv~ey~~~-g----sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk 450 (611)
|+++ ..++++ +..+|||||+.+ | +|.++... .++..+..++.|++.||.|||. ..+|+|||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADLS 198 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCC
Confidence 8865 333332 356899999942 4 67666432 2244567899999999999994 4689999999
Q ss_pred CCeEEeCCCCCeEEeeccccccc
Q 035917 451 SNVILVDEDFDARIMDFGLAKLM 473 (611)
Q Consensus 451 p~NILld~~~~~kl~DFGla~~~ 473 (611)
|+|||++. .++|+|||+|...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999998 9999999999754
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.75 E-value=5.1e-18 Score=166.76 Aligned_cols=146 Identities=23% Similarity=0.337 Sum_probs=124.5
Q ss_pred CCCcccceecCCCC--------CCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchh-HHhcCCCCCEEE
Q 035917 81 FICQFVGVSCWNDK--------ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQ-ICNWLPYLVLLD 151 (611)
Q Consensus 81 ~~c~w~Gv~C~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~-~~~~l~~L~~L~ 151 (611)
..|+|.+|.|.+.. ...++.|+|++|++++..|..+..+++|+.|+|++|.|+ .+|.. +.. +++|+.|+
T Consensus 17 ~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~-l~~L~~L~ 94 (229)
T 3e6j_A 17 CSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDS-LTQLTVLD 94 (229)
T ss_dssp CEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTT-CTTCCEEE
T ss_pred CEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCC-CcChhhccc-CCCcCEEE
Confidence 47999999997532 235789999999999999999999999999999999997 56654 455 99999999
Q ss_pred CcCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccCCCCCccCCCC---CcccCCCCCCCC
Q 035917 152 LSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF---DKADFDGNSDLC 228 (611)
Q Consensus 152 Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~---~~~~~~~n~~lc 228 (611)
|++|+|++..|..+..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..+..+ ..+.+.+|+..|
T Consensus 95 Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 95 LGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred CCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 9999999777777899999999999999999 899999999999999999999997766666554 445677777555
Q ss_pred C
Q 035917 229 G 229 (611)
Q Consensus 229 ~ 229 (611)
.
T Consensus 174 ~ 174 (229)
T 3e6j_A 174 E 174 (229)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.72 E-value=1.4e-17 Score=162.65 Aligned_cols=148 Identities=22% Similarity=0.276 Sum_probs=128.1
Q ss_pred CCCcccceecCCCC--------CCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEEC
Q 035917 81 FICQFVGVSCWNDK--------ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDL 152 (611)
Q Consensus 81 ~~c~w~Gv~C~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~L 152 (611)
+.|.|..|.|.+.. ...++.|+|++|++++..+..+..+++|+.|+|++|.+++..|..+.. +++|++|+|
T Consensus 9 C~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~-l~~L~~L~L 87 (220)
T 2v9t_B 9 CTCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQG-LRSLNSLVL 87 (220)
T ss_dssp SEEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTT-CSSCCEEEC
T ss_pred CEECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhC-CcCCCEEEC
Confidence 35789999996432 136889999999999988889999999999999999999888888888 999999999
Q ss_pred cCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccCCCCCccCCCC---CcccCCCCCCCCC
Q 035917 153 SNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF---DKADFDGNSDLCG 229 (611)
Q Consensus 153 s~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~---~~~~~~~n~~lc~ 229 (611)
++|+|++..+..+..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..|..+..+ ..+.+.+|+..|.
T Consensus 88 s~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 88 YGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 9999995544557899999999999999999999999999999999999999999888766654 4556778876663
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.72 E-value=2.8e-17 Score=158.70 Aligned_cols=148 Identities=22% Similarity=0.234 Sum_probs=122.8
Q ss_pred CCCcccceecCCCC--------CCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEEC
Q 035917 81 FICQFVGVSCWNDK--------ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDL 152 (611)
Q Consensus 81 ~~c~w~Gv~C~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~L 152 (611)
..|.|.+|.|.+.. ...++.|+|++|++++..+..+..+++|+.|+|++|++++..+..+.. +++|++|+|
T Consensus 5 C~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~L 83 (208)
T 2o6s_A 5 CSCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNK-LTSLTYLNL 83 (208)
T ss_dssp CEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTT-CTTCCEEEC
T ss_pred CEECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCC-CCCcCEEEC
Confidence 35899999996432 225889999999999877777899999999999999999544444556 999999999
Q ss_pred cCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccCCCCCccCCC---CCcccCCCCCCCCC
Q 035917 153 SNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG---FDKADFDGNSDLCG 229 (611)
Q Consensus 153 s~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~---~~~~~~~~n~~lc~ 229 (611)
++|++++..|..++++++|++|+|++|++++..|..+..+++|+.|++++|++++..+..+.. +..+.+.+|+..|.
T Consensus 84 s~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 163 (208)
T 2o6s_A 84 STNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT 163 (208)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC
T ss_pred CCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC
Confidence 999999776667899999999999999999888878999999999999999999877665554 45556778865543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=1.8e-17 Score=158.28 Aligned_cols=150 Identities=21% Similarity=0.296 Sum_probs=124.3
Q ss_pred CCCcccceecCCCC--------CCcEEEEEecCCcccccCCc-cCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEE
Q 035917 81 FICQFVGVSCWNDK--------ENRILNLELREMKLSGKIPE-PLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLD 151 (611)
Q Consensus 81 ~~c~w~Gv~C~~~~--------~~~v~~l~l~~~~l~g~~p~-~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~ 151 (611)
..|.|..+.|.+.. ...++.|+|++|++++..+. .++.+++|+.|+|++|.|++.+|..+.. +++|+.|+
T Consensus 6 C~C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~ 84 (192)
T 1w8a_A 6 CHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEG-ASHIQELQ 84 (192)
T ss_dssp SEEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTT-CTTCCEEE
T ss_pred CEECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCC-cccCCEEE
Confidence 35889999997532 12688999999999987775 4899999999999999999988988888 99999999
Q ss_pred CcCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccCCCCCcc-CC-CCCcccCCCCCCCCC
Q 035917 152 LSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSS-FK-GFDKADFDGNSDLCG 229 (611)
Q Consensus 152 Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~-~~-~~~~~~~~~n~~lc~ 229 (611)
|++|++++..|..++++++|++|+|++|+|++.+|..+..+++|++|+|++|.|++..+-. +. .+....+.++...|+
T Consensus 85 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~ 164 (192)
T 1w8a_A 85 LGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCG 164 (192)
T ss_dssp CCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBC
T ss_pred CCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCC
Confidence 9999999999988999999999999999999999999999999999999999999987732 11 122223344444565
Q ss_pred CC
Q 035917 230 GP 231 (611)
Q Consensus 230 ~~ 231 (611)
.|
T Consensus 165 ~P 166 (192)
T 1w8a_A 165 AP 166 (192)
T ss_dssp SS
T ss_pred CC
Confidence 54
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.3e-17 Score=162.75 Aligned_cols=148 Identities=18% Similarity=0.227 Sum_probs=127.9
Q ss_pred CCCcccceecCCCC--------CCcEEEEEecCCcccccCCc-cCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEE
Q 035917 81 FICQFVGVSCWNDK--------ENRILNLELREMKLSGKIPE-PLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLD 151 (611)
Q Consensus 81 ~~c~w~Gv~C~~~~--------~~~v~~l~l~~~~l~g~~p~-~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~ 151 (611)
+.|.|..+.|.+.. ...++.|+|++|++++..|. .+..+++|+.|+|++|.+++..|..+.. +++|+.|+
T Consensus 9 C~C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~-l~~L~~L~ 87 (220)
T 2v70_A 9 CRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEG-ASGVNEIL 87 (220)
T ss_dssp CEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTT-CTTCCEEE
T ss_pred CEECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCC-CCCCCEEE
Confidence 34789999996532 12467899999999998765 4899999999999999999766667877 99999999
Q ss_pred CcCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccCCCCCccCCCCC---cccCCCCCCCC
Q 035917 152 LSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFD---KADFDGNSDLC 228 (611)
Q Consensus 152 Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~---~~~~~~n~~lc 228 (611)
|++|.+++..|..+.++++|++|+|++|+|++..|..|.++++|+.|+|++|++++..|..|..+. .+.+.+|+..|
T Consensus 88 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 88 LTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp CCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred CCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence 999999988888899999999999999999999999999999999999999999999998877654 45577777665
Q ss_pred C
Q 035917 229 G 229 (611)
Q Consensus 229 ~ 229 (611)
.
T Consensus 168 ~ 168 (220)
T 2v70_A 168 N 168 (220)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.69 E-value=6.6e-18 Score=173.97 Aligned_cols=136 Identities=30% Similarity=0.494 Sum_probs=106.5
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.++.|+|++|.++|.+|..++.++ |+.|+|++|.+++.+|..+.. +++|+.|+|++|.++|.+|. +..+++|++|+|
T Consensus 175 ~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L 251 (313)
T 1ogq_A 175 LFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGS-DKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDL 251 (313)
T ss_dssp TCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCT-TSCCSEEECCSSEECCBGGG-CCCCTTCCEEEC
T ss_pred cCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhc-CCCCCEEECCCCceeeecCc-ccccCCCCEEEC
Confidence 455666666666666666666665 666666666666666666666 77788888888888777665 677888999999
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCCcc--CCCCCcccCCCCCCCCCCCCCCCc
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSS--FKGFDKADFDGNSDLCGGPLGSKC 236 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~--~~~~~~~~~~~n~~lc~~~~~~~c 236 (611)
++|+++|.+|..+..+++|+.|+|++|+++|.+|.. +.++..+.+.+|+.+||.|.+ .|
T Consensus 252 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~-~C 312 (313)
T 1ogq_A 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp CSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred cCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCC-CC
Confidence 999999999999999999999999999999999975 445667788999999998875 46
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.2e-16 Score=150.10 Aligned_cols=129 Identities=22% Similarity=0.225 Sum_probs=93.2
Q ss_pred CCCcccceecCCCC--------CCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEEC
Q 035917 81 FICQFVGVSCWNDK--------ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDL 152 (611)
Q Consensus 81 ~~c~w~Gv~C~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~L 152 (611)
..|+|.+|.|.+.. ...++.|+|++|++.+..+..++.+++|++|+|++|.+++..|..+.. +++|+.|+|
T Consensus 5 C~C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~l 83 (177)
T 2o6r_A 5 CSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDK-LTKLTILYL 83 (177)
T ss_dssp CEEETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTT-CTTCCEEEC
T ss_pred CEeCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccC-CCccCEEEC
Confidence 35889999996432 125677788888877666566777788888888888887433344455 778888888
Q ss_pred cCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccCCCCC
Q 035917 153 SNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIP 210 (611)
Q Consensus 153 s~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip 210 (611)
++|.+++..|..++++++|++|+|++|.|++..+..+..+++|+.|++++|.+++..|
T Consensus 84 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 84 HENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 8888876666667777888888888888876555556777788888888888777665
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.2e-16 Score=159.13 Aligned_cols=128 Identities=21% Similarity=0.239 Sum_probs=104.3
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.++.|+|++|++++..+..+..+++|++|+|++|.+++..|..+.. +++|++|+|++|++++..|..+.++++|++|+|
T Consensus 36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 114 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDD-LTELGTLGLANNQLASLPLGVFDHLTQLDKLYL 114 (251)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTT-CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhcc-CCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence 5778999999999888888999999999999999999766666776 889999999999998777777888899999999
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCCccCCCC---CcccCCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF---DKADFDGNS 225 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~---~~~~~~~n~ 225 (611)
++|+|++..|..|..+++|+.|+|++|++++..|..++.+ ..+.+.+|.
T Consensus 115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 166 (251)
T 3m19_A 115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQ 166 (251)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCc
Confidence 9999987777777888889999999998887766566544 344455553
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.62 E-value=4.8e-16 Score=161.16 Aligned_cols=120 Identities=21% Similarity=0.293 Sum_probs=82.7
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.+..|+|++|+++ .+|..++.+++|+.|+|++|.+++ +|+.+.. +++|+.|+|++|++.|.+|..++++++|+.|+|
T Consensus 184 ~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~-l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L 260 (328)
T 4fcg_A 184 NLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHH-LPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260 (328)
T ss_dssp TCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGG-CTTCCEEECTTCTTCCBCCCCTTCCCCCCEEEC
T ss_pred CCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-Cchhhcc-CCCCCEEECcCCcchhhhHHHhcCCCCCCEEEC
Confidence 4566666666666 666666777777777777777763 5556665 677777777777777777777777777777777
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCCccCCCCCcc
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKA 219 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~~~ 219 (611)
++|++.+.+|..+.++++|+.|+|++|++.|.+|.++++++.+
T Consensus 261 ~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L 303 (328)
T 4fcg_A 261 KDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN 303 (328)
T ss_dssp TTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTT
T ss_pred CCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCc
Confidence 7777777777767777777777777777777777766665544
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.4e-16 Score=166.64 Aligned_cols=135 Identities=10% Similarity=0.046 Sum_probs=99.0
Q ss_pred CCCCCeeeecCCceEEEEEeCCCCEEEEEeccccch---------------hHH--------HHHHHHHHHhccCCCCcc
Q 035917 326 FCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKL---------------GEK--------KFRNEMNRLGQLRHPNLA 382 (611)
Q Consensus 326 f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~---------------~~~--------~~~~Ev~~l~~l~H~nIv 382 (611)
|.....||+|++|.||+|..++|+.||||+++.... ... ...+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 778899999999999999999999999998753210 011 124566677777554432
Q ss_pred ceeeEEEeCCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC--
Q 035917 383 PLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF-- 460 (611)
Q Consensus 383 ~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~-- 460 (611)
-..-+.. ...+|||||+++++|.++... .....++.|++.+|.||| ..+||||||||.|||+++++
T Consensus 177 vp~p~~~--~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 177 VPEPIAQ--SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CCCEEEE--ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEECS
T ss_pred CCeeeec--cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCCc
Confidence 2221222 224799999999888765431 123567899999999999 78999999999999998776
Q ss_pred --------CeEEeecccccc
Q 035917 461 --------DARIMDFGLAKL 472 (611)
Q Consensus 461 --------~~kl~DFGla~~ 472 (611)
.+.|+||+-+..
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEE
T ss_pred ccccccccceEEEEeCCccc
Confidence 389999986653
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=9.5e-16 Score=172.17 Aligned_cols=161 Identities=20% Similarity=0.205 Sum_probs=118.1
Q ss_pred CCCCCCCCCCCCCCCCCCCCccc----ceecCCCC--------CCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCC
Q 035917 64 DPQRKLSSWSFGNSTIGFICQFV----GVSCWNDK--------ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSAND 131 (611)
Q Consensus 64 ~~~~~l~~W~~~~~~~~~~c~w~----Gv~C~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~ 131 (611)
|+...+++|+..-+....+|.+. .|.|.+.+ +..++.|+|++|+|++..|.+|.+|++|++|||++|+
T Consensus 8 ~~~~~~~~~~~~~p~~~~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~ 87 (635)
T 4g8a_A 8 DDDDKLAAANSSIPESWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 87 (635)
T ss_dssp -----------------CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred CCcchhhcccCCCCCCCCCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCc
Confidence 34445667764433333456543 46786421 2368899999999999888899999999999999999
Q ss_pred CCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccCC-CCC
Q 035917 132 LSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTG-TIP 210 (611)
Q Consensus 132 l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g-~ip 210 (611)
+++-.|..|.. +++|++|+|++|+|++..|..+.+|++|++|+|++|+|++..|..|+++++|++|+|++|.+++ .+|
T Consensus 88 i~~i~~~~f~~-L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~ 166 (635)
T 4g8a_A 88 IQTIEDGAYQS-LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 166 (635)
T ss_dssp CCEECTTTTTT-CTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCC
T ss_pred CCCcChhHhcC-CCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCc
Confidence 99655556776 9999999999999997777789999999999999999998777789999999999999999976 567
Q ss_pred ccCCCCC---cccCCCCC
Q 035917 211 SSFKGFD---KADFDGNS 225 (611)
Q Consensus 211 ~~~~~~~---~~~~~~n~ 225 (611)
..++.++ .+.+.+|.
T Consensus 167 ~~~~~l~~L~~L~L~~N~ 184 (635)
T 4g8a_A 167 EYFSNLTNLEHLDLSSNK 184 (635)
T ss_dssp GGGGGCTTCCEEECCSSC
T ss_pred hhhccchhhhhhcccCcc
Confidence 7665543 44455553
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.60 E-value=1.7e-15 Score=144.36 Aligned_cols=127 Identities=24% Similarity=0.374 Sum_probs=110.4
Q ss_pred EEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchh-HHhcCCCCCEEECcCCcCcccCccCccCCcCccccccc
Q 035917 99 LNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQ-ICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILS 177 (611)
Q Consensus 99 ~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~-~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~ 177 (611)
+.|++++++| +.+|..+.. +|+.|+|++|++++..|.. +.. +++|+.|+|++|++++.+|..++++++|++|+|+
T Consensus 11 ~~l~~s~~~l-~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 11 TTVDCTGRGL-KEIPRDIPL--HTTELLLNDNELGRISSDGLFGR-LPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCC-SSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGG-CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCc-CcCccCCCC--CCCEEECCCCcCCccCCcccccc-CCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 4789999999 578876654 9999999999999765543 666 9999999999999999999999999999999999
Q ss_pred ccccCCCCChhhhcCCCcccccccccccCCCCCccCCCCC---cccCCCCCCCCC
Q 035917 178 NNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFD---KADFDGNSDLCG 229 (611)
Q Consensus 178 ~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~---~~~~~~n~~lc~ 229 (611)
+|+|++..|..|.++++|++|+|++|++++.+|..+..++ .+.+.+|+..|.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 9999999999899999999999999999999998877654 455677775553
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.60 E-value=2.7e-15 Score=149.19 Aligned_cols=133 Identities=21% Similarity=0.205 Sum_probs=115.5
Q ss_pred CcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccc
Q 035917 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
..++.|+|++|.+++..|..+..+++|+.|+|++|.+++..|..+.. +++|+.|+|++|++++..|..+.++++|++|+
T Consensus 59 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 137 (251)
T 3m19_A 59 TKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDH-LTQLDKLYLGGNQLKSLPSGVFDRLTKLKELR 137 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTT-CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred ccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcc-cCCCCEEEcCCCcCCCcChhHhccCCcccEEE
Confidence 36889999999999988888999999999999999999655556666 99999999999999977766789999999999
Q ss_pred ccccccCCCCChhhhcCCCcccccccccccCCCCCccCCCC---CcccCCCCCCCCC
Q 035917 176 LSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF---DKADFDGNSDLCG 229 (611)
Q Consensus 176 L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~---~~~~~~~n~~lc~ 229 (611)
|++|+|++..|..|..+++|++|+|++|++++..|..+..+ ..+.+.+|+..|.
T Consensus 138 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 138 LNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 99999998888789999999999999999998877666554 4556778876554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=2.2e-15 Score=143.82 Aligned_cols=124 Identities=27% Similarity=0.410 Sum_probs=101.0
Q ss_pred EEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccccccc
Q 035917 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNK 180 (611)
Q Consensus 101 l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~ 180 (611)
+++++++|. .+|..+. ++|+.|+|++|+|+ .+|..+.. +++|+.|+|++|.+++..|..+.++++|++|+|++|+
T Consensus 15 l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~-l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 15 VRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSN-YKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGG-CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhc-ccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 344455555 4565543 68999999999998 78988887 9999999999999998888889999999999999999
Q ss_pred cCCCCChhhhcCCCcccccccccccCCCCCccCCC---CCcccCCCCCCCCC
Q 035917 181 LSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG---FDKADFDGNSDLCG 229 (611)
Q Consensus 181 l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~---~~~~~~~~n~~lc~ 229 (611)
|++..|..|.++++|+.|+|++|++++..+..|.. +..+.+.+|+..|.
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 99888888999999999999999999765555554 45566778876664
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.58 E-value=5.3e-15 Score=148.94 Aligned_cols=132 Identities=21% Similarity=0.184 Sum_probs=103.8
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.++.|+|++|.+++..+..++.+++|+.|+|++|.+++..|..+.. +++|++|+|++|++++..|..++++++|+.|+|
T Consensus 86 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 164 (272)
T 3rfs_A 86 NLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDK-LTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDL 164 (272)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTT-CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhcc-CCCCCEEECCCCccCccCHHHhccCccCCEEEC
Confidence 5778888888888777777888888888888888888655555666 888888888888888776667788888888888
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCCccCCCC---CcccCCCCCCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF---DKADFDGNSDLCG 229 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~---~~~~~~~n~~lc~ 229 (611)
++|++++..|..++.+++|+.|++++|++++..|..+..+ ..+.+.+|+..|.
T Consensus 165 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 220 (272)
T 3rfs_A 165 SYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT 220 (272)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc
Confidence 8888887777778888888888888888888777655544 4455667765543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.58 E-value=4e-15 Score=149.61 Aligned_cols=119 Identities=24% Similarity=0.274 Sum_probs=83.0
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.++.|+|++|++++..+..+..+++|++|+|++|.++ .+|..+...+++|++|+|++|.+++..|..+.++++|++|+|
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 116 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRL 116 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS-CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEEC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC-eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEEC
Confidence 3566777777777666667777778888888888777 455444323777777777777777655556677777777777
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCCccCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF 216 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~ 216 (611)
++|.+++..|..|..+++|++|+|++|.+++..+..+..+
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 156 (270)
T 2o6q_A 117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKL 156 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred CCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCC
Confidence 7777777766667777777777777777776555444433
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=3.3e-15 Score=145.67 Aligned_cols=113 Identities=14% Similarity=0.145 Sum_probs=107.0
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.++.|+|++|.+++..+..+..+++|+.|+|++|.+++..|..+.. +++|+.|+|++|++++..|..+.++++|++|+|
T Consensus 58 ~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 136 (220)
T 2v70_A 58 QLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKG-LESLKTLMLRSNRITCVGNDSFIGLSSVRLLSL 136 (220)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTT-CSSCCEEECTTSCCCCBCTTSSTTCTTCSEEEC
T ss_pred CCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcC-CcCCCEEECCCCcCCeECHhHcCCCccCCEEEC
Confidence 6889999999999998889999999999999999999777767777 999999999999999999999999999999999
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIP 210 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip 210 (611)
++|+|++..|..|..+++|+.|+|++|.+++..+
T Consensus 137 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 137 YDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp TTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 9999999999999999999999999999998876
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.56 E-value=9e-16 Score=139.77 Aligned_cols=121 Identities=25% Similarity=0.279 Sum_probs=103.8
Q ss_pred CcEEEEEecCCccc-ccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccc
Q 035917 96 NRILNLELREMKLS-GKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTL 174 (611)
Q Consensus 96 ~~v~~l~l~~~~l~-g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L 174 (611)
.+++.|+|++|+++ |.+|..+..+++|+.|+|++|.+++. ..+.. +++|++|+|++|.+++.+|..++++++|++|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~-l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPK-LNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCC-CTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhc-CCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 36889999999998 89999899999999999999999965 56666 8999999999999998899888889999999
Q ss_pred cccccccCCC-CChhhhcCCCcccccccccccCCCCC---ccCCCCCcc
Q 035917 175 ILSNNKLSGP-IPYQLSNLGRLKKFSVANNDLTGTIP---SSFKGFDKA 219 (611)
Q Consensus 175 ~L~~N~l~g~-iP~~l~~l~~L~~L~l~~N~l~g~ip---~~~~~~~~~ 219 (611)
+|++|.+++. .|..+..+++|+.|++++|.+++..+ ..+..++.+
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L 142 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQL 142 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCc
Confidence 9999999973 55789999999999999999997765 345444433
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=2.4e-15 Score=166.51 Aligned_cols=135 Identities=24% Similarity=0.296 Sum_probs=117.4
Q ss_pred CCcccceecCCCC----------CCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEE
Q 035917 82 ICQFVGVSCWNDK----------ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLD 151 (611)
Q Consensus 82 ~c~w~Gv~C~~~~----------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~ 151 (611)
.|.|.|+ |+... ...++.|+|++|++++..|..++.+++|++|+|++|.+++..|..+.. +++|++||
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~-l~~L~~L~ 80 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYS-LGSLEHLD 80 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTT-CTTCCEEE
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccc-cccCCEEE
Confidence 5999998 86321 136899999999999999999999999999999999999877788887 99999999
Q ss_pred CcCCcCcccCccCccCCcCcccccccccccCC-CCChhhhcCCCcccccccccccCCCCCc-cCCCCCc
Q 035917 152 LSNNDLSGPIPADLGNCTYLNTLILSNNKLSG-PIPYQLSNLGRLKKFSVANNDLTGTIPS-SFKGFDK 218 (611)
Q Consensus 152 Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g-~iP~~l~~l~~L~~L~l~~N~l~g~ip~-~~~~~~~ 218 (611)
|++|.+++..|..++++++|++|+|++|.+++ .+|..++++++|++|++++|.+.+.+|. .+.+++.
T Consensus 81 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~ 149 (549)
T 2z81_A 81 LSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTS 149 (549)
T ss_dssp CTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCE
T ss_pred CCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccc
Confidence 99999998888889999999999999999997 5778899999999999999997777774 5655543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=8e-15 Score=139.92 Aligned_cols=128 Identities=24% Similarity=0.268 Sum_probs=112.6
Q ss_pred CCCcccceecCCCC--------CCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEEC
Q 035917 81 FICQFVGVSCWNDK--------ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDL 152 (611)
Q Consensus 81 ~~c~w~Gv~C~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~L 152 (611)
..|.|..|.|.+.. ...++.|+|++|+++ .+|..+..+++|+.|+|++|.+++..|..+.. +++|+.|+|
T Consensus 8 C~C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~-l~~L~~L~L 85 (193)
T 2wfh_A 8 CTCLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSN-MTQLLTLIL 85 (193)
T ss_dssp CEEETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTT-CTTCCEEEC
T ss_pred CEeCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccC-CCCCCEEEC
Confidence 35789999996431 236889999999998 78889999999999999999999766677777 999999999
Q ss_pred cCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccCCCCC
Q 035917 153 SNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIP 210 (611)
Q Consensus 153 s~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip 210 (611)
++|++++..|..+.++++|++|+|++|.|++..+..|..+++|+.|+|++|.+.....
T Consensus 86 s~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 86 SYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 9999998888889999999999999999997666679999999999999999987544
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=4.6e-15 Score=160.30 Aligned_cols=143 Identities=18% Similarity=0.262 Sum_probs=121.6
Q ss_pred CCcccc--eecCCCC-------CCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCch-hHHhcCCCCCEEE
Q 035917 82 ICQFVG--VSCWNDK-------ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPA-QICNWLPYLVLLD 151 (611)
Q Consensus 82 ~c~w~G--v~C~~~~-------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~-~~~~~l~~L~~L~ 151 (611)
.|.|.+ |.|.+.. ..+++.|+|++|.+.+..|..++.+++|++|+|++|.+.+.+|+ .+.. +++|++|+
T Consensus 7 ~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~-l~~L~~L~ 85 (455)
T 3v47_A 7 ECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRG-LSSLIILK 85 (455)
T ss_dssp CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTT-CTTCCEEE
T ss_pred eeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccc-cccCCEEe
Confidence 577666 8886432 13689999999999999999999999999999999999988865 4665 99999999
Q ss_pred CcCCcCcccCccCccCCcCcccccccccccCCCCChh--hhcCCCcccccccccccCCCCCcc-CCCC---CcccCCCCC
Q 035917 152 LSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQ--LSNLGRLKKFSVANNDLTGTIPSS-FKGF---DKADFDGNS 225 (611)
Q Consensus 152 Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~--l~~l~~L~~L~l~~N~l~g~ip~~-~~~~---~~~~~~~n~ 225 (611)
|++|.+++.+|..++++++|++|+|++|.+++.+|.. +.++++|++|+|++|++++..|.. +.++ ..+.+.+|.
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence 9999999999999999999999999999999977766 899999999999999999988875 4444 445555554
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.4e-14 Score=152.18 Aligned_cols=143 Identities=22% Similarity=0.202 Sum_probs=118.3
Q ss_pred CCCcccceecCCCC--------CCcEEEEEecCCcccccCCccCc-CCCCCCEEEccCCCCCccCchhHHhcCCCCCEEE
Q 035917 81 FICQFVGVSCWNDK--------ENRILNLELREMKLSGKIPEPLK-FCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLD 151 (611)
Q Consensus 81 ~~c~w~Gv~C~~~~--------~~~v~~l~l~~~~l~g~~p~~l~-~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~ 151 (611)
+.|.|.-|.|.+.. ...++.|+|++|+|++..+..+. .+++|+.|+|++|+|++..|..+.. +++|+.|+
T Consensus 16 C~C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~-l~~L~~L~ 94 (361)
T 2xot_A 16 CLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVP-VPNLRYLD 94 (361)
T ss_dssp CEEETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTT-CTTCCEEE
T ss_pred CEECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccC-CCCCCEEE
Confidence 34788899996432 12467899999999998888887 9999999999999999766667777 99999999
Q ss_pred CcCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccCCCCCccC------CCCCcccCCCC
Q 035917 152 LSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF------KGFDKADFDGN 224 (611)
Q Consensus 152 Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~------~~~~~~~~~~n 224 (611)
|++|+|++..|..+.++++|++|+|++|++++..|..|.++++|+.|+|++|+|++..+..+ .++..+.+.+|
T Consensus 95 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N 173 (361)
T 2xot_A 95 LSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSN 173 (361)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSS
T ss_pred CCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCC
Confidence 99999998777789999999999999999998889999999999999999999997443333 33444455555
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=1.3e-14 Score=162.67 Aligned_cols=128 Identities=23% Similarity=0.258 Sum_probs=112.2
Q ss_pred CcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccc
Q 035917 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
.+++.|+|++|.+++..+..+..+++|++|+|++|.+++..|..+.. +++|++|+|++|.+++..|..++++++|++|+
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~-l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 110 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHG-LHHLSNLILTGNPIQSFSPGSFSGLTSLENLV 110 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT-CTTCCEEECTTCCCCCCCTTSSTTCTTCCEEE
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhc-hhhcCEeECCCCcccccChhhcCCcccCCEEE
Confidence 46889999999999998889999999999999999999877878877 99999999999999988899999999999999
Q ss_pred ccccccCCCCChhhhcCCCcccccccccccCC-CCCccCCCCCcc---cCCCC
Q 035917 176 LSNNKLSGPIPYQLSNLGRLKKFSVANNDLTG-TIPSSFKGFDKA---DFDGN 224 (611)
Q Consensus 176 L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g-~ip~~~~~~~~~---~~~~n 224 (611)
|++|.+++..|..++++++|++|++++|.+++ .+|..+++++.+ .+.+|
T Consensus 111 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n 163 (606)
T 3vq2_A 111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163 (606)
T ss_dssp CTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSS
T ss_pred ccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCC
Confidence 99999998887889999999999999999986 778877665543 34444
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=1.8e-14 Score=155.65 Aligned_cols=133 Identities=20% Similarity=0.209 Sum_probs=119.4
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.++.|+|++|.+.+.+|..++.+++|+.|+|++|.+++..|..+.. +++|+.|+|++|.+++..|..++++++|++|+|
T Consensus 276 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 276 GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWG-LTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp CCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTT-CTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred CceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcC-cccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 5889999999999999999999999999999999999888888887 999999999999999888999999999999999
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCCccCCC---CCcccCCCCCCCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG---FDKADFDGNSDLCGG 230 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~---~~~~~~~~n~~lc~~ 230 (611)
++|++++..|..+.++++|++|++++|++++..+..+.. +..+.+.+|+..|..
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 411 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 411 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCC
Confidence 999999999999999999999999999999866655554 455667788766654
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.51 E-value=1.1e-14 Score=159.06 Aligned_cols=142 Identities=25% Similarity=0.182 Sum_probs=119.9
Q ss_pred CCcccceecCCCCCCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccC
Q 035917 82 ICQFVGVSCWNDKENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPI 161 (611)
Q Consensus 82 ~c~w~Gv~C~~~~~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~i 161 (611)
.|.+.++.|.. ...+..|+|++|.+++..|..++.+++|+.|+|++|.|+|.+|..+...+++|+.|+|++|.|++.
T Consensus 108 ~N~l~~~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~- 184 (487)
T 3oja_A 108 NNNISRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV- 184 (487)
T ss_dssp SSCCCCEEECC--CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-
T ss_pred CCcCCCCCccc--cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-
Confidence 36778888853 357999999999999999999999999999999999999999988874499999999999999977
Q ss_pred ccCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccCCCCCccCCCC---CcccCCCCCCCCC
Q 035917 162 PADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF---DKADFDGNSDLCG 229 (611)
Q Consensus 162 P~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~---~~~~~~~n~~lc~ 229 (611)
|. +..+++|+.|+|++|.|+|..| .+..+++|+.|+|++|.|++ +|..+..+ ..+.+.+|+..|+
T Consensus 185 ~~-~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 185 KG-QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp EC-CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHH
T ss_pred cc-cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCc
Confidence 33 4469999999999999997555 59999999999999999996 78776554 4556777776654
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.50 E-value=4.4e-14 Score=131.88 Aligned_cols=107 Identities=24% Similarity=0.250 Sum_probs=92.0
Q ss_pred EEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccccccc
Q 035917 100 NLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNN 179 (611)
Q Consensus 100 ~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N 179 (611)
.|++++++|.. +|..+ .+.|+.|+|++|+|++..|..+.. +++|+.|+|++|+|++..|..+.++++|++|+|++|
T Consensus 13 ~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~-l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 13 TVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDR-LTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp EEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTT-CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcC-cccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 34555666664 66655 389999999999999877888887 999999999999999776667899999999999999
Q ss_pred ccCCCCChhhhcCCCcccccccccccCCCCC
Q 035917 180 KLSGPIPYQLSNLGRLKKFSVANNDLTGTIP 210 (611)
Q Consensus 180 ~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip 210 (611)
+|++..|..|..+++|+.|+|++|.+++..+
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9998777789999999999999999997755
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.50 E-value=7.8e-15 Score=136.37 Aligned_cols=111 Identities=27% Similarity=0.243 Sum_probs=77.2
Q ss_pred cEEEEEecCCccc-ccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccc
Q 035917 97 RILNLELREMKLS-GKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 97 ~v~~l~l~~~~l~-g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
.++.|+|++|++. |.+|..+..+++|+.|+|++|.+++. ..+.. +++|+.|+|++|.+++.+|..+.++++|++|+
T Consensus 25 ~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~-l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPK-LPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp SCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCC-CSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred cCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhcc-CCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 4667777777776 67777677777777777777777753 45555 67777777777777766666666677777777
Q ss_pred ccccccCCC-CChhhhcCCCcccccccccccCCCCC
Q 035917 176 LSNNKLSGP-IPYQLSNLGRLKKFSVANNDLTGTIP 210 (611)
Q Consensus 176 L~~N~l~g~-iP~~l~~l~~L~~L~l~~N~l~g~ip 210 (611)
|++|.+++. .+..+..+++|+.|++++|.+++..+
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 137 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLND 137 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTT
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHH
Confidence 777777753 22567777777777777777775544
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.50 E-value=9.8e-15 Score=167.09 Aligned_cols=159 Identities=24% Similarity=0.252 Sum_probs=76.4
Q ss_pred ChhHHHHHHHHHHhCCCC-CCCCCCCCCCCCCCCCCCcccceecCCCCCCcEEEEEec------------------CCcc
Q 035917 48 AEDDVKCLEGVKSSLNDP-QRKLSSWSFGNSTIGFICQFVGVSCWNDKENRILNLELR------------------EMKL 108 (611)
Q Consensus 48 ~~~d~~aL~~~k~~l~~~-~~~l~~W~~~~~~~~~~c~w~Gv~C~~~~~~~v~~l~l~------------------~~~l 108 (611)
...+.++|+++..++..+ ...-.+|...+ ...+.|.++++.. .+++.|+|. .+.+
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~s~---~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i 203 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPTGDS---TPSGTATNSAVST---PLTPKIELFANGKDEANQALLQHKKLSQYSI 203 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCcCCC---CccccCCCceecC---CccceEEeeCCCCCcchhhHhhcCccCcccc
Confidence 346778999998776322 12233564221 2346788877643 233333332 2222
Q ss_pred cc---------cCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccccccc
Q 035917 109 SG---------KIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNN 179 (611)
Q Consensus 109 ~g---------~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N 179 (611)
.+ .+|..+..++.|+.|+|++|.+. .||..++. +++|+.|+|++|.|+ .||..+++|++|++|+|++|
T Consensus 204 ~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~-l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N 280 (727)
T 4b8c_D 204 DEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFK-YDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHN 280 (727)
T ss_dssp ------------------CCCCCCEEECTTSCCS-CCCGGGGG-CCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTS
T ss_pred cCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcC-CCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCC
Confidence 22 12344566666777777777766 56666665 667777777777776 66666666777777777777
Q ss_pred ccCCCCChhhhcCCCcccccccccccCCCCCccCCCCC
Q 035917 180 KLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFD 217 (611)
Q Consensus 180 ~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~ 217 (611)
.|+ .+|..|++|++|++|+|++|.|+ .||.+|+++.
T Consensus 281 ~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~ 316 (727)
T 4b8c_D 281 RLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLC 316 (727)
T ss_dssp CCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCT
T ss_pred cCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCC
Confidence 766 66666666777777777777665 5666555443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=4.4e-14 Score=142.31 Aligned_cols=122 Identities=20% Similarity=0.222 Sum_probs=108.0
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.++.|+|++|++.+..+..+..+++|+.|+|++|.+++..|..+.. +++|++|+|++|.+++..|..+.++++|++|+|
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQS-LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTT-CTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccC-CcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 5889999999999888888999999999999999999666667777 999999999999999888888999999999999
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCC-CCCccCCCCCcc
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTG-TIPSSFKGFDKA 219 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g-~ip~~~~~~~~~ 219 (611)
++|.+++..+..++.+++|++|++++|.+++ .+|..+++++.+
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L 151 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNL 151 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTC
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCC
Confidence 9999998877789999999999999999987 478877665443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.50 E-value=6e-14 Score=142.72 Aligned_cols=131 Identities=29% Similarity=0.305 Sum_probs=108.1
Q ss_pred CcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccc
Q 035917 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
..+..|+|++|.+. .+|..+..+++|+.|+|++|+|++..|..+.. +++|+.|+|++|++++..|..+..+++|+.|+
T Consensus 77 ~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 154 (290)
T 1p9a_G 77 PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRG-LGELQELYLKGNELKTLPPGLLTPTPKLEKLS 154 (290)
T ss_dssp TTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTT-CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcC-CCCCCEEECCCCCCCccChhhcccccCCCEEE
Confidence 36889999999988 67888899999999999999999655566776 89999999999999977666778899999999
Q ss_pred ccccccCCCCChhhhcCCCcccccccccccCCCCCccCCC---CCcccCCCCCCCCC
Q 035917 176 LSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG---FDKADFDGNSDLCG 229 (611)
Q Consensus 176 L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~---~~~~~~~~n~~lc~ 229 (611)
|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+.. +..+.+.+|+..|.
T Consensus 155 L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 155 LANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp CTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred CCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCc
Confidence 9999999666666788999999999999998 67776654 34455677876664
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.50 E-value=7.2e-14 Score=140.42 Aligned_cols=132 Identities=23% Similarity=0.230 Sum_probs=102.0
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.+..|+|++|.+.+..+..+..+++|+.|+|++|.+++..|..+.. +++|+.|+|++|.+++..+..++.+++|+.|+|
T Consensus 86 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 164 (270)
T 2o6q_A 86 NLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDS-LTKLTYLSLGYNELQSLPKGVFDKLTSLKELRL 164 (270)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTT-CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCc-CcCCCEEECCCCcCCccCHhHccCCcccceeEe
Confidence 5778888888888766667788888888888888888655555666 888888888888888655556788888888888
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCCccCCC---CCcccCCCCCCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG---FDKADFDGNSDLCG 229 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~---~~~~~~~~n~~lc~ 229 (611)
++|.+++..|..|..+++|+.|++++|++++..+..+.. +..+.+.+|+..|.
T Consensus 165 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 165 YNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred cCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence 888888777777888888888888888888665555544 44456677776554
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.50 E-value=4.7e-15 Score=167.51 Aligned_cols=126 Identities=18% Similarity=0.317 Sum_probs=111.9
Q ss_pred CcEEEEEecCCccccc-----------------CCccCc--CCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCc
Q 035917 96 NRILNLELREMKLSGK-----------------IPEPLK--FCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNND 156 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~-----------------~p~~l~--~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~ 156 (611)
..++.|+|++|.++|. +|+.++ ++++|++|+|++|++.|.+|..+++ +++|+.|+|++|+
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~-l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA-LPEMQLINVACNR 284 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTT-CSSCCEEECTTCT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhc-CCCCCEEECcCCC
Confidence 3688999999999996 999999 9999999999999999999999998 9999999999998
Q ss_pred -Ccc-cCccCccCC------cCcccccccccccCCCCCh--hhhcCCCcccccccccccCCCCCccCCCCC---cccCCC
Q 035917 157 -LSG-PIPADLGNC------TYLNTLILSNNKLSGPIPY--QLSNLGRLKKFSVANNDLTGTIPSSFKGFD---KADFDG 223 (611)
Q Consensus 157 -l~G-~iP~~~~~l------~~L~~L~L~~N~l~g~iP~--~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~---~~~~~~ 223 (611)
|+| .+|..++++ ++|++|+|++|+++ .+|. .++++++|+.|++++|+++|.+| .++.++ .+.+.+
T Consensus 285 ~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~ 362 (636)
T 4eco_A 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAY 362 (636)
T ss_dssp TSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCS
T ss_pred CCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCC
Confidence 999 999998887 99999999999999 8998 89999999999999999999999 665443 344444
Q ss_pred C
Q 035917 224 N 224 (611)
Q Consensus 224 n 224 (611)
|
T Consensus 363 N 363 (636)
T 4eco_A 363 N 363 (636)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.50 E-value=2.4e-14 Score=146.44 Aligned_cols=142 Identities=20% Similarity=0.244 Sum_probs=117.1
Q ss_pred CCCcccceecCCCC--------CCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCC--ccCchhHHhcCCCCCEE
Q 035917 81 FICQFVGVSCWNDK--------ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLS--GNIPAQICNWLPYLVLL 150 (611)
Q Consensus 81 ~~c~w~Gv~C~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~--g~ip~~~~~~l~~L~~L 150 (611)
+.|.|.+|.|.+.. ...++.|+|++|++....+..+..+++|+.|+|++|.++ |.+|..+.. +++|++|
T Consensus 5 C~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~-~~~L~~L 83 (306)
T 2z66_A 5 CSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFG-TTSLKYL 83 (306)
T ss_dssp CEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHS-CSCCCEE
T ss_pred CeeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCccccccc-ccccCEE
Confidence 35899999997532 236889999999999544445899999999999999998 445778877 8999999
Q ss_pred ECcCCcCcccCccCccCCcCcccccccccccCCCCC-hhhhcCCCcccccccccccCCCCCccCCCCCc---ccCCCC
Q 035917 151 DLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIP-YQLSNLGRLKKFSVANNDLTGTIPSSFKGFDK---ADFDGN 224 (611)
Q Consensus 151 ~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP-~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~~---~~~~~n 224 (611)
+|++|.++ .+|..+.++++|++|+|++|.+++..+ ..+..+++|++|++++|.+++..|..+..++. +.+.+|
T Consensus 84 ~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 160 (306)
T 2z66_A 84 DLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 160 (306)
T ss_dssp ECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTC
T ss_pred ECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCC
Confidence 99999998 578889999999999999999997665 57899999999999999999888877765443 444444
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=2.3e-14 Score=159.21 Aligned_cols=109 Identities=27% Similarity=0.323 Sum_probs=101.5
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.+..|+|++|+|++ +|. ++.|++|+.|+|++|.|+ .||..++. +++|+.|+|++|+|++ || .++++++|++|+|
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~-l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~L 515 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAA-LRCLEVLQASDNALEN-VD-GVANLPRLQELLL 515 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGG-CTTCCEEECCSSCCCC-CG-GGTTCSSCCEEEC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhc-CCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEEC
Confidence 46689999999998 665 999999999999999999 89999998 9999999999999997 88 8999999999999
Q ss_pred cccccCCCC-ChhhhcCCCcccccccccccCCCCCc
Q 035917 177 SNNKLSGPI-PYQLSNLGRLKKFSVANNDLTGTIPS 211 (611)
Q Consensus 177 ~~N~l~g~i-P~~l~~l~~L~~L~l~~N~l~g~ip~ 211 (611)
++|+|++.+ |..|+.+++|+.|+|++|+|++.+|.
T Consensus 516 s~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 516 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp CSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred CCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 999999987 99999999999999999999988663
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.49 E-value=2.2e-14 Score=146.72 Aligned_cols=131 Identities=18% Similarity=0.260 Sum_probs=90.6
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCc-cCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSG-NIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g-~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
.+..|+|++|.+.+..|..+..+++|+.|+|++|.+++ .+|..+.. +++|+.|+|++|.+++..|..+.++++|+.|+
T Consensus 127 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~-l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 205 (306)
T 2z66_A 127 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE-LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 205 (306)
T ss_dssp TCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTT-CTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhh-CcCCCEEECCCCCcCCcCHHHhcCCCCCCEEE
Confidence 56677777777777777677777777777777777766 45666665 77777777777777776677777777777777
Q ss_pred ccccccCCCCChhhhcCCCcccccccccccCCCCCccCCCC----CcccCCCCCCCC
Q 035917 176 LSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF----DKADFDGNSDLC 228 (611)
Q Consensus 176 L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~----~~~~~~~n~~lc 228 (611)
|++|.+++..+..+..+++|+.|++++|++++.+|..+..+ ..+.+.+|+..|
T Consensus 206 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~ 262 (306)
T 2z66_A 206 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 262 (306)
T ss_dssp CTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred CCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeec
Confidence 77777776666667777777777777777777777665443 234455555333
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.49 E-value=6.5e-14 Score=131.27 Aligned_cols=106 Identities=23% Similarity=0.243 Sum_probs=92.8
Q ss_pred EEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccccc
Q 035917 99 LNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSN 178 (611)
Q Consensus 99 ~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~ 178 (611)
+.+++++++| +.+|..+. ++|+.|+|++|.|++..|..+.. +++|+.|+|++|+|++..|..+.++++|++|+|++
T Consensus 15 ~~l~~~~n~l-~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 15 TLVNCQNIRL-ASVPAGIP--TDKQRLWLNNNQITKLEPGVFDH-LVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SEEECCSSCC-SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTT-CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred cEEEeCCCCC-CccCCCcC--CCCcEEEeCCCCccccCHHHhcC-CcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 4688899988 46787664 89999999999999877888887 99999999999999975555678999999999999
Q ss_pred cccCCCCChhhhcCCCcccccccccccCCC
Q 035917 179 NKLSGPIPYQLSNLGRLKKFSVANNDLTGT 208 (611)
Q Consensus 179 N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ 208 (611)
|+|++..|..|..+++|++|+|++|.++..
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcccc
Confidence 999977666799999999999999998854
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=2.8e-14 Score=144.39 Aligned_cols=131 Identities=22% Similarity=0.268 Sum_probs=84.7
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
++..|+|++|.+.+..|..+..+++|+.|+|++|.+++..+..+.. +++|+.|+|++|.+++..+..+.++++|+.|+|
T Consensus 106 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 184 (285)
T 1ozn_A 106 RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD-LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184 (285)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT-CTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhcc-CCCccEEECCCCcccccCHHHhcCccccCEEEC
Confidence 4666777777777666666677777777777777776444444555 677777777777776555555666777777777
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCCccCCC---CCcccCCCCCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG---FDKADFDGNSDLC 228 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~---~~~~~~~~n~~lc 228 (611)
++|.+++..|..+..+++|+.|++++|++++..|..+.. +..+.+.+|+..|
T Consensus 185 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 239 (285)
T 1ozn_A 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (285)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred CCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccC
Confidence 777777666777777777777777777777655444433 3334455555444
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=9.3e-14 Score=140.56 Aligned_cols=128 Identities=24% Similarity=0.266 Sum_probs=108.7
Q ss_pred CcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCc-CcccCccCccCCcCcccc
Q 035917 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNND-LSGPIPADLGNCTYLNTL 174 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~-l~G~iP~~~~~l~~L~~L 174 (611)
..++.|+|++|++.+..+..+..+++|+.|+|++|.+++..|..+.. +++|++|+|++|. +++..|..+.++++|++|
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L 110 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTG-LALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTT-CTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCC-ccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence 36789999999999888888999999999999999999877888887 8999999999997 766667889999999999
Q ss_pred cccccccCCCCChhhhcCCCcccccccccccCCCCCccCCCCC---cccCCCC
Q 035917 175 ILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFD---KADFDGN 224 (611)
Q Consensus 175 ~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~---~~~~~~n 224 (611)
+|++|.+++..|..+.++++|++|++++|++++..+..++.++ .+.+.+|
T Consensus 111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 163 (285)
T 1ozn_A 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163 (285)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCC
Confidence 9999999988888899999999999999999977766665443 4445555
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=2.4e-14 Score=149.70 Aligned_cols=141 Identities=24% Similarity=0.303 Sum_probs=114.0
Q ss_pred CCCcccceecCCCC----------CCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEE
Q 035917 81 FICQFVGVSCWNDK----------ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLL 150 (611)
Q Consensus 81 ~~c~w~Gv~C~~~~----------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L 150 (611)
.+|.|.|+ |+-+. ...++.|+|++|++.+..+..+..+++|+.|+|++|.+++..|..+.. +++|++|
T Consensus 28 ~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L 105 (353)
T 2z80_A 28 LSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSS-LGSLEHL 105 (353)
T ss_dssp CEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTT-CTTCCEE
T ss_pred CCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCC-CCCCCEE
Confidence 46999998 75221 136889999999999877778999999999999999999877777887 9999999
Q ss_pred ECcCCcCcccCccCccCCcCcccccccccccCCCCCh--hhhcCCCcccccccccc-cCCCCCccCCCCCc---ccCCCC
Q 035917 151 DLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPY--QLSNLGRLKKFSVANND-LTGTIPSSFKGFDK---ADFDGN 224 (611)
Q Consensus 151 ~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~--~l~~l~~L~~L~l~~N~-l~g~ip~~~~~~~~---~~~~~n 224 (611)
+|++|.+++..+..++++++|++|+|++|.+++ +|. .+..+++|++|++++|+ +++..|..+.+++. +.+.+|
T Consensus 106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n 184 (353)
T 2z80_A 106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS 184 (353)
T ss_dssp ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSS-SCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEET
T ss_pred ECCCCcCCcCCHhHhCCCccCCEEECCCCCCcc-cCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCC
Confidence 999999996555558999999999999999995 554 78999999999999995 55555666665544 344444
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.48 E-value=9.9e-14 Score=139.58 Aligned_cols=114 Identities=24% Similarity=0.194 Sum_probs=102.9
Q ss_pred CcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccc
Q 035917 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
..+..|+|++|++++..+..++.+++|+.|+|++|.+++..|..+.. +++|+.|+|++|++++..|..++++++|+.|+
T Consensus 109 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 187 (272)
T 3rfs_A 109 TNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDK-LTNLTELDLSYNQLQSLPEGVFDKLTQLKDLR 187 (272)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT-CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhcc-CccCCEEECCCCCcCccCHHHhcCCccCCEEE
Confidence 36889999999999888888999999999999999999655555666 99999999999999988777789999999999
Q ss_pred ccccccCCCCChhhhcCCCcccccccccccCCCCC
Q 035917 176 LSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIP 210 (611)
Q Consensus 176 L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip 210 (611)
|++|.+++..|..+..+++|+.|++++|.++|..|
T Consensus 188 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 188 LYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 99999999888889999999999999999888776
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.48 E-value=3.2e-14 Score=159.51 Aligned_cols=120 Identities=17% Similarity=0.148 Sum_probs=86.5
Q ss_pred EEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccccc
Q 035917 98 ILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILS 177 (611)
Q Consensus 98 v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~ 177 (611)
+..++++++.+....+..+..+++|+.|+|++|.+++..|..+.. +++|+.|+|++|.+++..|..++++++|++|+|+
T Consensus 53 l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 131 (597)
T 3oja_B 53 QKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAY-AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131 (597)
T ss_dssp CSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTT-CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred ceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcC-CCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEee
Confidence 456777777776655555677777888888888777666666666 7778888888888777766677777788888888
Q ss_pred ccccCCCCChhhhcCCCcccccccccccCCCCCccCCCCCc
Q 035917 178 NNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDK 218 (611)
Q Consensus 178 ~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~~ 218 (611)
+|.|++..|..|+++++|++|+|++|.+++..|..+++++.
T Consensus 132 ~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 172 (597)
T 3oja_B 132 RNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTS 172 (597)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTT
T ss_pred CCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCc
Confidence 88777555555677777888888888777777766655443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.48 E-value=5.3e-14 Score=137.07 Aligned_cols=113 Identities=22% Similarity=0.280 Sum_probs=103.5
Q ss_pred CcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccc
Q 035917 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
..+..|+|++|.+++..|..+..+++|+.|+|++|.|+ .+|+.+...+++|+.|+|++|.+++..|..+.++++|++|+
T Consensus 56 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 134 (220)
T 2v9t_B 56 KKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLS 134 (220)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEE
Confidence 36889999999999999999999999999999999999 56665433399999999999999999999999999999999
Q ss_pred ccccccCCCCChhhhcCCCcccccccccccCCCC
Q 035917 176 LSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTI 209 (611)
Q Consensus 176 L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~i 209 (611)
|++|+|++..|..|..+++|+.|+|++|.+...-
T Consensus 135 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 168 (220)
T 2v9t_B 135 LYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDC 168 (220)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence 9999999988888999999999999999998653
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.48 E-value=7.8e-14 Score=134.33 Aligned_cols=113 Identities=24% Similarity=0.178 Sum_probs=78.4
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.++.|+|++|++.+..+..+..+++|++|+|++|.+++..+..+.. +++|++|+|++|++++..|..+.++++|+.|+|
T Consensus 53 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 131 (208)
T 2o6s_A 53 SLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDK-LTQLKELALNTNQLQSLPDGVFDKLTQLKDLRL 131 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT-CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcC-ccCCCEEEcCCCcCcccCHhHhccCCcCCEEEC
Confidence 4667777777777655555677777777777777777433334455 777777777777777655555677777777777
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIP 210 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip 210 (611)
++|.+++..+..+..+++|+.|++++|.+.+..|
T Consensus 132 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 165 (208)
T 2o6s_A 132 YQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 165 (208)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT
T ss_pred CCCccceeCHHHhccCCCccEEEecCCCeecCCC
Confidence 7777776666556777777777777766555444
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.47 E-value=7.1e-14 Score=152.09 Aligned_cols=134 Identities=24% Similarity=0.272 Sum_probs=117.8
Q ss_pred cccceecCCCC--------CCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCC
Q 035917 84 QFVGVSCWNDK--------ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNN 155 (611)
Q Consensus 84 ~w~Gv~C~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N 155 (611)
.|..|.|.+.. ...++.|+|++|++.+..|..+..+++|+.|+|++|.+++..|..+.. +++|++|+|++|
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-l~~L~~L~L~~n 90 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNN-LFNLRTLGLRSN 90 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTT-CTTCCEEECCSS
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhC-CccCCEEECCCC
Confidence 37889996431 235789999999999999999999999999999999999888888888 999999999999
Q ss_pred cCcccCccCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccCCCCCccCCCCCc
Q 035917 156 DLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDK 218 (611)
Q Consensus 156 ~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~~ 218 (611)
++++..+..++++++|++|+|++|.+++..|..|.++++|+.|++++|.+++..|..|.++..
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 153 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNS 153 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTT
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCC
Confidence 999665566899999999999999999999999999999999999999999888877766544
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.47 E-value=2.9e-14 Score=149.66 Aligned_cols=133 Identities=21% Similarity=0.180 Sum_probs=111.8
Q ss_pred CcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccc
Q 035917 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
.++..|+|++|+|++..+..+..+++|+.|+|++|+|++..|..+.. +++|+.|+|++|++++..|..+.++++|+.|+
T Consensus 64 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 142 (361)
T 2xot_A 64 TNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSD-LQALEVLLLYNNHIVVVDRNAFEDMAQLQKLY 142 (361)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTT-CTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred cccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCC-CcCCCEEECCCCcccEECHHHhCCcccCCEEE
Confidence 46889999999999998889999999999999999999655556666 99999999999999998899999999999999
Q ss_pred ccccccCCCCChhh---hcCCCcccccccccccCCCCCccCCCCC-----cccCCCCCCCCC
Q 035917 176 LSNNKLSGPIPYQL---SNLGRLKKFSVANNDLTGTIPSSFKGFD-----KADFDGNSDLCG 229 (611)
Q Consensus 176 L~~N~l~g~iP~~l---~~l~~L~~L~l~~N~l~g~ip~~~~~~~-----~~~~~~n~~lc~ 229 (611)
|++|+|++..+..+ ..+++|+.|+|++|+|++..+..+..++ .+.+.+|+..|.
T Consensus 143 L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~ 204 (361)
T 2xot_A 143 LSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECD 204 (361)
T ss_dssp CCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECC
T ss_pred CCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCC
Confidence 99999996444444 6799999999999999976555555543 356778876664
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.47 E-value=1.7e-14 Score=165.02 Aligned_cols=115 Identities=30% Similarity=0.487 Sum_probs=107.7
Q ss_pred CcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccc
Q 035917 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
..+..|+|++|.+. .+|+.+..|++|+.|+|++|.|+ .||..++. |++|++|||++|.|+ .||..+++|++|++|+
T Consensus 224 ~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~-l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~ 299 (727)
T 4b8c_D 224 QLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKN-LSNLRVLDLSHNRLT-SLPAELGSCFQLKYFY 299 (727)
T ss_dssp CCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGG-GTTCCEEECTTSCCS-SCCSSGGGGTTCSEEE
T ss_pred CCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhC-CCCCCEEeCcCCcCC-ccChhhcCCCCCCEEE
Confidence 46889999999998 88989999999999999999999 89999988 999999999999999 8999999999999999
Q ss_pred ccccccCCCCChhhhcCCCcccccccccccCCCCCccCCC
Q 035917 176 LSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215 (611)
Q Consensus 176 L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~ 215 (611)
|++|.|+ .||..|++|++|+.|+|++|.|+|.+|..+..
T Consensus 300 L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 338 (727)
T 4b8c_D 300 FFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTE 338 (727)
T ss_dssp CCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHH
T ss_pred CCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhh
Confidence 9999997 88999999999999999999999999987754
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=3.1e-14 Score=159.63 Aligned_cols=131 Identities=19% Similarity=0.176 Sum_probs=71.6
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCcc-CchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGN-IPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~-ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
.++.|+|++|.+.+.+|..++.+++|+.|+|++|.+++. +|..+.. +++|+.|+|++|++++.+|..++++++|+.|+
T Consensus 425 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~-l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 503 (606)
T 3vq2_A 425 KLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFAN-TTNLTFLDLSKCQLEQISWGVFDTLHRLQLLN 503 (606)
T ss_dssp TCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTT-CTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhcc-CCCCCEEECCCCcCCccChhhhcccccCCEEE
Confidence 344555555555555555555555555555555555553 4444444 55555556655555555555555555666666
Q ss_pred ccccccCCCCChhhhcCCCcccccccccccCCCCCccCCC----CCcccCCCCCCCCC
Q 035917 176 LSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG----FDKADFDGNSDLCG 229 (611)
Q Consensus 176 L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~----~~~~~~~~n~~lc~ 229 (611)
|++|++++.+|..+.++++|+.|++++|+++ .+|..+.. +..+.+.+|+..|.
T Consensus 504 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~ 560 (606)
T 3vq2_A 504 MSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACI 560 (606)
T ss_dssp CCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCS
T ss_pred CCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccC
Confidence 6666665555555555566666666666655 45544433 22334555555543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=1.1e-13 Score=157.38 Aligned_cols=128 Identities=22% Similarity=0.251 Sum_probs=112.6
Q ss_pred CcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccc
Q 035917 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
.+++.|+|++|++.+..+..++.+++|++|+|++|.+++..|..+.. +++|++|+|++|.+++..+..++++++|++|+
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 103 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQK-LPMLKVLNLQHNELSQLSDKTFAFCTNLTELH 103 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHH-CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhc-ccCcCEEECCCCccCccChhhhccCCCCCEEE
Confidence 47899999999999988888999999999999999999888888888 99999999999999965555799999999999
Q ss_pred ccccccCCCCChhhhcCCCcccccccccccCCCCCccCCCCCc---ccCCCC
Q 035917 176 LSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDK---ADFDGN 224 (611)
Q Consensus 176 L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~~---~~~~~n 224 (611)
|++|.+++..|..|+++++|++|++++|.+++..|..+++++. +.+.+|
T Consensus 104 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 155 (680)
T 1ziw_A 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 155 (680)
T ss_dssp CCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSS
T ss_pred CCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCC
Confidence 9999999888888999999999999999999998887765543 344554
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.47 E-value=6.9e-14 Score=163.13 Aligned_cols=131 Identities=22% Similarity=0.242 Sum_probs=107.3
Q ss_pred CcccceecCCCCCCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccC-chhHHhcCCCCCEEECcCCcCcccC
Q 035917 83 CQFVGVSCWNDKENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNI-PAQICNWLPYLVLLDLSNNDLSGPI 161 (611)
Q Consensus 83 c~w~Gv~C~~~~~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~i-p~~~~~~l~~L~~L~Ls~N~l~G~i 161 (611)
|.|..|.+ - ..+++.|+|++|.+++..|..+..+++|++|+|++|++.+.| |..+.+ +++|++|+|++|.+++..
T Consensus 14 ~~L~~vP~-l--p~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~-L~~L~~L~Ls~N~l~~~~ 89 (844)
T 3j0a_A 14 CNLTQVPQ-V--LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRN-LPNLRILDLGSSKIYFLH 89 (844)
T ss_dssp CCSSCCCS-S--CTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSS-CTTCCEEECTTCCCCEEC
T ss_pred CCCCCCCC-C--CCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcC-CCCCCEEECCCCcCcccC
Confidence 56777776 2 357889999999999988888999999999999999888888 556666 888999999999998888
Q ss_pred ccCccCCcCcccccccccccCCCCChh--hhcCCCcccccccccccCCCCC-ccCCCCC
Q 035917 162 PADLGNCTYLNTLILSNNKLSGPIPYQ--LSNLGRLKKFSVANNDLTGTIP-SSFKGFD 217 (611)
Q Consensus 162 P~~~~~l~~L~~L~L~~N~l~g~iP~~--l~~l~~L~~L~l~~N~l~g~ip-~~~~~~~ 217 (611)
|..++++++|++|+|++|.+++.+|.. +.++++|++|+|++|.+++..| ..+++++
T Consensus 90 p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~ 148 (844)
T 3j0a_A 90 PDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLN 148 (844)
T ss_dssp TTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCS
T ss_pred HhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCC
Confidence 888888899999999999888877765 8888888888888888887665 3454443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.47 E-value=9.2e-14 Score=136.21 Aligned_cols=113 Identities=21% Similarity=0.151 Sum_probs=101.6
Q ss_pred CcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccc
Q 035917 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
..++.|+|++|+|++..+..+..+++|+.|+|++|.|++..+..+.. +++|+.|+|++|+|+ .+|..+.++++|++|+
T Consensus 64 ~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~-l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~ 141 (229)
T 3e6j_A 64 INLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDR-LVHLKELFMCCNKLT-ELPRGIERLTHLTHLA 141 (229)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT-CTTCCEEECCSSCCC-SCCTTGGGCTTCSEEE
T ss_pred cCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCc-chhhCeEeccCCccc-ccCcccccCCCCCEEE
Confidence 36889999999997666667899999999999999999654555566 999999999999999 8999999999999999
Q ss_pred ccccccCCCCChhhhcCCCcccccccccccCCCCC
Q 035917 176 LSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIP 210 (611)
Q Consensus 176 L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip 210 (611)
|++|+|++..+..|..+++|+.|+|++|.+++..+
T Consensus 142 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 142 LDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 99999998777889999999999999999998876
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.46 E-value=2.8e-13 Score=127.01 Aligned_cols=126 Identities=24% Similarity=0.271 Sum_probs=102.7
Q ss_pred EEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccccc
Q 035917 99 LNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSN 178 (611)
Q Consensus 99 ~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~ 178 (611)
+.++++++++.. +|..+ .++|+.|+|++|++++..|..+.. +++|++|+|++|++++..|..++++++|++|+|++
T Consensus 10 ~~l~~~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~-l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 10 TEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDK-LTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TEEECCSSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTT-CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEecCCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcC-cccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 478899998874 45433 479999999999999655555666 99999999999999977666789999999999999
Q ss_pred cccCCCCChhhhcCCCcccccccccccCCCCCccCCC---CCcccCCCCCCCC
Q 035917 179 NKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG---FDKADFDGNSDLC 228 (611)
Q Consensus 179 N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~---~~~~~~~~n~~lc 228 (611)
|.|++..|..+..+++|+.|++++|++++..+..+.. +..+.+.+|+..|
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 9999888888899999999999999999766655554 4455677776444
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=6.6e-14 Score=157.12 Aligned_cols=132 Identities=18% Similarity=0.273 Sum_probs=118.0
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCcc-CchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGN-IPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~-ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
.+..++++.|.+.+..|..+..++.|+.|+|++|++.+. +|..+.. +++|++|||++|++++.+|..++++++|++|+
T Consensus 446 ~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~-l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~ 524 (635)
T 4g8a_A 446 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE-LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 524 (635)
T ss_dssp TCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTT-CTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred ccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhh-ccccCEEECCCCccCCcChHHHcCCCCCCEEE
Confidence 567889999999999999999999999999999986544 5666766 99999999999999999999999999999999
Q ss_pred ccccccCCCCChhhhcCCCcccccccccccCCCCCccCCCC----CcccCCCCCCCCC
Q 035917 176 LSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF----DKADFDGNSDLCG 229 (611)
Q Consensus 176 L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~----~~~~~~~n~~lc~ 229 (611)
|++|+|++..|..|.++++|++|+|++|+|++.+|..+..+ ..+.+.+|+..|.
T Consensus 525 Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 525 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp CTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred CCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 99999999999999999999999999999999999887654 4566788887775
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.45 E-value=1.2e-13 Score=143.94 Aligned_cols=112 Identities=19% Similarity=0.166 Sum_probs=95.7
Q ss_pred CcccceecCCCCCCcEEEEEecCCcccccCCccCcCCCCCCEEEccC-CCCCccCchhHHhcCCCCCEEECcCCcCcccC
Q 035917 83 CQFVGVSCWNDKENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSA-NDLSGNIPAQICNWLPYLVLLDLSNNDLSGPI 161 (611)
Q Consensus 83 c~w~Gv~C~~~~~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~-N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~i 161 (611)
|.|..|.|.+ .|+|.+ +|. |..+++|+.|+|++ |.|++..|..|.. |++|+.|+|++|+|+|..
T Consensus 8 C~~~~v~~~~------------~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~-l~~L~~L~l~~N~l~~~~ 72 (347)
T 2ifg_A 8 HGSSGLRCTR------------DGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRG-LGELRNLTIVKSGLRFVA 72 (347)
T ss_dssp SSSSCEECCS------------SCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCS-CCCCSEEECCSSCCCEEC
T ss_pred ccCCEEEcCC------------CCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhcc-ccCCCEEECCCCccceeC
Confidence 8888888842 125664 777 99999999999996 9999776677877 999999999999999999
Q ss_pred ccCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccCCCCC
Q 035917 162 PADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIP 210 (611)
Q Consensus 162 P~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip 210 (611)
|..|++|++|+.|+|++|+|++..|..+..++ |+.|+|++|.|.....
T Consensus 73 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 73 PDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCSCA 120 (347)
T ss_dssp TTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGG
T ss_pred HHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCCCc
Confidence 99999999999999999999976666666665 9999999999986543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.45 E-value=3.2e-14 Score=164.83 Aligned_cols=126 Identities=18% Similarity=0.257 Sum_probs=111.9
Q ss_pred CcEEEEEecCCcccc-----------------cCCccCc--CCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCc
Q 035917 96 NRILNLELREMKLSG-----------------KIPEPLK--FCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNND 156 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g-----------------~~p~~l~--~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~ 156 (611)
..++.|+|++|.|+| .+|+.++ +|++|+.|+|++|++.|.+|..+.. +++|+.|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~-L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYD-LPELQSLNIACNR 526 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGG-CSSCCEEECTTCT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhC-CCCCCEEECcCCC
Confidence 368899999999999 4999988 9999999999999999999999998 9999999999998
Q ss_pred -Ccc-cCccCccCCc-------CcccccccccccCCCCCh--hhhcCCCcccccccccccCCCCCccCCCCCc---ccCC
Q 035917 157 -LSG-PIPADLGNCT-------YLNTLILSNNKLSGPIPY--QLSNLGRLKKFSVANNDLTGTIPSSFKGFDK---ADFD 222 (611)
Q Consensus 157 -l~G-~iP~~~~~l~-------~L~~L~L~~N~l~g~iP~--~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~~---~~~~ 222 (611)
|+| .+|..+++++ +|+.|+|++|+|+ .+|. .++++++|+.|+|++|+++ .|| .+++++. +.+.
T Consensus 527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls 603 (876)
T 4ecn_A 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLD 603 (876)
T ss_dssp TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECC
T ss_pred CcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECc
Confidence 999 9998887776 9999999999999 9998 8999999999999999999 888 6665543 4455
Q ss_pred CCC
Q 035917 223 GNS 225 (611)
Q Consensus 223 ~n~ 225 (611)
+|.
T Consensus 604 ~N~ 606 (876)
T 4ecn_A 604 YNQ 606 (876)
T ss_dssp SSC
T ss_pred CCc
Confidence 554
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.44 E-value=3.3e-13 Score=139.71 Aligned_cols=140 Identities=22% Similarity=0.264 Sum_probs=118.0
Q ss_pred CCCcccceecCCCC--------CCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEEC
Q 035917 81 FICQFVGVSCWNDK--------ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDL 152 (611)
Q Consensus 81 ~~c~w~Gv~C~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~L 152 (611)
+.|.|..+.|.+.. ...++.|+|++|++.+..|..+..+++|+.|+|++|.+++..|..+.. +++|++|+|
T Consensus 31 c~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L 109 (332)
T 2ft3_A 31 CHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSP-LRKLQKLYI 109 (332)
T ss_dssp CEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTT-CTTCCEEEC
T ss_pred CcccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhC-cCCCCEEEC
Confidence 34789999996432 136789999999999988889999999999999999999888888888 999999999
Q ss_pred cCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccC--CCCCccCCCC--CcccCCCC
Q 035917 153 SNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLT--GTIPSSFKGF--DKADFDGN 224 (611)
Q Consensus 153 s~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~--g~ip~~~~~~--~~~~~~~n 224 (611)
++|.++ .+|..+. ++|++|+|++|.+++..+..+.++++|+.|++++|.++ |..|..+..+ ..+.+.+|
T Consensus 110 ~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n 182 (332)
T 2ft3_A 110 SKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEA 182 (332)
T ss_dssp CSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSS
T ss_pred CCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCC
Confidence 999998 7888776 89999999999999777778999999999999999996 4667666643 33444444
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.43 E-value=4e-14 Score=156.84 Aligned_cols=122 Identities=27% Similarity=0.388 Sum_probs=99.8
Q ss_pred cccce-ecCCCCCCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCc
Q 035917 84 QFVGV-SCWNDKENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIP 162 (611)
Q Consensus 84 ~w~Gv-~C~~~~~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP 162 (611)
.|.|+ .|.. ++++.|+|++|+|++ +|+.+. ++|+.|+|++|+|+ .|| .. +++|+.|+|++|+|++ ||
T Consensus 49 ~~~~l~~C~~---~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~-l~~L~~L~Ls~N~l~~-ip 116 (571)
T 3cvr_A 49 AVSLLKECLI---NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---EL-PASLEYLDACDNRLST-LP 116 (571)
T ss_dssp HHHHHHHHHH---TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CC-CTTCCEEECCSSCCSC-CC
T ss_pred hhhhcccccc---CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cc-cCCCCEEEccCCCCCC-cc
Confidence 79999 7853 478999999999998 887663 78999999999999 788 23 7899999999999997 88
Q ss_pred cCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccCCCCCccCCCCCcccCCCCC
Q 035917 163 ADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKADFDGNS 225 (611)
Q Consensus 163 ~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~~~~~~~n~ 225 (611)
. +.+ +|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|..+.++..+.+.+|.
T Consensus 117 ~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~~l~~L~~L~Ls~N~ 171 (571)
T 3cvr_A 117 E-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPELPTSLEVLSVRNNQ 171 (571)
T ss_dssp C-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSC
T ss_pred h-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCCcCCCcCEEECCCCC
Confidence 7 665 89999999999987 776 67888888888888887 77766666666666664
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=1.1e-13 Score=139.26 Aligned_cols=118 Identities=16% Similarity=0.212 Sum_probs=93.6
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.++.|+|++|.+.+..+..+..+++|+.|+|++|.+++..|..+.. +++|+.|+|++|++++..+..++++++|++|+|
T Consensus 53 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 131 (276)
T 2z62_A 53 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG-LSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (276)
T ss_dssp TCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT-CTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred CCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcC-CccccEEECCCCCccccCchhcccCCCCCEEEC
Confidence 5778888888888777777888888888888888888766666766 888888888888888766667888888888888
Q ss_pred cccccCC-CCChhhhcCCCcccccccccccCCCCCccCCC
Q 035917 177 SNNKLSG-PIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215 (611)
Q Consensus 177 ~~N~l~g-~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~ 215 (611)
++|.+++ .+|..++++++|+.|++++|++++..+..+..
T Consensus 132 ~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 171 (276)
T 2z62_A 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171 (276)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHH
T ss_pred cCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhh
Confidence 8888876 46888888888888888888888766655543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.42 E-value=4.3e-14 Score=145.24 Aligned_cols=127 Identities=21% Similarity=0.258 Sum_probs=108.0
Q ss_pred cEEEEEecCCcccccCCccC--cCCCCCCEEEccCCCCCccCchhHHhcC-----CCCCEEECcCCcCcccCccCccCCc
Q 035917 97 RILNLELREMKLSGKIPEPL--KFCKSMQRLDLSANDLSGNIPAQICNWL-----PYLVLLDLSNNDLSGPIPADLGNCT 169 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l--~~l~~L~~L~Ls~N~l~g~ip~~~~~~l-----~~L~~L~Ls~N~l~G~iP~~~~~l~ 169 (611)
+++.|+|++|+++|.+|..+ +.+++|+.|+|++|.+++. |..+.. + ++|++|+|++|++++..|..+++++
T Consensus 96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~-l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 173 (312)
T 1wwl_A 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAE-LQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173 (312)
T ss_dssp CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHH-HHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHH-HHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence 68899999999999999987 8999999999999999987 888877 5 8999999999999988889999999
Q ss_pred CcccccccccccCCC--CChhh--hcCCCcccccccccccCC--CCCcc----CCCCCcccCCCCC
Q 035917 170 YLNTLILSNNKLSGP--IPYQL--SNLGRLKKFSVANNDLTG--TIPSS----FKGFDKADFDGNS 225 (611)
Q Consensus 170 ~L~~L~L~~N~l~g~--iP~~l--~~l~~L~~L~l~~N~l~g--~ip~~----~~~~~~~~~~~n~ 225 (611)
+|++|+|++|+++|. +|..+ ..+++|+.|++++|++++ .+|.. +.++..+.+.+|.
T Consensus 174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~ 239 (312)
T 1wwl_A 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNS 239 (312)
T ss_dssp SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSC
T ss_pred CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCc
Confidence 999999999999887 34455 889999999999999984 34432 2566666777764
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=3.8e-13 Score=137.95 Aligned_cols=112 Identities=19% Similarity=0.230 Sum_probs=58.3
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCcc--CchhH--HhcCCCCCEEECcCCcCcccCcc---C-ccCC
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGN--IPAQI--CNWLPYLVLLDLSNNDLSGPIPA---D-LGNC 168 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~--ip~~~--~~~l~~L~~L~Ls~N~l~G~iP~---~-~~~l 168 (611)
+++.|+|++|.+.+..|..++.+++|++|+|++|++.|. +|... .. +++|++|+|++|+++ .+|. . ++++
T Consensus 146 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~-l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l 223 (310)
T 4glp_A 146 GLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHK-FPAIQNLALRNTGME-TPTGVCAALAAAG 223 (310)
T ss_dssp CCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTS-SCCCCSCBCCSSCCC-CHHHHHHHHHHHT
T ss_pred CCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhc-CCCCCEEECCCCCCC-chHHHHHHHHhcC
Confidence 466667777776666666666666777777777666542 22111 22 445555555555554 1121 1 2444
Q ss_pred cCcccccccccccCCCCChhhhcC---CCcccccccccccCCCCCc
Q 035917 169 TYLNTLILSNNKLSGPIPYQLSNL---GRLKKFSVANNDLTGTIPS 211 (611)
Q Consensus 169 ~~L~~L~L~~N~l~g~iP~~l~~l---~~L~~L~l~~N~l~g~ip~ 211 (611)
++|++|||++|+|++.+|..++.+ ++|++|+|++|+++ .+|.
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~ 268 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPK 268 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCS
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhh
Confidence 555555555555555544444443 35555555555555 3443
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.42 E-value=4e-13 Score=124.71 Aligned_cols=111 Identities=23% Similarity=0.226 Sum_probs=99.1
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCccc-CccCccCCcCccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP-IPADLGNCTYLNTLI 175 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~-iP~~~~~l~~L~~L~ 175 (611)
.++.|+|++|.+++. ..++.+++|+.|+|++|.+++.+|..+.. +++|+.|+|++|.+++. .+..+..+++|++|+
T Consensus 50 ~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~ 126 (168)
T 2ell_A 50 NLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEK-LPNLTHLNLSGNKLKDISTLEPLKKLECLKSLD 126 (168)
T ss_dssp GCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHH-CTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEE
T ss_pred CCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhh-CCCCCEEeccCCccCcchhHHHHhcCCCCCEEE
Confidence 688999999999987 78999999999999999999888988887 99999999999999864 337899999999999
Q ss_pred ccccccCCCCC---hhhhcCCCcccccccccccCCCCCc
Q 035917 176 LSNNKLSGPIP---YQLSNLGRLKKFSVANNDLTGTIPS 211 (611)
Q Consensus 176 L~~N~l~g~iP---~~l~~l~~L~~L~l~~N~l~g~ip~ 211 (611)
|++|.+++..+ ..+..+++|++|++++|.+. .+|.
T Consensus 127 l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 127 LFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp CCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred eeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence 99999997766 57899999999999999886 4454
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.42 E-value=1.6e-13 Score=131.13 Aligned_cols=106 Identities=21% Similarity=0.312 Sum_probs=52.6
Q ss_pred EEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccccc
Q 035917 98 ILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILS 177 (611)
Q Consensus 98 v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~ 177 (611)
++.|+|++|.+ ..++.+..+++|++|+|++|.+++..|..+.. +++|++|+|++|.+++..|..++++++|++|+|+
T Consensus 68 L~~L~l~~n~~--~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~-l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~ 144 (197)
T 4ezg_A 68 IKDLTINNIHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSG-LTSLTLLDISHSAHDDSILTKINTLPKVNSIDLS 144 (197)
T ss_dssp CSEEEEESCCC--SCCGGGTTCTTCCEEEEECTTCBGGGSCCCTT-CTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECC
T ss_pred CCEEEccCCCC--CcchhhhcCCCCCEEEeECCccCcccChhhcC-CCCCCEEEecCCccCcHhHHHHhhCCCCCEEEcc
Confidence 44555555532 22234455555555555555555444444444 5555555555555555455555555555555555
Q ss_pred ccccCCCCChhhhcCCCcccccccccccCC
Q 035917 178 NNKLSGPIPYQLSNLGRLKKFSVANNDLTG 207 (611)
Q Consensus 178 ~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g 207 (611)
+|.+.+.+| .+..+++|+.|++++|++++
T Consensus 145 ~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~ 173 (197)
T 4ezg_A 145 YNGAITDIM-PLKTLPELKSLNIQFDGVHD 173 (197)
T ss_dssp SCTBCCCCG-GGGGCSSCCEEECTTBCCCC
T ss_pred CCCCccccH-hhcCCCCCCEEECCCCCCcC
Confidence 554333444 34555555555555555544
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=4.9e-14 Score=164.43 Aligned_cols=130 Identities=23% Similarity=0.234 Sum_probs=102.2
Q ss_pred cEEEEEecCCcccccCCc-cCcCCCCCCEEEccCCCCC-----ccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcC
Q 035917 97 RILNLELREMKLSGKIPE-PLKFCKSMQRLDLSANDLS-----GNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTY 170 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~-~l~~l~~L~~L~Ls~N~l~-----g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~ 170 (611)
+++.|+|++|++++..+. .+..+++|+.|+|++|.++ +..|..+.. +++|+.|+|++|+|++.+|..+.++++
T Consensus 427 ~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 505 (844)
T 3j0a_A 427 HLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEG-LSHLQVLYLNHNYLNSLPPGVFSHLTA 505 (844)
T ss_dssp TCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSC-BCCEECCCCCHHHHTTCCTTSSSSCCS
T ss_pred ccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcC-cccccEEECCCCcccccChhHccchhh
Confidence 456677777777765443 2455777888888888776 333444555 788889999999998888888888999
Q ss_pred cccccccccccCCCCChhhhcCCCcccccccccccCCCCCccCCCCCcccCCCCCCCCC
Q 035917 171 LNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKADFDGNSDLCG 229 (611)
Q Consensus 171 L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~~~~~~~n~~lc~ 229 (611)
|+.|+|++|+|++..|..+. ++|+.|+|++|+|+|.+|..+.++..+.+.+|+..|.
T Consensus 506 L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~ 562 (844)
T 3j0a_A 506 LRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICE 562 (844)
T ss_dssp CSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCS
T ss_pred hheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCcccc
Confidence 99999999999877666655 7899999999999999999988888888999998884
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.41 E-value=2.6e-13 Score=152.05 Aligned_cols=127 Identities=24% Similarity=0.254 Sum_probs=112.6
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.+..|+|++|.+.+..|..++.+++|+.|+|++|.+++..|..++. +++|++|+|++|.|++..|..++++++|++|+|
T Consensus 76 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQN-VPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTT-CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcC-CCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 5778999999999999999999999999999999999877777777 999999999999999555555799999999999
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCCccCCCCCcccCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKADFDGN 224 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~~~~~~~n 224 (611)
++|.|++..|..|+++++|+.|++++|.+++.-+..+.++..+.+.+|
T Consensus 155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n 202 (597)
T 3oja_B 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYN 202 (597)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSS
T ss_pred eCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccC
Confidence 999999999999999999999999999999876666666666666555
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.41 E-value=3e-13 Score=146.27 Aligned_cols=140 Identities=18% Similarity=0.210 Sum_probs=116.6
Q ss_pred ccceecCCCC--------CCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCc
Q 035917 85 FVGVSCWNDK--------ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNND 156 (611)
Q Consensus 85 w~Gv~C~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~ 156 (611)
|..|.|.+.. ...++.|+|++|++.+..|..+..+++|+.|+|++|.+++..|..+.. +++|+.|+|++|+
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~-l~~L~~L~L~~n~ 134 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNG-LASLNTLELFDNW 134 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTT-CTTCCEEECCSSC
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccC-cccCCEEECCCCc
Confidence 5788886431 236889999999999999999999999999999999999877788887 9999999999999
Q ss_pred CcccCccCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccCCCCCc-cCCC---CCcccCCCCC
Q 035917 157 LSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPS-SFKG---FDKADFDGNS 225 (611)
Q Consensus 157 l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~-~~~~---~~~~~~~~n~ 225 (611)
+++..|..+.++++|++|+|++|.+++..+..|.++++|+.|++++|+.-+.+|. .+.+ +..+.+.+|.
T Consensus 135 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~ 207 (452)
T 3zyi_A 135 LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCN 207 (452)
T ss_dssp CSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSC
T ss_pred CCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCc
Confidence 9977777799999999999999999977777899999999999999766666665 3444 4444555553
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=3.3e-13 Score=151.28 Aligned_cols=139 Identities=19% Similarity=0.135 Sum_probs=117.5
Q ss_pred ccceecCCCC--------CCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCc
Q 035917 85 FVGVSCWNDK--------ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNND 156 (611)
Q Consensus 85 w~Gv~C~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~ 156 (611)
+.-|.|.+.. ...++.|+|++|.+++..|..++.+++|++|+|++|.+++..|..+.. +++|++|+|++|+
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~-l~~L~~L~Ls~n~ 92 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQS-QHRLDTLVLTANP 92 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTT-CTTCCEEECTTCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccC-ccccCeeeCCCCc
Confidence 3457785421 236889999999999999999999999999999999999888888888 9999999999999
Q ss_pred CcccCccCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccCC-CCCccC--CCCCcccCCCC
Q 035917 157 LSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTG-TIPSSF--KGFDKADFDGN 224 (611)
Q Consensus 157 l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g-~ip~~~--~~~~~~~~~~n 224 (611)
+++..|..++++++|++|+|++|.+++..|..++++++|++|++++|++++ .+|..+ .++..+.+.+|
T Consensus 93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 163 (606)
T 3t6q_A 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNN 163 (606)
T ss_dssp CSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSS
T ss_pred ccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccC
Confidence 999999999999999999999999998777789999999999999999998 445443 33444455555
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=3.9e-13 Score=138.93 Aligned_cols=134 Identities=23% Similarity=0.303 Sum_probs=115.4
Q ss_pred CCCcccceecCCCC--------CCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEEC
Q 035917 81 FICQFVGVSCWNDK--------ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDL 152 (611)
Q Consensus 81 ~~c~w~Gv~C~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~L 152 (611)
+.|.|..+.|.+.. ...++.|+|++|++++..+..++.+++|++|+|++|.+++..|..+.. +++|++|+|
T Consensus 29 c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L 107 (330)
T 1xku_A 29 CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAP-LVKLERLYL 107 (330)
T ss_dssp CEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTT-CTTCCEEEC
T ss_pred CcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcC-CCCCCEEEC
Confidence 35789999996421 235788999999999988889999999999999999999877888988 999999999
Q ss_pred cCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccC--CCCCccCCCCCc
Q 035917 153 SNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLT--GTIPSSFKGFDK 218 (611)
Q Consensus 153 s~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~--g~ip~~~~~~~~ 218 (611)
++|.++ .+|..+. ++|++|+|++|.+++..|..+.++++|+.|++++|.++ |..|..+.+++.
T Consensus 108 s~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~ 172 (330)
T 1xku_A 108 SKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 172 (330)
T ss_dssp CSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTT
T ss_pred CCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCC
Confidence 999998 7887765 79999999999999888888999999999999999996 366666655443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.40 E-value=2.5e-13 Score=123.41 Aligned_cols=104 Identities=21% Similarity=0.222 Sum_probs=94.7
Q ss_pred CcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcc-cCccCccCCcCcccc
Q 035917 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG-PIPADLGNCTYLNTL 174 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G-~iP~~~~~l~~L~~L 174 (611)
..++.|+|++|.+.+. +.++.+++|+.|+|++|.+++.+|..+.. +++|++|+|++|.+++ +.|..++++++|++|
T Consensus 42 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~-l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L 118 (149)
T 2je0_A 42 EELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEK-CPNLTHLNLSGNKIKDLSTIEPLKKLENLKSL 118 (149)
T ss_dssp TTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHH-CTTCCEEECTTSCCCSHHHHGGGGGCTTCCEE
T ss_pred CCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhh-CCCCCEEECCCCcCCChHHHHHHhhCCCCCEE
Confidence 3688999999999987 77999999999999999999889988887 9999999999999997 356889999999999
Q ss_pred cccccccCCCCC---hhhhcCCCcccccccc
Q 035917 175 ILSNNKLSGPIP---YQLSNLGRLKKFSVAN 202 (611)
Q Consensus 175 ~L~~N~l~g~iP---~~l~~l~~L~~L~l~~ 202 (611)
+|++|.+++..+ ..+..+++|+.|++++
T Consensus 119 ~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 119 DLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred eCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 999999998777 5799999999999874
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.40 E-value=4.2e-13 Score=128.14 Aligned_cols=108 Identities=19% Similarity=0.224 Sum_probs=96.4
Q ss_pred CcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccc
Q 035917 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
..+..|+|++|.+++..|..++.+++|+.|+|++|.+++.+|..+.. +++|+.|+|++|.+.+.+| .+.++++|+.|+
T Consensus 88 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~-l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~ 165 (197)
T 4ezg_A 88 SNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT-LPKVNSIDLSYNGAITDIM-PLKTLPELKSLN 165 (197)
T ss_dssp TTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTT-CSSCCEEECCSCTBCCCCG-GGGGCSSCCEEE
T ss_pred CCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhh-CCCCCEEEccCCCCccccH-hhcCCCCCCEEE
Confidence 36889999999999999999999999999999999999989999988 9999999999999666787 689999999999
Q ss_pred ccccccCCCCChhhhcCCCcccccccccccCC
Q 035917 176 LSNNKLSGPIPYQLSNLGRLKKFSVANNDLTG 207 (611)
Q Consensus 176 L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g 207 (611)
|++|.+++ +| .+..+++|+.|++++|++.+
T Consensus 166 l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 166 IQFDGVHD-YR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CTTBCCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred CCCCCCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence 99999996 55 68999999999999999875
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=2.9e-13 Score=150.30 Aligned_cols=131 Identities=19% Similarity=0.229 Sum_probs=91.7
Q ss_pred EEEEEecCCcccccCC-ccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCc-ccCccCccCCcCccccc
Q 035917 98 ILNLELREMKLSGKIP-EPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLS-GPIPADLGNCTYLNTLI 175 (611)
Q Consensus 98 v~~l~l~~~~l~g~~p-~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~-G~iP~~~~~l~~L~~L~ 175 (611)
++.|+|++|.+.+..| ..+..+++|+.|+|++|.+.+.+|..+.. +++|+.|+|++|.++ |.+|..+..+++|++|+
T Consensus 398 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~ 476 (570)
T 2z63_A 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG-LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476 (570)
T ss_dssp CCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTT-CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred CCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhc-CCcCcEEECcCCcCccccchhhhhcccCCCEEE
Confidence 4455666666665555 34667777777777777777777766666 777777777777776 56777777777788888
Q ss_pred ccccccCCCCChhhhcCCCcccccccccccCCCCCccCCCCC---cccCCCCCCCCC
Q 035917 176 LSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFD---KADFDGNSDLCG 229 (611)
Q Consensus 176 L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~---~~~~~~n~~lc~ 229 (611)
|++|++++..|..+.++++|+.|++++|++++..|..+.+++ .+.+.+|+..|.
T Consensus 477 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 533 (570)
T 2z63_A 477 LSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533 (570)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCC
Confidence 887777777777777777788888888877777666555443 344566655443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.39 E-value=5.9e-13 Score=135.32 Aligned_cols=110 Identities=32% Similarity=0.347 Sum_probs=66.2
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
+++.|+|++|.+++..+. +.+++|+.|+|++|.|+ .+|..+.. +++|+.|+|++|++++..|..+.++++|++|+|
T Consensus 56 ~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~~~-l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L 131 (290)
T 1p9a_G 56 RLTQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQT-LPALTVLDVSFNRLTSLPLGALRGLGELQELYL 131 (290)
T ss_dssp TCCEEECTTSCCCEEECC--SCCTTCCEEECCSSCCS-SCCCCTTT-CTTCCEEECCSSCCCCCCSSTTTTCTTCCEEEC
T ss_pred CCCEEECCCCccCcccCC--CCCCcCCEEECCCCcCC-cCchhhcc-CCCCCEEECCCCcCcccCHHHHcCCCCCCEEEC
Confidence 355555555555543221 45566666666666665 45655555 666666666666666555555666666666666
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIP 210 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip 210 (611)
++|+|++..|..|..+++|+.|+|++|+|++..+
T Consensus 132 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~ 165 (290)
T 1p9a_G 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPA 165 (290)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCT
T ss_pred CCCCCCccChhhcccccCCCEEECCCCcCCccCH
Confidence 6666665555556666666666666666664433
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=3.4e-13 Score=151.17 Aligned_cols=120 Identities=21% Similarity=0.202 Sum_probs=68.1
Q ss_pred cEEEEEecCCcccccCCcc-CcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCccc---CccCccCCcCcc
Q 035917 97 RILNLELREMKLSGKIPEP-LKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP---IPADLGNCTYLN 172 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~-l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~---iP~~~~~l~~L~ 172 (611)
.++.|+|++|.+.+..|+. +..+++|+.|+|++|.+++.+|..+.. +++|+.|+|++|.+++. .+..+..+++|+
T Consensus 401 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~ 479 (606)
T 3t6q_A 401 QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDG-LPALQHLNLQGNHFPKGNIQKTNSLQTLGRLE 479 (606)
T ss_dssp TCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTT-CTTCCEEECTTCBCGGGEECSSCGGGGCTTCC
T ss_pred cCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhC-CCCCCEEECCCCCCCccccccchhhccCCCcc
Confidence 4555666666666555443 556666666666666666555555554 55666666666665542 223455555556
Q ss_pred cccccccccCCCCChhhhcCCCcccccccccccCCCCCccCCCCC
Q 035917 173 TLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFD 217 (611)
Q Consensus 173 ~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~ 217 (611)
+|+|++|.+++..|..|.++++|+.|++++|++++.+|..+.++.
T Consensus 480 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~ 524 (606)
T 3t6q_A 480 ILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLK 524 (606)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCC
T ss_pred EEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccc
Confidence 666666555555555555555555555555555555555554443
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=6.9e-13 Score=147.28 Aligned_cols=120 Identities=21% Similarity=0.227 Sum_probs=86.6
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.++.|+|++|++++..+..+..+++|++|+|++|.+++..|..+.. +++|++|+|++|.+++..|..++++++|++|+|
T Consensus 29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~-l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQS-LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTT-CTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccC-chhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 5677788888877777777777888888888888777655555665 777777777777777766677777777777777
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCC-CCCccCCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTG-TIPSSFKGFD 217 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g-~ip~~~~~~~ 217 (611)
++|++++..+..++++++|++|++++|.+++ .+|..+++++
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~ 149 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCT
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccC
Confidence 7777776555457777777777777777766 4676655443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.38 E-value=2e-13 Score=140.18 Aligned_cols=114 Identities=19% Similarity=0.242 Sum_probs=49.9
Q ss_pred EEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCcc--CchhH--HhcCCCCCEEECcCCcCcc--cCccC-ccCCcC
Q 035917 98 ILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGN--IPAQI--CNWLPYLVLLDLSNNDLSG--PIPAD-LGNCTY 170 (611)
Q Consensus 98 v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~--ip~~~--~~~l~~L~~L~Ls~N~l~G--~iP~~-~~~l~~ 170 (611)
++.|+|++|.+.+..|..++.+++|+.|+|++|.+.|. +|..+ .. +++|+.|+|++|.+++ .+|.. +.++++
T Consensus 151 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~ 229 (312)
T 1wwl_A 151 LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLK-FPTLQVLALRNAGMETPSGVCSALAAARVQ 229 (312)
T ss_dssp CCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTS-CTTCCEEECTTSCCCCHHHHHHHHHHTTCC
T ss_pred CcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhcc-CCCCCEEECCCCcCcchHHHHHHHHhcCCC
Confidence 44444444444444444444444555555555544443 12222 22 4444444444444441 22211 233444
Q ss_pred cccccccccccCCCCC-hhhhcCCCcccccccccccCCCCCccC
Q 035917 171 LNTLILSNNKLSGPIP-YQLSNLGRLKKFSVANNDLTGTIPSSF 213 (611)
Q Consensus 171 L~~L~L~~N~l~g~iP-~~l~~l~~L~~L~l~~N~l~g~ip~~~ 213 (611)
|++|+|++|.+++.+| ..+..+++|+.|+|++|+++ .+|..+
T Consensus 230 L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~ 272 (312)
T 1wwl_A 230 LQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272 (312)
T ss_dssp CSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred CCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence 4445555554444443 22333444445555555444 444433
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.38 E-value=3.7e-13 Score=142.53 Aligned_cols=127 Identities=17% Similarity=0.158 Sum_probs=101.1
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.+..|+++++.+....+..+..+++|++|+|++|.+++..|..+.. +++|+.|+|++|.+++..|..++++++|++|+|
T Consensus 46 ~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 46 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAY-AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTT-CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccC-CCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 4567888888877655555788999999999999998766667777 899999999999999888888899999999999
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCCccCCCCCc---ccCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDK---ADFDGN 224 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~~---~~~~~n 224 (611)
++|.++...+..|.++++|++|++++|.+++..|..+..++. +.+.+|
T Consensus 125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n 175 (390)
T 3o6n_A 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 175 (390)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSS
T ss_pred CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCC
Confidence 999998544444688999999999999998877776665544 344444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=2.9e-13 Score=149.70 Aligned_cols=122 Identities=22% Similarity=0.231 Sum_probs=110.5
Q ss_pred CcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcc-cCccCccCCcCcccc
Q 035917 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG-PIPADLGNCTYLNTL 174 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G-~iP~~~~~l~~L~~L 174 (611)
..++.|+|++|++.+..|..++.+++|++|+|++|.+++..|..+.. +++|++|+|++|.+++ .+|..++++++|++|
T Consensus 50 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~-l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L 128 (549)
T 2z81_A 50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGP-LSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128 (549)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTT-CTTCCEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred CcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhcc-CCCCcEEECCCCcccccchhhhhhccCCccEE
Confidence 36889999999999999999999999999999999999877777887 9999999999999997 578899999999999
Q ss_pred cccccccCCCCC-hhhhcCCCcccccccccccCCCCCccCCCCCc
Q 035917 175 ILSNNKLSGPIP-YQLSNLGRLKKFSVANNDLTGTIPSSFKGFDK 218 (611)
Q Consensus 175 ~L~~N~l~g~iP-~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~~ 218 (611)
+|++|.+.+.+| ..+.++++|++|++++|.+++.+|..++.+..
T Consensus 129 ~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~ 173 (549)
T 2z81_A 129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRD 173 (549)
T ss_dssp EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSE
T ss_pred ECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhcccc
Confidence 999999777776 57999999999999999999999988766543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.38 E-value=4.5e-13 Score=131.88 Aligned_cols=125 Identities=19% Similarity=0.240 Sum_probs=106.1
Q ss_pred CcEEEEEecCCcccccCCccCcCCCCCCEEEccCCC-CCccCch-hHHhcCCCCCEEECcC-CcCcccCccCccCCcCcc
Q 035917 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSAND-LSGNIPA-QICNWLPYLVLLDLSN-NDLSGPIPADLGNCTYLN 172 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~-l~g~ip~-~~~~~l~~L~~L~Ls~-N~l~G~iP~~~~~l~~L~ 172 (611)
..++.|+|++|++.+..+..+..+++|+.|+|++|. ++ .||+ .+.. +++|+.|+|++ |++++..|..+.++++|+
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~-~i~~~~f~~-l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~ 108 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ-QLESHSFYN-LSKVTHIEIRNTRNLTYIDPDALKELPLLK 108 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCC-EECTTTEES-CTTCCEEEEEEETTCCEECTTSEECCTTCC
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcc-eeCHhHcCC-CcCCcEEECCCCCCeeEcCHHHhCCCCCCC
Confidence 368899999999999888899999999999999997 77 4554 5666 99999999999 999977777899999999
Q ss_pred cccccccccCCCCChhhhcCCCcc---ccccccc-ccCCCCCccCCCCC----cccCCCC
Q 035917 173 TLILSNNKLSGPIPYQLSNLGRLK---KFSVANN-DLTGTIPSSFKGFD----KADFDGN 224 (611)
Q Consensus 173 ~L~L~~N~l~g~iP~~l~~l~~L~---~L~l~~N-~l~g~ip~~~~~~~----~~~~~~n 224 (611)
+|+|++|.+++ +|. +..+++|+ .|++++| .+++..+..|.++. .+.+.+|
T Consensus 109 ~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n 166 (239)
T 2xwt_C 109 FLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNN 166 (239)
T ss_dssp EEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSC
T ss_pred EEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCC
Confidence 99999999997 887 88888888 9999999 89876666676655 4445555
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.3e-12 Score=143.74 Aligned_cols=125 Identities=22% Similarity=0.267 Sum_probs=99.7
Q ss_pred CcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCc--cCchhHHhcCCCCCEEECcCCcCcccCccC-ccCCcCcc
Q 035917 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSG--NIPAQICNWLPYLVLLDLSNNDLSGPIPAD-LGNCTYLN 172 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g--~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~-~~~l~~L~ 172 (611)
..++.|+|++|.+++.+|..++.+++|+.|+|++|++++ .+|..+.. +++|+.|+|++|.+++.+|.. +..+++|+
T Consensus 324 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~-l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~ 402 (520)
T 2z7x_B 324 SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQ-MKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402 (520)
T ss_dssp CCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTT-CTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred CcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhh-CCCCCEEECCCCcCCcccccchhccCccCC
Confidence 468899999999999999999999999999999999997 67778887 899999999999999878875 67778888
Q ss_pred cccccccccCCCCChhhhcCCCcccccccccccCCCCCccCCCC---CcccCCCC
Q 035917 173 TLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF---DKADFDGN 224 (611)
Q Consensus 173 ~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~---~~~~~~~n 224 (611)
.|+|++|.+++.+|..+. ++|+.|++++|+++ .+|..+..+ ..+.+.+|
T Consensus 403 ~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N 454 (520)
T 2z7x_B 403 SLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASN 454 (520)
T ss_dssp EEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSS
T ss_pred EEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCC
Confidence 888888888877776554 57777777777777 667654433 33444555
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.9e-13 Score=150.39 Aligned_cols=116 Identities=21% Similarity=0.172 Sum_probs=88.2
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
+++.|+|++|.+.+..|..+..+++|++|+|++|++++..|..+.. +++|++|||++|+++ .||.. .+++|++|+|
T Consensus 22 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~-l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKF-NQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTT-CTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred cccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhc-ccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 5778888888888777777888888888888888888766777776 788888888888887 57766 7788888888
Q ss_pred cccccCC-CCChhhhcCCCcccccccccccCCCCCccCCCC
Q 035917 177 SNNKLSG-PIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF 216 (611)
Q Consensus 177 ~~N~l~g-~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~ 216 (611)
++|.+++ .+|..++++++|++|++++|.+++.....+.++
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L 138 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHL 138 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGGGGGGGTTS
T ss_pred cCCccccccchhhhccCCcceEEEecCcccchhhccccccc
Confidence 8888876 577788888888888888887776433333333
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.1e-12 Score=141.34 Aligned_cols=139 Identities=19% Similarity=0.238 Sum_probs=115.3
Q ss_pred ccceecCCCC--------CCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCc
Q 035917 85 FVGVSCWNDK--------ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNND 156 (611)
Q Consensus 85 w~Gv~C~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~ 156 (611)
|..|.|.+.. ...++.|+|++|++.+..+..+..+++|+.|+|++|.+++..|..+.. +++|+.|+|++|+
T Consensus 45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~-l~~L~~L~L~~n~ 123 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNG-LANLNTLELFDNR 123 (440)
T ss_dssp SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTT-CSSCCEEECCSSC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccC-CccCCEEECCCCc
Confidence 6789996421 235778999999999999999999999999999999999766677777 9999999999999
Q ss_pred CcccCccCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccCCCCCc-cCCC---CCcccCCCC
Q 035917 157 LSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPS-SFKG---FDKADFDGN 224 (611)
Q Consensus 157 l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~-~~~~---~~~~~~~~n 224 (611)
+++..+..+.++++|++|+|++|.+++..+..|.++++|+.|++++|+..+.+|. .|.+ +..+.+.+|
T Consensus 124 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n 195 (440)
T 3zyj_A 124 LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMC 195 (440)
T ss_dssp CSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTS
T ss_pred CCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCC
Confidence 9966666799999999999999999977777899999999999999776666665 3444 444455555
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.36 E-value=6.5e-13 Score=147.70 Aligned_cols=125 Identities=21% Similarity=0.137 Sum_probs=105.6
Q ss_pred CcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccc
Q 035917 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
..++.|+|++|.+.+..|..++.+++|++|+|++|.+++..|..+.. +++|++|||++|+++ .+|.. .+++|++|+
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 127 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLF-NQDLEYLDVSHNRLQ-NISCC--PMASLRHLD 127 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTT-CTTCCEEECTTSCCC-EECSC--CCTTCSEEE
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCC-CCCCCEEECCCCcCC-ccCcc--ccccCCEEE
Confidence 46889999999999888889999999999999999999877888887 999999999999998 78877 899999999
Q ss_pred ccccccCC-CCChhhhcCCCcccccccccccCCCCCccCCCC--CcccCCCC
Q 035917 176 LSNNKLSG-PIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF--DKADFDGN 224 (611)
Q Consensus 176 L~~N~l~g-~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~--~~~~~~~n 224 (611)
|++|++++ ++|..|+++++|++|++++|++++.....+.++ ..+.+.+|
T Consensus 128 Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~L~~n 179 (562)
T 3a79_B 128 LSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLV 179 (562)
T ss_dssp CCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTSCEEEEEEEES
T ss_pred CCCCCccccCchHhhcccCcccEEecCCCccccCchhhhhhceeeEEEeecc
Confidence 99999987 678899999999999999999987544444444 44444444
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.35 E-value=1.3e-12 Score=138.22 Aligned_cols=126 Identities=25% Similarity=0.306 Sum_probs=110.0
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccC-ccCCcCccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPAD-LGNCTYLNTLI 175 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~-~~~l~~L~~L~ 175 (611)
.++.|+|++|.+.+..+..++.+++|+.|+|++|.+++..|..+.. +++|++|+|++|.++ .+|.. ++++++|++|+
T Consensus 70 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~ 147 (390)
T 3o6n_A 70 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQN-VPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLS 147 (390)
T ss_dssp CCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTT-CTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred cCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcC-CCCCCEEECCCCccC-cCCHHHhcCCCCCcEEE
Confidence 5778999999999988889999999999999999999877777777 999999999999999 56655 68999999999
Q ss_pred ccccccCCCCChhhhcCCCcccccccccccCCCCCccCCCCCcccCCCC
Q 035917 176 LSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKADFDGN 224 (611)
Q Consensus 176 L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~~~~~~~n 224 (611)
|++|.+++..|..+..+++|+.|++++|++++.-...+.++..+.+.+|
T Consensus 148 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n 196 (390)
T 3o6n_A 148 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYN 196 (390)
T ss_dssp CCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSS
T ss_pred CCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccc
Confidence 9999999888888999999999999999999865566666666666555
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.35 E-value=1.3e-12 Score=140.87 Aligned_cols=129 Identities=26% Similarity=0.315 Sum_probs=78.9
Q ss_pred EEEEEecCCcccccCCc-cCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 98 ILNLELREMKLSGKIPE-PLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 98 v~~l~l~~~~l~g~~p~-~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
+..|+|++++.-+.+++ .+..+++|+.|+|++|+++ .+|. +.. +++|+.|+|++|.+++..|..+.++++|+.|+|
T Consensus 162 L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~-~~~-l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 238 (440)
T 3zyj_A 162 LRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTP-LIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWM 238 (440)
T ss_dssp CCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCCC-CTT-CSSCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-cccc-cCC-CcccCEEECCCCccCccChhhhccCccCCEEEC
Confidence 34444444332222332 3555666666666666665 4553 444 666777777777777666777777777777777
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCCccCCC---CCcccCCCCCCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG---FDKADFDGNSDLCG 229 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~---~~~~~~~~n~~lc~ 229 (611)
++|++++..|..|.++++|+.|+|++|+|++..+..+.. +..+.+.+|+..|.
T Consensus 239 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 294 (440)
T 3zyj_A 239 IQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN 294 (440)
T ss_dssp TTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECS
T ss_pred CCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCC
Confidence 777777766777777777777777777777655554443 34445666666554
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.35 E-value=6.9e-13 Score=147.49 Aligned_cols=107 Identities=21% Similarity=0.177 Sum_probs=53.8
Q ss_pred cCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcc--cCccCccCCcCcccccccccccCCCCChh-hhcCC
Q 035917 117 KFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG--PIPADLGNCTYLNTLILSNNKLSGPIPYQ-LSNLG 193 (611)
Q Consensus 117 ~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G--~iP~~~~~l~~L~~L~L~~N~l~g~iP~~-l~~l~ 193 (611)
..+++|+.|+|++|.+++.+|..+.. +++|+.|+|++|++++ .+|..++++++|+.|+|++|.+++.+|.. +..++
T Consensus 350 ~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~ 428 (562)
T 3a79_B 350 PSPSSFTFLNFTQNVFTDSVFQGCST-LKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAE 428 (562)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCS-CSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCT
T ss_pred cCCCCceEEECCCCccccchhhhhcc-cCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcc
Confidence 34455555555555555555555544 5555555555555554 33344555555555555555555544432 44455
Q ss_pred CcccccccccccCCCCCccC-CCCCcccCCCC
Q 035917 194 RLKKFSVANNDLTGTIPSSF-KGFDKADFDGN 224 (611)
Q Consensus 194 ~L~~L~l~~N~l~g~ip~~~-~~~~~~~~~~n 224 (611)
+|+.|++++|+++|.+|..+ .++..+.+.+|
T Consensus 429 ~L~~L~l~~n~l~~~~~~~l~~~L~~L~L~~N 460 (562)
T 3a79_B 429 SILVLNLSSNMLTGSVFRCLPPKVKVLDLHNN 460 (562)
T ss_dssp TCCEEECCSSCCCGGGGSSCCTTCSEEECCSS
T ss_pred cCCEEECCCCCCCcchhhhhcCcCCEEECCCC
Confidence 55555555555555555444 23333333333
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.33 E-value=1.8e-12 Score=120.83 Aligned_cols=104 Identities=22% Similarity=0.234 Sum_probs=89.5
Q ss_pred CCcccceecCCCC--------CCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECc
Q 035917 82 ICQFVGVSCWNDK--------ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLS 153 (611)
Q Consensus 82 ~c~w~Gv~C~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls 153 (611)
.|+|..+.|.+.. ...++.|+|++|++++..|..+..+++|+.|+|++|+|++..|..+.. +++|++|+|+
T Consensus 8 ~C~~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~-l~~L~~L~L~ 86 (170)
T 3g39_A 8 SCSGTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDK-LTQLTQLSLN 86 (170)
T ss_dssp EEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTT-CTTCCEEECC
T ss_pred CcCCCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccC-CCCCCEEECC
Confidence 4789999996432 235778999999999999999999999999999999999544444556 9999999999
Q ss_pred CCcCcccCccCccCCcCcccccccccccCCCCC
Q 035917 154 NNDLSGPIPADLGNCTYLNTLILSNNKLSGPIP 186 (611)
Q Consensus 154 ~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP 186 (611)
+|+|++..|..+.++++|++|+|++|.|++..+
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 999998777779999999999999999997755
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=1e-12 Score=142.97 Aligned_cols=115 Identities=23% Similarity=0.271 Sum_probs=79.2
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCch-hHHhcCCCCCEEECcCCcCcccCccCccCCcCccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPA-QICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~-~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
.++.|+|++|.+++..|..+..|++|+.|+|++|.+++ +|. .+.. +++|+.|+|++|.+++.+|..+.++++|+.|+
T Consensus 57 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~-l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 134 (477)
T 2id5_A 57 HLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKL-IPLGVFTG-LSNLTKLDISENKIVILLDYMFQDLYNLKSLE 134 (477)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCS-CCTTSSTT-CTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCc-cCcccccC-CCCCCEEECCCCccccCChhHccccccCCEEE
Confidence 46677777777777777777777777777777777763 443 3444 67777777777777777676777777777777
Q ss_pred ccccccCCCCChhhhcCCCcccccccccccCCCCCccC
Q 035917 176 LSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213 (611)
Q Consensus 176 L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~ 213 (611)
|++|.+++..|..|.++++|+.|++++|.+++..+..+
T Consensus 135 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l 172 (477)
T 2id5_A 135 VGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEAL 172 (477)
T ss_dssp ECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHH
T ss_pred CCCCccceeChhhccCCCCCCEEECCCCcCcccChhHh
Confidence 77777776666667777777777777777765544433
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=5.2e-13 Score=136.93 Aligned_cols=108 Identities=17% Similarity=0.199 Sum_probs=62.4
Q ss_pred EEEEEecCCcccccCCccC--cCCCCCCEEEccCCCCCccCc----hhHHhcCCCCCEEECcCCcCcccCccCccCCcCc
Q 035917 98 ILNLELREMKLSGKIPEPL--KFCKSMQRLDLSANDLSGNIP----AQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYL 171 (611)
Q Consensus 98 v~~l~l~~~~l~g~~p~~l--~~l~~L~~L~Ls~N~l~g~ip----~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L 171 (611)
++.|+|++|.+.|.+|..+ +.+++|+.|+|++|.+++.+| ..+.. +++|+.|+|++|.+++..|..++++++|
T Consensus 93 L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~-~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 93 LKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL-KPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB-CSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred eeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh-ccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 5566666666666666665 666666666666666665544 22232 5666666666666665555566666666
Q ss_pred ccccccccccCCC--CC--hhhhcCCCcccccccccccC
Q 035917 172 NTLILSNNKLSGP--IP--YQLSNLGRLKKFSVANNDLT 206 (611)
Q Consensus 172 ~~L~L~~N~l~g~--iP--~~l~~l~~L~~L~l~~N~l~ 206 (611)
++|+|++|++.|. +| ..++.+++|++|+|++|+++
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 210 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME 210 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC
Confidence 6666666665542 11 12245555555555555554
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.32 E-value=2.1e-12 Score=139.56 Aligned_cols=111 Identities=19% Similarity=0.253 Sum_probs=63.2
Q ss_pred CcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCc
Q 035917 116 LKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRL 195 (611)
Q Consensus 116 l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L 195 (611)
+..+++|+.|+|++|++++ +| .+.. +++|+.|+|++|.+++..|..+.++++|+.|+|++|++++..|..|.++++|
T Consensus 192 ~~~l~~L~~L~L~~n~l~~-~~-~~~~-l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 268 (452)
T 3zyi_A 192 FEGLFNLKYLNLGMCNIKD-MP-NLTP-LVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASL 268 (452)
T ss_dssp TTTCTTCCEEECTTSCCSS-CC-CCTT-CTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred ccCCCCCCEEECCCCcccc-cc-cccc-cccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCC
Confidence 4445555555555555552 33 2333 5566666666666666666666666666666666666666666666666666
Q ss_pred ccccccccccCCCCCccCCC---CCcccCCCCCCCCC
Q 035917 196 KKFSVANNDLTGTIPSSFKG---FDKADFDGNSDLCG 229 (611)
Q Consensus 196 ~~L~l~~N~l~g~ip~~~~~---~~~~~~~~n~~lc~ 229 (611)
+.|+|++|+|++..+..+.. +..+.+.+|+..|.
T Consensus 269 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 305 (452)
T 3zyi_A 269 VELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCD 305 (452)
T ss_dssp CEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECS
T ss_pred CEEECCCCcCCccChHHhccccCCCEEEccCCCcCCC
Confidence 66666666666554444333 33344555655443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.32 E-value=2e-12 Score=133.03 Aligned_cols=140 Identities=24% Similarity=0.176 Sum_probs=110.9
Q ss_pred CcccceecCCCCCCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCc
Q 035917 83 CQFVGVSCWNDKENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIP 162 (611)
Q Consensus 83 c~w~Gv~C~~~~~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP 162 (611)
|...++.+.. ...+..|+|++|.+++..+..++.+++|+.|+|++|.+++..|..+...+++|++|+|++|.+++. |
T Consensus 109 n~l~~~~~~~--~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~ 185 (317)
T 3o53_A 109 NNISRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K 185 (317)
T ss_dssp SCCSEEEECC--CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E
T ss_pred CccCCcCccc--cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c
Confidence 4444555532 235889999999999988888999999999999999999877777754489999999999999865 4
Q ss_pred cCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccCCCCCccCCCC---CcccCCCCCCCC
Q 035917 163 ADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF---DKADFDGNSDLC 228 (611)
Q Consensus 163 ~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~---~~~~~~~n~~lc 228 (611)
. ...+++|++|+|++|++++ +|..+..+++|+.|++++|+++ .+|..+..+ ..+.+.+|+..|
T Consensus 186 ~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~ 251 (317)
T 3o53_A 186 G-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC 251 (317)
T ss_dssp C-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBH
T ss_pred c-ccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccC
Confidence 3 3458999999999999996 4555999999999999999999 578766544 445566666443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=1.3e-12 Score=136.33 Aligned_cols=121 Identities=21% Similarity=0.255 Sum_probs=107.0
Q ss_pred CcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchh-HHhcCCCCCEEECcCCcCcccCcc--CccCCcCcc
Q 035917 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQ-ICNWLPYLVLLDLSNNDLSGPIPA--DLGNCTYLN 172 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~-~~~~l~~L~~L~Ls~N~l~G~iP~--~~~~l~~L~ 172 (611)
..++.|+|++|++++..|..++.+++|++|+|++|.+++ +|.. +.. +++|++|+|++|.++ .+|. .+.++++|+
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~-l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~ 152 (353)
T 2z80_A 76 VNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSN-LSSSWFKP-LSSLTFLNLLGNPYK-TLGETSLFSHLTKLQ 152 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSS-CCHHHHTT-CTTCSEEECTTCCCS-SSCSSCSCTTCTTCC
T ss_pred CCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCc-CCHhHhCC-CccCCEEECCCCCCc-ccCchhhhccCCCCc
Confidence 368899999999999989999999999999999999995 6655 666 999999999999999 5665 789999999
Q ss_pred cccccccc-cCCCCChhhhcCCCcccccccccccCCCCCccCCCCCcc
Q 035917 173 TLILSNNK-LSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKA 219 (611)
Q Consensus 173 ~L~L~~N~-l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~~~ 219 (611)
+|+|++|+ +++..|..+.++++|+.|++++|.+++..|..+.+++.+
T Consensus 153 ~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L 200 (353)
T 2z80_A 153 ILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNV 200 (353)
T ss_dssp EEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEE
T ss_pred EEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccC
Confidence 99999995 676667889999999999999999999989888776544
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=3.4e-12 Score=131.90 Aligned_cols=114 Identities=24% Similarity=0.329 Sum_probs=69.5
Q ss_pred cEEEEEecCCccc--ccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccc
Q 035917 97 RILNLELREMKLS--GKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTL 174 (611)
Q Consensus 97 ~v~~l~l~~~~l~--g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L 174 (611)
.+..|+|++|.+. |..+..+..+++|+.|+|++|.++ .+|..+ .++|+.|+|++|.+++..|..+.++++|+.|
T Consensus 146 ~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~---~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 221 (330)
T 1xku_A 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKL 221 (330)
T ss_dssp TCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC---CTTCSEEECTTSCCCEECTGGGTTCTTCCEE
T ss_pred cccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCccc---cccCCEEECCCCcCCccCHHHhcCCCCCCEE
Confidence 4667777777764 355666666666666666666666 355433 2556666666666665555566666666666
Q ss_pred cccccccCCCCChhhhcCCCcccccccccccCCCCCccCCC
Q 035917 175 ILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215 (611)
Q Consensus 175 ~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~ 215 (611)
+|++|.+++..|..+..+++|+.|++++|+++ .+|..+..
T Consensus 222 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 261 (330)
T 1xku_A 222 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261 (330)
T ss_dssp ECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred ECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhcc
Confidence 66666666555555666666666666666665 55554443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.31 E-value=5.3e-13 Score=145.78 Aligned_cols=31 Identities=23% Similarity=0.156 Sum_probs=25.7
Q ss_pred hHHHHHHHHHHHhccCCCCccceeeEEEeCC
Q 035917 362 GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE 392 (611)
Q Consensus 362 ~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~ 392 (611)
+.++|..|++.+++++|+|+|+++|||....
T Consensus 322 g~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~ 352 (487)
T 3oja_A 322 GSETERLECERENQARQREIDALKEQYRTVI 352 (487)
T ss_dssp ---CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred cHHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence 3568999999999999999999999997643
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=2.4e-12 Score=146.31 Aligned_cols=133 Identities=22% Similarity=0.243 Sum_probs=98.0
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCcc----Cc----hhHHhcCCCCCEEECcCCcCcccCcc-CccC
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGN----IP----AQICNWLPYLVLLDLSNNDLSGPIPA-DLGN 167 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~----ip----~~~~~~l~~L~~L~Ls~N~l~G~iP~-~~~~ 167 (611)
.++.|+|++|++++..+..+..+++|+.|+|++|.+++. +| ..+.. +++|+.|+|++|+++ .||. .+.+
T Consensus 481 ~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~-l~~L~~L~L~~N~l~-~i~~~~~~~ 558 (680)
T 1ziw_A 481 NLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKG-LSHLHILNLESNGFD-EIPVEVFKD 558 (680)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTT-CTTCCEEECCSSCCC-CCCTTTTTT
T ss_pred CCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcC-CCCCCEEECCCCCCC-CCCHHHccc
Confidence 466777777777766666677777778888887777743 11 12444 778888888888887 5554 4788
Q ss_pred CcCcccccccccccCCCCChhhhcCCCcccccccccccCCCCCcc----CCCCCcccCCCCCCCCCCC
Q 035917 168 CTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSS----FKGFDKADFDGNSDLCGGP 231 (611)
Q Consensus 168 l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~----~~~~~~~~~~~n~~lc~~~ 231 (611)
+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|.. +.++..+.+.+|+..|..+
T Consensus 559 l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 559 LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred ccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 888888888888888666666788888888888888888877763 4566677788888888643
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.31 E-value=1.1e-12 Score=122.78 Aligned_cols=108 Identities=25% Similarity=0.222 Sum_probs=78.8
Q ss_pred cEEEEEecCCcccccCCccCcCCC-CCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCK-SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
.++.|+|++|++.. +|. +..+. +|+.|+|++|.+++. ..+.. +++|++|+|++|.+++..|..++.+++|++|+
T Consensus 20 ~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~-l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 20 RDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPL-LRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94 (176)
T ss_dssp SCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCC-CSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred CceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--ccccc-CCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence 57788888888874 443 44444 888888888888853 45555 78888888888888854333347888888888
Q ss_pred ccccccCCCCCh--hhhcCCCcccccccccccCCCCCc
Q 035917 176 LSNNKLSGPIPY--QLSNLGRLKKFSVANNDLTGTIPS 211 (611)
Q Consensus 176 L~~N~l~g~iP~--~l~~l~~L~~L~l~~N~l~g~ip~ 211 (611)
|++|.++ .+|. .+..+++|+.|++++|.++ .+|.
T Consensus 95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~ 130 (176)
T 1a9n_A 95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKH 130 (176)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTT
T ss_pred CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHh
Confidence 8888884 5665 6778888888888888887 4454
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.30 E-value=4.7e-12 Score=118.51 Aligned_cols=104 Identities=20% Similarity=0.243 Sum_probs=88.5
Q ss_pred CCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCccccccc
Q 035917 122 MQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVA 201 (611)
Q Consensus 122 L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~ 201 (611)
-+.+++++|.|+ .||..+ .++|+.|+|++|+|++.+|..++++++|++|+|++|+|++..|..|.++++|+.|+|+
T Consensus 14 ~~~l~~~~n~l~-~iP~~~---~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~ 89 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGI---PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLN 89 (174)
T ss_dssp SSEEECCSSCCS-SCCSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CcEEEeCCCCCC-ccCCCc---CCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECC
Confidence 378999999996 799866 4789999999999999999999999999999999999998766678999999999999
Q ss_pred ccccCCCCCccCCCC---CcccCCCCCCCCC
Q 035917 202 NNDLTGTIPSSFKGF---DKADFDGNSDLCG 229 (611)
Q Consensus 202 ~N~l~g~ip~~~~~~---~~~~~~~n~~lc~ 229 (611)
+|+|++..|..+..+ ..+.+.+|+..|.
T Consensus 90 ~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 90 DNHLKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp SSCCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred CCccceeCHHHhccccCCCEEEeCCCCcccc
Confidence 999997666556554 4456777765553
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.27 E-value=4.7e-12 Score=118.52 Aligned_cols=104 Identities=15% Similarity=0.231 Sum_probs=92.4
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhH-HhcCCCCCEEECcCCcCcccCcc--CccCCcCccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQI-CNWLPYLVLLDLSNNDLSGPIPA--DLGNCTYLNT 173 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~-~~~l~~L~~L~Ls~N~l~G~iP~--~~~~l~~L~~ 173 (611)
.+..|+|++|.+++. +.++.+++|+.|+|++|.+++ +|+.+ .. +++|++|+|++|.++ .+|. .+..+++|+.
T Consensus 43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~-l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~ 117 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICR-IGEGLDQA-LPDLTELILTNNSLV-ELGDLDPLASLKSLTY 117 (176)
T ss_dssp CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCE-ECSCHHHH-CTTCCEEECCSCCCC-CGGGGGGGGGCTTCCE
T ss_pred CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccc-cCcchhhc-CCCCCEEECCCCcCC-cchhhHhhhcCCCCCE
Confidence 688999999999986 679999999999999999995 56554 66 999999999999995 6787 7899999999
Q ss_pred ccccccccCCCCChh----hhcCCCcccccccccccC
Q 035917 174 LILSNNKLSGPIPYQ----LSNLGRLKKFSVANNDLT 206 (611)
Q Consensus 174 L~L~~N~l~g~iP~~----l~~l~~L~~L~l~~N~l~ 206 (611)
|+|++|.++ .+|.. +..+++|+.||++.|...
T Consensus 118 L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 118 LCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp EECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred EEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 999999998 56764 899999999999999764
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.26 E-value=3.7e-14 Score=135.66 Aligned_cols=104 Identities=25% Similarity=0.387 Sum_probs=60.6
Q ss_pred EEEEEecCCcccccCCc------cCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCc
Q 035917 98 ILNLELREMKLSGKIPE------PLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYL 171 (611)
Q Consensus 98 v~~l~l~~~~l~g~~p~------~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L 171 (611)
|+.++|+.+.++|.+|+ .++.+++|+.|+|++|.+++ +| .+.. +++|+.|+|++|.++ .+|..+..+++|
T Consensus 20 l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~-l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 20 VVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSG-MENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHH-HTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred ccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-cccc-CCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 44445555555555554 55566666666666666654 55 5554 566666666666665 455555555666
Q ss_pred ccccccccccCCCCChhhhcCCCcccccccccccCC
Q 035917 172 NTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTG 207 (611)
Q Consensus 172 ~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g 207 (611)
++|+|++|++++ +| .+..+++|+.|++++|++++
T Consensus 96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~ 129 (198)
T 1ds9_A 96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN 129 (198)
T ss_dssp SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCC
T ss_pred CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCc
Confidence 666666666664 34 45556666666666666654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.23 E-value=5.9e-12 Score=123.81 Aligned_cols=125 Identities=20% Similarity=0.219 Sum_probs=88.4
Q ss_pred cEEEEEecC-CcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCC---EEECcCC-cCcccCccCccCCcCc
Q 035917 97 RILNLELRE-MKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLV---LLDLSNN-DLSGPIPADLGNCTYL 171 (611)
Q Consensus 97 ~v~~l~l~~-~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~---~L~Ls~N-~l~G~iP~~~~~l~~L 171 (611)
.+..|+|++ |.+++..+..+..+++|+.|+|++|.+++ +|. +.. +++|+ .|+|++| .+++..|..+.++++|
T Consensus 81 ~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~-l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L 157 (239)
T 2xwt_C 81 KVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTK-VYSTDIFFILEITDNPYMTSIPVNAFQGLCNE 157 (239)
T ss_dssp TCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTT-CCBCCSEEEEEEESCTTCCEECTTTTTTTBSS
T ss_pred CCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccc-ccccccccEEECCCCcchhhcCcccccchhcc
Confidence 577788887 88887666777888888888888888875 776 555 77777 8888888 7776555667778888
Q ss_pred c-cccccccccCCCCChhhhcCCCcccccccccc-cCCCCCccCCCC----CcccCCCCC
Q 035917 172 N-TLILSNNKLSGPIPYQLSNLGRLKKFSVANND-LTGTIPSSFKGF----DKADFDGNS 225 (611)
Q Consensus 172 ~-~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~-l~g~ip~~~~~~----~~~~~~~n~ 225 (611)
+ .|+|++|+++ .+|......++|+.|++++|+ +++..|..+.++ ..+.+.+|.
T Consensus 158 ~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~ 216 (239)
T 2xwt_C 158 TLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTS 216 (239)
T ss_dssp EEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCC
T ss_pred eeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCc
Confidence 8 8888888887 666554444778888888884 775445555443 334455543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=2.1e-11 Score=121.58 Aligned_cols=144 Identities=12% Similarity=0.021 Sum_probs=111.5
Q ss_pred HhhhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccc-hhHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeEEEE
Q 035917 321 AASNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLR-HPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 321 ~~t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~~~~~lv~ 398 (611)
....+|.....++.|+.+.||++... ++.+++|+..... .....+.+|+++++.+. |..+.++++++...+..++||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 34456766677788888999999854 6899999986422 22346889999999985 677889999999888999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhc---------------------------------------
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHG--------------------------------------- 439 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------- 439 (611)
||++|.+|.+.+.. ......++.+++++|..||.-
T Consensus 90 e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 90 SEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp ECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999999876421 112346788999999999961
Q ss_pred -----------------CCCCeeecCCCCCeEEeCCCCCeEEeeccccc
Q 035917 440 -----------------CQPPFLHQNICSNVILVDEDFDARIMDFGLAK 471 (611)
Q Consensus 440 -----------------~~~~ivHrDlkp~NILld~~~~~kl~DFGla~ 471 (611)
....++|+|++|.||+++++..+.|.||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01458999999999999876566799998764
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.22 E-value=1e-11 Score=129.22 Aligned_cols=104 Identities=19% Similarity=0.212 Sum_probs=89.8
Q ss_pred CEEEccCC-CCCccCchhHHhcCCCCCEEECcC-CcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCcccccc
Q 035917 123 QRLDLSAN-DLSGNIPAQICNWLPYLVLLDLSN-NDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSV 200 (611)
Q Consensus 123 ~~L~Ls~N-~l~g~ip~~~~~~l~~L~~L~Ls~-N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 200 (611)
..+++++| +|+ .||. +.. +++|+.|+|++ |+|++..|..|++|++|+.|+|++|+|+|..|..|.+|++|+.|+|
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~-~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 87 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPG-AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCS-CSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CEEEcCCCCCCC-ccCC-CCC-CCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeC
Confidence 35799998 898 5998 887 99999999996 9999888889999999999999999999999999999999999999
Q ss_pred cccccCCCCCccCCC--CCcccCCCCCCCCC
Q 035917 201 ANNDLTGTIPSSFKG--FDKADFDGNSDLCG 229 (611)
Q Consensus 201 ~~N~l~g~ip~~~~~--~~~~~~~~n~~lc~ 229 (611)
++|+|++..|..+.. +..+.+.+|...|.
T Consensus 88 ~~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 88 SFNALESLSWKTVQGLSLQELVLSGNPLHCS 118 (347)
T ss_dssp CSSCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred CCCccceeCHHHcccCCceEEEeeCCCccCC
Confidence 999999766665554 45566677766553
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.21 E-value=1.1e-11 Score=128.30 Aligned_cols=126 Identities=25% Similarity=0.319 Sum_probs=106.0
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
++..|+|++|.+++ +|..+. ++|+.|+|++|.+++..|..+.. +++|+.|+|++|.+++..|..++.+++|+.|+|
T Consensus 173 ~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~-l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 248 (332)
T 2ft3_A 173 KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLR-YSKLYRLGLGHNQIRMIENGSLSFLPTLRELHL 248 (332)
T ss_dssp CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTT-CTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEEC
T ss_pred ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcC-CCCCCEEECCCCcCCcCChhHhhCCCCCCEEEC
Confidence 57788999999887 666554 78999999999999877778887 899999999999999888888999999999999
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCCccCCC---------CCcccCCCCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG---------FDKADFDGNSDL 227 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~---------~~~~~~~~n~~l 227 (611)
++|+++ .+|..+..+++|+.|++++|++++..+..+.. +..+.+.+|+..
T Consensus 249 ~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~ 307 (332)
T 2ft3_A 249 DNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307 (332)
T ss_dssp CSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSC
T ss_pred CCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCccc
Confidence 999999 89988999999999999999999766655543 344567777755
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.21 E-value=2.3e-11 Score=123.64 Aligned_cols=117 Identities=28% Similarity=0.398 Sum_probs=91.5
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.++.|+|++|.+++..+ +..+++|+.|+|++|.+++ +|. +.. +++|+.|+|++|++++ + +.+.++++|+.|+|
T Consensus 69 ~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~-l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l 141 (291)
T 1h6t_A 69 NVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LSS-LKD-LKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 141 (291)
T ss_dssp TCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GGG-GTT-CTTCCEEECTTSCCCC-C-GGGGGCTTCCEEEC
T ss_pred CCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Chh-hcc-CCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEc
Confidence 67889999998887544 8889999999999999885 443 666 8899999999999886 3 46788889999999
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCCccCCCCC---cccCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFD---KADFDGN 224 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~---~~~~~~n 224 (611)
++|++++. ..+..+++|+.|++++|++++..| +..++ .+.+.+|
T Consensus 142 ~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N 188 (291)
T 1h6t_A 142 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKN 188 (291)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred cCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCC
Confidence 99998865 468888999999999999887655 44433 3444444
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=1.2e-11 Score=137.40 Aligned_cols=100 Identities=27% Similarity=0.319 Sum_probs=91.2
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccC-ccCccCCcCccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPI-PADLGNCTYLNTLI 175 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~i-P~~~~~l~~L~~L~ 175 (611)
.++.|+|++|.|+ .+|..++.|++|+.|+|++|.|++ || .++. +++|+.|+|++|+|++.+ |..++++++|+.|+
T Consensus 464 ~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~-l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~ 539 (567)
T 1dce_A 464 LVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVAN-LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 539 (567)
T ss_dssp TCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTT-CSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred cCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCC-CCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEE
Confidence 6889999999999 899999999999999999999997 88 7887 999999999999999987 99999999999999
Q ss_pred ccccccCCCCChh---hhcCCCcccccc
Q 035917 176 LSNNKLSGPIPYQ---LSNLGRLKKFSV 200 (611)
Q Consensus 176 L~~N~l~g~iP~~---l~~l~~L~~L~l 200 (611)
|++|.|++.+|.. +..+++|+.|++
T Consensus 540 L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 540 LQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp CTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred ecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 9999999887742 345889998864
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.20 E-value=1.9e-11 Score=126.88 Aligned_cols=121 Identities=27% Similarity=0.420 Sum_probs=71.8
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.+..|+|++|.+++..+ +..+++|+.|+|++|.+++ ++ .+.. +++|+.|+|++|.+++. | .+..+++|+.|+|
T Consensus 222 ~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~-l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~L 294 (347)
T 4fmz_A 222 RLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-IN-AVKD-LTKLKMLNVGSNQISDI-S-VLNNLSQLNSLFL 294 (347)
T ss_dssp TCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTT-CTTCCEEECCSSCCCCC-G-GGGGCTTCSEEEC
T ss_pred cCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCC-Ch-hHhc-CCCcCEEEccCCccCCC-h-hhcCCCCCCEEEC
Confidence 45566666666654332 5666666666666666664 32 3444 66666666666666643 3 4566666666666
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCC-ccCCCCCcccCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIP-SSFKGFDKADFDGN 224 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip-~~~~~~~~~~~~~n 224 (611)
++|.+++..|..+..+++|+.|++++|++++..| ..+.++..+.+.+|
T Consensus 295 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~N 343 (347)
T 4fmz_A 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQ 343 (347)
T ss_dssp CSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGGGGGCTTCSEESSSCC
T ss_pred cCCcCCCcChhHhhccccCCEEEccCCccccccChhhhhccceeehhhh
Confidence 6666666666666666666666666666666555 22333444444444
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.20 E-value=2.5e-11 Score=131.43 Aligned_cols=118 Identities=21% Similarity=0.207 Sum_probs=70.3
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.+..|+|++|++++ +| ++.+++|+.|+|++|++++. + +.. +++|+.|+|++|+++| +| ++.+++|+.|+|
T Consensus 171 ~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~--l~~-l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l 240 (457)
T 3bz5_A 171 QLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL-D--LNQ-NIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDC 240 (457)
T ss_dssp TCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC-C--CTT-CTTCSEEECCSSCCSC-CC--CTTCTTCSEEEC
T ss_pred cCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee-c--ccc-CCCCCEEECcCCcccc-cC--ccccCCCCEEEe
Confidence 46677777777776 33 66666777777777777653 2 444 6667777777777765 55 666666666666
Q ss_pred cccccCCCCChhhhcCC-------CcccccccccccCCCCCcc-CCCCCcccCCCC
Q 035917 177 SNNKLSGPIPYQLSNLG-------RLKKFSVANNDLTGTIPSS-FKGFDKADFDGN 224 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~-------~L~~L~l~~N~l~g~ip~~-~~~~~~~~~~~n 224 (611)
++|+|+|..+..+.+|. +|+.|++++|.+.|.+|.. +.++..+.+.+|
T Consensus 241 ~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~~~~l~~L~~L~Ls~n 296 (457)
T 3bz5_A 241 SVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHN 296 (457)
T ss_dssp CSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCTTCCCCCCTTC
T ss_pred eCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCcccccccccCCEEECCCC
Confidence 66666665544444443 4455555555555555521 233333444444
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.19 E-value=1e-13 Score=132.60 Aligned_cols=110 Identities=22% Similarity=0.227 Sum_probs=98.5
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.++.|+|++|.+.+ +| .+..+++|+.|+|++|.++ .+|..+.. +++|+.|+|++|.+++ +| .++++++|++|+|
T Consensus 49 ~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~-~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l 122 (198)
T 1ds9_A 49 ACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAV-ADTLEELWISYNQIAS-LS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHH-HHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEE
T ss_pred CCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhc-CCcCCEEECcCCcCCc-CC-ccccCCCCCEEEC
Confidence 68899999999998 67 8999999999999999999 79988776 8999999999999997 66 6889999999999
Q ss_pred cccccCCCCC-hhhhcCCCcccccccccccCCCCCcc
Q 035917 177 SNNKLSGPIP-YQLSNLGRLKKFSVANNDLTGTIPSS 212 (611)
Q Consensus 177 ~~N~l~g~iP-~~l~~l~~L~~L~l~~N~l~g~ip~~ 212 (611)
++|.+++.-+ ..+..+++|++|++++|.+++.+|..
T Consensus 123 ~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~ 159 (198)
T 1ds9_A 123 SNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKEN 159 (198)
T ss_dssp SEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTT
T ss_pred CCCcCCchhHHHHHhcCCCCCEEEecCCccccccccc
Confidence 9999996332 47899999999999999999988763
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.18 E-value=2.5e-11 Score=134.43 Aligned_cols=96 Identities=31% Similarity=0.470 Sum_probs=45.7
Q ss_pred EEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccccc
Q 035917 98 ILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILS 177 (611)
Q Consensus 98 v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~ 177 (611)
+..|+|++|+|++ +|. +.. +|+.|+|++|+|++ ||. . +++|+.|+|++|.|++ ||. .+++|++|+|+
T Consensus 102 L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~-l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls 168 (571)
T 3cvr_A 102 LEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---L-PALLEYINADNNQLTM-LPE---LPTSLEVLSVR 168 (571)
T ss_dssp CCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---C-CTTCCEEECCSSCCSC-CCC---CCTTCCEEECC
T ss_pred CCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---c-CccccEEeCCCCccCc-CCC---cCCCcCEEECC
Confidence 3444444444444 333 332 44444444444443 443 2 4445555555555543 443 34455555555
Q ss_pred ccccCCCCChhhhcCCCcccccccccccCCCCCc
Q 035917 178 NNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPS 211 (611)
Q Consensus 178 ~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~ 211 (611)
+|+|++ +|. |. ++|+.|+|++|+|+ .+|.
T Consensus 169 ~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~ 197 (571)
T 3cvr_A 169 NNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA 197 (571)
T ss_dssp SSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC
T ss_pred CCCCCC-cch-hh--CCCCEEECcCCCCC-chhh
Confidence 555554 444 33 45555555555555 4444
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.18 E-value=1.5e-12 Score=141.01 Aligned_cols=94 Identities=31% Similarity=0.368 Sum_probs=58.5
Q ss_pred CEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccC----------------C-cCcccccccccccCCCC
Q 035917 123 QRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGN----------------C-TYLNTLILSNNKLSGPI 185 (611)
Q Consensus 123 ~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~----------------l-~~L~~L~L~~N~l~g~i 185 (611)
+.|++++|.++| +|. ..++|+.|+|++|.++| +|..+.+ + ++|++|+|++|++++ +
T Consensus 74 ~~L~l~~~~l~~-lp~----~~~~L~~L~l~~n~l~~-lp~~~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~-l 146 (454)
T 1jl5_A 74 HELELNNLGLSS-LPE----LPPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-L 146 (454)
T ss_dssp SEEECTTSCCSC-CCS----CCTTCSEEECCSSCCSS-CCCCCTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSS-C
T ss_pred CEEEecCCcccc-CCC----CcCCCCEEEccCCcCCc-cccccCCCcEEECCCCccCcccCCCCCCCEEECcCCCCCC-C
Confidence 445555555443 222 13467777777777776 5643321 1 466777777777775 6
Q ss_pred ChhhhcCCCcccccccccccCCCCCccCCCCCcccCCCCC
Q 035917 186 PYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKADFDGNS 225 (611)
Q Consensus 186 P~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~~~~~~~n~ 225 (611)
| .++++++|++|++++|++++ +|..+.++..+.+.+|.
T Consensus 147 p-~~~~l~~L~~L~l~~N~l~~-lp~~~~~L~~L~L~~n~ 184 (454)
T 1jl5_A 147 P-ELQNSSFLKIIDVDNNSLKK-LPDLPPSLEFIAAGNNQ 184 (454)
T ss_dssp C-CCTTCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSC
T ss_pred c-ccCCCCCCCEEECCCCcCcc-cCCCcccccEEECcCCc
Confidence 6 47777788888888887776 66666666666666553
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.18 E-value=4e-11 Score=122.84 Aligned_cols=102 Identities=26% Similarity=0.480 Sum_probs=59.4
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
+++.|+|++|.+.+..+ +..+++|+.|+|++|.+++ +| .+.. +++|+.|+|++|.+++ +|. +..+++|+.|+|
T Consensus 64 ~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~-l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l 136 (308)
T 1h6u_A 64 NLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAG-LQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYL 136 (308)
T ss_dssp TCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTT-CTTCCEEECTTSCCCC-CGG-GTTCTTCCEEEC
T ss_pred CCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcC-CCCCCEEECCCCCCCC-chh-hcCCCCCCEEEC
Confidence 45566666666654333 6666666666666666654 33 3444 5666666666666654 332 556666666666
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTG 207 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g 207 (611)
++|.+++..| +..+++|+.|++++|.+++
T Consensus 137 ~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~ 165 (308)
T 1h6u_A 137 DLNQITNISP--LAGLTNLQYLSIGNAQVSD 165 (308)
T ss_dssp CSSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred CCCccCcCcc--ccCCCCccEEEccCCcCCC
Confidence 6666654333 5566666666666666654
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.17 E-value=4.9e-12 Score=130.10 Aligned_cols=117 Identities=17% Similarity=0.182 Sum_probs=76.1
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.++.|+|++|.+++..| +..+++|++|+|++|.+++ +| . +++|+.|+|++|++++..+.. +++|+.|+|
T Consensus 59 ~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~-l~----~-~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l 127 (317)
T 3o53_A 59 KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-LL----V-GPSIETLHAANNNISRVSCSR---GQGKKNIYL 127 (317)
T ss_dssp TCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEE-EE----E-CTTCCEEECCSSCCSEEEECC---CSSCEEEEC
T ss_pred cCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccc-cc----C-CCCcCEEECCCCccCCcCccc---cCCCCEEEC
Confidence 56777777777776554 7777777777777777764 33 1 456666666666666544332 456777777
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCCccC----CCCCcccCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF----KGFDKADFDGN 224 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~----~~~~~~~~~~n 224 (611)
++|++++..|..++.+++|+.|++++|.+++..|..+ .++..+.+.+|
T Consensus 128 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N 179 (317)
T 3o53_A 128 ANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179 (317)
T ss_dssp CSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTS
T ss_pred CCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCC
Confidence 7777777666677777777777777777776655543 23444444444
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.17 E-value=4.3e-11 Score=121.55 Aligned_cols=119 Identities=29% Similarity=0.410 Sum_probs=97.5
Q ss_pred CcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccc
Q 035917 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
.++..|+|++|.+++. +.+..+++|+.|+|++|.+++ + +.+.. +++|+.|+|++|.+++. ..++++++|+.|+
T Consensus 90 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~i~~-~-~~l~~-l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~ 162 (291)
T 1h6t_A 90 KNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGISD-I-NGLVH-LPQLESLYLGNNKITDI--TVLSRLTKLDTLS 162 (291)
T ss_dssp TTCCEEECCSSCCCCG--GGGTTCTTCCEEECTTSCCCC-C-GGGGG-CTTCCEEECCSSCCCCC--GGGGGCTTCSEEE
T ss_pred CCCCEEECCCCcCCCC--hhhccCCCCCEEECCCCcCCC-C-hhhcC-CCCCCEEEccCCcCCcc--hhhccCCCCCEEE
Confidence 4688999999999872 459999999999999999996 4 45676 99999999999999875 5789999999999
Q ss_pred ccccccCCCCChhhhcCCCcccccccccccCCCCCccCCCC---CcccCCCCC
Q 035917 176 LSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF---DKADFDGNS 225 (611)
Q Consensus 176 L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~---~~~~~~~n~ 225 (611)
|++|.+++..| +..+++|+.|++++|.+++ +|. +..+ ..+.+.+|.
T Consensus 163 L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~~-l~~l~~L~~L~l~~n~ 211 (291)
T 1h6t_A 163 LEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LRA-LAGLKNLDVLELFSQE 211 (291)
T ss_dssp CCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CGG-GTTCTTCSEEEEEEEE
T ss_pred ccCCccccchh--hcCCCccCEEECCCCcCCC-Chh-hccCCCCCEEECcCCc
Confidence 99999997665 8999999999999999986 443 4443 334445543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.17 E-value=3.2e-11 Score=134.83 Aligned_cols=105 Identities=30% Similarity=0.406 Sum_probs=61.1
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.+..|+|++|.|++..| +..|++|+.|+|++|.|++ +| .+.. +++|+.|+|++|.+++ + +.+..|++|+.|+|
T Consensus 66 ~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~-l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~L 138 (605)
T 1m9s_A 66 NVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKD-LKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 138 (605)
T ss_dssp TCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTT-CTTCCEEECTTSCCCC-C-GGGGGCTTCSEEEC
T ss_pred CCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhcc-CCCCCEEEecCCCCCC-C-ccccCCCccCEEEC
Confidence 45666666666665433 5666666666666666653 33 4444 5666666666666654 2 23555666666666
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIP 210 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip 210 (611)
++|.|++. ..+..|++|+.|+|++|.+++..|
T Consensus 139 s~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 139 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 170 (605)
T ss_dssp CSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred CCCccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence 66666643 345566666666666666665544
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.16 E-value=5.7e-11 Score=128.44 Aligned_cols=100 Identities=26% Similarity=0.422 Sum_probs=69.0
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.++.|+|++|.+.+ +| +++.+++|++|++++|.+++ +|.. .++|++|+|++|++++ +| .++++++|+.|+|
T Consensus 132 ~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~----~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l 202 (454)
T 1jl5_A 132 LLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDL----PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA 202 (454)
T ss_dssp TCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCC----cccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence 56777777777776 66 57888888888888888875 6643 3567777888777776 66 5777777777777
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIP 210 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip 210 (611)
++|.+++ +|... ++|+.|++++|.++ .+|
T Consensus 203 ~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp 231 (454)
T 1jl5_A 203 DNNSLKK-LPDLP---LSLESIVAGNNILE-ELP 231 (454)
T ss_dssp CSSCCSS-CCCCC---TTCCEEECCSSCCS-SCC
T ss_pred CCCcCCc-CCCCc---CcccEEECcCCcCC-ccc
Confidence 7777775 44321 35666666666665 455
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.16 E-value=3.3e-11 Score=119.45 Aligned_cols=129 Identities=18% Similarity=0.152 Sum_probs=97.1
Q ss_pred eecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCC--ccceeeEEEeCCeeEEEEeccCCCChHHhh
Q 035917 333 ISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPN--LAPLLGYCVVEEEKLLIYKYMSSGTLYSLL 410 (611)
Q Consensus 333 g~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~n--Iv~l~g~~~~~~~~~lv~ey~~~gsL~~~l 410 (611)
+.|..+.||++...+|+.+++|..... ....+.+|+.+++.+++.+ +.+++++...++..++||||++|.+|. .
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~ 104 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S 104 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--T
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--c
Confidence 355669999998878888999997653 2245788999999986545 455888887777889999999998884 2
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------------------
Q 035917 411 QGNATELDWPTRFRIGLGAARGLAWLHHGC-------------------------------------------------- 440 (611)
Q Consensus 411 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------------------- 440 (611)
.. .+ ...++.++++.|..||...
T Consensus 105 ~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 177 (264)
T 1nd4_A 105 SH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR 177 (264)
T ss_dssp SC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred Cc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHh
Confidence 21 12 2356777888888888421
Q ss_pred -----CCCeeecCCCCCeEEeCCCCCeEEeecccccc
Q 035917 441 -----QPPFLHQNICSNVILVDEDFDARIMDFGLAKL 472 (611)
Q Consensus 441 -----~~~ivHrDlkp~NILld~~~~~kl~DFGla~~ 472 (611)
...++|+|++|.||+++++..+.|.|||.+..
T Consensus 178 ~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 178 MPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776677999998753
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.15 E-value=6.1e-11 Score=118.59 Aligned_cols=102 Identities=27% Similarity=0.330 Sum_probs=55.4
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.++.|+|++|.+++..+ +..+++|+.|+|++|++++ +|... .++|+.|+|++|++++ +| .++++++|+.|+|
T Consensus 64 ~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~~---~~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~L 135 (263)
T 1xeu_A 64 NLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGIP---SACLSRLFLDNNELRD-TD-SLIHLKNLEILSI 135 (263)
T ss_dssp TCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTCC---CSSCCEEECCSSCCSB-SG-GGTTCTTCCEEEC
T ss_pred CCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCccc---cCcccEEEccCCccCC-Ch-hhcCcccccEEEC
Confidence 45555666555554333 5555566666666665553 33221 1455666666666554 22 3555666666666
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGT 208 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ 208 (611)
++|++++. | .+..+++|+.|++++|++++.
T Consensus 136 s~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 136 RNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp TTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC
T ss_pred CCCcCCCC-h-HHccCCCCCEEECCCCcCcch
Confidence 66666543 3 355566666666666666554
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.15 E-value=6e-11 Score=132.62 Aligned_cols=103 Identities=31% Similarity=0.430 Sum_probs=77.6
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.+..|+|++|.|++ + +.+..|++|+.|+|++|.|++ +| .+.. |++|+.|+|++|.+++. ..++.|++|+.|+|
T Consensus 88 ~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~-l~-~l~~-l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~L 160 (605)
T 1m9s_A 88 NLGWLFLDENKIKD-L-SSLKDLKKLKSLSLEHNGISD-IN-GLVH-LPQLESLYLGNNKITDI--TVLSRLTKLDTLSL 160 (605)
T ss_dssp TCCEEECCSSCCCC-C-TTSTTCTTCCEEECTTSCCCC-CG-GGGG-CTTCSEEECCSSCCCCC--GGGGSCTTCSEEEC
T ss_pred CCCEEECcCCCCCC-C-hhhccCCCCCEEEecCCCCCC-Cc-cccC-CCccCEEECCCCccCCc--hhhcccCCCCEEEC
Confidence 57778888888776 2 367788888888888888875 43 4665 78888888888888764 46777888888888
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGT 208 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ 208 (611)
++|.|++..| +..+++|+.|+|++|+|++.
T Consensus 161 s~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l 190 (605)
T 1m9s_A 161 EDNQISDIVP--LAGLTKLQNLYLSKNHISDL 190 (605)
T ss_dssp CSSCCCCCGG--GTTCTTCCEEECCSSCCCBC
T ss_pred cCCcCCCchh--hccCCCCCEEECcCCCCCCC
Confidence 8888887666 77788888888888888763
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.15 E-value=5e-11 Score=119.24 Aligned_cols=117 Identities=24% Similarity=0.380 Sum_probs=95.0
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.++.|+|++|+++. +| .+..+++|+.|+|++|.+++ +|+ +.. +++|+.|+|++|++++ +|.... ++|+.|+|
T Consensus 42 ~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~-l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L 113 (263)
T 1xeu_A 42 GVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISD-LSP-LKD-LTKLEELSVNRNRLKN-LNGIPS--ACLSRLFL 113 (263)
T ss_dssp TCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTT-CSSCCEEECCSSCCSC-CTTCCC--SSCCEEEC
T ss_pred cCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCC-Chh-hcc-CCCCCEEECCCCccCC-cCcccc--CcccEEEc
Confidence 57899999999874 55 68999999999999999996 554 776 9999999999999986 554433 89999999
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCCccCC---CCCcccCCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFK---GFDKADFDGNS 225 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~---~~~~~~~~~n~ 225 (611)
++|++++ +| .+..+++|+.|++++|++++. | .+. ++..+.+.+|.
T Consensus 114 ~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~ 161 (263)
T 1xeu_A 114 DNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNE 161 (263)
T ss_dssp CSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSC
T ss_pred cCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCc
Confidence 9999997 44 589999999999999999975 4 343 44445566664
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.15 E-value=5.5e-11 Score=121.79 Aligned_cols=104 Identities=25% Similarity=0.381 Sum_probs=66.3
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.+..|+|++|.+.+. +.+..+++|+.|+|++|.+++ +|. +.. +++|+.|+|++|.+++..| ++++++|+.|+|
T Consensus 86 ~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~~-l~~-l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l 158 (308)
T 1h6u_A 86 KITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITD-VTP-LAG-LSNLQVLYLDLNQITNISP--LAGLTNLQYLSI 158 (308)
T ss_dssp SCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCC-CGG-GTT-CTTCCEEECCSSCCCCCGG--GGGCTTCCEEEC
T ss_pred CCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCC-chh-hcC-CCCCCEEECCCCccCcCcc--ccCCCCccEEEc
Confidence 466677777776653 356667777777777777764 443 554 6677777777777664333 666667777777
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTI 209 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~i 209 (611)
++|.+++. |. +..+++|+.|++++|.+++..
T Consensus 159 ~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~ 189 (308)
T 1h6u_A 159 GNAQVSDL-TP-LANLSKLTTLKADDNKISDIS 189 (308)
T ss_dssp CSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCG
T ss_pred cCCcCCCC-hh-hcCCCCCCEEECCCCccCcCh
Confidence 77776653 32 666667777777777666543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.13 E-value=9.8e-11 Score=126.71 Aligned_cols=99 Identities=19% Similarity=0.206 Sum_probs=58.5
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.+..|+|++|.+++. + ++.+++|+.|++++|.+.|.++ +.. +++|+.|+|++|++++ +| ++.+++|+.|+|
T Consensus 128 ~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~~--~~~-l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l 198 (457)
T 3bz5_A 128 LLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKLD--VTP-QTQLTTLDCSFNKITE-LD--VSQNKLLNRLNC 198 (457)
T ss_dssp TCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCCC--CTT-CTTCCEEECCSSCCCC-CC--CTTCTTCCEEEC
T ss_pred cCCEEECCCCcccee-c--cccCCcCCEEECCCCCcccccc--ccc-CCcCCEEECCCCccce-ec--cccCCCCCEEEC
Confidence 566777777777763 2 5666666666666665555553 334 5666666666666664 44 555555566666
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTG 207 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g 207 (611)
++|.+++. .++.+++|+.|++++|++++
T Consensus 199 ~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~ 226 (457)
T 3bz5_A 199 DTNNITKL---DLNQNIQLTFLDCSSNKLTE 226 (457)
T ss_dssp CSSCCSCC---CCTTCTTCSEEECCSSCCSC
T ss_pred cCCcCCee---ccccCCCCCEEECcCCcccc
Confidence 55555543 25555555555555555555
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.11 E-value=9e-11 Score=127.28 Aligned_cols=103 Identities=28% Similarity=0.406 Sum_probs=65.1
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
++..|+|++|.+.+..| +..+++|+.|+|++|.+++. |+ +.. +++|+.|+|++|++++..| ++++++|+.|+|
T Consensus 244 ~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~-~~~-l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L 316 (466)
T 1o6v_A 244 NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI-SP-LAG-LTALTNLELNENQLEDISP--ISNLKNLTYLTL 316 (466)
T ss_dssp TCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCC-GG-GTT-CTTCSEEECCSSCCSCCGG--GGGCTTCSEEEC
T ss_pred CCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcc-cc-ccC-CCccCeEEcCCCcccCchh--hcCCCCCCEEEC
Confidence 46667777777766543 66666777777777776653 32 444 6666666666666665433 566666666666
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGT 208 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ 208 (611)
++|++++..| +..+++|+.|++++|.+++.
T Consensus 317 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 317 YFNNISDISP--VSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp CSSCCSCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred cCCcCCCchh--hccCccCCEeECCCCccCCc
Confidence 6666666554 55666666666666666654
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.11 E-value=6.3e-11 Score=128.50 Aligned_cols=121 Identities=26% Similarity=0.391 Sum_probs=99.3
Q ss_pred CcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccc
Q 035917 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
..+..|+|++|.+++..+ +..+++|+.|+|++|.+++..| +.. +++|+.|+|++|++++..| ++.+++|+.|+
T Consensus 265 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~-l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~ 337 (466)
T 1o6v_A 265 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISN-LKNLTYLTLYFNNISDISP--VSSLTKLQRLF 337 (466)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGG-CTTCSEEECCSSCCSCCGG--GGGCTTCCEEE
T ss_pred CCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcC-CCCCCEEECcCCcCCCchh--hccCccCCEeE
Confidence 368899999999987544 8899999999999999997544 666 9999999999999998776 78999999999
Q ss_pred ccccccCCCCChhhhcCCCcccccccccccCCCCCc-cCCCCCcccCCCCC
Q 035917 176 LSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPS-SFKGFDKADFDGNS 225 (611)
Q Consensus 176 L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~-~~~~~~~~~~~~n~ 225 (611)
|++|.+++. ..+..+++|+.|++++|++++.+|- .+..+..+.+.+|.
T Consensus 338 l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~ 386 (466)
T 1o6v_A 338 FYNNKVSDV--SSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQA 386 (466)
T ss_dssp CCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGGGTTCTTCCEEECCCEE
T ss_pred CCCCccCCc--hhhccCCCCCEEeCCCCccCccchhhcCCCCCEEeccCCc
Confidence 999999976 4689999999999999999998871 22333444455553
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.10 E-value=7.8e-12 Score=129.18 Aligned_cols=106 Identities=21% Similarity=0.329 Sum_probs=51.3
Q ss_pred cEEEEEecCCccccc-CCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCC-cCccc-CccCccCCcCccc
Q 035917 97 RILNLELREMKLSGK-IPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNN-DLSGP-IPADLGNCTYLNT 173 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~-~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N-~l~G~-iP~~~~~l~~L~~ 173 (611)
+++.|+|+++.+++. +|..+..+++|+.|+|++|.+++.+|..+.. +++|+.|+|++| .+++. +|..+.++++|++
T Consensus 94 ~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~-~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~ 172 (336)
T 2ast_B 94 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAK-NSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 172 (336)
T ss_dssp CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTT-CTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhc-CCCCCEEECCCCCCCCHHHHHHHHhcCCCCCE
Confidence 344555555555443 4444455555555555555555444444444 455555555555 34432 4444444455555
Q ss_pred cccccc-ccCCC-CChhhhcCC-Cccccccccc
Q 035917 174 LILSNN-KLSGP-IPYQLSNLG-RLKKFSVANN 203 (611)
Q Consensus 174 L~L~~N-~l~g~-iP~~l~~l~-~L~~L~l~~N 203 (611)
|+|++| .+++. +|..+..++ +|++|++++|
T Consensus 173 L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~ 205 (336)
T 2ast_B 173 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 205 (336)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred EcCCCCCCcChHHHHHHHHhcccCCCEEEeCCC
Confidence 555555 44432 344444444 4444444444
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.09 E-value=7.4e-11 Score=123.03 Aligned_cols=122 Identities=19% Similarity=0.163 Sum_probs=81.5
Q ss_pred CCcccceecCCCC--------CCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCE-EEC
Q 035917 82 ICQFVGVSCWNDK--------ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVL-LDL 152 (611)
Q Consensus 82 ~c~w~Gv~C~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~-L~L 152 (611)
-|+|..|.|++.. ...++.|+|++|+|+...+..+..|++|++|+|++|.+.+.||...+..+++|.. +++
T Consensus 8 ~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 8 HCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp EEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred EeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 3788999996421 1246677777777775555567777777777777777776676554333666553 556
Q ss_pred cCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCccccccccc
Q 035917 153 SNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANN 203 (611)
Q Consensus 153 s~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N 203 (611)
+.|++++..|..+.++++|++|++++|++++..+..+....++..|++.+|
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~ 138 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN 138 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESC
T ss_pred cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccc
Confidence 667777666667777777777777777777665555555566666766553
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.09 E-value=5.2e-12 Score=130.54 Aligned_cols=116 Identities=21% Similarity=0.214 Sum_probs=92.0
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCcc-CchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGN-IPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~-ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
.+..|++++|.+.+.++. +..+++|+.|+|++|.+++. +|..+.. +++|+.|+|++|.+++.+|..++++++|++|+
T Consensus 71 ~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~-~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 71 GVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQ-CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTT-BCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred cceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhh-CCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 466777777777776555 56788889999998888876 7777776 88899999999888888888888888899999
Q ss_pred cccc-ccCC-CCChhhhcCCCccccccccc-ccCCC-CCccCC
Q 035917 176 LSNN-KLSG-PIPYQLSNLGRLKKFSVANN-DLTGT-IPSSFK 214 (611)
Q Consensus 176 L~~N-~l~g-~iP~~l~~l~~L~~L~l~~N-~l~g~-ip~~~~ 214 (611)
|++| .+++ .+|..+.++++|+.|++++| .+++. +|..+.
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~ 191 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVA 191 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHH
Confidence 9888 6776 37777888888999999888 88764 454443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.08 E-value=2.6e-11 Score=135.76 Aligned_cols=124 Identities=27% Similarity=0.357 Sum_probs=88.8
Q ss_pred CCCccccee--------cCCCCCCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEEC
Q 035917 81 FICQFVGVS--------CWNDKENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDL 152 (611)
Q Consensus 81 ~~c~w~Gv~--------C~~~~~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~L 152 (611)
.+|.|.|.. |.. ..++.|++++++|+ .+|..+. ++|+.|+|++|+|+ .||. . +++|++|+|
T Consensus 20 ~~~~~~~r~~~~~~~~~c~~---~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~-l~~L~~L~L 88 (622)
T 3g06_A 20 PAEESRGRAAVVQKMRACLN---NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---L-PPELRTLEV 88 (622)
T ss_dssp CGGGHHHHHHHHHHHHHHHH---HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---C-CTTCCEEEE
T ss_pred CcchhccccccCcccccccC---CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---c-CCCCCEEEc
Confidence 478997643 321 24778899998888 7777665 78888888888888 5776 3 788888888
Q ss_pred cCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccCCCCCccCCCCCcccCCCC
Q 035917 153 SNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKADFDGN 224 (611)
Q Consensus 153 s~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~~~~~~~n 224 (611)
++|+++ .||. .+++|++|+|++|++++ +|. .+++|+.|++++|++++ +|..+.++..+.+.+|
T Consensus 89 s~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~l~~L~~L~Ls~N 151 (622)
T 3g06_A 89 SGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVLPPGLQELSVSDN 151 (622)
T ss_dssp CSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSS
T ss_pred CCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCCCCCCCEEECcCC
Confidence 888887 5775 56788888888888875 444 45667777777777765 5665556655555555
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.07 E-value=1.6e-11 Score=129.64 Aligned_cols=129 Identities=16% Similarity=0.245 Sum_probs=107.4
Q ss_pred CcEEEEEecCCccc-ccCC---ccCcCCCCCCEEEccCCCCC--c---cCchhHHhcCCCCCEEECcCCcCc----ccCc
Q 035917 96 NRILNLELREMKLS-GKIP---EPLKFCKSMQRLDLSANDLS--G---NIPAQICNWLPYLVLLDLSNNDLS----GPIP 162 (611)
Q Consensus 96 ~~v~~l~l~~~~l~-g~~p---~~l~~l~~L~~L~Ls~N~l~--g---~ip~~~~~~l~~L~~L~Ls~N~l~----G~iP 162 (611)
..+..|+|++|+++ +.+| ..+..+++|+.|+|++|.++ | .+|..+.. +++|+.|+|++|.++ +.+|
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~-~~~L~~L~Ls~n~l~~~g~~~l~ 237 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAY-CQELKVLDLQDNTFTHLGSSALA 237 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGG-CTTCCEEECCSSCCHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhc-CCCccEEECcCCCCCcHHHHHHH
Confidence 37889999999998 5555 46788999999999999998 4 34446766 899999999999997 7899
Q ss_pred cCccCCcCcccccccccccCCC----CChhhhc--CCCcccccccccccCC----CCCccC----CCCCcccCCCCC
Q 035917 163 ADLGNCTYLNTLILSNNKLSGP----IPYQLSN--LGRLKKFSVANNDLTG----TIPSSF----KGFDKADFDGNS 225 (611)
Q Consensus 163 ~~~~~l~~L~~L~L~~N~l~g~----iP~~l~~--l~~L~~L~l~~N~l~g----~ip~~~----~~~~~~~~~~n~ 225 (611)
..+..+++|+.|+|++|.+++. +|..+.. +++|+.|+|++|.+++ .+|..+ .++..+.+.+|.
T Consensus 238 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~ 314 (386)
T 2ca6_A 238 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 314 (386)
T ss_dssp HHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSB
T ss_pred HHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCc
Confidence 9999999999999999999876 6777744 9999999999999998 588755 455566666664
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.06 E-value=6.6e-12 Score=132.70 Aligned_cols=129 Identities=18% Similarity=0.276 Sum_probs=106.5
Q ss_pred CcEEEEEecCCcccc----cCCccCcCC---------CCCCEEEccCCCCC-ccCc---hhHHhcCCCCCEEECcCCcCc
Q 035917 96 NRILNLELREMKLSG----KIPEPLKFC---------KSMQRLDLSANDLS-GNIP---AQICNWLPYLVLLDLSNNDLS 158 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g----~~p~~l~~l---------~~L~~L~Ls~N~l~-g~ip---~~~~~~l~~L~~L~Ls~N~l~ 158 (611)
..++.|+|++|.+++ .++..+..+ ++|+.|+|++|.++ +.+| ..+.. +++|+.|+|++|.++
T Consensus 122 ~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~-~~~L~~L~L~~n~l~ 200 (386)
T 2ca6_A 122 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS-HRLLHTVKMVQNGIR 200 (386)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHH-CTTCCEEECCSSCCC
T ss_pred CCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHh-CCCcCEEECcCCCCC
Confidence 368899999999974 356667667 89999999999998 5666 46666 899999999999998
Q ss_pred --c---cCccCccCCcCcccccccccccC----CCCChhhhcCCCcccccccccccCCC----CCcc-----CCCCCccc
Q 035917 159 --G---PIPADLGNCTYLNTLILSNNKLS----GPIPYQLSNLGRLKKFSVANNDLTGT----IPSS-----FKGFDKAD 220 (611)
Q Consensus 159 --G---~iP~~~~~l~~L~~L~L~~N~l~----g~iP~~l~~l~~L~~L~l~~N~l~g~----ip~~-----~~~~~~~~ 220 (611)
| .+|..+.++++|+.|+|++|.++ +.+|..+..+++|+.|+|++|.+++. +|.. +.++..+.
T Consensus 201 ~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~ 280 (386)
T 2ca6_A 201 PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLR 280 (386)
T ss_dssp HHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEE
T ss_pred HhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEE
Confidence 4 46668899999999999999997 78999999999999999999999876 5554 34455566
Q ss_pred CCCCC
Q 035917 221 FDGNS 225 (611)
Q Consensus 221 ~~~n~ 225 (611)
+.+|.
T Consensus 281 L~~n~ 285 (386)
T 2ca6_A 281 LQYNE 285 (386)
T ss_dssp CCSSC
T ss_pred CcCCc
Confidence 66654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.05 E-value=1.4e-10 Score=120.43 Aligned_cols=104 Identities=28% Similarity=0.366 Sum_probs=92.1
Q ss_pred CcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccc
Q 035917 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
..++.|+|++|.+++. +.+..+++|+.|+|++|.+++ +| .+.. +++|+.|+|++|.+++..|..++++++|+.|+
T Consensus 243 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~~~~-l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 317 (347)
T 4fmz_A 243 SQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD-IS-VLNN-LSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLF 317 (347)
T ss_dssp TTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-CG-GGGG-CTTCSEEECCSSCCCGGGHHHHHTCTTCSEEE
T ss_pred CCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCC-Ch-hhcC-CCCCCEEECcCCcCCCcChhHhhccccCCEEE
Confidence 4688999999999874 568999999999999999996 44 4666 99999999999999999999999999999999
Q ss_pred ccccccCCCCChhhhcCCCcccccccccccC
Q 035917 176 LSNNKLSGPIPYQLSNLGRLKKFSVANNDLT 206 (611)
Q Consensus 176 L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~ 206 (611)
|++|.+++..| +..+++|+.|++++|.++
T Consensus 318 L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 318 LSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp CCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred ccCCccccccC--hhhhhccceeehhhhccc
Confidence 99999998777 889999999999999886
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.04 E-value=3.6e-11 Score=125.94 Aligned_cols=113 Identities=20% Similarity=0.199 Sum_probs=83.4
Q ss_pred cEEEEEecCCcccccCC----ccCcCCC-CCCEEEccCCCCCccCchhHHhcC-----CCCCEEECcCCcCcccCccCcc
Q 035917 97 RILNLELREMKLSGKIP----EPLKFCK-SMQRLDLSANDLSGNIPAQICNWL-----PYLVLLDLSNNDLSGPIPADLG 166 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p----~~l~~l~-~L~~L~Ls~N~l~g~ip~~~~~~l-----~~L~~L~Ls~N~l~G~iP~~~~ 166 (611)
.++.|+|++|.+++..+ ..+..++ +|+.|+|++|.+++..+..+.. + ++|+.|+|++|.+++..+..++
T Consensus 23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~-~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQ-ILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHH-HHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHH-HHhccCCCccEEECcCCcCChHHHHHHH
Confidence 47788888888877666 5667777 7888888888888776766665 3 7888888888888877776544
Q ss_pred C----C-cCcccccccccccCCCCChhhhc-----CCCcccccccccccCCCCC
Q 035917 167 N----C-TYLNTLILSNNKLSGPIPYQLSN-----LGRLKKFSVANNDLTGTIP 210 (611)
Q Consensus 167 ~----l-~~L~~L~L~~N~l~g~iP~~l~~-----l~~L~~L~l~~N~l~g~ip 210 (611)
. + ++|++|+|++|.+++..+..+.. .++|++|+|++|.+++..+
T Consensus 102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~ 155 (362)
T 3goz_A 102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSS 155 (362)
T ss_dssp HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCH
T ss_pred HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHH
Confidence 3 3 78888888888887766655443 2588888888888875443
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.02 E-value=4.8e-11 Score=125.01 Aligned_cols=117 Identities=21% Similarity=0.231 Sum_probs=87.0
Q ss_pred cEEEEEecCCcccccCCccCcCC-----CCCCEEEccCCCCCccCchhHHhc---C-CCCCEEECcCCcCcccCccCccC
Q 035917 97 RILNLELREMKLSGKIPEPLKFC-----KSMQRLDLSANDLSGNIPAQICNW---L-PYLVLLDLSNNDLSGPIPADLGN 167 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l-----~~L~~L~Ls~N~l~g~ip~~~~~~---l-~~L~~L~Ls~N~l~G~iP~~~~~ 167 (611)
+++.|+|++|.+++..+..++.+ ++|+.|+|++|.+++..+..+... + ++|+.|+|++|.+++..+..+..
T Consensus 52 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 131 (362)
T 3goz_A 52 SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ 131 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred ceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHH
Confidence 58888888888888777666654 888888888888887777655541 2 78888888888888766655433
Q ss_pred -----CcCcccccccccccCCCCC----hhhhcCC-CcccccccccccCCCCCccC
Q 035917 168 -----CTYLNTLILSNNKLSGPIP----YQLSNLG-RLKKFSVANNDLTGTIPSSF 213 (611)
Q Consensus 168 -----l~~L~~L~L~~N~l~g~iP----~~l~~l~-~L~~L~l~~N~l~g~ip~~~ 213 (611)
.++|++|+|++|.+++.-+ ..+..++ +|+.|+|++|++++..+..+
T Consensus 132 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l 187 (362)
T 3goz_A 132 AFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAEL 187 (362)
T ss_dssp HHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHH
T ss_pred HHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHH
Confidence 3688888888888886443 3445555 88888888888887766433
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.02 E-value=7.7e-10 Score=115.61 Aligned_cols=140 Identities=15% Similarity=0.207 Sum_probs=106.1
Q ss_pred CCeeeecCCceEEEEEeCCCCEEEEEecc--ccc--hhHHHHHHHHHHHhccC--CCCccceeeEEEeC---CeeEEEEe
Q 035917 329 ENVIISTRTGTTYKAMLPDGSVLAVKRLN--TCK--LGEKKFRNEMNRLGQLR--HPNLAPLLGYCVVE---EEKLLIYK 399 (611)
Q Consensus 329 ~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~--~~~--~~~~~~~~Ev~~l~~l~--H~nIv~l~g~~~~~---~~~~lv~e 399 (611)
.+.++.|.++.||+....+ ..+++|+.. ... .....+.+|+.+++.++ +..+.++++++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 3568889999999988754 678889876 332 22456889999999997 45678888888766 44799999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGC--------------------------------------- 440 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------- 440 (611)
|++|..+.+... ..++...+..++.++++.|..||...
T Consensus 122 ~v~G~~l~~~~~---~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 122 FVSGRVLWDQSL---PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp CCCCBCCCCTTC---TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred ecCCeecCCCcc---ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 999987754221 24778888899999999999999620
Q ss_pred ----------------CCCeeecCCCCCeEEeCCCCC--eEEeecccccc
Q 035917 441 ----------------QPPFLHQNICSNVILVDEDFD--ARIMDFGLAKL 472 (611)
Q Consensus 441 ----------------~~~ivHrDlkp~NILld~~~~--~kl~DFGla~~ 472 (611)
...++|+|+++.||+++.++. +.|.||+.+..
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999997653 68999998874
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.02 E-value=1e-10 Score=130.99 Aligned_cols=88 Identities=23% Similarity=0.302 Sum_probs=59.5
Q ss_pred CCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCccccc
Q 035917 120 KSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFS 199 (611)
Q Consensus 120 ~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 199 (611)
++|+.|+|++|+|++ +| .. +++|+.|+|++|+|+ .||. .+++|+.|+|++|+|+ .+|..+.++++|+.|+
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~-l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~ 290 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VL-PSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVN 290 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CC-CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEE
T ss_pred CCCCEEEccCCccCc-CC---CC-CCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEE
Confidence 556666666666664 55 22 566777777777776 4565 4567777777777777 6677777777777777
Q ss_pred ccccccCCCCCccCCCCC
Q 035917 200 VANNDLTGTIPSSFKGFD 217 (611)
Q Consensus 200 l~~N~l~g~ip~~~~~~~ 217 (611)
|++|.++|.+|..+..+.
T Consensus 291 L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 291 LEGNPLSERTLQALREIT 308 (622)
T ss_dssp CCSCCCCHHHHHHHHHHH
T ss_pred ecCCCCCCcCHHHHHhcc
Confidence 777777777776655443
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.98 E-value=3.3e-11 Score=120.05 Aligned_cols=126 Identities=21% Similarity=0.225 Sum_probs=88.4
Q ss_pred CCcccceecCCCCCCcEEEEEecC---CcccccCCcc------------------------CcCCCCCCE--EEccCCCC
Q 035917 82 ICQFVGVSCWNDKENRILNLELRE---MKLSGKIPEP------------------------LKFCKSMQR--LDLSANDL 132 (611)
Q Consensus 82 ~c~w~Gv~C~~~~~~~v~~l~l~~---~~l~g~~p~~------------------------l~~l~~L~~--L~Ls~N~l 132 (611)
.|+|.|+.|+.+ .-+|+.+...+ ..+.|.+++. +...+.|.. ++++.|..
T Consensus 77 l~~~~g~i~~~~-~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~ 155 (267)
T 3rw6_A 77 LKAVNYKILDRE-NRRISIIINSSAPPHTILNELKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRR 155 (267)
T ss_dssp HHHTTSSCBCTT-SCBCCCEEEECCCCHHHHTSCCHHHHHHHHHHHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSH
T ss_pred HHhcCcEEECCC-CCEEEEEEecCCCcccccccCCHHHHHHHHHHHHhccchhccccCHHHcCCCcchhhcCccccCCHH
Confidence 689999999743 34676666655 3455555431 122223333 55666643
Q ss_pred CccCchhH---HhcCCCCCEEECcCCcCcc--cCccCccCCcCcccccccccccCCCCChhhhcCC--Cccccccccccc
Q 035917 133 SGNIPAQI---CNWLPYLVLLDLSNNDLSG--PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLG--RLKKFSVANNDL 205 (611)
Q Consensus 133 ~g~ip~~~---~~~l~~L~~L~Ls~N~l~G--~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~--~L~~L~l~~N~l 205 (611)
. .++..+ ...+++|+.|+||+|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|.+
T Consensus 156 ~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl 232 (267)
T 3rw6_A 156 S-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSL 232 (267)
T ss_dssp H-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTT
T ss_pred H-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcC
Confidence 2 333322 1238999999999999998 7778888999999999999999976 3455555 899999999999
Q ss_pred CCCCCc
Q 035917 206 TGTIPS 211 (611)
Q Consensus 206 ~g~ip~ 211 (611)
++.+|.
T Consensus 233 ~~~~~~ 238 (267)
T 3rw6_A 233 CDTFRD 238 (267)
T ss_dssp GGGCSS
T ss_pred ccccCc
Confidence 998873
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.82 E-value=3.7e-09 Score=110.09 Aligned_cols=109 Identities=22% Similarity=0.213 Sum_probs=91.8
Q ss_pred EEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchh-HHhcCCCCCEEECcCCcCcccCcc-CccCCcCccc-ccc
Q 035917 100 NLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQ-ICNWLPYLVLLDLSNNDLSGPIPA-DLGNCTYLNT-LIL 176 (611)
Q Consensus 100 ~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~-~~~~l~~L~~L~Ls~N~l~G~iP~-~~~~l~~L~~-L~L 176 (611)
.++.++++|+ .+|..+ .++|+.|+|++|+|+ .||+. |.. +++|+.|+|++|++.+.||. .+.++++|+. +++
T Consensus 13 ~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~-~i~~~~f~~-l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSG-FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCS-EECTTSSTT-CTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCC-CcCHHHHcC-CCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 4678899988 677766 468999999999999 67764 566 99999999999999888886 4688888764 677
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCCccC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~ 213 (611)
+.|++++..|..|..+++|++|++++|++++..+..+
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~ 124 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHK 124 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTT
T ss_pred cCCcccccCchhhhhccccccccccccccccCCchhh
Confidence 8899998888999999999999999999997665544
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.79 E-value=3.3e-10 Score=122.17 Aligned_cols=130 Identities=20% Similarity=0.286 Sum_probs=98.6
Q ss_pred CcEEEEEecCCccccc----CCccCcCCCCCCEEEccCCCCCccCchhHHhc----CCCCCEEECcCCcCccc----Ccc
Q 035917 96 NRILNLELREMKLSGK----IPEPLKFCKSMQRLDLSANDLSGNIPAQICNW----LPYLVLLDLSNNDLSGP----IPA 163 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~----~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~----l~~L~~L~Ls~N~l~G~----iP~ 163 (611)
..+..|+|++|.+++. ++..+..+++|+.|+|++|.+++..+..+... .++|+.|+|++|.+++. +|.
T Consensus 256 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~ 335 (461)
T 1z7x_W 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 335 (461)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHH
Confidence 3688999999998875 67777888999999999999876655555442 26899999999998876 566
Q ss_pred CccCCcCcccccccccccCCCCChhhhc-----CCCcccccccccccCC----CCCccC---CCCCcccCCCCC
Q 035917 164 DLGNCTYLNTLILSNNKLSGPIPYQLSN-----LGRLKKFSVANNDLTG----TIPSSF---KGFDKADFDGNS 225 (611)
Q Consensus 164 ~~~~l~~L~~L~L~~N~l~g~iP~~l~~-----l~~L~~L~l~~N~l~g----~ip~~~---~~~~~~~~~~n~ 225 (611)
.+.++++|+.|+|++|.+++..+..+.. .++|+.|++++|.+++ .+|..+ .++..+.+.+|.
T Consensus 336 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~ 409 (461)
T 1z7x_W 336 VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 409 (461)
T ss_dssp HHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSS
T ss_pred HHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCC
Confidence 7778889999999999888766655543 6788999999998886 677654 344555566664
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.78 E-value=4.2e-09 Score=107.37 Aligned_cols=189 Identities=17% Similarity=0.157 Sum_probs=120.2
Q ss_pred CCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccC-CCC--ccceeeEEEeCC---eeEEEEeccC
Q 035917 329 ENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLR-HPN--LAPLLGYCVVEE---EKLLIYKYMS 402 (611)
Q Consensus 329 ~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~-H~n--Iv~l~g~~~~~~---~~~lv~ey~~ 402 (611)
.+.++.|....||+.. ..+++|+.... .....+.+|+++|+.+. +.. +.+++.+....+ ..|+||||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 3568999999999853 56888886532 34567899999998884 333 233443332222 3478999999
Q ss_pred CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhc-------------------------------------------
Q 035917 403 SGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHG------------------------------------------- 439 (611)
Q Consensus 403 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------- 439 (611)
|.+|.+.... .++..++..++.++++.+..||..
T Consensus 100 G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 100 GVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 9888653321 366677778888888888888841
Q ss_pred ------------CCCCeeecCCCCCeEEeCC--CCCeEEeecccccccCCCCCCccccCC---Ccc---------ccccc
Q 035917 440 ------------CQPPFLHQNICSNVILVDE--DFDARIMDFGLAKLMTSSDESSFVNGD---LGE---------FGYIA 493 (611)
Q Consensus 440 ------------~~~~ivHrDlkp~NILld~--~~~~kl~DFGla~~~~~~~~~~~~~~~---~gt---------~~y~a 493 (611)
....++|+|++|.||++++ ...+.|.||+.+..-.....-...... .+. .++..
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~ 256 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKD 256 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCC
Confidence 1135899999999999987 456789999988753221100000000 000 01111
Q ss_pred -ccccCCCCCCcccchHHHHHHHHHHhCCCCCHHH
Q 035917 494 -PEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVD 527 (611)
Q Consensus 494 -PE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~ 527 (611)
|+.... .....+.|+++.++|.+.+|..++..
T Consensus 257 ~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 257 IPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp HHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred cHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence 221111 11236899999999999999876644
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.77 E-value=2.7e-10 Score=122.80 Aligned_cols=129 Identities=15% Similarity=0.083 Sum_probs=101.8
Q ss_pred CcEEEEEecCCcccccC----Ccc-CcCCCCCCEEEccCCCCCcc----CchhHHhcCCCCCEEECcCCcCcccCccCcc
Q 035917 96 NRILNLELREMKLSGKI----PEP-LKFCKSMQRLDLSANDLSGN----IPAQICNWLPYLVLLDLSNNDLSGPIPADLG 166 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~----p~~-l~~l~~L~~L~Ls~N~l~g~----ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~ 166 (611)
..++.|+|++|.+.+.- .+. ...+++|+.|+|++|.+++. +|..+.. +++|+.|+|++|.+++..+..+.
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~-~~~L~~L~Ls~n~i~~~~~~~l~ 305 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRA-KESLKELSLAGNELGDEGARLLC 305 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHH-CTTCCEEECTTCCCHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhh-CCCcceEECCCCCCchHHHHHHH
Confidence 36889999999987642 222 34689999999999999975 7888877 99999999999999876555444
Q ss_pred C-----CcCcccccccccccCCC----CChhhhcCCCcccccccccccCCCCCccC--------CCCCcccCCCCC
Q 035917 167 N-----CTYLNTLILSNNKLSGP----IPYQLSNLGRLKKFSVANNDLTGTIPSSF--------KGFDKADFDGNS 225 (611)
Q Consensus 167 ~-----l~~L~~L~L~~N~l~g~----iP~~l~~l~~L~~L~l~~N~l~g~ip~~~--------~~~~~~~~~~n~ 225 (611)
. .++|+.|+|++|.+++. +|..+..+++|+.|++++|.+++..+..+ .++..+.+.+|.
T Consensus 306 ~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~ 381 (461)
T 1z7x_W 306 ETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD 381 (461)
T ss_dssp HHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred HHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCC
Confidence 3 36999999999999976 67778889999999999999987655433 255556666653
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.67 E-value=1.8e-08 Score=100.31 Aligned_cols=81 Identities=23% Similarity=0.323 Sum_probs=69.1
Q ss_pred cCCCCCCEEEccCCCCCc--cCchhHHhcCCCCCEEECcCCcCcccCccCccCCc--CcccccccccccCCCCCh-----
Q 035917 117 KFCKSMQRLDLSANDLSG--NIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCT--YLNTLILSNNKLSGPIPY----- 187 (611)
Q Consensus 117 ~~l~~L~~L~Ls~N~l~g--~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~--~L~~L~L~~N~l~g~iP~----- 187 (611)
.++++|+.|+||+|+|++ .+|..+.. +++|+.|+|++|+|++. ..+..+. +|++|+|++|.+++.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~-l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~ 243 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQK-APNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYI 243 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHH-STTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhh-CCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHH
Confidence 468899999999999998 67777877 99999999999999976 3455555 999999999999998883
Q ss_pred --hhhcCCCcccccc
Q 035917 188 --QLSNLGRLKKFSV 200 (611)
Q Consensus 188 --~l~~l~~L~~L~l 200 (611)
.+..+++|+.||=
T Consensus 244 ~~il~~~P~L~~LDg 258 (267)
T 3rw6_A 244 SAIRERFPKLLRLDG 258 (267)
T ss_dssp HHHHHHCTTCCEESS
T ss_pred HHHHHHCcccCeECC
Confidence 3678899998873
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.60 E-value=6.6e-09 Score=109.14 Aligned_cols=129 Identities=20% Similarity=0.183 Sum_probs=82.9
Q ss_pred cEEEEEecCCcccccCCccC-cCCCCCCEEEccCCCCCccCchhHHh----cCCCCCEEECcCCcCcc----cCccCccC
Q 035917 97 RILNLELREMKLSGKIPEPL-KFCKSMQRLDLSANDLSGNIPAQICN----WLPYLVLLDLSNNDLSG----PIPADLGN 167 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l-~~l~~L~~L~Ls~N~l~g~ip~~~~~----~l~~L~~L~Ls~N~l~G----~iP~~~~~ 167 (611)
.++.|+|++|.++..-...+ ..+++|+.|+|++|.|+..-...+.. ..++|+.|+|++|.++. .++..+..
T Consensus 102 ~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~ 181 (372)
T 3un9_A 102 ALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAG 181 (372)
T ss_dssp CEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHT
T ss_pred CceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhc
Confidence 68888888888765333332 23567788888888887543334332 14678888888888764 24445567
Q ss_pred CcCcccccccccccCC----CCChhhhcCCCcccccccccccCCC----CCccC---CCCCcccCCCCC
Q 035917 168 CTYLNTLILSNNKLSG----PIPYQLSNLGRLKKFSVANNDLTGT----IPSSF---KGFDKADFDGNS 225 (611)
Q Consensus 168 l~~L~~L~L~~N~l~g----~iP~~l~~l~~L~~L~l~~N~l~g~----ip~~~---~~~~~~~~~~n~ 225 (611)
+++|++|||++|.|+. .++..+...++|+.|+|++|.++.. ++..+ .++..+.+.+|.
T Consensus 182 ~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~ 250 (372)
T 3un9_A 182 NTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNE 250 (372)
T ss_dssp CSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSS
T ss_pred CCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCC
Confidence 7788888888888764 2345566777888888888887642 22222 344555555553
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.52 E-value=3.1e-09 Score=111.65 Aligned_cols=113 Identities=19% Similarity=0.164 Sum_probs=83.2
Q ss_pred cEEEEEecCCcccccCCccC-----cCCCCCCEEEccCCCCCcc----CchhHHhcCCCCCEEECcCCcCccc----Ccc
Q 035917 97 RILNLELREMKLSGKIPEPL-----KFCKSMQRLDLSANDLSGN----IPAQICNWLPYLVLLDLSNNDLSGP----IPA 163 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l-----~~l~~L~~L~Ls~N~l~g~----ip~~~~~~l~~L~~L~Ls~N~l~G~----iP~ 163 (611)
+++.|+|++|+|+..-...+ ...+.|+.|+|++|.|+.. ++..+.. +++|++|||++|.++.. ++.
T Consensus 127 ~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~-~~~L~~L~Ls~N~l~~~g~~~L~~ 205 (372)
T 3un9_A 127 RARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAG-NTSVTHLSLLHTGLGDEGLELLAA 205 (372)
T ss_dssp TEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHT-CSSCCEEECTTSSCHHHHHHHHHH
T ss_pred hccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhc-CCCcCEEeCCCCCCCcHHHHHHHH
Confidence 57889999998875433333 2467899999999998742 4445555 78899999999998742 455
Q ss_pred CccCCcCcccccccccccCC----CCChhhhcCCCcccccccccccCCCCC
Q 035917 164 DLGNCTYLNTLILSNNKLSG----PIPYQLSNLGRLKKFSVANNDLTGTIP 210 (611)
Q Consensus 164 ~~~~l~~L~~L~L~~N~l~g----~iP~~l~~l~~L~~L~l~~N~l~g~ip 210 (611)
.+..+++|+.|+|++|.++. .++..+...++|++|+|++|.++..-.
T Consensus 206 ~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~ 256 (372)
T 3un9_A 206 QLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGR 256 (372)
T ss_dssp HGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHH
T ss_pred HHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHH
Confidence 66777889999999998875 344456667889999999998875433
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.41 E-value=2.3e-08 Score=111.30 Aligned_cols=128 Identities=9% Similarity=0.056 Sum_probs=92.6
Q ss_pred cEEEEEecCCcccccCCccCcC-CCCCCEEEcc----CCCCCcc-----CchhHHhcCCCCCEEECcCC--cCcccCccC
Q 035917 97 RILNLELREMKLSGKIPEPLKF-CKSMQRLDLS----ANDLSGN-----IPAQICNWLPYLVLLDLSNN--DLSGPIPAD 164 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~-l~~L~~L~Ls----~N~l~g~-----ip~~~~~~l~~L~~L~Ls~N--~l~G~iP~~ 164 (611)
++..|+|+.+++++..+..++. +++|+.|+|+ .|.+++. ++..+.. +++|+.|+|+++ .+++..+..
T Consensus 379 ~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~-~~~L~~L~L~~~~~~l~~~~~~~ 457 (592)
T 3ogk_B 379 ELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIG-CKKLRRFAFYLRQGGLTDLGLSY 457 (592)
T ss_dssp TCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHH-CTTCCEEEEECCGGGCCHHHHHH
T ss_pred cCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHh-CCCCCEEEEecCCCCccHHHHHH
Confidence 5778888888888877777765 8889999996 6788863 5555655 888888888743 477666666
Q ss_pred ccC-CcCcccccccccccCC-CCChhhhcCCCcccccccccccCCCC-Ccc---CCCCCcccCCCCC
Q 035917 165 LGN-CTYLNTLILSNNKLSG-PIPYQLSNLGRLKKFSVANNDLTGTI-PSS---FKGFDKADFDGNS 225 (611)
Q Consensus 165 ~~~-l~~L~~L~L~~N~l~g-~iP~~l~~l~~L~~L~l~~N~l~g~i-p~~---~~~~~~~~~~~n~ 225 (611)
++. +++|+.|+|++|++++ .+|..+.++++|+.|++++|.+++.. +.. +.++..+.+.+|.
T Consensus 458 ~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~ 524 (592)
T 3ogk_B 458 IGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR 524 (592)
T ss_dssp HHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred HHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence 654 7888888888888876 45666678888888888888886553 322 3455555666654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.35 E-value=8.1e-08 Score=90.41 Aligned_cols=110 Identities=17% Similarity=0.187 Sum_probs=82.4
Q ss_pred CcEEEEEecCC-cccc----cCCccCcCCCCCCEEEccCCCCCcc----CchhHHhcCCCCCEEECcCCcCccc----Cc
Q 035917 96 NRILNLELREM-KLSG----KIPEPLKFCKSMQRLDLSANDLSGN----IPAQICNWLPYLVLLDLSNNDLSGP----IP 162 (611)
Q Consensus 96 ~~v~~l~l~~~-~l~g----~~p~~l~~l~~L~~L~Ls~N~l~g~----ip~~~~~~l~~L~~L~Ls~N~l~G~----iP 162 (611)
..++.|+|++| .+.. .+...+...+.|++|+|++|.+... +...+.. .+.|+.|+|++|.++.. +.
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~-n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKV-NNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHH-CSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHh-CCCcCEEECcCCcCCHHHHHHHH
Confidence 36888999988 7764 2445567788999999999998743 3444444 67899999999998753 55
Q ss_pred cCccCCcCcccccc--cccccCCC----CChhhhcCCCcccccccccccC
Q 035917 163 ADLGNCTYLNTLIL--SNNKLSGP----IPYQLSNLGRLKKFSVANNDLT 206 (611)
Q Consensus 163 ~~~~~l~~L~~L~L--~~N~l~g~----iP~~l~~l~~L~~L~l~~N~l~ 206 (611)
..+...++|++|+| ++|.++.. +...+...++|+.|+|++|.+.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 66777888999999 88888754 3344566688999999888764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=3e-06 Score=86.31 Aligned_cols=135 Identities=15% Similarity=0.124 Sum_probs=91.0
Q ss_pred CeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCC---CccceeeEEE-eCCeeEEEEeccCCCC
Q 035917 330 NVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHP---NLAPLLGYCV-VEEEKLLIYKYMSSGT 405 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~---nIv~l~g~~~-~~~~~~lv~ey~~~gs 405 (611)
+.++.|....||+. |..+++|+-.. ......+.+|+++|..+.+. .+.+.+.++. ..+..++||||++|..
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 46788888899987 56788888532 23346789999999999753 2455666664 3455789999999988
Q ss_pred hHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhc----------------------------------------------
Q 035917 406 LYSLLQGNATELDWPTRFRIGLGAARGLAWLHHG---------------------------------------------- 439 (611)
Q Consensus 406 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------------- 439 (611)
+.+.... .++...+..++.++++.|..||..
T Consensus 100 l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 176 (306)
T 3tdw_A 100 LGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRF 176 (306)
T ss_dssp CHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHH
T ss_pred Cchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHH
Confidence 7653211 133334444444444444444421
Q ss_pred -----------CCCCeeecCCCCCeEEeCC---CCC-eEEeecccccc
Q 035917 440 -----------CQPPFLHQNICSNVILVDE---DFD-ARIMDFGLAKL 472 (611)
Q Consensus 440 -----------~~~~ivHrDlkp~NILld~---~~~-~kl~DFGla~~ 472 (611)
....++|+|+++.||+++. ++. ..|.||+.+..
T Consensus 177 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 177 QSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2345799999999999987 455 48999997764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=4.1e-06 Score=83.27 Aligned_cols=135 Identities=18% Similarity=0.141 Sum_probs=92.9
Q ss_pred eeeecCCc-eEEEEEeC-CCCEEEEEeccccchhHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeEEEEeccCCCChH
Q 035917 331 VIISTRTG-TTYKAMLP-DGSVLAVKRLNTCKLGEKKFRNEMNRLGQLR-HPNLAPLLGYCVVEEEKLLIYKYMSSGTLY 407 (611)
Q Consensus 331 ~ig~G~~g-~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~~~~~lv~ey~~~gsL~ 407 (611)
.+..|..| .||+.... ++..+++|+-... ...++.+|...|+.+. +--+-++++++.+++..++|||++++.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 45556655 68998754 4677899986432 3456888999998884 333667888999999999999999998876
Q ss_pred HhhhcCCCCCCHHHHHHHHHHHHHHHHHHhh-------------------------------------------------
Q 035917 408 SLLQGNATELDWPTRFRIGLGAARGLAWLHH------------------------------------------------- 438 (611)
Q Consensus 408 ~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~------------------------------------------------- 438 (611)
+..... ......++.+++..|.-||.
T Consensus 109 ~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 183 (272)
T 4gkh_A 109 QVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM 183 (272)
T ss_dssp HHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred ccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence 654311 11122344445555555552
Q ss_pred --c----CCCCeeecCCCCCeEEeCCCCCeEEeecccccc
Q 035917 439 --G----CQPPFLHQNICSNVILVDEDFDARIMDFGLAKL 472 (611)
Q Consensus 439 --~----~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~ 472 (611)
. ....++|+|+.+.||++++++.+-|.||+.+..
T Consensus 184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 0 012379999999999999877777999987753
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.25 E-value=9.2e-08 Score=106.37 Aligned_cols=82 Identities=12% Similarity=0.223 Sum_probs=35.7
Q ss_pred CCCCCCEEEccCCCCCcc----CchhHHhcCCCCCEEECcCCcCc----ccCccCccCCcCcccccccccccCCCCChhh
Q 035917 118 FCKSMQRLDLSANDLSGN----IPAQICNWLPYLVLLDLSNNDLS----GPIPADLGNCTYLNTLILSNNKLSGPIPYQL 189 (611)
Q Consensus 118 ~l~~L~~L~Ls~N~l~g~----ip~~~~~~l~~L~~L~Ls~N~l~----G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l 189 (611)
.+++|++|+|++|.+++. ++..+.. +++|+.|+|++|.++ +.++..+.++++|+.|+|++|.+.+ +|..+
T Consensus 162 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~-~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~ 239 (592)
T 3ogk_B 162 HCRKIKTLLMEESSFSEKDGKWLHELAQH-NTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFF 239 (592)
T ss_dssp HCTTCSEEECTTCEEECCCSHHHHHHHHH-CCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHH
T ss_pred hCCCCCEEECccccccCcchhHHHHHHhc-CCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHH
Confidence 344455555555444433 2222233 444555555554444 2233333444445555554444443 33444
Q ss_pred hcCCCccccccc
Q 035917 190 SNLGRLKKFSVA 201 (611)
Q Consensus 190 ~~l~~L~~L~l~ 201 (611)
.++++|+.|+++
T Consensus 240 ~~~~~L~~L~l~ 251 (592)
T 3ogk_B 240 KAAANLEEFCGG 251 (592)
T ss_dssp HHCTTCCEEEEC
T ss_pred hhhhHHHhhccc
Confidence 444444444443
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=4.2e-06 Score=86.88 Aligned_cols=78 Identities=4% Similarity=-0.017 Sum_probs=55.0
Q ss_pred Cee-eecCCceEEEEEeC-------CCCEEEEEeccccc---h-hHHHHHHHHHHHhccC-C--CCccceeeEEEeC---
Q 035917 330 NVI-ISTRTGTTYKAMLP-------DGSVLAVKRLNTCK---L-GEKKFRNEMNRLGQLR-H--PNLAPLLGYCVVE--- 391 (611)
Q Consensus 330 ~~i-g~G~~g~Vy~~~~~-------~g~~vAvK~~~~~~---~-~~~~~~~Ev~~l~~l~-H--~nIv~l~g~~~~~--- 391 (611)
+.| +.|....+|+.... +++.+++|+..... . ....+.+|+.+++.+. + -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 77888999998764 26788999875432 1 2245788999888884 3 3466777777654
Q ss_pred CeeEEEEeccCCCChH
Q 035917 392 EEKLLIYKYMSSGTLY 407 (611)
Q Consensus 392 ~~~~lv~ey~~~gsL~ 407 (611)
+..++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3468999999987654
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.00 E-value=4.3e-07 Score=100.87 Aligned_cols=114 Identities=19% Similarity=0.203 Sum_probs=72.1
Q ss_pred cEEEEEecCCcccccCCccCc-CCCCCCEEEccCC-CCCcc-CchhHHhcCCCCCEEECcCCcCcccCccCcc----CCc
Q 035917 97 RILNLELREMKLSGKIPEPLK-FCKSMQRLDLSAN-DLSGN-IPAQICNWLPYLVLLDLSNNDLSGPIPADLG----NCT 169 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~-~l~~L~~L~Ls~N-~l~g~-ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~----~l~ 169 (611)
+++.|+|+++.+++..+..+. .+++|+.|+|++| .++.. ++..+.. +++|++|+|++|.+++..+..+. .++
T Consensus 106 ~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~-~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 106 WLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAAT-CRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHH-CTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHh-CCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 577788887777776666554 5778888888777 44433 4443334 77888888888877765544433 556
Q ss_pred CcccccccccccCCCCC-----hhhhcCCCccccccccc-ccCCCCCccCC
Q 035917 170 YLNTLILSNNKLSGPIP-----YQLSNLGRLKKFSVANN-DLTGTIPSSFK 214 (611)
Q Consensus 170 ~L~~L~L~~N~l~g~iP-----~~l~~l~~L~~L~l~~N-~l~g~ip~~~~ 214 (611)
+|+.|+|++|. +.++ ..+..+++|+.|++++| .+++ +|..+.
T Consensus 185 ~L~~L~l~~~~--~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~ 232 (594)
T 2p1m_B 185 SLVSLNISCLA--SEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQ 232 (594)
T ss_dssp CCCEEECTTCC--SCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHH
T ss_pred cCcEEEecccC--CcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHh
Confidence 78888887776 2332 12344677888888777 3333 554443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.98 E-value=4.4e-07 Score=100.80 Aligned_cols=126 Identities=13% Similarity=0.065 Sum_probs=95.0
Q ss_pred cEEEEEecCCcccccCCccCc-CCCCCCEEEcc--C----CCCCc-----cCchhHHhcCCCCCEEECcCCcCcccCccC
Q 035917 97 RILNLELREMKLSGKIPEPLK-FCKSMQRLDLS--A----NDLSG-----NIPAQICNWLPYLVLLDLSNNDLSGPIPAD 164 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~-~l~~L~~L~Ls--~----N~l~g-----~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~ 164 (611)
++..|.+..+++++.....+. .+++|+.|+|+ + |++++ .++..+.. +++|+.|+|++ .+++..+..
T Consensus 373 ~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~-~~~L~~L~L~~-~l~~~~~~~ 450 (594)
T 2p1m_B 373 KLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEH-CKDLRRLSLSG-LLTDKVFEY 450 (594)
T ss_dssp TCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHH-CTTCCEEECCS-SCCHHHHHH
T ss_pred hHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhh-CCCccEEeecC-cccHHHHHH
Confidence 577788899999887766665 58999999999 4 66662 23333555 89999999977 777776667
Q ss_pred ccC-CcCcccccccccccCCCCChhh-hcCCCcccccccccccCCCCCc----cCCCCCcccCCCC
Q 035917 165 LGN-CTYLNTLILSNNKLSGPIPYQL-SNLGRLKKFSVANNDLTGTIPS----SFKGFDKADFDGN 224 (611)
Q Consensus 165 ~~~-l~~L~~L~L~~N~l~g~iP~~l-~~l~~L~~L~l~~N~l~g~ip~----~~~~~~~~~~~~n 224 (611)
++. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++..+. .+.++..+.+.+|
T Consensus 451 l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~ 516 (594)
T 2p1m_B 451 IGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSC 516 (594)
T ss_dssp HHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESS
T ss_pred HHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCC
Confidence 766 8999999999999987666555 7799999999999999654433 2344555555554
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.92 E-value=8e-06 Score=83.83 Aligned_cols=98 Identities=19% Similarity=0.183 Sum_probs=77.6
Q ss_pred CCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcc-cccccccccCCCCChhhhcCCCccc
Q 035917 119 CKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLN-TLILSNNKLSGPIPYQLSNLGRLKK 197 (611)
Q Consensus 119 l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~-~L~L~~N~l~g~iP~~l~~l~~L~~ 197 (611)
+++|+.|+|++|+++ .||...+..|++|+.|+|++| ++-.-+..+.+|++|+ .|+|.+ +++-.-+..|.++++|+.
T Consensus 225 ~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~ 301 (329)
T 3sb4_A 225 MPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRY 301 (329)
T ss_dssp CTTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEE
T ss_pred cCCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCE
Confidence 789999999999998 788765555999999999998 6643345688999999 999988 676445578999999999
Q ss_pred ccccccccCCCCCccCCCCCcc
Q 035917 198 FSVANNDLTGTIPSSFKGFDKA 219 (611)
Q Consensus 198 L~l~~N~l~g~ip~~~~~~~~~ 219 (611)
+++++|+++..-+..|.++..+
T Consensus 302 l~l~~n~i~~I~~~aF~~~~~L 323 (329)
T 3sb4_A 302 VLATGDKITTLGDELFGNGVPS 323 (329)
T ss_dssp EEECSSCCCEECTTTTCTTCCC
T ss_pred EEeCCCccCccchhhhcCCcch
Confidence 9999998885555566655444
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.89 E-value=8.7e-06 Score=83.56 Aligned_cols=101 Identities=14% Similarity=0.128 Sum_probs=85.9
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCC-EEECcCCcCcccCccCccCCcCccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLV-LLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~-~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
.++.|+|++|++...-+..+..|.+|+.|+|++| ++ .|+...+..|++|+ .|+|++ +++-.-+..+.+|++|+.|+
T Consensus 227 ~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~ 303 (329)
T 3sb4_A 227 NLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVL 303 (329)
T ss_dssp TCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEE
T ss_pred CCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEE
Confidence 6889999999998766677999999999999998 66 68776555599999 999999 77644457799999999999
Q ss_pred ccccccCCCCChhhhcCCCcccccc
Q 035917 176 LSNNKLSGPIPYQLSNLGRLKKFSV 200 (611)
Q Consensus 176 L~~N~l~g~iP~~l~~l~~L~~L~l 200 (611)
|+.|+++..-+..|.++++|+.+..
T Consensus 304 l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 304 ATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp ECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred eCCCccCccchhhhcCCcchhhhcc
Confidence 9999999666678999999998753
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.89 E-value=2.7e-06 Score=79.88 Aligned_cols=97 Identities=12% Similarity=0.175 Sum_probs=75.4
Q ss_pred cCCccCcCCCCCCEEEccCC-CCCcc----CchhHHhcCCCCCEEECcCCcCccc----CccCccCCcCccccccccccc
Q 035917 111 KIPEPLKFCKSMQRLDLSAN-DLSGN----IPAQICNWLPYLVLLDLSNNDLSGP----IPADLGNCTYLNTLILSNNKL 181 (611)
Q Consensus 111 ~~p~~l~~l~~L~~L~Ls~N-~l~g~----ip~~~~~~l~~L~~L~Ls~N~l~G~----iP~~~~~l~~L~~L~L~~N~l 181 (611)
.+...+...+.|+.|+|++| .+... +...+.. .+.|++|+|++|.++.. +...+...++|++|+|++|.+
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~-~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i 105 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKT-NTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFI 105 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTT-CCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCC
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHh-CCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcC
Confidence 34445678899999999999 88743 3344444 68999999999999742 444556678999999999999
Q ss_pred CCC----CChhhhcCCCcccccc--cccccCCC
Q 035917 182 SGP----IPYQLSNLGRLKKFSV--ANNDLTGT 208 (611)
Q Consensus 182 ~g~----iP~~l~~l~~L~~L~l--~~N~l~g~ 208 (611)
+.. +...+...++|++|+| ++|.++..
T Consensus 106 ~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~ 138 (185)
T 1io0_A 106 SGSGILALVEALQSNTSLIELRIDNQSQPLGNN 138 (185)
T ss_dssp CHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHH
T ss_pred CHHHHHHHHHHHHhCCCceEEEecCCCCCCCHH
Confidence 853 4556778889999999 88988753
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.89 E-value=5.6e-05 Score=77.43 Aligned_cols=137 Identities=18% Similarity=0.259 Sum_probs=79.8
Q ss_pred eeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccC-----CCCcccee-e--EEEeCCeeEEEEeccC
Q 035917 331 VIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLR-----HPNLAPLL-G--YCVVEEEKLLIYKYMS 402 (611)
Q Consensus 331 ~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~-----H~nIv~l~-g--~~~~~~~~~lv~ey~~ 402 (611)
.|+.|..+.||+....+| .+++|+.... ..++..|+.++..+. .|.++... | +....+..+++|||++
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~ 114 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE 114 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence 455577889999987665 4899998653 234445555555543 34444311 1 2234667899999999
Q ss_pred CCChH--------------Hhhhc----C--C-------CCCCHHHHH-------------------------------H
Q 035917 403 SGTLY--------------SLLQG----N--A-------TELDWPTRF-------------------------------R 424 (611)
Q Consensus 403 ~gsL~--------------~~l~~----~--~-------~~l~~~~~~-------------------------------~ 424 (611)
|..+. ..+|. . . ..-.|.... .
T Consensus 115 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (346)
T 2q83_A 115 GRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDG 194 (346)
T ss_dssp CBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHH
T ss_pred CccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHH
Confidence 86542 11111 0 0 012343211 0
Q ss_pred HHHHHHHHHHHHhh----------cCCCCeeecCCCCCeEEeCCCCCeEEeeccccc
Q 035917 425 IGLGAARGLAWLHH----------GCQPPFLHQNICSNVILVDEDFDARIMDFGLAK 471 (611)
Q Consensus 425 i~~~ia~gL~yLH~----------~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~ 471 (611)
+...+..++.+|+. .....++|+|+++.||+++.++.+.|.||+.+.
T Consensus 195 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 195 FIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11123345666652 125789999999999999877889999999765
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=9e-05 Score=78.01 Aligned_cols=73 Identities=15% Similarity=0.082 Sum_probs=48.9
Q ss_pred CeeeecCCceEEEEEeC-CCCEEEEEeccccc--------hhHHHHHHHHHHHhccCC--CCcc-ceeeEEEeCCeeEEE
Q 035917 330 NVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK--------LGEKKFRNEMNRLGQLRH--PNLA-PLLGYCVVEEEKLLI 397 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--------~~~~~~~~Ev~~l~~l~H--~nIv-~l~g~~~~~~~~~lv 397 (611)
+.||.|..+.||++... +++.|+||...... ...+++..|.++++.+.. +..+ +++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 57899999999999854 46889999864321 122456789998887742 3433 44433 45567899
Q ss_pred EeccCCC
Q 035917 398 YKYMSSG 404 (611)
Q Consensus 398 ~ey~~~g 404 (611)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.72 E-value=1.9e-06 Score=89.86 Aligned_cols=110 Identities=16% Similarity=0.149 Sum_probs=77.6
Q ss_pred CcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHh-cCCCCCEEECcC--CcCccc-----CccCc--
Q 035917 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICN-WLPYLVLLDLSN--NDLSGP-----IPADL-- 165 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~-~l~~L~~L~Ls~--N~l~G~-----iP~~~-- 165 (611)
..+..|+|+++. .-.+++ +. +++|+.|+|+.+.++......+.. .+++|+.|+|+. |...|. +...+
T Consensus 172 P~L~~L~L~g~~-~l~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~ 248 (362)
T 2ra8_A 172 PLLNNLKIKGTN-NLSIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSK 248 (362)
T ss_dssp TTCCEEEEECCB-TCBCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCT
T ss_pred CCCcEEEEeCCC-Cceecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhc
Confidence 368899998872 113444 43 889999999998887654445542 289999999964 332222 11122
Q ss_pred cCCcCcccccccccccCCCCChhhh---cCCCcccccccccccCCC
Q 035917 166 GNCTYLNTLILSNNKLSGPIPYQLS---NLGRLKKFSVANNDLTGT 208 (611)
Q Consensus 166 ~~l~~L~~L~L~~N~l~g~iP~~l~---~l~~L~~L~l~~N~l~g~ 208 (611)
..+++|++|+|++|.+++..+..+. .+++|++|+|+.|.+++.
T Consensus 249 ~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~ 294 (362)
T 2ra8_A 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDE 294 (362)
T ss_dssp TTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHH
T ss_pred CCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChH
Confidence 3578999999999998865555554 478999999999999874
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00062 Score=69.17 Aligned_cols=135 Identities=17% Similarity=0.184 Sum_probs=91.1
Q ss_pred CeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccC---CCCccceeeEEEeCCeeEEEEeccCCCCh
Q 035917 330 NVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLR---HPNLAPLLGYCVVEEEKLLIYKYMSSGTL 406 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~---H~nIv~l~g~~~~~~~~~lv~ey~~~gsL 406 (611)
+.|+.|....+|+... ++..+++|+.... ....+..|.+.|+.|. ...+.++++++...+..++||||+++..+
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 5688899999999886 4678889987543 3567889999998884 35678888888878889999999998764
Q ss_pred H--------H---hhhcCCC---------------------CCCHHHHH---HHHH----------------HHHHHH-H
Q 035917 407 Y--------S---LLQGNAT---------------------ELDWPTRF---RIGL----------------GAARGL-A 434 (611)
Q Consensus 407 ~--------~---~l~~~~~---------------------~l~~~~~~---~i~~----------------~ia~gL-~ 434 (611)
. + .||.... .-+|.... ++.. .+...+ .
T Consensus 119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~ 198 (312)
T 3jr1_A 119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD 198 (312)
T ss_dssp CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence 2 1 1222110 12565432 1111 111112 2
Q ss_pred HHhh-cCCCCeeecCCCCCeEEeCCCCCeEEeecc
Q 035917 435 WLHH-GCQPPFLHQNICSNVILVDEDFDARIMDFG 468 (611)
Q Consensus 435 yLH~-~~~~~ivHrDlkp~NILld~~~~~kl~DFG 468 (611)
.|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 3321 2256799999999999999887 8888873
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.41 E-value=0.0032 Score=63.93 Aligned_cols=157 Identities=11% Similarity=0.049 Sum_probs=91.1
Q ss_pred cccHHHHHHhhhcCCC-----CCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCC--Ccccee
Q 035917 313 KVKLADLMAASNSFCS-----ENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHP--NLAPLL 385 (611)
Q Consensus 313 ~~~~~~l~~~t~~f~~-----~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~--nIv~l~ 385 (611)
.++.+++..+...|.. ...++ |....||+....+|+.+++|..+........+..|..++..+... .+.+++
T Consensus 10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeeccee
Confidence 4555555555555532 12455 788899998887788899999864433456777888888777422 234444
Q ss_pred eE-----EEeCCeeEEEEeccCCCChH-----H------h---hhc----C----CCCCCHHHH----HHHH--------
Q 035917 386 GY-----CVVEEEKLLIYKYMSSGTLY-----S------L---LQG----N----ATELDWPTR----FRIG-------- 426 (611)
Q Consensus 386 g~-----~~~~~~~~lv~ey~~~gsL~-----~------~---l~~----~----~~~l~~~~~----~~i~-------- 426 (611)
.. ....+..+++|||++|..+. . . +|. . ....++... ..+.
T Consensus 89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 168 (328)
T 1zyl_A 89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS 168 (328)
T ss_dssp CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence 32 22345668899999875431 0 1 111 0 011232211 0010
Q ss_pred -------HHHHHHHHHHhh----cCCCCeeecCCCCCeEEeCCCCCeEEeecccccc
Q 035917 427 -------LGAARGLAWLHH----GCQPPFLHQNICSNVILVDEDFDARIMDFGLAKL 472 (611)
Q Consensus 427 -------~~ia~gL~yLH~----~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~ 472 (611)
..+...++.+.. .....++|+|+++.||+++ + .+.|.||+.+..
T Consensus 169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 011111222221 1245689999999999999 4 899999987753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0011 Score=66.29 Aligned_cols=74 Identities=20% Similarity=0.212 Sum_probs=53.6
Q ss_pred CCeeeecCCceEEEEEeCCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCC---CccceeeEEEeCCeeEEEEeccCCC
Q 035917 329 ENVIISTRTGTTYKAMLPDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHP---NLAPLLGYCVVEEEKLLIYKYMSSG 404 (611)
Q Consensus 329 ~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~---nIv~l~g~~~~~~~~~lv~ey~~~g 404 (611)
.+.+|.|..+.||+..+.||+.|.||+-.... .....|..|+..|+.|.-. -+.+++++ + ..++||||++++
T Consensus 20 v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l~~~ 95 (288)
T 3f7w_A 20 VAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWVDER 95 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECCCCC
T ss_pred EEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEeeccc
Confidence 45689999999999999999999999875432 2234688999999888422 23344443 2 347899999876
Q ss_pred Ch
Q 035917 405 TL 406 (611)
Q Consensus 405 sL 406 (611)
..
T Consensus 96 ~~ 97 (288)
T 3f7w_A 96 PP 97 (288)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.32 E-value=9e-05 Score=77.11 Aligned_cols=109 Identities=14% Similarity=0.175 Sum_probs=74.1
Q ss_pred cEEEEEecCCcc---------cccCCccCcCCCCCCEEEccCCC-CCccCchhHHhcCCCCCEEECcCCcCcccCccCcc
Q 035917 97 RILNLELREMKL---------SGKIPEPLKFCKSMQRLDLSAND-LSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLG 166 (611)
Q Consensus 97 ~v~~l~l~~~~l---------~g~~p~~l~~l~~L~~L~Ls~N~-l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~ 166 (611)
++..|.+.++.. .+.+++.+..+++|+.|+|++|. + .+|+ + . +++|+.|+|..|.++...-..+.
T Consensus 140 ~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l--~l~~-~-~-~~~L~~L~L~~~~l~~~~l~~l~ 214 (362)
T 2ra8_A 140 HFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL--SIGK-K-P-RPNLKSLEIISGGLPDSVVEDIL 214 (362)
T ss_dssp TCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC--BCCS-C-B-CTTCSEEEEECSBCCHHHHHHHH
T ss_pred hhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc--eecc-c-c-CCCCcEEEEecCCCChHHHHHHH
Confidence 577777765532 12355556788999999999883 3 3454 3 3 78999999999887654444444
Q ss_pred --CCcCcccccccc--cccCCCC-----Chhh--hcCCCcccccccccccCCCCC
Q 035917 167 --NCTYLNTLILSN--NKLSGPI-----PYQL--SNLGRLKKFSVANNDLTGTIP 210 (611)
Q Consensus 167 --~l~~L~~L~L~~--N~l~g~i-----P~~l--~~l~~L~~L~l~~N~l~g~ip 210 (611)
.+++|+.|+|+. |...|.. ...+ ..+++|++|+|.+|.++...+
T Consensus 215 ~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~ 269 (362)
T 2ra8_A 215 GSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVV 269 (362)
T ss_dssp HSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHH
T ss_pred HccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHH
Confidence 789999999863 3332221 1122 357899999999998875443
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0012 Score=69.88 Aligned_cols=76 Identities=11% Similarity=0.131 Sum_probs=45.6
Q ss_pred CCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC-ccccCCCcccccccccccCCC---CCCcccchHHHHHHHH
Q 035917 441 QPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES-SFVNGDLGEFGYIAPEYSSTM---VASLKGDVYGIGVVLL 516 (611)
Q Consensus 441 ~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~SfGvvl~ 516 (611)
...++|+|+++.|||++.++ ++|.||+.+..-...... ..... -...|.+|+..... ......++.+....+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGN--LILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHH--HHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHH--HHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 67899999999999998776 999999988753211000 00000 01346666654321 1122345557777777
Q ss_pred HHh
Q 035917 517 ELA 519 (611)
Q Consensus 517 ell 519 (611)
+.+
T Consensus 308 ~~y 310 (420)
T 2pyw_A 308 NLF 310 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0016 Score=66.05 Aligned_cols=156 Identities=8% Similarity=0.071 Sum_probs=87.4
Q ss_pred ccHHHHHHhhhcCCCC-----CeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCC--ccceee
Q 035917 314 VKLADLMAASNSFCSE-----NVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPN--LAPLLG 386 (611)
Q Consensus 314 ~~~~~l~~~t~~f~~~-----~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~n--Iv~l~g 386 (611)
++.+++......|... +.|+.|....+|+....+| .+++|..... ...+++..|+.++..+.... +.+++.
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 5556666666666553 2355677789999987666 5788988652 12234667777777664212 222321
Q ss_pred ------EEEeCCeeEEEEeccCCCChHH--------------hhhcC--C--CC-------CCHHHHHHH----------
Q 035917 387 ------YCVVEEEKLLIYKYMSSGTLYS--------------LLQGN--A--TE-------LDWPTRFRI---------- 425 (611)
Q Consensus 387 ------~~~~~~~~~lv~ey~~~gsL~~--------------~l~~~--~--~~-------l~~~~~~~i---------- 425 (611)
+....+..+++|+|++|..+.. .+|.. . .+ ..|.....-
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1123456789999998765311 01110 0 01 124321110
Q ss_pred --HHHHHHHHHHHhhc----CCCCeeecCCCCCeEEeCCCCCeEEeeccccc
Q 035917 426 --GLGAARGLAWLHHG----CQPPFLHQNICSNVILVDEDFDARIMDFGLAK 471 (611)
Q Consensus 426 --~~~ia~gL~yLH~~----~~~~ivHrDlkp~NILld~~~~~kl~DFGla~ 471 (611)
...+.+.+++++.. ....++|+|+.+.|||++++....|.||+.+.
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 11133445555421 13569999999999999877656899998765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0012 Score=66.50 Aligned_cols=136 Identities=13% Similarity=0.087 Sum_probs=74.6
Q ss_pred CCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCc-cceeeEEEeCCeeEEEEecc-CCCCh
Q 035917 329 ENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNL-APLLGYCVVEEEKLLIYKYM-SSGTL 406 (611)
Q Consensus 329 ~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nI-v~l~g~~~~~~~~~lv~ey~-~~gsL 406 (611)
.+.|+.|....+|+. +.+++|+.........+..+|+.+++.+....+ .+++++ +.+.-++++||+ ++.++
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 567888999999998 558888875421111123568887777743333 344443 344467899999 55444
Q ss_pred HH------------------hhhcCCCC----CCH-HHHHHHHHH--------------HHHHHH----HHh-hcCCCCe
Q 035917 407 YS------------------LLQGNATE----LDW-PTRFRIGLG--------------AARGLA----WLH-HGCQPPF 444 (611)
Q Consensus 407 ~~------------------~l~~~~~~----l~~-~~~~~i~~~--------------ia~gL~----yLH-~~~~~~i 444 (611)
.. -+|..... .+. .....+... +.+.+. .+. ......+
T Consensus 96 ~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l 175 (301)
T 3dxq_A 96 SPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAA 175 (301)
T ss_dssp CHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEE
T ss_pred CHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCcee
Confidence 21 01211111 111 111111110 111111 111 1123458
Q ss_pred eecCCCCCeEEeCCCCCeEEeecccccc
Q 035917 445 LHQNICSNVILVDEDFDARIMDFGLAKL 472 (611)
Q Consensus 445 vHrDlkp~NILld~~~~~kl~DFGla~~ 472 (611)
+|+|+.+.||+ ..++.+.+.||..+..
T Consensus 176 ~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 176 CHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp ECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eccCCCcCCEE-ECCCCEEEEecccccC
Confidence 99999999999 5566789999988764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0031 Score=64.34 Aligned_cols=138 Identities=13% Similarity=0.094 Sum_probs=71.8
Q ss_pred eeeecCCce-EEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCC--CCccceeeEEEeCCeeEEEEeccCCCChH
Q 035917 331 VIISTRTGT-TYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRH--PNLAPLLGYCVVEEEKLLIYKYMSSGTLY 407 (611)
Q Consensus 331 ~ig~G~~g~-Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H--~nIv~l~g~~~~~~~~~lv~ey~~~gsL~ 407 (611)
.|+.|.... +|+....+|+.+++|....... .++..|+.++..+.. -.+.+++.+.... -+++||++.+..+.
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~--~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l~ 100 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG--GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALFT 100 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT--CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBHH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC--ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcchH
Confidence 354454443 6677655577788887643220 234566777666642 2344566553322 37899999776664
Q ss_pred Hhhhc---------------------CC----CCCCHHHHH-------H-------------HHHHHHHHHHHHh---hc
Q 035917 408 SLLQG---------------------NA----TELDWPTRF-------R-------------IGLGAARGLAWLH---HG 439 (611)
Q Consensus 408 ~~l~~---------------------~~----~~l~~~~~~-------~-------------i~~~ia~gL~yLH---~~ 439 (611)
+++.+ .. ..++..... . ....+...++.+. ..
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~ 180 (333)
T 3csv_A 101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE 180 (333)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence 43321 10 011111100 0 0001111222221 11
Q ss_pred CCCCeeecCCCCCeEEeCCC----CCeEEeecccccc
Q 035917 440 CQPPFLHQNICSNVILVDED----FDARIMDFGLAKL 472 (611)
Q Consensus 440 ~~~~ivHrDlkp~NILld~~----~~~kl~DFGla~~ 472 (611)
....++|+|+.+.||+++.+ ..+.|.||+.+..
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 24579999999999999874 6789999998864
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.87 E-value=0.001 Score=58.32 Aligned_cols=55 Identities=22% Similarity=0.332 Sum_probs=28.3
Q ss_pred EEEecCCccc-ccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcC
Q 035917 100 NLELREMKLS-GKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDL 157 (611)
Q Consensus 100 ~l~l~~~~l~-g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l 157 (611)
.++.++++|+ ..+|..+ ..+|+.|+|++|+|+ .||...+..+++|+.|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCe
Confidence 3455555554 3444322 234566666666666 35444333355666666666654
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0017 Score=68.51 Aligned_cols=79 Identities=15% Similarity=0.230 Sum_probs=55.7
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.++.+.|++ ++.-.-+..+..|.+|+.++|++|+++ .||...+. +++|+.+.|..| ++-.-...+.+|++|+.++|
T Consensus 158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l 233 (401)
T 4fdw_A 158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEI 233 (401)
T ss_dssp CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEEC
T ss_pred CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEec
Confidence 366677765 555444566888888999999888888 67777666 678888888744 55333345677788888887
Q ss_pred ccc
Q 035917 177 SNN 179 (611)
Q Consensus 177 ~~N 179 (611)
..|
T Consensus 234 ~~~ 236 (401)
T 4fdw_A 234 PEN 236 (401)
T ss_dssp CTT
T ss_pred CCC
Confidence 764
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0012 Score=57.91 Aligned_cols=55 Identities=24% Similarity=0.239 Sum_probs=30.4
Q ss_pred EEEccCCCCC-ccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccccccccc
Q 035917 124 RLDLSANDLS-GNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKL 181 (611)
Q Consensus 124 ~L~Ls~N~l~-g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l 181 (611)
.++.++++|+ ..+|..+ .++|+.|+|++|+|+..-+..+..+++|+.|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~l---p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAF---PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCC---CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCC---CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 5666666665 3455443 34566666666666633233345555566655555544
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0015 Score=68.94 Aligned_cols=102 Identities=16% Similarity=0.221 Sum_probs=51.6
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcc----cCc-cCccCCcCc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG----PIP-ADLGNCTYL 171 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G----~iP-~~~~~l~~L 171 (611)
.+..|+|+++ +.-.-...+.. ..|+.+.| .|+++ .|+...+..|++|+.++|++|.+.. .|+ ..+.+|++|
T Consensus 227 ~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~-~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L 302 (401)
T 4fdw_A 227 QLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVT-NIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKL 302 (401)
T ss_dssp TCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCC-EECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTC
T ss_pred CCCEEecCCC-ccCcccccccc-CCccEEEe-CCCcc-EEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccC
Confidence 3455555542 33222223434 56666666 34444 3443333336666666666665541 122 345566666
Q ss_pred ccccccccccCCCCChhhhcCCCccccccccc
Q 035917 172 NTLILSNNKLSGPIPYQLSNLGRLKKFSVANN 203 (611)
Q Consensus 172 ~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N 203 (611)
+.++|. |.++-.-...|.++.+|+.+.|..|
T Consensus 303 ~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~ 333 (401)
T 4fdw_A 303 ARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN 333 (401)
T ss_dssp CEECCC-TTCCEECTTTTTTCCSCCEEEECTT
T ss_pred CeEEeC-CceEEEhhhhhcCCCCccEEEECcc
Confidence 666666 3344222344566666666666443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0052 Score=64.07 Aligned_cols=139 Identities=17% Similarity=0.152 Sum_probs=82.4
Q ss_pred CeeeecCCceEEEEEeC--------CCCEEEEEeccccchhHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeEEEEec
Q 035917 330 NVIISTRTGTTYKAMLP--------DGSVLAVKRLNTCKLGEKKFRNEMNRLGQLR-HPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~--------~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
+.+..|-...+|+...+ +++.|++|+..........+.+|.++++.+. +.-..++++++. + .+||||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEEEE
Confidence 45666888889999875 3578999986443233456678999998884 322345665543 3 299999
Q ss_pred cCCCChHH--------------h---hhcCC----CCCC--HHHHHHHHHHHHH-------------------HHHHHh-
Q 035917 401 MSSGTLYS--------------L---LQGNA----TELD--WPTRFRIGLGAAR-------------------GLAWLH- 437 (611)
Q Consensus 401 ~~~gsL~~--------------~---l~~~~----~~l~--~~~~~~i~~~ia~-------------------gL~yLH- 437 (611)
++|..|.. . ||... .... |.++.++..++.. .+.+|.
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 98765531 0 12211 1122 4455555443321 233332
Q ss_pred ---h-cCCCCeeecCCCCCeEEeCCC----CCeEEeecccccc
Q 035917 438 ---H-GCQPPFLHQNICSNVILVDED----FDARIMDFGLAKL 472 (611)
Q Consensus 438 ---~-~~~~~ivHrDlkp~NILld~~----~~~kl~DFGla~~ 472 (611)
. .....++|+|+.+.||+++.+ +.+.+.||..+..
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1 123468999999999999876 6899999988764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0029 Score=67.32 Aligned_cols=72 Identities=15% Similarity=0.120 Sum_probs=49.0
Q ss_pred CeeeecCCceEEEEEeCC--------CCEEEEEeccccchhHHHHHHHHHHHhccCCCCc-cceeeEEEeCCeeEEEEec
Q 035917 330 NVIISTRTGTTYKAMLPD--------GSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNL-APLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~--------g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nI-v~l~g~~~~~~~~~lv~ey 400 (611)
+.|+.|-...+|+...++ ++.+++|+.... ...+.+.+|..++..+...++ .++++.+. + .+||||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~ 153 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEY 153 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEEE
Confidence 457778889999998753 578999988432 122456689999888853334 55666543 2 389999
Q ss_pred cCCCCh
Q 035917 401 MSSGTL 406 (611)
Q Consensus 401 ~~~gsL 406 (611)
+++.+|
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 986443
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.63 E-value=0.00043 Score=63.92 Aligned_cols=83 Identities=8% Similarity=0.104 Sum_probs=48.7
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCC-CCccCchhHHh---cCCCCCEEECcCCc-CcccCccCccCCcCc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSAND-LSGNIPAQICN---WLPYLVLLDLSNND-LSGPIPADLGNCTYL 171 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~-l~g~ip~~~~~---~l~~L~~L~Ls~N~-l~G~iP~~~~~l~~L 171 (611)
+++.|||++..++..=-..+..|++|+.|+|+++. ++..-=..+.. .+++|+.|||+++. +|..==..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 57888888777654322346677788888888764 55432223333 01357777777753 542211235566777
Q ss_pred cccccccc
Q 035917 172 NTLILSNN 179 (611)
Q Consensus 172 ~~L~L~~N 179 (611)
+.|+|++.
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 77777665
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0043 Score=64.36 Aligned_cols=73 Identities=12% Similarity=0.084 Sum_probs=43.6
Q ss_pred CeeeecCCceEEEEEeCC---------CCEEEEEeccccchhHHHHHHHHHHHhccCCCCc-cceeeEEEeCCeeEEEEe
Q 035917 330 NVIISTRTGTTYKAMLPD---------GSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNL-APLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~---------g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nI-v~l~g~~~~~~~~~lv~e 399 (611)
..++.|....+|+....+ ++.+++|+.........+...|..+++.+...++ .++++.. . -++|||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 356678888999998754 2688888875432111123678888887753333 3565443 2 368999
Q ss_pred ccCCCCh
Q 035917 400 YMSSGTL 406 (611)
Q Consensus 400 y~~~gsL 406 (611)
|++|..+
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987543
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.44 E-value=0.0013 Score=60.56 Aligned_cols=84 Identities=11% Similarity=0.081 Sum_probs=62.3
Q ss_pred CCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCc-CcccCccCccCC----cCcccccccccc-cCCCCChhhhcCC
Q 035917 120 KSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNND-LSGPIPADLGNC----TYLNTLILSNNK-LSGPIPYQLSNLG 193 (611)
Q Consensus 120 ~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~-l~G~iP~~~~~l----~~L~~L~L~~N~-l~g~iP~~l~~l~ 193 (611)
-.|+.||||++.++..=-..+.. +++|+.|+|+++. ++..-=..++.+ ++|+.|+|+++. +|..==..+..++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~-~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~ 139 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEG-LQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFR 139 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTT-CSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCT
T ss_pred ceEeEEeCcCCCccHHHHHHhcC-CCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCC
Confidence 47999999999987543344555 9999999999985 664322334543 479999999974 7643224578899
Q ss_pred Ccccccccccc
Q 035917 194 RLKKFSVANND 204 (611)
Q Consensus 194 ~L~~L~l~~N~ 204 (611)
+|+.|+|++..
T Consensus 140 ~L~~L~L~~c~ 150 (176)
T 3e4g_A 140 NLKYLFLSDLP 150 (176)
T ss_dssp TCCEEEEESCT
T ss_pred CCCEEECCCCC
Confidence 99999999864
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.24 E-value=0.0011 Score=62.39 Aligned_cols=42 Identities=21% Similarity=0.301 Sum_probs=18.2
Q ss_pred CcCCCCCCEEEccCCCCCcc----CchhHHhcCCCCCEEECcCCcCc
Q 035917 116 LKFCKSMQRLDLSANDLSGN----IPAQICNWLPYLVLLDLSNNDLS 158 (611)
Q Consensus 116 l~~l~~L~~L~Ls~N~l~g~----ip~~~~~~l~~L~~L~Ls~N~l~ 158 (611)
|..-+.|+.|+|++|.+... |-..+.. -+.|+.|+|++|.++
T Consensus 66 L~~N~~L~~L~L~~n~igd~ga~alA~aL~~-N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 66 ACNSKHIEKFSLANTAISDSEARGLIELIET-SPSLRVLNVESNFLT 111 (197)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHH-CSSCCEEECCSSBCC
T ss_pred HhhCCCcCEEEccCCCCChHHHHHHHHHHhc-CCccCeEecCCCcCC
Confidence 33344555555555555421 1222222 344555555555544
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.17 E-value=0.041 Score=52.14 Aligned_cols=101 Identities=12% Similarity=0.089 Sum_probs=66.0
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcccc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
-+|.++|...+.++++.+++.++.|.+++|.-+-.. ..+ ..+=+-|..|++..+|.+...+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc------------
Confidence 379999987777999999999999999988766210 011 1222356889999999887663 1110
Q ss_pred CCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCC
Q 035917 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFK 522 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~ 522 (611)
.....+.|||... ...+.+.=|||+|+++|.-+...
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 0123466888764 34578889999999999988443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.14 E-value=0.013 Score=62.57 Aligned_cols=73 Identities=12% Similarity=0.002 Sum_probs=46.5
Q ss_pred CeeeecCCceEEEEEeCC-CCEEEEEeccccchhHHHHHHHHHHHhccCCCCc-cceeeEEEeCCeeEEEEeccCCCCh
Q 035917 330 NVIISTRTGTTYKAMLPD-GSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNL-APLLGYCVVEEEKLLIYKYMSSGTL 406 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nI-v~l~g~~~~~~~~~lv~ey~~~gsL 406 (611)
+.|+.|-...+|+....+ +..+++|+........-+-.+|..++..+...++ .++++++ .+ .+||||+++.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence 457778889999998865 5788888874321111112578888888865555 4566665 23 259999987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.02 E-value=0.022 Score=58.24 Aligned_cols=32 Identities=22% Similarity=0.321 Sum_probs=28.0
Q ss_pred CCCeeecCCCCCeEEeCCCCCeEEeecccccc
Q 035917 441 QPPFLHQNICSNVILVDEDFDARIMDFGLAKL 472 (611)
Q Consensus 441 ~~~ivHrDlkp~NILld~~~~~kl~DFGla~~ 472 (611)
...++|+|+.+.||++++++.+.|.||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35699999999999999878899999987764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.18 E-value=0.0062 Score=57.17 Aligned_cols=87 Identities=14% Similarity=0.173 Sum_probs=61.7
Q ss_pred CcCCCCCCEEEccCC-CCCcc----CchhHHhcCCCCCEEECcCCcCccc----CccCccCCcCcccccccccccCCC--
Q 035917 116 LKFCKSMQRLDLSAN-DLSGN----IPAQICNWLPYLVLLDLSNNDLSGP----IPADLGNCTYLNTLILSNNKLSGP-- 184 (611)
Q Consensus 116 l~~l~~L~~L~Ls~N-~l~g~----ip~~~~~~l~~L~~L~Ls~N~l~G~----iP~~~~~l~~L~~L~L~~N~l~g~-- 184 (611)
+.+-+.|+.|+|++| .+... |-..+.. -+.|+.|+|++|.+... |-..+..-+.|+.|+|+.|.++..
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~-N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga 115 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACN-SKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL 115 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTT-CSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhh-CCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence 455678999999986 77532 3334444 57899999999999732 333344568899999999999743
Q ss_pred --CChhhhcCCCccccccccc
Q 035917 185 --IPYQLSNLGRLKKFSVANN 203 (611)
Q Consensus 185 --iP~~l~~l~~L~~L~l~~N 203 (611)
|-..|..-+.|+.|+|++|
T Consensus 116 ~ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 116 ARLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHHHTTTTCCCSEEECCCC
T ss_pred HHHHHHHhhCCceeEEECCCC
Confidence 2223445567999999865
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.48 E-value=0.23 Score=52.33 Aligned_cols=138 Identities=12% Similarity=0.137 Sum_probs=81.8
Q ss_pred CeeeecCCceEEEEEeCC--------CCEEEEEeccccchhHHHHHHHHHHHhccCCCC-ccceeeEEEeCCeeEEEEec
Q 035917 330 NVIISTRTGTTYKAMLPD--------GSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPN-LAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~--------g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~n-Iv~l~g~~~~~~~~~lv~ey 400 (611)
+.+..|-...+|+...++ ++.+++|+........-+..+|..+++.+.-.+ ..++++.+ . -++||||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEE
Confidence 356678888999998763 578999987442211112357888887774223 34555433 2 3789999
Q ss_pred cCCCChHH--------------h---hhc------------CCCCCCHHHHHHHHHHH-------------------HHH
Q 035917 401 MSSGTLYS--------------L---LQG------------NATELDWPTRFRIGLGA-------------------ARG 432 (611)
Q Consensus 401 ~~~gsL~~--------------~---l~~------------~~~~l~~~~~~~i~~~i-------------------a~g 432 (611)
++|..|.. . +|. ...+.-|.++.++..++ ...
T Consensus 152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e 231 (424)
T 3mes_A 152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE 231 (424)
T ss_dssp CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence 99865421 0 010 01112244443333221 222
Q ss_pred HHHHhh---------------------cCCCCeeecCCCCCeEEeCCCCCeEEeecccccc
Q 035917 433 LAWLHH---------------------GCQPPFLHQNICSNVILVDEDFDARIMDFGLAKL 472 (611)
Q Consensus 433 L~yLH~---------------------~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~ 472 (611)
+.+|.. .....++|+|+.+.||+ +.++.+.+.||..+..
T Consensus 232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 333321 11345899999999999 7788999999988764
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=93.32 E-value=0.17 Score=52.13 Aligned_cols=81 Identities=22% Similarity=0.425 Sum_probs=37.7
Q ss_pred CcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccccccccCCCCC-hhhhcCCC
Q 035917 116 LKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIP-YQLSNLGR 194 (611)
Q Consensus 116 l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP-~~l~~l~~ 194 (611)
+..+..|+.+.+..+ +. .|+...+..|++|+.+++.+|.++-.-+..+.+|++|+.++|..| ++ .|+ ..|.++.+
T Consensus 259 F~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~ 334 (379)
T 4h09_A 259 LQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK-TIQVYAFKNCKA 334 (379)
T ss_dssp TTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTT
T ss_pred cceeehhcccccccc-ce-eccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-cc-EEHHHHhhCCCC
Confidence 344455555555332 22 233333333556666666555554222234555566666655433 33 222 34555555
Q ss_pred cccccc
Q 035917 195 LKKFSV 200 (611)
Q Consensus 195 L~~L~l 200 (611)
|+.+.+
T Consensus 335 L~~i~i 340 (379)
T 4h09_A 335 LSTISY 340 (379)
T ss_dssp CCCCCC
T ss_pred CCEEEE
Confidence 555544
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=92.30 E-value=0.12 Score=53.86 Aligned_cols=101 Identities=14% Similarity=0.329 Sum_probs=71.9
Q ss_pred EEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCc-cCccCCcCcccccc
Q 035917 98 ILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIP-ADLGNCTYLNTLIL 176 (611)
Q Consensus 98 v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP-~~~~~l~~L~~L~L 176 (611)
++.+.++++-. -.-...+.++..|+.+.+. +.++ .|+...+..|++|+.++|..| ++ .|. ..+.+|++|+.+.|
T Consensus 267 L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~L~~i~i 341 (394)
T 4gt6_A 267 LASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQLERIAI 341 (394)
T ss_dssp CCEEECCTTCC-EECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEE
T ss_pred ccEEecccccc-eecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCCCCEEEE
Confidence 44555554322 1223457789999999996 4555 577665555999999999865 54 343 46889999999999
Q ss_pred cccccCCCCC-hhhhcCCCccccccccccc
Q 035917 177 SNNKLSGPIP-YQLSNLGRLKKFSVANNDL 205 (611)
Q Consensus 177 ~~N~l~g~iP-~~l~~l~~L~~L~l~~N~l 205 (611)
..| ++ .|+ ..|.++.+|+.+++.+|..
T Consensus 342 p~s-v~-~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 342 PSS-VT-KIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp CTT-CC-BCCGGGGTTCTTCCEEEESSCHH
T ss_pred Ccc-cC-EEhHhHhhCCCCCCEEEECCcee
Confidence 755 55 444 5689999999999988754
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=92.06 E-value=0.2 Score=52.12 Aligned_cols=84 Identities=11% Similarity=0.305 Sum_probs=62.1
Q ss_pred cCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCc-cCccCCcCcccccccccccCCCCChhhhcCC
Q 035917 115 PLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIP-ADLGNCTYLNTLILSNNKLSGPIPYQLSNLG 193 (611)
Q Consensus 115 ~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP-~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~ 193 (611)
.+..+..|+.+.+..+.. .|....+..+++|+.++++ +.++ .|+ ..+.+|++|+.++|..| ++-.-...|.++.
T Consensus 260 aF~~c~~L~~i~lp~~~~--~I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~ 334 (394)
T 4gt6_A 260 AFDSCAYLASVKMPDSVV--SIGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCE 334 (394)
T ss_dssp TTTTCSSCCEEECCTTCC--EECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT
T ss_pred eeeecccccEEecccccc--eecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCC
Confidence 577889999999976654 3554444448999999997 4455 454 45788999999999865 5422245688999
Q ss_pred Cccccccccc
Q 035917 194 RLKKFSVANN 203 (611)
Q Consensus 194 ~L~~L~l~~N 203 (611)
+|+.+.+..|
T Consensus 335 ~L~~i~ip~s 344 (394)
T 4gt6_A 335 QLERIAIPSS 344 (394)
T ss_dssp TCCEEEECTT
T ss_pred CCCEEEECcc
Confidence 9999998654
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=91.42 E-value=0.17 Score=52.62 Aligned_cols=55 Identities=15% Similarity=0.127 Sum_probs=21.9
Q ss_pred CCCCCEEECcCCcCcccCc-cCccCCcCcccccccccccCCCCChhhhcCCCccccccc
Q 035917 144 LPYLVLLDLSNNDLSGPIP-ADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVA 201 (611)
Q Consensus 144 l~~L~~L~Ls~N~l~G~iP-~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~ 201 (611)
+.+|+.+.+..| +. .|+ ..+.+|++|+.++|..+ ++-.-...|.++.+|+.+++.
T Consensus 296 ~~~L~~i~l~~~-i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp 351 (394)
T 4fs7_A 296 CSSLTEVKLLDS-VK-FIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFP 351 (394)
T ss_dssp CTTCCEEEECTT-CC-EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCC
T ss_pred cccccccccccc-cc-eechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEEC
Confidence 444555544433 22 222 22444445554444322 221112234444444444443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=90.59 E-value=0.19 Score=52.17 Aligned_cols=84 Identities=19% Similarity=0.212 Sum_probs=63.6
Q ss_pred cCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCc-cCccCCcCcccccccccccCCCCChhhhcCC
Q 035917 115 PLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIP-ADLGNCTYLNTLILSNNKLSGPIPYQLSNLG 193 (611)
Q Consensus 115 ~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP-~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~ 193 (611)
.+..+.+|+.+.+..+ ++ .|+...+..|++|+.++|.++ ++ .|+ ..+.+|++|+.++|..| ++-.-...|.++.
T Consensus 292 ~F~~~~~L~~i~l~~~-i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~ 366 (394)
T 4fs7_A 292 TFYGCSSLTEVKLLDS-VK-FIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCI 366 (394)
T ss_dssp TTTTCTTCCEEEECTT-CC-EECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCT
T ss_pred cccccccccccccccc-cc-eechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCC
Confidence 4678899999999765 55 566554444899999999855 55 454 46889999999999877 5523345689999
Q ss_pred Cccccccccc
Q 035917 194 RLKKFSVANN 203 (611)
Q Consensus 194 ~L~~L~l~~N 203 (611)
+|+.+++..|
T Consensus 367 ~L~~i~lp~~ 376 (394)
T 4fs7_A 367 NLKKVELPKR 376 (394)
T ss_dssp TCCEEEEEGG
T ss_pred CCCEEEECCC
Confidence 9999998655
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.94 E-value=0.43 Score=49.81 Aligned_cols=29 Identities=24% Similarity=0.416 Sum_probs=24.8
Q ss_pred eeecCCCCCeEEe------CCCCCeEEeecccccc
Q 035917 444 FLHQNICSNVILV------DEDFDARIMDFGLAKL 472 (611)
Q Consensus 444 ivHrDlkp~NILl------d~~~~~kl~DFGla~~ 472 (611)
++|+|+.+.|||+ +++..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567899999988764
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=88.69 E-value=0.7 Score=47.40 Aligned_cols=85 Identities=13% Similarity=0.256 Sum_probs=52.7
Q ss_pred cCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCc-cCccCCcCcccccccccccCCCCChhhhcCC
Q 035917 115 PLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIP-ADLGNCTYLNTLILSNNKLSGPIPYQLSNLG 193 (611)
Q Consensus 115 ~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP-~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~ 193 (611)
.+..+..|+.+.+..+ ++ .|....+..+.+|+.+++..+ +. .|+ ..+.+|++|+.+++.+|.++-.-+..|.++.
T Consensus 235 ~f~~~~~L~~i~lp~~-v~-~I~~~aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~ 310 (379)
T 4h09_A 235 AFYGMKALDEIAIPKN-VT-SIGSFLLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCV 310 (379)
T ss_dssp TTTTCSSCCEEEECTT-CC-EECTTTTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCT
T ss_pred cccCCccceEEEcCCC-cc-EeCccccceeehhcccccccc-ce-eccccccccccccccccccccccceehhhhhcCCC
Confidence 3455666676666554 33 344433333677777777654 33 333 3467788888888877777633345677888
Q ss_pred Cccccccccc
Q 035917 194 RLKKFSVANN 203 (611)
Q Consensus 194 ~L~~L~l~~N 203 (611)
+|+.+.|..|
T Consensus 311 ~L~~i~lp~~ 320 (379)
T 4h09_A 311 KLSSVTLPTA 320 (379)
T ss_dssp TCCEEECCTT
T ss_pred CCCEEEcCcc
Confidence 8888877543
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.08 E-value=0.97 Score=30.89 Aligned_cols=19 Identities=11% Similarity=0.051 Sum_probs=8.3
Q ss_pred hhhhhhhHHHHHHHHHHHH
Q 035917 245 AIIIAAGIFGAAASMLLAF 263 (611)
Q Consensus 245 ~~ii~~~v~~~~~~~l~~~ 263 (611)
..+++.++++++++++++.
T Consensus 11 ~~IA~gVVgGv~~~~ii~~ 29 (44)
T 2ks1_B 11 PSIATGMVGALLLLLVVAL 29 (44)
T ss_dssp SSSTHHHHHHHHHHHHHHH
T ss_pred ceEEeehhHHHHHHHHHHH
Confidence 3344444444444444443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.36 E-value=1.4 Score=30.01 Aligned_cols=28 Identities=21% Similarity=0.177 Sum_probs=11.9
Q ss_pred hhhhhhhHHHHHHHHHHHHHHHHHhhhhh
Q 035917 245 AIIIAAGIFGAAASMLLAFGLWWWYHLRW 273 (611)
Q Consensus 245 ~~ii~~~v~~~~~~~l~~~~l~~~~~~r~ 273 (611)
..+++.++.+++++++++.. ++++.+|+
T Consensus 10 ~aIA~gVVgGv~~v~ii~~~-~~~~~RRR 37 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVGLT-FAVYVRRK 37 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHH-HHHHHHTT
T ss_pred ceEEEeehHHHHHHHHHHHH-HHHHhhhh
Confidence 44444444444444444433 33344433
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=83.49 E-value=1.9 Score=29.38 Aligned_cols=9 Identities=22% Similarity=0.468 Sum_probs=3.7
Q ss_pred hhhhHHHHH
Q 035917 248 IAAGIFGAA 256 (611)
Q Consensus 248 i~~~v~~~~ 256 (611)
+++++++++
T Consensus 14 Ia~~vVGvl 22 (44)
T 2jwa_A 14 IISAVVGIL 22 (44)
T ss_dssp HHHHHHHHH
T ss_pred hHHHHHHHH
Confidence 333444433
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 611 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-46 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-45 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-45 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-44 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-43 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-41 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-40 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-40 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-39 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-39 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-39 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-38 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-38 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-37 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-37 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-37 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-35 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-35 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-35 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-35 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-34 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-34 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-34 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-34 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-33 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-33 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-33 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-32 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-32 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-31 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-31 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-31 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-30 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-30 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-29 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-29 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-28 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-26 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-25 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-25 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-24 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-24 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-24 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-23 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-23 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-23 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-23 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-23 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-22 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-21 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-21 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-20 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-20 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-19 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-18 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-18 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-17 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-17 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-16 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-15 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.002 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-07 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 8e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 9e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.004 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 9e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 9e-46
Identities = 62/262 (23%), Positives = 106/262 (40%), Gaps = 22/262 (8%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGE---KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394
GT YK +AVK LN + F+NE+ L + RH N+ +GY +
Sbjct: 22 GTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQL 78
Query: 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVI 454
++ ++ +LY L T+ + I A+G+ +LH +H+++ SN I
Sbjct: 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNI 135
Query: 455 LVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEY---SSTMVASLKGDVYGI 511
+ ED +I DFGLA + + S G ++APE S + DVY
Sbjct: 136 FLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAF 195
Query: 512 GVVLLELAG----FKG-NLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCV 566
G+VL EL + N D + + G + K + + + + C+
Sbjct: 196 GIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK--VRSNCPKAMKRLMA---ECL 250
Query: 567 VSRPKDRWSMYQVYQSLNSIAA 588
+ +R Q+ S+ +A
Sbjct: 251 KKKRDERPLFPQILASIELLAR 272
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-45
Identities = 44/249 (17%), Positives = 92/249 (36%), Gaps = 8/249 (3%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397
G +A+K + + E +F E + L H L L G C + +I
Sbjct: 18 GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77
Query: 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD 457
+YM++G L + L+ + + +L FLH+++ + LV+
Sbjct: 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVN 134
Query: 458 EDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLE 517
+ ++ DFGL++ + + +S V G + PE S K D++ GV++ E
Sbjct: 135 DQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWE 193
Query: 518 LAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMY 577
+ + + E I + L + + +C + +R +
Sbjct: 194 IYSLGKMPYERFTN----SETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFK 249
Query: 578 QVYQSLNSI 586
+ ++ +
Sbjct: 250 ILLSNILDV 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 3e-45
Identities = 50/250 (20%), Positives = 99/250 (39%), Gaps = 8/250 (3%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397
G + + +A+K + + E+ F E + +L HP L L G C+ + L+
Sbjct: 19 GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78
Query: 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD 457
+++M G L L+ T + L G + + + +H+++ + LV
Sbjct: 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG---MAYLEEACVIHRDLAARNCLVG 135
Query: 458 EDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLE 517
E+ ++ DFG+ + + D+ + G + +PE S S K DV+ GV++ E
Sbjct: 136 ENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWE 194
Query: 518 LAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMY 577
+ + + E I ++ +C RP+DR +
Sbjct: 195 VFSEGKIPYENRSN----SEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFS 250
Query: 578 QVYQSLNSIA 587
++ + L IA
Sbjct: 251 RLLRQLAEIA 260
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 9e-44
Identities = 60/287 (20%), Positives = 111/287 (38%), Gaps = 36/287 (12%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL-- 395
G ++ G +AVK ++ + E+ + LRH N+ + +
Sbjct: 17 GEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75
Query: 396 --LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGC-----QPPFLHQN 448
L+ Y G+L+ L + ++ L A GLA LH +P H++
Sbjct: 76 LWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 133
Query: 449 ICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV--NGDLGEFGYIAPEYSSTMV----- 501
+ S ILV ++ I D GLA S+ ++ + N +G Y+APE +
Sbjct: 134 LKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF 193
Query: 502 -ASLKGDVYGIGVVLLELA------GFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYD-- 552
+ + D+Y +G+V E+A G + L S S E + K +C +
Sbjct: 194 ESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPN 253
Query: 553 --------EEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591
E + K+ C + R + ++ ++L+ ++ Q G
Sbjct: 254 IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-43
Identities = 57/250 (22%), Positives = 105/250 (42%), Gaps = 10/250 (4%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397
G + + +AVK L + F E N + QL+H L L +E +I
Sbjct: 27 GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYII 85
Query: 398 YKYMSSGTLYSLLQGN-ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV 456
+YM +G+L L+ +L + A G+A++ ++H+++ + ILV
Sbjct: 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILV 142
Query: 457 DEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLL 516
+ +I DFGLA+L+ +E + G + APE + ++K DV+ G++L
Sbjct: 143 SDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLT 201
Query: 517 ELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSM 576
E+ G + ++ E + + EE+ Q ++ C RP+DR +
Sbjct: 202 EIV-THGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR---LCWKERPEDRPTF 257
Query: 577 YQVYQSLNSI 586
+ L
Sbjct: 258 DYLRSVLEDF 267
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 149 bits (376), Expect = 3e-41
Identities = 59/263 (22%), Positives = 120/263 (45%), Gaps = 10/263 (3%)
Query: 338 GTTYKAMLPD-GSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396
G Y+ + +AVK L + ++F E + +++HPNL LLG C E +
Sbjct: 31 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90
Query: 397 IYKYMSSGTLYSLL-QGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVIL 455
I ++M+ G L L + N E+ + + + +L + F+H+++ + L
Sbjct: 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCL 147
Query: 456 VDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVL 515
V E+ ++ DFGL++LMT ++ G + APE + S+K DV+ GV+L
Sbjct: 148 VGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 206
Query: 516 LELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWS 575
E+A + + ++ + E ++K + + + ++ C P DR S
Sbjct: 207 WEIATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPS 262
Query: 576 MYQVYQSLNSIAAQHGFSERYDE 598
+++Q+ ++ + S+ ++
Sbjct: 263 FAEIHQAFETMFQESSISDEVEK 285
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 3e-40
Identities = 63/256 (24%), Positives = 105/256 (41%), Gaps = 26/256 (10%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL-L 396
G G+ +AVK + + F E + + QLRH NL LLG V E+ L +
Sbjct: 21 GDVMLGDY-RGNKVAVKCIKNDAT-AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 78
Query: 397 IYKYMSSGTLYSLLQGN-ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVIL 455
+ +YM+ G+L L+ + L + L + +L F+H+++ + +L
Sbjct: 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVL 135
Query: 456 VDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVL 515
V ED A++ DFGL K +S+ ++ + APE S K DV+ G++L
Sbjct: 136 VSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEALREKKFSTKSDVWSFGILL 190
Query: 516 LELAG-----FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRP 570
E+ + + V G +A D G + + +K NC
Sbjct: 191 WEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD------GCPPAVYEVMK---NCWHLDA 241
Query: 571 KDRWSMYQVYQSLNSI 586
R S Q+ + L I
Sbjct: 242 AMRPSFLQLREQLEHI 257
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 145 bits (367), Expect = 7e-40
Identities = 55/289 (19%), Positives = 107/289 (37%), Gaps = 25/289 (8%)
Query: 316 LADLMAASNSFCSE---------NVIISTRTGTTYKAMLP----DGSVLAVKRLNT--CK 360
D A F E VI + G L +A+K L + +
Sbjct: 9 FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68
Query: 361 LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWP 420
+ F +E + +GQ HPN+ L G ++I ++M +G+L S L+ N +
Sbjct: 69 KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI 128
Query: 421 TRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480
+ G A G+ +L ++H+++ + ILV+ + ++ DFGL++ +
Sbjct: 129 QLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185
Query: 481 FVNGDLGEFG---YIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGR 537
LG + APE + DV+ G+V+ E+ + +
Sbjct: 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ----D 241
Query: 538 SKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586
AI++ + ++ +C R Q+ +L+ +
Sbjct: 242 VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-39
Identities = 54/271 (19%), Positives = 105/271 (38%), Gaps = 15/271 (5%)
Query: 324 NSFCSENVIISTRTGTTYKAMLPDGS-----VLAVKRLNTCKL--GEKKFRNEMNRLGQL 376
+ + VI + G YK ML S +A+K L F E +GQ
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 377 RHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWL 436
H N+ L G + ++I +YM +G L L+ E + G A G +
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG---M 123
Query: 437 HHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV-NGDLGEFGYIAPE 495
+ ++H+++ + ILV+ + ++ DFGL++++ E+++ +G + APE
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 496 YSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEI 555
S + DV+ G+V+ E+ + + S+ +AI+ +
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYG----ERPYWELSNHEVMKAINDGFRLPTPMDCP 239
Query: 556 LQFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586
++ C R + L+ +
Sbjct: 240 SAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-39
Identities = 53/250 (21%), Positives = 101/250 (40%), Gaps = 10/250 (4%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397
G + + +A+K L + + F E + +LRH L L EE ++
Sbjct: 31 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 89
Query: 398 YKYMSSGTLYSLLQGNATEL-DWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV 456
+YMS G+L L+G + P + A G+A++ ++H+++ + ILV
Sbjct: 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILV 146
Query: 457 DEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLL 516
E+ ++ DFGLA+L+ +E + G + APE + ++K DV+ G++L
Sbjct: 147 GENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLT 205
Query: 517 ELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSM 576
EL + + +++ E + C C P++R +
Sbjct: 206 ELTTKGRVPYPGMVNRE----VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTF 261
Query: 577 YQVYQSLNSI 586
+ L
Sbjct: 262 EYLQAFLEDY 271
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 9e-39
Identities = 62/264 (23%), Positives = 101/264 (38%), Gaps = 28/264 (10%)
Query: 338 GTTYKAMLPDGS----VLAVKRLN--TCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE 391
G Y L D AVK LN T +F E + HPN+ LLG C+
Sbjct: 41 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 100
Query: 392 EEK-LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNIC 450
E L++ YM G L + ++ GL A+G+ F+H+++
Sbjct: 101 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLA 157
Query: 451 SNVILVDEDFDARIMDFGLAKLMTSSDESS--FVNGDLGEFGYIAPEYSSTMVASLKGDV 508
+ ++DE F ++ DFGLA+ M + S G ++A E T + K DV
Sbjct: 158 ARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDV 217
Query: 509 YGIGVVLLELAGFKG------NLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVA 562
+ GV+L EL N D L R L + + + + +
Sbjct: 218 WSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL-------LQPEYCPDPLYEVML-- 268
Query: 563 CNCVVSRPKDRWSMYQVYQSLNSI 586
C + + R S ++ +++I
Sbjct: 269 -KCWHPKAEMRPSFSELVSRISAI 291
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 141 bits (355), Expect = 3e-38
Identities = 66/308 (21%), Positives = 115/308 (37%), Gaps = 48/308 (15%)
Query: 315 KLADLMAASNSFCSENVIISTRTGTTYKAMLP------DGSVLAVKRLNTCKL--GEKKF 366
KL L N+ I G ++A P +++AVK L + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 367 RNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATE---------- 416
+ E + + +PN+ LLG C V + L+++YM+ G L L+ +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 417 -------------LDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDAR 463
L + I A G+A+L F+H+++ + LV E+ +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180
Query: 464 IMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG--- 520
I DFGL++ + S+D D ++ PE + + DV+ GVVL E+
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 521 --FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQ 578
+ G + V G C + E+ ++ C P DR S
Sbjct: 241 QPYYGMAHEEVIYYVRDGNILA------CPENCPLELYNLMR---LCWSKLPADRPSFCS 291
Query: 579 VYQSLNSI 586
+++ L +
Sbjct: 292 IHRILQRM 299
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-38
Identities = 52/260 (20%), Positives = 98/260 (37%), Gaps = 24/260 (9%)
Query: 338 GTTYKAML---PDGSVLAVKRLN--TCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE 392
G+ + + +A+K L T K ++ E + QL +P + L+G C E
Sbjct: 23 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AE 81
Query: 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSN 452
+L+ + G L+ L G E+ + + G+ +L F+H+++ +
Sbjct: 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAAR 138
Query: 453 VILVDEDFDARIMDFGLAKLMTSSDESSFVNGDL-GEFGYIAPEYSSTMVASLKGDVYGI 511
+L+ A+I DFGL+K + + D + APE + S + DV+
Sbjct: 139 NVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSY 198
Query: 512 GVVLLELAG-----FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCV 566
GV + E +K V G+ E E+ + +C
Sbjct: 199 GVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP------ECPPELYALMS---DCW 249
Query: 567 VSRPKDRWSMYQVYQSLNSI 586
+ + +DR V Q + +
Sbjct: 250 IYKWEDRPDFLTVEQRMRAC 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 3e-37
Identities = 53/259 (20%), Positives = 105/259 (40%), Gaps = 26/259 (10%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGE---KKFRNEMNRLGQLRHPNLAPLLGYCVVEEE 393
G K DG +L K L+ + E + +E+N L +L+HPN+ +
Sbjct: 18 GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 77
Query: 394 KLL--IYKYMSSGTLYSLLQGNATE---LDWPTRFRIGLGAARGLAWLH--HGCQPPFLH 446
L + +Y G L S++ E LD R+ L H LH
Sbjct: 78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 137
Query: 447 QNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKG 506
+++ + +D + ++ DFGLA+++ + ++SF +G Y++PE + M + K
Sbjct: 138 RDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVGTPYYMSPEQMNRMSYNEKS 195
Query: 507 DVYGIGVVLLELAG----FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVA 562
D++ +G +L EL F + G+ + + Y +E+ + +
Sbjct: 196 DIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR------YSDELNEIIT-- 247
Query: 563 CNCVVSRPKDRWSMYQVYQ 581
+ + R S+ ++ +
Sbjct: 248 -RMLNLKDYHRPSVEEILE 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 3e-37
Identities = 53/261 (20%), Positives = 93/261 (35%), Gaps = 26/261 (9%)
Query: 338 GTTYKAMLPD---GSVLAVKRLNTCKLGE---KKFRNEMNRLGQLRHPNLAPLLGYCVVE 391
GT K +AVK L + E N + QL +P + ++G C
Sbjct: 21 GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-A 79
Query: 392 EEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICS 451
E +L+ + G L LQ N + + + G+ +L F+H+++ +
Sbjct: 80 ESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAA 135
Query: 452 NVILVDEDFDARIMDFGLAKLMTSS-DESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYG 510
+L+ A+I DFGL+K + + + + APE + S K DV+
Sbjct: 136 RNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWS 195
Query: 511 IGVVLLELAG-----FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNC 565
GV++ E ++G V + G C G E+ + C
Sbjct: 196 FGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG------CPAGCPREMYDLMN---LC 246
Query: 566 VVSRPKDRWSMYQVYQSLNSI 586
++R V L +
Sbjct: 247 WTYDVENRPGFAAVELRLRNY 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 9e-37
Identities = 66/294 (22%), Positives = 116/294 (39%), Gaps = 43/294 (14%)
Query: 324 NSFCSENVIISTRTGTTYKAMLPDGSVL---AVKRLN--TCKLGEKKFRNEMNRLGQL-R 377
N ++VI G KA + + A+KR+ K + F E+ L +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 378 HPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGN---------------ATELDWPTR 422
HPN+ LLG C L +Y G L L+ + A+ L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 423 FRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482
ARG+ + Q F+H+++ + ILV E++ A+I DFGL++ + +
Sbjct: 130 LHFAADVARGM---DYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 483 NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKG------NLVDWVNQLSSSG 536
++A E + V + DV+ GV+L E+ G + +L
Sbjct: 187 RLP---VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243
Query: 537 RSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590
R ++ ++ D+E+ ++ C +P +R S Q+ SLN + +
Sbjct: 244 RLEKPLN-------CDDEVYDLMR---QCWREKPYERPSFAQILVSLNRMLEER 287
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-35
Identities = 40/185 (21%), Positives = 84/185 (45%), Gaps = 10/185 (5%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGE--KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394
G +K P G V+A K ++ + E+ L + P + G + E
Sbjct: 20 GVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79
Query: 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVI 454
+ ++M G+L +L+ + ++ + +GL +L +H+++ + I
Sbjct: 80 SICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNI 136
Query: 455 LVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVV 514
LV+ + ++ DFG++ + S +SFV G Y++PE S++ D++ +G+
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHYSVQSDIWSMGLS 192
Query: 515 LLELA 519
L+E+A
Sbjct: 193 LVEMA 197
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (337), Expect = 1e-35
Identities = 60/252 (23%), Positives = 105/252 (41%), Gaps = 22/252 (8%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKK----FRNEMNRLGQLRHPNLAPLLGYCVVEE 392
G Y A + + V+A+K+++ + E+ L +LRHPN G + E
Sbjct: 29 GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88
Query: 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSN 452
L+ +Y L L + GA +GLA+LH +H+++ +
Sbjct: 89 TAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAG 144
Query: 453 VILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTM---VASLKGDVY 509
IL+ E ++ DFG A +M + N +G ++APE M K DV+
Sbjct: 145 NILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVW 198
Query: 510 GIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSR 569
+G+ +ELA K L + N +S+ + AL + E F+ +C+
Sbjct: 199 SLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQSGHWSEYFRNFVD---SCLQKI 254
Query: 570 PKDRWSMYQVYQ 581
P+DR + + +
Sbjct: 255 PQDRPTSEVLLK 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 5e-35
Identities = 56/253 (22%), Positives = 102/253 (40%), Gaps = 19/253 (7%)
Query: 338 GTTYKAMLPD-GSVLAVKRLNTCKLGE---KKFRNEMNRLGQLRHPNLAPLLGYCVVEEE 393
T YK + + +A L KL + ++F+ E L L+HPN+ +
Sbjct: 23 KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 82
Query: 394 K----LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNI 449
+L+ + M+SGTL + L+ + +GL +LH PP +H+++
Sbjct: 83 GKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDL 140
Query: 450 -CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDV 508
C N+ + +I D GLA L +S + + G ++APE DV
Sbjct: 141 KCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFMAPEMYEEKY-DESVDV 195
Query: 509 YGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVS 568
Y G+ +LE+A + + N R + A K E+ + ++ C+
Sbjct: 196 YAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE---GCIRQ 252
Query: 569 RPKDRWSMYQVYQ 581
+R+S+ +
Sbjct: 253 NKDERYSIKDLLN 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 8e-35
Identities = 51/248 (20%), Positives = 93/248 (37%), Gaps = 11/248 (4%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGE--KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394
G A+ +AVK ++ + + + + E+ L H N+ G+ +
Sbjct: 19 GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ 78
Query: 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVI 454
L +Y S G L+ ++ + + P R G+ +LH H++I +
Sbjct: 79 YLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENL 134
Query: 455 LVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEY-SSTMVASLKGDVYGIGV 513
L+DE + +I DFGLA + ++ +N G Y+APE + DV+ G+
Sbjct: 135 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 194
Query: 514 VLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDR 573
VL + + + KE K D L L +V P R
Sbjct: 195 VLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH---KILVENPSAR 251
Query: 574 WSMYQVYQ 581
++ + +
Sbjct: 252 ITIPDIKK 259
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 3e-34
Identities = 55/278 (19%), Positives = 100/278 (35%), Gaps = 32/278 (11%)
Query: 338 GTTYKAML------PDGSVLAVKRLNTCKL--GEKKFRNEMNRLGQL-RHPNLAPLLGYC 388
G +A +AVK L + +E+ L L H N+ LLG C
Sbjct: 37 GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96
Query: 389 VVEEEKLLIYKYMSSGTLYSLLQG-----------------NATELDWPTRFRIGLGAAR 431
+ L+I +Y G L + L+ + LD A+
Sbjct: 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAK 156
Query: 432 GLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGY 491
G+A+L +H+++ + IL+ +I DFGLA+ + + +
Sbjct: 157 GMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKW 213
Query: 492 IAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGY 551
+APE V + + DV+ G+ L EL + + S + + + L +
Sbjct: 214 MAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHA 273
Query: 552 DEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589
E+ +K C + P R + Q+ Q + ++
Sbjct: 274 PAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQISE 308
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 3e-34
Identities = 53/263 (20%), Positives = 93/263 (35%), Gaps = 26/263 (9%)
Query: 338 GTTYKAMLP----DGSVLAVKRLNTCKLGEKK----FRNEMNRLGQLRHPNLAPLLGYCV 389
G + +AVK L L + + F E+N + L H NL L G +
Sbjct: 22 GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81
Query: 390 VEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNI 449
++ + G+L L+ + T R + A G+ +L F+H+++
Sbjct: 82 -TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDL 137
Query: 450 CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDL-GEFGYIAPEYSSTMVASLKGDV 508
+ +L+ +I DFGL + + +D+ + F + APE T S D
Sbjct: 138 AARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDT 197
Query: 509 YGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEIL-----QFLKVAC 563
+ GV L E+ + Q G + I + +G V
Sbjct: 198 WMFGVTLWEMFTYG--------QEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMV 249
Query: 564 NCVVSRPKDRWSMYQVYQSLNSI 586
C +P+DR + + L
Sbjct: 250 QCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 4e-34
Identities = 54/279 (19%), Positives = 97/279 (34%), Gaps = 37/279 (13%)
Query: 338 GTTYKAMLPDGS------VLAVKRLNTCKLGE--KKFRNEMNRLGQL-RHPNLAPLLGYC 388
G A S +AVK L + +E+ + QL H N+ LLG C
Sbjct: 51 GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 110
Query: 389 VVEEEKLLIYKYMSSGTLYSLLQGN----------------------ATELDWPTRFRIG 426
+ LI++Y G L + L+ L +
Sbjct: 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA 170
Query: 427 LGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDL 486
A+G+ +L +H+++ + +LV +I DFGLA+ + S
Sbjct: 171 YQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNAR 227
Query: 487 GEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL 546
++APE + ++K DV+ G++L E+ N + ++ + + K
Sbjct: 228 LPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD 287
Query: 547 CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNS 585
EEI ++ +C + R S + L
Sbjct: 288 QPFYATEEIYIIMQ---SCWAFDSRKRPSFPNLTSFLGC 323
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 4e-34
Identities = 54/262 (20%), Positives = 101/262 (38%), Gaps = 25/262 (9%)
Query: 338 GTTYKAM-LPDGSVL----AVKRLN--TCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVV 390
GT YK + +P+G + A+K L T K+ +E + + +P++ LLG C+
Sbjct: 23 GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL- 81
Query: 391 EEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNIC 450
LI + M G L ++ + + + A+G+ +L +H+++
Sbjct: 82 TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLA 138
Query: 451 SNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYG 510
+ +LV +I DFGLAKL+ + ++ G ++A E + + + DV+
Sbjct: 139 ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWS 198
Query: 511 IGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEI-----LQFLKVACNC 565
GV + EL F G I L KG + + C
Sbjct: 199 YGVTVWELMTFG--------SKPYDGIPASEISSILE-KGERLPQPPICTIDVYMIMVKC 249
Query: 566 VVSRPKDRWSMYQVYQSLNSIA 587
+ R ++ + +A
Sbjct: 250 WMIDADSRPKFRELIIEFSKMA 271
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-33
Identities = 53/256 (20%), Positives = 103/256 (40%), Gaps = 25/256 (9%)
Query: 338 GTTYKAMLPD-GSVLAVKRLNTCKLGE-KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395
G YKA + + A K ++T E + + E++ L HPN+ LL E
Sbjct: 26 GKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 85
Query: 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVIL 455
++ ++ + G + +++ L + L +LH +H+++ + IL
Sbjct: 86 ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNIL 142
Query: 456 VDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEY-----SSTMVASLKGDVYG 510
D D ++ DFG++ T + + + +G ++APE S K DV+
Sbjct: 143 FTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWS 200
Query: 511 IGVVLLELAGFK-----GNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNC 565
+G+ L+E+A + N + + +++ S A + FLK C
Sbjct: 201 LGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-----SRWSSNFKDFLK---KC 252
Query: 566 VVSRPKDRWSMYQVYQ 581
+ RW+ Q+ Q
Sbjct: 253 LEKNVDARWTTSQLLQ 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 4e-33
Identities = 56/253 (22%), Positives = 92/253 (36%), Gaps = 27/253 (10%)
Query: 338 GTTYKAMLP-DGSVLAVKRLNTCKLG----EKKFRNEMNRLGQLRHPNLAPLLGYCVVEE 392
G Y A +LA+K L +L E + R E+ LRHPN+ L GY
Sbjct: 20 GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 79
Query: 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSN 452
LI +Y GT+Y LQ ++ D A L++ H +H++I
Sbjct: 80 RVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPE 135
Query: 453 VILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIG 512
+L+ + +I DFG + SS ++ G Y+ PE + K D++ +G
Sbjct: 136 NLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMHDEKVDLWSLG 191
Query: 513 VVLLELAG----FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVS 568
V+ E F+ N + R + E + +
Sbjct: 192 VLCYEFLVGKPPFEAN--TYQETYKRISRVEFTFP-----DFVTEGARDLIS---RLLKH 241
Query: 569 RPKDRWSMYQVYQ 581
P R + +V +
Sbjct: 242 NPSQRPMLREVLE 254
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 9e-33
Identities = 57/274 (20%), Positives = 107/274 (39%), Gaps = 25/274 (9%)
Query: 338 GTTYKAML------PDGSVLAVKRLNTCKL--GEKKFRNEMNRLGQLRHPNLAPLLGYCV 389
G Y+ + + +A+K +N +F NE + + + ++ LLG
Sbjct: 34 GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93
Query: 390 VEEEKLLIYKYMSSGTLYSLLQ---------GNATELDWPTRFRIGLGAARGLAWLHHGC 440
+ L+I + M+ G L S L+ ++ A G+A+L+
Sbjct: 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-- 151
Query: 441 QPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTM 500
F+H+++ + +V EDF +I DFG+ + + +D L +++PE
Sbjct: 152 -NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG 210
Query: 501 VASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLK 560
V + DV+ GVVL E+A + Q S+ + + + D +
Sbjct: 211 VFTTYSDVWSFGVVLWEIATLA----EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFE 266
Query: 561 VACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFSE 594
+ C PK R S ++ S+ + GF E
Sbjct: 267 LMRMCWQYNPKMRPSFLEIISSIKEE-MEPGFRE 299
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-32
Identities = 52/255 (20%), Positives = 94/255 (36%), Gaps = 15/255 (5%)
Query: 338 GTTYKAMLPD----GSVLAVKRLNTCKLGE--KKFRNEMNRLGQLRHPNLAPLLGYCVVE 391
G ++ + +A+K C +KF E + Q HP++ L+G E
Sbjct: 21 GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79
Query: 392 EEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICS 451
+I + + G L S LQ LD + + LA+L F+H++I +
Sbjct: 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAA 136
Query: 452 NVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGI 511
+LV + ++ DFGL++ M S G ++APE + + DV+
Sbjct: 137 RNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKWMAPESINFRRFTSASDVWMF 195
Query: 512 GVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPK 571
GV + E+ V GR + ++ + + C P
Sbjct: 196 GVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLPMPPNCPPTLYSLMT---KCWAYDPS 251
Query: 572 DRWSMYQVYQSLNSI 586
R ++ L++I
Sbjct: 252 RRPRFTELKAQLSTI 266
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 126 bits (317), Expect = 1e-32
Identities = 48/252 (19%), Positives = 94/252 (37%), Gaps = 20/252 (7%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKK-FRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395
G ++ G+ A K + T +K+ R E+ + LRHP L L + E +
Sbjct: 40 GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 99
Query: 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVIL 455
+IY++MS G L+ + ++ +GL +H ++H ++ I+
Sbjct: 100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIM 156
Query: 456 VDEDFDARIM--DFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGV 513
+ DFGL + G + APE + D++ +GV
Sbjct: 157 FTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAPEVAEGKPVGYYTDMWSVGV 213
Query: 514 VLLELAG----FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSR 569
+ L F G + L + +D + G E+ F++ +++
Sbjct: 214 LSYILLSGLSPFGGE--NDDETLRNVKSCDWNMDDSAF-SGISEDGKDFIR---KLLLAD 267
Query: 570 PKDRWSMYQVYQ 581
P R +++Q +
Sbjct: 268 PNTRMTIHQALE 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 124 bits (311), Expect = 1e-31
Identities = 54/252 (21%), Positives = 96/252 (38%), Gaps = 20/252 (7%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKK-FRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395
G ++ + G V K +NT +K +NE++ + QL HP L L + E +
Sbjct: 43 GVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102
Query: 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVIL 455
LI +++S G L+ + ++ A GL +H + +H +I I+
Sbjct: 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIM 159
Query: 456 VDEDFDARIM--DFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGV 513
+ + + DFGLA + + V + APE D++ IGV
Sbjct: 160 CETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGV 216
Query: 514 VLLELAG----FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSR 569
+ L F G D + L + R D+ E F+K N +
Sbjct: 217 LGYVLLSGLSPFAGE--DDLETLQNVKRCDWEFDEDAF-SSVSPEAKDFIK---NLLQKE 270
Query: 570 PKDRWSMYQVYQ 581
P+ R +++ +
Sbjct: 271 PRKRLTVHDALE 282
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 3e-31
Identities = 51/251 (20%), Positives = 112/251 (44%), Gaps = 22/251 (8%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKK-FRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395
GT Y AM + G +A++++N + +K+ NE+ + + ++PN+ L +V +E
Sbjct: 34 GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93
Query: 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVIL 455
++ +Y++ G+L ++ D + + L +LH +H++I S+ IL
Sbjct: 94 VVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNIL 148
Query: 456 VDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVL 515
+ D ++ DFG +T E S + +G ++APE + K D++ +G++
Sbjct: 149 LGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 206
Query: 516 LELAG----FKG-NLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRP 570
+E+ + N + + ++++G + + FL C+
Sbjct: 207 IEMIEGEPPYLNENPLRALYLIATNGTPELQNP-----EKLSAIFRDFLN---RCLDMDV 258
Query: 571 KDRWSMYQVYQ 581
+ R S ++ Q
Sbjct: 259 EKRGSAKELLQ 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 4e-31
Identities = 42/253 (16%), Positives = 90/253 (35%), Gaps = 23/253 (9%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKK----FRNEMNRLGQLRHPNLAPLLGYCVVEE 392
T A L A+K L + ++ E + + +L HP L +E
Sbjct: 22 STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE 81
Query: 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSN 452
+ Y +G L ++ + D L +LH +H+++
Sbjct: 82 KLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPE 137
Query: 453 VILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIG 512
IL++ED +I DFG AK+++ + + N +G Y++PE + A D++ +G
Sbjct: 138 NILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALG 197
Query: 513 VVLLELAG----FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVS 568
++ +L F+ + + + + + + ++ +V
Sbjct: 198 CIIYQLVAGLPPFRAG--NEYLIFQKIIKLEYDFP-----EKFFPKARDLVE---KLLVL 247
Query: 569 RPKDRWSMYQVYQ 581
R ++
Sbjct: 248 DATKRLGCEEMEG 260
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (298), Expect = 4e-30
Identities = 46/248 (18%), Positives = 89/248 (35%), Gaps = 13/248 (5%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396
G ++ + K + + + E++ L RH N+ L EE ++
Sbjct: 19 GIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78
Query: 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV 456
I++++S ++ + +A EL+ L +LH H +I I+
Sbjct: 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIY 135
Query: 457 DEDFDAR--IMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVV 514
+ I++FG A+ + D + Y APE V S D++ +G +
Sbjct: 136 QTRRSSTIKIIEFGQARQLKPGDNFRLLFTA---PEYYAPEVHQHDVVSTATDMWSLGTL 192
Query: 515 LLELA-GFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDR 573
+ L G L + Q+ + + E K E + F+ +V K R
Sbjct: 193 VYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD---RLLVKERKSR 249
Query: 574 WSMYQVYQ 581
+ + Q
Sbjct: 250 MTASEALQ 257
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 6e-30
Identities = 58/282 (20%), Positives = 103/282 (36%), Gaps = 43/282 (15%)
Query: 338 GTTYKAMLP--------DGSVLAVKRLNTCKL--GEKKFRNEMNRLGQL-RHPNLAPLLG 386
G A + +AVK L + +EM + + +H N+ LLG
Sbjct: 27 GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 86
Query: 387 YCVVEEEKLLIYKYMSSGTLYSLLQ---------------GNATELDWPTRFRIGLGAAR 431
C + +I +Y S G L LQ +L AR
Sbjct: 87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVAR 146
Query: 432 GLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGY 491
G+ + +H+++ + +LV ED +I DFGLA+ + D +
Sbjct: 147 GM---EYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKW 203
Query: 492 IAPEYSSTMVASLKGDVYGIGVVLLELAG-----FKGNLVDWVNQLSSSGRSKEAIDKAL 546
+APE + + + DV+ GV+L E+ + G V+ + +L G +
Sbjct: 204 MAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSN-- 261
Query: 547 CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAA 588
E+ ++ +C + P R + Q+ + L+ I A
Sbjct: 262 ----CTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRIVA 296
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 115 bits (288), Expect = 6e-29
Identities = 50/251 (19%), Positives = 88/251 (35%), Gaps = 17/251 (6%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLG--EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394
A ++A+K + L E NE+ L +++HPN+ L
Sbjct: 23 SEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL 82
Query: 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVI 454
LI + +S G L+ + R+ + +LH +
Sbjct: 83 YLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYY 141
Query: 455 LVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVV 514
+DED I DFGL+K+ D S ++ G GY+APE + S D + IGV+
Sbjct: 142 SLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 198
Query: 515 LLELAG----FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRP 570
L F + +++ D + F++ + + P
Sbjct: 199 AYILLCGYPPFYDE--NDAKLFEQILKAEYEFDSPYW-DDISDSAKDFIR---HLMEKDP 252
Query: 571 KDRWSMYQVYQ 581
+ R++ Q Q
Sbjct: 253 EKRFTCEQALQ 263
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (286), Expect = 6e-29
Identities = 45/273 (16%), Positives = 89/273 (32%), Gaps = 21/273 (7%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396
G Y + G +A+K K + E ++ P + +C E + +
Sbjct: 21 GDIYLGTDIAAGEEVAIKLECV-KTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79
Query: 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV 456
+ + +L L + + T + + ++H F+H+++ + L+
Sbjct: 80 MVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLM 136
Query: 457 ---DEDFDARIMDFGLAKLMTSSDESSFVNGD-----LGEFGYIAPEYSSTMVASLKGDV 508
+ I+DFGLAK + + G Y + + S + D+
Sbjct: 137 GLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDL 196
Query: 509 YGIGVVLLELAG-----FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVAC 563
+G VL+ + K + + KGY E +L
Sbjct: 197 ESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLN--- 253
Query: 564 NCVVSRPKDRWSMYQVYQSLNSIAAQHGFSERY 596
C R D+ + Q ++ + GFS Y
Sbjct: 254 FCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDY 286
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 8e-28
Identities = 47/274 (17%), Positives = 93/274 (33%), Gaps = 31/274 (11%)
Query: 338 GTTYKAM------LPDGSVLAVKRLNTCKL--GEKKFRNEMNRLGQLRHPNLAPLLGYCV 389
G +A +AVK L + +E+ L + H L
Sbjct: 27 GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86
Query: 390 VEEEK--LLIYKYMSSGTLYSLLQGNATE---------------LDWPTRFRIGLGAARG 432
+ ++I ++ G L + L+ E L A+G
Sbjct: 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 146
Query: 433 LAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYI 492
+ +L +H+++ + IL+ E +I DFGLA+ + + ++
Sbjct: 147 MEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 203
Query: 493 APEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYD 552
APE V +++ DV+ GV+L E+ + V R + +
Sbjct: 204 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTT 263
Query: 553 EEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586
E+ Q + +C P R + ++ + L ++
Sbjct: 264 PEMYQTML---DCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 106 bits (265), Expect = 5e-26
Identities = 35/278 (12%), Positives = 83/278 (29%), Gaps = 25/278 (8%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396
G ++ L + +A+K + + R+E L P + Y E +
Sbjct: 19 GVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77
Query: 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILV 456
+ + +L LL + T + +H + ++++I + L+
Sbjct: 78 LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLI 134
Query: 457 DEDF-----DARIMDFGLAKLMTSSDESSFVNGD-----LGEFGYIAPEYSSTMVASLKG 506
++DFG+ K + G Y++ S +
Sbjct: 135 GRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRD 194
Query: 507 DVYGIGVVLLELA----GFKG-NLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKV 561
D+ +G V + ++G + G K++ G+ EE +++
Sbjct: 195 DLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMH- 253
Query: 562 ACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFSE--RYD 597
+ + + + +E +D
Sbjct: 254 --YARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFD 289
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 7e-25
Identities = 37/256 (14%), Positives = 84/256 (32%), Gaps = 31/256 (12%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGE-------KKFRNEMNRLGQLR--HPNLAPLLGY 387
G+ Y + + D +A+K + ++ + + E+ L ++ + LL +
Sbjct: 18 GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 77
Query: 388 CVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQ 447
+ +LI + L + H LH+
Sbjct: 78 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV---RHCHNCGVLHR 134
Query: 448 NICSNVILVDED-FDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEY-SSTMVASLK 505
+I IL+D + + +++DFG L+ + + F G Y PE+
Sbjct: 135 DIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIRYHRYHGRS 190
Query: 506 GDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNC 565
V+ +G++L ++ + + + + E ++ C
Sbjct: 191 AAVWSLGILLYDMV---------CGDIPFEHDEEIIRGQVFFRQRVSSECQHLIR---WC 238
Query: 566 VVSRPKDRWSMYQVYQ 581
+ RP DR + ++
Sbjct: 239 LALRPSDRPTFEEIQN 254
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 102 bits (254), Expect = 9e-25
Identities = 46/253 (18%), Positives = 93/253 (36%), Gaps = 26/253 (10%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKK----FRNEMNRLGQLRHPNLAPLLGYCVVEE 392
+ A L +AVK L + FR E L HP + + E
Sbjct: 21 SEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 80
Query: 393 EKL----LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQN 448
++ +Y+ TL ++ + + A + L + Q +H++
Sbjct: 81 PAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQAL---NFSHQNGIIHRD 136
Query: 449 ICSNVILVDEDFDARIMDFGLAK-LMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGD 507
+ I++ ++MDFG+A+ + S + + +G Y++PE + + D
Sbjct: 137 VKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSD 196
Query: 508 VYGIGVVLLELAG----FKG-NLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVA 562
VY +G VL E+ F G + V Q ++ I + +G ++ +
Sbjct: 197 VYSLGCVLYEVLTGEPPFTGDSPVSVAYQH----VREDPIPPSARHEGLSADLDAVVL-- 250
Query: 563 CNCVVSRPKDRWS 575
+ P++R+
Sbjct: 251 -KALAKNPENRYQ 262
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (254), Expect = 2e-24
Identities = 41/187 (21%), Positives = 76/187 (40%), Gaps = 14/187 (7%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKK----FRNEMNRLGQLRHPNLAPLLGYCVVEE 392
G + +G A+K L + K +E L + HP + + G +
Sbjct: 18 GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ 77
Query: 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSN 452
+ +I Y+ G L+SLL+ + + +F A L + +++++
Sbjct: 78 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYA----AEVCLALEYLHSKDIIYRDLKPE 133
Query: 453 VILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIG 512
IL+D++ +I DFG AK + + G YIAPE ST + D + G
Sbjct: 134 NILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYIAPEVVSTKPYNKSIDWWSFG 188
Query: 513 VVLLELA 519
+++ E+
Sbjct: 189 ILIYEML 195
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 101 bits (251), Expect = 2e-24
Identities = 53/274 (19%), Positives = 99/274 (36%), Gaps = 39/274 (14%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKLGE---KKFRNEMNRLGQLRHPNLAPLLGYCVVEEEK 394
G YKA G A+K++ K E E++ L +L+H N+ L ++
Sbjct: 16 GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRL 75
Query: 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVI 454
+L+++++ L L+ T L G+A+ H LH+++ +
Sbjct: 76 VLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNL 131
Query: 455 LVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPE-YSSTMVASLKGDVYGIGV 513
L++ + + +I DFGLA+ ++ Y AP+ + S D++ +G
Sbjct: 132 LINREGELKIADFGLARAFGIPVRKYT--HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGC 189
Query: 514 VLLELAG----FKG-----------------NLVDWVN-----QLSSSGRSKEAIDKALC 547
+ E+ F G N +W N + + E +
Sbjct: 190 IFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESF 249
Query: 548 GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQ 581
KG DE + L + P R + Q +
Sbjct: 250 LKGLDESGIDLLS---KMLKLDPNQRITAKQALE 280
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 100 bits (250), Expect = 3e-24
Identities = 42/263 (15%), Positives = 91/263 (34%), Gaps = 29/263 (11%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGE----------KKFRNEMNRLGQLR-HPNLAPLL 385
+ + P AVK ++ G + E++ L ++ HPN+ L
Sbjct: 17 SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 76
Query: 386 GYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFL 445
L++ M G L+ L T L +I + LH + +
Sbjct: 77 DTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVICALH---KLNIV 132
Query: 446 HQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFG---YIAPEYSSTMVA 502
H+++ IL+D+D + ++ DFG + + ++ V G +
Sbjct: 133 HRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGY 192
Query: 503 SLKGDVYGIGVVLLELAG----FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQF 558
+ D++ GV++ L F + ++ SG + + Y + +
Sbjct: 193 GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW---DDYSDTVKDL 249
Query: 559 LKVACNCVVSRPKDRWSMYQVYQ 581
+ +V +P+ R++ +
Sbjct: 250 VS---RFLVVQPQKRYTAEEALA 269
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.1 bits (246), Expect = 1e-23
Identities = 47/257 (18%), Positives = 94/257 (36%), Gaps = 23/257 (8%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKK-------FRNEMNRLGQLRHPNLAPLLGYCV 389
K G A K + + + E++ L +++HPN+ L
Sbjct: 24 AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 83
Query: 390 VEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNI 449
+ + +LI + ++ G L+ L + L G+ +LH H ++
Sbjct: 84 NKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLH---SLQIAHFDL 139
Query: 450 CSNVILVDEDFDAR----IMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLK 505
I++ + + I+DFGLA + +E + G ++APE + L+
Sbjct: 140 KPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT---PEFVAPEIVNYEPLGLE 196
Query: 506 GDVYGIGVVLLE-LAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACN 564
D++ IGV+ L+G L D + ++ + + F++
Sbjct: 197 ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR---R 253
Query: 565 CVVSRPKDRWSMYQVYQ 581
+V PK R ++ Q
Sbjct: 254 LLVKDPKKRMTIQDSLQ 270
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.2 bits (246), Expect = 2e-23
Identities = 40/187 (21%), Positives = 75/187 (40%), Gaps = 10/187 (5%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGE---KKFRNEMNRLGQLRHPNLAPLLGYCVVEEE 393
G YKA G V+A+K++ E E++ L +L HPN+ LL E +
Sbjct: 16 GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 75
Query: 394 KLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNV 453
L+++++ + T + P +GLA+ LH+++
Sbjct: 76 LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC---HSHRVLHRDLKPQN 132
Query: 454 ILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPE-YSSTMVASLKGDVYGIG 512
+L++ + ++ DFGLA+ ++ Y APE S D++ +G
Sbjct: 133 LLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 190
Query: 513 VVLLELA 519
+ E+
Sbjct: 191 CIFAEMV 197
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.0 bits (246), Expect = 2e-23
Identities = 50/251 (19%), Positives = 81/251 (32%), Gaps = 26/251 (10%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKK----FRNEMNRLG-QLRHPNLAPLLGYCVVE 391
G + A A+K L + E L HP L + +
Sbjct: 16 GKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 75
Query: 392 EEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICS 451
E + +Y++ G L +Q + D GL +L +++++
Sbjct: 76 ENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFL---HSKGIVYRDLKL 131
Query: 452 NVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGI 511
+ IL+D+D +I DFG+ K D N G YIAPE + D +
Sbjct: 132 DNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSF 189
Query: 512 GVVLLELA----GFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVV 567
GV+L E+ F G D S + ++E L V
Sbjct: 190 GVLLYEMLIGQSPFHGQ--DEEELFHSIRMDNPFYP-----RWLEKEAKDLLV---KLFV 239
Query: 568 SRPKDRWSMYQ 578
P+ R +
Sbjct: 240 REPEKRLGVRG 250
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 6e-23
Identities = 38/190 (20%), Positives = 82/190 (43%), Gaps = 14/190 (7%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGE--KKFRNEMNRLGQLRHPNLAPLLGYC----VV 390
G A + +A+K+++ + ++ E+ L + RH N+ + +
Sbjct: 22 GMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81
Query: 391 EEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNIC 450
+ + + + ++ LY LL+ L RGL ++H LH+++
Sbjct: 82 QMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLK 136
Query: 451 SNVILVDEDFDARIMDFGLAKLMTS-SDESSFVNGDLGEFGYIAPEY-SSTMVASLKGDV 508
+ +L++ D +I DFGLA++ D + F+ + Y APE ++ + D+
Sbjct: 137 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 196
Query: 509 YGIGVVLLEL 518
+ +G +L E+
Sbjct: 197 WSVGCILAEM 206
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 98.7 bits (245), Expect = 6e-23
Identities = 49/264 (18%), Positives = 86/264 (32%), Gaps = 20/264 (7%)
Query: 324 NSFCSENVIISTRTGTTYKAMLPD-GSVLAVKRLNTCKLGEKK-------FRNEMNRLGQ 375
N F +I G Y D G + A+K L+ ++ K+ R ++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 376 LRHPNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAW 435
P + + ++ I M+ G L+ L + + RF GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEH 122
Query: 436 LHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPE 495
+H +++++ IL+DE RI D GLA + + V G GY+APE
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPE 175
Query: 496 YSSTMVA-SLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEE 554
VA D + +G +L +L + + E
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 235
Query: 555 ILQFLKVACNCVVSRPKDRWSMYQ 578
+ L+ + R
Sbjct: 236 LRSLLE---GLLQRDVNRRLGCLG 256
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.5 bits (239), Expect = 1e-22
Identities = 57/277 (20%), Positives = 104/277 (37%), Gaps = 42/277 (15%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKK------FRNEMNRLGQLRHPNLAPLLGYCVV 390
T YKA ++A+K++ E K E+ L +L HPN+ LL
Sbjct: 12 ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 71
Query: 391 EEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNIC 450
+ L++ +M L +++ N+ L L +GL +LH LH+++
Sbjct: 72 KSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLK 127
Query: 451 SNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPE-YSSTMVASLKGDVY 509
N +L+DE+ ++ DFGLAK S + + + Y APE + + D++
Sbjct: 128 PNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ--VVTRWYRAPELLFGARMYGVGVDMW 185
Query: 510 GIGVVLLELAG----FKGN-----------------LVDWVNQLS----SSGRSKEAIDK 544
+G +L EL G+ W + S + +S I
Sbjct: 186 AVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPL 245
Query: 545 ALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQ 581
+++L ++ + P R + Q +
Sbjct: 246 HHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALK 279
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.4 bits (234), Expect = 1e-21
Identities = 41/259 (15%), Positives = 88/259 (33%), Gaps = 28/259 (10%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYC---VVEE 392
G + A+K L C K R E+ + + P++ ++
Sbjct: 26 GKVLQIFNKRTQEKFALKMLQDCP----KARREVELHWRASQCPHIVRIVDVYENLYAGR 81
Query: 393 EKL-LIYKYMSSGTLYSLLQGNATE-LDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNIC 450
+ L ++ + + G L+S +Q + I + +LH H+++
Sbjct: 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVK 138
Query: 451 SNVILVD---EDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGD 507
+L + ++ DFG AK TS + + Y+APE D
Sbjct: 139 PENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY---YVAPEVLGPEKYDKSCD 195
Query: 508 VYGIGVVLLELAG----FKG-NLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVA 562
++ +GV++ L F + + + + R + EE+ ++
Sbjct: 196 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR-- 253
Query: 563 CNCVVSRPKDRWSMYQVYQ 581
N + + P R ++ +
Sbjct: 254 -NLLKTEPTQRMTITEFMN 271
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.2 bits (228), Expect = 7e-21
Identities = 44/206 (21%), Positives = 77/206 (37%), Gaps = 20/206 (9%)
Query: 325 SFCSENVIISTRTGTTYKAMLPD-GSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAP 383
S+ VI + G Y+A L D G ++A+K++ ++ E+ + +L H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFKNRELQIMRKLDHCNIVR 77
Query: 384 LLGYCVVEEEK------LLIYKYMSSGTLYSLLQGNATE--LDWPTRFRIGLGAARGLAW 435
L + EK L+ Y+ + + L R LA+
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 436 LHHGCQPPFLHQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAP 494
+H H++I N++L + ++ DFG AK + + + Y AP
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICSRYYRAP 191
Query: 495 -EYSSTMVASLKGDVYGIGVVLLELA 519
+ DV+ G VL EL
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELL 217
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.9 bits (222), Expect = 2e-20
Identities = 50/278 (17%), Positives = 87/278 (31%), Gaps = 40/278 (14%)
Query: 338 GTTYKA--MLPDGSVLAVKRLNTCKLGEKKFR------NEMNRLGQLRHPNLAPLLGYCV 389
G +KA + G +A+KR+ E + L HPN+ L C
Sbjct: 21 GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 80
Query: 390 VEEEKLLIYKYM-----SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPF 444
V + L + + T + RGL +LH
Sbjct: 81 VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---V 137
Query: 445 LHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASL 504
+H+++ ILV ++ DFGLA++ + + V L Y APE +
Sbjct: 138 VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL---WYRAPEVLLQSSYAT 194
Query: 505 KGDVYGIGVVLLELAG----FKG-----------------NLVDWVNQLSSSGRSKEAID 543
D++ +G + E+ F+G DW ++ ++ +
Sbjct: 195 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKS 254
Query: 544 KALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQ 581
K + + C+ P R S Y
Sbjct: 255 AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.8 bits (222), Expect = 3e-20
Identities = 49/248 (19%), Positives = 80/248 (32%), Gaps = 25/248 (10%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKK----FRNEMNRLGQLRHPNLAPLLGYCVVEE 392
G G A+K L + K E L RHP L L +
Sbjct: 19 GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 78
Query: 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSN 452
+ +Y + G L+ L T R A ++ L + ++++I
Sbjct: 79 RLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLE 134
Query: 453 VILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIG 512
+++D+D +I DFGL K S + G Y+APE D +G+G
Sbjct: 135 NLMLDKDGHIKITDFGLCKEGISDGATMKTF--CGTPEYLAPEVLEDNDYGRAVDWWGLG 192
Query: 513 VVLLELAG----FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVS 568
VV+ E+ F + + +L + + E L +
Sbjct: 193 VVMYEMMCGRLPFYNQDHERLFELILMEEIR-------FPRTLSPEAKSLLA---GLLKK 242
Query: 569 RPKDRWSM 576
PK R
Sbjct: 243 DPKQRLGG 250
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.1 bits (212), Expect = 6e-19
Identities = 36/197 (18%), Positives = 72/197 (36%), Gaps = 19/197 (9%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGE---KKFRNEMNRLGQLRHPNLAPLLGYCVVEEE 393
G +KA G +A+K++ E E+ L L+H N+ L+ C +
Sbjct: 24 GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 83
Query: 394 K--------LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFL 445
L++ + L + R+ GL ++ + L
Sbjct: 84 PYNRCKGSIYLVFDFCEHDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYI---HRNKIL 139
Query: 446 HQNICSNVILVDEDFDARIMDFGLAKLMTSSDES--SFVNGDLGEFGYIAPE-YSSTMVA 502
H+++ + +L+ D ++ DFGLA+ + + S + + Y PE
Sbjct: 140 HRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDY 199
Query: 503 SLKGDVYGIGVVLLELA 519
D++G G ++ E+
Sbjct: 200 GPPIDLWGAGCIMAEMW 216
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.1 bits (207), Expect = 3e-18
Identities = 42/192 (21%), Positives = 80/192 (41%), Gaps = 22/192 (11%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGE---KKFRNEMNRLGQLRHPNLAPLLGYCVVEE- 392
G A+ G+ +A+K+L E K+ E+ L +RH N+ LL +E
Sbjct: 32 GAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 91
Query: 393 -----EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQ 447
+ L+ +M + + L + +GL ++H H+
Sbjct: 92 LDDFTDFYLVMPFMGTDLGKLMKHEK---LGEDRIQFLVYQMLKGLRYIHAAGII---HR 145
Query: 448 NICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPE-YSSTMVASLKG 506
++ + V+ED + +I+DFGLA+ S + G + Y APE + M +
Sbjct: 146 DLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTV 200
Query: 507 DVYGIGVVLLEL 518
D++ +G ++ E+
Sbjct: 201 DIWSVGCIMAEM 212
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.3 bits (202), Expect = 6e-18
Identities = 31/186 (16%), Positives = 66/186 (35%), Gaps = 9/186 (4%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGE---KKFRNEMNRLGQLRHPNLAPLLGYCVVEEE 393
GT +KA ++A+KR+ E E+ L +L+H N+ L +++
Sbjct: 16 GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75
Query: 394 KLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNV 453
L++++ N + + L L LH+++
Sbjct: 76 LTLVFEFCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQN 131
Query: 454 ILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGV 513
+L++ + + ++ +FGLA+ + + S D++ G
Sbjct: 132 LLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGC 190
Query: 514 VLLELA 519
+ ELA
Sbjct: 191 IFAELA 196
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.2 bits (202), Expect = 1e-17
Identities = 49/257 (19%), Positives = 87/257 (33%), Gaps = 27/257 (10%)
Query: 338 GTTYKAML----PDGSVLAVKRLNTCKLGEKK-----FRNEMNRLGQLRH-PNLAPLLGY 387
G + G + A+K L + +K R E L +R P L L
Sbjct: 38 GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 97
Query: 388 CVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQ 447
E + LI Y++ G L++ L + T + + + L H + +++
Sbjct: 98 FQTETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKLGIIYR 153
Query: 448 NICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPE--YSSTMVASLK 505
+I IL+D + + DFGL+K +DE+ G Y+AP+
Sbjct: 154 DIKLENILLDSNGHVVLTDFGLSKEFV-ADETERAYDFCGTIEYMAPDIVRGGDSGHDKA 212
Query: 506 GDVYGIGVVLLELAG----FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKV 561
D + +GV++ EL F + S K + ++
Sbjct: 213 VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP---YPQEMSALAKDLIQ- 268
Query: 562 ACNCVVSRPKDRWSMYQ 578
++ PK R
Sbjct: 269 --RLLMKDPKKRLGCGP 283
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 82.2 bits (202), Expect = 1e-17
Identities = 36/187 (19%), Positives = 71/187 (37%), Gaps = 14/187 (7%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKK----FRNEMNRLGQLRHPNLAPLLGYCVVEE 392
G G+ A+K L+ K+ + K NE L + P L L
Sbjct: 55 GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 393 EKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSN 452
++ +Y++ G ++S L+ P +LH +++++
Sbjct: 115 NLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPE 170
Query: 453 VILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIG 512
+L+D+ ++ DFG AK + + G +APE + + D + +G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWTLC-----GTPEALAPEIILSKGYNKAVDWWALG 225
Query: 513 VVLLELA 519
V++ E+A
Sbjct: 226 VLIYEMA 232
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 78.7 bits (193), Expect = 1e-16
Identities = 32/186 (17%), Positives = 66/186 (35%), Gaps = 14/186 (7%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLR-HPNLAPLLGYCVVEEEKL 395
++A+ + + + VK L K +KK + E+ L LR PN+ L +
Sbjct: 49 SEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106
Query: 396 --LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNV 453
L+++++++ L Q L + L + H NV
Sbjct: 107 PALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNV 160
Query: 454 ILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGV 513
++ E R++D+GLA+ E + + + D++ +G
Sbjct: 161 MIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA--SRYFKGPELLVDYQMYDYSLDMWSLGC 218
Query: 514 VLLELA 519
+L +
Sbjct: 219 MLASMI 224
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.2 bits (181), Expect = 6e-15
Identities = 36/190 (18%), Positives = 75/190 (39%), Gaps = 18/190 (9%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGE---KKFRNEMNRLGQLRHPNLAPLLGYCV---- 389
G+ A G +AVK+L+ K+ E+ L ++H N+ LL
Sbjct: 32 GSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91
Query: 390 -VEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQN 448
E + + ++ L ++++ +L + RGL ++H H++
Sbjct: 92 LEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADII---HRD 146
Query: 449 ICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDV 508
+ + + V+ED + +I+DFGLA+ + + M + D+
Sbjct: 147 LKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT----RWYRAPEIMLNWMHYNQTVDI 202
Query: 509 YGIGVVLLEL 518
+ +G ++ EL
Sbjct: 203 WSVGCIMAEL 212
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 73.1 bits (178), Expect = 2e-14
Identities = 28/199 (14%), Positives = 66/199 (33%), Gaps = 19/199 (9%)
Query: 338 GTTYKAM-LPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396
T + A + + + +A+K + K+ + +E+ L ++ + KLL
Sbjct: 27 STVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86
Query: 397 IY---------------KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQ 441
+ + + L + + + +I GL ++H +
Sbjct: 87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH--RR 144
Query: 442 PPFLHQNI-CSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTM 500
+H +I NV++ D ++ +A L + + Y +PE
Sbjct: 145 CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGA 204
Query: 501 VASLKGDVYGIGVVLLELA 519
D++ ++ EL
Sbjct: 205 PWGCGADIWSTACLIFELI 223
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 70.0 bits (170), Expect = 2e-13
Identities = 31/130 (23%), Positives = 49/130 (37%), Gaps = 25/130 (19%)
Query: 100 NLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIP-------------------AQI 140
+L+L ++S P L + L L AN +S P
Sbjct: 245 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISP 302
Query: 141 CNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSV 200
+ L L L L N++S P + + T L L +NNK+S L+NL + S
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVSS--LANLTNINWLSA 358
Query: 201 ANNDLTGTIP 210
+N ++ P
Sbjct: 359 GHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 67.3 bits (163), Expect = 1e-12
Identities = 24/86 (27%), Positives = 41/86 (47%), Gaps = 7/86 (8%)
Query: 118 FCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILS 177
K++ L L N++S P + L L L +NN +S + L N T +N L
Sbjct: 305 NLKNLTYLTLYFNNISDISP---VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAG 359
Query: 178 NNKLSGPIPYQLSNLGRLKKFSVANN 203
+N++S P L+NL R+ + + +
Sbjct: 360 HNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 49.6 bits (117), Expect = 6e-07
Identities = 25/92 (27%), Positives = 40/92 (43%), Gaps = 7/92 (7%)
Query: 119 CKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSN 178
+++ L + N +S P I L L L+ N L L + T L L L+N
Sbjct: 196 LTNLESLIATNNQISDITPLGILTNLDEL---SLNGNQLKDIGT--LASLTNLTDLDLAN 250
Query: 179 NKLSGPIPYQLSNLGRLKKFSVANNDLTGTIP 210
N++S P LS L +L + + N ++ P
Sbjct: 251 NQISNLAP--LSGLTKLTELKLGANQISNISP 280
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 3e-04
Identities = 14/75 (18%), Positives = 27/75 (36%), Gaps = 7/75 (9%)
Query: 124 RLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSG 183
+ L +++ + + + L L + G + L + SNN+L+
Sbjct: 26 KTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQLTD 80
Query: 184 PIPYQLSNLGRLKKF 198
P L NL +L
Sbjct: 81 ITP--LKNLTKLVDI 93
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 3e-04
Identities = 12/55 (21%), Positives = 20/55 (36%), Gaps = 5/55 (9%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNN 155
L K+S L ++ L N +S P + N L + L L++
Sbjct: 334 LFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LAN-LTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 38.4 bits (88), Expect = 0.002
Identities = 15/68 (22%), Positives = 25/68 (36%), Gaps = 6/68 (8%)
Query: 144 LPYLVLLDLSNNDLSGPIP-ADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVAN 202
L + L +++ + DL T L L + G + L L + + +N
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSN 75
Query: 203 NDLTGTIP 210
N LT P
Sbjct: 76 NQLTDITP 83
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 65.5 bits (158), Expect = 3e-12
Identities = 27/96 (28%), Positives = 36/96 (37%), Gaps = 22/96 (22%)
Query: 139 QICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKF 198
L LDL NN + G +P L +L++L +S N L G IP Q NL R
Sbjct: 238 GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVS 296
Query: 199 SVANNDLTGTIPSSFKGFDKADFDGNSDLCGGPLGS 234
+ + N LCG PL +
Sbjct: 297 A---------------------YANNKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 63.6 bits (153), Expect = 2e-11
Identities = 47/168 (27%), Positives = 71/168 (42%), Gaps = 6/168 (3%)
Query: 49 EDDVKCLEGVKSSLNDPQRKLSSWSFGNSTIGFICQFVGVSCWNDKEN-RILNLELREMK 107
D + L +K L +P LSSW ++GV C D + R+ NL+L +
Sbjct: 5 PQDKQALLQIKKDLGNPTT-LSSWLPTTDCCN--RTWLGVLCDTDTQTYRVNNLDLSGLN 61
Query: 108 LSGK--IPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADL 165
L IP L + L + + L L L +++ ++SG IP L
Sbjct: 62 LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL 121
Query: 166 GNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213
L TL S N LSG +P +S+L L + N ++G IP S+
Sbjct: 122 SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 50.5 bits (119), Expect = 2e-07
Identities = 22/100 (22%), Positives = 35/100 (35%), Gaps = 8/100 (8%)
Query: 72 WSFGNSTIGFICQFVGVSCWNDKENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSAND 131
+ L+LR ++ G +P+ L K + L++S N+
Sbjct: 220 DKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 132 LSGNIPAQICNWLPYLVLLDLSNNDL--SGPIPADLGNCT 169
L G IP L + +NN P+PA CT
Sbjct: 280 LCGEIPQ--GGNLQRFDVSAYANNKCLCGSPLPA----CT 313
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 54.8 bits (131), Expect = 3e-09
Identities = 19/164 (11%), Positives = 41/164 (25%), Gaps = 27/164 (16%)
Query: 338 GTTYKAMLPDGSVLAVKRLNTCKL-----------GEKKFRNEMNRLGQLRHPNLAPLLG 386
+ VK G+ F R + L L G
Sbjct: 14 SAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG 73
Query: 387 YCVVE----EEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQP 442
V + E ++ + + + + +A +H
Sbjct: 74 LAVPKVYAWEGNAVLMELID--------AKELYRVRVENPDEVLDMILEEVAKFYH---R 122
Query: 443 PFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDL 486
+H ++ +LV + I+DF + + + D+
Sbjct: 123 GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDV 165
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.4 bits (134), Expect = 4e-09
Identities = 21/126 (16%), Positives = 38/126 (30%), Gaps = 10/126 (7%)
Query: 71 SWSFGNSTIGFICQFVGVSCWNDKENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSAN 130
+ + + + S +I S++ L++S N
Sbjct: 235 YLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNN 294
Query: 131 DLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLS 190
L +PA L L S N L+ +P N L+ + N L P
Sbjct: 295 KLI-ELPALPPR----LERLIASFNHLAE-VPELPQNLKQLH---VEYNPLRE-FPDIPE 344
Query: 191 NLGRLK 196
++ L+
Sbjct: 345 SVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.9 bits (86), Expect = 0.003
Identities = 20/86 (23%), Positives = 32/86 (37%), Gaps = 5/86 (5%)
Query: 139 QICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKF 198
I + L L N S I + L L +SNNKL +P + RL++
Sbjct: 254 NIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LP---ALPPRLERL 309
Query: 199 SVANNDLTGTIPSSFKGFDKADFDGN 224
+ N L +P + + + N
Sbjct: 310 IASFNHLA-EVPELPQNLKQLHVEYN 334
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.5 bits (85), Expect = 0.004
Identities = 13/64 (20%), Positives = 22/64 (34%), Gaps = 6/64 (9%)
Query: 118 FCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILS 177
+ L+L+ LS + P+L L S N L+ +P + L +
Sbjct: 36 LDRQAHELELNNLGLS-----SLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNN 89
Query: 178 NNKL 181
L
Sbjct: 90 LKAL 93
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.3 bits (129), Expect = 2e-08
Identities = 27/109 (24%), Positives = 47/109 (43%), Gaps = 5/109 (4%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNK 180
++ + S L +P + P LLDL NN ++ D N L+TLIL NNK
Sbjct: 11 HLRVVQCSDLGLE-KVPKDL---PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK 66
Query: 181 LSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKADFDGNSDLCG 229
+S P + L +L++ ++ N L +P + +++
Sbjct: 67 ISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITK 114
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 53.5 bits (127), Expect = 3e-08
Identities = 26/127 (20%), Positives = 37/127 (29%), Gaps = 1/127 (0%)
Query: 115 PLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTL 174
P LDL N ++ N L L L L NN +S P L L
Sbjct: 26 PKDLPPDTALLDLQNNKITEIKDGDFKN-LKNLHTLILINNKISKISPGAFAPLVKLERL 84
Query: 175 ILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKADFDGNSDLCGGPLGS 234
LS N+L L L+ + ++ + + N G
Sbjct: 85 YLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG 144
Query: 235 KCGGLSK 241
G+ K
Sbjct: 145 AFQGMKK 151
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 47.0 bits (110), Expect = 3e-06
Identities = 26/158 (16%), Positives = 53/158 (33%), Gaps = 27/158 (17%)
Query: 81 FICQFVGVSCWNDKENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQI 140
I + + ++ L +K SG + K + + ++ +++ IP +
Sbjct: 111 EITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL 169
Query: 141 CNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSG----------------- 183
P L L L N ++ A L L L LS N +S
Sbjct: 170 ---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 226
Query: 184 ------PIPYQLSNLGRLKKFSVANNDLTGTIPSSFKG 215
+P L++ ++ + NN+++ + F
Sbjct: 227 NNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 31/124 (25%), Positives = 51/124 (41%), Gaps = 10/124 (8%)
Query: 100 NLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG 159
L L K++ LK ++ +L LS N +S + N P+L L L+NN L
Sbjct: 175 ELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT-PHLRELHLNNNKLV- 232
Query: 160 PIPADLGNCTYLNTLILSNNKLSG------PIPYQLSNLGRLKKFSVANNDLTGT--IPS 211
+P L + Y+ + L NN +S P + S+ +N + PS
Sbjct: 233 KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 292
Query: 212 SFKG 215
+F+
Sbjct: 293 TFRC 296
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.8 bits (127), Expect = 3e-08
Identities = 17/91 (18%), Positives = 33/91 (36%), Gaps = 4/91 (4%)
Query: 121 SMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG----PIPADLGNCTYLNTLIL 176
+Q LD+ +LS A++ L ++ L + L+ I + L L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTG 207
+N+L + + + + L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 4e-06
Identities = 17/94 (18%), Positives = 33/94 (35%), Gaps = 14/94 (14%)
Query: 100 NLELREMKLSGK------IPEPLKFCKSMQRLDLSANDLSGNIPAQICNWL---PYLVLL 150
+L+++ + + + E L + Q + L L+ I + L P L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 151 DLSNNDLSGPIPADLG-----NCTYLNTLILSNN 179
+L +N+L + + L L N
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 5e-05
Identities = 19/102 (18%), Positives = 30/102 (29%), Gaps = 14/102 (13%)
Query: 89 SCWNDKENRILNLELREMKLSGK----IPEPLKFCKSMQRLDLSANDLSGNIPAQICNWL 144
+ + L L + +S + L S++ LDLS N L Q+ +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 145 P----YLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLS 182
L L L + S + L L L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMED------RLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 6e-05
Identities = 18/87 (20%), Positives = 31/87 (35%), Gaps = 9/87 (10%)
Query: 141 CNWLPYLVLLDLSNNDLSG----PIPADLGNCTYLNTLILSNNKLSGPIPYQLS-----N 191
L +L L++ D+S + A L L L LSNN L QL
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 192 LGRLKKFSVANNDLTGTIPSSFKGFDK 218
L++ + + + + + +K
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.6 bits (122), Expect = 1e-07
Identities = 15/92 (16%), Positives = 40/92 (43%), Gaps = 4/92 (4%)
Query: 123 QRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLS 182
Q LDL+ +L ++ ++ + ++ + + P+ + + + + LSN+ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQG--VIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIE 59
Query: 183 G-PIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213
+ LS +L+ S+ L+ I ++
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTL 91
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (107), Expect = 8e-06
Identities = 19/100 (19%), Positives = 36/100 (36%), Gaps = 4/100 (4%)
Query: 101 LELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG- 159
L+L L + L + + + + + + +DLSN+ +
Sbjct: 5 LDLTGKNLHPDVTGRL-LSQGVIAFRCPRSFMDQPLAEHFS--PFRVQHMDLSNSVIEVS 61
Query: 160 PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFS 199
+ L C+ L L L +LS PI L+ L + +
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.4 bits (98), Expect = 9e-05
Identities = 20/82 (24%), Positives = 32/82 (39%), Gaps = 4/82 (4%)
Query: 97 RILNLELREMKLSGK-IPEPLKFCKSM---QRLDLSANDLSGNIPAQICNWLPYLVLLDL 152
R+L+ + + + +PL S Q +DLS + + + I + L L L
Sbjct: 19 RLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL 78
Query: 153 SNNDLSGPIPADLGNCTYLNTL 174
LS PI L + L L
Sbjct: 79 EGLRLSDPIVNTLAKNSNLVRL 100
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.0 bits (84), Expect = 0.004
Identities = 26/134 (19%), Positives = 47/134 (35%), Gaps = 4/134 (2%)
Query: 81 FICQFVGVSCWNDKENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQI 140
V V+ ++ ++ R+ + ++ C ++ LDLS + + N Q
Sbjct: 136 EKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQE 195
Query: 141 CNWLPYLVLLDLSN-NDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFS 199
L YL L LS D+ +LG L TL + G + L L+
Sbjct: 196 FFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ--- 252
Query: 200 VANNDLTGTIPSSF 213
+ + T +
Sbjct: 253 INCSHFTTIARPTI 266
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.6 bits (119), Expect = 2e-07
Identities = 31/130 (23%), Positives = 50/130 (38%), Gaps = 3/130 (2%)
Query: 100 NLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSG 159
+L L ++S + S+ RL L N ++ P L L+ L L N+LS
Sbjct: 157 HLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR-DLGRLMTLYLFANNLSA 215
Query: 160 PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKA 219
L L L L++N L+KF +++++ ++P G D
Sbjct: 216 LPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAGRDLK 274
Query: 220 DFDGNSDLCG 229
N DL G
Sbjct: 275 RLAAN-DLQG 283
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.2 bits (109), Expect = 8e-07
Identities = 29/120 (24%), Positives = 38/120 (31%), Gaps = 25/120 (20%)
Query: 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPA------------------ 138
R+L+L +++ + L+ + LDLS N L PA
Sbjct: 1 RVLHLAHKDLT----VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE 56
Query: 139 --QICNWLPYLVLLDLSNNDL-SGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRL 195
LP L L L NN L L +C L L L N L Q L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.9 bits (108), Expect = 9e-07
Identities = 25/108 (23%), Positives = 37/108 (34%), Gaps = 27/108 (25%)
Query: 123 QRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNT--------- 173
+ L L+ DL+ + + L + LDLS+N L PA L L
Sbjct: 1 RVLHLAHKDLT--VLCHLEQ-LLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALE 56
Query: 174 -------------LILSNNKL-SGPIPYQLSNLGRLKKFSVANNDLTG 207
L+L NN+L L + RL ++ N L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 3e-05
Identities = 12/63 (19%), Positives = 23/63 (36%), Gaps = 3/63 (4%)
Query: 141 CNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSV 200
+ + + ++ +L+ +P DL L LS N L L RL + ++
Sbjct: 6 VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 201 ANN 203
Sbjct: 63 DRA 65
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (100), Expect = 4e-05
Identities = 14/62 (22%), Positives = 22/62 (35%), Gaps = 4/62 (6%)
Query: 119 CKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSN 178
S ++ +L+ +P + +L LS N L A L T L L L
Sbjct: 9 VASHLEVNCDKRNLT-ALPPDL---PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 179 NK 180
+
Sbjct: 65 AE 66
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 4e-05
Identities = 10/47 (21%), Positives = 16/47 (34%)
Query: 134 GNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNK 180
+P + + V+LD+S + L N L N K
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 0.001
Identities = 15/73 (20%), Positives = 24/73 (32%), Gaps = 3/73 (4%)
Query: 139 QICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKF 198
N L NN+L + L +S ++ Y L NL +L+
Sbjct: 171 CAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR 230
Query: 199 SVANNDLTGTIPS 211
S N +P+
Sbjct: 231 STYNL---KKLPT 240
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 7e-05
Identities = 19/66 (28%), Positives = 29/66 (43%), Gaps = 5/66 (7%)
Query: 113 PEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLN 172
PL + L N +S P + + LP L+ + L NN +S P L N + L
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LAS-LPNLIEVHLKNNQISDVSP--LANTSNLF 220
Query: 173 TLILSN 178
+ L+N
Sbjct: 221 IVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 1e-04
Identities = 16/56 (28%), Positives = 25/56 (44%), Gaps = 4/56 (7%)
Query: 147 LVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVAN 202
L L +N +S P L + L + L NN++S P L+N L ++ N
Sbjct: 175 LTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.6 bits (98), Expect = 9e-05
Identities = 15/87 (17%), Positives = 29/87 (33%), Gaps = 12/87 (13%)
Query: 118 FCKSMQRLDLSANDLSGNIPAQICNWL-----PYLVLLDLSNNDLSGPIPADL-----GN 167
+++ L L+ LS A + + L L L N++ L
Sbjct: 241 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 300
Query: 168 CTYLNTLILSNNKLS--GPIPYQLSNL 192
L L L+ N+ S + ++ +
Sbjct: 301 MPDLLFLELNGNRFSEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.001
Identities = 14/90 (15%), Positives = 28/90 (31%), Gaps = 3/90 (3%)
Query: 95 ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWL---PYLVLLD 151
E + L L+ + + L S++ + LS N + + + L + +
Sbjct: 6 EGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAE 65
Query: 152 LSNNDLSGPIPADLGNCTYLNTLILSNNKL 181
S+ L +L KL
Sbjct: 66 FSDIFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (84), Expect = 0.002
Identities = 22/111 (19%), Positives = 35/111 (31%), Gaps = 10/111 (9%)
Query: 107 KLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQIC-NWLPYLVLLDLSNNDLSGPIPADL 165
++ + + + L+LS N L P L +L+LS N+L D
Sbjct: 52 SMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDK 111
Query: 166 GNCTYLNTLILSNNKLSGPIP-------YQLSNLGRLKKFSVANNDLTGTI 209
L L L N LS +L + ++L I
Sbjct: 112 IKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD--GHELPPPI 160
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.003
Identities = 12/94 (12%), Positives = 31/94 (32%), Gaps = 13/94 (13%)
Query: 126 DLSANDLSGNIPAQICNWLP-----YLVLLDLSNNDLSGPIP-ADLGNCTYLNTLILSNN 179
L + ++ +P I + +L ++ + +L + + +N+
Sbjct: 2 PLGSETIT--VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQII---ANNS 56
Query: 180 KLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSF 213
+ + L + K + N LT P +
Sbjct: 57 DIKSVQG--IQYLPNVTKLFLNGNKLTDIKPLAN 88
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.3 bits (82), Expect = 0.004
Identities = 17/117 (14%), Positives = 35/117 (29%), Gaps = 7/117 (5%)
Query: 89 SCWNDKENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLV 148
R + L +++ L + ++ + L L
Sbjct: 6 CPHGSSGLRCTRDGALD------SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELR 59
Query: 149 LLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDL 205
L + + L P L+ L LS N L + ++ L++ ++ N L
Sbjct: 60 NLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPL 115
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 611 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.94 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.67 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.64 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.56 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.44 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.36 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.34 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.26 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.23 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.23 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.18 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.17 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.17 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.1 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.05 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.04 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.94 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.9 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.88 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.86 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.84 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.82 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.81 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.8 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.79 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.7 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.63 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.46 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.46 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.22 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.2 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.17 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.1 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.02 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.02 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.85 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.82 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.76 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.69 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.64 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.32 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.16 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.15 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.75 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.37 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.99 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.86 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 94.57 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=428.20 Aligned_cols=251 Identities=22% Similarity=0.328 Sum_probs=199.9
Q ss_pred cCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCCC
Q 035917 325 SFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSSG 404 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~g 404 (611)
+|...+.||+|+||.||+|++.+++.||||+++......++|.+|++++++++|||||+++|+|..++..++|||||++|
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g 85 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 85 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCC
Confidence 56667899999999999999989999999999877777789999999999999999999999999999999999999999
Q ss_pred ChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccC
Q 035917 405 TLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNG 484 (611)
Q Consensus 405 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 484 (611)
+|.+++......++|..++.++.|||+||+||| +.+|+||||||+|||+|+++.+||+|||+++........ ....
T Consensus 86 ~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~ 161 (263)
T d1sm2a_ 86 CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTG 161 (263)
T ss_dssp BHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred cHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCce-eecc
Confidence 999999876667999999999999999999999 789999999999999999999999999999876543322 2233
Q ss_pred CCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCH-HH-----HHHHHhhcCChhhhhchhhcCCCCHHHHHHH
Q 035917 485 DLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNL-VD-----WVNQLSSSGRSKEAIDKALCGKGYDEEILQF 558 (611)
Q Consensus 485 ~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~-~~-----~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 558 (611)
..||+.|+|||++.+..++.++|||||||++|||+++..|+ .. ........ .. ...+...++++.+
T Consensus 162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~------~~-~~~p~~~~~~l~~- 233 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG------FR-LYKPRLASTHVYQ- 233 (263)
T ss_dssp ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT------CC-CCCCTTSCHHHHH-
T ss_pred eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc------CC-CCCccccCHHHHH-
Confidence 46899999999999999999999999999999999865443 11 11111110 00 0112233445554
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 559 LKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 559 ~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
++.+||+.||++||||+||+++|+++++.
T Consensus 234 --li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 234 --IMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp --HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 55599999999999999999999999764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-53 Score=426.51 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=200.1
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEecccc---chhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTC---KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~---~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
++|...+.||+|+||+||+|++. ..||||+++.. ....++|.+|+++|++++|||||+++|++.+ +..++||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 56888899999999999999864 36999999643 2345789999999999999999999998754 568999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
|++|+|.+++......++|..++.++.||++||+||| +.+|+||||||+|||++.++.+||+|||+|+.........
T Consensus 85 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 85 CEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp CCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 9999999999866667999999999999999999999 7899999999999999999999999999998765433333
Q ss_pred cccCCCcccccccccccCC---CCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCChhhhhchhh--cCCC
Q 035917 481 FVNGDLGEFGYIAPEYSST---MVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGRSKEAIDKAL--CGKG 550 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~~~~~~~~~l--~~~~ 550 (611)
......||+.|||||++.+ ..++.++|||||||++|||++|+.||.+. .......+. ..+.+ ....
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~----~~p~~~~~~~~ 237 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY----LSPDLSKVRSN 237 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTS----CCCCGGGSCTT
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC----CCCcchhcccc
Confidence 3445579999999999864 35899999999999999999999987431 111111111 11111 1222
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 551 YDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 551 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
.++++.+++. +||+.||++||||+||+++|+.+.+..
T Consensus 238 ~~~~l~~li~---~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 238 CPKAMKRLMA---ECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp CCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred chHHHHHHHH---HHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 3445555554 999999999999999999999998764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-52 Score=427.42 Aligned_cols=265 Identities=22% Similarity=0.331 Sum_probs=199.4
Q ss_pred ccHHHHHHhhhcCC---------CCCeeeecCCceEEEEEeC-CC---CEEEEEeccccc--hhHHHHHHHHHHHhccCC
Q 035917 314 VKLADLMAASNSFC---------SENVIISTRTGTTYKAMLP-DG---SVLAVKRLNTCK--LGEKKFRNEMNRLGQLRH 378 (611)
Q Consensus 314 ~~~~~l~~~t~~f~---------~~~~ig~G~~g~Vy~~~~~-~g---~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H 378 (611)
++++|+..++.+|. ..++||+|+||+||+|++. ++ ..||||++.... ...++|.+|+++|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 45556666665554 3578999999999999964 23 368999986532 334679999999999999
Q ss_pred CCccceeeEEEeCCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC
Q 035917 379 PNLAPLLGYCVVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE 458 (611)
Q Consensus 379 ~nIv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~ 458 (611)
||||+++|+|..++..++|||||++|+|.+++......++|.+++.++.||++||+||| +.+|+||||||+|||++.
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~ 163 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNS 163 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECT
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECC
Confidence 99999999999999999999999999999999876667999999999999999999999 789999999999999999
Q ss_pred CCCeEEeecccccccCCCCCCc---cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhh
Q 035917 459 DFDARIMDFGLAKLMTSSDESS---FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSS 534 (611)
Q Consensus 459 ~~~~kl~DFGla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~ 534 (611)
++++||+|||+++.+....... ......||+.|||||.+.+..++.++|||||||++|||++ |+.||.+.....
T Consensus 164 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~-- 241 (299)
T d1jpaa_ 164 NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-- 241 (299)
T ss_dssp TCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--
T ss_pred CCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH--
Confidence 9999999999999775433211 1223458999999999999999999999999999999997 787774321110
Q ss_pred cCChhhhhchhh---cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 535 SGRSKEAIDKAL---CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 535 ~~~~~~~~~~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
....+.... .....++++.+ ++.+||+.||++||||.||+++|+++.+.
T Consensus 242 ---~~~~i~~~~~~~~~~~~~~~l~~---li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 242 ---VINAIEQDYRLPPPMDCPSALHQ---LMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ---HHHHHHTTCCCCCCTTCCHHHHH---HHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---HHHHHHcCCCCCCCccchHHHHH---HHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 001111111 11223444444 55599999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-52 Score=418.86 Aligned_cols=256 Identities=21% Similarity=0.320 Sum_probs=204.8
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
++|...+.||+|+||.||+|++.+++.||||+++......++|.+|+++|++++|||||+++|++.+ +..++|||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCC
Confidence 4667778999999999999999888999999998776677889999999999999999999998754 567999999999
Q ss_pred CChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccc
Q 035917 404 GTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482 (611)
Q Consensus 404 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 482 (611)
|+|.+++.... ..++|..+++|+.||++||.||| +.+|+||||||+|||+++++.+||+|||+|+.+.... ....
T Consensus 92 g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~~~ 167 (272)
T d1qpca_ 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAR 167 (272)
T ss_dssp CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EECC
T ss_pred CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCc-cccc
Confidence 99999886543 26999999999999999999999 7899999999999999999999999999999875433 2223
Q ss_pred cCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHH
Q 035917 483 NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVA 562 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~ 562 (611)
....||+.|||||++.+..++.++|||||||++|||++++.|+..................+ ..+...++++.+ ++
T Consensus 168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~-~~p~~~~~~l~~---li 243 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-VRPDNCPEELYQ---LM 243 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-CCCTTCCHHHHH---HH
T ss_pred cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-CCcccChHHHHH---HH
Confidence 34568999999999998899999999999999999999765432100000000000000111 112234455555 45
Q ss_pred hhcccCCCCCCCCHHHHHHHHHHchh
Q 035917 563 CNCVVSRPKDRWSMYQVYQSLNSIAA 588 (611)
Q Consensus 563 ~~Cl~~dP~~RPs~~evl~~L~~i~~ 588 (611)
.+||+.||++||||+||++.|+++-.
T Consensus 244 ~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 244 RLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 59999999999999999999998654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=412.02 Aligned_cols=254 Identities=17% Similarity=0.269 Sum_probs=210.3
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
++|...+.||+|+||+||+|+.++++.||||+++......++|.+|+.++++++|||||+++|+|.+++..++||||+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 57888899999999999999998899999999988777788999999999999999999999999999999999999999
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcccc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVN 483 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 483 (611)
|+|.+++......+++..+.+++.|+++||+||| +.+|+||||||+|||+++++.+||+|||+++........ ...
T Consensus 84 g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~ 159 (258)
T d1k2pa_ 84 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSV 159 (258)
T ss_dssp EEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCC
T ss_pred CcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCce-eec
Confidence 9999998766567999999999999999999999 789999999999999999999999999999876543322 233
Q ss_pred CCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHHHHHHHH
Q 035917 484 GDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEILQFLKVA 562 (611)
Q Consensus 484 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~ 562 (611)
...||+.|+|||.+.+..++.++|||||||++|||++ |+.||.......... .+.+... ...+...++++.+++.
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~-~i~~~~~-~~~p~~~~~~l~~li~-- 235 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE-HIAQGLR-LYRPHLASEKVYTIMY-- 235 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH-HHHTTCC-CCCCTTCCHHHHHHHH--
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHH-HHHhCCC-CCCcccccHHHHHHHH--
Confidence 4569999999999999999999999999999999998 677764321111000 0000000 1112233445555544
Q ss_pred hhcccCCCCCCCCHHHHHHHHHHc
Q 035917 563 CNCVVSRPKDRWSMYQVYQSLNSI 586 (611)
Q Consensus 563 ~~Cl~~dP~~RPs~~evl~~L~~i 586 (611)
+||+.||++|||++||+++|.+|
T Consensus 236 -~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 236 -SCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -HTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -HHccCCHhHCcCHHHHHHHhhCC
Confidence 99999999999999999999764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.3e-52 Score=421.17 Aligned_cols=255 Identities=23% Similarity=0.379 Sum_probs=208.7
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccC
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
++|...+.||+|+||+||+|++. +|+.||||+++......++|.+|+++|++++|||||+++|+|.+++..++|||||+
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 96 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 96 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeeccc
Confidence 46777789999999999999975 58899999998776677889999999999999999999999999999999999999
Q ss_pred CCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 403 SGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 403 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
+|+|.+++.... ..++|..++.++.||++||+||| +.+|+||||||+|||+++++.+||+|||+|+....... ..
T Consensus 97 ~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~-~~ 172 (287)
T d1opja_ 97 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TA 172 (287)
T ss_dssp TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS-EE
T ss_pred CcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCCc-ee
Confidence 999999997543 47999999999999999999999 78999999999999999999999999999997754332 22
Q ss_pred ccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh---cCCCCHHHHHHH
Q 035917 482 VNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL---CGKGYDEEILQF 558 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l---~~~~~~~~~~~l 558 (611)
.....||+.|+|||++.+..++.++|||||||++|||++++.|+...... ....+.+.... .....++++.+
T Consensus 173 ~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~----~~~~~~i~~~~~~~~~~~~~~~l~~- 247 (287)
T d1opja_ 173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVYE- 247 (287)
T ss_dssp ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HHHHHHHHTTCCCCCCTTCCHHHHH-
T ss_pred eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH----HHHHHHHhcCCCCCCCccchHHHHH-
Confidence 23345889999999999999999999999999999999976654210000 00111111111 11234445555
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 559 LKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 559 ~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
++.+||+.||++||||+||++.|+.+.++
T Consensus 248 --li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 248 --LMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp --HHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred --HHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 45599999999999999999999987654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=415.68 Aligned_cols=260 Identities=20% Similarity=0.294 Sum_probs=198.0
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCC-----CEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDG-----SVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLL 396 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g-----~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~l 396 (611)
+.|+..++||+|+||.||+|++.+. ..||||+++... ...++|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 3466778999999999999996532 479999996533 334579999999999999999999999999999999
Q ss_pred EEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCC
Q 035917 397 IYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~ 476 (611)
|||||.+|++.+++......++|..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999999999988766667999999999999999999999 789999999999999999999999999999976543
Q ss_pred CC-CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHH
Q 035917 477 DE-SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEI 555 (611)
Q Consensus 477 ~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 555 (611)
.. ........||+.|||||++.++.++.++|||||||++|||+++..|+...... ....+.+.............
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~----~~~~~~i~~~~~~~~~~~~~ 239 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HEVMKAINDGFRLPTPMDCP 239 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHHTTCCCCCCTTCB
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH----HHHHHHHhccCCCCCchhhH
Confidence 32 12223346899999999999999999999999999999999876554210000 00111111111111111122
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
..+.+++.+||+.||++||||.||++.|+++.+..
T Consensus 240 ~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 240 SAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 33445555999999999999999999999988753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-52 Score=415.98 Aligned_cols=249 Identities=20% Similarity=0.250 Sum_probs=199.1
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
++|...+.||+|+||+||+|+. .+|+.||||+++... ...+++.+|+++|++++|||||++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 4688889999999999999996 579999999996543 2345799999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
|++|+|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+|||+++++.+||+|||+|+.........
T Consensus 85 ~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 85 CSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 9999999999754 46999999999999999999999 7899999999999999999999999999999875443333
Q ss_pred cccCCCcccccccccccCCCCC-CcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhc---CCCCHHHHH
Q 035917 481 FVNGDLGEFGYIAPEYSSTMVA-SLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALC---GKGYDEEIL 556 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~---~~~~~~~~~ 556 (611)
.....+||+.|||||++.+..+ +.++|||||||++|||++|+.||........ ........... ....++++.
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~ 237 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---EYSDWKEKKTYLNPWKKIDSAPL 237 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH---HHHHHHTTCTTSTTGGGSCHHHH
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH---HHHHHhcCCCCCCccccCCHHHH
Confidence 3445679999999999988776 5789999999999999999988732100000 00000010000 112345555
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++++ +||+.||++|||++|+++|
T Consensus 238 ~li~---~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 238 ALLH---KILVENPSARITIPDIKKD 260 (271)
T ss_dssp HHHH---HHSCSSTTTSCCHHHHTTC
T ss_pred HHHH---HHcCCChhHCcCHHHHhcC
Confidence 5555 9999999999999999764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=409.55 Aligned_cols=254 Identities=19% Similarity=0.291 Sum_probs=202.3
Q ss_pred cCCCCCe-eeecCCceEEEEEeC---CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 325 SFCSENV-IISTRTGTTYKAMLP---DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 325 ~f~~~~~-ig~G~~g~Vy~~~~~---~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
+|...++ ||+|+||.||+|.+. ++..||||+++... ...++|.+|+++|++++|||||+++|+|.. +..++||
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm 87 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 87 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEE
Confidence 4445554 999999999999853 35589999996532 345789999999999999999999999865 5689999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
|||++|+|.+++......+++..+..++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 88 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 999999999998766667999999999999999999999 78999999999999999999999999999998754332
Q ss_pred C-ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchh---hcCCCCHH
Q 035917 479 S-SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKA---LCGKGYDE 553 (611)
Q Consensus 479 ~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~---l~~~~~~~ 553 (611)
. .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.... .....+... ..+...++
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-----~~~~~i~~~~~~~~p~~~~~ 239 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-----EVMAFIEQGKRMECPPECPP 239 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-----HHHHHHHTTCCCCCCTTCCH
T ss_pred ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-----HHHHHHHcCCCCCCCCcCCH
Confidence 2 12233468999999999998899999999999999999997 78887431100 001111110 11223344
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 554 EILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 554 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
++.+ ++.+||+.||++||||.+|++.|+.+....
T Consensus 240 ~l~~---li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 240 ELYA---LMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp HHHH---HHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHH---HHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 5555 555999999999999999999999876553
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-50 Score=407.23 Aligned_cols=243 Identities=20% Similarity=0.315 Sum_probs=202.1
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
+.|...+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++|++++|||||++++++.+++..++|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 3688889999999999999995 579999999986543 34577999999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
++|+|.+++.+. .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.+..... .
T Consensus 100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K 172 (293)
T ss_dssp TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--C
T ss_pred CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc--c
Confidence 999999988754 5899999999999999999999 78999999999999999999999999999997754322 2
Q ss_pred ccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHH-----HHHhhcCChhhhhchhh-cCCCCHHHH
Q 035917 482 VNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWV-----NQLSSSGRSKEAIDKAL-CGKGYDEEI 555 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~-----~~~~~~~~~~~~~~~~l-~~~~~~~~~ 555 (611)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ....... .+.+ .....++++
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~------~~~~~~~~~~s~~~ 246 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG------TPELQNPEKLSAIF 246 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC------SCCCSSGGGSCHHH
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC------CCCCCCcccCCHHH
Confidence 234579999999999999999999999999999999999999874311 1111000 0001 112234556
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+++. +||+.||++|||+.|+++|
T Consensus 247 ~~li~---~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 247 RDFLN---RCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HHHHH---HHTCSSTTTSCCHHHHTTC
T ss_pred HHHHH---HHccCChhHCcCHHHHhcC
Confidence 66555 9999999999999999876
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-50 Score=403.31 Aligned_cols=244 Identities=23% Similarity=0.265 Sum_probs=201.7
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 4688889999999999999996 468999999986432 23467899999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
|||++|+|.+++... ..+++..+..++.||++||+||| +.+|+||||||+|||++.++.+||+|||+|+......
T Consensus 86 Ey~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 86 EYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp ECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred eecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 999999999999754 35999999999999999999999 7899999999999999999999999999998764332
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-hcCCCCHHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-LCGKGYDEEILQ 557 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~~~ 557 (611)
.....||+.|||||++.+..++.++|||||||++|||++|+.||........ ...+.... ..+...++++.+
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~ 233 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET----YKRISRVEFTFPDFVTEGARD 233 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHTTCCCCCTTSCHHHHH
T ss_pred ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH----HHHHHcCCCCCCccCCHHHHH
Confidence 2234699999999999999999999999999999999999998742100000 00011111 112334566666
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++. +||+.||++|||++|+++|
T Consensus 234 li~---~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 234 LIS---RLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp HHH---HHTCSSGGGSCCHHHHHTC
T ss_pred HHH---HHccCCHhHCcCHHHHHcC
Confidence 666 9999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-50 Score=406.02 Aligned_cols=251 Identities=23% Similarity=0.377 Sum_probs=200.4
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
++|...+.||+|+||.||+|++.+++.||||+++......+.|.+|+.++++++|||||+++|+|. .+..++|||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCC
Confidence 467888999999999999999988889999999877777788999999999999999999999985 4568999999999
Q ss_pred CChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccc
Q 035917 404 GTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482 (611)
Q Consensus 404 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 482 (611)
|+|.+++.... ..++|..++.|+.||+.||+||| +.+|+||||||+|||+|+++++||+|||+++....... ...
T Consensus 96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~ 171 (285)
T d1fmka3 96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TAR 171 (285)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCc-eee
Confidence 99999886543 46999999999999999999999 78999999999999999999999999999987643332 222
Q ss_pred cCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHH------HHHHHhhcCChhhhhchhhcCCCCHHHHH
Q 035917 483 NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVD------WVNQLSSSGRSKEAIDKALCGKGYDEEIL 556 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 556 (611)
....||+.|+|||++..+.++.++|||||||++|||++++.|+.. ...... .+ .... .....++++.
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-~~-----~~~~-~~~~~~~~l~ 244 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RG-----YRMP-CPPECPESLH 244 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TT-----CCCC-CCTTSCHHHH
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-hc-----CCCC-CCcccCHHHH
Confidence 334689999999999999999999999999999999987655321 111111 11 1111 1223345555
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
+ ++.+||+.||++||+|++|++.|++....
T Consensus 245 ~---li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 245 D---LMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp H---HHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred H---HHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 5 45599999999999999999999986654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-50 Score=413.15 Aligned_cols=251 Identities=22% Similarity=0.284 Sum_probs=200.2
Q ss_pred hcCCCCCeeeecCCceEEEEEeCC-C-----CEEEEEeccccc--hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCee
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPD-G-----SVLAVKRLNTCK--LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEK 394 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~-g-----~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~ 394 (611)
++|...+.||+|+||+||+|+... + ..||||.+.... .....+.+|+.+|.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 567788999999999999998532 2 379999986532 2346799999999998 899999999999999999
Q ss_pred EEEEeccCCCChHHhhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 035917 395 LLIYKYMSSGTLYSLLQGNA----------------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSN 452 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~ 452 (611)
++|||||++|+|.++++... ..++|..++.++.||++||+||| +.+|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchh
Confidence 99999999999999997542 24899999999999999999999 789999999999
Q ss_pred eEEeCCCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHH
Q 035917 453 VILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQ 531 (611)
Q Consensus 453 NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~ 531 (611)
|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||++ |+.||.+...
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~- 272 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV- 272 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH-
Confidence 99999999999999999987755444333344568999999999999999999999999999999997 7888743100
Q ss_pred HhhcCChhhhhchhh---cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHH
Q 035917 532 LSSSGRSKEAIDKAL---CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLN 584 (611)
Q Consensus 532 ~~~~~~~~~~~~~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 584 (611)
.....+.+.... .+...++++.+++. +||+.||++||||+||+++|.
T Consensus 273 ---~~~~~~~~~~~~~~~~p~~~~~~l~~li~---~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 ---DANFYKLIQNGFKMDQPFYATEEIYIIMQ---SCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp ---SHHHHHHHHTTCCCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHH
T ss_pred ---HHHHHHHHhcCCCCCCCCcCCHHHHHHHH---HHcCCChhHCcCHHHHHHHHh
Confidence 000111111111 12234455555555 999999999999999999996
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=401.88 Aligned_cols=245 Identities=21% Similarity=0.272 Sum_probs=193.4
Q ss_pred CeeeecCCceEEEEEeCC---CCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccCC
Q 035917 330 NVIISTRTGTTYKAMLPD---GSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMSS 403 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~---g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~~ 403 (611)
+.||+|+||.||+|.+.+ ++.||||+++... ...++|.+|+++|++++|||||+++|+|.. +..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998643 5689999996532 234679999999999999999999999864 457899999999
Q ss_pred CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc-cc
Q 035917 404 GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS-FV 482 (611)
Q Consensus 404 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~-~~ 482 (611)
|+|.+++... ..++|..++.++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++.+....... ..
T Consensus 92 g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 9999999765 46999999999999999999999 7899999999999999999999999999999775433221 22
Q ss_pred cCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchh---hcCCCCHHHHHHH
Q 035917 483 NGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKA---LCGKGYDEEILQF 558 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~---l~~~~~~~~~~~l 558 (611)
....||+.|||||.+.+..++.++|||||||++|||++ |+.||.+..... ....+... ..+...++++.+
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-----~~~~i~~~~~~~~p~~~~~~~~~- 241 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----VTAMLEKGERMGCPAGCPREMYD- 241 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHHHTTCCCCCCTTCCHHHHH-
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-----HHHHHHcCCCCCCCcccCHHHHH-
Confidence 23468999999999999999999999999999999997 788874321110 01111111 112233455555
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHHHch
Q 035917 559 LKVACNCVVSRPKDRWSMYQVYQSLNSIA 587 (611)
Q Consensus 559 ~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 587 (611)
++.+||+.||++||||++|++.|+..-
T Consensus 242 --li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 242 --LMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp --HHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --HHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 455999999999999999999887753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=408.40 Aligned_cols=246 Identities=20% Similarity=0.276 Sum_probs=198.6
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccC
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
.|...+.||+|+||.||+|+. .+|+.||||+++... ...+.+.+|+++|++++|||||++++++.+++..++|||||+
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~ 92 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 92 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence 467778999999999999996 569999999996543 344679999999999999999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccc
Q 035917 403 SGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482 (611)
Q Consensus 403 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 482 (611)
+|+|.+++.+....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+..... ....
T Consensus 93 ~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~~ 167 (288)
T d2jfla1 93 GGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRR 167 (288)
T ss_dssp TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHHH
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCC--cccc
Confidence 99999998755557999999999999999999999 789999999999999999999999999999765321 1122
Q ss_pred cCCCcccccccccccC-----CCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc---hhh-cCCCCHH
Q 035917 483 NGDLGEFGYIAPEYSS-----TMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID---KAL-CGKGYDE 553 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~---~~l-~~~~~~~ 553 (611)
....||+.|||||++. ...|+.++|||||||++|||++|+.||.+.... .....+.. +.+ .....++
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~s~ 243 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM----RVLLKIAKSEPPTLAQPSRWSS 243 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG----GHHHHHHHSCCCCCSSGGGSCH
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH----HHHHHHHcCCCCCCCccccCCH
Confidence 3457999999999873 456899999999999999999999987431100 00001110 001 1122345
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 554 EILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 554 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++.++++ +||+.||++|||+.|+++|
T Consensus 244 ~~~~li~---~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 244 NFKDFLK---KCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHHHHH---HHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHH---HHccCChhHCcCHHHHhcC
Confidence 5555555 9999999999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=398.47 Aligned_cols=243 Identities=22% Similarity=0.285 Sum_probs=189.6
Q ss_pred CCCeeeecCCceEEEEEeC-CCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEe----CCeeEEEEe
Q 035917 328 SENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVV----EEEKLLIYK 399 (611)
Q Consensus 328 ~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~----~~~~~lv~e 399 (611)
..+.||+|+||+||+|+.. +++.||+|++.... ...+.|.+|+++|++++|||||++++++.+ +...++|||
T Consensus 13 ~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE 92 (270)
T d1t4ha_ 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 92 (270)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEe
Confidence 3467999999999999964 68899999986543 234679999999999999999999999875 345789999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCeEEeC-CCCCeEEeecccccccCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPP--FLHQNICSNVILVD-EDFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlkp~NILld-~~~~~kl~DFGla~~~~~~ 476 (611)
||++|+|.+++... ..+++..+..++.||++||+||| +.+ |+||||||+|||++ +++.+||+|||+|+.....
T Consensus 93 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 93 LMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred CCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 99999999999754 46899999999999999999999 555 99999999999996 5789999999999865332
Q ss_pred CCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHH
Q 035917 477 DESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEIL 556 (611)
Q Consensus 477 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 556 (611)
. ....+||+.|||||++.+ +++.++|||||||++|||++|+.||.+................+.......++++.
T Consensus 169 ~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 243 (270)
T d1t4ha_ 169 F----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 243 (270)
T ss_dssp S----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHH
T ss_pred c----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHH
Confidence 1 223479999999999865 69999999999999999999999984311000000000000111111122344555
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++++ +||+.||++|||+.|+++|
T Consensus 244 ~li~---~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 244 EIIE---GCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp HHHH---HHSCSSGGGSCCHHHHHTS
T ss_pred HHHH---HHccCCHhHCcCHHHHhCC
Confidence 5555 9999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9e-50 Score=408.39 Aligned_cols=259 Identities=24% Similarity=0.350 Sum_probs=206.3
Q ss_pred HHHHhhhcCCCCCeeeecCCceEEEEEeC------CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEE
Q 035917 318 DLMAASNSFCSENVIISTRTGTTYKAMLP------DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCV 389 (611)
Q Consensus 318 ~l~~~t~~f~~~~~ig~G~~g~Vy~~~~~------~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~ 389 (611)
+++-..++|...+.||+|+||+||+|+.. +++.||||+++... ...++|.+|+++|++++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 33334678889999999999999999853 46799999997543 23467999999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHhhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 035917 390 VEEEKLLIYKYMSSGTLYSLLQGNA-----------------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLH 446 (611)
Q Consensus 390 ~~~~~~lv~ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 446 (611)
..+..++||||+++|+|.+++.... ..++|..++.|+.|++.||+||| +.+|+|
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEe
Confidence 9999999999999999999986321 24899999999999999999999 789999
Q ss_pred cCCCCCeEEeCCCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCC-CH
Q 035917 447 QNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKG-NL 525 (611)
Q Consensus 447 rDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~-~~ 525 (611)
|||||+|||+|.++.+||+|||+|+.+.............||+.|+|||.+.+..++.++|||||||++|||+++.. |+
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 99999999999999999999999987654433333345578999999999999999999999999999999998864 44
Q ss_pred HHHH----HHHhhcCChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchh
Q 035917 526 VDWV----NQLSSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAA 588 (611)
Q Consensus 526 ~~~~----~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 588 (611)
.... ......+. .+. .+...+.+ +.+|+.+||+.||++||||.||+++|++|.+
T Consensus 244 ~~~~~~e~~~~v~~~~-----~~~-~p~~~~~~---~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 244 YGMAHEEVIYYVRDGN-----ILA-CPENCPLE---LYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp TTSCHHHHHHHHHTTC-----CCC-CCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCHHHHHHHHHcCC-----CCC-CCccchHH---HHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 3210 01111110 001 11223334 4556669999999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-50 Score=403.20 Aligned_cols=250 Identities=20% Similarity=0.306 Sum_probs=188.8
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch---hHHHHHHHHHHHhccCCCCccceeeEEEe--CCeeEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL---GEKKFRNEMNRLGQLRHPNLAPLLGYCVV--EEEKLLI 397 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~--~~~~~lv 397 (611)
++|...+.||+|+||.||+|+. .+|+.||||+++.... ..+.+.+|+++|++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5788889999999999999995 5799999999965432 33568999999999999999999999875 4557899
Q ss_pred EeccCCCChHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeecCCCCCeEEeCCCCCeEEeecccccc
Q 035917 398 YKYMSSGTLYSLLQGN---ATELDWPTRFRIGLGAARGLAWLHHGC--QPPFLHQNICSNVILVDEDFDARIMDFGLAKL 472 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlkp~NILld~~~~~kl~DFGla~~ 472 (611)
||||++|+|.+++... ...+++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998642 246999999999999999999999531 24599999999999999999999999999998
Q ss_pred cCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh--hcCCC
Q 035917 473 MTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA--LCGKG 550 (611)
Q Consensus 473 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~ 550 (611)
+.... .......||+.|||||++.+..++.++|||||||++|||++|+.||........ ...+.... ..+..
T Consensus 164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~----~~~i~~~~~~~~~~~ 237 (269)
T d2java1 164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL----AGKIREGKFRRIPYR 237 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHTCCCCCCTT
T ss_pred cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH----HHHHHcCCCCCCCcc
Confidence 75432 222345799999999999999999999999999999999999988742111100 00011111 11233
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 551 YDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 551 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.++++.++++ +||+.||++|||+.|+++|
T Consensus 238 ~s~~l~~li~---~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 238 YSDELNEIIT---RMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp SCHHHHHHHH---HHTCSSGGGSCCHHHHHTS
T ss_pred cCHHHHHHHH---HHcCCChhHCcCHHHHHhC
Confidence 4566666665 9999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=403.09 Aligned_cols=248 Identities=17% Similarity=0.212 Sum_probs=199.4
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++|++++|||||++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4688889999999999999996 579999999996432 23467999999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
|||++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 88 Ey~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 999999999988754 46999999999999999999999 78999999999999999999999999999998754433
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhh-cCCCCHHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKAL-CGKGYDEEILQ 557 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~ 557 (611)
.......+||+.|||||++.+..++.++|||||||++|||++|+.||........ ...+..... .+...++++.+
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~ 239 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI----FQKIIKLEYDFPEKFFPKARD 239 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHTTCCCCCTTCCHHHHH
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH----HHHHHcCCCCCCccCCHHHHH
Confidence 3334455799999999999999999999999999999999999998742100000 000111000 12234556666
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+++ +||+.||++|||++|++++
T Consensus 240 li~---~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 240 LVE---KLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp HHH---TTSCSSGGGSTTSGGGTCH
T ss_pred HHH---HHccCCHhHCcCHHHHcCC
Confidence 655 9999999999999997654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-49 Score=406.77 Aligned_cols=196 Identities=20% Similarity=0.326 Sum_probs=174.0
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEecccc--chhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTC--KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
.++|...+.||+|+||+||+|+. .+|+.||+|+++.. ....+++.+|+.+|++++|||||+++++|.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 56788889999999999999995 57899999999653 2335679999999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
||++|+|.+++.+. ..+++..+..++.|++.||.|||+ ..+|+||||||+|||+++++.+||+|||+|+......
T Consensus 85 y~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-- 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 159 (322)
T ss_dssp CCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT--
T ss_pred cCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc--
Confidence 99999999999754 359999999999999999999994 2489999999999999999999999999999764322
Q ss_pred ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCH
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNL 525 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~ 525 (611)
....+||+.|+|||++.+..|+.++||||+||++|||++|+.||
T Consensus 160 --~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf 203 (322)
T d1s9ja_ 160 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203 (322)
T ss_dssp --C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCS
T ss_pred --cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 23347999999999999999999999999999999999999887
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=397.47 Aligned_cols=255 Identities=24% Similarity=0.333 Sum_probs=202.4
Q ss_pred CCeeeecCCceEEEEEeCCC----CEEEEEecccc--chhHHHHHHHHHHHhccCCCCccceeeEEEe-CCeeEEEEecc
Q 035917 329 ENVIISTRTGTTYKAMLPDG----SVLAVKRLNTC--KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVV-EEEKLLIYKYM 401 (611)
Q Consensus 329 ~~~ig~G~~g~Vy~~~~~~g----~~vAvK~~~~~--~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~-~~~~~lv~ey~ 401 (611)
.++||+|+||+||+|++.++ ..||||+++.. ....++|.+|+++|++++|||||+++|+|.. ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 37899999999999997442 36999999643 2334779999999999999999999999876 45789999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC--
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES-- 479 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~-- 479 (611)
++|+|.+++......+++..+++++.|+++||.||| +.+|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999877667899999999999999999999 789999999999999999999999999999976543321
Q ss_pred ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc--hhhcCCCCHHHHHH
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID--KALCGKGYDEEILQ 557 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~ 557 (611)
.......||+.|+|||.+.+..++.++||||||+++|||++++.|+....... .....+.. ....+...++++.+
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~---~~~~~i~~g~~~~~p~~~~~~l~~ 265 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYLLQGRRLLQPEYCPDPLYE 265 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHHHHTTCCCCCCTTCCHHHHH
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH---HHHHHHHcCCCCCCcccCcHHHHH
Confidence 22233568999999999999999999999999999999999877653321111 00111110 01112233445555
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCC
Q 035917 558 FLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGF 592 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 592 (611)
++.+||+.||++||+|.||+++|+++.+.+..
T Consensus 266 ---li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 266 ---VMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp ---HHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred ---HHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 55599999999999999999999999877544
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-49 Score=404.24 Aligned_cols=253 Identities=20% Similarity=0.315 Sum_probs=198.8
Q ss_pred cCCCCCeeeecCCceEEEEEeC-CCC----EEEEEecccc--chhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEE
Q 035917 325 SFCSENVIISTRTGTTYKAMLP-DGS----VLAVKRLNTC--KLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~~-~g~----~vAvK~~~~~--~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
+|...++||+|+||+||+|++. +|+ .||||+++.. ....++|.+|++++++++|||||+++|+|.++ ..+++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v 88 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 88 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence 5778899999999999999853 444 6899988643 23457899999999999999999999999865 56788
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
+||+.+|+|.+++......+++..+++++.||++||+||| +.+|+||||||+|||++.++.+||+|||+|+......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 9999999999988877668999999999999999999999 7899999999999999999999999999999876544
Q ss_pred CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhc---CCCCHH
Q 035917 478 ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALC---GKGYDE 553 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~---~~~~~~ 553 (611)
.........||+.|+|||++.++.++.++|||||||++|||++ |+.||..... ......+..... +...++
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-----~~~~~~i~~~~~~~~p~~~~~ 240 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISSILEKGERLPQPPICTI 240 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-----GGHHHHHHHTCCCCCCTTBCH
T ss_pred ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHcCCCCCCCcccCH
Confidence 3333344568999999999999999999999999999999998 5666632110 111112211111 122344
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 554 EILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 554 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
++.+ ++.+||+.||++|||+.||+++|+.+.+.
T Consensus 241 ~~~~---li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 241 DVYM---IMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp HHHH---HHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHH---HHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 4444 55599999999999999999999988654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.1e-49 Score=402.35 Aligned_cols=244 Identities=24% Similarity=0.285 Sum_probs=197.5
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch----hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL----GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
.|+..+.||+|+||+||+|+. .+|+.||||+++.... ..+.+.+|+++|++++|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 477788999999999999995 5789999999965432 23568999999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
||++|+|..++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (309)
T ss_dssp CCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred ecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence 99999997766543 46999999999999999999999 789999999999999999999999999999865322
Q ss_pred ccccCCCcccccccccccCC---CCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHH
Q 035917 480 SFVNGDLGEFGYIAPEYSST---MVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEIL 556 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 556 (611)
....||+.|||||++.+ ..|+.++|||||||++|||++|..||.+........ .......+.+.....++++.
T Consensus 169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~-~i~~~~~~~~~~~~~s~~~~ 244 (309)
T d1u5ra_ 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQSGHWSEYFR 244 (309)
T ss_dssp ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHHHSCCCCCSCTTSCHHHH
T ss_pred ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH-HHHhCCCCCCCCCCCCHHHH
Confidence 23469999999998753 468999999999999999999999874321100000 00011112222334566666
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++++ +||+.||++|||++|+++|
T Consensus 245 ~li~---~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 245 NFVD---SCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHHH---HHTCSSGGGSCCHHHHTTC
T ss_pred HHHH---HHCcCChhHCcCHHHHHhC
Confidence 6666 9999999999999999874
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-48 Score=395.69 Aligned_cols=262 Identities=21% Similarity=0.298 Sum_probs=200.7
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCC----eeEEEEe
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE----EKLLIYK 399 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~----~~~lv~e 399 (611)
++|...+.||+|+||.||+|++ +|+.||||+++........++.|+..+.+++|||||+++|+|..++ ..++|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 3456678899999999999997 6889999999765443344556666777889999999999998754 5789999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeeecCCCCCeEEeCCCCCeEEeecccccccC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHG-----CQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~ 474 (611)
||++|+|.+++++. .++|..+++++.|+|.||+|+|+. ..++|+||||||+|||+++++.+||+|||+++...
T Consensus 82 y~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~ 159 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred cccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence 99999999999864 589999999999999999999942 13699999999999999999999999999999875
Q ss_pred CCCCC--ccccCCCcccccccccccCCC------CCCcccchHHHHHHHHHHhCCCCCHH-------------------H
Q 035917 475 SSDES--SFVNGDLGEFGYIAPEYSSTM------VASLKGDVYGIGVVLLELAGFKGNLV-------------------D 527 (611)
Q Consensus 475 ~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~SfGvvl~ell~~~~~~~-------------------~ 527 (611)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|..++. .
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T d1vjya_ 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHH
Confidence 43321 122345799999999987654 26789999999999999998765431 0
Q ss_pred HHHHHhhcCChhhhhchhhcCCC-CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCC
Q 035917 528 WVNQLSSSGRSKEAIDKALCGKG-YDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGF 592 (611)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 592 (611)
........ +..++.+.... ..+....+.+++.+||+.||++||||.||+++|+++.++.+.
T Consensus 240 ~~~~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~ 301 (303)
T d1vjya_ 240 EMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp HHHHHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCC
T ss_pred HHHHHHhc----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCC
Confidence 00000000 01111111111 123455677788899999999999999999999999988653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-49 Score=393.03 Aligned_cols=247 Identities=23% Similarity=0.311 Sum_probs=192.5
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeC-CeeEEEEeccC
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE-EEKLLIYKYMS 402 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~-~~~~lv~ey~~ 402 (611)
++|...+.||+|+||.||+|++ .|+.||||+++.+ ...++|.+|++++++++|||||+++|+|.++ +..++||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 3566678999999999999998 5789999999654 3457799999999999999999999999654 56799999999
Q ss_pred CCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCcc
Q 035917 403 SGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSF 481 (611)
Q Consensus 403 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 481 (611)
+|+|.+++.... ..++|..+++|+.||+.||.||| +.+|+||||||+|||++.++.+|++|||+++......
T Consensus 85 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~---- 157 (262)
T d1byga_ 85 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 157 (262)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCCC----
Confidence 999999997543 35899999999999999999999 7899999999999999999999999999998754322
Q ss_pred ccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhh----chhhcCCCCHHHHH
Q 035917 482 VNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAI----DKALCGKGYDEEIL 556 (611)
Q Consensus 482 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~----~~~l~~~~~~~~~~ 556 (611)
....+|..|+|||++.+..++.++|||||||++|||++ |+.|+.... .......+ .+.. ....++++.
T Consensus 158 -~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~-----~~~~~~~i~~~~~~~~-~~~~~~~~~ 230 (262)
T d1byga_ 158 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPRVEKGYKMDA-PDGCPPAVY 230 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-----GGGHHHHHTTTCCCCC-CTTCCHHHH
T ss_pred -ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHcCCCCCC-CccCCHHHH
Confidence 12357899999999998999999999999999999998 565543210 00111111 1111 122334555
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
+++ .+||+.||++||||.||+++|+++...
T Consensus 231 ~li---~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 231 EVM---KNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp HHH---HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH---HHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 555 499999999999999999999998653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=392.63 Aligned_cols=256 Identities=20% Similarity=0.259 Sum_probs=192.8
Q ss_pred hcCCCCCeeeecCCceEEEEEeCC----CCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPD----GSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~----g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
++|...+.||+|+||.||+|+... +..||||.++... ...+.|.+|+++|++++|||||+++|++. ++..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 467778899999999999998642 4579999986533 33467999999999999999999999985 5678999
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
|||+++|+|.+++......+++..++.++.||++||.||| +.+|+||||||+||+++.++.+||+|||+|+......
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 9999999999988766667999999999999999999999 7899999999999999999999999999998764332
Q ss_pred CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHHHHHHhhcCChhhhhchhhcCCCCHHHHH
Q 035917 478 ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDWVNQLSSSGRSKEAIDKALCGKGYDEEIL 556 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 556 (611)
. .......||+.|+|||.+.+..++.++|||||||++|||++ |..|+.......... .......+. .....++++.
T Consensus 163 ~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~-~i~~~~~~~-~~~~~~~~~~ 239 (273)
T d1mp8a_ 163 Y-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG-RIENGERLP-MPPNCPPTLY 239 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-HHHTTCCCC-CCTTCCHHHH
T ss_pred c-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHH-HHHcCCCCC-CCCCCCHHHH
Confidence 2 22233468999999999999999999999999999999987 677764311100000 000000011 1223445555
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 557 QFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 557 ~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
+++. +||+.||++|||+.||+++|+++.++
T Consensus 240 ~li~---~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 240 SLMT---KCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp HHHH---HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHH---HHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 5555 99999999999999999999998765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=399.08 Aligned_cols=255 Identities=19% Similarity=0.262 Sum_probs=194.1
Q ss_pred hcCCCCCeeeecCCceEEEEEeC------CCCEEEEEeccccc--hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCC-e
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP------DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEE-E 393 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~------~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~-~ 393 (611)
++|...+.||+|+||.||+|+.. +++.||||+++... ...+.+.+|+.++.++ +|+|||.+++++..++ .
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 46778899999999999999852 35789999997533 3346788898888887 6899999999987654 5
Q ss_pred eEEEEeccCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC
Q 035917 394 KLLIYKYMSSGTLYSLLQGNA---------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE 458 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~ 458 (611)
.++|||||++|+|.++++... ..++|..++.++.||++||+||| +.+|+||||||+|||+++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeECC
Confidence 789999999999999986431 24899999999999999999999 789999999999999999
Q ss_pred CCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCC-CHHH-----HHHHH
Q 035917 459 DFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKG-NLVD-----WVNQL 532 (611)
Q Consensus 459 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~-~~~~-----~~~~~ 532 (611)
++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+++.. ||.. .....
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999999987655443333445679999999999999999999999999999999998754 4422 11111
Q ss_pred hhcCChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhh
Q 035917 533 SSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQH 590 (611)
Q Consensus 533 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (611)
...+ ..+. .+...++++ .+++.+||+.||++||||.||++||+++.+..
T Consensus 250 ~~~~-----~~~~-~~~~~~~~l---~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 250 LKEG-----TRMR-APDYTTPEM---YQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp HHHT-----CCCC-CCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HhcC-----CCCC-CCccCCHHH---HHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 1111 0111 112233444 44555999999999999999999999998753
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-48 Score=399.56 Aligned_cols=246 Identities=20% Similarity=0.246 Sum_probs=185.4
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
+.|...+.||+|+||+||+|+. .+|+.||||++.... ...+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 4577889999999999999996 468999999996543 2345688999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC---CCCCeEEeecccccccCCCC
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD---EDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld---~~~~~kl~DFGla~~~~~~~ 477 (611)
|++|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||+. +++.+||+|||+|+......
T Consensus 89 ~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 89 VSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred cCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 9999999999754 46999999999999999999999 78999999999999994 57899999999998764332
Q ss_pred CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHH----HHhhcCChhhhhchhhcCCCCHH
Q 035917 478 ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVN----QLSSSGRSKEAIDKALCGKGYDE 553 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~~~~~~ 553 (611)
.....+||+.|||||++.+..++.++|||||||++|||++|+.||.+... ......... .. .......++
T Consensus 165 ---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~--~~-~~~~~~~s~ 238 (307)
T d1a06a_ 165 ---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE--FD-SPYWDDISD 238 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCC--CC-TTTTTTSCH
T ss_pred ---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC--CC-CccccCCCH
Confidence 22345699999999999999999999999999999999999998742110 001010000 00 001123445
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 554 EILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 554 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++.+++. +||+.||++|||+.|+++|
T Consensus 239 ~~~~li~---~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 239 SAKDFIR---HLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHHHH---HHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHH---HHccCCHhHCcCHHHHhcC
Confidence 5566555 9999999999999999886
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.5e-48 Score=401.25 Aligned_cols=246 Identities=20% Similarity=0.275 Sum_probs=202.9
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEecc
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
+.|...+.||+|+||.||+|+. .+|+.||||+++... ...+.+.+|+++|++++|||||++++++.+++..++|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4688889999999999999995 579999999997543 34567899999999999999999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC--CCCCeEEeecccccccCCCCCC
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD--EDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld--~~~~~kl~DFGla~~~~~~~~~ 479 (611)
++|+|.+++......+++..+..|+.||+.||+||| +.+|+||||||+|||++ .++.+||+|||+|+.+.....
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~- 184 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI- 184 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC-
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCCc-
Confidence 999999988766567999999999999999999999 78999999999999998 678999999999998754332
Q ss_pred ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHH-----HHHhhcCChhhhhchhhcCCCCHHH
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWV-----NQLSSSGRSKEAIDKALCGKGYDEE 554 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~~~~~~ 554 (611)
.....||+.|+|||++.+..++.++|||||||++|||++|..||.... ...... ... -+.......+++
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~-~~~---~~~~~~~~~s~~ 258 (352)
T d1koba_ 185 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC-DWE---FDEDAFSSVSPE 258 (352)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC-CCC---CCSSTTTTSCHH
T ss_pred --eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCC---CCcccccCCCHH
Confidence 222368999999999999999999999999999999999999874311 111100 000 000111234556
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 555 ILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 555 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+.+++. +||+.||++|||+.|+++|
T Consensus 259 ~~~li~---~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 259 AKDFIK---NLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHHHHH---TTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHH---HHccCChhHCcCHHHHhcC
Confidence 666555 9999999999999999886
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6e-48 Score=402.09 Aligned_cols=247 Identities=19% Similarity=0.319 Sum_probs=202.3
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc-hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ...+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35788889999999999999996 579999999997644 3456789999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC--CCCCeEEeecccccccCCCCC
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD--EDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld--~~~~~kl~DFGla~~~~~~~~ 478 (611)
|++|+|.+++......+++..+..|+.||+.||+||| +.+|+||||||+|||++ .++.+||+|||+++.+.....
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 9999999999766567999999999999999999999 78999999999999995 467899999999997754332
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhhcCChhhhhchhhcCCCCHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSSSGRSKEAIDKALCGKGYDE 553 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~~~~~~ 553 (611)
.....||+.|||||++.+..++.++|||||||++|||++|+.||.. ........... .+. ......++
T Consensus 182 ---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---~~~-~~~~~~s~ 254 (350)
T d1koaa2 182 ---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN---MDD-SAFSGISE 254 (350)
T ss_dssp ---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---SCC-GGGGGCCH
T ss_pred ---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---CCc-ccccCCCH
Confidence 2234699999999999999999999999999999999999988732 11111111000 000 00112345
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 554 EILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 554 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
++.+++. +||+.||++|||+.|+++|
T Consensus 255 ~~~~li~---~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 255 DGKDFIR---KLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHHH---HHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHHH---HHccCChhHCcCHHHHhcC
Confidence 5556555 9999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-48 Score=395.35 Aligned_cols=257 Identities=26% Similarity=0.390 Sum_probs=200.1
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCC--EEEEEecccc--chhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCeeEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGS--VLAVKRLNTC--KLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~--~vAvK~~~~~--~~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~~lv 397 (611)
++|...+.||+|+||.||+|++. +|. .||||+++.. ....++|.+|+++|.++ +|||||+++|+|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 56777899999999999999964 344 5788887543 23346799999999999 799999999999999999999
Q ss_pred EeccCCCChHHhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCe
Q 035917 398 YKYMSSGTLYSLLQGN---------------ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDA 462 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~ 462 (611)
|||+++|+|.++++.. ...++|..+.+++.||++||.||| +.+|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence 9999999999999643 246999999999999999999999 7899999999999999999999
Q ss_pred EEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCC-CHHHHHHHHhhcCChhhh
Q 035917 463 RIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKG-NLVDWVNQLSSSGRSKEA 541 (611)
Q Consensus 463 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~-~~~~~~~~~~~~~~~~~~ 541 (611)
||+|||+++........ ....||..|+|||.+.+..++.++|||||||++|||+++.. |+.......... .+.+.
T Consensus 167 kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~-~i~~~ 242 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE-KLPQG 242 (309)
T ss_dssp EECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-HGGGT
T ss_pred EEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH-HHHhc
Confidence 99999999865432211 22358999999999999999999999999999999998765 442210000000 00000
Q ss_pred hchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhC
Q 035917 542 IDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHG 591 (611)
Q Consensus 542 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (611)
..+. .....++++.+++. +||+.||++||||.||+++|+++.++..
T Consensus 243 ~~~~-~~~~~~~~~~~li~---~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 243 YRLE-KPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp CCCC-CCTTBCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CCCC-CCccCCHHHHHHHH---HHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 0111 11233455555555 9999999999999999999999987643
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=394.29 Aligned_cols=257 Identities=21% Similarity=0.317 Sum_probs=205.6
Q ss_pred hcCCCCCeeeecCCceEEEEEe------CCCCEEEEEeccccc--hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCCee
Q 035917 324 NSFCSENVIISTRTGTTYKAML------PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEEEK 394 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~------~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~~~ 394 (611)
++|...+.||+|+||.||+|++ .+++.||||+++... ....+|.+|+.++.++ +|||||+++|+|.+++..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 4666778999999999999985 346799999997543 3345799999999999 699999999999999999
Q ss_pred EEEEeccCCCChHHhhhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC
Q 035917 395 LLIYKYMSSGTLYSLLQGNA-----------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD 457 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld 457 (611)
++|||||++|+|.++++... ..+++..+..++.||++||+||| +.+|+||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccccccc
Confidence 99999999999999986432 25899999999999999999999 78999999999999999
Q ss_pred CCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCC
Q 035917 458 EDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGR 537 (611)
Q Consensus 458 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~ 537 (611)
.++.+|++|||+++...............||+.|+|||++.+..++.++|||||||++|||++++.|+..- ......
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~---~~~~~~ 256 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG---MPVDSK 256 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT---CCSSHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCC---CCHHHH
Confidence 99999999999999876544444444567999999999999999999999999999999999855443110 000001
Q ss_pred hhhhhchhhc---CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 538 SKEAIDKALC---GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 538 ~~~~~~~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
..+.++.... ....++++.+ |+.+||+.||++||||.||+++|+++..+
T Consensus 257 ~~~~i~~~~~~~~~~~~~~~l~~---Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 257 FYKMIKEGFRMLSPEHAPAEMYD---IMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHHTCCCCCCTTSCHHHHH---HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCcccccHHHHH---HHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 1122222121 1233444444 55599999999999999999999987655
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=389.09 Aligned_cols=245 Identities=19% Similarity=0.283 Sum_probs=199.3
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc-------hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK-------LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-------~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~ 395 (611)
+.|...+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++|++++|||||++++++.+++..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 4688889999999999999996 579999999985422 23578999999999999999999999999999999
Q ss_pred EEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC----CeEEeeccccc
Q 035917 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF----DARIMDFGLAK 471 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~----~~kl~DFGla~ 471 (611)
+|||||++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++ .+|++|||+|+
T Consensus 90 iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 999999999999999754 36999999999999999999999 78999999999999998776 49999999998
Q ss_pred ccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCChhhhhchhh
Q 035917 472 LMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGRSKEAIDKAL 546 (611)
Q Consensus 472 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~~~~~~~~~l 546 (611)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||... ..... ..... .....
T Consensus 166 ~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~-~~~~~--~~~~~ 239 (293)
T d1jksa_ 166 KIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS-AVNYE--FEDEY 239 (293)
T ss_dssp ECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-TTCCC--CCHHH
T ss_pred hcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHH-hcCCC--CCchh
Confidence 7653322 23446999999999999999999999999999999999999887421 11111 10000 00000
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 547 CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 547 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
....+.++.++++ +||+.||++|||++|+++|
T Consensus 240 -~~~~s~~~~~li~---~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 240 -FSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp -HTTSCHHHHHHHH---TTSCSSGGGSCCHHHHHHS
T ss_pred -cCCCCHHHHHHHH---HHccCChhHCcCHHHHhcC
Confidence 1123445555555 9999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=390.89 Aligned_cols=254 Identities=22% Similarity=0.286 Sum_probs=199.5
Q ss_pred hcCCCCCeeeecCCceEEEEEeC--------CCCEEEEEeccccc--hhHHHHHHHHHHHhcc-CCCCccceeeEEEeCC
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP--------DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQL-RHPNLAPLLGYCVVEE 392 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~--------~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~~~ 392 (611)
++|...+.||+|+||.||+|+.. ++..||||+++... ....++.+|+..+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 46677789999999999999842 23579999996543 3346789999999998 8999999999999999
Q ss_pred eeEEEEeccCCCChHHhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC
Q 035917 393 EKLLIYKYMSSGTLYSLLQGNA---------------TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD 457 (611)
Q Consensus 393 ~~~lv~ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld 457 (611)
..++|||||++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeec
Confidence 9999999999999999996442 25899999999999999999999 78999999999999999
Q ss_pred CCCCeEEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHH----HHHH
Q 035917 458 EDFDARIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDW----VNQL 532 (611)
Q Consensus 458 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~----~~~~ 532 (611)
.++.+||+|||+++...............||+.|+|||.+.++.|+.++|||||||++|||++ |..||.+. +...
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~ 249 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence 999999999999997765443333344569999999999999999999999999999999997 56555321 1111
Q ss_pred hhcCChhhhhchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhh
Q 035917 533 SSSGRSKEAIDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQ 589 (611)
Q Consensus 533 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 589 (611)
...+ ..+. .+...++++.+ ++.+||+.||++||||.||++.|+++...
T Consensus 250 i~~~-----~~~~-~p~~~~~~l~~---li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 250 LKEG-----HRMD-KPSNCTNELYM---MMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHTT-----CCCC-CCSSCCHHHHH---HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcC-----CCCC-CCccchHHHHH---HHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 1111 1111 11233445555 55599999999999999999999998653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=389.89 Aligned_cols=250 Identities=20% Similarity=0.283 Sum_probs=190.3
Q ss_pred hcCCCCCeeeecCCceEEEEEeC--CC--CEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP--DG--SVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~--~g--~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~ 395 (611)
++|...+.||+|+||.||+|++. ++ ..||||+++... ...++|.+|+.+|++++|||||+++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 45777789999999999999853 23 378999996532 234679999999999999999999999965 4678
Q ss_pred EEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
+|||||++|++.+++......+++..++.++.|+++||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 999999999999988765557999999999999999999999 78999999999999999999999999999998754
Q ss_pred CCCCc-cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhC-CCCCHHHH-----HHHHhhcCChhhhhchhhcC
Q 035917 476 SDESS-FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAG-FKGNLVDW-----VNQLSSSGRSKEAIDKALCG 548 (611)
Q Consensus 476 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~-~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~ 548 (611)
..... ......||..|+|||.+.+..++.++|||||||++|||++ |+.||... .......+ ..+. ..
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~-----~~~~-~~ 237 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG-----ERLP-RP 237 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC-----CCCC-CC
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCC-----CCCC-Cc
Confidence 43222 2223457889999999999999999999999999999997 78887421 11111111 0011 11
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHc
Q 035917 549 KGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSI 586 (611)
Q Consensus 549 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 586 (611)
...+.++.+ ++.+||+.||++||||.||++.|++.
T Consensus 238 ~~~~~~l~~---li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 238 EDCPQDIYN---VMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp TTCCHHHHH---HHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccHHHHH---HHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 223445555 44599999999999999999998875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-48 Score=395.19 Aligned_cols=255 Identities=21% Similarity=0.297 Sum_probs=202.9
Q ss_pred hcCCCCCeeeecCCceEEEEEeC------CCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeE
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP------DGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKL 395 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~------~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~ 395 (611)
++|...+.||+|+||.||+|.+. +++.||||+++... .....|.+|++++++++|||||+++|+|..++..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 46677789999999999999853 36789999997543 23356899999999999999999999999999999
Q ss_pred EEEeccCCCChHHhhhcC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEee
Q 035917 396 LIYKYMSSGTLYSLLQGN---------ATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMD 466 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~D 466 (611)
+|||||++|+|.+++... ...+++..+.+++.|+++||.||| +.+|+||||||+|||+|+++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEee
Confidence 999999999999988532 135799999999999999999999 78999999999999999999999999
Q ss_pred cccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCC-CCHHHHHHHHhhcCChhhhhchh
Q 035917 467 FGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFK-GNLVDWVNQLSSSGRSKEAIDKA 545 (611)
Q Consensus 467 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~-~~~~~~~~~~~~~~~~~~~~~~~ 545 (611)
||+|+.+.............||+.|+|||.+.+..++.++|||||||++|||+++. .|+....... ....+.+..
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~----~~~~i~~~~ 252 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ----VLRFVMEGG 252 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH----HHHHHHTTC
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHhCC
Confidence 99999775444333344456899999999999999999999999999999999875 4442210000 000111111
Q ss_pred h--cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchh
Q 035917 546 L--CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAA 588 (611)
Q Consensus 546 l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 588 (611)
. .....+++ +.+++.+||+.||++||||.||+++|++..+
T Consensus 253 ~~~~p~~~~~~---l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 253 LLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp CCCCCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCcccchHH---HHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1 11223344 4445559999999999999999999987754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-47 Score=390.92 Aligned_cols=246 Identities=20% Similarity=0.193 Sum_probs=202.4
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||.||+|+. .+|+.||||++++.. ...+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5788889999999999999995 579999999996532 23467899999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
|||++|+|.+++... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+|+......
T Consensus 85 ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~- 159 (337)
T d1o6la_ 85 EYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp ECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred eccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC-
Confidence 999999999998764 35899999999999999999999 7899999999999999999999999999998764322
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc-hhhcCCCCHHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID-KALCGKGYDEEILQ 557 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~~~~~~~~~~ 557 (611)
......+||+.|+|||++.+..|+.++||||+||++|||++|+.||......... ..+.. ....+...+.++.+
T Consensus 160 -~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~----~~i~~~~~~~p~~~s~~~~d 234 (337)
T d1o6la_ 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPRTLSPEAKS 234 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCTTSCHHHHH
T ss_pred -cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHH----HHHhcCCCCCCccCCHHHHH
Confidence 2233457999999999999999999999999999999999999887431111000 00000 00112334556666
Q ss_pred HHHHHhhcccCCCCCCCC-----HHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRWS-----MYQVYQS 582 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RPs-----~~evl~~ 582 (611)
++. +||+.||++||+ ++|+++|
T Consensus 235 li~---~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 235 LLA---GLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHH---HHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHH---hhccCCchhhcccccccHHHHHcC
Confidence 666 999999999994 8899886
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=386.53 Aligned_cols=246 Identities=17% Similarity=0.221 Sum_probs=202.4
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccC
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
++|...+.||+|+||+||+|+. .+|+.||||.++........+.+|+++|++++|||||++++++.+++..|+|||||+
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence 5677889999999999999996 468999999998776666779999999999999999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC--CCCeEEeecccccccCCCCCCc
Q 035917 403 SGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE--DFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 403 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~--~~~~kl~DFGla~~~~~~~~~~ 480 (611)
+|+|.+++......+++.++..++.||+.||+||| +.+|+||||||+|||++. ...+||+|||+++.......
T Consensus 85 gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~-- 159 (321)
T d1tkia_ 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-- 159 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE--
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCCc--
Confidence 99999999876557999999999999999999999 789999999999999984 45899999999987643322
Q ss_pred cccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHH-----HHHhhcCChhhhhchhhcCCCCHHHH
Q 035917 481 FVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWV-----NQLSSSGRSKEAIDKALCGKGYDEEI 555 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~~~~~~~ 555 (611)
.....||+.|+|||...+..++.++||||+||++|||++|+.||.... ........ ..+... ....++++
T Consensus 160 -~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~-~~~~s~~~ 234 (321)
T d1tkia_ 160 -FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY---TFDEEA-FKEISIEA 234 (321)
T ss_dssp -EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC---CCCHHH-HTTSCHHH
T ss_pred -ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCChhh-ccCCCHHH
Confidence 222358999999999999999999999999999999999999874311 11111000 000000 01234455
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 556 LQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 556 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.++++ +||+.||++|||+.|+++|
T Consensus 235 ~~li~---~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 235 MDFVD---RLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHH---TTSCSSGGGSCCHHHHHHS
T ss_pred HHHHH---HHccCChhHCcCHHHHhcC
Confidence 55555 9999999999999999986
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.1e-46 Score=383.98 Aligned_cols=243 Identities=19% Similarity=0.245 Sum_probs=200.7
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4688889999999999999996 569999999996532 23467999999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
|||++|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp CCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 999999999988755 35888999999999999999999 899999999999999999999999999999976432
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-hcCCCCHHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-LCGKGYDEEILQ 557 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~~~ 557 (611)
....+||+.|||||++.+..++.++|||||||++|||++|+.||........ ...+.... ..+...++++.+
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~ 230 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT----YEKILNAELRFPPFFNEDVKD 230 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHHCCCCCCTTSCHHHHH
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH----HHHHHcCCCCCCCCCCHHHHH
Confidence 2235799999999999999999999999999999999999999742100000 00011100 112234556666
Q ss_pred HHHHHhhcccCCCCCCC-----CHHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRW-----SMYQVYQS 582 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RP-----s~~evl~~ 582 (611)
+++ +||+.||.+|| |++|+++|
T Consensus 231 li~---~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 231 LLS---RLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHH---HHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHH---HHhhhCHHhccccchhhHHHHHcC
Confidence 666 99999999996 89999987
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6e-47 Score=382.70 Aligned_cols=253 Identities=17% Similarity=0.250 Sum_probs=197.8
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCC----ee
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE----EK 394 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~----~~ 394 (611)
+.|...+.||+|+||.||+|+. .+|+.||||+++... ...+.|.+|++++++++|||||++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 5688889999999999999995 579999999996532 22357999999999999999999999998654 37
Q ss_pred EEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccC
Q 035917 395 LLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMT 474 (611)
Q Consensus 395 ~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~ 474 (611)
|+|||||++|+|.+++... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++..+++|||.++...
T Consensus 87 ~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhhc
Confidence 8999999999999988654 36999999999999999999999 7899999999999999999999999999988654
Q ss_pred CCC-CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCChhhhhchhhcC
Q 035917 475 SSD-ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGRSKEAIDKALCG 548 (611)
Q Consensus 475 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~ 548 (611)
... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||... ......... ..+....
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~----~~~~~~~ 238 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP----IPPSARH 238 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC----CCGGGTS
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCC----CCCchhc
Confidence 332 222233457999999999999999999999999999999999999987421 111111110 1111222
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHHHHch
Q 035917 549 KGYDEEILQFLKVACNCVVSRPKDRW-SMYQVYQSLNSIA 587 (611)
Q Consensus 549 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~i~ 587 (611)
...++++.+++. +||+.||++|| |++++++.|.++.
T Consensus 239 ~~~s~~l~~li~---~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 239 EGLSADLDAVVL---KALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp SSCCHHHHHHHH---HHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cCCCHHHHHHHH---HHccCCHhHCHhHHHHHHHHHHHHh
Confidence 344566666666 99999999999 8999999988764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.1e-46 Score=392.68 Aligned_cols=243 Identities=19% Similarity=0.223 Sum_probs=195.6
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch----hHHHHH---HHHHHHhccCCCCccceeeEEEeCCeeE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL----GEKKFR---NEMNRLGQLRHPNLAPLLGYCVVEEEKL 395 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~----~~~~~~---~Ev~~l~~l~H~nIv~l~g~~~~~~~~~ 395 (611)
++|...++||+|+||.||+|+. .+|+.||||++..... ....+. +|+++++.++|||||++++++.+++..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5788889999999999999996 4699999999864321 223343 4577788889999999999999999999
Q ss_pred EEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
+|||||++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 84 ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 999999999999999754 45889999999999999999999 88999999999999999999999999999997654
Q ss_pred CCCCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc-----hhhcCC
Q 035917 476 SDESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID-----KALCGK 549 (611)
Q Consensus 476 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~-----~~l~~~ 549 (611)
.. .....||+.|+|||++.. ..|+.++|||||||++|||++|+.||.... .....+... +.....
T Consensus 160 ~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~~ 230 (364)
T d1omwa3 160 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK-----TKDKHEIDRMTLTMAVELPD 230 (364)
T ss_dssp SC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC-----SSCHHHHHHHSSSCCCCCCS
T ss_pred Cc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhcccCCCCCCC
Confidence 32 223469999999999864 568999999999999999999999974210 000111111 011123
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 035917 550 GYDEEILQFLKVACNCVVSRPKDRWS-----MYQVYQS 582 (611)
Q Consensus 550 ~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 582 (611)
..++++.+++. +||+.||++||| ++|+++|
T Consensus 231 ~~s~~~~~li~---~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 231 SFSPELRSLLE---GLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp SSCHHHHHHHH---HHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CCCHHHHHHHH---HHcccCHHHhCCCcccCHHHHHcC
Confidence 34566666666 999999999999 6899876
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.6e-46 Score=377.42 Aligned_cols=246 Identities=17% Similarity=0.272 Sum_probs=197.6
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch----------hHHHHHHHHHHHhccC-CCCccceeeEEEeC
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL----------GEKKFRNEMNRLGQLR-HPNLAPLLGYCVVE 391 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~----------~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~ 391 (611)
++|...+.||+|+||+||+|+. .+|+.||||+++.... ..+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 4678889999999999999995 5799999999865321 1246889999999997 99999999999999
Q ss_pred CeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccc
Q 035917 392 EEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAK 471 (611)
Q Consensus 392 ~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~ 471 (611)
+..|+|||||++|+|.+++... ..+++..++.++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhee
Confidence 9999999999999999999754 46999999999999999999999 7899999999999999999999999999999
Q ss_pred ccCCCCCCccccCCCcccccccccccC------CCCCCcccchHHHHHHHHHHhCCCCCHHHHH----HHHhhcCChhhh
Q 035917 472 LMTSSDESSFVNGDLGEFGYIAPEYSS------TMVASLKGDVYGIGVVLLELAGFKGNLVDWV----NQLSSSGRSKEA 541 (611)
Q Consensus 472 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~----~~~~~~~~~~~~ 541 (611)
....... .....||+.|+|||.+. ...++.++||||+||++|||++|+.||..-. ......+...
T Consensus 159 ~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~-- 233 (277)
T d1phka_ 159 QLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ-- 233 (277)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--
T ss_pred EccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCC--
Confidence 7754322 23356999999999874 3357889999999999999999998874211 1111111000
Q ss_pred hchhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 542 IDKALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 542 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.+.......++++.+++. +||+.||++|||+.||++|
T Consensus 234 -~~~~~~~~~s~~~~~li~---~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 234 -FGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp -CCTTTGGGSCHHHHHHHH---HHCCSSGGGSCCHHHHTTS
T ss_pred -CCCcccccCCHHHHHHHH---HHccCChhHCcCHHHHHcC
Confidence 000011124455555555 9999999999999999876
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-46 Score=384.12 Aligned_cols=249 Identities=16% Similarity=0.205 Sum_probs=191.5
Q ss_pred hcCCCC-CeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhcc-CCCCccceeeEEEe----CCeeEE
Q 035917 324 NSFCSE-NVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQL-RHPNLAPLLGYCVV----EEEKLL 396 (611)
Q Consensus 324 ~~f~~~-~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l-~H~nIv~l~g~~~~----~~~~~l 396 (611)
++|... ++||+|+||+||+|+. .+++.||||+++.. +.+.+|+.++.++ +|||||++++++.+ +...|+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i 86 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 86 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEE
Confidence 467654 5799999999999995 67999999999643 4577899987655 89999999999875 356899
Q ss_pred EEeccCCCChHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC---CCCeEEeecccccc
Q 035917 397 IYKYMSSGTLYSLLQGNA-TELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE---DFDARIMDFGLAKL 472 (611)
Q Consensus 397 v~ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~---~~~~kl~DFGla~~ 472 (611)
|||||++|+|.+++.... ..+++..+..|+.||+.||+||| +.+|+||||||+|||+++ ++.+||+|||+|+.
T Consensus 87 vmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 87 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccceeee
Confidence 999999999999998654 46999999999999999999999 789999999999999985 56799999999987
Q ss_pred cCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh--hcCCC
Q 035917 473 MTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA--LCGKG 550 (611)
Q Consensus 473 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~ 550 (611)
...... .....||+.|||||++.+..|+.++|||||||++|||++|+.||.................... .....
T Consensus 164 ~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (335)
T d2ozaa1 164 TTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240 (335)
T ss_dssp CCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTH
T ss_pred ccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcc
Confidence 654332 2345799999999999999999999999999999999999998843110000000000000000 00000
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 551 YDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 551 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.......+.+++.+||+.||++|||+.|+++|
T Consensus 241 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 01111234445559999999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.4e-46 Score=385.99 Aligned_cols=243 Identities=16% Similarity=0.176 Sum_probs=200.4
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIY 398 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 398 (611)
++|...+.||+|+||.||+|+. .+|+.||||+++... ...+.+.+|+++|++++|||||++++++...+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4788889999999999999996 579999999986432 23467899999999999999999999999999999999
Q ss_pred eccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCC
Q 035917 399 KYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 399 ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~ 478 (611)
||+.+|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred ccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 999999999998754 35999999999999999999999 789999999999999999999999999999976432
Q ss_pred CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchh-hcCCCCHHHHHH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKA-LCGKGYDEEILQ 557 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~~~ 557 (611)
.....||+.|||||++.+..++.++|||||||++|||++|+.||........ ...+.... ......++++.+
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~ 267 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI----YEKIVSGKVRFPSHFSSDLKD 267 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCTTCCHHHHH
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH----HHHHhcCCCCCCccCCHHHHH
Confidence 2234699999999999999999999999999999999999998742100000 00011100 112234556666
Q ss_pred HHHHHhhcccCCCCCCC-----CHHHHHHH
Q 035917 558 FLKVACNCVVSRPKDRW-----SMYQVYQS 582 (611)
Q Consensus 558 l~~l~~~Cl~~dP~~RP-----s~~evl~~ 582 (611)
+++ +||+.||++|+ |++|+++|
T Consensus 268 li~---~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 268 LLR---NLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHH---HHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHH---HHhhhCHHhccccccccHHHHHcC
Confidence 666 99999999994 89999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=369.99 Aligned_cols=251 Identities=20% Similarity=0.243 Sum_probs=192.6
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch---hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL---GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
++|...+.||+|+||+||+|+. .+|+.||||+++.... ..+++.+|+++|++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 4788889999999999999995 6799999999965432 23678999999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
|+.++.+..........+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-- 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-- 156 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc--
Confidence 99764444333444457999999999999999999999 7899999999999999999999999999998764332
Q ss_pred ccccCCCcccccccccccCCCC-CCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhh-cCChhhhhch------hh
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMV-ASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSS-SGRSKEAIDK------AL 546 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~-~~~~~~~~~~------~l 546 (611)
.......||+.|+|||.+.... ++.++|||||||++|||++|+.||.. ....... .+...+...+ ..
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 2233446999999999876655 58899999999999999999988731 1111100 0000000000 00
Q ss_pred -------c-------CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 547 -------C-------GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 547 -------~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
. ....++++.+ ++.+||+.||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~d---ll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRS---LLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHH---HHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhhhccCCCHHHHH---HHHHHccCChhHCcCHHHHhCC
Confidence 0 0112334444 4559999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=379.24 Aligned_cols=243 Identities=20% Similarity=0.243 Sum_probs=197.8
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc----hhHHHHHHHHHHHh-ccCCCCccceeeEEEeCCeeEEE
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK----LGEKKFRNEMNRLG-QLRHPNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~----~~~~~~~~Ev~~l~-~l~H~nIv~l~g~~~~~~~~~lv 397 (611)
++|...+.||+|+||+||+|+. .+|+.||||+++... ...+.+..|+.++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 4678889999999999999996 469999999996532 23356777877765 68999999999999999999999
Q ss_pred EeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCC
Q 035917 398 YKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSD 477 (611)
Q Consensus 398 ~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~ 477 (611)
||||++|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 82 mEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 9999999999999754 35899999999999999999999 7899999999999999999999999999998654322
Q ss_pred CCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHH----HHHHhhcCChhhhhchhhcCCCCHH
Q 035917 478 ESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDW----VNQLSSSGRSKEAIDKALCGKGYDE 553 (611)
Q Consensus 478 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~~~~~~ 553 (611)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..- +....... .+ ..+...++
T Consensus 158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~------~~-~~p~~~s~ 228 (320)
T d1xjda_ 158 --AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD------NP-FYPRWLEK 228 (320)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CC-CCCTTSCH
T ss_pred --ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC------CC-CCCccCCH
Confidence 2233457999999999999999999999999999999999999987421 11101000 11 11233455
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHH-HHHHH
Q 035917 554 EILQFLKVACNCVVSRPKDRWSMY-QVYQS 582 (611)
Q Consensus 554 ~~~~l~~l~~~Cl~~dP~~RPs~~-evl~~ 582 (611)
++.+++. +||+.||++||++. |+++|
T Consensus 229 ~~~dli~---~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 229 EAKDLLV---KLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp HHHHHHH---HHSCSSGGGSBTTBSCGGGS
T ss_pred HHHHHHH---HhcccCCCCCcCHHHHHHhC
Confidence 6666666 99999999999995 78764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=374.77 Aligned_cols=244 Identities=21% Similarity=0.245 Sum_probs=186.7
Q ss_pred CeeeecCCceEEEEEe-CCCCEEEEEeccccchh------HHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEeccC
Q 035917 330 NVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLG------EKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKYMS 402 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~------~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey~~ 402 (611)
++||+|+||+||+|+. .+|+.||||+++..... .+.+.+|+.+|++++|||||++++++..++..++|||||.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 6899999999999995 56999999999654321 2468899999999999999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCccc
Q 035917 403 SGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESSFV 482 (611)
Q Consensus 403 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 482 (611)
++++..+.. ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 84 ~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--~~ 157 (299)
T d1ua2a_ 84 TDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AY 157 (299)
T ss_dssp EEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CC
T ss_pred chHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcc--cc
Confidence 887766654 3346888999999999999999999 78999999999999999999999999999987644322 22
Q ss_pred cCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhh---c---CChhhhhc---h---
Q 035917 483 NGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSS---S---GRSKEAID---K--- 544 (611)
Q Consensus 483 ~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~---~---~~~~~~~~---~--- 544 (611)
...+||+.|+|||++.. ..++.++|||||||++|||++|..||.. ....... . ........ .
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 33469999999998765 4579999999999999999999887631 1111110 0 00000000 0
Q ss_pred -hh-------cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 545 -AL-------CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 545 -~l-------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.. .....++++. +++.+||+.||++|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~---dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLL---DLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHH---HHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCCCCChHHhcccCCHHHH---HHHHHHccCChhhCcCHHHHhCC
Confidence 00 0011234444 45559999999999999999876
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=372.22 Aligned_cols=239 Identities=16% Similarity=0.234 Sum_probs=194.5
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccch-------hHHHHHHHHHHHhccC--CCCccceeeEEEeCCe
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKL-------GEKKFRNEMNRLGQLR--HPNLAPLLGYCVVEEE 393 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~-------~~~~~~~Ev~~l~~l~--H~nIv~l~g~~~~~~~ 393 (611)
+.|...++||+|+||+||+|+. .+|+.||||+++.... ...++.+|+.+|++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 4678889999999999999995 5799999999864321 1234778999999997 8999999999999999
Q ss_pred eEEEEeccCC-CChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC-CCCeEEeeccccc
Q 035917 394 KLLIYKYMSS-GTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE-DFDARIMDFGLAK 471 (611)
Q Consensus 394 ~~lv~ey~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~-~~~~kl~DFGla~ 471 (611)
.++||||+.+ +++.+++... ..+++..+..++.|+++||+||| +.+|+||||||+|||++. ++.+||+|||+|+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccce
Confidence 9999999976 6788887644 46999999999999999999999 789999999999999985 4799999999998
Q ss_pred ccCCCCCCccccCCCcccccccccccCCCCC-CcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhchhhcCCC
Q 035917 472 LMTSSDESSFVNGDLGEFGYIAPEYSSTMVA-SLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAIDKALCGKG 550 (611)
Q Consensus 472 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 550 (611)
...... .+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... .... .......
T Consensus 160 ~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-i~~~--------~~~~~~~ 226 (273)
T d1xwsa_ 160 LLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-IIRG--------QVFFRQR 226 (273)
T ss_dssp ECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-HHHC--------CCCCSSC
T ss_pred eccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-Hhhc--------ccCCCCC
Confidence 754322 234579999999999887665 5678999999999999999999854211 1111 0111233
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 551 YDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 551 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
.++++.++++ +||+.||++|||++|+++|
T Consensus 227 ~s~~~~~li~---~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 227 VSSECQHLIR---WCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CCHHHHHHHH---HHTCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHH---HHccCCHhHCcCHHHHhcC
Confidence 4566666666 9999999999999999876
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.1e-44 Score=364.41 Aligned_cols=250 Identities=19% Similarity=0.232 Sum_probs=193.2
Q ss_pred hcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccch---hHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEec
Q 035917 324 NSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKL---GEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~---~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~ey 400 (611)
++|...+.||+|+||+||+|+..+|+.||||+++.... ..+++.+|+.+|++++|||||++++++.+++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 46777889999999999999999999999999965432 246899999999999999999999999999999999999
Q ss_pred cCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCCc
Q 035917 401 MSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDESS 480 (611)
Q Consensus 401 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 480 (611)
+.++.+..+... ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+|++|||++........
T Consensus 82 ~~~~~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-- 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-- 155 (286)
T ss_dssp CSEEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHHhh-cCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc--
Confidence 988766666543 357999999999999999999999 78999999999999999999999999999987643322
Q ss_pred cccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhh---c---CChhhhh-----c
Q 035917 481 FVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSS---S---GRSKEAI-----D 543 (611)
Q Consensus 481 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~---~---~~~~~~~-----~ 543 (611)
......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+ ....... . ....... .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 1223358999999998865 4569999999999999999999988731 1111100 0 0000000 0
Q ss_pred h----------hhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 544 K----------ALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 544 ~----------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
. .......++++.++++ +||+.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~---~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHH---HHTCSSTTTSCCHHHHHTS
T ss_pred cccccccCcchhhhcccCCHHHHHHHH---HHccCChhHCcCHHHHhcC
Confidence 0 0001123345555555 9999999999999999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=363.71 Aligned_cols=251 Identities=21% Similarity=0.267 Sum_probs=191.8
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CC-CCEEEEEeccccch---hHHHHHHHHHHHhcc---CCCCccceeeEEEe----
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PD-GSVLAVKRLNTCKL---GEKKFRNEMNRLGQL---RHPNLAPLLGYCVV---- 390 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~-g~~vAvK~~~~~~~---~~~~~~~Ev~~l~~l---~H~nIv~l~g~~~~---- 390 (611)
.++|...+.||+|+||+||+|+. .+ ++.||||+++.... ....+.+|+.+|+.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46788889999999999999996 34 66799999864322 223566788777666 79999999999863
Q ss_pred -CCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccc
Q 035917 391 -EEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGL 469 (611)
Q Consensus 391 -~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGl 469 (611)
....+++|||+.+|++..........+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhh
Confidence 24678999999988776665555567999999999999999999999 78999999999999999999999999999
Q ss_pred ccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhc-CC-hh---
Q 035917 470 AKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSS-GR-SK--- 539 (611)
Q Consensus 470 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~-~~-~~--- 539 (611)
++..... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||... ....... +. ..
T Consensus 163 ~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 163 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 9865322 2334457999999999999999999999999999999999999887321 1111000 00 00
Q ss_pred --------hhhch------hhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 540 --------EAIDK------ALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 540 --------~~~~~------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
..... .......++++.+++. +||+.||++|||+.|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~---~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL---KCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHH---HHSCSSTTTSCCHHHHHTS
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHH---HHCcCChhHCcCHHHHhcC
Confidence 00000 0001223455555555 9999999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.1e-43 Score=354.69 Aligned_cols=263 Identities=12% Similarity=0.097 Sum_probs=207.1
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhccCC-CCccceeeEEEeCCeeEEEEecc
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRH-PNLAPLLGYCVVEEEKLLIYKYM 401 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H-~nIv~l~g~~~~~~~~~lv~ey~ 401 (611)
++|...+.||+|+||+||+|+. .+|+.||||+++... ..+.+.+|++.++.++| +|++.+++++..+...++||||+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 5688889999999999999995 468999999985432 23457889999999975 89999999999999999999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCC-----CCCeEEeecccccccCCC
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDE-----DFDARIMDFGLAKLMTSS 476 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~-----~~~~kl~DFGla~~~~~~ 476 (611)
+|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||+|+.+...
T Consensus 84 -~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 84 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 67999998766667999999999999999999999 899999999999999974 568999999999986533
Q ss_pred CC-----CccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhhcCChhhhhchhh
Q 035917 477 DE-----SSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSSSGRSKEAIDKAL 546 (611)
Q Consensus 477 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~~~~~~~~~~~~l 546 (611)
.. .......+||+.|||||.+.+..++.++|||||||++|||++|+.||... ......-...........
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH
Confidence 21 11233457999999999999999999999999999999999999887310 000000000000011111
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCCCC
Q 035917 547 CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFSE 594 (611)
Q Consensus 547 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 594 (611)
.....++++.++++ .|+..+|++||+++.+.+.|+++.++.+..+
T Consensus 240 l~~~~p~~l~~ii~---~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~ 284 (293)
T d1csna_ 240 LCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLERLNTTE 284 (293)
T ss_dssp HTTTSCHHHHHHHH---HHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred hcCCCCHHHHHHHH---HHhcCCcccCcCHHHHHHHHHHHHHHcCCCC
Confidence 11223445555555 9999999999999999999999988876654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.4e-43 Score=356.07 Aligned_cols=262 Identities=16% Similarity=0.173 Sum_probs=200.0
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCcccee-eEEEeCCeeEEEEecc
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLL-GYCVVEEEKLLIYKYM 401 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~-g~~~~~~~~~lv~ey~ 401 (611)
+.|...+.||+|+||.||+|+. .+|+.||||++.... ..+++.+|++++++++|+|++..+ ++...++..++||||+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 4588889999999999999995 568999999986532 234588999999999877766555 4456677889999999
Q ss_pred CCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeC---CCCCeEEeecccccccCCCCC
Q 035917 402 SSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVD---EDFDARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 402 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld---~~~~~kl~DFGla~~~~~~~~ 478 (611)
. |+|.+.+......+++..+..++.|++.||+||| +.+|+||||||+|||++ .+..+||+|||+|+.+.....
T Consensus 86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 86 G-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp C-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred C-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 4 5777776655567999999999999999999999 78999999999999985 456799999999998754331
Q ss_pred C-----ccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhh------hchhhc
Q 035917 479 S-----SFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEA------IDKALC 547 (611)
Q Consensus 479 ~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~------~~~~l~ 547 (611)
. .......||+.|||||.+.+..++.++|||||||++|||++|+.||.......... ..... ......
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 240 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-KYERISEKKMSTPIEVL 240 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHHSCHHHH
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH-HHHHhhcccCCCChhHh
Confidence 1 12234579999999999999999999999999999999999998874211000000 00000 011111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHHHchhhhCCCC
Q 035917 548 GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQSLNSIAAQHGFSE 594 (611)
Q Consensus 548 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 594 (611)
....++++.++++ +||+.+|++||++.++.+.|+.+..+.+...
T Consensus 241 ~~~~p~~~~~li~---~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~ 284 (299)
T d1ckia_ 241 CKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284 (299)
T ss_dssp TTTSCHHHHHHHH---HHHHSCTTCCCCHHHHHHHHHHHHHHHTCCC
T ss_pred ccCCCHHHHHHHH---HHccCChhHCcCHHHHHHHHHHHHHHcCCCC
Confidence 2234455555555 9999999999999999999999877765554
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=362.89 Aligned_cols=253 Identities=19% Similarity=0.203 Sum_probs=189.5
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCccceeeEEEeC------CeeEEE
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE------EEKLLI 397 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~------~~~~lv 397 (611)
+|+..++||+|+||+||+|+. .+|+.||||+++... +.+.+|+++|++++|||||++++++... .+.++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc---hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 466778999999999999996 469999999996543 2235799999999999999999998653 246899
Q ss_pred EeccCCCChHHhhh--cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC-CeEEeecccccccC
Q 035917 398 YKYMSSGTLYSLLQ--GNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF-DARIMDFGLAKLMT 474 (611)
Q Consensus 398 ~ey~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~-~~kl~DFGla~~~~ 474 (611)
||||++|.+..+.. .....+++..+..++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||+++...
T Consensus 98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 99998764433332 23346999999999999999999999 89999999999999999765 89999999998765
Q ss_pred CCCCCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhh--cCChhhhh----
Q 035917 475 SSDESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSS--SGRSKEAI---- 542 (611)
Q Consensus 475 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~--~~~~~~~~---- 542 (611)
.... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.. ....... .....+.+
T Consensus 175 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 175 RGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp TTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred CCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 4322 233469999999998764 5689999999999999999999888631 1111100 00000000
Q ss_pred ----c-----------hhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHchhh
Q 035917 543 ----D-----------KALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS--LNSIAAQ 589 (611)
Q Consensus 543 ----~-----------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~~ 589 (611)
+ ........++++.+++. +||+.||++|||+.|+++| ++++...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~---~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCS---RLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHH---HHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHH---HHccCChhHCcCHHHHhcCHhhccccCC
Confidence 0 00111223445555555 9999999999999999987 6666543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=361.00 Aligned_cols=252 Identities=18% Similarity=0.234 Sum_probs=189.2
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc--hhHHHHHHHHHHHhccCCCCccceeeEEEeCC----eeE
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK--LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE----EKL 395 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~----~~~ 395 (611)
+..|...+.||+|+||+||+|+. .+|+.||||+++... ...+++.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 34577789999999999999985 689999999997543 23467899999999999999999999997653 235
Q ss_pred EEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCC
Q 035917 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTS 475 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~ 475 (611)
++++|+.+|+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 556677799999999754 5999999999999999999999 78999999999999999999999999999987643
Q ss_pred CCC-CccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHH---hhcCChh------
Q 035917 476 SDE-SSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQL---SSSGRSK------ 539 (611)
Q Consensus 476 ~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~---~~~~~~~------ 539 (611)
... .......+||+.|+|||++.. ..++.++||||+||++|||++|+.||... .... .......
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 321 122344579999999998744 56789999999999999999999886310 0000 0000000
Q ss_pred -----hhh--chhhc-------CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 540 -----EAI--DKALC-------GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 540 -----~~~--~~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
... .+... ....+.+ +.+++.+||+.||++|||+.|+++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~---~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLFPNADSK---ALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHH---HHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhcccccCCccCCCCHHHhCCCCCHH---HHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 00000 0112233 4455559999999999999999987
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=357.79 Aligned_cols=255 Identities=16% Similarity=0.190 Sum_probs=188.4
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEe--------C
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVV--------E 391 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~--------~ 391 (611)
++|...+.||+|+||+||+|+. .+|+.||||++.... ...+++.+|+++|++++||||+++++++.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 5788889999999999999996 579999999986432 234678999999999999999999999865 3
Q ss_pred CeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccc
Q 035917 392 EEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAK 471 (611)
Q Consensus 392 ~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~ 471 (611)
+..++||||+.++.+..+.. ....++...+..++.|+++||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~-~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCCCccchhhh-cccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecceee
Confidence 45789999998876654443 3356889999999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCCC--CccccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhh-cCChhhh-
Q 035917 472 LMTSSDE--SSFVNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSS-SGRSKEA- 541 (611)
Q Consensus 472 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~-~~~~~~~- 541 (611)
....... .......+||+.|+|||.+.+. .++.++|||||||++|||++|+.||.. ....... .+.....
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 7643221 1222335699999999988754 689999999999999999999888631 0000000 0000000
Q ss_pred ------------hchhhc-CCCCHHH------HHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 542 ------------IDKALC-GKGYDEE------ILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 542 ------------~~~~l~-~~~~~~~------~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
+..... .....+. -..+++++.+||+.||++|||++|+++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000000 0001111 1234556669999999999999999976
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-42 Score=357.90 Aligned_cols=250 Identities=22% Similarity=0.289 Sum_probs=187.7
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCC------e
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEE------E 393 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~------~ 393 (611)
+.|...+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++|++++|||||+++++|...+ +
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 4677788999999999999995 569999999997533 23467899999999999999999999997654 4
Q ss_pred eEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccccc
Q 035917 394 KLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLM 473 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~ 473 (611)
.++||||| +.+|..+.+.. .+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+|++|||+|+..
T Consensus 98 ~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceecc
Confidence 69999999 55788877643 5999999999999999999999 789999999999999999999999999999876
Q ss_pred CCCCCCccccCCCcccccccccccCC-CCCCcccchHHHHHHHHHHhCCCCCHHHH-----HHHHhh-cCC-hhh-----
Q 035917 474 TSSDESSFVNGDLGEFGYIAPEYSST-MVASLKGDVYGIGVVLLELAGFKGNLVDW-----VNQLSS-SGR-SKE----- 540 (611)
Q Consensus 474 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvvl~ell~~~~~~~~~-----~~~~~~-~~~-~~~----- 540 (611)
... .+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||... ...... .+. ..+
T Consensus 172 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 172 DSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp CSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred CCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 432 234469999999998865 45689999999999999999998876321 000000 000 000
Q ss_pred ------hhch---hh-------cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HHHch
Q 035917 541 ------AIDK---AL-------CGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS--LNSIA 587 (611)
Q Consensus 541 ------~~~~---~l-------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~ 587 (611)
.... .. .....++++.+++. +||+.||++|||+.|+++| ++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~---~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHH---HHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred cchhhhhhhccCCcccccchHHhccCCCHHHHHHHH---HHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0000 00 00122344445544 9999999999999999997 66554
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-42 Score=346.75 Aligned_cols=250 Identities=18% Similarity=0.214 Sum_probs=195.9
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeCCeeEEEEe
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVEEEKLLIYK 399 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 399 (611)
+.|...+.||+|+||+||+|+. .+|+.||||+++... ...+++.+|+.+|++++||||+++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 3577788999999999999995 578999999986433 235789999999999999999999999999999999999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecccccccCCCCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLMTSSDES 479 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~~~~~~~ 479 (611)
|+.+++|..++... ..+++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||.++.......
T Consensus 82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~- 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred eccccccccccccc-cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence 99999988877644 46899999999999999999999 78999999999999999999999999999987654332
Q ss_pred ccccCCCcccccccccccCCCC-CCcccchHHHHHHHHHHhCCCCCH------HHHHHHHhh-cCC-h-------hhhhc
Q 035917 480 SFVNGDLGEFGYIAPEYSSTMV-ASLKGDVYGIGVVLLELAGFKGNL------VDWVNQLSS-SGR-S-------KEAID 543 (611)
Q Consensus 480 ~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~SfGvvl~ell~~~~~~------~~~~~~~~~-~~~-~-------~~~~~ 543 (611)
......+++.|+|||.+.... ++.++|||||||++|||++|+.|| .+....... ... . ....+
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 222335788999999887655 689999999999999999998875 122211110 000 0 00000
Q ss_pred ------------hhhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 544 ------------KALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 544 ------------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
........++++.+++. +||+.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~---~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQ---NLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHH---HHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccchhhhccccCCHHHHHHHH---HHccCChhHCcCHHHHhcC
Confidence 00000122344555554 9999999999999999876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.5e-41 Score=351.41 Aligned_cols=190 Identities=18% Similarity=0.278 Sum_probs=164.3
Q ss_pred hcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhccC-CCCccceeeEEEeC--CeeEEEEe
Q 035917 324 NSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLR-HPNLAPLLGYCVVE--EEKLLIYK 399 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~--~~~~lv~e 399 (611)
++|...+.||+|+||+||+|+. .+|+.||||+++.. ..+++.+|+++|++++ ||||+++++++... ...++|||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 5788899999999999999996 57999999999753 3567899999999995 99999999999754 46889999
Q ss_pred ccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC-CeEEeecccccccCCCCC
Q 035917 400 YMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF-DARIMDFGLAKLMTSSDE 478 (611)
Q Consensus 400 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~-~~kl~DFGla~~~~~~~~ 478 (611)
||.+|+|.++.+ .+++..+..++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||+|+.......
T Consensus 113 ~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~ 185 (328)
T d3bqca1 113 HVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185 (328)
T ss_dssp CCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC
T ss_pred ecCCCcHHHHhc----CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCCc
Confidence 999999987643 4899999999999999999999 88999999999999998655 689999999987654332
Q ss_pred CccccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCH
Q 035917 479 SSFVNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNL 525 (611)
Q Consensus 479 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~ 525 (611)
.....||+.|+|||.+.+. .++.++||||+||++|||++|+.||
T Consensus 186 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf 230 (328)
T d3bqca1 186 ---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230 (328)
T ss_dssp ---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred ---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCC
Confidence 2344689999999987764 4799999999999999999998775
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-42 Score=355.27 Aligned_cols=247 Identities=19% Similarity=0.209 Sum_probs=195.2
Q ss_pred hcCCCCCeeeecCCceEEEEEe----CCCCEEEEEeccccc-----hhHHHHHHHHHHHhccCC-CCccceeeEEEeCCe
Q 035917 324 NSFCSENVIISTRTGTTYKAML----PDGSVLAVKRLNTCK-----LGEKKFRNEMNRLGQLRH-PNLAPLLGYCVVEEE 393 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~----~~g~~vAvK~~~~~~-----~~~~~~~~Ev~~l~~l~H-~nIv~l~g~~~~~~~ 393 (611)
++|...+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++|++++| |||+++++++.+.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5688889999999999999984 248999999986532 234568899999999976 899999999999999
Q ss_pred eEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccccc
Q 035917 394 KLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLM 473 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~ 473 (611)
.+++|||+.+|+|.+++.... .++......++.|++.||+|+| +.+|+||||||+|||++.++.+||+|||+++.+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 999999999999999987553 4678889999999999999999 789999999999999999999999999999876
Q ss_pred CCCCCCccccCCCcccccccccccCCC--CCCcccchHHHHHHHHHHhCCCCCHHHHHHHHhhcCChhhhhc----hhh-
Q 035917 474 TSSDESSFVNGDLGEFGYIAPEYSSTM--VASLKGDVYGIGVVLLELAGFKGNLVDWVNQLSSSGRSKEAID----KAL- 546 (611)
Q Consensus 474 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~SfGvvl~ell~~~~~~~~~~~~~~~~~~~~~~~~----~~l- 546 (611)
.... ........|++.|+|||.+.+. .++.++|||||||+||||++|+.||.... .......+.. ...
T Consensus 180 ~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~----~~~~~~~i~~~~~~~~~~ 254 (322)
T d1vzoa_ 180 VADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG----EKNSQAEISRRILKSEPP 254 (322)
T ss_dssp CGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT----SCCCHHHHHHHHHHCCCC
T ss_pred cccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHhcccCCCC
Confidence 4332 2222334699999999988654 46889999999999999999999874310 0111111111 111
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 035917 547 CGKGYDEEILQFLKVACNCVVSRPKDRW-----SMYQVYQS 582 (611)
Q Consensus 547 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 582 (611)
.+...++++.++++ +||+.||++|| |++|+++|
T Consensus 255 ~~~~~s~~~~~li~---~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 255 YPQEMSALAKDLIQ---RLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp CCTTSCHHHHHHHH---HHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CcccCCHHHHHHHH---HHcccCHHHcCCCCcccHHHHHcC
Confidence 12234556666666 99999999999 48899875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-41 Score=349.30 Aligned_cols=247 Identities=19% Similarity=0.238 Sum_probs=187.3
Q ss_pred hhcCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeC-----Ce
Q 035917 323 SNSFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE-----EE 393 (611)
Q Consensus 323 t~~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~-----~~ 393 (611)
++.|...+.||+|+||+||+|+. .+|+.||||+++... ...+++.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 45688889999999999999995 579999999997543 2345789999999999999999999998643 34
Q ss_pred eEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccccc
Q 035917 394 KLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLM 473 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~ 473 (611)
.+++++|+.+|+|.+++... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+|++|||++...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhccc
Confidence 46778888899999999653 5999999999999999999999 789999999999999999999999999999765
Q ss_pred CCCCCCccccCCCcccccccccccCCC-CCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhh-cCC-hhhh----
Q 035917 474 TSSDESSFVNGDLGEFGYIAPEYSSTM-VASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSS-SGR-SKEA---- 541 (611)
Q Consensus 474 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~-~~~-~~~~---- 541 (611)
.. ......||+.|+|||...+. .++.++|||||||++|||++|+.||.. ....... ... ..+.
T Consensus 172 ~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 172 DD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp TG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred Cc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 32 22345699999999986654 468999999999999999999988631 0000000 000 0000
Q ss_pred -------hchhh---c-------CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 542 -------IDKAL---C-------GKGYDEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 542 -------~~~~l---~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
....+ . ....++++.+ ++.+||+.||++|||+.|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d---li~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVD---LLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHH---HHHHHSCSSGGGSCCHHHHHTS
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHH---HHHHHCcCChhhCcCHHHHhcC
Confidence 00000 0 0122344444 4459999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-40 Score=344.13 Aligned_cols=249 Identities=20% Similarity=0.216 Sum_probs=182.8
Q ss_pred hcCCCCCeeeecCCceEEEEEeC-CCCEEEEEeccccc---hhHHHHHHHHHHHhccCCCCccceeeEEEeC------Ce
Q 035917 324 NSFCSENVIISTRTGTTYKAMLP-DGSVLAVKRLNTCK---LGEKKFRNEMNRLGQLRHPNLAPLLGYCVVE------EE 393 (611)
Q Consensus 324 ~~f~~~~~ig~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~Ev~~l~~l~H~nIv~l~g~~~~~------~~ 393 (611)
+.|...++||+|+||+||+|+.. +|+.||||+++... ...+++.+|+.++++++|||||++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 46778899999999999999964 69999999996543 2335689999999999999999999999643 57
Q ss_pred eEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeeccccccc
Q 035917 394 KLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFGLAKLM 473 (611)
Q Consensus 394 ~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~~~ 473 (611)
.|+|||||.++ +.+.+.. .+++..+..++.||+.||.||| +.+|+||||||+|||++.++..|++|||+++..
T Consensus 97 ~~iv~Ey~~~~-l~~~~~~---~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEECCSEE-HHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eEEEEeccchH-HHHhhhc---CCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcc
Confidence 89999999764 5555542 4899999999999999999999 789999999999999999999999999998865
Q ss_pred CCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHH-----HHHHHhh--cC----------
Q 035917 474 TSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVD-----WVNQLSS--SG---------- 536 (611)
Q Consensus 474 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~-----~~~~~~~--~~---------- 536 (611)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.. ....... ..
T Consensus 170 ~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 170 GTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred cccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 4322 22334689999999999999999999999999999999999988621 1000000 00
Q ss_pred ----------------ChhhhhchhhcCCCC---HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 035917 537 ----------------RSKEAIDKALCGKGY---DEEILQFLKVACNCVVSRPKDRWSMYQVYQS 582 (611)
Q Consensus 537 ----------------~~~~~~~~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 582 (611)
............... ...-..+.+++.+|++.||++|||++|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000001111111111 1123355666779999999999999999988
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.9e-37 Score=319.41 Aligned_cols=256 Identities=14% Similarity=0.095 Sum_probs=189.4
Q ss_pred cCCCCCeeeecCCceEEEEEe-CCCCEEEEEeccccchhHHHHHHHHHHHhccC-----------CCCccceeeEEEe--
Q 035917 325 SFCSENVIISTRTGTTYKAML-PDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLR-----------HPNLAPLLGYCVV-- 390 (611)
Q Consensus 325 ~f~~~~~ig~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~-----------H~nIv~l~g~~~~-- 390 (611)
.|...++||+|+||+||+|+. .+|+.||||+++......+.+.+|++++++++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 377789999999999999996 57999999999876666678899999998875 5789999988864
Q ss_pred CCeeEEEEeccCCCChHH-hhh-cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCC------Ce
Q 035917 391 EEEKLLIYKYMSSGTLYS-LLQ-GNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDF------DA 462 (611)
Q Consensus 391 ~~~~~lv~ey~~~gsL~~-~l~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~------~~ 462 (611)
....+++|+++..+.... ... .....+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++ .+
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccccccee
Confidence 345667777765554332 222 223468999999999999999999994 47899999999999998654 38
Q ss_pred EEeecccccccCCCCCCccccCCCcccccccccccCCCCCCcccchHHHHHHHHHHhCCCCCHHHHHH-----------H
Q 035917 463 RIMDFGLAKLMTSSDESSFVNGDLGEFGYIAPEYSSTMVASLKGDVYGIGVVLLELAGFKGNLVDWVN-----------Q 531 (611)
Q Consensus 463 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvvl~ell~~~~~~~~~~~-----------~ 531 (611)
|++|||.++...... ...+||+.|+|||++....++.++||||+||+++||++|+.||..... .
T Consensus 172 kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 172 KIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 999999998654322 234699999999999988999999999999999999999887642100 0
Q ss_pred H-hhcCC-----------hhhhhch-------------------hhcCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 035917 532 L-SSSGR-----------SKEAIDK-------------------ALCGKGYDEEILQFLKVACNCVVSRPKDRWSMYQVY 580 (611)
Q Consensus 532 ~-~~~~~-----------~~~~~~~-------------------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 580 (611)
. ..-+. .....+. .............+.+++.+|++.||++|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 0 00000 0000000 001112234455677788899999999999999999
Q ss_pred HH--HHHch
Q 035917 581 QS--LNSIA 587 (611)
Q Consensus 581 ~~--L~~i~ 587 (611)
+| +++..
T Consensus 327 ~Hp~f~~~~ 335 (362)
T d1q8ya_ 327 NHPWLKDTL 335 (362)
T ss_dssp TCGGGTTCT
T ss_pred cCcccCCCC
Confidence 87 55443
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.94 E-value=1.2e-27 Score=244.44 Aligned_cols=167 Identities=34% Similarity=0.524 Sum_probs=152.1
Q ss_pred CChhHHHHHHHHHHhCCCCCCCCCCCCCCCCCCCCCC--cccceecCCC-CCCcEEEEEecCCcccc--cCCccCcCCCC
Q 035917 47 VAEDDVKCLEGVKSSLNDPQRKLSSWSFGNSTIGFIC--QFVGVSCWND-KENRILNLELREMKLSG--KIPEPLKFCKS 121 (611)
Q Consensus 47 ~~~~d~~aL~~~k~~l~~~~~~l~~W~~~~~~~~~~c--~w~Gv~C~~~-~~~~v~~l~l~~~~l~g--~~p~~l~~l~~ 121 (611)
|.++|++||++||+++.||. .+++|..+ ++|| .|.||+|+.. ..+||+.|+|++++++| .+|+++++|++
T Consensus 3 c~~~e~~aLl~~k~~~~~~~-~l~sW~~~----~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~ 77 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPT-TLSSWLPT----TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPY 77 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCG-GGTTCCTT----SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTT
T ss_pred CCHHHHHHHHHHHHHCCCCC-cCCCCCCC----CCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcc
Confidence 67899999999999999885 68999743 3578 5999999753 23489999999999998 68999999999
Q ss_pred CCEEEccC-CCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCcccccc
Q 035917 122 MQRLDLSA-NDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSV 200 (611)
Q Consensus 122 L~~L~Ls~-N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 200 (611)
|++|+|++ |+|+|.||+++++ +++|++|||++|+|+|..|..+.++.+|+.+++++|.+.+.+|..++++++|+.+++
T Consensus 78 L~~L~Ls~~N~l~g~iP~~i~~-L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l 156 (313)
T d1ogqa_ 78 LNFLYIGGINNLVGPIPPAIAK-LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITF 156 (313)
T ss_dssp CSEEEEEEETTEESCCCGGGGG-CTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEEC
T ss_pred cccccccccccccccccccccc-ccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeec
Confidence 99999997 9999999999999 999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccCCCCCcc
Q 035917 201 ANNDLTGTIPSSFKGFDKA 219 (611)
Q Consensus 201 ~~N~l~g~ip~~~~~~~~~ 219 (611)
++|.++|.+|..+..+..+
T Consensus 157 ~~n~l~~~ip~~~~~l~~l 175 (313)
T d1ogqa_ 157 DGNRISGAIPDSYGSFSKL 175 (313)
T ss_dssp CSSCCEEECCGGGGCCCTT
T ss_pred ccccccccccccccccccc
Confidence 9999999999988766543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=3.3e-23 Score=195.81 Aligned_cols=160 Identities=12% Similarity=0.101 Sum_probs=118.9
Q ss_pred CCCeeeecCCceEEEEEeCCCCEEEEEeccccch-------------------hHHHHHHHHHHHhccCCCCccceeeEE
Q 035917 328 SENVIISTRTGTTYKAMLPDGSVLAVKRLNTCKL-------------------GEKKFRNEMNRLGQLRHPNLAPLLGYC 388 (611)
Q Consensus 328 ~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~~-------------------~~~~~~~Ev~~l~~l~H~nIv~l~g~~ 388 (611)
.++.||+|+||.||+|+..+|+.||||+++.... ....+.+|...+.++.|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 4679999999999999998999999998753211 113456789999999999999877653
Q ss_pred EeCCeeEEEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCeEEeCCCCCeEEeecc
Q 035917 389 VVEEEKLLIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHHGCQPPFLHQNICSNVILVDEDFDARIMDFG 468 (611)
Q Consensus 389 ~~~~~~~lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILld~~~~~kl~DFG 468 (611)
..+++|||++++.+.+ ++......++.|++++++||| +.+|+||||||+|||++++ .++|+|||
T Consensus 84 ----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDFG 147 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDFP 147 (191)
T ss_dssp ----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCCT
T ss_pred ----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEECC
Confidence 2479999998865543 223345678999999999999 7899999999999999965 58999999
Q ss_pred cccccCCCCCCccccCCCcccccccc------cccCCCCCCcccchHHHHHH
Q 035917 469 LAKLMTSSDESSFVNGDLGEFGYIAP------EYSSTMVASLKGDVYGIGVV 514 (611)
Q Consensus 469 la~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~t~ksDV~SfGvv 514 (611)
+|+....... ..|... |.+ ...|+.++|+||..--
T Consensus 148 ~a~~~~~~~~----------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 148 QSVEVGEEGW----------REILERDVRNIITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp TCEETTSTTH----------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred CcccCCCCCc----------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence 9976532211 111111 111 3567889999997543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.67 E-value=1.6e-17 Score=168.51 Aligned_cols=139 Identities=29% Similarity=0.527 Sum_probs=111.9
Q ss_pred cEEEEEecCCcccccCCccCcCCCCC-CEEEccCCCCCccCchhHHh----------------------cCCCCCEEECc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSM-QRLDLSANDLSGNIPAQICN----------------------WLPYLVLLDLS 153 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L-~~L~Ls~N~l~g~ip~~~~~----------------------~l~~L~~L~Ls 153 (611)
.+..+++++|.+.|.+|..++.+..| +.+++++|+++|..|..+.. .+++|+.|+++
T Consensus 150 ~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~ 229 (313)
T d1ogqa_ 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229 (313)
T ss_dssp TCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECC
T ss_pred ccceeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 45677788888888887777776665 66777777666655554432 16678888888
Q ss_pred CCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccCCCCCcc--CCCCCcccCCCCCCCCCCC
Q 035917 154 NNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSS--FKGFDKADFDGNSDLCGGP 231 (611)
Q Consensus 154 ~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~--~~~~~~~~~~~n~~lc~~~ 231 (611)
+|.++|.+| .++.+++|++|+|++|+|+|.+|.+|+++++|++|+|++|+|+|.||.. +.++..+.+.+|..+||.|
T Consensus 230 ~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p 308 (313)
T d1ogqa_ 230 KNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp SSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred ccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCC
Confidence 888888766 5788899999999999999999999999999999999999999999963 4566677889999999998
Q ss_pred CCCCcC
Q 035917 232 LGSKCG 237 (611)
Q Consensus 232 ~~~~c~ 237 (611)
++ .|.
T Consensus 309 lp-~c~ 313 (313)
T d1ogqa_ 309 LP-ACT 313 (313)
T ss_dssp SS-CCC
T ss_pred CC-CCC
Confidence 85 663
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.64 E-value=2.5e-16 Score=148.01 Aligned_cols=129 Identities=20% Similarity=0.234 Sum_probs=109.1
Q ss_pred CCCcccceecCCCC--------CCcEEEEEecCCcccccCCc-cCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEE
Q 035917 81 FICQFVGVSCWNDK--------ENRILNLELREMKLSGKIPE-PLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLD 151 (611)
Q Consensus 81 ~~c~w~Gv~C~~~~--------~~~v~~l~l~~~~l~g~~p~-~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~ 151 (611)
+.|+|..|.|++.. ...++.|+|++|.|++.++. .+..+++|+.|+|++|++.+..+..+.. +++|+.|+
T Consensus 6 C~C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~-~~~L~~L~ 84 (192)
T d1w8aa_ 6 CHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEG-ASHIQELQ 84 (192)
T ss_dssp SEEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTT-CTTCCEEE
T ss_pred CEEcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccccc-ccccceee
Confidence 44789999996432 12578899999999886654 5788999999999999999777777776 89999999
Q ss_pred CcCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccCCCCC
Q 035917 152 LSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIP 210 (611)
Q Consensus 152 Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip 210 (611)
|++|++++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+.+..+
T Consensus 85 Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 85 LGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred eccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence 99999997777788999999999999999998888889999999999999999887654
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.56 E-value=2.5e-15 Score=141.02 Aligned_cols=135 Identities=23% Similarity=0.358 Sum_probs=112.9
Q ss_pred cceecCCCCCCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCc
Q 035917 86 VGVSCWNDKENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADL 165 (611)
Q Consensus 86 ~Gv~C~~~~~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~ 165 (611)
.|-+|.. +.++.++++|+ .+|..+. +++++|+|++|.|++.++...+..+++|+.|+|++|++++.++..+
T Consensus 4 ~~C~C~~------~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~ 74 (192)
T d1w8aa_ 4 AMCHCEG------TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAF 74 (192)
T ss_dssp TTSEEET------TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTT
T ss_pred CCCEEcC------CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccc
Confidence 4667732 26899999998 6787663 7899999999999987765543339999999999999999999999
Q ss_pred cCCcCcccccccccccCCCCChhhhcCCCcccccccccccCCCCCccCCCCC---cccCCCCCCCCC
Q 035917 166 GNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFD---KADFDGNSDLCG 229 (611)
Q Consensus 166 ~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~---~~~~~~n~~lc~ 229 (611)
..+++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+. .+.+.+|+..|.
T Consensus 75 ~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 75 EGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp TTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred ccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence 9999999999999999988888899999999999999999988887776554 455677765543
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.44 E-value=1.1e-13 Score=119.84 Aligned_cols=102 Identities=28% Similarity=0.359 Sum_probs=89.7
Q ss_pred EEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccccccc
Q 035917 100 NLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNN 179 (611)
Q Consensus 100 ~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N 179 (611)
.|+|++|+++ .++ .+..++.|++|+|++|.++ .+|+.+.. +++|+.|++++|.++ .+| .++++++|+.|++++|
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~-l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAA-LRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGG-CTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhh-hhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 5899999998 444 4899999999999999998 68988887 999999999999998 466 5899999999999999
Q ss_pred ccCCCC-ChhhhcCCCcccccccccccCC
Q 035917 180 KLSGPI-PYQLSNLGRLKKFSVANNDLTG 207 (611)
Q Consensus 180 ~l~g~i-P~~l~~l~~L~~L~l~~N~l~g 207 (611)
+++..- +..+..+++|+.|++++|+++.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 998543 3568999999999999999974
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=1.1e-12 Score=129.21 Aligned_cols=131 Identities=29% Similarity=0.281 Sum_probs=109.0
Q ss_pred CcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccc
Q 035917 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
..+..|+|++|.+.+. ++.+..+++|+.|+|++|.+.+..+..+.. +.+|+.|++++|.+++..|..+..+++|+.|+
T Consensus 77 ~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~-l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~ 154 (266)
T d1p9ag_ 77 PVLGTLDLSHNQLQSL-PLLGQTLPALTVLDVSFNRLTSLPLGALRG-LGELQELYLKGNELKTLPPGLLTPTPKLEKLS 154 (266)
T ss_dssp TTCCEEECCSSCCSSC-CCCTTTCTTCCEEECCSSCCCCCCSSTTTT-CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccccccccccccccc-ccccccccccccccccccccceeecccccc-ccccccccccccccceeccccccccccchhcc
Confidence 3577889999988754 567888899999999999988654555554 89999999999999976666778899999999
Q ss_pred ccccccCCCCChhhhcCCCcccccccccccCCCCCccCCCC---CcccCCCCCCCCC
Q 035917 176 LSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF---DKADFDGNSDLCG 229 (611)
Q Consensus 176 L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~---~~~~~~~n~~lc~ 229 (611)
+++|+|++..|..|..+++|++|+|++|+|+ .||.++..+ ..+.+.||+..|.
T Consensus 155 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 155 LANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp CTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred cccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCC
Confidence 9999999988888999999999999999999 899876554 4456788887775
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=5.4e-13 Score=132.60 Aligned_cols=132 Identities=22% Similarity=0.266 Sum_probs=113.7
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
++..|+|++|++.+..+..+..+..|+.+++++|+|++..+..+.. +++|+.|+|++|+|++..|..+.++++|+.|++
T Consensus 106 ~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~-~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l 184 (284)
T d1ozna_ 106 RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD-LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184 (284)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT-CTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCEEecCCcccccccccccchhcccchhhhccccccccChhHhcc-ccchhhcccccCcccccchhhhccccccchhhh
Confidence 5788999999998877888889999999999999999544445555 899999999999999888888999999999999
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCCccCCCC---CcccCCCCCCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGF---DKADFDGNSDLCG 229 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~---~~~~~~~n~~lc~ 229 (611)
++|++++..|..|.++++|++|++++|.+++..|..++++ ..+.+.+|+..|.
T Consensus 185 ~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred hhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence 9999999999999999999999999999999888776654 4556778876663
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.26 E-value=2.5e-12 Score=127.68 Aligned_cols=114 Identities=21% Similarity=0.155 Sum_probs=104.8
Q ss_pred CcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccc
Q 035917 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
..+..+++++|.|++..+..+..++.|+.|+|++|+|++..|..+.. +++|+.|++++|++++..|..+.++++|++||
T Consensus 129 ~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~-l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~ 207 (284)
T d1ozna_ 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRG-LHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207 (284)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTT-CTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred cccchhhhccccccccChhHhccccchhhcccccCcccccchhhhcc-ccccchhhhhhccccccChhHhhhhhhccccc
Confidence 35789999999999877788999999999999999999765666666 99999999999999999999999999999999
Q ss_pred ccccccCCCCChhhhcCCCcccccccccccCCCCC
Q 035917 176 LSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIP 210 (611)
Q Consensus 176 L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip 210 (611)
+++|.+++..|..|+++++|++|++++|.+.+..+
T Consensus 208 l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 208 LFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp CCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred ccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 99999999999999999999999999999998765
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.23 E-value=8.1e-12 Score=122.76 Aligned_cols=108 Identities=27% Similarity=0.280 Sum_probs=78.7
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.++.|+|++|.+++..+..+..+++|+.|+|++|+|+ .||.. .. +++|+.|+|++|++++ +|..+.++++|++|+|
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~~-~~-l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GT-LPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDV 107 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEECC-SC-CTTCCEEECCSSCCSS-CCCCTTTCTTCCEEEC
T ss_pred CCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccccc-cc-cccccccccccccccc-cccccccccccccccc
Confidence 5788999999998877777888999999999999888 56643 44 8888888888888874 4566777777777777
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGT 208 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ 208 (611)
++|.+.+..+..+..+.+|+.|++++|.+++.
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l 139 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTL 139 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCC
T ss_pred cccccceeecccccccccccccccccccccee
Confidence 77777665555555555555555555555433
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.23 E-value=6.8e-12 Score=108.38 Aligned_cols=97 Identities=29% Similarity=0.419 Sum_probs=80.4
Q ss_pred CEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCcccccccc
Q 035917 123 QRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVAN 202 (611)
Q Consensus 123 ~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~ 202 (611)
++|||++|+++ .+| .+.. +++|++|||++|.++ .+|+.++.+++|++|++++|.|++ +| .+..+++|++|++++
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~-l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~ 74 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQ-LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN 74 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGG-GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred CEEEcCCCCCC-CCc-cccc-CCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCC
Confidence 58999999999 666 4777 999999999999998 789899999999999999999995 56 489999999999999
Q ss_pred cccCCCC-CccCCC---CCcccCCCCC
Q 035917 203 NDLTGTI-PSSFKG---FDKADFDGNS 225 (611)
Q Consensus 203 N~l~g~i-p~~~~~---~~~~~~~~n~ 225 (611)
|+++..- +..+.. +..+.+.+|+
T Consensus 75 N~i~~~~~~~~l~~~~~L~~L~l~~N~ 101 (124)
T d1dcea3 75 NRLQQSAAIQPLVSCPRLVLLNLQGNS 101 (124)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSG
T ss_pred CccCCCCCchhhcCCCCCCEEECCCCc
Confidence 9998543 234444 4445566665
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.18 E-value=7.2e-12 Score=113.59 Aligned_cols=105 Identities=24% Similarity=0.213 Sum_probs=62.3
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
++..|+|++|+++.. +..+..+++|+.||||+|.++ .++ .+.. +++|+.|+|++|+++...|..+..+++|+.|+|
T Consensus 19 ~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~-l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 19 RDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIR-KLD-GFPL-LRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 94 (162)
T ss_dssp SCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCC-EEC-CCCC-CSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred cCcEEECCCCCCCcc-CccccccccCCEEECCCCCCC-ccC-Cccc-CcchhhhhcccccccCCCcccccccccccccee
Confidence 455666666666543 444455666666777666666 443 2444 666666677666666433333455666666666
Q ss_pred cccccCCCCC--hhhhcCCCcccccccccccC
Q 035917 177 SNNKLSGPIP--YQLSNLGRLKKFSVANNDLT 206 (611)
Q Consensus 177 ~~N~l~g~iP--~~l~~l~~L~~L~l~~N~l~ 206 (611)
++|+++. ++ ..+..+++|++|++++|.++
T Consensus 95 ~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 95 TNNSLVE-LGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG
T ss_pred ccccccc-cccccccccccccchhhcCCCccc
Confidence 6666653 22 24566666666666666654
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.17 E-value=3.1e-11 Score=108.58 Aligned_cols=108 Identities=18% Similarity=0.161 Sum_probs=84.5
Q ss_pred CCcccceecCCCCCCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCC-CCccCch-hHHhcCCCCCEEECcCCcCcc
Q 035917 82 ICQFVGVSCWNDKENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSAND-LSGNIPA-QICNWLPYLVLLDLSNNDLSG 159 (611)
Q Consensus 82 ~c~w~Gv~C~~~~~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~-l~g~ip~-~~~~~l~~L~~L~Ls~N~l~G 159 (611)
|+.+.+|+|.+ +++. .+|..+..+++|+.|+|++|+ ++ .|+. .|.. +++|+.|+|++|+++.
T Consensus 7 c~~~~~l~c~~-------------~~~~-~~p~~l~~l~~l~~L~l~~n~~l~-~i~~~~f~~-l~~L~~L~Ls~N~l~~ 70 (156)
T d2ifga3 7 PHGSSGLRCTR-------------DGAL-DSLHHLPGAENLTELYIENQQHLQ-HLELRDLRG-LGELRNLTIVKSGLRF 70 (156)
T ss_dssp CSSSSCEECCS-------------SCCC-TTTTTSCSCSCCSEEECCSCSSCC-EECGGGSCS-CCCCSEEECCSSCCCE
T ss_pred cCCCCeEEecC-------------CCCc-cCcccccCccccCeeecCCCcccc-ccCchhhcc-ccccCcceeeccccCC
Confidence 34577788843 2222 456678889999999998765 77 5664 4555 9999999999999997
Q ss_pred cCccCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccC
Q 035917 160 PIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLT 206 (611)
Q Consensus 160 ~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~ 206 (611)
.-|..+..+++|++|+|++|+|+ .+|.......+|+.|+|++|.|.
T Consensus 71 i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 71 VAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp ECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred cccccccccccccceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 77778999999999999999999 66655555557999999999885
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.17 E-value=3.3e-11 Score=120.51 Aligned_cols=77 Identities=26% Similarity=0.261 Sum_probs=52.3
Q ss_pred CCCcccceecCCCC--------CCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEEC
Q 035917 81 FICQFVGVSCWNDK--------ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDL 152 (611)
Q Consensus 81 ~~c~w~Gv~C~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~L 152 (611)
+-|.|.+|.|++.+ ...++.|+|++|+++...+..+.++++|+.|++++|.+....|..+.. +++|+.|+|
T Consensus 8 c~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~-l~~L~~L~l 86 (305)
T d1xkua_ 8 CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAP-LVKLERLYL 86 (305)
T ss_dssp CEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTT-CTTCCEEEC
T ss_pred CEecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhC-CCccCEecc
Confidence 34789999996521 135778999999888665566777788888888877777544555554 555555555
Q ss_pred cCCcCc
Q 035917 153 SNNDLS 158 (611)
Q Consensus 153 s~N~l~ 158 (611)
++|+++
T Consensus 87 ~~n~l~ 92 (305)
T d1xkua_ 87 SKNQLK 92 (305)
T ss_dssp CSSCCS
T ss_pred cCCccC
Confidence 555543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.10 E-value=3.3e-11 Score=109.09 Aligned_cols=107 Identities=18% Similarity=0.153 Sum_probs=84.8
Q ss_pred cCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCC
Q 035917 115 PLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGR 194 (611)
Q Consensus 115 ~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~ 194 (611)
.+.++..|+.|||++|.++ .||..+.. +++|+.||||+|.++ .++ .+..+++|++|+|++|+++...|..+..+++
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~-l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~ 88 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGAT-LDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPD 88 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGG-TTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccc-cccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccc
Confidence 4567889999999999998 67765555 899999999999998 564 5889999999999999999766666788999
Q ss_pred cccccccccccCCCCC-ccCC---CCCcccCCCCC
Q 035917 195 LKKFSVANNDLTGTIP-SSFK---GFDKADFDGNS 225 (611)
Q Consensus 195 L~~L~l~~N~l~g~ip-~~~~---~~~~~~~~~n~ 225 (611)
|+.|++++|+++..-. ..+. ++..+.+.+|+
T Consensus 89 L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~ 123 (162)
T d1a9na_ 89 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNP 123 (162)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSG
T ss_pred cccceeccccccccccccccccccccchhhcCCCc
Confidence 9999999999985311 2333 34444555553
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.05 E-value=1.8e-10 Score=103.38 Aligned_cols=112 Identities=17% Similarity=0.142 Sum_probs=90.0
Q ss_pred CcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCc-CcccCccCccCCcCcccccccccccCCCCChhhhcCCC
Q 035917 116 LKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNND-LSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGR 194 (611)
Q Consensus 116 l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~-l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~ 194 (611)
.+.+.....++.+++++. .+|..+.. +++|+.|+|++|+ ++..-+..|.++++|+.|+|++|+|+..-|..|..+++
T Consensus 4 ~C~c~~~~~l~c~~~~~~-~~p~~l~~-l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~ 81 (156)
T d2ifga3 4 ACCPHGSSGLRCTRDGAL-DSLHHLPG-AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81 (156)
T ss_dssp SSCCSSSSCEECCSSCCC-TTTTTSCS-CSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSC
T ss_pred CCCcCCCCeEEecCCCCc-cCcccccC-ccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccc
Confidence 345566678999999998 67888877 8999999998765 77555567899999999999999999888888999999
Q ss_pred cccccccccccCCCCCccCCC--CCcccCCCCCCCCC
Q 035917 195 LKKFSVANNDLTGTIPSSFKG--FDKADFDGNSDLCG 229 (611)
Q Consensus 195 L~~L~l~~N~l~g~ip~~~~~--~~~~~~~~n~~lc~ 229 (611)
|++|+|++|+|+..-+..+.. +..+.+.+|+..|.
T Consensus 82 L~~L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~ 118 (156)
T d2ifga3 82 LSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCS 118 (156)
T ss_dssp CCEEECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred ccceeccCCCCcccChhhhccccccccccCCCcccCC
Confidence 999999999999544444443 44566778876653
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.04 E-value=1.5e-10 Score=115.52 Aligned_cols=126 Identities=25% Similarity=0.337 Sum_probs=104.3
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.+..+++++++++- +|.. .+++|+.|++++|..++.+|..+.. ++.++.|++++|.+++..|..+.++++|++|+|
T Consensus 151 ~L~~l~l~~n~l~~-l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~-~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L 226 (305)
T d1xkua_ 151 KLSYIRIADTNITT-IPQG--LPPSLTELHLDGNKITKVDAASLKG-LNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 226 (305)
T ss_dssp TCCEEECCSSCCCS-CCSS--CCTTCSEEECTTSCCCEECTGGGTT-CTTCCEEECCSSCCCEECTTTGGGSTTCCEEEC
T ss_pred ccCccccccCCccc-cCcc--cCCccCEEECCCCcCCCCChhHhhc-cccccccccccccccccccccccccccceeeec
Confidence 57789999998763 5543 3689999999999999988888887 899999999999999888889999999999999
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCCc-cC---------CCCCcccCCCCCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPS-SF---------KGFDKADFDGNSDLC 228 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~-~~---------~~~~~~~~~~n~~lc 228 (611)
++|+|+ .+|..|.++++|++|+|++|+++. |+. .| .++..+.+.+|+.-+
T Consensus 227 ~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~-i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 227 NNNKLV-KVPGGLADHKYIQVVYLHNNNISA-IGSNDFCPPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp CSSCCS-SCCTTTTTCSSCCEEECCSSCCCC-CCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred cccccc-ccccccccccCCCEEECCCCccCc-cChhhccCcchhcccCCCCEEECCCCcCcc
Confidence 999998 789899999999999999999984 432 22 234445677777543
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.94 E-value=5.4e-10 Score=114.56 Aligned_cols=61 Identities=31% Similarity=0.452 Sum_probs=28.6
Q ss_pred CCCCCEEECcCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccCCC
Q 035917 144 LPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGT 208 (611)
Q Consensus 144 l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ 208 (611)
+++++.|+|++|++++..| +..+++|+.|+|++|+|++ +| .|+++++|++|++++|++++.
T Consensus 306 ~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l 366 (384)
T d2omza2 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDL 366 (384)
T ss_dssp CTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBC
T ss_pred hcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCC
Confidence 3444444444444443221 4444555555555555542 23 345555555555555555543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.90 E-value=1.6e-09 Score=101.16 Aligned_cols=119 Identities=28% Similarity=0.421 Sum_probs=77.2
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.++.|+|++|.+++..| ++.+++|+.|++++|.+. .+|. +.. ++.|+.|++++|.+.... .+..+++|+.|++
T Consensus 63 nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~~-l~~-l~~L~~L~l~~~~~~~~~--~~~~l~~L~~L~l 135 (199)
T d2omxa2 63 NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DITP-LAN-LTNLTGLTLFNNQITDID--PLKNLTNLNRLEL 135 (199)
T ss_dssp TCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCGG-GTT-CTTCSEEECCSSCCCCCG--GGTTCTTCSEEEC
T ss_pred CcCcCccccccccCccc--ccCCcccccccccccccc-cccc-ccc-cccccccccccccccccc--ccchhhhhHHhhh
Confidence 57778888887776432 777778888888887776 3443 555 777777777777776432 3666777777777
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCC-ccCCCCCcccCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIP-SSFKGFDKADFDGN 224 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip-~~~~~~~~~~~~~n 224 (611)
++|++.. +| .+..+++|+.|++++|++++..| ..+.++..+.+.+|
T Consensus 136 ~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l~~l~~l~~L~~L~ls~N 182 (199)
T d2omxa2 136 SSNTISD-IS-ALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSN 182 (199)
T ss_dssp CSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSS
T ss_pred hhhhhcc-cc-cccccccccccccccccccCCccccCCCCCCEEECCCC
Confidence 7777763 33 46777777777777777775432 12333444445544
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.88 E-value=2e-09 Score=101.30 Aligned_cols=119 Identities=27% Similarity=0.375 Sum_probs=83.6
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
+++.|+|++|.+++. + .++.|++|+.|++++|++++ +| .+.. +++|+.|++++|.+. .++ .+..+++|+.+++
T Consensus 69 ~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~-l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~~ 141 (210)
T d1h6ta2 69 NVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LS-SLKD-LKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYL 141 (210)
T ss_dssp TCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GG-GGTT-CTTCCEEECTTSCCC-CCG-GGGGCTTCCEEEC
T ss_pred CCCEEeCCCccccCc-c-ccccCccccccccccccccc-cc-cccc-ccccccccccccccc-ccc-ccccccccccccc
Confidence 578889998888863 3 36788889999999888884 66 4565 888888888888876 333 5667777788888
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCCCC-ccCCCCCcccCCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIP-SSFKGFDKADFDGN 224 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip-~~~~~~~~~~~~~n 224 (611)
+.|.+++. ..+..+++|+.+++++|++++..| ..+.++..+.+.+|
T Consensus 142 ~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i~~l~~l~~L~~L~Ls~N 188 (210)
T d1h6ta2 142 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKN 188 (210)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSS
T ss_pred cccccccc--ccccccccccccccccccccccccccCCCCCCEEECCCC
Confidence 87777743 246677788888888888775433 12334444455555
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.86 E-value=1.3e-09 Score=104.66 Aligned_cols=102 Identities=22% Similarity=0.265 Sum_probs=76.9
Q ss_pred CCcccceecCCCC--------CCcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECc
Q 035917 82 ICQFVGVSCWNDK--------ENRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLS 153 (611)
Q Consensus 82 ~c~w~Gv~C~~~~--------~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls 153 (611)
-|.+..|.|.+.. ...++.|+|++|.+....+..+..+++|++|+|++|.+...+|...+..+++++.|++.
T Consensus 7 ~C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 7 HCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp EECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CCcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 3678888996321 12588999999999876666789999999999999999877776433337777877765
Q ss_pred -CCcCcccCccCccCCcCcccccccccccCC
Q 035917 154 -NNDLSGPIPADLGNCTYLNTLILSNNKLSG 183 (611)
Q Consensus 154 -~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g 183 (611)
.|++....|..+.++++|+.|++++|.+..
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~ 117 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNTGIKH 117 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESCCCCS
T ss_pred ccccccccccccccccccccccccchhhhcc
Confidence 466776666667778888888888877753
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.84 E-value=3.1e-09 Score=99.06 Aligned_cols=102 Identities=25% Similarity=0.449 Sum_probs=86.8
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.++.|+++++++.. + +.+..+++|++|+|++|.+++ +++ +.. +++|+.|++++|.+. .+| .+.++++|+.|++
T Consensus 41 ~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~-~~~-l~~-l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l 113 (199)
T d2omxa2 41 QVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-ITP-LKN-LTKLVDILMNNNQIA-DIT-PLANLTNLTGLTL 113 (199)
T ss_dssp TCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CGG-GTT-CTTCCEEECCSSCCC-CCG-GGTTCTTCSEEEC
T ss_pred CCCEEECCCCCCCC-c-cccccCCCcCcCccccccccC-ccc-ccC-Ccccccccccccccc-ccc-ccccccccccccc
Confidence 57899999998874 3 347889999999999999996 443 777 999999999999987 455 4889999999999
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTG 207 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g 207 (611)
++|.+.... .+..+++|+.|++++|++..
T Consensus 114 ~~~~~~~~~--~~~~l~~L~~L~l~~n~l~~ 142 (199)
T d2omxa2 114 FNNQITDID--PLKNLTNLNRLELSSNTISD 142 (199)
T ss_dssp CSSCCCCCG--GGTTCTTCSEEECCSSCCCC
T ss_pred ccccccccc--ccchhhhhHHhhhhhhhhcc
Confidence 999988643 48899999999999999975
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.82 E-value=2.2e-09 Score=109.81 Aligned_cols=82 Identities=30% Similarity=0.457 Sum_probs=72.3
Q ss_pred cCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCC
Q 035917 115 PLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGR 194 (611)
Q Consensus 115 ~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~ 194 (611)
.+..++.++.|+|++|++++ +++ +.. +++|+.|+|++|++++ +| .+++|++|++|+|++|++++..| +.++++
T Consensus 302 ~~~~~~~l~~L~ls~n~l~~-l~~-l~~-l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~ 374 (384)
T d2omza2 302 PISNLKNLTYLTLYFNNISD-ISP-VSS-LTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTR 374 (384)
T ss_dssp GGGGCTTCSEEECCSSCCSC-CGG-GGG-CTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTT
T ss_pred ccchhcccCeEECCCCCCCC-Ccc-ccc-CCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCC
Confidence 46778899999999999996 443 666 9999999999999985 55 68999999999999999997665 899999
Q ss_pred ccccccccc
Q 035917 195 LKKFSVANN 203 (611)
Q Consensus 195 L~~L~l~~N 203 (611)
|+.|+|++|
T Consensus 375 L~~L~L~~N 383 (384)
T d2omza2 375 ITQLGLNDQ 383 (384)
T ss_dssp CSEEECCCE
T ss_pred CCEeeCCCC
Confidence 999999998
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.81 E-value=4.6e-09 Score=98.81 Aligned_cols=113 Identities=29% Similarity=0.415 Sum_probs=93.2
Q ss_pred CcEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCccccc
Q 035917 96 NRILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLI 175 (611)
Q Consensus 96 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~ 175 (611)
.++..|+|++|.+++ +| .+..+++|+.|++++|.+. .++ .+.. +++|+.++++.|.+++. ..++++++|+.++
T Consensus 90 ~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~-~~~-~l~~-l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~ 162 (210)
T d1h6ta2 90 KNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGIS-DIN-GLVH-LPQLESLYLGNNKITDI--TVLSRLTKLDTLS 162 (210)
T ss_dssp TTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCC-CCG-GGGG-CTTCCEEECCSSCCCCC--GGGGGCTTCSEEE
T ss_pred ccccccccccccccc-cc-ccccccccccccccccccc-ccc-cccc-ccccccccccccccccc--ccccccccccccc
Confidence 368899999999986 33 5899999999999999987 454 4666 89999999999999853 3577899999999
Q ss_pred ccccccCCCCChhhhcCCCcccccccccccCCCCCccCCCCCcc
Q 035917 176 LSNNKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKA 219 (611)
Q Consensus 176 L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~~~ 219 (611)
+++|++++ ++. +.++++|+.|+|++|+++. +| .+.+++.+
T Consensus 163 l~~n~l~~-i~~-l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L 202 (210)
T d1h6ta2 163 LEDNQISD-IVP-LAGLTKLQNLYLSKNHISD-LR-ALAGLKNL 202 (210)
T ss_dssp CCSSCCCC-CGG-GTTCTTCCEEECCSSCCCB-CG-GGTTCTTC
T ss_pred cccccccc-ccc-ccCCCCCCEEECCCCCCCC-Ch-hhcCCCCC
Confidence 99999996 443 8999999999999999984 55 45555444
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.80 E-value=6e-11 Score=111.12 Aligned_cols=87 Identities=24% Similarity=0.354 Sum_probs=49.7
Q ss_pred cCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCC
Q 035917 115 PLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGR 194 (611)
Q Consensus 115 ~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~ 194 (611)
++..|++|+.|+|++|+++ .|+ .+.. +++|+.|+|++|.++ .+|.....+++|+.|++++|+++. ++ .+..+++
T Consensus 43 sl~~L~~L~~L~Ls~n~I~-~i~-~l~~-l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~ 116 (198)
T d1m9la_ 43 TLSTLKACKHLALSTNNIE-KIS-SLSG-MENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVN 116 (198)
T ss_dssp HHHHTTTCCEEECSEEEES-CCC-CHHH-HTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHH
T ss_pred HHhcccccceeECcccCCC-Ccc-cccC-CccccChhhcccccc-cccccccccccccccccccccccc-cc-ccccccc
Confidence 4555666666666666665 444 3444 566666666666665 455444444556666666666653 22 3555666
Q ss_pred cccccccccccCC
Q 035917 195 LKKFSVANNDLTG 207 (611)
Q Consensus 195 L~~L~l~~N~l~g 207 (611)
|+.|++++|+++.
T Consensus 117 L~~L~L~~N~i~~ 129 (198)
T d1m9la_ 117 LRVLYMSNNKITN 129 (198)
T ss_dssp SSEEEESEEECCC
T ss_pred ccccccccchhcc
Confidence 6666666666653
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.79 E-value=5.1e-11 Score=111.59 Aligned_cols=107 Identities=23% Similarity=0.245 Sum_probs=89.9
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.+..|+|++|+++ .++ .+..|++|+.|+|++|.++ .||..... +++|+.|++++|+++. ++ .+.++++|+.|+|
T Consensus 49 ~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~-~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~L 122 (198)
T d1m9la_ 49 ACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAV-ADTLEELWISYNQIAS-LS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHH-HHHCCEEECSEEECCC-HH-HHHHHHHSSEEEE
T ss_pred ccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccc-cccccccccccccccc-cc-ccccccccccccc
Confidence 5889999999998 454 5899999999999999998 68866555 6789999999999984 44 4788999999999
Q ss_pred cccccCCCCC-hhhhcCCCcccccccccccCCCC
Q 035917 177 SNNKLSGPIP-YQLSNLGRLKKFSVANNDLTGTI 209 (611)
Q Consensus 177 ~~N~l~g~iP-~~l~~l~~L~~L~l~~N~l~g~i 209 (611)
++|+++..-. ..|..+++|+.|++++|.+....
T Consensus 123 ~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 156 (198)
T d1m9la_ 123 SNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDY 156 (198)
T ss_dssp SEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHH
T ss_pred ccchhccccccccccCCCccceeecCCCccccCc
Confidence 9999984322 46899999999999999876543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.70 E-value=1.3e-08 Score=96.66 Aligned_cols=104 Identities=29% Similarity=0.506 Sum_probs=57.3
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCc--------------
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIP-------------- 162 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP-------------- 162 (611)
.+..|+|++|.+.+..| +..++.|+.|++++|.++ .++ .+.. +++|+.|++++|...+..+
T Consensus 64 ~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~-l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~ 138 (227)
T d1h6ua2 64 NLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAG-LQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDL 138 (227)
T ss_dssp TCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTT-CTTCCEEECTTSCCCCCGGGTTCTTCCEEECCS
T ss_pred CCcEeecCCceeecccc--cccccccccccccccccc-ccc-cccc-cccccccccccccccccchhccccchhhhhchh
Confidence 57777787777765432 566666666666666665 343 2333 5555555555554443211
Q ss_pred ------cCccCCcCcccccccccccCCCCChhhhcCCCcccccccccccCC
Q 035917 163 ------ADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFSVANNDLTG 207 (611)
Q Consensus 163 ------~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g 207 (611)
..+.++++|+.|++++|.+++..+ ++++++|+.|+|++|++++
T Consensus 139 ~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~--l~~l~~L~~L~Ls~n~l~~ 187 (227)
T d1h6ua2 139 NQITNISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD 187 (227)
T ss_dssp SCCCCCGGGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred hhhchhhhhccccccccccccccccccchh--hcccccceecccCCCccCC
Confidence 112344556666666665553322 5556666666666666654
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.63 E-value=2.1e-08 Score=95.17 Aligned_cols=103 Identities=29% Similarity=0.416 Sum_probs=73.2
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
.+..++++++...+. ..+...+.+..+.++++.+....+ +.. +++|+.|++++|.+++..+ ++++++|+.|+|
T Consensus 108 ~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~--~~~-~~~L~~L~l~~n~~~~~~~--l~~l~~L~~L~L 180 (227)
T d1h6ua2 108 SIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNISP--LAG-LTNLQYLSIGNAQVSDLTP--LANLSKLTTLKA 180 (227)
T ss_dssp TCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCGG--GGG-CTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred ccccccccccccccc--chhccccchhhhhchhhhhchhhh--hcc-ccccccccccccccccchh--hcccccceeccc
Confidence 466777777765543 235667778888888888775433 344 7788888888888764332 777888888888
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGT 208 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ 208 (611)
++|++++ +|. +.++++|++|+|++|++++.
T Consensus 181 s~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~i 210 (227)
T d1h6ua2 181 DDNKISD-ISP-LASLPNLIEVHLKNNQISDV 210 (227)
T ss_dssp CSSCCCC-CGG-GGGCTTCCEEECTTSCCCBC
T ss_pred CCCccCC-Chh-hcCCCCCCEEECcCCcCCCC
Confidence 8888875 443 77888888888888888753
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.46 E-value=1.3e-07 Score=94.72 Aligned_cols=97 Identities=34% Similarity=0.420 Sum_probs=80.4
Q ss_pred cEEEEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccc
Q 035917 97 RILNLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLIL 176 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L 176 (611)
+++.|+|++++|+ .+|+. +++|++|+|++|+|+ .||.. +.+|+.|++++|+++ .|+. +. +.|++|+|
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~----~~~L~~L~l~~n~l~-~l~~-lp--~~L~~L~L 105 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLK-ALSD-LP--PLLEYLGV 105 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC----CTTCCEEECCSSCCS-CCCS-CC--TTCCEEEC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc----hhhhhhhhhhhcccc-hhhh-hc--cccccccc
Confidence 4678999999997 57753 578999999999999 88864 567999999999997 5553 21 46999999
Q ss_pred cccccCCCCChhhhcCCCcccccccccccCCC
Q 035917 177 SNNKLSGPIPYQLSNLGRLKKFSVANNDLTGT 208 (611)
Q Consensus 177 ~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ 208 (611)
++|.++ .+|. ++.+++|+.|++++|.+++.
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~ 135 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL 135 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCSCC
T ss_pred cccccc-cccc-hhhhccceeecccccccccc
Confidence 999998 6775 68899999999999998754
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.46 E-value=1.2e-07 Score=90.43 Aligned_cols=104 Identities=22% Similarity=0.276 Sum_probs=87.1
Q ss_pred EEEecCCcccccCCccCcCCCCCCEEEccCCCCCccCch-hHHhcCCCCCEEECcCCcCcccCcc-CccCCcCccccccc
Q 035917 100 NLELREMKLSGKIPEPLKFCKSMQRLDLSANDLSGNIPA-QICNWLPYLVLLDLSNNDLSGPIPA-DLGNCTYLNTLILS 177 (611)
Q Consensus 100 ~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~ip~-~~~~~l~~L~~L~Ls~N~l~G~iP~-~~~~l~~L~~L~L~ 177 (611)
.++.++.+|. .+|+.+. +++++|+|++|+++ .||. .|.. +++|++|+|++|.+...+|. .+.++++++.|++.
T Consensus 12 ~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~-~l~~~~f~~-l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 12 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSG-FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCC-EECTTTTTT-CTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred EEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCC-ccChhHhhc-cchhhhhhhccccccceeecccccccccccccccc
Confidence 5777888888 7887653 58999999999998 5665 4555 99999999999999887765 57889999999876
Q ss_pred c-cccCCCCChhhhcCCCcccccccccccCCC
Q 035917 178 N-NKLSGPIPYQLSNLGRLKKFSVANNDLTGT 208 (611)
Q Consensus 178 ~-N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ 208 (611)
. |++....|..|.++++|+.|++++|.+...
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~ 118 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHL 118 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESCCCCSC
T ss_pred ccccccccccccccccccccccccchhhhccc
Confidence 4 788888888899999999999999999754
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.22 E-value=3.2e-07 Score=82.10 Aligned_cols=81 Identities=26% Similarity=0.287 Sum_probs=42.4
Q ss_pred cCCCCCCEEEccCCCCCcc--CchhHHhcCCCCCEEECcCCcCcccCcc-CccCCcCcccccccccccCCCCChh-----
Q 035917 117 KFCKSMQRLDLSANDLSGN--IPAQICNWLPYLVLLDLSNNDLSGPIPA-DLGNCTYLNTLILSNNKLSGPIPYQ----- 188 (611)
Q Consensus 117 ~~l~~L~~L~Ls~N~l~g~--ip~~~~~~l~~L~~L~Ls~N~l~G~iP~-~~~~l~~L~~L~L~~N~l~g~iP~~----- 188 (611)
..++.|++|+||+|+++.- ++..+.. +++|+.|||++|.++ .+++ ......+|+.|+|++|.++......
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~-l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~ 139 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQK-APNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYIS 139 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHH-STTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHH
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhh-CCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcccchhHHH
Confidence 3456666666666666531 2333444 666666666666665 2332 1222335666666666666544421
Q ss_pred --hhcCCCccccc
Q 035917 189 --LSNLGRLKKFS 199 (611)
Q Consensus 189 --l~~l~~L~~L~ 199 (611)
+..+++|+.||
T Consensus 140 ~i~~~~P~L~~LD 152 (162)
T d1koha1 140 AIRERFPKLLRLD 152 (162)
T ss_dssp HHHTTSTTCCEET
T ss_pred HHHHHCCCCCEEC
Confidence 34456666554
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.20 E-value=2.1e-06 Score=82.59 Aligned_cols=147 Identities=12% Similarity=0.055 Sum_probs=93.8
Q ss_pred HHHHhhhcCCCCCeeeecCCceEEEEEeCCCCEEEEEeccccc-hhHHHHHHHHHHHhccC-CCCccceeeEEEeCCeeE
Q 035917 318 DLMAASNSFCSENVIISTRTGTTYKAMLPDGSVLAVKRLNTCK-LGEKKFRNEMNRLGQLR-HPNLAPLLGYCVVEEEKL 395 (611)
Q Consensus 318 ~l~~~t~~f~~~~~ig~G~~g~Vy~~~~~~g~~vAvK~~~~~~-~~~~~~~~Ev~~l~~l~-H~nIv~l~g~~~~~~~~~ 395 (611)
++...-++|......+.++.+.||+... +++.+.+|+..... .....+.+|...+..+. +--+.+++.+...++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4444445554433333344568999865 55667788875432 22345778888887774 333567788888888999
Q ss_pred EEEeccCCCChHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhh-------------------------------------
Q 035917 396 LIYKYMSSGTLYSLLQGNATELDWPTRFRIGLGAARGLAWLHH------------------------------------- 438 (611)
Q Consensus 396 lv~ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~------------------------------------- 438 (611)
+||+++++.++.+..... .. ...++.++++.+..||.
T Consensus 87 lv~~~l~G~~~~~~~~~~---~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE---QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEECCSSEEHHHHTTTC---SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEEeccccccccccccc---cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 999999998876543211 11 12233444444444442
Q ss_pred ----------------c---CCCCeeecCCCCCeEEeCCCCCeEEeeccccc
Q 035917 439 ----------------G---CQPPFLHQNICSNVILVDEDFDARIMDFGLAK 471 (611)
Q Consensus 439 ----------------~---~~~~ivHrDlkp~NILld~~~~~kl~DFGla~ 471 (611)
. ....++|+|+.|.||++++++..-|.||+.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0 01237899999999999987666799998775
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.17 E-value=1.3e-07 Score=98.31 Aligned_cols=110 Identities=25% Similarity=0.320 Sum_probs=85.1
Q ss_pred cEEEEEecCCcccccC-CccCcCCCCCCEEEccCCCCCc----cCchhHHhcCCCCCEEECcCCcCccc----CccCcc-
Q 035917 97 RILNLELREMKLSGKI-PEPLKFCKSMQRLDLSANDLSG----NIPAQICNWLPYLVLLDLSNNDLSGP----IPADLG- 166 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~-p~~l~~l~~L~~L~Ls~N~l~g----~ip~~~~~~l~~L~~L~Ls~N~l~G~----iP~~~~- 166 (611)
.++.||++.+++++.- ..-+..+++|++|+|++|.++- .|+..+.. +++|+.|||++|.++.. +...+.
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~-~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRV-NPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHT-CTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhc-CCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 5899999999998732 2335567899999999999972 35555666 89999999999998621 222332
Q ss_pred CCcCcccccccccccCCC----CChhhhcCCCcccccccccccCC
Q 035917 167 NCTYLNTLILSNNKLSGP----IPYQLSNLGRLKKFSVANNDLTG 207 (611)
Q Consensus 167 ~l~~L~~L~L~~N~l~g~----iP~~l~~l~~L~~L~l~~N~l~g 207 (611)
...+|+.|+|++|+++.. ++..+..+++|+.|+|++|.++.
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 235899999999999754 56667889999999999998864
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.10 E-value=3e-07 Score=90.22 Aligned_cols=92 Identities=21% Similarity=0.311 Sum_probs=42.1
Q ss_pred CCCCCCEEEccCC-CCCcc-CchhHHhcCCCCCEEECcCC--cCccc-CccCccCCcCccccccccc-ccCCCCChhhhc
Q 035917 118 FCKSMQRLDLSAN-DLSGN-IPAQICNWLPYLVLLDLSNN--DLSGP-IPADLGNCTYLNTLILSNN-KLSGPIPYQLSN 191 (611)
Q Consensus 118 ~l~~L~~L~Ls~N-~l~g~-ip~~~~~~l~~L~~L~Ls~N--~l~G~-iP~~~~~l~~L~~L~L~~N-~l~g~iP~~l~~ 191 (611)
.+++|++|+|+++ +++.. ++..+...+++|+.|+|++. .++.. +.....++++|+.|+|++| .+++..+..+.+
T Consensus 119 ~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~ 198 (284)
T d2astb2 119 SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQ 198 (284)
T ss_dssp HCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGG
T ss_pred HHHhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcc
Confidence 3455555555542 33321 22223332344555555432 22211 2222234556666666654 355555555666
Q ss_pred CCCcccccccc-cccCCCC
Q 035917 192 LGRLKKFSVAN-NDLTGTI 209 (611)
Q Consensus 192 l~~L~~L~l~~-N~l~g~i 209 (611)
+++|++|++++ +.++...
T Consensus 199 ~~~L~~L~L~~C~~i~~~~ 217 (284)
T d2astb2 199 LNYLQHLSLSRCYDIIPET 217 (284)
T ss_dssp CTTCCEEECTTCTTCCGGG
T ss_pred cCcCCEEECCCCCCCChHH
Confidence 66666666665 3444433
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.02 E-value=3.4e-06 Score=84.00 Aligned_cols=78 Identities=31% Similarity=0.439 Sum_probs=63.6
Q ss_pred CCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCcccCccCccCCcCcccccccccccCCCCChhhhcCCCccccc
Q 035917 120 KSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGPIPADLGNCTYLNTLILSNNKLSGPIPYQLSNLGRLKKFS 199 (611)
Q Consensus 120 ~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 199 (611)
.+|+.|||++|.|+ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++. + .++|++|+
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~----~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~ 104 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL----PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-L--PPLLEYLG 104 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC----CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-C--CTTCCEEE
T ss_pred cCCCEEEeCCCCCC-CCCCC----CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh-h--cccccccc
Confidence 47899999999998 68853 678999999999999 889765 57888899999988 4443 1 14699999
Q ss_pred ccccccCCCCCc
Q 035917 200 VANNDLTGTIPS 211 (611)
Q Consensus 200 l~~N~l~g~ip~ 211 (611)
+++|.++ .+|.
T Consensus 105 L~~n~l~-~lp~ 115 (353)
T d1jl5a_ 105 VSNNQLE-KLPE 115 (353)
T ss_dssp CCSSCCS-SCCC
T ss_pred ccccccc-cccc
Confidence 9999998 4564
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.02 E-value=3.3e-07 Score=82.02 Aligned_cols=93 Identities=23% Similarity=0.184 Sum_probs=66.3
Q ss_pred CcCCCCCCEEEccCCCCCccCchhHHhcCCCCCEEECcCCcCccc--CccCccCCcCcccccccccccCCCCChhhhcCC
Q 035917 116 LKFCKSMQRLDLSANDLSGNIPAQICNWLPYLVLLDLSNNDLSGP--IPADLGNCTYLNTLILSNNKLSGPIPYQLSNLG 193 (611)
Q Consensus 116 l~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~Ls~N~l~G~--iP~~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~ 193 (611)
+..+..+..|++++|... .++..... +++|++||||+|+++.- ++..+..+++|+.|||++|.++..-+-......
T Consensus 38 l~~~~~~~~l~~~~~~~~-~l~~~~~~-~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~ 115 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAA-TLRIIEEN-IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGL 115 (162)
T ss_dssp TTTTTCCCCTTSHHHHHH-HHHHHHHH-CTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTC
T ss_pred hhhccchhhcchhhhHhh-hhHHHHHh-CCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhcc
Confidence 444455555555554332 44444444 89999999999999853 345577899999999999999954333344556
Q ss_pred CcccccccccccCCCCC
Q 035917 194 RLKKFSVANNDLTGTIP 210 (611)
Q Consensus 194 ~L~~L~l~~N~l~g~ip 210 (611)
+|+.|++++|.++....
T Consensus 116 ~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 116 KLEELWLDGNSLSDTFR 132 (162)
T ss_dssp CCSSCCCTTSTTSSSSS
T ss_pred ccceeecCCCCcCcCcc
Confidence 79999999999987655
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.85 E-value=6.8e-07 Score=92.55 Aligned_cols=112 Identities=20% Similarity=0.238 Sum_probs=82.2
Q ss_pred cEEEEEecCCcccccCCcc----C-cCCCCCCEEEccCCCCCccCchhHHh---cCCCCCEEECcCCcCccc----CccC
Q 035917 97 RILNLELREMKLSGKIPEP----L-KFCKSMQRLDLSANDLSGNIPAQICN---WLPYLVLLDLSNNDLSGP----IPAD 164 (611)
Q Consensus 97 ~v~~l~l~~~~l~g~~p~~----l-~~l~~L~~L~Ls~N~l~g~ip~~~~~---~l~~L~~L~Ls~N~l~G~----iP~~ 164 (611)
.+..+++++|.++..-... + .....|+.+++++|.++..-...+.. ..++|+.|||++|+++.. ++..
T Consensus 284 ~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~ 363 (460)
T d1z7xw1 284 SLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQG 363 (460)
T ss_dssp TCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhh
Confidence 5778999999886432221 1 23468999999999998653333321 267899999999999753 4444
Q ss_pred cc-CCcCcccccccccccCC----CCChhhhcCCCcccccccccccCCC
Q 035917 165 LG-NCTYLNTLILSNNKLSG----PIPYQLSNLGRLKKFSVANNDLTGT 208 (611)
Q Consensus 165 ~~-~l~~L~~L~L~~N~l~g----~iP~~l~~l~~L~~L~l~~N~l~g~ 208 (611)
+. ..+.|++|+|++|.|+. .++..+..+++|++|+|++|+++..
T Consensus 364 l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~ 412 (460)
T d1z7xw1 364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412 (460)
T ss_dssp HTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred hhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHH
Confidence 44 46789999999999974 3556677889999999999998753
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.82 E-value=1.5e-06 Score=87.46 Aligned_cols=109 Identities=15% Similarity=0.188 Sum_probs=58.5
Q ss_pred cEEEEEecCCcccc----cCCccCcCCCCCCEEEccCCCCCcc-----CchhHHhcCCCCCEEECcCCcCccc----Ccc
Q 035917 97 RILNLELREMKLSG----KIPEPLKFCKSMQRLDLSANDLSGN-----IPAQICNWLPYLVLLDLSNNDLSGP----IPA 163 (611)
Q Consensus 97 ~v~~l~l~~~~l~g----~~p~~l~~l~~L~~L~Ls~N~l~g~-----ip~~~~~~l~~L~~L~Ls~N~l~G~----iP~ 163 (611)
.+..++++++.+.- .+...+..++.|+.|+|++|.++.. +...+.. +++|+.|+|++|.++.. +..
T Consensus 159 ~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~-~~~L~~L~Ls~N~i~~~g~~~L~~ 237 (344)
T d2ca6a1 159 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAY-CQELKVLDLQDNTFTHLGSSALAI 237 (344)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGG-CTTCCEEECCSSCCHHHHHHHHHH
T ss_pred ccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcc-hhhhcccccccccccccccccccc
Confidence 45566666665542 2233344556667777777666532 1122333 56667777777666422 334
Q ss_pred CccCCcCcccccccccccCCCCChh----hhc--CCCcccccccccccC
Q 035917 164 DLGNCTYLNTLILSNNKLSGPIPYQ----LSN--LGRLKKFSVANNDLT 206 (611)
Q Consensus 164 ~~~~l~~L~~L~L~~N~l~g~iP~~----l~~--l~~L~~L~l~~N~l~ 206 (611)
.+..+++|++|+|++|.+++.-... +.. ...|++|++++|+++
T Consensus 238 ~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~ 286 (344)
T d2ca6a1 238 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 286 (344)
T ss_dssp HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred cccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCC
Confidence 4556666777777777665432222 222 245666777776654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.76 E-value=3.5e-05 Score=73.23 Aligned_cols=72 Identities=17% Similarity=0.134 Sum_probs=52.0
Q ss_pred eecC-CceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCC--CCccceeeEEEeCCeeEEEEeccCCCCh
Q 035917 333 ISTR-TGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRH--PNLAPLLGYCVVEEEKLLIYKYMSSGTL 406 (611)
Q Consensus 333 g~G~-~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H--~nIv~l~g~~~~~~~~~lv~ey~~~gsL 406 (611)
..|. .+.||+...+++..+++|.-.... ...+..|+..++.+.. -.+.+++++..+++..++||+|+++.++
T Consensus 19 ~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 19 TIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp SCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred CCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3444 367899998888889999875432 2346778888777643 3356678888888888999999987655
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.69 E-value=3.1e-05 Score=75.37 Aligned_cols=125 Identities=21% Similarity=0.253 Sum_probs=84.5
Q ss_pred cEEEEEecCC-cccc-cCCccCc-CCCCCCEEEccCC--CCCccCchhHHhcCCCCCEEECcCC-cCcccCccCccCCcC
Q 035917 97 RILNLELREM-KLSG-KIPEPLK-FCKSMQRLDLSAN--DLSGNIPAQICNWLPYLVLLDLSNN-DLSGPIPADLGNCTY 170 (611)
Q Consensus 97 ~v~~l~l~~~-~l~g-~~p~~l~-~l~~L~~L~Ls~N--~l~g~ip~~~~~~l~~L~~L~Ls~N-~l~G~iP~~~~~l~~ 170 (611)
++..|+|++. +++. .+...+. .++.|+.|++++. .++..--..+...+++|+.|||++| .+++..+..++++++
T Consensus 122 ~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~ 201 (284)
T d2astb2 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNY 201 (284)
T ss_dssp TCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTT
T ss_pred hccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCc
Confidence 4677777763 3332 1222232 3478999999864 4554322233333899999999985 588888888999999
Q ss_pred cccccccc-cccCCCCChhhhcCCCcccccccccccCCCCCccCCCCCcccC
Q 035917 171 LNTLILSN-NKLSGPIPYQLSNLGRLKKFSVANNDLTGTIPSSFKGFDKADF 221 (611)
Q Consensus 171 L~~L~L~~-N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ip~~~~~~~~~~~ 221 (611)
|++|+|++ +.++......++++++|+.|+++++--.+.++.-...++.+.+
T Consensus 202 L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~l~~l~~~lp~L~i 253 (284)
T d2astb2 202 LQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI 253 (284)
T ss_dssp CCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTCHHHHHHHSTTSEE
T ss_pred CCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCCCCHHHHHHHHHhCccccc
Confidence 99999999 5788777777899999999999887333333332233444444
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.64 E-value=2.6e-06 Score=85.52 Aligned_cols=111 Identities=17% Similarity=0.231 Sum_probs=82.5
Q ss_pred cEEEEEecCCccc--c--cC---------CccCcCCCCCCEEEccCCCCCcc----CchhHHhcCCCCCEEECcCCcCcc
Q 035917 97 RILNLELREMKLS--G--KI---------PEPLKFCKSMQRLDLSANDLSGN----IPAQICNWLPYLVLLDLSNNDLSG 159 (611)
Q Consensus 97 ~v~~l~l~~~~l~--g--~~---------p~~l~~l~~L~~L~Ls~N~l~g~----ip~~~~~~l~~L~~L~Ls~N~l~G 159 (611)
.++.|+|++|.+. | .+ .......+.|+.|++++|+++-. +...+.. ++.|+.|+|++|.++.
T Consensus 122 ~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~-~~~L~~L~L~~n~i~~ 200 (344)
T d2ca6a1 122 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS-HRLLHTVKMVQNGIRP 200 (344)
T ss_dssp TCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHH-CTTCCEEECCSSCCCH
T ss_pred cchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhh-hhhhcccccccccccc
Confidence 5788999988763 1 11 11124567899999999998733 3344555 8899999999999873
Q ss_pred c-----CccCccCCcCcccccccccccCCC----CChhhhcCCCcccccccccccCCC
Q 035917 160 P-----IPADLGNCTYLNTLILSNNKLSGP----IPYQLSNLGRLKKFSVANNDLTGT 208 (611)
Q Consensus 160 ~-----iP~~~~~l~~L~~L~L~~N~l~g~----iP~~l~~l~~L~~L~l~~N~l~g~ 208 (611)
. +...+..+++|+.|+|++|.|+.. +...+..+++|++|+|++|.+++.
T Consensus 201 ~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~ 258 (344)
T d2ca6a1 201 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 258 (344)
T ss_dssp HHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred cccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCch
Confidence 2 345577889999999999998643 445677889999999999998754
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.32 E-value=3.6e-05 Score=68.59 Aligned_cols=85 Identities=16% Similarity=0.223 Sum_probs=44.6
Q ss_pred cEEEEEecCC-ccccc----CCccCcCCCCCCEEEccCCCCCcc----CchhHHhcCCCCCEEECcCCcCccc----Ccc
Q 035917 97 RILNLELREM-KLSGK----IPEPLKFCKSMQRLDLSANDLSGN----IPAQICNWLPYLVLLDLSNNDLSGP----IPA 163 (611)
Q Consensus 97 ~v~~l~l~~~-~l~g~----~p~~l~~l~~L~~L~Ls~N~l~g~----ip~~~~~~l~~L~~L~Ls~N~l~G~----iP~ 163 (611)
.++.|+|+++ .++.. +-..+...+.|+.|+|++|.+... +...+.. .+.|+.|+|++|.++.. +-.
T Consensus 16 ~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~-n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 16 DLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIET-SPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHH-CSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhh-cccccceeeehhhcchHHHHHHHH
Confidence 4666666653 33321 223455556677777777666532 1222333 56666777776666532 112
Q ss_pred CccCCcCcccccccccccC
Q 035917 164 DLGNCTYLNTLILSNNKLS 182 (611)
Q Consensus 164 ~~~~l~~L~~L~L~~N~l~ 182 (611)
.+...++|+.|+|++|.+.
T Consensus 95 aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HTTTTCCCSEEECCCCSSC
T ss_pred HHHhCCcCCEEECCCCcCC
Confidence 2444556666666666544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.16 E-value=0.002 Score=63.37 Aligned_cols=92 Identities=10% Similarity=0.029 Sum_probs=57.5
Q ss_pred cccHHHHHHhhhcCC---CCCeeeecC-CceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCCCCc-----cc
Q 035917 313 KVKLADLMAASNSFC---SENVIISTR-TGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNL-----AP 383 (611)
Q Consensus 313 ~~~~~~l~~~t~~f~---~~~~ig~G~-~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nI-----v~ 383 (611)
.++.+.+..|...+. ...++--++ --.||++..++|+.|++|+.+....+.+++..|...+..|....+ +.
T Consensus 7 ~L~pd~i~~al~~~g~~~~~~~~~L~s~EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~ 86 (325)
T d1zyla1 7 TLHPDTIMDALFEHGIRVDSGLTPLNSYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVA 86 (325)
T ss_dssp CCCHHHHHHHHHHTTCCCCSCCEEECCSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCC
T ss_pred ccCHHHHHHHHHHcCCCCCcCccccccccceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCcee
Confidence 345555555554432 122222222 347999999999999999987665567788889988887742222 11
Q ss_pred e--eeEEEeCCeeEEEEeccCCC
Q 035917 384 L--LGYCVVEEEKLLIYKYMSSG 404 (611)
Q Consensus 384 l--~g~~~~~~~~~lv~ey~~~g 404 (611)
. -......+..+.++++++|.
T Consensus 87 ~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 87 FNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp BTTBSCEEETTEEEEEEECCCCE
T ss_pred cCCCeeeeeeeEEEEEEeecCCc
Confidence 1 11233456778899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.15 E-value=0.00074 Score=68.46 Aligned_cols=74 Identities=14% Similarity=0.053 Sum_probs=47.0
Q ss_pred CeeeecCCceEEEEEeCC-CCEEEEEecccc--------chhHHHHHHHHHHHhccC-C--CCccceeeEEEeCCeeEEE
Q 035917 330 NVIISTRTGTTYKAMLPD-GSVLAVKRLNTC--------KLGEKKFRNEMNRLGQLR-H--PNLAPLLGYCVVEEEKLLI 397 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~-g~~vAvK~~~~~--------~~~~~~~~~Ev~~l~~l~-H--~nIv~l~g~~~~~~~~~lv 397 (611)
+.||.|....||+....+ ++.|+||.-... .....+...|.+.|..+. + ..+.+++. .+++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEEE
Confidence 468889999999998654 678999964321 112234566888777662 2 23444544 356667899
Q ss_pred EeccCCCC
Q 035917 398 YKYMSSGT 405 (611)
Q Consensus 398 ~ey~~~gs 405 (611)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997644
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.75 E-value=0.00024 Score=63.00 Aligned_cols=89 Identities=13% Similarity=0.155 Sum_probs=63.1
Q ss_pred cCCCCCCEEEccCC-CCCcc----CchhHHhcCCCCCEEECcCCcCcccC----ccCccCCcCcccccccccccCCCC--
Q 035917 117 KFCKSMQRLDLSAN-DLSGN----IPAQICNWLPYLVLLDLSNNDLSGPI----PADLGNCTYLNTLILSNNKLSGPI-- 185 (611)
Q Consensus 117 ~~l~~L~~L~Ls~N-~l~g~----ip~~~~~~l~~L~~L~Ls~N~l~G~i----P~~~~~l~~L~~L~L~~N~l~g~i-- 185 (611)
.+.+.|+.|+|+++ .++.. +-..+.. .+.|+.|+|++|.+...- ...+...+.|+.|+|++|.++..-
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~-n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~ 90 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACN-SKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 90 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTT-CSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhh-CCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHH
Confidence 35689999999974 56533 2223334 678999999999997332 233456789999999999987432
Q ss_pred --ChhhhcCCCcccccccccccC
Q 035917 186 --PYQLSNLGRLKKFSVANNDLT 206 (611)
Q Consensus 186 --P~~l~~l~~L~~L~l~~N~l~ 206 (611)
-..+...++|+.|++++|.+.
T Consensus 91 ~l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 91 RLLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHHHhCCcCCEEECCCCcCC
Confidence 123556688999999988655
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.37 E-value=0.00046 Score=60.88 Aligned_cols=107 Identities=18% Similarity=0.178 Sum_probs=67.1
Q ss_pred cEEEEEecC-Ccccc----cCCccCcCCCCCCEEEccCCCCCccCch----hHHhcCCCCCEEECcCCcCccc----Ccc
Q 035917 97 RILNLELRE-MKLSG----KIPEPLKFCKSMQRLDLSANDLSGNIPA----QICNWLPYLVLLDLSNNDLSGP----IPA 163 (611)
Q Consensus 97 ~v~~l~l~~-~~l~g----~~p~~l~~l~~L~~L~Ls~N~l~g~ip~----~~~~~l~~L~~L~Ls~N~l~G~----iP~ 163 (611)
.++.|+|++ +.++. .+-..+...++|+.|+|++|.++..--. .+.. .+.|+.|++++|.++.. +-.
T Consensus 18 ~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~-~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 18 DLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKV-NNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHH-CSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhh-cccchhhhhccccccchhHHHHHH
Confidence 577788876 34532 1334456778888888888888654222 2333 67888888888887633 223
Q ss_pred CccCCcCccc--ccccccccCC----CCChhhhcCCCcccccccccc
Q 035917 164 DLGNCTYLNT--LILSNNKLSG----PIPYQLSNLGRLKKFSVANND 204 (611)
Q Consensus 164 ~~~~l~~L~~--L~L~~N~l~g----~iP~~l~~l~~L~~L~l~~N~ 204 (611)
.+...++|+. |+++.|.+.. .+-..+...++|+.|+++.|.
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence 4566677775 4445666642 233445667788888776553
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.99 E-value=0.017 Score=55.87 Aligned_cols=156 Identities=10% Similarity=0.023 Sum_probs=84.8
Q ss_pred ccHHHHHHhhhcCCCCCeee-----ecCCceEEEEEeCCCCEEEEEeccccchhHHHHHHHHHHHhccCC-----CCccc
Q 035917 314 VKLADLMAASNSFCSENVII-----STRTGTTYKAMLPDGSVLAVKRLNTCKLGEKKFRNEMNRLGQLRH-----PNLAP 383 (611)
Q Consensus 314 ~~~~~l~~~t~~f~~~~~ig-----~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H-----~nIv~ 383 (611)
++.+|+.....+|..+++.. .|---+.|+.+..+|+ +++|+.... ...+++..|++++..+.. |..+.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccce
Confidence 56678888888888766554 4445678998887765 899988543 223445566777766642 22221
Q ss_pred ee---eEEEeCCeeEEEEeccCCCChHH--------------hhh----cCC----CCCC-H-H----------------
Q 035917 384 LL---GYCVVEEEKLLIYKYMSSGTLYS--------------LLQ----GNA----TELD-W-P---------------- 420 (611)
Q Consensus 384 l~---g~~~~~~~~~lv~ey~~~gsL~~--------------~l~----~~~----~~l~-~-~---------------- 420 (611)
.. .+..-......++.+..+..... .++ ... .... + .
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 11 01222445566777765533211 000 000 0000 0 0
Q ss_pred HHHHHHHHHHHHHHHHh-hcCCCCeeecCCCCCeEEeCCCCCeEEeeccccc
Q 035917 421 TRFRIGLGAARGLAWLH-HGCQPPFLHQNICSNVILVDEDFDARIMDFGLAK 471 (611)
Q Consensus 421 ~~~~i~~~ia~gL~yLH-~~~~~~ivHrDlkp~NILld~~~~~kl~DFGla~ 471 (611)
.....+..+...+.-.+ .....+++|+|+.+.||+++.+...-|.||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 01111222222222222 1235679999999999999988777899999775
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.86 E-value=0.013 Score=58.80 Aligned_cols=72 Identities=15% Similarity=0.124 Sum_probs=47.8
Q ss_pred CeeeecCCceEEEEEeCCC--------CEEEEEeccccchhHHHHHHHHHHHhccCCCCc-cceeeEEEeCCeeEEEEec
Q 035917 330 NVIISTRTGTTYKAMLPDG--------SVLAVKRLNTCKLGEKKFRNEMNRLGQLRHPNL-APLLGYCVVEEEKLLIYKY 400 (611)
Q Consensus 330 ~~ig~G~~g~Vy~~~~~~g--------~~vAvK~~~~~~~~~~~~~~Ev~~l~~l~H~nI-v~l~g~~~~~~~~~lv~ey 400 (611)
+.|+.|-.-.+|+...+++ +.|.+++... ........+|..+++.+.-.++ .++++++. + .+||||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ceEEEE
Confidence 4677788889999987543 4677776643 2233445688888888853344 46666653 2 689999
Q ss_pred cCCCCh
Q 035917 401 MSSGTL 406 (611)
Q Consensus 401 ~~~gsL 406 (611)
+++..+
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=94.57 E-value=0.0064 Score=53.13 Aligned_cols=89 Identities=13% Similarity=0.170 Sum_probs=59.5
Q ss_pred cCCCCCCEEEccC-CCCCccCch----hHHhcCCCCCEEECcCCcCcccCc----cCccCCcCcccccccccccCCC---
Q 035917 117 KFCKSMQRLDLSA-NDLSGNIPA----QICNWLPYLVLLDLSNNDLSGPIP----ADLGNCTYLNTLILSNNKLSGP--- 184 (611)
Q Consensus 117 ~~l~~L~~L~Ls~-N~l~g~ip~----~~~~~l~~L~~L~Ls~N~l~G~iP----~~~~~l~~L~~L~L~~N~l~g~--- 184 (611)
.+.+.|+.|+|++ |.++...=. .+.. .+.|+.|+|++|.++..-- ..+...++|+.|++++|.++..
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~-n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~ 92 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKT-NTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 92 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTT-CCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhc-CCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence 4568999999997 567533222 2223 7889999999999874422 2345678899999999988633
Q ss_pred -CChhhhcCCCcccc--cccccccC
Q 035917 185 -IPYQLSNLGRLKKF--SVANNDLT 206 (611)
Q Consensus 185 -iP~~l~~l~~L~~L--~l~~N~l~ 206 (611)
+-..+...++|+.+ ++++|.+.
T Consensus 93 ~l~~~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 93 ALVEALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred HHHHHHHhCccccEEeeccCCCcCc
Confidence 22345667788764 44556553
|